sample_id,Unnamed: 0,bcr_patient_barcode,type,age_at_initial_pathologic_diagnosis,gender,race,ajcc_pathologic_tumor_stage,clinical_stage,histological_type,histological_grade,initial_pathologic_dx_year,menopause_status,birth_days_to,vital_status,tumor_status,last_contact_days_to,death_days_to,cause_of_death,new_tumor_event_type,new_tumor_event_site,new_tumor_event_site_other,new_tumor_event_dx_days_to,treatment_outcome_first_course,margin_status,residual_tumor,OS,OS.time,DSS,DSS.time,DFI,DFI.time,PFI,PFI.time,Redaction
TCGA-EA-A3HQ,1694,TCGA-EA-A3HQ,CESC,60.0,FEMALE,WHITE,[Not Available],Stage II,Cervical Squamous Cell Carcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21966.0,Alive,TUMOR FREE,1136.0,,,,,,,Complete Remission/Response,,,0.0,1136.0,0.0,1136.0,0.0,1136.0,0.0,1136.0,
TCGA-VS-A9V1,1884,TCGA-VS-A9V1,CESC,46.0,FEMALE,WHITE,[Not Available],Stage IVB,Mucinous Adenocarcinoma of Endocervical Type,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17001.0,Dead,WITH TUMOR,,157.0,Cervical Cancer,Distant Metastasis,,Retroperitoneo,58.0,Progressive Disease,,,1.0,157.0,1.0,157.0,,,1.0,58.0,
TCGA-QU-A6IM,8228,TCGA-QU-A6IM,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2003.0,[Not Available],-21792.0,Alive,TUMOR FREE,1247.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1247.0,0.0,1247.0,0.0,1247.0,0.0,1247.0,
TCGA-EL-A3ZQ,10101,TCGA-EL-A3ZQ,THCA,78.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-28783.0,Alive,TUMOR FREE,1862.0,,[Not Available],,,,,[Not Available],,R0,0.0,1862.0,0.0,1862.0,0.0,1862.0,0.0,1862.0,
TCGA-FD-A3SM,268,TCGA-FD-A3SM,BLCA,70.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-25852.0,Dead,WITH TUMOR,,547.0,[Not Available],Distant Metastasis,Lymph Node Only,,144.0,[Unknown],,,1.0,547.0,1.0,547.0,,,1.0,144.0,
TCGA-CV-7238,3535,TCGA-CV-7238,HNSC,69.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-25471.0,Alive,TUMOR FREE,2727.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2727.0,0.0,2727.0,0.0,2727.0,0.0,2727.0,
TCGA-VP-A879,8281,TCGA-VP-A879,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-25799.0,Dead,TUMOR FREE,,728.0,[Unknown],,,,,Complete Remission/Response,,,1.0,728.0,0.0,728.0,0.0,728.0,0.0,728.0,
TCGA-BR-4256,9284,TCGA-BR-4256,STAD,80.0,MALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],-29441.0,Dead,,,284.0,[Not Available],,,,,[Not Available],,,1.0,284.0,,284.0,,,0.0,284.0,
TCGA-CF-A7I0,165,TCGA-CF-A7I0,BLCA,54.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,[Not Available],-20059.0,Alive,TUMOR FREE,368.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,368.0,0.0,368.0,0.0,368.0,0.0,368.0,
TCGA-D3-A51E,8867,TCGA-D3-A51E,SKCM,39.0,FEMALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],1999.0,[Not Available],-14305.0,Alive,TUMOR FREE,5318.0,,[Not Available],,,,,[Not Available],,,0.0,5318.0,0.0,5318.0,,,0.0,5318.0,
TCGA-V1-A9O5,8249,TCGA-V1-A9O5,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-23725.0,Alive,,1932.0,,[Not Available],Biochemical evidence of disease,,,124.0,Complete Remission/Response,,,0.0,1932.0,0.0,1932.0,1.0,124.0,1.0,124.0,
TCGA-V4-A9F8,11116,TCGA-V4-A9F8,UVM,68.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,[Not Available],2012.0,[Not Available],-25168.0,Alive,TUMOR FREE,597.0,,[Not Available],,,,,[Not Available],,,0.0,597.0,0.0,597.0,,,0.0,597.0,
TCGA-CN-6998,3356,TCGA-CN-6998,HNSC,53.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-19447.0,Dead,WITH TUMOR,,357.0,[Not Available],,Oropharynx,tonsil,244.0,Progressive Disease,,,1.0,357.0,1.0,357.0,,,1.0,244.0,
TCGA-DK-A2HX,191,TCGA-DK-A2HX,BLCA,80.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-29332.0,Dead,TUMOR FREE,,1420.0,[Not Available],,,,,[Not Available],,,1.0,1420.0,0.0,1420.0,,,0.0,1420.0,
TCGA-EY-A72D,10981,TCGA-EY-A72D,UCEC,87.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31818.0,Alive,TUMOR FREE,179.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,179.0,0.0,179.0,0.0,179.0,0.0,179.0,
TCGA-IB-AAUV,7655,TCGA-IB-AAUV,PAAD,49.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-18059.0,Alive,TUMOR FREE,404.0,,,,,,,Complete Remission/Response,,,0.0,404.0,0.0,404.0,0.0,404.0,0.0,404.0,
TCGA-C5-A8YT,1665,TCGA-C5-A8YT,CESC,36.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2008.0,[Not Available],-13253.0,Dead,WITH TUMOR,,633.0,,,,,,[Not Available],,,1.0,633.0,1.0,633.0,,,1.0,633.0,
TCGA-DJ-A1QO,9938,TCGA-DJ-A1QO,THCA,69.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-25232.0,Alive,TUMOR FREE,1442.0,,[Not Available],New Primary Tumor,"Other, specify",Cecum,1062.0,[Not Available],,R0,0.0,1442.0,0.0,1442.0,0.0,1442.0,1.0,1062.0,
TCGA-NA-A4QV,11062,TCGA-NA-A4QV,UCS,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26379.0,Alive,TUMOR FREE,4269.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4269.0,0.0,4269.0,0.0,4269.0,0.0,4269.0,
TCGA-A2-A1FZ,599,TCGA-A2-A1FZ,BRCA,63.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23055.0,Alive,TUMOR FREE,683.0,,[Not Available],,,,,[Not Available],Negative,,0.0,683.0,0.0,683.0,0.0,683.0,0.0,683.0,
TCGA-DX-AB2Z,8666,TCGA-DX-AB2Z,SARC,87.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2010.0,[Not Available],-31780.0,Alive,TUMOR FREE,1533.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1533.0,0.0,1533.0,0.0,1533.0,0.0,1533.0,
TCGA-ZB-A96K,10462,TCGA-ZB-A96K,THYM,69.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2011.0,[Not Available],-25498.0,Alive,TUMOR FREE,1388.0,,[Not Available],,,,,[Not Available],,,0.0,1388.0,0.0,1388.0,,,0.0,1388.0,
TCGA-N5-A59E,11036,TCGA-N5-A59E,UCS,62.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22650.0,Dead,WITH TUMOR,,447.0,[Not Available],Locoregional Recurrence,Abdomen,,354.0,Complete Remission/Response,,,1.0,447.0,1.0,447.0,,,1.0,354.0,
TCGA-D1-A16F,10842,TCGA-D1-A16F,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22242.0,Alive,TUMOR FREE,80.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,80.0,0.0,80.0,0.0,80.0,0.0,80.0,
TCGA-CV-A6K0,3602,TCGA-CV-A6K0,HNSC,58.0,MALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-21488.0,Alive,TUMOR FREE,606.0,,[Not Available],,Cervical Lymph Nodes,neck,146.0,Complete Remission/Response,,,0.0,606.0,0.0,606.0,1.0,146.0,1.0,146.0,
TCGA-2G-AAGE,9738,TCGA-2G-AAGE,TGCT,21.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma,[Not Available],2007.0,[Not Available],-7753.0,Alive,TUMOR FREE,2478.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,121.0,Complete Remission/Response,,,0.0,2478.0,0.0,2478.0,1.0,121.0,1.0,121.0,
TCGA-LN-A49M,2560,TCGA-LN-A49M,ESCA,62.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G1,2010.0,[Not Available],-22933.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-AX-A1CK,10641,TCGA-AX-A1CK,UCEC,58.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21200.0,Alive,WITH TUMOR,2441.0,,[Not Available],,,,,[Not Available],,,0.0,2441.0,0.0,2441.0,,,0.0,2441.0,
TCGA-KO-8417,3850,TCGA-KO-8417,KICH,30.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-11139.0,Alive,TUMOR FREE,2815.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2815.0,0.0,2815.0,0.0,2815.0,0.0,2815.0,
TCGA-56-8629,6538,TCGA-56-8629,LUSC,63.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-23346.0,Alive,TUMOR FREE,481.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,
TCGA-FG-A87N,5137,TCGA-FG-A87N,LGG,37.0,FEMALE,ASIAN,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-13606.0,Alive,WITH TUMOR,567.0,,[Not Available],,,,,Stable Disease,,,0.0,567.0,0.0,567.0,,,0.0,567.0,
TCGA-BJ-A3PR,9881,TCGA-BJ-A3PR,THCA,69.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-25565.0,Alive,TUMOR FREE,1107.0,,[Not Available],,,,,[Not Available],,R0,0.0,1107.0,0.0,1107.0,0.0,1107.0,0.0,1107.0,
TCGA-BR-8077,9339,TCGA-BR-8077,STAD,58.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-21413.0,Alive,TUMOR FREE,21.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,21.0,0.0,21.0,0.0,21.0,0.0,21.0,
TCGA-91-6830,6214,TCGA-91-6830,LUAD,65.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-23922.0,Alive,WITH TUMOR,60.0,,[Not Available],Distant Metastasis,,,18.0,[Unknown],,,0.0,60.0,0.0,60.0,,,1.0,18.0,
TCGA-DD-AADM,5623,TCGA-DD-AADM,LIHC,58.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-21349.0,Dead,TUMOR FREE,,12.0,[Not Available],,,,,[Not Available],,R0,1.0,12.0,0.0,12.0,0.0,12.0,0.0,12.0,
TCGA-05-4432,5829,TCGA-05-4432,LUAD,66.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-24350.0,Alive,TUMOR FREE,761.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,761.0,0.0,761.0,0.0,761.0,0.0,761.0,
TCGA-CG-4443,9455,TCGA-CG-4443,STAD,68.0,MALE,[Not Available],Stage IA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2006.0,[Not Available],-24990.0,Alive,,912.0,,[Not Available],,,,,[Not Available],,,0.0,912.0,0.0,912.0,,,0.0,912.0,
TCGA-YG-AA3O,9263,TCGA-YG-AA3O,SKCM,62.0,MALE,[Unknown],[Not Available],[Not Applicable],,[Not Available],2011.0,[Not Available],-22999.0,Dead,WITH TUMOR,,1154.0,[Not Available],Regional lymph node,,,999.0,[Not Available],,,1.0,1154.0,1.0,1154.0,,,1.0,999.0,
TCGA-66-2780,6632,TCGA-66-2780,LUSC,65.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-23955.0,Dead,,,366.0,[Not Available],,,,,[Not Available],,,1.0,366.0,,366.0,,,0.0,366.0,
TCGA-BA-6873,3262,TCGA-BA-6873,HNSC,28.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-10512.0,Alive,WITH TUMOR,122.0,,[Not Available],,Oral Cavity,L Tongue and bilat. neck LNs,66.0,Progressive Disease,,,0.0,122.0,0.0,122.0,,,1.0,66.0,
TCGA-FP-7916,9539,TCGA-FP-7916,STAD,77.0,MALE,ASIAN,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-28475.0,Dead,WITH TUMOR,,428.0,[Not Available],,,,,Progressive Disease,,,1.0,428.0,1.0,428.0,,,1.0,428.0,
TCGA-BJ-A0ZJ,9859,TCGA-BJ-A0ZJ,THCA,36.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-13149.0,Alive,TUMOR FREE,1280.0,,[Not Available],,,,,[Not Available],,R0,0.0,1280.0,0.0,1280.0,0.0,1280.0,0.0,1280.0,
TCGA-18-3410,6329,TCGA-18-3410,LUSC,81.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-29827.0,Dead,TUMOR FREE,,146.0,[Not Available],,,,,[Not Applicable],,,1.0,146.0,0.0,146.0,,,0.0,146.0,
TCGA-AC-A5EI,787,TCGA-AC-A5EI,BRCA,88.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Other, specify",[Not Available],2012.0,[Not Available],-32375.0,Alive,TUMOR FREE,442.0,,[Not Available],,,,,[Not Available],Negative,,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,
TCGA-37-A5EM,6450,TCGA-37-A5EM,LUSC,49.0,MALE,WHITE,Stage II,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-18011.0,Alive,TUMOR FREE,867.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,867.0,0.0,867.0,0.0,867.0,0.0,867.0,
TCGA-ZB-A964,10449,TCGA-ZB-A964,THYM,70.0,MALE,WHITE,[Not Applicable],IVb,Thymoma; Type A,[Not Available],2011.0,[Not Available],-25861.0,Alive,TUMOR FREE,1287.0,,[Not Available],,,,,[Not Available],,,0.0,1287.0,0.0,1287.0,,,0.0,1287.0,
TCGA-CN-4737,3315,TCGA-CN-4737,HNSC,19.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-7301.0,Alive,TUMOR FREE,625.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,625.0,0.0,625.0,,,0.0,625.0,
TCGA-DX-A3U6,8584,TCGA-DX-A3U6,SARC,63.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2011.0,[Not Available],-23193.0,Dead,WITH TUMOR,,1088.0,[Not Available],Locoregional Recurrence,,,160.0,[Not Available],Negative,R0,1.0,1088.0,1.0,1088.0,1.0,160.0,1.0,160.0,
TCGA-DD-AAE8,5641,TCGA-DD-AAE8,LIHC,45.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-16549.0,Alive,TUMOR FREE,664.0,,[Not Available],Locoregional Recurrence,Liver,,28.0,[Not Available],,R0,0.0,664.0,0.0,664.0,1.0,28.0,1.0,28.0,
TCGA-85-A4CN,6739,TCGA-85-A4CN,LUSC,56.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-20490.0,Alive,TUMOR FREE,1038.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1038.0,0.0,1038.0,0.0,1038.0,0.0,1038.0,
TCGA-60-2722,6580,TCGA-60-2722,LUSC,66.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-24267.0,Alive,TUMOR FREE,908.0,,[Not Available],,,,851.0,Complete Remission/Response,,,0.0,908.0,0.0,908.0,1.0,851.0,1.0,851.0,
TCGA-FD-A3B5,259,TCGA-FD-A3B5,BLCA,86.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-31442.0,Dead,WITH TUMOR,,272.0,[Not Available],,,,,Progressive Disease,,,1.0,272.0,1.0,272.0,,,1.0,272.0,
TCGA-D9-A149,8900,TCGA-D9-A149,SKCM,65.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2007.0,[Not Available],-23779.0,Alive,TUMOR FREE,1663.0,,[Not Available],New primary melanoma,"Other, Specify",,1290.0,[Not Available],,,0.0,1663.0,0.0,1663.0,,,1.0,1290.0,
TCGA-AX-A3G4,10668,TCGA-AX-A3G4,UCEC,60.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22099.0,Alive,,9.0,,[Not Available],,,,,[Not Available],,,0.0,9.0,0.0,9.0,,,0.0,9.0,
TCGA-DX-AB30,8667,TCGA-DX-AB30,SARC,53.0,FEMALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2004.0,[Not Available],-19698.0,Dead,WITH TUMOR,,695.0,[Not Available],Distant Metastasis,Lung,,504.0,[Not Available],Negative,R0,1.0,695.0,1.0,695.0,1.0,504.0,1.0,504.0,
TCGA-G9-6366,8033,TCGA-G9-6366,PRAD,61.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-22428.0,Alive,,1947.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1947.0,0.0,1947.0,0.0,1947.0,0.0,1947.0,
TCGA-A4-A57E,4487,TCGA-A4-A57E,KIRP,59.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-21885.0,Dead,WITH TUMOR,,258.0,[Not Available],,,,,Progressive Disease,,,1.0,258.0,1.0,258.0,,,1.0,258.0,
TCGA-KN-8428,3827,TCGA-KN-8428,KICH,71.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-26252.0,Dead,WITH TUMOR,,1590.0,[Not Available],,,,478.0,Stable Disease,,,1.0,1590.0,1.0,1590.0,,,1.0,478.0,
TCGA-BH-A201,1156,TCGA-BH-A201,BRCA,64.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23423.0,Alive,TUMOR FREE,856.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,856.0,0.0,856.0,,,0.0,856.0,
TCGA-C5-A7CJ,1646,TCGA-C5-A7CJ,CESC,42.0,FEMALE,WHITE,[Not Available],Stage IIA,Cervical Squamous Cell Carcinoma,G2,2002.0,[Not Available],-15652.0,Dead,TUMOR FREE,,3097.0,,,,,,[Not Available],,,1.0,3097.0,0.0,3097.0,,,0.0,3097.0,
TCGA-LP-A4AW,1799,TCGA-LP-A4AW,CESC,52.0,FEMALE,ASIAN,[Not Available],Stage IA,Cervical Squamous Cell Carcinoma,G1,2011.0,Peri (6-12 months since last menstrual period),-19079.0,Alive,TUMOR FREE,27.0,,,,,,,[Not Available],,,0.0,27.0,0.0,27.0,,,0.0,27.0,
TCGA-HC-7819,8091,TCGA-HC-7819,PRAD,53.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19663.0,Alive,TUMOR FREE,543.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,543.0,0.0,543.0,0.0,543.0,0.0,543.0,
TCGA-ED-A8O5,5677,TCGA-ED-A8O5,LIHC,59.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-21648.0,Alive,TUMOR FREE,406.0,,[Not Available],,,,,[Not Available],,R0,0.0,406.0,0.0,406.0,0.0,406.0,0.0,406.0,
TCGA-VQ-A8PK,9662,TCGA-VQ-A8PK,STAD,58.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-21419.0,Dead,WITH TUMOR,,543.0,Stomach Cancer,Locoregional Recurrence|Distant Metastasis,Liver,,263.0,Progressive Disease,,,1.0,543.0,1.0,543.0,,,1.0,263.0,
TCGA-CG-4476,9467,TCGA-CG-4476,STAD,69.0,MALE,[Not Available],Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-25506.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-A2-A04N,527,TCGA-A2-A04N,BRCA,66.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24155.0,Alive,TUMOR FREE,4354.0,,[Not Available],,,,,[Not Available],Negative,,0.0,4354.0,0.0,4354.0,0.0,4354.0,0.0,4354.0,
TCGA-56-1622,6507,TCGA-56-1622,LUSC,58.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-21371.0,Dead,WITH TUMOR,,881.0,[Not Available],,,,,Complete Remission/Response,,,1.0,881.0,1.0,881.0,,,1.0,881.0,
TCGA-E9-A22G,1432,TCGA-E9-A22G,BRCA,47.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17300.0,Alive,TUMOR FREE,1239.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1239.0,0.0,1239.0,0.0,1239.0,0.0,1239.0,
TCGA-39-5021,6455,TCGA-39-5021,LUSC,70.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-25895.0,Dead,WITH TUMOR,2057.0,2086.0,[Not Available],,,,1875.0,Complete Remission/Response,,,1.0,2086.0,1.0,2086.0,1.0,1875.0,1.0,1875.0,
TCGA-MP-A4TK,6312,TCGA-MP-A4TK,LUAD,56.0,FEMALE,[Unknown],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-20581.0,Dead,WITH TUMOR,,582.0,[Not Available],Distant Metastasis,,,397.0,Complete Remission/Response,,,1.0,582.0,1.0,582.0,1.0,397.0,1.0,397.0,
TCGA-CJ-4636,4269,TCGA-CJ-4636,KIRC,51.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-18878.0,Alive,TUMOR FREE,1924.0,,[Not Available],,,,,[Not Available],,,0.0,1924.0,0.0,1924.0,,,0.0,1924.0,
TCGA-EP-A2KB,5683,TCGA-EP-A2KB,LIHC,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-16835.0,Dead,WITH TUMOR,,596.0,[Not Available],Intrahepatic Recurrence,Liver,,161.0,[Not Available],,R0,1.0,596.0,1.0,596.0,1.0,161.0,1.0,161.0,
TCGA-94-7033,6766,TCGA-94-7033,LUSC,73.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26948.0,Alive,TUMOR FREE,640.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,640.0,0.0,640.0,0.0,640.0,0.0,640.0,
TCGA-XU-A931,10430,TCGA-XU-A931,THYM,61.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type B3,[Not Available],2007.0,[Not Available],-22432.0,Dead,TUMOR FREE,,1609.0,[Not Available],New Primary Tumor,Lung,,1377.0,[Not Available],,,1.0,1609.0,0.0,1609.0,,,1.0,1377.0,
TCGA-2A-A8VL,7867,TCGA-2A-A8VL,PRAD,51.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-18658.0,Alive,TUMOR FREE,621.0,,[Not Available],,,,,[Not Available],,,0.0,621.0,0.0,621.0,,,0.0,621.0,
TCGA-AT-A5NU,4503,TCGA-AT-A5NU,KIRP,77.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-28137.0,Alive,,67.0,,[Not Available],,,,,[Unknown],,,0.0,67.0,0.0,67.0,,,0.0,67.0,
TCGA-G9-6339,8019,TCGA-G9-6339,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-21305.0,Alive,TUMOR FREE,2551.0,,[Not Available],Biochemical evidence of disease,,,1634.0,Complete Remission/Response,,,0.0,2551.0,0.0,2551.0,1.0,1634.0,1.0,1634.0,
TCGA-CD-A4MI,9442,TCGA-CD-A4MI,STAD,62.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2011.0,[Not Available],-22721.0,Dead,WITH TUMOR,,358.0,[Not Available],Locoregional Recurrence,,,271.0,Complete Remission/Response,,,1.0,358.0,1.0,358.0,1.0,271.0,1.0,271.0,
TCGA-HW-7487,5245,TCGA-HW-7487,LGG,39.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-14535.0,Alive,WITH TUMOR,1382.0,,[Not Available],,,,840.0,Progressive Disease,,,0.0,1382.0,0.0,1382.0,,,1.0,840.0,
TCGA-DQ-5629,3632,TCGA-DQ-5629,HNSC,64.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-23550.0,Dead,TUMOR FREE,,941.0,[Not Available],,,,,Complete Remission/Response,,,1.0,941.0,0.0,941.0,,,0.0,941.0,
TCGA-CN-4738,3316,TCGA-CN-4738,HNSC,53.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-19621.0,Dead,,,436.0,[Not Available],,,,,[Not Available],,,1.0,436.0,,436.0,,,0.0,436.0,
TCGA-E2-A1LL,1381,TCGA-E2-A1LL,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27028.0,Alive,WITH TUMOR,1309.0,,[Not Available],Distant Metastasis,Liver,,1303.0,[Not Available],Negative,,0.0,1309.0,0.0,1309.0,1.0,1303.0,1.0,1303.0,
TCGA-14-1456,3026,TCGA-14-1456,GBM,23.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-8710.0,Alive,WITH TUMOR,1246.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],98.0,[Not Available],,,0.0,1246.0,0.0,1246.0,,,1.0,98.0,
TCGA-EA-A3QD,1699,TCGA-EA-A3QD,CESC,59.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21655.0,Alive,TUMOR FREE,397.0,,,,,,,Complete Remission/Response,,,0.0,397.0,0.0,397.0,0.0,397.0,0.0,397.0,
TCGA-DQ-7596,3643,TCGA-DQ-7596,HNSC,48.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G4,2011.0,[Not Available],-17846.0,Alive,TUMOR FREE,1265.0,,[Not Available],,Cervical Lymph Nodes,,137.0,Persistent Disease,,,0.0,1265.0,0.0,1265.0,,,1.0,137.0,
TCGA-BH-A204,1159,TCGA-BH-A204,BRCA,80.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29529.0,Dead,,,2534.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,2534.0,,2534.0,,,0.0,2534.0,
TCGA-C8-A9FZ,1224,TCGA-C8-A9FZ,BRCA,49.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Mixed Histology (please specify),[Not Available],2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18038.0,Alive,TUMOR FREE,592.0,,[Not Available],,,,,[Not Available],Negative,,0.0,592.0,0.0,592.0,0.0,592.0,0.0,592.0,
TCGA-CG-5721,9474,TCGA-CG-5721,STAD,58.0,MALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,[Not Available],-21244.0,Alive,TUMOR FREE,183.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,183.0,0.0,183.0,,,0.0,183.0,
TCGA-V4-A9EC,11089,TCGA-V4-A9EC,UVM,75.0,FEMALE,WHITE,Stage IIB,Stage IIB,Spindle Cell,[Not Available],2012.0,[Not Available],-27655.0,Alive,TUMOR FREE,743.0,,[Not Available],,,,,[Not Available],,,0.0,743.0,0.0,743.0,,,0.0,743.0,
TCGA-AC-A6NO,796,TCGA-AC-A6NO,BRCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,[Unknown],-15996.0,Alive,TUMOR FREE,51.0,,[Not Available],,,,,[Not Available],Negative,,0.0,51.0,0.0,51.0,0.0,51.0,0.0,51.0,
TCGA-AO-A129,874,TCGA-AO-A129,BRCA,29.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10898.0,Alive,TUMOR FREE,3286.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3286.0,0.0,3286.0,0.0,3286.0,0.0,3286.0,
TCGA-43-6773,6480,TCGA-43-6773,LUSC,76.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-28036.0,Dead,TUMOR FREE,,116.0,[Not Available],,,,,[Not Available],,,1.0,116.0,0.0,116.0,,,0.0,116.0,
TCGA-CG-5730,9482,TCGA-CG-5730,STAD,80.0,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2005.0,[Not Available],-29432.0,Alive,TUMOR FREE,122.0,,[Not Available],,,,,[Not Available],,,0.0,122.0,0.0,122.0,,,0.0,122.0,
TCGA-FS-A1ZG,9156,TCGA-FS-A1ZG,SKCM,60.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2007.0,[Not Available],-22252.0,Dead,WITH TUMOR,,295.0,[Not Available],,,,140.0,[Not Available],,,1.0,295.0,1.0,295.0,,,1.0,140.0,
TCGA-DD-AACB,5581,TCGA-DD-AACB,LIHC,74.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2008.0,[Not Available],-27103.0,Alive,TUMOR FREE,2324.0,,[Not Available],,,,,[Not Available],,R0,0.0,2324.0,0.0,2324.0,0.0,2324.0,0.0,2324.0,
TCGA-E7-A7DU,248,TCGA-E7-A7DU,BLCA,73.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,[Not Available],-27000.0,Alive,TUMOR FREE,28.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,28.0,0.0,28.0,0.0,28.0,0.0,28.0,
TCGA-4A-A93X,4445,TCGA-4A-A93X,KIRP,58.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-21348.0,Alive,WITH TUMOR,390.0,,[Not Available],,,,,Stable Disease,,,0.0,390.0,0.0,390.0,,,0.0,390.0,
TCGA-DD-AACG,5586,TCGA-DD-AACG,LIHC,52.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G4,2008.0,[Not Available],-19174.0,Dead,WITH TUMOR,,469.0,[Not Available],Intrahepatic Recurrence,Liver,,125.0,[Not Available],,R0,1.0,469.0,1.0,469.0,1.0,125.0,1.0,125.0,
TCGA-29-2432,7350,TCGA-29-2432,OV,61.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-22605.0,Dead,WITH TUMOR,360.0,653.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],174.0,Progressive Disease,,,1.0,653.0,1.0,653.0,,,1.0,174.0,
TCGA-J8-A3NZ,10319,TCGA-J8-A3NZ,THCA,52.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19058.0,Alive,TUMOR FREE,524.0,,[Not Available],,,,,[Not Available],,R0,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,
TCGA-D3-A8GE,8886,TCGA-D3-A8GE,SKCM,26.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2012.0,[Not Available],-9517.0,Alive,WITH TUMOR,804.0,,[Not Available],Distant Metastasis,Lung,,59.0,[Not Available],,,0.0,804.0,0.0,804.0,,,1.0,59.0,
TCGA-DJ-A4V4,10009,TCGA-DJ-A4V4,THCA,48.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2012.0,[Not Available],-17878.0,Alive,TUMOR FREE,481.0,,[Not Available],,,,,[Not Available],,R0,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,
TCGA-05-4418,5821,TCGA-05-4418,LUAD,69.0,MALE,[Not Available],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-25417.0,Dead,,,274.0,[Not Available],,,,,[Not Available],,,1.0,274.0,,274.0,,,0.0,274.0,
TCGA-BS-A0TD,10793,TCGA-BS-A0TD,UCEC,65.0,FEMALE,ASIAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23950.0,Alive,TUMOR FREE,2379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2379.0,0.0,2379.0,0.0,2379.0,0.0,2379.0,
TCGA-39-5019,6454,TCGA-39-5019,LUSC,70.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-25756.0,Alive,TUMOR FREE,3387.0,,[Not Available],,,,378.0,Complete Remission/Response,,,0.0,3387.0,0.0,3387.0,1.0,378.0,1.0,378.0,
TCGA-CJ-6027,4332,TCGA-CJ-6027,KIRC,77.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2003.0,[Not Available],-28359.0,Dead,TUMOR FREE,,3615.0,[Not Available],,,,,Complete Remission/Response,,,1.0,3615.0,0.0,3615.0,0.0,3615.0,0.0,3615.0,
TCGA-CQ-A4CE,3412,TCGA-CQ-A4CE,HNSC,76.0,FEMALE,[Not Evaluated],Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-27793.0,Alive,TUMOR FREE,897.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,897.0,0.0,897.0,0.0,897.0,0.0,897.0,
TCGA-MP-A4TF,6308,TCGA-MP-A4TF,LUAD,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-21387.0,Dead,WITH TUMOR,,336.0,[Not Available],Distant Metastasis,,,195.0,Partial Remission/Response,,,1.0,336.0,1.0,336.0,,,1.0,195.0,
TCGA-50-6593,5954,TCGA-50-6593,LUAD,49.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-18152.0,Dead,WITH TUMOR,,336.0,[Not Available],Distant Metastasis,,,266.0,Progressive Disease,,,1.0,336.0,1.0,336.0,,,1.0,266.0,
TCGA-HT-7879,5196,TCGA-HT-7879,LGG,31.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-11622.0,Alive,TUMOR FREE,112.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,112.0,0.0,112.0,0.0,112.0,0.0,112.0,
TCGA-CR-7388,3456,TCGA-CR-7388,HNSC,70.0,FEMALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-25728.0,Dead,WITH TUMOR,,823.0,[Not Available],,Cervical Lymph Nodes,Right neck,334.0,Complete Remission/Response,,,1.0,823.0,1.0,823.0,,,1.0,334.0,
TCGA-50-5930,5940,TCGA-50-5930,LUAD,47.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-17238.0,Dead,WITH TUMOR,,282.0,[Not Available],Distant Metastasis,,,177.0,Progressive Disease,,,1.0,282.0,1.0,282.0,,,1.0,177.0,
TCGA-E2-A1L7,1371,TCGA-E2-A1L7,BRCA,40.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14854.0,Alive,TUMOR FREE,1836.0,,[Not Available],New Primary Tumor,"Other, specify",left breast,1619.0,[Not Available],Negative,,0.0,1836.0,0.0,1836.0,1.0,1619.0,1.0,1619.0,
TCGA-85-8072,6720,TCGA-85-8072,LUSC,60.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-22069.0,Alive,TUMOR FREE,932.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,932.0,0.0,932.0,0.0,932.0,0.0,932.0,
TCGA-AJ-A23O,10527,TCGA-AJ-A23O,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25433.0,Dead,TUMOR FREE,,312.0,[Not Available],,,,,[Not Available],,,1.0,312.0,0.0,312.0,,,0.0,312.0,
TCGA-B8-5165,4107,TCGA-B8-5165,KIRC,43.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-15898.0,Alive,TUMOR FREE,737.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,737.0,0.0,737.0,0.0,737.0,0.0,737.0,
TCGA-VQ-A91D,9674,TCGA-VQ-A91D,STAD,70.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,[Not Available],-25686.0,Dead,WITH TUMOR,,356.0,Stomach Cancer,Locoregional Recurrence,,,351.0,Progressive Disease,,,1.0,356.0,1.0,356.0,,,1.0,351.0,
TCGA-SH-A7BH,6875,TCGA-SH-A7BH,MESO,65.0,FEMALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2012.0,[Not Available],-23850.0,Dead,WITH TUMOR,,243.0,[Not Available],Locoregional Recurrence,"Other, specify",Ipsilateral Chest Cavity AND Ipsilateral Chest Wall,125.0,[Not Available],,R2,1.0,243.0,1.0,243.0,,,1.0,125.0,
TCGA-GC-A3WC,332,TCGA-GC-A3WC,BLCA,80.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-29295.0,Alive,TUMOR FREE,540.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,540.0,0.0,540.0,0.0,540.0,0.0,540.0,
TCGA-H2-A26U,10305,TCGA-H2-A26U,THCA,54.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19927.0,Alive,TUMOR FREE,517.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,517.0,0.0,517.0,,,0.0,517.0,
TCGA-EA-A5O9,1711,TCGA-EA-A5O9,CESC,39.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14472.0,Alive,TUMOR FREE,788.0,,,,,,,Complete Remission/Response,,,0.0,788.0,0.0,788.0,0.0,788.0,0.0,788.0,
TCGA-X7-A8DB,10388,TCGA-X7-A8DB,THYM,71.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type B2,[Not Available],2009.0,[Not Available],-26035.0,Alive,TUMOR FREE,1992.0,,[Not Available],,,,,[Not Available],,,0.0,1992.0,0.0,1992.0,,,0.0,1992.0,
TCGA-KS-A41L,10334,TCGA-KS-A41L,THCA,39.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2004.0,[Not Available],-14440.0,Alive,TUMOR FREE,3463.0,,[Not Available],,,,,[Not Available],,R0,0.0,3463.0,0.0,3463.0,0.0,3463.0,0.0,3463.0,
TCGA-J4-A67N,8135,TCGA-J4-A67N,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22420.0,Alive,WITH TUMOR,937.0,,[Not Available],Biochemical evidence of disease,,,442.0,Partial Remission/Response,,,0.0,937.0,0.0,937.0,,,1.0,442.0,
TCGA-DU-A7TC,5061,TCGA-DU-A7TC,LGG,32.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-11884.0,Alive,WITH TUMOR,1137.0,,[Not Available],,,,1114.0,[Discrepancy],,,0.0,1137.0,0.0,1137.0,,,1.0,1114.0,
TCGA-5P-A9JU,4447,TCGA-5P-A9JU,KIRP,81.0,MALE,WHITE,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-29594.0,Alive,TUMOR FREE,373.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,373.0,0.0,373.0,0.0,373.0,0.0,373.0,
TCGA-V4-A9E8,11086,TCGA-V4-A9E8,UVM,49.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,[Not Available],2011.0,[Not Available],-18073.0,Dead,WITH TUMOR,,808.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,,557.0,[Not Available],,,1.0,808.0,1.0,808.0,,,1.0,557.0,
TCGA-BR-6705,9312,TCGA-BR-6705,STAD,68.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-25073.0,Dead,WITH TUMOR,,779.0,[Not Available],,,,,Complete Remission/Response,,,1.0,779.0,1.0,779.0,,,1.0,779.0,
TCGA-D6-6827,3617,TCGA-D6-6827,HNSC,55.0,FEMALE,WHITE,Stage I,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-20175.0,Alive,TUMOR FREE,568.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,568.0,0.0,568.0,0.0,568.0,0.0,568.0,
TCGA-OR-A5K8,42,TCGA-OR-A5K8,ACC,39.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-14435.0,Alive,TUMOR FREE,749.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,749.0,0.0,749.0,0.0,749.0,0.0,749.0,
TCGA-LI-A9QH,8723,TCGA-LI-A9QH,SARC,72.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013.0,[Not Available],-26468.0,Dead,TUMOR FREE,,540.0,[Not Available],Distant Metastasis,Lung,,426.0,[Not Available],Negative,R2,1.0,540.0,0.0,540.0,,,1.0,426.0,
TCGA-OR-A5J1,1,TCGA-OR-A5J1,ACC,58.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-21496.0,Dead,WITH TUMOR,,1355.0,[Not Available],Distant Metastasis,Peritoneal Surfaces,,754.0,Complete Remission/Response,,,1.0,1355.0,1.0,1355.0,1.0,754.0,1.0,754.0,
TCGA-TM-A7C5,5371,TCGA-TM-A7C5,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2010.0,[Not Available],-11286.0,Alive,TUMOR FREE,1500.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1500.0,0.0,1500.0,0.0,1500.0,0.0,1500.0,
TCGA-LN-A4A2,2572,TCGA-LN-A4A2,ESCA,57.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G1,2011.0,[Not Available],-21122.0,Alive,TUMOR FREE,380.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,380.0,0.0,380.0,0.0,380.0,0.0,380.0,
TCGA-BH-A1EW,1136,TCGA-BH-A1EW,BRCA,38.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14090.0,Dead,WITH TUMOR,,1694.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1694.0,1.0,1694.0,,,1.0,1694.0,
TCGA-D6-6824,3614,TCGA-D6-6824,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-22633.0,Alive,TUMOR FREE,77.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,77.0,0.0,77.0,,,0.0,77.0,
TCGA-32-2494,3178,TCGA-32-2494,GBM,58.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-21198.0,Dead,WITH TUMOR,632.0,632.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],488.0,[Not Available],,,1.0,632.0,1.0,632.0,,,1.0,488.0,
TCGA-2G-AAHT,9766,TCGA-2G-AAHT,TGCT,32.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],2013.0,[Not Available],-11905.0,Alive,TUMOR FREE,542.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,
TCGA-CV-A6JT,3598,TCGA-CV-A6JT,HNSC,65.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-23806.0,Alive,TUMOR FREE,852.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,852.0,0.0,852.0,0.0,852.0,0.0,852.0,
TCGA-50-6597,5957,TCGA-50-6597,LUAD,79.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-29195.0,Dead,TUMOR FREE,,1268.0,[Not Available],,,,,Partial Remission/Response,,,1.0,1268.0,0.0,1268.0,,,0.0,1268.0,
TCGA-CR-7369,3442,TCGA-CR-7369,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-21897.0,Dead,TUMOR FREE,,1090.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1090.0,0.0,1090.0,,,0.0,1090.0,
TCGA-75-5147,6129,TCGA-75-5147,LUAD,,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],,[Not Available],,Alive,TUMOR FREE,1333.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1333.0,0.0,1333.0,0.0,1333.0,0.0,1333.0,
TCGA-27-1834,3121,TCGA-27-1834,GBM,56.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-20568.0,Dead,WITH TUMOR,1008.0,1233.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],335.0,[Not Available],,,1.0,1233.0,1.0,1233.0,,,1.0,335.0,
TCGA-D7-8579,9511,TCGA-D7-8579,STAD,66.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-24120.0,Alive,TUMOR FREE,636.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,636.0,0.0,636.0,0.0,636.0,0.0,636.0,
TCGA-VQ-A8DT,9643,TCGA-VQ-A8DT,STAD,43.0,MALE,[Unknown],Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,[Not Available],-15937.0,Alive,WITH TUMOR,1484.0,,[Not Available],Distant Metastasis,Liver,,1376.0,Complete Remission/Response,,,0.0,1484.0,0.0,1484.0,1.0,1376.0,1.0,1376.0,
TCGA-LP-A5U3,1802,TCGA-LP-A5U3,CESC,40.0,FEMALE,ASIAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14698.0,Alive,TUMOR FREE,25.0,,,,,,,Complete Remission/Response,,,0.0,25.0,0.0,25.0,0.0,25.0,0.0,25.0,
TCGA-BR-6457,9306,TCGA-BR-6457,STAD,69.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-25396.0,Alive,TUMOR FREE,416.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,416.0,0.0,416.0,0.0,416.0,0.0,416.0,
TCGA-Q1-A73S,1829,TCGA-Q1-A73S,CESC,33.0,FEMALE,WHITE,[Not Available],Stage IB1,Adenosquamous,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12229.0,Alive,TUMOR FREE,688.0,,,,,,,Complete Remission/Response,,,0.0,688.0,0.0,688.0,0.0,688.0,0.0,688.0,
TCGA-55-7913,6010,TCGA-55-7913,LUAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22326.0,Dead,WITH TUMOR,,561.0,[Not Available],Distant Metastasis,,,480.0,Complete Remission/Response,,,1.0,561.0,1.0,561.0,1.0,480.0,1.0,480.0,
TCGA-78-7536,6163,TCGA-78-7536,LUAD,69.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-25558.0,Dead,WITH TUMOR,,244.0,[Not Available],,,,231.0,Progressive Disease,,,1.0,244.0,1.0,244.0,,,1.0,231.0,
TCGA-43-7657,6482,TCGA-43-7657,LUSC,68.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25042.0,Alive,TUMOR FREE,236.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,236.0,0.0,236.0,0.0,236.0,0.0,236.0,
TCGA-DJ-A2Q2,9955,TCGA-DJ-A2Q2,THCA,57.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-20951.0,Alive,TUMOR FREE,1337.0,,[Not Available],,,,,[Not Available],,R0,0.0,1337.0,0.0,1337.0,0.0,1337.0,0.0,1337.0,
TCGA-EW-A1PG,1483,TCGA-EW-A1PG,BRCA,53.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19464.0,Alive,TUMOR FREE,1051.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1051.0,0.0,1051.0,0.0,1051.0,0.0,1051.0,
TCGA-3A-A9IX,7540,TCGA-3A-A9IX,PAAD,40.0,MALE,WHITE,Stage IA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-14729.0,Alive,TUMOR FREE,1037.0,,,,,,,Complete Remission/Response,,,0.0,1037.0,0.0,1037.0,0.0,1037.0,0.0,1037.0,
TCGA-AO-A1KO,883,TCGA-AO-A1KO,BRCA,46.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16817.0,Alive,TUMOR FREE,622.0,,[Not Available],,,,,[Not Available],Negative,,0.0,622.0,0.0,622.0,0.0,622.0,0.0,622.0,
TCGA-BB-A5HZ,3297,TCGA-BB-A5HZ,HNSC,65.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-23906.0,Alive,WITH TUMOR,827.0,,[Not Available],Distant Metastasis,Distant Metastasis,Adrenal Gland,438.0,Complete Remission/Response,,,0.0,827.0,0.0,827.0,,,1.0,438.0,
TCGA-ER-A2NC,9115,TCGA-ER-A2NC,SKCM,50.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2006.0,[Not Available],-18582.0,Dead,WITH TUMOR,,1333.0,[Not Available],Distant Metastasis,Bone,,1157.0,[Not Available],,,1.0,1333.0,1.0,1333.0,,,1.0,1157.0,
TCGA-OR-A5KX,53,TCGA-OR-A5KX,ACC,25.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-9298.0,Alive,WITH TUMOR,1364.0,,[Not Available],Distant Metastasis,Bone,,62.0,Progressive Disease,,,0.0,1364.0,0.0,1364.0,,,1.0,62.0,
TCGA-E2-A1L9,1373,TCGA-E2-A1L9,BRCA,40.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14868.0,Alive,TUMOR FREE,598.0,,[Not Available],,,,,[Not Available],Negative,,0.0,598.0,0.0,598.0,0.0,598.0,0.0,598.0,
TCGA-37-A5EN,6451,TCGA-37-A5EN,LUSC,59.0,MALE,WHITE,Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-21600.0,Alive,TUMOR FREE,660.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,660.0,0.0,660.0,0.0,660.0,0.0,660.0,
TCGA-49-4486,5902,TCGA-49-4486,LUAD,72.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1992.0,[Not Available],-26415.0,Dead,WITH TUMOR,,2318.0,[Not Available],Distant Metastasis,,,2045.0,Complete Remission/Response,,,1.0,2318.0,1.0,2318.0,1.0,2045.0,1.0,2045.0,
TCGA-EA-A3Y4,1701,TCGA-EA-A3Y4,CESC,40.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14706.0,Alive,TUMOR FREE,1122.0,,,,,,,Complete Remission/Response,,,0.0,1122.0,0.0,1122.0,0.0,1122.0,0.0,1122.0,
TCGA-ER-A2NE,9117,TCGA-ER-A2NE,SKCM,39.0,MALE,WHITE,Stage 0,[Not Applicable],,[Not Available],2007.0,[Not Available],-14259.0,Dead,WITH TUMOR,,613.0,[Not Available],,,,,[Not Available],,,,,,,,,,,
TCGA-10-0934,6997,TCGA-10-0934,OV,50.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,[Not Available],-18602.0,Dead,WITH TUMOR,119.0,204.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],111.0,Progressive Disease,,,1.0,204.0,1.0,204.0,,,1.0,111.0,
TCGA-AJ-A2QL,10529,TCGA-AJ-A2QL,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22057.0,Alive,TUMOR FREE,602.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,
TCGA-29-2436,7354,TCGA-29-2436,OV,36.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G2,2009.0,[Not Available],-13346.0,Alive,TUMOR FREE,297.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,297.0,0.0,297.0,0.0,297.0,0.0,297.0,
TCGA-D8-A1XU,1274,TCGA-D8-A1XU,BRCA,56.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20715.0,Alive,TUMOR FREE,395.0,,[Not Available],,,,,[Not Available],Negative,,0.0,395.0,0.0,395.0,0.0,395.0,0.0,395.0,
TCGA-XP-A8T8,2640,TCGA-XP-A8T8,ESCA,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Stage IIB,Esophagus Squamous Cell Carcinoma,G1,2011.0,[Not Available],-18048.0,Alive,TUMOR FREE,437.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,437.0,0.0,437.0,0.0,437.0,0.0,437.0,
TCGA-G3-AAV6,5731,TCGA-G3-AAV6,LIHC,53.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-19556.0,Dead,WITH TUMOR,,65.0,[Not Available],Intrahepatic Recurrence,Liver,,44.0,[Not Available],,R0,1.0,65.0,1.0,65.0,1.0,44.0,1.0,44.0,
TCGA-C8-A8HP,1221,TCGA-C8-A8HP,BRCA,59.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Metaplastic Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21613.0,Alive,TUMOR FREE,396.0,,[Not Available],,,,,[Not Available],Negative,,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,
TCGA-A3-3373,3919,TCGA-A3-3373,KIRC,54.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-19964.0,Alive,TUMOR FREE,1621.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1621.0,0.0,1621.0,0.0,1621.0,0.0,1621.0,
TCGA-AR-A0U4,913,TCGA-AR-A0U4,BRCA,54.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19729.0,Alive,TUMOR FREE,3261.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3261.0,0.0,3261.0,0.0,3261.0,0.0,3261.0,
TCGA-IG-A4QT,2483,TCGA-IG-A4QT,ESCA,56.0,MALE,WHITE,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-20506.0,Dead,TUMOR FREE,,283.0,[Not Available],,,,,Complete Remission/Response,,,1.0,283.0,0.0,283.0,0.0,283.0,0.0,283.0,
TCGA-AF-6672,8381,TCGA-AF-6672,READ,43.0,MALE,WHITE,Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-15965.0,Alive,WITH TUMOR,748.0,,[Not Available],Metastatic,,,279.0,Progressive Disease,,,0.0,748.0,0.0,748.0,,,1.0,279.0,
TCGA-DK-AA6S,222,TCGA-DK-AA6S,BLCA,60.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2000.0,[Not Available],-22027.0,Alive,TUMOR FREE,5050.0,,[Not Available],Distant Metastasis,"Other, specify",soft tissue pelvic mass,539.0,Complete Remission/Response,,,0.0,5050.0,0.0,5050.0,1.0,539.0,1.0,539.0,
TCGA-KS-A4ID,10342,TCGA-KS-A4ID,THCA,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-20413.0,Alive,TUMOR FREE,1011.0,,[Not Available],,,,,[Not Available],,R0,0.0,1011.0,0.0,1011.0,0.0,1011.0,0.0,1011.0,
TCGA-44-2657,5855,TCGA-44-2657,LUAD,74.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-27298.0,Alive,TUMOR FREE,1351.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1351.0,0.0,1351.0,0.0,1351.0,0.0,1351.0,
TCGA-MQ-A4LJ,6856,TCGA-MQ-A4LJ,MESO,53.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],1999.0,[Not Available],-19437.0,Dead,,,709.0,[Not Available],Intrapleural Progression,"Other, specify",Ipsilateral chest,409.0,[Not Available],,[Unknown],1.0,709.0,,709.0,,,1.0,409.0,
TCGA-DJ-A3VM,10000,TCGA-DJ-A3VM,THCA,68.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-24896.0,Alive,TUMOR FREE,840.0,,[Not Available],,,,,[Not Available],,R0,0.0,840.0,0.0,840.0,0.0,840.0,0.0,840.0,
TCGA-AF-A56L,8383,TCGA-AF-A56L,READ,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2008.0,[Not Available],-17734.0,Alive,TUMOR FREE,2007.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2007.0,0.0,2007.0,0.0,2007.0,0.0,2007.0,
TCGA-ED-A7PY,5672,TCGA-ED-A7PY,LIHC,20.0,FEMALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-7556.0,Alive,TUMOR FREE,390.0,,[Not Available],,,,,[Not Available],,R0,0.0,390.0,0.0,390.0,0.0,390.0,0.0,390.0,
TCGA-CM-6169,2284,TCGA-CM-6169,COAD,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-24564.0,Alive,TUMOR FREE,396.0,,[Not Available],,,,,[Not Available],,,0.0,396.0,0.0,396.0,,,0.0,396.0,
TCGA-QR-A6GS,7699,TCGA-QR-A6GS,PCPG,51.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2007.0,[Not Available],-18798.0,Alive,TUMOR FREE,38.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,38.0,0.0,38.0,0.0,38.0,0.0,38.0,
TCGA-XU-A92Q,10420,TCGA-XU-A92Q,THYM,50.0,MALE,ASIAN,[Not Applicable],I,Thymoma; Type A,[Not Available],2008.0,[Not Available],-18281.0,Alive,TUMOR FREE,1092.0,,[Not Available],,,,,[Not Available],,,0.0,1092.0,0.0,1092.0,,,0.0,1092.0,
TCGA-CX-A4AQ,3609,TCGA-CX-A4AQ,HNSC,56.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-20709.0,Alive,TUMOR FREE,1555.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1555.0,0.0,1555.0,,,0.0,1555.0,
TCGA-N5-A4RN,11030,TCGA-N5-A4RN,UCS,71.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26054.0,Alive,WITH TUMOR,1053.0,,[Not Available],Locoregional Recurrence,Pelvis,,570.0,Complete Remission/Response,,,0.0,1053.0,0.0,1053.0,,,1.0,570.0,
TCGA-E1-A7YQ,5085,TCGA-E1-A7YQ,LGG,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligodendroglioma,G3,2000.0,[Not Available],-21341.0,Dead,WITH TUMOR,,1578.0,[Not Available],,,,580.0,Stable Disease,,,1.0,1578.0,1.0,1578.0,,,1.0,580.0,
TCGA-DB-5278,4937,TCGA-DB-5278,LGG,17.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2007.0,[Not Available],-6480.0,Alive,WITH TUMOR,2772.0,,[Not Available],,,,507.0,Stable Disease,,,0.0,2772.0,0.0,2772.0,,,1.0,507.0,
TCGA-A5-AB3J,10524,TCGA-A5-AB3J,UCEC,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2013.0,Peri (6-12 months since last menstrual period),-19020.0,Alive,TUMOR FREE,512.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,
TCGA-25-1319,7268,TCGA-25-1319,OV,73.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,[Not Available],-26786.0,Dead,,1977.0,1977.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],730.0,[Not Available],,,1.0,1977.0,,1977.0,,,1.0,730.0,
TCGA-FV-A496,5697,TCGA-FV-A496,LIHC,84.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-30950.0,Alive,TUMOR FREE,10.0,,[Not Available],,,,,[Not Available],,R0,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,
TCGA-IG-A3QL,2476,TCGA-IG-A3QL,ESCA,54.0,MALE,WHITE,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2011.0,[Not Available],-19755.0,Alive,TUMOR FREE,1071.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1071.0,0.0,1071.0,0.0,1071.0,0.0,1071.0,
TCGA-55-8091,6018,TCGA-55-8091,LUAD,74.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27385.0,Alive,TUMOR FREE,600.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,
TCGA-93-7347,6228,TCGA-93-7347,LUAD,76.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27949.0,Alive,TUMOR FREE,683.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,683.0,0.0,683.0,0.0,683.0,0.0,683.0,
TCGA-SX-A71U,4670,TCGA-SX-A71U,KIRP,57.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-21079.0,Alive,TUMOR FREE,1357.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1357.0,0.0,1357.0,0.0,1357.0,0.0,1357.0,
TCGA-AX-A1C5,10631,TCGA-AX-A1C5,UCEC,47.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Indeterminate (neither Pre or Postmenopausal),-17383.0,Alive,WITH TUMOR,1001.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,
TCGA-EY-A1GX,10962,TCGA-EY-A1GX,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27962.0,Dead,TUMOR FREE,,1127.0,[Not Available],Locoregional Recurrence,"Other, specify",pelvic mass,743.0,Complete Remission/Response,,,1.0,1127.0,0.0,1127.0,1.0,743.0,1.0,743.0,
TCGA-DJ-A2PP,9942,TCGA-DJ-A2PP,THCA,47.0,MALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-17410.0,Alive,TUMOR FREE,930.0,,[Not Available],,,,,[Not Available],,R0,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,
TCGA-M7-A723,8223,TCGA-M7-A723,PRAD,54.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20064.0,Alive,TUMOR FREE,763.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,763.0,0.0,763.0,0.0,763.0,0.0,763.0,
TCGA-AP-A0LP,10588,TCGA-AP-A0LP,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27898.0,Alive,TUMOR FREE,1875.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1875.0,0.0,1875.0,0.0,1875.0,0.0,1875.0,
TCGA-13-1505,7095,TCGA-13-1505,OV,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-23238.0,Alive,WITH TUMOR,1998.0,,[Not Available],,[Not Applicable],[Not Applicable],1561.0,Complete Remission/Response,,,0.0,1998.0,0.0,1998.0,1.0,1561.0,1.0,1561.0,
TCGA-VS-A9UA,1865,TCGA-VS-A9UA,CESC,60.0,FEMALE,WHITE,[Not Available],Stage IIIA,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22221.0,Alive,TUMOR FREE,867.0,,,,,,,Complete Remission/Response,,,0.0,867.0,0.0,867.0,0.0,867.0,0.0,867.0,
TCGA-19-5958,3096,TCGA-19-5958,GBM,56.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-20466.0,Dead,WITH TUMOR,,428.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],356.0,Progressive Disease,,,1.0,428.0,1.0,428.0,,,1.0,356.0,
TCGA-VS-A8Q9,1845,TCGA-VS-A8Q9,CESC,79.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28881.0,Alive,TUMOR FREE,1630.0,,,,,,,Complete Remission/Response,,,0.0,1630.0,0.0,1630.0,0.0,1630.0,0.0,1630.0,
TCGA-B0-5077,4016,TCGA-B0-5077,KIRC,77.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-28405.0,Dead,TUMOR FREE,,1317.0,[Not Available],,,,,[Not Available],,,1.0,1317.0,0.0,1317.0,,,0.0,1317.0,
TCGA-V4-A9EF,11092,TCGA-V4-A9EF,UVM,56.0,MALE,WHITE,Stage IIIB,Stage IIIB,Spindle Cell,[Not Available],2012.0,[Not Available],-20763.0,Alive,TUMOR FREE,1165.0,,[Not Available],,,,,[Not Available],,,0.0,1165.0,0.0,1165.0,,,0.0,1165.0,
TCGA-EY-A214,10966,TCGA-EY-A214,UCEC,66.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24136.0,Alive,TUMOR FREE,438.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,438.0,0.0,438.0,0.0,438.0,0.0,438.0,
TCGA-XK-AAIR,8301,TCGA-XK-AAIR,PRAD,75.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-27703.0,Alive,TUMOR FREE,972.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,972.0,0.0,972.0,0.0,972.0,0.0,972.0,
TCGA-D3-A51N,8873,TCGA-D3-A51N,SKCM,56.0,FEMALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2012.0,[Not Available],-20559.0,Alive,WITH TUMOR,688.0,,[Not Available],Distant Metastasis,"Other, Specify",Adrenal Gland,18.0,[Not Available],,,0.0,688.0,0.0,688.0,,,1.0,18.0,
TCGA-IB-7652,7624,TCGA-IB-7652,PAAD,49.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-18129.0,Alive,TUMOR FREE,1116.0,,,,,,,Complete Remission/Response,,,0.0,1116.0,0.0,1116.0,0.0,1116.0,0.0,1116.0,
TCGA-12-5299,2995,TCGA-12-5299,GBM,56.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-20463.0,Dead,WITH TUMOR,98.0,98.0,[Not Available],,,,,[Not Available],,,1.0,98.0,1.0,98.0,,,1.0,98.0,
TCGA-UZ-A9PO,4688,TCGA-UZ-A9PO,KIRP,80.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-29220.0,Alive,TUMOR FREE,1911.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1911.0,0.0,1911.0,0.0,1911.0,0.0,1911.0,
TCGA-E2-A1IG,1361,TCGA-E2-A1IG,BRCA,45.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16757.0,Alive,TUMOR FREE,2140.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2140.0,0.0,2140.0,0.0,2140.0,0.0,2140.0,
TCGA-DJ-A3VA,9990,TCGA-DJ-A3VA,THCA,39.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-14495.0,Alive,TUMOR FREE,755.0,,[Not Available],,,,,[Not Available],,R0,0.0,755.0,0.0,755.0,0.0,755.0,0.0,755.0,
TCGA-HT-A74O,5243,TCGA-HT-A74O,LGG,34.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-12460.0,Alive,,3.0,,[Not Available],,,,,[Not Available],,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-L5-A88T,2532,TCGA-L5-A88T,ESCA,86.0,MALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2012.0,[Not Available],-31480.0,Alive,TUMOR FREE,694.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,694.0,0.0,694.0,0.0,694.0,0.0,694.0,
TCGA-V1-A8MF,8236,TCGA-V1-A8MF,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-24090.0,Alive,,1449.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0,
TCGA-EB-A6L9,8983,TCGA-EB-A6L9,SKCM,55.0,MALE,ASIAN,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-20172.0,Alive,TUMOR FREE,1109.0,,[Not Available],,,,,[Not Available],,,0.0,1109.0,0.0,1109.0,,,0.0,1109.0,
TCGA-R8-A6ML,5311,TCGA-R8-A6ML,LGG,52.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2005.0,[Not Available],-19185.0,Alive,,2860.0,,[Not Available],,,,,[Unknown],,,0.0,2860.0,0.0,2860.0,,,0.0,2860.0,
TCGA-EK-A2PL,1726,TCGA-EK-A2PL,CESC,36.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-13384.0,Alive,WITH TUMOR,13.0,,,,,,,[Not Available],,,0.0,13.0,0.0,13.0,,,0.0,13.0,
TCGA-PD-A5DF,5759,TCGA-PD-A5DF,LIHC,58.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-21414.0,Dead,WITH TUMOR,,639.0,[Not Available],,,,,[Not Available],,[Not Available],1.0,639.0,1.0,639.0,,,1.0,639.0,
TCGA-77-A5G8,6697,TCGA-77-A5G8,LUSC,70.0,MALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-25921.0,Alive,,1884.0,,[Not Available],,,,,[Unknown],,,0.0,1884.0,0.0,1884.0,,,0.0,1884.0,
TCGA-T3-A92M,3744,TCGA-T3-A92M,HNSC,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-19247.0,Alive,WITH TUMOR,417.0,,[Not Available],Distant Metastasis,Distant Metastasis,(Rt) Lung,417.0,[Unknown],,,0.0,417.0,0.0,417.0,,,1.0,417.0,
TCGA-EK-A2RA,1731,TCGA-EK-A2RA,CESC,74.0,FEMALE,[Not Available],[Not Available],Stage IIA2,Cervical Squamous Cell Carcinoma,G3,2011.0,[Not Available],-27209.0,Alive,WITH TUMOR,1246.0,,,,,,,[Not Available],,,0.0,1246.0,0.0,1246.0,,,0.0,1246.0,
TCGA-B2-5641,4081,TCGA-B2-5641,KIRC,79.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-28953.0,Alive,TUMOR FREE,656.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,656.0,0.0,656.0,0.0,656.0,0.0,656.0,
TCGA-FC-A6HD,8012,TCGA-FC-A6HD,PRAD,77.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-28197.0,Alive,TUMOR FREE,789.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,789.0,0.0,789.0,0.0,789.0,0.0,789.0,
TCGA-W2-A7H5,7820,TCGA-W2-A7H5,PCPG,25.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-9363.0,Alive,TUMOR FREE,611.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,611.0,0.0,611.0,0.0,611.0,0.0,611.0,
TCGA-DX-A1KU,8555,TCGA-DX-A1KU,SARC,82.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2010.0,[Not Available],-30054.0,Dead,WITH TUMOR,,427.0,[Not Available],Distant Metastasis,"Other, specify",Abdomen,94.0,[Not Available],[Not Available],R2,1.0,427.0,1.0,427.0,,,1.0,94.0,
TCGA-UZ-A9PX,4695,TCGA-UZ-A9PX,KIRP,73.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-26663.0,Alive,TUMOR FREE,1981.0,,[Not Available],,,,308.0,Complete Remission/Response,,,0.0,1981.0,0.0,1981.0,1.0,308.0,1.0,308.0,
TCGA-34-2604,6420,TCGA-34-2604,LUSC,81.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1999.0,[Not Available],-29827.0,Dead,TUMOR FREE,958.0,958.0,[Not Available],,,,,Complete Remission/Response,,,1.0,958.0,0.0,958.0,0.0,958.0,0.0,958.0,
TCGA-AC-A3HN,774,TCGA-AC-A3HN,BRCA,87.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32061.0,Alive,TUMOR FREE,496.0,,[Not Available],,,,,[Not Available],Negative,,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,
TCGA-D8-A27P,1292,TCGA-D8-A27P,BRCA,64.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23576.0,Alive,TUMOR FREE,49.0,,[Not Available],,,,,[Not Available],Negative,,0.0,49.0,0.0,49.0,0.0,49.0,0.0,49.0,
TCGA-DV-5568,4397,TCGA-DV-5568,KIRC,26.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2009.0,[Not Available],-9714.0,Alive,WITH TUMOR,370.0,,[Not Available],,,,,[Not Available],,,0.0,370.0,0.0,370.0,,,0.0,370.0,
TCGA-12-1597,2981,TCGA-12-1597,GBM,62.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-22865.0,Dead,WITH TUMOR,427.0,675.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],180.0,[Not Available],,,1.0,675.0,1.0,675.0,,,1.0,180.0,
TCGA-D8-A1XY,1277,TCGA-D8-A1XY,BRCA,74.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27106.0,Alive,TUMOR FREE,503.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,503.0,0.0,503.0,,,0.0,503.0,
TCGA-WB-A80Q,7836,TCGA-WB-A80Q,PCPG,64.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2003.0,[Not Available],-23653.0,Alive,TUMOR FREE,3880.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3880.0,0.0,3880.0,0.0,3880.0,0.0,3880.0,
TCGA-TQ-A7RP,5397,TCGA-TQ-A7RP,LGG,66.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-24109.0,Alive,WITH TUMOR,914.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,914.0,0.0,914.0,,,0.0,914.0,
TCGA-EB-A5UN,8980,TCGA-EB-A5UN,SKCM,49.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-18226.0,Alive,,1792.0,,[Not Available],Distant Metastasis,Brain,,1689.0,[Not Available],,,0.0,1792.0,0.0,1792.0,,,1.0,1689.0,
TCGA-FI-A2EY,10992,TCGA-FI-A2EY,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23042.0,Dead,TUMOR FREE,,880.0,[Not Available],New Primary Tumor,Lung,,577.0,Complete Remission/Response,,,1.0,880.0,0.0,880.0,0.0,880.0,1.0,577.0,
TCGA-QR-A707,7719,TCGA-QR-A707,PCPG,43.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-15870.0,Alive,TUMOR FREE,398.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,
TCGA-Z4-AAPG,8797,TCGA-Z4-AAPG,SARC,64.0,FEMALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013.0,[Not Available],-23390.0,Alive,TUMOR FREE,486.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,
TCGA-CG-5716,9469,TCGA-CG-5716,STAD,86.0,MALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,[Not Available],-31411.0,Alive,WITH TUMOR,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-HU-A4G2,9566,TCGA-HU-A4G2,STAD,45.0,MALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-16791.0,Alive,TUMOR FREE,739.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,739.0,0.0,739.0,0.0,739.0,0.0,739.0,
TCGA-L9-A743,6289,TCGA-L9-A743,LUAD,56.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2013.0,[Not Available],-20780.0,Alive,TUMOR FREE,664.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,664.0,0.0,664.0,0.0,664.0,0.0,664.0,
TCGA-DD-A3A2,5544,TCGA-DD-A3A2,LIHC,76.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,1998.0,[Not Available],-27930.0,Dead,TUMOR FREE,,2131.0,[Not Available],,,,,[Not Available],,R0,1.0,2131.0,0.0,2131.0,0.0,2131.0,0.0,2131.0,
TCGA-UZ-A9PU,4693,TCGA-UZ-A9PU,KIRP,77.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-28124.0,Dead,TUMOR FREE,,933.0,[Not Available],,,,,Complete Remission/Response,,,1.0,933.0,0.0,933.0,0.0,933.0,0.0,933.0,
TCGA-RS-A6TP,3739,TCGA-RS-A6TP,HNSC,58.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-21393.0,Alive,TUMOR FREE,516.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,
TCGA-B0-5109,4036,TCGA-B0-5109,KIRC,69.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2009.0,[Not Available],-25428.0,Dead,WITH TUMOR,,587.0,[Not Available],,,,70.0,[Not Available],,,1.0,587.0,1.0,587.0,,,1.0,70.0,
TCGA-KL-8345,3792,TCGA-KL-8345,KICH,75.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2008.0,[Not Available],-27412.0,Alive,TUMOR FREE,1665.0,,[Not Available],,,,,[Unknown],,,0.0,1665.0,0.0,1665.0,,,0.0,1665.0,
TCGA-VS-A9UR,1877,TCGA-VS-A9UR,CESC,53.0,FEMALE,WHITE,[Not Available],Stage IIA,Mucinous Adenocarcinoma of Endocervical Type,GX,2013.0,[Unknown],-19688.0,Alive,WITH TUMOR,793.0,,,Distant Metastasis,"Other, specify",Retroperitoneal,675.0,Complete Remission/Response,,,0.0,793.0,0.0,793.0,1.0,675.0,1.0,675.0,
TCGA-DB-A75M,4962,TCGA-DB-A75M,LGG,47.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-17289.0,Alive,TUMOR FREE,544.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,544.0,0.0,544.0,0.0,544.0,0.0,544.0,
TCGA-EB-A5UL,8978,TCGA-EB-A5UL,SKCM,71.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2012.0,[Not Available],-26058.0,Alive,TUMOR FREE,891.0,,[Not Available],,,,,[Not Available],,,0.0,891.0,0.0,891.0,,,0.0,891.0,
TCGA-EY-A1GE,10945,TCGA-EY-A1GE,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24667.0,Alive,TUMOR FREE,741.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,741.0,0.0,741.0,0.0,741.0,0.0,741.0,
TCGA-DJ-A3UU,9975,TCGA-DJ-A3UU,THCA,49.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-17919.0,Alive,WITH TUMOR,713.0,,[Not Available],,,,,[Not Available],,R1,0.0,713.0,0.0,713.0,,,0.0,713.0,
TCGA-BH-A1F5,1141,TCGA-BH-A1F5,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002.0,[Not Available],-22842.0,Dead,TUMOR FREE,,2712.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,2712.0,0.0,2712.0,,,0.0,2712.0,
TCGA-ZF-AA4T,491,TCGA-ZF-AA4T,BLCA,65.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-23974.0,Dead,WITH TUMOR,,599.0,[Not Available],Distant Metastasis,Lung,,511.0,[Unknown],,,1.0,599.0,1.0,599.0,,,1.0,511.0,
TCGA-2Z-A9J3,4423,TCGA-2Z-A9J3,KIRP,67.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-24626.0,Dead,WITH TUMOR,,1771.0,[Not Available],,,,790.0,Progressive Disease,,,1.0,1771.0,1.0,1771.0,,,1.0,790.0,
TCGA-BP-5170,4240,TCGA-BP-5170,KIRC,55.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-20229.0,Alive,TUMOR FREE,2412.0,,[Not Available],,,,,[Not Available],,,0.0,2412.0,0.0,2412.0,,,0.0,2412.0,
TCGA-E1-A7YI,5078,TCGA-E1-A7YI,LGG,33.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-12229.0,Dead,WITH TUMOR,,111.0,[Not Available],,,,56.0,[Unknown],,,1.0,111.0,1.0,111.0,,,1.0,56.0,
TCGA-DD-A3A5,5547,TCGA-DD-A3A5,LIHC,66.0,FEMALE,WHITE,Stage III,[Not Applicable],Hepatocellular Carcinoma,G2,1996.0,[Not Available],-24288.0,Dead,WITH TUMOR,,3125.0,[Not Available],Intrahepatic Recurrence,Liver,,84.0,[Not Available],,R0,1.0,3125.0,1.0,3125.0,1.0,84.0,1.0,84.0,
TCGA-34-5929,6433,TCGA-34-5929,LUSC,78.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-28844.0,Dead,TUMOR FREE,,151.0,[Not Available],,,,,Stable Disease,,,1.0,151.0,0.0,151.0,,,0.0,151.0,
TCGA-KK-A59Y,8175,TCGA-KK-A59Y,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-20768.0,Alive,TUMOR FREE,1968.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1968.0,0.0,1968.0,0.0,1968.0,0.0,1968.0,
TCGA-BG-A18B,10768,TCGA-BG-A18B,UCEC,53.0,FEMALE,WHITE,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G2,2010.0,Peri (6-12 months since last menstrual period),-19550.0,Alive,TUMOR FREE,470.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,470.0,0.0,470.0,0.0,470.0,0.0,470.0,
TCGA-VS-A94X,1852,TCGA-VS-A94X,CESC,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,[Not Evaluated],-14955.0,Dead,WITH TUMOR,,506.0,Cervical Cancer,,,,,Partial Remission/Response,,,1.0,506.0,1.0,506.0,,,1.0,506.0,
TCGA-XN-A8T3,7682,TCGA-XN-A8T3,PAAD,67.0,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-24810.0,Alive,WITH TUMOR,951.0,,,,,,,Progressive Disease,,,0.0,951.0,0.0,951.0,,,0.0,951.0,
TCGA-EE-A3JE,9084,TCGA-EE-A3JE,SKCM,75.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2009.0,[Not Available],-27463.0,Alive,TUMOR FREE,1562.0,,[Not Available],Regional lymph node,,,194.0,[Not Available],,,0.0,1562.0,0.0,1562.0,,,1.0,194.0,
TCGA-73-A9RS,6124,TCGA-73-A9RS,LUAD,41.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2013.0,[Not Available],-15162.0,Dead,WITH TUMOR,,340.0,[Not Available],Locoregional Recurrence,,,107.0,Progressive Disease,,,1.0,340.0,1.0,340.0,,,1.0,107.0,
TCGA-LL-A5YP,1538,TCGA-LL-A5YP,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18041.0,Alive,,450.0,,[Not Available],,,,,[Not Available],Negative,,0.0,450.0,0.0,450.0,0.0,450.0,0.0,450.0,
TCGA-G3-AAUZ,5724,TCGA-G3-AAUZ,LIHC,48.0,MALE,[Unknown],Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-17760.0,Alive,TUMOR FREE,480.0,,[Not Available],,,,,[Not Available],,R0,0.0,480.0,0.0,480.0,0.0,480.0,0.0,480.0,
TCGA-3C-AAAU,505,TCGA-3C-AAAU,BRCA,55.0,FEMALE,WHITE,Stage X,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20211.0,Alive,WITH TUMOR,4047.0,,[Not Available],Distant Metastasis,Lung,,1808.0,[Not Available],Negative,,0.0,4047.0,0.0,4047.0,1.0,1808.0,1.0,1808.0,
TCGA-EW-A1OZ,1468,TCGA-EW-A1OZ,BRCA,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20664.0,Alive,TUMOR FREE,1229.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1229.0,0.0,1229.0,0.0,1229.0,0.0,1229.0,
TCGA-BP-4982,4216,TCGA-BP-4982,KIRC,42.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-15451.0,Alive,TUMOR FREE,1014.0,,[Not Available],,,,,[Not Available],,,0.0,1014.0,0.0,1014.0,,,0.0,1014.0,
TCGA-QG-A5Z2,2407,TCGA-QG-A5Z2,COAD,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2012.0,[Not Available],-22367.0,Alive,TUMOR FREE,952.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,952.0,0.0,952.0,0.0,952.0,0.0,952.0,
TCGA-B4-5377,4083,TCGA-B4-5377,KIRC,68.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-25115.0,Alive,TUMOR FREE,365.0,,[Not Available],,,,,[Not Applicable],,,0.0,365.0,0.0,365.0,,,0.0,365.0,
TCGA-S9-A6WE,5338,TCGA-S9-A6WE,LGG,34.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2004.0,[Not Available],-12488.0,Alive,WITH TUMOR,4113.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,4113.0,0.0,4113.0,,,0.0,4113.0,
TCGA-HT-7474,5147,TCGA-HT-7474,LGG,52.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-19149.0,Alive,TUMOR FREE,114.0,,[Not Available],,,,,Stable Disease,,,0.0,114.0,0.0,114.0,,,0.0,114.0,
TCGA-B8-5552,4113,TCGA-B8-5552,KIRC,41.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-15219.0,Alive,TUMOR FREE,1046.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1046.0,0.0,1046.0,0.0,1046.0,0.0,1046.0,
TCGA-34-7107,6434,TCGA-34-7107,LUSC,70.0,MALE,WHITE,Stage II,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25677.0,Dead,,,34.0,[Not Available],,,,,[Not Available],,,1.0,34.0,,34.0,,,0.0,34.0,
TCGA-D1-A17Q,10869,TCGA-D1-A17Q,UCEC,54.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Peri (6-12 months since last menstrual period),-20015.0,Alive,TUMOR FREE,54.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,54.0,0.0,54.0,0.0,54.0,0.0,54.0,
TCGA-P5-A781,5288,TCGA-P5-A781,LGG,34.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-12757.0,Alive,TUMOR FREE,134.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,134.0,0.0,134.0,0.0,134.0,0.0,134.0,
TCGA-DM-A0XF,2328,TCGA-DM-A0XF,COAD,68.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],[Discrepancy],[Not Available],1999.0,[Not Available],-25032.0,Dead,,,1162.0,[Not Available],,,,,[Not Available],,,1.0,1162.0,,1162.0,,,0.0,1162.0,
TCGA-BB-8601,3294,TCGA-BB-8601,HNSC,84.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-30721.0,Alive,WITH TUMOR,624.0,,[Not Available],Locoregional Disease,Oral Cavity,,440.0,Progressive Disease,,,0.0,624.0,0.0,624.0,,,1.0,440.0,
TCGA-VN-A88O,8272,TCGA-VN-A88O,PRAD,49.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-17945.0,Alive,TUMOR FREE,481.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,
TCGA-UE-A6QT,8766,TCGA-UE-A6QT,SARC,50.0,FEMALE,ASIAN,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013.0,[Not Available],-18516.0,Alive,TUMOR FREE,402.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,402.0,0.0,402.0,0.0,402.0,0.0,402.0,
TCGA-X6-A8C2,8786,TCGA-X6-A8C2,SARC,56.0,MALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012.0,[Not Available],-20507.0,Alive,WITH TUMOR,1070.0,,[Not Available],New Primary Tumor,Lung,,7.0,[Not Available],Positive,R1,0.0,1070.0,0.0,1070.0,,,1.0,7.0,
TCGA-43-A474,6487,TCGA-43-A474,LUSC,66.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24286.0,Alive,TUMOR FREE,353.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,353.0,0.0,353.0,0.0,353.0,0.0,353.0,
TCGA-CM-5862,2272,TCGA-CM-5862,COAD,80.0,MALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-29493.0,Dead,WITH TUMOR,,153.0,[Not Available],,,,31.0,[Not Available],,,1.0,153.0,1.0,153.0,,,1.0,31.0,
TCGA-BA-A6DI,3275,TCGA-BA-A6DI,HNSC,62.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-22857.0,Dead,WITH TUMOR,,336.0,[Not Available],,Larynx,,266.0,Complete Remission/Response,,,1.0,336.0,1.0,336.0,1.0,266.0,1.0,266.0,
TCGA-CQ-5333,3385,TCGA-CQ-5333,HNSC,74.0,MALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-27110.0,Dead,WITH TUMOR,,341.0,[Not Available],,Oropharynx,,176.0,Complete Remission/Response,,,1.0,341.0,1.0,341.0,1.0,176.0,1.0,176.0,
TCGA-DE-A69K,9916,TCGA-DE-A69K,THCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2013.0,[Not Available],-21403.0,Alive,WITH TUMOR,434.0,,[Not Available],Biochemical evidence of disease,,,434.0,[Not Available],,R1,0.0,434.0,0.0,434.0,,,1.0,434.0,
TCGA-DD-AAD6,5610,TCGA-DD-AAD6,LIHC,66.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-24185.0,Alive,TUMOR FREE,672.0,,[Not Available],Locoregional Recurrence,Liver,,50.0,[Not Available],,R0,0.0,672.0,0.0,672.0,1.0,50.0,1.0,50.0,
TCGA-EI-6507,8506,TCGA-EI-6507,READ,60.0,MALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-22176.0,Alive,TUMOR FREE,607.0,,[Not Available],,,,,[Not Available],,,0.0,607.0,0.0,607.0,,,0.0,607.0,
TCGA-TQ-A7RH,5390,TCGA-TQ-A7RH,LGG,39.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-14524.0,Alive,WITH TUMOR,486.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,486.0,0.0,486.0,,,0.0,486.0,
TCGA-A3-A8OW,3935,TCGA-A3-A8OW,KIRC,37.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2011.0,[Not Available],-13546.0,Alive,TUMOR FREE,323.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,323.0,0.0,323.0,0.0,323.0,0.0,323.0,
TCGA-UZ-A9PL,4685,TCGA-UZ-A9PL,KIRP,59.0,MALE,WHITE,Stage II,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-21550.0,Alive,TUMOR FREE,3152.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3152.0,0.0,3152.0,0.0,3152.0,0.0,3152.0,
TCGA-32-1986,3174,TCGA-32-1986,GBM,68.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-25061.0,Dead,WITH TUMOR,386.0,386.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],233.0,[Not Available],,,1.0,386.0,1.0,386.0,,,1.0,233.0,
TCGA-D8-A27L,1289,TCGA-D8-A27L,BRCA,49.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18025.0,Alive,TUMOR FREE,499.0,,[Not Available],,,,,[Not Available],Negative,,0.0,499.0,0.0,499.0,0.0,499.0,0.0,499.0,
TCGA-KL-8332,3779,TCGA-KL-8332,KICH,55.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-20128.0,Alive,TUMOR FREE,2582.0,,[Not Available],,,,,[Unknown],,,0.0,2582.0,0.0,2582.0,,,0.0,2582.0,
TCGA-22-5472,6383,TCGA-22-5472,LUSC,67.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-24482.0,Dead,TUMOR FREE,,1975.0,[Not Available],,,,746.0,Complete Remission/Response,,,1.0,1975.0,0.0,1975.0,1.0,746.0,1.0,746.0,
TCGA-DD-AADS,5629,TCGA-DD-AADS,LIHC,63.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-23227.0,Alive,TUMOR FREE,474.0,,[Not Available],,,,,[Not Available],,R0,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,
TCGA-A3-3323,3895,TCGA-A3-3323,KIRC,53.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2006.0,[Not Available],-19456.0,Alive,TUMOR FREE,1106.0,,[Not Available],,,,,[Not Available],,,0.0,1106.0,0.0,1106.0,,,0.0,1106.0,
TCGA-D8-A1XC,1261,TCGA-D8-A1XC,BRCA,85.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Mucinous Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31220.0,Dead,WITH TUMOR,,377.0,[Not Available],,,,,[Not Available],Negative,,1.0,377.0,1.0,377.0,,,1.0,377.0,
TCGA-HZ-A77Q,7614,TCGA-HZ-A77Q,PAAD,55.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2013.0,[Not Available],-20366.0,Alive,TUMOR FREE,33.0,,,,,,,[Unknown],,,0.0,33.0,0.0,33.0,,,0.0,33.0,
TCGA-EJ-5524,7936,TCGA-EJ-5524,PRAD,57.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-20854.0,Alive,WITH TUMOR,1882.0,,[Not Available],Locoregional Recurrence,,,265.0,Progressive Disease,,,0.0,1882.0,0.0,1882.0,,,1.0,265.0,
TCGA-D5-6930,2322,TCGA-D5-6930,COAD,67.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-24764.0,Alive,TUMOR FREE,406.0,,[Not Available],,,,,[Not Available],,,0.0,406.0,0.0,406.0,,,0.0,406.0,
TCGA-L5-A4OO,2522,TCGA-L5-A4OO,ESCA,75.0,MALE,WHITE,Stage IIIC,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2010.0,[Not Available],-27757.0,Alive,,101.0,,[Not Available],,,,,[Unknown],,,0.0,101.0,0.0,101.0,,,0.0,101.0,
TCGA-EW-A1IY,1457,TCGA-EW-A1IY,BRCA,38.0,FEMALE,ASIAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14122.0,Alive,TUMOR FREE,258.0,,[Not Available],,,,,[Not Available],Negative,,0.0,258.0,0.0,258.0,0.0,258.0,0.0,258.0,
TCGA-WB-A819,7844,TCGA-WB-A819,PCPG,36.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-13233.0,Alive,TUMOR FREE,1031.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1031.0,0.0,1031.0,0.0,1031.0,0.0,1031.0,
TCGA-HC-7738,8078,TCGA-HC-7738,PRAD,58.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21195.0,Alive,WITH TUMOR,964.0,,[Not Available],Biochemical evidence of disease,"Other, specify",biochemical recurrence only,420.0,Partial Remission/Response,,,0.0,964.0,0.0,964.0,,,1.0,420.0,
TCGA-DX-A3LY,8580,TCGA-DX-A3LY,SARC,66.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2011.0,[Not Available],-24166.0,Alive,TUMOR FREE,1017.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1017.0,0.0,1017.0,0.0,1017.0,0.0,1017.0,
TCGA-CM-6163,2278,TCGA-CM-6163,COAD,74.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-27150.0,Alive,TUMOR FREE,427.0,,[Not Available],,,,,[Not Available],,,0.0,427.0,0.0,427.0,,,0.0,427.0,
TCGA-BS-A0TG,10795,TCGA-BS-A0TG,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22043.0,Alive,WITH TUMOR,2371.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2371.0,0.0,2371.0,0.0,2371.0,0.0,2371.0,
TCGA-DD-A118,5518,TCGA-DD-A118,LIHC,77.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2003.0,[Not Available],-28406.0,Alive,,3437.0,,[Not Available],Extrahepatic Recurrence,"Other, specify","lateral to the C-loop of the duodenum, anterior to the right  kidney",658.0,[Not Available],,R0,0.0,3437.0,0.0,3437.0,1.0,658.0,1.0,658.0,
TCGA-DX-A3UE,8592,TCGA-DX-A3UE,SARC,66.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2007.0,[Not Available],-24388.0,Dead,WITH TUMOR,,1061.0,[Not Available],Distant Metastasis,,,224.0,[Not Available],[Not Available],R0,1.0,1061.0,1.0,1061.0,1.0,224.0,1.0,224.0,
TCGA-DB-A75P,4964,TCGA-DB-A75P,LGG,25.0,FEMALE,[Unknown],[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-9413.0,Alive,TUMOR FREE,492.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,
TCGA-UF-A719,3750,TCGA-UF-A719,HNSC,54.0,MALE,[Unknown],Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2009.0,[Not Available],-19797.0,Alive,TUMOR FREE,1663.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1663.0,0.0,1663.0,0.0,1663.0,0.0,1663.0,
TCGA-BB-8596,3293,TCGA-BB-8596,HNSC,69.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2005.0,[Not Available],-25408.0,Alive,TUMOR FREE,2161.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2161.0,0.0,2161.0,,,0.0,2161.0,
TCGA-D6-A6EM,3623,TCGA-D6-A6EM,HNSC,65.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-23865.0,Alive,WITH TUMOR,232.0,,[Not Available],,Oral Cavity,oral tongue,232.0,Complete Remission/Response,,,0.0,232.0,0.0,232.0,1.0,232.0,1.0,232.0,
TCGA-S9-A7J2,5355,TCGA-S9-A7J2,LGG,25.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-9345.0,Alive,WITH TUMOR,62.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,62.0,0.0,62.0,,,0.0,62.0,
TCGA-B4-5832,4085,TCGA-B4-5832,KIRC,65.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-23806.0,Alive,TUMOR FREE,155.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,155.0,0.0,155.0,0.0,155.0,0.0,155.0,
TCGA-EL-A3N3,10082,TCGA-EL-A3N3,THCA,53.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2000.0,[Not Available],-19513.0,Alive,TUMOR FREE,5423.0,,[Not Available],,,,,[Not Available],,R0,0.0,5423.0,0.0,5423.0,0.0,5423.0,0.0,5423.0,
TCGA-EW-A1PD,1480,TCGA-EW-A1PD,BRCA,61.0,MALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,[Not Available],-22536.0,Alive,TUMOR FREE,424.0,,[Not Available],,,,,[Not Available],Negative,,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,
TCGA-53-7813,5965,TCGA-53-7813,LUAD,51.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-18875.0,Alive,TUMOR FREE,424.0,,[Not Available],,,,,Progressive Disease,,,0.0,424.0,0.0,424.0,,,0.0,424.0,
TCGA-12-3650,2990,TCGA-12-3650,GBM,46.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-17138.0,Dead,WITH TUMOR,333.0,333.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],239.0,[Not Available],,,1.0,333.0,1.0,333.0,,,1.0,239.0,
TCGA-CU-A3KJ,175,TCGA-CU-A3KJ,BLCA,75.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-27692.0,Alive,WITH TUMOR,562.0,,[Not Available],Distant Metastasis,Lung,,166.0,Progressive Disease,,,0.0,562.0,0.0,562.0,,,1.0,166.0,
TCGA-55-7815,6004,TCGA-55-7815,LUAD,76.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-28119.0,Alive,WITH TUMOR,773.0,,[Not Available],Locoregional Recurrence,,,466.0,Complete Remission/Response,,,0.0,773.0,0.0,773.0,1.0,466.0,1.0,466.0,
TCGA-L5-A43M,2513,TCGA-L5-A43M,ESCA,84.0,FEMALE,[Not Evaluated],[Unknown],[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2009.0,[Not Available],-30783.0,Alive,,272.0,,[Not Available],,,,,[Unknown],,,0.0,272.0,0.0,272.0,,,0.0,272.0,
TCGA-TS-A7P1,6882,TCGA-TS-A7P1,MESO,52.0,MALE,WHITE,Stage I,[Not Applicable],Epithelioid mesothelioma,[Not Available],2010.0,[Not Available],-19191.0,Dead,,,563.0,[Not Available],,,,494.0,[Not Available],,[Unknown],1.0,563.0,,563.0,,,1.0,494.0,
TCGA-DU-A6S3,5049,TCGA-DU-A6S3,LGG,60.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-22038.0,Alive,TUMOR FREE,656.0,,[Not Available],,,,,Stable Disease,,,0.0,656.0,0.0,656.0,,,0.0,656.0,
TCGA-TQ-A7RJ,5392,TCGA-TQ-A7RJ,LGG,25.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-9209.0,Alive,WITH TUMOR,1229.0,,[Not Available],,,,,Stable Disease,,,0.0,1229.0,0.0,1229.0,,,0.0,1229.0,
TCGA-99-8028,6274,TCGA-99-8028,LUAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-18542.0,Alive,TUMOR FREE,1118.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1118.0,0.0,1118.0,0.0,1118.0,0.0,1118.0,
TCGA-PE-A5DE,1577,TCGA-PE-A5DE,BRCA,41.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15216.0,Alive,TUMOR FREE,2645.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,2645.0,0.0,2645.0,,,0.0,2645.0,
TCGA-SP-A6QG,7797,TCGA-SP-A6QG,PCPG,35.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2008.0,[Not Available],-12874.0,Alive,TUMOR FREE,2417.0,,[Not Available],New Primary Tumor,"Other, specify","Breast, left",626.0,Complete Remission/Response,,,0.0,2417.0,0.0,2417.0,0.0,2417.0,1.0,626.0,
TCGA-E6-A1LZ,10911,TCGA-E6-A1LZ,UCEC,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28054.0,Alive,TUMOR FREE,2406.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2406.0,0.0,2406.0,0.0,2406.0,0.0,2406.0,
TCGA-Q1-A73P,1826,TCGA-Q1-A73P,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Type of Adenocarcinoma,G1,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16450.0,Alive,TUMOR FREE,483.0,,,,,,,Complete Remission/Response,,,0.0,483.0,0.0,483.0,0.0,483.0,0.0,483.0,
TCGA-G9-7509,8048,TCGA-G9-7509,PRAD,48.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-17538.0,Alive,TUMOR FREE,1610.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1610.0,0.0,1610.0,0.0,1610.0,0.0,1610.0,
TCGA-G3-A7M7,5721,TCGA-G3-A7M7,LIHC,65.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-24002.0,Alive,TUMOR FREE,361.0,,[Not Available],,,,,[Not Available],,R0,0.0,361.0,0.0,361.0,0.0,361.0,0.0,361.0,
TCGA-E2-A1IE,1359,TCGA-E2-A1IE,BRCA,61.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22510.0,Alive,WITH TUMOR,2362.0,,[Not Available],Distant Metastasis,Liver,,1810.0,[Not Available],Negative,,0.0,2362.0,0.0,2362.0,1.0,1810.0,1.0,1810.0,
TCGA-D8-A1JT,1252,TCGA-D8-A1JT,BRCA,70.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25677.0,Alive,TUMOR FREE,405.0,,[Not Available],,,,,[Not Available],Negative,,0.0,405.0,0.0,405.0,0.0,405.0,0.0,405.0,
TCGA-LK-A4NY,6845,TCGA-LK-A4NY,MESO,66.0,FEMALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2009.0,[Not Available],-24391.0,Dead,TUMOR FREE,,168.0,[Not Available],,,,,[Not Available],,R0,1.0,168.0,0.0,168.0,0.0,168.0,0.0,168.0,
TCGA-UT-A88E,6902,TCGA-UT-A88E,MESO,74.0,MALE,WHITE,Stage I,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-27347.0,Dead,WITH TUMOR,,434.0,[Not Available],Intrapleural Progression,"Other, specify",chest wall musculature invasion,121.0,[Not Available],,RX,1.0,434.0,1.0,434.0,,,1.0,121.0,
TCGA-C8-A12L,1177,TCGA-C8-A12L,BRCA,67.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24710.0,Alive,TUMOR FREE,363.0,,[Not Available],,,,,[Not Available],Negative,,0.0,363.0,0.0,363.0,0.0,363.0,0.0,363.0,
TCGA-CN-6992,3351,TCGA-CN-6992,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-22598.0,Alive,TUMOR FREE,1066.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1066.0,0.0,1066.0,,,0.0,1066.0,
TCGA-KK-A6E8,8187,TCGA-KK-A6E8,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-25026.0,Alive,TUMOR FREE,1770.0,,[Not Available],,,,,[Not Available],,,0.0,1770.0,0.0,1770.0,,,0.0,1770.0,
TCGA-VQ-A94O,9693,TCGA-VQ-A94O,STAD,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-27306.0,Dead,WITH TUMOR,,640.0,Stomach Cancer,Distant Metastasis,Liver,,185.0,Progressive Disease,,,1.0,640.0,1.0,640.0,,,1.0,185.0,
TCGA-B2-5639,4080,TCGA-B2-5639,KIRC,46.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-17045.0,Dead,WITH TUMOR,,1003.0,[Not Available],,,,163.0,Progressive Disease,,,1.0,1003.0,1.0,1003.0,,,1.0,163.0,
TCGA-R3-A69X,397,TCGA-R3-A69X,BLCA,70.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-25576.0,Alive,TUMOR FREE,433.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,433.0,0.0,433.0,0.0,433.0,0.0,433.0,
TCGA-F4-6807,2361,TCGA-F4-6807,COAD,51.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-18690.0,Alive,TUMOR FREE,1309.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1309.0,0.0,1309.0,0.0,1309.0,0.0,1309.0,
TCGA-CJ-5678,4323,TCGA-CJ-5678,KIRC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-22944.0,Dead,WITH TUMOR,,574.0,[Not Available],,,,399.0,[Not Available],,,1.0,574.0,1.0,574.0,,,1.0,399.0,
TCGA-C5-A905,1669,TCGA-C5-A905,CESC,37.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1994.0,[Not Available],-13584.0,Alive,TUMOR FREE,4879.0,,,,,,,[Not Available],,,0.0,4879.0,0.0,4879.0,,,0.0,4879.0,
TCGA-B0-5710,4066,TCGA-B0-5710,KIRC,57.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2008.0,[Not Available],-21168.0,Alive,WITH TUMOR,2430.0,,[Not Available],,,,1441.0,Progressive Disease,,,0.0,2430.0,0.0,2430.0,,,1.0,1441.0,
TCGA-D3-A3MV,8866,TCGA-D3-A3MV,SKCM,38.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2010.0,[Not Available],-14236.0,Alive,TUMOR FREE,1378.0,,[Not Available],Regional lymph node,,,16.0,[Not Available],,,0.0,1378.0,0.0,1378.0,,,1.0,16.0,
TCGA-XF-A8HE,420,TCGA-XF-A8HE,BLCA,47.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,[Not Available],-17212.0,Alive,TUMOR FREE,3817.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3817.0,0.0,3817.0,0.0,3817.0,0.0,3817.0,
TCGA-06-1804,2848,TCGA-06-1804,GBM,81.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-29802.0,Dead,WITH TUMOR,414.0,414.0,[Not Available],,,,,[Not Available],,,1.0,414.0,1.0,414.0,,,1.0,414.0,
TCGA-W2-A7HB,7823,TCGA-W2-A7HB,PCPG,24.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-8979.0,Alive,TUMOR FREE,604.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,604.0,0.0,604.0,0.0,604.0,0.0,604.0,
TCGA-DH-5140,4965,TCGA-DH-5140,LGG,38.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2007.0,[Not Available],-13943.0,Dead,WITH TUMOR,,607.0,[Not Available],,,,,Progressive Disease,,,1.0,607.0,1.0,607.0,,,1.0,607.0,
TCGA-37-4141,6447,TCGA-37-4141,LUSC,65.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-24048.0,Alive,TUMOR FREE,12.0,,[Not Available],,,,,[Not Available],,,0.0,12.0,0.0,12.0,,,0.0,12.0,
TCGA-85-6175,6703,TCGA-85-6175,LUSC,63.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-23228.0,Dead,WITH TUMOR,,294.0,[Not Available],,,,,Stable Disease,,,1.0,294.0,1.0,294.0,,,1.0,294.0,
TCGA-AR-A0U0,909,TCGA-AR-A0U0,BRCA,73.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26993.0,Alive,TUMOR FREE,1988.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1988.0,0.0,1988.0,0.0,1988.0,0.0,1988.0,
TCGA-ET-A25I,10202,TCGA-ET-A25I,THCA,37.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2008.0,[Not Available],-13786.0,Alive,TUMOR FREE,2485.0,,[Not Available],,,,,[Not Available],,R0,0.0,2485.0,0.0,2485.0,0.0,2485.0,0.0,2485.0,
TCGA-VP-A87B,8282,TCGA-VP-A87B,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-23271.0,Alive,WITH TUMOR,2722.0,,[Not Available],New Primary Tumor,Lung,,2473.0,Complete Remission/Response,,,0.0,2722.0,0.0,2722.0,0.0,2722.0,1.0,2473.0,
TCGA-N9-A4Q1,11057,TCGA-N9-A4Q1,UCS,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25791.0,Dead,WITH TUMOR,,2043.0,[Not Available],Distant Metastasis,"Other, specify",Pleural surface,1839.0,Complete Remission/Response,,,1.0,2043.0,1.0,2043.0,1.0,1839.0,1.0,1839.0,
TCGA-SC-A6LP,6869,TCGA-SC-A6LP,MESO,58.0,MALE,WHITE,Stage II,[Not Applicable],Biphasic mesothelioma,[Not Available],2012.0,[Not Available],-21411.0,Dead,WITH TUMOR,,78.0,[Not Available],,,,,[Not Available],,RX,1.0,78.0,1.0,78.0,,,1.0,78.0,
TCGA-A5-A2K5,10518,TCGA-A5-A2K5,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28057.0,Alive,TUMOR FREE,752.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,752.0,0.0,752.0,0.0,752.0,0.0,752.0,
TCGA-CR-6480,3429,TCGA-CR-6480,HNSC,53.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-19472.0,Alive,TUMOR FREE,362.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,362.0,0.0,362.0,,,0.0,362.0,
TCGA-OL-A6VR,1573,TCGA-OL-A6VR,BRCA,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,[Unknown],-17702.0,Alive,TUMOR FREE,1220.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1220.0,0.0,1220.0,0.0,1220.0,0.0,1220.0,
TCGA-3B-A9HJ,8538,TCGA-3B-A9HJ,SARC,68.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2011.0,[Not Available],-24962.0,Alive,TUMOR FREE,1104.0,,[Not Available],,,,,[Not Available],[Unknown],RX,0.0,1104.0,0.0,1104.0,,,0.0,1104.0,
TCGA-A2-A0CL,538,TCGA-A2-A0CL,BRCA,37.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13556.0,Alive,TUMOR FREE,3015.0,,[Not Available],,,,,[Not Available],Positive,,0.0,3015.0,0.0,3015.0,,,0.0,3015.0,
TCGA-14-1034,3013,TCGA-14-1034,GBM,60.0,FEMALE,[Not Available],[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1999.0,[Not Available],-22029.0,Dead,WITH TUMOR,485.0,485.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],282.0,[Not Available],,,1.0,485.0,1.0,485.0,,,1.0,282.0,
TCGA-85-A512,6749,TCGA-85-A512,LUSC,46.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-16811.0,Alive,TUMOR FREE,465.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,465.0,0.0,465.0,0.0,465.0,0.0,465.0,
TCGA-AA-3655,2055,TCGA-AA-3655,COAD,68.0,MALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-24896.0,Alive,TUMOR FREE,1856.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1856.0,0.0,1856.0,0.0,1856.0,0.0,1856.0,
TCGA-VF-A8AC,9795,TCGA-VF-A8AC,TGCT,29.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2011.0,[Not Available],-10598.0,Alive,TUMOR FREE,1083.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,1083.0,0.0,1083.0,0.0,1083.0,0.0,1083.0,
TCGA-E9-A227,1425,TCGA-E9-A227,BRCA,42.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15602.0,Alive,TUMOR FREE,975.0,,[Not Available],,,,,[Not Available],Negative,,0.0,975.0,0.0,975.0,0.0,975.0,0.0,975.0,
TCGA-DA-A3F8,8931,TCGA-DA-A3F8,SKCM,39.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2011.0,[Not Available],-14327.0,Alive,TUMOR FREE,1319.0,,[Not Available],,,,,[Not Available],,,0.0,1319.0,0.0,1319.0,,,0.0,1319.0,
TCGA-CV-A45R,3579,TCGA-CV-A45R,HNSC,46.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1997.0,[Not Available],-17125.0,Alive,TUMOR FREE,5480.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,5480.0,0.0,5480.0,0.0,5480.0,0.0,5480.0,
TCGA-EJ-A46D,7978,TCGA-EJ-A46D,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-19466.0,Alive,TUMOR FREE,626.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,
TCGA-78-7542,6167,TCGA-78-7542,LUAD,56.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],1993.0,[Not Available],-20763.0,Dead,,,321.0,[Not Available],,,,,[Not Available],,,1.0,321.0,,321.0,,,0.0,321.0,
TCGA-MB-A5YA,8726,TCGA-MB-A5YA,SARC,63.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-23115.0,Alive,TUMOR FREE,15.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,15.0,0.0,15.0,0.0,15.0,0.0,15.0,
TCGA-BQ-7062,4569,TCGA-BQ-7062,KIRP,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-23559.0,Alive,TUMOR FREE,116.0,,[Not Available],,,,,[Not Available],,,0.0,116.0,0.0,116.0,,,0.0,116.0,
TCGA-5P-A9K0,4452,TCGA-5P-A9K0,KIRP,75.0,MALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-27434.0,Alive,,677.0,,[Not Available],,,,,[Not Available],,,0.0,677.0,0.0,677.0,,,0.0,677.0,
TCGA-A2-A04W,534,TCGA-A2-A04W,BRCA,50.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18345.0,Alive,TUMOR FREE,3102.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3102.0,0.0,3102.0,0.0,3102.0,0.0,3102.0,
TCGA-55-8090,6017,TCGA-55-8090,LUAD,80.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-29235.0,Dead,WITH TUMOR,,598.0,[Not Available],Distant Metastasis,,,548.0,Complete Remission/Response,,,1.0,598.0,1.0,598.0,1.0,548.0,1.0,548.0,
TCGA-B1-A657,4512,TCGA-B1-A657,KIRP,54.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-19806.0,Alive,TUMOR FREE,641.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,641.0,0.0,641.0,0.0,641.0,0.0,641.0,
TCGA-FA-A4BB,2414,TCGA-FA-A4BB,DLBC,67.0,MALE,WHITE,[Not Applicable],Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2012.0,[Not Available],-24590.0,Alive,TUMOR FREE,132.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,132.0,0.0,132.0,,,0.0,132.0,
TCGA-D3-A5GR,8879,TCGA-D3-A5GR,SKCM,23.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],1998.0,[Not Available],-8637.0,Alive,WITH TUMOR,5424.0,,[Not Available],Regional lymph node,,,0.0,[Not Available],,,0.0,5424.0,0.0,5424.0,,,1.0,0.0,
TCGA-FI-A2EW,10990,TCGA-FI-A2EW,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIB,Serous endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26267.0,Alive,WITH TUMOR,1795.0,,[Not Available],Metastatic,Liver,,1169.0,Complete Remission/Response,,,0.0,1795.0,0.0,1795.0,1.0,1169.0,1.0,1169.0,
TCGA-VS-A9UZ,1882,TCGA-VS-A9UZ,CESC,61.0,FEMALE,WHITE,[Not Available],Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2009.0,Peri (6-12 months since last menstrual period),-22344.0,Alive,TUMOR FREE,2044.0,,,,,,,Complete Remission/Response,,,0.0,2044.0,0.0,2044.0,0.0,2044.0,0.0,2044.0,
TCGA-AR-A24V,944,TCGA-AR-A24V,BRCA,52.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Peri (6-12 months since last menstrual period),-19027.0,Alive,TUMOR FREE,3203.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3203.0,0.0,3203.0,0.0,3203.0,0.0,3203.0,
TCGA-KV-A6GE,4642,TCGA-KV-A6GE,KIRP,65.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-23979.0,Alive,TUMOR FREE,885.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,885.0,0.0,885.0,0.0,885.0,0.0,885.0,
TCGA-E9-A1R2,1409,TCGA-E9-A1R2,BRCA,51.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18936.0,Alive,TUMOR FREE,1063.0,,[Not Available],,,,,[Not Available],Positive,,0.0,1063.0,0.0,1063.0,,,0.0,1063.0,
TCGA-4P-AA8J,3242,TCGA-4P-AA8J,HNSC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-24222.0,Alive,TUMOR FREE,102.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,102.0,0.0,102.0,,,0.0,102.0,
TCGA-V5-A7RE,2617,TCGA-V5-A7RE,ESCA,45.0,MALE,WHITE,Stage IB,Stage IIIA,"Esophagus Adenocarcinoma, NOS",G2,,[Not Available],-16643.0,Alive,WITH TUMOR,500.0,,[Not Available],Distant Metastasis,"Other, specify",bone,294.0,Partial Remission/Response,,,0.0,500.0,0.0,500.0,,,1.0,294.0,
TCGA-YL-A8SF,8326,TCGA-YL-A8SF,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-22844.0,Alive,,1373.0,,[Not Available],,,,,Stable Disease,,,0.0,1373.0,0.0,1373.0,,,0.0,1373.0,
TCGA-EL-A3GX,10067,TCGA-EL-A3GX,THCA,41.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2000.0,[Not Available],-15212.0,Alive,TUMOR FREE,4494.0,,[Not Available],Locoregional Recurrence,"Other, specify",Left Thyroid Bed,439.0,[Not Available],,R0,0.0,4494.0,0.0,4494.0,1.0,439.0,1.0,439.0,
TCGA-HT-7855,5187,TCGA-HT-7855,LGG,39.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-14496.0,Alive,TUMOR FREE,585.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,585.0,0.0,585.0,0.0,585.0,0.0,585.0,
TCGA-EW-A1PB,1478,TCGA-EW-A1PB,BRCA,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25770.0,Alive,TUMOR FREE,608.0,,[Not Available],,,,,[Not Available],Negative,,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,
TCGA-DJ-A2PV,9948,TCGA-DJ-A2PV,THCA,53.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19547.0,Alive,TUMOR FREE,973.0,,[Not Available],,,,,[Not Available],,R0,0.0,973.0,0.0,973.0,0.0,973.0,0.0,973.0,
TCGA-BQ-5875,4535,TCGA-BQ-5875,KIRP,66.0,FEMALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004.0,[Not Available],-24153.0,Alive,TUMOR FREE,2639.0,,[Not Available],,,,,[Not Available],,,0.0,2639.0,0.0,2639.0,,,0.0,2639.0,
TCGA-18-3417,6335,TCGA-18-3417,LUSC,65.0,MALE,[Not Available],Stage IV,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-24019.0,Dead,TUMOR FREE,,1097.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1097.0,0.0,1097.0,,,0.0,1097.0,
TCGA-WK-A8XO,8771,TCGA-WK-A8XO,SARC,66.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2010.0,[Not Available],-24201.0,Dead,WITH TUMOR,,363.0,[Not Available],Locoregional Recurrence,"Other, specify",Abdominal,105.0,[Not Available],Negative,R0,1.0,363.0,1.0,363.0,1.0,105.0,1.0,105.0,
TCGA-EE-A2A0,9024,TCGA-EE-A2A0,SKCM,77.0,FEMALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2006.0,[Not Available],-28319.0,Dead,WITH TUMOR,,1424.0,[Not Available],Distant Metastasis,"Other, Specify",Left Inner Canthus,1247.0,[Not Available],,,1.0,1424.0,1.0,1424.0,,,1.0,1247.0,
TCGA-BH-A1F0,1139,TCGA-BH-A1F0,BRCA,80.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29335.0,Dead,WITH TUMOR,,785.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,785.0,1.0,785.0,,,1.0,785.0,
TCGA-ED-A7PZ,5673,TCGA-ED-A7PZ,LIHC,61.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-22601.0,Alive,TUMOR FREE,6.0,,[Not Available],,,,,[Not Available],,R0,0.0,6.0,0.0,6.0,0.0,6.0,0.0,6.0,
TCGA-CG-4300,9444,TCGA-CG-4300,STAD,79.0,MALE,[Not Available],Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2006.0,[Not Available],-29128.0,Dead,,,609.0,[Not Available],,,,,[Not Available],,,1.0,609.0,,609.0,,,0.0,609.0,
TCGA-BS-A0V6,10810,TCGA-BS-A0V6,UCEC,55.0,FEMALE,ASIAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20369.0,Alive,TUMOR FREE,2725.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2725.0,0.0,2725.0,0.0,2725.0,0.0,2725.0,
TCGA-QH-A6CX,5298,TCGA-QH-A6CX,LGG,66.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-24252.0,Dead,WITH TUMOR,,372.0,[Not Available],,,,273.0,Complete Remission/Response,,,1.0,372.0,1.0,372.0,1.0,273.0,1.0,273.0,
TCGA-RP-A6K9,9225,TCGA-RP-A6K9,SKCM,,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2001.0,[Not Available],,Alive,,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-DS-A3LQ,1687,TCGA-DS-A3LQ,CESC,46.0,FEMALE,[Not Available],[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16861.0,Alive,TUMOR FREE,699.0,,,,,,,Complete Remission/Response,,,0.0,699.0,0.0,699.0,0.0,699.0,0.0,699.0,
TCGA-P3-A6T4,3716,TCGA-P3-A6T4,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-20027.0,Dead,WITH TUMOR,,62.0,[Not Available],,,,,Progressive Disease,,,1.0,62.0,1.0,62.0,,,1.0,62.0,
TCGA-32-1980,3172,TCGA-32-1980,GBM,72.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-26467.0,Dead,WITH TUMOR,36.0,36.0,[Not Available],,,,,[Not Available],,,1.0,36.0,1.0,36.0,,,1.0,36.0,
TCGA-32-5222,3191,TCGA-32-5222,GBM,66.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-24134.0,Dead,WITH TUMOR,,585.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],118.0,[Not Available],,,1.0,585.0,1.0,585.0,,,1.0,118.0,
TCGA-FU-A40J,1764,TCGA-FU-A40J,CESC,38.0,FEMALE,WHITE,[Not Available],Stage IIIB,Endocervical Type of Adenocarcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14182.0,Alive,TUMOR FREE,426.0,,,,,,,Complete Remission/Response,,,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,
TCGA-63-A5MU,6605,TCGA-63-A5MU,LUSC,48.0,MALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-17801.0,Dead,WITH TUMOR,,,[Not Available],Distant Metastasis,,,420.0,Complete Remission/Response,,,1.0,,1.0,,1.0,420.0,1.0,420.0,
TCGA-B0-5692,4050,TCGA-B0-5692,KIRC,66.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-24140.0,Alive,TUMOR FREE,3944.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3944.0,0.0,3944.0,0.0,3944.0,0.0,3944.0,
TCGA-ER-A199,9093,TCGA-ER-A199,SKCM,86.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2007.0,[Not Available],-31661.0,Dead,WITH TUMOR,,279.0,[Not Available],,,,119.0,[Not Available],,,1.0,279.0,1.0,279.0,,,1.0,119.0,
TCGA-77-7142,6666,TCGA-77-7142,LUSC,59.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-21796.0,Alive,TUMOR FREE,2227.0,,[Not Available],,,,,[Not Available],,,0.0,2227.0,0.0,2227.0,,,0.0,2227.0,
TCGA-EY-A215,10967,TCGA-EY-A215,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22076.0,Alive,TUMOR FREE,574.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,574.0,0.0,574.0,0.0,574.0,0.0,574.0,
TCGA-D8-A73X,1302,TCGA-D8-A73X,BRCA,53.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19607.0,Alive,TUMOR FREE,767.0,,[Not Available],,,,,[Not Available],Negative,,0.0,767.0,0.0,767.0,0.0,767.0,0.0,767.0,
TCGA-E7-A5KE,241,TCGA-E7-A5KE,BLCA,78.0,FEMALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-28714.0,Alive,TUMOR FREE,17.0,,[Not Available],,,,,[Not Available],,,0.0,17.0,0.0,17.0,,,0.0,17.0,
TCGA-K4-A5RH,378,TCGA-K4-A5RH,BLCA,69.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-25305.0,Alive,WITH TUMOR,276.0,,[Not Available],Distant Metastasis,Lung,,196.0,Progressive Disease,,,0.0,276.0,0.0,276.0,,,1.0,196.0,
TCGA-BP-5198,4262,TCGA-BP-5198,KIRC,72.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2008.0,[Not Available],-26360.0,Alive,TUMOR FREE,603.0,,[Not Available],,,,,[Not Available],,,0.0,603.0,0.0,603.0,,,0.0,603.0,
TCGA-CV-A463,3589,TCGA-CV-A463,HNSC,82.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-30095.0,Dead,TUMOR FREE,,23.0,[Not Available],,,,,Complete Remission/Response,,,1.0,23.0,0.0,23.0,,,0.0,23.0,
TCGA-HC-7744,8082,TCGA-HC-7744,PRAD,46.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-17065.0,Alive,TUMOR FREE,531.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,531.0,0.0,531.0,0.0,531.0,0.0,531.0,
TCGA-ER-A42K,9126,TCGA-ER-A42K,SKCM,40.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-14628.0,Dead,WITH TUMOR,,394.0,[Not Available],,,,206.0,[Not Available],,,1.0,394.0,1.0,394.0,,,1.0,206.0,
TCGA-AG-3742,8415,TCGA-AG-3742,READ,85.0,FEMALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2004.0,[Not Available],-31078.0,Alive,WITH TUMOR,30.0,,[Not Available],,,,,[Not Available],,,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-BR-8678,9381,TCGA-BR-8678,STAD,76.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-28037.0,Alive,TUMOR FREE,754.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,754.0,0.0,754.0,0.0,754.0,0.0,754.0,
TCGA-CJ-4923,4317,TCGA-CJ-4923,KIRC,63.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-23353.0,Dead,WITH TUMOR,,572.0,[Not Available],,,,25.0,[Not Available],,,1.0,572.0,1.0,572.0,,,1.0,25.0,
TCGA-DU-A5TU,5045,TCGA-DU-A5TU,LGG,62.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-22811.0,Alive,WITH TUMOR,796.0,,[Not Available],,,,186.0,Progressive Disease,,,0.0,796.0,0.0,796.0,,,1.0,186.0,
TCGA-BR-4363,9294,TCGA-BR-4363,STAD,60.0,FEMALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-22196.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-97-8179,6261,TCGA-97-8179,LUAD,72.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26305.0,Alive,TUMOR FREE,435.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,435.0,0.0,435.0,0.0,435.0,0.0,435.0,
TCGA-44-A479,5895,TCGA-44-A479,LUAD,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27024.0,Alive,TUMOR FREE,486.0,,[Not Available],New Primary Tumor,,,437.0,Complete Remission/Response,,,0.0,486.0,0.0,486.0,0.0,486.0,1.0,437.0,
TCGA-F7-A624,3656,TCGA-F7-A624,HNSC,73.0,MALE,WHITE,Stage II,[Not Available],Head & Neck Squamous Cell Carcinoma,G3,2012.0,[Not Available],-26667.0,Alive,TUMOR FREE,378.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,
TCGA-55-8094,6020,TCGA-55-8094,LUAD,51.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-18903.0,Alive,WITH TUMOR,541.0,,[Not Available],,,,,Progressive Disease,,,0.0,541.0,0.0,541.0,,,0.0,541.0,
TCGA-VD-A8KK,11129,TCGA-VD-A8KK,UVM,54.0,MALE,[Not Evaluated],Stage IIIA,Stage IIIA,Spindle Cell,[Not Available],2013.0,[Not Available],-19958.0,Alive,TUMOR FREE,64.0,,[Not Available],,,,,[Not Available],,,0.0,64.0,0.0,64.0,,,0.0,64.0,
TCGA-26-6173,3114,TCGA-26-6173,GBM,57.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-21093.0,Alive,TUMOR FREE,241.0,,[Not Available],,,,,[Not Available],,,0.0,241.0,0.0,241.0,,,0.0,241.0,
TCGA-06-0213,2804,TCGA-06-0213,GBM,55.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-20134.0,Dead,WITH TUMOR,6.0,16.0,[Not Available],,,,,[Not Available],,,1.0,16.0,1.0,16.0,,,1.0,16.0,
TCGA-HQ-A2OF,369,TCGA-HQ-A2OF,BLCA,52.0,FEMALE,[Not Evaluated],Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-19016.0,Alive,TUMOR FREE,1947.0,,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,907.0,Complete Remission/Response,,,0.0,1947.0,0.0,1947.0,1.0,907.0,1.0,907.0,
TCGA-4Z-AA7W,105,TCGA-4Z-AA7W,BLCA,55.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-20424.0,Alive,WITH TUMOR,840.0,,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Rectum,760.0,Complete Remission/Response,,,0.0,840.0,0.0,840.0,1.0,760.0,1.0,760.0,
TCGA-G3-A5SL,5716,TCGA-G3-A5SL,LIHC,70.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-25671.0,Alive,TUMOR FREE,621.0,,[Not Available],,,,,[Not Available],,R0,0.0,621.0,0.0,621.0,0.0,621.0,0.0,621.0,
TCGA-EW-A1P3,1471,TCGA-EW-A1P3,BRCA,48.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17637.0,Alive,TUMOR FREE,1611.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0,
TCGA-CC-A8HT,5507,TCGA-CC-A8HT,LIHC,74.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-27334.0,Dead,WITH TUMOR,,140.0,[Not Available],Locoregional Recurrence,,,83.0,[Not Available],,R0,1.0,140.0,1.0,140.0,1.0,83.0,1.0,83.0,
TCGA-AX-A1C4,10630,TCGA-AX-A1C4,UCEC,52.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Indeterminate (neither Pre or Postmenopausal),-19209.0,Alive,TUMOR FREE,404.0,,[Not Available],,,,,[Not Applicable],,,0.0,404.0,0.0,404.0,,,0.0,404.0,
TCGA-BC-A8YO,5475,TCGA-BC-A8YO,LIHC,66.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-24189.0,Alive,WITH TUMOR,562.0,,[Not Available],Locoregional Recurrence,Liver,,220.0,[Not Available],,R0,0.0,562.0,0.0,562.0,1.0,220.0,1.0,220.0,
TCGA-75-7031,6140,TCGA-75-7031,LUAD,,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],,Alive,TUMOR FREE,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-CJ-4907,4310,TCGA-CJ-4907,KIRC,58.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-21208.0,Alive,TUMOR FREE,1499.0,,[Not Available],,,,,[Not Available],,,0.0,1499.0,0.0,1499.0,,,0.0,1499.0,
TCGA-43-6771,6479,TCGA-43-6771,LUSC,85.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-31052.0,Dead,WITH TUMOR,,166.0,[Not Available],,,,154.0,Progressive Disease,,,1.0,166.0,1.0,166.0,,,1.0,154.0,
TCGA-D3-A2JH,8846,TCGA-D3-A2JH,SKCM,68.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2010.0,[Not Available],-24882.0,Alive,TUMOR FREE,1280.0,,[Not Available],Distant Metastasis,Brain,,569.0,[Not Available],,,0.0,1280.0,0.0,1280.0,,,1.0,569.0,
TCGA-EE-A29D,9009,TCGA-EE-A29D,SKCM,87.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-31790.0,Dead,,,425.0,[Not Available],,,,,[Not Available],,,1.0,425.0,,425.0,,,0.0,425.0,
TCGA-56-8626,6536,TCGA-56-8626,LUSC,59.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-21908.0,Dead,TUMOR FREE,,302.0,[Not Available],,,,,Complete Remission/Response,,,1.0,302.0,0.0,302.0,0.0,302.0,0.0,302.0,
TCGA-IA-A40U,4627,TCGA-IA-A40U,KIRP,56.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-20463.0,Alive,TUMOR FREE,511.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,511.0,0.0,511.0,0.0,511.0,0.0,511.0,
TCGA-D1-A16R,10849,TCGA-D1-A16R,UCEC,39.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Indeterminate (neither Pre or Postmenopausal),-14465.0,Alive,TUMOR FREE,21.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,21.0,0.0,21.0,0.0,21.0,0.0,21.0,
TCGA-55-7576,5998,TCGA-55-7576,LUAD,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-19917.0,Alive,TUMOR FREE,670.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,670.0,0.0,670.0,0.0,670.0,0.0,670.0,
TCGA-78-7145,6142,TCGA-78-7145,LUAD,52.0,FEMALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2000.0,[Not Available],-19080.0,Dead,WITH TUMOR,,826.0,[Not Available],,,,422.0,[Not Available],,,1.0,826.0,1.0,826.0,,,1.0,422.0,
TCGA-A6-6780,2004,TCGA-A6-6780,COAD,74.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-27250.0,Alive,TUMOR FREE,612.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,612.0,0.0,612.0,0.0,612.0,0.0,612.0,
TCGA-CV-A45Z,3586,TCGA-CV-A45Z,HNSC,75.0,MALE,WHITE,[Discrepancy],Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,[Not Available],-27397.0,Dead,WITH TUMOR,,1466.0,[Not Available],,,,,[Not Available],,,1.0,1466.0,1.0,1466.0,,,1.0,1466.0,
TCGA-C8-A27A,1217,TCGA-C8-A27A,BRCA,48.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Peri (6-12 months since last menstrual period),-17779.0,Alive,TUMOR FREE,747.0,,[Not Available],,,,,[Not Available],Negative,,0.0,747.0,0.0,747.0,0.0,747.0,0.0,747.0,
TCGA-EL-A3ZN,10098,TCGA-EL-A3ZN,THCA,28.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-10266.0,Alive,TUMOR FREE,1614.0,,[Not Available],,,,,[Not Available],,R0,0.0,1614.0,0.0,1614.0,0.0,1614.0,0.0,1614.0,
TCGA-JV-A75J,8710,TCGA-JV-A75J,SARC,43.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2013.0,[Not Available],-16001.0,Dead,WITH TUMOR,,119.0,[Not Available],,,,,[Not Available],Positive,R2,1.0,119.0,1.0,119.0,,,1.0,119.0,
TCGA-BJ-A0Z9,9851,TCGA-BJ-A0Z9,THCA,57.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-21061.0,Alive,TUMOR FREE,1257.0,,[Not Available],,,,,[Not Available],,R1,0.0,1257.0,0.0,1257.0,,,0.0,1257.0,
TCGA-G7-A8LE,4607,TCGA-G7-A8LE,KIRP,62.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-22810.0,Alive,TUMOR FREE,2453.0,,[Not Available],,,,1447.0,Complete Remission/Response,,,0.0,2453.0,0.0,2453.0,1.0,1447.0,1.0,1447.0,
TCGA-16-0848,3047,TCGA-16-0848,GBM,57.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-20848.0,Dead,WITH TUMOR,302.0,535.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],129.0,[Not Available],,,1.0,535.0,1.0,535.0,,,1.0,129.0,
TCGA-3A-A9IU,7538,TCGA-3A-A9IU,PAAD,65.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-23998.0,Dead,WITH TUMOR,,458.0,Pancreatic Cancer,Distant Metastasis,Liver,,371.0,[Unknown],,,1.0,458.0,1.0,458.0,,,1.0,371.0,
TCGA-CA-5256,2236,TCGA-CA-5256,COAD,54.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-19785.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-38-4628,5845,TCGA-38-4628,LUAD,65.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-24057.0,Dead,WITH TUMOR,,1492.0,[Not Available],,,,1083.0,Complete Remission/Response,,,1.0,1492.0,1.0,1492.0,1.0,1083.0,1.0,1083.0,
TCGA-H9-A6BY,8060,TCGA-H9-A6BY,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-23297.0,Alive,,112.0,,[Not Available],,,,,[Unknown],,,0.0,112.0,0.0,112.0,,,0.0,112.0,
TCGA-HE-A5NL,4626,TCGA-HE-A5NL,KIRP,51.0,MALE,[Not Evaluated],Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-18913.0,Alive,TUMOR FREE,767.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,767.0,0.0,767.0,0.0,767.0,0.0,767.0,
TCGA-W2-A7HD,7825,TCGA-W2-A7HD,PCPG,76.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-27962.0,Alive,TUMOR FREE,561.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,561.0,0.0,561.0,0.0,561.0,0.0,561.0,
TCGA-EL-A4K1,10110,TCGA-EL-A4K1,THCA,68.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-24846.0,Alive,TUMOR FREE,1046.0,,[Not Available],,,,,[Not Available],,R0,0.0,1046.0,0.0,1046.0,0.0,1046.0,0.0,1046.0,
TCGA-GM-A5PV,1519,TCGA-GM-A5PV,BRCA,63.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23215.0,Alive,TUMOR FREE,412.0,,[Not Available],,,,,[Not Available],Negative,,0.0,412.0,0.0,412.0,0.0,412.0,0.0,412.0,
TCGA-FG-A70Z,5133,TCGA-FG-A70Z,LGG,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-19717.0,Alive,WITH TUMOR,328.0,,[Not Available],,,,,Stable Disease,,,0.0,328.0,0.0,328.0,,,0.0,328.0,
TCGA-55-8208,6028,TCGA-55-8208,LUAD,73.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26716.0,Alive,WITH TUMOR,674.0,,[Not Available],Distant Metastasis,,,511.0,Complete Remission/Response,,,0.0,674.0,0.0,674.0,1.0,511.0,1.0,511.0,
TCGA-V1-A8MJ,8238,TCGA-V1-A8MJ,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-21535.0,Alive,,1791.0,,[Not Available],,,,,Progressive Disease,,,0.0,1791.0,0.0,1791.0,,,0.0,1791.0,
TCGA-HW-8319,5251,TCGA-HW-8319,LGG,34.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2011.0,[Not Available],-12557.0,Dead,WITH TUMOR,,1209.0,[Not Available],,,,997.0,Partial Remission/Response,,,1.0,1209.0,1.0,1209.0,,,1.0,997.0,
TCGA-62-A46O,6064,TCGA-62-A46O,LUAD,65.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-24050.0,Dead,WITH TUMOR,,1454.0,[Not Available],Locoregional Recurrence|Distant Metastasis,,,943.0,Complete Remission/Response,,,1.0,1454.0,1.0,1454.0,1.0,943.0,1.0,943.0,
TCGA-HU-8604,9563,TCGA-HU-8604,STAD,82.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-30178.0,Alive,TUMOR FREE,694.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,694.0,0.0,694.0,0.0,694.0,0.0,694.0,
TCGA-3G-AB0O,10352,TCGA-3G-AB0O,THYM,47.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type B1,[Not Available],2009.0,[Not Available],-17528.0,Alive,TUMOR FREE,2086.0,,[Not Available],,,,,[Not Available],,,0.0,2086.0,0.0,2086.0,,,0.0,2086.0,
TCGA-B9-4617,4524,TCGA-B9-4617,KIRP,41.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-15053.0,Alive,TUMOR FREE,35.0,,[Not Available],,,,,[Not Available],,,0.0,35.0,0.0,35.0,,,0.0,35.0,
TCGA-FD-A3SR,273,TCGA-FD-A3SR,BLCA,68.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-24979.0,Dead,WITH TUMOR,,602.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",pelvis,372.0,[Unknown],,,1.0,602.0,1.0,602.0,,,1.0,372.0,
TCGA-39-5030,6461,TCGA-39-5030,LUSC,81.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-29893.0,Dead,,59.0,59.0,[Not Available],,,,,Complete Remission/Response,,,1.0,59.0,,59.0,0.0,59.0,0.0,59.0,
TCGA-A2-A0ST,570,TCGA-A2-A0ST,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22922.0,Alive,WITH TUMOR,3017.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3017.0,0.0,3017.0,0.0,3017.0,0.0,3017.0,
TCGA-05-4433,5830,TCGA-05-4433,LUAD,82.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-30194.0,Alive,TUMOR FREE,730.0,,[Not Available],,,,,[Not Applicable],,,0.0,730.0,0.0,730.0,,,0.0,730.0,
TCGA-IB-A7M4,7645,TCGA-IB-A7M4,PAAD,81.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,[Not Available],-29792.0,Alive,TUMOR FREE,483.0,,,,,,,Complete Remission/Response,,,0.0,483.0,0.0,483.0,0.0,483.0,0.0,483.0,
TCGA-CJ-5684,4329,TCGA-CJ-5684,KIRC,61.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-22561.0,Alive,TUMOR FREE,2231.0,,[Not Available],,,,,[Not Available],,,0.0,2231.0,0.0,2231.0,,,0.0,2231.0,
TCGA-D8-A1XK,1266,TCGA-D8-A1XK,BRCA,55.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20092.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,[Not Available],Negative,,0.0,441.0,0.0,441.0,0.0,441.0,0.0,441.0,
TCGA-EL-A3CX,10051,TCGA-EL-A3CX,THCA,22.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005.0,[Not Available],-8344.0,Alive,TUMOR FREE,3243.0,,[Not Available],,,,,[Not Available],,R0,0.0,3243.0,0.0,3243.0,0.0,3243.0,0.0,3243.0,
TCGA-IS-A3K8,8703,TCGA-IS-A3K8,SARC,44.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2002.0,[Not Available],-16265.0,Alive,TUMOR FREE,4845.0,,[Not Available],,,,,[Not Available],[Not Available],R0,0.0,4845.0,0.0,4845.0,0.0,4845.0,0.0,4845.0,
TCGA-W2-A7HA,7822,TCGA-W2-A7HA,PCPG,63.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-23059.0,Alive,TUMOR FREE,36.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,36.0,0.0,36.0,0.0,36.0,0.0,36.0,
TCGA-RW-A681,7762,TCGA-RW-A681,PCPG,56.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-20812.0,Alive,TUMOR FREE,1141.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1141.0,0.0,1141.0,0.0,1141.0,0.0,1141.0,
TCGA-06-0137,2750,TCGA-06-0137,GBM,63.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-23273.0,Dead,WITH TUMOR,702.0,812.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],487.0,[Not Available],,,1.0,812.0,1.0,812.0,,,1.0,487.0,
TCGA-ZG-A9MC,8363,TCGA-ZG-A9MC,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-25477.0,Alive,WITH TUMOR,455.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,455.0,0.0,455.0,,,0.0,455.0,
TCGA-V1-A9ZK,8265,TCGA-V1-A9ZK,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-25185.0,Alive,TUMOR FREE,1383.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1383.0,0.0,1383.0,0.0,1383.0,0.0,1383.0,
TCGA-6D-AA2E,3884,TCGA-6D-AA2E,KIRC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2013.0,[Not Available],-25043.0,Alive,TUMOR FREE,362.0,,[Not Available],,,,,[Unknown],,,0.0,362.0,0.0,362.0,,,0.0,362.0,
TCGA-AZ-4308,2213,TCGA-AZ-4308,COAD,47.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-17321.0,Alive,TUMOR FREE,3324.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3324.0,0.0,3324.0,0.0,3324.0,0.0,3324.0,
TCGA-BP-4988,4221,TCGA-BP-4988,KIRC,72.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-26576.0,Dead,TUMOR FREE,,828.0,[Not Available],,,,,[Not Available],,,1.0,828.0,0.0,828.0,,,0.0,828.0,
TCGA-DK-A1AF,189,TCGA-DK-A1AF,BLCA,84.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-30914.0,Alive,TUMOR FREE,536.0,,[Not Available],Metastatic,Lymph Node Only,,283.0,Progressive Disease,,,0.0,536.0,0.0,536.0,,,1.0,283.0,
TCGA-ED-A7PX,5671,TCGA-ED-A7PX,LIHC,48.0,FEMALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-17638.0,Alive,TUMOR FREE,6.0,,[Not Available],,,,,[Not Available],,R0,0.0,6.0,0.0,6.0,0.0,6.0,0.0,6.0,
TCGA-KL-8336,3783,TCGA-KL-8336,KICH,51.0,FEMALE,WHITE,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-18821.0,Dead,WITH TUMOR,,920.0,[Not Available],,,,47.0,[Unknown],,,1.0,920.0,1.0,920.0,,,1.0,47.0,
TCGA-B5-A1MZ,10722,TCGA-B5-A1MZ,UCEC,54.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Indeterminate (neither Pre or Postmenopausal),-19955.0,Alive,TUMOR FREE,1598.0,,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,613.0,Complete Remission/Response,,,0.0,1598.0,0.0,1598.0,1.0,613.0,1.0,613.0,
TCGA-XE-AANV,9813,TCGA-XE-AANV,TGCT,52.0,MALE,[Unknown],Stage IB,Stage IB,Seminoma; NOS,[Not Available],2010.0,[Not Available],-19112.0,Alive,TUMOR FREE,1701.0,,[Not Applicable],Locoregional Recurrence,Lymph Node(s),,1370.0,No Measureable Tumor or Tumor Markers,,,0.0,1701.0,0.0,1701.0,1.0,1370.0,1.0,1370.0,
TCGA-2G-AAGC,9737,TCGA-2G-AAGC,TGCT,28.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2007.0,[Not Available],-10518.0,Alive,TUMOR FREE,2585.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,317.0,Complete Remission/Response,,,0.0,2585.0,0.0,2585.0,1.0,317.0,1.0,317.0,
TCGA-D7-A74A,9527,TCGA-D7-A74A,STAD,61.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2013.0,[Not Available],-22435.0,Alive,TUMOR FREE,607.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,
TCGA-CV-6003,3490,TCGA-CV-6003,HNSC,50.0,FEMALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-18600.0,Alive,TUMOR FREE,1665.0,,[Not Available],,,,,[Not Available],,,0.0,1665.0,0.0,1665.0,,,0.0,1665.0,
TCGA-85-7699,6710,TCGA-85-7699,LUSC,73.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26965.0,Dead,WITH TUMOR,,1001.0,[Not Available],Distant Metastasis,,,760.0,Complete Remission/Response,,,1.0,1001.0,1.0,1001.0,1.0,760.0,1.0,760.0,
TCGA-CV-5442,3479,TCGA-CV-5442,HNSC,76.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2004.0,[Not Available],-28040.0,Alive,TUMOR FREE,2327.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2327.0,0.0,2327.0,,,0.0,2327.0,
TCGA-EB-A44O,8957,TCGA-EB-A44O,SKCM,69.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-25537.0,Alive,WITH TUMOR,81.0,,[Not Available],Regional lymph node,,,60.0,[Not Available],,,0.0,81.0,0.0,81.0,,,1.0,60.0,
TCGA-D3-A51J,8871,TCGA-D3-A51J,SKCM,19.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2001.0,[Not Available],-7194.0,Alive,TUMOR FREE,4414.0,,[Not Available],Regional lymph node,,,2008.0,[Not Available],,,0.0,4414.0,0.0,4414.0,,,1.0,2008.0,
TCGA-55-8511,6037,TCGA-55-8511,LUAD,73.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26986.0,Alive,WITH TUMOR,552.0,,[Not Available],,,,460.0,Complete Remission/Response,,,0.0,552.0,0.0,552.0,1.0,460.0,1.0,460.0,
TCGA-TQ-A7RG,5389,TCGA-TQ-A7RG,LGG,36.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-13227.0,Alive,WITH TUMOR,599.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,599.0,0.0,599.0,,,0.0,599.0,
TCGA-VR-A8EZ,2630,TCGA-VR-A8EZ,ESCA,47.0,MALE,WHITE,Stage IIIC,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-17449.0,Dead,WITH TUMOR,,553.0,[Not Available],Distant Metastasis,Bone,,379.0,,,,1.0,553.0,1.0,553.0,,,1.0,379.0,
TCGA-BR-8484,9370,TCGA-BR-8484,STAD,61.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-22583.0,Dead,TUMOR FREE,,766.0,[Not Available],,,,,Complete Remission/Response,,,1.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,
TCGA-CZ-5986,4390,TCGA-CZ-5986,KIRC,61.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-22456.0,Alive,TUMOR FREE,373.0,,[Not Available],,,,,[Not Available],,,0.0,373.0,0.0,373.0,,,0.0,373.0,
TCGA-BA-6870,3259,TCGA-BA-6870,HNSC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IVC,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-22222.0,Dead,,,451.0,[Not Available],,,,,[Not Available],,,1.0,451.0,,451.0,,,0.0,451.0,
TCGA-DX-A3M2,8582,TCGA-DX-A3M2,SARC,59.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2011.0,[Not Available],-21689.0,Alive,WITH TUMOR,1055.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,1055.0,0.0,1055.0,,,0.0,1055.0,
TCGA-FG-5963,5099,TCGA-FG-5963,LGG,23.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-8571.0,Dead,WITH TUMOR,,775.0,[Not Available],,,,395.0,Progressive Disease,,,1.0,775.0,1.0,775.0,,,1.0,395.0,
TCGA-CZ-5984,4388,TCGA-CZ-5984,KIRC,51.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-18775.0,Alive,TUMOR FREE,2067.0,,[Not Available],,,,,[Not Available],,,0.0,2067.0,0.0,2067.0,,,0.0,2067.0,
TCGA-VQ-A8PS,9667,TCGA-VQ-A8PS,STAD,76.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,[Not Available],-28035.0,Dead,WITH TUMOR,,406.0,Stomach Cancer,Distant Metastasis,Liver,,131.0,Progressive Disease,,,1.0,406.0,1.0,406.0,,,1.0,131.0,
TCGA-A2-A25E,609,TCGA-A2-A25E,BRCA,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12601.0,Alive,TUMOR FREE,3204.0,,[Not Available],Locoregional Recurrence,"Other, specify",Left Chest Wall,2989.0,[Not Available],Negative,,0.0,3204.0,0.0,3204.0,1.0,2989.0,1.0,2989.0,
TCGA-IN-A6RN,9599,TCGA-IN-A6RN,STAD,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-26409.0,Alive,TUMOR FREE,594.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,
TCGA-BQ-5880,4540,TCGA-BQ-5880,KIRP,79.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-29053.0,Dead,WITH TUMOR,,1314.0,[Not Available],,,,972.0,[Not Available],,,1.0,1314.0,1.0,1314.0,,,1.0,972.0,
TCGA-X2-A95T,8780,TCGA-X2-A95T,SARC,49.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2009.0,[Not Available],-18079.0,Alive,TUMOR FREE,1927.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1927.0,0.0,1927.0,0.0,1927.0,0.0,1927.0,
TCGA-V1-A9OY,8259,TCGA-V1-A9OY,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-21170.0,Alive,,1067.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1067.0,0.0,1067.0,0.0,1067.0,0.0,1067.0,
TCGA-55-7573,5996,TCGA-55-7573,LUAD,72.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26302.0,Alive,TUMOR FREE,487.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,487.0,0.0,487.0,0.0,487.0,0.0,487.0,
TCGA-BR-7723,9330,TCGA-BR-7723,STAD,59.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-21839.0,Dead,WITH TUMOR,,874.0,[Not Available],Distant Metastasis,Liver,,559.0,Complete Remission/Response,,,1.0,874.0,1.0,874.0,1.0,559.0,1.0,559.0,
TCGA-HC-8256,8097,TCGA-HC-8256,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19598.0,Alive,TUMOR FREE,860.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,860.0,0.0,860.0,0.0,860.0,0.0,860.0,
TCGA-A3-3326,3898,TCGA-A3-3326,KIRC,47.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2006.0,[Not Available],-17285.0,Alive,TUMOR FREE,1137.0,,[Not Available],,,,,[Not Available],,,0.0,1137.0,0.0,1137.0,,,0.0,1137.0,
TCGA-CQ-5331,3383,TCGA-CQ-5331,HNSC,73.0,FEMALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-26901.0,Alive,TUMOR FREE,1399.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1399.0,0.0,1399.0,,,0.0,1399.0,
TCGA-DI-A2QY,10909,TCGA-DI-A2QY,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23398.0,Dead,TUMOR FREE,,3349.0,[Not Available],,,,,Complete Remission/Response,,,1.0,3349.0,0.0,3349.0,0.0,3349.0,0.0,3349.0,
TCGA-CQ-7065,3400,TCGA-CQ-7065,HNSC,40.0,MALE,ASIAN,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-14676.0,Alive,TUMOR FREE,1628.0,,[Not Available],,Oral Cavity,,230.0,Complete Remission/Response,,,0.0,1628.0,0.0,1628.0,1.0,230.0,1.0,230.0,
TCGA-LN-A4A9,2578,TCGA-LN-A4A9,ESCA,58.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G1,2012.0,[Not Available],-21217.0,Dead,WITH TUMOR,,351.0,[Not Available],Locoregional Recurrence,,,274.0,Complete Remission/Response,,,1.0,351.0,1.0,351.0,1.0,274.0,1.0,274.0,
TCGA-B8-A7U6,4123,TCGA-B8-A7U6,KIRC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2013.0,[Not Available],-19803.0,Alive,TUMOR FREE,495.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,495.0,0.0,495.0,0.0,495.0,0.0,495.0,
TCGA-B5-A0KB,10693,TCGA-B5-A0KB,UCEC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22669.0,Alive,WITH TUMOR,824.0,,[Not Available],Locoregional Disease,"Other, specify",cul de sac mass,689.0,Complete Remission/Response,,,0.0,824.0,0.0,824.0,1.0,689.0,1.0,689.0,
TCGA-YJ-A8SW,8315,TCGA-YJ-A8SW,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2008.0,[Not Available],,Alive,,148.0,,[Not Available],,,,,[Unknown],,,0.0,148.0,0.0,148.0,,,0.0,148.0,
TCGA-HG-A2PA,1769,TCGA-HG-A2PA,CESC,38.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G2,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14025.0,Dead,WITH TUMOR,,773.0,,,,,,Complete Remission/Response,,,1.0,773.0,1.0,773.0,,,1.0,773.0,
TCGA-EO-A2CG,10928,TCGA-EO-A2CG,UCEC,69.0,FEMALE,ASIAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25279.0,Alive,TUMOR FREE,1564.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1564.0,0.0,1564.0,0.0,1564.0,0.0,1564.0,
TCGA-DF-A2KN,10893,TCGA-DF-A2KN,UCEC,,FEMALE,[Not Evaluated],[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,TUMOR FREE,67.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,67.0,0.0,67.0,0.0,67.0,0.0,67.0,
TCGA-A7-A3RF,654,TCGA-A7-A3RF,BRCA,79.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29184.0,Alive,WITH TUMOR,408.0,,[Not Available],Distant Metastasis,Bone,,174.0,[Not Available],Negative,,0.0,408.0,0.0,408.0,1.0,174.0,1.0,174.0,
TCGA-OR-A5JK,20,TCGA-OR-A5JK,ACC,49.0,MALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-18214.0,Alive,TUMOR FREE,1497.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1497.0,0.0,1497.0,,,0.0,1497.0,
TCGA-DU-7299,5025,TCGA-DU-7299,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2006.0,[Not Available],-12266.0,Dead,WITH TUMOR,,1339.0,[Not Available],,,,675.0,Progressive Disease,,,1.0,1339.0,1.0,1339.0,,,1.0,675.0,
TCGA-92-8063,6763,TCGA-92-8063,LUSC,52.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-19193.0,Alive,TUMOR FREE,122.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,122.0,0.0,122.0,0.0,122.0,0.0,122.0,
TCGA-BR-7716,9327,TCGA-BR-7716,STAD,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-22829.0,Alive,TUMOR FREE,1210.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1210.0,0.0,1210.0,0.0,1210.0,0.0,1210.0,
TCGA-EM-A3AI,10160,TCGA-EM-A3AI,THCA,67.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-24820.0,Alive,TUMOR FREE,685.0,,[Not Available],,,,,[Not Available],,R0,0.0,685.0,0.0,685.0,0.0,685.0,0.0,685.0,
TCGA-ET-A39L,10222,TCGA-ET-A39L,THCA,20.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-7636.0,Alive,TUMOR FREE,3299.0,,[Not Available],,,,,[Not Available],,R0,0.0,3299.0,0.0,3299.0,0.0,3299.0,0.0,3299.0,
TCGA-DJ-A3UY,9979,TCGA-DJ-A3UY,THCA,32.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-12004.0,Alive,TUMOR FREE,1091.0,,[Not Available],,,,,[Not Available],,R0,0.0,1091.0,0.0,1091.0,0.0,1091.0,0.0,1091.0,
TCGA-YL-A8HM,8319,TCGA-YL-A8HM,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-24121.0,Alive,WITH TUMOR,1482.0,,[Not Available],Biochemical evidence of disease,,,1473.0,Complete Remission/Response,,,0.0,1482.0,0.0,1482.0,1.0,1473.0,1.0,1473.0,
TCGA-DF-A2KR,10894,TCGA-DF-A2KR,UCEC,84.0,FEMALE,[Not Evaluated],[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31007.0,Alive,TUMOR FREE,2178.0,,[Not Available],New Primary Tumor,Lung,,2113.0,Complete Remission/Response,,,0.0,2178.0,0.0,2178.0,0.0,2178.0,1.0,2113.0,
TCGA-DJ-A2Q9,9962,TCGA-DJ-A2Q9,THCA,65.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-23951.0,Alive,TUMOR FREE,1092.0,,[Not Available],,,,,[Not Available],,R0,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,
TCGA-87-5896,3237,TCGA-87-5896,GBM,50.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-18391.0,Alive,TUMOR FREE,800.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,800.0,0.0,800.0,0.0,800.0,0.0,800.0,
TCGA-B5-A1MY,10721,TCGA-B5-A1MY,UCEC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22805.0,Dead,WITH TUMOR,,361.0,[Not Available],Locoregional Disease,"Other, specify",peritoneum,333.0,[Not Available],,,1.0,361.0,1.0,361.0,,,1.0,333.0,
TCGA-WX-AA46,5784,TCGA-WX-AA46,LIHC,61.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-22639.0,Alive,TUMOR FREE,756.0,,[Not Available],,,,,[Not Available],,R0,0.0,756.0,0.0,756.0,0.0,756.0,0.0,756.0,
TCGA-BB-A5HU,3295,TCGA-BB-A5HU,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-17502.0,Alive,TUMOR FREE,782.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,782.0,0.0,782.0,,,0.0,782.0,
TCGA-VD-AA8T,11141,TCGA-VD-AA8T,UVM,83.0,FEMALE,[Not Evaluated],Stage IIA,Stage IIB,Spindle Cell,[Not Available],2013.0,[Not Available],-30475.0,Alive,TUMOR FREE,49.0,,[Not Available],,,,,[Not Available],,,0.0,49.0,0.0,49.0,,,0.0,49.0,
TCGA-DM-A1D0,2329,TCGA-DM-A1D0,COAD,79.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2001.0,[Not Available],-28875.0,Alive,,3974.0,,[Not Available],,,,,[Not Available],,,0.0,3974.0,0.0,3974.0,,,0.0,3974.0,
TCGA-AK-3451,3953,TCGA-AK-3451,KIRC,48.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-17859.0,Alive,TUMOR FREE,2868.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2868.0,0.0,2868.0,0.0,2868.0,0.0,2868.0,
TCGA-AR-A1AV,928,TCGA-AR-A1AV,BRCA,68.0,MALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,[Not Available],-24875.0,Alive,TUMOR FREE,1864.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1864.0,0.0,1864.0,0.0,1864.0,0.0,1864.0,
TCGA-DX-A6BB,8607,TCGA-DX-A6BB,SARC,74.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-27150.0,Alive,WITH TUMOR,1105.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,1105.0,0.0,1105.0,,,0.0,1105.0,
TCGA-QS-A8F1,11019,TCGA-QS-A8F1,UCEC,85.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31386.0,Dead,WITH TUMOR,,135.0,[Not Available],,,,,Progressive Disease,,,1.0,135.0,1.0,135.0,,,1.0,135.0,
TCGA-BC-A10X,5463,TCGA-BC-A10X,LIHC,52.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2002.0,[Not Available],-19140.0,Dead,TUMOR FREE,,770.0,[Not Available],,,,,[Not Available],,R0,1.0,770.0,0.0,770.0,0.0,770.0,0.0,770.0,
TCGA-CV-7414,3554,TCGA-CV-7414,HNSC,78.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1995.0,[Not Available],-28603.0,Dead,,,14.0,[Not Available],,,,,Complete Remission/Response,,,1.0,14.0,,14.0,,,0.0,14.0,
TCGA-YL-A8HL,8318,TCGA-YL-A8HL,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-21249.0,Alive,,1565.0,,[Not Available],,,,,Stable Disease,,,0.0,1565.0,0.0,1565.0,,,0.0,1565.0,
TCGA-FE-A3PC,10270,TCGA-FE-A3PC,THCA,37.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-13817.0,Alive,TUMOR FREE,2606.0,,[Not Available],,,,,[Not Available],,R0,0.0,2606.0,0.0,2606.0,0.0,2606.0,0.0,2606.0,
TCGA-L5-A43E,2509,TCGA-L5-A43E,ESCA,74.0,MALE,WHITE,Stage I,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2011.0,[Not Available],-27143.0,Alive,TUMOR FREE,920.0,,[Not Available],New Primary Tumor,"Other, specify",Right diaphragm-HG spindle cell sarcoma,885.0,Complete Remission/Response,,,0.0,920.0,0.0,920.0,0.0,920.0,1.0,885.0,
TCGA-T2-A6WZ,3741,TCGA-T2-A6WZ,HNSC,53.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-19397.0,Dead,WITH TUMOR,,484.0,[Not Available],Distant Metastasis,Distant Metastasis,bilateral pulmonary nodules,229.0,Stable Disease,,,1.0,484.0,1.0,484.0,,,1.0,229.0,
TCGA-13-1477,7075,TCGA-13-1477,OV,49.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G2,2000.0,[Not Available],-18111.0,Dead,WITH TUMOR,1662.0,1662.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],235.0,Progressive Disease,,,1.0,1662.0,1.0,1662.0,,,1.0,235.0,
TCGA-G7-6790,4595,TCGA-G7-6790,KIRP,57.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-21169.0,Alive,TUMOR FREE,1575.0,,[Not Available],,,,1558.0,[Not Available],,,0.0,1575.0,0.0,1575.0,,,1.0,1558.0,
TCGA-TM-A84J,5380,TCGA-TM-A84J,LGG,63.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-23091.0,Alive,WITH TUMOR,735.0,,[Not Available],,,,454.0,Progressive Disease,,,0.0,735.0,0.0,735.0,,,1.0,454.0,
TCGA-BP-5176,4244,TCGA-BP-5176,KIRC,78.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-28727.0,Dead,TUMOR FREE,,1590.0,[Not Available],,,,,[Not Available],,,1.0,1590.0,0.0,1590.0,,,0.0,1590.0,
TCGA-ZF-AA5N,503,TCGA-ZF-AA5N,BLCA,62.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-22741.0,Dead,WITH TUMOR,,168.0,[Not Available],,,,,Progressive Disease,,,1.0,168.0,1.0,168.0,,,1.0,168.0,
TCGA-YL-A8SA,8323,TCGA-YL-A8SA,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-25340.0,Alive,,512.0,,[Not Available],,,,,Stable Disease,,,0.0,512.0,0.0,512.0,,,0.0,512.0,
TCGA-P5-A5F1,5271,TCGA-P5-A5F1,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-11070.0,Alive,TUMOR FREE,179.0,,[Not Available],,,,,[Not Available],,,0.0,179.0,0.0,179.0,,,0.0,179.0,
TCGA-QT-A69Q,7750,TCGA-QT-A69Q,PCPG,40.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-14866.0,Alive,TUMOR FREE,24.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,24.0,0.0,24.0,0.0,24.0,0.0,24.0,
TCGA-B2-4102,4076,TCGA-B2-4102,KIRC,61.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-22492.0,Alive,TUMOR FREE,952.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,952.0,0.0,952.0,0.0,952.0,0.0,952.0,
TCGA-VP-A87E,8285,TCGA-VP-A87E,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-21811.0,Alive,TUMOR FREE,2037.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2037.0,0.0,2037.0,0.0,2037.0,0.0,2037.0,
TCGA-FI-A3PX,10997,TCGA-FI-A3PX,UCEC,57.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,High Grade,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21063.0,Alive,TUMOR FREE,2384.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2384.0,0.0,2384.0,0.0,2384.0,0.0,2384.0,
TCGA-XU-A933,10432,TCGA-XU-A933,THYM,52.0,FEMALE,ASIAN,[Not Applicable],IIb,Thymoma; Type C,[Not Available],2009.0,[Not Available],-19276.0,Alive,TUMOR FREE,1789.0,,[Not Available],,,,,[Not Available],,,0.0,1789.0,0.0,1789.0,,,0.0,1789.0,
TCGA-B0-5075,4015,TCGA-B0-5075,KIRC,77.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-28205.0,Dead,TUMOR FREE,,637.0,[Not Available],,,,,[Not Available],,,1.0,637.0,0.0,637.0,,,0.0,637.0,
TCGA-P4-A5E6,4654,TCGA-P4-A5E6,KIRP,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004.0,[Not Available],-24615.0,Alive,TUMOR FREE,3035.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3035.0,0.0,3035.0,0.0,3035.0,0.0,3035.0,
TCGA-C9-A480,3301,TCGA-C9-A480,HNSC,45.0,FEMALE,ASIAN,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-16567.0,Alive,TUMOR FREE,386.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,386.0,0.0,386.0,0.0,386.0,0.0,386.0,
TCGA-VS-A9U7,1864,TCGA-VS-A9U7,CESC,30.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11210.0,Alive,TUMOR FREE,1472.0,,,,,,,Complete Remission/Response,,,0.0,1472.0,0.0,1472.0,0.0,1472.0,0.0,1472.0,
TCGA-DM-A28C,2344,TCGA-DM-A28C,COAD,74.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2001.0,[Not Available],-27073.0,Dead,,2475.0,2475.0,[Not Available],,,,1929.0,[Not Available],,,1.0,2475.0,,2475.0,,,1.0,1929.0,
TCGA-5R-AA1C,5452,TCGA-5R-AA1C,LIHC,57.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-21073.0,Alive,TUMOR FREE,520.0,,[Not Available],,,,,[Not Available],,R0,0.0,520.0,0.0,520.0,0.0,520.0,0.0,520.0,
TCGA-G5-6572,8535,TCGA-G5-6572,READ,56.0,MALE,WHITE,[Not Available],[Not Applicable],Rectal Adenocarcinoma,[Not Available],2004.0,[Not Available],-20475.0,Dead,TUMOR FREE,,1432.0,[Not Available],,,,,[Not Available],,,1.0,1432.0,0.0,1432.0,,,0.0,1432.0,
TCGA-CV-5435,3474,TCGA-CV-5435,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2000.0,[Not Available],-20926.0,Dead,WITH TUMOR,1438.0,2319.0,[Not Available],,Distant Metastasis,Lung,284.0,[Not Available],,,1.0,2319.0,1.0,2319.0,,,1.0,284.0,
TCGA-29-2431,7349,TCGA-29-2431,OV,59.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G2,2006.0,[Not Available],-21833.0,Alive,WITH TUMOR,1285.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],960.0,Complete Remission/Response,,,0.0,1285.0,0.0,1285.0,1.0,960.0,1.0,960.0,
TCGA-E2-A14Y,1324,TCGA-E2-A14Y,BRCA,35.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13004.0,Alive,TUMOR FREE,2109.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2109.0,0.0,2109.0,0.0,2109.0,0.0,2109.0,
TCGA-D6-8568,3618,TCGA-D6-8568,HNSC,62.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-22796.0,Alive,TUMOR FREE,759.0,,[Not Available],,,,,Stable Disease,,,0.0,759.0,0.0,759.0,,,0.0,759.0,
TCGA-FZ-5922,7573,TCGA-FZ-5922,PAAD,81.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2007.0,[Not Available],-29633.0,Dead,WITH TUMOR,,1101.0,Pancreatic Cancer,Distant Metastasis,Peritoneal Surfaces,,740.0,Progressive Disease,,,1.0,1101.0,1.0,1101.0,,,1.0,740.0,
TCGA-BR-7957,9333,TCGA-BR-7957,STAD,50.0,FEMALE,WHITE,Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",GX,2011.0,[Not Available],-18517.0,Dead,TUMOR FREE,,276.0,[Not Available],,,,,Complete Remission/Response,,,1.0,276.0,0.0,276.0,,,0.0,276.0,
TCGA-WC-A884,11150,TCGA-WC-A884,UVM,35.0,FEMALE,WHITE,Stage IIIB,Stage IIIB,Epithelioid Cell|Spindle Cell,[Not Available],2013.0,[Not Available],-12840.0,Alive,TUMOR FREE,12.0,,[Not Available],,,,,[Not Available],,,0.0,12.0,0.0,12.0,,,0.0,12.0,
TCGA-04-1353,6931,TCGA-04-1353,OV,64.0,FEMALE,ASIAN,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,[Not Available],2003.0,[Not Available],-23611.0,Alive,,16.0,,[Not Available],,,,,[Not Available],,,0.0,16.0,0.0,16.0,,,0.0,16.0,
TCGA-55-8087,6015,TCGA-55-8087,LUAD,59.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-21655.0,Alive,TUMOR FREE,462.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,462.0,0.0,462.0,0.0,462.0,0.0,462.0,
TCGA-22-1011,6366,TCGA-22-1011,LUSC,73.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-26732.0,Dead,TUMOR FREE,53.0,53.0,[Not Available],,,,,[Not Available],,,1.0,53.0,0.0,53.0,,,0.0,53.0,
TCGA-HC-7750,8087,TCGA-HC-7750,PRAD,50.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-18580.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,522.0,0.0,522.0,0.0,522.0,0.0,522.0,
TCGA-52-7622,6502,TCGA-52-7622,LUSC,62.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-22807.0,Alive,TUMOR FREE,862.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,862.0,0.0,862.0,0.0,862.0,0.0,862.0,
TCGA-D7-6815,9499,TCGA-D7-6815,STAD,70.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-25811.0,Alive,TUMOR FREE,486.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,
TCGA-EE-A29W,9022,TCGA-EE-A29W,SKCM,42.0,MALE,WHITE,Stage 0,[Not Applicable],,[Not Available],1997.0,[Not Available],-15396.0,Alive,TUMOR FREE,5932.0,,[Not Available],New primary melanoma,,,4408.0,[Not Available],,,,,,,,,,,
TCGA-06-5859,2875,TCGA-06-5859,GBM,63.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-23211.0,Alive,WITH TUMOR,139.0,,[Not Available],,,,,[Not Available],,,0.0,139.0,0.0,139.0,,,0.0,139.0,
TCGA-CS-4943,4914,TCGA-CS-4943,LGG,37.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-13565.0,Dead,WITH TUMOR,,1106.0,[Not Available],,,,,[Not Available],,,1.0,1106.0,1.0,1106.0,,,1.0,1106.0,
TCGA-HC-8265,8105,TCGA-HC-8265,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24382.0,Alive,TUMOR FREE,483.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,483.0,0.0,483.0,0.0,483.0,0.0,483.0,
TCGA-FW-A3R5,9181,TCGA-FW-A3R5,SKCM,68.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2010.0,[Not Available],-24868.0,Alive,TUMOR FREE,1124.0,,[Not Available],,,,,[Not Available],,,0.0,1124.0,0.0,1124.0,,,0.0,1124.0,
TCGA-E9-A6HE,1454,TCGA-E9-A6HE,BRCA,45.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16697.0,Alive,TUMOR FREE,847.0,,[Not Available],,,,,[Not Available],Negative,,0.0,847.0,0.0,847.0,0.0,847.0,0.0,847.0,
TCGA-B9-A44B,4528,TCGA-B9-A44B,KIRP,70.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-25763.0,Alive,TUMOR FREE,361.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,361.0,0.0,361.0,,,0.0,361.0,
TCGA-EJ-8470,7974,TCGA-EJ-8470,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-21209.0,Alive,TUMOR FREE,1159.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1159.0,0.0,1159.0,0.0,1159.0,0.0,1159.0,
TCGA-BG-A0YV,10764,TCGA-BG-A0YV,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24567.0,Alive,TUMOR FREE,382.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,382.0,0.0,382.0,0.0,382.0,0.0,382.0,
TCGA-ER-A19L,9104,TCGA-ER-A19L,SKCM,35.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1994.0,[Not Available],-13061.0,Dead,WITH TUMOR,,4000.0,[Not Available],Distant Metastasis,Lung,,3689.0,[Not Available],,,1.0,4000.0,1.0,4000.0,,,1.0,3689.0,
TCGA-AR-A2LH,955,TCGA-AR-A2LH,BRCA,55.0,FEMALE,WHITE,Stage III,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20288.0,Dead,,,616.0,[Not Available],Distant Metastasis,Bone,,434.0,[Not Available],Negative,,1.0,616.0,,616.0,1.0,434.0,1.0,434.0,
TCGA-MI-A75G,5751,TCGA-MI-A75G,LIHC,63.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-23284.0,Alive,TUMOR FREE,698.0,,[Not Available],,,,,[Not Available],,R0,0.0,698.0,0.0,698.0,0.0,698.0,0.0,698.0,
TCGA-EB-A5SF,8975,TCGA-EB-A5SF,SKCM,78.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-28772.0,Dead,TUMOR FREE,,369.0,[Not Available],,,,,[Not Available],,,1.0,369.0,0.0,369.0,,,0.0,369.0,
TCGA-EE-A2MI,9056,TCGA-EE-A2MI,SKCM,43.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],1986.0,[Not Available],-15880.0,Dead,WITH TUMOR,,6225.0,[Not Available],New primary melanoma,,,2673.0,[Not Available],,,1.0,6225.0,1.0,6225.0,,,1.0,2673.0,
TCGA-A2-A4S1,626,TCGA-A2-A4S1,BRCA,66.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Metaplastic Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24353.0,Alive,TUMOR FREE,820.0,,[Not Available],,,,,[Not Available],Negative,,0.0,820.0,0.0,820.0,0.0,820.0,0.0,820.0,
TCGA-97-A4M0,6265,TCGA-97-A4M0,LUAD,60.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22206.0,Alive,TUMOR FREE,652.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,652.0,0.0,652.0,0.0,652.0,0.0,652.0,
TCGA-3B-A9I3,8553,TCGA-3B-A9I3,SARC,62.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-22985.0,Alive,TUMOR FREE,808.0,,[Not Available],New Primary Tumor,"Other, specify",Axillary Lymph Node,87.0,[Not Available],Positive,R1,0.0,808.0,0.0,808.0,,,1.0,87.0,
TCGA-EJ-A8FU,8004,TCGA-EJ-A8FU,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23472.0,Alive,TUMOR FREE,138.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,138.0,0.0,138.0,0.0,138.0,0.0,138.0,
TCGA-CN-5360,3325,TCGA-CN-5360,HNSC,68.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-25034.0,Alive,TUMOR FREE,2169.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2169.0,0.0,2169.0,,,0.0,2169.0,
TCGA-KS-A4I3,10336,TCGA-KS-A4I3,THCA,41.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-14992.0,Alive,TUMOR FREE,1329.0,,[Not Available],,,,,[Not Available],,R1,0.0,1329.0,0.0,1329.0,,,0.0,1329.0,
TCGA-3B-A9I0,8551,TCGA-3B-A9I0,SARC,33.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-12148.0,Alive,WITH TUMOR,1096.0,,[Not Available],Distant Metastasis,Liver,,503.0,[Not Available],Negative,R0,0.0,1096.0,0.0,1096.0,1.0,503.0,1.0,503.0,
TCGA-YT-A95D,10441,TCGA-YT-A95D,THYM,50.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2012.0,[Not Available],-18363.0,Alive,TUMOR FREE,750.0,,[Not Available],New Primary Tumor,"Other, specify",Thyroid papillary carcinoma,168.0,[Not Available],,,0.0,750.0,0.0,750.0,,,1.0,168.0,
TCGA-ZG-A8QW,8343,TCGA-ZG-A8QW,PRAD,72.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-26632.0,Alive,TUMOR FREE,94.0,,[Not Available],,,,,Progressive Disease,,,0.0,94.0,0.0,94.0,,,0.0,94.0,
TCGA-TT-A6YO,7818,TCGA-TT-A6YO,PCPG,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-23554.0,Alive,TUMOR FREE,405.0,,[Not Available],Biochemical evidence of disease,,,377.0,Complete Remission/Response,,,0.0,405.0,0.0,405.0,1.0,377.0,1.0,377.0,
TCGA-EJ-A65M,7990,TCGA-EJ-A65M,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23767.0,Alive,TUMOR FREE,230.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,230.0,0.0,230.0,0.0,230.0,0.0,230.0,
TCGA-S3-AA10,1586,TCGA-S3-AA10,BRCA,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24075.0,Alive,TUMOR FREE,586.0,,[Not Available],,,,,[Not Available],Negative,,0.0,586.0,0.0,586.0,0.0,586.0,0.0,586.0,
TCGA-MX-A663,9617,TCGA-MX-A663,STAD,66.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-24421.0,Dead,WITH TUMOR,,300.0,[Not Available],Distant Metastasis,"Other, specify",Liver and left supraclavicular lymph node,218.0,Complete Remission/Response,,,1.0,300.0,1.0,300.0,1.0,218.0,1.0,218.0,
TCGA-B0-4816,3988,TCGA-B0-4816,KIRC,49.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2002.0,[Not Available],-18133.0,Dead,WITH TUMOR,,1371.0,[Not Available],,,,,[Not Available],,,1.0,1371.0,1.0,1371.0,,,1.0,1371.0,
TCGA-D8-A27T,1294,TCGA-D8-A27T,BRCA,53.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19591.0,Alive,TUMOR FREE,398.0,,[Not Available],,,,,[Not Available],Negative,,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,
TCGA-S7-A7WT,7785,TCGA-S7-A7WT,PCPG,74.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-27311.0,Alive,TUMOR FREE,1301.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0,
TCGA-19-2623,3081,TCGA-19-2623,GBM,65.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-23835.0,Alive,TUMOR FREE,229.0,,[Not Available],,,,,[Not Available],,,0.0,229.0,0.0,229.0,,,0.0,229.0,
TCGA-AC-A62Y,792,TCGA-AC-A62Y,BRCA,79.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28876.0,Alive,TUMOR FREE,530.0,,[Not Available],,,,,[Not Available],Positive,,0.0,530.0,0.0,530.0,,,0.0,530.0,
TCGA-A1-A0SD,514,TCGA-A1-A0SD,BRCA,59.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,[Not Available],-21793.0,Alive,,437.0,,[Not Available],,,,,[Not Available],Negative,,0.0,437.0,0.0,437.0,0.0,437.0,0.0,437.0,
TCGA-CD-5801,9417,TCGA-CD-5801,STAD,69.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,[Not Available],,Dead,WITH TUMOR,,401.0,[Not Available],,,,,Progressive Disease,,,1.0,401.0,1.0,401.0,,,1.0,401.0,
TCGA-S7-A7WL,7778,TCGA-S7-A7WL,PCPG,59.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-21643.0,Alive,TUMOR FREE,961.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,961.0,0.0,961.0,0.0,961.0,0.0,961.0,
TCGA-BR-8589,9375,TCGA-BR-8589,STAD,56.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-20727.0,Alive,TUMOR FREE,825.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,825.0,0.0,825.0,0.0,825.0,0.0,825.0,
TCGA-XP-A8T7,2639,TCGA-XP-A8T7,ESCA,63.0,FEMALE,WHITE,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2010.0,[Not Available],-23375.0,Alive,TUMOR FREE,1254.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1254.0,0.0,1254.0,0.0,1254.0,0.0,1254.0,
TCGA-86-A4P7,6210,TCGA-86-A4P7,LUAD,63.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-23330.0,Alive,TUMOR FREE,415.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,415.0,0.0,415.0,0.0,415.0,0.0,415.0,
TCGA-HT-A617,5233,TCGA-HT-A617,LGG,47.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-17331.0,Alive,,491.0,,[Not Available],,,,395.0,Progressive Disease,,,0.0,491.0,0.0,491.0,,,1.0,395.0,
TCGA-IN-A6RJ,9597,TCGA-IN-A6RJ,STAD,64.0,MALE,WHITE,Stage IA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-23439.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-80-5607,6174,TCGA-80-5607,LUAD,,FEMALE,[Not Available],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],,Alive,WITH TUMOR,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-AA-3492,2014,TCGA-AA-3492,COAD,90.0,FEMALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2002.0,[Not Available],-32871.0,Dead,TUMOR FREE,,92.0,[Not Available],,,,,[Unknown],,,1.0,92.0,0.0,92.0,,,0.0,92.0,
TCGA-BH-A0B3,1033,TCGA-BH-A0B3,BRCA,53.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19479.0,Alive,TUMOR FREE,1203.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1203.0,0.0,1203.0,0.0,1203.0,0.0,1203.0,
TCGA-97-7552,6249,TCGA-97-7552,LUAD,70.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-25578.0,Alive,TUMOR FREE,1932.0,,[Not Available],,,,798.0,Stable Disease,,,0.0,1932.0,0.0,1932.0,,,1.0,798.0,
TCGA-AP-A1DK,10594,TCGA-AP-A1DK,UCEC,53.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19509.0,Alive,TUMOR FREE,2767.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2767.0,0.0,2767.0,0.0,2767.0,0.0,2767.0,
TCGA-B0-5104,4032,TCGA-B0-5104,KIRC,90.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2002.0,[Not Available],-32873.0,Dead,TUMOR FREE,,2752.0,[Not Available],,,,,[Not Available],,,1.0,2752.0,0.0,2752.0,,,0.0,2752.0,
TCGA-A7-A26I,647,TCGA-A7-A26I,BRCA,65.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23948.0,Alive,TUMOR FREE,661.0,,[Not Available],,,,,[Not Available],Negative,,0.0,661.0,0.0,661.0,0.0,661.0,0.0,661.0,
TCGA-EJ-A46H,7982,TCGA-EJ-A46H,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22059.0,Alive,TUMOR FREE,724.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,724.0,0.0,724.0,0.0,724.0,0.0,724.0,
TCGA-41-2575,3195,TCGA-41-2575,GBM,75.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-27587.0,Dead,WITH TUMOR,290.0,290.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],131.0,[Not Available],,,1.0,290.0,1.0,290.0,,,1.0,131.0,
TCGA-C8-A26X,1210,TCGA-C8-A26X,BRCA,58.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21463.0,Alive,TUMOR FREE,376.0,,[Not Available],,,,,[Not Available],Negative,,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,
TCGA-32-2616,3181,TCGA-32-2616,GBM,48.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-17781.0,Dead,WITH TUMOR,224.0,224.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],182.0,[Not Available],,,1.0,224.0,1.0,224.0,,,1.0,182.0,
TCGA-C9-A47Z,3300,TCGA-C9-A47Z,HNSC,72.0,FEMALE,ASIAN,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-26592.0,Dead,TUMOR FREE,,191.0,[Not Available],,,,,Complete Remission/Response,,,1.0,191.0,0.0,191.0,0.0,191.0,0.0,191.0,
TCGA-AJ-A3NG,10548,TCGA-AJ-A3NG,UCEC,83.0,FEMALE,WHITE,[Not Applicable],Stage II,Mixed serous and endometrioid,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30351.0,Alive,TUMOR FREE,475.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,
TCGA-4V-A9QS,10368,TCGA-4V-A9QS,THYM,53.0,FEMALE,WHITE,[Not Applicable],IVa,Thymoma; Type B2,[Not Available],2012.0,[Not Available],-19443.0,Alive,WITH TUMOR,774.0,,[Not Available],Locoregional Recurrence,"Other, specify",PLEURA,752.0,[Not Available],,,0.0,774.0,0.0,774.0,,,1.0,752.0,
TCGA-CV-7423,3560,TCGA-CV-7423,HNSC,65.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1997.0,[Not Available],-24071.0,Dead,,,3059.0,[Not Available],,,,,[Not Available],,,1.0,3059.0,,3059.0,,,0.0,3059.0,
TCGA-2L-AAQI,7522,TCGA-2L-AAQI,PAAD,66.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-24381.0,Dead,WITH TUMOR,,103.0,Pancreatic Cancer,,,,,Progressive Disease,,,1.0,103.0,1.0,103.0,,,1.0,103.0,
TCGA-QU-A6IL,8227,TCGA-QU-A6IL,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2002.0,[Not Available],-23710.0,Alive,TUMOR FREE,97.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,97.0,0.0,97.0,0.0,97.0,0.0,97.0,
TCGA-Y8-A8S1,4710,TCGA-Y8-A8S1,KIRP,61.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-22319.0,Alive,TUMOR FREE,404.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,404.0,0.0,404.0,0.0,404.0,0.0,404.0,
TCGA-GI-A2C8,1498,TCGA-GI-A2C8,BRCA,63.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,[Not Available],-23103.0,Alive,,225.0,,[Not Available],,,,,[Not Available],Negative,,0.0,225.0,0.0,225.0,0.0,225.0,0.0,225.0,
TCGA-CR-6472,3424,TCGA-CR-6472,HNSC,59.0,MALE,WHITE,[Not Available],Stage IVB,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-21654.0,Alive,TUMOR FREE,1050.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1050.0,0.0,1050.0,,,0.0,1050.0,
TCGA-BT-A3PJ,139,TCGA-BT-A3PJ,BLCA,76.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-27821.0,Alive,TUMOR FREE,789.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,789.0,0.0,789.0,0.0,789.0,0.0,789.0,
TCGA-XJ-A83G,8295,TCGA-XJ-A83G,PRAD,51.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],,Alive,TUMOR FREE,1461.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1461.0,0.0,1461.0,0.0,1461.0,0.0,1461.0,
TCGA-CW-5581,4339,TCGA-CW-5581,KIRC,44.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-16195.0,Alive,TUMOR FREE,2799.0,,[Not Available],,,,,[Not Available],,,0.0,2799.0,0.0,2799.0,,,0.0,2799.0,
TCGA-EL-A3ZT,10104,TCGA-EL-A3ZT,THCA,35.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-13103.0,Alive,TUMOR FREE,1808.0,,[Not Available],,,,,[Not Available],,R0,0.0,1808.0,0.0,1808.0,0.0,1808.0,0.0,1808.0,
TCGA-FA-A86F,2421,TCGA-FA-A86F,DLBC,64.0,FEMALE,WHITE,[Not Applicable],Stage III,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013.0,[Not Available],-23641.0,Alive,WITH TUMOR,553.0,,[Not Available],,"Other, specify","Inguinal, mediastinal, submandibular, hilar",150.0,Partial Remission/Response,,,0.0,553.0,0.0,553.0,,,1.0,150.0,
TCGA-69-7978,6103,TCGA-69-7978,LUAD,59.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-21785.0,Alive,[Discrepancy],134.0,,[Not Available],,,,,[Unknown],,,0.0,134.0,0.0,134.0,,,0.0,134.0,
TCGA-53-A4EZ,5966,TCGA-53-A4EZ,LUAD,63.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-23201.0,Alive,TUMOR FREE,1071.0,,[Not Available],,,,,Stable Disease,,,0.0,1071.0,0.0,1071.0,,,0.0,1071.0,
TCGA-C8-A26W,1209,TCGA-C8-A26W,BRCA,58.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21391.0,Alive,TUMOR FREE,381.0,,[Not Available],,,,,[Not Available],Negative,,0.0,381.0,0.0,381.0,0.0,381.0,0.0,381.0,
TCGA-EB-A24C,8939,TCGA-EB-A24C,SKCM,56.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2011.0,[Not Available],-20539.0,Alive,TUMOR FREE,632.0,,[Not Available],Regional lymph node,,,465.0,[Not Available],,,0.0,632.0,0.0,632.0,,,1.0,465.0,
TCGA-VQ-A8E7,9650,TCGA-VQ-A8E7,STAD,59.0,MALE,WHITE,Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,[Not Available],-21664.0,Alive,WITH TUMOR,1138.0,,[Not Available],Distant Metastasis,"Other, specify",Adrenal,1048.0,Stable Disease,,,0.0,1138.0,0.0,1138.0,,,1.0,1048.0,
TCGA-D3-A3BZ,8852,TCGA-D3-A3BZ,SKCM,63.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2002.0,[Not Available],-23286.0,Alive,TUMOR FREE,3976.0,,[Not Available],,,,2340.0,[Not Available],,,0.0,3976.0,0.0,3976.0,,,1.0,2340.0,
TCGA-21-1070,6343,TCGA-21-1070,LUSC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-22273.0,Alive,TUMOR FREE,3636.0,,[Not Available],,,,,[Not Available],,,0.0,3636.0,0.0,3636.0,,,0.0,3636.0,
TCGA-42-2582,7410,TCGA-42-2582,OV,49.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-17961.0,Dead,WITH TUMOR,,1447.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],616.0,Stable Disease,,,1.0,1447.0,1.0,1447.0,,,1.0,616.0,
TCGA-PR-A5PH,7696,TCGA-PR-A5PH,PCPG,47.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2007.0,[Not Available],-17347.0,Alive,TUMOR FREE,854.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,854.0,0.0,854.0,0.0,854.0,0.0,854.0,
TCGA-75-6211,6134,TCGA-75-6211,LUAD,,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],,Dead,WITH TUMOR,,,[Not Available],,,,,Complete Remission/Response,,,1.0,,1.0,,,,1.0,,
TCGA-G9-6354,8026,TCGA-G9-6354,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-20403.0,Alive,TUMOR FREE,2066.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2066.0,0.0,2066.0,0.0,2066.0,0.0,2066.0,
TCGA-DK-A3IL,197,TCGA-DK-A3IL,BLCA,79.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-29047.0,Dead,TUMOR FREE,,413.0,[Not Available],,,,,Complete Remission/Response,,,1.0,413.0,0.0,413.0,,,0.0,413.0,
TCGA-EJ-7781,7959,TCGA-EJ-7781,PRAD,65.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23937.0,Alive,TUMOR FREE,1073.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1073.0,0.0,1073.0,0.0,1073.0,0.0,1073.0,
TCGA-O9-A75Z,4653,TCGA-O9-A75Z,KIRP,44.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-16183.0,Alive,,471.0,,[Not Available],,,,,[Unknown],,,0.0,471.0,0.0,471.0,,,0.0,471.0,
TCGA-98-8023,6785,TCGA-98-8023,LUSC,70.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25732.0,Alive,TUMOR FREE,649.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,649.0,0.0,649.0,0.0,649.0,0.0,649.0,
TCGA-N8-A4PO,11052,TCGA-N8-A4PO,UCS,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24124.0,Alive,WITH TUMOR,781.0,,[Not Available],Distant Metastasis,Bone,,158.0,Progressive Disease,,,0.0,781.0,0.0,781.0,,,1.0,158.0,
TCGA-BJ-A0ZC,9854,TCGA-BJ-A0ZC,THCA,55.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-20282.0,Alive,TUMOR FREE,352.0,,[Not Available],,,,,[Not Available],,R0,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,
TCGA-K1-A6RT,8715,TCGA-K1-A6RT,SARC,48.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-17739.0,Alive,WITH TUMOR,528.0,,[Not Available],Distant Metastasis,Lung,,129.0,[Not Available],Negative,R0,0.0,528.0,0.0,528.0,1.0,129.0,1.0,129.0,
TCGA-33-4583,6404,TCGA-33-4583,LUSC,73.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1999.0,[Not Available],-26799.0,Dead,TUMOR FREE,,4601.0,[Not Available],,,,,Complete Remission/Response,,,1.0,4601.0,0.0,4601.0,0.0,4601.0,0.0,4601.0,
TCGA-51-6867,6501,TCGA-51-6867,LUSC,72.0,FEMALE,WHITE,Stage I,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-26523.0,Dead,WITH TUMOR,,1856.0,[Not Available],,,,788.0,Complete Remission/Response,,,1.0,1856.0,1.0,1856.0,1.0,788.0,1.0,788.0,
TCGA-D1-A17R,10870,TCGA-D1-A17R,UCEC,58.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-21382.0,Dead,TUMOR FREE,,339.0,[Not Available],,,,,Complete Remission/Response,,,1.0,339.0,0.0,339.0,0.0,339.0,0.0,339.0,
TCGA-WE-A8ZQ,9243,TCGA-WE-A8ZQ,SKCM,48.0,MALE,[Not Evaluated],Stage IIA,[Not Applicable],,[Not Available],2009.0,[Not Available],-17824.0,Alive,WITH TUMOR,1923.0,,[Not Available],Distant Metastasis|Distant Metastasis,"Lung|Other, Specify",[Not Applicable]|left thigh,1757.0,[Not Available],,,0.0,1923.0,0.0,1923.0,,,1.0,1757.0,
TCGA-DD-AAVZ,5660,TCGA-DD-AAVZ,LIHC,38.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2009.0,[Not Available],-14005.0,Alive,TUMOR FREE,1900.0,,[Not Available],,,,,[Not Available],,R0,0.0,1900.0,0.0,1900.0,0.0,1900.0,0.0,1900.0,
TCGA-EE-A2GT,9044,TCGA-EE-A2GT,SKCM,77.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2009.0,[Not Available],-28364.0,Alive,WITH TUMOR,1365.0,,[Not Available],Locoregional Recurrence,,,281.0,[Not Available],,,0.0,1365.0,0.0,1365.0,,,1.0,281.0,
TCGA-QB-AA9O,9220,TCGA-QB-AA9O,SKCM,73.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-27009.0,Dead,WITH TUMOR,,549.0,[Not Available],,,,,[Not Available],,,1.0,549.0,1.0,549.0,,,1.0,549.0,
TCGA-66-2773,6629,TCGA-66-2773,LUSC,69.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-25355.0,Dead,TUMOR FREE,,92.0,[Not Available],,,,,[Not Available],,,1.0,92.0,0.0,92.0,,,0.0,92.0,
TCGA-CV-7434,3569,TCGA-CV-7434,HNSC,64.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,[Not Available],-23465.0,Dead,TUMOR FREE,,218.0,[Not Available],,,,,Complete Remission/Response,,,1.0,218.0,0.0,218.0,,,0.0,218.0,
TCGA-3H-AB3L,6830,TCGA-3H-AB3L,MESO,60.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2008.0,[Not Available],-21972.0,Dead,WITH TUMOR,,361.0,[Not Available],Intrapleural Progression,Ipsilateral Pleura,,222.0,[Not Available],,[Not Available],1.0,361.0,1.0,361.0,,,1.0,222.0,
TCGA-44-7669,5888,TCGA-44-7669,LUAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-21893.0,Dead,WITH TUMOR,,574.0,[Not Available],,,,390.0,Complete Remission/Response,,,1.0,574.0,1.0,574.0,1.0,390.0,1.0,390.0,
TCGA-CF-A3MI,156,TCGA-CF-A3MI,BLCA,62.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,[Not Available],-22716.0,Alive,TUMOR FREE,370.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,370.0,0.0,370.0,0.0,370.0,0.0,370.0,
TCGA-G4-6588,2389,TCGA-G4-6588,COAD,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-21532.0,Alive,TUMOR FREE,796.0,,[Not Available],,,,,[Not Available],,,0.0,796.0,0.0,796.0,,,0.0,796.0,
TCGA-E9-A1RG,1421,TCGA-E9-A1RG,BRCA,62.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22788.0,Alive,TUMOR FREE,647.0,,[Not Available],,,,,[Not Available],Negative,,0.0,647.0,0.0,647.0,0.0,647.0,0.0,647.0,
TCGA-D1-A17H,10864,TCGA-D1-A17H,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22389.0,Alive,TUMOR FREE,852.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,852.0,0.0,852.0,0.0,852.0,0.0,852.0,
TCGA-EM-A3AL,10163,TCGA-EM-A3AL,THCA,45.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-16439.0,Alive,TUMOR FREE,430.0,,[Not Available],,,,,[Not Available],,R0,0.0,430.0,0.0,430.0,0.0,430.0,0.0,430.0,
TCGA-ET-A3DO,10240,TCGA-ET-A3DO,THCA,33.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005.0,[Not Available],-12158.0,Alive,TUMOR FREE,3552.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,570.0,[Not Available],,R0,0.0,3552.0,0.0,3552.0,1.0,570.0,1.0,570.0,
TCGA-CC-A3MC,5494,TCGA-CC-A3MC,LIHC,54.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-20067.0,Alive,WITH TUMOR,363.0,,[Not Available],Locoregional Recurrence,Liver,,297.0,[Not Available],,R0,0.0,363.0,0.0,363.0,1.0,297.0,1.0,297.0,
TCGA-MH-A561,4647,TCGA-MH-A561,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-24271.0,Alive,TUMOR FREE,841.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,841.0,0.0,841.0,0.0,841.0,0.0,841.0,
TCGA-DD-AAEA,5643,TCGA-DD-AAEA,LIHC,65.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-24027.0,Alive,TUMOR FREE,575.0,,[Not Available],,,,,[Not Available],,R0,0.0,575.0,0.0,575.0,0.0,575.0,0.0,575.0,
TCGA-UN-AAZ9,4682,TCGA-UN-AAZ9,KIRP,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-27851.0,Alive,TUMOR FREE,548.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,548.0,0.0,548.0,0.0,548.0,0.0,548.0,
TCGA-E1-A7YE,5076,TCGA-E1-A7YE,LGG,32.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2001.0,[Not Available],-11971.0,Dead,WITH TUMOR,,886.0,[Not Available],,,,188.0,Stable Disease,,,1.0,886.0,1.0,886.0,,,1.0,188.0,
TCGA-75-6214,6136,TCGA-75-6214,LUAD,,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],,[Not Available],,Dead,WITH TUMOR,,1115.0,[Not Available],Distant Metastasis,,,419.0,Complete Remission/Response,,,1.0,1115.0,1.0,1115.0,1.0,419.0,1.0,419.0,
TCGA-HP-A5MZ,5736,TCGA-HP-A5MZ,LIHC,78.0,MALE,[Not Evaluated],Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,,[Not Available],-22702.0,Dead,TUMOR FREE,,91.0,[Not Available],,,,,[Not Available],,R0,1.0,91.0,0.0,91.0,0.0,91.0,0.0,91.0,
TCGA-C5-A7CO,1650,TCGA-C5-A7CO,CESC,68.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G2,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25045.0,Alive,TUMOR FREE,4482.0,,,,,,,Complete Remission/Response,,,0.0,4482.0,0.0,4482.0,0.0,4482.0,0.0,4482.0,
TCGA-R6-A8WG,2611,TCGA-R6-A8WG,ESCA,60.0,MALE,WHITE,[Not Available],Stage IIA,"Esophagus Adenocarcinoma, NOS",G3,2013.0,[Not Available],-22093.0,Dead,WITH TUMOR,,386.0,[Not Available],Distant Metastasis,"Other, specify",left supraclavicular nodal metastasis,107.0,,,,1.0,386.0,1.0,386.0,,,1.0,107.0,
TCGA-B1-A47O,4508,TCGA-B1-A47O,KIRP,54.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-19823.0,Alive,TUMOR FREE,842.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,
TCGA-D3-A2JF,8844,TCGA-D3-A2JF,SKCM,74.0,MALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2008.0,[Not Available],-27255.0,Alive,TUMOR FREE,1888.0,,[Not Available],New primary melanoma,,,25.0,[Not Available],,,0.0,1888.0,0.0,1888.0,,,1.0,25.0,
TCGA-EM-A2CT,10149,TCGA-EM-A2CT,THCA,20.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-7558.0,Alive,TUMOR FREE,1474.0,,[Not Available],,,,,[Not Available],,R0,0.0,1474.0,0.0,1474.0,0.0,1474.0,0.0,1474.0,
TCGA-L6-A4EQ,10344,TCGA-L6-A4EQ,THCA,47.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-17351.0,Alive,TUMOR FREE,1228.0,,[Not Available],,,,,[Not Available],,R0,0.0,1228.0,0.0,1228.0,0.0,1228.0,0.0,1228.0,
TCGA-23-2641,7156,TCGA-23-2641,OV,85.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-31232.0,Alive,,84.0,,[Not Available],,,,,[Not Available],,,0.0,84.0,0.0,84.0,,,0.0,84.0,
TCGA-EX-A8YF,1752,TCGA-EX-A8YF,CESC,44.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16258.0,Alive,WITH TUMOR,473.0,,,Locoregional Recurrence,"Other, specify",Vagina,396.0,Complete Remission/Response,,,0.0,473.0,0.0,473.0,1.0,396.0,1.0,396.0,
TCGA-BR-6456,9305,TCGA-BR-6456,STAD,74.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-27288.0,Dead,TUMOR FREE,,526.0,[Not Available],,,,,Complete Remission/Response,,,1.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,
TCGA-RC-A6M4,5762,TCGA-RC-A6M4,LIHC,74.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-27327.0,Alive,,22.0,,[Not Available],,,,,[Not Available],,R1,0.0,22.0,0.0,22.0,,,0.0,22.0,
TCGA-D1-A3JP,10891,TCGA-D1-A3JP,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22538.0,Alive,TUMOR FREE,515.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,515.0,0.0,515.0,,,0.0,515.0,
TCGA-RP-A690,9221,TCGA-RP-A690,SKCM,66.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2005.0,[Not Available],-24450.0,Alive,TUMOR FREE,6.0,,[Not Available],,,,,[Not Available],,,0.0,6.0,0.0,6.0,,,0.0,6.0,
TCGA-CV-7263,3547,TCGA-CV-7263,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1997.0,[Not Available],-23513.0,Dead,WITH TUMOR,,560.0,[Not Available],,,,,[Not Available],,,1.0,560.0,1.0,560.0,,,1.0,560.0,
TCGA-06-0214,2805,TCGA-06-0214,GBM,66.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-24187.0,Dead,WITH TUMOR,378.0,457.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],48.0,[Not Available],,,1.0,457.0,1.0,457.0,,,1.0,48.0,
TCGA-E2-A572,1388,TCGA-E2-A572,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26399.0,Alive,TUMOR FREE,1208.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1208.0,0.0,1208.0,0.0,1208.0,0.0,1208.0,
TCGA-FR-A69P,9133,TCGA-FR-A69P,SKCM,34.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-12679.0,Alive,TUMOR FREE,478.0,,[Not Available],Regional lymph node,,,274.0,[Not Available],,,0.0,478.0,0.0,478.0,,,1.0,274.0,
TCGA-78-7152,6148,TCGA-78-7152,LUAD,65.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2003.0,[Not Available],-23782.0,Dead,WITH TUMOR,,1215.0,[Not Available],,,,1202.0,Complete Remission/Response,,,1.0,1215.0,1.0,1215.0,1.0,1202.0,1.0,1202.0,
TCGA-A6-2675,1964,TCGA-A6-2675,COAD,78.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-28813.0,Alive,TUMOR FREE,1321.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1321.0,0.0,1321.0,0.0,1321.0,0.0,1321.0,
TCGA-DD-AADY,5633,TCGA-DD-AADY,LIHC,55.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-20233.0,Alive,TUMOR FREE,555.0,,[Not Available],,,,,[Not Available],,R0,0.0,555.0,0.0,555.0,0.0,555.0,0.0,555.0,
TCGA-HT-7684,5175,TCGA-HT-7684,LGG,58.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2008.0,[Not Available],-21352.0,Alive,TUMOR FREE,184.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,184.0,0.0,184.0,0.0,184.0,0.0,184.0,
TCGA-28-1747,3136,TCGA-28-1747,GBM,44.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-16301.0,Dead,,77.0,77.0,[Not Available],,,,,[Not Available],,,1.0,77.0,,77.0,,,0.0,77.0,
TCGA-3A-A9IH,7531,TCGA-3A-A9IH,PAAD,66.0,FEMALE,WHITE,Stage IA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-24174.0,Alive,WITH TUMOR,1021.0,,,Distant Metastasis,Lung,,763.0,Stable Disease,,,0.0,1021.0,0.0,1021.0,,,1.0,763.0,
TCGA-VQ-AA6K,9708,TCGA-VQ-AA6K,STAD,59.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2012.0,[Not Available],-21901.0,Dead,WITH TUMOR,,378.0,Stomach Cancer,Locoregional Recurrence,,,332.0,Progressive Disease,,,1.0,378.0,1.0,378.0,,,1.0,332.0,
TCGA-D7-A748,9526,TCGA-D7-A748,STAD,41.0,FEMALE,WHITE,Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2013.0,[Not Available],-15190.0,Dead,WITH TUMOR,,132.0,Stomach Cancer,Locoregional Recurrence|Distant Metastasis,,,99.0,Progressive Disease,,,1.0,132.0,1.0,132.0,,,1.0,99.0,
TCGA-AY-6197,2207,TCGA-AY-6197,COAD,60.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-21957.0,Alive,TUMOR FREE,652.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,652.0,0.0,652.0,0.0,652.0,0.0,652.0,
TCGA-KM-8477,3801,TCGA-KM-8477,KICH,56.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-20491.0,Alive,TUMOR FREE,1553.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1553.0,0.0,1553.0,0.0,1553.0,0.0,1553.0,
TCGA-VS-A9UY,1881,TCGA-VS-A9UY,CESC,29.0,FEMALE,[Unknown],[Not Available],Stage IVB,Cervical Squamous Cell Carcinoma,G2,2012.0,[Unknown],-10707.0,Dead,WITH TUMOR,,555.0,Cervical Cancer,Distant Metastasis,Head & Neck,,412.0,Progressive Disease,,,1.0,555.0,1.0,555.0,,,1.0,412.0,
TCGA-BR-7717,9328,TCGA-BR-7717,STAD,63.0,MALE,WHITE,Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-23102.0,Dead,TUMOR FREE,,552.0,[Not Available],,,,,Complete Remission/Response,,,1.0,552.0,0.0,552.0,,,0.0,552.0,
TCGA-4G-AAZT,1918,TCGA-4G-AAZT,CHOL,62.0,MALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2013.0,[Not Available],-22777.0,Alive,TUMOR FREE,420.0,,[Not Available],,,,,[Not Available],,R0,0.0,420.0,0.0,420.0,0.0,420.0,0.0,420.0,
TCGA-DU-A5TT,5044,TCGA-DU-A5TT,LGG,70.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-25726.0,Alive,WITH TUMOR,743.0,,[Not Available],,,,584.0,[Discrepancy],,,0.0,743.0,0.0,743.0,,,1.0,584.0,
TCGA-HC-A6HX,8117,TCGA-HC-A6HX,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-20263.0,Alive,TUMOR FREE,38.0,,[Not Available],,,,,[Unknown],,,0.0,38.0,0.0,38.0,,,0.0,38.0,
TCGA-EA-A5ZD,1712,TCGA-EA-A5ZD,CESC,40.0,FEMALE,ASIAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14629.0,Alive,TUMOR FREE,830.0,,,,,,,Complete Remission/Response,,,0.0,830.0,0.0,830.0,0.0,830.0,0.0,830.0,
TCGA-L5-A8NH,2542,TCGA-L5-A8NH,ESCA,54.0,MALE,WHITE,Stage IV,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2001.0,[Not Available],-19991.0,Dead,TUMOR FREE,,393.0,[Not Available],,,,,,,,1.0,393.0,0.0,393.0,,,0.0,393.0,
TCGA-GE-A2C6,10304,TCGA-GE-A2C6,THCA,33.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-12068.0,Alive,TUMOR FREE,381.0,,[Not Available],,,,,[Not Available],,RX,0.0,381.0,0.0,381.0,,,0.0,381.0,
TCGA-2J-AAB4,7504,TCGA-2J-AAB4,PAAD,48.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2012.0,[Not Available],-17794.0,Alive,TUMOR FREE,729.0,,,,,,,Complete Remission/Response,,,0.0,729.0,0.0,729.0,0.0,729.0,0.0,729.0,
TCGA-C5-A7UC,1651,TCGA-C5-A7UC,CESC,48.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2002.0,[Not Available],-17765.0,Dead,TUMOR FREE,,523.0,,,,,,[Not Available],,,1.0,523.0,0.0,523.0,,,0.0,523.0,
TCGA-J9-A52D,8155,TCGA-J9-A52D,PRAD,71.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012.0,[Not Available],-26023.0,Alive,TUMOR FREE,212.0,,[Not Available],,,,,[Not Available],,,0.0,212.0,0.0,212.0,,,0.0,212.0,
TCGA-BR-4294,9290,TCGA-BR-4294,STAD,65.0,MALE,WHITE,[Not Available],[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009.0,[Not Available],-23758.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-DD-A4NB,5553,TCGA-DD-A4NB,LIHC,25.0,MALE,WHITE,Stage I,[Not Applicable],Fibrolamellar Carcinoma,G2,2011.0,[Not Available],-9426.0,Alive,TUMOR FREE,989.0,,[Not Available],Extrahepatic Recurrence,"Other, specify",retroperitoneal lymph nodes,912.0,[Not Available],,R0,0.0,989.0,0.0,989.0,1.0,912.0,1.0,912.0,
TCGA-CA-6716,2240,TCGA-CA-6716,COAD,65.0,MALE,ASIAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-23943.0,Alive,TUMOR FREE,371.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,371.0,0.0,371.0,0.0,371.0,0.0,371.0,
TCGA-RC-A6M6,5764,TCGA-RC-A6M6,LIHC,75.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-27649.0,Alive,,9.0,,[Not Available],,,,,[Not Available],,R1,0.0,9.0,0.0,9.0,,,0.0,9.0,
TCGA-QK-A6V9,3728,TCGA-QK-A6V9,HNSC,56.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-20461.0,Alive,TUMOR FREE,833.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,833.0,0.0,833.0,0.0,833.0,0.0,833.0,
TCGA-ZN-A9VP,6910,TCGA-ZN-A9VP,MESO,51.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-18697.0,Alive,TUMOR FREE,228.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,228.0,0.0,228.0,,,0.0,228.0,
TCGA-E8-A437,10036,TCGA-E8-A437,THCA,57.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-21073.0,Alive,TUMOR FREE,1213.0,,[Not Available],,,,,[Not Available],,RX,0.0,1213.0,0.0,1213.0,,,0.0,1213.0,
TCGA-BR-4183,9276,TCGA-BR-4183,STAD,55.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2007.0,[Not Available],-20420.0,Dead,,,201.0,[Not Available],,,,,[Not Available],,,1.0,201.0,,201.0,,,0.0,201.0,
TCGA-CC-A8HS,5506,TCGA-CC-A8HS,LIHC,18.0,MALE,ASIAN,Stage IIIC,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-6617.0,Dead,WITH TUMOR,,300.0,[Not Available],Locoregional Recurrence,,,201.0,[Not Available],,R0,1.0,300.0,1.0,300.0,1.0,201.0,1.0,201.0,
TCGA-37-3783,6439,TCGA-37-3783,LUSC,51.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-18728.0,Alive,TUMOR FREE,122.0,,[Not Available],,,,,[Not Available],,,0.0,122.0,0.0,122.0,,,0.0,122.0,
TCGA-EE-A3AG,9074,TCGA-EE-A3AG,SKCM,25.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2009.0,[Not Available],-9161.0,Dead,WITH TUMOR,,1265.0,[Not Available],Regional lymph node,,,229.0,[Not Available],,,1.0,1265.0,1.0,1265.0,,,1.0,229.0,
TCGA-F2-A8YN,7552,TCGA-F2-A8YN,PAAD,76.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-28047.0,Alive,WITH TUMOR,517.0,,,,,,,Progressive Disease,,,0.0,517.0,0.0,517.0,,,0.0,517.0,
TCGA-CR-7397,3464,TCGA-CR-7397,HNSC,44.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-16351.0,Alive,TUMOR FREE,754.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,754.0,0.0,754.0,,,0.0,754.0,
TCGA-FY-A76V,10303,TCGA-FY-A76V,THCA,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2013.0,[Not Available],-19872.0,Alive,TUMOR FREE,51.0,,[Not Available],,,,,[Not Available],,R0,0.0,51.0,0.0,51.0,0.0,51.0,0.0,51.0,
TCGA-LN-A49X,2569,TCGA-LN-A49X,ESCA,44.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2011.0,[Not Available],-16154.0,Alive,TUMOR FREE,384.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,384.0,0.0,384.0,0.0,384.0,0.0,384.0,
TCGA-DU-6542,5008,TCGA-DU-6542,LGG,25.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-9380.0,Alive,WITH TUMOR,73.0,,[Not Available],,,,,Stable Disease,,,0.0,73.0,0.0,73.0,,,0.0,73.0,
TCGA-99-8032,6275,TCGA-99-8032,LUAD,61.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22635.0,Alive,TUMOR FREE,44.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,44.0,0.0,44.0,0.0,44.0,0.0,44.0,
TCGA-HC-7210,8068,TCGA-HC-7210,PRAD,74.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-27343.0,Alive,TUMOR FREE,868.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,868.0,0.0,868.0,0.0,868.0,0.0,868.0,
TCGA-GL-A4EM,4612,TCGA-GL-A4EM,KIRP,61.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-22635.0,Alive,TUMOR FREE,32.0,,[Not Available],,,,,[Not Available],,,0.0,32.0,0.0,32.0,,,0.0,32.0,
TCGA-E1-5303,5067,TCGA-E1-5303,LGG,38.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,1998.0,[Not Available],-14212.0,Dead,WITH TUMOR,,2052.0,[Not Available],,,,156.0,Progressive Disease,,,1.0,2052.0,1.0,2052.0,,,1.0,156.0,
TCGA-WW-A8ZI,8290,TCGA-WW-A8ZI,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-25593.0,Alive,TUMOR FREE,449.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,449.0,0.0,449.0,0.0,449.0,0.0,449.0,
TCGA-DC-6682,8493,TCGA-DC-6682,READ,57.0,MALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-21062.0,Alive,TUMOR FREE,762.0,,[Not Available],,,,,[Not Applicable],,,0.0,762.0,0.0,762.0,,,0.0,762.0,
TCGA-BK-A13C,10784,TCGA-BK-A13C,UCEC,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Peri (6-12 months since last menstrual period),-17317.0,Alive,TUMOR FREE,760.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,760.0,0.0,760.0,0.0,760.0,0.0,760.0,
TCGA-B5-A11Y,10712,TCGA-B5-A11Y,UCEC,59.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21860.0,Alive,TUMOR FREE,560.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,560.0,0.0,560.0,0.0,560.0,0.0,560.0,
TCGA-BA-5151,3249,TCGA-BA-5151,HNSC,72.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2010.0,[Not Available],-26569.0,Alive,TUMOR FREE,722.0,,[Not Available],,,,517.0,Complete Remission/Response,,,0.0,722.0,0.0,722.0,,,1.0,517.0,
TCGA-DW-5560,4570,TCGA-DW-5560,KIRP,38.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-13964.0,Alive,TUMOR FREE,1486.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1486.0,0.0,1486.0,0.0,1486.0,0.0,1486.0,
TCGA-XS-A8TJ,1891,TCGA-XS-A8TJ,CESC,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15298.0,Alive,TUMOR FREE,890.0,,,,,,,Complete Remission/Response,,,0.0,890.0,0.0,890.0,0.0,890.0,0.0,890.0,
TCGA-26-5136,3112,TCGA-26-5136,GBM,78.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-28496.0,Dead,WITH TUMOR,,577.0,[Not Available],,,,,[Unknown],,,1.0,577.0,1.0,577.0,,,1.0,577.0,
TCGA-S9-A7J1,5354,TCGA-S9-A7J1,LGG,43.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-15926.0,Alive,WITH TUMOR,249.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,249.0,0.0,249.0,,,0.0,249.0,
TCGA-EJ-5510,7925,TCGA-EJ-5510,PRAD,48.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-17895.0,Alive,TUMOR FREE,1887.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1887.0,0.0,1887.0,0.0,1887.0,0.0,1887.0,
TCGA-IR-A3LB,1777,TCGA-IR-A3LB,CESC,53.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Type of Adenocarcinoma,G3,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19374.0,Dead,WITH TUMOR,,2032.0,,Distant Metastasis,Lung,,317.0,Complete Remission/Response,,,1.0,2032.0,1.0,2032.0,1.0,317.0,1.0,317.0,
TCGA-F4-6570,2356,TCGA-F4-6570,COAD,78.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-28772.0,Dead,TUMOR FREE,,188.0,[Not Available],,,,,[Not Available],,,1.0,188.0,0.0,188.0,,,0.0,188.0,
TCGA-60-2695,6560,TCGA-60-2695,LUSC,74.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-27211.0,Alive,TUMOR FREE,642.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,642.0,0.0,642.0,0.0,642.0,0.0,642.0,
TCGA-SC-A6LR,6871,TCGA-SC-A6LR,MESO,73.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-26773.0,Alive,TUMOR FREE,1168.0,,[Not Available],,,,,[Not Available],,R2,0.0,1168.0,0.0,1168.0,,,0.0,1168.0,
TCGA-CV-5971,3484,TCGA-CV-5971,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-22279.0,Alive,TUMOR FREE,701.0,,[Not Available],,,,,[Not Available],,,0.0,701.0,0.0,701.0,,,0.0,701.0,
TCGA-UY-A78O,406,TCGA-UY-A78O,BLCA,75.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-27234.0,Alive,TUMOR FREE,2312.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2312.0,0.0,2312.0,0.0,2312.0,0.0,2312.0,
TCGA-EJ-5502,7917,TCGA-EJ-5502,PRAD,50.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-18447.0,Alive,TUMOR FREE,1171.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1171.0,0.0,1171.0,0.0,1171.0,0.0,1171.0,
TCGA-DB-5280,4939,TCGA-DB-5280,LGG,43.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2007.0,[Not Available],-15836.0,Alive,TUMOR FREE,1112.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0,
TCGA-DU-7301,5027,TCGA-DU-7301,LGG,53.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2006.0,[Not Available],-19644.0,Dead,WITH TUMOR,,788.0,[Not Available],,,,366.0,Progressive Disease,,,1.0,788.0,1.0,788.0,,,1.0,366.0,
TCGA-AJ-A23M,10525,TCGA-AJ-A23M,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22430.0,Dead,WITH TUMOR,,616.0,[Not Available],Locoregional Recurrence,"Other, specify",Abdominal Fluid,516.0,Stable Disease,,,1.0,616.0,1.0,616.0,,,1.0,516.0,
TCGA-D1-A1NU,10875,TCGA-D1-A1NU,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27272.0,Alive,TUMOR FREE,402.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,402.0,0.0,402.0,0.0,402.0,0.0,402.0,
TCGA-DX-A8BG,8634,TCGA-DX-A8BG,SARC,83.0,FEMALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2013.0,[Not Available],-30333.0,Alive,TUMOR FREE,546.0,,[Not Available],Distant Metastasis,Lung,,330.0,[Not Available],Negative,R0,0.0,546.0,0.0,546.0,1.0,330.0,1.0,330.0,
TCGA-3B-A9HQ,8542,TCGA-3B-A9HQ,SARC,66.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2007.0,[Not Available],-24386.0,Alive,,2085.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,2085.0,0.0,2085.0,0.0,2085.0,0.0,2085.0,
TCGA-BS-A0UJ,10804,TCGA-BS-A0UJ,UCEC,68.0,FEMALE,ASIAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25149.0,Alive,TUMOR FREE,2506.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2506.0,0.0,2506.0,0.0,2506.0,0.0,2506.0,
TCGA-97-8552,6263,TCGA-97-8552,LUAD,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-20331.0,Alive,TUMOR FREE,626.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,
TCGA-32-4209,3186,TCGA-32-4209,GBM,40.0,MALE,WHITE,[Not Available],[Not Applicable],Treated primary GBM,[Not Available],2009.0,[Not Available],-14903.0,Dead,WITH TUMOR,,618.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],94.0,[Not Available],,,1.0,618.0,1.0,618.0,,,1.0,94.0,
TCGA-L5-A4OR,2525,TCGA-L5-A4OR,ESCA,83.0,MALE,WHITE,Stage IA,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2010.0,[Not Available],-30417.0,Dead,TUMOR FREE,,96.0,[Not Available],,,,,Complete Remission/Response,,,1.0,96.0,0.0,96.0,0.0,96.0,0.0,96.0,
TCGA-D3-A8GN,8892,TCGA-D3-A8GN,SKCM,27.0,FEMALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],2000.0,[Not Available],-10185.0,Alive,TUMOR FREE,4897.0,,[Not Available],Distant Metastasis,Lung,,787.0,[Not Available],,,0.0,4897.0,0.0,4897.0,,,1.0,787.0,
TCGA-EW-A6SA,1494,TCGA-EW-A6SA,BRCA,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,[Not Available],-21623.0,Alive,TUMOR FREE,510.0,,[Not Available],,,,,[Not Available],Negative,,0.0,510.0,0.0,510.0,0.0,510.0,0.0,510.0,
TCGA-98-A53I,6793,TCGA-98-A53I,LUSC,64.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-23502.0,Alive,TUMOR FREE,565.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,565.0,0.0,565.0,0.0,565.0,0.0,565.0,
TCGA-49-4505,5908,TCGA-49-4505,LUAD,61.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],1996.0,[Not Available],-22628.0,Dead,WITH TUMOR,,428.0,[Not Available],Distant Metastasis|New Primary Tumor,,,417.0,Complete Remission/Response,,,1.0,428.0,1.0,428.0,1.0,417.0,1.0,417.0,
TCGA-PL-A8LZ,1581,TCGA-PL-A8LZ,BRCA,29.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10869.0,Alive,TUMOR FREE,302.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,302.0,0.0,302.0,,,0.0,302.0,
TCGA-77-8009,6674,TCGA-77-8009,LUSC,68.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-25037.0,Dead,,,1695.0,[Not Available],,,,607.0,Complete Remission/Response,,,1.0,1695.0,,1695.0,1.0,607.0,1.0,607.0,
TCGA-HT-A5R9,5226,TCGA-HT-A5R9,LGG,48.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-17775.0,Alive,,2.0,,[Not Available],,,,,[Not Available],,,0.0,2.0,0.0,2.0,,,0.0,2.0,
TCGA-HT-7601,5158,TCGA-HT-7601,LGG,30.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-10989.0,Alive,TUMOR FREE,153.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,153.0,0.0,153.0,,,0.0,153.0,
TCGA-22-4591,6370,TCGA-22-4591,LUSC,80.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-29250.0,Dead,WITH TUMOR,623.0,623.0,[Not Available],,,,443.0,Partial Remission/Response,,,1.0,623.0,1.0,623.0,,,1.0,443.0,
TCGA-HC-A6AN,8112,TCGA-HC-A6AN,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24697.0,Alive,WITH TUMOR,49.0,,[Not Available],,,,,[Not Applicable],,,0.0,49.0,0.0,49.0,,,0.0,49.0,
TCGA-EJ-7797,7971,TCGA-EJ-7797,PRAD,53.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19616.0,Alive,TUMOR FREE,983.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,983.0,0.0,983.0,0.0,983.0,0.0,983.0,
TCGA-WT-AB41,1596,TCGA-WT-AB41,BRCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,TUMOR FREE,1611.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0,
TCGA-X6-A8C7,8791,TCGA-X6-A8C7,SARC,24.0,FEMALE,WHITE,[Not Available],[Not Available],Synovial Sarcoma - Biphasic,[Not Available],2013.0,[Not Available],-9104.0,Alive,TUMOR FREE,896.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,896.0,0.0,896.0,0.0,896.0,0.0,896.0,
TCGA-AZ-5403,2223,TCGA-AZ-5403,COAD,43.0,MALE,WHITE,Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2000.0,[Not Available],-15983.0,Dead,WITH TUMOR,,1910.0,[Not Available],,,,304.0,[Not Available],,,1.0,1910.0,1.0,1910.0,,,1.0,304.0,
TCGA-95-8039,6242,TCGA-95-8039,LUAD,72.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26317.0,Alive,TUMOR FREE,830.0,,[Not Available],Locoregional Recurrence,,,228.0,Complete Remission/Response,,,0.0,830.0,0.0,830.0,1.0,228.0,1.0,228.0,
TCGA-OR-A5LF,69,TCGA-OR-A5LF,ACC,74.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2002.0,[Not Available],-27179.0,Dead,TUMOR FREE,,445.0,[Not Available],,,,,Complete Remission/Response,,,1.0,445.0,0.0,445.0,0.0,445.0,0.0,445.0,
TCGA-IR-A3LF,1779,TCGA-IR-A3LF,CESC,64.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Adenocarcinoma of the Usual Type,G2,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23721.0,Alive,TUMOR FREE,2949.0,,,,,,,Complete Remission/Response,,,0.0,2949.0,0.0,2949.0,0.0,2949.0,0.0,2949.0,
TCGA-EE-A3AH,9075,TCGA-EE-A3AH,SKCM,30.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1998.0,[Not Available],-10988.0,Dead,WITH TUMOR,,4222.0,[Not Available],Locoregional Recurrence,,,1981.0,[Not Available],,,1.0,4222.0,1.0,4222.0,,,1.0,1981.0,
TCGA-FU-A23K,1753,TCGA-FU-A23K,CESC,28.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10551.0,Alive,TUMOR FREE,372.0,,,,,,,Complete Remission/Response,,,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,
TCGA-QR-A6H5,7711,TCGA-QR-A6H5,PCPG,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2008.0,[Not Available],-10987.0,Alive,TUMOR FREE,959.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,959.0,0.0,959.0,0.0,959.0,0.0,959.0,
TCGA-34-5927,6431,TCGA-34-5927,LUSC,70.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-25857.0,Alive,TUMOR FREE,1361.0,,[Not Available],Distant Metastasis,,,245.0,[Unknown],,,0.0,1361.0,0.0,1361.0,,,1.0,245.0,
TCGA-XU-A92V,10424,TCGA-XU-A92V,THYM,72.0,FEMALE,ASIAN,[Not Applicable],IIa,Thymoma; Type AB,[Not Available],2012.0,[Not Available],-26646.0,Dead,TUMOR FREE,,124.0,[Not Available],,,,,[Not Available],,,1.0,124.0,0.0,124.0,,,0.0,124.0,
TCGA-DD-A4NO,5564,TCGA-DD-A4NO,LIHC,65.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2007.0,[Not Available],-24090.0,Alive,WITH TUMOR,2245.0,,[Not Available],Locoregional Recurrence,Liver,,990.0,[Not Available],,R0,0.0,2245.0,0.0,2245.0,1.0,990.0,1.0,990.0,
TCGA-56-8082,6522,TCGA-56-8082,LUSC,80.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-29440.0,Alive,TUMOR FREE,455.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,
TCGA-ZG-A9LM,8356,TCGA-ZG-A9LM,PRAD,72.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-26377.0,Alive,TUMOR FREE,378.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,
TCGA-XF-AAMF,448,TCGA-XF-AAMF,BLCA,68.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,[Not Available],-25023.0,Dead,WITH TUMOR,,329.0,[Not Available],Distant Metastasis,Lung,,157.0,Stable Disease,,,1.0,329.0,1.0,329.0,,,1.0,157.0,
TCGA-BT-A20O,126,TCGA-BT-A20O,BLCA,75.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2003.0,[Not Available],-27534.0,Dead,WITH TUMOR,,370.0,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,315.0,Progressive Disease,,,1.0,370.0,1.0,370.0,,,1.0,315.0,
TCGA-HZ-A49I,7609,TCGA-HZ-A49I,PAAD,77.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-28454.0,Dead,WITH TUMOR,,308.0,Pancreatic Cancer,,,,,Progressive Disease,,,1.0,308.0,1.0,308.0,,,1.0,308.0,
TCGA-BB-4228,3284,TCGA-BB-4228,HNSC,50.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,GX,2010.0,[Not Available],-18536.0,Alive,TUMOR FREE,559.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,559.0,0.0,559.0,0.0,559.0,0.0,559.0,
TCGA-MT-A51X,3697,TCGA-MT-A51X,HNSC,30.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-10976.0,Alive,TUMOR FREE,242.0,,[Not Available],,,,,[Unknown],,,0.0,242.0,0.0,242.0,,,0.0,242.0,
TCGA-HT-7877,5195,TCGA-HT-7877,LGG,20.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-7581.0,Alive,TUMOR FREE,4.0,,[Not Available],,,,,[Not Available],,,0.0,4.0,0.0,4.0,,,0.0,4.0,
TCGA-DJ-A3V3,9983,TCGA-DJ-A3V3,THCA,57.0,FEMALE,ASIAN,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-20997.0,Alive,TUMOR FREE,931.0,,[Not Available],,,,,[Not Available],,R0,0.0,931.0,0.0,931.0,0.0,931.0,0.0,931.0,
TCGA-EE-A2MT,9066,TCGA-EE-A2MT,SKCM,45.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2007.0,[Not Available],-16768.0,Alive,TUMOR FREE,2166.0,,[Not Available],,,,,[Not Available],,,0.0,2166.0,0.0,2166.0,,,0.0,2166.0,
TCGA-QR-A6GO,7697,TCGA-QR-A6GO,PCPG,43.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2009.0,[Not Available],-15799.0,Alive,TUMOR FREE,1065.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1065.0,0.0,1065.0,0.0,1065.0,0.0,1065.0,
TCGA-CG-4466,9462,TCGA-CG-4466,STAD,81.0,FEMALE,[Not Available],Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,[Not Available],-29739.0,Alive,TUMOR FREE,577.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,577.0,0.0,577.0,0.0,577.0,0.0,577.0,
TCGA-DD-AADD,5615,TCGA-DD-AADD,LIHC,51.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2011.0,[Not Available],-18752.0,Alive,TUMOR FREE,1231.0,,[Not Available],,,,,[Not Available],,R0,0.0,1231.0,0.0,1231.0,0.0,1231.0,0.0,1231.0,
TCGA-B8-4151,4095,TCGA-B8-4151,KIRC,51.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2009.0,[Not Available],-18760.0,Alive,TUMOR FREE,1299.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1299.0,0.0,1299.0,0.0,1299.0,0.0,1299.0,
TCGA-CS-4944,4915,TCGA-CS-4944,LGG,50.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-18494.0,Alive,WITH TUMOR,1828.0,,[Not Available],,,,,Stable Disease,,,0.0,1828.0,0.0,1828.0,,,0.0,1828.0,
TCGA-HZ-7918,7589,TCGA-HZ-7918,PAAD,72.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-26573.0,Alive,WITH TUMOR,969.0,,,Distant Metastasis,Liver,,542.0,Complete Remission/Response,,,0.0,969.0,0.0,969.0,1.0,542.0,1.0,542.0,
TCGA-DK-AA6R,221,TCGA-DK-AA6R,BLCA,68.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2001.0,[Not Available],-25196.0,Alive,WITH TUMOR,5041.0,,[Not Available],New Primary Tumor,"Other, specify",Colon,4907.0,Stable Disease,,,0.0,5041.0,0.0,5041.0,,,1.0,4907.0,
TCGA-D7-8576,9509,TCGA-D7-8576,STAD,54.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-20014.0,Dead,WITH TUMOR,,446.0,[Not Available],Locoregional Recurrence|Distant Metastasis,Lung,,204.0,Complete Remission/Response,,,1.0,446.0,1.0,446.0,1.0,204.0,1.0,204.0,
TCGA-IQ-7632,3681,TCGA-IQ-7632,HNSC,68.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-24986.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,441.0,0.0,441.0,,,0.0,441.0,
TCGA-B6-A40B,1024,TCGA-B6-A40B,BRCA,76.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27811.0,Alive,TUMOR FREE,3152.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3152.0,0.0,3152.0,0.0,3152.0,0.0,3152.0,
TCGA-WK-A8XX,8775,TCGA-WK-A8XX,SARC,70.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2007.0,[Not Available],-25701.0,Dead,WITH TUMOR,,1164.0,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,111.0,[Not Available],Negative,R0,1.0,1164.0,1.0,1164.0,1.0,111.0,1.0,111.0,
TCGA-JW-A69B,1790,TCGA-JW-A69B,CESC,44.0,FEMALE,WHITE,[Not Available],Stage IB2,Endocervical Type of Adenocarcinoma,GX,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16080.0,Alive,TUMOR FREE,863.0,,,,,,,Complete Remission/Response,,,0.0,863.0,0.0,863.0,0.0,863.0,0.0,863.0,
TCGA-CH-5766,7898,TCGA-CH-5766,PRAD,55.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-20392.0,Alive,TUMOR FREE,31.0,,[Not Available],,,,,[Not Available],,,0.0,31.0,0.0,31.0,,,0.0,31.0,
TCGA-BG-A187,10766,TCGA-BG-A187,UCEC,65.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,[Not Available],-24099.0,Alive,TUMOR FREE,448.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,448.0,0.0,448.0,0.0,448.0,0.0,448.0,
TCGA-33-AASB,6413,TCGA-33-AASB,LUSC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-24183.0,Dead,WITH TUMOR,,211.0,[Not Available],Distant Metastasis,,,30.0,Progressive Disease,,,1.0,211.0,1.0,211.0,,,1.0,30.0,
TCGA-E8-A242,10021,TCGA-E8-A242,THCA,56.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-20472.0,Alive,TUMOR FREE,950.0,,[Not Available],,,,,[Not Available],,R1,0.0,950.0,0.0,950.0,,,0.0,950.0,
TCGA-C5-A7X5,1656,TCGA-C5-A7X5,CESC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IVB,Cervical Squamous Cell Carcinoma,G3,2003.0,[Not Available],-26542.0,Dead,WITH TUMOR,,414.0,Cervical Cancer,,,,,[Not Available],,,1.0,414.0,1.0,414.0,,,1.0,414.0,
TCGA-AK-3436,3946,TCGA-AK-3436,KIRC,40.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-14842.0,Alive,TUMOR FREE,3331.0,,[Not Available],,,,1189.0,Progressive Disease,,,0.0,3331.0,0.0,3331.0,,,1.0,1189.0,
TCGA-VF-A8A8,9791,TCGA-VF-A8A8,TGCT,18.0,MALE,WHITE,Stage IA,Stage IA,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature),[Not Available],2011.0,[Not Available],-6822.0,Alive,TUMOR FREE,1131.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,1131.0,0.0,1131.0,0.0,1131.0,0.0,1131.0,
TCGA-WB-A80P,7835,TCGA-WB-A80P,PCPG,20.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],1988.0,[Not Available],-7608.0,Alive,WITH TUMOR,9634.0,,[Not Available],Distant Metastasis,Bone,,6866.0,Progressive Disease,,,0.0,9634.0,0.0,9634.0,,,1.0,6866.0,
TCGA-GN-A26A,9200,TCGA-GN-A26A,SKCM,63.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2006.0,[Not Available],-23288.0,Dead,WITH TUMOR,,988.0,[Not Available],Distant Metastasis,Lung,,750.0,[Not Available],,,1.0,988.0,1.0,988.0,,,1.0,750.0,
TCGA-QH-A6X3,5301,TCGA-QH-A6X3,LGG,27.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-10184.0,Alive,TUMOR FREE,313.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,313.0,0.0,313.0,0.0,313.0,0.0,313.0,
TCGA-B8-A54H,4119,TCGA-B8-A54H,KIRC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2012.0,[Not Available],-25243.0,Alive,TUMOR FREE,256.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,256.0,0.0,256.0,0.0,256.0,0.0,256.0,
TCGA-B7-5816,9270,TCGA-B7-5816,STAD,51.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-18698.0,Alive,TUMOR FREE,812.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,812.0,0.0,812.0,0.0,812.0,0.0,812.0,
TCGA-HC-A6AP,8114,TCGA-HC-A6AP,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22318.0,Alive,,71.0,,[Not Available],,,,,[Unknown],,,0.0,71.0,0.0,71.0,,,0.0,71.0,
TCGA-22-5480,6389,TCGA-22-5480,LUSC,66.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-24245.0,Dead,WITH TUMOR,2170.0,2170.0,[Not Available],,,,1779.0,Complete Remission/Response,,,1.0,2170.0,1.0,2170.0,1.0,1779.0,1.0,1779.0,
TCGA-AX-A2HA,10650,TCGA-AX-A2HA,UCEC,35.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2005.0,[Not Available],-13142.0,Alive,TUMOR FREE,2475.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2475.0,0.0,2475.0,0.0,2475.0,0.0,2475.0,
TCGA-DX-A6YZ,8620,TCGA-DX-A6YZ,SARC,59.0,MALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2007.0,[Not Available],-21886.0,Alive,TUMOR FREE,2625.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,2625.0,0.0,2625.0,0.0,2625.0,0.0,2625.0,
TCGA-FY-A4B4,10302,TCGA-FY-A4B4,THCA,62.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-22830.0,Alive,TUMOR FREE,657.0,,[Not Available],,,,,[Not Available],,R1,0.0,657.0,0.0,657.0,,,0.0,657.0,
TCGA-XU-A92X,10426,TCGA-XU-A92X,THYM,17.0,MALE,ASIAN,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2008.0,[Not Available],-6572.0,Alive,TUMOR FREE,2343.0,,[Not Available],,,,,[Not Available],,,0.0,2343.0,0.0,2343.0,,,0.0,2343.0,
TCGA-69-7979,6104,TCGA-69-7979,LUAD,71.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26180.0,Alive,,408.0,,[Not Available],,,,,Stable Disease,,,0.0,408.0,0.0,408.0,,,0.0,408.0,
TCGA-MK-A4N7,10348,TCGA-MK-A4N7,THCA,20.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-7570.0,Alive,TUMOR FREE,987.0,,[Not Available],,,,,[Not Available],,R0,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,
TCGA-77-7465,6671,TCGA-77-7465,LUSC,58.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-21548.0,Alive,,990.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,990.0,0.0,990.0,0.0,990.0,0.0,990.0,
TCGA-XJ-A83H,8296,TCGA-XJ-A83H,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],,Alive,,1280.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1280.0,0.0,1280.0,,,0.0,1280.0,
TCGA-CV-7253,3543,TCGA-CV-7253,HNSC,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1993.0,[Not Available],-21473.0,Dead,WITH TUMOR,,361.0,[Not Available],,,,,Partial Remission/Response,,,1.0,361.0,1.0,361.0,,,1.0,361.0,
TCGA-B0-5098,4028,TCGA-B0-5098,KIRC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,1998.0,[Not Available],-19620.0,Dead,[Discrepancy],,1584.0,[Not Available],,,,,[Not Available],,,1.0,1584.0,,1584.0,,,0.0,1584.0,
TCGA-ZG-A9L4,8351,TCGA-ZG-A9L4,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22388.0,Alive,,1108.0,,[Not Available],,,,,Stable Disease,,,0.0,1108.0,0.0,1108.0,,,0.0,1108.0,
TCGA-IG-A5S3,2487,TCGA-IG-A5S3,ESCA,69.0,FEMALE,WHITE,Stage IIB,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-25414.0,Alive,TUMOR FREE,712.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,712.0,0.0,712.0,0.0,712.0,0.0,712.0,
TCGA-C5-A7CK,1647,TCGA-C5-A7CK,CESC,58.0,FEMALE,WHITE,[Not Available],Stage IVA,Cervical Squamous Cell Carcinoma,G2,2001.0,[Not Available],-21520.0,Dead,TUMOR FREE,,4086.0,,,,,,[Not Available],,,1.0,4086.0,0.0,4086.0,,,0.0,4086.0,
TCGA-CD-8534,9432,TCGA-CD-8534,STAD,41.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-15227.0,Alive,WITH TUMOR,367.0,,[Not Available],Distant Metastasis,"Other, specify","Pancreas, Transverse Colon",201.0,Progressive Disease,,,0.0,367.0,0.0,367.0,,,1.0,201.0,
TCGA-27-2518,3126,TCGA-27-2518,GBM,52.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-19130.0,Dead,WITH TUMOR,753.0,753.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],539.0,[Not Available],,,1.0,753.0,1.0,753.0,,,1.0,539.0,
TCGA-36-2537,7397,TCGA-36-2537,OV,39.0,FEMALE,[Not Available],[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-14595.0,Alive,WITH TUMOR,788.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],431.0,Partial Remission/Response,,,0.0,788.0,0.0,788.0,,,1.0,431.0,
TCGA-FZ-5921,7572,TCGA-FZ-5921,PAAD,85.0,FEMALE,[Unknown],Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,GX,2007.0,[Not Available],-31074.0,Dead,WITH TUMOR,,155.0,,Locoregional Recurrence,Peritoneal Surfaces,,103.0,Progressive Disease,,,1.0,155.0,1.0,155.0,,,1.0,103.0,
TCGA-J4-A67S,8139,TCGA-J4-A67S,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-23332.0,Alive,WITH TUMOR,833.0,,[Not Available],Biochemical evidence of disease,,,708.0,Complete Remission/Response,,,0.0,833.0,0.0,833.0,1.0,708.0,1.0,708.0,
TCGA-VQ-A924,9688,TCGA-VQ-A924,STAD,69.0,MALE,[Unknown],Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008.0,[Not Available],-25351.0,Dead,WITH TUMOR,,1686.0,Stomach Cancer,,,,,Progressive Disease,,,1.0,1686.0,1.0,1686.0,,,1.0,1686.0,
TCGA-06-0881,2839,TCGA-06-0881,GBM,50.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-18278.0,Dead,WITH TUMOR,,504.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],141.0,[Not Available],,,1.0,504.0,1.0,504.0,,,1.0,141.0,
TCGA-V4-A9EV,11104,TCGA-V4-A9EV,UVM,59.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell|Epithelioid Cell,[Not Available],2012.0,[Not Available],-21855.0,Dead,WITH TUMOR,,1269.0,Metastatic Uveal Melanoma,,,,,[Not Available],,,1.0,1269.0,1.0,1269.0,,,1.0,1269.0,
TCGA-BH-A0DL,1067,TCGA-BH-A0DL,BRCA,64.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23628.0,Alive,TUMOR FREE,2381.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2381.0,0.0,2381.0,0.0,2381.0,0.0,2381.0,
TCGA-B0-4815,3987,TCGA-B0-4815,KIRC,65.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2001.0,[Not Available],-23873.0,Dead,WITH TUMOR,,1588.0,[Not Available],,,,,[Not Available],,,1.0,1588.0,1.0,1588.0,,,1.0,1588.0,
TCGA-H2-A2K9,10306,TCGA-H2-A2K9,THCA,25.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-9221.0,Alive,TUMOR FREE,659.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,659.0,0.0,659.0,,,0.0,659.0,
TCGA-DC-6157,8489,TCGA-DC-6157,READ,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-17807.0,Alive,TUMOR FREE,1581.0,,[Not Available],,,,,[Not Applicable],,,0.0,1581.0,0.0,1581.0,,,0.0,1581.0,
TCGA-AC-A8OQ,800,TCGA-AC-A8OQ,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26535.0,Alive,TUMOR FREE,34.0,,[Not Available],,,,,[Not Available],Negative,,0.0,34.0,0.0,34.0,0.0,34.0,0.0,34.0,
TCGA-E2-A15A,1334,TCGA-E2-A15A,BRCA,45.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16750.0,Alive,TUMOR FREE,710.0,,[Not Available],,,,,[Not Available],Negative,,0.0,710.0,0.0,710.0,0.0,710.0,0.0,710.0,
TCGA-73-4675,6119,TCGA-73-4675,LUAD,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-21614.0,Dead,TUMOR FREE,,922.0,[Not Available],Locoregional Recurrence,,,361.0,Progressive Disease,,,1.0,922.0,0.0,922.0,,,1.0,361.0,
TCGA-AP-A1E4,10604,TCGA-AP-A1E4,UCEC,54.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19814.0,Alive,WITH TUMOR,1555.0,,[Not Available],Metastatic,"Other, specify","Bone, lymph nodes",158.0,Progressive Disease,,,0.0,1555.0,0.0,1555.0,,,1.0,158.0,
TCGA-06-6389,2877,TCGA-06-6389,GBM,49.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-18248.0,Alive,WITH TUMOR,237.0,,[Not Available],,,,,[Not Available],,,0.0,237.0,0.0,237.0,,,0.0,237.0,
TCGA-ZF-A9R3,476,TCGA-ZF-A9R3,BLCA,53.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-19384.0,Dead,WITH TUMOR,,949.0,[Not Available],Distant Metastasis,Bone,,917.0,Complete Remission/Response,,,1.0,949.0,1.0,949.0,1.0,917.0,1.0,917.0,
TCGA-FG-7636,5108,TCGA-FG-7636,LGG,48.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2011.0,[Not Available],-17843.0,Alive,TUMOR FREE,544.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,544.0,0.0,544.0,0.0,544.0,0.0,544.0,
TCGA-AF-6136,8379,TCGA-AF-6136,READ,72.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-26490.0,Alive,WITH TUMOR,741.0,,[Not Available],,,,199.0,Progressive Disease,,,0.0,741.0,0.0,741.0,,,1.0,199.0,
TCGA-36-2552,7408,TCGA-36-2552,OV,64.0,FEMALE,[Not Available],[Not Applicable],Stage IIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-23379.0,Alive,TUMOR FREE,349.0,,[Not Available],,,,,[Not Available],,,0.0,349.0,0.0,349.0,,,0.0,349.0,
TCGA-F4-6459,2351,TCGA-F4-6459,COAD,61.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-22574.0,Dead,TUMOR FREE,,262.0,[Not Available],,,,,[Not Available],,,1.0,262.0,0.0,262.0,,,0.0,262.0,
TCGA-78-7537,6164,TCGA-78-7537,LUAD,72.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-26610.0,Dead,,,1622.0,[Not Available],,,,,[Not Available],,,1.0,1622.0,,1622.0,,,0.0,1622.0,
TCGA-2J-AABP,7515,TCGA-2J-AABP,PAAD,58.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Undifferentiated Carcinoma,G4,2013.0,[Not Available],-21484.0,Alive,TUMOR FREE,463.0,,,,,,,Complete Remission/Response,,,0.0,463.0,0.0,463.0,0.0,463.0,0.0,463.0,
TCGA-FI-A2EU,10989,TCGA-FI-A2EU,UCEC,68.0,FEMALE,[Not Available],[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24837.0,Alive,TUMOR FREE,2941.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2941.0,0.0,2941.0,0.0,2941.0,0.0,2941.0,
TCGA-HU-A4H0,9583,TCGA-HU-A4H0,STAD,72.0,MALE,ASIAN,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-26317.0,Alive,TUMOR FREE,64.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,64.0,0.0,64.0,0.0,64.0,0.0,64.0,
TCGA-UY-A9PE,414,TCGA-UY-A9PE,BLCA,86.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-31755.0,Alive,WITH TUMOR,189.0,,[Not Available],Distant Metastasis,Lung,,473.0,Complete Remission/Response,,,0.0,189.0,0.0,189.0,,,1.0,473.0,
TCGA-55-8299,6029,TCGA-55-8299,LUAD,61.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22626.0,Dead,WITH TUMOR,,469.0,[Not Available],Distant Metastasis,,,274.0,Complete Remission/Response,,,1.0,469.0,1.0,469.0,1.0,274.0,1.0,274.0,
TCGA-63-A5MI,6596,TCGA-63-A5MI,LUSC,65.0,MALE,[Not Evaluated],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-24040.0,Alive,TUMOR FREE,1784.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1784.0,0.0,1784.0,0.0,1784.0,0.0,1784.0,
TCGA-DD-AA3A,5577,TCGA-DD-AA3A,LIHC,81.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocholangiocarcinoma (Mixed),G4,2009.0,[Not Available],-29712.0,Dead,TUMOR FREE,,410.0,[Not Available],,,,,[Not Available],,R0,1.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,
TCGA-B6-A0RV,1000,TCGA-B6-A0RV,BRCA,42.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],1996.0,Indeterminate (neither Pre or Postmenopausal),-15507.0,Alive,TUMOR FREE,5156.0,,[Not Available],,,,,[Not Available],Negative,,0.0,5156.0,0.0,5156.0,0.0,5156.0,0.0,5156.0,
TCGA-52-7812,6506,TCGA-52-7812,LUSC,68.0,MALE,WHITE,[Discrepancy],[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-24887.0,Dead,WITH TUMOR,,835.0,[Not Available],Distant Metastasis,,,791.0,Progressive Disease,,,1.0,835.0,1.0,835.0,,,1.0,791.0,
TCGA-DC-6160,8491,TCGA-DC-6160,READ,68.0,MALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-24990.0,Alive,TUMOR FREE,1339.0,,[Not Available],,,,,[Not Applicable],,,0.0,1339.0,0.0,1339.0,,,0.0,1339.0,
TCGA-67-3774,6090,TCGA-67-3774,LUAD,73.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-26704.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],,,0.0,385.0,0.0,385.0,,,0.0,385.0,
TCGA-HT-A5RC,5229,TCGA-HT-A5RC,LGG,70.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-25772.0,Dead,WITH TUMOR,,162.0,[Not Available],,,,,Progressive Disease,,,1.0,162.0,1.0,162.0,,,1.0,162.0,
TCGA-HT-A74L,5242,TCGA-HT-A74L,LGG,22.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-8240.0,Alive,WITH TUMOR,336.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,336.0,0.0,336.0,,,0.0,336.0,
TCGA-EJ-A46E,7979,TCGA-EJ-A46E,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21054.0,Alive,TUMOR FREE,524.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,
TCGA-N5-A59F,11037,TCGA-N5-A59F,UCS,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23826.0,Dead,WITH TUMOR,,361.0,[Not Available],Locoregional Recurrence,Pelvis,,274.0,Complete Remission/Response,,,1.0,361.0,1.0,361.0,1.0,274.0,1.0,274.0,
TCGA-3A-A9IC,7530,TCGA-3A-A9IC,PAAD,61.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-22400.0,Dead,WITH TUMOR,,738.0,Pancreatic Cancer,,,,,Stable Disease,,,1.0,738.0,1.0,738.0,,,1.0,738.0,
TCGA-CD-A4MJ,9443,TCGA-CD-A4MJ,STAD,60.0,MALE,ASIAN,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-21932.0,Alive,WITH TUMOR,384.0,,[Not Available],Locoregional Recurrence,,,69.0,Complete Remission/Response,,,0.0,384.0,0.0,384.0,1.0,69.0,1.0,69.0,
TCGA-VD-A8KJ,11128,TCGA-VD-A8KJ,UVM,53.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,[Not Available],2011.0,[Not Available],-19562.0,Alive,TUMOR FREE,1150.0,,[Not Available],,,,,[Not Available],,,0.0,1150.0,0.0,1150.0,,,0.0,1150.0,
TCGA-A6-2685,1974,TCGA-A6-2685,COAD,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-17757.0,Alive,TUMOR FREE,1133.0,,[Not Available],Locoregional Disease,,,948.0,[Not Available],,,0.0,1133.0,0.0,1133.0,,,1.0,948.0,
TCGA-KO-8403,3837,TCGA-KO-8403,KICH,49.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-18171.0,Alive,TUMOR FREE,3208.0,,[Not Available],,,,,[Not Available],,,0.0,3208.0,0.0,3208.0,,,0.0,3208.0,
TCGA-D3-A8GV,8898,TCGA-D3-A8GV,SKCM,25.0,MALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],1993.0,[Not Available],-9344.0,Dead,WITH TUMOR,,5101.0,[Not Available],Regional lymph node,,,3896.0,[Not Available],,,1.0,5101.0,1.0,5101.0,,,1.0,3896.0,
TCGA-MH-A55Z,4645,TCGA-MH-A55Z,KIRP,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-24017.0,Alive,TUMOR FREE,845.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,845.0,0.0,845.0,0.0,845.0,0.0,845.0,
TCGA-FI-A2D2,10985,TCGA-FI-A2D2,UCEC,66.0,FEMALE,WHITE,[Not Applicable],Stage IB,Mixed serous and endometrioid,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24260.0,Dead,WITH TUMOR,,2352.0,[Not Available],Locoregional Recurrence,Lung,Liver,1917.0,Complete Remission/Response,,,1.0,2352.0,1.0,2352.0,1.0,1917.0,1.0,1917.0,
TCGA-G2-A3VY,321,TCGA-G2-A3VY,BLCA,66.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-24112.0,Alive,WITH TUMOR,536.0,,[Not Available],,,,,Stable Disease,,,0.0,536.0,0.0,536.0,,,0.0,536.0,
TCGA-EJ-8469,7973,TCGA-EJ-8469,PRAD,46.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-17014.0,Alive,WITH TUMOR,2324.0,,[Not Available],Locoregional Recurrence,,,1925.0,Partial Remission/Response,,,0.0,2324.0,0.0,2324.0,,,1.0,1925.0,
TCGA-05-4244,5803,TCGA-05-4244,LUAD,70.0,MALE,[Not Available],Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-25752.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-HV-A5A3,7580,TCGA-HV-A5A3,PAAD,50.0,MALE,ASIAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-18475.0,Dead,TUMOR FREE,,128.0,,,,,,Complete Remission/Response,,,1.0,128.0,0.0,128.0,0.0,128.0,0.0,128.0,
TCGA-XF-A9SL,430,TCGA-XF-A9SL,BLCA,69.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,[Not Available],-25460.0,Dead,TUMOR FREE,,2020.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2020.0,0.0,2020.0,,,0.0,2020.0,
TCGA-JV-A5VF,8709,TCGA-JV-A5VF,SARC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-25505.0,Dead,WITH TUMOR,,32.0,[Not Available],,,,,[Not Available],Positive,R2,1.0,32.0,1.0,32.0,,,1.0,32.0,
TCGA-B0-5095,4025,TCGA-B0-5095,KIRC,81.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2008.0,[Not Available],-29921.0,Dead,TUMOR FREE,,245.0,[Not Available],,,,,[Not Available],,,1.0,245.0,0.0,245.0,,,0.0,245.0,
TCGA-C8-A130,1190,TCGA-C8-A130,BRCA,52.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Peri (6-12 months since last menstrual period),-19117.0,Alive,TUMOR FREE,370.0,,[Not Available],,,,,[Not Available],Negative,,0.0,370.0,0.0,370.0,0.0,370.0,0.0,370.0,
TCGA-S9-A7R8,5366,TCGA-S9-A7R8,LGG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2004.0,[Not Available],-16275.0,Dead,WITH TUMOR,,961.0,[Not Available],,,,698.0,Progressive Disease,,,1.0,961.0,1.0,961.0,,,1.0,698.0,
TCGA-05-5715,5837,TCGA-05-5715,LUAD,69.0,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-25383.0,Alive,TUMOR FREE,62.0,,[Not Available],,,,,[Not Available],,,0.0,62.0,0.0,62.0,,,0.0,62.0,
TCGA-O2-A52W,6826,TCGA-O2-A52W,LUSC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-23156.0,Dead,TUMOR FREE,,261.0,[Not Available],,,,,[Not Applicable],,,1.0,261.0,0.0,261.0,,,0.0,261.0,
TCGA-H4-A2HQ,367,TCGA-H4-A2HQ,BLCA,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-23538.0,Alive,WITH TUMOR,590.0,,[Not Available],Distant Metastasis,Lung,,318.0,Complete Remission/Response,,,0.0,590.0,0.0,590.0,,,1.0,318.0,
TCGA-CH-5767,7899,TCGA-CH-5767,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-24287.0,Alive,TUMOR FREE,458.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,458.0,0.0,458.0,0.0,458.0,0.0,458.0,
TCGA-BH-A18M,1121,TCGA-BH-A18M,BRCA,39.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001.0,[Not Available],-14532.0,Dead,,,2207.0,[Not Available],,,,,[Not Available],Negative,,1.0,2207.0,,2207.0,0.0,2207.0,0.0,2207.0,
TCGA-HT-7676,5171,TCGA-HT-7676,LGG,26.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2009.0,[Not Available],-9667.0,Alive,TUMOR FREE,5.0,,[Not Available],,,,,[Not Available],,,0.0,5.0,0.0,5.0,,,0.0,5.0,
TCGA-HT-7677,5172,TCGA-HT-7677,LGG,53.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2009.0,[Not Available],-19610.0,Alive,[Discrepancy],494.0,,[Not Available],,,,,Stable Disease,,,0.0,494.0,0.0,494.0,,,0.0,494.0,
TCGA-HV-A5A4,7581,TCGA-HV-A5A4,PAAD,72.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-26311.0,Alive,,232.0,,,,,,,Complete Remission/Response,,,0.0,232.0,0.0,232.0,0.0,232.0,0.0,232.0,
TCGA-BA-6869,3258,TCGA-BA-6869,HNSC,62.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-22765.0,Alive,TUMOR FREE,644.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,644.0,0.0,644.0,0.0,644.0,0.0,644.0,
TCGA-OR-A5JC,12,TCGA-OR-A5JC,ACC,37.0,MALE,WHITE,[Not Available],[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2001.0,[Not Available],-13862.0,Dead,,,1750.0,[Not Available],,,,,[Not Available],,,1.0,1750.0,,1750.0,,,0.0,1750.0,
TCGA-BR-4361,9292,TCGA-BR-4361,STAD,66.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-24260.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-EW-A2FV,1487,TCGA-EW-A2FV,BRCA,39.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Other, specify",[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14316.0,Alive,TUMOR FREE,788.0,,[Not Available],,,,,[Not Available],Negative,,0.0,788.0,0.0,788.0,0.0,788.0,0.0,788.0,
TCGA-DC-6155,8487,TCGA-DC-6155,READ,31.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-11381.0,Alive,TUMOR FREE,425.0,,[Not Available],,,,,[Not Available],,,0.0,425.0,0.0,425.0,,,0.0,425.0,
TCGA-43-2576,6469,TCGA-43-2576,LUSC,62.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-22805.0,Alive,TUMOR FREE,1223.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1223.0,0.0,1223.0,0.0,1223.0,0.0,1223.0,
TCGA-14-0740,2998,TCGA-14-0740,GBM,70.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-25627.0,Dead,WITH TUMOR,364.0,364.0,[Not Available],,,,,[Not Available],,,1.0,364.0,1.0,364.0,,,1.0,364.0,
TCGA-BF-A5ES,8814,TCGA-BF-A5ES,SKCM,76.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-28092.0,Alive,TUMOR FREE,490.0,,[Not Available],,,,,[Not Available],,,0.0,490.0,0.0,490.0,,,0.0,490.0,
TCGA-IB-8127,7636,TCGA-IB-8127,PAAD,59.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-21676.0,Alive,WITH TUMOR,522.0,,,Locoregional Recurrence|Distant Metastasis,"Other, specify",Tumor Bed and Liver,486.0,Complete Remission/Response,,,0.0,522.0,0.0,522.0,1.0,486.0,1.0,486.0,
TCGA-XF-A9SK,429,TCGA-XF-A9SK,BLCA,65.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,[Not Available],-24019.0,Dead,WITH TUMOR,,486.0,[Not Available],Distant Metastasis,Bone,,382.0,Stable Disease,,,1.0,486.0,1.0,486.0,,,1.0,382.0,
TCGA-DX-A6BH,8611,TCGA-DX-A6BH,SARC,34.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2012.0,[Not Available],-12742.0,Alive,WITH TUMOR,821.0,,[Not Available],Locoregional Recurrence,,,232.0,[Not Available],Positive,R1,0.0,821.0,0.0,821.0,,,1.0,232.0,
TCGA-HT-7689,5179,TCGA-HT-7689,LGG,58.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2009.0,[Not Available],-21331.0,Alive,TUMOR FREE,455.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,
TCGA-D6-A4Z9,3620,TCGA-D6-A4Z9,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21659.0,Alive,TUMOR FREE,539.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,539.0,0.0,539.0,,,0.0,539.0,
TCGA-AD-5900,2186,TCGA-AD-5900,COAD,67.0,MALE,WHITE,Stage I,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-24776.0,Alive,TUMOR FREE,370.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,370.0,0.0,370.0,0.0,370.0,0.0,370.0,
TCGA-EB-A4XL,8966,TCGA-EB-A4XL,SKCM,56.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-20486.0,Alive,TUMOR FREE,777.0,,[Not Available],,,,,[Not Available],,,0.0,777.0,0.0,777.0,,,0.0,777.0,
TCGA-CN-4728,3307,TCGA-CN-4728,HNSC,56.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-20660.0,Alive,TUMOR FREE,1724.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1724.0,0.0,1724.0,,,0.0,1724.0,
TCGA-SC-A6LQ,6870,TCGA-SC-A6LQ,MESO,60.0,FEMALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-22014.0,Dead,WITH TUMOR,,297.0,[Not Available],Distant Metastasis,Abdomen,,238.0,[Not Available],,R0,1.0,297.0,1.0,297.0,1.0,238.0,1.0,238.0,
TCGA-QR-A70A,7721,TCGA-QR-A70A,PCPG,54.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2006.0,[Not Available],-19755.0,Alive,TUMOR FREE,2119.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2119.0,0.0,2119.0,0.0,2119.0,0.0,2119.0,
TCGA-DJ-A2Q1,9954,TCGA-DJ-A2Q1,THCA,44.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-16371.0,Alive,TUMOR FREE,1148.0,,[Not Available],,,,,[Not Available],,R0,0.0,1148.0,0.0,1148.0,0.0,1148.0,0.0,1148.0,
TCGA-HG-A9SC,1770,TCGA-HG-A9SC,CESC,49.0,FEMALE,WHITE,[Not Available],Stage IIB,Adenosquamous,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17963.0,Alive,TUMOR FREE,504.0,,,,,,,Complete Remission/Response,,,0.0,504.0,0.0,504.0,0.0,504.0,0.0,504.0,
TCGA-56-7579,6515,TCGA-56-7579,LUSC,61.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-22632.0,Dead,WITH TUMOR,,951.0,[Not Available],Locoregional Recurrence,,,149.0,Progressive Disease,,,1.0,951.0,1.0,951.0,,,1.0,149.0,
TCGA-19-2624,3082,TCGA-19-2624,GBM,51.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-18891.0,Dead,TUMOR FREE,5.0,5.0,[Not Available],,,,,[Not Available],,,1.0,5.0,0.0,5.0,,,0.0,5.0,
TCGA-IB-8126,7635,TCGA-IB-8126,PAAD,79.0,FEMALE,WHITE,Stage III,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,[Not Available],-29213.0,Alive,WITH TUMOR,462.0,,,Distant Metastasis,Lung,,83.0,Partial Remission/Response,,,0.0,462.0,0.0,462.0,,,1.0,83.0,
TCGA-73-7498,6122,TCGA-73-7498,LUAD,58.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-21527.0,Alive,TUMOR FREE,1189.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0,
TCGA-A2-A3KD,612,TCGA-A2-A3KD,BRCA,47.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17372.0,Alive,TUMOR FREE,1206.0,,[Not Available],,,,,[Not Available],Positive,,0.0,1206.0,0.0,1206.0,,,0.0,1206.0,
TCGA-CQ-6225,3394,TCGA-CQ-6225,HNSC,65.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-23988.0,Dead,,,403.0,[Not Available],,Oral Cavity,,180.0,Persistent Disease,,,1.0,403.0,,403.0,,,1.0,180.0,
TCGA-QG-A5Z1,2406,TCGA-QG-A5Z1,COAD,71.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-26220.0,Dead,TUMOR FREE,,256.0,[Not Available],,,,,[Not Available],,,1.0,256.0,0.0,256.0,,,0.0,256.0,
TCGA-CV-5440,3477,TCGA-CV-5440,HNSC,52.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2002.0,[Not Available],-19197.0,Alive,TUMOR FREE,3270.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3270.0,0.0,3270.0,,,0.0,3270.0,
TCGA-GS-A9TT,2448,TCGA-GS-A9TT,DLBC,70.0,MALE,WHITE,[Not Applicable],Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2011.0,[Not Available],-25794.0,Alive,TUMOR FREE,1163.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1163.0,0.0,1163.0,,,0.0,1163.0,
TCGA-BD-A3ER,5478,TCGA-BD-A3ER,LIHC,62.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-22657.0,Alive,WITH TUMOR,1115.0,,[Not Available],Locoregional Recurrence,Liver,,226.0,[Not Available],,R0,0.0,1115.0,0.0,1115.0,1.0,226.0,1.0,226.0,
TCGA-BA-A4IG,3265,TCGA-BA-A4IG,HNSC,77.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-28402.0,Alive,TUMOR FREE,855.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,855.0,0.0,855.0,,,0.0,855.0,
TCGA-EY-A1GF,10946,TCGA-EY-A1GF,UCEC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27450.0,Alive,TUMOR FREE,826.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,826.0,0.0,826.0,0.0,826.0,0.0,826.0,
TCGA-AH-6544,8465,TCGA-AH-6544,READ,60.0,MALE,WHITE,[Not Available],[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-21977.0,Alive,WITH TUMOR,1173.0,,[Not Available],,,,,Stable Disease,,,0.0,1173.0,0.0,1173.0,,,0.0,1173.0,
TCGA-44-A47B,5897,TCGA-44-A47B,LUAD,79.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-28869.0,Alive,TUMOR FREE,287.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,287.0,0.0,287.0,0.0,287.0,0.0,287.0,
TCGA-AQ-A1H3,894,TCGA-AQ-A1H3,BRCA,49.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18177.0,Alive,TUMOR FREE,989.0,,[Not Available],,,,,[Not Available],Negative,,0.0,989.0,0.0,989.0,0.0,989.0,0.0,989.0,
TCGA-BQ-7050,4560,TCGA-BQ-7050,KIRP,53.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-19550.0,Alive,TUMOR FREE,1864.0,,[Not Available],,,,,[Not Available],,,0.0,1864.0,0.0,1864.0,,,0.0,1864.0,
TCGA-EU-5906,4408,TCGA-EU-5906,KIRC,55.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-20246.0,Alive,TUMOR FREE,206.0,,[Not Available],,,,,[Not Available],,,0.0,206.0,0.0,206.0,,,0.0,206.0,
TCGA-91-8499,6225,TCGA-91-8499,LUAD,76.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27853.0,Alive,,36.0,,[Not Available],,,,,[Unknown],,,0.0,36.0,0.0,36.0,,,0.0,36.0,
TCGA-DU-7304,5029,TCGA-DU-7304,LGG,43.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2008.0,[Not Available],-15931.0,Dead,WITH TUMOR,,709.0,[Not Available],,,,309.0,Progressive Disease,,,1.0,709.0,1.0,709.0,,,1.0,309.0,
TCGA-A7-A0CH,632,TCGA-A7-A0CH,BRCA,79.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29104.0,Alive,TUMOR FREE,1079.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1079.0,0.0,1079.0,0.0,1079.0,0.0,1079.0,
TCGA-XU-A936,10433,TCGA-XU-A936,THYM,65.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type C,[Not Available],2012.0,[Not Available],-23924.0,Alive,TUMOR FREE,643.0,,[Not Available],,,,,[Not Available],,,0.0,643.0,0.0,643.0,,,0.0,643.0,
TCGA-B6-A409,1023,TCGA-B6-A409,BRCA,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16178.0,Dead,WITH TUMOR,,573.0,[Not Available],Distant Metastasis,Lung,,456.0,[Not Available],Negative,,1.0,573.0,1.0,573.0,1.0,456.0,1.0,456.0,
TCGA-BR-4188,9279,TCGA-BR-4188,STAD,53.0,FEMALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-19585.0,Dead,,,226.0,[Not Available],,,,,[Not Available],,,1.0,226.0,,226.0,,,0.0,226.0,
TCGA-06-0240,2811,TCGA-06-0240,GBM,57.0,MALE,WHITE,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2007.0,[Not Available],-20937.0,Dead,WITH TUMOR,,621.0,[Not Available],,,,,[Unknown],,,1.0,621.0,1.0,621.0,,,1.0,621.0,
TCGA-43-5668,6474,TCGA-43-5668,LUSC,78.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-28635.0,Dead,WITH TUMOR,,559.0,[Not Available],,,,470.0,Complete Remission/Response,,,1.0,559.0,1.0,559.0,1.0,470.0,1.0,470.0,
TCGA-FD-A3SO,270,TCGA-FD-A3SO,BLCA,68.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-25147.0,Dead,WITH TUMOR,,168.0,[Not Available],Locoregional (Urothelial tumor event),Renal Pelvis,,143.0,Progressive Disease,,,1.0,168.0,1.0,168.0,,,1.0,143.0,
TCGA-CM-4744,2259,TCGA-CM-4744,COAD,69.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-25506.0,Alive,TUMOR FREE,609.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,609.0,0.0,609.0,0.0,609.0,0.0,609.0,
TCGA-G7-6796,4599,TCGA-G7-6796,KIRP,58.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-21252.0,Alive,TUMOR FREE,2173.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2173.0,0.0,2173.0,0.0,2173.0,0.0,2173.0,
TCGA-PL-A8LV,1578,TCGA-PL-A8LV,BRCA,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Medullary Carcinoma,[Not Available],2013.0,[Unknown],-19746.0,Alive,WITH TUMOR,-7.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-CV-A45X,3584,TCGA-CV-A45X,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2000.0,[Not Available],-17464.0,Dead,TUMOR FREE,,198.0,[Not Available],,,,,Complete Remission/Response,,,1.0,198.0,0.0,198.0,,,0.0,198.0,
TCGA-E8-A2JQ,10023,TCGA-E8-A2JQ,THCA,18.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-6684.0,Alive,TUMOR FREE,356.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,356.0,0.0,356.0,,,0.0,356.0,
TCGA-UT-A88C,6900,TCGA-UT-A88C,MESO,62.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-23002.0,Dead,WITH TUMOR,,863.0,[Not Available],Intrapleural Progression,"Other, specify",Mediastinum and Contralateral pleura,479.0,[Not Available],,R0,1.0,863.0,1.0,863.0,1.0,479.0,1.0,479.0,
TCGA-BK-A0CC,10781,TCGA-BK-A0CC,UCEC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25479.0,Alive,WITH TUMOR,1067.0,,[Not Available],Locoregional Recurrence,"Other, specify",Right Pelvic Mass,1010.0,Complete Remission/Response,,,0.0,1067.0,0.0,1067.0,1.0,1010.0,1.0,1010.0,
TCGA-KN-8425,3824,TCGA-KN-8425,KICH,53.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-19692.0,Alive,TUMOR FREE,3179.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3179.0,0.0,3179.0,0.0,3179.0,0.0,3179.0,
TCGA-GU-AATP,352,TCGA-GU-AATP,BLCA,74.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27049.0,Alive,WITH TUMOR,1003.0,,[Not Available],New Primary Tumor,Urethra,,596.0,Progressive Disease,,,0.0,1003.0,0.0,1003.0,,,1.0,596.0,
TCGA-2H-A9GN,2469,TCGA-2H-A9GN,ESCA,70.0,MALE,[Unknown],Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2000.0,[Not Available],-25664.0,Dead,WITH TUMOR,,272.0,[Not Available],Distant Metastasis,Brain,,242.0,,,,1.0,272.0,1.0,272.0,,,1.0,242.0,
TCGA-GD-A3OQ,339,TCGA-GD-A3OQ,BLCA,48.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-17682.0,Alive,,95.0,,[Not Available],,,,,[Unknown],,,0.0,95.0,0.0,95.0,,,0.0,95.0,
TCGA-C5-A7CM,1649,TCGA-C5-A7CM,CESC,35.0,FEMALE,WHITE,[Not Available],Stage IB2,Endocervical Adenocarcinoma of the Usual Type,G2,2012.0,[Not Available],-12853.0,Alive,TUMOR FREE,619.0,,,,,,,Complete Remission/Response,,,0.0,619.0,0.0,619.0,0.0,619.0,0.0,619.0,
TCGA-P4-AAVL,4661,TCGA-P4-AAVL,KIRP,85.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-31082.0,Dead,WITH TUMOR,,487.0,[Not Available],,,,41.0,Complete Remission/Response,,,1.0,487.0,1.0,487.0,1.0,41.0,1.0,41.0,
TCGA-05-4405,5817,TCGA-05-4405,LUAD,74.0,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-27241.0,Alive,TUMOR FREE,610.0,,[Not Available],,,,,[Not Applicable],,,0.0,610.0,0.0,610.0,,,0.0,610.0,
TCGA-DY-A0XA,8496,TCGA-DY-A0XA,READ,57.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2001.0,[Not Available],-21115.0,Alive,,3846.0,,[Not Available],,,,,[Not Available],,,0.0,3846.0,0.0,3846.0,,,0.0,3846.0,
TCGA-QQ-A5V2,8745,TCGA-QQ-A5V2,SARC,42.0,MALE,WHITE,[Not Available],[Not Available],Giant cell 'MFH' / Undifferentiated pleomorphic sarcoma with giant cells,[Not Available],2006.0,[Not Available],-15420.0,Alive,,56.0,,[Not Available],,,,,[Not Available],[Unknown],R1,0.0,56.0,0.0,56.0,,,0.0,56.0,
TCGA-DU-8158,5032,TCGA-DU-8158,LGG,57.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2001.0,[Not Available],-21129.0,Dead,WITH TUMOR,,155.0,[Not Available],,,,,[Not Available],,,1.0,155.0,1.0,155.0,,,1.0,155.0,
TCGA-EM-A22Q,10138,TCGA-EM-A22Q,THCA,36.0,MALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-13341.0,Alive,TUMOR FREE,433.0,,[Not Available],,,,,[Not Available],,R0,0.0,433.0,0.0,433.0,0.0,433.0,0.0,433.0,
TCGA-77-7337,6668,TCGA-77-7337,LUSC,65.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-24065.0,Dead,,,3253.0,[Not Available],,,,,[Not Available],,,1.0,3253.0,,3253.0,,,0.0,3253.0,
TCGA-D3-A2J8,8837,TCGA-D3-A2J8,SKCM,48.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2003.0,[Not Available],-17626.0,Dead,WITH TUMOR,,1992.0,[Not Available],Locoregional Recurrence,,,1737.0,[Not Available],,,1.0,1992.0,1.0,1992.0,,,1.0,1737.0,
TCGA-CS-5395,4919,TCGA-CS-5395,LGG,43.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligodendroglioma,G2,2007.0,[Not Available],-15848.0,Dead,WITH TUMOR,,639.0,[Not Available],,,,287.0,Progressive Disease,,,1.0,639.0,1.0,639.0,,,1.0,287.0,
TCGA-56-A62T,6547,TCGA-56-A62T,LUSC,78.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2013.0,[Not Available],-28522.0,Alive,TUMOR FREE,440.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,
TCGA-78-7159,6154,TCGA-78-7159,LUAD,60.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-22261.0,Alive,,1974.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1974.0,0.0,1974.0,0.0,1974.0,0.0,1974.0,
TCGA-CC-A9FV,5512,TCGA-CC-A9FV,LIHC,57.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-21044.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-VN-A88I,8267,TCGA-VN-A88I,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21576.0,Alive,WITH TUMOR,269.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,269.0,0.0,269.0,,,0.0,269.0,
TCGA-97-7941,6254,TCGA-97-7941,LUAD,72.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26298.0,Alive,TUMOR FREE,484.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,484.0,0.0,484.0,0.0,484.0,0.0,484.0,
TCGA-24-1431,7184,TCGA-24-1431,OV,67.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,[Not Available],-24758.0,Dead,WITH TUMOR,583.0,567.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],199.0,[Not Available],,,1.0,567.0,1.0,567.0,,,1.0,199.0,
TCGA-60-2723,6581,TCGA-60-2723,LUSC,74.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-27225.0,Alive,TUMOR FREE,1092.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,
TCGA-CV-6954,3511,TCGA-CV-6954,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1998.0,[Not Available],-21557.0,Dead,TUMOR FREE,,2002.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2002.0,0.0,2002.0,,,0.0,2002.0,
TCGA-AS-3778,3963,TCGA-AS-3778,KIRC,35.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2010.0,[Not Available],-12937.0,Alive,TUMOR FREE,43.0,,[Not Available],,,,,[Unknown],,,0.0,43.0,0.0,43.0,,,0.0,43.0,
TCGA-QH-A65V,5291,TCGA-QH-A65V,LGG,43.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-15850.0,Alive,WITH TUMOR,384.0,,[Not Available],,,,,Stable Disease,,,0.0,384.0,0.0,384.0,,,0.0,384.0,
TCGA-LA-A446,6798,TCGA-LA-A446,LUSC,68.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-25199.0,Alive,TUMOR FREE,401.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,401.0,0.0,401.0,0.0,401.0,0.0,401.0,
TCGA-28-5220,3164,TCGA-28-5220,GBM,67.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-24622.0,Dead,WITH TUMOR,,388.0,[Not Available],,[Not Applicable],[Not Applicable],262.0,[Not Applicable],,,1.0,388.0,1.0,388.0,,,1.0,262.0,
TCGA-KL-8328,3775,TCGA-KL-8328,KICH,60.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2003.0,[Not Available],-21976.0,Alive,TUMOR FREE,3127.0,,[Not Available],,,,,[Not Evaluated],,,0.0,3127.0,0.0,3127.0,,,0.0,3127.0,
TCGA-BA-A4IF,3264,TCGA-BA-A4IF,HNSC,59.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-21635.0,Alive,TUMOR FREE,895.0,,[Not Available],New Primary Tumor,,LUL Lung,463.0,Complete Remission/Response,,,0.0,895.0,0.0,895.0,,,1.0,463.0,
TCGA-AX-A1CP,10643,TCGA-AX-A1CP,UCEC,84.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30737.0,Alive,,1107.0,,[Not Available],,,,722.0,[Not Available],,,0.0,1107.0,0.0,1107.0,,,1.0,722.0,
TCGA-DU-6405,5003,TCGA-DU-6405,LGG,51.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2000.0,[Not Available],-18686.0,Dead,WITH TUMOR,,605.0,[Not Available],,,,486.0,Progressive Disease,,,1.0,605.0,1.0,605.0,,,1.0,486.0,
TCGA-W5-AA39,1939,TCGA-W5-AA39,CHOL,81.0,MALE,WHITE,Stage II,[Not Applicable],Cholangiocarcinoma; intrahepatic,G4,2010.0,[Not Available],-29594.0,Dead,WITH TUMOR,,170.0,[Not Available],,,,,[Not Available],,RX,1.0,170.0,1.0,170.0,,,1.0,170.0,
TCGA-DM-A28G,2347,TCGA-DM-A28G,COAD,75.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2001.0,[Not Available],-27641.0,Dead,,1849.0,1849.0,[Not Available],,,,,[Not Available],,,1.0,1849.0,,1849.0,,,0.0,1849.0,
TCGA-21-5787,6359,TCGA-21-5787,LUSC,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-24071.0,Dead,WITH TUMOR,329.0,329.0,[Not Available],,,,103.0,Progressive Disease,,,1.0,329.0,1.0,329.0,,,1.0,103.0,
TCGA-H7-8501,3658,TCGA-H7-8501,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2012.0,[Not Available],-19808.0,Alive,TUMOR FREE,461.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,461.0,0.0,461.0,,,0.0,461.0,
TCGA-AR-A1AY,931,TCGA-AR-A1AY,BRCA,65.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23927.0,Alive,TUMOR FREE,1026.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1026.0,0.0,1026.0,0.0,1026.0,0.0,1026.0,
TCGA-85-8277,6722,TCGA-85-8277,LUSC,70.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25793.0,Dead,TUMOR FREE,,307.0,[Not Available],,,,,Complete Remission/Response,,,1.0,307.0,0.0,307.0,0.0,307.0,0.0,307.0,
TCGA-BP-5175,4243,TCGA-BP-5175,KIRC,60.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-21949.0,Alive,TUMOR FREE,932.0,,[Not Available],,,,,[Not Available],,,0.0,932.0,0.0,932.0,,,0.0,932.0,
TCGA-CN-6996,3354,TCGA-CN-6996,HNSC,58.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-21447.0,Dead,WITH TUMOR,,530.0,[Not Available],,Cervical Lymph Nodes,SUPRASTERNAL NOTCH NODE,350.0,Complete Remission/Response,,,1.0,530.0,1.0,530.0,,,1.0,350.0,
TCGA-OR-A5K6,41,TCGA-OR-A5K6,ACC,56.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-20657.0,Alive,WITH TUMOR,1493.0,,[Not Available],Distant Metastasis,Liver,,391.0,Complete Remission/Response,,,0.0,1493.0,0.0,1493.0,1.0,391.0,1.0,391.0,
TCGA-X9-A973,8793,TCGA-X9-A973,SARC,55.0,MALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2011.0,[Not Available],-20146.0,Alive,WITH TUMOR,1108.0,,[Not Available],Distant Metastasis,Lung,,119.0,[Not Available],Negative,R0,0.0,1108.0,0.0,1108.0,1.0,119.0,1.0,119.0,
TCGA-85-8479,6731,TCGA-85-8479,LUSC,66.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24350.0,Alive,TUMOR FREE,468.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,468.0,0.0,468.0,0.0,468.0,0.0,468.0,
TCGA-XQ-A8TB,8312,TCGA-XQ-A8TB,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24623.0,Alive,TUMOR FREE,770.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,770.0,0.0,770.0,0.0,770.0,0.0,770.0,
TCGA-EM-A2OY,10154,TCGA-EM-A2OY,THCA,46.0,FEMALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-17075.0,Alive,TUMOR FREE,983.0,,[Not Available],,,,,[Not Available],,R0,0.0,983.0,0.0,983.0,0.0,983.0,0.0,983.0,
TCGA-ET-A39K,10221,TCGA-ET-A39K,THCA,48.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-17789.0,Alive,TUMOR FREE,3267.0,,[Not Available],Locoregional Recurrence,,,711.0,[Not Available],,R1,0.0,3267.0,0.0,3267.0,,,1.0,711.0,
TCGA-VS-A954,1858,TCGA-VS-A954,CESC,67.0,FEMALE,[Unknown],[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24498.0,Alive,TUMOR FREE,1714.0,,,,,,,Complete Remission/Response,,,0.0,1714.0,0.0,1714.0,0.0,1714.0,0.0,1714.0,
TCGA-DD-AAVX,5658,TCGA-DD-AAVX,LIHC,38.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-14016.0,Alive,WITH TUMOR,1718.0,,[Not Available],Intrahepatic Recurrence,Liver,,393.0,[Not Available],,R0,0.0,1718.0,0.0,1718.0,1.0,393.0,1.0,393.0,
TCGA-O2-A5IB,6827,TCGA-O2-A5IB,LUSC,71.0,FEMALE,WHITE,Stage III,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-26211.0,Dead,WITH TUMOR,,340.0,[Not Available],Distant Metastasis,,,253.0,[Unknown],,,1.0,340.0,1.0,340.0,,,1.0,253.0,
TCGA-CW-5591,4347,TCGA-CW-5591,KIRC,56.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-20712.0,Alive,WITH TUMOR,2271.0,,[Not Available],,,,,[Not Available],,,0.0,2271.0,0.0,2271.0,,,0.0,2271.0,
TCGA-C8-A273,1213,TCGA-C8-A273,BRCA,29.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,Alive,TUMOR FREE,513.0,,[Not Available],,,,,[Not Available],Negative,,0.0,513.0,0.0,513.0,0.0,513.0,0.0,513.0,
TCGA-EL-A3D5,10057,TCGA-EL-A3D5,THCA,44.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-16217.0,Alive,TUMOR FREE,1737.0,,[Not Available],,,,,[Not Available],,R1,0.0,1737.0,0.0,1737.0,,,0.0,1737.0,
TCGA-LN-A7HZ,2588,TCGA-LN-A7HZ,ESCA,49.0,MALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-17931.0,Alive,TUMOR FREE,401.0,,[Not Available],Locoregional Recurrence,,,117.0,Complete Remission/Response,,,0.0,401.0,0.0,401.0,1.0,117.0,1.0,117.0,
TCGA-TM-A84S,5386,TCGA-TM-A84S,LGG,36.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-13424.0,Alive,TUMOR FREE,454.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,454.0,0.0,454.0,0.0,454.0,0.0,454.0,
TCGA-EJ-A65J,7989,TCGA-EJ-A65J,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22904.0,Alive,TUMOR FREE,451.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,451.0,0.0,451.0,0.0,451.0,0.0,451.0,
TCGA-DS-A0VL,1679,TCGA-DS-A0VL,CESC,25.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,2001.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9186.0,Alive,TUMOR FREE,81.0,,,,,,,Complete Remission/Response,,,0.0,81.0,0.0,81.0,0.0,81.0,0.0,81.0,
TCGA-VD-A8KE,11123,TCGA-VD-A8KE,UVM,74.0,FEMALE,[Not Evaluated],Stage IIA,Stage IIA,Epithelioid Cell|Spindle Cell,[Not Available],2012.0,[Not Available],-27290.0,Alive,TUMOR FREE,821.0,,[Not Available],,,,,[Not Available],,,0.0,821.0,0.0,821.0,,,0.0,821.0,
TCGA-CN-4742,3320,TCGA-CN-4742,HNSC,48.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-17793.0,Dead,WITH TUMOR,,397.0,[Not Available],,,,,Progressive Disease,,,1.0,397.0,1.0,397.0,,,1.0,397.0,
TCGA-D3-A2J9,8838,TCGA-D3-A2J9,SKCM,75.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2003.0,[Not Available],-27428.0,Dead,WITH TUMOR,,723.0,[Not Available],Distant Metastasis,Lung,,231.0,[Not Available],,,1.0,723.0,1.0,723.0,,,1.0,231.0,
TCGA-FR-A728,9135,TCGA-FR-A728,SKCM,54.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2013.0,[Not Available],-19936.0,Alive,TUMOR FREE,583.0,,[Not Available],Locoregional Recurrence,,,64.0,[Not Available],,,0.0,583.0,0.0,583.0,,,1.0,64.0,
TCGA-ZP-A9D4,5798,TCGA-ZP-A9D4,LIHC,64.0,FEMALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-23656.0,Alive,TUMOR FREE,395.0,,[Not Available],,,,,[Not Available],,R0,0.0,395.0,0.0,395.0,0.0,395.0,0.0,395.0,
TCGA-FE-A23A,10267,TCGA-FE-A23A,THCA,27.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-10177.0,Alive,TUMOR FREE,2489.0,,[Not Available],,,,,[Not Available],,R0,0.0,2489.0,0.0,2489.0,0.0,2489.0,0.0,2489.0,
TCGA-DD-AACI,5588,TCGA-DD-AACI,LIHC,69.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2008.0,[Not Available],-25236.0,Alive,WITH TUMOR,1618.0,,[Not Available],Intrahepatic Recurrence,Liver,,1432.0,[Not Available],,R0,0.0,1618.0,0.0,1618.0,1.0,1432.0,1.0,1432.0,
TCGA-AG-3732,8414,TCGA-AG-3732,READ,78.0,FEMALE,[Not Available],Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2005.0,[Not Available],-28521.0,Alive,TUMOR FREE,1003.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1003.0,0.0,1003.0,0.0,1003.0,0.0,1003.0,
TCGA-Q9-A6FW,2598,TCGA-Q9-A6FW,ESCA,61.0,MALE,WHITE,Stage IIIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2013.0,[Not Available],-22586.0,Alive,TUMOR FREE,238.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,238.0,0.0,238.0,0.0,238.0,0.0,238.0,
TCGA-VQ-A8PP,9665,TCGA-VQ-A8PP,STAD,76.0,MALE,[Unknown],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008.0,[Not Available],-27774.0,Dead,WITH TUMOR,,712.0,Stomach Cancer,Locoregional Recurrence,,,502.0,Progressive Disease,,,1.0,712.0,1.0,712.0,,,1.0,502.0,
TCGA-BH-A6R9,1171,TCGA-BH-A6R9,BRCA,61.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Metaplastic Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22325.0,Alive,TUMOR FREE,160.0,,[Not Available],,,,,[Not Available],Negative,,0.0,160.0,0.0,160.0,0.0,160.0,0.0,160.0,
TCGA-DX-A3U9,8587,TCGA-DX-A3U9,SARC,84.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2005.0,[Not Available],-31010.0,Dead,WITH TUMOR,,456.0,[Not Available],Locoregional Recurrence,,,203.0,[Not Available],[Not Available],R1,1.0,456.0,1.0,456.0,,,1.0,203.0,
TCGA-B8-A54E,4116,TCGA-B8-A54E,KIRC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2011.0,[Not Available],-22900.0,Alive,TUMOR FREE,909.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,909.0,0.0,909.0,0.0,909.0,0.0,909.0,
TCGA-LG-A6GG,5746,TCGA-LG-A6GG,LIHC,79.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-28871.0,Alive,TUMOR FREE,387.0,,[Not Available],,,,,[Not Available],,R0,0.0,387.0,0.0,387.0,0.0,387.0,0.0,387.0,
TCGA-5M-AAT6,1958,TCGA-5M-AAT6,COAD,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-14852.0,Dead,WITH TUMOR,,290.0,[Not Available],,,,219.0,Progressive Disease,,,1.0,290.0,1.0,290.0,,,1.0,219.0,
TCGA-OL-A66P,1570,TCGA-OL-A66P,BRCA,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,[Not Available],-27489.0,Alive,TUMOR FREE,428.0,,[Not Available],,,,,[Not Available],Negative,,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,
TCGA-QK-A6VB,3729,TCGA-QK-A6VB,HNSC,66.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-24144.0,Alive,TUMOR FREE,641.0,,[Not Available],New Primary Tumor,,Acute myeloid leukemia,613.0,Complete Remission/Response,,,0.0,641.0,0.0,641.0,,,1.0,613.0,
TCGA-EM-A1CV,10123,TCGA-EM-A1CV,THCA,32.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-11932.0,Alive,TUMOR FREE,1475.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,1475.0,0.0,1475.0,,,0.0,1475.0,
TCGA-AX-A2H2,10645,TCGA-AX-A2H2,UCEC,86.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIA,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31524.0,Dead,TUMOR FREE,,145.0,[Not Available],,,,,Complete Remission/Response,,,1.0,145.0,0.0,145.0,0.0,145.0,0.0,145.0,
TCGA-CV-7248,3540,TCGA-CV-7248,HNSC,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,[Not Available],-23082.0,Dead,TUMOR FREE,,521.0,[Not Available],,,,,[Not Available],,,1.0,521.0,0.0,521.0,,,0.0,521.0,
TCGA-DJ-A2PU,9947,TCGA-DJ-A2PU,THCA,52.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18998.0,Alive,TUMOR FREE,1033.0,,[Not Available],,,,,[Not Available],,R0,0.0,1033.0,0.0,1033.0,0.0,1033.0,0.0,1033.0,
TCGA-XF-A9T5,444,TCGA-XF-A9T5,BLCA,78.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-28578.0,Alive,TUMOR FREE,2027.0,,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Vagina,664.0,Complete Remission/Response,,,0.0,2027.0,0.0,2027.0,,,1.0,664.0,
TCGA-BP-5173,4241,TCGA-BP-5173,KIRC,75.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-27436.0,Dead,TUMOR FREE,,62.0,[Not Available],,,,,[Not Available],,,1.0,62.0,0.0,62.0,,,0.0,62.0,
TCGA-CC-5260,5484,TCGA-CC-5260,LIHC,61.0,FEMALE,ASIAN,Stage IIIC,[Not Applicable],Hepatocellular Carcinoma,G1,2010.0,[Not Available],-22345.0,Dead,TUMOR FREE,,87.0,[Not Available],,,,,[Not Available],,RX,1.0,87.0,0.0,87.0,,,0.0,87.0,
TCGA-BF-A5ER,8813,TCGA-BF-A5ER,SKCM,63.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-23199.0,Alive,TUMOR FREE,327.0,,[Not Available],,,,,[Not Available],,,0.0,327.0,0.0,327.0,,,0.0,327.0,
TCGA-CN-5370,3333,TCGA-CN-5370,HNSC,78.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2006.0,[Not Available],-28549.0,Dead,WITH TUMOR,,259.0,[Not Available],,Oral Cavity,,123.0,Complete Remission/Response,,,1.0,259.0,1.0,259.0,1.0,123.0,1.0,123.0,
TCGA-DH-A66G,4974,TCGA-DH-A66G,LGG,49.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-18199.0,Alive,WITH TUMOR,523.0,,[Not Available],,,,,Stable Disease,,,0.0,523.0,0.0,523.0,,,0.0,523.0,
TCGA-MR-A8JO,5755,TCGA-MR-A8JO,LIHC,34.0,MALE,WHITE,Stage I,[Not Applicable],Fibrolamellar Carcinoma,G3,2013.0,[Not Available],-12669.0,Alive,TUMOR FREE,330.0,,[Not Available],,,,,[Not Available],,RX,0.0,330.0,0.0,330.0,,,0.0,330.0,
TCGA-42-2587,7411,TCGA-42-2587,OV,75.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-27510.0,Alive,TUMOR FREE,722.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,722.0,0.0,722.0,0.0,722.0,0.0,722.0,
TCGA-CR-6493,3437,TCGA-CR-6493,HNSC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-25432.0,Dead,WITH TUMOR,,282.0,[Not Available],Locoregional Recurrence,Oral Cavity,Right gingiva,247.0,Complete Remission/Response,,,1.0,282.0,1.0,282.0,,,1.0,247.0,
TCGA-EJ-5497,7913,TCGA-EJ-5497,PRAD,47.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-17523.0,Alive,TUMOR FREE,405.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,405.0,0.0,405.0,0.0,405.0,0.0,405.0,
TCGA-CM-5348,2268,TCGA-CM-5348,COAD,72.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-26543.0,Alive,TUMOR FREE,699.0,,[Not Available],,,,,[Unknown],,,0.0,699.0,0.0,699.0,,,0.0,699.0,
TCGA-QQ-A5VC,8749,TCGA-QQ-A5VC,SARC,63.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-23357.0,Alive,TUMOR FREE,1092.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,
TCGA-UZ-A9PN,4687,TCGA-UZ-A9PN,KIRP,54.0,MALE,WHITE,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-19724.0,Dead,WITH TUMOR,,1136.0,[Not Available],,,,679.0,Complete Remission/Response,,,1.0,1136.0,1.0,1136.0,1.0,679.0,1.0,679.0,
TCGA-E9-A1RD,1418,TCGA-E9-A1RD,BRCA,67.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24719.0,Alive,TUMOR FREE,34.0,,[Not Available],,,,,[Not Available],Negative,,0.0,34.0,0.0,34.0,0.0,34.0,0.0,34.0,
TCGA-69-7765,6100,TCGA-69-7765,LUAD,56.0,MALE,BLACK OR AFRICAN AMERICAN,[Discrepancy],[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-20625.0,Alive,,165.0,,[Not Available],,,,,[Not Available],,,0.0,165.0,0.0,165.0,,,0.0,165.0,
TCGA-UF-A7JF,3759,TCGA-UF-A7JF,HNSC,80.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-29468.0,Alive,TUMOR FREE,1686.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1686.0,0.0,1686.0,,,0.0,1686.0,
TCGA-B5-A11M,10701,TCGA-B5-A11M,UCEC,43.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16063.0,Alive,TUMOR FREE,1362.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1362.0,0.0,1362.0,0.0,1362.0,0.0,1362.0,
TCGA-CD-8525,9423,TCGA-CD-8525,STAD,82.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2010.0,[Not Available],-30004.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-EM-A3AO,10165,TCGA-EM-A3AO,THCA,61.0,MALE,[Not Available],Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-22347.0,Alive,TUMOR FREE,1354.0,,[Not Available],,,,,[Not Available],,R0,0.0,1354.0,0.0,1354.0,,,0.0,1354.0,
TCGA-2Z-A9JK,4434,TCGA-2Z-A9JK,KIRP,50.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-18540.0,Alive,WITH TUMOR,1186.0,,[Not Available],,,,324.0,Stable Disease,,,0.0,1186.0,0.0,1186.0,,,1.0,324.0,
TCGA-EL-A3ZK,10095,TCGA-EL-A3ZK,THCA,41.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-15121.0,Alive,TUMOR FREE,1575.0,,[Not Available],,,,,[Not Available],,R0,0.0,1575.0,0.0,1575.0,0.0,1575.0,0.0,1575.0,
TCGA-AO-A1KT,888,TCGA-AO-A1KT,BRCA,78.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28660.0,Alive,TUMOR FREE,541.0,,[Not Available],,,,,[Not Available],Negative,,0.0,541.0,0.0,541.0,0.0,541.0,0.0,541.0,
TCGA-JX-A3Q0,1794,TCGA-JX-A3Q0,CESC,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage III,Cervical Squamous Cell Carcinoma,G2,1997.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23313.0,Alive,TUMOR FREE,6375.0,,,,,,,Complete Remission/Response,,,0.0,6375.0,0.0,6375.0,0.0,6375.0,0.0,6375.0,
TCGA-BJ-A0Z2,9848,TCGA-BJ-A0Z2,THCA,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVC,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-21008.0,Alive,WITH TUMOR,1514.0,,[Not Available],Distant Metastasis,Bone,,158.0,[Not Available],,RX,0.0,1514.0,0.0,1514.0,,,1.0,158.0,
TCGA-DH-A7UU,4978,TCGA-DH-A7UU,LGG,43.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-16037.0,Alive,WITH TUMOR,417.0,,[Not Available],,,,,Stable Disease,,,0.0,417.0,0.0,417.0,,,0.0,417.0,
TCGA-97-8171,6255,TCGA-97-8171,LUAD,81.0,MALE,ASIAN,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-29627.0,Alive,WITH TUMOR,568.0,,[Not Available],Distant Metastasis,,,441.0,Progressive Disease,,,0.0,568.0,0.0,568.0,,,1.0,441.0,
TCGA-CE-A27D,9896,TCGA-CE-A27D,THCA,28.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-10536.0,Alive,TUMOR FREE,374.0,,[Not Available],,,,,[Not Available],,R0,0.0,374.0,0.0,374.0,0.0,374.0,0.0,374.0,
TCGA-CN-A6V6,3374,TCGA-CN-A6V6,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2013.0,[Not Available],-21811.0,Alive,TUMOR FREE,635.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,635.0,0.0,635.0,,,0.0,635.0,
TCGA-XV-A9W5,9254,TCGA-XV-A9W5,SKCM,51.0,MALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],2013.0,[Not Available],-18739.0,Alive,WITH TUMOR,392.0,,[Not Available],,,,,[Not Available],,,0.0,392.0,0.0,392.0,,,0.0,392.0,
TCGA-95-7039,6235,TCGA-95-7039,LUAD,54.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-19981.0,Alive,WITH TUMOR,1272.0,,[Not Available],Locoregional Recurrence,,,1258.0,Complete Remission/Response,,,0.0,1272.0,0.0,1272.0,1.0,1258.0,1.0,1258.0,
TCGA-NC-A5HI,6806,TCGA-NC-A5HI,LUSC,68.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-24981.0,Alive,TUMOR FREE,1743.0,,[Not Available],New Primary Tumor,,,70.0,Complete Remission/Response,,,0.0,1743.0,0.0,1743.0,0.0,1743.0,1.0,70.0,
TCGA-BH-A18J,1118,TCGA-BH-A18J,BRCA,56.0,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2000.0,[Not Available],-20678.0,Dead,WITH TUMOR,,612.0,[Not Available],,,,,[Not Available],Negative,,1.0,612.0,1.0,612.0,,,1.0,612.0,
TCGA-77-8007,6672,TCGA-77-8007,LUSC,68.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-25102.0,Dead,,,198.0,[Not Available],,,,139.0,[Not Available],,,1.0,198.0,,198.0,,,1.0,139.0,
TCGA-CJ-4644,4277,TCGA-CJ-4644,KIRC,48.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-17882.0,Dead,WITH TUMOR,,336.0,[Not Available],,,,93.0,[Not Available],,,1.0,336.0,1.0,336.0,,,1.0,93.0,
TCGA-FV-A4ZP,5698,TCGA-FV-A4ZP,LIHC,78.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2005.0,[Not Available],-28771.0,Dead,TUMOR FREE,,2486.0,[Not Available],,,,,[Not Available],,R1,1.0,2486.0,0.0,2486.0,,,0.0,2486.0,
TCGA-FY-A3ON,10286,TCGA-FY-A3ON,THCA,20.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-7403.0,Alive,TUMOR FREE,595.0,,[Not Available],,,,,[Not Available],,R0,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,
TCGA-5M-AATE,1959,TCGA-5M-AATE,COAD,76.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-27870.0,Alive,WITH TUMOR,1200.0,,[Not Available],,,,810.0,Progressive Disease,,,0.0,1200.0,0.0,1200.0,,,1.0,810.0,
TCGA-5X-AA5U,7435,TCGA-5X-AA5U,OV,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIC,Serous Cystadenocarcinoma,GX,2013.0,[Not Available],-22438.0,Alive,TUMOR FREE,361.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,361.0,0.0,361.0,0.0,361.0,0.0,361.0,
TCGA-QS-A744,11018,TCGA-QS-A744,UCEC,86.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31520.0,Alive,TUMOR FREE,451.0,,[Not Available],,,,,[Not Applicable],,,0.0,451.0,0.0,451.0,,,0.0,451.0,
TCGA-UF-A7JD,3758,TCGA-UF-A7JD,HNSC,71.0,MALE,[Unknown],Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,[Not Available],-26101.0,Dead,TUMOR FREE,,739.0,[Not Available],,,,,Complete Remission/Response,,,1.0,739.0,0.0,739.0,,,0.0,739.0,
TCGA-B0-5812,4070,TCGA-B0-5812,KIRC,53.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-19600.0,Alive,TUMOR FREE,3834.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3834.0,0.0,3834.0,0.0,3834.0,0.0,3834.0,
TCGA-X6-A7WC,8784,TCGA-X6-A7WC,SARC,74.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-27252.0,Alive,TUMOR FREE,1379.0,,[Not Available],Distant Metastasis,Lung,,301.0,[Not Available],Negative,R0,0.0,1379.0,0.0,1379.0,1.0,301.0,1.0,301.0,
TCGA-EY-A212,10965,TCGA-EY-A212,UCEC,83.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30680.0,Dead,WITH TUMOR,,310.0,[Not Available],,,,,Partial Remission/Response,,,1.0,310.0,1.0,310.0,,,1.0,310.0,
TCGA-VS-A8EI,1840,TCGA-VS-A8EI,CESC,38.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,GX,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14129.0,Alive,TUMOR FREE,729.0,,,,,,,Complete Remission/Response,,,0.0,729.0,0.0,729.0,0.0,729.0,0.0,729.0,
TCGA-L5-A43I,2511,TCGA-L5-A43I,ESCA,77.0,MALE,WHITE,Stage IIIA,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2011.0,[Not Available],-28367.0,Dead,TUMOR FREE,,556.0,[Not Available],,,,,Complete Remission/Response,,,1.0,556.0,0.0,556.0,0.0,556.0,0.0,556.0,
TCGA-CH-5772,7903,TCGA-CH-5772,PRAD,63.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-23194.0,Alive,TUMOR FREE,486.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,
TCGA-XU-AAXY,10437,TCGA-XU-AAXY,THYM,43.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type B2,[Not Available],2009.0,[Not Available],-15756.0,Alive,TUMOR FREE,1891.0,,[Not Available],,,,,[Not Available],,,0.0,1891.0,0.0,1891.0,,,0.0,1891.0,
TCGA-SH-A9CU,6877,TCGA-SH-A9CU,MESO,60.0,MALE,WHITE,Stage IV,[Not Applicable],Epithelioid mesothelioma,[Not Available],2013.0,[Not Available],-22135.0,Dead,WITH TUMOR,,732.0,[Not Available],,,,,[Not Available],,RX,1.0,732.0,1.0,732.0,,,1.0,732.0,
TCGA-CW-5583,4340,TCGA-CW-5583,KIRC,51.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2003.0,[Not Available],-18666.0,Alive,TUMOR FREE,2489.0,,[Not Available],,,,,[Not Available],,,0.0,2489.0,0.0,2489.0,,,0.0,2489.0,
TCGA-G4-6302,2373,TCGA-G4-6302,COAD,90.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2006.0,[Not Available],-32872.0,Dead,TUMOR FREE,,2047.0,[Not Available],,,,,[Not Available],,,1.0,2047.0,0.0,2047.0,,,0.0,2047.0,
TCGA-A4-7732,4470,TCGA-A4-7732,KIRP,55.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-20226.0,Alive,TUMOR FREE,582.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,582.0,0.0,582.0,0.0,582.0,0.0,582.0,
TCGA-BP-5009,4236,TCGA-BP-5009,KIRC,52.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-19052.0,Dead,WITH TUMOR,,1092.0,[Not Available],,,,324.0,[Not Available],,,1.0,1092.0,1.0,1092.0,,,1.0,324.0,
TCGA-85-6798,6706,TCGA-85-6798,LUSC,57.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-20837.0,Dead,WITH TUMOR,,195.0,[Not Available],Distant Metastasis,,,180.0,Complete Remission/Response,,,1.0,195.0,1.0,195.0,1.0,180.0,1.0,180.0,
TCGA-BG-A0MA,10744,TCGA-BG-A0MA,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22036.0,Dead,WITH TUMOR,,326.0,[Not Available],Metastatic,Bone,,70.0,Progressive Disease,,,1.0,326.0,1.0,326.0,,,1.0,70.0,
TCGA-EO-A3B1,10936,TCGA-EO-A3B1,UCEC,63.0,FEMALE,[Not Available],[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23162.0,Alive,TUMOR FREE,820.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,820.0,0.0,820.0,0.0,820.0,0.0,820.0,
TCGA-77-7463,6670,TCGA-77-7463,LUSC,75.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-27520.0,Dead,,,1423.0,[Not Available],,,,,[Not Available],,,1.0,1423.0,,1423.0,,,0.0,1423.0,
TCGA-CN-4729,3308,TCGA-CN-4729,HNSC,73.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-26713.0,Alive,TUMOR FREE,392.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,392.0,0.0,392.0,,,0.0,392.0,
TCGA-BR-A4PF,9410,TCGA-BR-A4PF,STAD,72.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-26412.0,Alive,TUMOR FREE,35.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,35.0,0.0,35.0,0.0,35.0,0.0,35.0,
TCGA-CS-6665,4925,TCGA-CS-6665,LGG,51.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-18977.0,Alive,WITH TUMOR,1568.0,,[Not Available],,,,,Stable Disease,,,0.0,1568.0,0.0,1568.0,,,0.0,1568.0,
TCGA-77-8138,6680,TCGA-77-8138,LUSC,74.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-27225.0,Dead,WITH TUMOR,,539.0,[Not Available],Locoregional Recurrence,,,289.0,[Not Applicable],,,1.0,539.0,1.0,539.0,,,1.0,289.0,
TCGA-G4-6315,2382,TCGA-G4-6315,COAD,66.0,MALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-24174.0,Alive,TUMOR FREE,1883.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1883.0,0.0,1883.0,,,0.0,1883.0,
TCGA-DD-AADR,5628,TCGA-DD-AADR,LIHC,58.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2009.0,[Not Available],-21217.0,Alive,TUMOR FREE,2028.0,,[Not Available],Intrahepatic Recurrence,Liver,,1700.0,[Not Available],,R0,0.0,2028.0,0.0,2028.0,1.0,1700.0,1.0,1700.0,
TCGA-DW-7841,4578,TCGA-DW-7841,KIRP,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-22403.0,Alive,TUMOR FREE,445.0,,[Not Available],,,,,[Not Available],,,0.0,445.0,0.0,445.0,,,0.0,445.0,
TCGA-BH-A0AZ,1030,TCGA-BH-A0AZ,BRCA,47.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17465.0,Alive,TUMOR FREE,1919.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1919.0,0.0,1919.0,0.0,1919.0,0.0,1919.0,
TCGA-CD-8531,9429,TCGA-CD-8531,STAD,66.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-24453.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-RW-A68C,7770,TCGA-RW-A68C,PCPG,43.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-15962.0,Alive,TUMOR FREE,191.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,191.0,0.0,191.0,0.0,191.0,0.0,191.0,
TCGA-63-A5MG,6594,TCGA-63-A5MG,LUSC,68.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-24957.0,Alive,TUMOR FREE,2148.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2148.0,0.0,2148.0,0.0,2148.0,0.0,2148.0,
TCGA-AR-A24L,934,TCGA-AR-A24L,BRCA,26.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9706.0,Dead,WITH TUMOR,,2866.0,[Not Available],Locoregional Disease,,,1414.0,[Not Available],Negative,,1.0,2866.0,1.0,2866.0,1.0,1414.0,1.0,1414.0,
TCGA-44-7661,5885,TCGA-44-7661,LUAD,69.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25483.0,Dead,WITH TUMOR,,557.0,[Not Available],Locoregional Recurrence,,,335.0,Complete Remission/Response,,,1.0,557.0,1.0,557.0,1.0,335.0,1.0,335.0,
TCGA-IZ-8196,4635,TCGA-IZ-8196,KIRP,50.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-18540.0,Alive,TUMOR FREE,649.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,649.0,0.0,649.0,0.0,649.0,0.0,649.0,
TCGA-ZF-AA58,501,TCGA-ZF-AA58,BLCA,61.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-22549.0,Alive,TUMOR FREE,1649.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1649.0,0.0,1649.0,,,0.0,1649.0,
TCGA-P5-A5EX,5267,TCGA-P5-A5EX,LGG,41.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-15091.0,Alive,TUMOR FREE,243.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,243.0,0.0,243.0,,,0.0,243.0,
TCGA-EB-A430,8954,TCGA-EB-A430,SKCM,83.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-30344.0,Alive,TUMOR FREE,-2.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-CV-7255,3545,TCGA-CV-7255,HNSC,32.0,FEMALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1995.0,[Not Available],-11931.0,Dead,WITH TUMOR,,64.0,[Not Available],,,,,Complete Remission/Response,,,1.0,64.0,1.0,64.0,,,1.0,64.0,
TCGA-BH-A0AV,1027,TCGA-BH-A0AV,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,[Not Available],-19314.0,Alive,TUMOR FREE,1820.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1820.0,0.0,1820.0,0.0,1820.0,0.0,1820.0,
TCGA-TQ-A7RV,5402,TCGA-TQ-A7RV,LGG,27.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2009.0,[Not Available],-10167.0,Alive,WITH TUMOR,1868.0,,[Not Available],,,,530.0,Partial Remission/Response,,,0.0,1868.0,0.0,1868.0,,,1.0,530.0,
TCGA-EV-5903,4588,TCGA-EV-5903,KIRP,57.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-20888.0,Alive,TUMOR FREE,757.0,,[Not Available],,,,,[Not Available],,,0.0,757.0,0.0,757.0,,,0.0,757.0,
TCGA-CV-7247,3539,TCGA-CV-7247,HNSC,55.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1995.0,[Not Available],-20433.0,Dead,WITH TUMOR,,577.0,[Not Available],,,,,[Not Available],,,1.0,577.0,1.0,577.0,,,1.0,577.0,
TCGA-TM-A84I,5379,TCGA-TM-A84I,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-11221.0,Alive,TUMOR FREE,854.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,854.0,0.0,854.0,0.0,854.0,0.0,854.0,
TCGA-DA-A1HY,8917,TCGA-DA-A1HY,SKCM,42.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2002.0,[Not Available],-15357.0,Alive,TUMOR FREE,4407.0,,[Not Available],,,,,[Not Available],,,0.0,4407.0,0.0,4407.0,,,0.0,4407.0,
TCGA-EB-A5FP,8972,TCGA-EB-A5FP,SKCM,65.0,FEMALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2012.0,[Not Available],-23833.0,Dead,WITH TUMOR,,454.0,[Not Available],Regional lymph node|Distant Metastasis,[Not Available]|Lung,[Not Applicable]|[Not Applicable],24.0,[Not Available],,,1.0,454.0,1.0,454.0,,,1.0,24.0,
TCGA-Q3-A5QY,7664,TCGA-Q3-A5QY,PAAD,58.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-21277.0,Alive,,416.0,,,,,,,[Discrepancy],,,0.0,416.0,0.0,416.0,,,0.0,416.0,
TCGA-ZH-A8Y2,1946,TCGA-ZH-A8Y2,CHOL,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2011.0,[Not Available],-21743.0,Dead,WITH TUMOR,,701.0,[Not Available],Locoregional Recurrence,,,198.0,[Not Available],,R0,1.0,701.0,1.0,701.0,1.0,198.0,1.0,198.0,
TCGA-21-1076,6347,TCGA-21-1076,LUSC,54.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-19863.0,Alive,TUMOR FREE,1852.0,,[Not Available],,,,1575.0,[Not Available],,,0.0,1852.0,0.0,1852.0,,,1.0,1575.0,
TCGA-AL-3472,4499,TCGA-AL-3472,KIRP,57.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-21166.0,Alive,TUMOR FREE,2029.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2029.0,0.0,2029.0,0.0,2029.0,0.0,2029.0,
TCGA-ZM-AA06,9838,TCGA-ZM-AA06,TGCT,45.0,MALE,WHITE,Stage IB,Stage IB,Seminoma; NOS,[Not Available],2011.0,[Not Available],-16719.0,Alive,TUMOR FREE,1498.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,1498.0,0.0,1498.0,0.0,1498.0,0.0,1498.0,
TCGA-58-A46N,6559,TCGA-58-A46N,LUSC,52.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-19050.0,Alive,WITH TUMOR,910.0,,[Not Available],Locoregional Recurrence,,,630.0,Complete Remission/Response,,,0.0,910.0,0.0,910.0,1.0,630.0,1.0,630.0,
TCGA-B9-4113,4519,TCGA-B9-4113,KIRP,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2002.0,[Not Available],-23613.0,Dead,TUMOR FREE,,1536.0,[Not Available],,,,,[Not Available],,,1.0,1536.0,0.0,1536.0,,,0.0,1536.0,
TCGA-B8-5164,4106,TCGA-B8-5164,KIRC,65.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-23863.0,Alive,TUMOR FREE,26.0,,[Not Available],,,,,[Not Available],,,0.0,26.0,0.0,26.0,,,0.0,26.0,
TCGA-XV-AAZY,9257,TCGA-XV-AAZY,SKCM,76.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-27938.0,Alive,TUMOR FREE,405.0,,[Not Available],,,,,[Not Available],,,0.0,405.0,0.0,405.0,,,0.0,405.0,
TCGA-DD-AACX,5602,TCGA-DD-AACX,LIHC,66.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-24329.0,Alive,WITH TUMOR,170.0,,[Not Available],Extrahepatic Recurrence,"Other, specify",lymph node,42.0,[Not Available],,R0,0.0,170.0,0.0,170.0,1.0,42.0,1.0,42.0,
TCGA-C8-A1HL,1204,TCGA-C8-A1HL,BRCA,38.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],"Other, specify",[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,Alive,TUMOR FREE,317.0,,[Not Available],,,,,[Not Available],Negative,,0.0,317.0,0.0,317.0,0.0,317.0,0.0,317.0,
TCGA-YU-A90Q,9828,TCGA-YU-A90Q,TGCT,21.0,MALE,[Unknown],Stage IB,Stage IB,Seminoma; NOS,[Not Available],2008.0,[Not Available],-7846.0,Alive,TUMOR FREE,1964.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,1964.0,0.0,1964.0,0.0,1964.0,0.0,1964.0,
TCGA-DD-AADL,5622,TCGA-DD-AADL,LIHC,58.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2012.0,[Not Available],-21512.0,Alive,TUMOR FREE,636.0,,[Not Available],,,,,[Not Available],,R0,0.0,636.0,0.0,636.0,0.0,636.0,0.0,636.0,
TCGA-P5-A77X,5286,TCGA-P5-A77X,LGG,55.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-20128.0,Alive,TUMOR FREE,105.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,105.0,0.0,105.0,0.0,105.0,0.0,105.0,
TCGA-OR-A5LO,78,TCGA-OR-A5LO,ACC,61.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-22370.0,Dead,WITH TUMOR,,2405.0,[Not Available],Distant Metastasis,Lung,,153.0,Complete Remission/Response,,,1.0,2405.0,1.0,2405.0,1.0,153.0,1.0,153.0,
TCGA-76-6660,3230,TCGA-76-6660,GBM,73.0,MALE,WHITE,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2010.0,[Not Available],-26913.0,Dead,WITH TUMOR,,114.0,[Not Available],,,,,[Not Available],,,1.0,114.0,1.0,114.0,,,1.0,114.0,
TCGA-DI-A0WH,10901,TCGA-DI-A0WH,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,[Not Available],-23692.0,Alive,TUMOR FREE,496.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,
TCGA-E9-A1RF,1420,TCGA-E9-A1RF,BRCA,68.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25119.0,Alive,TUMOR FREE,200.0,,[Not Available],,,,,[Not Available],Negative,,0.0,200.0,0.0,200.0,0.0,200.0,0.0,200.0,
TCGA-FU-A770,1767,TCGA-FU-A770,CESC,33.0,FEMALE,WHITE,[Not Available],Stage IIIB,Endocervical Adenocarcinoma of the Usual Type,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12248.0,Alive,TUMOR FREE,34.0,,,,,,,[Unknown],,,0.0,34.0,0.0,34.0,,,0.0,34.0,
TCGA-D1-A176,10856,TCGA-D1-A176,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24521.0,Alive,TUMOR FREE,917.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,917.0,0.0,917.0,0.0,917.0,0.0,917.0,
TCGA-B0-5402,4047,TCGA-B0-5402,KIRC,64.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2010.0,[Not Available],-23477.0,Alive,WITH TUMOR,1290.0,,[Not Available],,,,444.0,Progressive Disease,,,0.0,1290.0,0.0,1290.0,,,1.0,444.0,
TCGA-QQ-A8VF,8753,TCGA-QQ-A8VF,SARC,70.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2005.0,[Not Available],-25682.0,Alive,TUMOR FREE,3406.0,,[Not Available],,,,,[Not Available],Negative,RX,0.0,3406.0,0.0,3406.0,,,0.0,3406.0,
TCGA-ZB-A969,10452,TCGA-ZB-A969,THYM,72.0,FEMALE,WHITE,[Not Applicable],IVb,Thymoma; Type C,[Not Available],2012.0,[Not Available],-26458.0,Alive,TUMOR FREE,1046.0,,[Not Available],,,,,[Not Available],,,0.0,1046.0,0.0,1046.0,,,0.0,1046.0,
TCGA-91-6847,6219,TCGA-91-6847,LUAD,62.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-22862.0,Alive,WITH TUMOR,842.0,,[Not Available],Distant Metastasis,,,772.0,Progressive Disease,,,0.0,842.0,0.0,842.0,,,1.0,772.0,
TCGA-B0-4712,3979,TCGA-B0-4712,KIRC,76.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-28095.0,Dead,WITH TUMOR,,1337.0,[Not Available],,,,,[Not Available],,,1.0,1337.0,1.0,1337.0,,,1.0,1337.0,
TCGA-VR-A8EU,2626,TCGA-VR-A8EU,ESCA,51.0,MALE,WHITE,Stage IV,Stage IV,Esophagus Squamous Cell Carcinoma,G2,2011.0,[Not Available],-18711.0,Dead,WITH TUMOR,,557.0,[Not Available],,,,,,,,1.0,557.0,1.0,557.0,,,1.0,557.0,
TCGA-IB-7646,7620,TCGA-IB-7646,PAAD,60.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2007.0,[Not Available],-22148.0,Dead,WITH TUMOR,,145.0,Pancreatic Cancer,Locoregional Recurrence,Liver,,132.0,Progressive Disease,,,1.0,145.0,1.0,145.0,,,1.0,132.0,
TCGA-EE-A2MD,9051,TCGA-EE-A2MD,SKCM,52.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1998.0,[Not Available],-19333.0,Dead,WITH TUMOR,,1438.0,[Not Available],Regional lymph node,,,1344.0,[Not Available],,,1.0,1438.0,1.0,1438.0,,,1.0,1344.0,
TCGA-BH-A0DP,1069,TCGA-BH-A0DP,BRCA,60.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199.0,Alive,TUMOR FREE,476.0,,[Not Available],,,,,[Not Available],Negative,,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,
TCGA-DJ-A2PT,9946,TCGA-DJ-A2PT,THCA,70.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-25837.0,Alive,TUMOR FREE,1181.0,,[Not Available],,,,,[Not Available],,R0,0.0,1181.0,0.0,1181.0,0.0,1181.0,0.0,1181.0,
TCGA-38-6178,5850,TCGA-38-6178,LUAD,70.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-25593.0,Alive,WITH TUMOR,448.0,,[Not Available],,,,,Stable Disease,,,0.0,448.0,0.0,448.0,,,0.0,448.0,
TCGA-2G-AAGI,9741,TCGA-2G-AAGI,TGCT,33.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Seminoma; NOS|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2006.0,[Not Available],-12366.0,Alive,TUMOR FREE,3137.0,,[Not Applicable],New Primary Tumor,Testes,,2193.0,Complete Remission/Response,,,0.0,3137.0,0.0,3137.0,1.0,2193.0,1.0,2193.0,
TCGA-DX-A6YU,8617,TCGA-DX-A6YU,SARC,50.0,FEMALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2012.0,[Not Available],-18351.0,Alive,TUMOR FREE,1045.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1045.0,0.0,1045.0,0.0,1045.0,0.0,1045.0,
TCGA-E9-A24A,1440,TCGA-E9-A24A,BRCA,69.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25370.0,Alive,TUMOR FREE,747.0,,[Not Available],,,,,[Not Available],Negative,,0.0,747.0,0.0,747.0,0.0,747.0,0.0,747.0,
TCGA-06-6698,2884,TCGA-06-6698,GBM,53.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-19591.0,Alive,WITH TUMOR,145.0,,[Not Available],,,,,[Not Available],,,0.0,145.0,0.0,145.0,,,0.0,145.0,
TCGA-G9-6365,8032,TCGA-G9-6365,PRAD,71.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-26207.0,Alive,TUMOR FREE,1363.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1363.0,0.0,1363.0,0.0,1363.0,0.0,1363.0,
TCGA-EO-A22U,10925,TCGA-EO-A22U,UCEC,83.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30557.0,Alive,TUMOR FREE,1407.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1407.0,0.0,1407.0,0.0,1407.0,0.0,1407.0,
TCGA-E2-A159,1333,TCGA-E2-A159,BRCA,50.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18621.0,Alive,TUMOR FREE,762.0,,[Not Available],,,,,[Not Available],Negative,,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,
TCGA-G5-6235,8534,TCGA-G5-6235,READ,72.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-26348.0,Alive,TUMOR FREE,1696.0,,[Not Available],,,,1042.0,[Not Available],,,0.0,1696.0,0.0,1696.0,,,1.0,1042.0,
TCGA-77-8148,6687,TCGA-77-8148,LUSC,68.0,MALE,[Not Evaluated],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-24918.0,Alive,,2023.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2023.0,0.0,2023.0,0.0,2023.0,0.0,2023.0,
TCGA-CE-A3ME,9898,TCGA-CE-A3ME,THCA,51.0,FEMALE,ASIAN,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18714.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,[Not Available],,R0,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-33-AASL,6417,TCGA-33-AASL,LUSC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-20940.0,Dead,WITH TUMOR,,826.0,[Not Available],Locoregional Recurrence,,,149.0,Progressive Disease,,,1.0,826.0,1.0,826.0,,,1.0,149.0,
TCGA-4Z-AA7Q,102,TCGA-4Z-AA7Q,BLCA,79.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-28981.0,Dead,TUMOR FREE,,510.0,[Not Available],,,,,[Not Applicable],,,1.0,510.0,0.0,510.0,,,0.0,510.0,
TCGA-D1-A3DA,10888,TCGA-D1-A3DA,UCEC,77.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28142.0,Alive,TUMOR FREE,483.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,483.0,0.0,483.0,0.0,483.0,0.0,483.0,
TCGA-BP-4985,4218,TCGA-BP-4985,KIRC,72.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-26611.0,Dead,WITH TUMOR,,952.0,[Not Available],,,,205.0,[Not Available],,,1.0,952.0,1.0,952.0,,,1.0,205.0,
TCGA-C5-A907,1670,TCGA-C5-A907,CESC,47.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G2,2013.0,[Not Available],-17304.0,Alive,TUMOR FREE,448.0,,,,,,,[Not Available],,,0.0,448.0,0.0,448.0,,,0.0,448.0,
TCGA-KK-A7AV,8191,TCGA-KK-A7AV,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-21192.0,Alive,TUMOR FREE,822.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,
TCGA-FD-A5BU,284,TCGA-FD-A5BU,BLCA,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27882.0,Alive,TUMOR FREE,588.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,
TCGA-DB-A64W,4958,TCGA-DB-A64W,LGG,65.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2012.0,[Not Available],-23936.0,Dead,TUMOR FREE,,438.0,[Not Available],,,,,Stable Disease,,,1.0,438.0,0.0,438.0,,,0.0,438.0,
TCGA-DQ-7591,3638,TCGA-DQ-7591,HNSC,62.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G4,2011.0,[Not Available],-22798.0,Alive,TUMOR FREE,622.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,622.0,0.0,622.0,,,0.0,622.0,
TCGA-14-1829,3035,TCGA-14-1829,GBM,57.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-20929.0,Alive,WITH TUMOR,218.0,,[Not Available],,,,,[Not Available],,,0.0,218.0,0.0,218.0,,,0.0,218.0,
TCGA-RC-A7SH,5768,TCGA-RC-A7SH,LIHC,42.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-15560.0,Alive,WITH TUMOR,468.0,,[Not Available],Extrahepatic Recurrence,Lung,,91.0,[Not Available],,R0,0.0,468.0,0.0,468.0,1.0,91.0,1.0,91.0,
TCGA-DD-A4NI,5559,TCGA-DD-A4NI,LIHC,67.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-24516.0,Alive,TUMOR FREE,816.0,,[Not Available],,,,,[Not Available],,R0,0.0,816.0,0.0,816.0,0.0,816.0,0.0,816.0,
TCGA-LG-A9QC,5747,TCGA-LG-A9QC,LIHC,48.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-17842.0,Alive,TUMOR FREE,425.0,,[Not Available],,,,,[Not Available],,R0,0.0,425.0,0.0,425.0,0.0,425.0,0.0,425.0,
TCGA-CR-6487,3433,TCGA-CR-6487,HNSC,50.0,MALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-18331.0,Alive,TUMOR FREE,234.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,234.0,0.0,234.0,0.0,234.0,0.0,234.0,
TCGA-LN-A9FP,2593,TCGA-LN-A9FP,ESCA,60.0,FEMALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G3,2013.0,[Not Available],-22104.0,Alive,WITH TUMOR,366.0,,[Not Available],Locoregional Recurrence,,,290.0,Complete Remission/Response,,,0.0,366.0,0.0,366.0,1.0,290.0,1.0,290.0,
TCGA-ZG-A9NI,8366,TCGA-ZG-A9NI,PRAD,73.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-26697.0,Alive,TUMOR FREE,132.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,132.0,0.0,132.0,0.0,132.0,0.0,132.0,
TCGA-IA-A83S,4630,TCGA-IA-A83S,KIRP,81.0,MALE,WHITE,[Discrepancy],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2003.0,[Not Available],-29677.0,Dead,,,2609.0,[Not Available],,,,,[Unknown],,,1.0,2609.0,,2609.0,,,0.0,2609.0,
TCGA-SH-A7BD,6874,TCGA-SH-A7BD,MESO,68.0,MALE,WHITE,Stage IV,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-25019.0,Dead,WITH TUMOR,,459.0,[Not Available],Locoregional Recurrence,"Other, specify",Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes AND Ipsilateral Chest Wall,200.0,[Not Available],,R2,1.0,459.0,1.0,459.0,,,1.0,200.0,
TCGA-FY-A3RA,10291,TCGA-FY-A3RA,THCA,21.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-7900.0,Alive,TUMOR FREE,550.0,,[Not Available],,,,,[Not Available],,R0,0.0,550.0,0.0,550.0,0.0,550.0,0.0,550.0,
TCGA-QR-A700,7714,TCGA-QR-A700,PCPG,67.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-24734.0,Alive,WITH TUMOR,978.0,,[Not Available],Distant Metastasis,Lung,,606.0,Progressive Disease,,,0.0,978.0,0.0,978.0,,,1.0,606.0,
TCGA-BP-5202,4266,TCGA-BP-5202,KIRC,75.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2008.0,[Not Available],-27556.0,Alive,TUMOR FREE,29.0,,[Not Available],,,,,[Not Available],,,0.0,29.0,0.0,29.0,,,0.0,29.0,
TCGA-IB-AAUR,7651,TCGA-IB-AAUR,PAAD,67.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,[Not Available],-24576.0,Alive,WITH TUMOR,338.0,,,Locoregional Recurrence,Tumor Bed,,318.0,Partial Remission/Response,,,0.0,338.0,0.0,338.0,,,1.0,318.0,
TCGA-B0-5094,4024,TCGA-B0-5094,KIRC,62.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2008.0,[Not Available],-22965.0,Dead,WITH TUMOR,,333.0,[Not Available],,,,75.0,[Not Available],,,1.0,333.0,1.0,333.0,,,1.0,75.0,
TCGA-BH-A0DQ,1070,TCGA-BH-A0DQ,BRCA,42.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15533.0,Alive,TUMOR FREE,98.0,,[Not Available],,,,,[Not Available],Negative,,0.0,98.0,0.0,98.0,0.0,98.0,0.0,98.0,
TCGA-BR-8284,9343,TCGA-BR-8284,STAD,72.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-26526.0,Dead,TUMOR FREE,,245.0,[Not Available],,,,,Complete Remission/Response,,,1.0,245.0,0.0,245.0,0.0,245.0,0.0,245.0,
TCGA-F9-A8NY,4592,TCGA-F9-A8NY,KIRP,38.0,FEMALE,ASIAN,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-14101.0,Alive,TUMOR FREE,36.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,36.0,0.0,36.0,,,0.0,36.0,
TCGA-DK-A3WX,206,TCGA-DK-A3WX,BLCA,67.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-24553.0,Dead,WITH TUMOR,,321.0,[Not Available],Locoregional (Urothelial tumor event),Bladder,,167.0,Progressive Disease,,,1.0,321.0,1.0,321.0,,,1.0,167.0,
TCGA-DA-A95V,8932,TCGA-DA-A95V,SKCM,83.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-30623.0,Alive,TUMOR FREE,2193.0,,[Not Available],,,,,[Not Available],,,0.0,2193.0,0.0,2193.0,,,0.0,2193.0,
TCGA-OR-A5K4,39,TCGA-OR-A5K4,ACC,64.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-23481.0,Alive,TUMOR FREE,1082.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1082.0,0.0,1082.0,0.0,1082.0,0.0,1082.0,
TCGA-50-5946,5950,TCGA-50-5946,LUAD,62.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-22852.0,Alive,WITH TUMOR,1617.0,,[Not Available],Distant Metastasis,,,221.0,Progressive Disease,,,0.0,1617.0,0.0,1617.0,,,1.0,221.0,
TCGA-AP-A0LE,10578,TCGA-AP-A0LE,UCEC,57.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20967.0,Alive,TUMOR FREE,3357.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3357.0,0.0,3357.0,0.0,3357.0,0.0,3357.0,
TCGA-63-A5MW,6607,TCGA-63-A5MW,LUSC,76.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-27892.0,Alive,TUMOR FREE,1639.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1639.0,0.0,1639.0,0.0,1639.0,0.0,1639.0,
TCGA-EA-A3HR,1695,TCGA-EA-A3HR,CESC,57.0,FEMALE,WHITE,[Not Available],Stage II,Cervical Squamous Cell Carcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20980.0,Alive,TUMOR FREE,940.0,,,,,,,Complete Remission/Response,,,0.0,940.0,0.0,940.0,0.0,940.0,0.0,940.0,
TCGA-MP-A4TC,6305,TCGA-MP-A4TC,LUAD,77.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-28471.0,Dead,TUMOR FREE,,74.0,[Not Available],,,,,Complete Remission/Response,,,1.0,74.0,0.0,74.0,0.0,74.0,0.0,74.0,
TCGA-4Z-AA7N,100,TCGA-4Z-AA7N,BLCA,65.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-24090.0,Dead,TUMOR FREE,,1367.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1367.0,0.0,1367.0,0.0,1367.0,0.0,1367.0,
TCGA-FS-A4FC,9178,TCGA-FS-A4FC,SKCM,75.0,FEMALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2007.0,[Not Available],-27482.0,Dead,WITH TUMOR,,1655.0,[Not Available],,,,,[Not Available],,,1.0,1655.0,1.0,1655.0,,,1.0,1655.0,
TCGA-A1-A0SH,518,TCGA-A1-A0SH,BRCA,39.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14595.0,Alive,TUMOR FREE,1437.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1437.0,0.0,1437.0,0.0,1437.0,0.0,1437.0,
TCGA-62-A472,6073,TCGA-62-A472,LUAD,70.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25893.0,Alive,WITH TUMOR,910.0,,[Not Available],Locoregional Recurrence,,,290.0,Complete Remission/Response,,,0.0,910.0,0.0,910.0,1.0,290.0,1.0,290.0,
TCGA-DJ-A2Q6,9959,TCGA-DJ-A2Q6,THCA,38.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-14193.0,Alive,TUMOR FREE,1109.0,,[Not Available],,,,,[Not Available],,R0,0.0,1109.0,0.0,1109.0,0.0,1109.0,0.0,1109.0,
TCGA-ZG-A9M4,8362,TCGA-ZG-A9M4,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24030.0,Alive,WITH TUMOR,547.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,547.0,0.0,547.0,,,0.0,547.0,
TCGA-DB-5274,4933,TCGA-DB-5274,LGG,37.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2006.0,[Not Available],-13680.0,Alive,TUMOR FREE,2289.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2289.0,0.0,2289.0,0.0,2289.0,0.0,2289.0,
TCGA-DS-A1OC,1685,TCGA-DS-A1OC,CESC,47.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17357.0,Alive,TUMOR FREE,376.0,,,,,,,Complete Remission/Response,,,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,
TCGA-4V-A9QW,10371,TCGA-4V-A9QW,THYM,62.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2013.0,[Not Available],-22781.0,Alive,TUMOR FREE,630.0,,[Not Available],,,,,[Not Available],,,0.0,630.0,0.0,630.0,,,0.0,630.0,
TCGA-71-8520,6112,TCGA-71-8520,LUAD,60.0,FEMALE,ASIAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-21921.0,Dead,WITH TUMOR,,210.0,[Not Available],Locoregional Recurrence,,,179.0,Complete Remission/Response,,,1.0,210.0,1.0,210.0,1.0,179.0,1.0,179.0,
TCGA-A6-6651,2000,TCGA-A6-6651,COAD,55.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-20110.0,Alive,TUMOR FREE,662.0,,[Not Available],,,,,[Not Available],,,0.0,662.0,0.0,662.0,,,0.0,662.0,
TCGA-DC-5337,8484,TCGA-DC-5337,READ,69.0,MALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-25202.0,Alive,TUMOR FREE,792.0,,[Not Available],,,,,[Unknown],,,0.0,792.0,0.0,792.0,,,0.0,792.0,
TCGA-EB-A41B,8951,TCGA-EB-A41B,SKCM,76.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-27998.0,Alive,TUMOR FREE,291.0,,[Not Available],,,,,[Not Available],,,0.0,291.0,0.0,291.0,,,0.0,291.0,
TCGA-E2-A150,1326,TCGA-E2-A150,BRCA,48.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17580.0,Alive,TUMOR FREE,1935.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0,
TCGA-BR-8363,9354,TCGA-BR-8363,STAD,73.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-26976.0,Dead,TUMOR FREE,,8.0,"Other, non-malignant disease",,,,,Complete Remission/Response,,,1.0,8.0,0.0,8.0,0.0,8.0,0.0,8.0,
TCGA-AC-A6IV,793,TCGA-AC-A6IV,BRCA,47.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,[Not Available],-17521.0,Alive,TUMOR FREE,568.0,,[Not Available],,,,,[Not Available],Negative,,0.0,568.0,0.0,568.0,0.0,568.0,0.0,568.0,
TCGA-G3-AAV4,5729,TCGA-G3-AAV4,LIHC,83.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-30466.0,Dead,TUMOR FREE,,27.0,[Not Available],,,,,[Not Available],,R0,1.0,27.0,0.0,27.0,0.0,27.0,0.0,27.0,
TCGA-IA-A40X,4628,TCGA-IA-A40X,KIRP,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-18239.0,Alive,TUMOR FREE,608.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,
TCGA-XF-A9SI,427,TCGA-XF-A9SI,BLCA,73.0,FEMALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-26719.0,Alive,TUMOR FREE,2423.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2423.0,0.0,2423.0,0.0,2423.0,0.0,2423.0,
TCGA-W5-AA33,1935,TCGA-W5-AA33,CHOL,60.0,MALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2011.0,[Not Available],-22090.0,Alive,TUMOR FREE,1449.0,,[Not Available],,,,,[Not Available],,R0,0.0,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0,
TCGA-OR-A5JR,26,TCGA-OR-A5JR,ACC,45.0,MALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2002.0,[Not Available],-16604.0,Alive,TUMOR FREE,3688.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3688.0,0.0,3688.0,0.0,3688.0,0.0,3688.0,
TCGA-VS-A8QM,1850,TCGA-VS-A8QM,CESC,47.0,FEMALE,[Unknown],[Not Available],Stage IVB,Cervical Squamous Cell Carcinoma,GX,2009.0,[Not Available],-17168.0,Dead,WITH TUMOR,,951.0,Cervical Cancer,,,,,Progressive Disease,,,1.0,951.0,1.0,951.0,,,1.0,951.0,
TCGA-B8-5550,4111,TCGA-B8-5550,KIRC,71.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-25937.0,Alive,WITH TUMOR,1476.0,,[Not Available],,,,694.0,Complete Remission/Response,,,0.0,1476.0,0.0,1476.0,1.0,694.0,1.0,694.0,
TCGA-DU-8167,5039,TCGA-DU-8167,LGG,69.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-25262.0,Alive,TUMOR FREE,471.0,,[Not Available],,,,,Stable Disease,,,0.0,471.0,0.0,471.0,,,0.0,471.0,
TCGA-DH-A669,4970,TCGA-DH-A669,LGG,70.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2007.0,[Not Available],-25809.0,Dead,TUMOR FREE,,919.0,[Not Available],,,,260.0,Stable Disease,,,1.0,919.0,0.0,919.0,,,1.0,260.0,
TCGA-A2-A25D,608,TCGA-A2-A25D,BRCA,90.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Alive,TUMOR FREE,552.0,,[Not Available],,,,,[Not Available],Positive,,0.0,552.0,0.0,552.0,,,0.0,552.0,
TCGA-AP-A1DQ,10598,TCGA-AP-A1DQ,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,High Grade,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27815.0,Dead,WITH TUMOR,,1423.0,[Not Available],Metastatic,"Other, specify","Lymph nodes, lung, bone",905.0,Complete Remission/Response,,,1.0,1423.0,1.0,1423.0,1.0,905.0,1.0,905.0,
TCGA-CJ-4912,4312,TCGA-CJ-4912,KIRC,61.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-22623.0,Alive,TUMOR FREE,1657.0,,[Not Available],,,,,[Not Available],,,0.0,1657.0,0.0,1657.0,,,0.0,1657.0,
TCGA-OR-A5JP,24,TCGA-OR-A5JP,ACC,40.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-14667.0,Alive,TUMOR FREE,464.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,464.0,0.0,464.0,0.0,464.0,0.0,464.0,
TCGA-EJ-A65F,7987,TCGA-EJ-A65F,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012.0,[Not Available],-21681.0,Alive,[Discrepancy],560.0,,[Not Available],Biochemical evidence of disease,,,75.0,Progressive Disease,,,0.0,560.0,0.0,560.0,,,1.0,75.0,
TCGA-AO-A03N,844,TCGA-AO-A03N,BRCA,59.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21816.0,Alive,WITH TUMOR,2031.0,,[Not Available],Locoregional Disease,,,1645.0,[Not Available],Negative,,0.0,2031.0,0.0,2031.0,1.0,1645.0,1.0,1645.0,
TCGA-J4-A83M,8148,TCGA-J4-A83M,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-23624.0,Alive,,543.0,,[Not Available],Biochemical evidence of disease,,,521.0,Complete Remission/Response,,,0.0,543.0,0.0,543.0,1.0,521.0,1.0,521.0,
TCGA-RX-A8JQ,7777,TCGA-RX-A8JQ,PCPG,44.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2013.0,[Not Available],-16182.0,Alive,TUMOR FREE,611.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,611.0,0.0,611.0,0.0,611.0,0.0,611.0,
TCGA-LN-A49R,2564,TCGA-LN-A49R,ESCA,46.0,MALE,ASIAN,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,G3,2011.0,[Not Available],-17109.0,Alive,TUMOR FREE,407.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,407.0,0.0,407.0,0.0,407.0,0.0,407.0,
TCGA-B4-5835,4087,TCGA-B4-5835,KIRC,64.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-23408.0,Alive,TUMOR FREE,16.0,,[Not Available],,,,,[Not Applicable],,,0.0,16.0,0.0,16.0,,,0.0,16.0,
TCGA-VQ-A8PF,9659,TCGA-VQ-A8PF,STAD,76.0,MALE,[Not Evaluated],Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-28116.0,Dead,TUMOR FREE,,76.0,[Not Available],,,,,Complete Remission/Response,,,1.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,
TCGA-DD-AAE7,5640,TCGA-DD-AAE7,LIHC,72.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-26568.0,Alive,TUMOR FREE,644.0,,[Not Available],,,,,[Not Available],,R0,0.0,644.0,0.0,644.0,0.0,644.0,0.0,644.0,
TCGA-85-6561,6705,TCGA-85-6561,LUSC,66.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-24234.0,Alive,TUMOR FREE,1224.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1224.0,0.0,1224.0,0.0,1224.0,0.0,1224.0,
TCGA-A1-A0SE,515,TCGA-A1-A0SE,BRCA,56.0,FEMALE,WHITE,Stage I,[Not Applicable],Mixed Histology (please specify),[Not Available],2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20717.0,Alive,TUMOR FREE,1321.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1321.0,0.0,1321.0,0.0,1321.0,0.0,1321.0,
TCGA-E2-A1AZ,1351,TCGA-E2-A1AZ,BRCA,63.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23230.0,Alive,TUMOR FREE,2329.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2329.0,0.0,2329.0,0.0,2329.0,0.0,2329.0,
TCGA-IB-A6UG,7643,TCGA-IB-A6UG,PAAD,65.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,[Not Available],-23751.0,Dead,WITH TUMOR,,41.0,"Other, non-malignant disease",,,,,Partial Remission/Response,,,1.0,41.0,0.0,41.0,,,1.0,41.0,
TCGA-FP-A9TM,9549,TCGA-FP-A9TM,STAD,77.0,MALE,WHITE,[Discrepancy],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,[Not Available],-28376.0,Alive,TUMOR FREE,189.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,189.0,0.0,189.0,0.0,189.0,0.0,189.0,
TCGA-AD-6890,2190,TCGA-AD-6890,COAD,65.0,MALE,WHITE,[Not Available],[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-23769.0,Alive,TUMOR FREE,746.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,746.0,0.0,746.0,0.0,746.0,0.0,746.0,
TCGA-HT-8010,5202,TCGA-HT-8010,LGG,64.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-23680.0,Alive,TUMOR FREE,50.0,,[Not Available],,,,,Stable Disease,,,0.0,50.0,0.0,50.0,,,0.0,50.0,
TCGA-ZP-A9D2,5797,TCGA-ZP-A9D2,LIHC,51.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-18717.0,Dead,WITH TUMOR,,765.0,[Not Available],Intrahepatic Recurrence,Liver,,315.0,[Not Available],,R0,1.0,765.0,1.0,765.0,1.0,315.0,1.0,315.0,
TCGA-CM-4751,2264,TCGA-CM-4751,COAD,62.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-22891.0,Alive,TUMOR FREE,822.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,
TCGA-43-A475,6488,TCGA-43-A475,LUSC,67.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24680.0,Alive,TUMOR FREE,296.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,296.0,0.0,296.0,0.0,296.0,0.0,296.0,
TCGA-V1-A8MU,8242,TCGA-V1-A8MU,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-20805.0,Alive,,1876.0,,[Not Available],,,,,Progressive Disease,,,0.0,1876.0,0.0,1876.0,,,0.0,1876.0,
TCGA-E8-A433,10033,TCGA-E8-A433,THCA,25.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-9145.0,Alive,TUMOR FREE,951.0,,[Not Available],,,,,[Not Available],,R0,0.0,951.0,0.0,951.0,0.0,951.0,0.0,951.0,
TCGA-63-A5MS,6603,TCGA-63-A5MS,LUSC,78.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-28827.0,Alive,TUMOR FREE,2381.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2381.0,0.0,2381.0,0.0,2381.0,0.0,2381.0,
TCGA-HT-8018,5207,TCGA-HT-8018,LGG,40.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2010.0,[Not Available],-14910.0,Dead,TUMOR FREE,,1152.0,[Not Available],,,,,Partial Remission/Response,,,1.0,1152.0,0.0,1152.0,,,0.0,1152.0,
TCGA-LL-A5YM,1535,TCGA-LL-A5YM,BRCA,88.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32478.0,Alive,WITH TUMOR,466.0,,[Not Available],Locoregional Recurrence,"Other, specify",Skin left chest wall,258.0,[Not Available],Negative,,0.0,466.0,0.0,466.0,1.0,258.0,1.0,258.0,
TCGA-TS-A7PB,6887,TCGA-TS-A7PB,MESO,62.0,MALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2011.0,[Not Available],-22822.0,Dead,,,982.0,[Not Available],,,,,[Not Available],,[Unknown],1.0,982.0,,982.0,,,0.0,982.0,
TCGA-D9-A1JX,8902,TCGA-D9-A1JX,SKCM,80.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2010.0,[Not Available],-29323.0,Dead,WITH TUMOR,,216.0,[Not Available],Distant Metastasis,"Other, Specify",iliac nymph nodes,195.0,[Not Available],,,1.0,216.0,1.0,216.0,,,1.0,195.0,
TCGA-56-7580,6516,TCGA-56-7580,LUSC,84.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-30740.0,Alive,TUMOR FREE,925.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,925.0,0.0,925.0,0.0,925.0,0.0,925.0,
TCGA-CV-5432,3472,TCGA-CV-5432,HNSC,68.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2000.0,[Not Available],-25006.0,Alive,TUMOR FREE,3930.0,,[Not Available],,,,,[Not Available],,,0.0,3930.0,0.0,3930.0,,,0.0,3930.0,
TCGA-EJ-5514,7928,TCGA-EJ-5514,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-24165.0,Alive,TUMOR FREE,1829.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1829.0,0.0,1829.0,0.0,1829.0,0.0,1829.0,
TCGA-NK-A5D1,6820,TCGA-NK-A5D1,LUSC,57.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-20909.0,Alive,WITH TUMOR,511.0,,[Not Available],Distant Metastasis,,,151.0,Progressive Disease,,,0.0,511.0,0.0,511.0,,,1.0,151.0,
TCGA-D3-A3CC,8859,TCGA-D3-A3CC,SKCM,69.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2005.0,[Not Available],-25396.0,Alive,WITH TUMOR,2644.0,,[Not Available],Locoregional Recurrence,,,96.0,[Not Available],,,0.0,2644.0,0.0,2644.0,,,1.0,96.0,
TCGA-BJ-A0ZA,9852,TCGA-BJ-A0ZA,THCA,67.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-24528.0,Alive,TUMOR FREE,574.0,,[Not Available],,,,,[Not Available],,R0,0.0,574.0,0.0,574.0,0.0,574.0,0.0,574.0,
TCGA-DD-AACL,5591,TCGA-DD-AACL,LIHC,66.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2008.0,[Not Available],-24355.0,Dead,,,107.0,[Not Available],,,,,[Not Available],,R0,1.0,107.0,,107.0,0.0,107.0,0.0,107.0,
TCGA-FU-A3WB,1762,TCGA-FU-A3WB,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IIA2,Cervical Squamous Cell Carcinoma,G2,2012.0,[Unknown],-15833.0,Alive,TUMOR FREE,491.0,,,,,,,Complete Remission/Response,,,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,
TCGA-OL-A5DA,1555,TCGA-OL-A5DA,BRCA,61.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22411.0,Alive,TUMOR FREE,1783.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1783.0,0.0,1783.0,0.0,1783.0,0.0,1783.0,
TCGA-DK-AA6L,217,TCGA-DK-AA6L,BLCA,48.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-17635.0,Dead,WITH TUMOR,,1163.0,[Not Available],Distant Metastasis,Bone,,920.0,Progressive Disease,,,1.0,1163.0,1.0,1163.0,,,1.0,920.0,
TCGA-E7-A85H,252,TCGA-E7-A85H,BLCA,64.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-23497.0,Alive,TUMOR FREE,394.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,394.0,0.0,394.0,0.0,394.0,0.0,394.0,
TCGA-66-2769,6626,TCGA-66-2769,LUSC,75.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-27515.0,Dead,,,215.0,[Not Available],,,,,[Not Available],,,1.0,215.0,,215.0,,,0.0,215.0,
TCGA-BF-AAP4,8821,TCGA-BF-AAP4,SKCM,61.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-22303.0,Alive,TUMOR FREE,335.0,,[Not Available],,,,,[Not Available],,,0.0,335.0,0.0,335.0,,,0.0,335.0,
TCGA-EJ-5515,7929,TCGA-EJ-5515,PRAD,60.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-22097.0,Alive,TUMOR FREE,1832.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1832.0,0.0,1832.0,0.0,1832.0,0.0,1832.0,
TCGA-SQ-A6I6,7803,TCGA-SQ-A6I6,PCPG,39.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-14451.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,[Unknown],,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-33-A5GW,6411,TCGA-33-A5GW,LUSC,67.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24586.0,Dead,TUMOR FREE,,9.0,[Not Available],,,,,Complete Remission/Response,,,1.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,
TCGA-HT-7620,5170,TCGA-HT-7620,LGG,40.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2007.0,[Not Available],-14659.0,Alive,TUMOR FREE,434.0,,[Not Available],,,,280.0,Complete Remission/Response,,,0.0,434.0,0.0,434.0,1.0,280.0,1.0,280.0,
TCGA-EL-A3D0,10054,TCGA-EL-A3D0,THCA,61.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2001.0,[Not Available],-22622.0,Alive,WITH TUMOR,4254.0,,[Not Available],,,,,[Not Available],,R2,0.0,4254.0,0.0,4254.0,,,0.0,4254.0,
TCGA-UY-A9PH,416,TCGA-UY-A9PH,BLCA,73.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-26654.0,Alive,TUMOR FREE,1561.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1561.0,0.0,1561.0,0.0,1561.0,0.0,1561.0,
TCGA-BG-A222,10772,TCGA-BG-A222,UCEC,49.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,[Not Available],-18220.0,Alive,TUMOR FREE,291.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,291.0,0.0,291.0,0.0,291.0,0.0,291.0,
TCGA-QK-A652,3722,TCGA-QK-A652,HNSC,60.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-22023.0,Alive,TUMOR FREE,645.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,645.0,0.0,645.0,0.0,645.0,0.0,645.0,
TCGA-A2-A1G6,603,TCGA-A2-A1G6,BRCA,50.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18514.0,Alive,TUMOR FREE,501.0,,[Not Available],,,,,[Not Available],Negative,,0.0,501.0,0.0,501.0,0.0,501.0,0.0,501.0,
TCGA-BB-4227,3283,TCGA-BB-4227,HNSC,66.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-24322.0,Alive,WITH TUMOR,134.0,,[Not Available],Locoregional Recurrence,Hypopharynx,,85.0,Stable Disease,,,0.0,134.0,0.0,134.0,,,1.0,85.0,
TCGA-WE-A8K1,9236,TCGA-WE-A8K1,SKCM,74.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2010.0,[Not Available],-27191.0,Alive,TUMOR FREE,1492.0,,[Not Available],,,,,[Not Available],,,0.0,1492.0,0.0,1492.0,,,0.0,1492.0,
TCGA-QB-A6FS,9219,TCGA-QB-A6FS,SKCM,49.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-18134.0,Alive,WITH TUMOR,220.0,,[Not Available],Distant Metastasis,"Other, Specify","SKIN, MID CHEST",63.0,[Not Available],,,0.0,220.0,0.0,220.0,,,1.0,63.0,
TCGA-AD-6888,2188,TCGA-AD-6888,COAD,73.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-26816.0,Dead,WITH TUMOR,,472.0,[Not Available],,,,343.0,Complete Remission/Response,,,1.0,472.0,1.0,472.0,1.0,343.0,1.0,343.0,
TCGA-69-7974,6102,TCGA-69-7974,LUAD,54.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-20021.0,Alive,WITH TUMOR,184.0,,[Not Available],,,,,Progressive Disease,,,0.0,184.0,0.0,184.0,,,0.0,184.0,
TCGA-AX-A2IN,10658,TCGA-AX-A2IN,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23275.0,Dead,WITH TUMOR,,947.0,[Not Available],New Primary Tumor,"Other, specify",Right Breast,257.0,[Not Available],,,1.0,947.0,1.0,947.0,,,1.0,257.0,
TCGA-EB-A5SH,8977,TCGA-EB-A5SH,SKCM,60.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],2009.0,[Not Available],-21920.0,Alive,TUMOR FREE,1643.0,,[Not Available],Locoregional Recurrence,,,1065.0,[Not Available],,,0.0,1643.0,0.0,1643.0,,,1.0,1065.0,
TCGA-UF-A718,3749,TCGA-UF-A718,HNSC,62.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-22836.0,Alive,TUMOR FREE,1971.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1971.0,0.0,1971.0,,,0.0,1971.0,
TCGA-CN-6013,3339,TCGA-CN-6013,HNSC,56.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-20703.0,Dead,WITH TUMOR,,727.0,[Not Available],,Distant Metastasis,LUNG,323.0,Complete Remission/Response,,,1.0,727.0,1.0,727.0,,,1.0,323.0,
TCGA-68-7757,6650,TCGA-68-7757,LUSC,74.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-27272.0,Alive,,211.0,,[Not Available],,,,,[Not Available],,,0.0,211.0,0.0,211.0,,,0.0,211.0,
TCGA-QR-A70X,7740,TCGA-QR-A70X,PCPG,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-16828.0,Alive,TUMOR FREE,183.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,
TCGA-AR-A24S,941,TCGA-AR-A24S,BRCA,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22587.0,Alive,,2976.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2976.0,0.0,2976.0,0.0,2976.0,0.0,2976.0,
TCGA-HU-8602,9562,TCGA-HU-8602,STAD,58.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-21522.0,Alive,TUMOR FREE,679.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,
TCGA-N9-A4Q8,11061,TCGA-N9-A4Q8,UCS,68.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25185.0,Dead,WITH TUMOR,,481.0,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,215.0,Complete Remission/Response,,,1.0,481.0,1.0,481.0,1.0,215.0,1.0,215.0,
TCGA-B9-5155,4525,TCGA-B9-5155,KIRP,71.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-26149.0,Alive,TUMOR FREE,665.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,665.0,0.0,665.0,0.0,665.0,0.0,665.0,
TCGA-ET-A40S,10252,TCGA-ET-A40S,THCA,62.0,MALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-22733.0,Alive,TUMOR FREE,1223.0,,[Not Available],,,,,[Not Available],,RX,0.0,1223.0,0.0,1223.0,,,0.0,1223.0,
TCGA-HC-7820,8092,TCGA-HC-7820,PRAD,72.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-26576.0,Alive,TUMOR FREE,747.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,747.0,0.0,747.0,0.0,747.0,0.0,747.0,
TCGA-OR-A5L5,60,TCGA-OR-A5L5,ACC,77.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-28270.0,Alive,TUMOR FREE,1317.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1317.0,0.0,1317.0,0.0,1317.0,0.0,1317.0,
TCGA-DQ-7592,3639,TCGA-DQ-7592,HNSC,57.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-21041.0,Alive,TUMOR FREE,1143.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1143.0,0.0,1143.0,,,0.0,1143.0,
TCGA-B0-5102,4031,TCGA-B0-5102,KIRC,74.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,1999.0,[Not Available],-27152.0,Dead,[Discrepancy],,2764.0,[Not Available],,,,2734.0,[Not Available],,,1.0,2764.0,,2764.0,,,1.0,2734.0,
TCGA-DJ-A3V2,9982,TCGA-DJ-A3V2,THCA,44.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-16382.0,Alive,TUMOR FREE,615.0,,[Not Available],,,,,[Not Available],,R0,0.0,615.0,0.0,615.0,0.0,615.0,0.0,615.0,
TCGA-BK-A6W4,10789,TCGA-BK-A6W4,UCEC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22766.0,Alive,TUMOR FREE,300.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,300.0,0.0,300.0,0.0,300.0,0.0,300.0,
TCGA-C4-A0F0,146,TCGA-C4-A0F0,BLCA,60.0,MALE,[Not Available],Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-22068.0,Alive,TUMOR FREE,59.0,,[Not Available],,,,,[Not Available],,,0.0,59.0,0.0,59.0,,,0.0,59.0,
TCGA-18-5592,6341,TCGA-18-5592,LUSC,57.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-21020.0,Alive,TUMOR FREE,1519.0,,[Not Available],,,,,[Unknown],,,0.0,1519.0,0.0,1519.0,,,0.0,1519.0,
TCGA-WB-A818,7843,TCGA-WB-A818,PCPG,37.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-13596.0,Alive,TUMOR FREE,1288.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,
TCGA-AU-3779,2201,TCGA-AU-3779,COAD,80.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-29460.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,[Unknown],,,0.0,441.0,0.0,441.0,,,0.0,441.0,
TCGA-TM-A7CA,5372,TCGA-TM-A7CA,LGG,44.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-16415.0,Alive,TUMOR FREE,1058.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1058.0,0.0,1058.0,0.0,1058.0,0.0,1058.0,
TCGA-Q1-A6DW,1824,TCGA-Q1-A6DW,CESC,44.0,FEMALE,WHITE,[Not Available],Stage I,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16200.0,Alive,,534.0,,,,,,,[Unknown],,,0.0,534.0,0.0,534.0,,,0.0,534.0,
TCGA-SS-A7HO,2410,TCGA-SS-A7HO,COAD,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-16416.0,Alive,WITH TUMOR,1829.0,,[Not Available],Locoregional Disease,,,506.0,Complete Remission/Response,,,0.0,1829.0,0.0,1829.0,1.0,506.0,1.0,506.0,
TCGA-85-7696,6707,TCGA-85-7696,LUSC,64.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-23413.0,Alive,TUMOR FREE,1111.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1111.0,0.0,1111.0,0.0,1111.0,0.0,1111.0,
TCGA-W6-AA0S,1940,TCGA-W6-AA0S,CHOL,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2013.0,[Not Available],-16951.0,Alive,TUMOR FREE,808.0,,[Not Available],Extrahepatic Recurrence,Non-regional / Distant Lymph Nodes,,549.0,[Not Available],,R0,0.0,808.0,0.0,808.0,1.0,549.0,1.0,549.0,
TCGA-A2-A0T3,579,TCGA-A2-A0T3,BRCA,37.0,FEMALE,WHITE,Stage IB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13680.0,Alive,TUMOR FREE,1516.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1516.0,0.0,1516.0,0.0,1516.0,0.0,1516.0,
TCGA-VQ-A94P,9694,TCGA-VQ-A94P,STAD,57.0,MALE,WHITE,[Discrepancy],[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",GX,2011.0,[Not Available],-21022.0,Dead,WITH TUMOR,,81.0,Stomach Cancer,,,,,Progressive Disease,,,1.0,81.0,1.0,81.0,,,1.0,81.0,
TCGA-B0-5707,4064,TCGA-B0-5707,KIRC,39.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-14598.0,Alive,TUMOR FREE,3744.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3744.0,0.0,3744.0,0.0,3744.0,0.0,3744.0,
TCGA-FS-A4F5,9174,TCGA-FS-A4F5,SKCM,77.0,FEMALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2005.0,[Not Available],-28412.0,Dead,WITH TUMOR,,874.0,[Not Available],,,,,[Not Available],,,1.0,874.0,1.0,874.0,,,1.0,874.0,
TCGA-QQ-A8VG,8754,TCGA-QQ-A8VG,SARC,52.0,MALE,WHITE,[Not Available],[Not Available],Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2009.0,[Not Available],-19304.0,Dead,WITH TUMOR,,1970.0,[Not Available],New Primary Tumor,Liver,,1852.0,[Not Available],Negative,RX,1.0,1970.0,1.0,1970.0,,,1.0,1852.0,
TCGA-G9-6378,8040,TCGA-G9-6378,PRAD,54.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-19879.0,Alive,TUMOR FREE,1155.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1155.0,0.0,1155.0,0.0,1155.0,0.0,1155.0,
TCGA-AA-3522,2030,TCGA-AA-3522,COAD,67.0,MALE,[Not Available],Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-24653.0,Alive,TUMOR FREE,1127.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1127.0,0.0,1127.0,0.0,1127.0,0.0,1127.0,
TCGA-CJ-4902,4306,TCGA-CJ-4902,KIRC,61.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-22424.0,Alive,TUMOR FREE,1520.0,,[Not Available],,,,,[Not Available],,,0.0,1520.0,0.0,1520.0,,,0.0,1520.0,
TCGA-A2-A0T1,577,TCGA-A2-A0T1,BRCA,55.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20227.0,Alive,TUMOR FREE,521.0,,[Not Available],,,,,[Not Available],Negative,,0.0,521.0,0.0,521.0,0.0,521.0,0.0,521.0,
TCGA-YT-A95H,10445,TCGA-YT-A95H,THYM,69.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2013.0,[Not Available],-25376.0,Alive,TUMOR FREE,711.0,,[Not Available],,,,,[Not Available],,,0.0,711.0,0.0,711.0,,,0.0,711.0,
TCGA-HF-7132,9551,TCGA-HF-7132,STAD,,MALE,[Not Available],Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2006.0,[Not Available],,Alive,TUMOR FREE,2351.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2351.0,0.0,2351.0,0.0,2351.0,0.0,2351.0,
TCGA-66-2788,6639,TCGA-66-2788,LUSC,56.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-20637.0,Alive,TUMOR FREE,699.0,,[Not Available],,,,,[Not Applicable],,,0.0,699.0,0.0,699.0,,,0.0,699.0,
TCGA-ET-A2N5,10218,TCGA-ET-A2N5,THCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2008.0,[Not Available],-17137.0,Alive,TUMOR FREE,2460.0,,[Not Available],,,,,[Not Available],,RX,0.0,2460.0,0.0,2460.0,,,0.0,2460.0,
TCGA-CV-7429,3565,TCGA-CV-7429,HNSC,55.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,1998.0,[Not Available],-20188.0,Dead,WITH TUMOR,,107.0,[Not Available],,,,,Partial Remission/Response,,,1.0,107.0,1.0,107.0,,,1.0,107.0,
TCGA-EK-A2RD,1734,TCGA-EK-A2RD,CESC,47.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17191.0,Alive,TUMOR FREE,2.0,,,,,,,[Not Available],,,0.0,2.0,0.0,2.0,,,0.0,2.0,
TCGA-MA-AA42,1809,TCGA-MA-AA42,CESC,75.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27460.0,Alive,TUMOR FREE,259.0,,,,,,,Complete Remission/Response,,,0.0,259.0,0.0,259.0,0.0,259.0,0.0,259.0,
TCGA-BP-5010,4237,TCGA-BP-5010,KIRC,63.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2007.0,[Not Available],-23130.0,Dead,WITH TUMOR,,878.0,[Not Available],,,,582.0,[Not Available],,,1.0,878.0,1.0,878.0,,,1.0,582.0,
TCGA-CV-6436,3492,TCGA-CV-6436,HNSC,62.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2007.0,[Not Available],-22885.0,Alive,TUMOR FREE,1899.0,,[Not Available],,,,,[Not Available],,,0.0,1899.0,0.0,1899.0,,,0.0,1899.0,
TCGA-HT-7881,5198,TCGA-HT-7881,LGG,38.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-14171.0,Alive,TUMOR FREE,1079.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1079.0,0.0,1079.0,0.0,1079.0,0.0,1079.0,
TCGA-63-A5MT,6604,TCGA-63-A5MT,LUSC,74.0,MALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-27263.0,Alive,WITH TUMOR,498.0,,[Not Available],Distant Metastasis,,,427.0,Complete Remission/Response,,,0.0,498.0,0.0,498.0,1.0,427.0,1.0,427.0,
TCGA-XM-AAZ2,10417,TCGA-XM-AAZ2,THYM,73.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],I,Thymoma; Type A,[Not Available],2012.0,[Not Available],-26861.0,Alive,TUMOR FREE,981.0,,[Not Available],,,,,[Not Available],,,0.0,981.0,0.0,981.0,,,0.0,981.0,
TCGA-CH-5750,7888,TCGA-CH-5750,PRAD,72.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-26389.0,Alive,TUMOR FREE,396.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,
TCGA-AF-2687,8367,TCGA-AF-2687,READ,57.0,MALE,WHITE,Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-21098.0,Alive,TUMOR FREE,1427.0,,[Not Available],,,,1267.0,Complete Remission/Response,,,0.0,1427.0,0.0,1427.0,1.0,1267.0,1.0,1267.0,
TCGA-NC-A5HE,6802,TCGA-NC-A5HE,LUSC,60.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-22179.0,Alive,TUMOR FREE,2336.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2336.0,0.0,2336.0,0.0,2336.0,0.0,2336.0,
TCGA-44-6778,5881,TCGA-44-6778,LUAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-21725.0,Alive,TUMOR FREE,1864.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1864.0,0.0,1864.0,0.0,1864.0,0.0,1864.0,
TCGA-86-8056,6189,TCGA-86-8056,LUAD,63.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23369.0,Alive,TUMOR FREE,139.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,139.0,0.0,139.0,0.0,139.0,0.0,139.0,
TCGA-EY-A1GV,10960,TCGA-EY-A1GV,UCEC,75.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27581.0,Alive,TUMOR FREE,481.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,
TCGA-FS-A1ZK,9159,TCGA-FS-A1ZK,SKCM,68.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],2005.0,[Not Available],-24839.0,Dead,WITH TUMOR,,728.0,[Not Available],,,,367.0,[Not Available],,,1.0,728.0,1.0,728.0,,,1.0,367.0,
TCGA-AA-A01R,2166,TCGA-AA-A01R,COAD,47.0,MALE,[Not Available],Stage III,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2004.0,[Not Available],-17289.0,Alive,WITH TUMOR,1065.0,,[Not Available],,,,608.0,Partial Remission/Response,,,0.0,1065.0,0.0,1065.0,,,1.0,608.0,
TCGA-FW-A3TV,9183,TCGA-FW-A3TV,SKCM,57.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-20972.0,Alive,WITH TUMOR,411.0,,[Not Available],Locoregional Recurrence,,,139.0,[Not Available],,,0.0,411.0,0.0,411.0,,,1.0,139.0,
TCGA-R6-A8WC,2610,TCGA-R6-A8WC,ESCA,56.0,MALE,WHITE,[Not Available],Stage IIA,"Esophagus Adenocarcinoma, NOS",G2,2013.0,[Not Available],-20812.0,Alive,WITH TUMOR,70.0,,[Not Available],,,,,[Not Applicable],,,0.0,70.0,0.0,70.0,,,0.0,70.0,
TCGA-BP-5007,4234,TCGA-BP-5007,KIRC,45.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-16793.0,Alive,TUMOR FREE,1140.0,,[Not Available],,,,,[Not Available],,,0.0,1140.0,0.0,1140.0,,,0.0,1140.0,
TCGA-BF-AAP8,8824,TCGA-BF-AAP8,SKCM,58.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-21414.0,Alive,TUMOR FREE,447.0,,[Not Available],,,,,[Not Available],,,0.0,447.0,0.0,447.0,,,0.0,447.0,
TCGA-AC-A5XU,789,TCGA-AC-A5XU,BRCA,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,[Not Available],-27191.0,Alive,TUMOR FREE,455.0,,[Not Available],,,,,[Not Available],Negative,,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,
TCGA-DA-A1I4,8921,TCGA-DA-A1I4,SKCM,51.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2006.0,[Not Available],-18961.0,Dead,WITH TUMOR,,1093.0,[Not Available],Distant Metastasis,Brain,,889.0,[Not Available],,,1.0,1093.0,1.0,1093.0,,,1.0,889.0,
TCGA-D3-A2JG,8845,TCGA-D3-A2JG,SKCM,30.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2001.0,[Not Available],-11105.0,Dead,WITH TUMOR,,3453.0,[Not Available],Distant Metastasis,"Other, Specify","Left ischial rectal fossa, soft tissue",3279.0,[Not Available],,,1.0,3453.0,1.0,3453.0,,,1.0,3279.0,
TCGA-QR-A70E,7724,TCGA-QR-A70E,PCPG,31.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-11400.0,Alive,TUMOR FREE,192.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,192.0,0.0,192.0,0.0,192.0,0.0,192.0,
TCGA-EL-A3GW,10066,TCGA-EL-A3GW,THCA,37.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-13670.0,Alive,TUMOR FREE,1527.0,,[Not Available],,,,,[Not Available],,R0,0.0,1527.0,0.0,1527.0,0.0,1527.0,0.0,1527.0,
TCGA-E9-A5UO,1452,TCGA-E9-A5UO,BRCA,41.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15050.0,Alive,TUMOR FREE,785.0,,[Not Available],,,,,[Not Available],Negative,,0.0,785.0,0.0,785.0,0.0,785.0,0.0,785.0,
TCGA-E9-A22H,1433,TCGA-E9-A22H,BRCA,42.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15504.0,Alive,TUMOR FREE,1232.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1232.0,0.0,1232.0,0.0,1232.0,0.0,1232.0,
TCGA-B8-4148,4094,TCGA-B8-4148,KIRC,63.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2009.0,[Not Available],-23062.0,Alive,TUMOR FREE,1520.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1520.0,0.0,1520.0,0.0,1520.0,0.0,1520.0,
TCGA-BW-A5NP,5480,TCGA-BW-A5NP,LIHC,26.0,FEMALE,WHITE,Stage IV,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-9809.0,Alive,WITH TUMOR,0.0,,[Not Available],Extrahepatic Recurrence,Liver,,102.0,[Not Available],,RX,0.0,0.0,0.0,0.0,,,1.0,102.0,
TCGA-XE-AAO4,9815,TCGA-XE-AAO4,TGCT,40.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2006.0,[Not Available],-14930.0,Alive,TUMOR FREE,367.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,367.0,0.0,367.0,0.0,367.0,0.0,367.0,
TCGA-F4-6854,2364,TCGA-F4-6854,COAD,77.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-28272.0,Alive,TUMOR FREE,16.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,16.0,0.0,16.0,0.0,16.0,0.0,16.0,
TCGA-DM-A1D9,2334,TCGA-DM-A1D9,COAD,67.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2000.0,[Not Available],-24514.0,Alive,,4270.0,,[Not Available],,,,,[Not Available],,,0.0,4270.0,0.0,4270.0,,,0.0,4270.0,
TCGA-XM-A8RE,10410,TCGA-XM-A8RE,THYM,54.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2013.0,[Not Available],-19903.0,Alive,TUMOR FREE,422.0,,[Not Available],,,,,[Not Available],,,0.0,422.0,0.0,422.0,,,0.0,422.0,
TCGA-FS-A1Z7,9149,TCGA-FS-A1Z7,SKCM,19.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2005.0,[Not Available],-7293.0,Dead,WITH TUMOR,,237.0,[Not Available],Distant Metastasis,Lung,,136.0,[Not Available],,,1.0,237.0,1.0,237.0,,,1.0,136.0,
TCGA-KK-A59V,8173,TCGA-KK-A59V,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2005.0,[Not Available],-23483.0,Alive,TUMOR FREE,3440.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3440.0,0.0,3440.0,0.0,3440.0,0.0,3440.0,
TCGA-WB-A81H,7850,TCGA-WB-A81H,PCPG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2009.0,[Not Available],-16425.0,Alive,TUMOR FREE,1946.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1946.0,0.0,1946.0,0.0,1946.0,0.0,1946.0,
TCGA-4W-AA9S,3203,TCGA-4W-AA9S,GBM,69.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2013.0,[Not Available],-25545.0,Alive,TUMOR FREE,44.0,,[Not Available],,,,,Stable Disease,,,0.0,44.0,0.0,44.0,,,0.0,44.0,
TCGA-DD-AACS,5597,TCGA-DD-AACS,LIHC,39.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2009.0,[Not Available],-14473.0,Alive,TUMOR FREE,1804.0,,[Not Available],,,,,[Not Available],,R0,0.0,1804.0,0.0,1804.0,0.0,1804.0,0.0,1804.0,
TCGA-CN-6010,3336,TCGA-CN-6010,HNSC,53.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-19475.0,Alive,TUMOR FREE,1523.0,,[Not Available],New Primary Tumor,,nasal cavity,540.0,Complete Remission/Response,,,0.0,1523.0,0.0,1523.0,,,1.0,540.0,
TCGA-E9-A1N8,1397,TCGA-E9-A1N8,BRCA,48.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17652.0,Alive,TUMOR FREE,1039.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1039.0,0.0,1039.0,0.0,1039.0,0.0,1039.0,
TCGA-77-A5GB,6699,TCGA-77-A5GB,LUSC,90.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-32872.0,Dead,,,937.0,[Not Available],New Primary Tumor,,,229.0,Complete Remission/Response,,,1.0,937.0,,937.0,0.0,937.0,1.0,229.0,
TCGA-FA-A7DS,2418,TCGA-FA-A7DS,DLBC,54.0,FEMALE,ASIAN,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013.0,[Not Available],-20087.0,Alive,TUMOR FREE,719.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,719.0,0.0,719.0,0.0,719.0,0.0,719.0,
TCGA-XF-AAMY,458,TCGA-XF-AAMY,BLCA,78.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-28509.0,Alive,TUMOR FREE,3011.0,,[Not Available],Distant Metastasis,Lung,,637.0,Complete Remission/Response,,,0.0,3011.0,0.0,3011.0,1.0,637.0,1.0,637.0,
TCGA-06-0686,2827,TCGA-06-0686,GBM,53.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-19503.0,Dead,WITH TUMOR,,432.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],160.0,[Not Available],,,1.0,432.0,1.0,432.0,,,1.0,160.0,
TCGA-85-8354,6729,TCGA-85-8354,LUSC,53.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-19692.0,Alive,TUMOR FREE,995.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,995.0,0.0,995.0,0.0,995.0,0.0,995.0,
TCGA-95-7043,6236,TCGA-95-7043,LUAD,63.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23165.0,Dead,WITH TUMOR,,503.0,[Not Available],,,,,Complete Remission/Response,,,1.0,503.0,1.0,503.0,,,1.0,503.0,
TCGA-DK-A3IM,198,TCGA-DK-A3IM,BLCA,76.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-28106.0,Dead,WITH TUMOR,,248.0,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,201.0,Complete Remission/Response,,,1.0,248.0,1.0,248.0,1.0,201.0,1.0,201.0,
TCGA-YD-A9TB,9261,TCGA-YD-A9TB,SKCM,,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1987.0,[Not Available],,Alive,WITH TUMOR,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-ET-A3BS,10234,TCGA-ET-A3BS,THCA,42.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-15421.0,Alive,TUMOR FREE,176.0,,[Not Available],,,,,[Not Available],,R0,0.0,176.0,0.0,176.0,0.0,176.0,0.0,176.0,
TCGA-LN-A8I1,2591,TCGA-LN-A8I1,ESCA,67.0,FEMALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G3,2013.0,[Not Available],-24551.0,Alive,TUMOR FREE,401.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,401.0,0.0,401.0,0.0,401.0,0.0,401.0,
TCGA-FS-A4FB,9177,TCGA-FS-A4FB,SKCM,46.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],2009.0,[Not Available],-16896.0,Dead,WITH TUMOR,,813.0,[Not Available],,,,,[Not Available],,,1.0,813.0,1.0,813.0,,,1.0,813.0,
TCGA-A3-3349,3907,TCGA-A3-3349,KIRC,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-12431.0,Alive,TUMOR FREE,1385.0,,[Not Available],,,,,[Not Available],,,0.0,1385.0,0.0,1385.0,,,0.0,1385.0,
TCGA-DU-6394,4993,TCGA-DU-6394,LGG,53.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,1994.0,[Not Available],-19541.0,Dead,WITH TUMOR,,682.0,[Not Available],,,,353.0,Progressive Disease,,,1.0,682.0,1.0,682.0,,,1.0,353.0,
TCGA-22-5483,6392,TCGA-22-5483,LUSC,74.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-27109.0,Dead,WITH TUMOR,573.0,573.0,[Not Available],,,,568.0,Complete Remission/Response,,,1.0,573.0,1.0,573.0,1.0,568.0,1.0,568.0,
TCGA-AC-A8OR,801,TCGA-AC-A8OR,BRCA,75.0,FEMALE,WHITE,Stage IA,[Not Applicable],Mucinous Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27605.0,Alive,TUMOR FREE,40.0,,[Not Available],,,,,[Not Available],Negative,,0.0,40.0,0.0,40.0,0.0,40.0,0.0,40.0,
TCGA-CD-5800,9416,TCGA-CD-5800,STAD,51.0,FEMALE,ASIAN,Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Papillary Type",G1,2010.0,[Not Available],,Alive,TUMOR FREE,400.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,400.0,0.0,400.0,0.0,400.0,0.0,400.0,
TCGA-IR-A3L7,1775,TCGA-IR-A3L7,CESC,37.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2000.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13559.0,Alive,TUMOR FREE,4483.0,,,,,,,Complete Remission/Response,,,0.0,4483.0,0.0,4483.0,0.0,4483.0,0.0,4483.0,
TCGA-AC-A3QQ,777,TCGA-AC-A3QQ,BRCA,54.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Peri (6-12 months since last menstrual period),-19723.0,Alive,TUMOR FREE,734.0,,[Not Available],,,,,[Not Available],Close,,0.0,734.0,0.0,734.0,,,0.0,734.0,
TCGA-D8-A13Y,1225,TCGA-D8-A13Y,BRCA,52.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19028.0,Alive,TUMOR FREE,1728.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1728.0,0.0,1728.0,0.0,1728.0,0.0,1728.0,
TCGA-MJ-A68J,8730,TCGA-MJ-A68J,SARC,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2012.0,[Not Available],-20100.0,Alive,WITH TUMOR,547.0,,[Not Available],New Primary Tumor,"Other, specify",Foot,268.0,[Not Available],Positive,R1,0.0,547.0,0.0,547.0,,,1.0,268.0,
TCGA-44-A47G,5899,TCGA-44-A47G,LUAD,73.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26800.0,Alive,TUMOR FREE,351.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,351.0,0.0,351.0,0.0,351.0,0.0,351.0,
TCGA-EW-A1J5,1462,TCGA-EW-A1J5,BRCA,59.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21559.0,Alive,TUMOR FREE,477.0,,[Not Available],,,,,[Not Available],Negative,,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,
TCGA-AX-A2H5,10647,TCGA-AX-A2H5,UCEC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2005.0,[Not Available],-24757.0,Alive,TUMOR FREE,2167.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2167.0,0.0,2167.0,0.0,2167.0,0.0,2167.0,
TCGA-BQ-5883,4543,TCGA-BQ-5883,KIRP,79.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-28877.0,Alive,TUMOR FREE,1242.0,,[Not Available],,,,,[Not Available],,,0.0,1242.0,0.0,1242.0,,,0.0,1242.0,
TCGA-CV-A6JN,3596,TCGA-CV-A6JN,HNSC,53.0,MALE,WHITE,[Not Available],Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-19635.0,Alive,TUMOR FREE,906.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,906.0,0.0,906.0,0.0,906.0,0.0,906.0,
TCGA-V4-A9F4,11113,TCGA-V4-A9F4,UVM,41.0,MALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell|Epithelioid Cell,[Not Available],2013.0,[Not Available],-15332.0,Alive,TUMOR FREE,634.0,,[Not Available],,,,,[Not Available],,,0.0,634.0,0.0,634.0,,,0.0,634.0,
TCGA-B5-A11I,10698,TCGA-B5-A11I,UCEC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23857.0,Alive,TUMOR FREE,2303.0,,[Not Available],Metastatic,Lung,,705.0,Complete Remission/Response,,,0.0,2303.0,0.0,2303.0,,,1.0,705.0,
TCGA-E2-A1LA,1374,TCGA-E2-A1LA,BRCA,59.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21773.0,Alive,TUMOR FREE,748.0,,[Not Available],,,,,[Not Available],Negative,,0.0,748.0,0.0,748.0,0.0,748.0,0.0,748.0,
TCGA-AP-A059,10567,TCGA-AP-A059,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25311.0,Alive,TUMOR FREE,1461.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1461.0,0.0,1461.0,0.0,1461.0,0.0,1461.0,
TCGA-39-5016,6453,TCGA-39-5016,LUSC,44.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-16306.0,Alive,TUMOR FREE,3850.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3850.0,0.0,3850.0,0.0,3850.0,0.0,3850.0,
TCGA-28-5207,3154,TCGA-28-5207,GBM,71.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-25975.0,Dead,WITH TUMOR,275.0,343.0,[Not Available],,,,,[Not Available],,,1.0,343.0,1.0,343.0,,,1.0,343.0,
TCGA-39-5011,6452,TCGA-39-5011,LUSC,70.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-25788.0,Alive,TUMOR FREE,4053.0,,[Not Available],,,,565.0,Complete Remission/Response,,,0.0,4053.0,0.0,4053.0,1.0,565.0,1.0,565.0,
TCGA-BH-A0DX,1074,TCGA-BH-A0DX,BRCA,62.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22833.0,Alive,TUMOR FREE,2156.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2156.0,0.0,2156.0,0.0,2156.0,0.0,2156.0,
TCGA-D8-A1JI,1244,TCGA-D8-A1JI,BRCA,54.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20072.0,Alive,TUMOR FREE,577.0,,[Not Available],,,,,[Not Available],Negative,,0.0,577.0,0.0,577.0,0.0,577.0,0.0,577.0,
TCGA-BH-A0E9,1081,TCGA-BH-A0E9,BRCA,53.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19415.0,Alive,TUMOR FREE,2489.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2489.0,0.0,2489.0,0.0,2489.0,0.0,2489.0,
TCGA-78-7220,6161,TCGA-78-7220,LUAD,53.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2000.0,[Not Available],-19480.0,Dead,WITH TUMOR,,807.0,[Not Available],,,,531.0,[Not Available],,,1.0,807.0,1.0,807.0,,,1.0,531.0,
TCGA-DD-AAE6,5639,TCGA-DD-AAE6,LIHC,59.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-21764.0,Alive,WITH TUMOR,141.0,,[Not Available],Intrahepatic Recurrence,Liver,,105.0,[Not Available],,R0,0.0,141.0,0.0,141.0,1.0,105.0,1.0,105.0,
TCGA-A4-7583,4467,TCGA-A4-7583,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-21962.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,[Not Available],,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-B5-A1MU,10717,TCGA-B5-A1MU,UCEC,79.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29027.0,Dead,WITH TUMOR,,1548.0,[Not Available],New Primary Tumor,"Other, specify",Breast,1365.0,Complete Remission/Response,,,1.0,1548.0,1.0,1548.0,,,1.0,1365.0,
TCGA-BS-A0TI,10796,TCGA-BS-A0TI,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23705.0,Alive,TUMOR FREE,1882.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1882.0,0.0,1882.0,0.0,1882.0,0.0,1882.0,
TCGA-G4-6323,2387,TCGA-G4-6323,COAD,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-18334.0,Alive,TUMOR FREE,419.0,,[Not Available],,,,,[Not Available],,,0.0,419.0,0.0,419.0,,,0.0,419.0,
TCGA-IN-AB1V,9607,TCGA-IN-AB1V,STAD,63.0,MALE,WHITE,Stage IA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,[Not Available],-23030.0,Alive,TUMOR FREE,479.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,479.0,0.0,479.0,0.0,479.0,0.0,479.0,
TCGA-E2-A1B0,1352,TCGA-E2-A1B0,BRCA,50.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18346.0,Alive,TUMOR FREE,1631.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1631.0,0.0,1631.0,0.0,1631.0,0.0,1631.0,
TCGA-DJ-A3VG,9995,TCGA-DJ-A3VG,THCA,40.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-14970.0,Alive,TUMOR FREE,1085.0,,[Not Available],,,,,[Not Available],,R0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0,
TCGA-2J-AABE,7509,TCGA-2J-AABE,PAAD,73.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-26943.0,Alive,TUMOR FREE,676.0,,,,,,,Complete Remission/Response,,,0.0,676.0,0.0,676.0,0.0,676.0,0.0,676.0,
TCGA-CV-7090,3519,TCGA-CV-7090,HNSC,39.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2001.0,[Not Available],-14515.0,Alive,TUMOR FREE,5252.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,5252.0,0.0,5252.0,0.0,5252.0,0.0,5252.0,
TCGA-H2-A3RI,10308,TCGA-H2-A3RI,THCA,29.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-10956.0,Alive,[Discrepancy],335.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,279.0,[Not Available],,[Not Available],0.0,335.0,0.0,335.0,,,1.0,279.0,
TCGA-EL-A3CN,10042,TCGA-EL-A3CN,THCA,47.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1999.0,[Not Available],-17456.0,Alive,TUMOR FREE,4731.0,,[Not Available],,,,,[Not Available],,R2,0.0,4731.0,0.0,4731.0,,,0.0,4731.0,
TCGA-C8-A131,1191,TCGA-C8-A131,BRCA,82.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29966.0,Alive,TUMOR FREE,411.0,,[Not Available],,,,,[Not Available],Negative,,0.0,411.0,0.0,411.0,0.0,411.0,0.0,411.0,
TCGA-FZ-5920,7571,TCGA-FZ-5920,PAAD,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2007.0,[Not Available],-19287.0,Dead,,,61.0,,,,,,[Unknown],,,1.0,61.0,,61.0,,,0.0,61.0,
TCGA-G9-6377,8039,TCGA-G9-6377,PRAD,61.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-22419.0,Alive,TUMOR FREE,958.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,958.0,0.0,958.0,0.0,958.0,0.0,958.0,
TCGA-ZG-A9ND,8365,TCGA-ZG-A9ND,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-20428.0,Alive,TUMOR FREE,410.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,
TCGA-IG-A3I8,2475,TCGA-IG-A3I8,ESCA,51.0,FEMALE,WHITE,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2011.0,[Not Available],-18786.0,Alive,TUMOR FREE,1012.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1012.0,0.0,1012.0,0.0,1012.0,0.0,1012.0,
TCGA-5P-A9K3,4454,TCGA-5P-A9K3,KIRP,59.0,MALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-21829.0,Dead,WITH TUMOR,,471.0,[Not Available],,,,17.0,Partial Remission/Response,,,1.0,471.0,1.0,471.0,,,1.0,17.0,
TCGA-CU-A3QU,176,TCGA-CU-A3QU,BLCA,58.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-21233.0,Alive,TUMOR FREE,158.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,158.0,0.0,158.0,,,0.0,158.0,
TCGA-77-7140,6664,TCGA-77-7140,LUSC,69.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-25303.0,Dead,,,632.0,[Not Available],,,,250.0,[Not Available],,,1.0,632.0,,632.0,,,1.0,250.0,
TCGA-L5-A4OI,2518,TCGA-L5-A4OI,ESCA,79.0,MALE,WHITE,Stage IIIC,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2012.0,[Not Available],-29190.0,Alive,WITH TUMOR,608.0,,[Not Available],Locoregional Recurrence,"Other, specify",Lymph Node,267.0,Stable Disease,,,0.0,608.0,0.0,608.0,,,1.0,267.0,
TCGA-ZF-A9RN,488,TCGA-ZF-A9RN,BLCA,67.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-24795.0,Dead,WITH TUMOR,,615.0,[Not Available],Distant Metastasis,Lung,,516.0,Partial Remission/Response,,,1.0,615.0,1.0,615.0,,,1.0,516.0,
TCGA-VQ-A927,9690,TCGA-VQ-A927,STAD,81.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G1,2013.0,[Not Available],-29676.0,Dead,WITH TUMOR,,200.0,[Not Available],,,,,Stable Disease,,,1.0,200.0,1.0,200.0,,,1.0,200.0,
TCGA-DD-A4NE,5555,TCGA-DD-A4NE,LIHC,75.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-27549.0,Dead,WITH TUMOR,,660.0,[Not Available],Locoregional Recurrence,Liver,,190.0,[Not Available],,R0,1.0,660.0,1.0,660.0,1.0,190.0,1.0,190.0,
TCGA-S9-A6WN,5344,TCGA-S9-A6WN,LGG,38.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-13961.0,Alive,WITH TUMOR,805.0,,[Not Available],,,,303.0,Progressive Disease,,,0.0,805.0,0.0,805.0,,,1.0,303.0,
TCGA-B5-A11P,10704,TCGA-B5-A11P,UCEC,87.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32047.0,Alive,TUMOR FREE,1583.0,,[Not Available],,,,,[Not Available],,,0.0,1583.0,0.0,1583.0,,,0.0,1583.0,
TCGA-EK-A2RL,1738,TCGA-EK-A2RL,CESC,32.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB,Endocervical Type of Adenocarcinoma,G2,2009.0,[Not Available],-12047.0,Dead,WITH TUMOR,,1453.0,Cervical Cancer,Locoregional Recurrence,Cervix,,1143.0,Progressive Disease,,,1.0,1453.0,1.0,1453.0,,,1.0,1143.0,
TCGA-FI-A2D0,10984,TCGA-FI-A2D0,UCEC,55.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2008.0,Peri (6-12 months since last menstrual period),-20393.0,Alive,TUMOR FREE,1213.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1213.0,0.0,1213.0,0.0,1213.0,0.0,1213.0,
TCGA-CW-6093,4351,TCGA-CW-6093,KIRC,73.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2004.0,[Not Available],-26909.0,Alive,TUMOR FREE,3146.0,,[Not Available],,,,,Stable Disease,,,0.0,3146.0,0.0,3146.0,,,0.0,3146.0,
TCGA-B5-A0JN,10675,TCGA-B5-A0JN,UCEC,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30933.0,Alive,TUMOR FREE,2445.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2445.0,0.0,2445.0,,,0.0,2445.0,
TCGA-4V-A9QI,10361,TCGA-4V-A9QI,THYM,68.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2007.0,[Not Available],-25181.0,Alive,TUMOR FREE,2936.0,,[Not Available],,,,,[Not Available],,,0.0,2936.0,0.0,2936.0,,,0.0,2936.0,
TCGA-KJ-A3U4,11001,TCGA-KJ-A3U4,UCEC,55.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20392.0,Alive,TUMOR FREE,1095.0,,[Not Available],Locoregional Recurrence,"Other, specify",abdominal,306.0,[Discrepancy],,,0.0,1095.0,0.0,1095.0,,,1.0,306.0,
TCGA-64-5774,6080,TCGA-64-5774,LUAD,60.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],-22059.0,Alive,TUMOR FREE,2676.0,,[Not Available],,,,246.0,Complete Remission/Response,,,0.0,2676.0,0.0,2676.0,1.0,246.0,1.0,246.0,
TCGA-A1-A0SJ,520,TCGA-A1-A0SJ,BRCA,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,[Not Available],-14383.0,Alive,TUMOR FREE,416.0,,[Not Available],,,,,[Not Available],Negative,,0.0,416.0,0.0,416.0,0.0,416.0,0.0,416.0,
TCGA-AR-A1AP,922,TCGA-AR-A1AP,BRCA,80.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29406.0,Alive,TUMOR FREE,2856.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2856.0,0.0,2856.0,0.0,2856.0,0.0,2856.0,
TCGA-AN-A0XU,839,TCGA-AN-A0XU,BRCA,54.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20052.0,Alive,TUMOR FREE,10.0,,[Not Available],,,,,[Not Available],Negative,,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,
TCGA-EI-6885,8518,TCGA-EI-6885,READ,57.0,FEMALE,WHITE,Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-21140.0,Alive,WITH TUMOR,415.0,,[Not Available],Locoregional Disease,,,295.0,[Not Available],,,0.0,415.0,0.0,415.0,,,1.0,295.0,
TCGA-VS-A9UP,1875,TCGA-VS-A9UP,CESC,43.0,FEMALE,[Unknown],[Not Available],Stage IIA,Mucinous Adenocarcinoma of Endocervical Type,G3,2011.0,Peri (6-12 months since last menstrual period),-15849.0,Alive,WITH TUMOR,1444.0,,,Distant Metastasis,"Other, specify",Paraortic lymph nodes,352.0,Complete Remission/Response,,,0.0,1444.0,0.0,1444.0,1.0,352.0,1.0,352.0,
TCGA-E2-A14R,1317,TCGA-E2-A14R,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22686.0,Alive,TUMOR FREE,1174.0,,[Not Available],New Primary Tumor,"Other, specify",Endometrial,971.0,[Not Available],Negative,,0.0,1174.0,0.0,1174.0,0.0,1174.0,1.0,971.0,
TCGA-KO-8408,3842,TCGA-KO-8408,KICH,47.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-17299.0,Dead,TUMOR FREE,,507.0,[Not Available],,,,46.0,[Not Available],,,1.0,507.0,0.0,507.0,,,1.0,46.0,
TCGA-KT-A74X,5261,TCGA-KT-A74X,LGG,26.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-9590.0,Alive,WITH TUMOR,438.0,,[Not Available],,,,,Stable Disease,,,0.0,438.0,0.0,438.0,,,0.0,438.0,
TCGA-GJ-A3OU,5733,TCGA-GJ-A3OU,LIHC,59.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-21671.0,Alive,[Discrepancy],879.0,,[Not Available],Intrahepatic Recurrence,Liver,,879.0,[Not Available],,RX,0.0,879.0,0.0,879.0,,,1.0,879.0,
TCGA-78-7148,6145,TCGA-78-7148,LUAD,71.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-25990.0,Dead,,,626.0,[Not Available],,,,182.0,[Not Available],,,1.0,626.0,,626.0,,,1.0,182.0,
TCGA-D5-6927,2319,TCGA-D5-6927,COAD,34.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-12737.0,Alive,TUMOR FREE,287.0,,[Not Available],,,,,[Unknown],,,0.0,287.0,0.0,287.0,,,0.0,287.0,
TCGA-D1-A1NS,10874,TCGA-D1-A1NS,UCEC,53.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19638.0,Alive,TUMOR FREE,43.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,43.0,0.0,43.0,0.0,43.0,0.0,43.0,
TCGA-CV-A6JO,3597,TCGA-CV-A6JO,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-25377.0,Dead,WITH TUMOR,,197.0,[Not Available],,Oral Cavity,submandibular,127.0,Progressive Disease,,,1.0,197.0,1.0,197.0,,,1.0,127.0,
TCGA-IB-AAUM,7646,TCGA-IB-AAUM,PAAD,76.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,[Not Available],-28013.0,Alive,WITH TUMOR,8.0,,,,,,,Partial Remission/Response,,,0.0,8.0,0.0,8.0,,,0.0,8.0,
TCGA-CJ-5680,4325,TCGA-CJ-5680,KIRC,65.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2003.0,[Not Available],-23778.0,Dead,WITH TUMOR,,768.0,[Not Available],,,,153.0,[Not Available],,,1.0,768.0,1.0,768.0,,,1.0,153.0,
TCGA-CA-6718,2242,TCGA-CA-6718,COAD,46.0,MALE,ASIAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-17109.0,Dead,WITH TUMOR,,306.0,[Not Available],,,,207.0,Complete Remission/Response,,,1.0,306.0,1.0,306.0,1.0,207.0,1.0,207.0,
TCGA-BS-A0U5,10798,TCGA-BS-A0U5,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27945.0,Alive,TUMOR FREE,2935.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2935.0,0.0,2935.0,0.0,2935.0,0.0,2935.0,
TCGA-ZJ-AAXJ,1902,TCGA-ZJ-AAXJ,CESC,43.0,FEMALE,[Unknown],[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,[Not Available],2010.0,[Unknown],-16007.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-B2-5635,4078,TCGA-B2-5635,KIRC,74.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-27183.0,Alive,TUMOR FREE,755.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,755.0,0.0,755.0,0.0,755.0,0.0,755.0,
TCGA-E9-A3QA,1446,TCGA-E9-A3QA,BRCA,33.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Medullary Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12142.0,Alive,TUMOR FREE,918.0,,[Not Available],,,,,[Not Available],Negative,,0.0,918.0,0.0,918.0,0.0,918.0,0.0,918.0,
TCGA-V4-A9EW,11105,TCGA-V4-A9EW,UVM,44.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell|Epithelioid Cell,[Not Available],2012.0,[Not Available],-16140.0,Alive,WITH TUMOR,1211.0,,[Not Available],Distant Metastasis,Liver,,197.0,[Not Available],,,0.0,1211.0,0.0,1211.0,,,1.0,197.0,
TCGA-55-8506,6033,TCGA-55-8506,LUAD,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22850.0,Alive,,11.0,,[Not Available],,,,,[Not Applicable],,,0.0,11.0,0.0,11.0,,,0.0,11.0,
TCGA-CH-5738,7879,TCGA-CH-5738,PRAD,72.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-26329.0,Alive,TUMOR FREE,212.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,212.0,0.0,212.0,0.0,212.0,0.0,212.0,
TCGA-DS-A7WF,1689,TCGA-DS-A7WF,CESC,41.0,FEMALE,[Unknown],[Not Available],Stage IB2,Adenosquamous,G3,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15319.0,Dead,WITH TUMOR,,492.0,Cervical Cancer,Distant Metastasis,Lung,,321.0,Partial Remission/Response,,,1.0,492.0,1.0,492.0,,,1.0,321.0,
TCGA-BR-8078,9340,TCGA-BR-8078,STAD,70.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-25861.0,Alive,TUMOR FREE,900.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,900.0,0.0,900.0,0.0,900.0,0.0,900.0,
TCGA-MA-AA3Z,1807,TCGA-MA-AA3Z,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15762.0,Alive,TUMOR FREE,595.0,,,,,,,Complete Remission/Response,,,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,
TCGA-BC-4073,5456,TCGA-BC-4073,LIHC,73.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2009.0,[Not Available],-26795.0,Alive,WITH TUMOR,849.0,,[Not Available],,,,,[Not Available],,R1,0.0,849.0,0.0,849.0,,,0.0,849.0,
TCGA-CV-5439,3476,TCGA-CV-5439,HNSC,62.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2002.0,[Not Available],-22686.0,Dead,WITH TUMOR,546.0,546.0,[Not Available],,Oropharynx,,211.0,[Not Available],,,1.0,546.0,1.0,546.0,,,1.0,211.0,
TCGA-QG-A5YV,2403,TCGA-QG-A5YV,COAD,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-23499.0,Alive,TUMOR FREE,1301.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0,
TCGA-CV-7422,3559,TCGA-CV-7422,HNSC,60.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,1997.0,[Not Available],-22098.0,Dead,WITH TUMOR,,1037.0,[Not Available],Locoregional Recurrence,Larynx,tracheal,733.0,Complete Remission/Response,,,1.0,1037.0,1.0,1037.0,,,1.0,733.0,
TCGA-HZ-7919,7590,TCGA-HZ-7919,PAAD,52.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-19064.0,Dead,WITH TUMOR,,593.0,Pancreatic Cancer,,,,,[Unknown],,,1.0,593.0,1.0,593.0,,,1.0,593.0,
TCGA-BJ-A3EZ,9879,TCGA-BJ-A3EZ,THCA,51.0,MALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18882.0,Alive,TUMOR FREE,487.0,,[Not Available],,,,,[Not Available],,R1,0.0,487.0,0.0,487.0,,,0.0,487.0,
TCGA-XF-A8HF,421,TCGA-XF-A8HF,BLCA,80.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,[Not Available],-29288.0,Dead,TUMOR FREE,,2954.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2954.0,0.0,2954.0,0.0,2954.0,0.0,2954.0,
TCGA-YL-A8SL,8331,TCGA-YL-A8SL,PRAD,74.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-27033.0,Alive,TUMOR FREE,987.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,
TCGA-AN-A0XP,835,TCGA-AN-A0XP,BRCA,69.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25305.0,Alive,TUMOR FREE,9.0,,[Not Available],,,,,[Not Available],Negative,,0.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,
TCGA-BH-A0E0,1076,TCGA-BH-A0E0,BRCA,38.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14175.0,Alive,TUMOR FREE,134.0,,[Not Available],,,,,[Not Available],Negative,,0.0,134.0,0.0,134.0,0.0,134.0,0.0,134.0,
TCGA-Z6-AAPN,2644,TCGA-Z6-AAPN,ESCA,57.0,MALE,WHITE,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G1,2013.0,[Not Available],-20926.0,Alive,TUMOR FREE,81.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,81.0,0.0,81.0,0.0,81.0,0.0,81.0,
TCGA-EJ-5495,7911,TCGA-EJ-5495,PRAD,68.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-24904.0,Alive,TUMOR FREE,1760.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1760.0,0.0,1760.0,0.0,1760.0,0.0,1760.0,
TCGA-D1-A16I,10844,TCGA-D1-A16I,UCEC,62.0,FEMALE,WHITE,[Not Applicable],Stage IC,Serous endometrial adenocarcinoma,High Grade,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22836.0,Dead,TUMOR FREE,,350.0,[Not Available],,,,,Complete Remission/Response,,,1.0,350.0,0.0,350.0,0.0,350.0,0.0,350.0,
TCGA-DJ-A13L,9918,TCGA-DJ-A13L,THCA,85.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-31388.0,Alive,TUMOR FREE,303.0,,[Not Available],,,,,[Not Available],,R0,0.0,303.0,0.0,303.0,0.0,303.0,0.0,303.0,
TCGA-DM-A28H,2348,TCGA-DM-A28H,COAD,50.0,MALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2002.0,[Not Available],-18325.0,Alive,,3561.0,,[Not Available],Locoregional Disease,,,484.0,[Not Available],,,0.0,3561.0,0.0,3561.0,,,1.0,484.0,
TCGA-YS-A95C,6907,TCGA-YS-A95C,MESO,54.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2013.0,[Not Available],-19818.0,Dead,TUMOR FREE,,133.0,[Not Available],,,,,[Not Available],,R0,1.0,133.0,0.0,133.0,0.0,133.0,0.0,133.0,
TCGA-06-5412,2866,TCGA-06-5412,GBM,78.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-28762.0,Dead,WITH TUMOR,138.0,138.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],88.0,[Not Available],,,1.0,138.0,1.0,138.0,,,1.0,88.0,
TCGA-A2-A0SY,575,TCGA-A2-A0SY,BRCA,62.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22928.0,Alive,TUMOR FREE,1347.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1347.0,0.0,1347.0,0.0,1347.0,0.0,1347.0,
TCGA-06-0173,2780,TCGA-06-0173,GBM,72.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-26549.0,Dead,WITH TUMOR,7.0,136.0,[Not Available],,,,,[Not Available],,,1.0,136.0,1.0,136.0,,,1.0,136.0,
TCGA-E1-A7YL,5081,TCGA-E1-A7YL,LGG,46.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-16982.0,Dead,WITH TUMOR,,492.0,[Not Available],,,,91.0,Progressive Disease,,,1.0,492.0,1.0,492.0,,,1.0,91.0,
TCGA-ET-A40Q,10250,TCGA-ET-A40Q,THCA,38.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-14136.0,Alive,TUMOR FREE,1407.0,,[Not Available],Distant Metastasis,Lung,,218.0,[Not Available],,R0,0.0,1407.0,0.0,1407.0,1.0,218.0,1.0,218.0,
TCGA-69-7980,6105,TCGA-69-7980,LUAD,70.0,FEMALE,WHITE,Stage I,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25583.0,Alive,TUMOR FREE,411.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,411.0,0.0,411.0,0.0,411.0,0.0,411.0,
TCGA-VD-A8KM,11131,TCGA-VD-A8KM,UVM,65.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Epithelioid Cell,[Not Available],2013.0,[Not Available],-24047.0,Alive,TUMOR FREE,4.0,,[Not Available],,,,,[Not Available],,,0.0,4.0,0.0,4.0,,,0.0,4.0,
TCGA-AK-3444,3949,TCGA-AK-3444,KIRC,80.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-29497.0,Alive,TUMOR FREE,1471.0,,[Not Available],,,,,[Not Available],,,0.0,1471.0,0.0,1471.0,,,0.0,1471.0,
TCGA-E8-A417,10029,TCGA-E8-A417,THCA,38.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-14019.0,Alive,TUMOR FREE,938.0,,[Not Available],,,,,[Not Available],,R0,0.0,938.0,0.0,938.0,0.0,938.0,0.0,938.0,
TCGA-D8-A27H,1286,TCGA-D8-A27H,BRCA,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26588.0,Alive,TUMOR FREE,397.0,,[Not Available],,,,,[Not Available],Negative,,0.0,397.0,0.0,397.0,0.0,397.0,0.0,397.0,
TCGA-AR-A5QQ,967,TCGA-AR-A5QQ,BRCA,68.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Other, specify",[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24841.0,Dead,WITH TUMOR,,322.0,[Not Available],Distant Metastasis,Lung,"Liver, bone, chest wall, adrenal glands",301.0,[Not Available],[Not Available],,1.0,322.0,1.0,322.0,,,1.0,301.0,
TCGA-5P-A9JY,4450,TCGA-5P-A9JY,KIRP,79.0,MALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-28881.0,Dead,TUMOR FREE,,1508.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1508.0,0.0,1508.0,0.0,1508.0,0.0,1508.0,
TCGA-A5-A1OJ,10513,TCGA-A5-A1OJ,UCEC,31.0,FEMALE,ASIAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11635.0,Alive,TUMOR FREE,1006.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1006.0,0.0,1006.0,0.0,1006.0,0.0,1006.0,
TCGA-64-5778,6082,TCGA-64-5778,LUAD,60.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-21927.0,Alive,WITH TUMOR,1305.0,,[Not Available],Distant Metastasis,,,962.0,Complete Remission/Response,,,0.0,1305.0,0.0,1305.0,1.0,962.0,1.0,962.0,
TCGA-WB-A80K,7830,TCGA-WB-A80K,PCPG,49.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-18033.0,Alive,TUMOR FREE,1255.0,,[Not Available],Distant Metastasis,Lymph Node(s),,772.0,Complete Remission/Response,,,0.0,1255.0,0.0,1255.0,1.0,772.0,1.0,772.0,
TCGA-KK-A6E4,8183,TCGA-KK-A6E4,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2004.0,[Not Available],-25338.0,Dead,TUMOR FREE,,3502.0,[Not Available],,,,,Complete Remission/Response,,,1.0,3502.0,0.0,3502.0,0.0,3502.0,0.0,3502.0,
TCGA-AO-A12F,880,TCGA-AO-A12F,BRCA,36.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13409.0,Alive,TUMOR FREE,1842.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1842.0,0.0,1842.0,0.0,1842.0,0.0,1842.0,
TCGA-55-8205,6025,TCGA-55-8205,LUAD,76.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-28063.0,Alive,WITH TUMOR,599.0,,[Not Available],Distant Metastasis,,,495.0,Progressive Disease,,,0.0,599.0,0.0,599.0,,,1.0,495.0,
TCGA-FI-A2CY,10983,TCGA-FI-A2CY,UCEC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Mixed serous and endometrioid,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22098.0,Alive,TUMOR FREE,2080.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2080.0,0.0,2080.0,0.0,2080.0,0.0,2080.0,
TCGA-ZF-A9R5,478,TCGA-ZF-A9R5,BLCA,59.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-21811.0,Alive,TUMOR FREE,1090.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1090.0,0.0,1090.0,0.0,1090.0,0.0,1090.0,
TCGA-CV-6941,3502,TCGA-CV-6941,HNSC,51.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,[Not Available],-18812.0,Dead,TUMOR FREE,,342.0,[Not Available],,,,,Complete Remission/Response,,,1.0,342.0,0.0,342.0,0.0,342.0,0.0,342.0,
TCGA-D7-6520,9491,TCGA-D7-6520,STAD,53.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2010.0,[Not Available],-19467.0,Alive,WITH TUMOR,573.0,,[Not Available],Distant Metastasis,Liver,,46.0,Progressive Disease,,,0.0,573.0,0.0,573.0,,,1.0,46.0,
TCGA-ER-A19N,9106,TCGA-ER-A19N,SKCM,47.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2008.0,[Not Available],-17443.0,Dead,TUMOR FREE,,1341.0,[Not Available],,,,0.0,[Not Available],,,1.0,1341.0,0.0,1341.0,,,1.0,0.0,
TCGA-IE-A3OV,8692,TCGA-IE-A3OV,SARC,42.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2004.0,[Not Available],-15607.0,Dead,WITH TUMOR,,2448.0,[Not Available],Distant Metastasis,Lung,,490.0,[Not Available],Negative,R0,1.0,2448.0,1.0,2448.0,1.0,490.0,1.0,490.0,
TCGA-52-7810,6504,TCGA-52-7810,LUSC,60.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-22241.0,Alive,TUMOR FREE,923.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,923.0,0.0,923.0,0.0,923.0,0.0,923.0,
TCGA-CD-8530,9428,TCGA-CD-8530,STAD,51.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-18992.0,Alive,TUMOR FREE,377.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,377.0,0.0,377.0,0.0,377.0,0.0,377.0,
TCGA-ET-A3BP,10232,TCGA-ET-A3BP,THCA,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-12594.0,Alive,TUMOR FREE,2406.0,,[Not Available],,,,,[Not Available],,R0,0.0,2406.0,0.0,2406.0,0.0,2406.0,0.0,2406.0,
TCGA-CH-5788,7904,TCGA-CH-5788,PRAD,69.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-25233.0,Alive,WITH TUMOR,821.0,,[Not Available],,,,,Progressive Disease,,,0.0,821.0,0.0,821.0,,,0.0,821.0,
TCGA-BH-A203,1158,TCGA-BH-A203,BRCA,78.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28609.0,Dead,WITH TUMOR,,1174.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1174.0,1.0,1174.0,,,1.0,1174.0,
TCGA-EM-A4FF,10190,TCGA-EM-A4FF,THCA,40.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-14796.0,Alive,TUMOR FREE,2573.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,1785.0,[Not Available],,R1,0.0,2573.0,0.0,2573.0,,,1.0,1785.0,
TCGA-4V-A9QU,10370,TCGA-4V-A9QU,THYM,76.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type AB,[Not Available],2013.0,[Not Available],-27896.0,Alive,TUMOR FREE,627.0,,[Not Available],,,,,[Not Available],,,0.0,627.0,0.0,627.0,,,0.0,627.0,
TCGA-KC-A4BR,8165,TCGA-KC-A4BR,PRAD,75.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-27741.0,Alive,WITH TUMOR,1349.0,,[Not Available],Biochemical evidence of disease,,,1022.0,Complete Remission/Response,,,0.0,1349.0,0.0,1349.0,1.0,1022.0,1.0,1022.0,
TCGA-MI-A75I,5753,TCGA-MI-A75I,LIHC,61.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G1,2011.0,[Not Available],-22341.0,Alive,,630.0,,[Not Available],,Liver,,265.0,[Not Available],,R0,0.0,630.0,0.0,630.0,1.0,265.0,1.0,265.0,
TCGA-WE-A8K4,9237,TCGA-WE-A8K4,SKCM,85.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2013.0,[Not Available],-31308.0,Alive,TUMOR FREE,614.0,,[Not Available],,,,,[Not Available],,,0.0,614.0,0.0,614.0,,,0.0,614.0,
TCGA-49-4512,5912,TCGA-49-4512,LUAD,69.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-25502.0,Dead,WITH TUMOR,157.0,905.0,[Not Available],,,,,Progressive Disease,,,1.0,905.0,1.0,905.0,,,1.0,905.0,
TCGA-FI-A2CX,10982,TCGA-FI-A2CX,UCEC,82.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30224.0,Alive,TUMOR FREE,2031.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2031.0,0.0,2031.0,0.0,2031.0,0.0,2031.0,
TCGA-KL-8324,3771,TCGA-KL-8324,KICH,67.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2000.0,[Not Available],-24650.0,Alive,TUMOR FREE,4676.0,,[Not Available],,,,,[Not Available],,,0.0,4676.0,0.0,4676.0,,,0.0,4676.0,
TCGA-T2-A6X0,3742,TCGA-T2-A6X0,HNSC,49.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-18114.0,Alive,TUMOR FREE,216.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,216.0,0.0,216.0,,,0.0,216.0,
TCGA-BP-4993,4225,TCGA-BP-4993,KIRC,58.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-21407.0,Alive,TUMOR FREE,177.0,,[Not Available],,,,,[Not Available],,,0.0,177.0,0.0,177.0,,,0.0,177.0,
TCGA-JY-A6FE,2498,TCGA-JY-A6FE,ESCA,49.0,MALE,WHITE,Stage III,[Not Available],Esophagus Squamous Cell Carcinoma,G3,2009.0,[Not Available],-18105.0,Dead,WITH TUMOR,,112.0,[Not Available],Distant Metastasis,"Other, specify",Pleural Mets,55.0,,,,1.0,112.0,1.0,112.0,,,1.0,55.0,
TCGA-CF-A1HS,151,TCGA-CF-A1HS,BLCA,75.0,FEMALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-27565.0,Alive,WITH TUMOR,382.0,,[Not Available],Distant Metastasis,"Other, specify",Pelvis,133.0,Complete Remission/Response,,,0.0,382.0,0.0,382.0,1.0,133.0,1.0,133.0,
TCGA-FG-A60K,5127,TCGA-FG-A60K,LGG,34.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-12445.0,Alive,WITH TUMOR,542.0,,[Not Available],,,,,Stable Disease,,,0.0,542.0,0.0,542.0,,,0.0,542.0,
TCGA-EW-A6SC,1496,TCGA-EW-A6SC,BRCA,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,[Not Available],-21918.0,Alive,TUMOR FREE,952.0,,[Not Available],,,,,[Not Available],Negative,,0.0,952.0,0.0,952.0,0.0,952.0,0.0,952.0,
TCGA-HE-A5NJ,4624,TCGA-HE-A5NJ,KIRP,58.0,MALE,[Not Evaluated],[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-21485.0,Alive,TUMOR FREE,1726.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1726.0,0.0,1726.0,0.0,1726.0,0.0,1726.0,
TCGA-V1-A8WN,8244,TCGA-V1-A8WN,PRAD,47.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-17520.0,Alive,,924.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,924.0,0.0,924.0,0.0,924.0,0.0,924.0,
TCGA-X7-A8M6,10401,TCGA-X7-A8M6,THYM,43.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2002.0,[Not Available],-15749.0,Alive,WITH TUMOR,4575.0,,[Not Available],Locoregional Recurrence,"Other, specify",mediastinum,1901.0,[Not Available],,,0.0,4575.0,0.0,4575.0,,,1.0,1901.0,
TCGA-KU-A6H8,3695,TCGA-KU-A6H8,HNSC,41.0,MALE,WHITE,Stage IVA,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-15066.0,Dead,WITH TUMOR,,327.0,[Not Available],Locoregional Recurrence,Oral Cavity,Right base of tongue and level 2 a cervical node,110.0,Progressive Disease,,,1.0,327.0,1.0,327.0,,,1.0,110.0,
TCGA-TM-A7CF,5373,TCGA-TM-A7CF,LGG,41.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2009.0,[Not Available],-15178.0,Alive,WITH TUMOR,1989.0,,[Not Available],,,,924.0,Complete Remission/Response,,,0.0,1989.0,0.0,1989.0,1.0,924.0,1.0,924.0,
TCGA-BR-8367,9358,TCGA-BR-8367,STAD,55.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-20441.0,Dead,WITH TUMOR,,801.0,[Not Available],Distant Metastasis,"Other, specify","Adrenal gland, bone",580.0,Complete Remission/Response,,,1.0,801.0,1.0,801.0,1.0,580.0,1.0,580.0,
TCGA-18-3409,6328,TCGA-18-3409,LUSC,74.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-27154.0,Alive,TUMOR FREE,3747.0,,[Not Available],New Primary Tumor,,,2291.0,Complete Remission/Response,,,0.0,3747.0,0.0,3747.0,0.0,3747.0,1.0,2291.0,
TCGA-VS-A9V2,1885,TCGA-VS-A9V2,CESC,29.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2013.0,Peri (6-12 months since last menstrual period),-10637.0,Alive,TUMOR FREE,555.0,,,,,,,Complete Remission/Response,,,0.0,555.0,0.0,555.0,0.0,555.0,0.0,555.0,
TCGA-50-6590,5951,TCGA-50-6590,LUAD,72.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-26444.0,Dead,TUMOR FREE,,1288.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,
TCGA-EE-A2GR,9042,TCGA-EE-A2GR,SKCM,78.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],2009.0,[Not Available],-28510.0,Dead,WITH TUMOR,,1301.0,[Not Available],,,,,[Not Available],,,1.0,1301.0,1.0,1301.0,,,1.0,1301.0,
TCGA-H6-A45N,7578,TCGA-H6-A45N,PAAD,88.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2012.0,[Not Available],-32475.0,Dead,WITH TUMOR,,421.0,Pancreatic Cancer,Locoregional Recurrence,Tumor Bed,,363.0,Progressive Disease,,,1.0,421.0,1.0,421.0,,,1.0,363.0,
TCGA-QR-A70O,7732,TCGA-QR-A70O,PCPG,35.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-13076.0,Alive,TUMOR FREE,111.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,111.0,0.0,111.0,0.0,111.0,0.0,111.0,
TCGA-EL-A3H8,10076,TCGA-EL-A3H8,THCA,35.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002.0,[Not Available],-12992.0,Alive,TUMOR FREE,4577.0,,[Not Available],,,,,[Not Available],,R0,0.0,4577.0,0.0,4577.0,0.0,4577.0,0.0,4577.0,
TCGA-ZS-A9CG,5802,TCGA-ZS-A9CG,LIHC,55.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-20100.0,Alive,TUMOR FREE,341.0,,[Not Available],,,,,[Not Available],,R0,0.0,341.0,0.0,341.0,0.0,341.0,0.0,341.0,
TCGA-CR-7373,3446,TCGA-CR-7373,HNSC,66.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-24448.0,Alive,TUMOR FREE,889.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,889.0,0.0,889.0,,,0.0,889.0,
TCGA-OR-A5L2,57,TCGA-OR-A5L2,ACC,83.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2001.0,[Not Available],-30535.0,Dead,TUMOR FREE,,1852.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1852.0,0.0,1852.0,0.0,1852.0,0.0,1852.0,
TCGA-MH-A855,4650,TCGA-MH-A855,KIRP,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-19029.0,Alive,TUMOR FREE,369.0,,[Not Available],,,,0.0,Complete Remission/Response,,,0.0,369.0,0.0,369.0,1.0,0.0,1.0,0.0,
TCGA-42-2589,7413,TCGA-42-2589,OV,54.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-19852.0,Alive,WITH TUMOR,1278.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],364.0,Complete Remission/Response,,,0.0,1278.0,0.0,1278.0,1.0,364.0,1.0,364.0,
TCGA-EJ-A7NH,7995,TCGA-EJ-A7NH,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-20734.0,Alive,TUMOR FREE,474.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,
TCGA-EE-A3JB,9082,TCGA-EE-A3JB,SKCM,60.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],1992.0,[Not Available],-22150.0,Alive,WITH TUMOR,6138.0,,[Not Available],Locoregional Recurrence,,,1434.0,[Not Available],,,0.0,6138.0,0.0,6138.0,,,1.0,1434.0,
TCGA-KV-A6GD,4641,TCGA-KV-A6GD,KIRP,85.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-31217.0,Alive,TUMOR FREE,560.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,560.0,0.0,560.0,0.0,560.0,0.0,560.0,
TCGA-CN-6024,3348,TCGA-CN-6024,HNSC,66.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-24259.0,Dead,WITH TUMOR,,337.0,[Not Available],,Cervical Lymph Nodes,,156.0,Progressive Disease,,,1.0,337.0,1.0,337.0,,,1.0,156.0,
TCGA-A2-A3XV,616,TCGA-A2-A3XV,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16971.0,Alive,TUMOR FREE,996.0,,[Not Available],,,,,[Not Available],Negative,,0.0,996.0,0.0,996.0,0.0,996.0,0.0,996.0,
TCGA-AX-A2HG,10654,TCGA-AX-A2HG,UCEC,56.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20771.0,Alive,TUMOR FREE,1163.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1163.0,0.0,1163.0,0.0,1163.0,0.0,1163.0,
TCGA-BR-A4CQ,9393,TCGA-BR-A4CQ,STAD,58.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-21207.0,Alive,WITH TUMOR,1064.0,,[Not Available],Distant Metastasis,,,962.0,Complete Remission/Response,,,0.0,1064.0,0.0,1064.0,1.0,962.0,1.0,962.0,
TCGA-OL-A5S0,1562,TCGA-OL-A5S0,BRCA,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24139.0,Alive,TUMOR FREE,620.0,,[Not Available],,,,,[Not Available],Negative,,0.0,620.0,0.0,620.0,0.0,620.0,0.0,620.0,
TCGA-AA-3489,2013,TCGA-AA-3489,COAD,75.0,MALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2002.0,[Not Available],-27606.0,Dead,WITH TUMOR,,214.0,[Not Available],,,,,[Unknown],,,1.0,214.0,1.0,214.0,,,1.0,214.0,
TCGA-E1-A7Z3,5092,TCGA-E1-A7Z3,LGG,31.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Astrocytoma,G2,1992.0,[Not Available],-11330.0,Dead,WITH TUMOR,,2235.0,[Not Available],,,,1569.0,Progressive Disease,,,1.0,2235.0,1.0,2235.0,,,1.0,1569.0,
TCGA-IB-A5ST,7641,TCGA-IB-A5ST,PAAD,64.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-23672.0,Alive,TUMOR FREE,635.0,,,,,,,Complete Remission/Response,,,0.0,635.0,0.0,635.0,0.0,635.0,0.0,635.0,
TCGA-BR-6803,9319,TCGA-BR-6803,STAD,54.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-19751.0,Alive,TUMOR FREE,949.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,949.0,0.0,949.0,0.0,949.0,0.0,949.0,
TCGA-DD-AACD,5583,TCGA-DD-AACD,LIHC,48.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2008.0,[Not Available],-17828.0,Dead,WITH TUMOR,,381.0,[Not Available],Locoregional Recurrence,Lung,,151.0,[Not Available],,R0,1.0,381.0,1.0,381.0,1.0,151.0,1.0,151.0,
TCGA-DX-A8BH,8635,TCGA-DX-A8BH,SARC,86.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013.0,[Not Available],-31770.0,Dead,WITH TUMOR,,439.0,[Not Available],Distant Metastasis,"Other, specify",Pleura,272.0,[Not Available],Positive,R0,1.0,439.0,1.0,439.0,1.0,272.0,1.0,272.0,
TCGA-FF-A7CQ,2429,TCGA-FF-A7CQ,DLBC,74.0,MALE,ASIAN,[Not Applicable],Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010.0,[Not Available],-27255.0,Alive,,298.0,,[Not Available],,Brain,,255.0,Stable Disease,,,0.0,298.0,0.0,298.0,,,1.0,255.0,
TCGA-27-2524,3130,TCGA-27-2524,GBM,56.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-20555.0,Dead,WITH TUMOR,231.0,231.0,[Not Available],,,,,[Not Available],,,1.0,231.0,1.0,231.0,,,1.0,231.0,
TCGA-BF-A1PV,8802,TCGA-BF-A1PV,SKCM,74.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2010.0,[Not Available],-27124.0,Alive,TUMOR FREE,14.0,,[Not Available],,,,,[Not Available],,,0.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-DK-A3IS,201,TCGA-DK-A3IS,BLCA,68.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-25098.0,Alive,TUMOR FREE,1529.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1529.0,0.0,1529.0,0.0,1529.0,0.0,1529.0,
TCGA-E2-A1IU,1369,TCGA-E2-A1IU,BRCA,60.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22279.0,Alive,TUMOR FREE,337.0,,[Not Available],,,,,[Not Available],Negative,,0.0,337.0,0.0,337.0,0.0,337.0,0.0,337.0,
TCGA-P3-A6T6,3718,TCGA-P3-A6T6,HNSC,53.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2009.0,[Not Available],-19694.0,Dead,WITH TUMOR,,395.0,[Not Available],Distant Metastasis,Distant Metastasis,lung,273.0,Complete Remission/Response,,,1.0,395.0,1.0,395.0,,,1.0,273.0,
TCGA-A7-A2KD,649,TCGA-A7-A2KD,BRCA,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19563.0,Alive,TUMOR FREE,679.0,,[Not Available],,,,,[Not Available],Negative,,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,
TCGA-14-0817,3007,TCGA-14-0817,GBM,69.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-25425.0,Dead,,164.0,164.0,[Not Available],,,,,[Not Available],,,1.0,164.0,,164.0,,,0.0,164.0,
TCGA-CD-A4MH,9441,TCGA-CD-A4MH,STAD,86.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-31683.0,Alive,TUMOR FREE,371.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,371.0,0.0,371.0,0.0,371.0,0.0,371.0,
TCGA-CV-7433,3568,TCGA-CV-7433,HNSC,49.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,1999.0,[Not Available],-18004.0,Dead,WITH TUMOR,,601.0,[Not Available],Distant Metastasis,Distant Metastasis,Lt. Deltoid,445.0,Progressive Disease,,,1.0,601.0,1.0,601.0,,,1.0,445.0,
TCGA-DK-A3IQ,200,TCGA-DK-A3IQ,BLCA,74.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-27194.0,Dead,WITH TUMOR,,539.0,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,250.0,Complete Remission/Response,,,1.0,539.0,1.0,539.0,1.0,250.0,1.0,250.0,
TCGA-KO-8407,3841,TCGA-KO-8407,KICH,42.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-15407.0,Alive,TUMOR FREE,2820.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2820.0,0.0,2820.0,0.0,2820.0,0.0,2820.0,
TCGA-IB-7897,7634,TCGA-IB-7897,PAAD,53.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,[Not Available],-19718.0,Dead,WITH TUMOR,,486.0,Pancreatic Cancer,Locoregional Recurrence|Distant Metastasis,Liver,,397.0,Progressive Disease,,,1.0,486.0,1.0,486.0,,,1.0,397.0,
TCGA-AZ-4323,2216,TCGA-AZ-4323,COAD,37.0,MALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2002.0,[Not Available],-13755.0,Dead,WITH TUMOR,,43.0,[Not Available],,,,,[Not Available],,,1.0,43.0,1.0,43.0,,,1.0,43.0,
TCGA-50-5935,5944,TCGA-50-5935,LUAD,86.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-31610.0,Dead,TUMOR FREE,653.0,653.0,[Not Available],,,,,Complete Remission/Response,,,1.0,653.0,0.0,653.0,0.0,653.0,0.0,653.0,
TCGA-BR-8486,9372,TCGA-BR-8486,STAD,90.0,FEMALE,WHITE,Stage IA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-32872.0,Alive,TUMOR FREE,615.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,615.0,0.0,615.0,0.0,615.0,0.0,615.0,
TCGA-CA-5796,2237,TCGA-CA-5796,COAD,52.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-19353.0,Alive,TUMOR FREE,377.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,377.0,0.0,377.0,0.0,377.0,0.0,377.0,
TCGA-HT-8110,5215,TCGA-HT-8110,LGG,57.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2011.0,[Not Available],-21183.0,Alive,TUMOR FREE,419.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,419.0,0.0,419.0,0.0,419.0,0.0,419.0,
TCGA-G7-A8LB,4604,TCGA-G7-A8LB,KIRP,70.0,MALE,WHITE,Stage IV,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-25782.0,Alive,WITH TUMOR,547.0,,[Not Available],,,,,Stable Disease,,,0.0,547.0,0.0,547.0,,,0.0,547.0,
TCGA-BH-A18U,1128,TCGA-BH-A18U,BRCA,72.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26426.0,Dead,TUMOR FREE,,1563.0,[Not Available],,,,,[Not Available],Negative,,1.0,1563.0,0.0,1563.0,0.0,1563.0,0.0,1563.0,
TCGA-UY-A8OD,410,TCGA-UY-A8OD,BLCA,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-24588.0,Alive,TUMOR FREE,3432.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3432.0,0.0,3432.0,0.0,3432.0,0.0,3432.0,
TCGA-34-8456,6437,TCGA-34-8456,LUSC,71.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26183.0,Alive,TUMOR FREE,804.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,804.0,0.0,804.0,0.0,804.0,0.0,804.0,
TCGA-HW-8320,5252,TCGA-HW-8320,LGG,36.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2011.0,[Not Available],-13503.0,Alive,WITH TUMOR,1217.0,,[Not Available],,,,,Stable Disease,,,0.0,1217.0,0.0,1217.0,,,0.0,1217.0,
TCGA-AK-3430,3942,TCGA-AK-3430,KIRC,61.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-22612.0,Dead,,,480.0,[Not Available],,,,,[Not Available],,,1.0,480.0,,480.0,,,0.0,480.0,
TCGA-KM-8442,3798,TCGA-KM-8442,KICH,38.0,MALE,[Unknown],Stage II,[Not Available],Kidney Chromophobe,[Not Available],2009.0,[Not Available],-14212.0,Alive,TUMOR FREE,1437.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1437.0,0.0,1437.0,,,0.0,1437.0,
TCGA-86-8672,6204,TCGA-86-8672,LUAD,59.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-21682.0,Dead,TUMOR FREE,,19.0,[Not Available],,,,,Complete Remission/Response,,,1.0,19.0,0.0,19.0,0.0,19.0,0.0,19.0,
TCGA-C5-A1BI,1610,TCGA-C5-A1BI,CESC,31.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2001.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11564.0,Alive,TUMOR FREE,1112.0,,,,,,,Complete Remission/Response,,,0.0,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0,
TCGA-B6-A0IH,979,TCGA-B6-A0IH,BRCA,81.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29907.0,Dead,,,3418.0,[Not Available],,,,,[Not Available],Negative,,1.0,3418.0,,3418.0,0.0,3418.0,0.0,3418.0,
TCGA-K4-A3WS,372,TCGA-K4-A3WS,BLCA,66.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-24124.0,Alive,TUMOR FREE,761.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,761.0,0.0,761.0,0.0,761.0,0.0,761.0,
TCGA-4A-A93Y,4446,TCGA-4A-A93Y,KIRP,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-23226.0,Alive,TUMOR FREE,352.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,
TCGA-CG-5720,9473,TCGA-CG-5720,STAD,71.0,MALE,[Not Available],Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003.0,[Not Available],-26176.0,Dead,TUMOR FREE,,30.0,[Not Available],,,,,[Not Available],,,1.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-DX-AB2G,8654,TCGA-DX-AB2G,SARC,36.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2013.0,[Not Available],-13239.0,Alive,TUMOR FREE,478.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,478.0,0.0,478.0,0.0,478.0,0.0,478.0,
TCGA-FG-6690,5104,TCGA-FG-6690,LGG,70.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-25667.0,Alive,WITH TUMOR,1294.0,,[Not Available],,,,,Stable Disease,,,0.0,1294.0,0.0,1294.0,,,0.0,1294.0,
TCGA-E2-A1B1,1353,TCGA-E2-A1B1,BRCA,45.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16603.0,Alive,TUMOR FREE,2653.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2653.0,0.0,2653.0,0.0,2653.0,0.0,2653.0,
TCGA-56-8622,6532,TCGA-56-8622,LUSC,68.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24861.0,Alive,TUMOR FREE,55.0,,[Not Available],,,,,[Not Applicable],,,0.0,55.0,0.0,55.0,,,0.0,55.0,
TCGA-FI-A2D5,10987,TCGA-FI-A2D5,UCEC,56.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20666.0,Dead,WITH TUMOR,,421.0,[Not Available],Metastatic,"Other, specify",vaginal cuff,280.0,Partial Remission/Response,,,1.0,421.0,1.0,421.0,,,1.0,280.0,
TCGA-SB-A6J6,9784,TCGA-SB-A6J6,TGCT,22.0,MALE,WHITE,Stage IA,[Not Available],Seminoma; NOS,[Not Available],2013.0,[Not Available],-8233.0,Alive,TUMOR FREE,413.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,413.0,0.0,413.0,0.0,413.0,0.0,413.0,
TCGA-X9-A971,8792,TCGA-X9-A971,SARC,52.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2013.0,[Not Available],-19207.0,Alive,WITH TUMOR,831.0,,[Not Available],Distant Metastasis,Lung,,224.0,[Not Available],Negative,R0,0.0,831.0,0.0,831.0,1.0,224.0,1.0,224.0,
TCGA-K4-A4AC,376,TCGA-K4-A4AC,BLCA,83.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-30655.0,Dead,WITH TUMOR,,278.0,[Not Available],Distant Metastasis,"Other, specify",psoas,170.0,Partial Remission/Response,,,1.0,278.0,1.0,278.0,,,1.0,170.0,
TCGA-KL-8343,3790,TCGA-KL-8343,KICH,72.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-26562.0,Dead,WITH TUMOR,,2172.0,[Not Available],,,,,[Unknown],,,1.0,2172.0,1.0,2172.0,,,1.0,2172.0,
TCGA-E9-A247,1437,TCGA-E9-A247,BRCA,59.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21562.0,Alive,TUMOR FREE,1186.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1186.0,0.0,1186.0,0.0,1186.0,0.0,1186.0,
TCGA-DI-A2QT,10907,TCGA-DI-A2QT,UCEC,51.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18835.0,Dead,WITH TUMOR,,377.0,[Not Available],,,,,[Not Available],,,1.0,377.0,1.0,377.0,,,1.0,377.0,
TCGA-D1-A16G,10843,TCGA-D1-A16G,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous endometrial adenocarcinoma,High Grade,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27065.0,Dead,WITH TUMOR,,834.0,[Not Available],Locoregional Disease,"Other, specify",Lymph nodes,642.0,Complete Remission/Response,,,1.0,834.0,1.0,834.0,,,1.0,642.0,
TCGA-G2-A2EC,312,TCGA-G2-A2EC,BLCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-21215.0,Dead,WITH TUMOR,,696.0,[Not Available],Distant Metastasis,"Other, specify",small bowel,679.0,Partial Remission/Response,,,1.0,696.0,1.0,696.0,,,1.0,679.0,
TCGA-2G-AAG3,9730,TCGA-2G-AAG3,TGCT,53.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Seminoma; NOS|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2009.0,[Not Available],-19583.0,Alive,TUMOR FREE,1593.0,,[Not Applicable],New Primary Tumor,Lung,,181.0,Complete Remission/Response,,,0.0,1593.0,0.0,1593.0,0.0,1593.0,1.0,181.0,
TCGA-AR-A0TV,904,TCGA-AR-A0TV,BRCA,66.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24279.0,Alive,TUMOR FREE,2288.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2288.0,0.0,2288.0,0.0,2288.0,0.0,2288.0,
TCGA-93-7348,6229,TCGA-93-7348,LUAD,75.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27456.0,Alive,TUMOR FREE,531.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,531.0,0.0,531.0,0.0,531.0,0.0,531.0,
TCGA-AR-A252,950,TCGA-AR-A252,BRCA,50.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18611.0,Alive,TUMOR FREE,2838.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2838.0,0.0,2838.0,0.0,2838.0,0.0,2838.0,
TCGA-5N-A9KM,116,TCGA-5N-A9KM,BLCA,73.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-26906.0,Dead,WITH TUMOR,,530.0,[Not Available],,,,276.0,Complete Remission/Response,,,1.0,530.0,1.0,530.0,1.0,276.0,1.0,276.0,
TCGA-BA-A6DB,3270,TCGA-BA-A6DB,HNSC,24.0,FEMALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-8967.0,Alive,WITH TUMOR,216.0,,[Not Available],Locoregional Disease,Cervical Lymph Nodes,,208.0,Complete Remission/Response,,,0.0,216.0,0.0,216.0,1.0,208.0,1.0,208.0,
TCGA-BQ-7046,4557,TCGA-BQ-7046,KIRP,61.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2002.0,[Not Available],-22337.0,Alive,TUMOR FREE,2948.0,,[Not Available],,,,,[Not Available],,,0.0,2948.0,0.0,2948.0,,,0.0,2948.0,
TCGA-IE-A4EI,8694,TCGA-IE-A4EI,SARC,67.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-24663.0,Alive,TUMOR FREE,594.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,
TCGA-B0-5099,4029,TCGA-B0-5099,KIRC,88.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2002.0,[Not Available],-32364.0,Dead,[Discrepancy],,485.0,[Not Available],,,,,[Not Available],,,1.0,485.0,,485.0,,,0.0,485.0,
TCGA-CQ-6221,3390,TCGA-CQ-6221,HNSC,79.0,MALE,WHITE,[Not Available],Stage II,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-29026.0,Alive,TUMOR FREE,1000.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0,
TCGA-LN-A49K,2558,TCGA-LN-A49K,ESCA,66.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2010.0,[Not Available],-24379.0,Dead,TUMOR FREE,,180.0,[Not Available],,,,,Complete Remission/Response,,,1.0,180.0,0.0,180.0,0.0,180.0,0.0,180.0,
TCGA-NF-A4WU,11073,TCGA-NF-A4WU,UCS,59.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21901.0,Alive,TUMOR FREE,298.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,298.0,0.0,298.0,0.0,298.0,0.0,298.0,
TCGA-ZF-A9R9,480,TCGA-ZF-A9R9,BLCA,58.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-21491.0,Dead,WITH TUMOR,,864.0,[Not Available],Distant Metastasis,"Other, specify",penis,629.0,Complete Remission/Response,,,1.0,864.0,1.0,864.0,,,1.0,629.0,
TCGA-78-7155,6151,TCGA-78-7155,LUAD,68.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-24863.0,Dead,,,1171.0,[Not Available],,,,209.0,[Not Available],,,1.0,1171.0,,1171.0,,,1.0,209.0,
TCGA-BR-A4PD,9408,TCGA-BR-A4PD,STAD,72.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-26334.0,Alive,TUMOR FREE,628.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,628.0,0.0,628.0,0.0,628.0,0.0,628.0,
TCGA-EL-A3ZO,10099,TCGA-EL-A3ZO,THCA,79.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-28924.0,Alive,TUMOR FREE,2211.0,,[Not Available],,,,,[Not Available],,R0,0.0,2211.0,0.0,2211.0,0.0,2211.0,0.0,2211.0,
TCGA-DK-AA76,230,TCGA-DK-AA76,BLCA,64.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-23542.0,Alive,WITH TUMOR,366.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,
TCGA-B0-5085,4021,TCGA-B0-5085,KIRC,76.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-27793.0,Dead,TUMOR FREE,,770.0,[Not Available],,,,,[Not Available],,,1.0,770.0,0.0,770.0,,,0.0,770.0,
TCGA-CF-A1HR,150,TCGA-CF-A1HR,BLCA,62.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-22777.0,Alive,WITH TUMOR,389.0,,[Not Available],Distant Metastasis,Liver,,294.0,Complete Remission/Response,,,0.0,389.0,0.0,389.0,1.0,294.0,1.0,294.0,
TCGA-3A-A9IV,7539,TCGA-3A-A9IV,PAAD,59.0,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2011.0,[Not Available],-21732.0,Alive,TUMOR FREE,1103.0,,,,,,,Complete Remission/Response,,,0.0,1103.0,0.0,1103.0,0.0,1103.0,0.0,1103.0,
TCGA-CN-6022,3346,TCGA-CN-6022,HNSC,49.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-17971.0,Dead,WITH TUMOR,,281.0,[Not Available],,Cervical Lymph Nodes,,101.0,Progressive Disease,,,1.0,281.0,1.0,281.0,,,1.0,101.0,
TCGA-CZ-5989,4393,TCGA-CZ-5989,KIRC,60.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-22170.0,Alive,TUMOR FREE,1905.0,,[Not Available],,,,,[Not Available],,,0.0,1905.0,0.0,1905.0,,,0.0,1905.0,
TCGA-B5-A11X,10711,TCGA-B5-A11X,UCEC,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24217.0,Alive,TUMOR FREE,596.0,,[Not Available],Metastatic,"Other, specify",lymph nodes,397.0,[Not Available],,,0.0,596.0,0.0,596.0,,,1.0,397.0,
TCGA-AJ-A3EM,10542,TCGA-AJ-A3EM,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25557.0,Alive,TUMOR FREE,677.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,677.0,0.0,677.0,0.0,677.0,0.0,677.0,
TCGA-56-7731,6519,TCGA-56-7731,LUSC,66.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-24441.0,Dead,TUMOR FREE,,3.0,[Not Available],,,,,[Not Applicable],,,1.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-86-8585,6200,TCGA-86-8585,LUAD,57.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-20918.0,Alive,TUMOR FREE,353.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,353.0,0.0,353.0,0.0,353.0,0.0,353.0,
TCGA-EJ-A46G,7981,TCGA-EJ-A46G,PRAD,71.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012.0,[Not Available],-26219.0,Alive,TUMOR FREE,668.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,668.0,0.0,668.0,0.0,668.0,0.0,668.0,
TCGA-KR-A7K8,5745,TCGA-KR-A7K8,LIHC,57.0,MALE,[Unknown],Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-20914.0,Alive,TUMOR FREE,906.0,,[Not Available],,,,,[Not Available],,R0,0.0,906.0,0.0,906.0,0.0,906.0,0.0,906.0,
TCGA-KM-8440,3796,TCGA-KM-8440,KICH,37.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2009.0,[Not Available],-13860.0,Alive,TUMOR FREE,1366.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1366.0,0.0,1366.0,0.0,1366.0,0.0,1366.0,
TCGA-DK-AA6Q,220,TCGA-DK-AA6Q,BLCA,61.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-22314.0,Dead,WITH TUMOR,,413.0,[Not Available],Distant Metastasis,Liver,,285.0,Progressive Disease,,,1.0,413.0,1.0,413.0,,,1.0,285.0,
TCGA-ZM-AA05,9837,TCGA-ZM-AA05,TGCT,36.0,MALE,WHITE,Stage IIC,Stage IIC,Seminoma; NOS,[Not Available],2011.0,[Not Available],-13295.0,Alive,TUMOR FREE,1126.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,1126.0,0.0,1126.0,0.0,1126.0,0.0,1126.0,
TCGA-FI-A2F9,10995,TCGA-FI-A2F9,UCEC,79.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28886.0,Alive,TUMOR FREE,1803.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1803.0,0.0,1803.0,0.0,1803.0,0.0,1803.0,
TCGA-ZF-AA51,496,TCGA-ZF-AA51,BLCA,69.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-25484.0,Alive,TUMOR FREE,1714.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1714.0,0.0,1714.0,0.0,1714.0,0.0,1714.0,
TCGA-5C-A9VH,5450,TCGA-5C-A9VH,LIHC,70.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-25608.0,Alive,TUMOR FREE,322.0,,[Not Available],,,,,[Not Available],,R0,0.0,322.0,0.0,322.0,0.0,322.0,0.0,322.0,
TCGA-W2-A7HC,7824,TCGA-W2-A7HC,PCPG,67.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-24834.0,Alive,TUMOR FREE,439.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,439.0,0.0,439.0,0.0,439.0,0.0,439.0,
TCGA-X7-A8M5,10400,TCGA-X7-A8M5,THYM,65.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type B3,[Not Available],2001.0,[Not Available],-24036.0,Alive,TUMOR FREE,1645.0,,[Not Available],,,,,[Not Available],,,0.0,1645.0,0.0,1645.0,,,0.0,1645.0,
TCGA-EB-A551,8969,TCGA-EB-A551,SKCM,78.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-28671.0,Alive,TUMOR FREE,590.0,,[Not Available],,,,,[Not Available],,,0.0,590.0,0.0,590.0,,,0.0,590.0,
TCGA-OR-A5LD,67,TCGA-OR-A5LD,ACC,52.0,MALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],1998.0,[Not Available],-19111.0,Dead,WITH TUMOR,,1197.0,[Not Available],Distant Metastasis,Lung,,444.0,[Unknown],,,1.0,1197.0,1.0,1197.0,,,1.0,444.0,
TCGA-ZG-A9LB,8355,TCGA-ZG-A9LB,PRAD,72.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-26447.0,Alive,WITH TUMOR,583.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,583.0,0.0,583.0,,,0.0,583.0,
TCGA-EM-A4FO,10195,TCGA-EM-A4FO,THCA,72.0,MALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-26589.0,Alive,TUMOR FREE,802.0,,[Not Available],,,,,[Not Available],,R0,0.0,802.0,0.0,802.0,0.0,802.0,0.0,802.0,
TCGA-DD-AAEH,5648,TCGA-DD-AAEH,LIHC,73.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-26894.0,Alive,TUMOR FREE,784.0,,[Not Available],Extrahepatic Recurrence,Bone,,644.0,[Not Available],,R0,0.0,784.0,0.0,784.0,1.0,644.0,1.0,644.0,
TCGA-DB-A75K,4960,TCGA-DB-A75K,LGG,55.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-20241.0,Alive,TUMOR FREE,368.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,368.0,0.0,368.0,0.0,368.0,0.0,368.0,
TCGA-ND-A4WF,11072,TCGA-ND-A4WF,UCS,77.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28398.0,Dead,WITH TUMOR,,167.0,[Not Available],,,,,Progressive Disease,,,1.0,167.0,1.0,167.0,,,1.0,167.0,
TCGA-CV-7091,3520,TCGA-CV-7091,HNSC,54.0,MALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2001.0,[Not Available],-19938.0,Alive,TUMOR FREE,3381.0,,[Not Available],,,,,[Not Available],,,0.0,3381.0,0.0,3381.0,,,0.0,3381.0,
TCGA-97-7937,6252,TCGA-97-7937,LUAD,65.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23919.0,Alive,TUMOR FREE,564.0,,[Not Available],,,,,Stable Disease,,,0.0,564.0,0.0,564.0,,,0.0,564.0,
TCGA-37-3789,6440,TCGA-37-3789,LUSC,65.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-23782.0,Alive,TUMOR FREE,13.0,,[Not Available],,,,,[Not Available],,,0.0,13.0,0.0,13.0,,,0.0,13.0,
TCGA-DJ-A3UO,9969,TCGA-DJ-A3UO,THCA,63.0,MALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-23292.0,Alive,TUMOR FREE,957.0,,[Not Available],New Primary Tumor,"Other, specify",Prostate,641.0,[Not Available],,R0,0.0,957.0,0.0,957.0,,,1.0,641.0,
TCGA-IQ-A6SH,3691,TCGA-IQ-A6SH,HNSC,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage IVC,Head & Neck Squamous Cell Carcinoma,G1,2013.0,[Not Available],-20109.0,Alive,TUMOR FREE,471.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,471.0,0.0,471.0,,,0.0,471.0,
TCGA-XR-A8TC,5786,TCGA-XR-A8TC,LIHC,43.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-15817.0,Alive,WITH TUMOR,1339.0,,[Not Available],,,,,[Not Available],,R0,0.0,1339.0,0.0,1339.0,0.0,1339.0,0.0,1339.0,
TCGA-DD-AAVW,5657,TCGA-DD-AAVW,LIHC,35.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-12986.0,Alive,TUMOR FREE,2317.0,,[Not Available],,,,,[Not Available],,R0,0.0,2317.0,0.0,2317.0,0.0,2317.0,0.0,2317.0,
TCGA-AJ-A5DV,10556,TCGA-AJ-A5DV,UCEC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23892.0,Alive,TUMOR FREE,679.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,
TCGA-CN-6016,3340,TCGA-CN-6016,HNSC,64.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-23664.0,Alive,TUMOR FREE,1443.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1443.0,0.0,1443.0,,,0.0,1443.0,
TCGA-58-8386,6548,TCGA-58-8386,LUSC,75.0,MALE,[Not Evaluated],Stage IV,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-27455.0,Dead,TUMOR FREE,,1.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1.0,0.0,1.0,,,0.0,1.0,
TCGA-AD-6895,2191,TCGA-AD-6895,COAD,84.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-30879.0,Alive,TUMOR FREE,763.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,763.0,0.0,763.0,0.0,763.0,0.0,763.0,
TCGA-QT-A5XJ,7743,TCGA-QT-A5XJ,PCPG,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-15535.0,Alive,WITH TUMOR,1102.0,,[Not Available],Distant Metastasis,"Other, specify",Bilateral Breasts SubQ Tissue,77.0,Progressive Disease,,,0.0,1102.0,0.0,1102.0,,,1.0,77.0,
TCGA-D7-A4YY,9516,TCGA-D7-A4YY,STAD,61.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-22287.0,Alive,TUMOR FREE,419.0,,[Not Available],,,,,Stable Disease,,,0.0,419.0,0.0,419.0,,,0.0,419.0,
TCGA-EJ-5508,7923,TCGA-EJ-5508,PRAD,65.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-23758.0,Alive,TUMOR FREE,1965.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1965.0,0.0,1965.0,0.0,1965.0,0.0,1965.0,
TCGA-A6-5664,1988,TCGA-A6-5664,COAD,80.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-29426.0,Alive,WITH TUMOR,672.0,,[Not Available],,,,183.0,[Not Available],,,0.0,672.0,0.0,672.0,,,1.0,183.0,
TCGA-97-8547,6262,TCGA-97-8547,LUAD,78.0,FEMALE,[Not Evaluated],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-28801.0,Alive,TUMOR FREE,657.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,657.0,0.0,657.0,0.0,657.0,0.0,657.0,
TCGA-49-AAR3,5923,TCGA-49-AAR3,LUAD,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-25469.0,Alive,[Discrepancy],1893.0,,[Not Available],Locoregional Recurrence,,,1893.0,Complete Remission/Response,,,0.0,1893.0,0.0,1893.0,1.0,1893.0,1.0,1893.0,
TCGA-26-5139,3113,TCGA-26-5139,GBM,65.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-23782.0,Alive,WITH TUMOR,48.0,,[Not Available],,,,,[Not Available],,,0.0,48.0,0.0,48.0,,,0.0,48.0,
TCGA-86-8358,6198,TCGA-86-8358,LUAD,44.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-16409.0,Alive,TUMOR FREE,653.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,653.0,0.0,653.0,0.0,653.0,0.0,653.0,
TCGA-F4-6569,2355,TCGA-F4-6569,COAD,60.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-22203.0,Alive,TUMOR FREE,1087.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1087.0,0.0,1087.0,0.0,1087.0,0.0,1087.0,
TCGA-S9-A89Z,5368,TCGA-S9-A89Z,LGG,40.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-14858.0,Alive,WITH TUMOR,623.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,623.0,0.0,623.0,,,0.0,623.0,
TCGA-66-2792,6643,TCGA-66-2792,LUSC,58.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-21428.0,Alive,TUMOR FREE,913.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,913.0,0.0,913.0,0.0,913.0,0.0,913.0,
TCGA-DD-A4NV,5569,TCGA-DD-A4NV,LIHC,61.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2007.0,[Not Available],-22438.0,Alive,TUMOR FREE,2398.0,,[Not Available],,,,,[Not Available],,R0,0.0,2398.0,0.0,2398.0,0.0,2398.0,0.0,2398.0,
TCGA-MU-A8JM,1813,TCGA-MU-A8JM,CESC,46.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2013.0,[Unknown],-17156.0,Alive,TUMOR FREE,607.0,,,,,,,Complete Remission/Response,,,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,
TCGA-BR-A4IY,9398,TCGA-BR-A4IY,STAD,58.0,MALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-21314.0,Alive,TUMOR FREE,392.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,392.0,0.0,392.0,0.0,392.0,0.0,392.0,
TCGA-DD-A1ED,5528,TCGA-DD-A1ED,LIHC,68.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2006.0,[Not Available],-25039.0,Alive,TUMOR FREE,2301.0,,[Not Available],,,,,[Not Available],,R0,0.0,2301.0,0.0,2301.0,0.0,2301.0,0.0,2301.0,
TCGA-EJ-7785,7963,TCGA-EJ-7785,PRAD,54.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19939.0,Alive,TUMOR FREE,1177.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1177.0,0.0,1177.0,0.0,1177.0,0.0,1177.0,
TCGA-BF-AAP1,8819,TCGA-BF-AAP1,SKCM,86.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-31666.0,Alive,TUMOR FREE,409.0,,[Not Available],,,,,[Not Available],,,0.0,409.0,0.0,409.0,,,0.0,409.0,
TCGA-A2-A0YM,594,TCGA-A2-A0YM,BRCA,67.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24831.0,Alive,TUMOR FREE,965.0,,[Not Available],,,,,[Not Available],Negative,,0.0,965.0,0.0,965.0,0.0,965.0,0.0,965.0,
TCGA-EI-6512,8511,TCGA-EI-6512,READ,64.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-23537.0,Alive,TUMOR FREE,538.0,,[Not Available],,,,,[Not Available],,,0.0,538.0,0.0,538.0,,,0.0,538.0,
TCGA-E2-A158,1332,TCGA-E2-A158,BRCA,43.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15903.0,Alive,TUMOR FREE,450.0,,[Not Available],,,,,[Not Available],Negative,,0.0,450.0,0.0,450.0,0.0,450.0,0.0,450.0,
TCGA-2G-AAFV,9726,TCGA-2G-AAFV,TGCT,31.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor,[Not Available],2011.0,[Not Available],-11598.0,Alive,TUMOR FREE,1389.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,1389.0,0.0,1389.0,0.0,1389.0,0.0,1389.0,
TCGA-D1-A15V,10827,TCGA-D1-A15V,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24886.0,Alive,TUMOR FREE,1201.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1201.0,0.0,1201.0,0.0,1201.0,0.0,1201.0,
TCGA-06-0744,2829,TCGA-06-0744,GBM,66.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-24471.0,Dead,WITH TUMOR,,1426.0,[Not Available],,[Not Applicable],[Not Applicable],1277.0,[Not Available],,,1.0,1426.0,1.0,1426.0,,,1.0,1277.0,
TCGA-EE-A2GN,9039,TCGA-EE-A2GN,SKCM,67.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2003.0,[Not Available],-24683.0,Dead,WITH TUMOR,,3106.0,[Not Available],Distant Metastasis,"Other, Specify",adrenal gland,2422.0,[Not Available],,,1.0,3106.0,1.0,3106.0,,,1.0,2422.0,
TCGA-78-7633,6168,TCGA-78-7633,LUAD,67.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-24713.0,Dead,WITH TUMOR,,1528.0,[Not Available],Locoregional Recurrence,,,1450.0,Complete Remission/Response,,,1.0,1528.0,1.0,1528.0,1.0,1450.0,1.0,1450.0,
TCGA-EL-A3GS,10063,TCGA-EL-A3GS,THCA,37.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-13542.0,Alive,TUMOR FREE,1989.0,,[Not Available],,,,,[Not Available],,R0,0.0,1989.0,0.0,1989.0,0.0,1989.0,0.0,1989.0,
TCGA-L9-A7SV,6290,TCGA-L9-A7SV,LUAD,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2013.0,[Not Available],-25298.0,Alive,TUMOR FREE,565.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,565.0,0.0,565.0,0.0,565.0,0.0,565.0,
TCGA-27-1836,3123,TCGA-27-1836,GBM,33.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-12060.0,Dead,WITH TUMOR,,914.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],172.0,[Not Available],,,1.0,914.0,1.0,914.0,,,1.0,172.0,
TCGA-05-4396,5812,TCGA-05-4396,LUAD,76.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-28094.0,Dead,,,303.0,[Not Available],,,,,[Not Available],,,1.0,303.0,,303.0,,,0.0,303.0,
TCGA-EE-A29S,9019,TCGA-EE-A29S,SKCM,79.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2006.0,[Not Available],-29087.0,Dead,WITH TUMOR,,1864.0,[Not Available],Locoregional Recurrence,,,1418.0,[Not Available],,,1.0,1864.0,1.0,1864.0,,,1.0,1418.0,
TCGA-DU-7012,5015,TCGA-DU-7012,LGG,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Astrocytoma,G3,2001.0,[Not Available],-27039.0,Dead,WITH TUMOR,,199.0,[Not Available],,,,,Progressive Disease,,,1.0,199.0,1.0,199.0,,,1.0,199.0,
TCGA-2G-AAFY,9727,TCGA-2G-AAFY,TGCT,24.0,MALE,WHITE,Stage IIA,Stage IIA,Non-Seminoma; Embryonal Carcinoma,[Not Available],2011.0,[Not Available],-9023.0,Alive,TUMOR FREE,1099.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,1099.0,0.0,1099.0,0.0,1099.0,0.0,1099.0,
TCGA-VP-AA1N,8289,TCGA-VP-AA1N,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-25781.0,Alive,TUMOR FREE,1365.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1365.0,0.0,1365.0,0.0,1365.0,0.0,1365.0,
TCGA-FV-A3I1,5693,TCGA-FV-A3I1,LIHC,81.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],,Dead,TUMOR FREE,,247.0,[Not Available],,,,,[Not Available],,R0,1.0,247.0,0.0,247.0,0.0,247.0,0.0,247.0,
TCGA-HF-7136,9554,TCGA-HF-7136,STAD,,MALE,[Not Available],Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],,Alive,WITH TUMOR,,,[Not Available],,,,,Progressive Disease,,,0.0,,0.0,,,,0.0,,
TCGA-27-2523,3129,TCGA-27-2523,GBM,63.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-23034.0,Dead,WITH TUMOR,489.0,489.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],402.0,[Not Available],,,1.0,489.0,1.0,489.0,,,1.0,402.0,
TCGA-H7-A6C5,3661,TCGA-H7-A6C5,HNSC,65.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-23808.0,Alive,TUMOR FREE,642.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,642.0,0.0,642.0,0.0,642.0,0.0,642.0,
TCGA-B1-A47M,4506,TCGA-B1-A47M,KIRP,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-29068.0,Alive,WITH TUMOR,659.0,,[Not Available],,,,408.0,[Unknown],,,0.0,659.0,0.0,659.0,,,1.0,408.0,
TCGA-D1-A1NY,10878,TCGA-D1-A1NY,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24683.0,Alive,TUMOR FREE,513.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,513.0,0.0,513.0,0.0,513.0,0.0,513.0,
TCGA-FD-A5BZ,288,TCGA-FD-A5BZ,BLCA,77.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-28451.0,Dead,WITH TUMOR,,835.0,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,533.0,[Not Applicable],,,1.0,835.0,1.0,835.0,,,1.0,533.0,
TCGA-UL-AAZ6,1592,TCGA-UL-AAZ6,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26999.0,Alive,TUMOR FREE,518.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,518.0,0.0,518.0,,,0.0,518.0,
TCGA-HE-7128,4618,TCGA-HE-7128,KIRP,,MALE,[Not Available],Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],,Alive,TUMOR FREE,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-B6-A0WY,1006,TCGA-B6-A0WY,BRCA,40.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14778.0,Dead,WITH TUMOR,,3461.0,[Not Available],Distant Metastasis,Bone,,2011.0,[Not Available],Negative,,1.0,3461.0,1.0,3461.0,1.0,2011.0,1.0,2011.0,
TCGA-MH-A562,4648,TCGA-MH-A562,KIRP,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-20933.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,
TCGA-KO-8411,3845,TCGA-KO-8411,KICH,58.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-21371.0,Alive,TUMOR FREE,3958.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3958.0,0.0,3958.0,0.0,3958.0,0.0,3958.0,
TCGA-D7-5579,9488,TCGA-D7-5579,STAD,74.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2010.0,[Not Available],-27175.0,Alive,TUMOR FREE,636.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,636.0,0.0,636.0,0.0,636.0,0.0,636.0,
TCGA-EY-A3QX,10974,TCGA-EY-A3QX,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23663.0,Dead,WITH TUMOR,,989.0,[Not Available],Locoregional Recurrence,"Other, specify",Peritoneum,896.0,Complete Remission/Response,,,1.0,989.0,1.0,989.0,,,1.0,896.0,
TCGA-DU-A5TP,5041,TCGA-DU-A5TP,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-12111.0,Alive,TUMOR FREE,1012.0,,[Not Available],,,,203.0,[Discrepancy],,,0.0,1012.0,0.0,1012.0,,,1.0,203.0,
TCGA-4V-A9QL,10363,TCGA-4V-A9QL,THYM,58.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2009.0,[Not Available],-21216.0,Alive,TUMOR FREE,1908.0,,[Not Available],,,,,[Not Available],,,0.0,1908.0,0.0,1908.0,,,0.0,1908.0,
TCGA-MH-A854,4649,TCGA-MH-A854,KIRP,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-22804.0,Alive,TUMOR FREE,536.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,536.0,0.0,536.0,0.0,536.0,0.0,536.0,
TCGA-B6-A0WX,1005,TCGA-B6-A0WX,BRCA,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],"Other, specify",[Not Available],1998.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14784.0,Dead,WITH TUMOR,,639.0,[Not Available],Distant Metastasis,Bone,,563.0,[Not Available],Negative,,1.0,639.0,1.0,639.0,1.0,563.0,1.0,563.0,
TCGA-J9-A52C,8154,TCGA-J9-A52C,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20966.0,Alive,,178.0,,[Not Available],,,,,[Not Applicable],,,0.0,178.0,0.0,178.0,,,0.0,178.0,
TCGA-19-5951,3090,TCGA-19-5951,GBM,76.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-27995.0,Dead,WITH TUMOR,244.0,244.0,[Not Available],,,,,[Not Available],,,1.0,244.0,1.0,244.0,,,1.0,244.0,
TCGA-GN-A26D,9202,TCGA-GN-A26D,SKCM,72.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-26494.0,Dead,WITH TUMOR,,1460.0,[Not Available],Locoregional Recurrence,,,622.0,[Not Available],,,1.0,1460.0,1.0,1460.0,,,1.0,622.0,
TCGA-EY-A5W2,10980,TCGA-EY-A5W2,UCEC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26498.0,Alive,TUMOR FREE,516.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,
TCGA-36-2540,7399,TCGA-36-2540,OV,26.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G1,2008.0,[Not Available],-9760.0,Alive,WITH TUMOR,724.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],665.0,Complete Remission/Response,,,0.0,724.0,0.0,724.0,1.0,665.0,1.0,665.0,
TCGA-CG-5723,9476,TCGA-CG-5723,STAD,83.0,MALE,[Not Available],Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003.0,[Not Available],-30376.0,Alive,,3196.0,,[Not Available],,,,,[Unknown],,,0.0,3196.0,0.0,3196.0,,,0.0,3196.0,
TCGA-52-7809,6503,TCGA-52-7809,LUSC,74.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-27233.0,Dead,WITH TUMOR,,166.0,[Not Available],,,,,Progressive Disease,,,1.0,166.0,1.0,166.0,,,1.0,166.0,
TCGA-FG-A4MT,5121,TCGA-FG-A4MT,LGG,27.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-10082.0,Alive,TUMOR FREE,1164.0,,[Not Available],,,,499.0,Complete Remission/Response,,,0.0,1164.0,0.0,1164.0,1.0,499.0,1.0,499.0,
TCGA-SI-AA8C,8765,TCGA-SI-AA8C,SARC,20.0,FEMALE,WHITE,[Not Available],[Not Available],Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2013.0,[Not Available],-7530.0,Alive,WITH TUMOR,597.0,,[Not Available],Distant Metastasis,Lung,,273.0,[Not Available],Positive,R1,0.0,597.0,0.0,597.0,,,1.0,273.0,
TCGA-EW-A1P7,1475,TCGA-EW-A1P7,BRCA,59.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21750.0,Alive,WITH TUMOR,915.0,,[Not Available],Distant Metastasis,"Other, specify",mediastinal lymph nodes,729.0,[Not Available],Negative,,0.0,915.0,0.0,915.0,1.0,729.0,1.0,729.0,
TCGA-VF-A8AB,9794,TCGA-VF-A8AB,TGCT,31.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2011.0,[Not Available],-11659.0,Alive,TUMOR FREE,760.0,,[Not Applicable],,,,,[Unknown],,,0.0,760.0,0.0,760.0,,,0.0,760.0,
TCGA-FE-A3PB,10269,TCGA-FE-A3PB,THCA,33.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-12136.0,Alive,TUMOR FREE,2590.0,,[Not Available],,,,,[Not Available],,R0,0.0,2590.0,0.0,2590.0,0.0,2590.0,0.0,2590.0,
TCGA-69-7760,6096,TCGA-69-7760,LUAD,73.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26777.0,Alive,TUMOR FREE,202.0,,[Not Available],,,,,[Not Available],,,0.0,202.0,0.0,202.0,,,0.0,202.0,
TCGA-14-4157,3040,TCGA-14-4157,GBM,40.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-14816.0,Alive,,104.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],96.0,[Not Available],,,0.0,104.0,0.0,104.0,,,1.0,96.0,
TCGA-IQ-7631,3680,TCGA-IQ-7631,HNSC,60.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-22151.0,Alive,TUMOR FREE,1172.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1172.0,0.0,1172.0,0.0,1172.0,0.0,1172.0,
TCGA-P5-A72Z,5278,TCGA-P5-A72Z,LGG,64.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-23482.0,Alive,TUMOR FREE,354.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,354.0,0.0,354.0,0.0,354.0,0.0,354.0,
TCGA-ZB-A966,10451,TCGA-ZB-A966,THYM,78.0,FEMALE,WHITE,[Not Applicable],IVb,Thymoma; Type C,[Not Available],2012.0,[Not Available],-28621.0,Dead,WITH TUMOR,,379.0,[Not Available],Locoregional Recurrence,Lung,,296.0,[Not Available],,,1.0,379.0,1.0,379.0,,,1.0,296.0,
TCGA-G9-6332,8015,TCGA-G9-6332,PRAD,55.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2005.0,[Not Available],-20166.0,Alive,WITH TUMOR,2657.0,,[Not Available],Biochemical evidence of disease,,,1180.0,Complete Remission/Response,,,0.0,2657.0,0.0,2657.0,1.0,1180.0,1.0,1180.0,
TCGA-55-6982,5985,TCGA-55-6982,LUAD,79.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],,Dead,WITH TUMOR,,995.0,[Not Available],Distant Metastasis,,,183.0,Progressive Disease,,,1.0,995.0,1.0,995.0,,,1.0,183.0,
TCGA-WC-A87W,11144,TCGA-WC-A87W,UVM,57.0,FEMALE,WHITE,Stage IIA,Stage IIA,Spindle Cell,[Not Available],2010.0,[Not Available],-20872.0,Alive,TUMOR FREE,1703.0,,[Not Available],New Primary Tumor,Skin,,606.0,[Not Available],,,0.0,1703.0,0.0,1703.0,,,1.0,606.0,
TCGA-CZ-4863,4363,TCGA-CZ-4863,KIRC,51.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-18730.0,Alive,TUMOR FREE,1928.0,,[Not Available],,,,,[Not Available],,,0.0,1928.0,0.0,1928.0,,,0.0,1928.0,
TCGA-BP-4801,4193,TCGA-BP-4801,KIRC,57.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-20825.0,Alive,TUMOR FREE,1124.0,,[Not Available],,,,,[Not Available],,,0.0,1124.0,0.0,1124.0,,,0.0,1124.0,
TCGA-DS-A0VM,1680,TCGA-DS-A0VM,CESC,51.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18839.0,Alive,TUMOR FREE,3589.0,,,Distant Metastasis,Lung,,868.0,Complete Remission/Response,,,0.0,3589.0,0.0,3589.0,1.0,868.0,1.0,868.0,
TCGA-50-6673,5958,TCGA-50-6673,LUAD,84.0,FEMALE,WHITE,Stage I,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],-30689.0,Dead,,,22.0,[Not Available],,,,,[Unknown],,,1.0,22.0,,22.0,,,0.0,22.0,
TCGA-EM-A3O9,10182,TCGA-EM-A3O9,THCA,40.0,MALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-14783.0,Alive,TUMOR FREE,281.0,,[Not Available],,,,,[Not Available],,R0,0.0,281.0,0.0,281.0,0.0,281.0,0.0,281.0,
TCGA-V1-A8X3,8248,TCGA-V1-A8X3,PRAD,51.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-18980.0,Alive,,202.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,202.0,0.0,202.0,0.0,202.0,0.0,202.0,
TCGA-CQ-A4CB,3410,TCGA-CQ-A4CB,HNSC,59.0,MALE,[Not Evaluated],Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-21574.0,Alive,TUMOR FREE,893.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,893.0,0.0,893.0,0.0,893.0,0.0,893.0,
TCGA-B8-A54D,4115,TCGA-B8-A54D,KIRC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2011.0,[Not Available],-25429.0,Alive,TUMOR FREE,830.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,830.0,0.0,830.0,0.0,830.0,0.0,830.0,
TCGA-DX-A6YV,8618,TCGA-DX-A6YV,SARC,74.0,MALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2008.0,[Not Available],-27053.0,Dead,WITH TUMOR,,1536.0,[Not Available],Distant Metastasis,"Other, specify",Groin - lymph nodes,516.0,[Not Available],Negative,R0,1.0,1536.0,1.0,1536.0,1.0,516.0,1.0,516.0,
TCGA-44-7672,5891,TCGA-44-7672,LUAD,52.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-19200.0,Alive,TUMOR FREE,719.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,719.0,0.0,719.0,0.0,719.0,0.0,719.0,
TCGA-CN-5373,3334,TCGA-CN-5373,HNSC,55.0,FEMALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2010.0,[Not Available],-20143.0,Alive,TUMOR FREE,1584.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1584.0,0.0,1584.0,0.0,1584.0,0.0,1584.0,
TCGA-CV-A460,3587,TCGA-CV-A460,HNSC,72.0,MALE,WHITE,[Discrepancy],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2001.0,[Not Available],-26539.0,Dead,[Discrepancy],,1838.0,[Not Available],New Primary Tumor,,mediastinum,1425.0,Complete Remission/Response,,,1.0,1838.0,,1838.0,,,1.0,1425.0,
TCGA-QR-A6GX,7703,TCGA-QR-A6GX,PCPG,28.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-10548.0,Alive,TUMOR FREE,579.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,
TCGA-BP-5181,4248,TCGA-BP-5181,KIRC,58.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-21514.0,Alive,TUMOR FREE,1495.0,,[Not Available],,,,,[Not Available],,,0.0,1495.0,0.0,1495.0,,,0.0,1495.0,
TCGA-XF-A8HH,423,TCGA-XF-A8HH,BLCA,61.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,[Not Available],-22393.0,Dead,WITH TUMOR,,57.0,[Not Available],,,,,Partial Remission/Response,,,1.0,57.0,1.0,57.0,,,1.0,57.0,
TCGA-EE-A3AD,9071,TCGA-EE-A3AD,SKCM,50.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2009.0,[Not Available],-18491.0,Dead,WITH TUMOR,,875.0,[Not Available],Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis,"Other, Specify|Lung|Other, Specify|Other, Specify|Brain|Liver",spinal cord|[Not Applicable]|right anterior abdomen - skin and soft tissue|right anterior chest - skin and soft tissue|[Not Applicable]|[Not Applicable],554.0,[Not Available],,,1.0,875.0,1.0,875.0,,,1.0,554.0,
TCGA-XJ-A9DK,8298,TCGA-XJ-A9DK,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],,Alive,TUMOR FREE,275.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,275.0,0.0,275.0,0.0,275.0,0.0,275.0,
TCGA-FA-A6HN,2416,TCGA-FA-A6HN,DLBC,73.0,MALE,ASIAN,[Not Applicable],[Not Available],Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013.0,[Not Available],-27025.0,Dead,TUMOR FREE,,58.0,[Not Available],,,,,Progressive Disease,,,1.0,58.0,0.0,58.0,,,0.0,58.0,
TCGA-BJ-A2N7,9874,TCGA-BJ-A2N7,THCA,30.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-11188.0,Alive,TUMOR FREE,559.0,,[Not Available],,,,,[Not Available],,R0,0.0,559.0,0.0,559.0,0.0,559.0,0.0,559.0,
TCGA-D3-A2JP,8851,TCGA-D3-A2JP,SKCM,37.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-13552.0,Alive,WITH TUMOR,1812.0,,[Not Available],Distant Metastasis,Liver,,227.0,[Not Available],,,0.0,1812.0,0.0,1812.0,,,1.0,227.0,
TCGA-DB-A4XA,4942,TCGA-DB-A4XA,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-11195.0,Alive,WITH TUMOR,573.0,,[Not Available],,,,,Stable Disease,,,0.0,573.0,0.0,573.0,,,0.0,573.0,
TCGA-CS-4942,4913,TCGA-CS-4942,LGG,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Astrocytoma,G3,2006.0,[Not Available],-16297.0,Dead,WITH TUMOR,,1335.0,[Not Available],,,,1184.0,Progressive Disease,,,1.0,1335.0,1.0,1335.0,,,1.0,1184.0,
TCGA-AL-A5DJ,4502,TCGA-AL-A5DJ,KIRP,54.0,FEMALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-20079.0,Dead,WITH TUMOR,,1498.0,[Not Available],,,,,Progressive Disease,,,1.0,1498.0,1.0,1498.0,,,1.0,1498.0,
TCGA-MQ-A6BL,6860,TCGA-MQ-A6BL,MESO,78.0,MALE,WHITE,Stage II,[Not Applicable],Biphasic mesothelioma,[Not Available],2007.0,[Not Available],-28590.0,Dead,,,333.0,[Not Available],Distant Metastasis,"Other, specify",Bone (Scapula),186.0,[Not Available],,[Unknown],1.0,333.0,,333.0,,,1.0,186.0,
TCGA-CG-5732,9483,TCGA-CG-5732,STAD,66.0,MALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2003.0,[Not Available],-24379.0,Dead,WITH TUMOR,,2100.0,[Not Available],,,,1949.0,[Discrepancy],,,1.0,2100.0,1.0,2100.0,,,1.0,1949.0,
TCGA-IN-A6RL,9598,TCGA-IN-A6RL,STAD,84.0,MALE,WHITE,[Discrepancy],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-30783.0,Dead,WITH TUMOR,,406.0,[Not Available],Distant Metastasis,,,307.0,Complete Remission/Response,,,1.0,406.0,1.0,406.0,1.0,307.0,1.0,307.0,
TCGA-EE-A29C,9008,TCGA-EE-A29C,SKCM,20.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2007.0,[Not Available],-7510.0,Dead,WITH TUMOR,,2402.0,[Not Available],Regional lymph node,,,204.0,[Not Available],,,1.0,2402.0,1.0,2402.0,,,1.0,204.0,
TCGA-CV-5977,3487,TCGA-CV-5977,HNSC,66.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-24115.0,Alive,TUMOR FREE,1840.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1840.0,0.0,1840.0,,,0.0,1840.0,
TCGA-FR-A2OS,9128,TCGA-FR-A2OS,SKCM,49.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-18122.0,Dead,WITH TUMOR,,368.0,[Not Available],Locoregional Recurrence,,,283.0,[Not Available],,,1.0,368.0,1.0,368.0,,,1.0,283.0,
TCGA-CV-A465,3591,TCGA-CV-A465,HNSC,24.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2008.0,[Not Available],-9015.0,Dead,TUMOR FREE,,215.0,[Not Available],,,,,Complete Remission/Response,,,1.0,215.0,0.0,215.0,0.0,215.0,0.0,215.0,
TCGA-EJ-5509,7924,TCGA-EJ-5509,PRAD,63.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-23368.0,Alive,TUMOR FREE,1464.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1464.0,0.0,1464.0,0.0,1464.0,0.0,1464.0,
TCGA-DJ-A2Q3,9956,TCGA-DJ-A2Q3,THCA,61.0,FEMALE,ASIAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-22637.0,Alive,TUMOR FREE,1224.0,,[Not Available],New Primary Tumor,Lung,,385.0,[Not Available],,R0,0.0,1224.0,0.0,1224.0,0.0,1224.0,1.0,385.0,
TCGA-HC-A6HY,8118,TCGA-HC-A6HY,PRAD,51.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-18779.0,Alive,TUMOR FREE,134.0,,[Not Available],,,,,[Unknown],,,0.0,134.0,0.0,134.0,,,0.0,134.0,
TCGA-YL-A8SC,8325,TCGA-YL-A8SC,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-24206.0,Alive,WITH TUMOR,1261.0,,[Not Available],Biochemical evidence of disease,,,152.0,Partial Remission/Response,,,0.0,1261.0,0.0,1261.0,,,1.0,152.0,
TCGA-CM-4752,2265,TCGA-CM-4752,COAD,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-21519.0,Alive,TUMOR FREE,396.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,
TCGA-VD-A8KI,11127,TCGA-VD-A8KI,UVM,68.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Epithelioid Cell|Spindle Cell,[Not Available],2012.0,[Not Available],-24966.0,Dead,WITH TUMOR,,1113.0,Metastatic Uveal Melanoma,,,,,[Not Available],,,1.0,1113.0,1.0,1113.0,,,1.0,1113.0,
TCGA-HT-8109,5214,TCGA-HT-8109,LGG,64.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-23486.0,Alive,TUMOR FREE,169.0,,[Not Available],,,,,[Unknown],,,0.0,169.0,0.0,169.0,,,0.0,169.0,
TCGA-BA-5149,3248,TCGA-BA-5149,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-17177.0,Dead,WITH TUMOR,,806.0,[Not Available],,Distant Metastasis,Lung,389.0,Complete Remission/Response,,,1.0,806.0,1.0,806.0,,,1.0,389.0,
TCGA-06-2570,2862,TCGA-06-2570,GBM,21.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-7936.0,Alive,TUMOR FREE,958.0,,[Not Available],,,,,[Not Available],,,0.0,958.0,0.0,958.0,,,0.0,958.0,
TCGA-LN-A5U7,2583,TCGA-LN-A5U7,ESCA,46.0,MALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G1,2012.0,[Not Available],-16928.0,Alive,TUMOR FREE,768.0,,[Not Available],Locoregional Recurrence,,,535.0,Complete Remission/Response,,,0.0,768.0,0.0,768.0,1.0,535.0,1.0,535.0,
TCGA-HT-7860,5191,TCGA-HT-7860,LGG,60.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-22034.0,Alive,TUMOR FREE,15.0,,[Not Available],,,,,[Not Available],,,0.0,15.0,0.0,15.0,,,0.0,15.0,
TCGA-3X-AAVB,1911,TCGA-3X-AAVB,CHOL,70.0,FEMALE,WHITE,Stage IVB,[Not Applicable],Cholangiocarcinoma; distal,G1,2012.0,[Not Available],-25819.0,Alive,,402.0,,[Not Available],,,,,[Not Available],,R0,0.0,402.0,0.0,402.0,,,0.0,402.0,
TCGA-VR-A8ET,2625,TCGA-VR-A8ET,ESCA,64.0,MALE,WHITE,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2010.0,[Not Available],-23517.0,Dead,TUMOR FREE,,47.0,[Not Available],,,,,,,,1.0,47.0,0.0,47.0,,,0.0,47.0,
TCGA-CK-5913,2250,TCGA-CK-5913,COAD,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-21399.0,Alive,TUMOR FREE,1561.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1561.0,0.0,1561.0,0.0,1561.0,0.0,1561.0,
TCGA-SG-A849,8760,TCGA-SG-A849,SARC,78.0,MALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013.0,[Not Available],-28498.0,Alive,TUMOR FREE,533.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,533.0,0.0,533.0,,,0.0,533.0,
TCGA-E1-5319,5073,TCGA-E1-5319,LGG,48.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1998.0,[Not Available],-17612.0,Dead,WITH TUMOR,,2907.0,[Not Available],,,,923.0,Stable Disease,,,1.0,2907.0,1.0,2907.0,,,1.0,923.0,
TCGA-BH-A1FG,1148,TCGA-BH-A1FG,BRCA,88.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32295.0,Dead,,,3736.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,3736.0,,3736.0,,,0.0,3736.0,
TCGA-D8-A1JD,1239,TCGA-D8-A1JD,BRCA,41.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15166.0,Alive,TUMOR FREE,552.0,,[Not Available],,,,,[Not Available],Negative,,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,
TCGA-55-8089,6016,TCGA-55-8089,LUAD,56.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-20576.0,Dead,TUMOR FREE,,702.0,[Not Available],,,,,Complete Remission/Response,,,1.0,702.0,0.0,702.0,0.0,702.0,0.0,702.0,
TCGA-LP-A5U2,1801,TCGA-LP-A5U2,CESC,30.0,FEMALE,ASIAN,[Not Available],Stage IIIB,Endocervical Adenocarcinoma of the Usual Type,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11049.0,Alive,TUMOR FREE,9.0,,,,,,,Complete Remission/Response,,,0.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,
TCGA-MH-A857,4652,TCGA-MH-A857,KIRP,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-23114.0,Alive,TUMOR FREE,890.0,,[Not Available],,,,,Stable Disease,,,0.0,890.0,0.0,890.0,,,0.0,890.0,
TCGA-AJ-A23N,10526,TCGA-AJ-A23N,UCEC,70.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25772.0,Dead,WITH TUMOR,,439.0,[Not Available],,,,,Progressive Disease,,,1.0,439.0,1.0,439.0,,,1.0,439.0,
TCGA-AX-A2HF,10653,TCGA-AX-A2HF,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24689.0,Alive,WITH TUMOR,848.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,848.0,0.0,848.0,0.0,848.0,0.0,848.0,
TCGA-B0-5399,4045,TCGA-B0-5399,KIRC,46.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-17145.0,Alive,TUMOR FREE,1411.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1411.0,0.0,1411.0,0.0,1411.0,0.0,1411.0,
TCGA-06-0122,2740,TCGA-06-0122,GBM,84.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-30968.0,Dead,,8.0,187.0,[Not Available],,,,,[Not Available],,,1.0,187.0,,187.0,,,0.0,187.0,
TCGA-BP-4995,4227,TCGA-BP-4995,KIRC,68.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-24850.0,Alive,TUMOR FREE,1371.0,,[Not Available],,,,,[Not Available],,,0.0,1371.0,0.0,1371.0,,,0.0,1371.0,
TCGA-78-7167,6160,TCGA-78-7167,LUAD,77.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-28295.0,Dead,WITH TUMOR,,2681.0,[Not Available],,,,726.0,[Not Available],,,1.0,2681.0,1.0,2681.0,,,1.0,726.0,
TCGA-D3-A3CF,8861,TCGA-D3-A3CF,SKCM,61.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-22409.0,Dead,WITH TUMOR,,746.0,[Not Available],Distant Metastasis,Bone,,129.0,[Not Available],,,1.0,746.0,1.0,746.0,,,1.0,129.0,
TCGA-BR-8372,9363,TCGA-BR-8372,STAD,63.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-23346.0,Alive,TUMOR FREE,951.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,951.0,0.0,951.0,0.0,951.0,0.0,951.0,
TCGA-PE-A5DD,1576,TCGA-PE-A5DD,BRCA,64.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23686.0,Alive,TUMOR FREE,1953.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1953.0,0.0,1953.0,0.0,1953.0,0.0,1953.0,
TCGA-EJ-5499,7915,TCGA-EJ-5499,PRAD,61.0,MALE,ASIAN,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-22286.0,Alive,TUMOR FREE,1415.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1415.0,0.0,1415.0,0.0,1415.0,0.0,1415.0,
TCGA-BR-8289,9346,TCGA-BR-8289,STAD,57.0,MALE,WHITE,Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-20849.0,Dead,TUMOR FREE,,81.0,[Not Available],,,,,Complete Remission/Response,,,1.0,81.0,0.0,81.0,,,0.0,81.0,
TCGA-DD-AACO,5594,TCGA-DD-AACO,LIHC,40.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2009.0,[Not Available],-14796.0,Alive,WITH TUMOR,1876.0,,[Not Available],Intrahepatic Recurrence,Liver,,479.0,[Not Available],,R0,0.0,1876.0,0.0,1876.0,1.0,479.0,1.0,479.0,
TCGA-KC-A7F3,8167,TCGA-KC-A7F3,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-24676.0,Alive,TUMOR FREE,665.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,665.0,0.0,665.0,0.0,665.0,0.0,665.0,
TCGA-UY-A78M,404,TCGA-UY-A78M,BLCA,81.0,FEMALE,ASIAN,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-29706.0,Dead,WITH TUMOR,,690.0,[Not Available],,,,,[Unknown],,,1.0,690.0,1.0,690.0,,,1.0,690.0,
TCGA-NK-A5CR,6817,TCGA-NK-A5CR,LUSC,77.0,MALE,[Unknown],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-28126.0,Alive,TUMOR FREE,2542.0,,[Not Available],,,,,Stable Disease,,,0.0,2542.0,0.0,2542.0,,,0.0,2542.0,
TCGA-CF-A47S,157,TCGA-CF-A47S,BLCA,41.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,[Not Available],-15225.0,Alive,TUMOR FREE,333.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,333.0,0.0,333.0,0.0,333.0,0.0,333.0,
TCGA-D3-A8GB,8883,TCGA-D3-A8GB,SKCM,48.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2003.0,[Not Available],-17871.0,Dead,WITH TUMOR,,938.0,[Not Available],Distant Metastasis,"Other, Specify",Soft tissue,347.0,[Not Available],,,1.0,938.0,1.0,938.0,,,1.0,347.0,
TCGA-SH-A7BC,6873,TCGA-SH-A7BC,MESO,66.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2011.0,[Not Available],-24459.0,Dead,WITH TUMOR,,727.0,[Not Available],Locoregional Recurrence,"Other, specify",Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes,507.0,[Not Available],,R2,1.0,727.0,1.0,727.0,,,1.0,507.0,
TCGA-DU-5874,4990,TCGA-DU-5874,LGG,62.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-22847.0,Alive,TUMOR FREE,461.0,,[Not Available],,,,,Stable Disease,,,0.0,461.0,0.0,461.0,,,0.0,461.0,
TCGA-RW-A67V,7757,TCGA-RW-A67V,PCPG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2004.0,[Not Available],-16139.0,Alive,TUMOR FREE,2643.0,,[Not Available],Locoregional Disease,"Other, specify",Left adrenal,551.0,Progressive Disease,,,0.0,2643.0,0.0,2643.0,,,1.0,551.0,
TCGA-S9-A7QW,5357,TCGA-S9-A7QW,LGG,54.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-19869.0,Alive,WITH TUMOR,458.0,,[Not Available],,,,382.0,Complete Remission/Response,,,0.0,458.0,0.0,458.0,1.0,382.0,1.0,382.0,
TCGA-ED-A5KG,5667,TCGA-ED-A5KG,LIHC,60.0,FEMALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-22258.0,Alive,WITH TUMOR,854.0,,[Not Available],New Primary Tumor,"Other, specify",Kidney,110.0,[Not Available],,R0,0.0,854.0,0.0,854.0,0.0,854.0,1.0,110.0,
TCGA-EE-A2A2,9026,TCGA-EE-A2A2,SKCM,71.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-26048.0,Alive,TUMOR FREE,1814.0,,[Not Available],,,,,[Not Available],,,0.0,1814.0,0.0,1814.0,,,0.0,1814.0,
TCGA-F5-6861,8530,TCGA-F5-6861,READ,60.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-21936.0,Alive,TUMOR FREE,1160.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1160.0,0.0,1160.0,0.0,1160.0,0.0,1160.0,
TCGA-A6-A566,2008,TCGA-A6-A566,COAD,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2007.0,[Not Available],-20181.0,Dead,WITH TUMOR,,758.0,[Not Available],,,,257.0,Progressive Disease,,,1.0,758.0,1.0,758.0,,,1.0,257.0,
TCGA-CV-A45O,3576,TCGA-CV-A45O,HNSC,57.0,MALE,WHITE,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G2,1994.0,[Not Available],-20868.0,Alive,TUMOR FREE,851.0,,[Not Available],,,,,[Not Applicable],,,0.0,851.0,0.0,851.0,,,0.0,851.0,
TCGA-58-8391,6552,TCGA-58-8391,LUSC,57.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-21102.0,Alive,WITH TUMOR,2167.0,,[Not Available],Distant Metastasis|New Primary Tumor,,,2033.0,Complete Remission/Response,,,0.0,2167.0,0.0,2167.0,1.0,2033.0,1.0,2033.0,
TCGA-B0-5092,4023,TCGA-B0-5092,KIRC,53.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2008.0,[Not Available],-19611.0,Dead,WITH TUMOR,,459.0,[Not Available],,,,,[Not Available],,,1.0,459.0,1.0,459.0,,,1.0,459.0,
TCGA-96-7544,6775,TCGA-96-7544,LUSC,83.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-30548.0,Dead,TUMOR FREE,,2160.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2160.0,0.0,2160.0,0.0,2160.0,0.0,2160.0,
TCGA-QR-A6GZ,7705,TCGA-QR-A6GZ,PCPG,31.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2009.0,[Not Available],-11573.0,Alive,TUMOR FREE,928.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,
TCGA-GF-A769,9191,TCGA-GF-A769,SKCM,39.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2010.0,[Not Available],-14304.0,Dead,WITH TUMOR,,1070.0,[Not Available],,,,,[Not Available],,,1.0,1070.0,1.0,1070.0,,,1.0,1070.0,
TCGA-AX-A3GI,10674,TCGA-AX-A3GI,UCEC,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2011.0,[Not Available],-24388.0,Alive,,12.0,,[Not Available],,,,,[Not Available],,,0.0,12.0,0.0,12.0,,,0.0,12.0,
TCGA-EY-A2ON,10969,TCGA-EY-A2ON,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22624.0,Dead,WITH TUMOR,,610.0,[Not Available],,,,226.0,Progressive Disease,,,1.0,610.0,1.0,610.0,,,1.0,226.0,
TCGA-DU-A6S7,5051,TCGA-DU-A6S7,LGG,27.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-10170.0,Alive,TUMOR FREE,638.0,,[Not Available],,,,,Stable Disease,,,0.0,638.0,0.0,638.0,,,0.0,638.0,
TCGA-HC-A9TE,8124,TCGA-HC-A9TE,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23543.0,Alive,WITH TUMOR,587.0,,[Not Available],Biochemical evidence of disease,"Other, specify",Biochemical,216.0,Partial Remission/Response,,,0.0,587.0,0.0,587.0,,,1.0,216.0,
TCGA-QQ-A5V9,8746,TCGA-QQ-A5V9,SARC,76.0,MALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],1997.0,[Not Available],-27977.0,Dead,WITH TUMOR,,1424.0,[Not Available],Distant Metastasis,Lung,,405.0,[Not Available],Negative,R0,1.0,1424.0,1.0,1424.0,1.0,405.0,1.0,405.0,
TCGA-D3-A3CB,8858,TCGA-D3-A3CB,SKCM,39.0,MALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],1999.0,[Not Available],-14563.0,Alive,TUMOR FREE,5065.0,,[Not Available],,,,,[Not Available],,,0.0,5065.0,0.0,5065.0,,,0.0,5065.0,
TCGA-3U-A98D,6837,TCGA-3U-A98D,MESO,80.0,MALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2012.0,[Not Available],-29500.0,Dead,,,142.0,[Not Available],Locoregional Recurrence,Ipsilateral Chest Wall,,125.0,[Not Available],,[Not Available],1.0,142.0,,142.0,,,1.0,125.0,
TCGA-43-3394,6472,TCGA-43-3394,LUSC,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-19310.0,Dead,WITH TUMOR,,1190.0,[Not Available],,,,552.0,Complete Remission/Response,,,1.0,1190.0,1.0,1190.0,1.0,552.0,1.0,552.0,
TCGA-EA-A1QS,1692,TCGA-EA-A1QS,CESC,46.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16923.0,Alive,TUMOR FREE,1203.0,,,,,,,Complete Remission/Response,,,0.0,1203.0,0.0,1203.0,0.0,1203.0,0.0,1203.0,
TCGA-3H-AB3U,6835,TCGA-3H-AB3U,MESO,71.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2009.0,[Not Available],-26220.0,Dead,WITH TUMOR,,826.0,[Not Available],Intrapleural Progression,Ipsilateral Pleura,,108.0,[Not Available],,[Unknown],1.0,826.0,1.0,826.0,,,1.0,108.0,
TCGA-N5-A4RA,11025,TCGA-N5-A4RA,UCS,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23359.0,Dead,,,1591.0,[Not Available],,,,,[Unknown],,,1.0,1591.0,,1591.0,,,0.0,1591.0,
TCGA-FC-A8O0,8013,TCGA-FC-A8O0,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-25115.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,
TCGA-W8-A86G,1595,TCGA-W8-A86G,BRCA,66.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24125.0,Alive,TUMOR FREE,347.0,,[Not Available],,,,,[Not Available],Negative,,0.0,347.0,0.0,347.0,0.0,347.0,0.0,347.0,
TCGA-WX-AA44,5783,TCGA-WX-AA44,LIHC,64.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-23654.0,Alive,WITH TUMOR,615.0,,[Not Available],Intrahepatic Recurrence,Liver,,246.0,[Not Available],,RX,0.0,615.0,0.0,615.0,,,1.0,246.0,
TCGA-85-8288,6724,TCGA-85-8288,LUSC,70.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25629.0,Dead,TUMOR FREE,,402.0,[Not Available],,,,,Complete Remission/Response,,,1.0,402.0,0.0,402.0,0.0,402.0,0.0,402.0,
TCGA-B8-4154,4097,TCGA-B8-4154,KIRC,73.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-26882.0,Alive,TUMOR FREE,1380.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1380.0,0.0,1380.0,0.0,1380.0,0.0,1380.0,
TCGA-BH-A0C7,1060,TCGA-BH-A0C7,BRCA,48.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Peri (6-12 months since last menstrual period),-17871.0,Alive,TUMOR FREE,2767.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2767.0,0.0,2767.0,0.0,2767.0,0.0,2767.0,
TCGA-DX-A8BZ,8650,TCGA-DX-A8BZ,SARC,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2013.0,[Not Available],-28853.0,Dead,WITH TUMOR,,200.0,[Not Available],Distant Metastasis,Lung,,90.0,[Not Available],Positive,R0,1.0,200.0,1.0,200.0,1.0,90.0,1.0,90.0,
TCGA-BG-A0MU,10754,TCGA-BG-A0MU,UCEC,78.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28621.0,Alive,TUMOR FREE,617.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,617.0,0.0,617.0,0.0,617.0,0.0,617.0,
TCGA-DU-A7TG,5063,TCGA-DU-A7TG,LGG,40.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2008.0,[Not Available],-14671.0,Dead,,,1351.0,[Not Available],,,,,[Unknown],,,1.0,1351.0,,1351.0,,,0.0,1351.0,
TCGA-75-5126,6127,TCGA-75-5126,LUAD,,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],,Alive,WITH TUMOR,,,[Not Available],,,,,Partial Remission/Response,,,0.0,,0.0,,,,0.0,,
TCGA-86-A4JF,6209,TCGA-86-A4JF,LUAD,56.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-20491.0,Dead,WITH TUMOR,,737.0,[Not Available],Distant Metastasis,,,436.0,Complete Remission/Response,,,1.0,737.0,1.0,737.0,1.0,436.0,1.0,436.0,
TCGA-BJ-A18Z,9861,TCGA-BJ-A18Z,THCA,58.0,MALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-21519.0,Alive,TUMOR FREE,1263.0,,[Not Available],,,,,[Not Available],,R1,0.0,1263.0,0.0,1263.0,,,0.0,1263.0,
TCGA-HC-7745,8083,TCGA-HC-7745,PRAD,65.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24078.0,Alive,TUMOR FREE,721.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,721.0,0.0,721.0,0.0,721.0,0.0,721.0,
TCGA-55-8085,6014,TCGA-55-8085,LUAD,64.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23596.0,Alive,TUMOR FREE,904.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,904.0,0.0,904.0,0.0,904.0,0.0,904.0,
TCGA-28-5208,3155,TCGA-28-5208,GBM,52.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-19053.0,Dead,WITH TUMOR,,544.0,[Not Available],,[Not Applicable],[Not Applicable],148.0,Progressive Disease,,,1.0,544.0,1.0,544.0,,,1.0,148.0,
TCGA-21-5784,6357,TCGA-21-5784,LUSC,80.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-29362.0,Alive,TUMOR FREE,1268.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1268.0,0.0,1268.0,0.0,1268.0,0.0,1268.0,
TCGA-HC-7749,8086,TCGA-HC-7749,PRAD,70.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25688.0,Alive,TUMOR FREE,724.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,724.0,0.0,724.0,0.0,724.0,0.0,724.0,
TCGA-66-2795,6646,TCGA-66-2795,LUSC,68.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-24897.0,Alive,TUMOR FREE,122.0,,[Not Available],,,,,[Not Available],,,0.0,122.0,0.0,122.0,,,0.0,122.0,
TCGA-FU-A3HY,1757,TCGA-FU-A3HY,CESC,47.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G2,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17228.0,Alive,TUMOR FREE,954.0,,,,,,,Complete Remission/Response,,,0.0,954.0,0.0,954.0,0.0,954.0,0.0,954.0,
TCGA-D6-6825,3615,TCGA-D6-6825,HNSC,73.0,MALE,WHITE,Stage I,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-26976.0,Alive,TUMOR FREE,491.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,
TCGA-US-A77E,7675,TCGA-US-A77E,PAAD,73.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2012.0,[Not Available],-26745.0,Dead,WITH TUMOR,,430.0,Pancreatic Cancer,Distant Metastasis,Liver,,166.0,[Not Available],,,1.0,430.0,1.0,430.0,,,1.0,166.0,
TCGA-F5-6464,8522,TCGA-F5-6464,READ,77.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-28168.0,Dead,,,303.0,[Not Available],,,,,[Not Available],,,1.0,303.0,,303.0,,,0.0,303.0,
TCGA-BQ-7053,4562,TCGA-BQ-7053,KIRP,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-20837.0,Alive,TUMOR FREE,1516.0,,[Not Available],,,,,[Not Available],,,0.0,1516.0,0.0,1516.0,,,0.0,1516.0,
TCGA-2L-AAQE,7521,TCGA-2L-AAQE,PAAD,56.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-20618.0,Dead,WITH TUMOR,,684.0,Pancreatic Cancer,,,,,Progressive Disease,,,1.0,684.0,1.0,684.0,,,1.0,684.0,
TCGA-B6-A0RU,999,TCGA-B6-A0RU,BRCA,40.0,FEMALE,WHITE,Stage IA,[Not Applicable],"Other, specify",[Not Available],1990.0,Indeterminate (neither Pre or Postmenopausal),-14920.0,Alive,TUMOR FREE,8605.0,,[Not Available],New Primary Tumor,"Other, specify",Right Breast,3076.0,[Not Available],Negative,,0.0,8605.0,0.0,8605.0,1.0,3076.0,1.0,3076.0,
TCGA-CC-A9FU,5511,TCGA-CC-A9FU,LIHC,52.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-19326.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-D7-A6EX,9520,TCGA-D7-A6EX,STAD,72.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013.0,[Not Available],-26525.0,Alive,TUMOR FREE,344.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,344.0,0.0,344.0,0.0,344.0,0.0,344.0,
TCGA-49-6742,5914,TCGA-49-6742,LUAD,70.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-25839.0,Dead,WITH TUMOR,,488.0,[Not Available],,,,214.0,Progressive Disease,,,1.0,488.0,1.0,488.0,,,1.0,214.0,
TCGA-AR-A24T,942,TCGA-AR-A24T,BRCA,46.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17135.0,Alive,TUMOR FREE,3202.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3202.0,0.0,3202.0,0.0,3202.0,0.0,3202.0,
TCGA-BP-4991,4223,TCGA-BP-4991,KIRC,54.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-19739.0,Alive,TUMOR FREE,1413.0,,[Not Available],,,,,[Not Available],,,0.0,1413.0,0.0,1413.0,,,0.0,1413.0,
TCGA-WC-A881,11147,TCGA-WC-A881,UVM,75.0,MALE,WHITE,Stage IIB,Stage IIB,Spindle Cell,[Not Available],2011.0,[Not Available],-27443.0,Alive,TUMOR FREE,1065.0,,[Not Available],,,,,[Not Available],,,0.0,1065.0,0.0,1065.0,,,0.0,1065.0,
TCGA-RT-A6YA,7755,TCGA-RT-A6YA,PCPG,71.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2009.0,[Not Available],-26095.0,Alive,TUMOR FREE,1540.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1540.0,0.0,1540.0,0.0,1540.0,0.0,1540.0,
TCGA-DA-A1IA,8925,TCGA-DA-A1IA,SKCM,32.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2005.0,[Not Available],-11744.0,Dead,WITH TUMOR,,2005.0,[Not Available],,,,,[Not Available],,,1.0,2005.0,1.0,2005.0,,,1.0,2005.0,
TCGA-2X-A9D6,9776,TCGA-2X-A9D6,TGCT,42.0,MALE,WHITE,Stage I,[Not Available],Seminoma; NOS,[Not Available],2013.0,[Not Available],-15371.0,Alive,WITH TUMOR,607.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,
TCGA-D6-A74Q,3629,TCGA-D6-A74Q,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-24702.0,Alive,TUMOR FREE,710.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,710.0,0.0,710.0,,,0.0,710.0,
TCGA-FB-AAPY,7563,TCGA-FB-AAPY,PAAD,71.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2007.0,[Not Available],-26085.0,Dead,TUMOR FREE,,1059.0,,,,,,Complete Remission/Response,,,1.0,1059.0,0.0,1059.0,0.0,1059.0,0.0,1059.0,
TCGA-94-8491,6771,TCGA-94-8491,LUSC,73.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-26698.0,Alive,TUMOR FREE,810.0,,[Not Available],Distant Metastasis,,,641.0,Progressive Disease,,,0.0,810.0,0.0,810.0,,,1.0,641.0,
TCGA-A4-A5DU,4488,TCGA-A4-A5DU,KIRP,45.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-16779.0,Alive,TUMOR FREE,496.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,
TCGA-V3-A9ZX,11082,TCGA-V3-A9ZX,UVM,56.0,MALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell|Spindle Cell,[Not Available],2013.0,[Not Available],-20539.0,Alive,TUMOR FREE,470.0,,[Not Available],Distant Metastasis,Liver,,233.0,[Not Available],,,0.0,470.0,0.0,470.0,,,1.0,233.0,
TCGA-E2-A15H,1340,TCGA-E2-A15H,BRCA,38.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13985.0,Alive,TUMOR FREE,393.0,,[Not Available],,,,,[Not Available],Negative,,0.0,393.0,0.0,393.0,0.0,393.0,0.0,393.0,
TCGA-LK-A4O0,6847,TCGA-LK-A4O0,MESO,81.0,MALE,WHITE,Stage IA,[Not Applicable],Sarcomatoid mesothelioma,[Not Available],2009.0,[Not Available],-29798.0,Dead,TUMOR FREE,,185.0,[Not Available],,,,,[Not Available],,R0,1.0,185.0,0.0,185.0,0.0,185.0,0.0,185.0,
TCGA-AK-3453,3954,TCGA-AK-3453,KIRC,58.0,FEMALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-21271.0,Alive,TUMOR FREE,2531.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2531.0,0.0,2531.0,0.0,2531.0,0.0,2531.0,
TCGA-E9-A226,1424,TCGA-E9-A226,BRCA,45.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16511.0,Dead,WITH TUMOR,,1048.0,[Not Available],Distant Metastasis,Bone,,790.0,[Not Available],Negative,,1.0,1048.0,1.0,1048.0,1.0,790.0,1.0,790.0,
TCGA-VD-A8KG,11125,TCGA-VD-A8KG,UVM,47.0,FEMALE,[Not Evaluated],Stage IIA,Stage IIA,Spindle Cell,[Not Available],2012.0,[Not Available],-17417.0,Alive,TUMOR FREE,19.0,,[Not Available],,,,,[Not Available],,,0.0,19.0,0.0,19.0,,,0.0,19.0,
TCGA-3A-A9I5,7526,TCGA-3A-A9I5,PAAD,57.0,MALE,WHITE,[Discrepancy],[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2009.0,[Not Available],-21175.0,Alive,TUMOR FREE,1794.0,,,,,,,Complete Remission/Response,,,0.0,1794.0,0.0,1794.0,0.0,1794.0,0.0,1794.0,
TCGA-FS-A1ZP,9162,TCGA-FS-A1ZP,SKCM,52.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1997.0,[Not Available],-19175.0,Dead,WITH TUMOR,,2273.0,[Not Available],,,,,[Not Available],,,1.0,2273.0,1.0,2273.0,,,1.0,2273.0,
TCGA-BH-A8FZ,1173,TCGA-BH-A8FZ,BRCA,58.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21343.0,Alive,TUMOR FREE,574.0,,[Not Available],,,,,[Not Available],Negative,,0.0,574.0,0.0,574.0,0.0,574.0,0.0,574.0,
TCGA-BT-A20V,132,TCGA-BT-A20V,BLCA,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-21551.0,Dead,,,154.0,[Not Available],,,,,[Not Available],,,1.0,154.0,,154.0,,,0.0,154.0,
TCGA-CV-6948,3506,TCGA-CV-6948,HNSC,79.0,FEMALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1994.0,[Not Available],-29153.0,Dead,TUMOR FREE,,1289.0,[Not Available],,,,,[Not Available],,,1.0,1289.0,0.0,1289.0,,,0.0,1289.0,
TCGA-XF-AAMG,449,TCGA-XF-AAMG,BLCA,49.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,[Not Available],-18021.0,Alive,TUMOR FREE,3364.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3364.0,0.0,3364.0,0.0,3364.0,0.0,3364.0,
TCGA-AX-A3G1,10666,TCGA-AX-A3G1,UCEC,84.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31037.0,Dead,,,624.0,[Not Available],,,,,[Not Available],,,1.0,624.0,,624.0,,,0.0,624.0,
TCGA-85-8071,6719,TCGA-85-8071,LUSC,52.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-19158.0,Alive,TUMOR FREE,815.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,815.0,0.0,815.0,0.0,815.0,0.0,815.0,
TCGA-B9-A5W9,4531,TCGA-B9-A5W9,KIRP,40.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-14668.0,Alive,TUMOR FREE,5.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,5.0,0.0,5.0,0.0,5.0,0.0,5.0,
TCGA-BR-7959,9335,TCGA-BR-7959,STAD,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2011.0,[Not Available],-21730.0,Alive,TUMOR FREE,1010.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1010.0,0.0,1010.0,0.0,1010.0,0.0,1010.0,
TCGA-GU-A763,347,TCGA-GU-A763,BLCA,72.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-26527.0,Alive,WITH TUMOR,997.0,,[Not Available],Distant Metastasis,Lung,,303.0,Stable Disease,,,0.0,997.0,0.0,997.0,,,1.0,303.0,
TCGA-HU-A4G9,9570,TCGA-HU-A4G9,STAD,67.0,FEMALE,ASIAN,Stage IA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-24753.0,Alive,TUMOR FREE,736.0,,[Not Available],,,,,Stable Disease,,,0.0,736.0,0.0,736.0,,,0.0,736.0,
TCGA-EB-A3XD,8945,TCGA-EB-A3XD,SKCM,53.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-19431.0,Alive,TUMOR FREE,1160.0,,[Not Available],,,,,[Not Available],,,0.0,1160.0,0.0,1160.0,,,0.0,1160.0,
TCGA-GN-A4U4,9204,TCGA-GN-A4U4,SKCM,73.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2011.0,[Not Available],-26761.0,Alive,TUMOR FREE,1197.0,,[Not Available],Distant Metastasis,Liver,,217.0,[Not Available],,,0.0,1197.0,0.0,1197.0,,,1.0,217.0,
TCGA-E9-A1RH,1422,TCGA-E9-A1RH,BRCA,63.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23224.0,Alive,TUMOR FREE,1417.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1417.0,0.0,1417.0,0.0,1417.0,0.0,1417.0,
TCGA-FX-A48G,8680,TCGA-FX-A48G,SARC,56.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-20756.0,Dead,WITH TUMOR,,605.0,[Not Available],Distant Metastasis,Lung,,168.0,[Not Available],[Unknown],RX,1.0,605.0,1.0,605.0,,,1.0,168.0,
TCGA-ET-A2MX,10211,TCGA-ET-A2MX,THCA,27.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-10044.0,Alive,TUMOR FREE,2689.0,,[Not Available],,,,,[Not Available],,R0,0.0,2689.0,0.0,2689.0,0.0,2689.0,0.0,2689.0,
TCGA-B0-5701,4059,TCGA-B0-5701,KIRC,65.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2007.0,[Not Available],-23915.0,Alive,TUMOR FREE,2461.0,,[Not Available],,,,224.0,Complete Remission/Response,,,0.0,2461.0,0.0,2461.0,1.0,224.0,1.0,224.0,
TCGA-MM-A564,4416,TCGA-MM-A564,KIRC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2012.0,[Not Available],-24916.0,Alive,TUMOR FREE,607.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,
TCGA-36-2547,7404,TCGA-36-2547,OV,64.0,FEMALE,[Not Available],[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-23706.0,Alive,,624.0,,[Not Available],,,,,[Not Available],,,0.0,624.0,0.0,624.0,,,0.0,624.0,
TCGA-MZ-A5BI,3703,TCGA-MZ-A5BI,HNSC,53.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-19500.0,Dead,,,217.0,[Not Available],,,,,Complete Remission/Response,,,1.0,217.0,,217.0,,,0.0,217.0,
TCGA-RU-A8FL,2409,TCGA-RU-A8FL,COAD,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-18975.0,Alive,WITH TUMOR,1177.0,,[Not Available],Metastatic,,,256.0,Partial Remission/Response,,,0.0,1177.0,0.0,1177.0,,,1.0,256.0,
TCGA-KP-A3W3,11005,TCGA-KP-A3W3,UCEC,72.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26310.0,Alive,WITH TUMOR,794.0,,[Not Available],Distant Metastasis,Liver,,661.0,Complete Remission/Response,,,0.0,794.0,0.0,794.0,1.0,661.0,1.0,661.0,
TCGA-DZ-6134,4584,TCGA-DZ-6134,KIRP,69.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2005.0,[Not Available],-25529.0,Alive,TUMOR FREE,1856.0,,[Not Available],,,,,[Not Available],,,0.0,1856.0,0.0,1856.0,,,0.0,1856.0,
TCGA-EJ-7330,7957,TCGA-EJ-7330,PRAD,68.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25050.0,Alive,TUMOR FREE,191.0,,[Not Available],,,,,[Not Available],,,0.0,191.0,0.0,191.0,,,0.0,191.0,
TCGA-AK-3440,3947,TCGA-AK-3440,KIRC,58.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-21337.0,Alive,TUMOR FREE,2865.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2865.0,0.0,2865.0,0.0,2865.0,0.0,2865.0,
TCGA-XX-A899,1598,TCGA-XX-A899,BRCA,46.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17022.0,Alive,TUMOR FREE,467.0,,[Not Available],,,,,[Not Available],Negative,,0.0,467.0,0.0,467.0,0.0,467.0,0.0,467.0,
TCGA-CR-6492,3436,TCGA-CR-6492,HNSC,78.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-28600.0,Alive,TUMOR FREE,479.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,479.0,0.0,479.0,,,0.0,479.0,
TCGA-OR-A5KZ,55,TCGA-OR-A5KZ,ACC,42.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-15594.0,Dead,WITH TUMOR,,125.0,[Not Available],Locoregional Recurrence,"Other, specify",abdomen,36.0,Progressive Disease,,,1.0,125.0,1.0,125.0,,,1.0,36.0,
TCGA-06-0189,2792,TCGA-06-0189,GBM,55.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-20297.0,Dead,WITH TUMOR,454.0,469.0,[Not Available],,,,,[Not Available],,,1.0,469.0,1.0,469.0,,,1.0,469.0,
TCGA-KN-8418,3818,TCGA-KN-8418,KICH,41.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2002.0,[Not Available],-15086.0,Alive,TUMOR FREE,3935.0,,[Not Available],,,,,[Not Available],,,0.0,3935.0,0.0,3935.0,,,0.0,3935.0,
TCGA-E2-A15J,1342,TCGA-E2-A15J,BRCA,51.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18771.0,Alive,TUMOR FREE,1640.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1640.0,0.0,1640.0,0.0,1640.0,0.0,1640.0,
TCGA-EJ-5511,7926,TCGA-EJ-5511,PRAD,55.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-20409.0,Alive,TUMOR FREE,1476.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1476.0,0.0,1476.0,0.0,1476.0,0.0,1476.0,
TCGA-GV-A3QH,360,TCGA-GV-A3QH,BLCA,67.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-24681.0,Dead,TUMOR FREE,,258.0,[Not Available],Locoregional (Urothelial tumor event),Bladder,,125.0,Stable Disease,,,1.0,258.0,0.0,258.0,,,1.0,125.0,
TCGA-ZP-A9CV,5792,TCGA-ZP-A9CV,LIHC,59.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G1,2011.0,[Not Available],-21633.0,Dead,WITH TUMOR,,1088.0,[Not Available],,,,,[Not Available],,R0,1.0,1088.0,1.0,1088.0,,,1.0,1088.0,
TCGA-DJ-A2Q4,9957,TCGA-DJ-A2Q4,THCA,53.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19689.0,Alive,TUMOR FREE,1032.0,,[Not Available],,,,,[Not Available],,R0,0.0,1032.0,0.0,1032.0,0.0,1032.0,0.0,1032.0,
TCGA-S9-A6TW,5324,TCGA-S9-A6TW,LGG,40.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-14679.0,Alive,TUMOR FREE,1250.0,,[Not Available],,,,861.0,Partial Remission/Response,,,0.0,1250.0,0.0,1250.0,,,1.0,861.0,
TCGA-DJ-A13O,9920,TCGA-DJ-A13O,THCA,56.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-20779.0,Alive,TUMOR FREE,1161.0,,[Not Available],,,,,[Not Available],,R0,0.0,1161.0,0.0,1161.0,0.0,1161.0,0.0,1161.0,
TCGA-97-A4M3,6268,TCGA-97-A4M3,LUAD,69.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-25384.0,Alive,TUMOR FREE,540.0,,[Not Available],New Primary Tumor,,,54.0,Complete Remission/Response,,,0.0,540.0,0.0,540.0,0.0,540.0,1.0,54.0,
TCGA-63-7023,6591,TCGA-63-7023,LUSC,,MALE,[Not Available],Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],,Alive,TUMOR FREE,1682.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1682.0,0.0,1682.0,0.0,1682.0,0.0,1682.0,
TCGA-D9-A4Z5,8909,TCGA-D9-A4Z5,SKCM,68.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-24979.0,Alive,TUMOR FREE,218.0,,[Not Available],,,,,[Not Available],,,0.0,218.0,0.0,218.0,,,0.0,218.0,
TCGA-HZ-8637,7605,TCGA-HZ-8637,PAAD,76.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,[Not Available],-27929.0,Dead,TUMOR FREE,,517.0,"Other, non-malignant disease",,,,,Complete Remission/Response,,,1.0,517.0,0.0,517.0,0.0,517.0,0.0,517.0,
TCGA-3A-A9IL,7533,TCGA-3A-A9IL,PAAD,39.0,FEMALE,WHITE,Stage I,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2007.0,[Not Available],-14599.0,Alive,TUMOR FREE,2741.0,,,,,,,[Unknown],,,0.0,2741.0,0.0,2741.0,,,0.0,2741.0,
TCGA-A3-3370,3917,TCGA-A3-3370,KIRC,48.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-17621.0,Alive,TUMOR FREE,2274.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2274.0,0.0,2274.0,0.0,2274.0,0.0,2274.0,
TCGA-CC-A7IF,5499,TCGA-CC-A7IF,LIHC,59.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-21845.0,Dead,WITH TUMOR,,649.0,[Not Available],New Primary Tumor,Lung,,254.0,[Not Available],,R0,1.0,649.0,1.0,649.0,0.0,649.0,1.0,254.0,
TCGA-32-2615,3180,TCGA-32-2615,GBM,62.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-22916.0,Dead,WITH TUMOR,485.0,485.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],131.0,[Not Available],,,1.0,485.0,1.0,485.0,,,1.0,131.0,
TCGA-B0-5120,4043,TCGA-B0-5120,KIRC,72.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-26559.0,Alive,TUMOR FREE,1169.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1169.0,0.0,1169.0,0.0,1169.0,0.0,1169.0,
TCGA-XU-A92Y,10427,TCGA-XU-A92Y,THYM,71.0,FEMALE,WHITE,[Not Applicable],IIb,Thymoma; Type B3,[Not Available],2004.0,[Not Available],-26021.0,Dead,WITH TUMOR,,3488.0,[Not Available],Locoregional Recurrence,"Other, specify","posterior mediastinal tumour, adrenal/perinephric tumour involving left pleural space, diaphragm, chest wall, spine",1224.0,[Not Available],,,1.0,3488.0,1.0,3488.0,,,1.0,1224.0,
TCGA-RC-A7SF,5767,TCGA-RC-A7SF,LIHC,66.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-24432.0,Alive,WITH TUMOR,579.0,,[Not Available],Locoregional Recurrence,Liver,,502.0,[Not Available],,R0,0.0,579.0,0.0,579.0,1.0,502.0,1.0,502.0,
TCGA-DJ-A4UW,10006,TCGA-DJ-A4UW,THCA,34.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2012.0,[Not Available],-12563.0,Alive,TUMOR FREE,819.0,,[Not Available],,,,,[Not Available],,R1,0.0,819.0,0.0,819.0,,,0.0,819.0,
TCGA-C8-A1HI,1201,TCGA-C8-A1HI,BRCA,40.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,Alive,TUMOR FREE,343.0,,[Not Available],,,,,[Not Available],Negative,,0.0,343.0,0.0,343.0,0.0,343.0,0.0,343.0,
TCGA-F5-6864,8532,TCGA-F5-6864,READ,74.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-27058.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-76-6192,3221,TCGA-76-6192,GBM,74.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-27322.0,Dead,WITH TUMOR,100.0,100.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],76.0,[Not Available],,,1.0,100.0,1.0,100.0,,,1.0,76.0,
TCGA-EM-A1YC,10127,TCGA-EM-A1YC,THCA,71.0,FEMALE,[Not Available],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2007.0,[Not Available],-26143.0,Alive,TUMOR FREE,2391.0,,[Not Available],,,,,[Not Available],,R0,0.0,2391.0,0.0,2391.0,0.0,2391.0,0.0,2391.0,
TCGA-C8-A12X,1187,TCGA-C8-A12X,BRCA,62.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Mucinous Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22889.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],Negative,,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-OR-A5JJ,19,TCGA-OR-A5JJ,ACC,65.0,MALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-24082.0,Dead,WITH TUMOR,,490.0,[Not Available],,,,,Progressive Disease,,,1.0,490.0,1.0,490.0,,,1.0,490.0,
TCGA-ZG-A9KY,8347,TCGA-ZG-A9KY,PRAD,73.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-27000.0,Alive,,130.0,,[Not Available],,,,,Stable Disease,,,0.0,130.0,0.0,130.0,,,0.0,130.0,
TCGA-91-6848,6220,TCGA-91-6848,LUAD,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-21829.0,Alive,TUMOR FREE,224.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,224.0,0.0,224.0,0.0,224.0,0.0,224.0,
TCGA-AD-6963,2194,TCGA-AD-6963,COAD,58.0,MALE,WHITE,[Not Available],[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-21294.0,Alive,TUMOR FREE,834.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,834.0,0.0,834.0,0.0,834.0,0.0,834.0,
TCGA-QK-A6VC,3730,TCGA-QK-A6VC,HNSC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-22865.0,Alive,TUMOR FREE,600.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,600.0,0.0,600.0,,,0.0,600.0,
TCGA-CR-7402,3468,TCGA-CR-7402,HNSC,68.0,MALE,WHITE,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-25138.0,Alive,TUMOR FREE,911.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,
TCGA-KK-A8I5,8201,TCGA-KK-A8I5,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-20337.0,Alive,TUMOR FREE,3096.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3096.0,0.0,3096.0,0.0,3096.0,0.0,3096.0,
TCGA-D3-A8GQ,8895,TCGA-D3-A8GQ,SKCM,66.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],2004.0,[Not Available],-24348.0,Dead,WITH TUMOR,,884.0,[Not Available],Distant Metastasis,Liver,,578.0,[Not Available],,,1.0,884.0,1.0,884.0,,,1.0,578.0,
TCGA-GM-A2DB,1502,TCGA-GM-A2DB,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22883.0,Alive,TUMOR FREE,2406.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2406.0,0.0,2406.0,0.0,2406.0,0.0,2406.0,
TCGA-XY-A8S3,9825,TCGA-XY-A8S3,TGCT,24.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Choriocarcinoma,[Not Available],2012.0,[Not Available],-8835.0,Alive,TUMOR FREE,843.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,843.0,0.0,843.0,0.0,843.0,0.0,843.0,
TCGA-21-5783,6356,TCGA-21-5783,LUSC,76.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-27904.0,Dead,,,2680.0,[Not Available],,,,,[Not Available],,,1.0,2680.0,,2680.0,,,0.0,2680.0,
TCGA-G2-A2EF,313,TCGA-G2-A2EF,BLCA,50.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-18467.0,Alive,TUMOR FREE,1884.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1884.0,0.0,1884.0,,,0.0,1884.0,
TCGA-JY-A6FD,2497,TCGA-JY-A6FD,ESCA,51.0,FEMALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G1,2008.0,[Not Available],-18808.0,Alive,TUMOR FREE,2069.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2069.0,0.0,2069.0,0.0,2069.0,0.0,2069.0,
TCGA-S7-A7WM,7779,TCGA-S7-A7WM,PCPG,76.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-27984.0,Alive,TUMOR FREE,1112.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0,
TCGA-DY-A1DD,8498,TCGA-DY-A1DD,READ,77.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],1999.0,[Not Available],-28159.0,Dead,,1741.0,1741.0,[Not Available],,,,,[Not Available],,,1.0,1741.0,,1741.0,,,0.0,1741.0,
TCGA-SX-A7SM,4674,TCGA-SX-A7SM,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-22044.0,Dead,WITH TUMOR,,363.0,[Not Available],,,,,Progressive Disease,,,1.0,363.0,1.0,363.0,,,1.0,363.0,
TCGA-UP-A6WW,3767,TCGA-UP-A6WW,HNSC,58.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-21427.0,Alive,TUMOR FREE,518.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,518.0,0.0,518.0,,,0.0,518.0,
TCGA-DX-A6Z2,8622,TCGA-DX-A6Z2,SARC,82.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2007.0,[Not Available],-30042.0,Alive,WITH TUMOR,3079.0,,[Not Available],Distant Metastasis,Lung,,2659.0,[Not Available],Positive,R0,0.0,3079.0,0.0,3079.0,1.0,2659.0,1.0,2659.0,
TCGA-P5-A735,5282,TCGA-P5-A735,LGG,38.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-14152.0,Alive,TUMOR FREE,292.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,292.0,0.0,292.0,0.0,292.0,0.0,292.0,
TCGA-06-6700,2886,TCGA-06-6700,GBM,76.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-27850.0,Alive,WITH TUMOR,145.0,,[Not Available],,,,,[Not Available],,,0.0,145.0,0.0,145.0,,,0.0,145.0,
TCGA-CD-A486,9435,TCGA-CD-A486,STAD,68.0,MALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-24879.0,Dead,WITH TUMOR,,192.0,[Not Available],Distant Metastasis,Liver,liver and lung,79.0,Complete Remission/Response,,,1.0,192.0,1.0,192.0,1.0,79.0,1.0,79.0,
TCGA-MP-A4TJ,6311,TCGA-MP-A4TJ,LUAD,62.0,FEMALE,[Unknown],Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-22875.0,Dead,,,339.0,[Not Available],,,,,Complete Remission/Response,,,1.0,339.0,,339.0,0.0,339.0,0.0,339.0,
TCGA-WB-A81P,7856,TCGA-WB-A81P,PCPG,73.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-26867.0,Alive,TUMOR FREE,395.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,395.0,0.0,395.0,0.0,395.0,0.0,395.0,
TCGA-S9-A7IX,5350,TCGA-S9-A7IX,LGG,57.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-21095.0,Dead,WITH TUMOR,,819.0,[Not Available],,,,350.0,Progressive Disease,,,1.0,819.0,1.0,819.0,,,1.0,350.0,
TCGA-A2-A0YJ,591,TCGA-A2-A0YJ,BRCA,39.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14448.0,Alive,WITH TUMOR,566.0,,[Not Available],Distant Metastasis,"Other, specify",Left Cervical Lymph Node,559.0,[Not Available],Negative,,0.0,566.0,0.0,566.0,1.0,559.0,1.0,559.0,
TCGA-G9-6384,8042,TCGA-G9-6384,PRAD,53.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-19620.0,Alive,TUMOR FREE,765.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,765.0,0.0,765.0,0.0,765.0,0.0,765.0,
TCGA-A7-A5ZV,664,TCGA-A7-A5ZV,BRCA,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Carcinoma NOS,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22966.0,Alive,TUMOR FREE,368.0,,[Not Available],,,,,[Not Available],Negative,,0.0,368.0,0.0,368.0,0.0,368.0,0.0,368.0,
TCGA-BT-A20R,129,TCGA-BT-A20R,BLCA,79.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-28987.0,Dead,,,154.0,[Not Available],,,,,[Not Available],,,1.0,154.0,,154.0,,,0.0,154.0,
TCGA-22-4604,6377,TCGA-22-4604,LUSC,73.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-26952.0,Dead,WITH TUMOR,,399.0,[Not Available],,,,306.0,[Not Available],,,1.0,399.0,1.0,399.0,,,1.0,306.0,
TCGA-EL-A3ZP,10100,TCGA-EL-A3ZP,THCA,19.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-7101.0,Alive,TUMOR FREE,1992.0,,[Not Available],,,,,[Not Available],,R0,0.0,1992.0,0.0,1992.0,0.0,1992.0,0.0,1992.0,
TCGA-BT-A42B,141,TCGA-BT-A42B,BLCA,59.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-21788.0,Dead,WITH TUMOR,,534.0,[Not Available],,,,,Partial Remission/Response,,,1.0,534.0,1.0,534.0,,,1.0,534.0,
TCGA-BR-8286,9345,TCGA-BR-8286,STAD,49.0,MALE,WHITE,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-17966.0,Alive,TUMOR FREE,895.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,895.0,0.0,895.0,0.0,895.0,0.0,895.0,
TCGA-BT-A2LB,136,TCGA-BT-A2LB,BLCA,73.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-26846.0,Dead,TUMOR FREE,,492.0,[Not Available],,,,,Complete Remission/Response,,,1.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,
TCGA-LL-A5YO,1537,TCGA-LL-A5YO,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18354.0,Alive,TUMOR FREE,440.0,,[Not Available],,,,,[Not Available],Negative,,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,
TCGA-A4-A48D,4485,TCGA-A4-A48D,KIRP,84.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-31038.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-UZ-A9PM,4686,TCGA-UZ-A9PM,KIRP,62.0,MALE,WHITE,Stage II,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-22646.0,Alive,TUMOR FREE,3811.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3811.0,0.0,3811.0,0.0,3811.0,0.0,3811.0,
TCGA-AF-2690,8369,TCGA-AF-2690,READ,76.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-28119.0,Dead,TUMOR FREE,,524.0,[Not Available],,,,,[Not Available],,,1.0,524.0,0.0,524.0,,,0.0,524.0,
TCGA-E8-A438,10037,TCGA-E8-A438,THCA,23.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-8752.0,Alive,TUMOR FREE,1019.0,,[Not Available],,,,,[Not Available],,R0,0.0,1019.0,0.0,1019.0,0.0,1019.0,0.0,1019.0,
TCGA-67-3771,6087,TCGA-67-3771,LUAD,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-28406.0,Alive,TUMOR FREE,610.0,,[Not Available],,,,,[Not Available],,,0.0,610.0,0.0,610.0,,,0.0,610.0,
TCGA-O2-A52Q,6823,TCGA-O2-A52Q,LUSC,44.0,FEMALE,WHITE,Stage III,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-16429.0,Dead,WITH TUMOR,,113.0,[Not Available],Distant Metastasis,,,87.0,[Unknown],,,1.0,113.0,1.0,113.0,,,1.0,87.0,
TCGA-ZM-AA0N,9844,TCGA-ZM-AA0N,TGCT,44.0,MALE,WHITE,Stage IB,Stage IB,Seminoma; NOS,[Not Available],2013.0,[Not Available],-16094.0,Alive,TUMOR FREE,634.0,,[Not Applicable],Distant Metastasis,Retroperitoneal lymph nodes,,490.0,No Measureable Tumor or Tumor Markers,,,0.0,634.0,0.0,634.0,1.0,490.0,1.0,490.0,
TCGA-A6-6652,2001,TCGA-A6-6652,COAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-21638.0,Alive,WITH TUMOR,751.0,,[Not Available],,,,,[Not Applicable],,,0.0,751.0,0.0,751.0,,,0.0,751.0,
TCGA-WY-A85D,5424,TCGA-WY-A85D,LGG,60.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2010.0,[Not Available],-21979.0,Alive,WITH TUMOR,1147.0,,[Not Available],,,,887.0,Partial Remission/Response,,,0.0,1147.0,0.0,1147.0,,,1.0,887.0,
TCGA-4V-A9QJ,10362,TCGA-4V-A9QJ,THYM,64.0,MALE,WHITE,[Not Applicable],III,Thymoma; Type B3,[Not Available],2007.0,[Not Available],-23510.0,Alive,TUMOR FREE,2849.0,,[Not Available],Locoregional Recurrence,Pleura/Pleural effusion,,793.0,[Not Available],,,0.0,2849.0,0.0,2849.0,,,1.0,793.0,
TCGA-QR-A6GU,7701,TCGA-QR-A6GU,PCPG,31.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2008.0,[Not Available],-11592.0,Alive,TUMOR FREE,1791.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1791.0,0.0,1791.0,0.0,1791.0,0.0,1791.0,
TCGA-3B-A9HY,8549,TCGA-3B-A9HY,SARC,49.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-18109.0,Alive,TUMOR FREE,314.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,314.0,0.0,314.0,0.0,314.0,0.0,314.0,
TCGA-R6-A6L6,2603,TCGA-R6-A6L6,ESCA,68.0,MALE,WHITE,[Not Available],Stage IV,"Esophagus Adenocarcinoma, NOS",G3,2010.0,[Not Available],-25092.0,Dead,WITH TUMOR,,214.0,[Not Available],,,,,,,,1.0,214.0,1.0,214.0,,,1.0,214.0,
TCGA-33-4566,6402,TCGA-33-4566,LUSC,40.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1996.0,[Not Available],-14643.0,Dead,,,5287.0,[Not Available],,,,,[Unknown],,,1.0,5287.0,,5287.0,,,0.0,5287.0,
TCGA-RY-A845,5319,TCGA-RY-A845,LGG,40.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-14617.0,Alive,TUMOR FREE,596.0,,[Not Available],,,,,[Not Applicable],,,0.0,596.0,0.0,596.0,,,0.0,596.0,
TCGA-14-0862,3008,TCGA-14-0862,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-22179.0,Dead,WITH TUMOR,88.0,88.0,[Not Available],,,,,[Not Available],,,1.0,88.0,1.0,88.0,,,1.0,88.0,
TCGA-D7-8573,9506,TCGA-D7-8573,STAD,57.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-20963.0,Alive,WITH TUMOR,593.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,593.0,0.0,593.0,0.0,593.0,0.0,593.0,
TCGA-BH-A5J0,1169,TCGA-BH-A5J0,BRCA,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23072.0,Alive,TUMOR FREE,715.0,,[Not Available],,,,,[Not Available],Negative,,0.0,715.0,0.0,715.0,0.0,715.0,0.0,715.0,
TCGA-NA-A4R1,11067,TCGA-NA-A4R1,UCS,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27688.0,Dead,WITH TUMOR,,203.0,[Not Available],,,,,[Not Available],,,1.0,203.0,1.0,203.0,,,1.0,203.0,
TCGA-RE-A7BO,2612,TCGA-RE-A7BO,ESCA,72.0,FEMALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2006.0,[Not Available],-26348.0,Dead,TUMOR FREE,,213.0,[Not Available],,,,,,,,1.0,213.0,0.0,213.0,,,0.0,213.0,
TCGA-56-5898,6509,TCGA-56-5898,LUSC,69.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-25441.0,Alive,TUMOR FREE,555.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,555.0,0.0,555.0,0.0,555.0,0.0,555.0,
TCGA-EJ-5518,7932,TCGA-EJ-5518,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-24313.0,Alive,WITH TUMOR,2118.0,,[Not Available],Distant Metastasis,Bone,,2104.0,Progressive Disease,,,0.0,2118.0,0.0,2118.0,,,1.0,2104.0,
TCGA-BJ-A28V,9868,TCGA-BJ-A28V,THCA,80.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-29508.0,Alive,TUMOR FREE,987.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,987.0,0.0,987.0,,,0.0,987.0,
TCGA-78-8660,6172,TCGA-78-8660,LUAD,69.0,MALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-25422.0,Dead,WITH TUMOR,,321.0,[Not Available],Distant Metastasis,,,242.0,[Unknown],,,1.0,321.0,1.0,321.0,,,1.0,242.0,
TCGA-37-4129,6442,TCGA-37-4129,LUSC,52.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-19154.0,Alive,TUMOR FREE,242.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,242.0,0.0,242.0,0.0,242.0,0.0,242.0,
TCGA-39-5034,6463,TCGA-39-5034,LUSC,73.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-26682.0,Dead,,1107.0,1107.0,[Not Available],,,,352.0,Complete Remission/Response,,,1.0,1107.0,,1107.0,1.0,352.0,1.0,352.0,
TCGA-E7-A519,239,TCGA-E7-A519,BLCA,72.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-26427.0,Alive,TUMOR FREE,508.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,508.0,0.0,508.0,0.0,508.0,0.0,508.0,
TCGA-CD-A48A,9438,TCGA-CD-A48A,STAD,57.0,MALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-20839.0,Alive,TUMOR FREE,378.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,
TCGA-CQ-A4C6,3406,TCGA-CQ-A4C6,HNSC,63.0,MALE,ASIAN,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-23205.0,Alive,TUMOR FREE,1353.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1353.0,0.0,1353.0,0.0,1353.0,0.0,1353.0,
TCGA-CH-5740,7881,TCGA-CH-5740,PRAD,57.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-20880.0,Alive,TUMOR FREE,31.0,,[Not Available],,,,,[Not Available],,,0.0,31.0,0.0,31.0,,,0.0,31.0,
TCGA-D5-6929,2321,TCGA-D5-6929,COAD,49.0,FEMALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-17919.0,Alive,TUMOR FREE,408.0,,[Not Available],,,,,[Not Available],,,0.0,408.0,0.0,408.0,,,0.0,408.0,
TCGA-CV-7236,3534,TCGA-CV-7236,HNSC,77.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2007.0,[Not Available],-28250.0,Dead,TUMOR FREE,,144.0,[Not Available],,,,,[Not Available],,,1.0,144.0,0.0,144.0,,,0.0,144.0,
TCGA-EY-A1GU,10959,TCGA-EY-A1GU,UCEC,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24304.0,Dead,TUMOR FREE,,997.0,[Not Available],,,,,Complete Remission/Response,,,1.0,997.0,0.0,997.0,0.0,997.0,0.0,997.0,
TCGA-AO-A126,872,TCGA-AO-A126,BRCA,39.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14264.0,Alive,TUMOR FREE,3307.0,,[Not Available],Locoregional Disease,,,267.0,[Not Available],Negative,,0.0,3307.0,0.0,3307.0,1.0,267.0,1.0,267.0,
TCGA-EM-A3AQ,10167,TCGA-EM-A3AQ,THCA,85.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-31198.0,Alive,TUMOR FREE,904.0,,[Not Available],,,,,[Not Available],,R0,0.0,904.0,0.0,904.0,0.0,904.0,0.0,904.0,
TCGA-B0-4945,4014,TCGA-B0-4945,KIRC,75.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2003.0,[Not Available],-27523.0,Dead,TUMOR FREE,,2145.0,[Not Available],,,,,[Not Available],,,1.0,2145.0,0.0,2145.0,,,0.0,2145.0,
TCGA-PL-A8LY,1580,TCGA-PL-A8LY,BRCA,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11199.0,Alive,WITH TUMOR,8.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,8.0,0.0,8.0,,,0.0,8.0,
TCGA-49-4487,5903,TCGA-49-4487,LUAD,72.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1992.0,[Not Available],-26583.0,Dead,WITH TUMOR,,855.0,[Not Available],,,,697.0,Complete Remission/Response,,,1.0,855.0,1.0,855.0,1.0,697.0,1.0,697.0,
TCGA-EE-A180,8995,TCGA-EE-A180,SKCM,69.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2001.0,[Not Available],-25523.0,Dead,WITH TUMOR,,2889.0,[Not Available],New primary melanoma,,,850.0,[Not Available],,,1.0,2889.0,1.0,2889.0,,,1.0,850.0,
TCGA-Y6-A8TL,8313,TCGA-Y6-A8TL,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-23776.0,Alive,TUMOR FREE,992.0,,[Not Available],,,,,[Not Available],,,0.0,992.0,0.0,992.0,,,0.0,992.0,
TCGA-CJ-4900,4304,TCGA-CJ-4900,KIRC,69.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-25508.0,Dead,WITH TUMOR,,1714.0,[Not Available],,,,,[Not Available],,,1.0,1714.0,1.0,1714.0,,,1.0,1714.0,
TCGA-DD-AACE,5584,TCGA-DD-AACE,LIHC,62.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2008.0,[Not Available],-22727.0,Alive,TUMOR FREE,2184.0,,[Not Available],Intrahepatic Recurrence,Liver,,1279.0,[Not Available],,R0,0.0,2184.0,0.0,2184.0,1.0,1279.0,1.0,1279.0,
TCGA-EM-A3FK,10170,TCGA-EM-A3FK,THCA,30.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-10992.0,Alive,TUMOR FREE,723.0,,[Not Available],,,,,[Not Available],,R0,0.0,723.0,0.0,723.0,0.0,723.0,0.0,723.0,
TCGA-86-8075,6192,TCGA-86-8075,LUAD,66.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-24402.0,Dead,TUMOR FREE,,694.0,[Not Available],Locoregional Recurrence,,,199.0,Complete Remission/Response,,,1.0,694.0,0.0,694.0,1.0,199.0,1.0,199.0,
TCGA-2G-AAF8,9716,TCGA-2G-AAF8,TGCT,33.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2004.0,[Not Available],-12256.0,Alive,TUMOR FREE,3911.0,,[Not Applicable],New Primary Tumor,Testes,,3149.0,Complete Remission/Response,,,0.0,3911.0,0.0,3911.0,1.0,3149.0,1.0,3149.0,
TCGA-ZF-A9R0,473,TCGA-ZF-A9R0,BLCA,82.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-30222.0,Dead,WITH TUMOR,,680.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",right hemipelvis,559.0,Progressive Disease,,,1.0,680.0,1.0,680.0,,,1.0,559.0,
TCGA-GM-A2DF,1505,TCGA-GM-A2DF,BRCA,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19614.0,Alive,TUMOR FREE,2155.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2155.0,0.0,2155.0,0.0,2155.0,0.0,2155.0,
TCGA-WB-A81R,7858,TCGA-WB-A81R,PCPG,55.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-20438.0,Alive,TUMOR FREE,49.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,49.0,0.0,49.0,0.0,49.0,0.0,49.0,
TCGA-A6-6782,2006,TCGA-A6-6782,COAD,82.0,MALE,WHITE,Stage IIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-30012.0,Alive,TUMOR FREE,617.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,617.0,0.0,617.0,0.0,617.0,0.0,617.0,
TCGA-B5-A121,10714,TCGA-B5-A121,UCEC,57.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21018.0,Alive,TUMOR FREE,504.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,504.0,0.0,504.0,0.0,504.0,0.0,504.0,
TCGA-V5-AASX,2620,TCGA-V5-AASX,ESCA,74.0,MALE,WHITE,[Not Available],Stage IV,"Esophagus Adenocarcinoma, NOS",G2,,[Not Available],-27081.0,Alive,WITH TUMOR,273.0,,[Not Available],Distant Metastasis,"Other, specify",bone,273.0,[Unknown],,,0.0,273.0,0.0,273.0,,,1.0,273.0,
TCGA-C4-A0EZ,145,TCGA-C4-A0EZ,BLCA,69.0,FEMALE,[Not Available],Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-25202.0,Dead,WITH TUMOR,,273.0,[Not Available],,,,,Partial Remission/Response,,,1.0,273.0,1.0,273.0,,,1.0,273.0,Redacted
TCGA-BG-A0M8,10742,TCGA-BG-A0M8,UCEC,50.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2008.0,Indeterminate (neither Pre or Postmenopausal),-18308.0,Alive,TUMOR FREE,2020.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2020.0,0.0,2020.0,0.0,2020.0,0.0,2020.0,
TCGA-E2-A1B6,1356,TCGA-E2-A1B6,BRCA,44.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16370.0,Alive,TUMOR FREE,867.0,,[Not Available],,,,,[Not Available],Negative,,0.0,867.0,0.0,867.0,0.0,867.0,0.0,867.0,
TCGA-VB-A8QN,2460,TCGA-VB-A8QN,DLBC,55.0,MALE,WHITE,[Not Applicable],Stage III,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013.0,[Not Available],-20270.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-VQ-A94R,9695,TCGA-VQ-A94R,STAD,63.0,MALE,WHITE,[Discrepancy],[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,[Not Available],-23246.0,Dead,WITH TUMOR,,1294.0,Stomach Cancer,Locoregional Recurrence,,,1018.0,Progressive Disease,,,1.0,1294.0,1.0,1294.0,,,1.0,1018.0,
TCGA-HC-8213,8095,TCGA-HC-8213,PRAD,48.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-17673.0,Alive,TUMOR FREE,589.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,589.0,0.0,589.0,0.0,589.0,0.0,589.0,
TCGA-75-7025,6137,TCGA-75-7025,LUAD,,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],,[Not Available],,Alive,TUMOR FREE,3305.0,,[Not Available],Locoregional Recurrence|Distant Metastasis,,,1481.0,Complete Remission/Response,,,0.0,3305.0,0.0,3305.0,1.0,1481.0,1.0,1481.0,
TCGA-KS-A4IC,10341,TCGA-KS-A4IC,THCA,45.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-16671.0,Alive,TUMOR FREE,1073.0,,[Not Available],,,,,[Not Available],,RX,0.0,1073.0,0.0,1073.0,,,0.0,1073.0,
TCGA-DD-A73G,5576,TCGA-DD-A73G,LIHC,73.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2005.0,[Not Available],-26949.0,Alive,TUMOR FREE,3478.0,,[Not Available],,,,,[Not Available],,R0,0.0,3478.0,0.0,3478.0,0.0,3478.0,0.0,3478.0,
TCGA-FB-AAQ2,7567,TCGA-FB-AAQ2,PAAD,81.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-29585.0,Dead,WITH TUMOR,,153.0,,Distant Metastasis,Liver,,92.0,Partial Remission/Response,,,1.0,153.0,1.0,153.0,,,1.0,92.0,
TCGA-CV-A6JE,3594,TCGA-CV-A6JE,HNSC,78.0,MALE,WHITE,[Not Available],Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-28658.0,Alive,TUMOR FREE,1075.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1075.0,0.0,1075.0,0.0,1075.0,0.0,1075.0,
TCGA-MA-AA43,1810,TCGA-MA-AA43,CESC,48.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2013.0,Peri (6-12 months since last menstrual period),-17658.0,Alive,TUMOR FREE,346.0,,,,,,,Complete Remission/Response,,,0.0,346.0,0.0,346.0,0.0,346.0,0.0,346.0,
TCGA-CN-4736,3314,TCGA-CN-4736,HNSC,70.0,FEMALE,WHITE,[Not Available],Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-25683.0,Dead,WITH TUMOR,,395.0,[Not Available],,Cervical Lymph Nodes,R NECK,209.0,Complete Remission/Response,,,1.0,395.0,1.0,395.0,1.0,209.0,1.0,209.0,
TCGA-A6-6137,1992,TCGA-A6-6137,COAD,55.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-20095.0,Alive,TUMOR FREE,824.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,824.0,0.0,824.0,0.0,824.0,0.0,824.0,
TCGA-SR-A6N0,7814,TCGA-SR-A6N0,PCPG,45.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-16489.0,Alive,TUMOR FREE,1509.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1509.0,0.0,1509.0,0.0,1509.0,0.0,1509.0,
TCGA-FD-A3SN,269,TCGA-FD-A3SN,BLCA,79.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-29169.0,Alive,TUMOR FREE,887.0,,[Not Available],Distant Metastasis,Lung,,110.0,Progressive Disease,,,0.0,887.0,0.0,887.0,,,1.0,110.0,
TCGA-BR-4292,9289,TCGA-BR-4292,STAD,73.0,FEMALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2009.0,[Not Available],-26670.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-DX-A48R,8600,TCGA-DX-A48R,SARC,41.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2002.0,[Not Available],-15107.0,Alive,WITH TUMOR,805.0,,[Not Available],Locoregional Recurrence,,,315.0,[Not Available],Positive,R1,0.0,805.0,0.0,805.0,,,1.0,315.0,
TCGA-DU-A5TR,5042,TCGA-DU-A5TR,LGG,51.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-18791.0,Alive,TUMOR FREE,908.0,,[Not Available],,,,848.0,[Discrepancy],,,0.0,908.0,0.0,908.0,,,1.0,848.0,
TCGA-85-8070,6718,TCGA-85-8070,LUSC,71.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26183.0,Alive,TUMOR FREE,960.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,960.0,0.0,960.0,0.0,960.0,0.0,960.0,
TCGA-A4-A4ZT,4486,TCGA-A4-A4ZT,KIRP,71.0,FEMALE,WHITE,Stage I,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-26058.0,Alive,TUMOR FREE,516.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,
TCGA-K4-A6FZ,381,TCGA-K4-A6FZ,BLCA,75.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27686.0,Alive,TUMOR FREE,55.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,55.0,0.0,55.0,0.0,55.0,0.0,55.0,
TCGA-S9-A6WL,5342,TCGA-S9-A6WL,LGG,52.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-19234.0,Alive,WITH TUMOR,946.0,,[Not Available],,,,240.0,Progressive Disease,,,0.0,946.0,0.0,946.0,,,1.0,240.0,
TCGA-CV-6433,3491,TCGA-CV-6433,HNSC,57.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-20855.0,Alive,WITH TUMOR,641.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,641.0,0.0,641.0,0.0,641.0,0.0,641.0,
TCGA-JY-A93C,2503,TCGA-JY-A93C,ESCA,47.0,MALE,ASIAN,Stage IIIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2011.0,[Not Available],-17228.0,Alive,WITH TUMOR,705.0,,[Not Available],Locoregional Recurrence,,,652.0,Complete Remission/Response,,,0.0,705.0,0.0,705.0,1.0,652.0,1.0,652.0,
TCGA-D1-A163,10834,TCGA-D1-A163,UCEC,50.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G2,2008.0,Peri (6-12 months since last menstrual period),-18604.0,Alive,TUMOR FREE,991.0,,[Not Available],Metastatic,"Other, specify",Paraaortic retroperitoneal lymphnode,223.0,Complete Remission/Response,,,0.0,991.0,0.0,991.0,1.0,223.0,1.0,223.0,
TCGA-CN-6989,3350,TCGA-CN-6989,HNSC,64.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-23515.0,Dead,WITH TUMOR,,980.0,[Not Available],,,,436.0,Complete Remission/Response,,,1.0,980.0,1.0,980.0,,,1.0,436.0,
TCGA-DW-5561,4571,TCGA-DW-5561,KIRP,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-18744.0,Alive,[Discrepancy],414.0,,[Not Available],,,,,[Not Available],,,0.0,414.0,0.0,414.0,,,0.0,414.0,
TCGA-D3-A1QA,8833,TCGA-D3-A1QA,SKCM,55.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2005.0,[Not Available],-20223.0,Alive,WITH TUMOR,2765.0,,[Not Available],Distant Metastasis,Lung,,1393.0,[Not Available],,,0.0,2765.0,0.0,2765.0,,,1.0,1393.0,
TCGA-XF-AAN2,462,TCGA-XF-AAN2,BLCA,73.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-26720.0,Dead,TUMOR FREE,,1869.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1869.0,0.0,1869.0,0.0,1869.0,0.0,1869.0,
TCGA-EE-A29A,9006,TCGA-EE-A29A,SKCM,68.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2003.0,[Not Available],-25095.0,Dead,WITH TUMOR,,1927.0,[Not Available],Locoregional Recurrence,,,867.0,[Not Available],,,1.0,1927.0,1.0,1927.0,,,1.0,867.0,
TCGA-LD-A9QF,1529,TCGA-LD-A9QF,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26869.0,Alive,TUMOR FREE,323.0,,[Not Available],,,,,[Not Available],Negative,,0.0,323.0,0.0,323.0,0.0,323.0,0.0,323.0,
TCGA-BA-7269,3263,TCGA-BA-7269,HNSC,61.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2010.0,[Not Available],-22609.0,Alive,TUMOR FREE,1273.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1273.0,0.0,1273.0,0.0,1273.0,0.0,1273.0,
TCGA-WY-A85C,5423,TCGA-WY-A85C,LGG,36.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-13506.0,Alive,WITH TUMOR,1426.0,,[Not Available],,,,809.0,Progressive Disease,,,0.0,1426.0,0.0,1426.0,,,1.0,809.0,
TCGA-DK-A3X2,209,TCGA-DK-A3X2,BLCA,85.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-31160.0,Dead,WITH TUMOR,,547.0,[Not Available],Distant Metastasis,Liver,,533.0,Complete Remission/Response,,,1.0,547.0,1.0,547.0,,,1.0,533.0,
TCGA-OR-A5LN,77,TCGA-OR-A5LN,ACC,31.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-11414.0,Alive,TUMOR FREE,2342.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2342.0,0.0,2342.0,0.0,2342.0,0.0,2342.0,
TCGA-AP-A1E3,10603,TCGA-AP-A1E3,UCEC,45.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16544.0,Alive,WITH TUMOR,847.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,847.0,0.0,847.0,,,0.0,847.0,
TCGA-ER-A3ET,9122,TCGA-ER-A3ET,SKCM,64.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2005.0,[Not Available],-23650.0,Dead,WITH TUMOR,,2829.0,[Not Available],Distant Metastasis,Lung,,2435.0,[Not Available],,,1.0,2829.0,1.0,2829.0,,,1.0,2435.0,
TCGA-EU-5905,4407,TCGA-EU-5905,KIRC,67.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-24475.0,Alive,TUMOR FREE,119.0,,[Not Available],,,,,[Not Available],,,0.0,119.0,0.0,119.0,,,0.0,119.0,
TCGA-AX-A3FX,10664,TCGA-AX-A3FX,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25260.0,Dead,,,1333.0,[Not Available],Locoregional Recurrence,"Other, specify",Chest,938.0,[Not Available],,,1.0,1333.0,,1333.0,,,1.0,938.0,
TCGA-P5-A72W,5276,TCGA-P5-A72W,LGG,35.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-12848.0,Alive,TUMOR FREE,317.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,317.0,0.0,317.0,0.0,317.0,0.0,317.0,
TCGA-DX-A6YR,8614,TCGA-DX-A6YR,SARC,75.0,MALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2011.0,[Not Available],-27434.0,Alive,TUMOR FREE,1247.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1247.0,0.0,1247.0,0.0,1247.0,0.0,1247.0,
TCGA-B1-7332,4505,TCGA-B1-7332,KIRP,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-22277.0,Alive,TUMOR FREE,1141.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1141.0,0.0,1141.0,0.0,1141.0,0.0,1141.0,
TCGA-N8-A4PL,11049,TCGA-N8-A4PL,UCS,82.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30069.0,Dead,WITH TUMOR,,418.0,[Not Available],Locoregional Recurrence,Lymph Node(s),,138.0,Progressive Disease,,,1.0,418.0,1.0,418.0,,,1.0,138.0,
TCGA-IB-A7LX,7644,TCGA-IB-A7LX,PAAD,57.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-20898.0,Dead,WITH TUMOR,,250.0,Pancreatic Cancer,Distant Metastasis,Liver,,7.0,Progressive Disease,,,1.0,250.0,1.0,250.0,,,1.0,7.0,
TCGA-X7-A8DJ,10395,TCGA-X7-A8DJ,THYM,68.0,MALE,[Unknown],[Not Applicable],I,Thymoma; Type AB,[Not Available],2013.0,[Not Available],-25042.0,Alive,TUMOR FREE,289.0,,[Not Available],,,,,[Not Available],,,0.0,289.0,0.0,289.0,,,0.0,289.0,
TCGA-KM-8476,3800,TCGA-KM-8476,KICH,47.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2002.0,[Not Available],-17240.0,Alive,TUMOR FREE,3745.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3745.0,0.0,3745.0,0.0,3745.0,0.0,3745.0,
TCGA-BR-7196,9321,TCGA-BR-7196,STAD,64.0,MALE,WHITE,Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-23611.0,Alive,WITH TUMOR,666.0,,[Not Available],Distant Metastasis,Lung,,348.0,Complete Remission/Response,,,0.0,666.0,0.0,666.0,,,1.0,348.0,
TCGA-GS-A9TU,2449,TCGA-GS-A9TU,DLBC,45.0,MALE,WHITE,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2004.0,[Not Available],-16720.0,Alive,TUMOR FREE,3897.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3897.0,0.0,3897.0,0.0,3897.0,0.0,3897.0,
TCGA-CG-5719,9472,TCGA-CG-5719,STAD,54.0,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2010.0,[Not Available],-19966.0,Alive,TUMOR FREE,31.0,,[Not Available],,,,,[Not Available],,,0.0,31.0,0.0,31.0,,,0.0,31.0,
TCGA-EL-A3T7,10088,TCGA-EL-A3T7,THCA,47.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-17302.0,Alive,TUMOR FREE,1256.0,,[Not Available],,,,,[Not Available],,R0,0.0,1256.0,0.0,1256.0,0.0,1256.0,0.0,1256.0,
TCGA-UF-A7JC,3757,TCGA-UF-A7JC,HNSC,42.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-15452.0,Dead,WITH TUMOR,,546.0,[Not Available],,Oral Cavity,,229.0,Complete Remission/Response,,,1.0,546.0,1.0,546.0,,,1.0,229.0,
TCGA-DD-AACM,5592,TCGA-DD-AACM,LIHC,48.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2009.0,[Not Available],-17590.0,Alive,WITH TUMOR,1769.0,,[Not Available],Extrahepatic Recurrence,Lung,,1097.0,[Not Available],,R0,0.0,1769.0,0.0,1769.0,1.0,1097.0,1.0,1097.0,
TCGA-FD-A3N5,263,TCGA-FD-A3N5,BLCA,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-25342.0,Dead,WITH TUMOR,,685.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Pelvis,346.0,[Not Available],,,1.0,685.0,1.0,685.0,,,1.0,346.0,
TCGA-WB-A816,7841,TCGA-WB-A816,PCPG,42.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-15400.0,Alive,TUMOR FREE,1254.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1254.0,0.0,1254.0,0.0,1254.0,0.0,1254.0,
TCGA-EK-A2RC,1733,TCGA-EK-A2RC,CESC,33.0,FEMALE,[Not Available],[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2009.0,[Not Available],-12353.0,Alive,TUMOR FREE,129.0,,,,,,,[Not Available],,,0.0,129.0,0.0,129.0,,,0.0,129.0,
TCGA-MT-A51W,3696,TCGA-MT-A51W,HNSC,52.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-19098.0,Alive,TUMOR FREE,437.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,437.0,0.0,437.0,0.0,437.0,0.0,437.0,
TCGA-DJ-A2Q8,9961,TCGA-DJ-A2Q8,THCA,47.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-17438.0,Alive,TUMOR FREE,1189.0,,[Not Available],,,,,[Not Available],,R0,0.0,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0,
TCGA-AH-6897,8470,TCGA-AH-6897,READ,48.0,MALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-17536.0,Alive,TUMOR FREE,804.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,804.0,0.0,804.0,0.0,804.0,0.0,804.0,
TCGA-2Z-A9J6,4425,TCGA-2Z-A9J6,KIRP,60.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-22265.0,Alive,TUMOR FREE,1731.0,,[Not Available],,,,,[Unknown],,,0.0,1731.0,0.0,1731.0,,,0.0,1731.0,
TCGA-BR-4257,9285,TCGA-BR-4257,STAD,79.0,FEMALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],-29014.0,Dead,,,294.0,[Not Available],,,,,[Not Available],,,1.0,294.0,,294.0,,,0.0,294.0,
TCGA-G9-6371,8037,TCGA-G9-6371,PRAD,58.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-21365.0,Alive,TUMOR FREE,1226.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1226.0,0.0,1226.0,0.0,1226.0,0.0,1226.0,
TCGA-B8-A54I,4120,TCGA-B8-A54I,KIRC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2012.0,[Not Available],-17722.0,Alive,TUMOR FREE,150.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,150.0,0.0,150.0,0.0,150.0,0.0,150.0,
TCGA-E2-A153,1328,TCGA-E2-A153,BRCA,51.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18875.0,Alive,TUMOR FREE,707.0,,[Not Available],,,,,[Not Available],Negative,,0.0,707.0,0.0,707.0,0.0,707.0,0.0,707.0,
TCGA-TM-A84M,5382,TCGA-TM-A84M,LGG,40.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-14660.0,Alive,TUMOR FREE,754.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,754.0,0.0,754.0,0.0,754.0,0.0,754.0,
TCGA-AR-A2LR,963,TCGA-AR-A2LR,BRCA,49.0,FEMALE,WHITE,Stage I,[Not Applicable],Metaplastic Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18214.0,Alive,TUMOR FREE,1742.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1742.0,0.0,1742.0,0.0,1742.0,0.0,1742.0,
TCGA-SI-AA8B,8764,TCGA-SI-AA8B,SARC,80.0,FEMALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013.0,[Not Available],-29315.0,Dead,WITH TUMOR,,262.0,[Not Available],,,,,[Not Available],Positive,R1,1.0,262.0,1.0,262.0,,,1.0,262.0,
TCGA-YB-A89D,7684,TCGA-YB-A89D,PAAD,59.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-21792.0,Alive,TUMOR FREE,350.0,,,,,,,Complete Remission/Response,,,0.0,350.0,0.0,350.0,0.0,350.0,0.0,350.0,
TCGA-BQ-5884,4544,TCGA-BQ-5884,KIRP,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-21730.0,Alive,TUMOR FREE,792.0,,[Not Available],,,,,[Not Available],,,0.0,792.0,0.0,792.0,,,0.0,792.0,
TCGA-P5-A737,5284,TCGA-P5-A737,LGG,47.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-17390.0,Alive,TUMOR FREE,372.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,
TCGA-L5-A88S,2531,TCGA-L5-A88S,ESCA,84.0,MALE,WHITE,Stage IB,[Not Available],Esophagus Squamous Cell Carcinoma,GX,2013.0,[Not Available],-30954.0,Alive,TUMOR FREE,471.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,471.0,0.0,471.0,0.0,471.0,0.0,471.0,
TCGA-D7-A6ET,9518,TCGA-D7-A6ET,STAD,76.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,[Not Available],-27928.0,Alive,WITH TUMOR,804.0,,[Not Available],Locoregional Recurrence,,,777.0,Complete Remission/Response,,,0.0,804.0,0.0,804.0,1.0,777.0,1.0,777.0,
TCGA-KN-8432,3831,TCGA-KN-8432,KICH,86.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2010.0,[Not Available],-31591.0,Alive,,76.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,
TCGA-32-4210,3187,TCGA-32-4210,GBM,73.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-26768.0,Dead,WITH TUMOR,113.0,113.0,[Not Available],,,,,[Not Available],,,1.0,113.0,1.0,113.0,,,1.0,113.0,
TCGA-BH-A0BQ,1050,TCGA-BH-A0BQ,BRCA,39.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14494.0,Alive,TUMOR FREE,2255.0,,[Not Available],Locoregional Recurrence,"Other, specify",Dermis and epidermis,1709.0,[Not Available],Negative,,0.0,2255.0,0.0,2255.0,1.0,1709.0,1.0,1709.0,
TCGA-HU-A4GN,9576,TCGA-HU-A4GN,STAD,61.0,MALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-22288.0,Alive,TUMOR FREE,912.0,,[Not Available],,"Other, specify",thyroid,168.0,Complete Remission/Response,,,0.0,912.0,0.0,912.0,1.0,168.0,1.0,168.0,
TCGA-RD-A8N0,9632,TCGA-RD-A8N0,STAD,53.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2006.0,[Not Available],-19491.0,Alive,TUMOR FREE,1236.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1236.0,0.0,1236.0,0.0,1236.0,0.0,1236.0,
TCGA-YL-A9WL,8340,TCGA-YL-A9WL,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21626.0,Alive,WITH TUMOR,740.0,,[Not Available],Biochemical evidence of disease,,,740.0,Complete Remission/Response,,,0.0,740.0,0.0,740.0,1.0,740.0,1.0,740.0,
TCGA-VQ-AA6A,9701,TCGA-VQ-AA6A,STAD,56.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-20764.0,Alive,TUMOR FREE,1184.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1184.0,0.0,1184.0,0.0,1184.0,0.0,1184.0,
TCGA-73-4668,6117,TCGA-73-4668,LUAD,66.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-24255.0,Alive,WITH TUMOR,467.0,,[Not Available],,,,236.0,Complete Remission/Response,,,0.0,467.0,0.0,467.0,1.0,236.0,1.0,236.0,
TCGA-14-1825,3033,TCGA-14-1825,GBM,70.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-25684.0,Dead,WITH TUMOR,,232.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],82.0,[Not Available],,,1.0,232.0,1.0,232.0,,,1.0,82.0,
TCGA-DD-AACA,5580,TCGA-DD-AACA,LIHC,65.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2008.0,[Not Available],-23973.0,Alive,WITH TUMOR,2301.0,,[Not Available],Locoregional Recurrence,Liver,,776.0,[Not Available],,R0,0.0,2301.0,0.0,2301.0,1.0,776.0,1.0,776.0,
TCGA-CH-5751,7889,TCGA-CH-5751,PRAD,68.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-24957.0,Alive,WITH TUMOR,1065.0,,[Not Available],Distant Metastasis,Bone,,365.0,Complete Remission/Response,,,0.0,1065.0,0.0,1065.0,1.0,365.0,1.0,365.0,
TCGA-AC-A3YI,783,TCGA-AC-A3YI,BRCA,74.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27143.0,Alive,TUMOR FREE,707.0,,[Not Available],,,,,[Not Available],Negative,,0.0,707.0,0.0,707.0,0.0,707.0,0.0,707.0,
TCGA-AR-A24X,946,TCGA-AR-A24X,BRCA,52.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19030.0,Alive,TUMOR FREE,3004.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3004.0,0.0,3004.0,0.0,3004.0,0.0,3004.0,
TCGA-DM-A28A,2343,TCGA-DM-A28A,COAD,78.0,MALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2001.0,[Not Available],-28833.0,Dead,,805.0,805.0,[Not Available],,,,,[Not Available],,,1.0,805.0,,805.0,,,0.0,805.0,
TCGA-VS-A950,1855,TCGA-VS-A950,CESC,42.0,FEMALE,[Unknown],[Not Available],Stage IIIA,Cervical Squamous Cell Carcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15365.0,Alive,WITH TUMOR,1221.0,,,,,,,Partial Remission/Response,,,0.0,1221.0,0.0,1221.0,,,0.0,1221.0,
TCGA-VN-A943,8276,TCGA-VN-A943,PRAD,71.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-26162.0,Alive,TUMOR FREE,496.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,
TCGA-S7-A7WU,7786,TCGA-S7-A7WU,PCPG,63.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-23187.0,Alive,TUMOR FREE,928.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,
TCGA-91-8497,6224,TCGA-91-8497,LUAD,75.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27632.0,Dead,TUMOR FREE,,434.0,[Not Available],,,,,Complete Remission/Response,,,1.0,434.0,0.0,434.0,0.0,434.0,0.0,434.0,
TCGA-KD-A5QU,8720,TCGA-KD-A5QU,SARC,41.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-15018.0,Dead,WITH TUMOR,,1073.0,[Not Available],Distant Metastasis,Lung,,1060.0,[Not Available],Negative,R0,1.0,1073.0,1.0,1073.0,1.0,1060.0,1.0,1060.0,
TCGA-BP-5001,4231,TCGA-BP-5001,KIRC,43.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-15858.0,Alive,TUMOR FREE,1177.0,,[Not Available],,,,,[Not Available],,,0.0,1177.0,0.0,1177.0,,,0.0,1177.0,
TCGA-G9-6385,8043,TCGA-G9-6385,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-24399.0,Alive,TUMOR FREE,830.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,830.0,0.0,830.0,0.0,830.0,0.0,830.0,
TCGA-MH-A856,4651,TCGA-MH-A856,KIRP,54.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-20006.0,Alive,TUMOR FREE,947.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,947.0,0.0,947.0,0.0,947.0,0.0,947.0,
TCGA-EM-A2CR,10147,TCGA-EM-A2CR,THCA,46.0,FEMALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-16807.0,Alive,TUMOR FREE,415.0,,[Not Available],,,,,[Not Available],,R0,0.0,415.0,0.0,415.0,0.0,415.0,0.0,415.0,
TCGA-49-AARO,5928,TCGA-49-AARO,LUAD,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2003.0,[Not Available],-14527.0,Alive,WITH TUMOR,3759.0,,[Not Available],Locoregional Recurrence,,,1144.0,Complete Remission/Response,,,0.0,3759.0,0.0,3759.0,1.0,1144.0,1.0,1144.0,
TCGA-DK-A3IN,199,TCGA-DK-A3IN,BLCA,72.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-26562.0,Dead,TUMOR FREE,,250.0,[Not Available],,,,,Complete Remission/Response,,,1.0,250.0,0.0,250.0,0.0,250.0,0.0,250.0,
TCGA-BA-A4II,3267,TCGA-BA-A4II,HNSC,46.0,MALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-17011.0,Alive,WITH TUMOR,918.0,,[Not Available],Locoregional Disease,Oral Cavity,L FOM,197.0,Complete Remission/Response,,,0.0,918.0,0.0,918.0,1.0,197.0,1.0,197.0,
TCGA-EJ-A7NF,7993,TCGA-EJ-A7NF,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-20587.0,Alive,TUMOR FREE,250.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,250.0,0.0,250.0,0.0,250.0,0.0,250.0,
TCGA-LK-A4O7,6852,TCGA-LK-A4O7,MESO,64.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-23606.0,Dead,WITH TUMOR,,350.0,[Not Available],,,,,[Not Available],,R0,1.0,350.0,1.0,350.0,,,1.0,350.0,
TCGA-BH-A8G0,1174,TCGA-BH-A8G0,BRCA,54.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Peri (6-12 months since last menstrual period),-19975.0,Alive,TUMOR FREE,662.0,,[Not Available],,,,,[Not Available],Negative,,0.0,662.0,0.0,662.0,0.0,662.0,0.0,662.0,
TCGA-BQ-5876,4536,TCGA-BQ-5876,KIRP,75.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004.0,[Not Available],-27409.0,Alive,TUMOR FREE,586.0,,[Not Available],,,,,[Not Available],,,0.0,586.0,0.0,586.0,,,0.0,586.0,
TCGA-DX-A3UA,8588,TCGA-DX-A3UA,SARC,47.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2009.0,[Not Available],-17342.0,Dead,[Discrepancy],,325.0,[Not Available],,,,,[Not Available],[Not Available],R0,1.0,325.0,,325.0,0.0,325.0,0.0,325.0,
TCGA-CM-6164,2279,TCGA-CM-6164,COAD,46.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-16802.0,Alive,TUMOR FREE,883.0,,[Not Available],,,,,[Not Available],,,0.0,883.0,0.0,883.0,,,0.0,883.0,
TCGA-VQ-A91A,9673,TCGA-VQ-A91A,STAD,67.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G1,2011.0,[Not Available],-24670.0,Alive,TUMOR FREE,1200.0,,[Not Available],New Primary Tumor,,,129.0,Complete Remission/Response,,,0.0,1200.0,0.0,1200.0,0.0,1200.0,1.0,129.0,
TCGA-BC-A216,5468,TCGA-BC-A216,LIHC,62.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-22968.0,Alive,TUMOR FREE,1351.0,,[Not Available],,,,,[Not Available],,R0,0.0,1351.0,0.0,1351.0,0.0,1351.0,0.0,1351.0,
TCGA-X8-AAAR,2637,TCGA-X8-AAAR,ESCA,69.0,MALE,WHITE,[Unknown],[Not Available],"Esophagus Adenocarcinoma, NOS",G1,2013.0,[Not Available],-25370.0,Alive,TUMOR FREE,554.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,
TCGA-XY-A8S2,9824,TCGA-XY-A8S2,TGCT,67.0,MALE,WHITE,Stage I,Stage I,Non-Seminoma; Embryonal Carcinoma|[Not Available]|[Not Available]|[Not Available],[Not Available],2012.0,[Not Available],-24759.0,Alive,TUMOR FREE,672.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,672.0,0.0,672.0,0.0,672.0,0.0,672.0,
TCGA-B9-A5W7,4529,TCGA-B9-A5W7,KIRP,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-17465.0,Alive,TUMOR FREE,585.0,,[Not Available],,,,564.0,Complete Remission/Response,,,0.0,585.0,0.0,585.0,1.0,564.0,1.0,564.0,
TCGA-62-8394,6058,TCGA-62-8394,LUAD,65.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-23758.0,Dead,TUMOR FREE,,139.0,[Not Available],,,,,Complete Remission/Response,,,1.0,139.0,0.0,139.0,0.0,139.0,0.0,139.0,
TCGA-FY-A40K,10296,TCGA-FY-A40K,THCA,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-17092.0,Alive,TUMOR FREE,461.0,,[Not Available],,,,,[Not Available],,R0,0.0,461.0,0.0,461.0,0.0,461.0,0.0,461.0,
TCGA-55-6986,5989,TCGA-55-6986,LUAD,74.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],,Alive,TUMOR FREE,3261.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3261.0,0.0,3261.0,0.0,3261.0,0.0,3261.0,
TCGA-BJ-A45F,9887,TCGA-BJ-A45F,THCA,59.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-21713.0,Alive,TUMOR FREE,105.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,105.0,0.0,105.0,,,0.0,105.0,
TCGA-PA-A5YG,87,TCGA-PA-A5YG,ACC,51.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-18926.0,Alive,TUMOR FREE,756.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,756.0,0.0,756.0,0.0,756.0,0.0,756.0,
TCGA-CV-6951,3508,TCGA-CV-6951,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1996.0,[Not Available],-21166.0,Dead,WITH TUMOR,,915.0,[Not Available],,,,,[Not Available],,,1.0,915.0,1.0,915.0,,,1.0,915.0,
TCGA-2Y-A9H0,5435,TCGA-2Y-A9H0,LIHC,49.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2004.0,[Not Available],-18109.0,Alive,TUMOR FREE,3675.0,,[Not Available],,,,,[Not Available],,R0,0.0,3675.0,0.0,3675.0,0.0,3675.0,0.0,3675.0,
TCGA-FY-A40L,10297,TCGA-FY-A40L,THCA,55.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-20243.0,Alive,TUMOR FREE,726.0,,[Not Available],,,,,[Not Available],,RX,0.0,726.0,0.0,726.0,,,0.0,726.0,
TCGA-EE-A2MF,9053,TCGA-EE-A2MF,SKCM,39.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],1979.0,[Not Available],-14312.0,Dead,WITH TUMOR,,8174.0,[Not Available],New primary melanoma,,,8071.0,[Not Available],,,1.0,8174.0,1.0,8174.0,,,1.0,8071.0,
TCGA-VQ-A8PX,9670,TCGA-VQ-A8PX,STAD,51.0,MALE,[Unknown],Stage IA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,[Not Available],-18902.0,Alive,TUMOR FREE,1964.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1964.0,0.0,1964.0,0.0,1964.0,0.0,1964.0,
TCGA-56-8307,6527,TCGA-56-8307,LUSC,55.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-20411.0,Alive,TUMOR FREE,818.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,818.0,0.0,818.0,0.0,818.0,0.0,818.0,
TCGA-AK-3427,3939,TCGA-AK-3427,KIRC,65.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,GX,2004.0,[Not Available],-24067.0,Alive,TUMOR FREE,3583.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3583.0,0.0,3583.0,0.0,3583.0,0.0,3583.0,
TCGA-MQ-A4KX,6853,TCGA-MQ-A4KX,MESO,55.0,MALE,WHITE,Stage I,[Not Applicable],Epithelioid mesothelioma,[Not Available],2002.0,[Not Available],-20336.0,Dead,,,2459.0,[Not Available],Distant Metastasis,"Other, specify",IPSILATERAL CHEST,471.0,[Not Available],,R0,1.0,2459.0,,2459.0,1.0,471.0,1.0,471.0,
TCGA-A6-3810,1979,TCGA-A6-3810,COAD,62.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-22999.0,Alive,TUMOR FREE,1111.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1111.0,0.0,1111.0,0.0,1111.0,0.0,1111.0,
TCGA-CK-6751,2257,TCGA-CK-6751,COAD,88.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2002.0,[Not Available],-32354.0,Alive,TUMOR FREE,3780.0,,[Not Available],,,,,[Not Available],,,0.0,3780.0,0.0,3780.0,,,0.0,3780.0,
TCGA-AK-3426,3938,TCGA-AK-3426,KIRC,37.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-13770.0,Dead,WITH TUMOR,,885.0,[Not Available],,,,256.0,[Not Available],,,1.0,885.0,1.0,885.0,,,1.0,256.0,
TCGA-06-0166,2775,TCGA-06-0166,GBM,51.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2001.0,[Not Available],-18902.0,Dead,WITH TUMOR,161.0,178.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],66.0,[Not Available],,,1.0,178.0,1.0,178.0,,,1.0,66.0,
TCGA-HT-A74K,5241,TCGA-HT-A74K,LGG,58.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-21189.0,Alive,TUMOR FREE,467.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,467.0,0.0,467.0,0.0,467.0,0.0,467.0,
TCGA-XE-AAOL,9822,TCGA-XE-AAOL,TGCT,38.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Seminoma; NOS,[Not Available],2008.0,[Not Available],-14230.0,Alive,TUMOR FREE,13.0,,[Not Applicable],,,,,[Unknown],,,0.0,13.0,0.0,13.0,,,0.0,13.0,
TCGA-55-8096,6021,TCGA-55-8096,LUAD,67.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-24684.0,Dead,WITH TUMOR,,719.0,[Not Available],Distant Metastasis,,,566.0,Complete Remission/Response,,,1.0,719.0,1.0,719.0,1.0,566.0,1.0,566.0,
TCGA-CK-4950,2246,TCGA-CK-4950,COAD,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2008.0,[Not Available],-24944.0,Alive,TUMOR FREE,2599.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2599.0,0.0,2599.0,0.0,2599.0,0.0,2599.0,
TCGA-HC-A6AQ,8115,TCGA-HC-A6AQ,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22208.0,Alive,TUMOR FREE,106.0,,[Not Available],,,,,[Unknown],,,0.0,106.0,0.0,106.0,,,0.0,106.0,
TCGA-EY-A1GK,10950,TCGA-EY-A1GK,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27127.0,Alive,TUMOR FREE,693.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,693.0,0.0,693.0,0.0,693.0,0.0,693.0,
TCGA-14-0787,3002,TCGA-14-0787,GBM,69.0,MALE,ASIAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1999.0,[Not Available],-25326.0,Dead,,68.0,68.0,[Not Available],,,,,[Not Available],,,1.0,68.0,,68.0,,,0.0,68.0,
TCGA-OR-A5L8,62,TCGA-OR-A5L8,ACC,36.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-13472.0,Alive,TUMOR FREE,885.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,885.0,0.0,885.0,0.0,885.0,0.0,885.0,
TCGA-XD-AAUG,7678,TCGA-XD-AAUG,PAAD,66.0,FEMALE,WHITE,Stage IV,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-24291.0,Alive,TUMOR FREE,420.0,,,,,,,[Discrepancy],,,0.0,420.0,0.0,420.0,,,0.0,420.0,
TCGA-F2-A44G,7549,TCGA-F2-A44G,PAAD,79.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-29150.0,Dead,WITH TUMOR,,233.0,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",malignant ascites,214.0,Complete Remission/Response,,,1.0,233.0,1.0,233.0,1.0,214.0,1.0,214.0,
TCGA-KO-8414,3847,TCGA-KO-8414,KICH,50.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-18502.0,Alive,TUMOR FREE,3212.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3212.0,0.0,3212.0,0.0,3212.0,0.0,3212.0,
TCGA-B2-A4SR,4082,TCGA-B2-A4SR,KIRC,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,[Not Available],2012.0,[Not Available],-22637.0,Alive,TUMOR FREE,507.0,,[Not Available],,,,266.0,Complete Remission/Response,,,0.0,507.0,0.0,507.0,1.0,266.0,1.0,266.0,
TCGA-2G-AAFO,9725,TCGA-2G-AAFO,TGCT,33.0,MALE,WHITE,Stage IIA,Stage IIA,Non-Seminoma; Embryonal Carcinoma,[Not Available],2013.0,[Not Available],-12298.0,Alive,TUMOR FREE,685.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,685.0,0.0,685.0,0.0,685.0,0.0,685.0,
TCGA-BR-4280,9288,TCGA-BR-4280,STAD,78.0,FEMALE,WHITE,Stage III,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,[Not Available],-28515.0,Dead,,,201.0,[Not Available],,,,,[Not Available],,,1.0,201.0,,201.0,,,0.0,201.0,
TCGA-EE-A29M,9014,TCGA-EE-A29M,SKCM,33.0,FEMALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2007.0,[Not Available],-12350.0,Alive,TUMOR FREE,1729.0,,[Not Available],,,,,[Not Available],,,0.0,1729.0,0.0,1729.0,,,0.0,1729.0,
TCGA-ZB-A96P,10466,TCGA-ZB-A96P,THYM,73.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type B1,[Not Available],2013.0,[Not Available],-26870.0,Alive,TUMOR FREE,753.0,,[Not Available],,,,,[Not Available],,,0.0,753.0,0.0,753.0,,,0.0,753.0,
TCGA-DX-AB32,8668,TCGA-DX-AB32,SARC,51.0,MALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2006.0,[Not Available],-18631.0,Alive,TUMOR FREE,3102.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,3102.0,0.0,3102.0,0.0,3102.0,0.0,3102.0,
TCGA-D1-A101,10824,TCGA-D1-A101,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22078.0,Alive,TUMOR FREE,53.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,53.0,0.0,53.0,0.0,53.0,0.0,53.0,
TCGA-KN-8436,3835,TCGA-KN-8436,KICH,62.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2009.0,[Not Available],-22997.0,Alive,TUMOR FREE,1288.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,
TCGA-E9-A1N4,1394,TCGA-E9-A1N4,BRCA,41.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15055.0,Alive,TUMOR FREE,1000.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0,
TCGA-ZB-A96B,10454,TCGA-ZB-A96B,THYM,51.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type B1,[Not Available],2009.0,[Not Available],-18892.0,Alive,TUMOR FREE,2211.0,,[Not Available],New Primary Tumor,"Other, specify",bladder,91.0,[Not Available],,,0.0,2211.0,0.0,2211.0,,,1.0,91.0,
TCGA-H7-A6C4,3660,TCGA-H7-A6C4,HNSC,35.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-13137.0,Alive,TUMOR FREE,414.0,,[Not Available],Locoregional Recurrence,Distant Metastasis,stoma site,235.0,Complete Remission/Response,,,0.0,414.0,0.0,414.0,,,1.0,235.0,
TCGA-R6-A6L4,2602,TCGA-R6-A6L4,ESCA,27.0,MALE,WHITE,[Not Available],Stage IIIA,"Esophagus Adenocarcinoma, NOS",G2,2012.0,[Not Available],-10222.0,Dead,WITH TUMOR,,496.0,[Not Available],Distant Metastasis,Liver,,160.0,Progressive Disease,,,1.0,496.0,1.0,496.0,,,1.0,160.0,
TCGA-ER-A197,9091,TCGA-ER-A197,SKCM,83.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2006.0,[Not Available],-30454.0,Dead,WITH TUMOR,,424.0,[Not Available],Distant Metastasis,Lung,,110.0,[Not Available],,,1.0,424.0,1.0,424.0,,,1.0,110.0,
TCGA-ER-A1A1,9113,TCGA-ER-A1A1,SKCM,58.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2005.0,[Not Available],-21209.0,Alive,TUMOR FREE,3196.0,,[Not Available],,,,1971.0,[Not Available],,,0.0,3196.0,0.0,3196.0,,,1.0,1971.0,
TCGA-43-8116,6485,TCGA-43-8116,LUSC,73.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26790.0,Alive,TUMOR FREE,358.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,
TCGA-DC-6154,8486,TCGA-DC-6154,READ,57.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-21093.0,Alive,TUMOR FREE,365.0,,[Not Available],,,,,[Not Available],,,0.0,365.0,0.0,365.0,,,0.0,365.0,
TCGA-55-6981,5984,TCGA-55-6981,LUAD,53.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-19497.0,Dead,TUMOR FREE,,1379.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1379.0,0.0,1379.0,0.0,1379.0,0.0,1379.0,
TCGA-EE-A3J7,9079,TCGA-EE-A3J7,SKCM,43.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1998.0,[Not Available],-15896.0,Alive,TUMOR FREE,1949.0,,[Not Available],Regional lymph node,,,1270.0,[Not Available],,,0.0,1949.0,0.0,1949.0,,,1.0,1270.0,
TCGA-56-8628,6537,TCGA-56-8628,LUSC,78.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-28805.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,
TCGA-BT-A3PK,140,TCGA-BT-A3PK,BLCA,80.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-29314.0,Dead,WITH TUMOR,,303.0,[Not Available],,,,,Stable Disease,,,1.0,303.0,1.0,303.0,,,1.0,303.0,
TCGA-TS-A8AV,6891,TCGA-TS-A8AV,MESO,55.0,MALE,WHITE,Stage III,[Not Applicable],Sarcomatoid mesothelioma,[Not Available],2011.0,[Not Available],-20437.0,Dead,,,,[Not Available],,,,,[Not Available],,[Unknown],1.0,,,,,,0.0,,
TCGA-AX-A3FS,10660,TCGA-AX-A3FS,UCEC,82.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30102.0,Alive,,7.0,,[Not Available],,,,,[Not Available],,,0.0,7.0,0.0,7.0,,,0.0,7.0,
TCGA-D6-A6EP,3626,TCGA-D6-A6EP,HNSC,62.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-22674.0,Alive,TUMOR FREE,424.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,
TCGA-EJ-A8FP,8002,TCGA-EJ-A8FP,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2013.0,[Not Available],-21769.0,Alive,TUMOR FREE,299.0,,[Not Available],Biochemical evidence of disease,,,117.0,Complete Remission/Response,,,0.0,299.0,0.0,299.0,1.0,117.0,1.0,117.0,
TCGA-C8-A1HM,1205,TCGA-C8-A1HM,BRCA,74.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27063.0,Alive,TUMOR FREE,375.0,,[Not Available],,,,,[Not Available],Negative,,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,
TCGA-A6-6654,2003,TCGA-A6-6654,COAD,65.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-23953.0,Alive,TUMOR FREE,726.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,726.0,0.0,726.0,0.0,726.0,0.0,726.0,
TCGA-P5-A5F0,5270,TCGA-P5-A5F0,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-12157.0,Alive,[Discrepancy],287.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,287.0,0.0,287.0,,,0.0,287.0,
TCGA-EA-A3HU,1698,TCGA-EA-A3HU,CESC,43.0,FEMALE,WHITE,[Not Available],Stage II,Cervical Squamous Cell Carcinoma,G2,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15909.0,Alive,TUMOR FREE,1013.0,,,,,,,Complete Remission/Response,,,0.0,1013.0,0.0,1013.0,0.0,1013.0,0.0,1013.0,
TCGA-HW-7489,5246,TCGA-HW-7489,LGG,38.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-14201.0,Dead,WITH TUMOR,,1262.0,[Not Available],,,,,Progressive Disease,,,1.0,1262.0,1.0,1262.0,,,1.0,1262.0,
TCGA-YU-A90S,9829,TCGA-YU-A90S,TGCT,26.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2009.0,[Not Available],-9531.0,Alive,,971.0,,[Not Applicable],,,,,[Not Available],,,0.0,971.0,0.0,971.0,,,0.0,971.0,
TCGA-IN-7806,9592,TCGA-IN-7806,STAD,50.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-18404.0,Alive,TUMOR FREE,1106.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,
TCGA-DX-A7EO,8628,TCGA-DX-A7EO,SARC,20.0,FEMALE,WHITE,[Not Available],[Not Available],Synovial Sarcoma - Biphasic,[Not Available],2002.0,[Not Available],-7604.0,Alive,TUMOR FREE,4627.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,4627.0,0.0,4627.0,0.0,4627.0,0.0,4627.0,
TCGA-A2-A1FV,596,TCGA-A2-A1FV,BRCA,74.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27287.0,Alive,TUMOR FREE,714.0,,[Not Available],,,,,[Not Available],Negative,,0.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,
TCGA-LL-A740,1544,TCGA-LL-A740,BRCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22416.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,[Not Available],Negative,,0.0,441.0,0.0,441.0,0.0,441.0,0.0,441.0,
TCGA-P8-A5KD,7691,TCGA-P8-A5KD,PCPG,35.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-12954.0,Alive,TUMOR FREE,123.0,,[Not Available],,,,,[Unknown],,,0.0,123.0,0.0,123.0,,,0.0,123.0,
TCGA-C8-A12Q,1182,TCGA-C8-A12Q,BRCA,78.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28733.0,Dead,WITH TUMOR,,385.0,[Not Available],,,,,[Not Available],Negative,,1.0,385.0,1.0,385.0,,,1.0,385.0,
TCGA-HZ-8636,7604,TCGA-HZ-8636,PAAD,58.0,FEMALE,WHITE,Stage IV,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,[Not Available],-21501.0,Dead,WITH TUMOR,,545.0,Pancreatic Cancer,,,,,Progressive Disease,,,1.0,545.0,1.0,545.0,,,1.0,545.0,
TCGA-E7-A7PW,250,TCGA-E7-A7PW,BLCA,63.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-23057.0,Alive,TUMOR FREE,416.0,,[Not Available],Distant Metastasis,Bone,,174.0,Complete Remission/Response,,,0.0,416.0,0.0,416.0,1.0,174.0,1.0,174.0,
TCGA-BR-6454,9303,TCGA-BR-6454,STAD,58.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-21501.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-BR-6566,9311,TCGA-BR-6566,STAD,64.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-23404.0,Alive,TUMOR FREE,997.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,997.0,0.0,997.0,0.0,997.0,0.0,997.0,
TCGA-E2-A15C,1335,TCGA-E2-A15C,BRCA,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22583.0,Alive,TUMOR FREE,694.0,,[Not Available],,,,,[Not Available],Negative,,0.0,694.0,0.0,694.0,0.0,694.0,0.0,694.0,
TCGA-HU-A4H4,9586,TCGA-HU-A4H4,STAD,53.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,[Not Available],-19665.0,Alive,TUMOR FREE,725.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,725.0,0.0,725.0,0.0,725.0,0.0,725.0,
TCGA-CG-4444,9456,TCGA-CG-4444,STAD,76.0,MALE,[Not Available],Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2006.0,[Not Available],-27912.0,Alive,TUMOR FREE,1431.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1431.0,0.0,1431.0,0.0,1431.0,0.0,1431.0,
TCGA-BH-A1F2,1140,TCGA-BH-A1F2,BRCA,53.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999.0,[Not Available],-19701.0,Dead,TUMOR FREE,,959.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,959.0,0.0,959.0,,,0.0,959.0,
TCGA-62-A46V,6069,TCGA-62-A46V,LUAD,78.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-28495.0,Alive,TUMOR FREE,2199.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2199.0,0.0,2199.0,0.0,2199.0,0.0,2199.0,
TCGA-XJ-A9DX,8300,TCGA-XJ-A9DX,PRAD,51.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],,Alive,TUMOR FREE,973.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,973.0,0.0,973.0,,,0.0,973.0,
TCGA-V4-A9F2,11111,TCGA-V4-A9F2,UVM,78.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,[Not Available],2012.0,[Not Available],-28832.0,Alive,TUMOR FREE,734.0,,[Not Available],,,,,[Not Available],,,0.0,734.0,0.0,734.0,,,0.0,734.0,
TCGA-MK-A4N6,10347,TCGA-MK-A4N6,THCA,35.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-12904.0,Alive,TUMOR FREE,1098.0,,[Not Available],,,,,[Not Available],,R0,0.0,1098.0,0.0,1098.0,0.0,1098.0,0.0,1098.0,
TCGA-G9-6363,8030,TCGA-G9-6363,PRAD,64.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-23480.0,Alive,TUMOR FREE,1378.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1378.0,0.0,1378.0,0.0,1378.0,0.0,1378.0,
TCGA-55-6970,5977,TCGA-55-6970,LUAD,67.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],-24773.0,Dead,WITH TUMOR,,464.0,[Not Available],Locoregional Recurrence,,,457.0,Stable Disease,,,1.0,464.0,1.0,464.0,,,1.0,457.0,
TCGA-DX-A3U8,8586,TCGA-DX-A3U8,SARC,43.0,MALE,[Unknown],[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-15751.0,Dead,WITH TUMOR,,138.0,[Not Available],Distant Metastasis,Lung,,128.0,[Not Available],[Not Available],R0,1.0,138.0,1.0,138.0,1.0,128.0,1.0,128.0,
TCGA-BT-A42F,144,TCGA-BT-A42F,BLCA,64.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-23713.0,Alive,TUMOR FREE,864.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,864.0,0.0,864.0,,,0.0,864.0,
TCGA-HZ-7926,7596,TCGA-HZ-7926,PAAD,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,[Not Available],-21024.0,Dead,WITH TUMOR,,518.0,Pancreatic Cancer,Distant Metastasis,Lung,,340.0,Progressive Disease,,,1.0,518.0,1.0,518.0,,,1.0,340.0,
TCGA-S7-A7WN,7780,TCGA-S7-A7WN,PCPG,40.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-14611.0,Alive,TUMOR FREE,1133.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0,
TCGA-V1-A9Z9,8262,TCGA-V1-A9Z9,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-23360.0,Alive,TUMOR FREE,540.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,540.0,0.0,540.0,0.0,540.0,0.0,540.0,
TCGA-SR-A6MY,7812,TCGA-SR-A6MY,PCPG,54.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-19892.0,Alive,TUMOR FREE,750.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,750.0,0.0,750.0,0.0,750.0,0.0,750.0,
TCGA-B0-5084,4020,TCGA-B0-5084,KIRC,33.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-12219.0,Dead,WITH TUMOR,,222.0,[Not Available],,,,65.0,[Not Available],,,1.0,222.0,1.0,222.0,,,1.0,65.0,
TCGA-QR-A70K,7729,TCGA-QR-A70K,PCPG,61.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-22519.0,Alive,TUMOR FREE,274.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,274.0,0.0,274.0,0.0,274.0,0.0,274.0,
TCGA-2Z-A9JO,4438,TCGA-2Z-A9JO,KIRP,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-20466.0,Alive,TUMOR FREE,949.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,949.0,0.0,949.0,0.0,949.0,0.0,949.0,
TCGA-EL-A4JX,10107,TCGA-EL-A4JX,THCA,31.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-11465.0,Alive,TUMOR FREE,1398.0,,[Not Available],,,,,[Not Available],,R0,0.0,1398.0,0.0,1398.0,0.0,1398.0,0.0,1398.0,
TCGA-BP-5195,4260,TCGA-BP-5195,KIRC,75.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2008.0,[Not Available],-27547.0,Alive,TUMOR FREE,749.0,,[Not Available],,,,,[Not Available],,,0.0,749.0,0.0,749.0,,,0.0,749.0,
TCGA-D8-A27E,1283,TCGA-D8-A27E,BRCA,66.0,FEMALE,WHITE,Stage IA,[Not Applicable],"Other, specify",[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24315.0,Alive,TUMOR FREE,530.0,,[Not Available],,,,,[Not Available],Negative,,0.0,530.0,0.0,530.0,0.0,530.0,0.0,530.0,
TCGA-ET-A39R,10227,TCGA-ET-A39R,THCA,24.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-8828.0,Alive,TUMOR FREE,2863.0,,[Not Available],,,,,[Not Available],,R0,0.0,2863.0,0.0,2863.0,0.0,2863.0,0.0,2863.0,
TCGA-SR-A6MP,7804,TCGA-SR-A6MP,PCPG,30.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2009.0,[Not Available],-11050.0,Alive,TUMOR FREE,1558.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1558.0,0.0,1558.0,0.0,1558.0,0.0,1558.0,
TCGA-XK-AAJA,8305,TCGA-XK-AAJA,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-22771.0,Alive,,930.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,
TCGA-MW-A4EC,4418,TCGA-MW-A4EC,KIRC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2012.0,[Not Available],-26649.0,Alive,TUMOR FREE,498.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,498.0,0.0,498.0,0.0,498.0,0.0,498.0,
TCGA-34-5232,6425,TCGA-34-5232,LUSC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-27633.0,Alive,TUMOR FREE,2471.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2471.0,0.0,2471.0,0.0,2471.0,0.0,2471.0,
TCGA-99-8033,6276,TCGA-99-8033,LUAD,74.0,FEMALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27342.0,Dead,WITH TUMOR,,656.0,[Not Available],,,,,Progressive Disease,,,1.0,656.0,1.0,656.0,,,1.0,656.0,
TCGA-85-A4CL,6738,TCGA-85-A4CL,LUSC,65.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24005.0,Dead,TUMOR FREE,,921.0,[Not Available],,,,,Complete Remission/Response,,,1.0,921.0,0.0,921.0,0.0,921.0,0.0,921.0,
TCGA-OR-A5JW,31,TCGA-OR-A5JW,ACC,47.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-17513.0,Alive,TUMOR FREE,2202.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2202.0,0.0,2202.0,0.0,2202.0,0.0,2202.0,
TCGA-DX-A48V,8602,TCGA-DX-A48V,SARC,78.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-28754.0,Alive,TUMOR FREE,1820.0,,[Not Available],Distant Metastasis,"Other, specify",Flank,1407.0,[Not Available],Negative,R0,0.0,1820.0,0.0,1820.0,1.0,1407.0,1.0,1407.0,
TCGA-QR-A70W,7739,TCGA-QR-A70W,PCPG,40.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2009.0,[Not Available],-14613.0,Alive,TUMOR FREE,1271.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1271.0,0.0,1271.0,0.0,1271.0,0.0,1271.0,
TCGA-GC-A4ZW,334,TCGA-GC-A4ZW,BLCA,71.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-25964.0,Alive,TUMOR FREE,15.0,,[Not Available],,,,,[Unknown],,,0.0,15.0,0.0,15.0,,,0.0,15.0,
TCGA-EJ-7789,7966,TCGA-EJ-7789,PRAD,66.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24107.0,Alive,TUMOR FREE,1105.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1105.0,0.0,1105.0,0.0,1105.0,0.0,1105.0,
TCGA-N6-A4VC,11039,TCGA-N6-A4VC,UCS,83.0,FEMALE,WHITE,[Not Applicable],Stage III,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30643.0,Dead,WITH TUMOR,,597.0,[Not Available],Distant Metastasis,Lung,,171.0,Progressive Disease,,,1.0,597.0,1.0,597.0,,,1.0,171.0,
TCGA-06-0168,2777,TCGA-06-0168,GBM,59.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-21776.0,Dead,WITH TUMOR,579.0,598.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],461.0,[Not Available],,,1.0,598.0,1.0,598.0,,,1.0,461.0,
TCGA-66-2771,6628,TCGA-66-2771,LUSC,60.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-22219.0,Alive,TUMOR FREE,578.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,
TCGA-H2-A422,10310,TCGA-H2-A422,THCA,40.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-14721.0,Alive,TUMOR FREE,566.0,,[Not Available],,,,,[Not Available],,RX,0.0,566.0,0.0,566.0,,,0.0,566.0,
TCGA-VS-A9UO,1874,TCGA-VS-A9UO,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IIB,Mucinous Adenocarcinoma of Endocervical Type,G2,2011.0,Peri (6-12 months since last menstrual period),-15813.0,Alive,TUMOR FREE,1456.0,,,,,,,Complete Remission/Response,,,0.0,1456.0,0.0,1456.0,0.0,1456.0,0.0,1456.0,
TCGA-VQ-A94T,9696,TCGA-VQ-A94T,STAD,73.0,MALE,[Unknown],Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-26702.0,Dead,WITH TUMOR,,342.0,[Not Available],Locoregional Recurrence,,,296.0,Progressive Disease,,,1.0,342.0,1.0,342.0,,,1.0,296.0,
TCGA-21-1071,6344,TCGA-21-1071,LUSC,67.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-24515.0,Dead,WITH TUMOR,1426.0,1426.0,[Not Available],,,,993.0,[Not Available],,,1.0,1426.0,1.0,1426.0,,,1.0,993.0,
TCGA-CZ-4859,4359,TCGA-CZ-4859,KIRC,59.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-21842.0,Alive,TUMOR FREE,1787.0,,[Not Available],,,,,[Not Available],,,0.0,1787.0,0.0,1787.0,,,0.0,1787.0,
TCGA-BQ-5877,4537,TCGA-BQ-5877,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004.0,[Not Available],-22095.0,Dead,WITH TUMOR,,270.0,[Not Available],,,,127.0,[Not Available],,,1.0,270.0,1.0,270.0,,,1.0,127.0,
TCGA-KL-8323,3770,TCGA-KL-8323,KICH,57.0,FEMALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2000.0,[Not Available],-20849.0,Dead,WITH TUMOR,,1158.0,[Not Available],,,,758.0,[Unknown],,,1.0,1158.0,1.0,1158.0,,,1.0,758.0,
TCGA-MX-A5UG,9615,TCGA-MX-A5UG,STAD,78.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2007.0,[Not Available],-28714.0,Dead,TUMOR FREE,,113.0,Stomach Cancer,,,,,[Not Applicable],,,1.0,113.0,1.0,113.0,,,0.0,113.0,
TCGA-CQ-6218,3387,TCGA-CQ-6218,HNSC,52.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-19096.0,Alive,TUMOR FREE,1253.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1253.0,0.0,1253.0,,,0.0,1253.0,
TCGA-DD-AADO,5625,TCGA-DD-AADO,LIHC,55.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-20139.0,Alive,TUMOR FREE,453.0,,[Not Available],,,,,[Not Available],,R0,0.0,453.0,0.0,453.0,0.0,453.0,0.0,453.0,
TCGA-02-2486,2738,TCGA-02-2486,GBM,64.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-23394.0,Dead,WITH TUMOR,,618.0,[Not Available],,,,,[Not Available],,,1.0,618.0,1.0,618.0,,,1.0,618.0,
TCGA-D3-A2JL,8848,TCGA-D3-A2JL,SKCM,43.0,FEMALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],1999.0,[Not Available],-15710.0,Alive,TUMOR FREE,5219.0,,[Not Available],Distant Metastasis,Lung,,2638.0,[Not Available],,,0.0,5219.0,0.0,5219.0,,,1.0,2638.0,
TCGA-FS-A1ZC,9152,TCGA-FS-A1ZC,SKCM,51.0,MALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],1978.0,[Not Available],-18843.0,Dead,WITH TUMOR,,10870.0,[Not Available],,,,10334.0,[Not Available],,,1.0,10870.0,1.0,10870.0,,,1.0,10334.0,
TCGA-BG-A0MG,10746,TCGA-BG-A0MG,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26957.0,Alive,TUMOR FREE,1477.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1477.0,0.0,1477.0,0.0,1477.0,0.0,1477.0,
TCGA-C4-A0F6,148,TCGA-C4-A0F6,BLCA,82.0,FEMALE,[Not Available],Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-29951.0,Alive,TUMOR FREE,700.0,,[Not Available],,,,,[Not Available],,,0.0,700.0,0.0,700.0,,,0.0,700.0,
TCGA-FB-A78T,7557,TCGA-FB-A78T,PAAD,71.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-26179.0,Dead,,,375.0,Pancreatic Cancer,,,,,Complete Remission/Response,,,1.0,375.0,1.0,375.0,0.0,375.0,0.0,375.0,
TCGA-BG-A0W1,10761,TCGA-BG-A0W1,UCEC,89.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32750.0,Alive,TUMOR FREE,1607.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1607.0,0.0,1607.0,0.0,1607.0,0.0,1607.0,
TCGA-DH-A7UV,4979,TCGA-DH-A7UV,LGG,49.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-18161.0,Alive,WITH TUMOR,566.0,,[Not Available],,,,,Stable Disease,,,0.0,566.0,0.0,566.0,,,0.0,566.0,
TCGA-V1-A9O9,8251,TCGA-V1-A9O9,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-20805.0,Alive,,2870.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2870.0,0.0,2870.0,0.0,2870.0,0.0,2870.0,
TCGA-DA-A1I7,8923,TCGA-DA-A1I7,SKCM,62.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2007.0,[Not Available],-22940.0,Alive,WITH TUMOR,2703.0,,[Not Available],Distant Metastasis,"Other, Specify",skin scrotum,755.0,[Not Available],,,0.0,2703.0,0.0,2703.0,,,1.0,755.0,
TCGA-RW-A67Y,7760,TCGA-RW-A67Y,PCPG,43.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-15729.0,Alive,TUMOR FREE,216.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,216.0,0.0,216.0,0.0,216.0,0.0,216.0,
TCGA-CM-6168,2283,TCGA-CM-6168,COAD,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-30834.0,Alive,TUMOR FREE,395.0,,[Not Available],,,,,[Not Available],,,0.0,395.0,0.0,395.0,,,0.0,395.0,
TCGA-X6-A7WB,8783,TCGA-X6-A7WB,SARC,58.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-21467.0,Dead,WITH TUMOR,,550.0,[Not Available],Distant Metastasis,Lung,,104.0,[Not Available],Positive,R1,1.0,550.0,1.0,550.0,,,1.0,104.0,
TCGA-CM-5861,2271,TCGA-CM-5861,COAD,63.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-23253.0,Alive,TUMOR FREE,457.0,,[Not Available],Locoregional Disease,,,335.0,[Not Available],,,0.0,457.0,0.0,457.0,,,1.0,335.0,
TCGA-VS-A9UQ,1876,TCGA-VS-A9UQ,CESC,32.0,FEMALE,[Unknown],[Not Available],Stage IB,Mucinous Adenocarcinoma of Endocervical Type,G2,2011.0,Peri (6-12 months since last menstrual period),-11853.0,Alive,TUMOR FREE,1263.0,,,Distant Metastasis,"Other, specify",Ovary,561.0,Complete Remission/Response,,,0.0,1263.0,0.0,1263.0,1.0,561.0,1.0,561.0,
TCGA-55-8092,6019,TCGA-55-8092,LUAD,75.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27597.0,Dead,WITH TUMOR,,154.0,[Not Available],Locoregional Recurrence,,,127.0,Complete Remission/Response,,,1.0,154.0,1.0,154.0,1.0,127.0,1.0,127.0,
TCGA-CD-5802,9418,TCGA-CD-5802,STAD,58.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,[Not Available],-21331.0,Alive,TUMOR FREE,406.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,406.0,0.0,406.0,0.0,406.0,0.0,406.0,
TCGA-DA-A95W,8933,TCGA-DA-A95W,SKCM,52.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2011.0,[Not Available],-19105.0,Alive,TUMOR FREE,1136.0,,[Not Available],,,,,[Not Available],,,0.0,1136.0,0.0,1136.0,,,0.0,1136.0,
TCGA-IB-AAUU,7654,TCGA-IB-AAUU,PAAD,35.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,[Not Available],-13127.0,Alive,TUMOR FREE,245.0,,,,,,,Complete Remission/Response,,,0.0,245.0,0.0,245.0,0.0,245.0,0.0,245.0,
TCGA-D5-6537,2308,TCGA-D5-6537,COAD,64.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-23381.0,Dead,WITH TUMOR,,146.0,[Not Available],,,,123.0,[Not Available],,,1.0,146.0,1.0,146.0,,,1.0,123.0,
TCGA-MQ-A4LV,6859,TCGA-MQ-A4LV,MESO,63.0,MALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2002.0,[Not Available],-23110.0,Dead,TUMOR FREE,,107.0,[Not Available],Intrapleural Progression,Ipsilateral Pleura,,99.0,[Not Available],,R0,1.0,107.0,0.0,107.0,1.0,99.0,1.0,99.0,
TCGA-G3-AAV3,5728,TCGA-G3-AAV3,LIHC,58.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-21449.0,Alive,TUMOR FREE,412.0,,[Not Available],,,,,[Not Available],,R0,0.0,412.0,0.0,412.0,0.0,412.0,0.0,412.0,
TCGA-BH-A0BF,1043,TCGA-BH-A0BF,BRCA,56.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20691.0,Dead,TUMOR FREE,,1324.0,[Not Available],,,,,[Not Available],Negative,,1.0,1324.0,0.0,1324.0,0.0,1324.0,0.0,1324.0,
TCGA-EY-A2OM,10968,TCGA-EY-A2OM,UCEC,55.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20398.0,Alive,TUMOR FREE,694.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,694.0,0.0,694.0,0.0,694.0,0.0,694.0,
TCGA-UD-AAC1,6895,TCGA-UD-AAC1,MESO,71.0,FEMALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2005.0,[Not Available],-26057.0,Dead,WITH TUMOR,,789.0,[Not Available],Intrapleural Progression,Ipsilateral Pleura,,85.0,[Not Available],,R2,1.0,789.0,1.0,789.0,,,1.0,85.0,
TCGA-BH-A18H,1116,TCGA-BH-A18H,BRCA,63.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23065.0,Alive,TUMOR FREE,652.0,,[Not Available],,,,,[Not Available],Negative,,0.0,652.0,0.0,652.0,0.0,652.0,0.0,652.0,
TCGA-EL-A3CO,10043,TCGA-EL-A3CO,THCA,88.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1999.0,[Not Available],-32146.0,Dead,,,2973.0,[Not Available],,,,,[Not Available],,R1,1.0,2973.0,,2973.0,,,0.0,2973.0,
TCGA-22-1000,6363,TCGA-22-1000,LUSC,76.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-27901.0,Dead,WITH TUMOR,,454.0,[Not Available],,,,263.0,Complete Remission/Response,,,1.0,454.0,1.0,454.0,1.0,263.0,1.0,263.0,
TCGA-A5-A0VP,10508,TCGA-A5-A0VP,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27335.0,Alive,TUMOR FREE,1288.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,
TCGA-IB-AAUW,7656,TCGA-IB-AAUW,PAAD,63.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,[Not Available],-23306.0,Dead,WITH TUMOR,,230.0,,Locoregional Recurrence,Tumor Bed,,185.0,Complete Remission/Response,,,1.0,230.0,1.0,230.0,1.0,185.0,1.0,185.0,
TCGA-CV-5966,3482,TCGA-CV-5966,HNSC,63.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2005.0,[Not Available],-23119.0,Dead,TUMOR FREE,,545.0,[Not Available],,,,,Complete Remission/Response,,,1.0,545.0,0.0,545.0,,,0.0,545.0,
TCGA-21-A5DI,6360,TCGA-21-A5DI,LUSC,77.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-28374.0,Alive,TUMOR FREE,979.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,979.0,0.0,979.0,0.0,979.0,0.0,979.0,
TCGA-4C-A93U,9845,TCGA-4C-A93U,THCA,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2013.0,[Not Available],-27348.0,Alive,TUMOR FREE,129.0,,[Not Available],,,,,[Not Available],,R0,0.0,129.0,0.0,129.0,,,0.0,129.0,
TCGA-50-5055,5936,TCGA-50-5055,LUAD,79.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-28988.0,Dead,WITH TUMOR,,1830.0,[Not Available],Locoregional Recurrence|Distant Metastasis,,,771.0,Stable Disease,,,1.0,1830.0,1.0,1830.0,,,1.0,771.0,
TCGA-55-8616,6043,TCGA-55-8616,LUAD,58.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-21225.0,Alive,TUMOR FREE,48.0,,[Not Available],,,,,[Not Applicable],,,0.0,48.0,0.0,48.0,,,0.0,48.0,
TCGA-EP-A2KC,5684,TCGA-EP-A2KC,LIHC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-22677.0,Dead,TUMOR FREE,,19.0,[Not Available],,,,,[Not Available],,R0,1.0,19.0,0.0,19.0,0.0,19.0,0.0,19.0,
TCGA-RY-A83Z,5316,TCGA-RY-A83Z,LGG,54.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-19903.0,Alive,WITH TUMOR,301.0,,[Not Available],,,,,Stable Disease,,,0.0,301.0,0.0,301.0,,,0.0,301.0,
TCGA-J9-A52E,8156,TCGA-J9-A52E,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-23741.0,Alive,TUMOR FREE,323.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,323.0,0.0,323.0,,,0.0,323.0,
TCGA-DD-AADU,5630,TCGA-DD-AADU,LIHC,60.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-21940.0,Alive,TUMOR FREE,554.0,,[Not Available],,,,,[Not Available],,R0,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,
TCGA-Q1-A5R3,1821,TCGA-Q1-A5R3,CESC,56.0,FEMALE,WHITE,[Not Available],[Not Available],Cervical Squamous Cell Carcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20574.0,Alive,TUMOR FREE,485.0,,,,,,,Complete Remission/Response,,,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,
TCGA-EE-A2MP,9062,TCGA-EE-A2MP,SKCM,34.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],1991.0,[Not Available],-12474.0,Alive,WITH TUMOR,7563.0,,[Not Available],Locoregional Recurrence,,,365.0,[Not Available],,,0.0,7563.0,0.0,7563.0,,,1.0,365.0,
TCGA-C8-A134,1194,TCGA-C8-A134,BRCA,52.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Peri (6-12 months since last menstrual period),-19010.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,[Not Available],Negative,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-E2-A15M,1345,TCGA-E2-A15M,BRCA,66.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24266.0,Dead,TUMOR FREE,,336.0,[Not Available],,,,,[Not Available],Negative,,1.0,336.0,0.0,336.0,0.0,336.0,0.0,336.0,
TCGA-ZB-A96F,10458,TCGA-ZB-A96F,THYM,39.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2010.0,[Not Available],-14344.0,Alive,TUMOR FREE,1761.0,,[Not Available],,,,,[Not Available],,,0.0,1761.0,0.0,1761.0,,,0.0,1761.0,
TCGA-B0-5097,4027,TCGA-B0-5097,KIRC,59.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-21852.0,Alive,WITH TUMOR,665.0,,[Not Available],,,,359.0,[Not Available],,,0.0,665.0,0.0,665.0,,,1.0,359.0,
TCGA-E2-A1LH,1378,TCGA-E2-A1LH,BRCA,59.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21628.0,Alive,TUMOR FREE,3247.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3247.0,0.0,3247.0,0.0,3247.0,0.0,3247.0,
TCGA-EJ-5494,7910,TCGA-EJ-5494,PRAD,50.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-18596.0,Alive,TUMOR FREE,1477.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1477.0,0.0,1477.0,0.0,1477.0,0.0,1477.0,
TCGA-4V-A9QT,10369,TCGA-4V-A9QT,THYM,79.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type B1,[Not Available],2012.0,[Not Available],-28951.0,Alive,TUMOR FREE,813.0,,[Not Available],,,,,[Not Available],,,0.0,813.0,0.0,813.0,,,0.0,813.0,
TCGA-60-2710,6570,TCGA-60-2710,LUSC,67.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-24669.0,Alive,TUMOR FREE,2024.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2024.0,0.0,2024.0,0.0,2024.0,0.0,2024.0,
TCGA-VF-A8AD,9796,TCGA-VF-A8AD,TGCT,36.0,MALE,WHITE,Stage IB,Stage IB,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2011.0,[Not Available],-13499.0,Alive,WITH TUMOR,1006.0,,[Not Applicable],Locoregional Recurrence,Testes,,276.0,Complete Remission/Response,,,0.0,1006.0,0.0,1006.0,1.0,276.0,1.0,276.0,
TCGA-AN-A0XV,840,TCGA-AN-A0XV,BRCA,67.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24779.0,Alive,TUMOR FREE,162.0,,[Not Available],,,,,[Not Available],Negative,,0.0,162.0,0.0,162.0,0.0,162.0,0.0,162.0,
TCGA-B5-A0JX,10681,TCGA-B5-A0JX,UCEC,62.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22834.0,Alive,TUMOR FREE,1787.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1787.0,0.0,1787.0,0.0,1787.0,0.0,1787.0,
TCGA-FB-AAPP,7559,TCGA-FB-AAPP,PAAD,71.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2009.0,[Not Available],-26239.0,Dead,WITH TUMOR,,485.0,Pancreatic Cancer,Distant Metastasis,Lung,,150.0,Progressive Disease,,,1.0,485.0,1.0,485.0,,,1.0,150.0,
TCGA-BR-8380,9365,TCGA-BR-8380,STAD,55.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-20157.0,Alive,WITH TUMOR,21.0,,[Not Available],Locoregional Recurrence,,,467.0,Complete Remission/Response,,,0.0,21.0,0.0,21.0,1.0,467.0,1.0,467.0,
TCGA-CV-6935,3496,TCGA-CV-6935,HNSC,67.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,1999.0,[Not Available],-24799.0,Dead,WITH TUMOR,,295.0,[Not Available],,,,,[Not Available],,,1.0,295.0,1.0,295.0,,,1.0,295.0,
TCGA-DC-4745,8482,TCGA-DC-4745,READ,49.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-17958.0,Alive,TUMOR FREE,639.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,
TCGA-DU-6408,5006,TCGA-DU-6408,LGG,23.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,1998.0,[Not Available],-8752.0,Dead,,,3470.0,[Not Available],,,,2097.0,Progressive Disease,,,1.0,3470.0,,3470.0,,,1.0,2097.0,
TCGA-MH-A560,4646,TCGA-MH-A560,KIRP,62.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-22866.0,Alive,TUMOR FREE,924.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,924.0,0.0,924.0,0.0,924.0,0.0,924.0,
TCGA-A3-3316,3890,TCGA-A3-3316,KIRC,57.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-20931.0,Alive,TUMOR FREE,1493.0,,[Not Available],,,,,[Not Available],,,0.0,1493.0,0.0,1493.0,,,0.0,1493.0,
TCGA-36-2544,7402,TCGA-36-2544,OV,58.0,FEMALE,[Not Available],[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-21384.0,Alive,WITH TUMOR,638.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],325.0,Partial Remission/Response,,,0.0,638.0,0.0,638.0,,,1.0,325.0,
TCGA-C8-A12V,1185,TCGA-C8-A12V,BRCA,55.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20346.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,385.0,0.0,385.0,,,0.0,385.0,
TCGA-CM-6674,2288,TCGA-CM-6674,COAD,39.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-14368.0,Alive,TUMOR FREE,394.0,,[Not Available],,,,,[Not Available],,,0.0,394.0,0.0,394.0,,,0.0,394.0,
TCGA-35-3615,5838,TCGA-35-3615,LUAD,57.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-21076.0,Alive,TUMOR FREE,14.0,,[Not Available],,,,,[Not Available],,,0.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-94-7943,6768,TCGA-94-7943,LUSC,80.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-29282.0,Alive,WITH TUMOR,559.0,,[Not Available],Locoregional Recurrence,,,556.0,Complete Remission/Response,,,0.0,559.0,0.0,559.0,1.0,556.0,1.0,556.0,
TCGA-A3-A8OX,3936,TCGA-A3-A8OX,KIRC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2012.0,[Not Available],-23998.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-QR-A705,7717,TCGA-QR-A705,PCPG,63.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2010.0,[Not Available],-23086.0,Alive,TUMOR FREE,317.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,317.0,0.0,317.0,0.0,317.0,0.0,317.0,
TCGA-WB-A81M,7854,TCGA-WB-A81M,PCPG,42.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-15505.0,Alive,TUMOR FREE,1394.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1394.0,0.0,1394.0,0.0,1394.0,0.0,1394.0,
TCGA-D3-A3CE,8860,TCGA-D3-A3CE,SKCM,74.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],2001.0,[Not Available],-27355.0,Dead,WITH TUMOR,,1832.0,[Not Available],Regional lymph node,,,0.0,[Not Available],,,1.0,1832.0,1.0,1832.0,,,1.0,0.0,
TCGA-B2-5633,4077,TCGA-B2-5633,KIRC,56.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-20493.0,Alive,TUMOR FREE,963.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,963.0,0.0,963.0,0.0,963.0,0.0,963.0,
TCGA-PC-A5DK,8735,TCGA-PC-A5DK,SARC,63.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2004.0,[Not Available],-23019.0,Alive,TUMOR FREE,3740.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,3740.0,0.0,3740.0,0.0,3740.0,0.0,3740.0,
TCGA-D1-A16B,10839,TCGA-D1-A16B,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23450.0,Alive,TUMOR FREE,1106.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,
TCGA-HT-7609,5166,TCGA-HT-7609,LGG,34.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2007.0,[Not Available],-12607.0,Alive,TUMOR FREE,1399.0,,[Not Available],,,,,Stable Disease,,,0.0,1399.0,0.0,1399.0,,,0.0,1399.0,
TCGA-DD-AAVR,5653,TCGA-DD-AAVR,LIHC,44.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-16157.0,Alive,TUMOR FREE,2513.0,,[Not Available],,,,,[Not Available],,R0,0.0,2513.0,0.0,2513.0,0.0,2513.0,0.0,2513.0,
TCGA-K4-A5RJ,380,TCGA-K4-A5RJ,BLCA,75.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27518.0,Alive,TUMOR FREE,539.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,539.0,0.0,539.0,0.0,539.0,0.0,539.0,
TCGA-SH-A9CT,6876,TCGA-SH-A9CT,MESO,67.0,MALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],2013.0,[Not Available],-24528.0,Dead,WITH TUMOR,,449.0,[Not Available],,,,,[Not Available],,[Not Available],1.0,449.0,1.0,449.0,,,1.0,449.0,
TCGA-CD-5804,9420,TCGA-CD-5804,STAD,90.0,MALE,ASIAN,[Discrepancy],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,[Not Available],-32872.0,Alive,TUMOR FREE,368.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,368.0,0.0,368.0,0.0,368.0,0.0,368.0,
TCGA-86-7954,6185,TCGA-86-7954,LUAD,68.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25062.0,Alive,TUMOR FREE,605.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,605.0,0.0,605.0,0.0,605.0,0.0,605.0,
TCGA-BR-A452,9391,TCGA-BR-A452,STAD,57.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-21107.0,Dead,TUMOR FREE,,229.0,[Not Available],,,,,Complete Remission/Response,,,1.0,229.0,0.0,229.0,0.0,229.0,0.0,229.0,
TCGA-EW-A6S9,1493,TCGA-EW-A6S9,BRCA,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,[Not Available],-12755.0,Alive,TUMOR FREE,463.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,463.0,0.0,463.0,,,0.0,463.0,
TCGA-BR-4253,9282,TCGA-BR-4253,STAD,80.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-29397.0,Dead,,,124.0,[Not Available],,,,,[Not Available],,,1.0,124.0,,124.0,,,0.0,124.0,
TCGA-KN-8429,3828,TCGA-KN-8429,KICH,38.0,FEMALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-13903.0,Alive,TUMOR FREE,2650.0,,[Not Available],,,,1989.0,Complete Remission/Response,,,0.0,2650.0,0.0,2650.0,1.0,1989.0,1.0,1989.0,
TCGA-62-A46S,6067,TCGA-62-A46S,LUAD,73.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-26825.0,Dead,WITH TUMOR,,1653.0,[Not Available],Locoregional Recurrence|Distant Metastasis,,,527.0,Complete Remission/Response,,,1.0,1653.0,1.0,1653.0,1.0,527.0,1.0,527.0,
TCGA-AP-A1DH,10593,TCGA-AP-A1DH,UCEC,62.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22652.0,Alive,TUMOR FREE,2180.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2180.0,0.0,2180.0,0.0,2180.0,0.0,2180.0,
TCGA-DH-5144,4969,TCGA-DH-5144,LGG,56.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2009.0,[Not Available],-20558.0,Alive,TUMOR FREE,748.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,748.0,0.0,748.0,0.0,748.0,0.0,748.0,
TCGA-CV-5443,3480,TCGA-CV-5443,HNSC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2004.0,[Not Available],-23287.0,Alive,TUMOR FREE,2784.0,,[Not Available],,,,,[Not Available],,,0.0,2784.0,0.0,2784.0,,,0.0,2784.0,
TCGA-A5-A0R9,10505,TCGA-A5-A0R9,UCEC,51.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18982.0,Alive,TUMOR FREE,749.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,749.0,0.0,749.0,0.0,749.0,0.0,749.0,
TCGA-06-A7TL,2893,TCGA-06-A7TL,GBM,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2013.0,[Not Available],-11297.0,Alive,WITH TUMOR,539.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],188.0,Stable Disease,,,0.0,539.0,0.0,539.0,,,1.0,188.0,
TCGA-AC-A4ZE,785,TCGA-AC-A4ZE,BRCA,63.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23284.0,Alive,TUMOR FREE,890.0,,[Not Available],,,,,[Not Available],Negative,,0.0,890.0,0.0,890.0,0.0,890.0,0.0,890.0,
TCGA-X7-A8M4,10399,TCGA-X7-A8M4,THYM,41.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2002.0,[Not Available],-15070.0,Alive,TUMOR FREE,3808.0,,[Not Available],,,,,[Not Available],,,0.0,3808.0,0.0,3808.0,,,0.0,3808.0,
TCGA-LN-A49Y,2570,TCGA-LN-A49Y,ESCA,77.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2011.0,[Not Available],-28125.0,Alive,WITH TUMOR,379.0,,[Not Available],Locoregional Recurrence,,,90.0,Complete Remission/Response,,,0.0,379.0,0.0,379.0,1.0,90.0,1.0,90.0,
TCGA-L5-A4OE,2514,TCGA-L5-A4OE,ESCA,81.0,MALE,WHITE,Stage IIIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2011.0,[Not Available],-29591.0,Dead,,,730.0,[Not Available],,,,,Complete Remission/Response,,,1.0,730.0,,730.0,0.0,730.0,0.0,730.0,
TCGA-XV-AAZV,9255,TCGA-XV-AAZV,SKCM,56.0,FEMALE,WHITE,Stage II,[Not Applicable],,[Not Available],2013.0,[Not Available],-20545.0,Alive,TUMOR FREE,412.0,,[Not Available],,,,,[Not Available],,,0.0,412.0,0.0,412.0,,,0.0,412.0,
TCGA-SC-A6LM,6867,TCGA-SC-A6LM,MESO,64.0,FEMALE,WHITE,Stage IV,[Not Applicable],Epithelioid mesothelioma,[Not Available],2010.0,[Not Available],-23400.0,Dead,WITH TUMOR,,881.0,[Not Available],Locoregional Recurrence,"Other, specify",Ipsilateral Chest Cavity AND Other,363.0,[Not Available],,R2,1.0,881.0,1.0,881.0,,,1.0,363.0,
TCGA-S7-A7X1,7791,TCGA-S7-A7X1,PCPG,23.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-8426.0,Alive,TUMOR FREE,576.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,576.0,0.0,576.0,0.0,576.0,0.0,576.0,
TCGA-E2-A10F,1312,TCGA-E2-A10F,BRCA,47.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17257.0,Alive,TUMOR FREE,878.0,,[Not Available],,,,,[Not Available],Negative,,0.0,878.0,0.0,878.0,0.0,878.0,0.0,878.0,
TCGA-DJ-A13X,9928,TCGA-DJ-A13X,THCA,51.0,FEMALE,[Not Available],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-18689.0,Alive,TUMOR FREE,253.0,,[Not Available],,,,,[Not Available],,R0,0.0,253.0,0.0,253.0,0.0,253.0,0.0,253.0,
TCGA-N9-A4Q7,11060,TCGA-N9-A4Q7,UCS,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25419.0,Alive,TUMOR FREE,604.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,604.0,0.0,604.0,0.0,604.0,0.0,604.0,
TCGA-CV-7102,3526,TCGA-CV-7102,HNSC,76.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2000.0,[Not Available],-27805.0,Dead,,,56.0,[Not Available],,,,,Complete Remission/Response,,,1.0,56.0,,56.0,,,0.0,56.0,
TCGA-CM-6166,2281,TCGA-CM-6166,COAD,48.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-17807.0,Alive,TUMOR FREE,669.0,,[Not Available],,,,,[Not Available],,,0.0,669.0,0.0,669.0,,,0.0,669.0,
TCGA-X4-A8KS,8292,TCGA-X4-A8KS,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22571.0,Alive,TUMOR FREE,979.0,,[Not Available],,,,,Stable Disease,,,0.0,979.0,0.0,979.0,,,0.0,979.0,
TCGA-AJ-A3OJ,10550,TCGA-AJ-A3OJ,UCEC,54.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2011.0,Indeterminate (neither Pre or Postmenopausal),-19826.0,Alive,TUMOR FREE,467.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,467.0,0.0,467.0,0.0,467.0,0.0,467.0,
TCGA-AZ-6607,2232,TCGA-AZ-6607,COAD,69.0,MALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-25448.0,Dead,WITH TUMOR,,97.0,[Not Available],,,,,Complete Remission/Response,,,1.0,97.0,1.0,97.0,,,1.0,97.0,
TCGA-J4-A6M7,8143,TCGA-J4-A6M7,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-19640.0,Alive,TUMOR FREE,512.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,
TCGA-CD-8526,9424,TCGA-CD-8526,STAD,73.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,[Not Available],-26840.0,Alive,TUMOR FREE,381.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,381.0,0.0,381.0,0.0,381.0,0.0,381.0,
TCGA-27-2527,3132,TCGA-27-2527,GBM,81.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-29619.0,Dead,WITH TUMOR,438.0,438.0,[Not Available],,,,,[Not Available],,,1.0,438.0,1.0,438.0,,,1.0,438.0,
TCGA-D1-A0ZO,10816,TCGA-D1-A0ZO,UCEC,75.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27482.0,Alive,TUMOR FREE,602.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,
TCGA-2Y-A9HB,5446,TCGA-2Y-A9HB,LIHC,66.0,MALE,[Not Evaluated],Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-24359.0,Alive,TUMOR FREE,260.0,,[Not Available],,,,,[Not Available],,R0,0.0,260.0,0.0,260.0,0.0,260.0,0.0,260.0,
TCGA-A5-A0R7,10503,TCGA-A5-A0R7,UCEC,55.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20250.0,Alive,TUMOR FREE,535.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,535.0,0.0,535.0,0.0,535.0,0.0,535.0,
TCGA-BA-4076,3245,TCGA-BA-4076,HNSC,39.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2003.0,[Not Available],-14405.0,Dead,WITH TUMOR,,415.0,[Not Available],,Larynx,,286.0,Complete Remission/Response,,,1.0,415.0,1.0,415.0,,,1.0,286.0,
TCGA-DG-A2KK,1673,TCGA-DG-A2KK,CESC,51.0,FEMALE,[Not Evaluated],[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18834.0,Alive,TUMOR FREE,2496.0,,,,,,,Complete Remission/Response,,,0.0,2496.0,0.0,2496.0,0.0,2496.0,0.0,2496.0,
TCGA-MN-A4N5,6294,TCGA-MN-A4N5,LUAD,63.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23257.0,Alive,TUMOR FREE,84.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,84.0,0.0,84.0,0.0,84.0,0.0,84.0,
TCGA-KM-8438,3794,TCGA-KM-8438,KICH,45.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2000.0,[Not Available],-16683.0,Alive,WITH TUMOR,4622.0,,[Not Available],,,,2317.0,Complete Remission/Response,,,0.0,4622.0,0.0,4622.0,1.0,2317.0,1.0,2317.0,
TCGA-L3-A524,6797,TCGA-L3-A524,LUSC,45.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-16765.0,Dead,TUMOR FREE,,490.0,[Not Available],,,,,Complete Remission/Response,,,1.0,490.0,0.0,490.0,0.0,490.0,0.0,490.0,
TCGA-GV-A3JX,356,TCGA-GV-A3JX,BLCA,59.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-21888.0,Alive,TUMOR FREE,581.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,581.0,0.0,581.0,0.0,581.0,0.0,581.0,
TCGA-22-5492,6396,TCGA-22-5492,LUSC,73.0,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-26838.0,Dead,,506.0,506.0,[Not Available],,,,,[Not Available],,,1.0,506.0,,506.0,,,0.0,506.0,
TCGA-BD-A2L6,5476,TCGA-BD-A2L6,LIHC,69.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-25489.0,Alive,WITH TUMOR,1363.0,,[Not Available],Intrahepatic Recurrence,Liver,,415.0,[Not Available],,R0,0.0,1363.0,0.0,1363.0,1.0,415.0,1.0,415.0,
TCGA-BH-A0HN,1100,TCGA-BH-A0HN,BRCA,67.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24731.0,Alive,TUMOR FREE,516.0,,[Not Available],,,,,[Not Available],Negative,,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,Redacted
TCGA-OD-A75X,9218,TCGA-OD-A75X,SKCM,49.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1989.0,[Not Available],-17910.0,Dead,WITH TUMOR,,9061.0,[Not Available],Distant Metastasis|Distant Metastasis|Distant Metastasis,"Brain|Other, Specify|Lung",[Not Applicable]|stomach|[Not Applicable],8987.0,[Not Available],,,1.0,9061.0,1.0,9061.0,,,1.0,8987.0,
TCGA-90-7769,6756,TCGA-90-7769,LUSC,55.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-20276.0,Alive,TUMOR FREE,358.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,
TCGA-AZ-6599,2226,TCGA-AZ-6599,COAD,72.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2001.0,[Not Available],-26438.0,Dead,TUMOR FREE,,206.0,[Not Available],,,,,Complete Remission/Response,,,1.0,206.0,0.0,206.0,0.0,206.0,0.0,206.0,
TCGA-55-8621,6046,TCGA-55-8621,LUAD,75.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27485.0,Alive,TUMOR FREE,515.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,515.0,0.0,515.0,0.0,515.0,0.0,515.0,
TCGA-AH-6643,8468,TCGA-AH-6643,READ,50.0,MALE,WHITE,Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-18273.0,Dead,WITH TUMOR,,1314.0,[Not Available],,,,1026.0,Complete Remission/Response,,,1.0,1314.0,1.0,1314.0,1.0,1026.0,1.0,1026.0,
TCGA-W2-A7H7,7821,TCGA-W2-A7H7,PCPG,59.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-21711.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,522.0,0.0,522.0,0.0,522.0,0.0,522.0,
TCGA-FS-A1Z4,9148,TCGA-FS-A1Z4,SKCM,62.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],2001.0,[Not Available],-22932.0,Dead,WITH TUMOR,,854.0,[Not Available],,,,,[Not Available],,,1.0,854.0,1.0,854.0,,,1.0,854.0,
TCGA-E2-A14T,1319,TCGA-E2-A14T,BRCA,52.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19237.0,Alive,TUMOR FREE,2311.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2311.0,0.0,2311.0,0.0,2311.0,0.0,2311.0,
TCGA-EB-A4IQ,8961,TCGA-EB-A4IQ,SKCM,42.0,FEMALE,ASIAN,Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-15516.0,Dead,TUMOR FREE,,636.0,[Not Available],Locoregional Recurrence|Regional lymph node,[Not Available]|[Not Available],[Not Applicable]|[Not Applicable],337.0,[Not Available],,,1.0,636.0,0.0,636.0,,,1.0,337.0,
TCGA-BR-A4IU,9396,TCGA-BR-A4IU,STAD,34.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-12601.0,Alive,TUMOR FREE,838.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,838.0,0.0,838.0,0.0,838.0,0.0,838.0,
TCGA-DD-AAE1,5635,TCGA-DD-AAE1,LIHC,52.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-19073.0,Alive,TUMOR FREE,552.0,,[Not Available],,,,,[Not Available],,R0,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,
TCGA-D1-A1O7,10882,TCGA-D1-A1O7,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22037.0,Alive,TUMOR FREE,32.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,32.0,0.0,32.0,0.0,32.0,0.0,32.0,
TCGA-E3-A3E1,10017,TCGA-E3-A3E1,THCA,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-16895.0,Alive,TUMOR FREE,2449.0,,[Not Available],,,,,[Not Available],,R0,0.0,2449.0,0.0,2449.0,0.0,2449.0,0.0,2449.0,
TCGA-AK-3429,3941,TCGA-AK-3429,KIRC,54.0,FEMALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-19849.0,Alive,TUMOR FREE,3328.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3328.0,0.0,3328.0,0.0,3328.0,0.0,3328.0,
TCGA-55-7724,5999,TCGA-55-7724,LUAD,76.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27891.0,Alive,TUMOR FREE,705.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,705.0,0.0,705.0,0.0,705.0,0.0,705.0,
TCGA-XA-A8JR,8293,TCGA-XA-A8JR,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-25090.0,Alive,TUMOR FREE,376.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,
TCGA-HC-A8D1,8123,TCGA-HC-A8D1,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-25137.0,Alive,TUMOR FREE,573.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,573.0,0.0,573.0,0.0,573.0,0.0,573.0,
TCGA-HZ-A8P1,7616,TCGA-HZ-A8P1,PAAD,81.0,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,[Not Available],-29631.0,Alive,TUMOR FREE,7.0,,,,,,,[Unknown],,,0.0,7.0,0.0,7.0,,,0.0,7.0,
TCGA-AX-A1C8,10633,TCGA-AX-A1C8,UCEC,77.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28452.0,Alive,,776.0,,[Not Available],,,,,[Not Applicable],,,0.0,776.0,0.0,776.0,,,0.0,776.0,
TCGA-D7-6822,9503,TCGA-D7-6822,STAD,77.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-28214.0,Alive,TUMOR FREE,375.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,
TCGA-CJ-6032,4336,TCGA-CJ-6032,KIRC,63.0,FEMALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-23310.0,Alive,TUMOR FREE,3639.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3639.0,0.0,3639.0,0.0,3639.0,0.0,3639.0,
TCGA-IR-A3LA,1776,TCGA-IR-A3LA,CESC,60.0,FEMALE,WHITE,[Not Available],Stage IB1,Endometrioid Adenocarcinoma of Endocervix,G3,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21949.0,Alive,TUMOR FREE,4172.0,,,,,,,Complete Remission/Response,,,0.0,4172.0,0.0,4172.0,0.0,4172.0,0.0,4172.0,
TCGA-FD-A5C0,289,TCGA-FD-A5C0,BLCA,61.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-22500.0,Dead,WITH TUMOR,,550.0,[Not Available],New Primary Tumor,Lung,,27.0,Complete Remission/Response,,,1.0,550.0,1.0,550.0,,,1.0,27.0,
TCGA-G4-6314,2381,TCGA-G4-6314,COAD,76.0,FEMALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-27958.0,Alive,WITH TUMOR,1093.0,,[Not Available],,,,38.0,[Not Available],,,0.0,1093.0,0.0,1093.0,,,1.0,38.0,
TCGA-DD-AACT,5598,TCGA-DD-AACT,LIHC,69.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-25292.0,Alive,TUMOR FREE,1562.0,,[Not Available],,,,,[Not Available],,R0,0.0,1562.0,0.0,1562.0,0.0,1562.0,0.0,1562.0,
TCGA-BA-A6DL,3277,TCGA-BA-A6DL,HNSC,59.0,MALE,WHITE,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21886.0,Alive,TUMOR FREE,623.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,623.0,0.0,623.0,0.0,623.0,0.0,623.0,
TCGA-DB-A4XB,4943,TCGA-DB-A4XB,LGG,38.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2011.0,[Not Available],-13990.0,Alive,TUMOR FREE,919.0,,[Not Available],,,,,Stable Disease,,,0.0,919.0,0.0,919.0,,,0.0,919.0,
TCGA-AO-A1KR,886,TCGA-AO-A1KR,BRCA,51.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18900.0,Alive,TUMOR FREE,2513.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2513.0,0.0,2513.0,0.0,2513.0,0.0,2513.0,
TCGA-D9-A1X3,8903,TCGA-D9-A1X3,SKCM,63.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2010.0,[Not Available],-23171.0,Alive,WITH TUMOR,551.0,,[Not Available],,,,,[Not Available],,,0.0,551.0,0.0,551.0,,,0.0,551.0,
TCGA-DJ-A2QA,9963,TCGA-DJ-A2QA,THCA,56.0,FEMALE,ASIAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-20784.0,Alive,TUMOR FREE,1020.0,,[Not Available],,,,,[Not Available],,R0,0.0,1020.0,0.0,1020.0,0.0,1020.0,0.0,1020.0,
TCGA-EJ-7782,7960,TCGA-EJ-7782,PRAD,71.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-25965.0,Alive,TUMOR FREE,1167.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1167.0,0.0,1167.0,0.0,1167.0,0.0,1167.0,
TCGA-ER-A3ES,9121,TCGA-ER-A3ES,SKCM,25.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1987.0,[Not Available],-9366.0,Dead,WITH TUMOR,,7514.0,[Not Available],,,,,[Not Available],,,1.0,7514.0,1.0,7514.0,,,1.0,7514.0,
TCGA-90-A59Q,6760,TCGA-90-A59Q,LUSC,61.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-22420.0,Dead,WITH TUMOR,,322.0,[Not Available],Distant Metastasis,,,274.0,Complete Remission/Response,,,1.0,322.0,1.0,322.0,1.0,274.0,1.0,274.0,
TCGA-DD-A4NN,5563,TCGA-DD-A4NN,LIHC,56.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2004.0,[Not Available],-20548.0,Dead,WITH TUMOR,,899.0,[Not Available],Extrahepatic Recurrence,Lung,,166.0,[Not Available],,R0,1.0,899.0,1.0,899.0,1.0,166.0,1.0,166.0,
TCGA-BP-4970,4207,TCGA-BP-4970,KIRC,44.0,MALE,ASIAN,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-16228.0,Alive,TUMOR FREE,433.0,,[Not Available],,,,,[Not Available],,,0.0,433.0,0.0,433.0,,,0.0,433.0,
TCGA-DX-A48K,8595,TCGA-DX-A48K,SARC,65.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-23756.0,Alive,TUMOR FREE,1399.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1399.0,0.0,1399.0,0.0,1399.0,0.0,1399.0,
TCGA-KO-8406,3840,TCGA-KO-8406,KICH,17.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-6556.0,Alive,TUMOR FREE,3145.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3145.0,0.0,3145.0,0.0,3145.0,0.0,3145.0,
TCGA-CJ-5682,4327,TCGA-CJ-5682,KIRC,60.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-22244.0,Alive,WITH TUMOR,3736.0,,[Not Available],,,,55.0,Stable Disease,,,0.0,3736.0,0.0,3736.0,,,1.0,55.0,
TCGA-CR-6484,3432,TCGA-CR-6484,HNSC,67.0,FEMALE,ASIAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-24569.0,Alive,TUMOR FREE,354.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,354.0,0.0,354.0,,,0.0,354.0,
TCGA-GF-A6C9,9190,TCGA-GF-A6C9,SKCM,78.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-28774.0,Alive,TUMOR FREE,480.0,,[Not Available],,,,,[Not Available],,,0.0,480.0,0.0,480.0,,,0.0,480.0,
TCGA-AF-5654,8378,TCGA-AF-5654,READ,73.0,FEMALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-26738.0,Dead,TUMOR FREE,,512.0,[Not Available],,,,,[Not Available],,,1.0,512.0,0.0,512.0,,,0.0,512.0,
TCGA-HT-8113,5217,TCGA-HT-8113,LGG,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligodendroglioma,G2,2006.0,[Not Available],-18173.0,Alive,TUMOR FREE,900.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,900.0,0.0,900.0,0.0,900.0,0.0,900.0,
TCGA-SI-A71O,8761,TCGA-SI-A71O,SARC,29.0,MALE,WHITE,[Not Available],[Not Available],Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2013.0,[Not Available],-10710.0,Dead,WITH TUMOR,,694.0,[Not Available],Distant Metastasis,Lung,,264.0,[Not Available],Positive,RX,1.0,694.0,1.0,694.0,,,1.0,264.0,
TCGA-69-8255,6108,TCGA-69-8255,LUAD,71.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26289.0,Alive,,129.0,,[Not Available],,,,,[Unknown],,,0.0,129.0,0.0,129.0,,,0.0,129.0,
TCGA-RD-A8NB,9639,TCGA-RD-A8NB,STAD,80.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2000.0,[Not Available],-29503.0,Dead,WITH TUMOR,,513.0,Stomach Cancer,Distant Metastasis,Non-regional / Distant Lymph Nodes,,230.0,Partial Remission/Response,,,1.0,513.0,1.0,513.0,,,1.0,230.0,
TCGA-EA-A78R,1716,TCGA-EA-A78R,CESC,54.0,FEMALE,ASIAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2013.0,Peri (6-12 months since last menstrual period),-19942.0,Alive,TUMOR FREE,410.0,,,,,,,Complete Remission/Response,,,0.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,
TCGA-4G-AAZO,1916,TCGA-4G-AAZO,CHOL,71.0,FEMALE,WHITE,Stage II,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2012.0,[Not Available],-25989.0,Alive,WITH TUMOR,1177.0,,[Not Available],Intrahepatic Recurrence,Liver,,424.0,[Not Available],,R1,0.0,1177.0,0.0,1177.0,,,1.0,424.0,
TCGA-C5-A1M6,1618,TCGA-C5-A1M6,CESC,55.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20090.0,Dead,WITH TUMOR,,955.0,Cervical Cancer,Distant Metastasis,Lung,,316.0,Complete Remission/Response,,,1.0,955.0,1.0,955.0,1.0,316.0,1.0,316.0,
TCGA-62-A46R,6066,TCGA-62-A46R,LUAD,54.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-20063.0,Dead,TUMOR FREE,,1725.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1725.0,0.0,1725.0,0.0,1725.0,0.0,1725.0,
TCGA-CR-7385,3454,TCGA-CR-7385,HNSC,42.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-15477.0,Alive,TUMOR FREE,997.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,997.0,0.0,997.0,,,0.0,997.0,
TCGA-V1-A9OT,8257,TCGA-V1-A9OT,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-22630.0,Alive,,476.0,,[Not Available],Biochemical evidence of disease,,,292.0,Progressive Disease,,,0.0,476.0,0.0,476.0,,,1.0,292.0,
TCGA-DJ-A3UW,9977,TCGA-DJ-A3UW,THCA,50.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-18487.0,Alive,TUMOR FREE,1812.0,,[Not Available],,,,,[Not Available],,R0,0.0,1812.0,0.0,1812.0,0.0,1812.0,0.0,1812.0,
TCGA-NG-A4VU,11077,TCGA-NG-A4VU,UCS,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23323.0,Dead,WITH TUMOR,,442.0,[Not Available],Progression of Disease,Pelvis,,281.0,Progressive Disease,,,1.0,442.0,1.0,442.0,,,1.0,281.0,
TCGA-DD-AADB,5613,TCGA-DD-AADB,LIHC,51.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2011.0,[Not Available],-18728.0,Alive,TUMOR FREE,1242.0,,[Not Available],,,,,[Not Available],,R0,0.0,1242.0,0.0,1242.0,0.0,1242.0,0.0,1242.0,
TCGA-J7-6720,4638,TCGA-J7-6720,KIRP,42.0,MALE,ASIAN,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-15620.0,Alive,TUMOR FREE,388.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,388.0,0.0,388.0,0.0,388.0,0.0,388.0,
TCGA-VS-A9U5,1862,TCGA-VS-A9U5,CESC,57.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2010.0,Peri (6-12 months since last menstrual period),-21149.0,Alive,TUMOR FREE,1535.0,,,,,,,Complete Remission/Response,,,0.0,1535.0,0.0,1535.0,0.0,1535.0,0.0,1535.0,
TCGA-OL-A66I,1564,TCGA-OL-A66I,BRCA,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,[Not Evaluated],-13458.0,Alive,TUMOR FREE,714.0,,[Not Available],,,,,[Not Available],Negative,,0.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,
TCGA-L5-A891,2537,TCGA-L5-A891,ESCA,51.0,MALE,WHITE,[Unknown],[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2005.0,[Not Available],-18925.0,Alive,TUMOR FREE,114.0,,[Not Available],,,,,[Unknown],,,0.0,114.0,0.0,114.0,,,0.0,114.0,
TCGA-EY-A1GH,10947,TCGA-EY-A1GH,UCEC,70.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25802.0,Alive,TUMOR FREE,710.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,710.0,0.0,710.0,0.0,710.0,0.0,710.0,
TCGA-AR-A1AQ,923,TCGA-AR-A1AQ,BRCA,49.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18109.0,Alive,TUMOR FREE,3021.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3021.0,0.0,3021.0,0.0,3021.0,0.0,3021.0,
TCGA-43-3920,6473,TCGA-43-3920,LUSC,71.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-26059.0,Alive,TUMOR FREE,1007.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1007.0,0.0,1007.0,0.0,1007.0,0.0,1007.0,
TCGA-55-7284,5994,TCGA-55-7284,LUAD,74.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27087.0,Dead,WITH TUMOR,,243.0,[Not Available],Distant Metastasis,,,231.0,Complete Remission/Response,,,1.0,243.0,1.0,243.0,1.0,231.0,1.0,231.0,
TCGA-N5-A4RF,11027,TCGA-N5-A4RF,UCS,68.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25041.0,Alive,TUMOR FREE,1806.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1806.0,0.0,1806.0,0.0,1806.0,0.0,1806.0,
TCGA-DZ-6132,4582,TCGA-DZ-6132,KIRP,69.0,MALE,[Not Available],Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2003.0,[Not Available],-25417.0,Alive,TUMOR FREE,2460.0,,[Not Available],,,,,[Not Available],,,0.0,2460.0,0.0,2460.0,,,0.0,2460.0,
TCGA-2A-AAYF,7874,TCGA-2A-AAYF,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-20866.0,Alive,TUMOR FREE,1364.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1364.0,0.0,1364.0,0.0,1364.0,0.0,1364.0,
TCGA-5T-A9QA,512,TCGA-5T-A9QA,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2013.0,[Unknown],-19031.0,Alive,,303.0,,[Not Available],,,,,[Not Available],[Unknown],,0.0,303.0,0.0,303.0,,,0.0,303.0,
TCGA-2Y-A9GS,5427,TCGA-2Y-A9GS,LIHC,58.0,MALE,WHITE,[Discrepancy],[Not Applicable],Hepatocellular Carcinoma,G2,2006.0,[Not Available],-21318.0,Dead,WITH TUMOR,,724.0,[Not Available],Extrahepatic Recurrence,Lung,,102.0,[Not Available],,R0,1.0,724.0,1.0,724.0,1.0,102.0,1.0,102.0,
TCGA-BH-A0DT,1072,TCGA-BH-A0DT,BRCA,41.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15078.0,Alive,TUMOR FREE,2403.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2403.0,0.0,2403.0,0.0,2403.0,0.0,2403.0,
TCGA-B0-5119,4042,TCGA-B0-5119,KIRC,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-22607.0,Alive,TUMOR FREE,1552.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1552.0,0.0,1552.0,0.0,1552.0,0.0,1552.0,
TCGA-D7-8575,9508,TCGA-D7-8575,STAD,75.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-27712.0,Dead,WITH TUMOR,,554.0,[Not Available],Distant Metastasis,Peritoneal Surfaces,,427.0,Complete Remission/Response,,,1.0,554.0,1.0,554.0,1.0,427.0,1.0,427.0,
TCGA-F2-A7TX,7551,TCGA-F2-A7TX,PAAD,77.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,[Not Available],-28239.0,Dead,WITH TUMOR,,95.0,Pancreatic Cancer,,,,,Progressive Disease,,,1.0,95.0,1.0,95.0,,,1.0,95.0,
TCGA-KO-8413,3846,TCGA-KO-8413,KICH,46.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-17067.0,Alive,TUMOR FREE,3038.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3038.0,0.0,3038.0,0.0,3038.0,0.0,3038.0,
TCGA-Y8-A896,4704,TCGA-Y8-A896,KIRP,62.0,MALE,WHITE,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-22750.0,Alive,TUMOR FREE,567.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,
TCGA-ZB-A96A,10453,TCGA-ZB-A96A,THYM,53.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type B2|Thymoma; Type B3,[Not Available],2008.0,[Not Available],-19424.0,Alive,TUMOR FREE,2354.0,,[Not Available],,,,,[Not Available],,,0.0,2354.0,0.0,2354.0,,,0.0,2354.0,
TCGA-B0-5705,4062,TCGA-B0-5705,KIRC,65.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2002.0,[Not Available],-23746.0,Alive,TUMOR FREE,4537.0,,[Not Available],,,,842.0,Complete Remission/Response,,,0.0,4537.0,0.0,4537.0,1.0,842.0,1.0,842.0,
TCGA-50-5045,5933,TCGA-50-5045,LUAD,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Discrepancy],[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],-20961.0,Dead,WITH TUMOR,,2174.0,[Not Available],Locoregional Recurrence,,,1433.0,Progressive Disease,,,1.0,2174.0,1.0,2174.0,,,1.0,1433.0,
TCGA-HU-A4GQ,9578,TCGA-HU-A4GQ,STAD,71.0,MALE,ASIAN,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-26200.0,Dead,[Discrepancy],,3.0,Stomach Cancer,,,,,Complete Remission/Response,,,1.0,3.0,1.0,3.0,0.0,3.0,0.0,3.0,
TCGA-BJ-A45H,9889,TCGA-BJ-A45H,THCA,45.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-16541.0,Alive,WITH TUMOR,865.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,865.0,0.0,865.0,,,0.0,865.0,
TCGA-IF-A4AJ,8699,TCGA-IF-A4AJ,SARC,80.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],1995.0,[Not Available],-29469.0,Dead,WITH TUMOR,,767.0,[Not Available],Distant Metastasis,Lung,,560.0,[Not Available],Negative,R0,1.0,767.0,1.0,767.0,1.0,560.0,1.0,560.0,
TCGA-BA-A6DF,3273,TCGA-BA-A6DF,HNSC,80.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-29283.0,Dead,TUMOR FREE,,238.0,[Not Available],,,,,Complete Remission/Response,,,1.0,238.0,0.0,238.0,,,0.0,238.0,
TCGA-L7-A6VZ,2557,TCGA-L7-A6VZ,ESCA,62.0,MALE,WHITE,Stage IIIC,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2013.0,[Not Available],-22730.0,Alive,TUMOR FREE,315.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,315.0,0.0,315.0,0.0,315.0,0.0,315.0,
TCGA-G3-A7M9,5723,TCGA-G3-A7M9,LIHC,70.0,MALE,WHITE,Stage IIIB,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-25588.0,Dead,,,56.0,[Not Available],,,,,[Not Available],,R0,1.0,56.0,,56.0,0.0,56.0,0.0,56.0,
TCGA-EB-A4P0,8965,TCGA-EB-A4P0,SKCM,82.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-30225.0,Dead,TUMOR FREE,,326.0,[Not Available],,,,,[Not Available],,,1.0,326.0,0.0,326.0,,,0.0,326.0,
TCGA-J9-A8CL,8158,TCGA-J9-A8CL,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-24145.0,Alive,WITH TUMOR,405.0,,[Not Available],Biochemical evidence of disease,,,132.0,[Unknown],,,0.0,405.0,0.0,405.0,,,1.0,132.0,
TCGA-94-8490,6770,TCGA-94-8490,LUSC,70.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25588.0,Alive,TUMOR FREE,153.0,,[Not Available],,,,,[Not Available],,,0.0,153.0,0.0,153.0,,,0.0,153.0,
TCGA-BH-A209,1161,TCGA-BH-A209,BRCA,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Medullary Carcinoma,[Not Available],1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28403.0,Dead,TUMOR FREE,,3959.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,3959.0,0.0,3959.0,,,0.0,3959.0,
TCGA-DC-4749,8483,TCGA-DC-4749,READ,57.0,MALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-21092.0,Alive,TUMOR FREE,762.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,
TCGA-DJ-A1QF,9931,TCGA-DJ-A1QF,THCA,61.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-22310.0,Alive,TUMOR FREE,931.0,,[Not Available],,,,,[Not Available],,R0,0.0,931.0,0.0,931.0,0.0,931.0,0.0,931.0,
TCGA-FG-8188,5118,TCGA-FG-8188,LGG,41.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-15051.0,Alive,WITH TUMOR,455.0,,[Not Available],,,,384.0,Stable Disease,,,0.0,455.0,0.0,455.0,,,1.0,384.0,
TCGA-CH-5789,7905,TCGA-CH-5789,PRAD,61.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-22494.0,Alive,TUMOR FREE,304.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,304.0,0.0,304.0,0.0,304.0,0.0,304.0,
TCGA-EL-A3T6,10087,TCGA-EL-A3T6,THCA,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2003.0,[Not Available],-12777.0,Alive,TUMOR FREE,2988.0,,[Not Available],,,,,[Not Available],,R0,0.0,2988.0,0.0,2988.0,0.0,2988.0,0.0,2988.0,
TCGA-85-7698,6709,TCGA-85-7698,LUSC,48.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-17651.0,Alive,TUMOR FREE,952.0,,[Not Available],Distant Metastasis,,,650.0,Complete Remission/Response,,,0.0,952.0,0.0,952.0,1.0,650.0,1.0,650.0,
TCGA-FF-8046,2425,TCGA-FF-8046,DLBC,51.0,MALE,ASIAN,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2011.0,[Not Available],-18853.0,Alive,TUMOR FREE,751.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,751.0,0.0,751.0,0.0,751.0,0.0,751.0,
TCGA-V1-A8MG,8237,TCGA-V1-A8MG,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-19710.0,Alive,,857.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,857.0,0.0,857.0,0.0,857.0,0.0,857.0,
TCGA-D5-7000,2325,TCGA-D5-7000,COAD,79.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-28913.0,Alive,TUMOR FREE,312.0,,[Not Available],,,,,[Not Available],,,0.0,312.0,0.0,312.0,,,0.0,312.0,
TCGA-GC-A3RD,331,TCGA-GC-A3RD,BLCA,83.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-30529.0,Alive,TUMOR FREE,428.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,
TCGA-EY-A1GI,10948,TCGA-EY-A1GI,UCEC,52.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19117.0,Alive,TUMOR FREE,710.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,710.0,0.0,710.0,0.0,710.0,0.0,710.0,
TCGA-AF-A56K,8382,TCGA-AF-A56K,READ,56.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2006.0,[Not Available],-20527.0,Alive,TUMOR FREE,2635.0,,[Not Available],Locoregional Disease,,,1217.0,Complete Remission/Response,,,0.0,2635.0,0.0,2635.0,1.0,1217.0,1.0,1217.0,
TCGA-BR-8080,9341,TCGA-BR-8080,STAD,72.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2011.0,[Not Available],-26546.0,Dead,TUMOR FREE,,292.0,[Not Available],,,,,Complete Remission/Response,,,1.0,292.0,0.0,292.0,0.0,292.0,0.0,292.0,
TCGA-IG-A625,2488,TCGA-IG-A625,ESCA,60.0,MALE,ASIAN,Stage IIIB,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-22070.0,Dead,TUMOR FREE,,390.0,[Not Available],,,,,[Unknown],,,1.0,390.0,0.0,390.0,,,0.0,390.0,
TCGA-CN-5366,3330,TCGA-CN-5366,HNSC,51.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2006.0,[Not Available],-18904.0,Dead,WITH TUMOR,,360.0,[Not Available],,Cervical Lymph Nodes,L NECK,276.0,Complete Remission/Response,,,1.0,360.0,1.0,360.0,,,1.0,276.0,
TCGA-XU-A92T,10422,TCGA-XU-A92T,THYM,81.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type AB,[Not Available],2010.0,[Not Available],-29613.0,Alive,TUMOR FREE,1376.0,,[Not Available],,,,,[Not Available],,,0.0,1376.0,0.0,1376.0,,,0.0,1376.0,
TCGA-DJ-A4UL,10001,TCGA-DJ-A4UL,THCA,68.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-24939.0,Alive,TUMOR FREE,939.0,,[Not Available],,,,,[Not Available],,R0,0.0,939.0,0.0,939.0,0.0,939.0,0.0,939.0,
TCGA-D3-A8GM,8891,TCGA-D3-A8GM,SKCM,73.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2005.0,[Not Available],-26782.0,Dead,TUMOR FREE,,3259.0,[Not Available],,,,,[Not Available],,,1.0,3259.0,0.0,3259.0,,,0.0,3259.0,
TCGA-HW-A5KL,5257,TCGA-HW-A5KL,LGG,42.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-15513.0,Alive,WITH TUMOR,878.0,,[Not Available],,,,,Stable Disease,,,0.0,878.0,0.0,878.0,,,0.0,878.0,
TCGA-H6-8124,7577,TCGA-H6-8124,PAAD,56.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-20741.0,Alive,WITH TUMOR,392.0,,,Distant Metastasis,Liver,,259.0,Complete Remission/Response,,,0.0,392.0,0.0,392.0,1.0,259.0,1.0,259.0,
TCGA-XJ-A83F,8294,TCGA-XJ-A83F,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],,Alive,TUMOR FREE,1127.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1127.0,0.0,1127.0,0.0,1127.0,0.0,1127.0,
TCGA-06-0645,2822,TCGA-06-0645,GBM,55.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-20449.0,Dead,WITH TUMOR,98.0,175.0,[Not Available],,,,,[Not Available],,,1.0,175.0,1.0,175.0,,,1.0,175.0,
TCGA-69-7764,6099,TCGA-69-7764,LUAD,75.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-27693.0,Alive,TUMOR FREE,414.0,,[Not Available],,,,,[Not Available],,,0.0,414.0,0.0,414.0,,,0.0,414.0,
TCGA-BH-A1FM,1152,TCGA-BH-A1FM,BRCA,44.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998.0,[Not Available],-16289.0,Dead,,,1388.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1388.0,,1388.0,,,0.0,1388.0,
TCGA-AJ-A2QN,10531,TCGA-AJ-A2QN,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21915.0,Alive,TUMOR FREE,1069.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1069.0,0.0,1069.0,0.0,1069.0,0.0,1069.0,
TCGA-QR-A703,7716,TCGA-QR-A703,PCPG,23.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2008.0,[Not Available],-8421.0,Alive,TUMOR FREE,1167.0,,[Not Available],New Primary Tumor,"Other, specify",Left Adrenal Pheochromocytoma,0.0,Complete Remission/Response,,,0.0,1167.0,0.0,1167.0,0.0,1167.0,1.0,0.0,
TCGA-ET-A3BT,10235,TCGA-ET-A3BT,THCA,60.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2007.0,[Not Available],-22108.0,Alive,TUMOR FREE,2665.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,267.0,[Not Available],,R0,0.0,2665.0,0.0,2665.0,,,1.0,267.0,
TCGA-EY-A1GR,10956,TCGA-EY-A1GR,UCEC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24784.0,Alive,TUMOR FREE,536.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,536.0,0.0,536.0,0.0,536.0,0.0,536.0,
TCGA-CC-A5UC,5495,TCGA-CC-A5UC,LIHC,63.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-23156.0,Dead,WITH TUMOR,,347.0,[Not Available],New Primary Tumor,Lung,,312.0,[Not Available],,R0,1.0,347.0,1.0,347.0,0.0,347.0,1.0,312.0,
TCGA-OR-A5K0,35,TCGA-OR-A5K0,ACC,69.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-25400.0,Alive,WITH TUMOR,1029.0,,[Not Available],Distant Metastasis,Lung,,659.0,Progressive Disease,,,0.0,1029.0,0.0,1029.0,,,1.0,659.0,
TCGA-3H-AB3S,6833,TCGA-3H-AB3S,MESO,69.0,MALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],2009.0,[Not Available],-25471.0,Dead,WITH TUMOR,,385.0,[Not Available],Locoregional Recurrence,"Other, specify",Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes AND Ipsilateral Chest Wall,186.0,[Not Available],,[Unknown],1.0,385.0,1.0,385.0,,,1.0,186.0,
TCGA-B0-5713,4069,TCGA-B0-5713,KIRC,75.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-27644.0,Alive,TUMOR FREE,2782.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2782.0,0.0,2782.0,0.0,2782.0,0.0,2782.0,
TCGA-DK-A1AB,185,TCGA-DK-A1AB,BLCA,74.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-27126.0,Dead,,,508.0,[Not Available],Metastatic,Lung,,364.0,Progressive Disease,,,1.0,508.0,,508.0,,,1.0,364.0,
TCGA-XV-AAZW,9256,TCGA-XV-AAZW,SKCM,62.0,FEMALE,WHITE,Stage II,[Not Applicable],,[Not Available],2013.0,[Not Available],-22778.0,Dead,WITH TUMOR,,393.0,[Not Available],,,,,[Not Available],,,1.0,393.0,1.0,393.0,,,1.0,393.0,
TCGA-BR-A44U,9390,TCGA-BR-A44U,STAD,70.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-25577.0,Dead,TUMOR FREE,,422.0,[Not Available],,,,,Complete Remission/Response,,,1.0,422.0,0.0,422.0,0.0,422.0,0.0,422.0,
TCGA-78-7163,6158,TCGA-78-7163,LUAD,60.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],1992.0,[Not Available],-22002.0,Alive,TUMOR FREE,7248.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,7248.0,0.0,7248.0,0.0,7248.0,0.0,7248.0,
TCGA-BP-4968,4205,TCGA-BP-4968,KIRC,40.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-14651.0,Alive,TUMOR FREE,1746.0,,[Not Available],,,,,[Not Available],,,0.0,1746.0,0.0,1746.0,,,0.0,1746.0,
TCGA-XF-A9SW,436,TCGA-XF-A9SW,BLCA,85.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-31049.0,Dead,WITH TUMOR,,362.0,[Not Available],,,,,Partial Remission/Response,,,1.0,362.0,1.0,362.0,,,1.0,362.0,
TCGA-2Y-A9GT,5428,TCGA-2Y-A9GT,LIHC,51.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2006.0,[Not Available],-18768.0,Dead,WITH TUMOR,,1624.0,[Not Available],Locoregional Recurrence,Liver,,1083.0,[Not Available],,R0,1.0,1624.0,1.0,1624.0,1.0,1083.0,1.0,1083.0,
TCGA-BJ-A2N8,9875,TCGA-BJ-A2N8,THCA,30.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-11024.0,Alive,TUMOR FREE,504.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,504.0,0.0,504.0,,,0.0,504.0,
TCGA-T2-A6X2,3743,TCGA-T2-A6X2,HNSC,82.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-30013.0,Alive,TUMOR FREE,987.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,
TCGA-EM-A3SX,10187,TCGA-EM-A3SX,THCA,28.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-10447.0,Alive,WITH TUMOR,908.0,,[Not Available],,,,,[Not Available],,R1,0.0,908.0,0.0,908.0,,,0.0,908.0,
TCGA-B6-A0WS,1001,TCGA-B6-A0WS,BRCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996.0,Indeterminate (neither Pre or Postmenopausal),-21230.0,Dead,TUMOR FREE,,2965.0,[Not Available],,,,,[Not Available],Positive,,1.0,2965.0,0.0,2965.0,,,0.0,2965.0,
TCGA-CF-A5UA,164,TCGA-CF-A5UA,BLCA,67.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,[Not Available],-24625.0,Alive,TUMOR FREE,365.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,
TCGA-CD-8528,9426,TCGA-CD-8528,STAD,43.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,[Not Available],-15986.0,Alive,TUMOR FREE,375.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,
TCGA-06-0237,2809,TCGA-06-0237,GBM,75.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-27735.0,Dead,WITH TUMOR,315.0,415.0,[Not Available],,,,,[Not Available],,,1.0,415.0,1.0,415.0,,,1.0,415.0,
TCGA-12-0821,2963,TCGA-12-0821,GBM,62.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-22949.0,Dead,WITH TUMOR,323.0,323.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],259.0,[Not Available],,,1.0,323.0,1.0,323.0,,,1.0,259.0,
TCGA-44-A4SS,5900,TCGA-44-A4SS,LUAD,73.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26991.0,Alive,TUMOR FREE,415.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,415.0,0.0,415.0,0.0,415.0,0.0,415.0,
TCGA-CS-5397,4921,TCGA-CS-5397,LGG,54.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-19866.0,Dead,WITH TUMOR,,194.0,[Not Available],,,,,Progressive Disease,,,1.0,194.0,1.0,194.0,,,1.0,194.0,
TCGA-HC-A8CY,8121,TCGA-HC-A8CY,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23154.0,Alive,WITH TUMOR,290.0,,[Not Available],,,,,[Unknown],,,0.0,290.0,0.0,290.0,,,0.0,290.0,
TCGA-E2-A1BC,1357,TCGA-E2-A1BC,BRCA,63.0,FEMALE,[Not Available],Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23168.0,Alive,TUMOR FREE,501.0,,[Not Available],,,,,[Not Available],Positive,,0.0,501.0,0.0,501.0,,,0.0,501.0,
TCGA-KP-A3VZ,11002,TCGA-KP-A3VZ,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous endometrial adenocarcinoma,High Grade,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25366.0,Alive,WITH TUMOR,722.0,,[Not Available],,,,,[Not Available],,,0.0,722.0,0.0,722.0,,,0.0,722.0,
TCGA-HT-7691,5181,TCGA-HT-7691,LGG,31.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2008.0,[Not Available],-11465.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,[Not Available],,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-43-7656,6481,TCGA-43-7656,LUSC,71.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25991.0,Alive,TUMOR FREE,596.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,596.0,0.0,596.0,0.0,596.0,0.0,596.0,
TCGA-A2-A0T6,582,TCGA-A2-A0T6,BRCA,50.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18334.0,Alive,TUMOR FREE,575.0,,[Not Available],,,,,[Not Available],Negative,,0.0,575.0,0.0,575.0,0.0,575.0,0.0,575.0,
TCGA-IP-7968,9609,TCGA-IP-7968,STAD,74.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-27114.0,Alive,TUMOR FREE,77.0,,[Not Available],,,,,[Not Available],,,0.0,77.0,0.0,77.0,,,0.0,77.0,
TCGA-D8-A1XG,1264,TCGA-D8-A1XG,BRCA,86.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31748.0,Alive,TUMOR FREE,448.0,,[Not Available],,,,,[Not Available],Negative,,0.0,448.0,0.0,448.0,0.0,448.0,0.0,448.0,
TCGA-DJ-A3UP,9970,TCGA-DJ-A3UP,THCA,38.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-13899.0,Alive,TUMOR FREE,499.0,,[Not Available],,,,,[Not Available],,R0,0.0,499.0,0.0,499.0,0.0,499.0,0.0,499.0,
TCGA-P3-A5QF,3710,TCGA-P3-A5QF,HNSC,49.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-18035.0,Dead,WITH TUMOR,,330.0,[Not Available],,Distant Metastasis,Lung,140.0,[Unknown],,,1.0,330.0,1.0,330.0,,,1.0,140.0,
TCGA-06-0878,2837,TCGA-06-0878,GBM,74.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-27319.0,Alive,WITH TUMOR,218.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],66.0,[Not Available],,,0.0,218.0,0.0,218.0,,,1.0,66.0,
TCGA-BH-A42U,1166,TCGA-BH-A42U,BRCA,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29330.0,Alive,TUMOR FREE,3364.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3364.0,0.0,3364.0,0.0,3364.0,0.0,3364.0,
TCGA-V4-A9EE,11091,TCGA-V4-A9EE,UVM,86.0,MALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell,[Not Available],2012.0,[Not Available],-31421.0,Dead,WITH TUMOR,,398.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,,211.0,[Not Available],,,1.0,398.0,1.0,398.0,,,1.0,211.0,
TCGA-L9-A5IP,6288,TCGA-L9-A5IP,LUAD,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-14681.0,Dead,WITH TUMOR,,58.0,[Not Available],Locoregional Recurrence|Distant Metastasis,,,49.0,Progressive Disease,,,1.0,58.0,1.0,58.0,,,1.0,49.0,
TCGA-BC-A69H,5473,TCGA-BC-A69H,LIHC,64.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-23380.0,Alive,TUMOR FREE,444.0,,[Not Available],,,,,[Not Available],,R0,0.0,444.0,0.0,444.0,0.0,444.0,0.0,444.0,
TCGA-FE-A231,10258,TCGA-FE-A231,THCA,70.0,MALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-25703.0,Alive,TUMOR FREE,961.0,,[Not Available],,,,,[Not Available],,R0,0.0,961.0,0.0,961.0,,,0.0,961.0,
TCGA-FG-6689,5103,TCGA-FG-6689,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-11312.0,Alive,WITH TUMOR,454.0,,[Not Available],,,,119.0,Progressive Disease,,,0.0,454.0,0.0,454.0,,,1.0,119.0,
TCGA-FS-A4FD,9179,TCGA-FS-A4FD,SKCM,39.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2004.0,[Not Available],-14426.0,Dead,WITH TUMOR,,2454.0,[Not Available],Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis,Lung|Lung|Bone|Brain,[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable],2010.0,[Not Available],,,1.0,2454.0,1.0,2454.0,,,1.0,2010.0,
TCGA-NH-A8F8,2402,TCGA-NH-A8F8,COAD,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2013.0,[Not Available],-29185.0,Dead,WITH TUMOR,,511.0,[Not Available],,,,,[Unknown],,,1.0,511.0,1.0,511.0,,,1.0,511.0,
TCGA-BR-A4QM,9413,TCGA-BR-A4QM,STAD,65.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-23999.0,Alive,WITH TUMOR,156.0,,[Not Available],Locoregional Recurrence,,,127.0,Complete Remission/Response,,,0.0,156.0,0.0,156.0,1.0,127.0,1.0,127.0,
TCGA-HU-8610,9565,TCGA-HU-8610,STAD,75.0,MALE,ASIAN,Stage IA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,[Not Available],-27594.0,Alive,TUMOR FREE,23.0,,[Not Available],,,,,Stable Disease,,,0.0,23.0,0.0,23.0,,,0.0,23.0,
TCGA-UT-A97Y,6904,TCGA-UT-A97Y,MESO,81.0,FEMALE,WHITE,Stage I,[Not Applicable],Epithelioid mesothelioma,[Not Available],2011.0,[Not Available],-29905.0,Dead,WITH TUMOR,,144.0,[Not Available],,,,,[Not Available],,RX,1.0,144.0,1.0,144.0,,,1.0,144.0,
TCGA-VQ-AA6I,9706,TCGA-VQ-AA6I,STAD,68.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-25091.0,Dead,WITH TUMOR,,491.0,Stomach Cancer,Locoregional Recurrence,,,475.0,Progressive Disease,,,1.0,491.0,1.0,491.0,,,1.0,475.0,
TCGA-A5-A1OF,10510,TCGA-A5-A1OF,UCEC,47.0,FEMALE,[Not Available],[Not Applicable],Stage IA,Mixed serous and endometrioid,High Grade,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17308.0,Alive,TUMOR FREE,973.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,973.0,0.0,973.0,0.0,973.0,0.0,973.0,
TCGA-DK-A1AE,188,TCGA-DK-A1AE,BLCA,84.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-30707.0,Alive,WITH TUMOR,491.0,,[Not Available],Metastatic,Bone,,211.0,Progressive Disease,,,0.0,491.0,0.0,491.0,,,1.0,211.0,
TCGA-E6-A1LX,10910,TCGA-E6-A1LX,UCEC,40.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14731.0,Alive,TUMOR FREE,711.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,711.0,0.0,711.0,0.0,711.0,0.0,711.0,
TCGA-3S-AAYX,10359,TCGA-3S-AAYX,THYM,55.0,FEMALE,WHITE,[Not Applicable],IIb,Thymoma; Type B1,[Not Available],2013.0,[Not Available],-20350.0,Alive,TUMOR FREE,571.0,,[Not Available],,,,,[Not Available],,,0.0,571.0,0.0,571.0,,,0.0,571.0,
TCGA-TM-A84L,5381,TCGA-TM-A84L,LGG,31.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2010.0,[Not Available],-11498.0,Dead,WITH TUMOR,,1242.0,[Not Available],,,,987.0,Complete Remission/Response,,,1.0,1242.0,1.0,1242.0,1.0,987.0,1.0,987.0,
TCGA-F5-6571,8524,TCGA-F5-6571,READ,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-22666.0,Alive,WITH TUMOR,1288.0,,[Not Available],Metastatic,,,122.0,Complete Remission/Response,,,0.0,1288.0,0.0,1288.0,1.0,122.0,1.0,122.0,
TCGA-WR-A838,7502,TCGA-WR-A838,OV,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2013.0,[Not Available],-26418.0,Dead,WITH TUMOR,,304.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],245.0,Progressive Disease,,,1.0,304.0,1.0,304.0,,,1.0,245.0,
TCGA-KN-8421,3820,TCGA-KN-8421,KICH,47.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-17524.0,Alive,TUMOR FREE,2674.0,,[Not Available],,,,,[Not Available],,,0.0,2674.0,0.0,2674.0,,,0.0,2674.0,
TCGA-UD-AABZ,6894,TCGA-UD-AABZ,MESO,46.0,MALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],2004.0,[Not Available],-16913.0,Dead,WITH TUMOR,,197.0,[Not Available],,,,,[Not Available],,RX,1.0,197.0,1.0,197.0,,,1.0,197.0,
TCGA-E2-A15S,1349,TCGA-E2-A15S,BRCA,34.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-12671.0,Alive,TUMOR FREE,428.0,,[Not Available],,,,,[Not Available],Negative,,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,
TCGA-P3-A5QA,3708,TCGA-P3-A5QA,HNSC,41.0,MALE,[Unknown],Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-15125.0,Alive,TUMOR FREE,2182.0,,[Not Available],Locoregional Disease,Oral Cavity,tongue,1601.0,Complete Remission/Response,,,0.0,2182.0,0.0,2182.0,1.0,1601.0,1.0,1601.0,
TCGA-RT-A6YC,7756,TCGA-RT-A6YC,PCPG,31.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-11572.0,Alive,TUMOR FREE,246.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,246.0,0.0,246.0,0.0,246.0,0.0,246.0,
TCGA-HC-A631,8109,TCGA-HC-A631,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24749.0,Alive,WITH TUMOR,54.0,,[Not Available],,,,,[Not Applicable],,,0.0,54.0,0.0,54.0,,,0.0,54.0,
TCGA-32-1979,3171,TCGA-32-1979,GBM,69.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-25252.0,Dead,WITH TUMOR,593.0,593.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],265.0,[Not Available],,,1.0,593.0,1.0,593.0,,,1.0,265.0,
TCGA-2Z-A9JR,4441,TCGA-2Z-A9JR,KIRP,57.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-20932.0,Alive,TUMOR FREE,161.0,,[Not Available],,,,,[Unknown],,,0.0,161.0,0.0,161.0,,,0.0,161.0,
TCGA-SX-A71R,4668,TCGA-SX-A71R,KIRP,51.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-18742.0,Alive,TUMOR FREE,1457.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1457.0,0.0,1457.0,0.0,1457.0,0.0,1457.0,
TCGA-AA-A01P,2164,TCGA-AA-A01P,COAD,80.0,FEMALE,[Not Available],Stage III,[Not Applicable],Colon Adenocarcinoma,[Not Available],2003.0,[Not Available],-29554.0,Dead,WITH TUMOR,,1158.0,[Not Available],,,,762.0,[Unknown],,,1.0,1158.0,1.0,1158.0,,,1.0,762.0,
TCGA-BH-A18Q,1124,TCGA-BH-A18Q,BRCA,56.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001.0,[Not Available],-20675.0,Dead,,,1692.0,[Not Available],,,,,[Not Available],Negative,,1.0,1692.0,,1692.0,0.0,1692.0,0.0,1692.0,
TCGA-EM-A1YA,10125,TCGA-EM-A1YA,THCA,74.0,FEMALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-27224.0,Alive,TUMOR FREE,602.0,,[Not Available],,,,,[Not Available],,R0,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,
TCGA-DK-AA6X,226,TCGA-DK-AA6X,BLCA,63.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-23208.0,Alive,TUMOR FREE,467.0,,[Not Available],,,,,Progressive Disease,,,0.0,467.0,0.0,467.0,,,0.0,467.0,
TCGA-EE-A3AC,9070,TCGA-EE-A3AC,SKCM,47.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2009.0,[Not Available],-17319.0,Alive,TUMOR FREE,1948.0,,[Not Available],,,,,[Not Available],,,0.0,1948.0,0.0,1948.0,,,0.0,1948.0,
TCGA-D1-A17A,10859,TCGA-D1-A17A,UCEC,59.0,FEMALE,WHITE,[Not Applicable],Stage IIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21560.0,Alive,TUMOR FREE,48.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,48.0,0.0,48.0,0.0,48.0,0.0,48.0,
TCGA-DC-6681,8492,TCGA-DC-6681,READ,70.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-25659.0,Alive,TUMOR FREE,790.0,,[Not Available],,,,,[Not Applicable],,,0.0,790.0,0.0,790.0,,,0.0,790.0,
TCGA-SL-A6JA,11023,TCGA-SL-A6JA,UCEC,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28401.0,Alive,TUMOR FREE,7.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,7.0,0.0,7.0,0.0,7.0,0.0,7.0,
TCGA-06-0174,2781,TCGA-06-0174,GBM,54.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-19824.0,Dead,WITH TUMOR,67.0,98.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],47.0,[Not Available],,,1.0,98.0,1.0,98.0,,,1.0,47.0,
TCGA-B5-A11U,10708,TCGA-B5-A11U,UCEC,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27160.0,Alive,TUMOR FREE,509.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,509.0,0.0,509.0,,,0.0,509.0,
TCGA-55-8097,6022,TCGA-55-8097,LUAD,60.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22260.0,Alive,TUMOR FREE,476.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,
TCGA-CK-6747,2255,TCGA-CK-6747,COAD,87.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-32052.0,Alive,TUMOR FREE,2523.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2523.0,0.0,2523.0,0.0,2523.0,0.0,2523.0,
TCGA-CJ-5676,4321,TCGA-CJ-5676,KIRC,47.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-17170.0,Alive,WITH TUMOR,4067.0,,[Not Available],,,,2219.0,Complete Remission/Response,,,0.0,4067.0,0.0,4067.0,1.0,2219.0,1.0,2219.0,
TCGA-68-8251,6652,TCGA-68-8251,LUSC,78.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-28739.0,Alive,TUMOR FREE,406.0,,[Not Available],,,,,Stable Disease,,,0.0,406.0,0.0,406.0,,,0.0,406.0,
TCGA-DU-8161,5033,TCGA-DU-8161,LGG,63.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2009.0,[Not Available],-23064.0,Dead,WITH TUMOR,,722.0,[Not Available],,,,111.0,Progressive Disease,,,1.0,722.0,1.0,722.0,,,1.0,111.0,
TCGA-20-0991,7115,TCGA-20-0991,OV,78.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Serous Cystadenocarcinoma,G3,2006.0,[Not Available],-28694.0,Alive,TUMOR FREE,797.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,797.0,0.0,797.0,0.0,797.0,0.0,797.0,Redacted
TCGA-EE-A2MR,9064,TCGA-EE-A2MR,SKCM,61.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],2002.0,[Not Available],-22535.0,Alive,TUMOR FREE,4088.0,,[Not Available],,,,3136.0,[Not Available],,,0.0,4088.0,0.0,4088.0,,,1.0,3136.0,
TCGA-CQ-5324,3377,TCGA-CQ-5324,HNSC,59.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-21803.0,Alive,TUMOR FREE,1593.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1593.0,0.0,1593.0,,,0.0,1593.0,
TCGA-BQ-7060,4567,TCGA-BQ-7060,KIRP,53.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-19479.0,Alive,TUMOR FREE,214.0,,[Not Available],,,,,[Not Available],,,0.0,214.0,0.0,214.0,,,0.0,214.0,
TCGA-EA-A5ZF,1714,TCGA-EA-A5ZF,CESC,56.0,FEMALE,ASIAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Peri (6-12 months since last menstrual period),-20506.0,Alive,WITH TUMOR,828.0,,,Locoregional Recurrence,Cervix,,440.0,Complete Remission/Response,,,0.0,828.0,0.0,828.0,1.0,440.0,1.0,440.0,
TCGA-W2-A7HF,7827,TCGA-W2-A7HF,PCPG,28.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-10436.0,Alive,TUMOR FREE,538.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,538.0,0.0,538.0,0.0,538.0,0.0,538.0,
TCGA-CS-6667,4927,TCGA-CS-6667,LGG,39.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-14375.0,Alive,WITH TUMOR,1469.0,,[Not Available],,,,,Stable Disease,,,0.0,1469.0,0.0,1469.0,,,0.0,1469.0,
TCGA-KO-8405,3839,TCGA-KO-8405,KICH,29.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-10671.0,Alive,TUMOR FREE,3056.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3056.0,0.0,3056.0,0.0,3056.0,0.0,3056.0,
TCGA-DX-AB2L,8657,TCGA-DX-AB2L,SARC,35.0,MALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2009.0,[Not Available],-12974.0,Alive,TUMOR FREE,2007.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,2007.0,0.0,2007.0,,,0.0,2007.0,
TCGA-2Y-A9H3,5438,TCGA-2Y-A9H3,LIHC,45.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G1,2010.0,[Not Available],-16443.0,Alive,TUMOR FREE,1516.0,,[Not Available],Locoregional Recurrence,Liver,,22.0,[Not Available],,R0,0.0,1516.0,0.0,1516.0,1.0,22.0,1.0,22.0,
TCGA-F5-6811,8526,TCGA-F5-6811,READ,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-26575.0,Alive,TUMOR FREE,979.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,979.0,0.0,979.0,0.0,979.0,0.0,979.0,
TCGA-60-2697,6562,TCGA-60-2697,LUSC,41.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1992.0,[Not Available],-14984.0,Dead,WITH TUMOR,,372.0,[Not Available],,,,200.0,Complete Remission/Response,,,1.0,372.0,1.0,372.0,1.0,200.0,1.0,200.0,
TCGA-27-2528,3133,TCGA-27-2528,GBM,62.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-22867.0,Dead,WITH TUMOR,480.0,480.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],72.0,[Not Available],,,1.0,480.0,1.0,480.0,,,1.0,72.0,
TCGA-FS-A1YX,9144,TCGA-FS-A1YX,SKCM,39.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],2001.0,[Not Available],-14387.0,Dead,WITH TUMOR,,1478.0,[Not Available],,,,,[Not Available],,,1.0,1478.0,1.0,1478.0,,,1.0,1478.0,
TCGA-AX-A0IS,10624,TCGA-AX-A0IS,UCEC,52.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19173.0,Dead,WITH TUMOR,,1858.0,[Not Available],,,,448.0,Complete Remission/Response,,,1.0,1858.0,1.0,1858.0,1.0,448.0,1.0,448.0,
TCGA-CC-A7IE,5498,TCGA-CC-A7IE,LIHC,57.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-20985.0,Dead,WITH TUMOR,,217.0,[Not Available],New Primary Tumor,Lung,,169.0,[Not Available],,R0,1.0,217.0,1.0,217.0,0.0,217.0,1.0,169.0,
TCGA-E1-A7YH,5077,TCGA-E1-A7YH,LGG,47.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2005.0,[Not Available],-17465.0,Dead,WITH TUMOR,,2835.0,[Not Available],,,,689.0,Stable Disease,,,1.0,2835.0,1.0,2835.0,,,1.0,689.0,
TCGA-12-0615,2937,TCGA-12-0615,GBM,78.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-28583.0,Dead,WITH TUMOR,426.0,467.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],160.0,[Not Available],,,1.0,467.0,1.0,467.0,,,1.0,160.0,
TCGA-EE-A2GK,9036,TCGA-EE-A2GK,SKCM,46.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],2007.0,[Not Available],-16879.0,Alive,TUMOR FREE,1665.0,,[Not Available],,,,1498.0,[Not Available],,,0.0,1665.0,0.0,1665.0,,,1.0,1498.0,
TCGA-RY-A847,5320,TCGA-RY-A847,LGG,45.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-16732.0,Alive,TUMOR FREE,933.0,,[Not Available],,,,,[Not Applicable],,,0.0,933.0,0.0,933.0,,,0.0,933.0,
TCGA-36-2534,7396,TCGA-36-2534,OV,72.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,[Not Available],-26621.0,Alive,WITH TUMOR,907.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],383.0,Partial Remission/Response,,,0.0,907.0,0.0,907.0,,,1.0,383.0,
TCGA-18-3416,6334,TCGA-18-3416,LUSC,83.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-30435.0,Dead,WITH TUMOR,,973.0,[Not Available],Distant Metastasis,,,940.0,Complete Remission/Response,,,1.0,973.0,1.0,973.0,1.0,940.0,1.0,940.0,
TCGA-CV-A6K1,3603,TCGA-CV-A6K1,HNSC,65.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-23848.0,Alive,TUMOR FREE,685.0,,[Not Available],New Primary Tumor,Oral Cavity,Tonsil,401.0,Complete Remission/Response,,,0.0,685.0,0.0,685.0,,,1.0,401.0,
TCGA-L5-A8NS,2551,TCGA-L5-A8NS,ESCA,76.0,MALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2001.0,[Not Available],-27800.0,Alive,WITH TUMOR,408.0,,[Not Available],Distant Metastasis,Lung,,300.0,[Unknown],,,0.0,408.0,0.0,408.0,,,1.0,300.0,
TCGA-N6-A4VE,11041,TCGA-N6-A4VE,UCS,84.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30794.0,Dead,WITH TUMOR,,291.0,[Not Available],Distant Metastasis,Bone,,275.0,Progressive Disease,,,1.0,291.0,1.0,291.0,,,1.0,275.0,
TCGA-ZB-A96E,10457,TCGA-ZB-A96E,THYM,60.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type A|Thymoma; Type AB,[Not Available],2010.0,[Not Available],-22092.0,Alive,TUMOR FREE,1819.0,,[Not Available],,,,,[Not Available],,,0.0,1819.0,0.0,1819.0,,,0.0,1819.0,
TCGA-LN-A8HZ,2589,TCGA-LN-A8HZ,ESCA,56.0,MALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G3,2013.0,[Not Available],-20510.0,Alive,TUMOR FREE,375.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,
TCGA-DJ-A13M,9919,TCGA-DJ-A13M,THCA,28.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-10530.0,Alive,TUMOR FREE,1484.0,,[Not Available],,,,,[Not Available],,R0,0.0,1484.0,0.0,1484.0,0.0,1484.0,0.0,1484.0,
TCGA-C8-A1HE,1198,TCGA-C8-A1HE,BRCA,59.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,TUMOR FREE,375.0,,[Not Available],,,,,[Not Available],Negative,,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,
TCGA-SR-A6MR,7806,TCGA-SR-A6MR,PCPG,41.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2007.0,[Not Available],-14991.0,Alive,WITH TUMOR,2409.0,,[Not Available],New Primary Tumor,Retroperitoneum,,928.0,Stable Disease,,,0.0,2409.0,0.0,2409.0,,,1.0,928.0,
TCGA-DD-AAD1,5606,TCGA-DD-AAD1,LIHC,51.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2010.0,[Not Available],-18794.0,Alive,WITH TUMOR,564.0,,[Not Available],Intrahepatic Recurrence,Liver,,127.0,[Not Available],,R1,0.0,564.0,0.0,564.0,,,1.0,127.0,
TCGA-BA-5152,3250,TCGA-BA-5152,HNSC,56.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-20783.0,Alive,TUMOR FREE,1288.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1288.0,0.0,1288.0,,,0.0,1288.0,
TCGA-ND-A4W6,11069,TCGA-ND-A4W6,UCS,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24835.0,Dead,WITH TUMOR,,317.0,[Not Available],,,,,Progressive Disease,,,1.0,317.0,1.0,317.0,,,1.0,317.0,
TCGA-BT-A20Q,128,TCGA-BT-A20Q,BLCA,73.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-26778.0,Dead,WITH TUMOR,,593.0,[Not Available],,,,,Progressive Disease,,,1.0,593.0,1.0,593.0,,,1.0,593.0,
TCGA-IR-A3LK,1782,TCGA-IR-A3LK,CESC,69.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25440.0,Dead,WITH TUMOR,,908.0,Cervical Cancer,Distant Metastasis,"Other, specify","thoracic lymph nodes, liver, abdominal wall",574.0,Complete Remission/Response,,,1.0,908.0,1.0,908.0,1.0,574.0,1.0,574.0,
TCGA-HC-7230,8072,TCGA-HC-7230,PRAD,50.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-18577.0,Alive,TUMOR FREE,1001.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,
TCGA-49-AAR0,5921,TCGA-49-AAR0,LUAD,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-20932.0,Alive,TUMOR FREE,4765.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4765.0,0.0,4765.0,0.0,4765.0,0.0,4765.0,
TCGA-MP-A4T2,6298,TCGA-MP-A4T2,LUAD,71.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2003.0,[Not Available],-26010.0,Dead,WITH TUMOR,,1136.0,[Not Available],Distant Metastasis,,,575.0,Complete Remission/Response,,,1.0,1136.0,1.0,1136.0,1.0,575.0,1.0,575.0,
TCGA-05-4389,5809,TCGA-05-4389,LUAD,70.0,MALE,[Not Available],Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-25660.0,Alive,TUMOR FREE,1369.0,,[Not Available],,,,,[Not Applicable],,,0.0,1369.0,0.0,1369.0,,,0.0,1369.0,
TCGA-CL-4957,8479,TCGA-CL-4957,READ,79.0,FEMALE,[Not Available],[Discrepancy],[Not Applicable],Rectal Adenocarcinoma,[Not Available],2008.0,[Not Available],-29081.0,Alive,,425.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,425.0,0.0,425.0,0.0,425.0,0.0,425.0,
TCGA-AX-A06H,10621,TCGA-AX-A06H,UCEC,60.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22270.0,Alive,WITH TUMOR,833.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,833.0,0.0,833.0,0.0,833.0,0.0,833.0,
TCGA-Z4-AAPF,8796,TCGA-Z4-AAPF,SARC,35.0,FEMALE,WHITE,[Not Available],[Not Available],Sarcoma; synovial; poorly differentiated,[Not Available],2013.0,[Not Available],-12959.0,Alive,TUMOR FREE,485.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,
TCGA-66-2742,6612,TCGA-66-2742,LUSC,70.0,MALE,[Not Available],Stage IV,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-25688.0,Alive,TUMOR FREE,641.0,,[Not Available],,,,,[Not Applicable],,,0.0,641.0,0.0,641.0,,,0.0,641.0,
TCGA-AZ-5407,2224,TCGA-AZ-5407,COAD,51.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-18820.0,Alive,TUMOR FREE,2683.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2683.0,0.0,2683.0,0.0,2683.0,0.0,2683.0,
TCGA-E7-A3X6,235,TCGA-E7-A3X6,BLCA,70.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,[Not Available],-25584.0,Dead,WITH TUMOR,,904.0,[Not Available],Distant Metastasis,Bone,,369.0,Complete Remission/Response,,,1.0,904.0,1.0,904.0,1.0,369.0,1.0,369.0,
TCGA-78-8655,6171,TCGA-78-8655,LUAD,77.0,FEMALE,[Not Evaluated],Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2003.0,[Not Available],-28379.0,Alive,,2360.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2360.0,0.0,2360.0,0.0,2360.0,0.0,2360.0,
TCGA-BA-4077,3246,TCGA-BA-4077,HNSC,45.0,FEMALE,WHITE,Stage IVA,Stage IVB,Head & Neck Squamous Cell Carcinoma,G2,2003.0,[Not Available],-16536.0,Dead,WITH TUMOR,,1134.0,[Not Available],,,,,Persistent Disease,,,1.0,1134.0,1.0,1134.0,,,1.0,1134.0,
TCGA-UY-A78L,403,TCGA-UY-A78L,BLCA,62.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-22717.0,Alive,WITH TUMOR,1127.0,,[Not Available],,,,355.0,Progressive Disease,,,0.0,1127.0,0.0,1127.0,,,1.0,355.0,
TCGA-F5-6702,8525,TCGA-F5-6702,READ,71.0,MALE,WHITE,Stage IVA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-26123.0,Alive,WITH TUMOR,452.0,,[Not Available],,,,368.0,Progressive Disease,,,0.0,452.0,0.0,452.0,,,1.0,368.0,
TCGA-3M-AB47,9269,TCGA-3M-AB47,STAD,51.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],,Dead,WITH TUMOR,,,Stomach Cancer,Locoregional Recurrence,,,395.0,Stable Disease,,,1.0,,1.0,,,,1.0,395.0,
TCGA-D7-A6EZ,9522,TCGA-D7-A6EZ,STAD,66.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,[Not Available],-24425.0,Dead,WITH TUMOR,,618.0,[Not Available],,,,,Complete Remission/Response,,,1.0,618.0,1.0,618.0,,,1.0,618.0,
TCGA-EJ-8474,7976,TCGA-EJ-8474,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25561.0,Alive,TUMOR FREE,766.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,
TCGA-29-A5NZ,7355,TCGA-29-A5NZ,OV,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2011.0,[Not Available],-24161.0,Dead,WITH TUMOR,,1088.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],358.0,Complete Remission/Response,,,1.0,1088.0,1.0,1088.0,1.0,358.0,1.0,358.0,
TCGA-KL-8338,3785,TCGA-KL-8338,KICH,51.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-18667.0,Alive,TUMOR FREE,2633.0,,[Not Available],,,,,[Unknown],,,0.0,2633.0,0.0,2633.0,,,0.0,2633.0,
TCGA-HT-A61A,5236,TCGA-HT-A61A,LGG,20.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-7664.0,Alive,TUMOR FREE,194.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,194.0,0.0,194.0,0.0,194.0,0.0,194.0,
TCGA-EY-A1GO,10953,TCGA-EY-A1GO,UCEC,65.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23853.0,Alive,WITH TUMOR,586.0,,[Not Available],Metastatic,Lung,,517.0,Complete Remission/Response,,,0.0,586.0,0.0,586.0,1.0,517.0,1.0,517.0,
TCGA-IF-A4AK,8700,TCGA-IF-A4AK,SARC,82.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-30141.0,Alive,TUMOR FREE,1590.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1590.0,0.0,1590.0,0.0,1590.0,0.0,1590.0,
TCGA-CV-7430,3566,TCGA-CV-7430,HNSC,56.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1996.0,[Not Available],-20763.0,Dead,WITH TUMOR,,495.0,[Not Available],,,,,[Not Available],,,1.0,495.0,1.0,495.0,,,1.0,495.0,
TCGA-DX-A48L,8596,TCGA-DX-A48L,SARC,49.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-18113.0,Dead,WITH TUMOR,,738.0,[Not Available],Distant Metastasis,Lung,,316.0,[Not Available],[Not Available],R0,1.0,738.0,1.0,738.0,1.0,316.0,1.0,316.0,
TCGA-E2-A1L6,1370,TCGA-E2-A1L6,BRCA,44.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16403.0,Alive,TUMOR FREE,1648.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1648.0,0.0,1648.0,0.0,1648.0,0.0,1648.0,
TCGA-FG-A4MU,5122,TCGA-FG-A4MU,LGG,58.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2012.0,[Not Available],-21450.0,Alive,WITH TUMOR,326.0,,[Not Available],,,,,[Unknown],,,0.0,326.0,0.0,326.0,,,0.0,326.0,
TCGA-J2-8192,6278,TCGA-J2-8192,LUAD,65.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23892.0,Alive,TUMOR FREE,739.0,,[Not Available],Locoregional Recurrence,,,482.0,Progressive Disease,,,0.0,739.0,0.0,739.0,,,1.0,482.0,
TCGA-HT-A616,5232,TCGA-HT-A616,LGG,36.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-13222.0,Alive,,55.0,,[Not Available],,,,,[Not Available],,,0.0,55.0,0.0,55.0,,,0.0,55.0,
TCGA-FB-A7DR,7558,TCGA-FB-A7DR,PAAD,48.0,MALE,ASIAN,Stage IIA,[Not Applicable],Pancreas-Colloid (mucinous non-cystic) Carcinoma,G2,2012.0,[Not Available],-17649.0,Dead,TUMOR FREE,,353.0,Pancreatic Cancer,,,,,Complete Remission/Response,,,1.0,353.0,1.0,353.0,0.0,353.0,0.0,353.0,
TCGA-86-7714,6183,TCGA-86-7714,LUAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22619.0,Dead,WITH TUMOR,,625.0,[Not Available],,,,,Stable Disease,,,1.0,625.0,1.0,625.0,,,1.0,625.0,
TCGA-CJ-4913,4313,TCGA-CJ-4913,KIRC,45.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-16757.0,Dead,WITH TUMOR,,1173.0,[Not Available],,,,538.0,[Not Available],,,1.0,1173.0,1.0,1173.0,,,1.0,538.0,
TCGA-DU-7018,5019,TCGA-DU-7018,LGG,57.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2006.0,[Not Available],-21019.0,Dead,WITH TUMOR,,933.0,[Not Available],,,,338.0,Progressive Disease,,,1.0,933.0,1.0,933.0,,,1.0,338.0,
TCGA-E2-A1IO,1368,TCGA-E2-A1IO,BRCA,37.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13671.0,Alive,TUMOR FREE,1855.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1855.0,0.0,1855.0,0.0,1855.0,0.0,1855.0,
TCGA-DD-AADK,5621,TCGA-DD-AADK,LIHC,68.0,FEMALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-25046.0,Alive,TUMOR FREE,1049.0,,[Not Available],,,,,[Not Available],,R0,0.0,1049.0,0.0,1049.0,0.0,1049.0,0.0,1049.0,
TCGA-HU-8608,9564,TCGA-HU-8608,STAD,70.0,MALE,ASIAN,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-25789.0,Alive,WITH TUMOR,641.0,,[Not Available],Distant Metastasis,Lung,,277.0,Complete Remission/Response,,,0.0,641.0,0.0,641.0,1.0,277.0,1.0,277.0,
TCGA-02-2470,2735,TCGA-02-2470,GBM,57.0,MALE,WHITE,[Not Available],[Not Applicable],Treated primary GBM,[Not Available],2007.0,[Not Available],-21021.0,Dead,WITH TUMOR,393.0,393.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],183.0,[Not Available],,,1.0,393.0,1.0,393.0,,,1.0,183.0,
TCGA-66-2783,6635,TCGA-66-2783,LUSC,67.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-24686.0,Alive,TUMOR FREE,759.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,759.0,0.0,759.0,0.0,759.0,0.0,759.0,
TCGA-D8-A1JN,1249,TCGA-D8-A1JN,BRCA,80.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29331.0,Alive,TUMOR FREE,620.0,,[Not Available],,,,,[Not Available],Negative,,0.0,620.0,0.0,620.0,0.0,620.0,0.0,620.0,
TCGA-LN-A7HX,2586,TCGA-LN-A7HX,ESCA,72.0,MALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-26517.0,Alive,TUMOR FREE,372.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,
TCGA-ZB-A96C,10455,TCGA-ZB-A96C,THYM,77.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2009.0,[Not Available],-28222.0,Alive,TUMOR FREE,2163.0,,[Not Available],,,,,[Not Available],,,0.0,2163.0,0.0,2163.0,,,0.0,2163.0,
TCGA-ET-A39O,10225,TCGA-ET-A39O,THCA,39.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2006.0,[Not Available],-14295.0,Alive,TUMOR FREE,3059.0,,[Not Available],,,,,[Not Available],,R0,0.0,3059.0,0.0,3059.0,0.0,3059.0,0.0,3059.0,
TCGA-4R-AA8I,5448,TCGA-4R-AA8I,LIHC,66.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-24279.0,Dead,WITH TUMOR,,262.0,[Not Available],Locoregional Recurrence,Liver,,158.0,[Not Available],,R0,1.0,262.0,1.0,262.0,1.0,158.0,1.0,158.0,
TCGA-VM-A8CB,5408,TCGA-VM-A8CB,LGG,33.0,MALE,[Unknown],[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-12340.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,[Unknown],,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-DB-A4XD,4945,TCGA-DB-A4XD,LGG,32.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-11741.0,Alive,TUMOR FREE,1210.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1210.0,0.0,1210.0,0.0,1210.0,0.0,1210.0,
TCGA-E2-A109,1307,TCGA-E2-A109,BRCA,64.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23521.0,Alive,TUMOR FREE,1417.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1417.0,0.0,1417.0,0.0,1417.0,0.0,1417.0,
TCGA-NH-A6GB,2399,TCGA-NH-A6GB,COAD,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2013.0,[Not Available],-26100.0,Alive,WITH TUMOR,476.0,,[Not Available],,,,,Progressive Disease,,,0.0,476.0,0.0,476.0,,,0.0,476.0,
TCGA-2Z-A9J2,4422,TCGA-2Z-A9J2,KIRP,71.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-26134.0,Alive,TUMOR FREE,1795.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1795.0,0.0,1795.0,0.0,1795.0,0.0,1795.0,
TCGA-DX-A2J1,8574,TCGA-DX-A2J1,SARC,53.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2007.0,[Not Available],-19707.0,Alive,TUMOR FREE,2901.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,2901.0,0.0,2901.0,,,0.0,2901.0,
TCGA-DD-AACQ,5596,TCGA-DD-AACQ,LIHC,50.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2009.0,[Not Available],-18429.0,Dead,WITH TUMOR,,432.0,[Not Available],Locoregional Recurrence,Liver,,105.0,[Not Available],,R0,1.0,432.0,1.0,432.0,1.0,105.0,1.0,105.0,
TCGA-2Z-A9J7,4426,TCGA-2Z-A9J7,KIRP,63.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-23230.0,Dead,WITH TUMOR,,139.0,[Not Available],,,,96.0,Progressive Disease,,,1.0,139.0,1.0,139.0,,,1.0,96.0,
TCGA-2A-A8W3,7873,TCGA-2A-A8W3,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25557.0,Alive,[Discrepancy],863.0,,[Not Available],Biochemical evidence of disease,,,198.0,[Not Available],,,0.0,863.0,0.0,863.0,,,1.0,198.0,
TCGA-N5-A4R8,11024,TCGA-N5-A4R8,UCS,65.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24102.0,Dead,,,3115.0,[Not Available],,,,,Complete Remission/Response,,,1.0,3115.0,,3115.0,0.0,3115.0,0.0,3115.0,
TCGA-P3-A5QE,3709,TCGA-P3-A5QE,HNSC,49.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma Basaloid Type,G2,2009.0,[Not Available],-18002.0,Alive,TUMOR FREE,1559.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1559.0,0.0,1559.0,0.0,1559.0,0.0,1559.0,
TCGA-KL-8326,3773,TCGA-KL-8326,KICH,69.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2001.0,[Not Available],-25267.0,Alive,TUMOR FREE,3322.0,,[Not Available],,,,,[Unknown],,,0.0,3322.0,0.0,3322.0,,,0.0,3322.0,
TCGA-3C-AALJ,507,TCGA-3C-AALJ,BRCA,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22848.0,Alive,TUMOR FREE,1474.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1474.0,0.0,1474.0,0.0,1474.0,0.0,1474.0,
TCGA-PG-A6IB,11008,TCGA-PG-A6IB,UCEC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24969.0,Alive,TUMOR FREE,648.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,648.0,0.0,648.0,0.0,648.0,0.0,648.0,
TCGA-CM-5868,2275,TCGA-CM-5868,COAD,59.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-21672.0,Alive,WITH TUMOR,518.0,,[Not Available],,,,,[Not Available],,,0.0,518.0,0.0,518.0,,,0.0,518.0,
TCGA-QG-A5YW,2404,TCGA-QG-A5YW,COAD,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-20391.0,Alive,TUMOR FREE,896.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,896.0,0.0,896.0,0.0,896.0,0.0,896.0,
TCGA-AO-A0JG,865,TCGA-AO-A0JG,BRCA,49.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Other, specify",[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18021.0,Alive,TUMOR FREE,798.0,,[Not Available],,,,,[Not Available],Close,,0.0,798.0,0.0,798.0,,,0.0,798.0,
TCGA-A7-A26F,644,TCGA-A7-A26F,BRCA,55.0,FEMALE,WHITE,Stage IA,[Not Applicable],"Other, specify",[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20210.0,Alive,TUMOR FREE,738.0,,[Not Available],,,,,[Not Available],Negative,,0.0,738.0,0.0,738.0,0.0,738.0,0.0,738.0,
TCGA-AP-A1DV,10600,TCGA-AP-A1DV,UCEC,59.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21901.0,Alive,TUMOR FREE,204.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,204.0,0.0,204.0,0.0,204.0,0.0,204.0,
TCGA-BA-A6D8,3268,TCGA-BA-A6D8,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21778.0,Alive,WITH TUMOR,850.0,,[Not Available],Distant Metastasis,Oral Cavity,R Floor of Mouth,849.0,Complete Remission/Response,,,0.0,850.0,0.0,850.0,,,1.0,849.0,
TCGA-EJ-A7NN,7999,TCGA-EJ-A7NN,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22499.0,Alive,TUMOR FREE,197.0,,[Not Available],Biochemical evidence of disease,,,197.0,Complete Remission/Response,,,0.0,197.0,0.0,197.0,1.0,197.0,1.0,197.0,
TCGA-XF-A9SG,425,TCGA-XF-A9SG,BLCA,81.0,MALE,[Unknown],Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-29825.0,Alive,TUMOR FREE,1479.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1479.0,0.0,1479.0,0.0,1479.0,0.0,1479.0,
TCGA-CQ-5325,3378,TCGA-CQ-5325,HNSC,65.0,MALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-23833.0,Dead,WITH TUMOR,,654.0,[Not Available],,Oral Cavity,,204.0,Complete Remission/Response,,,1.0,654.0,1.0,654.0,1.0,204.0,1.0,204.0,
TCGA-DB-A4X9,4941,TCGA-DB-A4X9,LGG,33.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2010.0,[Not Available],-12131.0,Alive,TUMOR FREE,1412.0,,[Not Available],,,,501.0,Complete Remission/Response,,,0.0,1412.0,0.0,1412.0,1.0,501.0,1.0,501.0,
TCGA-BR-A4J5,9403,TCGA-BR-A4J5,STAD,56.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012.0,[Not Available],-20714.0,Alive,TUMOR FREE,862.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,862.0,0.0,862.0,0.0,862.0,0.0,862.0,
TCGA-WB-A81V,7861,TCGA-WB-A81V,PCPG,57.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2006.0,[Not Available],-21106.0,Alive,TUMOR FREE,2161.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2161.0,0.0,2161.0,0.0,2161.0,0.0,2161.0,
TCGA-78-7153,6149,TCGA-78-7153,LUAD,65.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2003.0,[Not Available],-23922.0,Alive,,3635.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3635.0,0.0,3635.0,0.0,3635.0,0.0,3635.0,
TCGA-G9-6336,8017,TCGA-G9-6336,PRAD,57.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-20851.0,Alive,TUMOR FREE,2068.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2068.0,0.0,2068.0,0.0,2068.0,0.0,2068.0,
TCGA-3B-A9HS,8544,TCGA-3B-A9HS,SARC,60.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2008.0,[Not Available],-21946.0,Dead,WITH TUMOR,,1366.0,[Not Available],Locoregional Recurrence,,,139.0,[Not Available],Negative,R0,1.0,1366.0,1.0,1366.0,1.0,139.0,1.0,139.0,
TCGA-SN-A84W,9787,TCGA-SN-A84W,TGCT,30.0,MALE,WHITE,IS,[Not Available],Seminoma; NOS|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2013.0,[Not Available],-11251.0,Alive,TUMOR FREE,293.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,293.0,0.0,293.0,0.0,293.0,0.0,293.0,
TCGA-2G-AAG5,9731,TCGA-2G-AAG5,TGCT,36.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature),[Not Available],2008.0,[Not Available],-13497.0,Alive,TUMOR FREE,2299.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,451.0,Complete Remission/Response,,,0.0,2299.0,0.0,2299.0,1.0,451.0,1.0,451.0,
TCGA-BH-A0B6,1036,TCGA-BH-A0B6,BRCA,47.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,[Not Available],-17346.0,Alive,TUMOR FREE,2483.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2483.0,0.0,2483.0,0.0,2483.0,0.0,2483.0,
TCGA-2G-AAGT,9749,TCGA-2G-AAGT,TGCT,30.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature),[Not Available],2002.0,[Not Available],-10967.0,Alive,TUMOR FREE,4406.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,15.0,Complete Remission/Response,,,0.0,4406.0,0.0,4406.0,1.0,15.0,1.0,15.0,
TCGA-E2-A1B4,1354,TCGA-E2-A1B4,BRCA,74.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27241.0,Dead,TUMOR FREE,,1004.0,[Not Available],,,,,[Not Available],Negative,,1.0,1004.0,0.0,1004.0,0.0,1004.0,0.0,1004.0,
TCGA-86-8281,6197,TCGA-86-8281,LUAD,75.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27409.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-B6-A0WV,1003,TCGA-B6-A0WV,BRCA,67.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24803.0,Dead,TUMOR FREE,,2417.0,[Not Available],,,,,[Not Available],Negative,,1.0,2417.0,0.0,2417.0,0.0,2417.0,0.0,2417.0,
TCGA-CG-4442,9454,TCGA-CG-4442,STAD,85.0,MALE,[Not Available],Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,[Not Available],-31350.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-BP-4960,4198,TCGA-BP-4960,KIRC,46.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-17099.0,Alive,TUMOR FREE,2172.0,,[Not Available],,,,,[Not Available],,,0.0,2172.0,0.0,2172.0,,,0.0,2172.0,
TCGA-LN-A7HW,2585,TCGA-LN-A7HW,ESCA,59.0,MALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-21840.0,Alive,TUMOR FREE,365.0,,[Not Available],Locoregional Recurrence,,,97.0,Complete Remission/Response,,,0.0,365.0,0.0,365.0,1.0,97.0,1.0,97.0,
TCGA-KR-A7K2,5743,TCGA-KR-A7K2,LIHC,64.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocholangiocarcinoma (Mixed),G1,2013.0,[Not Available],-23699.0,Alive,TUMOR FREE,829.0,,[Not Available],,,,,[Not Available],,R0,0.0,829.0,0.0,829.0,0.0,829.0,0.0,829.0,
TCGA-63-6202,6587,TCGA-63-6202,LUSC,,MALE,[Not Available],Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],,Alive,TUMOR FREE,1602.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1602.0,0.0,1602.0,0.0,1602.0,0.0,1602.0,
TCGA-BR-7715,9326,TCGA-BR-7715,STAD,65.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-23861.0,Alive,TUMOR FREE,1023.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1023.0,0.0,1023.0,0.0,1023.0,0.0,1023.0,
TCGA-WE-AAA0,9249,TCGA-WE-AAA0,SKCM,47.0,MALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2011.0,[Not Available],-17261.0,Alive,TUMOR FREE,1229.0,,[Not Available],Distant Metastasis|Distant Metastasis,"Other, Specify|Brain",Spleen|[Not Applicable],650.0,[Not Available],,,0.0,1229.0,0.0,1229.0,,,1.0,650.0,
TCGA-VS-A94Z,1854,TCGA-VS-A94Z,CESC,38.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14046.0,Alive,TUMOR FREE,1015.0,,,,,,,Complete Remission/Response,,,0.0,1015.0,0.0,1015.0,0.0,1015.0,0.0,1015.0,
TCGA-DK-A6B2,214,TCGA-DK-A6B2,BLCA,70.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-25625.0,Alive,WITH TUMOR,477.0,,[Not Available],Distant Metastasis,Liver,,268.0,Complete Remission/Response,,,0.0,477.0,0.0,477.0,,,1.0,268.0,
TCGA-E1-A7YW,5089,TCGA-E1-A7YW,LGG,28.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2002.0,[Not Available],-10571.0,Dead,WITH TUMOR,,1120.0,[Not Available],,,,409.0,Progressive Disease,,,1.0,1120.0,1.0,1120.0,,,1.0,409.0,
TCGA-XF-A9T3,442,TCGA-XF-A9T3,BLCA,69.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-25532.0,Alive,TUMOR FREE,68.0,,[Not Available],,,,,[Unknown],,,0.0,68.0,0.0,68.0,,,0.0,68.0,
TCGA-DU-5847,4980,TCGA-DU-5847,LGG,34.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-12606.0,Alive,WITH TUMOR,548.0,,[Not Available],,,,,Stable Disease,,,0.0,548.0,0.0,548.0,,,0.0,548.0,
TCGA-HT-8564,5221,TCGA-HT-8564,LGG,47.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-17499.0,Alive,WITH TUMOR,478.0,,[Not Available],,,,120.0,Progressive Disease,,,0.0,478.0,0.0,478.0,,,1.0,120.0,
TCGA-HT-7481,5154,TCGA-HT-7481,LGG,39.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2006.0,[Not Available],-14306.0,Alive,WITH TUMOR,2918.0,,[Not Available],,,,880.0,Stable Disease,,,0.0,2918.0,0.0,2918.0,,,1.0,880.0,
TCGA-FG-A87Q,5138,TCGA-FG-A87Q,LGG,61.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-22565.0,Alive,TUMOR FREE,174.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,174.0,0.0,174.0,0.0,174.0,0.0,174.0,
TCGA-BP-5187,4254,TCGA-BP-5187,KIRC,54.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-19999.0,Alive,TUMOR FREE,406.0,,[Not Available],,,,,[Not Available],,,0.0,406.0,0.0,406.0,,,0.0,406.0,
TCGA-DD-A3A3,5545,TCGA-DD-A3A3,LIHC,45.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,1999.0,[Not Available],-16708.0,Dead,,,535.0,[Not Available],,,,,[Not Available],,R0,1.0,535.0,,535.0,0.0,535.0,0.0,535.0,
TCGA-BJ-A4O8,9893,TCGA-BJ-A4O8,THCA,47.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-17430.0,Alive,TUMOR FREE,591.0,,[Not Available],,,,,[Not Available],,R0,0.0,591.0,0.0,591.0,0.0,591.0,0.0,591.0,
TCGA-BQ-5882,4542,TCGA-BQ-5882,KIRP,54.0,MALE,[Not Available],Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-20042.0,Dead,WITH TUMOR,,658.0,[Not Available],,,,340.0,[Not Available],,,1.0,658.0,1.0,658.0,,,1.0,340.0,
TCGA-B0-5694,4052,TCGA-B0-5694,KIRC,71.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2008.0,[Not Available],-26060.0,Dead,WITH TUMOR,,480.0,[Not Available],,,,288.0,[Not Available],,,1.0,480.0,1.0,480.0,,,1.0,288.0,
TCGA-97-8175,6258,TCGA-97-8175,LUAD,55.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-20206.0,Alive,TUMOR FREE,551.0,,[Not Available],Locoregional Recurrence,,,294.0,Complete Remission/Response,,,0.0,551.0,0.0,551.0,1.0,294.0,1.0,294.0,
TCGA-WC-AA9E,11155,TCGA-WC-AA9E,UVM,60.0,MALE,WHITE,Stage IIA,Stage IIIC,Spindle Cell,[Not Available],2013.0,[Not Available],-21976.0,Alive,WITH TUMOR,838.0,,[Not Available],,,,,[Not Available],,,0.0,838.0,0.0,838.0,,,0.0,838.0,
TCGA-E2-A1LI,1379,TCGA-E2-A1LI,BRCA,57.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21064.0,Alive,TUMOR FREE,3121.0,,[Not Available],,,,,[Not Available],Close,,0.0,3121.0,0.0,3121.0,,,0.0,3121.0,
TCGA-R5-A805,9625,TCGA-R5-A805,STAD,71.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,[Not Available],-26122.0,Dead,WITH TUMOR,,281.0,Stomach Cancer,,,,,[Not Available],,,1.0,281.0,1.0,281.0,,,1.0,281.0,
TCGA-EK-A2RJ,1736,TCGA-EK-A2RJ,CESC,51.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2009.0,[Not Available],-18664.0,Alive,TUMOR FREE,53.0,,,,,,,[Not Available],,,0.0,53.0,0.0,53.0,,,0.0,53.0,
TCGA-D8-A147,1233,TCGA-D8-A147,BRCA,45.0,FEMALE,WHITE,[Not Available],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Indeterminate (neither Pre or Postmenopausal),-16736.0,Alive,TUMOR FREE,584.0,,[Not Available],,,,,[Not Available],Negative,,0.0,584.0,0.0,584.0,0.0,584.0,0.0,584.0,
TCGA-D5-6531,2302,TCGA-D5-6531,COAD,75.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-27633.0,Alive,TUMOR FREE,540.0,,[Not Available],,,,,[Not Available],,,0.0,540.0,0.0,540.0,,,0.0,540.0,
TCGA-WK-A8XZ,8777,TCGA-WK-A8XZ,SARC,56.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2007.0,[Not Available],-20460.0,Dead,WITH TUMOR,,1722.0,[Not Available],Distant Metastasis,"Other, specify",Scalp,89.0,[Not Available],Negative,R0,1.0,1722.0,1.0,1722.0,1.0,89.0,1.0,89.0,
TCGA-85-A4QR,6744,TCGA-85-A4QR,LUSC,67.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24756.0,Alive,TUMOR FREE,600.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,
TCGA-VD-A8K9,11119,TCGA-VD-A8K9,UVM,71.0,FEMALE,[Not Evaluated],Stage IIA,Stage IIB,Spindle Cell,[Not Available],2011.0,[Not Available],-26292.0,Alive,TUMOR FREE,1424.0,,[Not Available],,,,,[Not Available],,,0.0,1424.0,0.0,1424.0,,,0.0,1424.0,
TCGA-93-A4JP,6233,TCGA-93-A4JP,LUAD,64.0,MALE,ASIAN,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-23620.0,Alive,WITH TUMOR,578.0,,[Not Available],Distant Metastasis,,,497.0,Partial Remission/Response,,,0.0,578.0,0.0,578.0,,,1.0,497.0,
TCGA-LN-A9FQ,2594,TCGA-LN-A9FQ,ESCA,62.0,MALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G3,2013.0,[Not Available],-22717.0,Alive,TUMOR FREE,391.0,,[Not Available],Locoregional Recurrence,,,82.0,Complete Remission/Response,,,0.0,391.0,0.0,391.0,1.0,82.0,1.0,82.0,
TCGA-S9-A89V,5367,TCGA-S9-A89V,LGG,70.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-25570.0,Alive,WITH TUMOR,569.0,,[Not Available],,,,129.0,Progressive Disease,,,0.0,569.0,0.0,569.0,,,1.0,129.0,
TCGA-OR-A5KW,52,TCGA-OR-A5KW,ACC,55.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-20328.0,Alive,TUMOR FREE,2076.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2076.0,0.0,2076.0,0.0,2076.0,0.0,2076.0,
TCGA-S4-A8RP,7671,TCGA-S4-A8RP,PAAD,77.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2010.0,[Not Available],-28353.0,Dead,,,702.0,,,,,,[Unknown],,,1.0,702.0,,702.0,,,0.0,702.0,
TCGA-BT-A20W,133,TCGA-BT-A20W,BLCA,71.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-26078.0,Dead,TUMOR FREE,,254.0,[Not Available],,,,,Complete Remission/Response,,,1.0,254.0,0.0,254.0,0.0,254.0,0.0,254.0,
TCGA-D1-A16O,10847,TCGA-D1-A16O,UCEC,44.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16114.0,Alive,TUMOR FREE,1023.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1023.0,0.0,1023.0,0.0,1023.0,0.0,1023.0,
TCGA-38-4627,5844,TCGA-38-4627,LUAD,64.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2003.0,[Not Available],-23510.0,Dead,,,1147.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1147.0,,1147.0,0.0,1147.0,0.0,1147.0,
TCGA-CN-A498,3358,TCGA-CN-A498,HNSC,61.0,FEMALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-22330.0,Dead,WITH TUMOR,,773.0,[Not Available],Locoregional Recurrence,Oral Cavity,"tongue, r neck nodes",186.0,Complete Remission/Response,,,1.0,773.0,1.0,773.0,1.0,186.0,1.0,186.0,
TCGA-DX-A48P,8599,TCGA-DX-A48P,SARC,54.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-19794.0,Alive,TUMOR FREE,1400.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1400.0,0.0,1400.0,0.0,1400.0,0.0,1400.0,
TCGA-AA-3511,2022,TCGA-AA-3511,COAD,64.0,MALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-23407.0,Alive,TUMOR FREE,212.0,,[Not Available],,,,59.0,Complete Remission/Response,,,0.0,212.0,0.0,212.0,1.0,59.0,1.0,59.0,
TCGA-J4-A67R,8138,TCGA-J4-A67R,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-23807.0,Alive,TUMOR FREE,910.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,910.0,0.0,910.0,0.0,910.0,0.0,910.0,
TCGA-EO-A3AZ,10934,TCGA-EO-A3AZ,UCEC,80.0,FEMALE,[Not Available],[Not Applicable],Stage IB,Mixed serous and endometrioid,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29234.0,Alive,TUMOR FREE,826.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,826.0,0.0,826.0,0.0,826.0,0.0,826.0,
TCGA-GN-A264,9194,TCGA-GN-A264,SKCM,60.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1997.0,[Not Available],-22254.0,Dead,WITH TUMOR,,3587.0,[Not Available],Distant Metastasis,Lung,,3221.0,[Not Available],,,1.0,3587.0,1.0,3587.0,,,1.0,3221.0,
TCGA-A2-A0T5,581,TCGA-A2-A0T5,BRCA,39.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14503.0,Alive,TUMOR FREE,531.0,,[Not Available],,,,,[Not Available],Negative,,0.0,531.0,0.0,531.0,0.0,531.0,0.0,531.0,
TCGA-CN-A49A,3360,TCGA-CN-A49A,HNSC,60.0,MALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-21995.0,Dead,WITH TUMOR,,526.0,[Not Available],Distant Metastasis,Distant Metastasis,spine,344.0,Complete Remission/Response,,,1.0,526.0,1.0,526.0,,,1.0,344.0,
TCGA-AX-A1CA,10635,TCGA-AX-A1CA,UCEC,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2009.0,[Not Available],-25817.0,Alive,TUMOR FREE,974.0,,[Not Available],,,,,[Not Applicable],,,0.0,974.0,0.0,974.0,,,0.0,974.0,
TCGA-V1-A9OX,8258,TCGA-V1-A9OX,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-20805.0,Alive,,1134.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1134.0,0.0,1134.0,,,0.0,1134.0,
TCGA-D8-A1XR,1271,TCGA-D8-A1XR,BRCA,56.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20488.0,Alive,TUMOR FREE,482.0,,[Not Available],,,,,[Not Available],Negative,,0.0,482.0,0.0,482.0,0.0,482.0,0.0,482.0,
TCGA-E1-5311,5071,TCGA-E1-5311,LGG,31.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,1994.0,[Not Available],-11332.0,Dead,WITH TUMOR,,4084.0,[Not Available],,,,2602.0,Stable Disease,,,1.0,4084.0,1.0,4084.0,,,1.0,2602.0,
TCGA-D6-A6EK,3622,TCGA-D6-A6EK,HNSC,67.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-24558.0,Alive,TUMOR FREE,875.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,875.0,0.0,875.0,,,0.0,875.0,
TCGA-F6-A8O3,5096,TCGA-F6-A8O3,LGG,34.0,MALE,ASIAN,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-12578.0,Alive,TUMOR FREE,7.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,7.0,0.0,7.0,0.0,7.0,0.0,7.0,
TCGA-B0-5113,4038,TCGA-B0-5113,KIRC,69.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-25369.0,Alive,TUMOR FREE,1175.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1175.0,0.0,1175.0,0.0,1175.0,0.0,1175.0,
TCGA-19-2619,3078,TCGA-19-2619,GBM,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-20159.0,Alive,WITH TUMOR,294.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],146.0,[Not Available],,,0.0,294.0,0.0,294.0,,,1.0,146.0,
TCGA-AC-A2FG,765,TCGA-AC-A2FG,BRCA,79.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29211.0,Alive,TUMOR FREE,1853.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1853.0,0.0,1853.0,0.0,1853.0,0.0,1853.0,
TCGA-AA-3510,2021,TCGA-AA-3510,COAD,70.0,MALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-25902.0,Alive,TUMOR FREE,1946.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1946.0,0.0,1946.0,0.0,1946.0,0.0,1946.0,
TCGA-77-8008,6673,TCGA-77-8008,LUSC,68.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-24948.0,Dead,,,2639.0,[Not Available],,,,,[Not Available],,,1.0,2639.0,,2639.0,,,0.0,2639.0,
TCGA-BH-A18I,1117,TCGA-BH-A18I,BRCA,53.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19489.0,Alive,TUMOR FREE,1093.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1093.0,0.0,1093.0,0.0,1093.0,0.0,1093.0,
TCGA-5C-AAPD,5451,TCGA-5C-AAPD,LIHC,61.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocholangiocarcinoma (Mixed),G1,2013.0,[Not Available],-22552.0,Alive,TUMOR FREE,20.0,,[Not Available],,,,,[Not Available],,R0,0.0,20.0,0.0,20.0,0.0,20.0,0.0,20.0,
TCGA-J4-A83N,8149,TCGA-J4-A83N,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20841.0,Alive,TUMOR FREE,992.0,,[Not Available],New Primary Tumor,,,433.0,Complete Remission/Response,,,0.0,992.0,0.0,992.0,0.0,992.0,1.0,433.0,
TCGA-EW-A1J1,1459,TCGA-EW-A1J1,BRCA,38.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14122.0,Alive,TUMOR FREE,575.0,,[Not Available],,,,,[Not Available],Negative,,0.0,575.0,0.0,575.0,0.0,575.0,0.0,575.0,
TCGA-WB-A820,7863,TCGA-WB-A820,PCPG,40.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2004.0,[Not Available],-14949.0,Dead,WITH TUMOR,,309.0,[Not Available],,,,,Progressive Disease,,,1.0,309.0,1.0,309.0,,,1.0,309.0,
TCGA-BR-6452,9301,TCGA-BR-6452,STAD,78.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-28827.0,Alive,TUMOR FREE,1055.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1055.0,0.0,1055.0,0.0,1055.0,0.0,1055.0,
TCGA-27-1832,3119,TCGA-27-1832,GBM,59.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-21678.0,Dead,WITH TUMOR,0.0,300.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],176.0,[Not Available],,,1.0,300.0,1.0,300.0,,,1.0,176.0,
TCGA-DU-6396,4995,TCGA-DU-6396,LGG,31.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,1996.0,[Not Available],-11427.0,Dead,WITH TUMOR,,2286.0,[Not Available],,,,106.0,Progressive Disease,,,1.0,2286.0,1.0,2286.0,,,1.0,106.0,
TCGA-MP-A4SY,6297,TCGA-MP-A4SY,LUAD,61.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-22448.0,Dead,TUMOR FREE,,1501.0,[Not Available],Locoregional Recurrence,,,489.0,Complete Remission/Response,,,1.0,1501.0,0.0,1501.0,1.0,489.0,1.0,489.0,
TCGA-06-0209,2801,TCGA-06-0209,GBM,76.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1997.0,[Not Available],-27877.0,Dead,WITH TUMOR,119.0,232.0,[Not Available],,,,,[Not Available],,,1.0,232.0,1.0,232.0,,,1.0,232.0,
TCGA-DJ-A3VJ,9997,TCGA-DJ-A3VJ,THCA,22.0,MALE,WHITE,Stage I,[Not Applicable],"Other, specify",[Not Available],2010.0,[Not Available],-8341.0,Alive,TUMOR FREE,1108.0,,[Not Available],,,,,[Not Available],,R0,0.0,1108.0,0.0,1108.0,0.0,1108.0,0.0,1108.0,
TCGA-W5-AA2W,1930,TCGA-W5-AA2W,CHOL,31.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2010.0,[Not Available],-11438.0,Dead,WITH TUMOR,,924.0,[Not Available],Intrahepatic Recurrence,Liver,,237.0,[Not Available],,R0,1.0,924.0,1.0,924.0,,,1.0,237.0,
TCGA-FD-A6TI,303,TCGA-FD-A6TI,BLCA,73.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-26874.0,Dead,TUMOR FREE,,294.0,[Not Available],,,,,[Unknown],,,1.0,294.0,0.0,294.0,,,0.0,294.0,
TCGA-3B-A9HR,8543,TCGA-3B-A9HR,SARC,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2007.0,[Not Available],-14041.0,Dead,WITH TUMOR,,2694.0,[Not Available],Distant Metastasis,Lung,,496.0,[Not Available],Negative,R0,1.0,2694.0,1.0,2694.0,1.0,496.0,1.0,496.0,
TCGA-CN-4731,3310,TCGA-CN-4731,HNSC,63.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-23194.0,Dead,WITH TUMOR,,998.0,[Not Available],,Oral Cavity,,243.0,Persistent Disease,,,1.0,998.0,1.0,998.0,,,1.0,243.0,
TCGA-IN-8462,9594,TCGA-IN-8462,STAD,80.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-29242.0,Alive,WITH TUMOR,572.0,,[Not Available],Distant Metastasis,,,270.0,Progressive Disease,,,0.0,572.0,0.0,572.0,,,1.0,270.0,
TCGA-HC-7740,8079,TCGA-HC-7740,PRAD,59.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21883.0,Alive,TUMOR FREE,717.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,717.0,0.0,717.0,0.0,717.0,0.0,717.0,
TCGA-HD-8224,3669,TCGA-HD-8224,HNSC,63.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-23069.0,Dead,WITH TUMOR,,446.0,[Not Available],Distant Metastasis,Distant Metastasis,Lung,171.0,Progressive Disease,,,1.0,446.0,1.0,446.0,,,1.0,171.0,
TCGA-UZ-A9PR,4691,TCGA-UZ-A9PR,KIRP,84.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-30681.0,Alive,TUMOR FREE,2627.0,,[Not Available],,,,2494.0,Complete Remission/Response,,,0.0,2627.0,0.0,2627.0,1.0,2494.0,1.0,2494.0,
TCGA-L5-A43H,2510,TCGA-L5-A43H,ESCA,75.0,MALE,WHITE,Stage III,[Not Available],Esophagus Squamous Cell Carcinoma,GX,2011.0,[Not Available],-27592.0,Dead,WITH TUMOR,,9.0,[Not Available],,,,,Complete Remission/Response,,,1.0,9.0,1.0,9.0,,,1.0,9.0,
TCGA-CS-6670,4930,TCGA-CS-6670,LGG,43.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-16066.0,Alive,WITH TUMOR,1426.0,,[Not Available],,,,,[Discrepancy],,,0.0,1426.0,0.0,1426.0,,,0.0,1426.0,
TCGA-PR-A5PF,7694,TCGA-PR-A5PF,PCPG,62.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-22987.0,Alive,TUMOR FREE,546.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,
TCGA-ZB-A96M,10464,TCGA-ZB-A96M,THYM,56.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2011.0,[Not Available],-20623.0,Alive,TUMOR FREE,14.0,,[Not Available],,,,,[Not Available],,,0.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-EJ-5531,7941,TCGA-EJ-5531,PRAD,62.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-22760.0,Alive,TUMOR FREE,1273.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1273.0,0.0,1273.0,0.0,1273.0,0.0,1273.0,
TCGA-GM-A2DK,1508,TCGA-GM-A2DK,BRCA,58.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21198.0,Alive,TUMOR FREE,2645.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2645.0,0.0,2645.0,0.0,2645.0,0.0,2645.0,
TCGA-A2-A25A,605,TCGA-A2-A25A,BRCA,44.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16084.0,Alive,TUMOR FREE,3276.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3276.0,0.0,3276.0,0.0,3276.0,0.0,3276.0,
TCGA-GS-A9U4,2456,TCGA-GS-A9U4,DLBC,27.0,FEMALE,WHITE,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2011.0,[Not Available],-10075.0,Dead,WITH TUMOR,,391.0,[Not Available],,Cervical Lymph Nodes,,106.0,Progressive Disease,,,1.0,391.0,1.0,391.0,,,1.0,106.0,
TCGA-44-2659,5856,TCGA-44-2659,LUAD,65.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-23808.0,Alive,TUMOR FREE,1367.0,,[Not Available],Locoregional Recurrence,,,1146.0,Complete Remission/Response,,,0.0,1367.0,0.0,1367.0,1.0,1146.0,1.0,1146.0,
TCGA-FG-7634,5107,TCGA-FG-7634,LGG,28.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2008.0,[Not Available],-10476.0,Alive,WITH TUMOR,467.0,,[Not Available],,,,,Stable Disease,,,0.0,467.0,0.0,467.0,,,0.0,467.0,
TCGA-Z7-A8R5,1600,TCGA-Z7-A8R5,BRCA,61.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22280.0,Alive,WITH TUMOR,3287.0,,[Not Available],Locoregional Recurrence,,,181.0,[Not Available],Positive,,0.0,3287.0,0.0,3287.0,,,1.0,181.0,
TCGA-DM-A0X9,2326,TCGA-DM-A0X9,COAD,71.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2001.0,[Not Available],-26217.0,Alive,,3641.0,,[Not Available],,,,,[Not Available],,,0.0,3641.0,0.0,3641.0,,,0.0,3641.0,
TCGA-EE-A2GC,9030,TCGA-EE-A2GC,SKCM,82.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2008.0,[Not Available],-30084.0,Alive,TUMOR FREE,2051.0,,[Not Available],,,,,[Not Available],,,0.0,2051.0,0.0,2051.0,,,0.0,2051.0,
TCGA-98-8020,6782,TCGA-98-8020,LUSC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-20509.0,Dead,WITH TUMOR,,84.0,[Not Available],Distant Metastasis,,,11.0,[Unknown],,,1.0,84.0,1.0,84.0,,,1.0,11.0,
TCGA-AZ-4614,2217,TCGA-AZ-4614,COAD,71.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-26267.0,Dead,WITH TUMOR,,172.0,[Not Available],,,,,[Not Available],,,1.0,172.0,1.0,172.0,,,1.0,172.0,
TCGA-IE-A6BZ,8697,TCGA-IE-A6BZ,SARC,65.0,FEMALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012.0,[Not Available],-23756.0,Alive,TUMOR FREE,605.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,605.0,0.0,605.0,0.0,605.0,0.0,605.0,
TCGA-DJ-A3UZ,9980,TCGA-DJ-A3UZ,THCA,70.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-25846.0,Alive,TUMOR FREE,1246.0,,[Not Available],,,,,[Not Available],,R0,0.0,1246.0,0.0,1246.0,0.0,1246.0,0.0,1246.0,
TCGA-CV-7099,3523,TCGA-CV-7099,HNSC,85.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2002.0,[Not Available],-31134.0,Dead,TUMOR FREE,,243.0,[Not Available],,,,,Complete Remission/Response,,,1.0,243.0,0.0,243.0,0.0,243.0,0.0,243.0,
TCGA-VD-A8KA,11120,TCGA-VD-A8KA,UVM,22.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,[Not Available],2011.0,[Not Available],-8271.0,Alive,WITH TUMOR,1178.0,,[Not Available],Distant Metastasis,Liver,,1008.0,[Not Available],,,0.0,1178.0,0.0,1178.0,,,1.0,1008.0,
TCGA-ZF-A9RD,482,TCGA-ZF-A9RD,BLCA,75.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-27496.0,Dead,,,408.0,[Not Available],,,,,[Unknown],,,1.0,408.0,,408.0,,,0.0,408.0,
TCGA-63-A5MM,6599,TCGA-63-A5MM,LUSC,69.0,FEMALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-25348.0,Dead,WITH TUMOR,,456.0,[Not Available],,,,218.0,Complete Remission/Response,,,1.0,456.0,1.0,456.0,1.0,218.0,1.0,218.0,
TCGA-AR-A2LK,957,TCGA-AR-A2LK,BRCA,62.0,FEMALE,WHITE,Stage III,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22800.0,Dead,,,1649.0,[Not Available],Distant Metastasis,Bone,,1304.0,[Not Available],Negative,,1.0,1649.0,,1649.0,1.0,1304.0,1.0,1304.0,
TCGA-VQ-A8PO,9664,TCGA-VQ-A8PO,STAD,74.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2008.0,[Not Available],-27250.0,Dead,,,282.0,Stomach Cancer,Locoregional Recurrence,,,256.0,Progressive Disease,,,1.0,282.0,1.0,282.0,,,1.0,256.0,
TCGA-93-A4JQ,6234,TCGA-93-A4JQ,LUAD,49.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-17951.0,Alive,TUMOR FREE,526.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,
TCGA-AD-6548,2187,TCGA-AD-6548,COAD,81.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-29758.0,Alive,TUMOR FREE,650.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,650.0,0.0,650.0,0.0,650.0,0.0,650.0,
TCGA-5P-A9KA,4459,TCGA-5P-A9KA,KIRP,61.0,MALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-22545.0,Alive,TUMOR FREE,395.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,395.0,0.0,395.0,0.0,395.0,0.0,395.0,
TCGA-CN-A63U,3364,TCGA-CN-A63U,HNSC,50.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-18272.0,Alive,TUMOR FREE,964.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,964.0,0.0,964.0,,,0.0,964.0,
TCGA-E9-A1NH,1405,TCGA-E9-A1NH,BRCA,71.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26221.0,Alive,TUMOR FREE,576.0,,[Not Available],,,,,[Not Available],Negative,,0.0,576.0,0.0,576.0,0.0,576.0,0.0,576.0,
TCGA-AF-A56N,8384,TCGA-AF-A56N,READ,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2012.0,[Not Available],-17480.0,Alive,TUMOR FREE,360.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,360.0,0.0,360.0,0.0,360.0,0.0,360.0,
TCGA-LN-A4A1,2571,TCGA-LN-A4A1,ESCA,60.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G3,2011.0,[Not Available],-21954.0,Alive,WITH TUMOR,383.0,,[Not Available],Locoregional Recurrence,,,205.0,Complete Remission/Response,,,0.0,383.0,0.0,383.0,1.0,205.0,1.0,205.0,
TCGA-EB-A553,8970,TCGA-EB-A553,SKCM,62.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-22972.0,Alive,TUMOR FREE,226.0,,[Not Available],,,,,[Not Available],,,0.0,226.0,0.0,226.0,,,0.0,226.0,
TCGA-G9-6373,8038,TCGA-G9-6373,PRAD,68.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-24887.0,Alive,TUMOR FREE,811.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,811.0,0.0,811.0,0.0,811.0,0.0,811.0,
TCGA-SX-A7SS,4680,TCGA-SX-A7SS,KIRP,67.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-24660.0,Alive,TUMOR FREE,1615.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1615.0,0.0,1615.0,0.0,1615.0,0.0,1615.0,
TCGA-XR-A8TG,5790,TCGA-XR-A8TG,LIHC,58.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-21544.0,Alive,TUMOR FREE,898.0,,[Not Available],Intrahepatic Recurrence,Liver,,350.0,[Not Available],,R0,0.0,898.0,0.0,898.0,1.0,350.0,1.0,350.0,
TCGA-ZG-A9L6,8353,TCGA-ZG-A9L6,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23681.0,Alive,WITH TUMOR,687.0,,[Not Available],Biochemical evidence of disease,,,664.0,Partial Remission/Response,,,0.0,687.0,0.0,687.0,,,1.0,664.0,
TCGA-TM-A84T,5387,TCGA-TM-A84T,LGG,19.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-6994.0,Alive,WITH TUMOR,724.0,,[Not Available],,,,,Stable Disease,,,0.0,724.0,0.0,724.0,,,0.0,724.0,
TCGA-B0-5698,4056,TCGA-B0-5698,KIRC,77.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-28438.0,Alive,TUMOR FREE,3631.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3631.0,0.0,3631.0,0.0,3631.0,0.0,3631.0,
TCGA-C5-A2LS,1632,TCGA-C5-A2LS,CESC,37.0,FEMALE,WHITE,[Not Available],Stage IB2,Endocervical Adenocarcinoma of the Usual Type,G1,2005.0,[Not Available],-13857.0,Alive,TUMOR FREE,1345.0,,,,,,,Complete Remission/Response,,,0.0,1345.0,0.0,1345.0,0.0,1345.0,0.0,1345.0,
TCGA-DD-AAEE,5646,TCGA-DD-AAEE,LIHC,55.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2012.0,[Not Available],-20396.0,Alive,WITH TUMOR,810.0,,[Not Available],Intrahepatic Recurrence,Liver,,224.0,[Not Available],,R0,0.0,810.0,0.0,810.0,1.0,224.0,1.0,224.0,
TCGA-HT-7694,5184,TCGA-HT-7694,LGG,60.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2008.0,[Not Available],-21930.0,Alive,TUMOR FREE,210.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,210.0,0.0,210.0,0.0,210.0,0.0,210.0,
TCGA-HV-A7OP,7585,TCGA-HV-A7OP,PAAD,72.0,MALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,GX,2012.0,[Not Available],-26322.0,Alive,,978.0,,,Distant Metastasis,Liver,,342.0,[Discrepancy],,,0.0,978.0,0.0,978.0,,,1.0,342.0,
TCGA-QT-A5XL,7745,TCGA-QT-A5XL,PCPG,27.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-10028.0,Alive,TUMOR FREE,55.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,55.0,0.0,55.0,0.0,55.0,0.0,55.0,
TCGA-CQ-5327,3380,TCGA-CQ-5327,HNSC,61.0,FEMALE,ASIAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-22307.0,Alive,TUMOR FREE,1660.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1660.0,0.0,1660.0,,,0.0,1660.0,
TCGA-ZB-A962,10447,TCGA-ZB-A962,THYM,64.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type A,[Not Available],2010.0,[Not Available],-23461.0,Alive,TUMOR FREE,1647.0,,[Not Available],Distant Metastasis,Liver,,1091.0,[Not Available],,,0.0,1647.0,0.0,1647.0,,,1.0,1091.0,
TCGA-D3-A2JA,8839,TCGA-D3-A2JA,SKCM,68.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2003.0,[Not Available],-25085.0,Alive,TUMOR FREE,3514.0,,[Not Available],Regional lymph node,,,40.0,[Not Available],,,0.0,3514.0,0.0,3514.0,,,1.0,40.0,
TCGA-EE-A3J5,9078,TCGA-EE-A3J5,SKCM,71.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2000.0,[Not Available],-26226.0,Dead,WITH TUMOR,,1124.0,[Not Available],Locoregional Recurrence,,,467.0,[Not Available],,,1.0,1124.0,1.0,1124.0,,,1.0,467.0,
TCGA-G3-A5SI,5713,TCGA-G3-A5SI,LIHC,44.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-16126.0,Dead,WITH TUMOR,,768.0,[Not Available],Intrahepatic Recurrence,Liver,,348.0,[Not Available],,R0,1.0,768.0,1.0,768.0,1.0,348.0,1.0,348.0,
TCGA-X6-A8C3,8787,TCGA-X6-A8C3,SARC,59.0,FEMALE,ASIAN,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2013.0,[Not Available],-21751.0,Alive,TUMOR FREE,583.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,583.0,0.0,583.0,,,0.0,583.0,
TCGA-XN-A8T5,7683,TCGA-XN-A8T5,PAAD,53.0,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2012.0,[Not Available],-19707.0,Alive,WITH TUMOR,720.0,,,Distant Metastasis,Liver,,242.0,Progressive Disease,,,0.0,720.0,0.0,720.0,,,1.0,242.0,
TCGA-51-4081,6500,TCGA-51-4081,LUSC,55.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-20261.0,Alive,TUMOR FREE,911.0,,[Not Available],,,,,[Not Available],,,0.0,911.0,0.0,911.0,,,0.0,911.0,
TCGA-2G-AAGJ,9742,TCGA-2G-AAGJ,TGCT,28.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,Stage IA,Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS,[Not Available],2006.0,[Not Available],-10348.0,Alive,TUMOR FREE,2938.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,171.0,Complete Remission/Response,,,0.0,2938.0,0.0,2938.0,1.0,171.0,1.0,171.0,
TCGA-E1-A7Z2,5091,TCGA-E1-A7Z2,LGG,58.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-21341.0,Dead,WITH TUMOR,,398.0,[Not Available],,,,213.0,Progressive Disease,,,1.0,398.0,1.0,398.0,,,1.0,213.0,
TCGA-LL-A5YN,1536,TCGA-LL-A5YN,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16884.0,Alive,TUMOR FREE,447.0,,[Not Available],,,,,[Not Available],Negative,,0.0,447.0,0.0,447.0,0.0,447.0,0.0,447.0,
TCGA-PJ-A8JU,4666,TCGA-PJ-A8JU,KIRP,81.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-29830.0,Alive,TUMOR FREE,380.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,380.0,0.0,380.0,0.0,380.0,0.0,380.0,
TCGA-W5-AA38,1938,TCGA-W5-AA38,CHOL,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2011.0,[Not Available],-20285.0,Alive,TUMOR FREE,1471.0,,[Not Available],Locoregional Recurrence,Liver,,377.0,[Not Available],,R0,0.0,1471.0,0.0,1471.0,1.0,377.0,1.0,377.0,
TCGA-BJ-A0ZH,9858,TCGA-BJ-A0ZH,THCA,52.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-19114.0,Alive,TUMOR FREE,460.0,,[Not Available],,,,,[Not Available],,RX,0.0,460.0,0.0,460.0,,,0.0,460.0,
TCGA-CN-4739,3317,TCGA-CN-4739,HNSC,71.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-26081.0,Dead,WITH TUMOR,,1394.0,[Not Available],Locoregional Recurrence,Oropharynx,"OROPHARYNX, OVERLAPPING",1302.0,Complete Remission/Response,,,1.0,1394.0,1.0,1394.0,,,1.0,1302.0,
TCGA-A3-3376,3921,TCGA-A3-3376,KIRC,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-18954.0,Dead,TUMOR FREE,,1696.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1696.0,0.0,1696.0,0.0,1696.0,0.0,1696.0,
TCGA-OL-A5RX,1559,TCGA-OL-A5RX,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18942.0,Alive,TUMOR FREE,878.0,,[Not Available],,,,,[Not Available],Negative,,0.0,878.0,0.0,878.0,0.0,878.0,0.0,878.0,
TCGA-22-4613,6381,TCGA-22-4613,LUSC,73.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-26722.0,Dead,,358.0,358.0,[Not Available],,,,,[Not Available],,,1.0,358.0,,358.0,,,0.0,358.0,
TCGA-XF-AAN4,464,TCGA-XF-AAN4,BLCA,77.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-28302.0,Dead,TUMOR FREE,,823.0,[Not Available],,,,,Complete Remission/Response,,,1.0,823.0,0.0,823.0,0.0,823.0,0.0,823.0,
TCGA-FW-A3I3,9180,TCGA-FW-A3I3,SKCM,59.0,FEMALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2011.0,[Not Available],-21731.0,Alive,TUMOR FREE,531.0,,[Not Available],,,,,[Not Available],,,0.0,531.0,0.0,531.0,,,0.0,531.0,
TCGA-XF-A9SX,437,TCGA-XF-A9SX,BLCA,63.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-23349.0,Dead,WITH TUMOR,,719.0,[Not Available],Distant Metastasis,Lung,,475.0,Progressive Disease,,,1.0,719.0,1.0,719.0,,,1.0,475.0,
TCGA-DX-A6YQ,8613,TCGA-DX-A6YQ,SARC,86.0,FEMALE,[Unknown],[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2011.0,[Not Available],-31421.0,Dead,TUMOR FREE,,93.0,[Not Available],,,,,[Not Available],Negative,R0,1.0,93.0,0.0,93.0,0.0,93.0,0.0,93.0,
TCGA-BG-A0W2,10762,TCGA-BG-A0W2,UCEC,57.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20998.0,Alive,TUMOR FREE,1721.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1721.0,0.0,1721.0,0.0,1721.0,0.0,1721.0,
TCGA-XK-AAK1,8310,TCGA-XK-AAK1,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22965.0,Alive,TUMOR FREE,979.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,979.0,0.0,979.0,0.0,979.0,0.0,979.0,
TCGA-FS-A1Z0,9146,TCGA-FS-A1Z0,SKCM,32.0,FEMALE,WHITE,Stage IA,[Not Applicable],,[Not Available],1990.0,[Not Available],-11815.0,Dead,WITH TUMOR,,6164.0,[Not Available],Distant Metastasis,Lung,,5503.0,[Not Available],,,1.0,6164.0,1.0,6164.0,,,1.0,5503.0,
TCGA-DD-A1EI,5533,TCGA-DD-A1EI,LIHC,46.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-17097.0,Alive,TUMOR FREE,183.0,,[Not Available],,,,,[Not Available],,R0,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,
TCGA-C4-A0F7,149,TCGA-C4-A0F7,BLCA,77.0,MALE,[Not Available],Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-28428.0,Dead,WITH TUMOR,,62.0,[Not Available],,,,,[Not Available],,,1.0,62.0,1.0,62.0,,,1.0,62.0,Redacted
TCGA-BT-A42C,142,TCGA-BT-A42C,BLCA,64.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-23584.0,Alive,TUMOR FREE,873.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,873.0,0.0,873.0,0.0,873.0,0.0,873.0,
TCGA-CM-6676,2290,TCGA-CM-6676,COAD,82.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-30223.0,Alive,TUMOR FREE,337.0,,[Not Available],,,,,[Not Available],,,0.0,337.0,0.0,337.0,,,0.0,337.0,
TCGA-EL-A4KI,10119,TCGA-EL-A4KI,THCA,63.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-23182.0,Alive,WITH TUMOR,727.0,,[Not Available],Distant Metastasis,Lung,,265.0,[Not Available],,R0,0.0,727.0,0.0,727.0,1.0,265.0,1.0,265.0,
TCGA-55-A48X,6047,TCGA-55-A48X,LUAD,63.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-23341.0,Alive,TUMOR FREE,689.0,,[Not Available],New Primary Tumor,,,615.0,Complete Remission/Response,,,0.0,689.0,0.0,689.0,0.0,689.0,1.0,615.0,
TCGA-D1-A17M,10867,TCGA-D1-A17M,UCEC,56.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20685.0,Alive,TUMOR FREE,311.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,311.0,0.0,311.0,0.0,311.0,0.0,311.0,
TCGA-KL-8333,3780,TCGA-KL-8333,KICH,69.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-25229.0,Alive,TUMOR FREE,2991.0,,[Not Available],,,,,[Unknown],,,0.0,2991.0,0.0,2991.0,,,0.0,2991.0,
TCGA-IQ-A61L,3688,TCGA-IQ-A61L,HNSC,72.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-26506.0,Alive,WITH TUMOR,416.0,,[Not Available],Locoregional Recurrence,Oral Cavity,,156.0,Progressive Disease,,,0.0,416.0,0.0,416.0,,,1.0,156.0,
TCGA-L3-A4E7,6796,TCGA-L3-A4E7,LUSC,71.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-26232.0,Alive,TUMOR FREE,392.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,392.0,0.0,392.0,0.0,392.0,0.0,392.0,
TCGA-SN-A84Y,9789,TCGA-SN-A84Y,TGCT,18.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma,[Not Available],2013.0,[Not Available],-6805.0,Alive,WITH TUMOR,524.0,,[Not Applicable],Distant Metastasis,"Other, specify",bone,44.0,Progressive Disease,,,0.0,524.0,0.0,524.0,,,1.0,44.0,
TCGA-A6-6653,2002,TCGA-A6-6653,COAD,82.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-29996.0,Alive,TUMOR FREE,742.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,742.0,0.0,742.0,0.0,742.0,0.0,742.0,
TCGA-ZF-AA56,500,TCGA-ZF-AA56,BLCA,79.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-28937.0,Dead,WITH TUMOR,,259.0,[Not Available],Distant Metastasis,Liver,,248.0,Progressive Disease,,,1.0,259.0,1.0,259.0,,,1.0,248.0,
TCGA-BR-A4IZ,9399,TCGA-BR-A4IZ,STAD,45.0,FEMALE,ASIAN,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-16695.0,Dead,TUMOR FREE,,273.0,[Not Available],,,,,Progressive Disease,,,1.0,273.0,0.0,273.0,,,0.0,273.0,
TCGA-LL-A73Y,1542,TCGA-LL-A73Y,BRCA,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24647.0,Alive,TUMOR FREE,477.0,,[Not Available],,,,,[Not Available],Negative,,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,
TCGA-D7-A4YT,9512,TCGA-D7-A4YT,STAD,56.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,[Not Available],-20742.0,Alive,TUMOR FREE,434.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,434.0,0.0,434.0,0.0,434.0,0.0,434.0,
TCGA-2J-AAB8,7506,TCGA-2J-AAB8,PAAD,71.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,[Not Available],-26028.0,Alive,TUMOR FREE,80.0,,,,,,,[Unknown],,,0.0,80.0,0.0,80.0,,,0.0,80.0,
TCGA-94-8035,6769,TCGA-94-8035,LUSC,64.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-23399.0,Alive,TUMOR FREE,122.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,122.0,0.0,122.0,0.0,122.0,0.0,122.0,
TCGA-D8-A1XW,1276,TCGA-D8-A1XW,BRCA,53.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19478.0,Alive,TUMOR FREE,1309.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1309.0,0.0,1309.0,0.0,1309.0,0.0,1309.0,
TCGA-HC-A6AL,8111,TCGA-HC-A6AL,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-23618.0,Alive,TUMOR FREE,67.0,,[Not Available],,,,,[Unknown],,,0.0,67.0,0.0,67.0,,,0.0,67.0,
TCGA-97-A4M5,6269,TCGA-97-A4M5,LUAD,83.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-30665.0,Alive,TUMOR FREE,634.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,634.0,0.0,634.0,0.0,634.0,0.0,634.0,
TCGA-74-6584,3210,TCGA-74-6584,GBM,55.0,FEMALE,[Not Available],[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-20232.0,Alive,WITH TUMOR,228.0,,[Not Available],,[Not Applicable],[Not Applicable],91.0,[Not Available],,,0.0,228.0,0.0,228.0,,,1.0,91.0,
TCGA-WK-A8XQ,8772,TCGA-WK-A8XQ,SARC,57.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2009.0,[Not Available],-20891.0,Dead,WITH TUMOR,,146.0,[Not Available],Locoregional Recurrence,"Other, specify",Abdominal/retroperitoneal,27.0,[Not Available],Positive,R2,1.0,146.0,1.0,146.0,,,1.0,27.0,
TCGA-ED-A459,5665,TCGA-ED-A459,LIHC,47.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-17402.0,Alive,TUMOR FREE,910.0,,[Not Available],,,,,[Not Available],,R0,0.0,910.0,0.0,910.0,0.0,910.0,0.0,910.0,
TCGA-51-4079,6498,TCGA-51-4079,LUSC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-26899.0,Dead,,,12.0,[Not Available],,,,,[Not Available],,,1.0,12.0,,12.0,,,0.0,12.0,
TCGA-DV-5567,4396,TCGA-DV-5567,KIRC,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2008.0,[Not Available],-14642.0,Alive,WITH TUMOR,2004.0,,[Not Available],,,,2004.0,Complete Remission/Response,,,0.0,2004.0,0.0,2004.0,1.0,2004.0,1.0,2004.0,
TCGA-QT-A5XP,7749,TCGA-QT-A5XP,PCPG,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-21072.0,Alive,TUMOR FREE,134.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,134.0,0.0,134.0,0.0,134.0,0.0,134.0,
TCGA-YL-A9WK,8339,TCGA-YL-A9WK,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-23272.0,Alive,WITH TUMOR,2136.0,,[Not Available],Biochemical evidence of disease,,,1009.0,Stable Disease,,,0.0,2136.0,0.0,2136.0,,,1.0,1009.0,
TCGA-KK-A5A1,8177,TCGA-KK-A5A1,PRAD,72.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2003.0,[Not Available],-26415.0,Dead,,,2469.0,[Not Available],Locoregional Recurrence,,,203.0,Partial Remission/Response,,,1.0,2469.0,,2469.0,,,1.0,203.0,
TCGA-2A-A8VO,7868,TCGA-2A-A8VO,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-20958.0,Alive,TUMOR FREE,1701.0,,[Not Available],,,,,[Not Available],,,0.0,1701.0,0.0,1701.0,,,0.0,1701.0,
TCGA-44-6776,5879,TCGA-44-6776,LUAD,60.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-22150.0,Alive,TUMOR FREE,2616.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2616.0,0.0,2616.0,0.0,2616.0,0.0,2616.0,
TCGA-EL-A4KH,10118,TCGA-EL-A4KH,THCA,36.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-13275.0,Alive,TUMOR FREE,823.0,,[Not Available],,,,,[Not Available],,R0,0.0,823.0,0.0,823.0,0.0,823.0,0.0,823.0,
TCGA-77-8130,6676,TCGA-77-8130,LUSC,69.0,MALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-25260.0,Alive,TUMOR FREE,4765.0,,[Not Available],New Primary Tumor,,,4471.0,Complete Remission/Response,,,0.0,4765.0,0.0,4765.0,0.0,4765.0,1.0,4471.0,
TCGA-50-7109,5959,TCGA-50-7109,LUAD,60.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-21979.0,Dead,WITH TUMOR,,308.0,[Not Available],Distant Metastasis,,,15.0,Progressive Disease,,,1.0,308.0,1.0,308.0,,,1.0,15.0,
TCGA-C5-A1MJ,1626,TCGA-C5-A1MJ,CESC,61.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Type of Adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22308.0,Dead,TUMOR FREE,,14.0,,,,,,[Not Available],,,1.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-28-2499,3146,TCGA-28-2499,GBM,59.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-21838.0,,,95.0,,[Not Available],,,,,[Not Available],,,0.0,95.0,,95.0,,,0.0,95.0,
TCGA-CJ-4643,4276,TCGA-CJ-4643,KIRC,67.0,FEMALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-24477.0,Alive,TUMOR FREE,1793.0,,[Not Available],,,,,[Not Available],,,0.0,1793.0,0.0,1793.0,,,0.0,1793.0,
TCGA-CV-7180,3531,TCGA-CV-7180,HNSC,34.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1996.0,[Not Available],-12523.0,Dead,WITH TUMOR,,327.0,[Not Available],,,,,[Not Available],,,1.0,327.0,1.0,327.0,,,1.0,327.0,
TCGA-2G-AAFL,9722,TCGA-2G-AAFL,TGCT,35.0,MALE,WHITE,Stage IB,Stage IB,Non-Seminoma; Embryonal Carcinoma,[Not Available],2013.0,[Not Available],-12898.0,Alive,TUMOR FREE,750.0,,[Not Applicable],New Primary Tumor,Testes,,38.0,Complete Remission/Response,,,0.0,750.0,0.0,750.0,1.0,38.0,1.0,38.0,
TCGA-5U-AB0F,10382,TCGA-5U-AB0F,THYM,58.0,FEMALE,WHITE,[Not Applicable],III,Thymoma; Type AB,[Not Available],2013.0,[Not Available],-21511.0,Alive,TUMOR FREE,459.0,,[Not Available],,,,,[Not Available],,,0.0,459.0,0.0,459.0,,,0.0,459.0,
TCGA-XE-A8H1,9806,TCGA-XE-A8H1,TGCT,24.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma,[Not Available],2009.0,[Not Available],-8893.0,Alive,TUMOR FREE,209.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,209.0,0.0,209.0,0.0,209.0,0.0,209.0,
TCGA-A3-3320,3893,TCGA-A3-3320,KIRC,52.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2005.0,[Not Available],-19138.0,Alive,TUMOR FREE,1508.0,,[Not Available],,,,,[Not Available],,,0.0,1508.0,0.0,1508.0,,,0.0,1508.0,
TCGA-V1-A8WV,8246,TCGA-V1-A8WV,PRAD,52.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-19345.0,Alive,,686.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,686.0,0.0,686.0,0.0,686.0,0.0,686.0,
TCGA-AO-A12E,879,TCGA-AO-A12E,BRCA,51.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18721.0,Alive,TUMOR FREE,2142.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2142.0,0.0,2142.0,0.0,2142.0,0.0,2142.0,
TCGA-OR-A5LB,65,TCGA-OR-A5LB,ACC,59.0,MALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2006.0,[Not Available],-21565.0,Dead,WITH TUMOR,,1204.0,[Not Available],Distant Metastasis,Liver,,611.0,Progressive Disease,,,1.0,1204.0,1.0,1204.0,,,1.0,611.0,
TCGA-BQ-7044,4555,TCGA-BQ-7044,KIRP,73.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2000.0,[Not Available],-26831.0,Alive,TUMOR FREE,3760.0,,[Not Available],,,,,[Not Available],,,0.0,3760.0,0.0,3760.0,,,0.0,3760.0,
TCGA-76-6656,3228,TCGA-76-6656,GBM,66.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-24265.0,Dead,,147.0,147.0,[Not Available],,,,,[Not Available],,,1.0,147.0,,147.0,,,0.0,147.0,
TCGA-E2-A1BD,1358,TCGA-E2-A1BD,BRCA,53.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19627.0,Alive,TUMOR FREE,1133.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0,
TCGA-DD-A113,5514,TCGA-DD-A113,LIHC,55.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2006.0,[Not Available],-20188.0,Alive,WITH TUMOR,2425.0,,[Not Available],Intrahepatic Recurrence,Liver,,1676.0,[Not Available],,R0,0.0,2425.0,0.0,2425.0,1.0,1676.0,1.0,1676.0,
TCGA-3S-A8YW,10358,TCGA-3S-A8YW,THYM,63.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type C,[Not Available],2013.0,[Not Available],-23053.0,Alive,TUMOR FREE,643.0,,[Not Available],New Primary Tumor,"Other, specify",Skin (cheek),224.0,[Not Available],,,0.0,643.0,0.0,643.0,,,1.0,224.0,
TCGA-D1-A0ZU,10821,TCGA-D1-A0ZU,UCEC,34.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12458.0,Alive,TUMOR FREE,872.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,872.0,0.0,872.0,0.0,872.0,0.0,872.0,
TCGA-PC-A5DM,8737,TCGA-PC-A5DM,SARC,73.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2005.0,[Not Available],-26699.0,Dead,,,193.0,[Not Available],,,,,[Not Available],Positive,R1,1.0,193.0,,193.0,,,0.0,193.0,
TCGA-C8-A274,1214,TCGA-C8-A274,BRCA,63.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23337.0,Alive,TUMOR FREE,508.0,,[Not Available],,,,,[Not Available],Negative,,0.0,508.0,0.0,508.0,0.0,508.0,0.0,508.0,
TCGA-2Y-A9H2,5437,TCGA-2Y-A9H2,LIHC,64.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-23653.0,Alive,TUMOR FREE,1731.0,,[Not Available],,,,,[Not Available],,R0,0.0,1731.0,0.0,1731.0,0.0,1731.0,0.0,1731.0,
TCGA-B1-5398,4504,TCGA-B1-5398,KIRP,73.0,MALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-26820.0,Alive,TUMOR FREE,1251.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1251.0,0.0,1251.0,0.0,1251.0,0.0,1251.0,
TCGA-W5-AA34,1936,TCGA-W5-AA34,CHOL,75.0,FEMALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2012.0,[Not Available],-27535.0,Dead,WITH TUMOR,,555.0,[Not Available],Intrahepatic Recurrence,Liver,,40.0,[Not Available],,R0,1.0,555.0,1.0,555.0,1.0,40.0,1.0,40.0,
TCGA-55-7574,5997,TCGA-55-7574,LUAD,64.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23703.0,Dead,WITH TUMOR,,995.0,[Not Available],Distant Metastasis,,,478.0,Complete Remission/Response,,,1.0,995.0,1.0,995.0,1.0,478.0,1.0,478.0,
TCGA-E2-A15L,1344,TCGA-E2-A15L,BRCA,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23845.0,Alive,TUMOR FREE,626.0,,[Not Available],,,,,[Not Available],Negative,,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,
TCGA-HC-A8D0,8122,TCGA-HC-A8D0,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22465.0,Alive,TUMOR FREE,775.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,
TCGA-OR-A5JH,17,TCGA-OR-A5JH,ACC,32.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical Carcinoma- Oncocytic Type,[Not Available],2008.0,[Not Available],-11994.0,Alive,TUMOR FREE,2110.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2110.0,0.0,2110.0,0.0,2110.0,0.0,2110.0,
TCGA-B3-A6W5,4518,TCGA-B3-A6W5,KIRP,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-15945.0,Alive,TUMOR FREE,309.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,309.0,0.0,309.0,0.0,309.0,0.0,309.0,
TCGA-E1-A7YJ,5079,TCGA-E1-A7YJ,LGG,55.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-20180.0,Dead,WITH TUMOR,,592.0,[Not Available],,,,516.0,Stable Disease,,,1.0,592.0,1.0,592.0,,,1.0,516.0,
TCGA-94-A5I4,6773,TCGA-94-A5I4,LUSC,61.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-22299.0,Alive,WITH TUMOR,491.0,,[Not Available],Distant Metastasis,,,314.0,Complete Remission/Response,,,0.0,491.0,0.0,491.0,1.0,314.0,1.0,314.0,
TCGA-CV-5978,3488,TCGA-CV-5978,HNSC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Stage IVB,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-19480.0,Dead,WITH TUMOR,215.0,215.0,[Not Available],,,,,[Not Available],,,1.0,215.0,1.0,215.0,,,1.0,215.0,
TCGA-OR-A5L1,56,TCGA-OR-A5L1,ACC,37.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-13840.0,Alive,WITH TUMOR,1781.0,,[Not Available],Distant Metastasis,Bone,,685.0,Complete Remission/Response,,,0.0,1781.0,0.0,1781.0,1.0,685.0,1.0,685.0,
TCGA-CV-5979,3489,TCGA-CV-5979,HNSC,26.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-9567.0,Alive,TUMOR FREE,1315.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1315.0,0.0,1315.0,,,0.0,1315.0,
TCGA-QR-A6ZZ,7713,TCGA-QR-A6ZZ,PCPG,30.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-11075.0,Alive,TUMOR FREE,48.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,48.0,0.0,48.0,0.0,48.0,0.0,48.0,
TCGA-DX-A3U7,8585,TCGA-DX-A3U7,SARC,67.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2009.0,[Not Available],-24723.0,Dead,WITH TUMOR,,1552.0,[Not Available],Distant Metastasis,Lung,,349.0,[Not Available],Negative,R0,1.0,1552.0,1.0,1552.0,1.0,349.0,1.0,349.0,
TCGA-FV-A495,5696,TCGA-FV-A495,LIHC,51.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-18740.0,Alive,TUMOR FREE,1.0,,[Not Available],,,,,[Not Available],,R0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,
TCGA-DU-5851,4982,TCGA-DU-5851,LGG,40.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2010.0,[Not Available],-14802.0,Alive,WITH TUMOR,531.0,,[Not Available],,,,,Stable Disease,,,0.0,531.0,0.0,531.0,,,0.0,531.0,
TCGA-KK-A6E1,8180,TCGA-KK-A6E1,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-21063.0,Alive,TUMOR FREE,2198.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2198.0,0.0,2198.0,0.0,2198.0,0.0,2198.0,
TCGA-DD-A4NP,5565,TCGA-DD-A4NP,LIHC,32.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2005.0,[Not Available],-11838.0,Alive,TUMOR FREE,3308.0,,[Not Available],Intrahepatic Recurrence,Liver,,1286.0,[Not Available],,R0,0.0,3308.0,0.0,3308.0,1.0,1286.0,1.0,1286.0,
TCGA-FS-A1ZT,9166,TCGA-FS-A1ZT,SKCM,55.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2005.0,[Not Available],-20284.0,Alive,TUMOR FREE,1617.0,,[Not Available],,,,,[Not Available],,,0.0,1617.0,0.0,1617.0,,,0.0,1617.0,
TCGA-86-6562,6178,TCGA-86-6562,LUAD,52.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-19301.0,Dead,WITH TUMOR,,376.0,[Not Available],,,,274.0,Progressive Disease,,,1.0,376.0,1.0,376.0,,,1.0,274.0,
TCGA-J9-A52B,8153,TCGA-J9-A52B,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22849.0,Alive,,422.0,,[Not Available],Biochemical evidence of disease,,,57.0,Complete Remission/Response,,,0.0,422.0,0.0,422.0,1.0,57.0,1.0,57.0,
TCGA-CQ-7063,3398,TCGA-CQ-7063,HNSC,59.0,FEMALE,WHITE,Stage I,[Not Available],Head & Neck Squamous Cell Carcinoma,G1,2008.0,[Not Available],-21723.0,Alive,TUMOR FREE,2133.0,,[Not Available],Locoregional Disease,Oral Cavity,left oral tongue,1160.0,Complete Remission/Response,,,0.0,2133.0,0.0,2133.0,1.0,1160.0,1.0,1160.0,
TCGA-A2-A0SU,571,TCGA-A2-A0SU,BRCA,66.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24219.0,Alive,TUMOR FREE,1662.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1662.0,0.0,1662.0,0.0,1662.0,0.0,1662.0,
TCGA-ET-A3BU,10236,TCGA-ET-A3BU,THCA,28.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-10510.0,Alive,TUMOR FREE,2367.0,,[Not Available],,,,,[Not Available],,R0,0.0,2367.0,0.0,2367.0,0.0,2367.0,0.0,2367.0,
TCGA-HC-7747,8084,TCGA-HC-7747,PRAD,52.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19188.0,Alive,TUMOR FREE,748.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,748.0,0.0,748.0,0.0,748.0,0.0,748.0,
TCGA-UY-A78N,405,TCGA-UY-A78N,BLCA,80.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-29132.0,Dead,WITH TUMOR,,2641.0,[Not Available],Distant Metastasis,Renal Pelvis,,2472.0,Complete Remission/Response,,,1.0,2641.0,1.0,2641.0,,,1.0,2472.0,
TCGA-BH-A0BC,1041,TCGA-BH-A0BC,BRCA,60.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21949.0,Alive,TUMOR FREE,974.0,,[Not Available],,,,,[Not Available],Negative,,0.0,974.0,0.0,974.0,0.0,974.0,0.0,974.0,
TCGA-68-8250,6651,TCGA-68-8250,LUSC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-24118.0,Alive,TUMOR FREE,244.0,,[Not Available],,,,,[Not Available],,,0.0,244.0,0.0,244.0,,,0.0,244.0,
TCGA-PZ-A5RE,7663,TCGA-PZ-A5RE,PAAD,44.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,[Not Available],-16255.0,Dead,WITH TUMOR,,470.0,Pancreatic Cancer,Distant Metastasis,Liver,,393.0,[Unknown],,,1.0,470.0,1.0,470.0,,,1.0,393.0,
TCGA-05-4417,5820,TCGA-05-4417,LUAD,51.0,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-18780.0,Alive,TUMOR FREE,455.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,455.0,0.0,455.0,,,0.0,455.0,
TCGA-N9-A4Q3,11058,TCGA-N9-A4Q3,UCS,65.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24031.0,Alive,WITH TUMOR,1672.0,,[Not Available],Distant Metastasis,Lung,,735.0,Complete Remission/Response,,,0.0,1672.0,0.0,1672.0,1.0,735.0,1.0,735.0,
TCGA-RW-A68B,7769,TCGA-RW-A68B,PCPG,31.0,MALE,[Not Evaluated],[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-11557.0,Alive,TUMOR FREE,727.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,727.0,0.0,727.0,0.0,727.0,0.0,727.0,
TCGA-TS-A7OY,6879,TCGA-TS-A7OY,MESO,62.0,MALE,WHITE,Stage IV,[Not Applicable],Epithelioid mesothelioma,[Not Available],2009.0,[Not Available],-22720.0,Dead,,,255.0,[Not Available],,,,,[Not Available],,[Unknown],1.0,255.0,,255.0,,,0.0,255.0,
TCGA-KK-A7AQ,8189,TCGA-KK-A7AQ,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-22731.0,Alive,TUMOR FREE,1610.0,,[Not Available],Biochemical evidence of disease,,,1217.0,Complete Remission/Response,,,0.0,1610.0,0.0,1610.0,1.0,1217.0,1.0,1217.0,
TCGA-EM-A4G1,10200,TCGA-EM-A4G1,THCA,26.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-9844.0,Alive,TUMOR FREE,416.0,,[Not Available],,,,,[Not Available],,R0,0.0,416.0,0.0,416.0,0.0,416.0,0.0,416.0,
TCGA-A4-A7UZ,4494,TCGA-A4-A7UZ,KIRP,71.0,MALE,WHITE,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-26264.0,Alive,,0.0,,[Not Available],,,,,[Not Applicable],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-EM-A3FR,10177,TCGA-EM-A3FR,THCA,55.0,FEMALE,[Not Available],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-20349.0,Alive,TUMOR FREE,457.0,,[Not Available],,,,,[Not Available],,R0,0.0,457.0,0.0,457.0,0.0,457.0,0.0,457.0,
TCGA-AL-7173,4501,TCGA-AL-7173,KIRP,72.0,FEMALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-26326.0,Alive,WITH TUMOR,2060.0,,[Not Available],,,,332.0,Progressive Disease,,,0.0,2060.0,0.0,2060.0,,,1.0,332.0,
TCGA-DX-A8BT,8646,TCGA-DX-A8BT,SARC,63.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2011.0,[Not Available],-23204.0,Alive,TUMOR FREE,1230.0,,[Not Available],Locoregional Recurrence,"Other, specify",Axilla,668.0,[Not Available],Positive,R1,0.0,1230.0,0.0,1230.0,,,1.0,668.0,
TCGA-LD-A74U,1526,TCGA-LD-A74U,BRCA,79.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Other, specify",[Not Available],2013.0,[Not Available],-28981.0,Alive,WITH TUMOR,402.0,,[Not Available],,,,,[Not Available],Negative,,0.0,402.0,0.0,402.0,0.0,402.0,0.0,402.0,
TCGA-B5-A3S1,10730,TCGA-B5-A3S1,UCEC,71.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26031.0,Alive,WITH TUMOR,902.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,902.0,0.0,902.0,0.0,902.0,0.0,902.0,
TCGA-V1-A9ZG,8263,TCGA-V1-A9ZG,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-23725.0,Alive,TUMOR FREE,1517.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1517.0,0.0,1517.0,0.0,1517.0,0.0,1517.0,
TCGA-NJ-A4YF,6314,TCGA-NJ-A4YF,LUAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-18584.0,Alive,TUMOR FREE,2161.0,,[Not Available],,,,,Stable Disease,,,0.0,2161.0,0.0,2161.0,,,0.0,2161.0,
TCGA-YZ-A984,11159,TCGA-YZ-A984,UVM,50.0,FEMALE,WHITE,Stage IIB,Stage IIIA,Spindle Cell|Epithelioid Cell,[Not Available],2011.0,[Not Available],-18342.0,Dead,WITH TUMOR,,1396.0,Metastatic Uveal Melanoma,New Primary Tumor,"Other, specify",Thyroid,154.0,[Not Available],,,1.0,1396.0,1.0,1396.0,,,1.0,154.0,
TCGA-AX-A3G6,10669,TCGA-AX-A3G6,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G2,2010.0,[Not Available],-24681.0,Alive,,8.0,,[Not Available],,,,,[Not Available],,,0.0,8.0,0.0,8.0,,,0.0,8.0,
TCGA-BH-A0RX,1108,TCGA-BH-A0RX,BRCA,59.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21857.0,Alive,TUMOR FREE,170.0,,[Not Available],,,,,[Not Available],Negative,,0.0,170.0,0.0,170.0,0.0,170.0,0.0,170.0,
TCGA-VN-A88P,8273,TCGA-VN-A88P,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21916.0,Alive,TUMOR FREE,1260.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1260.0,0.0,1260.0,0.0,1260.0,0.0,1260.0,
TCGA-39-5037,6466,TCGA-39-5037,LUSC,65.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-23868.0,Alive,TUMOR FREE,1690.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1690.0,0.0,1690.0,0.0,1690.0,0.0,1690.0,
TCGA-DJ-A2PX,9950,TCGA-DJ-A2PX,THCA,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-20088.0,Alive,TUMOR FREE,881.0,,[Not Available],,,,,[Not Available],,R0,0.0,881.0,0.0,881.0,0.0,881.0,0.0,881.0,
TCGA-G9-6367,8034,TCGA-G9-6367,PRAD,60.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-22176.0,Alive,WITH TUMOR,1222.0,,[Not Available],,,,,Progressive Disease,,,0.0,1222.0,0.0,1222.0,,,0.0,1222.0,
TCGA-13-2071,7110,TCGA-13-2071,OV,63.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-23367.0,Dead,WITH TUMOR,,773.0,[Not Available],,[Not Applicable],[Not Applicable],322.0,Complete Remission/Response,,,1.0,773.0,1.0,773.0,,,1.0,322.0,
TCGA-P8-A5KC,7690,TCGA-P8-A5KC,PCPG,48.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-17790.0,Alive,TUMOR FREE,883.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,883.0,0.0,883.0,0.0,883.0,0.0,883.0,
TCGA-A3-3362,3913,TCGA-A3-3362,KIRC,60.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-21988.0,Alive,TUMOR FREE,1559.0,,[Not Available],,,,,[Not Available],,,0.0,1559.0,0.0,1559.0,,,0.0,1559.0,
TCGA-02-0047,2671,TCGA-02-0047,GBM,78.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-28759.0,Dead,WITH TUMOR,448.0,448.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],57.0,[Not Available],,,1.0,448.0,1.0,448.0,,,1.0,57.0,
TCGA-HV-A5A6,7583,TCGA-HV-A5A6,PAAD,65.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2001.0,[Not Available],-24025.0,Dead,WITH TUMOR,,2036.0,Other malignancy,Distant Metastasis,Lung,,1511.0,Complete Remission/Response,,,1.0,2036.0,0.0,2036.0,1.0,1511.0,1.0,1511.0,
TCGA-75-6207,6133,TCGA-75-6207,LUAD,,MALE,[Not Available],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],,Dead,,,,[Not Available],,,,,Complete Remission/Response,,,1.0,,,,0.0,,0.0,,
TCGA-EI-6508,8507,TCGA-EI-6508,READ,48.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-17827.0,Alive,TUMOR FREE,636.0,,[Not Available],,,,,[Not Available],,,0.0,636.0,0.0,636.0,,,0.0,636.0,
TCGA-VS-A8EH,1839,TCGA-VS-A8EH,CESC,56.0,FEMALE,[Unknown],[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2012.0,Peri (6-12 months since last menstrual period),-20728.0,Alive,TUMOR FREE,986.0,,,,,,,Complete Remission/Response,,,0.0,986.0,0.0,986.0,0.0,986.0,0.0,986.0,
TCGA-D1-A0ZV,10822,TCGA-D1-A0ZV,UCEC,58.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21374.0,Alive,TUMOR FREE,728.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,728.0,0.0,728.0,0.0,728.0,0.0,728.0,
TCGA-86-6851,6179,TCGA-86-6851,LUAD,73.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26808.0,Alive,TUMOR FREE,179.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,179.0,0.0,179.0,0.0,179.0,0.0,179.0,
TCGA-AX-A2HJ,10656,TCGA-AX-A2HJ,UCEC,35.0,FEMALE,ASIAN,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009.0,[Not Available],-13112.0,Alive,TUMOR FREE,935.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,935.0,0.0,935.0,0.0,935.0,0.0,935.0,
TCGA-WE-A8JZ,9235,TCGA-WE-A8JZ,SKCM,70.0,MALE,[Not Evaluated],Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-25884.0,Alive,TUMOR FREE,731.0,,[Not Available],,,,,[Not Available],,,0.0,731.0,0.0,731.0,,,0.0,731.0,
TCGA-06-6701,2887,TCGA-06-6701,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-22051.0,Alive,WITH TUMOR,151.0,,[Not Available],,,,,[Not Available],,,0.0,151.0,0.0,151.0,,,0.0,151.0,
TCGA-FK-A4UB,10278,TCGA-FK-A4UB,THCA,51.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005.0,[Not Available],-18792.0,Alive,TUMOR FREE,3531.0,,[Not Available],,,,,[Not Available],,R1,0.0,3531.0,0.0,3531.0,,,0.0,3531.0,
TCGA-41-2572,3193,TCGA-41-2572,GBM,67.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-24505.0,Dead,WITH TUMOR,406.0,406.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],122.0,[Not Available],,,1.0,406.0,1.0,406.0,,,1.0,122.0,
TCGA-A2-A0YI,590,TCGA-A2-A0YI,BRCA,62.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22961.0,Alive,TUMOR FREE,1505.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1505.0,0.0,1505.0,0.0,1505.0,0.0,1505.0,
TCGA-2X-A9D5,9775,TCGA-2X-A9D5,TGCT,49.0,MALE,WHITE,Stage I,Stage II,Seminoma; NOS,[Not Available],2013.0,[Not Available],-17969.0,Alive,TUMOR FREE,435.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,435.0,0.0,435.0,0.0,435.0,0.0,435.0,
TCGA-RW-A7CZ,7774,TCGA-RW-A7CZ,PCPG,72.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2013.0,[Not Available],-26657.0,Alive,TUMOR FREE,422.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,422.0,0.0,422.0,0.0,422.0,0.0,422.0,
TCGA-EI-7002,8520,TCGA-EI-7002,READ,58.0,MALE,WHITE,Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-21192.0,Alive,TUMOR FREE,364.0,,[Not Available],,,,,[Not Available],,,0.0,364.0,0.0,364.0,,,0.0,364.0,
TCGA-FB-AAPZ,7564,TCGA-FB-AAPZ,PAAD,54.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2008.0,[Not Available],-19847.0,Alive,TUMOR FREE,716.0,,,Distant Metastasis,"Other, specify",Adrenal and right buttock,716.0,Complete Remission/Response,,,0.0,716.0,0.0,716.0,1.0,716.0,1.0,716.0,
TCGA-06-0119,2739,TCGA-06-0119,GBM,81.0,FEMALE,WHITE,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2005.0,[Not Available],-29606.0,Dead,WITH TUMOR,,82.0,[Not Available],,,,,[Not Available],,,1.0,82.0,1.0,82.0,,,1.0,82.0,
TCGA-62-8398,6061,TCGA-62-8398,LUAD,55.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-20197.0,Dead,TUMOR FREE,,444.0,[Not Available],,,,,Complete Remission/Response,,,1.0,444.0,0.0,444.0,0.0,444.0,0.0,444.0,
TCGA-B9-7268,4527,TCGA-B9-7268,KIRP,59.0,MALE,WHITE,Stage II,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-21705.0,Alive,TUMOR FREE,671.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,671.0,0.0,671.0,0.0,671.0,0.0,671.0,
TCGA-75-6212,6135,TCGA-75-6212,LUAD,,FEMALE,[Not Available],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],,[Not Available],,Dead,WITH TUMOR,,1516.0,[Not Available],New Primary Tumor,,,1340.0,Complete Remission/Response,,,1.0,1516.0,1.0,1516.0,0.0,1516.0,1.0,1340.0,
TCGA-K4-A4AB,375,TCGA-K4-A4AB,BLCA,76.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27922.0,Alive,,84.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,84.0,0.0,84.0,,,0.0,84.0,
TCGA-2H-A9GH,2463,TCGA-2H-A9GH,ESCA,44.0,MALE,[Unknown],Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,1998.0,[Not Available],-16197.0,Dead,WITH TUMOR,,951.0,[Not Available],Locoregional Recurrence,,,800.0,,,,1.0,951.0,1.0,951.0,,,1.0,800.0,
TCGA-HZ-A8P0,7615,TCGA-HZ-A8P0,PAAD,76.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,[Not Available],-27850.0,Alive,TUMOR FREE,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-44-3919,5867,TCGA-44-3919,LUAD,71.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-26081.0,Dead,WITH TUMOR,,1026.0,[Not Available],Locoregional Recurrence,,,921.0,Complete Remission/Response,,,1.0,1026.0,1.0,1026.0,1.0,921.0,1.0,921.0,
TCGA-44-4112,5868,TCGA-44-4112,LUAD,60.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-22106.0,Dead,WITH TUMOR,,808.0,[Not Available],,,,619.0,Complete Remission/Response,,,1.0,808.0,1.0,808.0,1.0,619.0,1.0,619.0,
TCGA-EE-A3J3,9076,TCGA-EE-A3J3,SKCM,42.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],1986.0,[Not Available],-15446.0,Dead,WITH TUMOR,,5237.0,[Not Available],Regional lymph node,,,4523.0,[Not Available],,,1.0,5237.0,1.0,5237.0,,,1.0,4523.0,
TCGA-LN-A49P,2563,TCGA-LN-A49P,ESCA,71.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2011.0,[Not Available],-26189.0,Alive,WITH TUMOR,375.0,,[Not Available],Locoregional Recurrence,,,320.0,Complete Remission/Response,,,0.0,375.0,0.0,375.0,1.0,320.0,1.0,320.0,
TCGA-4V-A9QQ,10366,TCGA-4V-A9QQ,THYM,65.0,FEMALE,WHITE,[Not Applicable],IVa,Thymoma; Type B3,[Not Available],2010.0,[Not Available],-23894.0,Alive,WITH TUMOR,1572.0,,[Not Available],Locoregional Recurrence,Pleura/Pleural effusion,,782.0,[Not Available],,,0.0,1572.0,0.0,1572.0,,,1.0,782.0,
TCGA-4X-A9FA,10374,TCGA-4X-A9FA,THYM,52.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type A,[Not Available],2013.0,[Not Available],-19032.0,Alive,TUMOR FREE,392.0,,[Not Available],,,,,[Not Available],,,0.0,392.0,0.0,392.0,,,0.0,392.0,
TCGA-AJ-A3OL,10552,TCGA-AJ-A3OL,UCEC,55.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20115.0,Dead,WITH TUMOR,,449.0,[Not Available],Distant Metastasis,"Other, specify","Lung, Liver, and Brain",424.0,Complete Remission/Response,,,1.0,449.0,1.0,449.0,1.0,424.0,1.0,424.0,
TCGA-EJ-7786,7964,TCGA-EJ-7786,PRAD,62.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22793.0,Alive,TUMOR FREE,1096.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,
TCGA-F5-6814,8529,TCGA-F5-6814,READ,57.0,MALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-20828.0,Alive,TUMOR FREE,1131.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1131.0,0.0,1131.0,0.0,1131.0,0.0,1131.0,
TCGA-DA-A3F5,8930,TCGA-DA-A3F5,SKCM,45.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1994.0,[Not Available],-16701.0,Dead,WITH TUMOR,,6873.0,[Not Available],Distant Metastasis,Lung,,6841.0,[Not Available],,,1.0,6873.0,1.0,6873.0,,,1.0,6841.0,
TCGA-AJ-A3BG,10535,TCGA-AJ-A3BG,UCEC,65.0,FEMALE,WHITE,[Not Applicable],Stage IA,Mixed serous and endometrioid,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23861.0,Alive,WITH TUMOR,550.0,,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,480.0,Complete Remission/Response,,,0.0,550.0,0.0,550.0,1.0,480.0,1.0,480.0,
TCGA-AP-A1DP,10597,TCGA-AP-A1DP,UCEC,70.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25601.0,Dead,WITH TUMOR,,1081.0,[Not Available],Metastatic,"Other, specify","Lung, liver, lymph nodes",831.0,Complete Remission/Response,,,1.0,1081.0,1.0,1081.0,1.0,831.0,1.0,831.0,
TCGA-4Z-AA81,108,TCGA-4Z-AA81,BLCA,80.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-29457.0,Dead,TUMOR FREE,,1270.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1270.0,0.0,1270.0,0.0,1270.0,0.0,1270.0,
TCGA-AP-A0LL,10584,TCGA-AP-A0LL,UCEC,56.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20700.0,Alive,TUMOR FREE,2554.0,,[Not Available],,,,790.0,Complete Remission/Response,,,0.0,2554.0,0.0,2554.0,1.0,790.0,1.0,790.0,
TCGA-EJ-A8FS,8003,TCGA-EJ-A8FS,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-24380.0,Alive,TUMOR FREE,266.0,,[Not Available],Biochemical evidence of disease,,,216.0,Complete Remission/Response,,,0.0,266.0,0.0,266.0,1.0,216.0,1.0,216.0,
TCGA-ER-A196,9090,TCGA-ER-A196,SKCM,64.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2007.0,[Not Available],-23533.0,Alive,TUMOR FREE,1785.0,,[Not Available],,,,,[Not Available],,,0.0,1785.0,0.0,1785.0,,,0.0,1785.0,
TCGA-BR-8682,9384,TCGA-BR-8682,STAD,52.0,MALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012.0,[Not Available],-19165.0,Alive,TUMOR FREE,991.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,991.0,0.0,991.0,0.0,991.0,0.0,991.0,
TCGA-W5-AA36,1937,TCGA-W5-AA36,CHOL,51.0,FEMALE,WHITE,Stage IV,[Not Applicable],Cholangiocarcinoma; hilar/perihilar,G3,2008.0,[Not Available],-18882.0,Dead,WITH TUMOR,,1402.0,[Not Available],Intrahepatic Recurrence,Liver,,362.0,[Not Available],,R0,1.0,1402.0,1.0,1402.0,,,1.0,362.0,
TCGA-55-6969,5976,TCGA-55-6969,LUAD,52.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],-19270.0,Alive,TUMOR FREE,1239.0,,[Not Available],,,,,[Not Available],,,0.0,1239.0,0.0,1239.0,,,0.0,1239.0,
TCGA-D7-6527,9497,TCGA-D7-6527,STAD,62.0,MALE,WHITE,Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2010.0,[Not Available],-22793.0,Dead,WITH TUMOR,,312.0,[Not Available],Distant Metastasis,Liver,,75.0,Progressive Disease,,,1.0,312.0,1.0,312.0,,,1.0,75.0,
TCGA-DY-A1DG,8501,TCGA-DY-A1DG,READ,75.0,MALE,WHITE,Stage IVA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2000.0,[Not Available],-27396.0,Dead,,,1566.0,[Not Available],,,,592.0,[Not Available],,,1.0,1566.0,,1566.0,,,1.0,592.0,
TCGA-78-7535,6162,TCGA-78-7535,LUAD,45.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2000.0,[Not Available],-16571.0,Dead,WITH TUMOR,,949.0,[Not Available],,,,809.0,Stable Disease,,,1.0,949.0,1.0,949.0,,,1.0,809.0,
TCGA-50-5931,5941,TCGA-50-5931,LUAD,75.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-27733.0,Dead,WITH TUMOR,,434.0,[Not Available],Distant Metastasis,,,425.0,Progressive Disease,,,1.0,434.0,1.0,434.0,,,1.0,425.0,
TCGA-BH-A0BA,1040,TCGA-BH-A0BA,BRCA,51.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Mixed Histology (please specify),[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18839.0,Alive,TUMOR FREE,1132.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1132.0,0.0,1132.0,0.0,1132.0,0.0,1132.0,
TCGA-DO-A2HM,10013,TCGA-DO-A2HM,THCA,49.0,MALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18068.0,Alive,TUMOR FREE,71.0,,[Not Available],,,,,[Not Available],,RX,0.0,71.0,0.0,71.0,,,0.0,71.0,
TCGA-GS-A9TW,2451,TCGA-GS-A9TW,DLBC,23.0,FEMALE,WHITE,[Not Applicable],Stage II,Primary mediastinal (thymic) DLBCL,[Not Available],2010.0,[Not Available],-8493.0,Alive,TUMOR FREE,1617.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1617.0,0.0,1617.0,0.0,1617.0,0.0,1617.0,
TCGA-E1-A7Z6,5094,TCGA-E1-A7Z6,LGG,41.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2009.0,[Not Available],-14985.0,Dead,WITH TUMOR,,984.0,[Not Available],,,,294.0,Progressive Disease,,,1.0,984.0,1.0,984.0,,,1.0,294.0,
TCGA-YG-AA3N,9262,TCGA-YG-AA3N,SKCM,67.0,MALE,[Unknown],Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-24525.0,Alive,TUMOR FREE,306.0,,[Not Available],,,,,[Not Available],,,0.0,306.0,0.0,306.0,,,0.0,306.0,
TCGA-E1-A7YM,5082,TCGA-E1-A7YM,LGG,63.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-23263.0,Dead,WITH TUMOR,,648.0,[Not Available],,,,88.0,Progressive Disease,,,1.0,648.0,1.0,648.0,,,1.0,88.0,
TCGA-73-4658,6113,TCGA-73-4658,LUAD,80.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],-29508.0,Dead,TUMOR FREE,1600.0,1600.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1600.0,0.0,1600.0,0.0,1600.0,0.0,1600.0,
TCGA-KK-A7AW,8192,TCGA-KK-A7AW,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-20869.0,Alive,TUMOR FREE,1054.0,,[Not Available],,,,,[Unknown],,,0.0,1054.0,0.0,1054.0,,,0.0,1054.0,
TCGA-VQ-A8PJ,9661,TCGA-VQ-A8PJ,STAD,53.0,MALE,[Unknown],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",GX,2011.0,[Not Available],-19390.0,Dead,WITH TUMOR,,82.0,Stomach Cancer,,,,,Progressive Disease,,,1.0,82.0,1.0,82.0,,,1.0,82.0,
TCGA-P7-A5NY,7689,TCGA-P7-A5NY,PCPG,21.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-7834.0,Alive,TUMOR FREE,957.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,957.0,0.0,957.0,0.0,957.0,0.0,957.0,
TCGA-E2-A1LG,1377,TCGA-E2-A1LG,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Peri (6-12 months since last menstrual period),-18492.0,Alive,TUMOR FREE,1523.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1523.0,0.0,1523.0,0.0,1523.0,0.0,1523.0,
TCGA-06-0152,2764,TCGA-06-0152,GBM,68.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1995.0,[Not Available],-24844.0,Dead,WITH TUMOR,359.0,375.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],299.0,[Not Available],,,1.0,375.0,1.0,375.0,,,1.0,299.0,
TCGA-56-A4BY,6542,TCGA-56-A4BY,LUSC,66.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24445.0,Dead,WITH TUMOR,,543.0,[Not Available],,,,,Complete Remission/Response,,,1.0,543.0,1.0,543.0,,,1.0,543.0,
TCGA-DS-A0VN,1681,TCGA-DS-A0VN,CESC,47.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17433.0,Alive,TUMOR FREE,3609.0,,,,,,,Complete Remission/Response,,,0.0,3609.0,0.0,3609.0,0.0,3609.0,0.0,3609.0,
TCGA-DD-AAVY,5659,TCGA-DD-AAVY,LIHC,56.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2009.0,[Not Available],-20709.0,Alive,TUMOR FREE,1970.0,,[Not Available],,,,,[Not Available],,R0,0.0,1970.0,0.0,1970.0,0.0,1970.0,0.0,1970.0,
TCGA-A5-A2K2,10515,TCGA-A5-A2K2,UCEC,77.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28456.0,Alive,TUMOR FREE,3595.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3595.0,0.0,3595.0,0.0,3595.0,0.0,3595.0,
TCGA-IN-A7NR,9604,TCGA-IN-A7NR,STAD,64.0,FEMALE,WHITE,Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,[Not Available],-23415.0,Alive,TUMOR FREE,198.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,198.0,0.0,198.0,,,0.0,198.0,
TCGA-DV-A4VZ,4404,TCGA-DV-A4VZ,KIRC,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-19560.0,Alive,TUMOR FREE,365.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,
TCGA-PK-A5H9,89,TCGA-PK-A5H9,ACC,27.0,FEMALE,ASIAN,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-10173.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,
TCGA-SR-A6MT,7808,TCGA-SR-A6MT,PCPG,57.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2004.0,[Not Available],-20944.0,Alive,TUMOR FREE,3247.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3247.0,0.0,3247.0,0.0,3247.0,0.0,3247.0,
TCGA-HZ-A9TJ,7617,TCGA-HZ-A9TJ,PAAD,70.0,MALE,WHITE,Stage IV,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2013.0,[Not Available],-25849.0,Alive,WITH TUMOR,603.0,,,Distant Metastasis,Peritoneal Surfaces,,555.0,[Unknown],,,0.0,603.0,0.0,603.0,,,1.0,555.0,
TCGA-28-5204,3153,TCGA-28-5204,GBM,72.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-26490.0,Dead,WITH TUMOR,,454.0,[Not Available],,,,,[Not Available],,,1.0,454.0,1.0,454.0,,,1.0,454.0,
TCGA-A4-8517,4482,TCGA-A4-8517,KIRP,71.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-26090.0,Alive,TUMOR FREE,597.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,597.0,0.0,597.0,0.0,597.0,0.0,597.0,
TCGA-B5-A11L,10700,TCGA-B5-A11L,UCEC,71.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26120.0,Dead,TUMOR FREE,,2240.0,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal Apex,131.0,Complete Remission/Response,,,1.0,2240.0,0.0,2240.0,1.0,131.0,1.0,131.0,
TCGA-66-2787,6638,TCGA-66-2787,LUSC,57.0,MALE,[Not Available],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-21124.0,Alive,TUMOR FREE,1217.0,,[Not Available],,,,,[Not Applicable],,,0.0,1217.0,0.0,1217.0,,,0.0,1217.0,
TCGA-EO-A3KU,10937,TCGA-EO-A3KU,UCEC,68.0,FEMALE,[Not Available],[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25116.0,Alive,TUMOR FREE,677.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,677.0,0.0,677.0,0.0,677.0,0.0,677.0,
TCGA-ET-A39P,10226,TCGA-ET-A39P,THCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-26817.0,Alive,TUMOR FREE,2900.0,,[Not Available],,,,,[Not Available],,R1,0.0,2900.0,0.0,2900.0,,,0.0,2900.0,
TCGA-FR-A44A,9132,TCGA-FR-A44A,SKCM,29.0,FEMALE,WHITE,Stage II,[Not Applicable],,[Not Available],1999.0,[Not Available],-10707.0,Alive,TUMOR FREE,5299.0,,[Not Available],,,,,[Not Available],,,0.0,5299.0,0.0,5299.0,,,0.0,5299.0,
TCGA-2Y-A9GW,5431,TCGA-2Y-A9GW,LIHC,64.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-23587.0,Dead,WITH TUMOR,,1271.0,[Not Available],Locoregional Recurrence,Liver,,1229.0,[Not Available],,R0,1.0,1271.0,1.0,1271.0,1.0,1229.0,1.0,1229.0,
TCGA-92-7340,6761,TCGA-92-7340,LUSC,45.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-16447.0,Alive,WITH TUMOR,82.0,,[Not Available],,,,,Stable Disease,,,0.0,82.0,0.0,82.0,,,0.0,82.0,
TCGA-ET-A2MY,10212,TCGA-ET-A2MY,THCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-26406.0,Alive,TUMOR FREE,1787.0,,[Not Available],,,,,[Not Available],,R0,0.0,1787.0,0.0,1787.0,0.0,1787.0,0.0,1787.0,
TCGA-ZJ-A8QO,1892,TCGA-ZJ-A8QO,CESC,73.0,FEMALE,[Unknown],[Not Available],[Not Available],Cervical Squamous Cell Carcinoma,[Not Available],2007.0,[Unknown],-26723.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-AN-A0XL,832,TCGA-AN-A0XL,BRCA,61.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22341.0,Alive,TUMOR FREE,163.0,,[Not Available],,,,,[Not Available],Negative,,0.0,163.0,0.0,163.0,0.0,163.0,0.0,163.0,
TCGA-BR-8485,9371,TCGA-BR-8485,STAD,68.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-24845.0,Alive,TUMOR FREE,280.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,280.0,0.0,280.0,0.0,280.0,0.0,280.0,
TCGA-IB-AAUP,7649,TCGA-IB-AAUP,PAAD,68.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-24864.0,Alive,TUMOR FREE,431.0,,,,,,,Complete Remission/Response,,,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,
TCGA-FG-8182,5114,TCGA-FG-8182,LGG,35.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-12972.0,Alive,WITH TUMOR,416.0,,[Not Available],,,,,Stable Disease,,,0.0,416.0,0.0,416.0,,,0.0,416.0,
TCGA-3C-AALK,508,TCGA-3C-AALK,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,[Unknown],-19074.0,Alive,TUMOR FREE,1448.0,,[Not Available],,,,,[Not Available],Close,,0.0,1448.0,0.0,1448.0,,,0.0,1448.0,
TCGA-C5-A8XH,1659,TCGA-C5-A8XH,CESC,39.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-14444.0,Dead,TUMOR FREE,,1394.0,,,,,,[Not Available],,,1.0,1394.0,0.0,1394.0,,,0.0,1394.0,
TCGA-FW-A5DX,9184,TCGA-FW-A5DX,SKCM,71.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-26056.0,Alive,TUMOR FREE,640.0,,[Not Available],,,,,[Not Available],,,0.0,640.0,0.0,640.0,,,0.0,640.0,
TCGA-S3-A6ZH,1584,TCGA-S3-A6ZH,BRCA,29.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,[Unknown],-10832.0,Alive,TUMOR FREE,641.0,,[Not Available],,,,,[Not Available],Negative,,0.0,641.0,0.0,641.0,0.0,641.0,0.0,641.0,
TCGA-55-7903,6006,TCGA-55-7903,LUAD,64.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23509.0,Alive,TUMOR FREE,567.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,
TCGA-BR-8291,9347,TCGA-BR-8291,STAD,61.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",GX,2011.0,[Not Available],-22552.0,Dead,TUMOR FREE,,607.0,[Not Available],,,,,Complete Remission/Response,,,1.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,
TCGA-98-A538,6786,TCGA-98-A538,LUSC,67.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24698.0,Alive,TUMOR FREE,826.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,826.0,0.0,826.0,0.0,826.0,0.0,826.0,
TCGA-22-5474,6385,TCGA-22-5474,LUSC,74.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-27271.0,Dead,TUMOR FREE,445.0,445.0,[Not Available],,,,,Complete Remission/Response,,,1.0,445.0,0.0,445.0,0.0,445.0,0.0,445.0,
TCGA-46-3769,6495,TCGA-46-3769,LUSC,57.0,MALE,WHITE,[Discrepancy],[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-20941.0,Alive,TUMOR FREE,135.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,135.0,0.0,135.0,0.0,135.0,0.0,135.0,
TCGA-JY-A6FA,2495,TCGA-JY-A6FA,ESCA,51.0,MALE,ASIAN,Stage IIB,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2006.0,[Not Available],-18978.0,Dead,WITH TUMOR,,1361.0,[Not Available],Distant Metastasis,Lung,,477.0,,,,1.0,1361.0,1.0,1361.0,,,1.0,477.0,
TCGA-FD-A62N,291,TCGA-FD-A62N,BLCA,69.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-25297.0,Alive,TUMOR FREE,82.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,82.0,0.0,82.0,0.0,82.0,0.0,82.0,
TCGA-BP-4961,4199,TCGA-BP-4961,KIRC,47.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-17284.0,Alive,TUMOR FREE,1935.0,,[Not Available],,,,,[Not Available],,,0.0,1935.0,0.0,1935.0,,,0.0,1935.0,
TCGA-ZF-AA5H,502,TCGA-ZF-AA5H,BLCA,60.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-22122.0,Alive,WITH TUMOR,897.0,,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",peritoneum,177.0,Stable Disease,,,0.0,897.0,0.0,897.0,,,1.0,177.0,
TCGA-YF-AA3M,472,TCGA-YF-AA3M,BLCA,57.0,MALE,[Unknown],Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-21097.0,Alive,WITH TUMOR,415.0,,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Pelvis,381.0,Complete Remission/Response,,,0.0,415.0,0.0,415.0,1.0,381.0,1.0,381.0,
TCGA-MQ-A4LP,6858,TCGA-MQ-A4LP,MESO,67.0,MALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2000.0,[Not Available],-24652.0,Dead,,,527.0,[Not Available],,,,,[Not Available],,[Unknown],1.0,527.0,,527.0,,,0.0,527.0,
TCGA-KC-A4BV,8166,TCGA-KC-A4BV,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-24138.0,Alive,WITH TUMOR,1328.0,,[Not Available],Biochemical evidence of disease,,,1328.0,Complete Remission/Response,,,0.0,1328.0,0.0,1328.0,1.0,1328.0,1.0,1328.0,
TCGA-A6-2684,1973,TCGA-A6-2684,COAD,75.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-27708.0,Alive,TUMOR FREE,1127.0,,[Not Available],Locoregional Disease,,,976.0,[Not Available],,,0.0,1127.0,0.0,1127.0,,,1.0,976.0,
TCGA-OL-A66N,1568,TCGA-OL-A66N,BRCA,59.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21608.0,Alive,TUMOR FREE,792.0,,[Not Available],,,,,[Not Available],Negative,,0.0,792.0,0.0,792.0,0.0,792.0,0.0,792.0,
TCGA-XD-AAUH,7679,TCGA-XD-AAUH,PAAD,57.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-20858.0,Alive,,395.0,,,New Primary Tumor,"Other, specify",Left shoulder,87.0,[Unknown],,,0.0,395.0,0.0,395.0,,,1.0,87.0,
TCGA-69-7761,6097,TCGA-69-7761,LUAD,84.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-31041.0,Alive,TUMOR FREE,186.0,,[Not Available],,,,,[Not Available],,,0.0,186.0,0.0,186.0,,,0.0,186.0,
TCGA-G9-6361,8028,TCGA-G9-6361,PRAD,61.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-22565.0,Alive,TUMOR FREE,1415.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1415.0,0.0,1415.0,0.0,1415.0,0.0,1415.0,
TCGA-EY-A1GC,10943,TCGA-EY-A1GC,UCEC,62.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22656.0,Alive,TUMOR FREE,1647.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1647.0,0.0,1647.0,0.0,1647.0,0.0,1647.0,
TCGA-KL-8341,3788,TCGA-KL-8341,KICH,41.0,MALE,ASIAN,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-15045.0,Dead,WITH TUMOR,,754.0,[Not Available],,,,175.0,[Unknown],,,1.0,754.0,1.0,754.0,,,1.0,175.0,
TCGA-DD-A1EJ,5534,TCGA-DD-A1EJ,LIHC,71.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-26009.0,Dead,WITH TUMOR,,1005.0,[Not Available],Intrahepatic Recurrence,Liver,,263.0,[Not Available],,R0,1.0,1005.0,1.0,1005.0,1.0,263.0,1.0,263.0,
TCGA-V4-A9F1,11110,TCGA-V4-A9F1,UVM,46.0,FEMALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell,[Not Available],2012.0,[Not Available],-16852.0,Alive,TUMOR FREE,938.0,,[Not Available],,,,,[Not Available],,,0.0,938.0,0.0,938.0,,,0.0,938.0,
TCGA-E1-A7YU,5087,TCGA-E1-A7YU,LGG,42.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,1996.0,[Not Available],-15345.0,Dead,WITH TUMOR,,23.0,[Not Available],,,,,[Unknown],,,1.0,23.0,1.0,23.0,,,1.0,23.0,
TCGA-55-A48Y,6048,TCGA-55-A48Y,LUAD,69.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-25384.0,Alive,TUMOR FREE,630.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,630.0,0.0,630.0,0.0,630.0,0.0,630.0,
TCGA-12-5295,2994,TCGA-12-5295,GBM,60.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-22161.0,Dead,WITH TUMOR,399.0,454.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],399.0,[Not Available],,,1.0,454.0,1.0,454.0,,,1.0,399.0,
TCGA-BK-A4ZD,10786,TCGA-BK-A4ZD,UCEC,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15536.0,Alive,TUMOR FREE,506.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,506.0,0.0,506.0,0.0,506.0,0.0,506.0,
TCGA-BC-A5W4,5472,TCGA-BC-A5W4,LIHC,69.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-25503.0,Dead,TUMOR FREE,,547.0,[Not Available],Locoregional Recurrence,,,384.0,[Not Available],,R1,1.0,547.0,0.0,547.0,,,1.0,384.0,
TCGA-90-7766,6754,TCGA-90-7766,LUSC,66.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-24354.0,Alive,WITH TUMOR,289.0,,[Not Available],Locoregional Recurrence,,,289.0,Progressive Disease,,,0.0,289.0,0.0,289.0,,,1.0,289.0,
TCGA-P7-A5NX,7688,TCGA-P7-A5NX,PCPG,78.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-28497.0,Alive,TUMOR FREE,818.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,818.0,0.0,818.0,0.0,818.0,0.0,818.0,
TCGA-A7-A425,655,TCGA-A7-A425,BRCA,70.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25678.0,Alive,WITH TUMOR,447.0,,[Not Available],Locoregional Recurrence,"Other, specify",Left Breast,419.0,[Not Available],Negative,,0.0,447.0,0.0,447.0,1.0,419.0,1.0,419.0,
TCGA-KS-A4IB,10340,TCGA-KS-A4IB,THCA,41.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-15157.0,Alive,TUMOR FREE,2577.0,,[Not Available],,,,,[Not Available],,R0,0.0,2577.0,0.0,2577.0,0.0,2577.0,0.0,2577.0,
TCGA-RW-A686,7765,TCGA-RW-A686,PCPG,62.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-22718.0,Alive,TUMOR FREE,587.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,587.0,0.0,587.0,0.0,587.0,0.0,587.0,
TCGA-80-5608,6175,TCGA-80-5608,LUAD,,FEMALE,[Not Available],Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],,[Not Available],,Alive,TUMOR FREE,2832.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2832.0,0.0,2832.0,0.0,2832.0,0.0,2832.0,
TCGA-2A-A8VV,7870,TCGA-2A-A8VV,PRAD,52.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-19065.0,Alive,TUMOR FREE,671.0,,[Not Available],,,,,[Not Available],,,0.0,671.0,0.0,671.0,,,0.0,671.0,
TCGA-YL-A8SR,8335,TCGA-YL-A8SR,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23488.0,Alive,,273.0,,[Not Available],,,,,Stable Disease,,,0.0,273.0,0.0,273.0,,,0.0,273.0,
TCGA-BS-A0WQ,10814,TCGA-BS-A0WQ,UCEC,55.0,FEMALE,ASIAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20131.0,Alive,TUMOR FREE,2022.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2022.0,0.0,2022.0,0.0,2022.0,0.0,2022.0,
TCGA-BH-A0DH,1064,TCGA-BH-A0DH,BRCA,63.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23366.0,Alive,TUMOR FREE,1156.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1156.0,0.0,1156.0,0.0,1156.0,0.0,1156.0,
TCGA-ZG-A9L9,8354,TCGA-ZG-A9L9,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22108.0,Alive,WITH TUMOR,617.0,,[Not Available],Biochemical evidence of disease,,,51.0,Progressive Disease,,,0.0,617.0,0.0,617.0,,,1.0,51.0,
TCGA-ER-A19J,9102,TCGA-ER-A19J,SKCM,54.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2004.0,[Not Available],-19733.0,Dead,WITH TUMOR,196.0,196.0,[Not Available],Distant Metastasis,Lung,,98.0,[Not Available],,,1.0,196.0,1.0,196.0,,,1.0,98.0,
TCGA-CS-6188,4923,TCGA-CS-6188,LGG,48.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-17729.0,Dead,WITH TUMOR,,814.0,[Not Available],,,,647.0,Progressive Disease,,,1.0,814.0,1.0,814.0,,,1.0,647.0,
TCGA-DJ-A4UQ,10003,TCGA-DJ-A4UQ,THCA,60.0,MALE,ASIAN,Stage IVA,[Not Applicable],"Other, specify",[Not Available],2012.0,[Not Available],-22097.0,Alive,WITH TUMOR,1005.0,,[Not Available],,,,,[Not Available],,R0,0.0,1005.0,0.0,1005.0,,,0.0,1005.0,
TCGA-DQ-5625,3631,TCGA-DQ-5625,HNSC,52.0,FEMALE,WHITE,[Not Available],Stage II,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-19211.0,Dead,TUMOR FREE,,1133.0,[Not Available],,Oral Cavity,,1058.0,Complete Remission/Response,,,1.0,1133.0,0.0,1133.0,1.0,1058.0,1.0,1058.0,
TCGA-EJ-7315,7950,TCGA-EJ-7315,PRAD,68.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25154.0,Alive,TUMOR FREE,1008.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1008.0,0.0,1008.0,0.0,1008.0,0.0,1008.0,
TCGA-HT-8105,5210,TCGA-HT-8105,LGG,54.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-20041.0,Alive,TUMOR FREE,190.0,,[Not Available],,,,,Stable Disease,,,0.0,190.0,0.0,190.0,,,0.0,190.0,
TCGA-OL-A5D7,1553,TCGA-OL-A5D7,BRCA,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25643.0,Alive,TUMOR FREE,1780.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1780.0,0.0,1780.0,0.0,1780.0,0.0,1780.0,
TCGA-2F-A9KP,94,TCGA-2F-A9KP,BLCA,66.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-24428.0,Dead,WITH TUMOR,,364.0,[Not Available],Distant Metastasis,Liver,,343.0,Progressive Disease,,,1.0,364.0,1.0,364.0,,,1.0,343.0,
TCGA-06-0195,2796,TCGA-06-0195,GBM,63.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1994.0,[Not Available],-23132.0,Dead,WITH TUMOR,214.0,225.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],147.0,[Not Available],,,1.0,225.0,1.0,225.0,,,1.0,147.0,
TCGA-66-2757,6618,TCGA-66-2757,LUSC,65.0,FEMALE,[Not Available],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-24014.0,Dead,WITH TUMOR,,1338.0,[Not Available],,,,912.0,[Not Applicable],,,1.0,1338.0,1.0,1338.0,,,1.0,912.0,
TCGA-5P-A9JV,4448,TCGA-5P-A9JV,KIRP,49.0,MALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2005.0,[Not Available],-17973.0,Alive,,2043.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2043.0,0.0,2043.0,0.0,2043.0,0.0,2043.0,
TCGA-D9-A3Z4,8906,TCGA-D9-A3Z4,SKCM,54.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-19749.0,Dead,WITH TUMOR,,519.0,[Not Available],Regional lymph node,"Other, Specify",lymph node,192.0,[Not Available],,,1.0,519.0,1.0,519.0,,,1.0,192.0,
TCGA-S3-AA0Z,1585,TCGA-S3-AA0Z,BRCA,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23314.0,Alive,TUMOR FREE,629.0,,[Not Available],,,,,[Not Available],Negative,,0.0,629.0,0.0,629.0,0.0,629.0,0.0,629.0,
TCGA-CN-A6V7,3375,TCGA-CN-A6V7,HNSC,40.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2013.0,[Not Available],-14895.0,Alive,TUMOR FREE,594.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,594.0,0.0,594.0,,,0.0,594.0,
TCGA-XU-A92R,10421,TCGA-XU-A92R,THYM,76.0,FEMALE,ASIAN,[Not Applicable],IVb,Thymoma; Type AB,[Not Available],2007.0,[Not Available],-27971.0,Alive,TUMOR FREE,2739.0,,[Not Available],,,,,[Not Available],,,0.0,2739.0,0.0,2739.0,,,0.0,2739.0,
TCGA-22-1012,6367,TCGA-22-1012,LUSC,80.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-29273.0,Dead,TUMOR FREE,,429.0,[Not Available],,,,,Complete Remission/Response,,,1.0,429.0,0.0,429.0,0.0,429.0,0.0,429.0,
TCGA-B8-5158,4102,TCGA-B8-5158,KIRC,56.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2010.0,[Not Available],-20764.0,Alive,TUMOR FREE,1218.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1218.0,0.0,1218.0,0.0,1218.0,0.0,1218.0,
TCGA-D1-A167,10836,TCGA-D1-A167,UCEC,70.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25575.0,Alive,TUMOR FREE,478.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,478.0,0.0,478.0,0.0,478.0,0.0,478.0,
TCGA-RW-A67W,7758,TCGA-RW-A67W,PCPG,46.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-16983.0,Alive,TUMOR FREE,604.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,604.0,0.0,604.0,0.0,604.0,0.0,604.0,
TCGA-3G-AB19,10356,TCGA-3G-AB19,THYM,76.0,FEMALE,WHITE,[Not Applicable],IIb,Thymoma; Type A,[Not Available],2006.0,[Not Available],-27827.0,Dead,TUMOR FREE,,2910.0,[Not Available],New Primary Tumor,Lung,,2420.0,[Not Available],,,1.0,2910.0,0.0,2910.0,,,1.0,2420.0,
TCGA-FB-AAPU,7562,TCGA-FB-AAPU,PAAD,41.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,[Not Available],-15129.0,Dead,WITH TUMOR,,381.0,Pancreatic Cancer,,,,,Progressive Disease,,,1.0,381.0,1.0,381.0,,,1.0,381.0,
TCGA-X4-A8KQ,8291,TCGA-X4-A8KQ,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-23999.0,Alive,WITH TUMOR,1383.0,,[Not Available],,,,,Progressive Disease,,,0.0,1383.0,0.0,1383.0,,,0.0,1383.0,
TCGA-BQ-5886,4546,TCGA-BQ-5886,KIRP,75.0,MALE,WHITE,Stage III,[Discrepancy],Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-27670.0,Alive,TUMOR FREE,792.0,,[Not Available],,,,,[Not Available],,,0.0,792.0,0.0,792.0,,,0.0,792.0,
TCGA-CF-A3MH,155,TCGA-CF-A3MH,BLCA,75.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,[Not Available],-27458.0,Alive,TUMOR FREE,398.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,
TCGA-CS-6668,4928,TCGA-CS-6668,LGG,57.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-20836.0,Alive,WITH TUMOR,1519.0,,[Not Available],,,,,Stable Disease,,,0.0,1519.0,0.0,1519.0,,,0.0,1519.0,
TCGA-HT-A619,5235,TCGA-HT-A619,LGG,51.0,FEMALE,ASIAN,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-18857.0,Alive,TUMOR FREE,651.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,651.0,0.0,651.0,0.0,651.0,0.0,651.0,
TCGA-E9-A249,1439,TCGA-E9-A249,BRCA,45.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16689.0,Alive,TUMOR FREE,217.0,,[Not Available],,,,,[Not Available],Negative,,0.0,217.0,0.0,217.0,0.0,217.0,0.0,217.0,
TCGA-2Y-A9GZ,5434,TCGA-2Y-A9GZ,LIHC,82.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-30082.0,Dead,WITH TUMOR,,848.0,[Not Available],Locoregional Recurrence,Liver,,719.0,[Not Available],,R0,1.0,848.0,1.0,848.0,1.0,719.0,1.0,719.0,
TCGA-DX-A7ES,8631,TCGA-DX-A7ES,SARC,50.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2013.0,[Not Available],-18528.0,Alive,TUMOR FREE,610.0,,[Not Available],,,,,[Not Available],Positive,R0,0.0,610.0,0.0,610.0,0.0,610.0,0.0,610.0,
TCGA-CI-6622,8476,TCGA-CI-6622,READ,74.0,MALE,WHITE,Stage IIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-27336.0,Alive,TUMOR FREE,1362.0,,[Not Available],,,,,[Unknown],,,0.0,1362.0,0.0,1362.0,,,0.0,1362.0,
TCGA-CV-7242,3536,TCGA-CV-7242,HNSC,60.0,FEMALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-22136.0,Alive,TUMOR FREE,1095.0,,[Not Available],,,,,[Not Available],,,0.0,1095.0,0.0,1095.0,,,0.0,1095.0,
TCGA-DU-6403,5001,TCGA-DU-6403,LGG,60.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,1999.0,[Not Available],-22031.0,Dead,WITH TUMOR,,354.0,[Not Available],,,,,[Not Available],,,1.0,354.0,1.0,354.0,,,1.0,354.0,
TCGA-Z2-A8RT,9265,TCGA-Z2-A8RT,SKCM,42.0,FEMALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-15342.0,Alive,TUMOR FREE,839.0,,[Not Available],,,,,[Not Available],,,0.0,839.0,0.0,839.0,,,0.0,839.0,
TCGA-KP-A3W0,11003,TCGA-KP-A3W0,UCEC,72.0,FEMALE,[Not Evaluated],[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26378.0,Alive,TUMOR FREE,404.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,404.0,0.0,404.0,0.0,404.0,0.0,404.0,
TCGA-D3-A3ML,8862,TCGA-D3-A3ML,SKCM,70.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2003.0,[Not Available],-25643.0,Dead,WITH TUMOR,,422.0,[Not Available],Regional lymph node,,,32.0,[Not Available],,,1.0,422.0,1.0,422.0,,,1.0,32.0,
TCGA-DB-A64X,4959,TCGA-DB-A64X,LGG,56.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-20625.0,Alive,TUMOR FREE,563.0,,[Not Available],,,,,Stable Disease,,,0.0,563.0,0.0,563.0,,,0.0,563.0,
TCGA-EM-A22M,10134,TCGA-EM-A22M,THCA,52.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19059.0,Alive,TUMOR FREE,442.0,,[Not Available],,,,,[Not Available],,R0,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,
TCGA-IA-A83W,4633,TCGA-IA-A83W,KIRP,70.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2003.0,[Not Available],-25678.0,Dead,TUMOR FREE,,2043.0,[Not Available],,,,1408.0,Complete Remission/Response,,,1.0,2043.0,0.0,2043.0,1.0,1408.0,1.0,1408.0,
TCGA-IB-A5SS,7640,TCGA-IB-A5SS,PAAD,64.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-23431.0,Dead,WITH TUMOR,,460.0,Pancreatic Cancer,Distant Metastasis,Liver,,66.0,Complete Remission/Response,,,1.0,460.0,1.0,460.0,1.0,66.0,1.0,66.0,
TCGA-IM-A4EB,10318,TCGA-IM-A4EB,THCA,37.0,MALE,WHITE,Stage I,[Not Applicable],"Other, specify",[Not Available],2012.0,[Not Available],-13635.0,Alive,TUMOR FREE,780.0,,[Not Available],,,,,[Not Available],,R0,0.0,780.0,0.0,780.0,0.0,780.0,0.0,780.0,
TCGA-BM-6198,8472,TCGA-BM-6198,READ,73.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-26837.0,Alive,TUMOR FREE,646.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,646.0,0.0,646.0,0.0,646.0,0.0,646.0,
TCGA-F7-8489,3646,TCGA-F7-8489,HNSC,48.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-17873.0,Alive,TUMOR FREE,658.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,
TCGA-ED-A8O6,5678,TCGA-ED-A8O6,LIHC,50.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-18572.0,Dead,TUMOR FREE,,56.0,[Not Available],,,,,[Not Available],,R0,1.0,56.0,0.0,56.0,0.0,56.0,0.0,56.0,
TCGA-EO-A22S,10923,TCGA-EO-A22S,UCEC,58.0,FEMALE,[Not Available],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21328.0,Alive,TUMOR FREE,1872.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1872.0,0.0,1872.0,0.0,1872.0,0.0,1872.0,
TCGA-D1-A16N,10846,TCGA-D1-A16N,UCEC,51.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Peri (6-12 months since last menstrual period),-18787.0,Alive,TUMOR FREE,945.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,945.0,0.0,945.0,0.0,945.0,0.0,945.0,
TCGA-EW-A6SD,1497,TCGA-EW-A6SD,BRCA,32.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,[Not Available],-12006.0,Alive,TUMOR FREE,1010.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1010.0,0.0,1010.0,0.0,1010.0,0.0,1010.0,
TCGA-LL-A6FP,1539,TCGA-LL-A6FP,BRCA,90.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873.0,Alive,TUMOR FREE,677.0,,[Not Available],,,,,[Not Available],Negative,,0.0,677.0,0.0,677.0,0.0,677.0,0.0,677.0,
TCGA-SJ-A6ZI,11020,TCGA-SJ-A6ZI,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2013.0,[Unknown],-23653.0,Alive,TUMOR FREE,631.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,631.0,0.0,631.0,0.0,631.0,0.0,631.0,
TCGA-DJ-A2QB,9964,TCGA-DJ-A2QB,THCA,53.0,FEMALE,ASIAN,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-19601.0,Alive,TUMOR FREE,1070.0,,[Not Available],,,,,[Not Available],,R0,0.0,1070.0,0.0,1070.0,,,0.0,1070.0,
TCGA-CV-6938,3499,TCGA-CV-6938,HNSC,87.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1996.0,[Not Available],-31825.0,Dead,TUMOR FREE,,144.0,[Not Available],,,,,[Not Available],,,1.0,144.0,0.0,144.0,,,0.0,144.0,
TCGA-CX-7082,3605,TCGA-CX-7082,HNSC,82.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-30174.0,Dead,TUMOR FREE,,11.0,[Not Available],,,,,Complete Remission/Response,,,1.0,11.0,0.0,11.0,,,0.0,11.0,
TCGA-X7-A8D9,10387,TCGA-X7-A8D9,THYM,,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2006.0,[Not Available],,Alive,TUMOR FREE,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-HT-7471,5144,TCGA-HT-7471,LGG,37.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2010.0,[Not Available],-13564.0,Alive,TUMOR FREE,4.0,,[Not Available],,,,,[Not Available],,,0.0,4.0,0.0,4.0,,,0.0,4.0,
TCGA-D7-8572,9505,TCGA-D7-8572,STAD,57.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-20870.0,Alive,WITH TUMOR,511.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,511.0,0.0,511.0,0.0,511.0,0.0,511.0,
TCGA-EJ-7325,7954,TCGA-EJ-7325,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23029.0,Alive,TUMOR FREE,1070.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1070.0,0.0,1070.0,0.0,1070.0,0.0,1070.0,
TCGA-19-A60I,3099,TCGA-19-A60I,GBM,39.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2012.0,[Not Available],-14437.0,Alive,WITH TUMOR,541.0,,[Not Available],,,,,Stable Disease,,,0.0,541.0,0.0,541.0,,,0.0,541.0,
TCGA-HT-7856,5188,TCGA-HT-7856,LGG,35.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2008.0,[Not Available],-13145.0,Alive,TUMOR FREE,1189.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0,
TCGA-EL-A3CT,10047,TCGA-EL-A3CT,THCA,78.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-28597.0,Dead,,,1854.0,[Not Available],,,,,[Not Available],,R0,1.0,1854.0,,1854.0,,,0.0,1854.0,
TCGA-55-7816,6005,TCGA-55-7816,LUAD,49.0,FEMALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-18170.0,Dead,WITH TUMOR,,468.0,[Not Available],,,,,Progressive Disease,,,1.0,468.0,1.0,468.0,,,1.0,468.0,
TCGA-G3-A7M8,5722,TCGA-G3-A7M8,LIHC,31.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-11527.0,Alive,TUMOR FREE,430.0,,[Not Available],,,,,[Not Available],,RX,0.0,430.0,0.0,430.0,,,0.0,430.0,
TCGA-B6-A0RH,989,TCGA-B6-A0RH,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1991.0,Indeterminate (neither Pre or Postmenopausal),-18759.0,Dead,TUMOR FREE,,6456.0,[Not Available],Locoregional Disease,"Other, specify",Chest Wall,2165.0,[Not Available],Negative,,1.0,6456.0,0.0,6456.0,1.0,2165.0,1.0,2165.0,
TCGA-VS-A952,1856,TCGA-VS-A952,CESC,66.0,FEMALE,WHITE,[Not Available],Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24345.0,Alive,TUMOR FREE,1778.0,,,,,,,Complete Remission/Response,,,0.0,1778.0,0.0,1778.0,0.0,1778.0,0.0,1778.0,
TCGA-06-2565,2858,TCGA-06-2565,GBM,59.0,MALE,ASIAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-21559.0,Dead,WITH TUMOR,,506.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],178.0,[Not Available],,,1.0,506.0,1.0,506.0,,,1.0,178.0,
TCGA-G3-A3CK,5712,TCGA-G3-A3CK,LIHC,61.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-22462.0,Alive,TUMOR FREE,585.0,,[Not Available],,,,,[Not Available],,R0,0.0,585.0,0.0,585.0,0.0,585.0,0.0,585.0,
TCGA-W3-AA21,9234,TCGA-W3-AA21,SKCM,26.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1994.0,[Not Available],-9527.0,Dead,WITH TUMOR,,3195.0,[Not Available],Distant Metastasis,"Other, Specify",Chest,2952.0,[Not Available],,,1.0,3195.0,1.0,3195.0,,,1.0,2952.0,
TCGA-27-1838,3125,TCGA-27-1838,GBM,59.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-21706.0,Dead,WITH TUMOR,350.0,350.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],119.0,[Not Available],,,1.0,350.0,1.0,350.0,,,1.0,119.0,
TCGA-CS-6186,4922,TCGA-CS-6186,LGG,58.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2009.0,[Not Available],-21321.0,Dead,WITH TUMOR,,538.0,[Not Available],,,,188.0,Progressive Disease,,,1.0,538.0,1.0,538.0,,,1.0,188.0,
TCGA-DU-7298,5024,TCGA-DU-7298,LGG,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Astrocytoma,G3,2006.0,[Not Available],-14205.0,Dead,WITH TUMOR,,576.0,[Not Available],,,,200.0,Progressive Disease,,,1.0,576.0,1.0,576.0,,,1.0,200.0,
TCGA-3A-A9J0,7542,TCGA-3A-A9J0,PAAD,75.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-27453.0,Alive,WITH TUMOR,743.0,,,Distant Metastasis,Lung,,363.0,Progressive Disease,,,0.0,743.0,0.0,743.0,,,1.0,363.0,
TCGA-BR-A4J9,9407,TCGA-BR-A4J9,STAD,55.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-20093.0,Alive,TUMOR FREE,14.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,14.0,0.0,14.0,0.0,14.0,0.0,14.0,
TCGA-LN-A4A4,2574,TCGA-LN-A4A4,ESCA,36.0,MALE,ASIAN,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,GX,2011.0,[Not Available],-13419.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-HZ-A4BK,7611,TCGA-HZ-A4BK,PAAD,72.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2012.0,[Not Available],-26503.0,Alive,WITH TUMOR,657.0,,,,,,,Progressive Disease,,,0.0,657.0,0.0,657.0,,,0.0,657.0,
TCGA-66-2727,6609,TCGA-66-2727,LUSC,55.0,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-20150.0,Dead,,,516.0,[Not Available],,,,,[Not Available],,,1.0,516.0,,516.0,,,0.0,516.0,
TCGA-P5-A5F6,5274,TCGA-P5-A5F6,LGG,26.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-9575.0,Alive,TUMOR FREE,39.0,,[Not Available],,,,,[Not Available],,,0.0,39.0,0.0,39.0,,,0.0,39.0,
TCGA-56-A4ZJ,6543,TCGA-56-A4ZJ,LUSC,75.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-27516.0,Alive,TUMOR FREE,640.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,640.0,0.0,640.0,0.0,640.0,0.0,640.0,
TCGA-BP-4974,4211,TCGA-BP-4974,KIRC,58.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-21310.0,Dead,WITH TUMOR,,211.0,[Not Available],,,,35.0,[Not Available],,,1.0,211.0,1.0,211.0,,,1.0,35.0,
TCGA-CR-6481,3430,TCGA-CR-6481,HNSC,47.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-17203.0,Alive,TUMOR FREE,311.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,311.0,0.0,311.0,,,0.0,311.0,
TCGA-DX-A8BN,8640,TCGA-DX-A8BN,SARC,78.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2011.0,[Not Available],-28760.0,Alive,TUMOR FREE,1161.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,1161.0,0.0,1161.0,,,0.0,1161.0,
TCGA-EE-A2GL,9037,TCGA-EE-A2GL,SKCM,40.0,FEMALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2006.0,[Not Available],-14701.0,Alive,WITH TUMOR,2423.0,,[Not Available],Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis,"Lung|Other, Specify|Bone|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify",[Not Applicable]|right anterior chest - skin and soft tissue|[Not Applicable]|LN left neck|left head - skin and soft tissue|spleen|left anterior chest - skin and soft tissue|LN right neck|right head - skin and soft tissue|LN left pelvic,2329.0,[Not Available],,,0.0,2423.0,0.0,2423.0,,,1.0,2329.0,
TCGA-A3-3378,3922,TCGA-A3-3378,KIRC,60.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-22090.0,Alive,TUMOR FREE,630.0,,[Not Available],,,,,[Not Available],,,0.0,630.0,0.0,630.0,,,0.0,630.0,
TCGA-93-A4JO,6232,TCGA-93-A4JO,LUAD,70.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-25898.0,Dead,TUMOR FREE,,33.0,[Not Available],,,,,[Not Applicable],,,1.0,33.0,0.0,33.0,,,0.0,33.0,
TCGA-EJ-7125,7946,TCGA-EJ-7125,PRAD,44.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2005.0,[Not Available],-16425.0,Alive,TUMOR FREE,2850.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2850.0,0.0,2850.0,0.0,2850.0,0.0,2850.0,
TCGA-EM-A2CP,10145,TCGA-EM-A2CP,THCA,26.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-9759.0,Alive,TUMOR FREE,91.0,,[Not Available],,,,,[Not Available],,R0,0.0,91.0,0.0,91.0,0.0,91.0,0.0,91.0,
TCGA-HT-8111,5216,TCGA-HT-8111,LGG,32.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-11810.0,Alive,,7.0,,[Not Available],,,,,[Not Available],,,0.0,7.0,0.0,7.0,,,0.0,7.0,
TCGA-A7-A6VV,667,TCGA-A7-A6VV,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Peri (6-12 months since last menstrual period),-18695.0,Alive,TUMOR FREE,313.0,,[Not Available],,,,,[Not Available],Negative,,0.0,313.0,0.0,313.0,0.0,313.0,0.0,313.0,
TCGA-BP-4177,4140,TCGA-BP-4177,KIRC,65.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-23955.0,Alive,TUMOR FREE,1670.0,,[Not Available],,,,,[Not Available],,,0.0,1670.0,0.0,1670.0,,,0.0,1670.0,
TCGA-KL-8340,3787,TCGA-KL-8340,KICH,34.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-12696.0,Alive,TUMOR FREE,2024.0,,[Not Available],,,,,[Unknown],,,0.0,2024.0,0.0,2024.0,,,0.0,2024.0,
TCGA-FP-7829,9538,TCGA-FP-7829,STAD,69.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2011.0,[Not Available],-25534.0,Alive,TUMOR FREE,594.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,
TCGA-FX-A3NJ,8676,TCGA-FX-A3NJ,SARC,54.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-19903.0,Alive,TUMOR FREE,947.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,947.0,0.0,947.0,0.0,947.0,0.0,947.0,
TCGA-19-2620,3079,TCGA-19-2620,GBM,70.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-25665.0,Dead,TUMOR FREE,148.0,148.0,[Not Available],,,,,[Not Available],,,1.0,148.0,0.0,148.0,,,0.0,148.0,
TCGA-CA-6719,2243,TCGA-CA-6719,COAD,77.0,MALE,ASIAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-28343.0,Alive,WITH TUMOR,435.0,,[Not Available],,,,354.0,Progressive Disease,,,0.0,435.0,0.0,435.0,,,1.0,354.0,
TCGA-BA-4074,3243,TCGA-BA-4074,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,[Not Available],-25282.0,Dead,WITH TUMOR,,462.0,[Not Available],,Distant Metastasis,bone (humerus),396.0,Complete Remission/Response,,,1.0,462.0,1.0,462.0,,,1.0,396.0,
TCGA-E7-A7DV,249,TCGA-E7-A7DV,BLCA,44.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-16145.0,Alive,WITH TUMOR,37.0,,[Not Available],,,,,Stable Disease,,,0.0,37.0,0.0,37.0,,,0.0,37.0,
TCGA-XF-A9SM,431,TCGA-XF-A9SM,BLCA,76.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,[Not Available],-27826.0,Alive,TUMOR FREE,1048.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1048.0,0.0,1048.0,0.0,1048.0,0.0,1048.0,
TCGA-SW-A7EA,9640,TCGA-SW-A7EA,STAD,61.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",GX,2013.0,[Not Available],-22294.0,Alive,TUMOR FREE,579.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,
TCGA-XU-AAXX,10436,TCGA-XU-AAXX,THYM,44.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2007.0,[Not Available],-16265.0,Alive,TUMOR FREE,2721.0,,[Not Available],,,,,[Not Available],,,0.0,2721.0,0.0,2721.0,,,0.0,2721.0,
TCGA-D3-A3C1,8853,TCGA-D3-A3C1,SKCM,,MALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],1998.0,[Not Available],,Alive,WITH TUMOR,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-FR-A7U9,9138,TCGA-FR-A7U9,SKCM,63.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-23245.0,Alive,TUMOR FREE,571.0,,[Not Available],Locoregional Recurrence,,,95.0,[Not Available],,,0.0,571.0,0.0,571.0,,,1.0,95.0,
TCGA-14-0813,3006,TCGA-14-0813,GBM,78.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2004.0,[Not Available],-28582.0,Dead,,41.0,41.0,[Not Available],,,,,[Not Available],,,1.0,41.0,,41.0,,,0.0,41.0,
TCGA-EK-A2H1,1720,TCGA-EK-A2H1,CESC,20.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-7649.0,Alive,TUMOR FREE,799.0,,,,,,,[Not Available],,,0.0,799.0,0.0,799.0,,,0.0,799.0,
TCGA-AR-A1AR,924,TCGA-AR-A1AR,BRCA,50.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18482.0,Dead,WITH TUMOR,,524.0,[Not Available],New Primary Tumor,"Other, specify",Breast,268.0,[Not Available],Negative,,1.0,524.0,1.0,524.0,1.0,268.0,1.0,268.0,
TCGA-BR-A4QL,9412,TCGA-BR-A4QL,STAD,75.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-27668.0,Dead,TUMOR FREE,,491.0,[Not Available],,,,,Complete Remission/Response,,,1.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,
TCGA-C5-A7X8,1657,TCGA-C5-A7X8,CESC,35.0,FEMALE,WHITE,[Not Available],Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2003.0,[Not Available],-12977.0,Alive,TUMOR FREE,83.0,,,,,,,[Not Available],,,0.0,83.0,0.0,83.0,,,0.0,83.0,
TCGA-FR-A3R1,9129,TCGA-FR-A3R1,SKCM,69.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-25271.0,Alive,WITH TUMOR,685.0,,[Not Available],Locoregional Recurrence,,,678.0,[Not Available],,,0.0,685.0,0.0,685.0,,,1.0,678.0,
TCGA-D7-A6F0,9523,TCGA-D7-A6F0,STAD,79.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,[Not Available],-28923.0,Alive,TUMOR FREE,678.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,678.0,0.0,678.0,0.0,678.0,0.0,678.0,
TCGA-RC-A6M5,5763,TCGA-RC-A6M5,LIHC,20.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Fibrolamellar Carcinoma,G2,2012.0,[Not Available],-7634.0,Alive,,15.0,,[Not Available],,,,,[Not Available],,R0,0.0,15.0,0.0,15.0,,,0.0,15.0,
TCGA-ER-A3PL,9124,TCGA-ER-A3PL,SKCM,30.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2009.0,[Not Available],-11032.0,Alive,WITH TUMOR,1010.0,,[Not Available],,,,945.0,[Not Available],,,0.0,1010.0,0.0,1010.0,,,1.0,945.0,
TCGA-EJ-AB27,8006,TCGA-EJ-AB27,PRAD,51.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-18648.0,Alive,TUMOR FREE,145.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,145.0,0.0,145.0,0.0,145.0,0.0,145.0,
TCGA-J4-AAU2,8152,TCGA-J4-AAU2,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-21656.0,Alive,TUMOR FREE,825.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,825.0,0.0,825.0,0.0,825.0,0.0,825.0,
TCGA-BK-A0CB,10780,TCGA-BK-A0CB,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21930.0,Alive,TUMOR FREE,1092.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,
TCGA-QK-A8Z7,3731,TCGA-QK-A8Z7,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma Basaloid Type,[Not Available],2013.0,[Not Available],-21711.0,Alive,TUMOR FREE,392.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,392.0,0.0,392.0,,,0.0,392.0,
TCGA-Y8-A8RZ,4708,TCGA-Y8-A8RZ,KIRP,55.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-20386.0,Alive,TUMOR FREE,205.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,205.0,0.0,205.0,0.0,205.0,0.0,205.0,
TCGA-UY-A8OB,408,TCGA-UY-A8OB,BLCA,63.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-23360.0,Alive,TUMOR FREE,2109.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2109.0,0.0,2109.0,,,0.0,2109.0,
TCGA-FR-A3YN,9130,TCGA-FR-A3YN,SKCM,44.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2005.0,[Not Available],-16278.0,Alive,TUMOR FREE,2828.0,,[Not Available],,,,,[Not Available],,,0.0,2828.0,0.0,2828.0,,,0.0,2828.0,
TCGA-IB-7649,7622,TCGA-IB-7649,PAAD,73.0,FEMALE,[Unknown],Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2007.0,[Not Available],-26773.0,Dead,,,467.0,,Distant Metastasis,Liver,,282.0,Partial Remission/Response,,,1.0,467.0,,467.0,,,1.0,282.0,
TCGA-DX-AATS,8651,TCGA-DX-AATS,SARC,72.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2008.0,[Not Available],-26624.0,Dead,TUMOR FREE,,35.0,[Not Available],,,,,[Not Available],Positive,R1,1.0,35.0,0.0,35.0,,,0.0,35.0,
TCGA-MR-A520,5754,TCGA-MR-A520,LIHC,58.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-21398.0,Alive,TUMOR FREE,229.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,229.0,0.0,229.0,,,0.0,229.0,
TCGA-HT-8015,5206,TCGA-HT-8015,LGG,21.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2008.0,[Not Available],-7760.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3.0,0.0,3.0,0.0,3.0,0.0,3.0,
TCGA-EJ-AB20,8005,TCGA-EJ-AB20,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22626.0,Alive,TUMOR FREE,131.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,131.0,0.0,131.0,0.0,131.0,0.0,131.0,
TCGA-59-2372,7433,TCGA-59-2372,OV,73.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G2,2005.0,[Not Available],,Dead,,,1363.0,[Not Available],,,,,[Not Available],,,1.0,1363.0,,1363.0,,,0.0,1363.0,
TCGA-DD-A73B,5571,TCGA-DD-A73B,LIHC,72.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-26390.0,Dead,WITH TUMOR,,283.0,[Not Available],Locoregional Recurrence,Liver,,240.0,[Not Available],,R0,1.0,283.0,1.0,283.0,1.0,240.0,1.0,240.0,
TCGA-AR-A0TW,905,TCGA-AR-A0TW,BRCA,50.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18263.0,Alive,TUMOR FREE,3009.0,,[Not Available],,,,739.0,[Not Available],Negative,,0.0,3009.0,0.0,3009.0,1.0,739.0,1.0,739.0,
TCGA-DD-AAVP,5651,TCGA-DD-AAVP,LIHC,48.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2007.0,[Not Available],-17833.0,Alive,TUMOR FREE,2752.0,,[Not Available],Locoregional Recurrence,Liver,,903.0,[Not Available],,R0,0.0,2752.0,0.0,2752.0,1.0,903.0,1.0,903.0,
TCGA-KK-A7AZ,8194,TCGA-KK-A7AZ,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-20507.0,Alive,,1519.0,,[Not Available],,,,,[Unknown],,,0.0,1519.0,0.0,1519.0,,,0.0,1519.0,
TCGA-VP-A875,8278,TCGA-VP-A875,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2005.0,[Not Available],-24742.0,Alive,TUMOR FREE,2309.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2309.0,0.0,2309.0,0.0,2309.0,0.0,2309.0,
TCGA-EL-A3CV,10049,TCGA-EL-A3CV,THCA,40.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005.0,[Not Available],-14785.0,Alive,TUMOR FREE,1154.0,,[Not Available],,,,,[Not Available],,R1,0.0,1154.0,0.0,1154.0,,,0.0,1154.0,
TCGA-XK-AAJT,8308,TCGA-XK-AAJT,PRAD,75.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-27428.0,Alive,TUMOR FREE,1434.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1434.0,0.0,1434.0,,,0.0,1434.0,
TCGA-A2-A3XU,615,TCGA-A2-A3XU,BRCA,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-13046.0,Dead,WITH TUMOR,,912.0,[Not Available],Distant Metastasis,Bone,,574.0,[Not Available],Negative,,1.0,912.0,1.0,912.0,1.0,574.0,1.0,574.0,
TCGA-CQ-A4CG,3413,TCGA-CQ-A4CG,HNSC,78.0,FEMALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-28637.0,Dead,WITH TUMOR,,430.0,[Not Available],,Distant Metastasis,new primary in left upper lung lobe with metastasis to brain,350.0,Complete Remission/Response,,,1.0,430.0,1.0,430.0,1.0,350.0,1.0,350.0,
TCGA-NH-A50T,2394,TCGA-NH-A50T,COAD,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2012.0,[Not Available],-25089.0,Alive,TUMOR FREE,553.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,553.0,0.0,553.0,0.0,553.0,0.0,553.0,
TCGA-SP-A6QI,7799,TCGA-SP-A6QI,PCPG,47.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2005.0,[Not Available],-17167.0,Alive,TUMOR FREE,3347.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3347.0,0.0,3347.0,0.0,3347.0,0.0,3347.0,
TCGA-EB-A57M,8971,TCGA-EB-A57M,SKCM,56.0,MALE,ASIAN,Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-20698.0,Dead,TUMOR FREE,,472.0,[Not Available],,,,,[Not Available],,,1.0,472.0,0.0,472.0,,,0.0,472.0,
TCGA-KK-A7B3,8198,TCGA-KK-A7B3,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22830.0,Alive,TUMOR FREE,899.0,,[Not Available],Biochemical evidence of disease,,,294.0,Complete Remission/Response,,,0.0,899.0,0.0,899.0,1.0,294.0,1.0,294.0,
TCGA-CV-7568,3575,TCGA-CV-7568,HNSC,48.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,1995.0,[Not Available],-17670.0,Dead,,,927.0,[Not Available],,,,,[Not Available],,,1.0,927.0,,927.0,,,0.0,927.0,
TCGA-MG-AAMC,8226,TCGA-MG-AAMC,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-21846.0,Alive,TUMOR FREE,173.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,173.0,0.0,173.0,0.0,173.0,0.0,173.0,
TCGA-FT-A3EE,310,TCGA-FT-A3EE,BLCA,80.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-29293.0,Dead,TUMOR FREE,,99.0,[Not Available],,,,,[Not Available],,,1.0,99.0,0.0,99.0,,,0.0,99.0,
TCGA-L4-A4E5,6283,TCGA-L4-A4E5,LUAD,48.0,FEMALE,WHITE,Stage I,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-17680.0,Alive,TUMOR FREE,578.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,
TCGA-V1-A9OH,8254,TCGA-V1-A9OH,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-23360.0,Alive,,2403.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2403.0,0.0,2403.0,0.0,2403.0,0.0,2403.0,
TCGA-14-0871,3012,TCGA-14-0871,GBM,74.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-27387.0,Dead,,880.0,880.0,[Not Available],,,,,[Not Available],,,1.0,880.0,,880.0,,,0.0,880.0,
TCGA-B0-4706,3976,TCGA-B0-4706,KIRC,61.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2007.0,[Not Available],-22331.0,Dead,TUMOR FREE,26.0,65.0,[Not Available],,,,,[Not Available],,,1.0,65.0,0.0,65.0,,,0.0,65.0,
TCGA-CN-5361,3326,TCGA-CN-5361,HNSC,80.0,MALE,WHITE,Stage IVA,[Not Available],Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-29383.0,Dead,TUMOR FREE,,2120.0,[Not Available],New Primary Tumor,,,2062.0,Complete Remission/Response,,,1.0,2120.0,0.0,2120.0,,,1.0,2062.0,
TCGA-2G-AAKL,9770,TCGA-2G-AAKL,TGCT,26.0,MALE,WHITE,Stage II,Stage II,Non-Seminoma; Embryonal Carcinoma,[Not Available],1995.0,[Not Available],-9813.0,Alive,TUMOR FREE,7023.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,7023.0,0.0,7023.0,,,0.0,7023.0,
TCGA-A6-2677,1966,TCGA-A6-2677,COAD,68.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-25143.0,Dead,TUMOR FREE,,740.0,[Not Available],,,,,[Not Available],,,1.0,740.0,0.0,740.0,,,0.0,740.0,
TCGA-BH-A2L8,1164,TCGA-BH-A2L8,BRCA,45.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16658.0,Alive,TUMOR FREE,612.0,,[Not Available],,,,,[Not Available],Negative,,0.0,612.0,0.0,612.0,0.0,612.0,0.0,612.0,
TCGA-FS-A1ZB,9151,TCGA-FS-A1ZB,SKCM,57.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],2002.0,[Not Available],-20963.0,Dead,WITH TUMOR,,1486.0,[Not Available],,,,1461.0,[Not Available],,,1.0,1486.0,1.0,1486.0,,,1.0,1461.0,
TCGA-DD-A73F,5575,TCGA-DD-A73F,LIHC,77.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2010.0,[Not Available],-28234.0,Alive,TUMOR FREE,1085.0,,[Not Available],,,,,[Not Available],,R0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0,
TCGA-EM-A4FN,10194,TCGA-EM-A4FN,THCA,49.0,FEMALE,[Unknown],Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-18185.0,Alive,TUMOR FREE,802.0,,[Not Available],,,,,[Not Available],,R0,0.0,802.0,0.0,802.0,,,0.0,802.0,
TCGA-BH-A0E1,1077,TCGA-BH-A0E1,BRCA,52.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Peri (6-12 months since last menstrual period),-19192.0,Alive,TUMOR FREE,477.0,,[Not Available],,,,,[Not Available],Negative,,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,
TCGA-3G-AB0T,10354,TCGA-3G-AB0T,THYM,45.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type B1,[Not Available],2000.0,[Not Available],-16728.0,Dead,WITH TUMOR,,2488.0,[Not Available],Distant Metastasis,Pleura/Pleural effusion,,1786.0,[Not Available],,,1.0,2488.0,1.0,2488.0,,,1.0,1786.0,
TCGA-HT-7858,5190,TCGA-HT-7858,LGG,28.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2007.0,[Not Available],-10422.0,Alive,TUMOR FREE,1540.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1540.0,0.0,1540.0,0.0,1540.0,0.0,1540.0,
TCGA-77-8153,6689,TCGA-77-8153,LUSC,77.0,FEMALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-28253.0,Alive,TUMOR FREE,1992.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1992.0,0.0,1992.0,0.0,1992.0,0.0,1992.0,
TCGA-HT-8013,5205,TCGA-HT-8013,LGG,37.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2005.0,[Not Available],-13753.0,Dead,WITH TUMOR,,1933.0,[Not Available],,,,1306.0,Stable Disease,,,1.0,1933.0,1.0,1933.0,,,1.0,1306.0,
TCGA-VW-A7QS,5415,TCGA-VW-A7QS,LGG,35.0,FEMALE,ASIAN,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-12820.0,Alive,WITH TUMOR,706.0,,[Not Available],,,,,Stable Disease,,,0.0,706.0,0.0,706.0,,,0.0,706.0,
TCGA-BA-5558,3255,TCGA-BA-5558,HNSC,65.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2006.0,[Not Available],-23984.0,Alive,TUMOR FREE,1995.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1995.0,0.0,1995.0,,,0.0,1995.0,
TCGA-EM-A22K,10132,TCGA-EM-A22K,THCA,46.0,FEMALE,[Not Available],Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-16890.0,Alive,TUMOR FREE,479.0,,[Not Available],,,,,[Not Available],,R1,0.0,479.0,0.0,479.0,,,0.0,479.0,
TCGA-VS-A9UU,1879,TCGA-VS-A9UU,CESC,42.0,FEMALE,[Unknown],[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G1,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15534.0,Alive,TUMOR FREE,442.0,,,,,,,Complete Remission/Response,,,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,
TCGA-ZM-AA0H,9843,TCGA-ZM-AA0H,TGCT,50.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],2010.0,[Not Available],-18419.0,Alive,TUMOR FREE,1736.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,1736.0,0.0,1736.0,0.0,1736.0,0.0,1736.0,
TCGA-FJ-A3ZF,308,TCGA-FJ-A3ZF,BLCA,73.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-26825.0,Alive,TUMOR FREE,524.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,
TCGA-X6-A8C4,8788,TCGA-X6-A8C4,SARC,70.0,FEMALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013.0,[Not Available],-25896.0,Dead,WITH TUMOR,,628.0,[Not Available],Distant Metastasis,Lung,,71.0,[Not Available],Positive,R1,1.0,628.0,1.0,628.0,,,1.0,71.0,
TCGA-E8-A44M,10039,TCGA-E8-A44M,THCA,23.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-8523.0,Alive,TUMOR FREE,917.0,,[Not Available],,,,,[Not Available],,R0,0.0,917.0,0.0,917.0,0.0,917.0,0.0,917.0,
TCGA-IQ-A61K,3687,TCGA-IQ-A61K,HNSC,70.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-25697.0,Dead,TUMOR FREE,,161.0,[Not Available],,,,,[Not Applicable],,,1.0,161.0,0.0,161.0,,,0.0,161.0,
TCGA-EL-A4JW,10106,TCGA-EL-A4JW,THCA,38.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-13928.0,Alive,TUMOR FREE,1056.0,,[Not Available],,,,,[Not Available],,R0,0.0,1056.0,0.0,1056.0,0.0,1056.0,0.0,1056.0,
TCGA-BP-5178,4246,TCGA-BP-5178,KIRC,71.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-26070.0,Dead,WITH TUMOR,,1912.0,[Not Available],,,,396.0,[Not Available],,,1.0,1912.0,1.0,1912.0,,,1.0,396.0,
TCGA-HE-A5NH,4622,TCGA-HE-A5NH,KIRP,62.0,MALE,[Not Evaluated],Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-22888.0,Alive,TUMOR FREE,791.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,
TCGA-IN-A6RO,9600,TCGA-IN-A6RO,STAD,70.0,MALE,ASIAN,Stage IA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-25789.0,Dead,WITH TUMOR,,,[Unknown],Distant Metastasis,,,154.0,[Discrepancy],,,1.0,,1.0,,,,1.0,154.0,
TCGA-L5-A4OU,2528,TCGA-L5-A4OU,ESCA,81.0,MALE,WHITE,Stage IIA,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2009.0,[Not Available],-29674.0,Alive,TUMOR FREE,882.0,,[Not Available],,,,,[Unknown],,,0.0,882.0,0.0,882.0,,,0.0,882.0,
TCGA-BH-A0DV,1073,TCGA-BH-A0DV,BRCA,54.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Peri (6-12 months since last menstrual period),-19781.0,Alive,TUMOR FREE,2064.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2064.0,0.0,2064.0,0.0,2064.0,0.0,2064.0,
TCGA-CC-A7IK,5504,TCGA-CC-A7IK,LIHC,59.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-21552.0,Dead,WITH TUMOR,,262.0,[Not Available],Locoregional Recurrence,,,150.0,[Not Available],,R0,1.0,262.0,1.0,262.0,1.0,150.0,1.0,150.0,
TCGA-G6-A8L6,4411,TCGA-G6-A8L6,KIRC,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2013.0,[Not Available],-20306.0,Dead,WITH TUMOR,,313.0,[Not Available],,,,304.0,Progressive Disease,,,1.0,313.0,1.0,313.0,,,1.0,304.0,
TCGA-QH-A6X5,5303,TCGA-QH-A6X5,LGG,58.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-21239.0,Alive,,497.0,,[Not Available],,,,,[Unknown],,,0.0,497.0,0.0,497.0,,,0.0,497.0,
TCGA-CN-6021,3345,TCGA-CN-6021,HNSC,63.0,FEMALE,WHITE,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-23212.0,Dead,WITH TUMOR,,276.0,[Not Available],,,,,Progressive Disease,,,1.0,276.0,1.0,276.0,,,1.0,276.0,
TCGA-A2-A4S3,628,TCGA-A2-A4S3,BRCA,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21762.0,Alive,TUMOR FREE,666.0,,[Not Available],,,,,[Not Available],Negative,,0.0,666.0,0.0,666.0,0.0,666.0,0.0,666.0,
TCGA-06-2557,2851,TCGA-06-2557,GBM,76.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-27980.0,Dead,WITH TUMOR,33.0,33.0,[Not Available],,,,,[Not Available],,,1.0,33.0,1.0,33.0,,,1.0,33.0,
TCGA-EM-A2P3,10159,TCGA-EM-A2P3,THCA,47.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-17495.0,Alive,TUMOR FREE,444.0,,[Not Available],,,,,[Not Available],,R0,0.0,444.0,0.0,444.0,0.0,444.0,0.0,444.0,
TCGA-H7-7774,3657,TCGA-H7-7774,HNSC,75.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-27519.0,Alive,TUMOR FREE,407.0,,[Not Available],New Primary Tumor,Oral Cavity,hard palate (right),252.0,Complete Remission/Response,,,0.0,407.0,0.0,407.0,,,1.0,252.0,
TCGA-FX-A8OO,8682,TCGA-FX-A8OO,SARC,31.0,FEMALE,WHITE,[Not Available],[Not Available],Sarcoma; synovial; poorly differentiated,[Not Available],2013.0,[Not Available],-11376.0,Dead,TUMOR FREE,,245.0,[Not Available],,,,,[Not Available],Negative,R0,1.0,245.0,0.0,245.0,0.0,245.0,0.0,245.0,
TCGA-2J-AABK,7513,TCGA-2J-AABK,PAAD,71.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-26188.0,Alive,TUMOR FREE,484.0,,,,,,,Complete Remission/Response,,,0.0,484.0,0.0,484.0,0.0,484.0,0.0,484.0,
TCGA-BJ-A0ZB,9853,TCGA-BJ-A0ZB,THCA,66.0,MALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-24415.0,Alive,TUMOR FREE,122.0,,[Not Available],,,,,[Not Available],,R1,0.0,122.0,0.0,122.0,,,0.0,122.0,
TCGA-CC-A3MB,5493,TCGA-CC-A3MB,LIHC,36.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2011.0,[Not Available],-13255.0,Dead,WITH TUMOR,,315.0,[Not Available],New Primary Tumor,Lung,,260.0,[Not Available],,R0,1.0,315.0,1.0,315.0,0.0,315.0,1.0,260.0,
TCGA-55-1594,5968,TCGA-55-1594,LUAD,68.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-25008.0,Alive,TUMOR FREE,1178.0,,[Not Available],,,,,[Not Available],,,0.0,1178.0,0.0,1178.0,,,0.0,1178.0,
TCGA-CG-4474,9465,TCGA-CG-4474,STAD,67.0,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-24686.0,Alive,WITH TUMOR,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-A5-A3LO,10520,TCGA-A5-A3LO,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23401.0,Alive,TUMOR FREE,776.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,776.0,0.0,776.0,0.0,776.0,0.0,776.0,
TCGA-14-1043,3015,TCGA-14-1043,GBM,61.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2004.0,[Not Available],-22392.0,Dead,WITH TUMOR,24.0,24.0,[Not Available],,,,,[Not Available],,,1.0,24.0,1.0,24.0,,,1.0,24.0,
TCGA-4V-A9QM,10364,TCGA-4V-A9QM,THYM,39.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2011.0,[Not Available],-14576.0,Alive,TUMOR FREE,1253.0,,[Not Available],,,,,[Not Available],,,0.0,1253.0,0.0,1253.0,,,0.0,1253.0,
TCGA-D7-6817,9500,TCGA-D7-6817,STAD,63.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,[Not Available],-23142.0,Alive,TUMOR FREE,389.0,,[Not Available],,,,,[Not Available],,,0.0,389.0,0.0,389.0,,,0.0,389.0,
TCGA-JY-A6FH,2500,TCGA-JY-A6FH,ESCA,53.0,MALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2010.0,[Not Available],-19549.0,Alive,TUMOR FREE,1441.0,,[Not Available],Distant Metastasis,Lung,,749.0,Progressive Disease,,,0.0,1441.0,0.0,1441.0,,,1.0,749.0,
TCGA-BQ-7056,4564,TCGA-BQ-7056,KIRP,75.0,FEMALE,WHITE,Stage III,[Discrepancy],Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-27467.0,Alive,WITH TUMOR,612.0,,[Not Available],,,,143.0,[Not Available],,,0.0,612.0,0.0,612.0,,,1.0,143.0,
TCGA-BS-A0UV,10808,TCGA-BS-A0UV,UCEC,55.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20266.0,Alive,TUMOR FREE,2228.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2228.0,0.0,2228.0,0.0,2228.0,0.0,2228.0,
TCGA-VQ-A91S,9679,TCGA-VQ-A91S,STAD,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",GX,2012.0,[Not Available],-23187.0,Alive,TUMOR FREE,1000.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0,
TCGA-V1-A9O7,8250,TCGA-V1-A9O7,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-22265.0,Alive,,2499.0,,[Not Available],Biochemical evidence of disease,,,819.0,Progressive Disease,,,0.0,2499.0,0.0,2499.0,,,1.0,819.0,
TCGA-50-5932,5942,TCGA-50-5932,LUAD,75.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-27454.0,Dead,WITH TUMOR,1091.0,1235.0,[Not Available],Locoregional Recurrence,,,1090.0,Progressive Disease,,,1.0,1235.0,1.0,1235.0,,,1.0,1090.0,
TCGA-CM-6161,2276,TCGA-CM-6161,COAD,36.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-13363.0,Alive,TUMOR FREE,457.0,,[Not Available],,,,,[Not Available],,,0.0,457.0,0.0,457.0,,,0.0,457.0,
TCGA-60-2720,6578,TCGA-60-2720,LUSC,60.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-22238.0,Alive,TUMOR FREE,97.0,,[Not Available],,,,,[Not Available],,,0.0,97.0,0.0,97.0,,,0.0,97.0,
TCGA-SX-A71V,4671,TCGA-SX-A71V,KIRP,80.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-29332.0,Alive,TUMOR FREE,876.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,876.0,0.0,876.0,0.0,876.0,0.0,876.0,
TCGA-63-A5MR,6602,TCGA-63-A5MR,LUSC,70.0,FEMALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-25879.0,Alive,TUMOR FREE,2716.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2716.0,0.0,2716.0,0.0,2716.0,0.0,2716.0,
TCGA-RW-A68G,7773,TCGA-RW-A68G,PCPG,49.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-17959.0,Alive,TUMOR FREE,1274.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1274.0,0.0,1274.0,0.0,1274.0,0.0,1274.0,
TCGA-19-1787,3073,TCGA-19-1787,GBM,48.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-17894.0,Dead,WITH TUMOR,385.0,385.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],308.0,[Not Available],,,1.0,385.0,1.0,385.0,,,1.0,308.0,
TCGA-EE-A20F,9003,TCGA-EE-A20F,SKCM,53.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],2002.0,[Not Available],-19372.0,Alive,TUMOR FREE,2785.0,,[Not Available],,,,,[Not Available],,,0.0,2785.0,0.0,2785.0,,,0.0,2785.0,
TCGA-VN-A88R,8275,TCGA-VN-A88R,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-19513.0,Alive,,784.0,,[Not Available],Biochemical evidence of disease,,,512.0,Partial Remission/Response,,,0.0,784.0,0.0,784.0,,,1.0,512.0,
TCGA-AJ-A3BI,10537,TCGA-AJ-A3BI,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24623.0,Alive,TUMOR FREE,575.0,,[Not Available],Locoregional Recurrence,"Other, specify",Anterior Abd. Mass,373.0,[Not Available],,,0.0,575.0,0.0,575.0,,,1.0,373.0,
TCGA-D3-A5GN,8877,TCGA-D3-A5GN,SKCM,15.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],2001.0,[Not Available],-5684.0,Alive,TUMOR FREE,4129.0,,[Not Available],New primary melanoma,,,1279.0,[Not Available],,,0.0,4129.0,0.0,4129.0,,,1.0,1279.0,
TCGA-CF-A9FM,171,TCGA-CF-A9FM,BLCA,50.0,MALE,ASIAN,Stage I,[Not Applicable],[Not Available],High Grade,2013.0,[Not Available],-18445.0,Alive,TUMOR FREE,398.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,
TCGA-PK-A5HA,90,TCGA-PK-A5HA,ACC,63.0,MALE,[Unknown],Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-23345.0,Alive,TUMOR FREE,1201.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1201.0,0.0,1201.0,0.0,1201.0,0.0,1201.0,
TCGA-BH-A0DK,1066,TCGA-BH-A0DK,BRCA,49.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18237.0,Alive,TUMOR FREE,423.0,,[Not Available],,,,,[Not Available],Negative,,0.0,423.0,0.0,423.0,0.0,423.0,0.0,423.0,
TCGA-EM-A2CL,10141,TCGA-EM-A2CL,THCA,31.0,MALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-11649.0,Alive,TUMOR FREE,401.0,,[Not Available],,,,,[Not Available],,R0,0.0,401.0,0.0,401.0,0.0,401.0,0.0,401.0,
TCGA-FY-A3R9,10290,TCGA-FY-A3R9,THCA,66.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-24215.0,Alive,TUMOR FREE,504.0,,[Not Available],,,,,[Not Available],,R0,0.0,504.0,0.0,504.0,0.0,504.0,0.0,504.0,
TCGA-A5-A1OH,10512,TCGA-A5-A1OH,UCEC,86.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31451.0,Alive,TUMOR FREE,1105.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1105.0,0.0,1105.0,0.0,1105.0,0.0,1105.0,
TCGA-2F-A9KO,93,TCGA-2F-A9KO,BLCA,63.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-23323.0,Dead,WITH TUMOR,,734.0,[Not Available],Distant Metastasis,Liver,,651.0,Progressive Disease,,,1.0,734.0,1.0,734.0,,,1.0,651.0,
TCGA-KQ-A41S,390,TCGA-KQ-A41S,BLCA,87.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-32041.0,Alive,TUMOR FREE,35.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,35.0,0.0,35.0,0.0,35.0,0.0,35.0,
TCGA-C8-A135,1195,TCGA-C8-A135,BRCA,64.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23667.0,Alive,TUMOR FREE,393.0,,[Not Available],,,,,[Not Available],Negative,,0.0,393.0,0.0,393.0,0.0,393.0,0.0,393.0,
TCGA-DE-A4MB,9912,TCGA-DE-A4MB,THCA,79.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-29011.0,Alive,WITH TUMOR,352.0,,[Not Available],,,,,[Not Available],,R1,0.0,352.0,0.0,352.0,,,0.0,352.0,
TCGA-CF-A9FF,168,TCGA-CF-A9FF,BLCA,52.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-19195.0,Alive,TUMOR FREE,361.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,361.0,0.0,361.0,0.0,361.0,0.0,361.0,
TCGA-BR-7703,9323,TCGA-BR-7703,STAD,81.0,MALE,WHITE,Stage IA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2011.0,[Not Available],-29711.0,Alive,TUMOR FREE,1100.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1100.0,0.0,1100.0,0.0,1100.0,0.0,1100.0,
TCGA-E9-A1R6,1413,TCGA-E9-A1R6,BRCA,63.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23347.0,Alive,TUMOR FREE,339.0,,[Not Available],,,,,[Not Available],Negative,,0.0,339.0,0.0,339.0,0.0,339.0,0.0,339.0,
TCGA-85-7950,6714,TCGA-85-7950,LUSC,46.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-16975.0,Alive,TUMOR FREE,576.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,576.0,0.0,576.0,0.0,576.0,0.0,576.0,
TCGA-DJ-A1QD,9929,TCGA-DJ-A1QD,THCA,20.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-7460.0,Alive,TUMOR FREE,1462.0,,[Not Available],,,,,[Not Available],,R0,0.0,1462.0,0.0,1462.0,0.0,1462.0,0.0,1462.0,
TCGA-BP-4964,4202,TCGA-BP-4964,KIRC,54.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-20084.0,Alive,TUMOR FREE,1862.0,,[Not Available],,,,,[Not Available],,,0.0,1862.0,0.0,1862.0,,,0.0,1862.0,
TCGA-VS-A8QH,1849,TCGA-VS-A8QH,CESC,76.0,FEMALE,WHITE,[Not Available],Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27909.0,Dead,WITH TUMOR,,1210.0,Cervical Cancer,,,,,Partial Remission/Response,,,1.0,1210.0,1.0,1210.0,,,1.0,1210.0,
TCGA-DX-A6YS,8615,TCGA-DX-A6YS,SARC,61.0,MALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2008.0,[Not Available],-22310.0,Alive,TUMOR FREE,2381.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,2381.0,0.0,2381.0,0.0,2381.0,0.0,2381.0,
TCGA-EM-A4FU,10198,TCGA-EM-A4FU,THCA,35.0,MALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2009.0,[Not Available],-12912.0,Alive,TUMOR FREE,1840.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,781.0,[Not Available],,R0,0.0,1840.0,0.0,1840.0,1.0,781.0,1.0,781.0,
TCGA-A3-3383,3925,TCGA-A3-3383,KIRC,52.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-19324.0,Alive,,861.0,,[Not Available],,,,,[Not Available],,,0.0,861.0,0.0,861.0,,,0.0,861.0,
TCGA-ZJ-AAXB,1898,TCGA-ZJ-AAXB,CESC,42.0,FEMALE,WHITE,[Not Available],Stage IB2,Endocervical Adenocarcinoma of the Usual Type,G3,2009.0,[Unknown],-15492.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-HC-8260,8101,TCGA-HC-8260,PRAD,43.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-15884.0,Alive,TUMOR FREE,686.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,686.0,0.0,686.0,0.0,686.0,0.0,686.0,
TCGA-4X-A9FD,10377,TCGA-4X-A9FD,THYM,43.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2010.0,[Not Available],-15968.0,Alive,TUMOR FREE,1503.0,,[Not Available],,,,,[Not Available],,,0.0,1503.0,0.0,1503.0,,,0.0,1503.0,
TCGA-3U-A98I,6842,TCGA-3U-A98I,MESO,68.0,MALE,WHITE,Stage IV,[Not Applicable],Biphasic mesothelioma,[Not Available],2013.0,[Not Available],-25108.0,Dead,WITH TUMOR,,860.0,[Not Available],Intrapleural Progression,,,404.0,[Not Available],,[Not Available],1.0,860.0,1.0,860.0,,,1.0,404.0,
TCGA-EE-A2GM,9038,TCGA-EE-A2GM,SKCM,70.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2004.0,[Not Available],-25711.0,Alive,TUMOR FREE,2296.0,,[Not Available],Locoregional Recurrence,,,1218.0,[Not Available],,,0.0,2296.0,0.0,2296.0,,,1.0,1218.0,
TCGA-26-5133,3109,TCGA-26-5133,GBM,59.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-21560.0,Alive,TUMOR FREE,452.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],370.0,[Not Available],,,0.0,452.0,0.0,452.0,,,1.0,370.0,
TCGA-19-5952,3091,TCGA-19-5952,GBM,62.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-22841.0,Dead,,567.0,575.0,[Not Available],,,,,[Not Available],,,1.0,575.0,,575.0,,,0.0,575.0,
TCGA-EJ-7123,7945,TCGA-EJ-7123,PRAD,59.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-21741.0,Alive,TUMOR FREE,2572.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2572.0,0.0,2572.0,0.0,2572.0,0.0,2572.0,
TCGA-CW-6087,4348,TCGA-CW-6087,KIRC,61.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2003.0,[Not Available],-22438.0,Dead,TUMOR FREE,,41.0,[Not Available],,,,,[Not Available],,,1.0,41.0,0.0,41.0,,,0.0,41.0,
TCGA-AR-A0TT,902,TCGA-AR-A0TT,BRCA,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19679.0,Alive,TUMOR FREE,3316.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3316.0,0.0,3316.0,0.0,3316.0,0.0,3316.0,
TCGA-44-6775,5878,TCGA-44-6775,LUAD,72.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26415.0,Alive,WITH TUMOR,705.0,,[Not Available],Locoregional Recurrence,,,684.0,Complete Remission/Response,,,0.0,705.0,0.0,705.0,1.0,684.0,1.0,684.0,
TCGA-KS-A4I7,10338,TCGA-KS-A4I7,THCA,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-22398.0,Alive,TUMOR FREE,987.0,,[Not Available],,,,,[Not Available],,R0,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,
TCGA-FS-A1ZJ,9158,TCGA-FS-A1ZJ,SKCM,75.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],2001.0,[Not Available],-27476.0,Dead,WITH TUMOR,,1441.0,[Not Available],,,,1225.0,[Not Available],,,1.0,1441.0,1.0,1441.0,,,1.0,1225.0,
TCGA-CR-7389,3457,TCGA-CR-7389,HNSC,55.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-20169.0,Alive,TUMOR FREE,392.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,392.0,0.0,392.0,0.0,392.0,0.0,392.0,
TCGA-2L-AAQM,7525,TCGA-2L-AAQM,PAAD,52.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2010.0,[Not Available],-19315.0,Alive,TUMOR FREE,1383.0,,,,,,,Stable Disease,,,0.0,1383.0,0.0,1383.0,,,0.0,1383.0,
TCGA-CN-4723,3303,TCGA-CN-4723,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-24815.0,Alive,TUMOR FREE,1699.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1699.0,0.0,1699.0,,,0.0,1699.0,
TCGA-CK-6746,2254,TCGA-CK-6746,COAD,84.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-30957.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-BT-A42E,143,TCGA-BT-A42E,BLCA,74.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27045.0,Alive,TUMOR FREE,1108.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1108.0,0.0,1108.0,0.0,1108.0,0.0,1108.0,
TCGA-NJ-A7XG,6322,TCGA-NJ-A7XG,LUAD,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2013.0,[Not Available],-18127.0,Alive,WITH TUMOR,617.0,,[Not Available],,,,,Stable Disease,,,0.0,617.0,0.0,617.0,,,0.0,617.0,
TCGA-OR-A5JA,10,TCGA-OR-A5JA,ACC,53.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2004.0,[Not Available],-19436.0,Dead,WITH TUMOR,,922.0,[Not Available],,,,,[Not Available],,,1.0,922.0,1.0,922.0,,,1.0,922.0,
TCGA-XM-A8RD,10409,TCGA-XM-A8RD,THYM,69.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2010.0,[Not Available],-25402.0,Alive,TUMOR FREE,1546.0,,[Not Available],,,,,[Not Available],,,0.0,1546.0,0.0,1546.0,,,0.0,1546.0,
TCGA-MX-A666,9618,TCGA-MX-A666,STAD,61.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,[Not Available],-22288.0,Alive,TUMOR FREE,427.0,,[Not Available],,,,,Stable Disease,,,0.0,427.0,0.0,427.0,,,0.0,427.0,
TCGA-CQ-6222,3391,TCGA-CQ-6222,HNSC,63.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-23326.0,Alive,TUMOR FREE,2016.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2016.0,0.0,2016.0,,,0.0,2016.0,
TCGA-DU-A5TS,5043,TCGA-DU-A5TS,LGG,42.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-15650.0,Alive,TUMOR FREE,964.0,,[Not Available],,,,551.0,Stable Disease,,,0.0,964.0,0.0,964.0,,,1.0,551.0,
TCGA-EB-A42Y,8952,TCGA-EB-A42Y,SKCM,73.0,FEMALE,ASIAN,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-26712.0,Dead,WITH TUMOR,,721.0,[Not Available],Regional lymph node,,,721.0,[Not Available],,,1.0,721.0,1.0,721.0,,,1.0,721.0,
TCGA-49-6761,5918,TCGA-49-6761,LUAD,68.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-24849.0,Alive,TUMOR FREE,354.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,354.0,0.0,354.0,0.0,354.0,0.0,354.0,
TCGA-GL-8500,4611,TCGA-GL-8500,KIRP,63.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-23338.0,Alive,TUMOR FREE,841.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,841.0,0.0,841.0,0.0,841.0,0.0,841.0,
TCGA-BH-A18V,1129,TCGA-BH-A18V,BRCA,48.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001.0,[Not Available],-17682.0,Dead,,,1556.0,[Not Available],,,,,[Not Available],Negative,,1.0,1556.0,,1556.0,0.0,1556.0,0.0,1556.0,
TCGA-HC-7081,8066,TCGA-HC-7081,PRAD,62.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],,Alive,WITH TUMOR,1136.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1136.0,0.0,1136.0,,,0.0,1136.0,
TCGA-QR-A6H6,7712,TCGA-QR-A6H6,PCPG,27.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2012.0,[Not Available],-10180.0,Alive,TUMOR FREE,474.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,
TCGA-ER-A19O,9107,TCGA-ER-A19O,SKCM,56.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2006.0,[Not Available],-20740.0,Dead,WITH TUMOR,,,[Not Available],Distant Metastasis,"Other, Specify",Rt. chest wall,308.0,[Not Available],,,1.0,,1.0,,,,1.0,308.0,
TCGA-AK-3465,3961,TCGA-AK-3465,KIRC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,GX,2008.0,[Not Available],-26232.0,Alive,TUMOR FREE,369.0,,[Not Available],,,,,[Not Available],,,0.0,369.0,0.0,369.0,,,0.0,369.0,
TCGA-DD-AAW3,5664,TCGA-DD-AAW3,LIHC,69.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2009.0,[Not Available],-25254.0,Alive,TUMOR FREE,1633.0,,[Not Available],,,,,[Not Available],,R0,0.0,1633.0,0.0,1633.0,0.0,1633.0,0.0,1633.0,
TCGA-66-2756,6617,TCGA-66-2756,LUSC,68.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-24929.0,Alive,TUMOR FREE,30.0,,[Not Available],,,,,[Not Available],,,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-B0-4842,4005,TCGA-B0-4842,KIRC,73.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-27019.0,Dead,WITH TUMOR,,1724.0,[Not Available],,,,250.0,[Not Available],,,1.0,1724.0,1.0,1724.0,,,1.0,250.0,
TCGA-2G-AAGS,9748,TCGA-2G-AAGS,TGCT,39.0,MALE,WHITE,Stage IIIB,Stage IIIB,Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor,[Not Available],2001.0,[Not Available],-14312.0,Alive,TUMOR FREE,4816.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,4816.0,0.0,4816.0,0.0,4816.0,0.0,4816.0,
TCGA-VS-A8EB,1836,TCGA-VS-A8EB,CESC,41.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,GX,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15215.0,Dead,WITH TUMOR,,305.0,Cervical Cancer,,,,,Progressive Disease,,,1.0,305.0,1.0,305.0,,,1.0,305.0,
TCGA-AR-A1AW,929,TCGA-AR-A1AW,BRCA,65.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23855.0,Alive,TUMOR FREE,2632.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2632.0,0.0,2632.0,0.0,2632.0,0.0,2632.0,
TCGA-B5-A11Q,10705,TCGA-B5-A11Q,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23538.0,Alive,TUMOR FREE,976.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,976.0,0.0,976.0,0.0,976.0,0.0,976.0,
TCGA-85-A4PA,6742,TCGA-85-A4PA,LUSC,61.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-22614.0,Alive,TUMOR FREE,741.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,741.0,0.0,741.0,0.0,741.0,0.0,741.0,
TCGA-63-A5MV,6606,TCGA-63-A5MV,LUSC,69.0,MALE,[Not Evaluated],Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-25505.0,Alive,TUMOR FREE,1100.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1100.0,0.0,1100.0,0.0,1100.0,0.0,1100.0,
TCGA-BQ-5885,4545,TCGA-BQ-5885,KIRP,63.0,MALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-23173.0,Alive,TUMOR FREE,921.0,,[Not Available],,,,,[Not Available],,,0.0,921.0,0.0,921.0,,,0.0,921.0,
TCGA-G4-6310,2379,TCGA-G4-6310,COAD,69.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-25243.0,Alive,TUMOR FREE,1935.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0,
TCGA-BJ-A3PT,9882,TCGA-BJ-A3PT,THCA,51.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18903.0,Alive,TUMOR FREE,709.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,709.0,0.0,709.0,,,0.0,709.0,
TCGA-06-0188,2791,TCGA-06-0188,GBM,71.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-26080.0,Dead,WITH TUMOR,,1356.0,[Not Available],,[Not Applicable],[Not Applicable],310.0,[Not Available],,,1.0,1356.0,1.0,1356.0,,,1.0,310.0,
TCGA-D8-A27K,1288,TCGA-D8-A27K,BRCA,47.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17426.0,Alive,TUMOR FREE,1461.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1461.0,0.0,1461.0,0.0,1461.0,0.0,1461.0,
TCGA-E1-A7YV,5088,TCGA-E1-A7YV,LGG,26.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2010.0,[Not Available],-9546.0,Dead,WITH TUMOR,,987.0,[Not Available],,,,97.0,Progressive Disease,,,1.0,987.0,1.0,987.0,,,1.0,97.0,
TCGA-32-1991,3176,TCGA-32-1991,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-22021.0,Dead,WITH TUMOR,515.0,515.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],345.0,[Not Available],,,1.0,515.0,1.0,515.0,,,1.0,345.0,
TCGA-AH-6549,8467,TCGA-AH-6549,READ,66.0,MALE,WHITE,[Not Available],[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-24337.0,Alive,TUMOR FREE,532.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,
TCGA-E9-A22B,1429,TCGA-E9-A22B,BRCA,71.0,FEMALE,WHITE,Stage IA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26278.0,Alive,TUMOR FREE,1167.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1167.0,0.0,1167.0,0.0,1167.0,0.0,1167.0,
TCGA-A5-A0VO,10507,TCGA-A5-A0VO,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23547.0,Dead,TUMOR FREE,,875.0,[Not Available],,,,,Complete Remission/Response,,,1.0,875.0,0.0,875.0,0.0,875.0,0.0,875.0,
TCGA-60-2708,6568,TCGA-60-2708,LUSC,64.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-23691.0,Alive,TUMOR FREE,2447.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2447.0,0.0,2447.0,0.0,2447.0,0.0,2447.0,
TCGA-A7-A0D9,634,TCGA-A7-A0D9,BRCA,37.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13836.0,Alive,TUMOR FREE,1139.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1139.0,0.0,1139.0,0.0,1139.0,0.0,1139.0,
TCGA-33-A4WN,6410,TCGA-33-A4WN,LUSC,60.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-22268.0,Dead,TUMOR FREE,,143.0,[Not Available],,,,,Complete Remission/Response,,,1.0,143.0,0.0,143.0,0.0,143.0,0.0,143.0,
TCGA-BR-6706,9313,TCGA-BR-6706,STAD,63.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,[Not Available],-23053.0,Dead,WITH TUMOR,,549.0,[Not Available],Locoregional Recurrence,,,402.0,Complete Remission/Response,,,1.0,549.0,1.0,549.0,1.0,402.0,1.0,402.0,
TCGA-X7-A8M0,10396,TCGA-X7-A8M0,THYM,61.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type B2|Thymoma; Type B3,[Not Available],2007.0,[Not Available],-22596.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,[Not Available],,,0.0,441.0,0.0,441.0,,,0.0,441.0,
TCGA-MB-A5Y8,8724,TCGA-MB-A5Y8,SARC,60.0,FEMALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012.0,[Not Available],-22115.0,Alive,TUMOR FREE,773.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,773.0,0.0,773.0,0.0,773.0,0.0,773.0,
TCGA-DB-A4XE,4946,TCGA-DB-A4XE,LGG,27.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-10150.0,Alive,TUMOR FREE,1139.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1139.0,0.0,1139.0,0.0,1139.0,0.0,1139.0,
TCGA-D1-A17N,10868,TCGA-D1-A17N,UCEC,46.0,FEMALE,[Not Available],[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Peri (6-12 months since last menstrual period),-17045.0,Alive,TUMOR FREE,46.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,46.0,0.0,46.0,0.0,46.0,0.0,46.0,
TCGA-B5-A1MR,10715,TCGA-B5-A1MR,UCEC,65.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24017.0,Alive,TUMOR FREE,6859.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,6859.0,0.0,6859.0,0.0,6859.0,0.0,6859.0,
TCGA-O1-A52J,6323,TCGA-O1-A52J,LUAD,74.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-27223.0,Dead,WITH TUMOR,,1798.0,[Not Available],Locoregional Recurrence,,,898.0,[Unknown],,,1.0,1798.0,1.0,1798.0,,,1.0,898.0,
TCGA-D7-A747,9525,TCGA-D7-A747,STAD,57.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2013.0,[Not Available],-20923.0,Dead,WITH TUMOR,,255.0,Stomach Cancer,,,,,Progressive Disease,,,1.0,255.0,1.0,255.0,,,1.0,255.0,
TCGA-KK-A8I9,8205,TCGA-KK-A8I9,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22295.0,Alive,WITH TUMOR,1001.0,,[Not Available],Biochemical evidence of disease,,,940.0,Complete Remission/Response,,,0.0,1001.0,0.0,1001.0,1.0,940.0,1.0,940.0,
TCGA-06-0171,2779,TCGA-06-0171,GBM,65.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-24085.0,Dead,WITH TUMOR,396.0,399.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],117.0,[Not Available],,,1.0,399.0,1.0,399.0,,,1.0,117.0,
TCGA-ER-A19W,9112,TCGA-ER-A19W,SKCM,48.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1994.0,[Not Available],-17830.0,Dead,WITH TUMOR,,4507.0,[Not Available],Distant Metastasis,Brain,,4126.0,[Not Available],,,1.0,4507.0,1.0,4507.0,,,1.0,4126.0,
TCGA-49-4514,5913,TCGA-49-4514,LUAD,79.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-28908.0,Alive,TUMOR FREE,1700.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1700.0,0.0,1700.0,0.0,1700.0,0.0,1700.0,
TCGA-2G-AAGX,9752,TCGA-2G-AAGX,TGCT,22.0,MALE,WHITE,Stage IA,Stage IA,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor,[Not Available],2000.0,[Not Available],-8326.0,Alive,TUMOR FREE,5514.0,,[Not Applicable],New Primary Tumor,Testes,,4323.0,Complete Remission/Response,,,0.0,5514.0,0.0,5514.0,1.0,4323.0,1.0,4323.0,
TCGA-44-7659,5883,TCGA-44-7659,LUAD,70.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-25730.0,Alive,TUMOR FREE,691.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,691.0,0.0,691.0,0.0,691.0,0.0,691.0,
TCGA-D5-5541,2299,TCGA-D5-5541,COAD,63.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-23109.0,Alive,TUMOR FREE,1701.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1701.0,0.0,1701.0,0.0,1701.0,0.0,1701.0,
TCGA-XF-AAML,452,TCGA-XF-AAML,BLCA,75.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-27422.0,Dead,TUMOR FREE,,232.0,[Not Available],,,,,Complete Remission/Response,,,1.0,232.0,0.0,232.0,0.0,232.0,0.0,232.0,
TCGA-BH-A0BP,1049,TCGA-BH-A0BP,BRCA,76.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27917.0,Dead,TUMOR FREE,,2296.0,[Not Available],,,,,[Not Available],Negative,,1.0,2296.0,0.0,2296.0,0.0,2296.0,0.0,2296.0,
TCGA-BR-7722,9329,TCGA-BR-7722,STAD,62.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-22701.0,Dead,TUMOR FREE,,466.0,[Not Available],,,,,Complete Remission/Response,,,1.0,466.0,0.0,466.0,0.0,466.0,0.0,466.0,
TCGA-XF-A9T4,443,TCGA-XF-A9T4,BLCA,48.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-17728.0,Dead,WITH TUMOR,,495.0,[Not Available],Distant Metastasis,Lung,,182.0,Partial Remission/Response,,,1.0,495.0,1.0,495.0,,,1.0,182.0,
TCGA-BA-5559,3256,TCGA-BA-5559,HNSC,71.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2006.0,[Not Available],-26286.0,Dead,WITH TUMOR,,2083.0,[Not Available],,Oropharynx,,1614.0,Complete Remission/Response,,,1.0,2083.0,1.0,2083.0,,,1.0,1614.0,
TCGA-DU-6410,5007,TCGA-DU-6410,LGG,56.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2010.0,[Not Available],-20567.0,Alive,WITH TUMOR,242.0,,[Not Available],,,,,[Not Available],,,0.0,242.0,0.0,242.0,,,0.0,242.0,
TCGA-C5-A7CL,1648,TCGA-C5-A7CL,CESC,48.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2002.0,[Not Available],-17869.0,Dead,WITH TUMOR,,471.0,Cervical Cancer,,,,,[Not Available],,,1.0,471.0,1.0,471.0,,,1.0,471.0,
TCGA-2Z-A9JI,4432,TCGA-2Z-A9JI,KIRP,38.0,MALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-14196.0,Alive,TUMOR FREE,1567.0,,[Not Available],,,,286.0,Complete Remission/Response,,,0.0,1567.0,0.0,1567.0,1.0,286.0,1.0,286.0,
TCGA-EJ-7791,7967,TCGA-EJ-7791,PRAD,67.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24621.0,Alive,TUMOR FREE,1118.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1118.0,0.0,1118.0,0.0,1118.0,0.0,1118.0,
TCGA-58-8388,6550,TCGA-58-8388,LUSC,60.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-21949.0,Dead,TUMOR FREE,,412.0,[Not Available],,,,,Complete Remission/Response,,,1.0,412.0,0.0,412.0,0.0,412.0,0.0,412.0,
TCGA-BK-A6W3,10788,TCGA-BK-A6W3,UCEC,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12590.0,Alive,TUMOR FREE,305.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,305.0,0.0,305.0,0.0,305.0,0.0,305.0,
TCGA-2G-AAFN,9724,TCGA-2G-AAFN,TGCT,26.0,MALE,WHITE,Stage IIIB,Stage IIIB,Non-Seminoma; Embryonal Carcinoma,[Not Available],2013.0,[Not Available],-9805.0,Alive,TUMOR FREE,773.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,773.0,0.0,773.0,0.0,773.0,0.0,773.0,
TCGA-D3-A1Q5,8828,TCGA-D3-A1Q5,SKCM,60.0,MALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],1996.0,[Not Available],-22200.0,Dead,,,3424.0,[Not Available],Locoregional Recurrence,,,2452.0,[Not Available],,,1.0,3424.0,,3424.0,,,1.0,2452.0,
TCGA-BR-8592,9378,TCGA-BR-8592,STAD,63.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-23133.0,Dead,TUMOR FREE,,191.0,[Not Available],,,,,Complete Remission/Response,,,1.0,191.0,0.0,191.0,0.0,191.0,0.0,191.0,
TCGA-EJ-A65G,7988,TCGA-EJ-A65G,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20821.0,Alive,TUMOR FREE,666.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,666.0,0.0,666.0,0.0,666.0,0.0,666.0,
TCGA-KK-A6E0,8179,TCGA-KK-A6E0,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21700.0,Alive,TUMOR FREE,1483.0,,[Not Available],Biochemical evidence of disease,,,941.0,Complete Remission/Response,,,0.0,1483.0,0.0,1483.0,1.0,941.0,1.0,941.0,
TCGA-HT-7692,5182,TCGA-HT-7692,LGG,43.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2009.0,[Not Available],-15727.0,Alive,TUMOR FREE,90.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,90.0,0.0,90.0,0.0,90.0,0.0,90.0,
TCGA-FC-A5OB,8010,TCGA-FC-A5OB,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-19413.0,Alive,WITH TUMOR,680.0,,[Not Available],,,,,[Unknown],,,0.0,680.0,0.0,680.0,,,0.0,680.0,
TCGA-RD-A8N4,9635,TCGA-RD-A8N4,STAD,58.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2006.0,[Not Available],-21324.0,Alive,TUMOR FREE,2171.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2171.0,0.0,2171.0,0.0,2171.0,0.0,2171.0,
TCGA-EE-A20C,9002,TCGA-EE-A20C,SKCM,59.0,MALE,WHITE,Stage 0,[Not Applicable],,[Not Available],1997.0,[Not Available],-21660.0,Dead,WITH TUMOR,,4601.0,[Not Available],New primary melanoma,,,142.0,[Not Available],,,,,,,,,,,
TCGA-AO-A12B,876,TCGA-AO-A12B,BRCA,63.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23150.0,Alive,TUMOR FREE,2989.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2989.0,0.0,2989.0,0.0,2989.0,0.0,2989.0,
TCGA-64-1679,6077,TCGA-64-1679,LUAD,58.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-21310.0,Alive,TUMOR FREE,2488.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2488.0,0.0,2488.0,0.0,2488.0,0.0,2488.0,
TCGA-S7-A7WQ,7783,TCGA-S7-A7WQ,PCPG,19.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-7269.0,Alive,TUMOR FREE,820.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,820.0,0.0,820.0,0.0,820.0,0.0,820.0,
TCGA-33-4547,6401,TCGA-33-4547,LUSC,68.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-25056.0,Alive,TUMOR FREE,2419.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2419.0,0.0,2419.0,0.0,2419.0,0.0,2419.0,
TCGA-G7-7502,4602,TCGA-G7-7502,KIRP,83.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-30346.0,Alive,TUMOR FREE,786.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,786.0,0.0,786.0,0.0,786.0,0.0,786.0,
TCGA-D3-A8GP,8894,TCGA-D3-A8GP,SKCM,77.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2002.0,[Not Available],-28234.0,Alive,TUMOR FREE,4646.0,,[Not Available],Locoregional Recurrence,,,535.0,[Not Available],,,0.0,4646.0,0.0,4646.0,,,1.0,535.0,
TCGA-22-4609,6380,TCGA-22-4609,LUSC,81.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-29844.0,Dead,TUMOR FREE,,291.0,[Not Available],,,,,Complete Remission/Response,,,1.0,291.0,0.0,291.0,0.0,291.0,0.0,291.0,
TCGA-E9-A1RI,1423,TCGA-E9-A1RI,BRCA,43.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15942.0,Alive,TUMOR FREE,1449.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0,
TCGA-19-5955,3094,TCGA-19-5955,GBM,83.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-30550.0,Dead,,54.0,54.0,[Not Available],,,,,[Not Available],,,1.0,54.0,,54.0,,,0.0,54.0,
TCGA-C5-A8YQ,1663,TCGA-C5-A8YQ,CESC,79.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28873.0,Dead,WITH TUMOR,,715.0,Cervical Cancer,,,,,[Not Available],,,1.0,715.0,1.0,715.0,,,1.0,715.0,
TCGA-FB-A4P6,7554,TCGA-FB-A4P6,PAAD,54.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2012.0,[Not Available],-19904.0,Alive,TUMOR FREE,767.0,,,Locoregional Recurrence,,,620.0,Complete Remission/Response,,,0.0,767.0,0.0,767.0,1.0,620.0,1.0,620.0,
TCGA-FD-A3N6,264,TCGA-FD-A3N6,BLCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-15758.0,Alive,TUMOR FREE,851.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,851.0,0.0,851.0,0.0,851.0,0.0,851.0,
TCGA-HW-7491,5248,TCGA-HW-7491,LGG,35.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2009.0,[Not Available],-12874.0,Alive,WITH TUMOR,2078.0,,[Not Available],,,,2197.0,Progressive Disease,,,0.0,2078.0,0.0,2078.0,,,1.0,2197.0,
TCGA-CF-A8HY,167,TCGA-CF-A8HY,BLCA,59.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-21636.0,Alive,TUMOR FREE,345.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,345.0,0.0,345.0,0.0,345.0,0.0,345.0,
TCGA-G9-A9S0,8055,TCGA-G9-A9S0,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19530.0,Dead,WITH TUMOR,,791.0,Prostate Cancer,Distant Metastasis,Bone,,423.0,Progressive Disease,,,1.0,791.0,1.0,791.0,,,1.0,423.0,
TCGA-DD-AADP,5626,TCGA-DD-AADP,LIHC,45.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-16760.0,Alive,TUMOR FREE,458.0,,[Not Available],,,,,[Not Available],,R0,0.0,458.0,0.0,458.0,0.0,458.0,0.0,458.0,
TCGA-EO-A3AS,10930,TCGA-EO-A3AS,UCEC,86.0,FEMALE,[Not Available],[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31450.0,Alive,TUMOR FREE,1046.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1046.0,0.0,1046.0,0.0,1046.0,0.0,1046.0,
TCGA-B5-A1MW,10719,TCGA-B5-A1MW,UCEC,55.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20183.0,Alive,TUMOR FREE,447.0,,[Not Available],Locoregional Disease,"Other, specify",vaginal cuff,311.0,Complete Remission/Response,,,0.0,447.0,0.0,447.0,1.0,311.0,1.0,311.0,
TCGA-76-4927,3213,TCGA-76-4927,GBM,58.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-21193.0,Dead,WITH TUMOR,535.0,535.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],416.0,[Not Available],,,1.0,535.0,1.0,535.0,,,1.0,416.0,
TCGA-DU-7019,5020,TCGA-DU-7019,LGG,39.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,[Discrepancy],2009.0,[Not Available],-14279.0,Alive,TUMOR FREE,800.0,,[Not Available],,,,,Stable Disease,,,0.0,800.0,0.0,800.0,,,0.0,800.0,
TCGA-HC-7752,8088,TCGA-HC-7752,PRAD,61.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22366.0,Alive,TUMOR FREE,782.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,782.0,0.0,782.0,0.0,782.0,0.0,782.0,
TCGA-BT-A2LA,135,TCGA-BT-A2LA,BLCA,54.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-20032.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,522.0,0.0,522.0,0.0,522.0,0.0,522.0,
TCGA-75-6205,6131,TCGA-75-6205,LUAD,,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],,Dead,WITH TUMOR,,,[Not Available],,,,,Complete Remission/Response,,,1.0,,1.0,,,,1.0,,
TCGA-CG-4455,9458,TCGA-CG-4455,STAD,72.0,MALE,[Not Available],Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2008.0,[Not Available],-26421.0,Alive,TUMOR FREE,366.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,
TCGA-78-7161,6156,TCGA-78-7161,LUAD,69.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25294.0,Dead,WITH TUMOR,,291.0,[Not Available],,,,162.0,Progressive Disease,,,1.0,291.0,1.0,291.0,,,1.0,162.0,
TCGA-EY-A1GJ,10949,TCGA-EY-A1GJ,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26715.0,Alive,TUMOR FREE,727.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,727.0,0.0,727.0,0.0,727.0,0.0,727.0,
TCGA-ET-A2N3,10216,TCGA-ET-A2N3,THCA,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2008.0,[Not Available],-12603.0,Alive,TUMOR FREE,2535.0,,[Not Available],,,,,[Not Available],,RX,0.0,2535.0,0.0,2535.0,,,0.0,2535.0,
TCGA-56-8624,6534,TCGA-56-8624,LUSC,84.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-30798.0,Alive,TUMOR FREE,420.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,420.0,0.0,420.0,0.0,420.0,0.0,420.0,
TCGA-FG-6688,5102,TCGA-FG-6688,LGG,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-21745.0,Alive,WITH TUMOR,571.0,,[Not Available],,,,405.0,Progressive Disease,,,0.0,571.0,0.0,571.0,,,1.0,405.0,
TCGA-IG-A51D,2485,TCGA-IG-A51D,ESCA,63.0,MALE,WHITE,Stage IIB,Stage IV,Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-23259.0,Alive,TUMOR FREE,518.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,518.0,0.0,518.0,,,0.0,518.0,
TCGA-CK-5915,2252,TCGA-CK-5915,COAD,63.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-23040.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-ZF-AA4X,495,TCGA-ZF-AA4X,BLCA,56.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-20579.0,Alive,WITH TUMOR,2044.0,,[Not Available],Locoregional (Urothelial tumor event),Bladder,,1665.0,Complete Remission/Response,,,0.0,2044.0,0.0,2044.0,1.0,1665.0,1.0,1665.0,
TCGA-05-4249,5805,TCGA-05-4249,LUAD,67.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-24532.0,Alive,TUMOR FREE,1523.0,,[Not Available],,,,,[Not Applicable],,,0.0,1523.0,0.0,1523.0,,,0.0,1523.0,
TCGA-EO-A22T,10924,TCGA-EO-A22T,UCEC,56.0,FEMALE,ASIAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20608.0,Alive,TUMOR FREE,2035.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2035.0,0.0,2035.0,0.0,2035.0,0.0,2035.0,
TCGA-B4-5834,4086,TCGA-B4-5834,KIRC,59.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2010.0,[Not Available],-21713.0,Alive,TUMOR FREE,38.0,,[Not Available],,,,,[Not Applicable],,,0.0,38.0,0.0,38.0,,,0.0,38.0,
TCGA-G3-A25V,5703,TCGA-G3-A25V,LIHC,68.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-25144.0,Alive,WITH TUMOR,860.0,,[Not Available],Intrahepatic Recurrence,Liver,,489.0,[Not Available],,R0,0.0,860.0,0.0,860.0,1.0,489.0,1.0,489.0,
TCGA-CU-A3YL,177,TCGA-CU-A3YL,BLCA,67.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-24524.0,Alive,TUMOR FREE,906.0,,[Not Available],Distant Metastasis,Lung,,370.0,Complete Remission/Response,,,0.0,906.0,0.0,906.0,1.0,370.0,1.0,370.0,
TCGA-IQ-A61I,3685,TCGA-IQ-A61I,HNSC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,[Not Available],-23035.0,Dead,TUMOR FREE,,2.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2.0,0.0,2.0,,,0.0,2.0,
TCGA-26-5134,3110,TCGA-26-5134,GBM,74.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-27111.0,Alive,TUMOR FREE,167.0,,[Not Available],,,,,[Not Available],,,0.0,167.0,0.0,167.0,,,0.0,167.0,
TCGA-B3-8121,4517,TCGA-B3-8121,KIRP,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-17760.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-06-0190,2793,TCGA-06-0190,GBM,62.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-22835.0,Dead,WITH TUMOR,313.0,317.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],88.0,[Not Available],,,1.0,317.0,1.0,317.0,,,1.0,88.0,
TCGA-FV-A23B,5689,TCGA-FV-A23B,LIHC,70.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,[Not Available],2005.0,[Not Available],-25788.0,Dead,WITH TUMOR,,1852.0,[Not Available],Locoregional Recurrence,Liver,,1453.0,[Not Available],,R0,1.0,1852.0,1.0,1852.0,1.0,1453.0,1.0,1453.0,
TCGA-GS-A9TX,2452,TCGA-GS-A9TX,DLBC,37.0,MALE,WHITE,[Not Applicable],Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2011.0,[Not Available],-13708.0,Alive,TUMOR FREE,1373.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1373.0,0.0,1373.0,0.0,1373.0,0.0,1373.0,
TCGA-C8-A1HJ,1202,TCGA-C8-A1HJ,BRCA,53.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Peri (6-12 months since last menstrual period),-19629.0,Alive,TUMOR FREE,5.0,,[Not Available],,,,,[Not Available],Negative,,0.0,5.0,0.0,5.0,0.0,5.0,0.0,5.0,
TCGA-E1-5307,5070,TCGA-E1-5307,LGG,62.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2000.0,[Not Available],-22837.0,Dead,WITH TUMOR,,1762.0,[Not Available],,,,1452.0,Stable Disease,,,1.0,1762.0,1.0,1762.0,,,1.0,1452.0,
TCGA-LT-A5Z6,392,TCGA-LT-A5Z6,BLCA,56.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-20746.0,Alive,TUMOR FREE,474.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,
TCGA-G3-A5SM,5717,TCGA-G3-A5SM,LIHC,58.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-21236.0,Alive,TUMOR FREE,520.0,,[Not Available],Intrahepatic Recurrence,Liver,,252.0,[Not Available],,R0,0.0,520.0,0.0,520.0,1.0,252.0,1.0,252.0,
TCGA-CV-7104,3528,TCGA-CV-7104,HNSC,61.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2000.0,[Not Available],-22349.0,Dead,TUMOR FREE,,393.0,[Not Available],,,,,Complete Remission/Response,,,1.0,393.0,0.0,393.0,,,0.0,393.0,
TCGA-ZF-AA54,499,TCGA-ZF-AA54,BLCA,71.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-26128.0,Dead,,,590.0,[Not Available],,,,,[Unknown],,,1.0,590.0,,590.0,,,0.0,590.0,
TCGA-XY-A9T9,9826,TCGA-XY-A9T9,TGCT,37.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],2013.0,[Not Available],-13604.0,Alive,TUMOR FREE,281.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,281.0,0.0,281.0,0.0,281.0,0.0,281.0,
TCGA-12-0688,2948,TCGA-12-0688,GBM,74.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-27085.0,Dead,WITH TUMOR,734.0,811.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],228.0,[Not Available],,,1.0,811.0,1.0,811.0,,,1.0,228.0,
TCGA-2J-AABI,7512,TCGA-2J-AABI,PAAD,55.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2011.0,[Not Available],-20316.0,Alive,WITH TUMOR,969.0,,,Distant Metastasis,Liver,,728.0,Progressive Disease,,,0.0,969.0,0.0,969.0,,,1.0,728.0,
TCGA-GL-A9DC,4615,TCGA-GL-A9DC,KIRP,66.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-24348.0,Alive,TUMOR FREE,392.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,392.0,0.0,392.0,0.0,392.0,0.0,392.0,
TCGA-FI-A2F4,10993,TCGA-FI-A2F4,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23621.0,Alive,TUMOR FREE,2230.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2230.0,0.0,2230.0,0.0,2230.0,0.0,2230.0,
TCGA-G3-A25S,5700,TCGA-G3-A25S,LIHC,64.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2009.0,[Not Available],-23571.0,Dead,WITH TUMOR,,416.0,[Not Available],Extrahepatic Recurrence,"Other, specify",Bone and Lung,37.0,[Not Available],,R1,1.0,416.0,1.0,416.0,,,1.0,37.0,
TCGA-HT-A5R7,5225,TCGA-HT-A5R7,LGG,33.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-12092.0,Alive,TUMOR FREE,615.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,615.0,0.0,615.0,0.0,615.0,0.0,615.0,
TCGA-OR-A5L9,63,TCGA-OR-A5L9,ACC,53.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-19526.0,Alive,TUMOR FREE,871.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,871.0,0.0,871.0,0.0,871.0,0.0,871.0,
TCGA-FD-A6TC,297,TCGA-FD-A6TC,BLCA,79.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-28963.0,Alive,TUMOR FREE,187.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,187.0,0.0,187.0,0.0,187.0,0.0,187.0,
TCGA-AX-A3FW,10663,TCGA-AX-A3FW,UCEC,66.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24419.0,Alive,,17.0,,[Not Available],,,,,[Not Available],,,0.0,17.0,0.0,17.0,,,0.0,17.0,
TCGA-X7-A8DI,10394,TCGA-X7-A8DI,THYM,57.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2013.0,[Not Available],-21086.0,Alive,TUMOR FREE,705.0,,[Not Available],,,,,[Not Available],,,0.0,705.0,0.0,705.0,,,0.0,705.0,
TCGA-S7-A7WV,7787,TCGA-S7-A7WV,PCPG,35.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-12893.0,Alive,TUMOR FREE,849.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,849.0,0.0,849.0,0.0,849.0,0.0,849.0,
TCGA-TQ-A7RM,5394,TCGA-TQ-A7RM,LGG,41.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-15154.0,Alive,WITH TUMOR,1116.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1116.0,0.0,1116.0,,,0.0,1116.0,
TCGA-AA-A022,2172,TCGA-AA-A022,COAD,88.0,FEMALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-32446.0,Alive,WITH TUMOR,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-E2-A15F,1338,TCGA-E2-A15F,BRCA,64.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23660.0,Alive,TUMOR FREE,658.0,,[Not Available],,,,,[Not Available],Negative,,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,
TCGA-DD-A1EF,5530,TCGA-DD-A1EF,LIHC,57.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2007.0,[Not Available],-21165.0,Dead,WITH TUMOR,,394.0,[Not Available],,,,,[Not Available],,R0,1.0,394.0,1.0,394.0,,,1.0,394.0,
TCGA-CG-4305,9447,TCGA-CG-4305,STAD,69.0,MALE,[Not Available],Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-25295.0,Alive,TUMOR FREE,485.0,,[Not Available],,,,457.0,[Unknown],,,0.0,485.0,0.0,485.0,,,1.0,457.0,
TCGA-B3-4104,4516,TCGA-B3-4104,KIRP,75.0,MALE,WHITE,Stage II,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-27709.0,Alive,TUMOR FREE,1049.0,,[Not Available],,,,,[Not Available],,,0.0,1049.0,0.0,1049.0,,,0.0,1049.0,
TCGA-98-7454,6781,TCGA-98-7454,LUSC,73.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26827.0,Alive,TUMOR FREE,652.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,652.0,0.0,652.0,0.0,652.0,0.0,652.0,
TCGA-G5-6233,8533,TCGA-G5-6233,READ,74.0,MALE,WHITE,[Discrepancy],[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-27190.0,Dead,WITH TUMOR,,556.0,[Not Available],,,,92.0,[Not Available],,,1.0,556.0,1.0,556.0,,,1.0,92.0,
TCGA-CQ-5334,3386,TCGA-CQ-5334,HNSC,87.0,MALE,WHITE,Stage IVA,Stage IVB,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-32024.0,Dead,WITH TUMOR,,129.0,[Not Available],,Oral Cavity,,50.0,Progressive Disease,,,1.0,129.0,1.0,129.0,,,1.0,50.0,
TCGA-A5-A0RA,10506,TCGA-A5-A0RA,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25060.0,Alive,TUMOR FREE,884.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,884.0,0.0,884.0,0.0,884.0,0.0,884.0,
TCGA-WB-A80V,7837,TCGA-WB-A80V,PCPG,63.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-23254.0,Alive,TUMOR FREE,887.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,887.0,0.0,887.0,0.0,887.0,0.0,887.0,
TCGA-34-5236,6427,TCGA-34-5236,LUSC,60.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-21935.0,Dead,WITH TUMOR,,276.0,[Not Available],Locoregional Recurrence,,,113.0,Progressive Disease,,,1.0,276.0,1.0,276.0,,,1.0,113.0,
TCGA-78-7154,6150,TCGA-78-7154,LUAD,72.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2003.0,[Not Available],-26481.0,Dead,,,593.0,[Not Available],,,,,[Not Available],,,1.0,593.0,,593.0,,,0.0,593.0,
TCGA-OR-A5JG,16,TCGA-OR-A5JG,ACC,61.0,MALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-22390.0,Dead,WITH TUMOR,,541.0,[Not Available],,,,,[Not Available],,,1.0,541.0,1.0,541.0,,,1.0,541.0,
TCGA-63-A5M9,6592,TCGA-63-A5M9,LUSC,,FEMALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],,Alive,,0.0,,[Not Available],,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-BG-A186,10765,TCGA-BG-A186,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2010.0,[Not Available],-22370.0,Alive,TUMOR FREE,419.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,419.0,0.0,419.0,0.0,419.0,0.0,419.0,
TCGA-OU-A5PI,83,TCGA-OU-A5PI,ACC,53.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-19492.0,Alive,WITH TUMOR,1171.0,,[Not Available],Distant Metastasis,Lung,,351.0,Stable Disease,,,0.0,1171.0,0.0,1171.0,,,1.0,351.0,
TCGA-DD-AAD3,5608,TCGA-DD-AAD3,LIHC,43.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-15706.0,Alive,TUMOR FREE,1295.0,,[Not Available],,,,,[Not Available],,R0,0.0,1295.0,0.0,1295.0,0.0,1295.0,0.0,1295.0,
TCGA-FP-7735,9537,TCGA-FP-7735,STAD,77.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-28232.0,Dead,TUMOR FREE,,106.0,[Not Available],,,,,Complete Remission/Response,,,1.0,106.0,0.0,106.0,0.0,106.0,0.0,106.0,
TCGA-X6-A7WD,8785,TCGA-X6-A7WD,SARC,63.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2013.0,[Not Available],-23341.0,Alive,WITH TUMOR,938.0,,[Not Available],Distant Metastasis,Lung,,558.0,[Not Available],Negative,R0,0.0,938.0,0.0,938.0,1.0,558.0,1.0,558.0,
TCGA-A3-3363,3914,TCGA-A3-3363,KIRC,50.0,MALE,ASIAN,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-18596.0,Alive,TUMOR FREE,319.0,,[Not Available],,,,,[Not Available],,,0.0,319.0,0.0,319.0,,,0.0,319.0,
TCGA-86-7955,6186,TCGA-86-7955,LUAD,62.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22772.0,Alive,TUMOR FREE,1072.0,,[Not Available],Locoregional Recurrence,,,820.0,Complete Remission/Response,,,0.0,1072.0,0.0,1072.0,1.0,820.0,1.0,820.0,
TCGA-EW-A1J3,1461,TCGA-EW-A1J3,BRCA,61.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22332.0,Alive,TUMOR FREE,504.0,,[Not Available],,,,,[Not Available],Negative,,0.0,504.0,0.0,504.0,0.0,504.0,0.0,504.0,
TCGA-EA-A97N,1717,TCGA-EA-A97N,CESC,38.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13984.0,Alive,TUMOR FREE,11.0,,,,,,,Complete Remission/Response,,,0.0,11.0,0.0,11.0,0.0,11.0,0.0,11.0,
TCGA-CQ-7068,3402,TCGA-CQ-7068,HNSC,80.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-29530.0,Alive,TUMOR FREE,1309.0,,[Not Available],New Primary Tumor,Oral Cavity,left buccal mucosa,1148.0,Complete Remission/Response,,,0.0,1309.0,0.0,1309.0,0.0,1309.0,1.0,1148.0,
TCGA-78-7158,6153,TCGA-78-7158,LUAD,59.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-21742.0,Dead,WITH TUMOR,,179.0,[Not Available],,,,132.0,Progressive Disease,,,1.0,179.0,1.0,179.0,,,1.0,132.0,
TCGA-V4-A9EU,11103,TCGA-V4-A9EU,UVM,83.0,FEMALE,WHITE,Stage IIIC,Stage IIIC,Epithelioid Cell,[Not Available],2011.0,[Not Available],-30409.0,Alive,TUMOR FREE,709.0,,[Not Available],New Primary Tumor,"Other, specify",Biliary,86.0,[Not Available],,,0.0,709.0,0.0,709.0,,,1.0,86.0,
TCGA-BL-A0C8,117,TCGA-BL-A0C8,BLCA,73.0,MALE,WHITE,Stage I,[Not Applicable],[Not Available],High Grade,2009.0,[Not Available],-26819.0,Alive,,1219.0,,[Not Available],Locoregional (Urothelial tumor event),Bladder,,630.0,Complete Remission/Response,,,0.0,1219.0,0.0,1219.0,1.0,630.0,1.0,630.0,
TCGA-FR-A8YC,9140,TCGA-FR-A8YC,SKCM,78.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2011.0,[Not Available],-28680.0,Dead,WITH TUMOR,,1059.0,[Not Available],,,,,[Not Available],,,1.0,1059.0,1.0,1059.0,,,1.0,1059.0,
TCGA-IG-A3YB,2479,TCGA-IG-A3YB,ESCA,61.0,MALE,WHITE,Stage IIIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-22316.0,Alive,TUMOR FREE,80.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,80.0,0.0,80.0,0.0,80.0,0.0,80.0,
TCGA-XE-AAOD,9819,TCGA-XE-AAOD,TGCT,39.0,MALE,WHITE,Stage IB,Stage IB,Seminoma; NOS|Non-Seminoma; Choriocarcinoma,[Not Available],2008.0,[Not Available],-14265.0,Alive,TUMOR FREE,2058.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,2058.0,0.0,2058.0,0.0,2058.0,0.0,2058.0,
TCGA-44-3918,5866,TCGA-44-3918,LUAD,60.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-22236.0,Alive,WITH TUMOR,1036.0,,[Not Available],,,,511.0,Complete Remission/Response,,,0.0,1036.0,0.0,1036.0,1.0,511.0,1.0,511.0,
TCGA-2J-AABV,7519,TCGA-2J-AABV,PAAD,74.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G4,2012.0,[Not Available],-27082.0,Dead,WITH TUMOR,,652.0,Pancreatic Cancer,Distant Metastasis,Liver,,126.0,Progressive Disease,,,1.0,652.0,1.0,652.0,,,1.0,126.0,
TCGA-AD-6965,2196,TCGA-AD-6965,COAD,62.0,MALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-22853.0,Alive,WITH TUMOR,805.0,,[Not Available],,,,648.0,Complete Remission/Response,,,0.0,805.0,0.0,805.0,1.0,648.0,1.0,648.0,
TCGA-BR-A4QI,9411,TCGA-BR-A4QI,STAD,70.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-25928.0,Dead,WITH TUMOR,,652.0,[Not Available],Distant Metastasis,"Other, specify",Pancreas,383.0,Complete Remission/Response,,,1.0,652.0,1.0,652.0,1.0,383.0,1.0,383.0,
TCGA-EM-A3AP,10166,TCGA-EM-A3AP,THCA,31.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-11592.0,Alive,TUMOR FREE,254.0,,[Not Available],,,,,[Not Available],,R0,0.0,254.0,0.0,254.0,0.0,254.0,0.0,254.0,
TCGA-UF-A7JT,3765,TCGA-UF-A7JT,HNSC,72.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2009.0,[Not Available],-26375.0,Dead,WITH TUMOR,,993.0,[Not Available],,,Cervix,718.0,Complete Remission/Response,,,1.0,993.0,1.0,993.0,,,1.0,718.0,
TCGA-AX-A2HK,10657,TCGA-AX-A2HK,UCEC,77.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28316.0,Dead,WITH TUMOR,,90.0,[Not Available],,,,,Complete Remission/Response,,,1.0,90.0,1.0,90.0,,,1.0,90.0,
TCGA-2G-AAG6,9732,TCGA-2G-AAG6,TGCT,24.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Yolk Sac Tumor,[Not Available],2008.0,[Not Available],-9071.0,Alive,TUMOR FREE,2231.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,2231.0,0.0,2231.0,0.0,2231.0,0.0,2231.0,
TCGA-FG-A4MY,5125,TCGA-FG-A4MY,LGG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-16310.0,Alive,WITH TUMOR,721.0,,[Not Available],,,,,Stable Disease,,,0.0,721.0,0.0,721.0,,,0.0,721.0,
TCGA-RP-A694,9223,TCGA-RP-A694,SKCM,71.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2009.0,[Not Available],-26044.0,Alive,TUMOR FREE,21.0,,[Not Available],,,,,[Not Available],,,0.0,21.0,0.0,21.0,,,0.0,21.0,
TCGA-44-7667,5887,TCGA-44-7667,LUAD,49.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-18062.0,Alive,TUMOR FREE,1097.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1097.0,0.0,1097.0,0.0,1097.0,0.0,1097.0,
TCGA-CM-6165,2280,TCGA-CM-6165,COAD,74.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-27302.0,Alive,TUMOR FREE,488.0,,[Not Available],,,,,[Not Available],,,0.0,488.0,0.0,488.0,,,0.0,488.0,
TCGA-AX-A0IU,10625,TCGA-AX-A0IU,UCEC,79.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29063.0,Alive,TUMOR FREE,1087.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1087.0,0.0,1087.0,0.0,1087.0,0.0,1087.0,
TCGA-HF-7134,9553,TCGA-HF-7134,STAD,,MALE,[Not Available],Stage IA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],,Alive,TUMOR FREE,1588.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1588.0,0.0,1588.0,0.0,1588.0,0.0,1588.0,
TCGA-EI-6882,8515,TCGA-EI-6882,READ,59.0,MALE,WHITE,Stage IIA,[Not Applicable],Rectal Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-21682.0,Alive,TUMOR FREE,262.0,,[Not Available],,,,,[Not Available],,,0.0,262.0,0.0,262.0,,,0.0,262.0,
TCGA-2G-AAL5,9772,TCGA-2G-AAL5,TGCT,31.0,MALE,WHITE,Stage I,Stage I,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS,[Not Available],1994.0,[Not Available],-11478.0,Alive,TUMOR FREE,7437.0,,[Not Applicable],New Primary Tumor,Testes,,3723.0,Complete Remission/Response,,,0.0,7437.0,0.0,7437.0,1.0,3723.0,1.0,3723.0,
TCGA-TS-A8AS,6890,TCGA-TS-A8AS,MESO,77.0,MALE,WHITE,Stage IA,[Not Applicable],Epithelioid mesothelioma,[Not Available],2011.0,[Not Available],-28273.0,Dead,,,795.0,[Not Available],,,,,[Not Available],,[Unknown],1.0,795.0,,795.0,,,0.0,795.0,
TCGA-D3-A3C3,8854,TCGA-D3-A3C3,SKCM,,FEMALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],1985.0,[Not Available],,Alive,WITH TUMOR,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-MZ-A7D7,3705,TCGA-MZ-A7D7,HNSC,51.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,[Not Available],2013.0,[Not Available],-18974.0,Alive,WITH TUMOR,547.0,,[Not Available],Distant Metastasis,Distant Metastasis,lung,339.0,Complete Remission/Response,,,0.0,547.0,0.0,547.0,,,1.0,339.0,
TCGA-2Z-A9J5,4424,TCGA-2Z-A9J5,KIRP,80.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-29275.0,Alive,TUMOR FREE,3050.0,,[Not Available],,,,,[Unknown],,,0.0,3050.0,0.0,3050.0,,,0.0,3050.0,
TCGA-ZJ-AAXI,1901,TCGA-ZJ-AAXI,CESC,67.0,FEMALE,[Unknown],[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,[Unknown],-24497.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-B8-5551,4112,TCGA-B8-5551,KIRC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-23976.0,Alive,TUMOR FREE,16.0,,[Not Available],,,,,[Not Available],,,0.0,16.0,0.0,16.0,,,0.0,16.0,
TCGA-D3-A51K,8872,TCGA-D3-A51K,SKCM,51.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2011.0,[Not Available],-18971.0,Alive,TUMOR FREE,1002.0,,[Not Available],,,,,[Not Available],,,0.0,1002.0,0.0,1002.0,,,0.0,1002.0,
TCGA-J9-A8CN,8160,TCGA-J9-A8CN,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19662.0,Alive,TUMOR FREE,1237.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1237.0,0.0,1237.0,0.0,1237.0,0.0,1237.0,
TCGA-RY-A840,5317,TCGA-RY-A840,LGG,47.0,MALE,[Unknown],[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-17501.0,Alive,WITH TUMOR,854.0,,[Not Available],,,,,Stable Disease,,,0.0,854.0,0.0,854.0,,,0.0,854.0,
TCGA-EW-A1IX,1456,TCGA-EW-A1IX,BRCA,48.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2008.0,Peri (6-12 months since last menstrual period),-17597.0,Alive,TUMOR FREE,1208.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1208.0,0.0,1208.0,0.0,1208.0,0.0,1208.0,
TCGA-CV-7089,3518,TCGA-CV-7089,HNSC,74.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,[Not Available],-27149.0,Dead,TUMOR FREE,,1972.0,[Not Available],,,,,[Not Available],,,1.0,1972.0,0.0,1972.0,,,0.0,1972.0,
TCGA-CV-6940,3501,TCGA-CV-6940,HNSC,80.0,FEMALE,WHITE,Stage III,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2002.0,[Not Available],-29382.0,Dead,TUMOR FREE,,804.0,[Not Available],,,,,Complete Remission/Response,,,1.0,804.0,0.0,804.0,0.0,804.0,0.0,804.0,
TCGA-DB-A4XC,4944,TCGA-DB-A4XC,LGG,26.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2010.0,[Not Available],-9705.0,Alive,TUMOR FREE,1421.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1421.0,0.0,1421.0,,,0.0,1421.0,
TCGA-78-7150,6147,TCGA-78-7150,LUAD,59.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-21891.0,Dead,WITH TUMOR,,666.0,[Not Available],,,,139.0,[Not Available],,,1.0,666.0,1.0,666.0,,,1.0,139.0,
TCGA-EB-A6QY,8984,TCGA-EB-A6QY,SKCM,71.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-26216.0,Alive,TUMOR FREE,382.0,,[Not Available],Regional lymph node,,,36.0,[Not Available],,,0.0,382.0,0.0,382.0,,,1.0,36.0,
TCGA-IG-A8O2,2491,TCGA-IG-A8O2,ESCA,62.0,MALE,ASIAN,Stage IIIB,[Not Available],Esophagus Squamous Cell Carcinoma,G3,2013.0,[Not Available],-22869.0,Dead,TUMOR FREE,,142.0,[Not Available],,,,,Complete Remission/Response,,,1.0,142.0,0.0,142.0,0.0,142.0,0.0,142.0,
TCGA-CC-A7IJ,5503,TCGA-CC-A7IJ,LIHC,56.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-20751.0,Alive,TUMOR FREE,382.0,,[Not Available],,,,,[Not Available],,R0,0.0,382.0,0.0,382.0,0.0,382.0,0.0,382.0,
TCGA-AR-A24O,937,TCGA-AR-A24O,BRCA,43.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15977.0,Alive,WITH TUMOR,3607.0,,[Not Available],,,,2561.0,[Not Available],Negative,,0.0,3607.0,0.0,3607.0,1.0,2561.0,1.0,2561.0,
TCGA-D3-A1Q7,8830,TCGA-D3-A1Q7,SKCM,42.0,FEMALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2002.0,[Not Available],-15531.0,Alive,TUMOR FREE,4053.0,,[Not Available],Distant Metastasis,"Other, Specify",soft tissue left buttock,921.0,[Not Available],,,0.0,4053.0,0.0,4053.0,,,1.0,921.0,
TCGA-DD-AAVV,5656,TCGA-DD-AAVV,LIHC,56.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2007.0,[Not Available],-20751.0,Alive,TUMOR FREE,2455.0,,[Not Available],,,,,[Not Available],,R0,0.0,2455.0,0.0,2455.0,0.0,2455.0,0.0,2455.0,
TCGA-27-1837,3124,TCGA-27-1837,GBM,36.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-13368.0,Dead,WITH TUMOR,427.0,427.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],136.0,[Not Available],,,1.0,427.0,1.0,427.0,,,1.0,136.0,
TCGA-SW-A7EB,9641,TCGA-SW-A7EB,STAD,45.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2013.0,[Not Available],-16475.0,Alive,TUMOR FREE,176.0,,[Not Available],,,,,Progressive Disease,,,0.0,176.0,0.0,176.0,,,0.0,176.0,
TCGA-05-4403,5816,TCGA-05-4403,LUAD,76.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-27881.0,Alive,,578.0,,[Not Available],,,,,[Not Available],,,0.0,578.0,0.0,578.0,,,0.0,578.0,
TCGA-DD-A1E9,5524,TCGA-DD-A1E9,LIHC,70.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2002.0,[Not Available],-25808.0,Dead,,,2759.0,[Not Available],Intrahepatic Recurrence,Liver,,720.0,[Not Available],,R0,1.0,2759.0,,2759.0,1.0,720.0,1.0,720.0,
TCGA-HI-7169,8127,TCGA-HI-7169,PRAD,55.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-20133.0,Alive,TUMOR FREE,2684.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2684.0,0.0,2684.0,0.0,2684.0,0.0,2684.0,
TCGA-85-7844,6713,TCGA-85-7844,LUSC,71.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26141.0,Alive,TUMOR FREE,911.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,
TCGA-27-1831,3118,TCGA-27-1831,GBM,66.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-24447.0,Dead,WITH TUMOR,505.0,505.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],144.0,[Not Available],,,1.0,505.0,1.0,505.0,,,1.0,144.0,
TCGA-A7-A6VY,670,TCGA-A7-A6VY,BRCA,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17640.0,Alive,TUMOR FREE,266.0,,[Not Available],,,,,[Not Available],Negative,,0.0,266.0,0.0,266.0,0.0,266.0,0.0,266.0,
TCGA-DU-8166,5038,TCGA-DU-8166,LGG,29.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-10641.0,Alive,WITH TUMOR,516.0,,[Not Available],,,,193.0,Progressive Disease,,,0.0,516.0,0.0,516.0,,,1.0,193.0,
TCGA-VR-AA7B,2634,TCGA-VR-AA7B,ESCA,65.0,FEMALE,WHITE,Stage IV,Stage IIB,Esophagus Squamous Cell Carcinoma,G2,2011.0,[Not Available],-23915.0,Alive,WITH TUMOR,342.0,,[Not Available],Distant Metastasis,Brain,,207.0,[Not Available],,,0.0,342.0,0.0,342.0,,,1.0,207.0,
TCGA-B5-A11E,10694,TCGA-B5-A11E,UCEC,53.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Peri (6-12 months since last menstrual period),-19458.0,Alive,TUMOR FREE,1820.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1820.0,0.0,1820.0,0.0,1820.0,0.0,1820.0,
TCGA-A3-3387,3927,TCGA-A3-3387,KIRC,49.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-17920.0,Alive,TUMOR FREE,617.0,,[Not Available],,,,,[Not Available],,,0.0,617.0,0.0,617.0,,,0.0,617.0,
TCGA-50-6595,5956,TCGA-50-6595,LUAD,74.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-27197.0,Dead,WITH TUMOR,,189.0,[Not Available],Distant Metastasis,,,182.0,Progressive Disease,,,1.0,189.0,1.0,189.0,,,1.0,182.0,
TCGA-G9-6348,8023,TCGA-G9-6348,PRAD,68.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-24936.0,Alive,TUMOR FREE,1515.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1515.0,0.0,1515.0,0.0,1515.0,0.0,1515.0,
TCGA-BS-A0TA,10791,TCGA-BS-A0TA,UCEC,58.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21505.0,Dead,WITH TUMOR,,740.0,[Not Available],,,,394.0,Stable Disease,,,1.0,740.0,1.0,740.0,,,1.0,394.0,
TCGA-A2-A0YE,586,TCGA-A2-A0YE,BRCA,48.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17727.0,Alive,TUMOR FREE,554.0,,[Not Available],,,,,[Not Available],Negative,,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,
TCGA-VN-A88K,8268,TCGA-VN-A88K,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21524.0,Alive,,776.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,776.0,0.0,776.0,0.0,776.0,0.0,776.0,
TCGA-CC-A3MA,5492,TCGA-CC-A3MA,LIHC,61.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-22375.0,Dead,WITH TUMOR,,303.0,[Not Available],Locoregional Recurrence,,,261.0,[Not Available],,R0,1.0,303.0,1.0,303.0,1.0,261.0,1.0,261.0,
TCGA-2G-AAH2,9756,TCGA-2G-AAH2,TGCT,20.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS,[Not Available],1998.0,[Not Available],-7635.0,Alive,TUMOR FREE,6060.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,6060.0,0.0,6060.0,0.0,6060.0,0.0,6060.0,
TCGA-EL-A4KD,10116,TCGA-EL-A4KD,THCA,41.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-15291.0,Alive,TUMOR FREE,1326.0,,[Not Available],,,,,[Not Available],,R0,0.0,1326.0,0.0,1326.0,0.0,1326.0,0.0,1326.0,
TCGA-B5-A11O,10703,TCGA-B5-A11O,UCEC,62.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22720.0,Alive,TUMOR FREE,2609.0,,[Not Available],New Primary Tumor,"Other, specify",Right Breast,1924.0,Complete Remission/Response,,,0.0,2609.0,0.0,2609.0,0.0,2609.0,1.0,1924.0,
TCGA-NI-A4U2,5756,TCGA-NI-A4U2,LIHC,71.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2005.0,[Not Available],-26011.0,Dead,WITH TUMOR,,1791.0,[Not Available],Locoregional Recurrence,Liver,,106.0,[Not Available],,R0,1.0,1791.0,1.0,1791.0,1.0,106.0,1.0,106.0,
TCGA-HT-A74H,5239,TCGA-HT-A74H,LGG,62.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-22850.0,Alive,,74.0,,[Not Available],,,,,Stable Disease,,,0.0,74.0,0.0,74.0,,,0.0,74.0,
TCGA-B5-A3FB,10726,TCGA-B5-A3FB,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26779.0,Alive,TUMOR FREE,2844.0,,[Not Available],,,,,[Not Available],,,0.0,2844.0,0.0,2844.0,,,0.0,2844.0,
TCGA-CN-5365,3329,TCGA-CN-5365,HNSC,38.0,MALE,WHITE,Stage IVB,Stage IVC,Head & Neck Squamous Cell Carcinoma,G2,2006.0,[Not Available],-14190.0,Dead,WITH TUMOR,,351.0,[Not Available],,,,,Progressive Disease,,,1.0,351.0,1.0,351.0,,,1.0,351.0,
TCGA-AQ-A1H2,893,TCGA-AQ-A1H2,BRCA,84.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30958.0,Alive,TUMOR FREE,475.0,,[Not Available],,,,,[Not Available],Negative,,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,
TCGA-5P-A9K6,4456,TCGA-5P-A9K6,KIRP,64.0,MALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-23384.0,Alive,,1914.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1914.0,0.0,1914.0,0.0,1914.0,0.0,1914.0,
TCGA-EB-A299,8941,TCGA-EB-A299,SKCM,63.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2011.0,[Not Available],-23322.0,Alive,TUMOR FREE,378.0,,[Not Available],,,,,[Not Available],,,0.0,378.0,0.0,378.0,,,0.0,378.0,
TCGA-EJ-8468,7972,TCGA-EJ-8468,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-23371.0,Alive,TUMOR FREE,2347.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2347.0,0.0,2347.0,0.0,2347.0,0.0,2347.0,
TCGA-P5-A733,5281,TCGA-P5-A733,LGG,52.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-19142.0,Alive,TUMOR FREE,414.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,414.0,0.0,414.0,0.0,414.0,0.0,414.0,
TCGA-XK-AAJR,8307,TCGA-XK-AAJR,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22643.0,Alive,TUMOR FREE,1124.0,,[Not Available],Biochemical evidence of disease,,,131.0,Complete Remission/Response,,,0.0,1124.0,0.0,1124.0,1.0,131.0,1.0,131.0,
TCGA-BS-A0U7,10799,TCGA-BS-A0U7,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23166.0,Dead,TUMOR FREE,,935.0,[Not Available],,,,,Complete Remission/Response,,,1.0,935.0,0.0,935.0,0.0,935.0,0.0,935.0,
TCGA-DD-A39W,5538,TCGA-DD-A39W,LIHC,29.0,FEMALE,WHITE,Stage III,[Not Applicable],Hepatocellular Carcinoma,G2,1995.0,[Not Available],-10699.0,Dead,,,827.0,[Not Available],,,,,[Not Available],,R0,1.0,827.0,,827.0,0.0,827.0,0.0,827.0,
TCGA-AC-A2QH,769,TCGA-AC-A2QH,BRCA,58.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Metaplastic Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21488.0,Alive,TUMOR FREE,1005.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1005.0,0.0,1005.0,0.0,1005.0,0.0,1005.0,
TCGA-B5-A11N,10702,TCGA-B5-A11N,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25442.0,Alive,TUMOR FREE,1876.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1876.0,0.0,1876.0,0.0,1876.0,0.0,1876.0,
TCGA-EY-A1GT,10958,TCGA-EY-A1GT,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25151.0,Alive,TUMOR FREE,490.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,490.0,0.0,490.0,0.0,490.0,0.0,490.0,
TCGA-US-A779,7674,TCGA-US-A779,PAAD,54.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,[Not Available],-20051.0,Dead,WITH TUMOR,,511.0,Pancreatic Cancer,,,,,[Not Available],,,1.0,511.0,1.0,511.0,,,1.0,511.0,
TCGA-W5-AA30,1933,TCGA-W5-AA30,CHOL,82.0,MALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2010.0,[Not Available],-30039.0,Alive,TUMOR FREE,1153.0,,[Not Available],,,,,[Not Available],,R0,0.0,1153.0,0.0,1153.0,0.0,1153.0,0.0,1153.0,
TCGA-86-8671,6203,TCGA-86-8671,LUAD,72.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26448.0,Alive,TUMOR FREE,839.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,839.0,0.0,839.0,0.0,839.0,0.0,839.0,
TCGA-A3-A8OV,3934,TCGA-A3-A8OV,KIRC,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2011.0,[Not Available],-27526.0,Alive,TUMOR FREE,340.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,340.0,0.0,340.0,0.0,340.0,0.0,340.0,
TCGA-CV-7254,3544,TCGA-CV-7254,HNSC,55.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,1996.0,[Not Available],-20306.0,Dead,WITH TUMOR,,1459.0,[Not Available],,,,,[Not Available],,,1.0,1459.0,1.0,1459.0,,,1.0,1459.0,
TCGA-55-6975,5980,TCGA-55-6975,LUAD,61.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],,Dead,WITH TUMOR,,118.0,[Not Available],,,,,Progressive Disease,,,1.0,118.0,1.0,118.0,,,1.0,118.0,
TCGA-GM-A2DH,1506,TCGA-GM-A2DH,BRCA,58.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21344.0,Alive,TUMOR FREE,2193.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2193.0,0.0,2193.0,0.0,2193.0,0.0,2193.0,
TCGA-06-0211,2803,TCGA-06-0211,GBM,47.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1997.0,[Not Available],-17515.0,Dead,WITH TUMOR,360.0,360.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],53.0,[Not Available],,,1.0,360.0,1.0,360.0,,,1.0,53.0,
TCGA-CV-7177,3529,TCGA-CV-7177,HNSC,82.0,FEMALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G2,1999.0,[Not Available],-30180.0,Dead,WITH TUMOR,,663.0,[Not Available],,,,,[Not Available],,,1.0,663.0,1.0,663.0,,,1.0,663.0,
TCGA-TQ-A7RQ,5398,TCGA-TQ-A7RQ,LGG,38.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-14187.0,Alive,TUMOR FREE,795.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,795.0,0.0,795.0,0.0,795.0,0.0,795.0,
TCGA-BQ-7059,4566,TCGA-BQ-7059,KIRP,71.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-26136.0,Alive,TUMOR FREE,232.0,,[Not Available],,,,,[Not Available],,,0.0,232.0,0.0,232.0,,,0.0,232.0,
TCGA-2G-AAGF,9739,TCGA-2G-AAGF,TGCT,28.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2007.0,[Not Available],-10348.0,Alive,TUMOR FREE,2734.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,139.0,Complete Remission/Response,,,0.0,2734.0,0.0,2734.0,1.0,139.0,1.0,139.0,
TCGA-D8-A27V,1295,TCGA-D8-A27V,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22958.0,Alive,TUMOR FREE,381.0,,[Not Available],,,,,[Not Available],Negative,,0.0,381.0,0.0,381.0,0.0,381.0,0.0,381.0,
TCGA-IB-AAUQ,7650,TCGA-IB-AAUQ,PAAD,50.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-18315.0,Dead,WITH TUMOR,,183.0,Pancreatic Cancer,Distant Metastasis,Non-regional / Distant Lymph Nodes,,107.0,Partial Remission/Response,,,1.0,183.0,1.0,183.0,,,1.0,107.0,
TCGA-IN-A6RS,9603,TCGA-IN-A6RS,STAD,76.0,MALE,WHITE,Stage IA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,[Not Available],-27808.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-CV-7435,3570,TCGA-CV-7435,HNSC,57.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1999.0,[Not Available],-21049.0,Dead,TUMOR FREE,,4680.0,[Not Available],,,,,Complete Remission/Response,,,1.0,4680.0,0.0,4680.0,,,0.0,4680.0,
TCGA-B5-A11R,10706,TCGA-B5-A11R,UCEC,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18878.0,Alive,TUMOR FREE,2349.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2349.0,0.0,2349.0,0.0,2349.0,0.0,2349.0,
TCGA-33-4589,6407,TCGA-33-4589,LUSC,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1992.0,[Not Available],-22754.0,Dead,TUMOR FREE,,47.0,[Not Available],,,,,Complete Remission/Response,,,1.0,47.0,0.0,47.0,0.0,47.0,0.0,47.0,
TCGA-G3-A25Y,5706,TCGA-G3-A25Y,LIHC,52.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2006.0,[Not Available],-19055.0,Dead,WITH TUMOR,,452.0,[Not Available],Locoregional Recurrence,Liver,,355.0,[Not Available],,R0,1.0,452.0,1.0,452.0,1.0,355.0,1.0,355.0,
TCGA-ED-A66X,5669,TCGA-ED-A66X,LIHC,35.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-12947.0,Alive,TUMOR FREE,406.0,,[Not Available],Intrahepatic Recurrence,Liver,,124.0,[Not Available],,R0,0.0,406.0,0.0,406.0,1.0,124.0,1.0,124.0,
TCGA-L9-A50W,6287,TCGA-L9-A50W,LUAD,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27414.0,Dead,WITH TUMOR,,442.0,[Not Available],Distant Metastasis,,,389.0,Complete Remission/Response,,,1.0,442.0,1.0,442.0,1.0,389.0,1.0,389.0,
TCGA-HT-7482,5155,TCGA-HT-7482,LGG,18.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2005.0,[Not Available],-6857.0,Alive,TUMOR FREE,3253.0,,[Not Available],,,,374.0,Partial Remission/Response,,,0.0,3253.0,0.0,3253.0,,,1.0,374.0,
TCGA-DQ-7593,3640,TCGA-DQ-7593,HNSC,58.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G4,2011.0,[Not Available],-21439.0,Alive,TUMOR FREE,1224.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1224.0,0.0,1224.0,,,0.0,1224.0,
TCGA-55-8301,6030,TCGA-55-8301,LUAD,58.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-21535.0,Alive,WITH TUMOR,534.0,,[Not Available],Locoregional Recurrence,,,238.0,Complete Remission/Response,,,0.0,534.0,0.0,534.0,1.0,238.0,1.0,238.0,
TCGA-KK-A8I7,8203,TCGA-KK-A8I7,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-20256.0,Alive,TUMOR FREE,2002.0,,[Not Available],Biochemical evidence of disease,,,1088.0,Progressive Disease,,,0.0,2002.0,0.0,2002.0,,,1.0,1088.0,
TCGA-S9-A7IZ,5352,TCGA-S9-A7IZ,LGG,48.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-17874.0,Alive,WITH TUMOR,608.0,,[Not Available],,,,467.0,Partial Remission/Response,,,0.0,608.0,0.0,608.0,,,1.0,467.0,
TCGA-EM-A2CK,10140,TCGA-EM-A2CK,THCA,28.0,MALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-10485.0,Alive,TUMOR FREE,544.0,,[Not Available],,,,,[Not Available],,R0,0.0,544.0,0.0,544.0,0.0,544.0,0.0,544.0,
TCGA-DU-5871,4988,TCGA-DU-5871,LGG,37.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2009.0,[Not Available],-13673.0,Alive,TUMOR FREE,576.0,,[Not Available],,,,,Stable Disease,,,0.0,576.0,0.0,576.0,,,0.0,576.0,
TCGA-B3-3926,4514,TCGA-B3-3926,KIRP,59.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-21876.0,Alive,TUMOR FREE,883.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,883.0,0.0,883.0,0.0,883.0,0.0,883.0,
TCGA-XF-AAMQ,453,TCGA-XF-AAMQ,BLCA,59.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-21660.0,Alive,TUMOR FREE,2177.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2177.0,0.0,2177.0,0.0,2177.0,0.0,2177.0,
TCGA-D3-A51R,8874,TCGA-D3-A51R,SKCM,60.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2008.0,[Not Available],-22040.0,Alive,WITH TUMOR,1941.0,,[Not Available],Regional lymph node,,,1016.0,[Not Available],,,0.0,1941.0,0.0,1941.0,,,1.0,1016.0,
TCGA-DD-AAW2,5663,TCGA-DD-AAW2,LIHC,69.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2009.0,[Not Available],-25420.0,Alive,WITH TUMOR,1855.0,,[Not Available],Intrahepatic Recurrence,Liver,,391.0,[Not Available],,R0,0.0,1855.0,0.0,1855.0,1.0,391.0,1.0,391.0,
TCGA-ET-A39T,10229,TCGA-ET-A39T,THCA,55.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2006.0,[Not Available],-20164.0,Alive,TUMOR FREE,2987.0,,[Not Available],,,,,[Not Available],,R0,0.0,2987.0,0.0,2987.0,0.0,2987.0,0.0,2987.0,
TCGA-BR-8683,9385,TCGA-BR-8683,STAD,75.0,MALE,ASIAN,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-27549.0,Dead,TUMOR FREE,,300.0,[Not Available],,,,,Complete Remission/Response,,,1.0,300.0,0.0,300.0,0.0,300.0,0.0,300.0,
TCGA-UY-A8OC,409,TCGA-UY-A8OC,BLCA,90.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-32918.0,Dead,WITH TUMOR,,92.0,[Not Available],Distant Metastasis,Lymph Node Only,,32.0,Partial Remission/Response,,,1.0,92.0,1.0,92.0,,,1.0,32.0,
TCGA-66-2770,6627,TCGA-66-2770,LUSC,79.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-28945.0,Alive,,700.0,,[Not Available],,,,,[Not Available],,,0.0,700.0,0.0,700.0,,,0.0,700.0,
TCGA-LD-A7W5,1527,TCGA-LD-A7W5,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19169.0,Alive,WITH TUMOR,216.0,,[Not Available],,,,,[Not Available],Positive,,0.0,216.0,0.0,216.0,,,0.0,216.0,
TCGA-BJ-A45I,9890,TCGA-BJ-A45I,THCA,51.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2012.0,[Not Available],-18767.0,Alive,TUMOR FREE,470.0,,[Not Available],,,,110.0,[Not Available],,R2,0.0,470.0,0.0,470.0,,,1.0,110.0,
TCGA-58-A46J,6555,TCGA-58-A46J,LUSC,64.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-23653.0,Alive,TUMOR FREE,2589.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2589.0,0.0,2589.0,0.0,2589.0,0.0,2589.0,
TCGA-CN-6997,3355,TCGA-CN-6997,HNSC,66.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-24298.0,Dead,TUMOR FREE,,988.0,[Not Available],,Distant Metastasis,LUNG,279.0,Complete Remission/Response,,,1.0,988.0,0.0,988.0,,,1.0,279.0,
TCGA-BA-6871,3260,TCGA-BA-6871,HNSC,75.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-27708.0,Dead,WITH TUMOR,,108.0,[Not Available],,,,,Stable Disease,,,1.0,108.0,1.0,108.0,,,1.0,108.0,
TCGA-63-7020,6588,TCGA-63-7020,LUSC,,MALE,[Not Available],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],,Alive,TUMOR FREE,2133.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2133.0,0.0,2133.0,0.0,2133.0,0.0,2133.0,
TCGA-28-2502,3147,TCGA-28-2502,GBM,65.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-23807.0,Alive,,20.0,,[Not Available],,,,,[Not Available],,,0.0,20.0,0.0,20.0,,,0.0,20.0,
TCGA-FS-A1ZA,9150,TCGA-FS-A1ZA,SKCM,45.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2003.0,[Not Available],-16705.0,Dead,WITH TUMOR,,843.0,[Not Available],,,,663.0,[Not Available],,,1.0,843.0,1.0,843.0,,,1.0,663.0,
TCGA-HI-7168,8126,TCGA-HI-7168,PRAD,62.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2005.0,[Not Available],-22881.0,Alive,WITH TUMOR,3323.0,,[Not Available],Biochemical evidence of disease,Bone,,2505.0,Stable Disease,,,0.0,3323.0,0.0,3323.0,,,1.0,2505.0,
TCGA-UB-AA0U,5778,TCGA-UB-AA0U,LIHC,60.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-21985.0,Alive,TUMOR FREE,327.0,,[Not Available],Intrahepatic Recurrence,Liver,,106.0,[Not Available],,R1,0.0,327.0,0.0,327.0,,,1.0,106.0,
TCGA-QH-A65X,5292,TCGA-QH-A65X,LGG,28.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-10440.0,Alive,TUMOR FREE,482.0,,[Not Available],,,,,Stable Disease,,,0.0,482.0,0.0,482.0,,,0.0,482.0,
TCGA-21-1078,6349,TCGA-21-1078,LUSC,77.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-28125.0,Dead,WITH TUMOR,469.0,474.0,[Not Available],,,,257.0,[Not Available],,,1.0,474.0,1.0,474.0,,,1.0,257.0,
TCGA-HT-7882,5199,TCGA-HT-7882,LGG,66.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2010.0,[Not Available],-24450.0,Dead,WITH TUMOR,,113.0,[Not Available],,,,,Progressive Disease,,,1.0,113.0,1.0,113.0,,,1.0,113.0,
TCGA-FZ-5926,7576,TCGA-FZ-5926,PAAD,73.0,FEMALE,WHITE,Stage III,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2001.0,[Not Available],-26881.0,Dead,WITH TUMOR,,541.0,,,,,,Progressive Disease,,,1.0,541.0,1.0,541.0,,,1.0,541.0,
TCGA-98-A53J,6794,TCGA-98-A53J,LUSC,77.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-28485.0,Alive,TUMOR FREE,630.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,630.0,0.0,630.0,0.0,630.0,0.0,630.0,
TCGA-EE-A29L,9013,TCGA-EE-A29L,SKCM,78.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-28824.0,Dead,,,79.0,[Not Available],Distant Metastasis,Brain,,55.0,[Not Available],,,1.0,79.0,,79.0,,,1.0,55.0,
TCGA-FS-A1ZU,9167,TCGA-FS-A1ZU,SKCM,70.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2002.0,[Not Available],-25856.0,Dead,WITH TUMOR,,808.0,[Not Available],,,,679.0,[Not Available],,,1.0,808.0,1.0,808.0,,,1.0,679.0,
TCGA-BF-A3DL,8807,TCGA-BF-A3DL,SKCM,84.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2011.0,[Not Available],-30805.0,Alive,TUMOR FREE,769.0,,[Not Available],,,,,[Not Available],,,0.0,769.0,0.0,769.0,,,0.0,769.0,
TCGA-EY-A549,10978,TCGA-EY-A549,UCEC,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28570.0,Alive,TUMOR FREE,605.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,605.0,0.0,605.0,0.0,605.0,0.0,605.0,
TCGA-XF-AAME,447,TCGA-XF-AAME,BLCA,64.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-23448.0,Dead,WITH TUMOR,,2828.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Vagina,1651.0,Progressive Disease,,,1.0,2828.0,1.0,2828.0,,,1.0,1651.0,
TCGA-FS-A1ZY,9169,TCGA-FS-A1ZY,SKCM,71.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2006.0,[Not Available],-26197.0,Dead,WITH TUMOR,,824.0,[Not Available],,,,,[Not Available],,,1.0,824.0,1.0,824.0,,,1.0,824.0,
TCGA-04-1516,6944,TCGA-04-1516,OV,48.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous Cystadenocarcinoma,G3,2006.0,[Not Available],-17768.0,Alive,TUMOR FREE,1265.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1265.0,0.0,1265.0,0.0,1265.0,0.0,1265.0,
TCGA-W3-AA1O,9229,TCGA-W3-AA1O,SKCM,85.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],1997.0,[Not Available],-31351.0,Dead,WITH TUMOR,,122.0,[Not Available],,,,,[Not Available],,,1.0,122.0,1.0,122.0,,,1.0,122.0,
TCGA-YL-A8HJ,8316,TCGA-YL-A8HJ,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2009.0,[Not Available],-21416.0,Alive,TUMOR FREE,1611.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0,
TCGA-OR-A5K3,38,TCGA-OR-A5K3,ACC,53.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical Carcinoma- Oncocytic Type,[Not Available],2005.0,[Not Available],-19375.0,Alive,TUMOR FREE,3465.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3465.0,0.0,3465.0,0.0,3465.0,0.0,3465.0,
TCGA-QC-AA9N,8744,TCGA-QC-AA9N,SARC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013.0,[Not Available],-19395.0,Alive,TUMOR FREE,537.0,,[Not Available],,,,,[Not Available],Negative,RX,0.0,537.0,0.0,537.0,,,0.0,537.0,
TCGA-ZH-A8Y4,1948,TCGA-ZH-A8Y4,CHOL,58.0,MALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2010.0,[Not Available],-21503.0,Dead,WITH TUMOR,,741.0,[Not Available],Locoregional Recurrence,,,281.0,[Not Available],,R1,1.0,741.0,1.0,741.0,,,1.0,281.0,
TCGA-F5-6863,8531,TCGA-F5-6863,READ,71.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-25936.0,Dead,WITH TUMOR,,361.0,[Not Available],,,,191.0,[Unknown],,,1.0,361.0,1.0,361.0,,,1.0,191.0,
TCGA-XR-A8TF,5789,TCGA-XR-A8TF,LIHC,74.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-27145.0,Dead,TUMOR FREE,,693.0,[Not Available],Intrahepatic Recurrence,Liver,,231.0,[Not Available],,R0,1.0,693.0,0.0,693.0,1.0,231.0,1.0,231.0,
TCGA-76-6280,3223,TCGA-76-6280,GBM,57.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-20931.0,Dead,WITH TUMOR,346.0,346.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],108.0,[Not Available],,,1.0,346.0,1.0,346.0,,,1.0,108.0,
TCGA-EL-A3TA,10091,TCGA-EL-A3TA,THCA,42.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005.0,[Not Available],-15366.0,Alive,TUMOR FREE,2035.0,,[Not Available],,,,,[Not Available],,R0,0.0,2035.0,0.0,2035.0,0.0,2035.0,0.0,2035.0,
TCGA-E2-A573,1389,TCGA-E2-A573,BRCA,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Peri (6-12 months since last menstrual period),-17689.0,Alive,TUMOR FREE,1062.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1062.0,0.0,1062.0,0.0,1062.0,0.0,1062.0,
TCGA-D1-A2G5,10885,TCGA-D1-A2G5,UCEC,50.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18322.0,Alive,WITH TUMOR,1455.0,,[Not Available],Distant Metastasis,"Other, specify",omentum,1122.0,Complete Remission/Response,,,0.0,1455.0,0.0,1455.0,1.0,1122.0,1.0,1122.0,
TCGA-HU-A4G6,9568,TCGA-HU-A4G6,STAD,74.0,MALE,ASIAN,Stage IA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Papillary Type",G3,2011.0,[Not Available],-27208.0,Alive,TUMOR FREE,738.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,738.0,0.0,738.0,0.0,738.0,0.0,738.0,
TCGA-C8-A12P,1181,TCGA-C8-A12P,BRCA,55.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20332.0,Alive,TUMOR FREE,358.0,,[Not Available],,,,,[Not Available],Negative,,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,
TCGA-BR-8368,9359,TCGA-BR-8368,STAD,84.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-30874.0,Alive,TUMOR FREE,131.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,131.0,0.0,131.0,0.0,131.0,0.0,131.0,
TCGA-G3-AAV1,5726,TCGA-G3-AAV1,LIHC,51.0,MALE,ASIAN,Stage IIIC,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-18973.0,Dead,WITH TUMOR,,359.0,[Not Available],Locoregional Recurrence,Liver,,49.0,[Not Available],,R0,1.0,359.0,1.0,359.0,1.0,49.0,1.0,49.0,
TCGA-ZC-AAAH,10473,TCGA-ZC-AAAH,THYM,52.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type B2,[Not Available],2013.0,[Not Available],-19146.0,Alive,TUMOR FREE,497.0,,[Not Available],Locoregional Recurrence,"Other, specify",Mediastinum,166.0,[Not Available],,,0.0,497.0,0.0,497.0,,,1.0,166.0,
TCGA-EQ-5647,9529,TCGA-EQ-5647,STAD,86.0,FEMALE,WHITE,Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,[Not Available],-31431.0,Dead,WITH TUMOR,,19.0,[Not Available],,,,,[Not Available],,,1.0,19.0,1.0,19.0,,,1.0,19.0,
TCGA-HU-A4GP,9577,TCGA-HU-A4GP,STAD,62.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G2,2011.0,[Not Available],-22711.0,Alive,TUMOR FREE,273.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,273.0,0.0,273.0,0.0,273.0,0.0,273.0,
TCGA-14-0736,2997,TCGA-14-0736,GBM,49.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1999.0,[Not Available],-18219.0,Dead,WITH TUMOR,460.0,460.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],128.0,[Not Available],,,1.0,460.0,1.0,460.0,,,1.0,128.0,
TCGA-DK-A3WW,205,TCGA-DK-A3WW,BLCA,57.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-20909.0,Alive,TUMOR FREE,633.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,633.0,0.0,633.0,0.0,633.0,0.0,633.0,
TCGA-D1-A1O5,10881,TCGA-D1-A1O5,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22580.0,Alive,TUMOR FREE,458.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,458.0,0.0,458.0,0.0,458.0,0.0,458.0,
TCGA-ZJ-AAX8,1896,TCGA-ZJ-AAX8,CESC,58.0,FEMALE,[Unknown],[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2009.0,[Unknown],-21481.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-HT-A5R5,5224,TCGA-HT-A5R5,LGG,33.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-12403.0,Alive,TUMOR FREE,4.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4.0,0.0,4.0,0.0,4.0,0.0,4.0,
TCGA-EL-A3GP,10060,TCGA-EL-A3GP,THCA,70.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-25696.0,Alive,,1506.0,,[Not Available],,,,,[Not Available],,R0,0.0,1506.0,0.0,1506.0,0.0,1506.0,0.0,1506.0,
TCGA-DU-7300,5026,TCGA-DU-7300,LGG,53.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2006.0,[Not Available],-19610.0,Dead,WITH TUMOR,,1886.0,[Not Available],,,,317.0,Progressive Disease,,,1.0,1886.0,1.0,1886.0,,,1.0,317.0,
TCGA-B8-A54G,4118,TCGA-B8-A54G,KIRC,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2012.0,[Not Available],-18612.0,Alive,TUMOR FREE,53.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,53.0,0.0,53.0,0.0,53.0,0.0,53.0,
TCGA-BH-A0DG,1063,TCGA-BH-A0DG,BRCA,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11204.0,Alive,TUMOR FREE,2041.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2041.0,0.0,2041.0,0.0,2041.0,0.0,2041.0,
TCGA-V1-A9OL,8255,TCGA-V1-A9OL,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-24090.0,Alive,,1913.0,,[Not Available],Biochemical evidence of disease,,,105.0,Complete Remission/Response,,,0.0,1913.0,0.0,1913.0,1.0,105.0,1.0,105.0,
TCGA-G9-6362,8029,TCGA-G9-6362,PRAD,57.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-21149.0,Alive,WITH TUMOR,1443.0,,[Not Available],,,,,Progressive Disease,,,0.0,1443.0,0.0,1443.0,,,0.0,1443.0,
TCGA-YL-A8S9,8322,TCGA-YL-A8S9,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-23204.0,Alive,,1842.0,,[Not Available],Locoregional Recurrence,,,1006.0,Stable Disease,,,0.0,1842.0,0.0,1842.0,,,1.0,1006.0,
TCGA-DK-A6B6,216,TCGA-DK-A6B6,BLCA,57.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-21007.0,Alive,TUMOR FREE,1115.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1115.0,0.0,1115.0,0.0,1115.0,0.0,1115.0,
TCGA-EE-A2GH,9033,TCGA-EE-A2GH,SKCM,34.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1996.0,[Not Available],-12727.0,Alive,TUMOR FREE,6699.0,,[Not Available],,,,,[Not Available],,,0.0,6699.0,0.0,6699.0,,,0.0,6699.0,
TCGA-EM-A3ST,10185,TCGA-EM-A3ST,THCA,62.0,FEMALE,[Unknown],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-22990.0,Alive,WITH TUMOR,1182.0,,[Not Available],Biochemical evidence of disease,,,966.0,[Not Available],,R0,0.0,1182.0,0.0,1182.0,1.0,966.0,1.0,966.0,
TCGA-DI-A2QU,10908,TCGA-DI-A2QU,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24488.0,Dead,WITH TUMOR,,946.0,[Not Available],,,,,[Not Available],,,1.0,946.0,1.0,946.0,,,1.0,946.0,
TCGA-VQ-AA68,9699,TCGA-VQ-AA68,STAD,52.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-19304.0,Alive,TUMOR FREE,1328.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1328.0,0.0,1328.0,0.0,1328.0,0.0,1328.0,
TCGA-AX-A2H8,10649,TCGA-AX-A2H8,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23448.0,Alive,TUMOR FREE,1861.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1861.0,0.0,1861.0,0.0,1861.0,0.0,1861.0,
TCGA-WN-A9G9,4700,TCGA-WN-A9G9,KIRP,55.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],,Alive,TUMOR FREE,791.0,,[Not Available],,,,791.0,Complete Remission/Response,,,0.0,791.0,0.0,791.0,1.0,791.0,1.0,791.0,
TCGA-50-5936,5945,TCGA-50-5936,LUAD,58.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-21238.0,Dead,WITH TUMOR,,257.0,[Not Available],,,,150.0,Progressive Disease,,,1.0,257.0,1.0,257.0,,,1.0,150.0,
TCGA-DH-A7US,4976,TCGA-DH-A7US,LGG,50.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-18429.0,Alive,WITH TUMOR,706.0,,[Not Available],,,,,Stable Disease,,,0.0,706.0,0.0,706.0,,,0.0,706.0,
TCGA-EB-A85I,8989,TCGA-EB-A85I,SKCM,66.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-24408.0,Alive,TUMOR FREE,362.0,,[Not Available],,,,,[Not Available],,,0.0,362.0,0.0,362.0,,,0.0,362.0,
TCGA-EM-A3AR,10168,TCGA-EM-A3AR,THCA,41.0,MALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-15313.0,Alive,TUMOR FREE,1133.0,,[Not Available],,,,,[Not Available],,R0,0.0,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0,
TCGA-DX-A7EQ,8629,TCGA-DX-A7EQ,SARC,72.0,MALE,WHITE,[Not Available],[Not Available],Synovial Sarcoma - Monophasic,[Not Available],2006.0,[Not Available],-26503.0,Dead,WITH TUMOR,,897.0,[Not Available],Distant Metastasis,Lung,,251.0,[Not Available],Negative,R0,1.0,897.0,1.0,897.0,1.0,251.0,1.0,251.0,
TCGA-WB-A81I,7851,TCGA-WB-A81I,PCPG,64.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-23566.0,Alive,TUMOR FREE,679.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,
TCGA-OR-A5K1,36,TCGA-OR-A5K1,ACC,48.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2006.0,[Not Available],-17596.0,Alive,TUMOR FREE,3289.0,,[Not Available],Locoregional Recurrence,Peritoneal Surfaces,,826.0,Complete Remission/Response,,,0.0,3289.0,0.0,3289.0,1.0,826.0,1.0,826.0,
TCGA-98-8022,6784,TCGA-98-8022,LUSC,61.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-22487.0,Dead,TUMOR FREE,,933.0,[Not Available],,,,,Complete Remission/Response,,,1.0,933.0,0.0,933.0,0.0,933.0,0.0,933.0,
TCGA-CV-7245,3538,TCGA-CV-7245,HNSC,62.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-22646.0,Alive,TUMOR FREE,797.0,,[Not Available],,,,,[Not Available],,,0.0,797.0,0.0,797.0,,,0.0,797.0,
TCGA-AC-A2FO,768,TCGA-AC-A2FO,BRCA,65.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23928.0,Alive,TUMOR FREE,2255.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2255.0,0.0,2255.0,0.0,2255.0,0.0,2255.0,
TCGA-EL-A3T9,10090,TCGA-EL-A3T9,THCA,69.0,FEMALE,WHITE,Stage IV,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005.0,[Not Available],-25484.0,Dead,WITH TUMOR,,174.0,[Not Available],,,,,[Not Available],,R1,1.0,174.0,1.0,174.0,,,1.0,174.0,
TCGA-FF-8061,2427,TCGA-FF-8061,DLBC,42.0,MALE,ASIAN,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010.0,[Not Available],-15358.0,Alive,TUMOR FREE,832.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,832.0,0.0,832.0,0.0,832.0,0.0,832.0,
TCGA-CR-7394,3462,TCGA-CR-7394,HNSC,70.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-25581.0,Alive,TUMOR FREE,1346.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1346.0,0.0,1346.0,,,0.0,1346.0,
TCGA-B0-5081,4018,TCGA-B0-5081,KIRC,79.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-29219.0,Dead,WITH TUMOR,,362.0,[Not Available],,,,213.0,[Not Available],,,1.0,362.0,1.0,362.0,,,1.0,213.0,
TCGA-DD-AADG,5618,TCGA-DD-AADG,LIHC,70.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-25887.0,Alive,TUMOR FREE,1145.0,,[Not Available],Intrahepatic Recurrence,Liver,,270.0,[Not Available],,R0,0.0,1145.0,0.0,1145.0,1.0,270.0,1.0,270.0,
TCGA-V1-A9Z7,8260,TCGA-V1-A9Z7,PRAD,54.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-20075.0,Alive,,874.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,874.0,0.0,874.0,0.0,874.0,0.0,874.0,
TCGA-CZ-5469,4385,TCGA-CZ-5469,KIRC,41.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-15242.0,Dead,WITH TUMOR,,946.0,[Not Available],,,,110.0,[Not Available],,,1.0,946.0,1.0,946.0,,,1.0,110.0,
TCGA-EK-A2RB,1732,TCGA-EK-A2RB,CESC,48.0,FEMALE,WHITE,[Not Available],Stage IVB,Cervical Squamous Cell Carcinoma,G3,2011.0,[Not Available],-17752.0,Alive,TUMOR FREE,9.0,,,,,,,[Not Available],,,0.0,9.0,0.0,9.0,,,0.0,9.0,
TCGA-55-8514,6040,TCGA-55-8514,LUAD,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-25608.0,Alive,TUMOR FREE,520.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,520.0,0.0,520.0,0.0,520.0,0.0,520.0,
TCGA-CN-A6UY,3371,TCGA-CN-A6UY,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-20967.0,Alive,TUMOR FREE,713.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,713.0,0.0,713.0,,,0.0,713.0,
TCGA-CN-A63T,3363,TCGA-CN-A63T,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-22201.0,Alive,TUMOR FREE,225.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,225.0,0.0,225.0,,,0.0,225.0,
TCGA-D3-A3C8,8857,TCGA-D3-A3C8,SKCM,58.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-21281.0,Alive,WITH TUMOR,1409.0,,[Not Available],Distant Metastasis,"Other, Specify","Lymph nodes, neck",55.0,[Not Available],,,0.0,1409.0,0.0,1409.0,,,1.0,55.0,
TCGA-CV-7421,3558,TCGA-CV-7421,HNSC,76.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1997.0,[Not Available],-27961.0,Dead,,,2.0,[Not Available],,,,,[Not Available],,,1.0,2.0,,2.0,,,0.0,2.0,
TCGA-A3-A8OU,3933,TCGA-A3-A8OU,KIRC,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2011.0,[Not Available],-27377.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-05-4402,5815,TCGA-05-4402,LUAD,57.0,FEMALE,[Not Available],Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-20819.0,Dead,TUMOR FREE,,244.0,[Not Available],,,,,Complete Remission/Response,,,1.0,244.0,0.0,244.0,,,0.0,244.0,
TCGA-EK-A2RE,1735,TCGA-EK-A2RE,CESC,26.0,FEMALE,WHITE,[Not Available],Stage IIA,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9743.0,Alive,TUMOR FREE,57.0,,,,,,,[Not Available],,,0.0,57.0,0.0,57.0,,,0.0,57.0,
TCGA-YL-A8HK,8317,TCGA-YL-A8HK,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-21850.0,Alive,WITH TUMOR,1491.0,,[Not Available],Biochemical evidence of disease,,,1376.0,Complete Remission/Response,,,0.0,1491.0,0.0,1491.0,1.0,1376.0,1.0,1376.0,
TCGA-XF-A9T6,445,TCGA-XF-A9T6,BLCA,88.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-32207.0,Alive,,64.0,,[Not Available],,,,,[Unknown],,,0.0,64.0,0.0,64.0,,,0.0,64.0,
TCGA-49-4488,5904,TCGA-49-4488,LUAD,74.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1992.0,[Not Available],-27332.0,Dead,,,869.0,[Not Available],,,,634.0,[Not Available],,,1.0,869.0,,869.0,,,1.0,634.0,
TCGA-G9-7522,8052,TCGA-G9-7522,PRAD,49.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-18033.0,Alive,TUMOR FREE,1078.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1078.0,0.0,1078.0,0.0,1078.0,0.0,1078.0,
TCGA-EB-A3Y7,8949,TCGA-EB-A3Y7,SKCM,86.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-31622.0,Dead,TUMOR FREE,,326.0,[Not Available],,,,,[Not Available],,,1.0,326.0,0.0,326.0,,,0.0,326.0,
TCGA-DM-A280,2339,TCGA-DM-A280,COAD,70.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],1998.0,[Not Available],-25649.0,Dead,,236.0,236.0,[Not Available],,,,,[Not Available],,,1.0,236.0,,236.0,,,0.0,236.0,
TCGA-79-5596,6702,TCGA-79-5596,LUSC,,MALE,[Not Available],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],,Alive,TUMOR FREE,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-ZU-A8S4,1953,TCGA-ZU-A8S4,CHOL,52.0,MALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2012.0,[Not Available],-19264.0,Dead,WITH TUMOR,,98.0,[Not Available],Intrahepatic Recurrence,Liver,,72.0,[Not Available],,R0,1.0,98.0,1.0,98.0,1.0,72.0,1.0,72.0,
TCGA-F9-A7Q0,4590,TCGA-F9-A7Q0,KIRP,37.0,FEMALE,ASIAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-13523.0,Alive,TUMOR FREE,398.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,
TCGA-J8-A3YD,10323,TCGA-J8-A3YD,THCA,47.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-17416.0,Alive,TUMOR FREE,968.0,,[Not Available],,,,,[Not Available],,R0,0.0,968.0,0.0,968.0,0.0,968.0,0.0,968.0,
TCGA-EB-A44N,8956,TCGA-EB-A44N,SKCM,59.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-21623.0,Dead,WITH TUMOR,,205.0,[Not Available],Regional lymph node|Distant Metastasis|Distant Metastasis,[Not Available]|Bone|Liver,[Not Applicable]|[Not Applicable]|[Not Applicable],115.0,[Not Available],,,1.0,205.0,1.0,205.0,,,1.0,115.0,
TCGA-SR-A6MX,7811,TCGA-SR-A6MX,PCPG,55.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2013.0,[Not Available],-20186.0,Dead,WITH TUMOR,,95.0,[Not Available],,,,,Progressive Disease,,,1.0,95.0,1.0,95.0,,,1.0,95.0,
TCGA-06-5858,2874,TCGA-06-5858,GBM,45.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-16662.0,Alive,WITH TUMOR,187.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],97.0,[Not Available],,,0.0,187.0,0.0,187.0,,,1.0,97.0,
TCGA-ET-A25K,10204,TCGA-ET-A25K,THCA,36.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-13351.0,Alive,TUMOR FREE,2142.0,,[Not Available],,,,,[Not Available],,R0,0.0,2142.0,0.0,2142.0,0.0,2142.0,0.0,2142.0,
TCGA-CK-4947,2244,TCGA-CK-4947,COAD,46.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2003.0,[Not Available],-16980.0,Alive,WITH TUMOR,534.0,,[Not Available],,,,21.0,Stable Disease,,,0.0,534.0,0.0,534.0,,,1.0,21.0,
TCGA-B9-4117,4523,TCGA-B9-4117,KIRP,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-17622.0,Alive,TUMOR FREE,14.0,,[Not Available],,,,,[Not Available],,,0.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-EL-A3CZ,10053,TCGA-EL-A3CZ,THCA,37.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-13718.0,Alive,WITH TUMOR,2418.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,1426.0,[Not Available],,R1,0.0,2418.0,0.0,2418.0,,,1.0,1426.0,
TCGA-EB-A5SG,8976,TCGA-EB-A5SG,SKCM,57.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2008.0,[Not Available],-20978.0,Alive,TUMOR FREE,2076.0,,[Not Available],Locoregional Recurrence,,,1372.0,[Not Available],,,0.0,2076.0,0.0,2076.0,,,1.0,1372.0,
TCGA-2H-A9GF,2461,TCGA-2H-A9GF,ESCA,67.0,MALE,[Unknown],Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2001.0,[Not Available],-24487.0,Dead,WITH TUMOR,,784.0,[Not Available],Distant Metastasis,Brain,,172.0,,,,1.0,784.0,1.0,784.0,,,1.0,172.0,
TCGA-HZ-7920,7591,TCGA-HZ-7920,PAAD,71.0,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-26167.0,Dead,TUMOR FREE,,236.0,"Other, non-malignant disease",,,,,Complete Remission/Response,,,1.0,236.0,0.0,236.0,0.0,236.0,0.0,236.0,
TCGA-EE-A29P,9016,TCGA-EE-A29P,SKCM,73.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2006.0,[Not Available],-26899.0,Alive,WITH TUMOR,1716.0,,[Not Available],Distant Metastasis,Lung,,1668.0,[Not Available],,,0.0,1716.0,0.0,1716.0,,,1.0,1668.0,
TCGA-RQ-A6JB,2458,TCGA-RQ-A6JB,DLBC,62.0,FEMALE,WHITE,[Not Applicable],[Not Available],Primary DLBCL of the CNS,[Not Available],2011.0,[Not Available],-22859.0,Alive,,1.0,,[Not Available],,,,,[Unknown],,,0.0,1.0,0.0,1.0,,,0.0,1.0,
TCGA-3N-A9WC,8799,TCGA-3N-A9WC,SKCM,82.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2009.0,[Not Available],-30286.0,Alive,WITH TUMOR,2022.0,,[Not Available],Distant Metastasis,Lung,,1705.0,[Not Available],,,0.0,2022.0,0.0,2022.0,,,1.0,1705.0,
TCGA-N5-A4RT,11033,TCGA-N5-A4RT,UCS,69.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25386.0,Alive,TUMOR FREE,2485.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2485.0,0.0,2485.0,0.0,2485.0,0.0,2485.0,
TCGA-60-2715,6575,TCGA-60-2715,LUSC,51.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-18990.0,Dead,WITH TUMOR,,1075.0,[Not Available],,,,,Progressive Disease,,,1.0,1075.0,1.0,1075.0,,,1.0,1075.0,
TCGA-MP-A4TH,6309,TCGA-MP-A4TH,LUAD,70.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-25759.0,Alive,TUMOR FREE,741.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,741.0,0.0,741.0,0.0,741.0,0.0,741.0,
TCGA-BR-8686,9386,TCGA-BR-8686,STAD,69.0,MALE,ASIAN,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-25372.0,Dead,TUMOR FREE,,635.0,[Not Available],,,,,Complete Remission/Response,,,1.0,635.0,0.0,635.0,0.0,635.0,0.0,635.0,
TCGA-ER-A19T,9111,TCGA-ER-A19T,SKCM,51.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2006.0,[Not Available],-18732.0,Dead,WITH TUMOR,,270.0,[Not Available],Distant Metastasis,Brain,,118.0,[Not Available],,,1.0,270.0,1.0,270.0,,,1.0,118.0,
TCGA-76-4928,3214,TCGA-76-4928,GBM,85.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-31267.0,Dead,WITH TUMOR,94.0,94.0,[Not Available],,,,,[Not Available],,,1.0,94.0,1.0,94.0,,,1.0,94.0,
TCGA-RT-A6Y9,7754,TCGA-RT-A6Y9,PCPG,50.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2005.0,[Not Available],-18594.0,Alive,TUMOR FREE,3293.0,,[Not Available],New Primary Tumor,"Other, specify",left thigh,3282.0,Complete Remission/Response,,,0.0,3293.0,0.0,3293.0,0.0,3293.0,1.0,3282.0,
TCGA-HZ-7289,7588,TCGA-HZ-7289,PAAD,77.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2010.0,[Not Available],-28174.0,Dead,WITH TUMOR,,661.0,Pancreatic Cancer,Distant Metastasis,Liver,,228.0,[Unknown],,,1.0,661.0,1.0,661.0,,,1.0,228.0,
TCGA-XF-A9ST,433,TCGA-XF-A9ST,BLCA,68.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,[Not Available],-25080.0,Dead,,,128.0,[Not Available],,,,,[Unknown],,,1.0,128.0,,128.0,,,0.0,128.0,
TCGA-CV-7424,3561,TCGA-CV-7424,HNSC,67.0,MALE,ASIAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1997.0,[Not Available],-24775.0,Dead,WITH TUMOR,,453.0,[Not Available],,,,,[Not Available],,,1.0,453.0,1.0,453.0,,,1.0,453.0,
TCGA-IE-A4EH,8693,TCGA-IE-A4EH,SARC,35.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-12871.0,Alive,TUMOR FREE,819.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,819.0,0.0,819.0,0.0,819.0,0.0,819.0,
TCGA-AR-A0TU,903,TCGA-AR-A0TU,BRCA,35.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13039.0,Alive,TUMOR FREE,709.0,,[Not Available],,,,,[Not Available],Negative,,0.0,709.0,0.0,709.0,0.0,709.0,0.0,709.0,
TCGA-DJ-A2PQ,9943,TCGA-DJ-A2PQ,THCA,26.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-9664.0,Alive,TUMOR FREE,1077.0,,[Not Available],,,,,[Not Available],,R0,0.0,1077.0,0.0,1077.0,0.0,1077.0,0.0,1077.0,
TCGA-GU-A766,349,TCGA-GU-A766,BLCA,62.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-22774.0,Alive,WITH TUMOR,480.0,,[Not Available],,,,,Progressive Disease,,,0.0,480.0,0.0,480.0,,,0.0,480.0,
TCGA-66-2758,6619,TCGA-66-2758,LUSC,71.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-26209.0,Alive,TUMOR FREE,639.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,
TCGA-DQ-5624,3630,TCGA-DQ-5624,HNSC,43.0,FEMALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-15867.0,Alive,TUMOR FREE,1778.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1778.0,0.0,1778.0,,,0.0,1778.0,
TCGA-DU-6397,4996,TCGA-DU-6397,LGG,45.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,1997.0,[Not Available],-16695.0,Dead,WITH TUMOR,,1401.0,[Not Available],,,,837.0,Progressive Disease,,,1.0,1401.0,1.0,1401.0,,,1.0,837.0,
TCGA-EJ-7331,7958,TCGA-EJ-7331,PRAD,64.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23458.0,Alive,TUMOR FREE,742.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,742.0,0.0,742.0,0.0,742.0,0.0,742.0,
TCGA-EK-A2IP,1721,TCGA-EK-A2IP,CESC,28.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2006.0,[Not Available],-10347.0,Alive,,202.0,,,,,,,[Not Available],,,0.0,202.0,0.0,202.0,,,0.0,202.0,
TCGA-DU-5853,4984,TCGA-DU-5853,LGG,29.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2010.0,[Not Available],-10624.0,Alive,WITH TUMOR,407.0,,[Not Available],,,,,Stable Disease,,,0.0,407.0,0.0,407.0,,,0.0,407.0,
TCGA-B8-A8YJ,4124,TCGA-B8-A8YJ,KIRC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2013.0,[Not Available],-21994.0,Alive,TUMOR FREE,431.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,
TCGA-J4-A6G1,8141,TCGA-J4-A6G1,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24945.0,Alive,TUMOR FREE,769.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,769.0,0.0,769.0,0.0,769.0,0.0,769.0,
TCGA-XK-AAJP,8306,TCGA-XK-AAJP,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24320.0,Alive,TUMOR FREE,1259.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1259.0,0.0,1259.0,0.0,1259.0,0.0,1259.0,
TCGA-LN-A5U5,2581,TCGA-LN-A5U5,ESCA,57.0,MALE,ASIAN,Stage IV,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-20993.0,Dead,WITH TUMOR,,136.0,[Not Available],,,,,Progressive Disease,,,1.0,136.0,1.0,136.0,,,1.0,136.0,
TCGA-P3-A5Q5,3706,TCGA-P3-A5Q5,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2004.0,[Not Available],-19728.0,Alive,TUMOR FREE,910.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,910.0,0.0,910.0,,,0.0,910.0,
TCGA-C5-A1M5,1617,TCGA-C5-A1M5,CESC,53.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1996.0,Indeterminate (neither Pre or Postmenopausal),-19672.0,Dead,WITH TUMOR,,2052.0,Cervical Cancer,Distant Metastasis,"Other, specify",Regional recurrence NOS,693.0,Complete Remission/Response,,,1.0,2052.0,1.0,2052.0,1.0,693.0,1.0,693.0,
TCGA-A4-8310,4477,TCGA-A4-8310,KIRP,58.0,MALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-21312.0,Alive,TUMOR FREE,780.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,780.0,0.0,780.0,0.0,780.0,0.0,780.0,
TCGA-XE-AAOJ,9821,TCGA-XE-AAOJ,TGCT,24.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature),[Not Available],2009.0,[Not Available],-9046.0,Alive,TUMOR FREE,1550.0,,[Not Applicable],Locoregional Recurrence,"Other, specify",Mature teratoma: abdominal wall,266.0,"Normalization of Tumor Markers, but Residual Tumor Mass",,,0.0,1550.0,0.0,1550.0,,,1.0,266.0,
TCGA-X6-A8C6,8790,TCGA-X6-A8C6,SARC,55.0,MALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2011.0,[Not Available],-20090.0,Dead,WITH TUMOR,,1067.0,[Not Available],Distant Metastasis,Bone,"& leg, opposite thigh",408.0,[Not Available],Positive,R1,1.0,1067.0,1.0,1067.0,,,1.0,408.0,
TCGA-CU-A0YR,174,TCGA-CU-A0YR,BLCA,83.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-30674.0,Dead,WITH TUMOR,,460.0,[Not Available],Metastatic,Lymph Node Only,,219.0,Complete Remission/Response,,,1.0,460.0,1.0,460.0,,,1.0,219.0,
TCGA-BH-A1FU,1155,TCGA-BH-A1FU,BRCA,44.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1997.0,[Not Available],-16174.0,Dead,WITH TUMOR,,1688.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1688.0,1.0,1688.0,,,1.0,1688.0,
TCGA-DD-A11D,5523,TCGA-DD-A11D,LIHC,57.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2006.0,[Not Available],-21003.0,Dead,WITH TUMOR,,1560.0,[Not Available],Intrahepatic Recurrence,Liver,,498.0,[Not Available],,R0,1.0,1560.0,1.0,1560.0,1.0,498.0,1.0,498.0,
TCGA-HU-A4H5,9587,TCGA-HU-A4H5,STAD,71.0,MALE,ASIAN,Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Papillary Type",GX,2011.0,[Not Available],-26232.0,Alive,TUMOR FREE,724.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,724.0,0.0,724.0,0.0,724.0,0.0,724.0,
TCGA-QH-A6CY,5299,TCGA-QH-A6CY,LGG,38.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-14140.0,Alive,WITH TUMOR,408.0,,[Not Available],,,,,Stable Disease,,,0.0,408.0,0.0,408.0,,,0.0,408.0,
TCGA-B9-4116,4522,TCGA-B9-4116,KIRP,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-27692.0,Alive,TUMOR FREE,627.0,,[Not Available],,,,,[Not Available],,,0.0,627.0,0.0,627.0,,,0.0,627.0,
TCGA-56-8504,6531,TCGA-56-8504,LUSC,74.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-27210.0,Alive,TUMOR FREE,510.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,510.0,0.0,510.0,0.0,510.0,0.0,510.0,
TCGA-R6-A6DQ,2600,TCGA-R6-A6DQ,ESCA,74.0,FEMALE,WHITE,[Not Available],Stage IIIA,"Esophagus Adenocarcinoma, NOS",G3,2010.0,[Not Available],-27098.0,Dead,WITH TUMOR,,231.0,[Not Available],,,,,,,,1.0,231.0,1.0,231.0,,,1.0,231.0,
TCGA-95-7567,6238,TCGA-95-7567,LUAD,61.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22437.0,Alive,TUMOR FREE,568.0,,[Not Available],,,,,Stable Disease,,,0.0,568.0,0.0,568.0,,,0.0,568.0,
TCGA-77-A5G1,6693,TCGA-77-A5G1,LUSC,75.0,MALE,[Not Evaluated],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-27555.0,Alive,,4026.0,,[Not Available],New Primary Tumor,,,2197.0,Complete Remission/Response,,,0.0,4026.0,0.0,4026.0,0.0,4026.0,1.0,2197.0,
TCGA-OR-A5KQ,47,TCGA-OR-A5KQ,ACC,20.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2006.0,[Not Available],-7459.0,Alive,TUMOR FREE,2677.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2677.0,0.0,2677.0,0.0,2677.0,0.0,2677.0,
TCGA-DX-A3UF,8593,TCGA-DX-A3UF,SARC,65.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2007.0,[Not Available],-23993.0,Dead,WITH TUMOR,,2599.0,[Not Available],Locoregional Recurrence,,,964.0,[Not Available],Positive,R1,1.0,2599.0,1.0,2599.0,,,1.0,964.0,
TCGA-C5-A1BM,1614,TCGA-C5-A1BM,CESC,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1997.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28815.0,Dead,TUMOR FREE,,2520.0,,,,,,Complete Remission/Response,,,1.0,2520.0,0.0,2520.0,0.0,2520.0,0.0,2520.0,
TCGA-NC-A5HF,6803,TCGA-NC-A5HF,LUSC,74.0,MALE,WHITE,Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-27038.0,Dead,WITH TUMOR,,138.0,[Not Available],Distant Metastasis,,,132.0,Progressive Disease,,,1.0,138.0,1.0,138.0,,,1.0,132.0,
TCGA-XE-AAO6,9816,TCGA-XE-AAO6,TGCT,47.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2007.0,[Not Available],-17417.0,Alive,TUMOR FREE,240.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,240.0,0.0,240.0,0.0,240.0,0.0,240.0,
TCGA-D1-A160,10831,TCGA-D1-A160,UCEC,70.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25673.0,Alive,TUMOR FREE,112.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,112.0,0.0,112.0,0.0,112.0,0.0,112.0,
TCGA-CQ-6229,3397,TCGA-CQ-6229,HNSC,61.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-22541.0,Alive,TUMOR FREE,1179.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1179.0,0.0,1179.0,0.0,1179.0,0.0,1179.0,
TCGA-EB-A6R0,8986,TCGA-EB-A6R0,SKCM,58.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-21367.0,Dead,TUMOR FREE,,608.0,[Not Available],,,,,[Not Available],,,1.0,608.0,0.0,608.0,,,0.0,608.0,
TCGA-D8-A146,1232,TCGA-D8-A146,BRCA,57.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20861.0,Alive,TUMOR FREE,643.0,,[Not Available],,,,,[Not Available],Negative,,0.0,643.0,0.0,643.0,0.0,643.0,0.0,643.0,
TCGA-L5-A8NJ,2544,TCGA-L5-A8NJ,ESCA,77.0,MALE,WHITE,Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2000.0,[Not Available],-28200.0,Alive,WITH TUMOR,501.0,,[Not Available],Distant Metastasis,Lung,,396.0,[Unknown],,,0.0,501.0,0.0,501.0,,,1.0,396.0,
TCGA-91-6835,6216,TCGA-91-6835,LUAD,81.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-29887.0,Alive,TUMOR FREE,79.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,79.0,0.0,79.0,0.0,79.0,0.0,79.0,
TCGA-B9-A8YH,4533,TCGA-B9-A8YH,KIRP,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-19051.0,Alive,TUMOR FREE,532.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,
TCGA-KS-A41J,10333,TCGA-KS-A41J,THCA,28.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2000.0,[Not Available],-10411.0,Alive,TUMOR FREE,477.0,,[Not Available],,,,,[Not Available],,R0,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,
TCGA-2G-AAG7,9733,TCGA-2G-AAG7,TGCT,33.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor,[Not Available],2008.0,[Not Available],-12180.0,Alive,TUMOR FREE,2475.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,2475.0,0.0,2475.0,0.0,2475.0,0.0,2475.0,
TCGA-E2-A14Z,1325,TCGA-E2-A14Z,BRCA,64.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23682.0,Dead,WITH TUMOR,,563.0,[Not Available],Distant Metastasis,Bone,,188.0,[Not Available],Negative,,1.0,563.0,1.0,563.0,1.0,188.0,1.0,188.0,
TCGA-US-A77G,7676,TCGA-US-A77G,PAAD,64.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,[Not Available],-23443.0,Dead,TUMOR FREE,,12.0,Surgical Complications,,,,,[Not Available],,,1.0,12.0,0.0,12.0,,,0.0,12.0,
TCGA-DA-A95Y,8935,TCGA-DA-A95Y,SKCM,68.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-25083.0,Dead,WITH TUMOR,,430.0,[Not Available],Distant Metastasis,Lung,,338.0,[Not Available],,,1.0,430.0,1.0,430.0,,,1.0,338.0,
TCGA-OR-A5JY,33,TCGA-OR-A5JY,ACC,68.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-25190.0,Dead,WITH TUMOR,,552.0,[Not Available],Distant Metastasis,Liver,,75.0,Progressive Disease,,,1.0,552.0,1.0,552.0,,,1.0,75.0,
TCGA-Q3-AA2A,7665,TCGA-Q3-AA2A,PAAD,64.0,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,[Not Available],-23685.0,Alive,TUMOR FREE,95.0,,,,,,,[Unknown],,,0.0,95.0,0.0,95.0,,,0.0,95.0,
TCGA-CV-7243,3537,TCGA-CV-7243,HNSC,50.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-18466.0,Alive,TUMOR FREE,954.0,,[Not Available],,,,,[Not Available],,,0.0,954.0,0.0,954.0,,,0.0,954.0,
TCGA-VR-AA7D,2635,TCGA-VR-AA7D,ESCA,58.0,MALE,[Unknown],Stage IIIC,Stage IIIC,Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21468.0,Dead,WITH TUMOR,,279.0,[Not Available],Distant Metastasis,"Other, specify",Head and neck lymph node,244.0,,,,1.0,279.0,1.0,279.0,,,1.0,244.0,
TCGA-JL-A3YX,1524,TCGA-JL-A3YX,BRCA,46.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,,352.0,,[Not Available],,,,,[Not Available],Negative,,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,
TCGA-CC-A3M9,5491,TCGA-CC-A3M9,LIHC,45.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-16460.0,Dead,WITH TUMOR,,300.0,[Not Available],Locoregional Recurrence,,,219.0,[Not Available],,R0,1.0,300.0,1.0,300.0,1.0,219.0,1.0,219.0,
TCGA-36-2532,7394,TCGA-36-2532,OV,61.0,FEMALE,[Not Available],[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,[Not Available],-22333.0,Alive,WITH TUMOR,897.0,,[Not Available],,,,,[Not Available],,,0.0,897.0,0.0,897.0,,,0.0,897.0,
TCGA-G7-6792,4596,TCGA-G7-6792,KIRP,40.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-14664.0,Alive,TUMOR FREE,2765.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2765.0,0.0,2765.0,0.0,2765.0,0.0,2765.0,
TCGA-5P-A9JZ,4451,TCGA-5P-A9JZ,KIRP,51.0,FEMALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-18885.0,Alive,TUMOR FREE,2744.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2744.0,0.0,2744.0,0.0,2744.0,0.0,2744.0,
TCGA-DD-A1EE,5529,TCGA-DD-A1EE,LIHC,73.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2006.0,[Not Available],-26858.0,Dead,WITH TUMOR,,349.0,[Not Available],Intrahepatic Recurrence,Liver,,44.0,[Not Available],,R0,1.0,349.0,1.0,349.0,1.0,44.0,1.0,44.0,
TCGA-DJ-A4UR,10004,TCGA-DJ-A4UR,THCA,36.0,FEMALE,ASIAN,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-13463.0,Alive,WITH TUMOR,1058.0,,[Not Available],Distant Metastasis,Lung,,113.0,[Not Available],,R0,0.0,1058.0,0.0,1058.0,1.0,113.0,1.0,113.0,
TCGA-G9-7521,8051,TCGA-G9-7521,PRAD,52.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-19216.0,Alive,[Discrepancy],942.0,,[Not Available],,,,,[Discrepancy],,,0.0,942.0,0.0,942.0,,,0.0,942.0,
TCGA-36-2542,7400,TCGA-36-2542,OV,59.0,FEMALE,ASIAN,[Not Applicable],Stage IIIB,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-21902.0,Alive,TUMOR FREE,657.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,657.0,0.0,657.0,0.0,657.0,0.0,657.0,
TCGA-P3-A5Q6,3707,TCGA-P3-A5Q6,HNSC,49.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2005.0,[Not Available],-17917.0,Dead,WITH TUMOR,,480.0,[Not Available],,Distant Metastasis,Lung,280.0,Complete Remission/Response,,,1.0,480.0,1.0,480.0,,,1.0,280.0,
TCGA-CN-4740,3318,TCGA-CN-4740,HNSC,79.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-29186.0,Dead,WITH TUMOR,,839.0,[Not Available],,,PTERYGOID FOSSA,224.0,Complete Remission/Response,,,1.0,839.0,1.0,839.0,,,1.0,224.0,
TCGA-FY-A3YR,10295,TCGA-FY-A3YR,THCA,64.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-23395.0,Alive,TUMOR FREE,528.0,,[Not Available],,,,,[Not Available],,R0,0.0,528.0,0.0,528.0,0.0,528.0,0.0,528.0,
TCGA-HT-A618,5234,TCGA-HT-A618,LGG,37.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-13595.0,Alive,TUMOR FREE,512.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,
TCGA-ET-A25O,10208,TCGA-ET-A25O,THCA,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-12924.0,Alive,TUMOR FREE,1986.0,,[Not Available],,,,,[Not Available],,R0,0.0,1986.0,0.0,1986.0,0.0,1986.0,0.0,1986.0,
TCGA-QR-A70P,7733,TCGA-QR-A70P,PCPG,45.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2004.0,[Not Available],-16655.0,Dead,WITH TUMOR,,3563.0,[Not Available],Locoregional Disease,"Other, specify",L jugular area,648.0,Progressive Disease,,,1.0,3563.0,1.0,3563.0,,,1.0,648.0,
TCGA-XF-AAN1,461,TCGA-XF-AAN1,BLCA,75.0,FEMALE,[Unknown],Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-27687.0,Dead,WITH TUMOR,,941.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Pelvis and vagina,650.0,Partial Remission/Response,,,1.0,941.0,1.0,941.0,,,1.0,650.0,
TCGA-KO-8415,3848,TCGA-KO-8415,KICH,44.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-16395.0,Alive,TUMOR FREE,2939.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2939.0,0.0,2939.0,0.0,2939.0,0.0,2939.0,
TCGA-G4-6307,2377,TCGA-G4-6307,COAD,37.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-13648.0,Alive,TUMOR FREE,1674.0,,[Not Available],,,,,[Not Available],,,0.0,1674.0,0.0,1674.0,,,0.0,1674.0,
TCGA-DX-A8BM,8639,TCGA-DX-A8BM,SARC,60.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2011.0,[Not Available],-22152.0,Alive,TUMOR FREE,1456.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1456.0,0.0,1456.0,0.0,1456.0,0.0,1456.0,
TCGA-ZG-A9LS,8358,TCGA-ZG-A9LS,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23540.0,Alive,TUMOR FREE,516.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,
TCGA-ZJ-AAXU,1905,TCGA-ZJ-AAXU,CESC,51.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,[Unknown],-18773.0,Alive,,5.0,,,,,,,[Unknown],,,0.0,5.0,0.0,5.0,,,0.0,5.0,
TCGA-XF-A9SH,426,TCGA-XF-A9SH,BLCA,65.0,FEMALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,[Not Available],-24060.0,Dead,WITH TUMOR,,1971.0,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,547.0,Stable Disease,,,1.0,1971.0,1.0,1971.0,,,1.0,547.0,
TCGA-PG-A917,11013,TCGA-PG-A917,UCEC,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27104.0,Alive,TUMOR FREE,212.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,212.0,0.0,212.0,0.0,212.0,0.0,212.0,
TCGA-55-8203,6023,TCGA-55-8203,LUAD,69.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25477.0,Alive,TUMOR FREE,547.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,547.0,0.0,547.0,0.0,547.0,0.0,547.0,
TCGA-E8-A3X7,10024,TCGA-E8-A3X7,THCA,57.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-20983.0,Alive,TUMOR FREE,951.0,,[Not Available],,,,,[Not Available],,RX,0.0,951.0,0.0,951.0,,,0.0,951.0,
TCGA-EE-A17Z,8994,TCGA-EE-A17Z,SKCM,57.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2008.0,[Not Available],-20970.0,Dead,WITH TUMOR,,263.0,[Not Available],Regional lymph node,,,138.0,[Not Available],,,1.0,263.0,1.0,263.0,,,1.0,138.0,
TCGA-06-2562,2855,TCGA-06-2562,GBM,81.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-29753.0,Dead,WITH TUMOR,,382.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],151.0,[Not Available],,,1.0,382.0,1.0,382.0,,,1.0,151.0,
TCGA-XF-A9SY,438,TCGA-XF-A9SY,BLCA,60.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-22212.0,Alive,WITH TUMOR,640.0,,[Not Available],Distant Metastasis,"Other, specify",Groin,168.0,Progressive Disease,,,0.0,640.0,0.0,640.0,,,1.0,168.0,
TCGA-G4-6322,2386,TCGA-G4-6322,COAD,65.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2009.0,[Not Available],-23825.0,Alive,WITH TUMOR,792.0,,[Not Available],,,,789.0,[Not Available],,,0.0,792.0,0.0,792.0,,,1.0,789.0,
TCGA-CQ-6220,3389,TCGA-CQ-6220,HNSC,69.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-25366.0,Dead,,,985.0,[Not Available],,,,,Complete Remission/Response,,,1.0,985.0,,985.0,0.0,985.0,0.0,985.0,
TCGA-OR-A5LR,80,TCGA-OR-A5LR,ACC,30.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-11261.0,Alive,TUMOR FREE,853.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,853.0,0.0,853.0,0.0,853.0,0.0,853.0,
TCGA-HT-7485,5157,TCGA-HT-7485,LGG,42.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2006.0,[Not Available],-15589.0,Alive,TUMOR FREE,122.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,122.0,0.0,122.0,0.0,122.0,0.0,122.0,
TCGA-44-6148,5876,TCGA-44-6148,LUAD,60.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22138.0,Alive,TUMOR FREE,704.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,704.0,0.0,704.0,0.0,704.0,0.0,704.0,
TCGA-J8-A4HW,10329,TCGA-J8-A4HW,THCA,59.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-21587.0,Alive,TUMOR FREE,79.0,,[Not Available],,,,,[Not Available],,R0,0.0,79.0,0.0,79.0,0.0,79.0,0.0,79.0,
TCGA-G2-AA3B,322,TCGA-G2-AA3B,BLCA,75.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-27646.0,Alive,TUMOR FREE,2008.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2008.0,0.0,2008.0,0.0,2008.0,0.0,2008.0,
TCGA-DD-AAD8,5611,TCGA-DD-AAD8,LIHC,73.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-26781.0,Alive,TUMOR FREE,1219.0,,[Not Available],,,,,[Not Available],,R0,0.0,1219.0,0.0,1219.0,0.0,1219.0,0.0,1219.0,
TCGA-DJ-A3UK,9966,TCGA-DJ-A3UK,THCA,35.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-13145.0,Alive,TUMOR FREE,1123.0,,[Not Available],,,,,[Not Available],,R0,0.0,1123.0,0.0,1123.0,0.0,1123.0,0.0,1123.0,
TCGA-HT-8107,5212,TCGA-HT-8107,LGG,62.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-22880.0,Alive,TUMOR FREE,14.0,,[Not Available],,,,,Stable Disease,,,0.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-HT-A5RA,5227,TCGA-HT-A5RA,LGG,65.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-23769.0,Alive,WITH TUMOR,832.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,832.0,0.0,832.0,,,0.0,832.0,
TCGA-22-A5C4,6397,TCGA-22-A5C4,LUSC,70.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-25629.0,Alive,TUMOR FREE,671.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,671.0,0.0,671.0,0.0,671.0,0.0,671.0,
TCGA-DX-A8BU,8647,TCGA-DX-A8BU,SARC,58.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2006.0,[Not Available],-21470.0,Dead,WITH TUMOR,,1116.0,[Not Available],Distant Metastasis,Lung,,107.0,[Not Available],Positive,R1,1.0,1116.0,1.0,1116.0,,,1.0,107.0,
TCGA-DW-7837,4574,TCGA-DW-7837,KIRP,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-15891.0,Alive,WITH TUMOR,1142.0,,[Not Available],,,,,[Not Available],,,0.0,1142.0,0.0,1142.0,,,0.0,1142.0,
TCGA-P5-A5EV,5265,TCGA-P5-A5EV,LGG,39.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-14310.0,Alive,WITH TUMOR,7.0,,[Not Available],,,,,[Not Available],,,0.0,7.0,0.0,7.0,,,0.0,7.0,
TCGA-QK-AA3J,3736,TCGA-QK-AA3J,HNSC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2013.0,[Not Available],-25469.0,Alive,TUMOR FREE,466.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,466.0,0.0,466.0,0.0,466.0,0.0,466.0,
TCGA-2Y-A9GV,5430,TCGA-2Y-A9GV,LIHC,54.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2007.0,[Not Available],-20011.0,Dead,WITH TUMOR,,2532.0,[Not Available],New Primary Tumor,"Other, specify",Renal met from prior lung primary,1745.0,[Not Available],,R0,1.0,2532.0,1.0,2532.0,0.0,2532.0,1.0,1745.0,
TCGA-KC-A4BL,8162,TCGA-KC-A4BL,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-24081.0,Alive,WITH TUMOR,934.0,,[Not Available],Biochemical evidence of disease,,,193.0,Partial Remission/Response,,,0.0,934.0,0.0,934.0,,,1.0,193.0,
TCGA-AA-3712,2078,TCGA-AA-3712,COAD,65.0,MALE,[Not Available],Stage III,[Not Applicable],Colon Adenocarcinoma,[Not Available],2004.0,[Not Available],-23831.0,Alive,WITH TUMOR,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-EL-A3CW,10050,TCGA-EL-A3CW,THCA,87.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2000.0,[Not Available],-31934.0,Dead,,,1734.0,[Not Available],,,,,[Not Available],,R0,1.0,1734.0,,1734.0,0.0,1734.0,0.0,1734.0,
TCGA-UD-AAC5,6897,TCGA-UD-AAC5,MESO,66.0,MALE,WHITE,Stage I,[Not Applicable],Epithelioid mesothelioma,[Not Available],2005.0,[Not Available],-24314.0,Dead,WITH TUMOR,,253.0,[Not Available],Distant Metastasis,Abdomen,,230.0,[Not Available],,RX,1.0,253.0,1.0,253.0,,,1.0,230.0,
TCGA-ZG-A9LU,8359,TCGA-ZG-A9LU,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24742.0,Alive,WITH TUMOR,579.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,579.0,0.0,579.0,,,0.0,579.0,
TCGA-CF-A27C,152,TCGA-CF-A27C,BLCA,52.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-19270.0,Alive,TUMOR FREE,425.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,425.0,0.0,425.0,0.0,425.0,0.0,425.0,
TCGA-EJ-A7NJ,7996,TCGA-EJ-A7NJ,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-21748.0,Alive,TUMOR FREE,197.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,197.0,0.0,197.0,0.0,197.0,0.0,197.0,
TCGA-60-2721,6579,TCGA-60-2721,LUSC,73.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-27007.0,Alive,TUMOR FREE,983.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,983.0,0.0,983.0,0.0,983.0,0.0,983.0,
TCGA-DK-A1A3,180,TCGA-DK-A1A3,BLCA,60.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-22235.0,Dead,WITH TUMOR,,665.0,[Not Available],,,,,[Not Available],,,1.0,665.0,1.0,665.0,,,1.0,665.0,
TCGA-ET-A3DS,10244,TCGA-ET-A3DS,THCA,33.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-12252.0,Alive,TUMOR FREE,2033.0,,[Not Available],,,,,[Not Available],,R0,0.0,2033.0,0.0,2033.0,0.0,2033.0,0.0,2033.0,
TCGA-AJ-A3IA,10544,TCGA-AJ-A3IA,UCEC,77.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28470.0,Alive,TUMOR FREE,633.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,633.0,0.0,633.0,0.0,633.0,0.0,633.0,
TCGA-A5-A0G1,10480,TCGA-A5-A0G1,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24477.0,Dead,TUMOR FREE,,3251.0,[Not Available],,,,,Complete Remission/Response,,,1.0,3251.0,0.0,3251.0,0.0,3251.0,0.0,3251.0,
TCGA-F2-7273,7547,TCGA-F2-7273,PAAD,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-20071.0,Dead,WITH TUMOR,,592.0,Pancreatic Cancer,Distant Metastasis,Liver,,256.0,Progressive Disease,,,1.0,592.0,1.0,592.0,,,1.0,256.0,
TCGA-EL-A3MY,10079,TCGA-EL-A3MY,THCA,81.0,MALE,WHITE,Stage IVC,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-29706.0,Dead,WITH TUMOR,,533.0,[Not Available],,,,,[Not Available],,RX,1.0,533.0,1.0,533.0,,,1.0,533.0,
TCGA-J4-A67O,8136,TCGA-J4-A67O,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-21714.0,Alive,TUMOR FREE,839.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,839.0,0.0,839.0,0.0,839.0,0.0,839.0,
TCGA-XJ-A9DI,8297,TCGA-XJ-A9DI,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],,Alive,TUMOR FREE,1461.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1461.0,0.0,1461.0,0.0,1461.0,0.0,1461.0,
TCGA-C8-A133,1193,TCGA-C8-A133,BRCA,65.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Other, specify",[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23922.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],Negative,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-F2-6879,7545,TCGA-F2-6879,PAAD,57.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2009.0,[Not Available],-20984.0,Dead,WITH TUMOR,,334.0,,Distant Metastasis,,,183.0,Complete Remission/Response,,,1.0,334.0,1.0,334.0,1.0,183.0,1.0,183.0,
TCGA-DD-AADV,5631,TCGA-DD-AADV,LIHC,50.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-18300.0,Alive,TUMOR FREE,574.0,,[Not Available],,,,,[Not Available],,R0,0.0,574.0,0.0,574.0,0.0,574.0,0.0,574.0,
TCGA-A4-A772,4493,TCGA-A4-A772,KIRP,39.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-14278.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Applicable],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-P5-A780,5287,TCGA-P5-A780,LGG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-16161.0,Alive,TUMOR FREE,72.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,72.0,0.0,72.0,0.0,72.0,0.0,72.0,
TCGA-L5-A8NK,2545,TCGA-L5-A8NK,ESCA,84.0,FEMALE,WHITE,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G1,2004.0,[Not Available],-30719.0,Alive,WITH TUMOR,412.0,,[Not Available],Locoregional Recurrence,,,325.0,[Unknown],,,0.0,412.0,0.0,412.0,,,1.0,325.0,
TCGA-56-A49D,6539,TCGA-56-A49D,LUSC,67.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24745.0,Alive,TUMOR FREE,637.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,637.0,0.0,637.0,0.0,637.0,0.0,637.0,
TCGA-4Z-AA7O,101,TCGA-4Z-AA7O,BLCA,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-23645.0,Alive,TUMOR FREE,512.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,
TCGA-C8-A12W,1186,TCGA-C8-A12W,BRCA,49.0,FEMALE,ASIAN,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18140.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],Negative,,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-FD-A5C1,290,TCGA-FD-A5C1,BLCA,61.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-22505.0,Alive,TUMOR FREE,1792.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1792.0,0.0,1792.0,0.0,1792.0,0.0,1792.0,
TCGA-ZH-A8Y5,1949,TCGA-ZH-A8Y5,CHOL,69.0,MALE,WHITE,Stage IVB,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2012.0,[Not Available],-25268.0,Alive,WITH TUMOR,1229.0,,[Not Available],Extrahepatic Recurrence,Lung,,242.0,[Not Available],,R0,0.0,1229.0,0.0,1229.0,,,1.0,242.0,
TCGA-BP-4162,4129,TCGA-BP-4162,KIRC,65.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2002.0,[Not Available],-23966.0,Alive,TUMOR FREE,3074.0,,[Not Available],,,,,[Not Available],,,0.0,3074.0,0.0,3074.0,,,0.0,3074.0,
TCGA-CV-A45P,3577,TCGA-CV-A45P,HNSC,82.0,FEMALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1998.0,[Not Available],-30297.0,Alive,WITH TUMOR,639.0,,[Not Available],Locoregional Recurrence,Oral Cavity,Floor of mouth,639.0,Complete Remission/Response,,,0.0,639.0,0.0,639.0,1.0,639.0,1.0,639.0,
TCGA-13-A5FT,7111,TCGA-13-A5FT,OV,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-24743.0,Alive,TUMOR FREE,2143.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2143.0,0.0,2143.0,0.0,2143.0,0.0,2143.0,
TCGA-CR-6488,3434,TCGA-CR-6488,HNSC,68.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-25176.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-CR-6467,3421,TCGA-CR-6467,HNSC,59.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2006.0,[Not Available],-21689.0,Alive,TUMOR FREE,1777.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1777.0,0.0,1777.0,,,0.0,1777.0,
TCGA-CR-6477,3427,TCGA-CR-6477,HNSC,56.0,FEMALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-20815.0,Alive,TUMOR FREE,514.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,514.0,0.0,514.0,,,0.0,514.0,
TCGA-DB-A4XH,4949,TCGA-DB-A4XH,LGG,53.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-19710.0,Alive,TUMOR FREE,962.0,,[Not Available],,,,,Stable Disease,,,0.0,962.0,0.0,962.0,,,0.0,962.0,
TCGA-E9-A1N3,1393,TCGA-E9-A1N3,BRCA,70.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25714.0,Alive,TUMOR FREE,1059.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1059.0,0.0,1059.0,0.0,1059.0,0.0,1059.0,
TCGA-05-4415,5819,TCGA-05-4415,LUAD,57.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-20880.0,Dead,WITH TUMOR,,91.0,[Not Available],,,,60.0,Progressive Disease,,,1.0,91.0,1.0,91.0,,,1.0,60.0,
TCGA-RR-A6KB,3240,TCGA-RR-A6KB,GBM,51.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2007.0,[Not Available],-18713.0,Alive,,0.0,,[Not Available],,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-VD-A8KH,11126,TCGA-VD-A8KH,UVM,69.0,MALE,[Not Evaluated],Stage IIIB,Stage IIIB,Epithelioid Cell|Spindle Cell,[Not Available],2012.0,[Not Available],-25388.0,Alive,TUMOR FREE,1158.0,,[Not Available],,,,,[Not Available],,,0.0,1158.0,0.0,1158.0,,,0.0,1158.0,
TCGA-TM-A84R,5385,TCGA-TM-A84R,LGG,46.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-16843.0,Alive,TUMOR FREE,566.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,566.0,0.0,566.0,0.0,566.0,0.0,566.0,
TCGA-EI-6506,8505,TCGA-EI-6506,READ,78.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-28587.0,Alive,TUMOR FREE,625.0,,[Not Available],,,,,[Not Available],,,0.0,625.0,0.0,625.0,,,0.0,625.0,
TCGA-D8-A1XT,1273,TCGA-D8-A1XT,BRCA,61.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22448.0,Alive,TUMOR FREE,506.0,,[Not Available],,,,,[Not Available],Negative,,0.0,506.0,0.0,506.0,0.0,506.0,0.0,506.0,
TCGA-AR-A2LL,958,TCGA-AR-A2LL,BRCA,70.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25747.0,Alive,TUMOR FREE,2012.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2012.0,0.0,2012.0,0.0,2012.0,0.0,2012.0,
TCGA-44-5644,5870,TCGA-44-5644,LUAD,51.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-18644.0,Alive,TUMOR FREE,863.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,863.0,0.0,863.0,0.0,863.0,0.0,863.0,
TCGA-EM-A2P2,10158,TCGA-EM-A2P2,THCA,46.0,MALE,[Not Available],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-16895.0,Alive,TUMOR FREE,526.0,,[Not Available],,,,,[Not Available],,R0,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,
TCGA-33-4538,6400,TCGA-33-4538,LUSC,66.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-24174.0,Dead,,,2979.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2979.0,,2979.0,0.0,2979.0,0.0,2979.0,
TCGA-G4-6626,2391,TCGA-G4-6626,COAD,90.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-32871.0,Dead,TUMOR FREE,,1422.0,[Not Available],,,,,[Not Available],,,1.0,1422.0,0.0,1422.0,,,0.0,1422.0,
TCGA-JW-AAVH,1792,TCGA-JW-AAVH,CESC,46.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16894.0,Alive,TUMOR FREE,552.0,,,,,,,Complete Remission/Response,,,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,
TCGA-DA-A1HV,8915,TCGA-DA-A1HV,SKCM,75.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2008.0,[Not Available],-27553.0,Alive,TUMOR FREE,2329.0,,[Not Available],Distant Metastasis,"Other, Specify",mediastinum,866.0,[Not Available],,,0.0,2329.0,0.0,2329.0,,,1.0,866.0,
TCGA-LN-A4MR,2580,TCGA-LN-A4MR,ESCA,57.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21142.0,Alive,TUMOR FREE,402.0,,[Not Available],Locoregional Recurrence,,,226.0,Complete Remission/Response,,,0.0,402.0,0.0,402.0,1.0,226.0,1.0,226.0,
TCGA-B0-5108,4035,TCGA-B0-5108,KIRC,54.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2009.0,[Not Available],-19932.0,Alive,TUMOR FREE,1782.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1782.0,0.0,1782.0,0.0,1782.0,0.0,1782.0,
TCGA-Z6-A8JE,2642,TCGA-Z6-A8JE,ESCA,57.0,MALE,WHITE,Stage IIIA,Stage IIIA,Esophagus Squamous Cell Carcinoma,G3,2013.0,[Not Available],-20855.0,Alive,TUMOR FREE,64.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,64.0,0.0,64.0,0.0,64.0,0.0,64.0,
TCGA-N8-A4PM,11050,TCGA-N8-A4PM,UCS,73.0,FEMALE,WHITE,[Not Applicable],Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26971.0,Alive,WITH TUMOR,829.0,,[Not Available],Locoregional Recurrence,Lymph Node(s),,524.0,Complete Remission/Response,,,0.0,829.0,0.0,829.0,1.0,524.0,1.0,524.0,
TCGA-MZ-A6I9,3704,TCGA-MZ-A6I9,HNSC,68.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-24939.0,Dead,WITH TUMOR,,489.0,[Not Available],Distant Metastasis,Distant Metastasis,"lung, mediastinal lymph node",246.0,[Not Applicable],,,1.0,489.0,1.0,489.0,,,1.0,246.0,
TCGA-BP-4998,4228,TCGA-BP-4998,KIRC,49.0,MALE,ASIAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-17997.0,Alive,TUMOR FREE,932.0,,[Not Available],,,,,[Not Available],,,0.0,932.0,0.0,932.0,,,0.0,932.0,
TCGA-2G-AAGM,9744,TCGA-2G-AAGM,TGCT,51.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor,[Not Available],2004.0,[Not Available],-18696.0,Alive,TUMOR FREE,3891.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,3891.0,0.0,3891.0,,,0.0,3891.0,
TCGA-D8-A142,1229,TCGA-D8-A142,BRCA,74.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27313.0,Alive,TUMOR FREE,425.0,,[Not Available],,,,,[Not Available],Negative,,0.0,425.0,0.0,425.0,0.0,425.0,0.0,425.0,
TCGA-FE-A235,10262,TCGA-FE-A235,THCA,26.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002.0,[Not Available],-9859.0,Alive,TUMOR FREE,3571.0,,[Not Available],,,,,[Not Available],,R0,0.0,3571.0,0.0,3571.0,0.0,3571.0,0.0,3571.0,
TCGA-06-0221,2808,TCGA-06-0221,GBM,31.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2000.0,[Not Available],-11333.0,Dead,WITH TUMOR,548.0,603.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],260.0,[Not Available],,,1.0,603.0,1.0,603.0,,,1.0,260.0,
TCGA-HF-A5NB,9555,TCGA-HF-A5NB,STAD,75.0,FEMALE,[Not Evaluated],Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,,[Not Available],-27676.0,Alive,TUMOR FREE,928.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,
TCGA-26-6174,3115,TCGA-26-6174,GBM,65.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-23884.0,Alive,,71.0,,[Not Available],,,,,[Not Available],,,0.0,71.0,0.0,71.0,,,0.0,71.0,
TCGA-2K-A9WE,4420,TCGA-2K-A9WE,KIRP,53.0,MALE,WHITE,Stage II,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-19603.0,Alive,TUMOR FREE,214.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,214.0,0.0,214.0,0.0,214.0,0.0,214.0,
TCGA-B0-5703,4061,TCGA-B0-5703,KIRC,73.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2009.0,[Not Available],-26897.0,Alive,TUMOR FREE,2246.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2246.0,0.0,2246.0,0.0,2246.0,0.0,2246.0,
TCGA-A2-A0T4,580,TCGA-A2-A0T4,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22849.0,Alive,TUMOR FREE,624.0,,[Not Available],,,,,[Not Available],Negative,,0.0,624.0,0.0,624.0,0.0,624.0,0.0,624.0,
TCGA-49-AARR,5930,TCGA-49-AARR,LUAD,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-24942.0,Alive,WITH TUMOR,4992.0,,[Not Available],New Primary Tumor,,,1099.0,Complete Remission/Response,,,0.0,4992.0,0.0,4992.0,1.0,4812.0,1.0,1099.0,
TCGA-A5-A0R6,10502,TCGA-A5-A0R6,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23449.0,Alive,TUMOR FREE,1153.0,,[Not Available],New Primary Tumor,"Other, specify",Rectum,961.0,Complete Remission/Response,,,0.0,1153.0,0.0,1153.0,0.0,1153.0,1.0,961.0,
TCGA-FR-A8YD,9141,TCGA-FR-A8YD,SKCM,56.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-20782.0,Dead,WITH TUMOR,,1103.0,[Not Available],,,,,[Not Available],,,1.0,1103.0,1.0,1103.0,,,1.0,1103.0,
TCGA-UY-A9PB,412,TCGA-UY-A9PB,BLCA,49.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-17885.0,Alive,TUMOR FREE,899.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,899.0,0.0,899.0,0.0,899.0,0.0,899.0,
TCGA-J2-8194,6279,TCGA-J2-8194,LUAD,69.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25441.0,Alive,WITH TUMOR,724.0,,[Not Available],Distant Metastasis,,,470.0,Progressive Disease,,,0.0,724.0,0.0,724.0,,,1.0,470.0,
TCGA-BK-A13B,10783,TCGA-BK-A13B,UCEC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21493.0,Alive,WITH TUMOR,966.0,,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal,760.0,Complete Remission/Response,,,0.0,966.0,0.0,966.0,1.0,760.0,1.0,760.0,
TCGA-3U-A98H,6841,TCGA-3U-A98H,MESO,57.0,MALE,WHITE,Stage IV,[Not Applicable],Biphasic mesothelioma,[Not Available],2010.0,[Not Available],-21034.0,Dead,WITH TUMOR,,1156.0,[Not Available],Intrapleural Progression,,,798.0,[Not Available],,[Not Available],1.0,1156.0,1.0,1156.0,,,1.0,798.0,
TCGA-77-8154,6690,TCGA-77-8154,LUSC,67.0,MALE,[Not Evaluated],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-24640.0,Alive,TUMOR FREE,1841.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1841.0,0.0,1841.0,0.0,1841.0,0.0,1841.0,
TCGA-D1-A16E,10841,TCGA-D1-A16E,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26859.0,Alive,TUMOR FREE,1119.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1119.0,0.0,1119.0,0.0,1119.0,0.0,1119.0,
TCGA-ZB-A963,10448,TCGA-ZB-A963,THYM,46.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type AB,[Not Available],2011.0,[Not Available],-16990.0,Alive,TUMOR FREE,1482.0,,[Not Available],,,,,[Not Available],,,0.0,1482.0,0.0,1482.0,,,0.0,1482.0,
TCGA-AN-A0XN,833,TCGA-AN-A0XN,BRCA,68.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25029.0,Alive,TUMOR FREE,10.0,,[Not Available],,,,,[Not Available],Negative,,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,
TCGA-D6-A4ZB,3621,TCGA-D6-A4ZB,HNSC,61.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-22455.0,Alive,TUMOR FREE,376.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,
TCGA-L5-A8NE,2539,TCGA-L5-A8NE,ESCA,77.0,MALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2000.0,[Not Available],-28243.0,Alive,TUMOR FREE,1688.0,,[Not Available],,,,,[Unknown],,,0.0,1688.0,0.0,1688.0,,,0.0,1688.0,
TCGA-EB-A5KH,8973,TCGA-EB-A5KH,SKCM,55.0,MALE,ASIAN,Stage III,[Not Applicable],,[Not Available],2011.0,[Not Available],-20424.0,Dead,TUMOR FREE,,619.0,[Not Available],,,,,[Not Available],,,1.0,619.0,0.0,619.0,,,0.0,619.0,
TCGA-4Z-AA89,114,TCGA-4Z-AA89,BLCA,60.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-22271.0,Alive,WITH TUMOR,1029.0,,[Not Available],New Primary Tumor,Lung,,648.0,Complete Remission/Response,,,0.0,1029.0,0.0,1029.0,,,1.0,648.0,
TCGA-RY-A843,5318,TCGA-RY-A843,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-11083.0,Alive,WITH TUMOR,63.0,,[Not Available],,,,,[Not Available],,,0.0,63.0,0.0,63.0,,,0.0,63.0,
TCGA-KB-A93J,9614,TCGA-KB-A93J,STAD,78.0,MALE,WHITE,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2008.0,[Not Available],-28599.0,Alive,,1124.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1124.0,0.0,1124.0,0.0,1124.0,0.0,1124.0,
TCGA-95-7944,6239,TCGA-95-7944,LUAD,71.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26003.0,Alive,TUMOR FREE,377.0,,[Not Available],,,,,Stable Disease,,,0.0,377.0,0.0,377.0,,,0.0,377.0,
TCGA-97-8177,6260,TCGA-97-8177,LUAD,59.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-21648.0,Alive,TUMOR FREE,499.0,,[Not Available],,,,,[Not Evaluated],,,0.0,499.0,0.0,499.0,,,0.0,499.0,
TCGA-MQ-A6BS,6864,TCGA-MQ-A6BS,MESO,55.0,MALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-20384.0,Dead,TUMOR FREE,,608.0,[Not Available],,,,,[Not Available],,R0,1.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,
TCGA-J4-A67K,8132,TCGA-J4-A67K,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24908.0,Alive,TUMOR FREE,1004.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1004.0,0.0,1004.0,0.0,1004.0,0.0,1004.0,
TCGA-76-6285,3226,TCGA-76-6285,GBM,64.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-23674.0,Dead,WITH TUMOR,254.0,254.0,[Not Available],,,,,[Not Available],,,1.0,254.0,1.0,254.0,,,1.0,254.0,
TCGA-CG-5722,9475,TCGA-CG-5722,STAD,67.0,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,[Not Available],-24472.0,Alive,WITH TUMOR,30.0,,[Not Available],,,,,[Not Available],,,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-A4-7584,4468,TCGA-A4-7584,KIRP,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-21782.0,Alive,TUMOR FREE,650.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,650.0,0.0,650.0,0.0,650.0,0.0,650.0,
TCGA-FD-A6TB,296,TCGA-FD-A6TB,BLCA,82.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-30185.0,Alive,TUMOR FREE,572.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,572.0,0.0,572.0,0.0,572.0,0.0,572.0,
TCGA-P6-A5OH,86,TCGA-P6-A5OH,ACC,59.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-21627.0,Dead,WITH TUMOR,,0.0,[Not Available],,,,,[Not Available],,,1.0,0.0,1.0,0.0,,,1.0,0.0,
TCGA-DO-A1K0,10012,TCGA-DO-A1K0,THCA,30.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-11216.0,Alive,WITH TUMOR,655.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,577.0,[Not Available],,R0,0.0,655.0,0.0,655.0,1.0,577.0,1.0,577.0,
TCGA-81-5910,3235,TCGA-81-5910,GBM,64.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-23567.0,Dead,WITH TUMOR,,49.0,[Not Available],,,,,[Not Available],,,1.0,49.0,1.0,49.0,,,1.0,49.0,
TCGA-77-8145,6685,TCGA-77-8145,LUSC,73.0,MALE,[Not Evaluated],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-26707.0,Dead,,,212.0,[Not Available],Distant Metastasis,,,136.0,[Unknown],,,1.0,212.0,,212.0,,,1.0,136.0,
TCGA-CH-5746,7886,TCGA-CH-5746,PRAD,57.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-20941.0,Alive,TUMOR FREE,731.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,731.0,0.0,731.0,0.0,731.0,0.0,731.0,
TCGA-MP-A4SW,6296,TCGA-MP-A4SW,LUAD,53.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-19640.0,Dead,,,1778.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1778.0,,1778.0,0.0,1778.0,0.0,1778.0,
TCGA-D8-A1XA,1259,TCGA-D8-A1XA,BRCA,64.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23387.0,Alive,TUMOR FREE,839.0,,[Not Available],,,,,[Not Available],Negative,,0.0,839.0,0.0,839.0,0.0,839.0,0.0,839.0,
TCGA-ZF-A9RF,484,TCGA-ZF-A9RF,BLCA,74.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-27281.0,Alive,TUMOR FREE,1949.0,,[Not Available],Locoregional (Urothelial tumor event),Bladder,,1565.0,Complete Remission/Response,,,0.0,1949.0,0.0,1949.0,1.0,1565.0,1.0,1565.0,
TCGA-62-A471,6072,TCGA-62-A471,LUAD,64.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-23689.0,Alive,TUMOR FREE,1246.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1246.0,0.0,1246.0,0.0,1246.0,0.0,1246.0,
TCGA-2G-AAF1,9713,TCGA-2G-AAF1,TGCT,28.0,MALE,ASIAN,IS,Stage IS,Seminoma; NOS,[Not Available],2011.0,[Not Available],-10511.0,Alive,TUMOR FREE,1403.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,1403.0,0.0,1403.0,0.0,1403.0,0.0,1403.0,
TCGA-2Y-A9H4,5439,TCGA-2Y-A9H4,LIHC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-25096.0,Alive,TUMOR FREE,1452.0,,[Not Available],,,,,[Not Available],,R0,0.0,1452.0,0.0,1452.0,0.0,1452.0,0.0,1452.0,
TCGA-FF-8043,2424,TCGA-FF-8043,DLBC,70.0,FEMALE,ASIAN,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010.0,[Not Available],-25612.0,Alive,TUMOR FREE,965.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,965.0,0.0,965.0,0.0,965.0,0.0,965.0,
TCGA-GU-A762,346,TCGA-GU-A762,BLCA,87.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-31812.0,Dead,WITH TUMOR,,232.0,[Not Available],,,,,Progressive Disease,,,1.0,232.0,1.0,232.0,,,1.0,232.0,
TCGA-IN-AB1X,9608,TCGA-IN-AB1X,STAD,78.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,[Not Available],-28493.0,Alive,TUMOR FREE,411.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,411.0,0.0,411.0,0.0,411.0,0.0,411.0,
TCGA-B6-A2IU,1017,TCGA-B6-A2IU,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],1998.0,Indeterminate (neither Pre or Postmenopausal),-22905.0,Alive,WITH TUMOR,5176.0,,[Not Available],New Primary Tumor,"Other, specify",Lung,4224.0,[Not Available],Negative,,0.0,5176.0,0.0,5176.0,0.0,5176.0,1.0,4224.0,
TCGA-3G-AB14,10355,TCGA-3G-AB14,THYM,51.0,MALE,WHITE,[Not Applicable],III,Thymoma; Type B2,[Not Available],2012.0,[Not Available],-18733.0,Dead,TUMOR FREE,,775.0,[Not Available],,,,,[Not Available],,,1.0,775.0,0.0,775.0,,,0.0,775.0,
TCGA-C8-A8HR,1223,TCGA-C8-A8HR,BRCA,49.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013.0,Peri (6-12 months since last menstrual period),-17921.0,Alive,TUMOR FREE,408.0,,[Not Available],,,,,[Not Available],Negative,,0.0,408.0,0.0,408.0,0.0,408.0,0.0,408.0,
TCGA-A3-3319,3892,TCGA-A3-3319,KIRC,70.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-25699.0,Alive,TUMOR FREE,1130.0,,[Not Available],,,,,[Not Available],,,0.0,1130.0,0.0,1130.0,,,0.0,1130.0,
TCGA-50-5942,5948,TCGA-50-5942,LUAD,67.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-24781.0,Alive,WITH TUMOR,1847.0,,[Not Available],Locoregional Recurrence,,,1378.0,Stable Disease,,,0.0,1847.0,0.0,1847.0,,,1.0,1378.0,
TCGA-C8-A12Y,1188,TCGA-C8-A12Y,BRCA,44.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,Alive,TUMOR FREE,1476.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1476.0,0.0,1476.0,0.0,1476.0,0.0,1476.0,
TCGA-NK-A5CT,6818,TCGA-NK-A5CT,LUSC,70.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-25726.0,Alive,WITH TUMOR,1997.0,,[Not Available],Locoregional Recurrence,,,1990.0,Stable Disease,,,0.0,1997.0,0.0,1997.0,,,1.0,1990.0,
TCGA-TS-A7P6,6884,TCGA-TS-A7P6,MESO,61.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2011.0,[Not Available],-22338.0,Dead,,,283.0,[Not Available],,,,,[Not Available],,[Unknown],1.0,283.0,,283.0,,,0.0,283.0,
TCGA-AJ-A3BH,10536,TCGA-AJ-A3BH,UCEC,,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,TUMOR FREE,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-CG-4465,9461,TCGA-CG-4465,STAD,69.0,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2008.0,[Not Available],-25233.0,Dead,,,274.0,[Not Available],,,,,[Not Available],,,1.0,274.0,,274.0,,,0.0,274.0,
TCGA-F7-A61S,3650,TCGA-F7-A61S,HNSC,62.0,MALE,WHITE,Stage III,[Not Available],Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-22655.0,Alive,TUMOR FREE,576.0,,[Not Available],Locoregional Recurrence,Cervical Lymph Nodes,,213.0,Complete Remission/Response,,,0.0,576.0,0.0,576.0,1.0,213.0,1.0,213.0,
TCGA-SX-A7SN,4675,TCGA-SX-A7SN,KIRP,52.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-19116.0,Alive,TUMOR FREE,578.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,
TCGA-26-1439,3103,TCGA-26-1439,GBM,63.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-23302.0,Dead,WITH TUMOR,,422.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],284.0,[Not Available],,,1.0,422.0,1.0,422.0,,,1.0,284.0,
TCGA-MA-AA3Y,1806,TCGA-MA-AA3Y,CESC,48.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17795.0,Alive,TUMOR FREE,542.0,,,,,,,Complete Remission/Response,,,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,
TCGA-D3-A2JB,8840,TCGA-D3-A2JB,SKCM,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage 0,[Not Applicable],,[Not Available],1997.0,[Not Available],-25784.0,Dead,TUMOR FREE,,5110.0,[Not Available],Locoregional Recurrence,,,3035.0,[Not Available],,,,,,,,,,,
TCGA-FY-A3NP,10285,TCGA-FY-A3NP,THCA,69.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-25462.0,Alive,TUMOR FREE,491.0,,[Not Available],,,,,[Not Available],,R0,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,
TCGA-MJ-A68H,8729,TCGA-MJ-A68H,SARC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2013.0,[Not Available],-21105.0,Alive,TUMOR FREE,456.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,456.0,0.0,456.0,0.0,456.0,0.0,456.0,
TCGA-4Z-AA80,107,TCGA-4Z-AA80,BLCA,73.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-26873.0,Dead,TUMOR FREE,,19.0,[Not Available],,,,,[Not Applicable],,,1.0,19.0,0.0,19.0,,,0.0,19.0,
TCGA-D1-A16Y,10853,TCGA-D1-A16Y,UCEC,56.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20455.0,Alive,TUMOR FREE,532.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,
TCGA-GU-A42Q,344,TCGA-GU-A42Q,BLCA,67.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-24534.0,Dead,TUMOR FREE,,344.0,[Not Available],,,,,Complete Remission/Response,,,1.0,344.0,0.0,344.0,0.0,344.0,0.0,344.0,
TCGA-NA-A4QY,11065,TCGA-NA-A4QY,UCS,62.0,FEMALE,WHITE,[Not Applicable],Stage III,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22756.0,Dead,WITH TUMOR,,114.0,[Not Available],,,,,[Not Available],,,1.0,114.0,1.0,114.0,,,1.0,114.0,
TCGA-ZG-A9LN,8357,TCGA-ZG-A9LN,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-21050.0,Alive,WITH TUMOR,115.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,115.0,0.0,115.0,,,0.0,115.0,
TCGA-QH-A6CU,5295,TCGA-QH-A6CU,LGG,52.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-19149.0,Alive,TUMOR FREE,451.0,,[Not Available],,,,,Stable Disease,,,0.0,451.0,0.0,451.0,,,0.0,451.0,
TCGA-KC-A7FD,8171,TCGA-KC-A7FD,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22745.0,Alive,TUMOR FREE,270.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,270.0,0.0,270.0,0.0,270.0,0.0,270.0,
TCGA-4K-AA1I,9779,TCGA-4K-AA1I,TGCT,26.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2013.0,[Not Available],-9679.0,Alive,TUMOR FREE,3.0,,[Not Applicable],,,,,,,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-D1-A174,10854,TCGA-D1-A174,UCEC,51.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Indeterminate (neither Pre or Postmenopausal),-18702.0,Alive,TUMOR FREE,594.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,
TCGA-IG-A3YC,2480,TCGA-IG-A3YC,ESCA,62.0,MALE,WHITE,Stage IIIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-22774.0,Alive,WITH TUMOR,612.0,,[Not Available],New Primary Tumor,Lung,,542.0,Stable Disease,,,0.0,612.0,0.0,612.0,,,1.0,542.0,
TCGA-DU-A7TD,5062,TCGA-DU-A7TD,LGG,52.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2012.0,[Not Available],-19025.0,Dead,WITH TUMOR,,228.0,[Not Available],,,,188.0,Progressive Disease,,,1.0,228.0,1.0,228.0,,,1.0,188.0,
TCGA-BH-A18T,1127,TCGA-BH-A18T,BRCA,70.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25674.0,Dead,WITH TUMOR,,224.0,[Not Available],,,,,[Not Available],Negative,,1.0,224.0,1.0,224.0,,,1.0,224.0,
TCGA-32-1982,3173,TCGA-32-1982,GBM,76.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-27764.0,Dead,WITH TUMOR,142.0,142.0,[Not Available],,,,,[Not Available],,,1.0,142.0,1.0,142.0,,,1.0,142.0,
TCGA-DD-AAE0,5634,TCGA-DD-AAE0,LIHC,45.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G4,2013.0,[Not Available],-16732.0,Alive,TUMOR FREE,555.0,,[Not Available],,,,,[Not Available],,R0,0.0,555.0,0.0,555.0,0.0,555.0,0.0,555.0,
TCGA-4Z-AA7M,99,TCGA-4Z-AA7M,BLCA,65.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-23817.0,Alive,TUMOR FREE,495.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,495.0,0.0,495.0,0.0,495.0,0.0,495.0,
TCGA-LG-A9QD,5748,TCGA-LG-A9QD,LIHC,68.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-24969.0,Alive,WITH TUMOR,366.0,,[Not Available],,,,,[Not Available],,R0,0.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,
TCGA-2G-AAFI,9720,TCGA-2G-AAFI,TGCT,41.0,MALE,WHITE,Stage IB,Stage IB,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2013.0,[Not Available],-14976.0,Alive,TUMOR FREE,675.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,675.0,0.0,675.0,0.0,675.0,0.0,675.0,
TCGA-F4-6805,2359,TCGA-F4-6805,COAD,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-21241.0,Alive,TUMOR FREE,1047.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1047.0,0.0,1047.0,0.0,1047.0,0.0,1047.0,
TCGA-ZB-A96I,10461,TCGA-ZB-A96I,THYM,71.0,FEMALE,WHITE,[Not Applicable],III,Thymoma; Type AB,[Not Available],2010.0,[Not Available],-26208.0,Alive,TUMOR FREE,1653.0,,[Not Available],,,,,[Not Available],,,0.0,1653.0,0.0,1653.0,,,0.0,1653.0,
TCGA-B3-4103,4515,TCGA-B3-4103,KIRP,56.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-20708.0,Alive,TUMOR FREE,930.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,
TCGA-EY-A2OP,10971,TCGA-EY-A2OP,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23090.0,Alive,TUMOR FREE,944.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,944.0,0.0,944.0,0.0,944.0,0.0,944.0,
TCGA-CI-6624,8478,TCGA-CI-6624,READ,53.0,FEMALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-19419.0,Alive,,1466.0,,[Not Available],,,,,[Unknown],,,0.0,1466.0,0.0,1466.0,,,0.0,1466.0,
TCGA-D6-6517,3612,TCGA-D6-6517,HNSC,59.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-21791.0,Alive,WITH TUMOR,292.0,,[Not Available],,Distant Metastasis,tracheostoma,161.0,Progressive Disease,,,0.0,292.0,0.0,292.0,,,1.0,161.0,
TCGA-EM-A2P0,10156,TCGA-EM-A2P0,THCA,33.0,MALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-12127.0,Alive,TUMOR FREE,535.0,,[Not Available],,,,,[Not Available],,R0,0.0,535.0,0.0,535.0,0.0,535.0,0.0,535.0,
TCGA-CW-5585,4342,TCGA-CW-5585,KIRC,51.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2003.0,[Not Available],-18898.0,Alive,WITH TUMOR,2609.0,,[Not Available],,,,,[Not Available],,,0.0,2609.0,0.0,2609.0,,,0.0,2609.0,
TCGA-EE-A3AF,9073,TCGA-EE-A3AF,SKCM,48.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-17731.0,Dead,WITH TUMOR,,420.0,[Not Available],Locoregional Recurrence,,,201.0,[Not Available],,,1.0,420.0,1.0,420.0,,,1.0,201.0,
TCGA-LL-A440,1530,TCGA-LL-A440,BRCA,61.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22497.0,Alive,TUMOR FREE,759.0,,[Not Available],,,,,[Not Available],Negative,,0.0,759.0,0.0,759.0,0.0,759.0,0.0,759.0,
TCGA-BF-A3DM,8808,TCGA-BF-A3DM,SKCM,63.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2011.0,[Not Available],-23076.0,Alive,TUMOR FREE,601.0,,[Not Available],,,,,[Not Available],,,0.0,601.0,0.0,601.0,,,0.0,601.0,
TCGA-SN-A84X,9788,TCGA-SN-A84X,TGCT,21.0,MALE,WHITE,IS,Stage IB,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Seminoma; NOS,[Not Available],2013.0,[Not Available],-7833.0,Alive,TUMOR FREE,312.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,312.0,0.0,312.0,0.0,312.0,0.0,312.0,
TCGA-V4-A9EI,11094,TCGA-V4-A9EI,UVM,78.0,MALE,WHITE,Stage IIIB,Stage IIIB,Epithelioid Cell,[Not Available],2012.0,[Not Available],-28562.0,Dead,WITH TUMOR,,389.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,,203.0,[Not Available],,,1.0,389.0,1.0,389.0,,,1.0,203.0,
TCGA-P5-A5EZ,5269,TCGA-P5-A5EZ,LGG,39.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-14375.0,Alive,TUMOR FREE,70.0,,[Not Available],,,,,[Not Available],,,0.0,70.0,0.0,70.0,,,0.0,70.0,
TCGA-A2-A0YK,592,TCGA-A2-A0YK,BRCA,61.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22625.0,Alive,TUMOR FREE,588.0,,[Not Available],,,,,[Not Available],Close,,0.0,588.0,0.0,588.0,,,0.0,588.0,
TCGA-C8-A1HO,1207,TCGA-C8-A1HO,BRCA,34.0,FEMALE,ASIAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12715.0,Alive,TUMOR FREE,375.0,,[Not Available],,,,,[Not Available],Negative,,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,
TCGA-3B-A9HX,8548,TCGA-3B-A9HX,SARC,70.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-25627.0,Alive,TUMOR FREE,1303.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1303.0,0.0,1303.0,0.0,1303.0,0.0,1303.0,
TCGA-DX-AB2H,8655,TCGA-DX-AB2H,SARC,80.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2013.0,[Not Available],-29569.0,Alive,TUMOR FREE,482.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,482.0,0.0,482.0,0.0,482.0,0.0,482.0,
TCGA-FS-A1ZM,9160,TCGA-FS-A1ZM,SKCM,74.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2001.0,[Not Available],-27210.0,Alive,TUMOR FREE,3080.0,,[Not Available],,,,,[Not Available],,,0.0,3080.0,0.0,3080.0,,,0.0,3080.0,
TCGA-C5-A1BN,1615,TCGA-C5-A1BN,CESC,26.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9783.0,Dead,WITH TUMOR,,166.0,Cervical Cancer,,,,,Progressive Disease,,,1.0,166.0,1.0,166.0,,,1.0,166.0,
TCGA-KC-A7F6,8169,TCGA-KC-A7F6,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23367.0,Alive,TUMOR FREE,263.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,263.0,0.0,263.0,0.0,263.0,0.0,263.0,
TCGA-VQ-A8PC,9656,TCGA-VQ-A8PC,STAD,65.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2009.0,[Not Available],-23912.0,Dead,WITH TUMOR,,1407.0,[Unknown],Locoregional Recurrence,,,1287.0,Progressive Disease,,,1.0,1407.0,1.0,1407.0,,,1.0,1287.0,
TCGA-AC-A62X,791,TCGA-AC-A62X,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26627.0,Alive,TUMOR FREE,417.0,,[Not Available],,,,,[Not Available],Negative,,0.0,417.0,0.0,417.0,0.0,417.0,0.0,417.0,
TCGA-AH-6644,8469,TCGA-AH-6644,READ,73.0,MALE,WHITE,[Not Available],[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-26892.0,Alive,TUMOR FREE,838.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,838.0,0.0,838.0,0.0,838.0,0.0,838.0,
TCGA-AA-3660,2056,TCGA-AA-3660,COAD,51.0,FEMALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-18932.0,Alive,TUMOR FREE,2375.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2375.0,0.0,2375.0,0.0,2375.0,0.0,2375.0,
TCGA-P5-A5F4,5273,TCGA-P5-A5F4,LGG,35.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-12851.0,Alive,[Discrepancy],231.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,231.0,0.0,231.0,,,0.0,231.0,
TCGA-18-3414,6332,TCGA-18-3414,LUSC,73.0,MALE,ASIAN,Stage IV,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-26938.0,Dead,TUMOR FREE,,716.0,[Not Available],,,,,Complete Remission/Response,,,1.0,716.0,0.0,716.0,,,0.0,716.0,
TCGA-M7-A722,8222,TCGA-M7-A722,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23880.0,Alive,TUMOR FREE,1060.0,,[Not Available],Biochemical evidence of disease,,,559.0,Partial Remission/Response,,,0.0,1060.0,0.0,1060.0,,,1.0,559.0,
TCGA-55-6543,5972,TCGA-55-6543,LUAD,60.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],,Alive,TUMOR FREE,435.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,435.0,0.0,435.0,0.0,435.0,0.0,435.0,
TCGA-EL-A4K0,10109,TCGA-EL-A4K0,THCA,54.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-20042.0,Alive,TUMOR FREE,944.0,,[Not Available],,,,,[Not Available],,RX,0.0,944.0,0.0,944.0,,,0.0,944.0,
TCGA-HR-A2OG,9213,TCGA-HR-A2OG,SKCM,50.0,FEMALE,[Not Evaluated],[Not Available],[Not Applicable],,[Not Available],,[Not Available],-21767.0,Alive,TUMOR FREE,7.0,,[Not Available],,,,,[Not Available],,,0.0,7.0,0.0,7.0,,,0.0,7.0,
TCGA-IG-A7DP,2490,TCGA-IG-A7DP,ESCA,50.0,FEMALE,WHITE,Stage IIIA,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2013.0,[Not Available],-18364.0,Alive,TUMOR FREE,452.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,452.0,0.0,452.0,0.0,452.0,0.0,452.0,
TCGA-RD-A8MV,9630,TCGA-RD-A8MV,STAD,56.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2001.0,[Not Available],-20771.0,Alive,TUMOR FREE,3720.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3720.0,0.0,3720.0,0.0,3720.0,0.0,3720.0,
TCGA-EI-6513,8512,TCGA-EI-6513,READ,59.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-21776.0,Alive,TUMOR FREE,497.0,,[Not Available],,,,,[Not Available],,,0.0,497.0,0.0,497.0,,,0.0,497.0,
TCGA-D7-6518,9489,TCGA-D7-6518,STAD,75.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-27594.0,Alive,TUMOR FREE,582.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,582.0,0.0,582.0,0.0,582.0,0.0,582.0,
TCGA-KR-A7K7,5744,TCGA-KR-A7K7,LIHC,61.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-22587.0,Alive,WITH TUMOR,951.0,,[Not Available],Extrahepatic Recurrence,"Other, specify",Adrenal bilateral,239.0,[Not Available],,R0,0.0,951.0,0.0,951.0,1.0,239.0,1.0,239.0,
TCGA-LN-A4A5,2575,TCGA-LN-A4A5,ESCA,49.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2011.0,[Not Available],-18160.0,Dead,WITH TUMOR,,681.0,[Not Available],Locoregional Recurrence,,,224.0,Complete Remission/Response,,,1.0,681.0,1.0,681.0,1.0,224.0,1.0,224.0,
TCGA-W2-A7HE,7826,TCGA-W2-A7HE,PCPG,80.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-29241.0,Alive,TUMOR FREE,505.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,505.0,0.0,505.0,0.0,505.0,0.0,505.0,
TCGA-DZ-6131,4581,TCGA-DZ-6131,KIRP,31.0,MALE,WHITE,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2003.0,[Not Available],-11487.0,Alive,TUMOR FREE,2429.0,,[Not Available],,,,,[Not Available],,,0.0,2429.0,0.0,2429.0,,,0.0,2429.0,
TCGA-QH-A6X4,5302,TCGA-QH-A6X4,LGG,47.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-17258.0,Alive,TUMOR FREE,442.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,
TCGA-UC-A7PI,1835,TCGA-UC-A7PI,CESC,44.0,FEMALE,WHITE,[Not Available],Stage IB1,Endometrioid Adenocarcinoma of Endocervix,G1,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16427.0,Alive,TUMOR FREE,2114.0,,,Locoregional Recurrence,"Other, specify",,778.0,Complete Remission/Response,,,0.0,2114.0,0.0,2114.0,1.0,778.0,1.0,778.0,
TCGA-FG-A6IZ,5129,TCGA-FG-A6IZ,LGG,60.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-22275.0,Alive,TUMOR FREE,457.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,457.0,0.0,457.0,0.0,457.0,0.0,457.0,
TCGA-KK-A6E3,8182,TCGA-KK-A6E3,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2004.0,[Not Available],-20547.0,Alive,TUMOR FREE,2056.0,,[Not Available],,,,,[Not Available],,,0.0,2056.0,0.0,2056.0,,,0.0,2056.0,
TCGA-HC-7233,8075,TCGA-HC-7233,PRAD,73.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],,Alive,TUMOR FREE,1355.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1355.0,0.0,1355.0,0.0,1355.0,0.0,1355.0,
TCGA-CJ-5689,4331,TCGA-CJ-5689,KIRC,90.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2005.0,[Not Available],-32872.0,Dead,TUMOR FREE,,1620.0,[Not Available],,,,,[Not Available],,,1.0,1620.0,0.0,1620.0,,,0.0,1620.0,
TCGA-XY-A89B,9823,TCGA-XY-A89B,TGCT,35.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2013.0,[Not Available],-12955.0,Alive,TUMOR FREE,471.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,471.0,0.0,471.0,0.0,471.0,0.0,471.0,
TCGA-QK-A6IH,3725,TCGA-QK-A6IH,HNSC,65.0,FEMALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-23936.0,Alive,WITH TUMOR,653.0,,[Not Available],,Distant Metastasis,Lung,228.0,Progressive Disease,,,0.0,653.0,0.0,653.0,,,1.0,228.0,
TCGA-FG-8185,5115,TCGA-FG-8185,LGG,37.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-13621.0,Alive,TUMOR FREE,433.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,433.0,0.0,433.0,0.0,433.0,0.0,433.0,
TCGA-CZ-4864,4364,TCGA-CZ-4864,KIRC,86.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2002.0,[Not Available],-31557.0,Dead,TUMOR FREE,2830.0,2830.0,[Not Available],,,,,[Not Available],,,1.0,2830.0,0.0,2830.0,,,0.0,2830.0,
TCGA-G9-6333,8016,TCGA-G9-6333,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-24249.0,Alive,TUMOR FREE,2465.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2465.0,0.0,2465.0,0.0,2465.0,0.0,2465.0,
TCGA-CR-7364,3438,TCGA-CR-7364,HNSC,66.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-24192.0,Alive,TUMOR FREE,1435.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1435.0,0.0,1435.0,0.0,1435.0,0.0,1435.0,
TCGA-L5-A4OW,2529,TCGA-L5-A4OW,ESCA,56.0,FEMALE,[Not Evaluated],Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2006.0,[Not Available],-20796.0,Dead,TUMOR FREE,,217.0,[Not Available],,,,,Complete Remission/Response,,,1.0,217.0,0.0,217.0,0.0,217.0,0.0,217.0,
TCGA-A2-A0CK,537,TCGA-A2-A0CK,BRCA,60.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22094.0,Alive,TUMOR FREE,4159.0,,[Not Available],New Primary Tumor,"Other, specify",LEFT BREAST,1364.0,[Not Available],Negative,,0.0,4159.0,0.0,4159.0,1.0,1364.0,1.0,1364.0,
TCGA-06-0743,2828,TCGA-06-0743,GBM,69.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-25434.0,Dead,WITH TUMOR,,803.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],176.0,[Not Available],,,1.0,803.0,1.0,803.0,,,1.0,176.0,
TCGA-E7-A97P,255,TCGA-E7-A97P,BLCA,73.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-26956.0,Dead,TUMOR FREE,,437.0,[Not Available],,,,,Complete Remission/Response,,,1.0,437.0,0.0,437.0,0.0,437.0,0.0,437.0,
TCGA-L9-A443,6285,TCGA-L9-A443,LUAD,63.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-23062.0,Dead,TUMOR FREE,,193.0,[Not Available],,,,,Complete Remission/Response,,,1.0,193.0,0.0,193.0,0.0,193.0,0.0,193.0,
TCGA-ER-A2ND,9116,TCGA-ER-A2ND,SKCM,57.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2004.0,[Not Available],-20867.0,Dead,WITH TUMOR,,710.0,[Not Available],,,,,[Not Available],,,1.0,710.0,1.0,710.0,,,1.0,710.0,
TCGA-LL-A5YL,1534,TCGA-LL-A5YL,BRCA,64.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23395.0,Alive,,519.0,,[Not Available],,,,,[Not Available],Negative,,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,
TCGA-WK-A8XY,8776,TCGA-WK-A8XY,SARC,53.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2007.0,[Not Available],-19597.0,Dead,WITH TUMOR,,1991.0,[Not Available],Locoregional Recurrence,"Other, specify",Intraabdominal,103.0,[Not Available],Positive,R1,1.0,1991.0,1.0,1991.0,,,1.0,103.0,
TCGA-CC-5264,5488,TCGA-CC-5264,LIHC,71.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-25979.0,Dead,TUMOR FREE,,102.0,[Not Available],,,,,[Not Available],,RX,1.0,102.0,0.0,102.0,,,0.0,102.0,
TCGA-XE-A8H4,9807,TCGA-XE-A8H4,TGCT,23.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2008.0,[Not Available],-8728.0,Alive,TUMOR FREE,559.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,559.0,0.0,559.0,0.0,559.0,0.0,559.0,
TCGA-EA-A5FO,1710,TCGA-EA-A5FO,CESC,59.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21561.0,Alive,TUMOR FREE,815.0,,,,,,,Complete Remission/Response,,,0.0,815.0,0.0,815.0,0.0,815.0,0.0,815.0,
TCGA-62-A46P,6065,TCGA-62-A46P,LUAD,65.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-23993.0,Dead,TUMOR FREE,,594.0,[Not Available],Distant Metastasis,,,267.0,Complete Remission/Response,,,1.0,594.0,0.0,594.0,1.0,267.0,1.0,267.0,
TCGA-HI-7171,8129,TCGA-HI-7171,PRAD,56.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-20776.0,Dead,WITH TUMOR,,1329.0,[Unknown],,,,,Stable Disease,,,1.0,1329.0,1.0,1329.0,,,1.0,1329.0,
TCGA-BP-4986,4219,TCGA-BP-4986,KIRC,75.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-27612.0,Alive,TUMOR FREE,785.0,,[Not Available],,,,,[Not Available],,,0.0,785.0,0.0,785.0,,,0.0,785.0,
TCGA-ZR-A9CJ,2645,TCGA-ZR-A9CJ,ESCA,65.0,MALE,WHITE,Stage IIIC,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2012.0,[Not Available],-23752.0,Dead,WITH TUMOR,,600.0,[Not Available],Distant Metastasis,Liver,,163.0,[Unknown],,,1.0,600.0,1.0,600.0,,,1.0,163.0,
TCGA-VN-A88L,8269,TCGA-VN-A88L,PRAD,54.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20026.0,Alive,TUMOR FREE,746.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,746.0,0.0,746.0,0.0,746.0,0.0,746.0,
TCGA-P4-A5EA,4657,TCGA-P4-A5EA,KIRP,54.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-19748.0,Dead,WITH TUMOR,,201.0,[Not Available],,,,44.0,Complete Remission/Response,,,1.0,201.0,1.0,201.0,1.0,44.0,1.0,44.0,
TCGA-34-2608,6422,TCGA-34-2608,LUSC,84.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1999.0,[Not Available],-30958.0,Dead,TUMOR FREE,1000.0,1000.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0,
TCGA-C5-A1BF,1609,TCGA-C5-A1BF,CESC,46.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G1,1997.0,[Not Available],-16975.0,Dead,WITH TUMOR,,570.0,Cervical Cancer,Distant Metastasis,"Other, specify","Lung, Sternum",93.0,Complete Remission/Response,,,1.0,570.0,1.0,570.0,1.0,93.0,1.0,93.0,
TCGA-IQ-A6SG,3690,TCGA-IQ-A6SG,HNSC,61.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-22529.0,Alive,TUMOR FREE,579.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,
TCGA-BG-A18C,10769,TCGA-BG-A18C,UCEC,72.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,[Not Available],-26602.0,Alive,TUMOR FREE,470.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,470.0,0.0,470.0,0.0,470.0,0.0,470.0,
TCGA-78-8662,6173,TCGA-78-8662,LUAD,53.0,FEMALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2000.0,[Not Available],-19563.0,Dead,,,3361.0,[Not Available],Locoregional Recurrence,,,3044.0,Complete Remission/Response,,,1.0,3361.0,,3361.0,1.0,3044.0,1.0,3044.0,
TCGA-HT-7610,5167,TCGA-HT-7610,LGG,25.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2007.0,[Not Available],-9447.0,Alive,TUMOR FREE,1706.0,,[Not Available],,,,1205.0,Stable Disease,,,0.0,1706.0,0.0,1706.0,,,1.0,1205.0,
TCGA-VQ-AA6D,9703,TCGA-VQ-AA6D,STAD,52.0,FEMALE,[Unknown],Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2013.0,[Not Available],-19090.0,Alive,TUMOR FREE,521.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,521.0,0.0,521.0,0.0,521.0,0.0,521.0,
TCGA-CH-5737,7878,TCGA-CH-5737,PRAD,73.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-26753.0,Alive,TUMOR FREE,91.0,,[Not Available],,,,,[Not Available],,,0.0,91.0,0.0,91.0,,,0.0,91.0,
TCGA-06-0139,2752,TCGA-06-0139,GBM,40.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-14729.0,Dead,WITH TUMOR,327.0,362.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],152.0,[Not Available],,,1.0,362.0,1.0,362.0,,,1.0,152.0,
TCGA-BH-A1EO,1131,TCGA-BH-A1EO,BRCA,68.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25136.0,Dead,TUMOR FREE,,2798.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,2798.0,0.0,2798.0,,,0.0,2798.0,
TCGA-06-6694,2881,TCGA-06-6694,GBM,76.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1994.0,[Not Available],-27909.0,Dead,WITH TUMOR,224.0,224.0,[Not Available],,,,,[Not Available],,,1.0,224.0,1.0,224.0,,,1.0,224.0,
TCGA-KK-A6E5,8184,TCGA-KK-A6E5,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-23144.0,Alive,TUMOR FREE,2073.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2073.0,0.0,2073.0,0.0,2073.0,0.0,2073.0,
TCGA-J4-A83J,8145,TCGA-J4-A83J,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-24960.0,Alive,TUMOR FREE,696.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,696.0,0.0,696.0,0.0,696.0,0.0,696.0,
TCGA-B5-A11J,10699,TCGA-B5-A11J,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23485.0,Alive,TUMOR FREE,1656.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1656.0,0.0,1656.0,0.0,1656.0,0.0,1656.0,
TCGA-CZ-5456,4372,TCGA-CZ-5456,KIRC,57.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-21164.0,Alive,WITH TUMOR,2422.0,,[Not Available],,,,951.0,[Not Available],,,0.0,2422.0,0.0,2422.0,,,1.0,951.0,
TCGA-EJ-7784,7962,TCGA-EJ-7784,PRAD,63.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23183.0,Alive,TUMOR FREE,781.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,781.0,0.0,781.0,0.0,781.0,0.0,781.0,
TCGA-85-8049,6716,TCGA-85-8049,LUSC,57.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-20995.0,Alive,TUMOR FREE,579.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,
TCGA-B8-A54K,4122,TCGA-B8-A54K,KIRC,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2012.0,[Not Available],-22627.0,Alive,TUMOR FREE,469.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,469.0,0.0,469.0,0.0,469.0,0.0,469.0,
TCGA-V1-A9OF,8253,TCGA-V1-A9OF,PRAD,49.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-18250.0,Alive,,1184.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1184.0,0.0,1184.0,0.0,1184.0,0.0,1184.0,
TCGA-4Z-AA84,111,TCGA-4Z-AA84,BLCA,61.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-22397.0,Alive,WITH TUMOR,460.0,,[Not Available],,,,,Progressive Disease,,,0.0,460.0,0.0,460.0,,,0.0,460.0,
TCGA-34-A5IX,6438,TCGA-34-A5IX,LUSC,80.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-29391.0,Alive,TUMOR FREE,1031.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1031.0,0.0,1031.0,0.0,1031.0,0.0,1031.0,
TCGA-78-8648,6170,TCGA-78-8648,LUAD,58.0,FEMALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-21443.0,Dead,,,1209.0,[Not Available],Locoregional Recurrence,,,720.0,[Unknown],,,1.0,1209.0,,1209.0,,,1.0,720.0,
TCGA-EE-A183,8998,TCGA-EE-A183,SKCM,48.0,MALE,WHITE,Stage 0,[Not Applicable],,[Not Available],2007.0,[Not Available],-17788.0,Dead,WITH TUMOR,,818.0,[Not Available],Locoregional Recurrence,,,450.0,[Not Available],,,,,,,,,,,
TCGA-A2-A0EN,558,TCGA-A2-A0EN,BRCA,70.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25771.0,Alive,TUMOR FREE,4088.0,,[Not Available],,,,,[Not Available],Negative,,0.0,4088.0,0.0,4088.0,0.0,4088.0,0.0,4088.0,
TCGA-HU-A4G3,9567,TCGA-HU-A4G3,STAD,54.0,MALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-20064.0,Alive,TUMOR FREE,170.0,,[Not Available],,,,,Stable Disease,,,0.0,170.0,0.0,170.0,,,0.0,170.0,
TCGA-2L-AAQL,7524,TCGA-2L-AAQL,PAAD,82.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-30092.0,Dead,WITH TUMOR,,292.0,Pancreatic Cancer,,,,,Progressive Disease,,,1.0,292.0,1.0,292.0,,,1.0,292.0,
TCGA-DX-A23V,8568,TCGA-DX-A23V,SARC,57.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2003.0,[Not Available],-21155.0,Dead,WITH TUMOR,,2034.0,[Not Available],Locoregional Recurrence,,,378.0,[Not Available],[Not Available],R1,1.0,2034.0,1.0,2034.0,,,1.0,378.0,
TCGA-A3-3374,3920,TCGA-A3-3374,KIRC,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-18890.0,Alive,,1314.0,,[Not Available],,,,,[Not Available],,,0.0,1314.0,0.0,1314.0,,,0.0,1314.0,
TCGA-QH-A86X,5308,TCGA-QH-A86X,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-12385.0,Alive,TUMOR FREE,337.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,337.0,0.0,337.0,0.0,337.0,0.0,337.0,
TCGA-TQ-A7RS,5400,TCGA-TQ-A7RS,LGG,25.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-9172.0,Alive,TUMOR FREE,-1.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-CV-5441,3478,TCGA-CV-5441,HNSC,58.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,[Not Available],-21305.0,Alive,TUMOR FREE,2886.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2886.0,0.0,2886.0,,,0.0,2886.0,
TCGA-BA-A6DJ,3276,TCGA-BA-A6DJ,HNSC,62.0,MALE,ASIAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-22967.0,Dead,WITH TUMOR,,407.0,[Not Available],,Distant Metastasis,Lungs,240.0,Complete Remission/Response,,,1.0,407.0,1.0,407.0,,,1.0,240.0,
TCGA-EY-A1GQ,10955,TCGA-EY-A1GQ,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27905.0,Alive,WITH TUMOR,544.0,,[Not Available],Metastatic,"Other, specify","R external iliac node, presacral peritoneal implant, ascitic fluid",334.0,Complete Remission/Response,,,0.0,544.0,0.0,544.0,1.0,334.0,1.0,334.0,
TCGA-B6-A40C,1025,TCGA-B6-A40C,BRCA,51.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005.0,[Unknown],-18852.0,Alive,TUMOR FREE,2164.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2164.0,0.0,2164.0,0.0,2164.0,0.0,2164.0,
TCGA-R2-A69V,1830,TCGA-R2-A69V,CESC,42.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2011.0,Peri (6-12 months since last menstrual period),-15479.0,Alive,TUMOR FREE,596.0,,,,,,,Complete Remission/Response,,,0.0,596.0,0.0,596.0,0.0,596.0,0.0,596.0,
TCGA-OR-A5KV,51,TCGA-OR-A5KV,ACC,17.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2003.0,[Not Available],-6250.0,Alive,TUMOR FREE,3878.0,,[Not Available],Distant Metastasis,Lung,,1116.0,Complete Remission/Response,,,0.0,3878.0,0.0,3878.0,1.0,1116.0,1.0,1116.0,
TCGA-ZH-A8Y8,1952,TCGA-ZH-A8Y8,CHOL,73.0,MALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2013.0,[Not Available],-26744.0,Alive,TUMOR FREE,602.0,,[Not Available],,,,,[Not Available],,R0,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,
TCGA-EE-A2GB,9029,TCGA-EE-A2GB,SKCM,51.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2007.0,[Not Available],-18876.0,Alive,TUMOR FREE,1803.0,,[Not Available],,,,,[Not Available],,,0.0,1803.0,0.0,1803.0,,,0.0,1803.0,
TCGA-DM-A28F,2346,TCGA-DM-A28F,COAD,73.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2002.0,[Not Available],-26856.0,Dead,,1094.0,1094.0,[Not Available],,,,,[Not Available],,,1.0,1094.0,,1094.0,,,0.0,1094.0,
TCGA-2W-A8YY,1602,TCGA-2W-A8YY,CESC,51.0,FEMALE,WHITE,[Not Available],Stage IB2,Adenosquamous,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18886.0,Alive,TUMOR FREE,533.0,,,,,,,Complete Remission/Response,,,0.0,533.0,0.0,533.0,0.0,533.0,0.0,533.0,
TCGA-32-4213,3189,TCGA-32-4213,GBM,47.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-17237.0,Alive,WITH TUMOR,604.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],353.0,[Not Available],,,0.0,604.0,0.0,604.0,,,1.0,353.0,
TCGA-33-4582,6403,TCGA-33-4582,LUSC,55.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-20402.0,Dead,WITH TUMOR,,3149.0,[Not Available],Locoregional Recurrence,,,2923.0,Complete Remission/Response,,,1.0,3149.0,1.0,3149.0,1.0,2923.0,1.0,2923.0,
TCGA-IG-A50L,2484,TCGA-IG-A50L,ESCA,58.0,MALE,ASIAN,Stage IIIA,Stage IIIA,Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21214.0,Alive,TUMOR FREE,16.0,,[Not Available],,,,,[Not Available],,,0.0,16.0,0.0,16.0,,,0.0,16.0,
TCGA-BH-A0HA,1094,TCGA-BH-A0HA,BRCA,31.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11379.0,Alive,TUMOR FREE,1611.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0,
TCGA-FE-A3PA,10268,TCGA-FE-A3PA,THCA,16.0,MALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2002.0,[Not Available],-6068.0,Alive,TUMOR FREE,3235.0,,[Not Available],,,,,[Not Available],,R2,0.0,3235.0,0.0,3235.0,,,0.0,3235.0,
TCGA-4Z-AA7Y,106,TCGA-4Z-AA7Y,BLCA,60.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-22056.0,Alive,TUMOR FREE,1522.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1522.0,0.0,1522.0,0.0,1522.0,0.0,1522.0,
TCGA-FF-A7CW,2431,TCGA-FF-A7CW,DLBC,72.0,MALE,ASIAN,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2012.0,[Not Available],-26520.0,Alive,TUMOR FREE,791.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,
TCGA-WC-A888,11152,TCGA-WC-A888,UVM,76.0,MALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell|Spindle Cell,[Not Available],2013.0,[Not Available],-28117.0,Dead,TUMOR FREE,,575.0,[Not Available],,,,,[Not Available],,,1.0,575.0,0.0,575.0,,,0.0,575.0,
TCGA-KL-8325,3772,TCGA-KL-8325,KICH,56.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2000.0,[Not Available],-20768.0,Dead,TUMOR FREE,,725.0,[Not Available],,,,,[Not Available],,,1.0,725.0,0.0,725.0,,,0.0,725.0,
TCGA-HC-7736,8076,TCGA-HC-7736,PRAD,59.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-21703.0,Alive,TUMOR FREE,1103.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1103.0,0.0,1103.0,0.0,1103.0,0.0,1103.0,
TCGA-EO-A22Y,10927,TCGA-EO-A22Y,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25127.0,Alive,TUMOR FREE,1567.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1567.0,0.0,1567.0,0.0,1567.0,0.0,1567.0,
TCGA-BH-A0HP,1102,TCGA-BH-A0HP,BRCA,65.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23883.0,Alive,TUMOR FREE,414.0,,[Not Available],,,,,[Not Available],Negative,,0.0,414.0,0.0,414.0,0.0,414.0,0.0,414.0,
TCGA-CQ-A4CD,3411,TCGA-CQ-A4CD,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVB,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-25497.0,Alive,TUMOR FREE,1022.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1022.0,0.0,1022.0,,,0.0,1022.0,
TCGA-50-6592,5953,TCGA-50-6592,LUAD,71.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-26191.0,Dead,WITH TUMOR,,777.0,[Not Available],,,,,Progressive Disease,,,1.0,777.0,1.0,777.0,,,1.0,777.0,
TCGA-QQ-A5VB,8748,TCGA-QQ-A5VB,SARC,53.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],1994.0,[Not Available],-19654.0,Dead,WITH TUMOR,,1478.0,[Not Available],Locoregional Recurrence,"Other, specify",Left Pelvis,111.0,[Not Available],Positive,R1,1.0,1478.0,1.0,1478.0,,,1.0,111.0,
TCGA-E8-A416,10028,TCGA-E8-A416,THCA,51.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-18932.0,Alive,TUMOR FREE,952.0,,[Not Available],,,,,[Not Available],,R0,0.0,952.0,0.0,952.0,0.0,952.0,0.0,952.0,
TCGA-BR-7958,9334,TCGA-BR-7958,STAD,60.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-22204.0,Alive,TUMOR FREE,899.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,899.0,0.0,899.0,0.0,899.0,0.0,899.0,
TCGA-DK-A1A5,181,TCGA-DK-A1A5,BLCA,79.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-29111.0,Dead,TUMOR FREE,,65.0,[Not Available],,,,,Complete Remission/Response,,,1.0,65.0,0.0,65.0,0.0,65.0,0.0,65.0,
TCGA-IB-7886,7627,TCGA-IB-7886,PAAD,80.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2010.0,[Not Available],-29319.0,Dead,TUMOR FREE,,123.0,"Other, non-malignant disease",,,,,Complete Remission/Response,,,1.0,123.0,0.0,123.0,0.0,123.0,0.0,123.0,
TCGA-ZM-AA0E,9841,TCGA-ZM-AA0E,TGCT,39.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2012.0,[Not Available],-14255.0,Alive,TUMOR FREE,811.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,811.0,0.0,811.0,0.0,811.0,0.0,811.0,
TCGA-AR-A2LQ,962,TCGA-AR-A2LQ,BRCA,59.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21865.0,Alive,TUMOR FREE,1233.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1233.0,0.0,1233.0,0.0,1233.0,0.0,1233.0,
TCGA-LB-A8F3,7659,TCGA-LB-A8F3,PAAD,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,[Not Available],-23624.0,Alive,TUMOR FREE,379.0,,,,,,,[Unknown],,,0.0,379.0,0.0,379.0,,,0.0,379.0,
TCGA-85-A510,6747,TCGA-85-A510,LUSC,74.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-27067.0,Alive,TUMOR FREE,482.0,,[Not Available],Distant Metastasis,,,363.0,Complete Remission/Response,,,0.0,482.0,0.0,482.0,1.0,363.0,1.0,363.0,
TCGA-BP-4963,4201,TCGA-BP-4963,KIRC,63.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-23373.0,Alive,TUMOR FREE,1834.0,,[Not Available],,,,,[Not Available],,,0.0,1834.0,0.0,1834.0,,,0.0,1834.0,
TCGA-AF-6655,8380,TCGA-AF-6655,READ,66.0,MALE,WHITE,Stage IIIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-24417.0,Alive,TUMOR FREE,609.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,609.0,0.0,609.0,0.0,609.0,0.0,609.0,
TCGA-GM-A2D9,1500,TCGA-GM-A2D9,BRCA,69.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25490.0,Dead,WITH TUMOR,,1812.0,[Not Available],Distant Metastasis,Bone,,536.0,[Not Available],Negative,,1.0,1812.0,1.0,1812.0,1.0,536.0,1.0,536.0,
TCGA-WE-A8ZY,9247,TCGA-WE-A8ZY,SKCM,62.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2010.0,[Not Available],-22676.0,Dead,WITH TUMOR,,1506.0,[Not Available],Distant Metastasis|[Not Available],Liver|[Not Available],[Not Applicable]|[Not Applicable],1389.0,[Not Available],,,1.0,1506.0,1.0,1506.0,,,1.0,1389.0,
TCGA-06-0142,2755,TCGA-06-0142,GBM,81.0,MALE,WHITE,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2002.0,[Not Available],-29642.0,Dead,WITH TUMOR,,67.0,[Not Available],,,,,[Not Available],,,1.0,67.0,1.0,67.0,,,1.0,67.0,
TCGA-2Z-A9JN,4437,TCGA-2Z-A9JN,KIRP,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-18264.0,Alive,TUMOR FREE,740.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,740.0,0.0,740.0,0.0,740.0,0.0,740.0,
TCGA-77-A5GF,6700,TCGA-77-A5GF,LUSC,70.0,MALE,[Not Evaluated],Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25654.0,Dead,WITH TUMOR,,840.0,[Not Available],Locoregional Recurrence,,,722.0,Complete Remission/Response,,,1.0,840.0,1.0,840.0,1.0,722.0,1.0,722.0,
TCGA-BR-8687,9387,TCGA-BR-8687,STAD,67.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-24472.0,Dead,WITH TUMOR,,250.0,[Not Available],,,,,Stable Disease,,,1.0,250.0,1.0,250.0,,,1.0,250.0,
TCGA-B4-5838,4089,TCGA-B4-5838,KIRC,52.0,MALE,WHITE,[Discrepancy],[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-19242.0,Alive,WITH TUMOR,166.0,,[Not Available],,,,,[Not Applicable],,,0.0,166.0,0.0,166.0,,,0.0,166.0,
TCGA-ER-A19M,9105,TCGA-ER-A19M,SKCM,36.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2006.0,[Not Available],-13300.0,Dead,WITH TUMOR,,1857.0,[Not Available],Locoregional Recurrence,"Other, Specify",lt.Brachial plexus,1152.0,[Not Available],,,1.0,1857.0,1.0,1857.0,,,1.0,1152.0,
TCGA-D1-A0ZS,10820,TCGA-D1-A0ZS,UCEC,54.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19821.0,Alive,TUMOR FREE,148.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,148.0,0.0,148.0,0.0,148.0,0.0,148.0,
TCGA-FS-A1YW,9143,TCGA-FS-A1YW,SKCM,52.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],1987.0,[Not Available],-19078.0,Dead,WITH TUMOR,,6598.0,[Not Available],,,,,[Not Available],,,1.0,6598.0,1.0,6598.0,,,1.0,6598.0,
TCGA-19-4068,3087,TCGA-19-4068,GBM,68.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-24945.0,Alive,TUMOR FREE,137.0,,[Not Available],,,,,[Not Available],,,0.0,137.0,0.0,137.0,,,0.0,137.0,
TCGA-EE-A29V,9021,TCGA-EE-A29V,SKCM,85.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-31092.0,Dead,WITH TUMOR,,787.0,[Not Available],Locoregional Recurrence,,,96.0,[Not Available],,,1.0,787.0,1.0,787.0,,,1.0,96.0,
TCGA-DU-7009,5012,TCGA-DU-7009,LGG,32.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2000.0,[Not Available],-11854.0,Dead,WITH TUMOR,,4695.0,[Not Available],,,,2960.0,Progressive Disease,,,1.0,4695.0,1.0,4695.0,,,1.0,2960.0,
TCGA-76-6191,3220,TCGA-76-6191,GBM,57.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-20937.0,Dead,WITH TUMOR,508.0,508.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],323.0,[Not Available],,,1.0,508.0,1.0,508.0,,,1.0,323.0,
TCGA-CN-A6V3,3373,TCGA-CN-A6V3,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,[Not Available],-22397.0,Alive,TUMOR FREE,742.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,742.0,0.0,742.0,,,0.0,742.0,
TCGA-HC-A76X,8120,TCGA-HC-A76X,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22756.0,Alive,TUMOR FREE,150.0,,[Not Available],,,,,[Unknown],,,0.0,150.0,0.0,150.0,,,0.0,150.0,
TCGA-GS-A9TY,2453,TCGA-GS-A9TY,DLBC,82.0,FEMALE,WHITE,[Not Applicable],Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2005.0,[Not Available],-30256.0,Alive,WITH TUMOR,3333.0,,[Not Available],,Pleura/Pleural effusion,,3255.0,Complete Remission/Response,,,0.0,3333.0,0.0,3333.0,1.0,3255.0,1.0,3255.0,
TCGA-3X-AAVC,1912,TCGA-3X-AAVC,CHOL,72.0,FEMALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; hilar/perihilar,G3,2012.0,[Not Available],-26493.0,Alive,TUMOR FREE,709.0,,[Not Available],,,,,[Not Available],,R0,0.0,709.0,0.0,709.0,0.0,709.0,0.0,709.0,
TCGA-VS-A959,1861,TCGA-VS-A959,CESC,76.0,FEMALE,[Unknown],[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27897.0,Alive,TUMOR FREE,1561.0,,,,,,,Complete Remission/Response,,,0.0,1561.0,0.0,1561.0,0.0,1561.0,0.0,1561.0,
TCGA-UB-A7MA,5772,TCGA-UB-A7MA,LIHC,62.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocholangiocarcinoma (Mixed),G2,2013.0,[Not Available],-22843.0,Alive,WITH TUMOR,848.0,,[Not Available],Intrahepatic Recurrence,Liver,,221.0,[Not Available],,R1,0.0,848.0,0.0,848.0,,,1.0,221.0,
TCGA-EL-A3ZL,10096,TCGA-EL-A3ZL,THCA,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-12649.0,Alive,TUMOR FREE,1895.0,,[Not Available],,,,,[Not Available],,R0,0.0,1895.0,0.0,1895.0,0.0,1895.0,0.0,1895.0,
TCGA-FS-A1Z3,9147,TCGA-FS-A1Z3,SKCM,72.0,FEMALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2002.0,[Not Available],-26435.0,Dead,WITH TUMOR,,636.0,[Not Available],,,,276.0,[Not Available],,,1.0,636.0,1.0,636.0,,,1.0,276.0,
TCGA-ER-A19F,9099,TCGA-ER-A19F,SKCM,82.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2003.0,[Not Available],-30176.0,Dead,TUMOR FREE,,802.0,[Not Available],,,,,[Not Available],,,1.0,802.0,0.0,802.0,,,0.0,802.0,
TCGA-HC-8261,8102,TCGA-HC-8261,PRAD,48.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-17874.0,Alive,TUMOR FREE,546.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,
TCGA-WC-A880,11146,TCGA-WC-A880,UVM,63.0,MALE,WHITE,Stage IIIA,Stage IIB,Epithelioid Cell|Spindle Cell,[Not Available],2011.0,[Not Available],-23325.0,Alive,TUMOR FREE,1258.0,,[Not Available],,,,,[Not Available],,,0.0,1258.0,0.0,1258.0,,,0.0,1258.0,
TCGA-78-7539,6165,TCGA-78-7539,LUAD,75.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27445.0,Alive,,791.0,,[Not Available],Distant Metastasis,,,688.0,Complete Remission/Response,,,0.0,791.0,0.0,791.0,1.0,688.0,1.0,688.0,
TCGA-DJ-A2PW,9949,TCGA-DJ-A2PW,THCA,65.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-23987.0,Alive,TUMOR FREE,1060.0,,[Not Available],,,,,[Not Available],,R0,0.0,1060.0,0.0,1060.0,0.0,1060.0,0.0,1060.0,
TCGA-BG-A220,10770,TCGA-BG-A220,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,[Not Available],-25346.0,Alive,TUMOR FREE,434.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,434.0,0.0,434.0,0.0,434.0,0.0,434.0,
TCGA-F7-A623,3655,TCGA-F7-A623,HNSC,70.0,MALE,WHITE,Stage IVA,[Not Available],Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-25592.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,616.0,0.0,616.0,,,0.0,616.0,
TCGA-AR-A24K,933,TCGA-AR-A24K,BRCA,46.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16961.0,Alive,TUMOR FREE,1548.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1548.0,0.0,1548.0,0.0,1548.0,0.0,1548.0,
TCGA-DJ-A13W,9927,TCGA-DJ-A13W,THCA,45.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-16558.0,Alive,TUMOR FREE,1593.0,,[Not Available],,,,,[Not Available],,R0,0.0,1593.0,0.0,1593.0,0.0,1593.0,0.0,1593.0,
TCGA-CV-6960,3515,TCGA-CV-6960,HNSC,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,1999.0,[Not Available],-18194.0,Dead,TUMOR FREE,,862.0,[Not Available],,,,,[Not Available],,,1.0,862.0,0.0,862.0,,,0.0,862.0,
TCGA-NI-A8LF,5757,TCGA-NI-A8LF,LIHC,74.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-27162.0,Alive,TUMOR FREE,799.0,,[Not Available],,,,,[Not Available],,R0,0.0,799.0,0.0,799.0,0.0,799.0,0.0,799.0,
TCGA-D7-5578,9487,TCGA-D7-5578,STAD,80.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2010.0,[Not Available],-29390.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],,,0.0,385.0,0.0,385.0,,,0.0,385.0,
TCGA-VD-A8KN,11132,TCGA-VD-A8KN,UVM,60.0,FEMALE,[Not Evaluated],Stage IIA,Stage IIB,Epithelioid Cell|Spindle Cell,[Not Available],2013.0,[Not Available],-21935.0,Alive,TUMOR FREE,68.0,,[Not Available],,,,,[Not Available],,,0.0,68.0,0.0,68.0,,,0.0,68.0,
TCGA-68-A59J,6654,TCGA-68-A59J,LUSC,74.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-27031.0,Alive,TUMOR FREE,448.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,448.0,0.0,448.0,0.0,448.0,0.0,448.0,
TCGA-XM-A8RF,10411,TCGA-XM-A8RF,THYM,84.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type A,[Not Available],2011.0,[Not Available],-30893.0,Alive,TUMOR FREE,797.0,,[Not Available],,,,,[Not Available],,,0.0,797.0,0.0,797.0,,,0.0,797.0,
TCGA-SP-A6QF,7796,TCGA-SP-A6QF,PCPG,48.0,MALE,ASIAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2007.0,[Not Available],-17795.0,Alive,TUMOR FREE,2513.0,,[Not Available],New Primary Tumor,"Other, specify",Thyroid,588.0,Complete Remission/Response,,,0.0,2513.0,0.0,2513.0,0.0,2513.0,1.0,588.0,
TCGA-UF-A7JS,3764,TCGA-UF-A7JS,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21676.0,Dead,WITH TUMOR,,680.0,[Not Available],Locoregional Recurrence,Cervical Lymph Nodes,,519.0,Complete Remission/Response,,,1.0,680.0,1.0,680.0,,,1.0,519.0,
TCGA-EP-A26S,5681,TCGA-EP-A26S,LIHC,70.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-25677.0,Alive,TUMOR FREE,608.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,608.0,0.0,608.0,,,0.0,608.0,
TCGA-HU-A4H2,9584,TCGA-HU-A4H2,STAD,58.0,FEMALE,ASIAN,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-21496.0,Alive,TUMOR FREE,394.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,394.0,0.0,394.0,0.0,394.0,0.0,394.0,
TCGA-19-2631,3085,TCGA-19-2631,GBM,74.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-27200.0,Dead,TUMOR FREE,213.0,213.0,[Not Available],,,,,[Not Available],,,1.0,213.0,0.0,213.0,,,0.0,213.0,
TCGA-ER-A2NB,9114,TCGA-ER-A2NB,SKCM,57.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2010.0,[Not Available],-20938.0,Dead,WITH TUMOR,,857.0,[Not Available],,,,461.0,[Not Available],,,1.0,857.0,1.0,857.0,,,1.0,461.0,
TCGA-XF-A9SP,432,TCGA-XF-A9SP,BLCA,59.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,[Not Available],-21776.0,Dead,WITH TUMOR,,454.0,[Not Available],Locoregional (Urothelial tumor event),Renal Pelvis,,310.0,Stable Disease,,,1.0,454.0,1.0,454.0,,,1.0,310.0,
TCGA-FR-A8YE,9142,TCGA-FR-A8YE,SKCM,41.0,MALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2006.0,[Not Available],-15159.0,Alive,TUMOR FREE,3176.0,,[Not Available],,,,,[Not Available],,,0.0,3176.0,0.0,3176.0,,,0.0,3176.0,
TCGA-DJ-A1QL,9935,TCGA-DJ-A1QL,THCA,70.0,MALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-25713.0,Alive,TUMOR FREE,535.0,,[Not Available],,,,,[Not Available],,R0,0.0,535.0,0.0,535.0,0.0,535.0,0.0,535.0,
TCGA-77-8128,6675,TCGA-77-8128,LUSC,60.0,MALE,[Not Evaluated],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1999.0,[Not Available],-21986.0,Dead,,,1150.0,[Not Available],,,,,[Not Applicable],,,1.0,1150.0,,1150.0,,,0.0,1150.0,
TCGA-G3-A25W,5704,TCGA-G3-A25W,LIHC,79.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-29018.0,Alive,TUMOR FREE,935.0,,[Not Available],,,,,[Not Available],,R0,0.0,935.0,0.0,935.0,0.0,935.0,0.0,935.0,
TCGA-N8-A4PQ,11054,TCGA-N8-A4PQ,UCS,76.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27772.0,Alive,TUMOR FREE,572.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,572.0,0.0,572.0,0.0,572.0,0.0,572.0,
TCGA-DJ-A1QQ,9939,TCGA-DJ-A1QQ,THCA,43.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-15949.0,Alive,TUMOR FREE,534.0,,[Not Available],,,,,[Not Available],,R0,0.0,534.0,0.0,534.0,0.0,534.0,0.0,534.0,
TCGA-BT-A20X,134,TCGA-BT-A20X,BLCA,56.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-20519.0,Dead,WITH TUMOR,,251.0,[Not Available],,,,,Progressive Disease,,,1.0,251.0,1.0,251.0,,,1.0,251.0,
TCGA-XF-A8HD,419,TCGA-XF-A8HD,BLCA,77.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-28305.0,Alive,TUMOR FREE,2964.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2964.0,0.0,2964.0,0.0,2964.0,0.0,2964.0,
TCGA-D5-5539,2297,TCGA-D5-5539,COAD,60.0,MALE,WHITE,Stage IIIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-22097.0,Alive,WITH TUMOR,596.0,,[Not Available],,,,579.0,[Not Available],,,0.0,596.0,0.0,596.0,,,1.0,579.0,
TCGA-DA-A3F3,8929,TCGA-DA-A3F3,SKCM,52.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2010.0,[Not Available],-19330.0,Dead,WITH TUMOR,,319.0,[Not Available],,,,,[Not Available],,,1.0,319.0,1.0,319.0,,,1.0,319.0,
TCGA-EJ-A65D,7985,TCGA-EJ-A65D,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012.0,[Not Available],-24297.0,Alive,TUMOR FREE,393.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,393.0,0.0,393.0,0.0,393.0,0.0,393.0,
TCGA-EE-A2M8,9049,TCGA-EE-A2M8,SKCM,54.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],2000.0,[Not Available],-19808.0,Dead,WITH TUMOR,,601.0,[Not Available],Distant Metastasis,Brain,,498.0,[Not Available],,,1.0,601.0,1.0,601.0,,,1.0,498.0,
TCGA-NQ-A638,6866,TCGA-NQ-A638,MESO,66.0,MALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-24410.0,Alive,TUMOR FREE,-8.0,,[Not Available],,,,,[Not Available],,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-GS-A9TQ,2447,TCGA-GS-A9TQ,DLBC,69.0,FEMALE,WHITE,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2012.0,[Not Available],-25292.0,Alive,TUMOR FREE,982.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,982.0,0.0,982.0,0.0,982.0,0.0,982.0,
TCGA-06-0877,2836,TCGA-06-0877,GBM,78.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-28760.0,Alive,WITH TUMOR,204.0,,[Not Available],,,,,[Not Available],,,0.0,204.0,0.0,204.0,,,0.0,204.0,
TCGA-PK-A5HB,91,TCGA-PK-A5HB,ACC,63.0,MALE,[Unknown],[Not Available],[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2003.0,[Not Available],-23293.0,Alive,WITH TUMOR,1293.0,,[Not Available],Distant Metastasis,Lung,,213.0,[Not Available],,,0.0,1293.0,0.0,1293.0,,,1.0,213.0,
TCGA-DU-6400,4998,TCGA-DU-6400,LGG,66.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1998.0,[Not Available],-24122.0,Dead,WITH TUMOR,,37.0,[Not Available],,,,,[Not Available],,,1.0,37.0,1.0,37.0,,,1.0,37.0,
TCGA-BQ-7049,4559,TCGA-BQ-7049,KIRP,45.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005.0,[Not Available],-16717.0,Dead,TUMOR FREE,,1364.0,[Not Available],,,,,[Not Available],,,1.0,1364.0,0.0,1364.0,,,0.0,1364.0,
TCGA-AO-A03M,843,TCGA-AO-A03M,BRCA,29.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10616.0,Alive,TUMOR FREE,1866.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1866.0,0.0,1866.0,0.0,1866.0,0.0,1866.0,
TCGA-EB-A44Q,8959,TCGA-EB-A44Q,SKCM,51.0,FEMALE,ASIAN,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-18910.0,Alive,TUMOR FREE,422.0,,[Not Available],,,,,[Not Available],,,0.0,422.0,0.0,422.0,,,0.0,422.0,
TCGA-B0-4811,3984,TCGA-B0-4811,KIRC,48.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2001.0,[Not Available],-17792.0,Dead,WITH TUMOR,,1417.0,[Not Available],,,,458.0,[Not Available],,,1.0,1417.0,1.0,1417.0,,,1.0,458.0,
TCGA-D8-A1JG,1242,TCGA-D8-A1JG,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22878.0,Alive,TUMOR FREE,1612.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1612.0,0.0,1612.0,0.0,1612.0,0.0,1612.0,
TCGA-E8-A436,10035,TCGA-E8-A436,THCA,53.0,FEMALE,ASIAN,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-19640.0,Alive,TUMOR FREE,455.0,,[Not Available],,,,,[Not Available],,R0,0.0,455.0,0.0,455.0,,,0.0,455.0,
TCGA-B0-5691,4049,TCGA-B0-5691,KIRC,66.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2002.0,[Not Available],-24120.0,Alive,WITH TUMOR,3431.0,,[Not Available],,,,3250.0,[Not Available],,,0.0,3431.0,0.0,3431.0,,,1.0,3250.0,
TCGA-BH-A0BS,1052,TCGA-BH-A0BS,BRCA,55.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20374.0,Alive,TUMOR FREE,2612.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2612.0,0.0,2612.0,0.0,2612.0,0.0,2612.0,
TCGA-EE-A2MN,9061,TCGA-EE-A2MN,SKCM,58.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],2000.0,[Not Available],-21202.0,Dead,WITH TUMOR,,1446.0,[Not Available],Distant Metastasis,Brain,,969.0,[Not Available],,,1.0,1446.0,1.0,1446.0,,,1.0,969.0,
TCGA-06-0219,2807,TCGA-06-0219,GBM,67.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2000.0,[Not Available],-24488.0,Dead,WITH TUMOR,11.0,22.0,[Not Available],,,,,[Not Available],,,1.0,22.0,1.0,22.0,,,1.0,22.0,
TCGA-BJ-A0Z3,9849,TCGA-BJ-A0Z3,THCA,33.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-12295.0,Alive,TUMOR FREE,497.0,,[Not Available],,,,,[Not Available],,RX,0.0,497.0,0.0,497.0,,,0.0,497.0,
TCGA-V4-A9E5,11084,TCGA-V4-A9E5,UVM,51.0,FEMALE,WHITE,Stage IIIB,Stage IIIB,Spindle Cell,[Not Available],2008.0,[Not Available],-18948.0,Alive,TUMOR FREE,2499.0,,[Not Available],,,,,[Not Available],,,0.0,2499.0,0.0,2499.0,,,0.0,2499.0,
TCGA-HN-A2OB,1522,TCGA-HN-A2OB,BRCA,45.0,FEMALE,[Not Evaluated],Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16672.0,Dead,WITH TUMOR,,1900.0,[Not Available],Distant Metastasis,Bone,,1543.0,[Not Available],Negative,,1.0,1900.0,1.0,1900.0,1.0,1543.0,1.0,1543.0,
TCGA-XM-A8RL,10415,TCGA-XM-A8RL,THYM,44.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type B1,[Not Available],2007.0,[Not Available],-16384.0,Alive,TUMOR FREE,2562.0,,[Not Available],,,,,[Not Available],,,0.0,2562.0,0.0,2562.0,,,0.0,2562.0,
TCGA-DD-A11A,5520,TCGA-DD-A11A,LIHC,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2004.0,[Not Available],-24646.0,Alive,,79.0,,[Not Available],,,,,[Not Available],,R0,0.0,79.0,0.0,79.0,0.0,79.0,0.0,79.0,
TCGA-DU-8165,5037,TCGA-DU-8165,LGG,60.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-21964.0,Alive,TUMOR FREE,582.0,,[Not Available],,,,,Stable Disease,,,0.0,582.0,0.0,582.0,,,0.0,582.0,
TCGA-CR-7370,3443,TCGA-CR-7370,HNSC,72.0,FEMALE,WHITE,[Not Available],Stage II,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-26468.0,Alive,TUMOR FREE,105.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,105.0,0.0,105.0,0.0,105.0,0.0,105.0,
TCGA-CE-A3MD,9897,TCGA-CE-A3MD,THCA,31.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-11399.0,Alive,TUMOR FREE,389.0,,[Not Available],,,,,[Not Available],,R0,0.0,389.0,0.0,389.0,0.0,389.0,0.0,389.0,
TCGA-BS-A0UL,10805,TCGA-BS-A0UL,UCEC,54.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2004.0,Peri (6-12 months since last menstrual period),-19982.0,Alive,TUMOR FREE,2481.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2481.0,0.0,2481.0,0.0,2481.0,0.0,2481.0,
TCGA-CD-5813,9421,TCGA-CD-5813,STAD,60.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2010.0,[Not Available],-21995.0,Dead,WITH TUMOR,,377.0,[Not Available],Distant Metastasis,Liver,,315.0,Complete Remission/Response,,,1.0,377.0,1.0,377.0,1.0,315.0,1.0,315.0,
TCGA-DD-AAVS,5654,TCGA-DD-AAVS,LIHC,56.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-20586.0,Alive,TUMOR FREE,1823.0,,[Not Available],,,,,[Not Available],,R0,0.0,1823.0,0.0,1823.0,0.0,1823.0,0.0,1823.0,
TCGA-ZC-AAA7,10470,TCGA-ZC-AAA7,THYM,63.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type C,[Not Available],2008.0,[Not Available],-23265.0,Dead,WITH TUMOR,,853.0,[Not Available],,,,,[Not Available],,,1.0,853.0,1.0,853.0,,,1.0,853.0,
TCGA-12-0618,2939,TCGA-12-0618,GBM,49.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-18071.0,Dead,,50.0,395.0,[Not Available],,,,,[Not Available],,,1.0,395.0,,395.0,,,0.0,395.0,
TCGA-HI-7170,8128,TCGA-HI-7170,PRAD,58.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-21199.0,Alive,TUMOR FREE,2522.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2522.0,0.0,2522.0,0.0,2522.0,0.0,2522.0,
TCGA-FF-8041,2422,TCGA-FF-8041,DLBC,28.0,FEMALE,ASIAN,[Not Applicable],Stage I,Primary mediastinal (thymic) DLBCL,[Not Available],2010.0,[Not Available],-10466.0,Alive,TUMOR FREE,1081.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1081.0,0.0,1081.0,0.0,1081.0,0.0,1081.0,
TCGA-EM-A2CM,10142,TCGA-EM-A2CM,THCA,62.0,FEMALE,[Not Available],Stage III,[Not Applicable],"Other, specify",[Not Available],2010.0,[Not Available],-22726.0,Alive,WITH TUMOR,1253.0,,[Not Available],,,,,[Not Available],,R0,0.0,1253.0,0.0,1253.0,0.0,1253.0,0.0,1253.0,
TCGA-AL-3468,4497,TCGA-AL-3468,KIRP,74.0,MALE,WHITE,Stage II,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005.0,[Not Available],-27205.0,Dead,TUMOR FREE,,2331.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2331.0,0.0,2331.0,0.0,2331.0,0.0,2331.0,
TCGA-CV-6955,3512,TCGA-CV-6955,HNSC,74.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,[Not Available],-27261.0,Dead,WITH TUMOR,,334.0,[Not Available],,,,,[Not Available],,,1.0,334.0,1.0,334.0,,,1.0,334.0,
TCGA-OR-A5JZ,34,TCGA-OR-A5JZ,ACC,60.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-22218.0,Alive,WITH TUMOR,822.0,,[Not Available],Distant Metastasis,Liver,,247.0,Progressive Disease,,,0.0,822.0,0.0,822.0,,,1.0,247.0,
TCGA-ER-A19D,9097,TCGA-ER-A19D,SKCM,46.0,FEMALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2004.0,[Not Available],-16968.0,Dead,WITH TUMOR,,383.0,[Not Available],Distant Metastasis,Lung,,357.0,[Not Available],,,1.0,383.0,1.0,383.0,,,1.0,357.0,
TCGA-12-3652,2992,TCGA-12-3652,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-21920.0,Dead,WITH TUMOR,1050.0,1062.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],203.0,[Not Available],,,1.0,1062.0,1.0,1062.0,,,1.0,203.0,
TCGA-GJ-A6C0,5734,TCGA-GJ-A6C0,LIHC,75.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-27626.0,Dead,,,31.0,[Not Available],,,,,[Not Available],,RX,1.0,31.0,,31.0,,,0.0,31.0,
TCGA-HD-8314,3670,TCGA-HD-8314,HNSC,58.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma Basaloid Type,G4,2012.0,[Not Available],-21517.0,Alive,TUMOR FREE,670.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,670.0,0.0,670.0,0.0,670.0,0.0,670.0,
TCGA-L5-A8NI,2543,TCGA-L5-A8NI,ESCA,79.0,MALE,WHITE,Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2004.0,[Not Available],-29135.0,Dead,WITH TUMOR,,410.0,[Not Available],Locoregional Recurrence,,,401.0,,,,1.0,410.0,1.0,410.0,,,1.0,401.0,
TCGA-DD-A4NL,5562,TCGA-DD-A4NL,LIHC,46.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2007.0,[Not Available],-16874.0,Alive,TUMOR FREE,1711.0,,[Not Available],,,,,[Not Available],,R0,0.0,1711.0,0.0,1711.0,0.0,1711.0,0.0,1711.0,
TCGA-39-5028,6459,TCGA-39-5028,LUSC,75.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-27707.0,Dead,,52.0,52.0,[Not Available],,,,,[Not Available],,,1.0,52.0,,52.0,,,0.0,52.0,
TCGA-3B-A9HU,8546,TCGA-3B-A9HU,SARC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-19669.0,Alive,WITH TUMOR,768.0,,[Not Available],Distant Metastasis,Lung,,631.0,[Not Available],Negative,R0,0.0,768.0,0.0,768.0,1.0,631.0,1.0,631.0,
TCGA-CG-4462,9460,TCGA-CG-4462,STAD,72.0,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2008.0,[Not Available],-26511.0,Dead,WITH TUMOR,,0.0,[Not Available],,,,,[Not Available],,,1.0,0.0,1.0,0.0,,,1.0,0.0,
TCGA-UF-A71D,3753,TCGA-UF-A71D,HNSC,54.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-19747.0,Alive,TUMOR FREE,1461.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1461.0,0.0,1461.0,,,0.0,1461.0,
TCGA-E8-A413,10025,TCGA-E8-A413,THCA,38.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-13909.0,Alive,TUMOR FREE,912.0,,[Not Available],,,,,[Not Available],,R0,0.0,912.0,0.0,912.0,0.0,912.0,0.0,912.0,
TCGA-3H-AB3M,6831,TCGA-3H-AB3M,MESO,53.0,FEMALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2008.0,[Not Available],-19503.0,Dead,WITH TUMOR,,885.0,[Not Available],Distant Metastasis,Lung,,107.0,[Not Available],,[Not Available],1.0,885.0,1.0,885.0,,,1.0,107.0,
TCGA-28-5216,3161,TCGA-28-5216,GBM,52.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-19239.0,Alive,TUMOR FREE,415.0,,[Not Available],,,,,[Not Available],,,0.0,415.0,0.0,415.0,,,0.0,415.0,
TCGA-DX-A3M1,8581,TCGA-DX-A3M1,SARC,79.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2010.0,[Not Available],-28932.0,Alive,WITH TUMOR,1359.0,,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,1212.0,[Not Available],Positive,R2,0.0,1359.0,0.0,1359.0,,,1.0,1212.0,
TCGA-HC-7209,8067,TCGA-HC-7209,PRAD,60.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22129.0,Alive,TUMOR FREE,440.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,
TCGA-2G-AAGK,9743,TCGA-2G-AAGK,TGCT,20.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma,[Not Available],2005.0,[Not Available],-7378.0,Alive,TUMOR FREE,3621.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,713.0,Complete Remission/Response,,,0.0,3621.0,0.0,3621.0,1.0,713.0,1.0,713.0,
TCGA-CG-5728,9481,TCGA-CG-5728,STAD,88.0,FEMALE,[Not Available],Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003.0,[Not Available],-32293.0,Alive,WITH TUMOR,1980.0,,[Not Available],,,,,[Not Available],,,0.0,1980.0,0.0,1980.0,,,0.0,1980.0,
TCGA-FS-A1ZZ,9170,TCGA-FS-A1ZZ,SKCM,54.0,FEMALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2006.0,[Not Available],-19733.0,Dead,WITH TUMOR,,822.0,[Not Available],,,,,[Not Available],,,1.0,822.0,1.0,822.0,,,1.0,822.0,
TCGA-HT-A4DV,5223,TCGA-HT-A4DV,LGG,51.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-18799.0,Alive,TUMOR FREE,792.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,792.0,0.0,792.0,0.0,792.0,0.0,792.0,
TCGA-G9-6353,8025,TCGA-G9-6353,PRAD,58.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-21221.0,Alive,TUMOR FREE,1542.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1542.0,0.0,1542.0,0.0,1542.0,0.0,1542.0,
TCGA-H9-A6BX,8059,TCGA-H9-A6BX,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22039.0,Alive,TUMOR FREE,941.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,941.0,0.0,941.0,0.0,941.0,0.0,941.0,
TCGA-P5-A5EU,5264,TCGA-P5-A5EU,LGG,35.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-12851.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-DX-A8BK,8637,TCGA-DX-A8BK,SARC,61.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2009.0,[Not Available],-22407.0,Alive,TUMOR FREE,1885.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1885.0,0.0,1885.0,0.0,1885.0,0.0,1885.0,
TCGA-XF-AAN3,463,TCGA-XF-AAN3,BLCA,76.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-27909.0,Alive,TUMOR FREE,2625.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2625.0,0.0,2625.0,,,0.0,2625.0,
TCGA-97-7546,6247,TCGA-97-7546,LUAD,76.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-27913.0,Alive,WITH TUMOR,1285.0,,[Not Available],New Primary Tumor,,,1255.0,Progressive Disease,,,0.0,1285.0,0.0,1285.0,,,1.0,1255.0,
TCGA-55-8505,6032,TCGA-55-8505,LUAD,62.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22676.0,Alive,TUMOR FREE,440.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,
TCGA-B8-5162,4104,TCGA-B8-5162,KIRC,62.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-23008.0,Alive,TUMOR FREE,36.0,,[Not Available],,,,,[Not Available],,,0.0,36.0,0.0,36.0,,,0.0,36.0,
TCGA-DM-A1D8,2333,TCGA-DM-A1D8,COAD,50.0,FEMALE,WHITE,[Not Available],[Not Applicable],Colon Adenocarcinoma,[Not Available],2000.0,[Not Available],-18311.0,Dead,,383.0,383.0,[Not Available],,,,,[Not Available],,,1.0,383.0,,383.0,,,0.0,383.0,
TCGA-A2-A3Y0,621,TCGA-A2-A3Y0,BRCA,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21024.0,Alive,TUMOR FREE,1546.0,,[Not Available],,,,,[Not Available],Close,,0.0,1546.0,0.0,1546.0,,,0.0,1546.0,
TCGA-VQ-A8DU,9644,TCGA-VQ-A8DU,STAD,63.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-23042.0,Dead,WITH TUMOR,,166.0,Stomach Cancer,Distant Metastasis,Liver,,158.0,Progressive Disease,,,1.0,166.0,1.0,166.0,,,1.0,158.0,
TCGA-K4-A3WU,373,TCGA-K4-A3WU,BLCA,87.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-32134.0,Alive,TUMOR FREE,105.0,,[Not Available],,,,,[Not Applicable],,,0.0,105.0,0.0,105.0,,,0.0,105.0,
TCGA-VQ-AA6J,9707,TCGA-VQ-AA6J,STAD,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-27506.0,Alive,TUMOR FREE,838.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,838.0,0.0,838.0,0.0,838.0,0.0,838.0,
TCGA-BQ-5879,4539,TCGA-BQ-5879,KIRP,32.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005.0,[Not Available],-11862.0,Dead,WITH TUMOR,,697.0,[Not Available],,,,130.0,[Not Available],,,1.0,697.0,1.0,697.0,,,1.0,130.0,
TCGA-EM-A1YD,10128,TCGA-EM-A1YD,THCA,53.0,FEMALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2007.0,[Not Available],-19366.0,Alive,TUMOR FREE,1734.0,,[Not Available],,,,,[Not Available],,R0,0.0,1734.0,0.0,1734.0,0.0,1734.0,0.0,1734.0,
TCGA-AQ-A0Y5,892,TCGA-AQ-A0Y5,BRCA,70.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25793.0,Dead,TUMOR FREE,,172.0,[Not Available],,,,,[Not Available],Negative,,1.0,172.0,0.0,172.0,0.0,172.0,0.0,172.0,
TCGA-VS-A94W,1851,TCGA-VS-A94W,CESC,39.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14399.0,Alive,TUMOR FREE,1243.0,,,,,,,Complete Remission/Response,,,0.0,1243.0,0.0,1243.0,0.0,1243.0,0.0,1243.0,
TCGA-77-A5G7,6696,TCGA-77-A5G7,LUSC,63.0,MALE,[Not Evaluated],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-23090.0,Dead,,,180.0,[Not Available],,,,,Complete Remission/Response,,,1.0,180.0,,180.0,0.0,180.0,0.0,180.0,
TCGA-QR-A70T,7736,TCGA-QR-A70T,PCPG,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Paraganglioma,[Not Available],2011.0,[Not Available],-14780.0,Alive,TUMOR FREE,267.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,267.0,0.0,267.0,0.0,267.0,0.0,267.0,
TCGA-ET-A3DT,10245,TCGA-ET-A3DT,THCA,23.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-8761.0,Alive,TUMOR FREE,1330.0,,[Not Available],,,,,[Not Available],,R0,0.0,1330.0,0.0,1330.0,0.0,1330.0,0.0,1330.0,
TCGA-E3-A3DZ,10015,TCGA-E3-A3DZ,THCA,55.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-20251.0,Alive,TUMOR FREE,1436.0,,[Not Available],,,,,[Not Available],,R0,0.0,1436.0,0.0,1436.0,0.0,1436.0,0.0,1436.0,
TCGA-ZG-A9L1,8349,TCGA-ZG-A9L1,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-24214.0,Alive,WITH TUMOR,1302.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1302.0,0.0,1302.0,,,0.0,1302.0,
TCGA-L6-A4ET,10345,TCGA-L6-A4ET,THCA,49.0,FEMALE,WHITE,Stage IVC,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-17978.0,Alive,TUMOR FREE,664.0,,[Not Available],,,,,[Not Available],,R0,0.0,664.0,0.0,664.0,,,0.0,664.0,
TCGA-NC-A5HT,6816,TCGA-NC-A5HT,LUSC,69.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-25466.0,Alive,WITH TUMOR,804.0,,[Not Available],Locoregional Recurrence,,,203.0,Complete Remission/Response,,,0.0,804.0,0.0,804.0,1.0,203.0,1.0,203.0,
TCGA-UF-A7JH,3760,TCGA-UF-A7JH,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-21558.0,Alive,TUMOR FREE,896.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,896.0,0.0,896.0,,,0.0,896.0,
TCGA-23-1110,7136,TCGA-23-1110,OV,42.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,[Not Available],-15383.0,Alive,TUMOR FREE,1658.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],326.0,Complete Remission/Response,,,0.0,1658.0,0.0,1658.0,1.0,326.0,1.0,326.0,Redacted
TCGA-E2-A155,1330,TCGA-E2-A155,BRCA,58.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21348.0,Alive,TUMOR FREE,640.0,,[Not Available],,,,,[Not Available],Negative,,0.0,640.0,0.0,640.0,0.0,640.0,0.0,640.0,
TCGA-A3-A6NL,3930,TCGA-A3-A6NL,KIRC,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2012.0,[Not Available],-17952.0,Alive,TUMOR FREE,689.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,689.0,0.0,689.0,0.0,689.0,0.0,689.0,
TCGA-WZ-A7V3,9801,TCGA-WZ-A7V3,TGCT,20.0,MALE,WHITE,Stage I,[Not Available],Seminoma; NOS,[Not Available],2012.0,[Not Available],-7325.0,Alive,TUMOR FREE,753.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,753.0,0.0,753.0,0.0,753.0,0.0,753.0,
TCGA-B8-5549,4110,TCGA-B8-5549,KIRC,53.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-19561.0,Alive,TUMOR FREE,194.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,194.0,0.0,194.0,0.0,194.0,0.0,194.0,
TCGA-AS-3777,3962,TCGA-AS-3777,KIRC,63.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,[Not Available],2009.0,[Not Available],-23039.0,Alive,TUMOR FREE,1238.0,,[Not Available],,,,,[Unknown],,,0.0,1238.0,0.0,1238.0,,,0.0,1238.0,
TCGA-CH-5745,7885,TCGA-CH-5745,PRAD,68.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-24837.0,Alive,TUMOR FREE,91.0,,[Not Available],,,,,[Not Available],,,0.0,91.0,0.0,91.0,,,0.0,91.0,
TCGA-BQ-7048,4558,TCGA-BQ-7048,KIRP,64.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2003.0,[Not Available],-23460.0,Alive,WITH TUMOR,2839.0,,[Not Available],,,,229.0,[Not Available],,,0.0,2839.0,0.0,2839.0,,,1.0,229.0,
TCGA-CF-A3MF,153,TCGA-CF-A3MF,BLCA,34.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,[Not Available],-12557.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-CN-A642,3370,TCGA-CN-A642,HNSC,57.0,MALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,[Not Available],-21011.0,Dead,WITH TUMOR,,82.0,[Not Available],,,,,Progressive Disease,,,1.0,82.0,1.0,82.0,,,1.0,82.0,
TCGA-EA-A43B,1705,TCGA-EA-A43B,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15871.0,Alive,TUMOR FREE,791.0,,,,,,,Complete Remission/Response,,,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,
TCGA-2G-AAGO,9746,TCGA-2G-AAGO,TGCT,41.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma,[Not Available],2003.0,[Not Available],-15300.0,Alive,TUMOR FREE,4026.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,4026.0,0.0,4026.0,,,0.0,4026.0,
TCGA-E9-A295,1441,TCGA-E9-A295,BRCA,71.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25957.0,Alive,TUMOR FREE,375.0,,[Not Available],,,,,[Not Available],Negative,,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,
TCGA-UB-A7ME,5776,TCGA-UB-A7ME,LIHC,51.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-18846.0,Alive,TUMOR FREE,486.0,,[Not Available],,,,,[Not Available],,R0,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,
TCGA-ED-A627,5668,TCGA-ED-A627,LIHC,74.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-27303.0,Alive,TUMOR FREE,423.0,,[Not Available],,,,,[Not Available],,R0,0.0,423.0,0.0,423.0,0.0,423.0,0.0,423.0,
TCGA-EB-A5SE,8974,TCGA-EB-A5SE,SKCM,73.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-26965.0,Dead,WITH TUMOR,,401.0,[Not Available],Distant Metastasis,Brain,,367.0,[Not Available],,,1.0,401.0,1.0,401.0,,,1.0,367.0,
TCGA-BH-A1FC,1145,TCGA-BH-A1FC,BRCA,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Medullary Carcinoma,[Not Available],1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28706.0,Dead,TUMOR FREE,,3472.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,3472.0,0.0,3472.0,,,0.0,3472.0,
TCGA-LL-A6FQ,1540,TCGA-LL-A6FQ,BRCA,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28375.0,Alive,,80.0,,[Not Available],,,,,[Not Available],Negative,,0.0,80.0,0.0,80.0,0.0,80.0,0.0,80.0,
TCGA-E2-A1IJ,1364,TCGA-E2-A1IJ,BRCA,57.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20956.0,Alive,TUMOR FREE,865.0,,[Not Available],,,,,[Not Available],Negative,,0.0,865.0,0.0,865.0,0.0,865.0,0.0,865.0,
TCGA-EE-A2MQ,9063,TCGA-EE-A2MQ,SKCM,70.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2006.0,[Not Available],-25926.0,Dead,WITH TUMOR,,1315.0,[Not Available],Regional lymph node,,,986.0,[Not Available],,,1.0,1315.0,1.0,1315.0,,,1.0,986.0,
TCGA-3U-A98F,6839,TCGA-3U-A98F,MESO,73.0,MALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2012.0,[Not Available],-26926.0,Dead,WITH TUMOR,,536.0,[Not Available],Intrapleural Progression,,,365.0,[Not Available],,[Not Available],1.0,536.0,1.0,536.0,,,1.0,365.0,
TCGA-E9-A2JS,1442,TCGA-E9-A2JS,BRCA,72.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26407.0,Dead,WITH TUMOR,,904.0,[Not Available],Distant Metastasis,Bone,Liver,524.0,[Not Available],Negative,,1.0,904.0,1.0,904.0,1.0,524.0,1.0,524.0,
TCGA-AC-A6IW,794,TCGA-AC-A6IW,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26896.0,Alive,TUMOR FREE,413.0,,[Not Available],,,,,[Not Available],Negative,,0.0,413.0,0.0,413.0,0.0,413.0,0.0,413.0,
TCGA-B5-A3FD,10728,TCGA-B5-A3FD,UCEC,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Indeterminate (neither Pre or Postmenopausal),-25813.0,Dead,TUMOR FREE,,1197.0,[Not Available],Locoregional Recurrence,"Other, specify",endometrium,562.0,[Not Available],,,1.0,1197.0,0.0,1197.0,,,1.0,562.0,
TCGA-DX-A48U,8601,TCGA-DX-A48U,SARC,57.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2005.0,[Not Available],-20853.0,Alive,TUMOR FREE,3310.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,3310.0,0.0,3310.0,0.0,3310.0,0.0,3310.0,
TCGA-BR-8364,9355,TCGA-BR-8364,STAD,42.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-15389.0,Alive,TUMOR FREE,675.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,675.0,0.0,675.0,0.0,675.0,0.0,675.0,
TCGA-SX-A7SQ,4678,TCGA-SX-A7SQ,KIRP,48.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-17696.0,Alive,TUMOR FREE,1266.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1266.0,0.0,1266.0,0.0,1266.0,0.0,1266.0,
TCGA-VS-A958,1860,TCGA-VS-A958,CESC,46.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16905.0,Alive,TUMOR FREE,1525.0,,,,,,,Complete Remission/Response,,,0.0,1525.0,0.0,1525.0,0.0,1525.0,0.0,1525.0,
TCGA-IQ-A61J,3686,TCGA-IQ-A61J,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-19913.0,Alive,TUMOR FREE,1021.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1021.0,0.0,1021.0,,,0.0,1021.0,
TCGA-TQ-A7RI,5391,TCGA-TQ-A7RI,LGG,37.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-13799.0,Alive,TUMOR FREE,62.0,,[Not Available],,,,,[Unknown],,,0.0,62.0,0.0,62.0,,,0.0,62.0,
TCGA-E2-A1B5,1355,TCGA-E2-A1B5,BRCA,46.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17039.0,Alive,TUMOR FREE,984.0,,[Not Available],,,,,[Not Available],Negative,,0.0,984.0,0.0,984.0,0.0,984.0,0.0,984.0,
TCGA-BH-A0B7,1037,TCGA-BH-A0B7,BRCA,42.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15593.0,Alive,TUMOR FREE,2559.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2559.0,0.0,2559.0,0.0,2559.0,0.0,2559.0,
TCGA-DX-A8BR,8644,TCGA-DX-A8BR,SARC,63.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2002.0,[Not Available],-23302.0,Alive,TUMOR FREE,4573.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,4573.0,0.0,4573.0,0.0,4573.0,0.0,4573.0,
TCGA-N6-A4VF,11042,TCGA-N6-A4VF,UCS,51.0,FEMALE,WHITE,[Not Applicable],Stage IB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2009.0,Peri (6-12 months since last menstrual period),-18806.0,Dead,TUMOR FREE,,522.0,[Not Available],,,,,[Not Available],,,1.0,522.0,0.0,522.0,,,0.0,522.0,
TCGA-DA-A1I1,8919,TCGA-DA-A1I1,SKCM,55.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],1996.0,[Not Available],-20399.0,Alive,TUMOR FREE,6768.0,,[Not Available],Distant Metastasis,"Other, Specify",Jejunum,5591.0,[Not Available],,,0.0,6768.0,0.0,6768.0,,,1.0,5591.0,
TCGA-D8-A1Y3,1282,TCGA-D8-A1Y3,BRCA,61.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22317.0,Alive,TUMOR FREE,430.0,,[Not Available],,,,,[Not Available],Negative,,0.0,430.0,0.0,430.0,0.0,430.0,0.0,430.0,
TCGA-27-2521,3128,TCGA-27-2521,GBM,34.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-12685.0,Dead,WITH TUMOR,,510.0,[Not Available],,,,,[Not Available],,,1.0,510.0,1.0,510.0,,,1.0,510.0,
TCGA-ZG-A9L0,8348,TCGA-ZG-A9L0,PRAD,71.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-26055.0,Alive,TUMOR FREE,355.0,,[Not Available],,,,,Stable Disease,,,0.0,355.0,0.0,355.0,,,0.0,355.0,
TCGA-AR-A0U2,911,TCGA-AR-A0U2,BRCA,47.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17390.0,Dead,WITH TUMOR,,2551.0,[Not Available],Distant Metastasis,Bone,Liver,1609.0,[Not Available],Negative,,1.0,2551.0,1.0,2551.0,1.0,1609.0,1.0,1609.0,
TCGA-AG-3591,8395,TCGA-AG-3591,READ,66.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-24167.0,Alive,TUMOR FREE,1035.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1035.0,0.0,1035.0,0.0,1035.0,0.0,1035.0,
TCGA-S7-A7WP,7782,TCGA-S7-A7WP,PCPG,25.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-9241.0,Alive,TUMOR FREE,944.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,944.0,0.0,944.0,0.0,944.0,0.0,944.0,
TCGA-DJ-A3VE,9993,TCGA-DJ-A3VE,THCA,50.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18417.0,Alive,TUMOR FREE,577.0,,[Not Available],,,,,[Not Available],,R0,0.0,577.0,0.0,577.0,0.0,577.0,0.0,577.0,
TCGA-S9-A7QX,5358,TCGA-S9-A7QX,LGG,36.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-13332.0,Alive,WITH TUMOR,564.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,564.0,0.0,564.0,,,0.0,564.0,
TCGA-DD-A4NH,5558,TCGA-DD-A4NH,LIHC,65.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-23865.0,Alive,WITH TUMOR,917.0,,[Not Available],Extrahepatic Recurrence,Lung,,161.0,[Not Available],,R0,0.0,917.0,0.0,917.0,1.0,161.0,1.0,161.0,
TCGA-VP-A878,8280,TCGA-VP-A878,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-21402.0,Alive,WITH TUMOR,3130.0,,[Not Available],Biochemical evidence of disease,,,98.0,Partial Remission/Response,,,0.0,3130.0,0.0,3130.0,,,1.0,98.0,
TCGA-A2-A0YC,584,TCGA-A2-A0YC,BRCA,59.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21685.0,Alive,WITH TUMOR,990.0,,[Not Available],Locoregional Disease,,,756.0,[Not Available],Close,,0.0,990.0,0.0,990.0,,,1.0,756.0,
TCGA-ZJ-AAXA,1897,TCGA-ZJ-AAXA,CESC,64.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2009.0,[Unknown],-23603.0,Alive,,43.0,,,,,,,[Unknown],,,0.0,43.0,0.0,43.0,,,0.0,43.0,
TCGA-06-2563,2856,TCGA-06-2563,GBM,72.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-26643.0,Alive,WITH TUMOR,932.0,,[Not Available],,[Not Applicable],[Not Applicable],554.0,[Not Available],,,0.0,932.0,0.0,932.0,,,1.0,554.0,
TCGA-CG-5734,9485,TCGA-CG-5734,STAD,68.0,MALE,[Not Available],Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,[Not Available],-25079.0,Dead,,,243.0,[Not Available],,,,,[Not Available],,,1.0,243.0,,243.0,,,0.0,243.0,
TCGA-BR-8591,9377,TCGA-BR-8591,STAD,79.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-29054.0,Alive,TUMOR FREE,856.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,856.0,0.0,856.0,0.0,856.0,0.0,856.0,
TCGA-QH-A6CS,5294,TCGA-QH-A6CS,LGG,41.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-15092.0,Alive,WITH TUMOR,588.0,,[Not Available],,,,498.0,Stable Disease,,,0.0,588.0,0.0,588.0,,,1.0,498.0,
TCGA-HT-7476,5149,TCGA-HT-7476,LGG,26.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-9614.0,Alive,TUMOR FREE,199.0,,[Not Available],,,,,Stable Disease,,,0.0,199.0,0.0,199.0,,,0.0,199.0,
TCGA-NF-A4WX,11074,TCGA-NF-A4WX,UCS,61.0,FEMALE,[Unknown],[Not Applicable],Stage IV,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22407.0,Alive,TUMOR FREE,452.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,452.0,0.0,452.0,,,0.0,452.0,
TCGA-TM-A84C,5375,TCGA-TM-A84C,LGG,32.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-11849.0,Dead,WITH TUMOR,,492.0,[Not Available],,,,,Progressive Disease,,,1.0,492.0,1.0,492.0,,,1.0,492.0,
TCGA-55-8508,6035,TCGA-55-8508,LUAD,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22159.0,Alive,TUMOR FREE,617.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,617.0,0.0,617.0,0.0,617.0,0.0,617.0,
TCGA-E7-A6ME,246,TCGA-E7-A6ME,BLCA,75.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-27670.0,Alive,TUMOR FREE,731.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,731.0,0.0,731.0,0.0,731.0,0.0,731.0,
TCGA-BG-A3EW,10776,TCGA-BG-A3EW,UCEC,62.0,FEMALE,WHITE,[Not Applicable],Stage III,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22705.0,Alive,TUMOR FREE,344.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,344.0,0.0,344.0,0.0,344.0,0.0,344.0,
TCGA-EM-A4FM,10193,TCGA-EM-A4FM,THCA,59.0,FEMALE,[Unknown],Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-21595.0,Alive,WITH TUMOR,162.0,,[Not Available],,,,,[Not Available],,R1,0.0,162.0,0.0,162.0,,,0.0,162.0,
TCGA-BC-A10U,5461,TCGA-BC-A10U,LIHC,69.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G2,2000.0,[Not Available],-25305.0,Dead,WITH TUMOR,,837.0,[Not Available],Intrahepatic Recurrence,,,586.0,[Not Available],,R1,1.0,837.0,1.0,837.0,,,1.0,586.0,
TCGA-B0-5107,4034,TCGA-B0-5107,KIRC,65.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2007.0,[Not Available],-23929.0,Dead,WITH TUMOR,,927.0,[Not Available],,,,549.0,[Not Available],,,1.0,927.0,1.0,927.0,,,1.0,549.0,
TCGA-H9-7775,8058,TCGA-H9-7775,PRAD,68.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24898.0,Alive,TUMOR FREE,185.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,185.0,0.0,185.0,0.0,185.0,0.0,185.0,
TCGA-S5-A6DX,398,TCGA-S5-A6DX,BLCA,83.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-30594.0,Dead,WITH TUMOR,,56.0,[Not Available],,,,,[Unknown],,,1.0,56.0,1.0,56.0,,,1.0,56.0,
TCGA-2G-AAEW,9711,TCGA-2G-AAEW,TGCT,31.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],2011.0,[Not Available],-11325.0,Dead,WITH TUMOR,,618.0,Testicular Germ Cell Tumor (TGCT),Locoregional Recurrence,Retroperitoneal lymph nodes,,143.0,,,,1.0,618.0,1.0,618.0,,,1.0,143.0,
TCGA-22-1016,6368,TCGA-22-1016,LUSC,65.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-24078.0,Dead,TUMOR FREE,802.0,822.0,[Not Available],,,,,Complete Remission/Response,,,1.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,
TCGA-EX-A1H5,1746,TCGA-EX-A1H5,CESC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21338.0,Alive,TUMOR FREE,619.0,,,,,,,Complete Remission/Response,,,0.0,619.0,0.0,619.0,0.0,619.0,0.0,619.0,
TCGA-5P-A9JW,4449,TCGA-5P-A9JW,KIRP,64.0,MALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-23570.0,Alive,,3241.0,,[Not Available],,,,3228.0,Complete Remission/Response,,,0.0,3241.0,0.0,3241.0,1.0,3228.0,1.0,3228.0,
TCGA-YD-A89C,9259,TCGA-YD-A89C,SKCM,43.0,FEMALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2013.0,[Not Available],-15804.0,Alive,TUMOR FREE,210.0,,[Not Available],,,,,[Not Available],,,0.0,210.0,0.0,210.0,,,0.0,210.0,
TCGA-55-8619,6044,TCGA-55-8619,LUAD,72.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26616.0,Alive,TUMOR FREE,416.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,416.0,0.0,416.0,0.0,416.0,0.0,416.0,
TCGA-OR-A5KY,54,TCGA-OR-A5KY,ACC,23.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-8745.0,Dead,WITH TUMOR,,391.0,[Not Available],Locoregional Recurrence,Peritoneal Surfaces,,178.0,Progressive Disease,,,1.0,391.0,1.0,391.0,,,1.0,178.0,
TCGA-2G-AAH4,9758,TCGA-2G-AAH4,TGCT,34.0,MALE,WHITE,Stage II,Stage II,Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Seminoma; NOS,[Not Available],1997.0,[Not Available],-12481.0,Alive,TUMOR FREE,6210.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,6210.0,0.0,6210.0,,,0.0,6210.0,
TCGA-55-8614,6041,TCGA-55-8614,LUAD,76.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27924.0,Alive,TUMOR FREE,536.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,536.0,0.0,536.0,0.0,536.0,0.0,536.0,
TCGA-CJ-4908,4311,TCGA-CJ-4908,KIRC,38.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-14226.0,Alive,TUMOR FREE,1531.0,,[Not Available],,,,,[Not Available],,,0.0,1531.0,0.0,1531.0,,,0.0,1531.0,
TCGA-K1-A6RU,8716,TCGA-K1-A6RU,SARC,66.0,FEMALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2013.0,[Not Available],-24356.0,Dead,WITH TUMOR,,711.0,[Not Available],Distant Metastasis,Bone,,142.0,[Not Available],Positive,R1,1.0,711.0,1.0,711.0,,,1.0,142.0,
TCGA-CE-A482,9900,TCGA-CE-A482,THCA,27.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-10192.0,Alive,TUMOR FREE,325.0,,[Not Available],,,,,[Not Available],,R0,0.0,325.0,0.0,325.0,0.0,325.0,0.0,325.0,
TCGA-DS-A7WI,1691,TCGA-DS-A7WI,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IIA2,Cervical Squamous Cell Carcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15970.0,Dead,WITH TUMOR,,252.0,Cervical Cancer,Locoregional Recurrence,"Other, specify",Retroperitoneum,206.0,Complete Remission/Response,,,1.0,252.0,1.0,252.0,1.0,206.0,1.0,206.0,
TCGA-EW-A1P6,1474,TCGA-EW-A1P6,BRCA,64.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23485.0,Alive,TUMOR FREE,562.0,,[Not Available],,,,,[Not Available],Close,,0.0,562.0,0.0,562.0,,,0.0,562.0,
TCGA-BJ-A4O9,9894,TCGA-BJ-A4O9,THCA,51.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-18938.0,Alive,TUMOR FREE,714.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,714.0,0.0,714.0,,,0.0,714.0,
TCGA-ZS-A9CE,5800,TCGA-ZS-A9CE,LIHC,79.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G1,2011.0,[Not Available],-29051.0,Alive,TUMOR FREE,1241.0,,[Not Available],New Primary Tumor,"Other, specify",Right Temple,892.0,[Not Available],,R0,0.0,1241.0,0.0,1241.0,0.0,1241.0,1.0,892.0,
TCGA-CD-A489,9437,TCGA-CD-A489,STAD,58.0,MALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-21517.0,Dead,WITH TUMOR,,344.0,[Not Available],Locoregional Recurrence,,,277.0,Complete Remission/Response,,,1.0,344.0,1.0,344.0,1.0,277.0,1.0,277.0,
TCGA-97-A4M7,6271,TCGA-97-A4M7,LUAD,74.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27062.0,Alive,TUMOR FREE,629.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,629.0,0.0,629.0,0.0,629.0,0.0,629.0,
TCGA-AR-A24U,943,TCGA-AR-A24U,BRCA,47.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17523.0,Alive,TUMOR FREE,3128.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3128.0,0.0,3128.0,0.0,3128.0,0.0,3128.0,
TCGA-DD-A115,5516,TCGA-DD-A115,LIHC,53.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2002.0,[Not Available],-19697.0,Dead,WITH TUMOR,,2542.0,[Not Available],Intrahepatic Recurrence,Liver,,469.0,[Not Available],,R0,1.0,2542.0,1.0,2542.0,1.0,469.0,1.0,469.0,
TCGA-5G-A9ZZ,10378,TCGA-5G-A9ZZ,THYM,52.0,FEMALE,WHITE,[Not Applicable],IIb,Thymoma; Type C,[Not Available],2012.0,[Not Available],-19117.0,Alive,TUMOR FREE,835.0,,[Not Available],,,,,[Not Available],,,0.0,835.0,0.0,835.0,,,0.0,835.0,
TCGA-E2-A2P6,1384,TCGA-E2-A2P6,BRCA,77.0,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28411.0,Alive,TUMOR FREE,1051.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1051.0,0.0,1051.0,0.0,1051.0,0.0,1051.0,
TCGA-A1-A0SF,516,TCGA-A1-A0SF,BRCA,54.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19731.0,Alive,TUMOR FREE,1463.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1463.0,0.0,1463.0,0.0,1463.0,0.0,1463.0,
TCGA-EW-A2FS,1486,TCGA-EW-A2FS,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15302.0,Alive,TUMOR FREE,1604.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1604.0,0.0,1604.0,0.0,1604.0,0.0,1604.0,
TCGA-CZ-4865,4365,TCGA-CZ-4865,KIRC,70.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-25709.0,Dead,TUMOR FREE,,166.0,[Not Available],,,,,[Not Available],,,1.0,166.0,0.0,166.0,,,0.0,166.0,
TCGA-43-8115,6484,TCGA-43-8115,LUSC,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26406.0,Alive,TUMOR FREE,407.0,,[Not Available],,,,,Stable Disease,,,0.0,407.0,0.0,407.0,,,0.0,407.0,
TCGA-P3-A6T5,3717,TCGA-P3-A6T5,HNSC,79.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-28977.0,Dead,WITH TUMOR,,882.0,[Not Available],Locoregional Disease,Oral Cavity,,335.0,Complete Remission/Response,,,1.0,882.0,1.0,882.0,,,1.0,335.0,
TCGA-CN-5364,3328,TCGA-CN-5364,HNSC,55.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2006.0,[Not Available],-20362.0,Dead,TUMOR FREE,,493.0,[Not Available],,,,,Complete Remission/Response,,,1.0,493.0,0.0,493.0,,,0.0,493.0,
TCGA-BR-6802,9318,TCGA-BR-6802,STAD,65.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-23915.0,Alive,TUMOR FREE,940.0,,[Not Available],Distant Metastasis,Non-regional / Distant Lymph Nodes,,807.0,Complete Remission/Response,,,0.0,940.0,0.0,940.0,1.0,807.0,1.0,807.0,
TCGA-XJ-A9DQ,8299,TCGA-XJ-A9DQ,PRAD,48.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],,Alive,,91.0,,[Not Available],,,,,[Unknown],,,0.0,91.0,0.0,91.0,,,0.0,91.0,
TCGA-A3-3358,3911,TCGA-A3-3358,KIRC,57.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-21087.0,Alive,TUMOR FREE,1307.0,,[Not Available],,,,,[Not Available],,,0.0,1307.0,0.0,1307.0,,,0.0,1307.0,
TCGA-S3-AA11,1587,TCGA-S3-AA11,BRCA,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24813.0,Alive,TUMOR FREE,421.0,,[Not Available],,,,,[Not Available],Negative,,0.0,421.0,0.0,421.0,0.0,421.0,0.0,421.0,
TCGA-06-0745,2830,TCGA-06-0745,GBM,59.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-21884.0,Dead,WITH TUMOR,164.0,239.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],92.0,[Not Available],,,1.0,239.0,1.0,239.0,,,1.0,92.0,
TCGA-E9-A22E,1431,TCGA-E9-A22E,BRCA,56.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20574.0,Alive,TUMOR FREE,1269.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1269.0,0.0,1269.0,0.0,1269.0,0.0,1269.0,
TCGA-19-5956,3095,TCGA-19-5956,GBM,53.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-19591.0,Dead,WITH TUMOR,,684.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],647.0,Stable Disease,,,1.0,684.0,1.0,684.0,,,1.0,647.0,
TCGA-RW-A7D0,7775,TCGA-RW-A7D0,PCPG,47.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-17422.0,Alive,TUMOR FREE,352.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,
TCGA-CX-7085,3606,TCGA-CX-7085,HNSC,77.0,FEMALE,WHITE,Stage I,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-28221.0,Alive,WITH TUMOR,321.0,,[Not Available],Locoregional Recurrence,Oropharynx,Submandibular gland,92.0,Complete Remission/Response,,,0.0,321.0,0.0,321.0,1.0,92.0,1.0,92.0,
TCGA-BD-A3EP,5477,TCGA-BD-A3EP,LIHC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-27756.0,Alive,TUMOR FREE,409.0,,[Not Available],,,,,[Not Available],,R0,0.0,409.0,0.0,409.0,0.0,409.0,0.0,409.0,
TCGA-VD-AA8S,11140,TCGA-VD-AA8S,UVM,40.0,MALE,[Not Evaluated],Stage IIA,Stage IIB,Spindle Cell,[Not Available],2013.0,[Not Available],-14681.0,Alive,TUMOR FREE,427.0,,[Not Available],,,,,[Not Available],,,0.0,427.0,0.0,427.0,,,0.0,427.0,
TCGA-B6-A0I1,968,TCGA-B6-A0I1,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26902.0,Dead,TUMOR FREE,,2361.0,[Not Available],Distant Metastasis,Lung,,1120.0,[Not Available],Negative,,1.0,2361.0,0.0,2361.0,1.0,1120.0,1.0,1120.0,
TCGA-CN-A497,3357,TCGA-CN-A497,HNSC,63.0,MALE,[Unknown],Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-23310.0,Alive,TUMOR FREE,1065.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1065.0,0.0,1065.0,,,0.0,1065.0,
TCGA-OY-A56P,7499,TCGA-OY-A56P,OV,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIB,Serous Cystadenocarcinoma,G3,2010.0,[Not Available],-17580.0,Alive,WITH TUMOR,1207.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],794.0,Complete Remission/Response,,,0.0,1207.0,0.0,1207.0,1.0,794.0,1.0,794.0,
TCGA-RN-A68Q,8756,TCGA-RN-A68Q,SARC,62.0,FEMALE,WHITE,[Not Available],[Not Available],Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2010.0,[Not Available],-22981.0,Alive,TUMOR FREE,22.0,,[Not Available],,,,,[Not Available],[Unknown],RX,0.0,22.0,0.0,22.0,,,0.0,22.0,
TCGA-UF-A7J9,3755,TCGA-UF-A7J9,HNSC,75.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-27459.0,Alive,TUMOR FREE,1358.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1358.0,0.0,1358.0,,,0.0,1358.0,
TCGA-DU-5852,4983,TCGA-DU-5852,LGG,61.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2010.0,[Not Available],-22348.0,Dead,WITH TUMOR,,205.0,[Not Available],,,,24.0,Progressive Disease,,,1.0,205.0,1.0,205.0,,,1.0,24.0,
TCGA-BQ-5894,4554,TCGA-BQ-5894,KIRP,42.0,MALE,[Not Available],Stage IV,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-15510.0,Alive,WITH TUMOR,84.0,,[Not Available],,,,,[Not Available],,,0.0,84.0,0.0,84.0,,,0.0,84.0,
TCGA-CH-5794,7909,TCGA-CH-5794,PRAD,65.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-23924.0,Alive,TUMOR FREE,882.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,882.0,0.0,882.0,0.0,882.0,0.0,882.0,
TCGA-CM-5349,2269,TCGA-CM-5349,COAD,68.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-24867.0,Alive,TUMOR FREE,915.0,,[Not Available],,,,,[Unknown],,,0.0,915.0,0.0,915.0,,,0.0,915.0,
TCGA-EM-A3FN,10173,TCGA-EM-A3FN,THCA,42.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-15655.0,Alive,TUMOR FREE,367.0,,[Not Available],,,,,[Not Available],,R0,0.0,367.0,0.0,367.0,0.0,367.0,0.0,367.0,
TCGA-ET-A3DU,10246,TCGA-ET-A3DU,THCA,21.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-7869.0,Alive,TUMOR FREE,1911.0,,[Not Available],,,,,[Not Available],,R1,0.0,1911.0,0.0,1911.0,,,0.0,1911.0,
TCGA-FU-A3HZ,1758,TCGA-FU-A3HZ,CESC,64.0,FEMALE,WHITE,[Not Available],Stage IIA2,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23565.0,Alive,TUMOR FREE,1103.0,,,,,,,Complete Remission/Response,,,0.0,1103.0,0.0,1103.0,0.0,1103.0,0.0,1103.0,
TCGA-MP-A4TI,6310,TCGA-MP-A4TI,LUAD,72.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-26565.0,Dead,WITH TUMOR,,429.0,[Not Available],Locoregional Recurrence|Distant Metastasis,,,84.0,[Unknown],,,1.0,429.0,1.0,429.0,,,1.0,84.0,
TCGA-55-A494,6054,TCGA-55-A494,LUAD,61.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22540.0,Alive,TUMOR FREE,481.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,
TCGA-DD-A39X,5539,TCGA-DD-A39X,LIHC,78.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,1998.0,[Not Available],-28528.0,Dead,WITH TUMOR,,1694.0,[Not Available],Intrahepatic Recurrence,Liver,,1032.0,[Not Available],,R0,1.0,1694.0,1.0,1694.0,1.0,1032.0,1.0,1032.0,
TCGA-EJ-7321,7953,TCGA-EJ-7321,PRAD,57.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21108.0,Alive,TUMOR FREE,824.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,824.0,0.0,824.0,0.0,824.0,0.0,824.0,
TCGA-V5-A7RC,2616,TCGA-V5-A7RC,ESCA,55.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IV,Esophagus Squamous Cell Carcinoma,GX,,[Not Available],-20439.0,Dead,WITH TUMOR,,104.0,[Not Available],Distant Metastasis,Liver,,88.0,Progressive Disease,,,1.0,104.0,1.0,104.0,,,1.0,88.0,
TCGA-49-4506,5909,TCGA-49-4506,LUAD,68.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],1997.0,[Not Available],-25132.0,Dead,[Discrepancy],,999.0,[Not Available],Locoregional Recurrence,,,692.0,Complete Remission/Response,,,1.0,999.0,,999.0,1.0,692.0,1.0,692.0,
TCGA-92-8065,6765,TCGA-92-8065,LUSC,74.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-27049.0,Alive,TUMOR FREE,70.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,70.0,0.0,70.0,0.0,70.0,0.0,70.0,
TCGA-B9-4114,4520,TCGA-B9-4114,KIRP,49.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-17989.0,Alive,WITH TUMOR,857.0,,[Not Available],,,,637.0,[Not Available],,,0.0,857.0,0.0,857.0,,,1.0,637.0,
TCGA-F4-6809,2363,TCGA-F4-6809,COAD,52.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-19039.0,Dead,WITH TUMOR,,403.0,[Not Available],,,,,[Not Available],,,1.0,403.0,1.0,403.0,,,1.0,403.0,
TCGA-S9-A7QZ,5360,TCGA-S9-A7QZ,LGG,41.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-15300.0,Alive,WITH TUMOR,826.0,,[Not Available],,,,774.0,Partial Remission/Response,,,0.0,826.0,0.0,826.0,,,1.0,774.0,
TCGA-KK-A8IM,8217,TCGA-KK-A8IM,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-20425.0,Alive,TUMOR FREE,1915.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1915.0,0.0,1915.0,0.0,1915.0,0.0,1915.0,
TCGA-IR-A3LC,1778,TCGA-IR-A3LC,CESC,40.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14697.0,Alive,TUMOR FREE,3935.0,,,,,,,Complete Remission/Response,,,0.0,3935.0,0.0,3935.0,0.0,3935.0,0.0,3935.0,
TCGA-D3-A3C7,8856,TCGA-D3-A3C7,SKCM,57.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],2009.0,[Not Available],-20979.0,Alive,TUMOR FREE,1429.0,,[Not Available],,,,,[Not Available],,,0.0,1429.0,0.0,1429.0,,,0.0,1429.0,
TCGA-BG-A18A,10767,TCGA-BG-A18A,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27086.0,Alive,TUMOR FREE,426.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,
TCGA-D7-A4Z0,9517,TCGA-D7-A4Z0,STAD,60.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012.0,[Not Available],-22129.0,Alive,TUMOR FREE,449.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,449.0,0.0,449.0,0.0,449.0,0.0,449.0,
TCGA-DU-6404,5002,TCGA-DU-6404,LGG,24.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2000.0,[Not Available],-9021.0,Dead,WITH TUMOR,,4068.0,[Not Available],,,,1154.0,Progressive Disease,,,1.0,4068.0,1.0,4068.0,,,1.0,1154.0,
TCGA-B0-5706,4063,TCGA-B0-5706,KIRC,45.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-16442.0,Alive,TUMOR FREE,3205.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3205.0,0.0,3205.0,0.0,3205.0,0.0,3205.0,
TCGA-S5-AA26,399,TCGA-S5-AA26,BLCA,46.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-16972.0,Alive,TUMOR FREE,503.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,503.0,0.0,503.0,0.0,503.0,0.0,503.0,
TCGA-CC-5263,5487,TCGA-CC-5263,LIHC,35.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2010.0,[Not Available],-12863.0,Dead,TUMOR FREE,,129.0,[Not Available],,,,,[Not Available],,RX,1.0,129.0,0.0,129.0,,,0.0,129.0,
TCGA-BP-5177,4245,TCGA-BP-5177,KIRC,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-17147.0,Alive,TUMOR FREE,293.0,,[Not Available],,,,,[Not Available],,,0.0,293.0,0.0,293.0,,,0.0,293.0,
TCGA-98-A53B,6789,TCGA-98-A53B,LUSC,69.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-25390.0,Dead,TUMOR FREE,,61.0,[Not Available],,,,,Complete Remission/Response,,,1.0,61.0,0.0,61.0,0.0,61.0,0.0,61.0,
TCGA-12-0616,2938,TCGA-12-0616,GBM,36.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-13451.0,Dead,WITH TUMOR,439.0,448.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],398.0,[Not Available],,,1.0,448.0,1.0,448.0,,,1.0,398.0,
TCGA-A5-A0R8,10504,TCGA-A5-A0R8,UCEC,81.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29777.0,Alive,TUMOR FREE,596.0,,[Not Available],,,,42.0,Complete Remission/Response,,,0.0,596.0,0.0,596.0,1.0,42.0,1.0,42.0,
TCGA-HT-7902,5201,TCGA-HT-7902,LGG,30.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2009.0,[Not Available],-11118.0,Alive,TUMOR FREE,956.0,,[Not Available],,,,,Stable Disease,,,0.0,956.0,0.0,956.0,,,0.0,956.0,
TCGA-43-A56V,6490,TCGA-43-A56V,LUSC,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-22475.0,Alive,WITH TUMOR,366.0,,[Not Available],Locoregional Recurrence|Distant Metastasis,,,355.0,Complete Remission/Response,,,0.0,366.0,0.0,366.0,1.0,355.0,1.0,355.0,
TCGA-06-0879,2838,TCGA-06-0879,GBM,52.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-19154.0,Dead,WITH TUMOR,,1229.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],699.0,[Not Available],,,1.0,1229.0,1.0,1229.0,,,1.0,699.0,
TCGA-VF-A8AE,9797,TCGA-VF-A8AE,TGCT,39.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2012.0,[Not Available],-14535.0,Alive,TUMOR FREE,727.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,727.0,0.0,727.0,0.0,727.0,0.0,727.0,
TCGA-BS-A0UA,10802,TCGA-BS-A0UA,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24872.0,Alive,TUMOR FREE,3495.0,,[Not Available],Locoregional Disease,"Other, specify",endometrium,520.0,Complete Remission/Response,,,0.0,3495.0,0.0,3495.0,1.0,520.0,1.0,520.0,
TCGA-A5-A2K7,10519,TCGA-A5-A2K7,UCEC,41.0,FEMALE,[Not Available],[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14980.0,Alive,TUMOR FREE,1063.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1063.0,0.0,1063.0,0.0,1063.0,0.0,1063.0,
TCGA-KT-A7W1,5262,TCGA-KT-A7W1,LGG,45.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-16560.0,Alive,TUMOR FREE,438.0,,[Not Available],,,,84.0,Progressive Disease,,,0.0,438.0,0.0,438.0,,,1.0,84.0,
TCGA-S9-A6WD,5337,TCGA-S9-A6WD,LGG,58.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2008.0,[Not Available],-21231.0,Alive,WITH TUMOR,2289.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,2289.0,0.0,2289.0,,,0.0,2289.0,
TCGA-FG-5964,5100,TCGA-FG-5964,LGG,62.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-22735.0,Alive,WITH TUMOR,1588.0,,[Not Available],,,,,Stable Disease,,,0.0,1588.0,0.0,1588.0,,,0.0,1588.0,
TCGA-DJ-A4UT,10005,TCGA-DJ-A4UT,THCA,32.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-11813.0,Alive,TUMOR FREE,823.0,,[Not Available],,,,,[Not Available],,R0,0.0,823.0,0.0,823.0,0.0,823.0,0.0,823.0,
TCGA-63-5131,6586,TCGA-63-5131,LUSC,,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],,Dead,TUMOR FREE,,,[Not Available],,,,,Complete Remission/Response,,,1.0,,0.0,,0.0,,0.0,,
TCGA-C5-A2LV,1634,TCGA-C5-A2LV,CESC,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13447.0,Alive,TUMOR FREE,2234.0,,,,,,,Complete Remission/Response,,,0.0,2234.0,0.0,2234.0,0.0,2234.0,0.0,2234.0,
TCGA-AJ-A3EJ,10539,TCGA-AJ-A3EJ,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27317.0,Dead,WITH TUMOR,,50.0,[Not Available],,,,,[Not Available],,,1.0,50.0,1.0,50.0,,,1.0,50.0,
TCGA-BP-5184,4251,TCGA-BP-5184,KIRC,54.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-19746.0,Alive,TUMOR FREE,1133.0,,[Not Available],,,,,[Not Available],,,0.0,1133.0,0.0,1133.0,,,0.0,1133.0,
TCGA-66-2754,6615,TCGA-66-2754,LUSC,67.0,MALE,[Not Available],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-24471.0,Alive,TUMOR FREE,61.0,,[Not Available],,,,,[Not Available],,,0.0,61.0,0.0,61.0,,,0.0,61.0,
TCGA-AR-A1AH,914,TCGA-AR-A1AH,BRCA,51.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18991.0,Alive,TUMOR FREE,3807.0,,[Not Available],New Primary Tumor,"Other, specify",Renal,1136.0,[Not Available],Negative,,0.0,3807.0,0.0,3807.0,0.0,3807.0,1.0,1136.0,
TCGA-EB-A82B,8987,TCGA-EB-A82B,SKCM,58.0,FEMALE,ASIAN,Stage III,[Not Applicable],,[Not Available],2013.0,[Not Available],-21239.0,Alive,TUMOR FREE,390.0,,[Not Available],,,,,[Not Available],,,0.0,390.0,0.0,390.0,,,0.0,390.0,
TCGA-19-2629,3084,TCGA-19-2629,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-22257.0,Dead,WITH TUMOR,501.0,737.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],145.0,[Not Available],,,1.0,737.0,1.0,737.0,,,1.0,145.0,
TCGA-E6-A8L9,10915,TCGA-E6-A8L9,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22333.0,Alive,TUMOR FREE,1013.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1013.0,0.0,1013.0,0.0,1013.0,0.0,1013.0,
TCGA-WC-A87T,11142,TCGA-WC-A87T,UVM,64.0,MALE,WHITE,Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,[Not Available],2007.0,[Not Available],-23409.0,Alive,TUMOR FREE,2600.0,,[Not Available],New Primary Tumor,Skin,,2020.0,[Not Available],,,0.0,2600.0,0.0,2600.0,,,1.0,2020.0,
TCGA-GU-AATO,351,TCGA-GU-AATO,BLCA,75.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-27684.0,Dead,WITH TUMOR,,324.0,[Not Available],,,,,Progressive Disease,,,1.0,324.0,1.0,324.0,,,1.0,324.0,
TCGA-V4-A9EX,11106,TCGA-V4-A9EX,UVM,55.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell,[Not Available],2012.0,[Not Available],-20447.0,Dead,WITH TUMOR,,730.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,,381.0,[Not Available],,,1.0,730.0,1.0,730.0,,,1.0,381.0,
TCGA-UF-A7JO,3763,TCGA-UF-A7JO,HNSC,79.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-28951.0,Dead,WITH TUMOR,,631.0,[Not Available],Locoregional Disease,Oral Cavity,Floor of mouth,525.0,Complete Remission/Response,,,1.0,631.0,1.0,631.0,,,1.0,525.0,
TCGA-T7-A92I,4419,TCGA-T7-A92I,KIRC,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2013.0,[Not Available],-17331.0,Alive,TUMOR FREE,356.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,356.0,0.0,356.0,0.0,356.0,0.0,356.0,
TCGA-QF-A5YS,11014,TCGA-QF-A5YS,UCEC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Mixed serous and endometrioid,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20841.0,Alive,TUMOR FREE,689.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,689.0,0.0,689.0,0.0,689.0,0.0,689.0,
TCGA-44-7670,5889,TCGA-44-7670,LUAD,47.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-17392.0,Alive,TUMOR FREE,882.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,882.0,0.0,882.0,0.0,882.0,0.0,882.0,
TCGA-85-8580,6733,TCGA-85-8580,LUSC,52.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-19301.0,Alive,TUMOR FREE,1113.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1113.0,0.0,1113.0,0.0,1113.0,0.0,1113.0,
TCGA-CV-7440,3573,TCGA-CV-7440,HNSC,38.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,GX,2000.0,[Not Available],-13992.0,Dead,,,675.0,[Not Available],,,,,[Not Available],,,1.0,675.0,,675.0,,,0.0,675.0,
TCGA-A2-A0CV,547,TCGA-A2-A0CV,BRCA,41.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15289.0,Alive,TUMOR FREE,3011.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3011.0,0.0,3011.0,0.0,3011.0,0.0,3011.0,
TCGA-KL-8334,3781,TCGA-KL-8334,KICH,37.0,FEMALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-13602.0,Alive,TUMOR FREE,2949.0,,[Not Available],,,,,[Unknown],,,0.0,2949.0,0.0,2949.0,,,0.0,2949.0,
TCGA-06-0216,2806,TCGA-06-0216,GBM,61.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1999.0,[Not Available],-22524.0,Dead,WITH TUMOR,684.0,735.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],175.0,[Not Available],,,1.0,735.0,1.0,735.0,,,1.0,175.0,
TCGA-EM-A3OB,10184,TCGA-EM-A3OB,THCA,33.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-12282.0,Alive,TUMOR FREE,1176.0,,[Not Available],,,,,[Not Available],,R0,0.0,1176.0,0.0,1176.0,0.0,1176.0,0.0,1176.0,
TCGA-HU-A4H8,9589,TCGA-HU-A4H8,STAD,77.0,MALE,ASIAN,Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,[Not Available],-28292.0,[Discrepancy],WITH TUMOR,428.0,,[Not Available],Distant Metastasis,,,354.0,Complete Remission/Response,,,0.0,428.0,,428.0,1.0,354.0,1.0,354.0,
TCGA-D1-A16S,10850,TCGA-D1-A16S,UCEC,70.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,High Grade,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25690.0,Alive,TUMOR FREE,568.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,568.0,0.0,568.0,0.0,568.0,0.0,568.0,
TCGA-D5-6536,2307,TCGA-D5-6536,COAD,73.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-26890.0,Alive,WITH TUMOR,543.0,,[Not Available],Locoregional Disease,,,493.0,[Not Available],,,0.0,543.0,0.0,543.0,,,1.0,493.0,
TCGA-GC-A6I3,336,TCGA-GC-A6I3,BLCA,90.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-32873.0,Alive,TUMOR FREE,423.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,423.0,0.0,423.0,,,0.0,423.0,
TCGA-D5-6539,2310,TCGA-D5-6539,COAD,45.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-16703.0,Alive,TUMOR FREE,380.0,,[Not Available],,,,,[Not Available],,,0.0,380.0,0.0,380.0,,,0.0,380.0,
TCGA-DU-7309,5031,TCGA-DU-7309,LGG,41.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-15197.0,Alive,WITH TUMOR,84.0,,[Not Available],,,,,Stable Disease,,,0.0,84.0,0.0,84.0,,,0.0,84.0,
TCGA-HZ-8001,7597,TCGA-HZ-8001,PAAD,69.0,MALE,WHITE,Stage III,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-25227.0,Alive,TUMOR FREE,706.0,,,,,,,Complete Remission/Response,,,0.0,706.0,0.0,706.0,0.0,706.0,0.0,706.0,
TCGA-33-6738,6409,TCGA-33-6738,LUSC,80.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-29368.0,Alive,TUMOR FREE,1927.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1927.0,0.0,1927.0,0.0,1927.0,0.0,1927.0,
TCGA-DD-AADI,5619,TCGA-DD-AADI,LIHC,43.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-15928.0,Alive,TUMOR FREE,1085.0,,[Not Available],,,,,[Not Available],,R0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0,
TCGA-EK-A2RO,1741,TCGA-EK-A2RO,CESC,59.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21844.0,Alive,WITH TUMOR,2.0,,,,,,,[Not Available],,,0.0,2.0,0.0,2.0,,,0.0,2.0,
TCGA-D1-A16J,10845,TCGA-D1-A16J,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22319.0,Alive,TUMOR FREE,910.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,910.0,0.0,910.0,0.0,910.0,0.0,910.0,
TCGA-VR-A8EW,2627,TCGA-VR-A8EW,ESCA,57.0,MALE,ASIAN,Stage IIIB,Stage IIIB,Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-20902.0,Dead,WITH TUMOR,,247.0,[Not Available],,,,,,,,1.0,247.0,1.0,247.0,,,1.0,247.0,
TCGA-WY-A859,5420,TCGA-WY-A859,LGG,34.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-12631.0,Alive,WITH TUMOR,1213.0,,[Not Available],,,,,Stable Disease,,,0.0,1213.0,0.0,1213.0,,,0.0,1213.0,
TCGA-QR-A70J,7728,TCGA-QR-A70J,PCPG,42.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-15420.0,Alive,TUMOR FREE,399.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,399.0,0.0,399.0,0.0,399.0,0.0,399.0,
TCGA-X7-A8DD,10390,TCGA-X7-A8DD,THYM,54.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type B1,[Not Available],2011.0,[Not Available],-19971.0,Alive,TUMOR FREE,1114.0,,[Not Available],,,,,[Not Available],,,0.0,1114.0,0.0,1114.0,,,0.0,1114.0,
TCGA-CV-7100,3524,TCGA-CV-7100,HNSC,66.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2001.0,[Not Available],-24183.0,Dead,WITH TUMOR,,274.0,[Not Available],,,,,[Not Available],,,1.0,274.0,1.0,274.0,,,1.0,274.0,
TCGA-50-8457,5960,TCGA-50-8457,LUAD,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23055.0,Alive,TUMOR FREE,1125.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1125.0,0.0,1125.0,0.0,1125.0,0.0,1125.0,
TCGA-BG-A0VZ,10760,TCGA-BG-A0VZ,UCEC,58.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21414.0,Alive,TUMOR FREE,1601.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1601.0,0.0,1601.0,0.0,1601.0,0.0,1601.0,
TCGA-KK-A7AU,8190,TCGA-KK-A7AU,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-23118.0,Alive,TUMOR FREE,1775.0,,[Not Available],Biochemical evidence of disease,,,207.0,Progressive Disease,,,0.0,1775.0,0.0,1775.0,,,1.0,207.0,
TCGA-EM-A2CU,10150,TCGA-EM-A2CU,THCA,47.0,FEMALE,[Not Available],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-17231.0,Alive,WITH TUMOR,400.0,,[Not Available],,,,,[Not Available],,R0,0.0,400.0,0.0,400.0,0.0,400.0,0.0,400.0,
TCGA-G3-A25T,5701,TCGA-G3-A25T,LIHC,45.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-16461.0,Alive,WITH TUMOR,1553.0,,[Not Available],Intrahepatic Recurrence,Liver,,452.0,[Not Available],,R0,0.0,1553.0,0.0,1553.0,1.0,452.0,1.0,452.0,
TCGA-GM-A4E0,1518,TCGA-GM-A4E0,BRCA,67.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24788.0,Alive,TUMOR FREE,2191.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2191.0,0.0,2191.0,0.0,2191.0,0.0,2191.0,
TCGA-DB-A64Q,4953,TCGA-DB-A64Q,LGG,31.0,FEMALE,[Unknown],[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-11637.0,Alive,TUMOR FREE,182.0,,[Not Available],,,,,Stable Disease,,,0.0,182.0,0.0,182.0,,,0.0,182.0,
TCGA-HT-8114,5218,TCGA-HT-8114,LGG,36.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-13198.0,Alive,TUMOR FREE,1040.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1040.0,0.0,1040.0,0.0,1040.0,0.0,1040.0,
TCGA-55-8206,6026,TCGA-55-8206,LUAD,56.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-20690.0,Alive,TUMOR FREE,888.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,888.0,0.0,888.0,0.0,888.0,0.0,888.0,
TCGA-EK-A2PI,1724,TCGA-EK-A2PI,CESC,44.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2009.0,[Not Available],-16324.0,Alive,WITH TUMOR,586.0,,,,,,,[Not Available],,,0.0,586.0,0.0,586.0,,,0.0,586.0,
TCGA-DJ-A13V,9926,TCGA-DJ-A13V,THCA,21.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-7915.0,Alive,TUMOR FREE,1313.0,,[Not Available],,,,,[Not Available],,R0,0.0,1313.0,0.0,1313.0,0.0,1313.0,0.0,1313.0,
TCGA-HT-8563,5220,TCGA-HT-8563,LGG,30.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2011.0,[Not Available],-11305.0,Alive,TUMOR FREE,860.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,860.0,0.0,860.0,0.0,860.0,0.0,860.0,
TCGA-V4-A9EY,11107,TCGA-V4-A9EY,UVM,66.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,[Not Available],2012.0,[Not Available],-24187.0,Alive,TUMOR FREE,837.0,,[Not Available],,,,,[Not Available],,,0.0,837.0,0.0,837.0,,,0.0,837.0,
TCGA-SU-A7E7,8232,TCGA-SU-A7E7,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22185.0,Alive,TUMOR FREE,551.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,551.0,0.0,551.0,0.0,551.0,0.0,551.0,
TCGA-EL-A4K6,10113,TCGA-EL-A4K6,THCA,75.0,MALE,WHITE,Stage IV,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-27416.0,Alive,WITH TUMOR,1343.0,,[Not Available],Distant Metastasis,Lung,,874.0,[Not Available],,R0,0.0,1343.0,0.0,1343.0,,,1.0,874.0,
TCGA-FP-8211,9544,TCGA-FP-8211,STAD,62.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-22957.0,Alive,TUMOR FREE,413.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,413.0,0.0,413.0,0.0,413.0,0.0,413.0,
TCGA-ET-A39S,10228,TCGA-ET-A39S,THCA,27.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-10000.0,Alive,TUMOR FREE,1676.0,,[Not Available],,,,,[Not Available],,R0,0.0,1676.0,0.0,1676.0,0.0,1676.0,0.0,1676.0,
TCGA-EQ-8122,9530,TCGA-EQ-8122,STAD,71.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-26289.0,Dead,,,243.0,[Not Available],,,,,[Not Available],,,1.0,243.0,,243.0,,,0.0,243.0,
TCGA-LL-A8F5,1547,TCGA-LL-A8F5,BRCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22544.0,Alive,TUMOR FREE,596.0,,[Not Available],,,,,[Not Available],Negative,,0.0,596.0,0.0,596.0,0.0,596.0,0.0,596.0,
TCGA-E9-A1RE,1419,TCGA-E9-A1RE,BRCA,74.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27392.0,Alive,TUMOR FREE,1419.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1419.0,0.0,1419.0,0.0,1419.0,0.0,1419.0,
TCGA-AR-A250,948,TCGA-AR-A250,BRCA,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21309.0,Alive,TUMOR FREE,2707.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2707.0,0.0,2707.0,0.0,2707.0,0.0,2707.0,
TCGA-19-A6J4,3100,TCGA-19-A6J4,GBM,68.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2013.0,[Not Available],-25058.0,Dead,WITH TUMOR,,121.0,[Not Available],,,,,[Unknown],,,1.0,121.0,1.0,121.0,,,1.0,121.0,
TCGA-CV-6936,3497,TCGA-CV-6936,HNSC,68.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2004.0,[Not Available],-25020.0,Dead,WITH TUMOR,,166.0,[Not Available],Locoregional Recurrence,Oral Cavity,mandibular,157.0,Progressive Disease,,,1.0,166.0,1.0,166.0,,,1.0,157.0,
TCGA-DU-7006,5009,TCGA-DU-7006,LGG,60.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,1995.0,[Not Available],-21990.0,Dead,WITH TUMOR,,349.0,[Not Available],,,,,Progressive Disease,,,1.0,349.0,1.0,349.0,,,1.0,349.0,
TCGA-55-A48Z,6049,TCGA-55-A48Z,LUAD,60.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22056.0,Alive,WITH TUMOR,651.0,,[Not Available],Distant Metastasis,,,536.0,Stable Disease,,,0.0,651.0,0.0,651.0,,,1.0,536.0,
TCGA-55-6985,5988,TCGA-55-6985,LUAD,58.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],-21381.0,Alive,TUMOR FREE,1233.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1233.0,0.0,1233.0,0.0,1233.0,0.0,1233.0,
TCGA-IN-8663,9595,TCGA-IN-8663,STAD,68.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-25172.0,Dead,TUMOR FREE,,103.0,"Other, non-malignant disease",,,,,[Not Available],,,1.0,103.0,0.0,103.0,,,0.0,103.0,
TCGA-CH-5741,7882,TCGA-CH-5741,PRAD,56.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-20759.0,Alive,TUMOR FREE,395.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,395.0,0.0,395.0,0.0,395.0,0.0,395.0,
TCGA-A4-8515,4480,TCGA-A4-8515,KIRP,47.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-17345.0,Alive,TUMOR FREE,709.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,709.0,0.0,709.0,0.0,709.0,0.0,709.0,
TCGA-P5-A5ET,5263,TCGA-P5-A5ET,LGG,27.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-10027.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-W5-AA2T,1928,TCGA-W5-AA2T,CHOL,64.0,FEMALE,WHITE,Stage II,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2008.0,[Not Available],-23560.0,Dead,WITH TUMOR,,1220.0,[Not Available],Extrahepatic Recurrence,Bone,,295.0,[Not Available],,R0,1.0,1220.0,1.0,1220.0,1.0,295.0,1.0,295.0,
TCGA-BH-A0W5,1111,TCGA-BH-A0W5,BRCA,77.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,[Not Available],-28304.0,Alive,TUMOR FREE,1288.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,
TCGA-WY-A85E,5425,TCGA-WY-A85E,LGG,48.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-17878.0,Alive,WITH TUMOR,633.0,,[Not Available],,,,532.0,Partial Remission/Response,,,0.0,633.0,0.0,633.0,,,1.0,532.0,
TCGA-GM-A3NW,1513,TCGA-GM-A3NW,BRCA,63.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23041.0,Alive,TUMOR FREE,3361.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3361.0,0.0,3361.0,0.0,3361.0,0.0,3361.0,
TCGA-DX-A7EM,8626,TCGA-DX-A7EM,SARC,61.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-22531.0,Alive,TUMOR FREE,1892.0,,[Not Available],,,,,[Not Available],Positive,R0,0.0,1892.0,0.0,1892.0,0.0,1892.0,0.0,1892.0,
TCGA-GV-A3QI,361,TCGA-GV-A3QI,BLCA,47.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-17383.0,Alive,WITH TUMOR,1110.0,,[Not Available],Distant Metastasis,"Other, specify",Abdominal wall,768.0,Complete Remission/Response,,,0.0,1110.0,0.0,1110.0,1.0,768.0,1.0,768.0,
TCGA-E9-A1NG,1404,TCGA-E9-A1NG,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22896.0,Dead,TUMOR FREE,,786.0,[Not Available],,,,,[Not Available],Negative,,1.0,786.0,0.0,786.0,0.0,786.0,0.0,786.0,
TCGA-B9-A8YI,4534,TCGA-B9-A8YI,KIRP,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-28917.0,Alive,TUMOR FREE,374.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,374.0,0.0,374.0,0.0,374.0,0.0,374.0,
TCGA-DU-7011,5014,TCGA-DU-7011,LGG,25.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2000.0,[Not Available],-9322.0,Dead,WITH TUMOR,,3200.0,[Not Available],,,,,Stable Disease,,,1.0,3200.0,1.0,3200.0,,,1.0,3200.0,
TCGA-D6-6516,3611,TCGA-D6-6516,HNSC,69.0,MALE,WHITE,Stage I,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-25242.0,Alive,TUMOR FREE,773.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,773.0,0.0,773.0,0.0,773.0,0.0,773.0,
TCGA-HT-7690,5180,TCGA-HT-7690,LGG,29.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2009.0,[Not Available],-10673.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,[Not Available],,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-DA-A1I0,8918,TCGA-DA-A1I0,SKCM,63.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2008.0,[Not Available],-23157.0,Dead,WITH TUMOR,,620.0,[Not Available],Distant Metastasis,Brain,,599.0,[Not Available],,,1.0,620.0,1.0,620.0,,,1.0,599.0,
TCGA-12-3653,2993,TCGA-12-3653,GBM,34.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-12529.0,Dead,WITH TUMOR,357.0,442.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],224.0,[Not Available],,,1.0,442.0,1.0,442.0,,,1.0,224.0,
TCGA-E1-A7YY,5090,TCGA-E1-A7YY,LGG,27.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1998.0,[Not Available],-9867.0,Dead,WITH TUMOR,,4445.0,[Not Available],,,,958.0,Stable Disease,,,1.0,4445.0,1.0,4445.0,,,1.0,958.0,
TCGA-BH-A1F6,1142,TCGA-BH-A1F6,BRCA,51.0,FEMALE,WHITE,[Not Available],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996.0,[Not Available],-18691.0,Dead,,,2965.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,2965.0,,2965.0,,,0.0,2965.0,
TCGA-CM-5864,2274,TCGA-CM-5864,COAD,60.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-22219.0,Alive,TUMOR FREE,457.0,,[Not Available],,,,,[Not Available],,,0.0,457.0,0.0,457.0,,,0.0,457.0,
TCGA-VQ-A8PD,9657,TCGA-VQ-A8PD,STAD,69.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-25244.0,Dead,WITH TUMOR,,496.0,[Not Available],Distant Metastasis,"Other, specify",,134.0,Progressive Disease,,,1.0,496.0,1.0,496.0,,,1.0,134.0,
TCGA-44-8120,5894,TCGA-44-8120,LUAD,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-21188.0,Alive,TUMOR FREE,260.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,260.0,0.0,260.0,0.0,260.0,0.0,260.0,
TCGA-A2-A0YD,585,TCGA-A2-A0YD,BRCA,63.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23021.0,Alive,TUMOR FREE,769.0,,[Not Available],,,,,[Not Available],Negative,,0.0,769.0,0.0,769.0,0.0,769.0,0.0,769.0,
TCGA-CD-8524,9422,TCGA-CD-8524,STAD,61.0,FEMALE,ASIAN,Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,[Not Available],-22445.0,Alive,WITH TUMOR,388.0,,[Not Available],Locoregional Recurrence,,,69.0,Complete Remission/Response,,,0.0,388.0,0.0,388.0,1.0,69.0,1.0,69.0,
TCGA-55-1592,5967,TCGA-55-1592,LUAD,65.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],,Dead,WITH TUMOR,,701.0,[Not Available],,,,452.0,Complete Remission/Response,,,1.0,701.0,1.0,701.0,1.0,452.0,1.0,452.0,
TCGA-DK-AA75,229,TCGA-DK-AA75,BLCA,82.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-30090.0,Dead,WITH TUMOR,,340.0,[Not Available],Distant Metastasis,Bone,,328.0,Stable Disease,,,1.0,340.0,1.0,340.0,,,1.0,328.0,
TCGA-B0-5106,4033,TCGA-B0-5106,KIRC,64.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-23547.0,Dead,TUMOR FREE,,1598.0,[Not Available],,,,,[Not Available],,,1.0,1598.0,0.0,1598.0,,,0.0,1598.0,
TCGA-K7-A6G5,5740,TCGA-K7-A6G5,LIHC,66.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-24233.0,Alive,TUMOR FREE,512.0,,[Not Available],,,,,[Not Available],,RX,0.0,512.0,0.0,512.0,,,0.0,512.0,
TCGA-60-2726,6584,TCGA-60-2726,LUSC,56.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-20618.0,Dead,TUMOR FREE,358.0,358.0,[Not Available],,,,,Complete Remission/Response,,,1.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,
TCGA-BH-A18R,1125,TCGA-BH-A18R,BRCA,50.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001.0,[Not Available],-18524.0,Dead,TUMOR FREE,,1142.0,[Not Available],,,,,[Not Available],Negative,,1.0,1142.0,0.0,1142.0,0.0,1142.0,0.0,1142.0,
TCGA-59-A5PD,7434,TCGA-59-A5PD,OV,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IC,Serous Cystadenocarcinoma,G3,2011.0,[Not Available],-20263.0,Dead,WITH TUMOR,,624.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],145.0,Complete Remission/Response,,,1.0,624.0,1.0,624.0,1.0,145.0,1.0,145.0,
TCGA-L5-A8NQ,2549,TCGA-L5-A8NQ,ESCA,71.0,MALE,WHITE,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G3,2001.0,[Not Available],-26250.0,Dead,WITH TUMOR,,650.0,[Not Available],Locoregional Recurrence,,,337.0,,,,1.0,650.0,1.0,650.0,,,1.0,337.0,
TCGA-XC-AA0X,6828,TCGA-XC-AA0X,LUSC,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2013.0,[Not Available],-28211.0,Dead,TUMOR FREE,,6.0,[Not Available],,,,,[Not Applicable],,,1.0,6.0,0.0,6.0,,,0.0,6.0,
TCGA-BP-5180,4247,TCGA-BP-5180,KIRC,53.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-19413.0,Alive,TUMOR FREE,2263.0,,[Not Available],,,,,[Not Available],,,0.0,2263.0,0.0,2263.0,,,0.0,2263.0,
TCGA-EJ-7794,7970,TCGA-EJ-7794,PRAD,67.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-24478.0,Alive,TUMOR FREE,1306.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1306.0,0.0,1306.0,0.0,1306.0,0.0,1306.0,
TCGA-HT-7680,5173,TCGA-HT-7680,LGG,32.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-11970.0,Alive,TUMOR FREE,23.0,,[Not Available],,,,,Stable Disease,,,0.0,23.0,0.0,23.0,,,0.0,23.0,
TCGA-06-5410,2864,TCGA-06-5410,GBM,72.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-26395.0,Dead,WITH TUMOR,108.0,108.0,[Not Available],,,,,[Not Available],,,1.0,108.0,1.0,108.0,,,1.0,108.0,
TCGA-QL-A97D,2408,TCGA-QL-A97D,COAD,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2012.0,[Not Available],-30914.0,Alive,TUMOR FREE,666.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,666.0,0.0,666.0,0.0,666.0,0.0,666.0,
TCGA-XF-AAMZ,459,TCGA-XF-AAMZ,BLCA,81.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-29667.0,Dead,WITH TUMOR,,1348.0,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,1344.0,Partial Remission/Response,,,1.0,1348.0,1.0,1348.0,,,1.0,1344.0,
TCGA-VP-A87D,8284,TCGA-VP-A87D,PRAD,54.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-19818.0,Alive,TUMOR FREE,1853.0,,[Not Available],Biochemical evidence of disease,,,1194.0,Complete Remission/Response,,,0.0,1853.0,0.0,1853.0,1.0,1194.0,1.0,1194.0,
TCGA-76-6193,3222,TCGA-76-6193,GBM,78.0,MALE,[Not Available],[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-28742.0,Dead,,82.0,82.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],64.0,[Not Available],,,1.0,82.0,,82.0,,,1.0,64.0,
TCGA-CJ-4882,4289,TCGA-CJ-4882,KIRC,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-21074.0,Alive,TUMOR FREE,1883.0,,[Not Available],,,,,[Not Available],,,0.0,1883.0,0.0,1883.0,,,0.0,1883.0,
TCGA-VQ-A8P8,9654,TCGA-VQ-A8P8,STAD,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-26443.0,Alive,TUMOR FREE,942.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,942.0,0.0,942.0,0.0,942.0,0.0,942.0,
TCGA-ZB-A96R,10468,TCGA-ZB-A96R,THYM,38.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type B1|Thymoma; Type B2,[Not Available],2010.0,[Not Available],-13977.0,Alive,TUMOR FREE,1804.0,,[Not Available],,,,,[Not Available],,,0.0,1804.0,0.0,1804.0,,,0.0,1804.0,
TCGA-EM-A22L,10133,TCGA-EM-A22L,THCA,33.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-12092.0,Alive,TUMOR FREE,318.0,,[Not Available],,,,,[Not Available],,R0,0.0,318.0,0.0,318.0,0.0,318.0,0.0,318.0,
TCGA-Y8-A898,4706,TCGA-Y8-A898,KIRP,69.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-25344.0,Alive,TUMOR FREE,475.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,
TCGA-TM-A84B,5374,TCGA-TM-A84B,LGG,40.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-14933.0,Dead,WITH TUMOR,,758.0,[Not Available],,,,,Progressive Disease,,,1.0,758.0,1.0,758.0,,,1.0,758.0,
TCGA-AR-A1AL,918,TCGA-AR-A1AL,BRCA,60.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22023.0,Alive,TUMOR FREE,2971.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2971.0,0.0,2971.0,0.0,2971.0,0.0,2971.0,
TCGA-19-5960,3098,TCGA-19-5960,GBM,56.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-20641.0,Dead,WITH TUMOR,,455.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],382.0,Stable Disease,,,1.0,455.0,1.0,455.0,,,1.0,382.0,
TCGA-F7-A50J,3649,TCGA-F7-A50J,HNSC,67.0,FEMALE,WHITE,Stage III,[Not Available],Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-24758.0,Alive,TUMOR FREE,947.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,947.0,0.0,947.0,0.0,947.0,0.0,947.0,
TCGA-55-A4DF,6055,TCGA-55-A4DF,LUAD,88.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-32432.0,Dead,WITH TUMOR,,614.0,[Not Available],Distant Metastasis,,,515.0,Complete Remission/Response,,,1.0,614.0,1.0,614.0,1.0,515.0,1.0,515.0,
TCGA-D3-A8GJ,8888,TCGA-D3-A8GJ,SKCM,18.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1994.0,[Not Available],-6684.0,Alive,TUMOR FREE,7342.0,,[Not Available],Distant Metastasis,Brain,,1443.0,[Not Available],,,0.0,7342.0,0.0,7342.0,,,1.0,1443.0,
TCGA-CR-6471,3423,TCGA-CR-6471,HNSC,58.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-21315.0,Dead,WITH TUMOR,,1202.0,[Not Available],,Oropharynx,,498.0,Complete Remission/Response,,,1.0,1202.0,1.0,1202.0,,,1.0,498.0,
TCGA-HD-7831,3666,TCGA-HD-7831,HNSC,74.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-27334.0,Alive,WITH TUMOR,667.0,,[Not Available],Distant Metastasis,Distant Metastasis,Lung,667.0,Complete Remission/Response,,,0.0,667.0,0.0,667.0,,,1.0,667.0,
TCGA-55-7994,6012,TCGA-55-7994,LUAD,81.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-29858.0,Alive,TUMOR FREE,603.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,603.0,0.0,603.0,0.0,603.0,0.0,603.0,
TCGA-A4-8311,4478,TCGA-A4-8311,KIRP,60.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-22220.0,Alive,TUMOR FREE,729.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,729.0,0.0,729.0,0.0,729.0,0.0,729.0,
TCGA-5C-A9VG,5449,TCGA-5C-A9VG,LIHC,58.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-21273.0,Alive,TUMOR FREE,328.0,,[Not Available],,,,,[Not Available],,R0,0.0,328.0,0.0,328.0,0.0,328.0,0.0,328.0,
TCGA-GV-A3QF,358,TCGA-GV-A3QF,BLCA,79.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-28890.0,Dead,TUMOR FREE,,617.0,[Not Available],,,,,Stable Disease,,,1.0,617.0,0.0,617.0,,,0.0,617.0,
TCGA-A6-5666,1990,TCGA-A6-5666,COAD,78.0,MALE,WHITE,Stage IIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-28514.0,Alive,WITH TUMOR,995.0,,[Not Available],,,,509.0,Complete Remission/Response,,,0.0,995.0,0.0,995.0,1.0,509.0,1.0,509.0,
TCGA-EO-A3L0,10940,TCGA-EO-A3L0,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28003.0,Alive,TUMOR FREE,1554.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1554.0,0.0,1554.0,0.0,1554.0,0.0,1554.0,
TCGA-D8-A1XS,1272,TCGA-D8-A1XS,BRCA,48.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Other, specify",[Not Available],2010.0,[Not Available],-17708.0,Alive,TUMOR FREE,496.0,,[Not Available],,,,,[Not Available],Negative,,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,
TCGA-C5-A0TN,1607,TCGA-C5-A0TN,CESC,21.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,1997.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-7760.0,Dead,WITH TUMOR,,348.0,Cervical Cancer,Distant Metastasis,"Other, specify",Pelvis/Liver,62.0,Progressive Disease,,,1.0,348.0,1.0,348.0,,,1.0,62.0,
TCGA-ET-A2MZ,10213,TCGA-ET-A2MZ,THCA,39.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-14408.0,Alive,TUMOR FREE,1133.0,,[Not Available],,,,,[Not Available],,RX,0.0,1133.0,0.0,1133.0,,,0.0,1133.0,
TCGA-W5-AA2G,1919,TCGA-W5-AA2G,CHOL,62.0,FEMALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2008.0,[Not Available],-22933.0,Alive,TUMOR FREE,1976.0,,[Not Available],,,,,[Not Available],,R0,0.0,1976.0,0.0,1976.0,0.0,1976.0,0.0,1976.0,
TCGA-DF-A2KS,10895,TCGA-DF-A2KS,UCEC,69.0,FEMALE,[Not Evaluated],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25313.0,Alive,TUMOR FREE,3318.0,,[Not Available],New Primary Tumor,"Other, specify",colorectal,2277.0,Complete Remission/Response,,,0.0,3318.0,0.0,3318.0,0.0,3318.0,1.0,2277.0,
TCGA-GN-A262,9192,TCGA-GN-A262,SKCM,47.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2001.0,[Not Available],-17239.0,Alive,WITH TUMOR,4255.0,,[Not Available],Locoregional Recurrence,,,2908.0,[Not Available],,,0.0,4255.0,0.0,4255.0,,,1.0,2908.0,
TCGA-R6-A6Y0,2606,TCGA-R6-A6Y0,ESCA,54.0,MALE,WHITE,[Not Available],Stage IVA,"Esophagus Adenocarcinoma, NOS",G2,2005.0,[Not Available],-20045.0,Alive,WITH TUMOR,1641.0,,[Not Available],,,,,Stable Disease,,,0.0,1641.0,0.0,1641.0,,,0.0,1641.0,
TCGA-HT-7606,5163,TCGA-HT-7606,LGG,30.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2008.0,[Not Available],-11233.0,Alive,TUMOR FREE,526.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,
TCGA-CZ-5455,4371,TCGA-CZ-5455,KIRC,63.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-23150.0,Dead,WITH TUMOR,,561.0,[Not Available],,,,,[Not Available],,,1.0,561.0,1.0,561.0,,,1.0,561.0,
TCGA-DJ-A2PZ,9952,TCGA-DJ-A2PZ,THCA,63.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-23332.0,Alive,TUMOR FREE,256.0,,[Not Available],,,,,[Not Available],,R0,0.0,256.0,0.0,256.0,0.0,256.0,0.0,256.0,
TCGA-EE-A29T,9020,TCGA-EE-A29T,SKCM,51.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1982.0,[Not Available],-18779.0,Alive,TUMOR FREE,11252.0,,[Not Available],Regional lymph node,,,7483.0,[Not Available],,,0.0,11252.0,0.0,11252.0,,,1.0,7483.0,
TCGA-D1-A0ZN,10815,TCGA-D1-A0ZN,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Peri (6-12 months since last menstrual period),-22026.0,Alive,TUMOR FREE,512.0,,[Not Available],New Primary Tumor,"Other, specify",Breast left,448.0,Complete Remission/Response,,,0.0,512.0,0.0,512.0,0.0,512.0,1.0,448.0,
TCGA-KK-A6DY,8178,TCGA-KK-A6DY,PRAD,50.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2002.0,[Not Available],-18420.0,Alive,WITH TUMOR,4295.0,,[Not Available],,,,,[Not Applicable],,,0.0,4295.0,0.0,4295.0,,,0.0,4295.0,
TCGA-YC-A89H,468,TCGA-YC-A89H,BLCA,78.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-28741.0,Alive,TUMOR FREE,573.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,573.0,0.0,573.0,0.0,573.0,0.0,573.0,
TCGA-CH-5739,7880,TCGA-CH-5739,PRAD,65.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-23953.0,Alive,TUMOR FREE,671.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,671.0,0.0,671.0,0.0,671.0,0.0,671.0,
TCGA-EJ-7327,7955,TCGA-EJ-7327,PRAD,61.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22475.0,Alive,TUMOR FREE,923.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,923.0,0.0,923.0,0.0,923.0,0.0,923.0,
TCGA-CN-6017,3341,TCGA-CN-6017,HNSC,55.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-20358.0,Dead,TUMOR FREE,,853.0,[Not Available],,,,,Complete Remission/Response,,,1.0,853.0,0.0,853.0,,,0.0,853.0,
TCGA-HC-7232,8074,TCGA-HC-7232,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24324.0,Alive,WITH TUMOR,1161.0,,[Not Available],Biochemical evidence of disease,,,766.0,Complete Remission/Response,,,0.0,1161.0,0.0,1161.0,1.0,766.0,1.0,766.0,
TCGA-G4-6306,2376,TCGA-G4-6306,COAD,71.0,MALE,WHITE,[Discrepancy],[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-26163.0,Alive,TUMOR FREE,1359.0,,[Not Available],,,,,[Not Available],,,0.0,1359.0,0.0,1359.0,,,0.0,1359.0,
TCGA-EE-A2GS,9043,TCGA-EE-A2GS,SKCM,28.0,FEMALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2006.0,[Not Available],-10421.0,Dead,WITH TUMOR,,2470.0,[Not Available],Distant Metastasis,"Other, Specify",right buttock,1565.0,[Not Available],,,1.0,2470.0,1.0,2470.0,,,1.0,1565.0,
TCGA-2A-A8W1,7872,TCGA-2A-A8W1,PRAD,54.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19964.0,Alive,,112.0,,[Not Available],,,,,[Not Available],,,0.0,112.0,0.0,112.0,,,0.0,112.0,
TCGA-CJ-5677,4322,TCGA-CJ-5677,KIRC,54.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-19849.0,Dead,WITH TUMOR,,782.0,[Not Available],,,,288.0,[Not Available],,,1.0,782.0,1.0,782.0,,,1.0,288.0,
TCGA-3B-A9HL,8539,TCGA-3B-A9HL,SARC,67.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2011.0,[Not Available],-24628.0,Dead,TUMOR FREE,,599.0,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,229.0,[Not Available],Positive,R1,1.0,599.0,0.0,599.0,,,1.0,229.0,
TCGA-B0-5117,4041,TCGA-B0-5117,KIRC,40.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-14612.0,Alive,TUMOR FREE,1608.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1608.0,0.0,1608.0,0.0,1608.0,0.0,1608.0,
TCGA-EY-A2OO,10970,TCGA-EY-A2OO,UCEC,56.0,FEMALE,WHITE,[Not Applicable],Stage IB,Mixed serous and endometrioid,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20797.0,Alive,TUMOR FREE,1392.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1392.0,0.0,1392.0,0.0,1392.0,0.0,1392.0,
TCGA-KK-A8IL,8216,TCGA-KK-A8IL,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-23849.0,Dead,,,628.0,[Unknown],,,,,[Unknown],,,1.0,628.0,,628.0,,,0.0,628.0,
TCGA-43-6770,6478,TCGA-43-6770,LUSC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-21683.0,Alive,TUMOR FREE,653.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,653.0,0.0,653.0,0.0,653.0,0.0,653.0,
TCGA-IG-A3Y9,2477,TCGA-IG-A3Y9,ESCA,72.0,MALE,WHITE,Stage IIIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-26330.0,Dead,TUMOR FREE,,26.0,[Not Available],,,,,Complete Remission/Response,,,1.0,26.0,0.0,26.0,0.0,26.0,0.0,26.0,
TCGA-3E-AAAZ,7544,TCGA-3E-AAAZ,PAAD,71.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,[Not Available],-26234.0,Dead,WITH TUMOR,,2182.0,"Other, specify",New Primary Tumor,Lung,,1600.0,[Unknown],,,1.0,2182.0,0.0,2182.0,,,1.0,1600.0,
TCGA-41-4097,3199,TCGA-41-4097,GBM,63.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-23107.0,Dead,WITH TUMOR,6.0,6.0,[Not Available],,,,,[Not Available],,,1.0,6.0,1.0,6.0,,,1.0,6.0,
TCGA-CV-A461,3588,TCGA-CV-A461,HNSC,65.0,MALE,WHITE,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G2,2004.0,[Not Available],-23955.0,Dead,TUMOR FREE,,2064.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2064.0,0.0,2064.0,0.0,2064.0,0.0,2064.0,
TCGA-D3-A2JE,8843,TCGA-D3-A2JE,SKCM,75.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-27604.0,Dead,WITH TUMOR,,841.0,[Not Available],,,,149.0,[Not Available],,,1.0,841.0,1.0,841.0,,,1.0,149.0,
TCGA-EK-A2RN,1740,TCGA-EK-A2RN,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16487.0,Alive,WITH TUMOR,71.0,,,,,,,[Not Available],,,0.0,71.0,0.0,71.0,,,0.0,71.0,
TCGA-QK-A6IF,3723,TCGA-QK-A6IF,HNSC,61.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2013.0,[Not Available],-22463.0,Alive,TUMOR FREE,704.0,,[Not Available],Distant Metastasis,Distant Metastasis,pulmonary nodules throughout both lungs,502.0,Complete Remission/Response,,,0.0,704.0,0.0,704.0,,,1.0,502.0,
TCGA-XM-AAZ3,10418,TCGA-XM-AAZ3,THYM,64.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type AB,[Not Available],2011.0,[Not Available],-23617.0,Alive,TUMOR FREE,1150.0,,[Not Available],,,,,[Not Available],,,0.0,1150.0,0.0,1150.0,,,0.0,1150.0,
TCGA-S3-AA17,1591,TCGA-S3-AA17,BRCA,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23642.0,Alive,TUMOR FREE,424.0,,[Not Available],,,,,[Not Available],Negative,,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,
TCGA-KK-A7AY,8193,TCGA-KK-A7AY,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-22220.0,Alive,TUMOR FREE,1754.0,,[Not Available],Biochemical evidence of disease,,,1124.0,Complete Remission/Response,,,0.0,1754.0,0.0,1754.0,1.0,1124.0,1.0,1124.0,
TCGA-L5-A4OX,2530,TCGA-L5-A4OX,ESCA,60.0,MALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2006.0,[Not Available],-22015.0,Dead,TUMOR FREE,,226.0,[Not Available],,,,,Complete Remission/Response,,,1.0,226.0,0.0,226.0,0.0,226.0,0.0,226.0,
TCGA-PC-A5DN,8738,TCGA-PC-A5DN,SARC,77.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2005.0,[Not Available],-28421.0,Dead,TUMOR FREE,,1175.0,[Not Available],,,,,[Not Available],[Not Available],R1,1.0,1175.0,0.0,1175.0,,,0.0,1175.0,
TCGA-IB-7891,7632,TCGA-IB-7891,PAAD,49.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,[Not Available],-18202.0,Dead,WITH TUMOR,,913.0,Pancreatic Cancer,Distant Metastasis,"Other, specify",Lung and Liver,525.0,Complete Remission/Response,,,1.0,913.0,1.0,913.0,1.0,525.0,1.0,525.0,
TCGA-BR-4255,9283,TCGA-BR-4255,STAD,76.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-27893.0,Dead,,,124.0,[Not Available],,,,,[Not Available],,,1.0,124.0,,124.0,,,0.0,124.0,
TCGA-J2-A4AE,6281,TCGA-J2-A4AE,LUAD,77.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-28163.0,Alive,TUMOR FREE,1079.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1079.0,0.0,1079.0,0.0,1079.0,0.0,1079.0,
TCGA-EJ-A65E,7986,TCGA-EJ-A65E,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012.0,[Not Available],-24558.0,Alive,TUMOR FREE,417.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,417.0,0.0,417.0,0.0,417.0,0.0,417.0,
TCGA-R6-A6XG,2604,TCGA-R6-A6XG,ESCA,64.0,MALE,WHITE,[Not Available],Stage IIIA,"Esophagus Adenocarcinoma, NOS",G2,2011.0,[Not Available],-23484.0,Alive,WITH TUMOR,1168.0,,[Not Available],Distant Metastasis,"Other, specify",brain,572.0,Complete Remission/Response,,,0.0,1168.0,0.0,1168.0,1.0,572.0,1.0,572.0,
TCGA-AZ-4682,2221,TCGA-AZ-4682,COAD,61.0,MALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-22409.0,Dead,WITH TUMOR,,680.0,[Not Available],,,,,[Not Available],,,1.0,680.0,1.0,680.0,,,1.0,680.0,
TCGA-AR-A5QN,965,TCGA-AR-A5QN,BRCA,68.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25089.0,Alive,TUMOR FREE,1013.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,1013.0,0.0,1013.0,,,0.0,1013.0,
TCGA-ER-A19S,9110,TCGA-ER-A19S,SKCM,81.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2008.0,[Not Available],-29603.0,Alive,TUMOR FREE,1505.0,,[Not Available],,,,,[Not Available],,,0.0,1505.0,0.0,1505.0,,,0.0,1505.0,
TCGA-66-2767,6624,TCGA-66-2767,LUSC,62.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-22888.0,Alive,TUMOR FREE,61.0,,[Not Available],,,,,[Not Available],,,0.0,61.0,0.0,61.0,,,0.0,61.0,
TCGA-AK-3443,3948,TCGA-AK-3443,KIRC,45.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,GX,2006.0,[Not Available],-16578.0,Alive,TUMOR FREE,1423.0,,[Not Available],,,,,[Not Available],,,0.0,1423.0,0.0,1423.0,,,0.0,1423.0,
TCGA-AR-A254,951,TCGA-AR-A254,BRCA,50.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18270.0,Alive,TUMOR FREE,2605.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2605.0,0.0,2605.0,0.0,2605.0,0.0,2605.0,
TCGA-B5-A3FH,10729,TCGA-B5-A3FH,UCEC,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27221.0,Alive,TUMOR FREE,841.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,841.0,0.0,841.0,0.0,841.0,0.0,841.0,
TCGA-P4-A5E7,4655,TCGA-P4-A5E7,KIRP,74.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004.0,[Not Available],-27029.0,Alive,TUMOR FREE,2649.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2649.0,0.0,2649.0,0.0,2649.0,0.0,2649.0,
TCGA-KN-8422,3821,TCGA-KN-8422,KICH,28.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-10303.0,Alive,TUMOR FREE,775.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,
TCGA-BH-A1EU,1134,TCGA-BH-A1EU,BRCA,83.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30339.0,Dead,TUMOR FREE,,1286.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1286.0,0.0,1286.0,,,0.0,1286.0,
TCGA-EL-A3CL,10040,TCGA-EL-A3CL,THCA,70.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1994.0,[Not Available],-25761.0,Dead,,,963.0,[Not Available],,,,,[Not Available],,R0,1.0,963.0,,963.0,0.0,963.0,0.0,963.0,
TCGA-EM-A22J,10131,TCGA-EM-A22J,THCA,56.0,FEMALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-20539.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,[Not Available],,RX,0.0,441.0,0.0,441.0,,,0.0,441.0,
TCGA-EL-A3H2,10071,TCGA-EL-A3H2,THCA,58.0,MALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002.0,[Not Available],-21266.0,Dead,WITH TUMOR,,1019.0,[Not Available],,,,,[Not Available],,R0,1.0,1019.0,1.0,1019.0,,,1.0,1019.0,
TCGA-K4-A54R,377,TCGA-K4-A54R,BLCA,59.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-21601.0,Alive,TUMOR FREE,842.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,
TCGA-05-4427,5827,TCGA-05-4427,LUAD,65.0,FEMALE,[Not Available],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-23893.0,Alive,TUMOR FREE,791.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,
TCGA-GV-A3QK,362,TCGA-GV-A3QK,BLCA,56.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-20802.0,Alive,WITH TUMOR,832.0,,[Not Available],,,,,Stable Disease,,,0.0,832.0,0.0,832.0,,,0.0,832.0,
TCGA-05-5429,5836,TCGA-05-5429,LUAD,60.0,MALE,[Not Available],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-22066.0,Dead,TUMOR FREE,,275.0,[Not Available],,,,,[Not Applicable],,,1.0,275.0,0.0,275.0,,,0.0,275.0,
TCGA-A7-A5ZX,666,TCGA-A7-A5ZX,BRCA,48.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17683.0,Alive,TUMOR FREE,336.0,,[Not Available],,,,,[Not Available],[Unknown],,0.0,336.0,0.0,336.0,,,0.0,336.0,
TCGA-DK-A3IV,204,TCGA-DK-A3IV,BLCA,60.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-22237.0,Dead,WITH TUMOR,,294.0,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,212.0,Stable Disease,,,1.0,294.0,1.0,294.0,,,1.0,212.0,
TCGA-56-8503,6530,TCGA-56-8503,LUSC,76.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-28095.0,Alive,TUMOR FREE,41.0,,[Not Available],,,,,[Not Applicable],,,0.0,41.0,0.0,41.0,,,0.0,41.0,
TCGA-EJ-5522,7935,TCGA-EJ-5522,PRAD,51.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-18802.0,Alive,TUMOR FREE,2079.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2079.0,0.0,2079.0,0.0,2079.0,0.0,2079.0,
TCGA-5U-AB0D,10380,TCGA-5U-AB0D,THYM,71.0,FEMALE,WHITE,[Not Applicable],IVb,Thymoma; Type C,[Not Available],2013.0,[Not Available],-26167.0,Alive,WITH TUMOR,714.0,,[Not Available],,,,,[Not Available],,,0.0,714.0,0.0,714.0,,,0.0,714.0,
TCGA-A2-A1G1,601,TCGA-A2-A1G1,BRCA,85.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31223.0,Alive,TUMOR FREE,584.0,,[Not Available],,,,,[Not Available],Negative,,0.0,584.0,0.0,584.0,0.0,584.0,0.0,584.0,
TCGA-F4-6704,2358,TCGA-F4-6704,COAD,60.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIIC,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-21949.0,Alive,TUMOR FREE,47.0,,[Not Available],,,,,[Not Available],,,0.0,47.0,0.0,47.0,,,0.0,47.0,
TCGA-E9-A54Y,1449,TCGA-E9-A54Y,BRCA,63.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23057.0,Alive,TUMOR FREE,725.0,,[Not Available],,,,,[Not Available],Negative,,0.0,725.0,0.0,725.0,0.0,725.0,0.0,725.0,
TCGA-EP-A3RK,5686,TCGA-EP-A3RK,LIHC,73.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-26985.0,Alive,WITH TUMOR,363.0,,[Not Available],Locoregional Recurrence,Liver,,320.0,[Not Available],,[Not Available],0.0,363.0,0.0,363.0,,,1.0,320.0,
TCGA-BR-8371,9362,TCGA-BR-8371,STAD,62.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-22883.0,Dead,WITH TUMOR,,359.0,[Not Available],Distant Metastasis,"Other, specify",Brain,357.0,Progressive Disease,,,1.0,359.0,1.0,359.0,,,1.0,357.0,
TCGA-K4-A83P,383,TCGA-K4-A83P,BLCA,77.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),[Unknown],2013.0,[Not Available],-28463.0,Alive,WITH TUMOR,495.0,,[Not Available],Distant Metastasis,Liver,,70.0,Partial Remission/Response,,,0.0,495.0,0.0,495.0,,,1.0,70.0,
TCGA-A6-5657,1983,TCGA-A6-5657,COAD,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-23920.0,Alive,TUMOR FREE,962.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,962.0,0.0,962.0,0.0,962.0,0.0,962.0,
TCGA-EM-A2CO,10144,TCGA-EM-A2CO,THCA,77.0,FEMALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-28424.0,Alive,TUMOR FREE,184.0,,[Not Available],,,,,[Not Available],,R0,0.0,184.0,0.0,184.0,0.0,184.0,0.0,184.0,
TCGA-CR-5249,3419,TCGA-CR-5249,HNSC,35.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,GX,2007.0,[Not Available],-13047.0,Alive,TUMOR FREE,1152.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1152.0,0.0,1152.0,0.0,1152.0,0.0,1152.0,
TCGA-EJ-A65B,7984,TCGA-EJ-A65B,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012.0,[Not Available],-20204.0,Alive,TUMOR FREE,710.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,710.0,0.0,710.0,0.0,710.0,0.0,710.0,
TCGA-KK-A8IH,8212,TCGA-KK-A8IH,PRAD,50.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-18560.0,Alive,TUMOR FREE,2013.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2013.0,0.0,2013.0,0.0,2013.0,0.0,2013.0,
TCGA-CZ-5459,4375,TCGA-CZ-5459,KIRC,63.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-23318.0,Alive,TUMOR FREE,1683.0,,[Not Available],,,,,[Not Available],,,0.0,1683.0,0.0,1683.0,,,0.0,1683.0,
TCGA-E9-A3X8,1447,TCGA-E9-A3X8,BRCA,48.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17588.0,Alive,TUMOR FREE,926.0,,[Not Available],,,,,[Not Available],Negative,,0.0,926.0,0.0,926.0,0.0,926.0,0.0,926.0,
TCGA-FG-A6J1,5130,TCGA-FG-A6J1,LGG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-16106.0,Alive,WITH TUMOR,500.0,,[Not Available],,,,,Stable Disease,,,0.0,500.0,0.0,500.0,,,0.0,500.0,
TCGA-DJ-A1QE,9930,TCGA-DJ-A1QE,THCA,62.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2003.0,[Not Available],-22645.0,Alive,TUMOR FREE,4134.0,,[Not Available],,,,,[Not Available],,R0,0.0,4134.0,0.0,4134.0,0.0,4134.0,0.0,4134.0,
TCGA-BH-A8FY,1172,TCGA-BH-A8FY,BRCA,87.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31932.0,Dead,TUMOR FREE,,295.0,[Not Available],,,,,[Not Available],Negative,,1.0,295.0,0.0,295.0,0.0,295.0,0.0,295.0,
TCGA-G3-A3CI,5710,TCGA-G3-A3CI,LIHC,71.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-26224.0,Alive,TUMOR FREE,180.0,,[Not Available],,,,,[Not Available],,R0,0.0,180.0,0.0,180.0,0.0,180.0,0.0,180.0,
TCGA-TP-A8TT,8234,TCGA-TP-A8TT,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23476.0,Alive,,526.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,526.0,0.0,526.0,,,0.0,526.0,
TCGA-2A-A8VT,7869,TCGA-2A-A8VT,PRAD,47.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-17365.0,Alive,[Discrepancy],1373.0,,[Not Available],,,,,[Discrepancy],,,0.0,1373.0,0.0,1373.0,,,0.0,1373.0,
TCGA-D5-6926,2318,TCGA-D5-6926,COAD,65.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-23768.0,Alive,TUMOR FREE,275.0,,[Not Available],,,,,[Not Available],,,0.0,275.0,0.0,275.0,,,0.0,275.0,
TCGA-BC-A10Q,5457,TCGA-BC-A10Q,LIHC,72.0,FEMALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,[Not Available],1998.0,[Not Available],-26400.0,Dead,WITH TUMOR,,1135.0,[Not Available],Intrahepatic Recurrence,,,340.0,[Not Available],,R1,1.0,1135.0,1.0,1135.0,,,1.0,340.0,
TCGA-VS-A957,1859,TCGA-VS-A957,CESC,64.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23585.0,Alive,TUMOR FREE,1688.0,,,,,,,Complete Remission/Response,,,0.0,1688.0,0.0,1688.0,0.0,1688.0,0.0,1688.0,
TCGA-EA-A6QX,1715,TCGA-EA-A6QX,CESC,49.0,FEMALE,ASIAN,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2013.0,Peri (6-12 months since last menstrual period),-18035.0,Alive,TUMOR FREE,730.0,,,,,,,Complete Remission/Response,,,0.0,730.0,0.0,730.0,0.0,730.0,0.0,730.0,
TCGA-DD-AACK,5590,TCGA-DD-AACK,LIHC,70.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-25796.0,Alive,TUMOR FREE,9.0,,[Not Available],,,,,[Not Available],,R0,0.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,
TCGA-WE-A8ZR,9244,TCGA-WE-A8ZR,SKCM,49.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-18051.0,Dead,WITH TUMOR,,274.0,[Not Available],Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Locoregional Recurrence,"Liver|Lung|Bone|Other, Specify|Other, Specify",[Not Applicable]|[Not Applicable]|[Not Applicable]|spleen|subcutaneous chest wall,126.0,[Not Available],,,1.0,274.0,1.0,274.0,,,1.0,126.0,
TCGA-EE-A2A1,9025,TCGA-EE-A2A1,SKCM,46.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2004.0,[Not Available],-17109.0,Alive,TUMOR FREE,3527.0,,[Not Available],Regional lymph node,,,3488.0,[Not Available],,,0.0,3527.0,0.0,3527.0,,,1.0,3488.0,
TCGA-BF-A1PX,8803,TCGA-BF-A1PX,SKCM,56.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2010.0,[Not Available],-20626.0,Dead,TUMOR FREE,,282.0,[Not Available],,,,,[Not Available],,,1.0,282.0,0.0,282.0,,,0.0,282.0,
TCGA-IG-A97H,2492,TCGA-IG-A97H,ESCA,36.0,MALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G3,2013.0,[Not Available],-13166.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,441.0,0.0,441.0,0.0,441.0,0.0,441.0,
TCGA-96-A4JK,6779,TCGA-96-A4JK,LUSC,65.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-23974.0,Alive,TUMOR FREE,589.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,589.0,0.0,589.0,0.0,589.0,0.0,589.0,
TCGA-XE-AAO3,9814,TCGA-XE-AAO3,TGCT,33.0,MALE,ASIAN,Stage I,Stage I,Seminoma; NOS,[Not Available],2006.0,[Not Available],-12095.0,Alive,TUMOR FREE,2857.0,,[Not Applicable],,,,,[Unknown],,,0.0,2857.0,0.0,2857.0,,,0.0,2857.0,
TCGA-06-0649,2825,TCGA-06-0649,GBM,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-26796.0,Dead,WITH TUMOR,62.0,64.0,[Not Available],,,,,[Not Available],,,1.0,64.0,1.0,64.0,,,1.0,64.0,
TCGA-HU-A4H6,9588,TCGA-HU-A4H6,STAD,72.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-26445.0,Alive,WITH TUMOR,644.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,644.0,0.0,644.0,0.0,644.0,0.0,644.0,
TCGA-WB-A80Y,7838,TCGA-WB-A80Y,PCPG,59.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-21902.0,Dead,TUMOR FREE,,596.0,[Not Available],,,,,Complete Remission/Response,,,1.0,596.0,0.0,596.0,0.0,596.0,0.0,596.0,
TCGA-PG-A5BC,11007,TCGA-PG-A5BC,UCEC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436.0,Alive,TUMOR FREE,707.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,707.0,0.0,707.0,0.0,707.0,0.0,707.0,
TCGA-AP-A0LS,10590,TCGA-AP-A0LS,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23126.0,Alive,TUMOR FREE,2904.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2904.0,0.0,2904.0,0.0,2904.0,0.0,2904.0,
TCGA-D7-6818,9501,TCGA-D7-6818,STAD,53.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-19391.0,Dead,WITH TUMOR,,376.0,[Not Available],Locoregional Recurrence,,,247.0,Progressive Disease,,,1.0,376.0,1.0,376.0,,,1.0,247.0,
TCGA-EK-A2RM,1739,TCGA-EK-A2RM,CESC,40.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2009.0,[Not Available],-14842.0,Alive,WITH TUMOR,50.0,,,,,,,[Not Available],,,0.0,50.0,0.0,50.0,,,0.0,50.0,
TCGA-BH-A0DD,1061,TCGA-BH-A0DD,BRCA,58.0,MALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,[Not Available],-21386.0,Alive,TUMOR FREE,2486.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2486.0,0.0,2486.0,0.0,2486.0,0.0,2486.0,
TCGA-50-5939,5946,TCGA-50-5939,LUAD,85.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-31236.0,Dead,TUMOR FREE,,460.0,[Not Available],,,,,Complete Remission/Response,,,1.0,460.0,0.0,460.0,0.0,460.0,0.0,460.0,
TCGA-QC-A6FX,8742,TCGA-QC-A6FX,SARC,68.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013.0,[Not Available],-25113.0,Alive,TUMOR FREE,637.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,637.0,0.0,637.0,0.0,637.0,0.0,637.0,
TCGA-YS-A95B,6906,TCGA-YS-A95B,MESO,28.0,FEMALE,WHITE,Stage IV,[Not Applicable],Epithelioid mesothelioma,[Not Available],2009.0,[Not Available],-10510.0,Dead,WITH TUMOR,,39.0,[Not Available],,,,,[Not Available],,R2,1.0,39.0,1.0,39.0,,,1.0,39.0,
TCGA-BA-5555,3252,TCGA-BA-5555,HNSC,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-19956.0,Alive,TUMOR FREE,520.0,,[Not Available],,Oropharynx,L tonsil,248.0,Complete Remission/Response,,,0.0,520.0,0.0,520.0,,,1.0,248.0,
TCGA-TS-A8AI,6889,TCGA-TS-A8AI,MESO,58.0,MALE,WHITE,Stage IV,[Not Applicable],Epithelioid mesothelioma,[Not Available],2009.0,[Not Available],-21323.0,Dead,,,328.0,[Not Available],,,,,[Not Available],,[Unknown],1.0,328.0,,328.0,,,0.0,328.0,
TCGA-19-5953,3092,TCGA-19-5953,GBM,58.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-21204.0,Dead,WITH TUMOR,144.0,144.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],119.0,[Not Available],,,1.0,144.0,1.0,144.0,,,1.0,119.0,
TCGA-VT-AB3D,8770,TCGA-VT-AB3D,SARC,71.0,MALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013.0,[Not Available],-26100.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-B6-A0WZ,1007,TCGA-B6-A0WZ,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996.0,Indeterminate (neither Pre or Postmenopausal),-18584.0,Alive,TUMOR FREE,6292.0,,[Not Available],New Primary Tumor,Bone,,5117.0,[Not Available],Negative,,0.0,6292.0,0.0,6292.0,0.0,6292.0,1.0,5117.0,
TCGA-2A-AAYU,7876,TCGA-2A-AAYU,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20582.0,Alive,TUMOR FREE,615.0,,[Not Available],,,,,[Discrepancy],,,0.0,615.0,0.0,615.0,,,0.0,615.0,
TCGA-DD-A1EL,5536,TCGA-DD-A1EL,LIHC,23.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2009.0,[Not Available],-8573.0,Dead,WITH TUMOR,,415.0,[Not Available],,,,,[Not Available],,R0,1.0,415.0,1.0,415.0,,,1.0,415.0,
TCGA-ZF-A9R1,474,TCGA-ZF-A9R1,BLCA,81.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-29610.0,Alive,WITH TUMOR,773.0,,[Not Available],Distant Metastasis,Bone,,758.0,Complete Remission/Response,,,0.0,773.0,0.0,773.0,,,1.0,758.0,
TCGA-QK-A8ZB,3735,TCGA-QK-A8ZB,HNSC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-25192.0,Alive,TUMOR FREE,542.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,542.0,0.0,542.0,,,0.0,542.0,
TCGA-5L-AAT0,510,TCGA-5L-AAT0,BRCA,42.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15393.0,Alive,TUMOR FREE,1477.0,,[Not Available],,,,,[Not Available],Positive,,0.0,1477.0,0.0,1477.0,,,0.0,1477.0,
TCGA-N6-A4V9,11038,TCGA-N6-A4V9,UCS,59.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2011.0,[Unknown],-21677.0,Alive,TUMOR FREE,979.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,979.0,0.0,979.0,0.0,979.0,0.0,979.0,
TCGA-BH-A0EA,1082,TCGA-BH-A0EA,BRCA,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26548.0,Dead,TUMOR FREE,,991.0,[Not Available],,,,,[Not Available],Negative,,1.0,991.0,0.0,991.0,0.0,991.0,0.0,991.0,
TCGA-N5-A4RV,11035,TCGA-N5-A4RV,UCS,62.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22978.0,Alive,TUMOR FREE,2042.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2042.0,0.0,2042.0,0.0,2042.0,0.0,2042.0,
TCGA-OR-A5JU,29,TCGA-OR-A5JU,ACC,58.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-21292.0,Dead,WITH TUMOR,,289.0,[Not Available],Distant Metastasis,"Other, specify",Ovarian,268.0,Progressive Disease,,,1.0,289.0,1.0,289.0,,,1.0,268.0,
TCGA-2H-A9GL,2467,TCGA-2H-A9GL,ESCA,74.0,MALE,[Unknown],Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2000.0,[Not Available],-27115.0,Dead,WITH TUMOR,,180.0,[Not Available],Distant Metastasis,,,109.0,,,,1.0,180.0,1.0,180.0,,,1.0,109.0,
TCGA-X7-A8D7,10385,TCGA-X7-A8D7,THYM,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],IIa,Thymoma; Type B1,[Not Available],2003.0,[Not Available],-17161.0,Alive,TUMOR FREE,325.0,,[Not Available],New Primary Tumor,Lung,,265.0,[Not Available],,,0.0,325.0,0.0,325.0,,,1.0,265.0,
TCGA-ED-A7XO,5674,TCGA-ED-A7XO,LIHC,29.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-10828.0,Alive,WITH TUMOR,427.0,,[Not Available],Locoregional Recurrence,Liver,,262.0,[Not Available],,R0,0.0,427.0,0.0,427.0,1.0,262.0,1.0,262.0,
TCGA-D5-6922,2315,TCGA-D5-6922,COAD,76.0,MALE,WHITE,Stage IIIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-27771.0,Alive,TUMOR FREE,308.0,,[Not Available],,,,,[Not Available],,,0.0,308.0,0.0,308.0,,,0.0,308.0,
TCGA-76-4925,3211,TCGA-76-4925,GBM,76.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-28011.0,Dead,,146.0,146.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],88.0,[Not Available],,,1.0,146.0,,146.0,,,1.0,88.0,
TCGA-IN-A6RR,9602,TCGA-IN-A6RR,STAD,84.0,MALE,WHITE,[Discrepancy],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,[Not Available],-30734.0,Dead,TUMOR FREE,,205.0,[Not Available],,,,,[Unknown],,,1.0,205.0,0.0,205.0,,,0.0,205.0,
TCGA-97-A4M1,6266,TCGA-97-A4M1,LUAD,52.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-19272.0,Alive,TUMOR FREE,601.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,601.0,0.0,601.0,0.0,601.0,0.0,601.0,
TCGA-CE-A481,9899,TCGA-CE-A481,THCA,41.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-15268.0,Alive,TUMOR FREE,346.0,,[Not Available],,,,,[Not Available],,R0,0.0,346.0,0.0,346.0,0.0,346.0,0.0,346.0,
TCGA-DX-AB2Q,8660,TCGA-DX-AB2Q,SARC,65.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2009.0,[Not Available],-23748.0,Alive,TUMOR FREE,2030.0,,[Not Available],Distant Metastasis,"Other, specify",inguinal lymph node,490.0,[Not Available],Negative,R0,0.0,2030.0,0.0,2030.0,1.0,490.0,1.0,490.0,
TCGA-BC-A10W,5462,TCGA-BC-A10W,LIHC,50.0,MALE,ASIAN,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G3,2002.0,[Not Available],-18562.0,Dead,WITH TUMOR,,91.0,[Not Available],,,,,[Not Available],,R1,1.0,91.0,1.0,91.0,,,1.0,91.0,
TCGA-55-6968,5975,TCGA-55-6968,LUAD,61.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],-22344.0,Dead,WITH TUMOR,,1293.0,[Not Available],,,,,Stable Disease,,,1.0,1293.0,1.0,1293.0,,,1.0,1293.0,
TCGA-49-AAR2,5922,TCGA-49-AAR2,LUAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-23479.0,Alive,TUMOR FREE,2224.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2224.0,0.0,2224.0,0.0,2224.0,0.0,2224.0,
TCGA-AZ-6608,2233,TCGA-AZ-6608,COAD,55.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-20094.0,Dead,[Discrepancy],,59.0,[Not Available],,,,,Progressive Disease,,,1.0,59.0,,59.0,,,0.0,59.0,
TCGA-EE-A3AA,9068,TCGA-EE-A3AA,SKCM,47.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2001.0,[Not Available],-17196.0,Alive,TUMOR FREE,3781.0,,[Not Available],,,,,[Not Available],,,0.0,3781.0,0.0,3781.0,,,0.0,3781.0,
TCGA-HD-A4C1,3673,TCGA-HD-A4C1,HNSC,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-15096.0,Alive,,11.0,,[Not Available],,,,,[Not Applicable],,,0.0,11.0,0.0,11.0,,,0.0,11.0,
TCGA-DK-A1AC,186,TCGA-DK-A1AC,BLCA,72.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2000.0,[Not Available],-26307.0,Alive,TUMOR FREE,3981.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3981.0,0.0,3981.0,0.0,3981.0,0.0,3981.0,
TCGA-W4-A7U4,9800,TCGA-W4-A7U4,TGCT,23.0,MALE,WHITE,[Not Available],Stage I,Non-Seminoma; Embryonal Carcinoma|[Not Available],[Not Available],2011.0,[Not Available],-8518.0,Alive,TUMOR FREE,738.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,738.0,0.0,738.0,0.0,738.0,0.0,738.0,
TCGA-EV-5902,4587,TCGA-EV-5902,KIRP,58.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-21344.0,Alive,TUMOR FREE,578.0,,[Not Available],,,,,[Not Available],,,0.0,578.0,0.0,578.0,,,0.0,578.0,
TCGA-CD-A48C,9439,TCGA-CD-A48C,STAD,79.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-29203.0,Dead,WITH TUMOR,,353.0,[Not Available],Locoregional Recurrence,,,230.0,Complete Remission/Response,,,1.0,353.0,1.0,353.0,1.0,230.0,1.0,230.0,
TCGA-EO-A3KX,10939,TCGA-EO-A3KX,UCEC,80.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29260.0,Alive,TUMOR FREE,1170.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1170.0,0.0,1170.0,0.0,1170.0,0.0,1170.0,
TCGA-DJ-A3VF,9994,TCGA-DJ-A3VF,THCA,60.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-22234.0,Alive,TUMOR FREE,292.0,,[Not Available],,,,,[Not Available],,R0,0.0,292.0,0.0,292.0,,,0.0,292.0,
TCGA-GL-A9DE,4617,TCGA-GL-A9DE,KIRP,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-27330.0,Alive,TUMOR FREE,496.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,
TCGA-DD-AAVU,5655,TCGA-DD-AAVU,LIHC,46.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-16889.0,Alive,TUMOR FREE,2202.0,,[Not Available],Intrahepatic Recurrence,Liver,,1630.0,[Not Available],,R0,0.0,2202.0,0.0,2202.0,1.0,1630.0,1.0,1630.0,
TCGA-MP-A5C7,6313,TCGA-MP-A5C7,LUAD,76.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-28015.0,Alive,TUMOR FREE,2248.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2248.0,0.0,2248.0,0.0,2248.0,0.0,2248.0,
TCGA-ZC-AAAF,10472,TCGA-ZC-AAAF,THYM,74.0,FEMALE,WHITE,[Not Applicable],IIb,Thymoma; Type AB,[Not Available],2011.0,[Not Available],-27099.0,Alive,TUMOR FREE,1165.0,,[Not Available],,,,,[Not Available],,,0.0,1165.0,0.0,1165.0,,,0.0,1165.0,
TCGA-B0-5400,4046,TCGA-B0-5400,KIRC,59.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2008.0,[Not Available],-21819.0,Alive,TUMOR FREE,1733.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1733.0,0.0,1733.0,0.0,1733.0,0.0,1733.0,
TCGA-BJ-A2N9,9876,TCGA-BJ-A2N9,THCA,42.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-15411.0,Alive,WITH TUMOR,623.0,,[Not Available],Distant Metastasis,,,225.0,[Not Available],,R1,0.0,623.0,0.0,623.0,,,1.0,225.0,
TCGA-CF-A47W,160,TCGA-CF-A47W,BLCA,42.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,[Not Available],-15497.0,Alive,TUMOR FREE,368.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,368.0,0.0,368.0,0.0,368.0,0.0,368.0,
TCGA-B6-A0X5,1011,TCGA-B6-A0X5,BRCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22380.0,Dead,WITH TUMOR,,2097.0,[Not Available],Distant Metastasis,"Other, specify",Liver and Pleura and Bone,1343.0,[Not Available],Negative,,1.0,2097.0,1.0,2097.0,1.0,1343.0,1.0,1343.0,
TCGA-A6-3809,1978,TCGA-A6-3809,COAD,71.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2009.0,[Not Available],-26274.0,Alive,TUMOR FREE,996.0,,[Not Available],,,,,[Not Available],,,0.0,996.0,0.0,996.0,,,0.0,996.0,
TCGA-UC-A7PG,1834,TCGA-UC-A7PG,CESC,44.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G1,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16231.0,Dead,WITH TUMOR,,370.0,Cervical Cancer,,,,,Progressive Disease,,,1.0,370.0,1.0,370.0,,,1.0,370.0,
TCGA-GN-A4U8,9207,TCGA-GN-A4U8,SKCM,51.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2009.0,[Not Available],-18953.0,Alive,TUMOR FREE,1487.0,,[Not Available],,,,,[Not Available],,,0.0,1487.0,0.0,1487.0,,,0.0,1487.0,
TCGA-ET-A3BV,10237,TCGA-ET-A3BV,THCA,47.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-17441.0,Alive,TUMOR FREE,2294.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,1204.0,[Not Available],,R0,0.0,2294.0,0.0,2294.0,1.0,1204.0,1.0,1204.0,
TCGA-NH-A6GC,2400,TCGA-NH-A6GC,COAD,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVB,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2013.0,[Not Available],-24355.0,Alive,,389.0,,[Not Available],,,,,[Unknown],,,0.0,389.0,0.0,389.0,,,0.0,389.0,
TCGA-D3-A5GL,8876,TCGA-D3-A5GL,SKCM,74.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2003.0,[Not Available],-27095.0,Alive,TUMOR FREE,3826.0,,[Not Available],Distant Metastasis,"Other, Specify",Large Intestine,1092.0,[Not Available],,,0.0,3826.0,0.0,3826.0,,,1.0,1092.0,
TCGA-FY-A3NN,10284,TCGA-FY-A3NN,THCA,48.0,FEMALE,[Not Available],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-17613.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-BK-A139,10782,TCGA-BK-A139,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27077.0,Dead,WITH TUMOR,,943.0,[Not Available],Locoregional Recurrence,"Other, specify",Paravaginal mass involving the bladder and rectal walls,684.0,[Discrepancy],,,1.0,943.0,1.0,943.0,,,1.0,684.0,
TCGA-AR-A5QP,966,TCGA-AR-A5QP,BRCA,54.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19805.0,Alive,TUMOR FREE,1185.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,1185.0,0.0,1185.0,,,0.0,1185.0,
TCGA-G9-A9S7,8057,TCGA-G9-A9S7,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20213.0,Alive,WITH TUMOR,728.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,728.0,0.0,728.0,,,0.0,728.0,
TCGA-KB-A93H,9613,TCGA-KB-A93H,STAD,79.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G1,2011.0,[Not Available],-28966.0,Alive,TUMOR FREE,1145.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1145.0,0.0,1145.0,0.0,1145.0,0.0,1145.0,
TCGA-C5-A7X3,1655,TCGA-C5-A7X3,CESC,70.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,1997.0,[Not Available],-25665.0,Dead,TUMOR FREE,,284.0,,,,,,[Not Available],,,1.0,284.0,0.0,284.0,,,0.0,284.0,
TCGA-UZ-A9PJ,4683,TCGA-UZ-A9PJ,KIRP,78.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-28490.0,Dead,,,797.0,[Not Available],,,,,Complete Remission/Response,,,1.0,797.0,,797.0,0.0,797.0,0.0,797.0,
TCGA-2G-AAFE,9717,TCGA-2G-AAFE,TGCT,37.0,MALE,WHITE,Stage IIA,Stage IIA,Seminoma; NOS,[Not Available],2001.0,[Not Available],-13845.0,Alive,TUMOR FREE,4702.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,617.0,Complete Remission/Response,,,0.0,4702.0,0.0,4702.0,1.0,617.0,1.0,617.0,
TCGA-EM-A2CN,10143,TCGA-EM-A2CN,THCA,62.0,MALE,[Not Available],Stage IVC,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-22817.0,Alive,WITH TUMOR,715.0,,[Not Available],,,,,[Not Available],,R0,0.0,715.0,0.0,715.0,,,0.0,715.0,
TCGA-TK-A8OK,8233,TCGA-TK-A8OK,PRAD,73.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-26976.0,Alive,TUMOR FREE,27.0,,[Not Available],,,,,[Unknown],,,0.0,27.0,0.0,27.0,,,0.0,27.0,
TCGA-CR-7371,3444,TCGA-CR-7371,HNSC,45.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-16568.0,Dead,,,94.0,[Not Available],,,,,[Not Available],,,1.0,94.0,,94.0,,,0.0,94.0,
TCGA-BB-4224,3281,TCGA-BB-4224,HNSC,52.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2004.0,[Not Available],-19119.0,Alive,WITH TUMOR,278.0,,[Not Available],,Oral Cavity,,175.0,Progressive Disease,,,0.0,278.0,0.0,278.0,,,1.0,175.0,
TCGA-F7-A61W,3652,TCGA-F7-A61W,HNSC,51.0,MALE,ASIAN,Stage IVA,[Not Available],Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-18879.0,Alive,TUMOR FREE,14.0,,[Not Available],,,,,[Unknown],,,0.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-Y6-A9XI,8314,TCGA-Y6-A9XI,PRAD,72.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-26471.0,Alive,TUMOR FREE,526.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,
TCGA-DU-5870,4987,TCGA-DU-5870,LGG,34.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1995.0,[Not Available],-12764.0,Alive,WITH TUMOR,5546.0,,[Not Available],,,,4347.0,Progressive Disease,,,0.0,5546.0,0.0,5546.0,,,1.0,4347.0,
TCGA-D3-A1Q6,8829,TCGA-D3-A1Q6,SKCM,55.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2003.0,[Not Available],-20230.0,Dead,TUMOR FREE,,2184.0,[Not Available],Regional lymph node,,,48.0,[Not Available],,,1.0,2184.0,0.0,2184.0,,,1.0,48.0,
TCGA-22-4596,6374,TCGA-22-4596,LUSC,69.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-25448.0,Dead,TUMOR FREE,17.0,17.0,[Not Available],,,,,[Not Available],,,1.0,17.0,0.0,17.0,,,0.0,17.0,
TCGA-EM-A4FH,10191,TCGA-EM-A4FH,THCA,69.0,MALE,[Unknown],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-25500.0,Alive,TUMOR FREE,892.0,,[Not Available],,,,,[Not Available],,R0,0.0,892.0,0.0,892.0,0.0,892.0,0.0,892.0,
TCGA-DI-A1BU,10902,TCGA-DI-A1BU,UCEC,55.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Mixed serous and endometrioid,G3,2008.0,[Not Available],-20114.0,Alive,TUMOR FREE,1195.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1195.0,0.0,1195.0,0.0,1195.0,0.0,1195.0,
TCGA-02-2483,2736,TCGA-02-2483,GBM,43.0,MALE,ASIAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-15964.0,Alive,WITH TUMOR,466.0,,[Not Available],,,,,[Not Available],,,0.0,466.0,0.0,466.0,,,0.0,466.0,
TCGA-D1-A17K,10865,TCGA-D1-A17K,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27283.0,Alive,TUMOR FREE,854.0,,[Not Available],Locoregional Disease,"Other, specify","Vagina, apex",815.0,Complete Remission/Response,,,0.0,854.0,0.0,854.0,1.0,815.0,1.0,815.0,
TCGA-06-5414,2868,TCGA-06-5414,GBM,61.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-22527.0,Alive,WITH TUMOR,273.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],167.0,[Not Available],,,0.0,273.0,0.0,273.0,,,1.0,167.0,
TCGA-QU-A6IP,8231,TCGA-QU-A6IP,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2004.0,[Not Available],-24212.0,Alive,TUMOR FREE,2620.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2620.0,0.0,2620.0,0.0,2620.0,0.0,2620.0,
TCGA-BQ-5888,4548,TCGA-BQ-5888,KIRP,74.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-27346.0,Alive,TUMOR FREE,403.0,,[Not Available],,,,,[Not Available],,,0.0,403.0,0.0,403.0,,,0.0,403.0,
TCGA-D3-A8GC,8884,TCGA-D3-A8GC,SKCM,48.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2000.0,[Not Available],-17668.0,Dead,WITH TUMOR,,2421.0,[Not Available],Distant Metastasis,"Other, Specify",Supraclavicular lymph nodes,1859.0,[Not Available],,,1.0,2421.0,1.0,2421.0,,,1.0,1859.0,
TCGA-64-5781,6084,TCGA-64-5781,LUAD,55.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-20219.0,Alive,TUMOR FREE,1559.0,,[Not Available],,,,96.0,Progressive Disease,,,0.0,1559.0,0.0,1559.0,,,1.0,96.0,
TCGA-BF-A1PZ,8804,TCGA-BF-A1PZ,SKCM,71.0,FEMALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2010.0,[Not Available],-26240.0,Alive,TUMOR FREE,853.0,,[Not Available],,,,,[Not Available],,,0.0,853.0,0.0,853.0,,,0.0,853.0,
TCGA-BF-A1Q0,8805,TCGA-BF-A1Q0,SKCM,80.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2010.0,[Not Available],-29380.0,Alive,TUMOR FREE,831.0,,[Not Available],,,,,[Not Available],,,0.0,831.0,0.0,831.0,,,0.0,831.0,
TCGA-70-6723,6657,TCGA-70-6723,LUSC,65.0,MALE,ASIAN,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-24035.0,Alive,WITH TUMOR,375.0,,[Not Available],Locoregional Recurrence,,,312.0,Progressive Disease,,,0.0,375.0,0.0,375.0,,,1.0,312.0,
TCGA-WB-A81D,7846,TCGA-WB-A81D,PCPG,82.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-30101.0,Alive,TUMOR FREE,1090.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1090.0,0.0,1090.0,0.0,1090.0,0.0,1090.0,
TCGA-06-A5U1,2889,TCGA-06-A5U1,GBM,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2011.0,[Not Available],-28545.0,Dead,WITH TUMOR,,57.0,[Not Available],,,,,Progressive Disease,,,1.0,57.0,1.0,57.0,,,1.0,57.0,
TCGA-06-A6S1,2891,TCGA-06-A6S1,GBM,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2012.0,[Not Available],-19443.0,Dead,WITH TUMOR,,78.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],46.0,Progressive Disease,,,1.0,78.0,1.0,78.0,,,1.0,46.0,
TCGA-FE-A234,10261,TCGA-FE-A234,THCA,26.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-9724.0,Alive,WITH TUMOR,2075.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,483.0,[Not Available],,R0,0.0,2075.0,0.0,2075.0,1.0,483.0,1.0,483.0,
TCGA-55-8615,6042,TCGA-55-8615,LUAD,67.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-24786.0,Alive,WITH TUMOR,446.0,,[Not Available],Distant Metastasis,,,224.0,Complete Remission/Response,,,0.0,446.0,0.0,446.0,1.0,224.0,1.0,224.0,
TCGA-HE-A5NF,4621,TCGA-HE-A5NF,KIRP,58.0,MALE,[Not Evaluated],Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-21524.0,Alive,TUMOR FREE,2582.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2582.0,0.0,2582.0,0.0,2582.0,0.0,2582.0,
TCGA-QR-A70I,7727,TCGA-QR-A70I,PCPG,24.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Paraganglioma,[Not Available],2010.0,[Not Available],-9070.0,Alive,TUMOR FREE,910.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,910.0,0.0,910.0,0.0,910.0,0.0,910.0,
TCGA-41-5651,3200,TCGA-41-5651,GBM,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-21698.0,Dead,WITH TUMOR,,460.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],210.0,[Not Available],,,1.0,460.0,1.0,460.0,,,1.0,210.0,
TCGA-43-6143,6476,TCGA-43-6143,LUSC,70.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-25820.0,Alive,TUMOR FREE,699.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,699.0,0.0,699.0,0.0,699.0,0.0,699.0,
TCGA-QK-A6IJ,3727,TCGA-QK-A6IJ,HNSC,71.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-25966.0,Alive,TUMOR FREE,387.0,,[Not Available],,,,,[Unknown],,,0.0,387.0,0.0,387.0,,,0.0,387.0,
TCGA-BH-A0BL,1046,TCGA-BH-A0BL,BRCA,35.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12841.0,Alive,TUMOR FREE,2278.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2278.0,0.0,2278.0,0.0,2278.0,0.0,2278.0,
TCGA-55-6980,5983,TCGA-55-6980,LUAD,56.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],,Alive,TUMOR FREE,2109.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2109.0,0.0,2109.0,0.0,2109.0,0.0,2109.0,
TCGA-PL-A8LX,1579,TCGA-PL-A8LX,BRCA,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12840.0,Alive,WITH TUMOR,5.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,5.0,0.0,5.0,,,0.0,5.0,
TCGA-ZJ-A8QR,1894,TCGA-ZJ-A8QR,CESC,38.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Available],Stage I,Cervical Squamous Cell Carcinoma,GX,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14225.0,Dead,,,582.0,,,,,,[Unknown],,,1.0,582.0,,582.0,,,0.0,582.0,
TCGA-A4-7286,4464,TCGA-A4-7286,KIRP,42.0,MALE,WHITE,[Not Available],Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-15631.0,Alive,TUMOR FREE,554.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,
TCGA-BA-A6DA,3269,TCGA-BA-A6DA,HNSC,41.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-15004.0,Alive,TUMOR FREE,351.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,351.0,0.0,351.0,,,0.0,351.0,
TCGA-EY-A54A,10979,TCGA-EY-A54A,UCEC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24822.0,Alive,TUMOR FREE,447.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,447.0,0.0,447.0,0.0,447.0,0.0,447.0,
TCGA-D1-A16Q,10848,TCGA-D1-A16Q,UCEC,54.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19873.0,Alive,TUMOR FREE,324.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,324.0,0.0,324.0,0.0,324.0,0.0,324.0,
TCGA-ZP-A9D1,5796,TCGA-ZP-A9D1,LIHC,56.0,FEMALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-20584.0,Alive,TUMOR FREE,21.0,,[Not Available],,,,,[Not Available],,R0,0.0,21.0,0.0,21.0,0.0,21.0,0.0,21.0,
TCGA-E9-A248,1438,TCGA-E9-A248,BRCA,51.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Peri (6-12 months since last menstrual period),-18684.0,Alive,TUMOR FREE,59.0,,[Not Available],,,,,[Not Available],Negative,,0.0,59.0,0.0,59.0,0.0,59.0,0.0,59.0,
TCGA-19-1390,3070,TCGA-19-1390,GBM,63.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-23063.0,Dead,,772.0,772.0,[Not Available],,,,,[Not Available],,,1.0,772.0,,772.0,,,0.0,772.0,
TCGA-KK-A8IB,8207,TCGA-KK-A8IB,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24041.0,Alive,,83.0,,[Not Available],,,,,[Unknown],,,0.0,83.0,0.0,83.0,,,0.0,83.0,
TCGA-D8-A3Z6,1298,TCGA-D8-A3Z6,BRCA,56.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20629.0,Alive,TUMOR FREE,563.0,,[Not Available],,,,,[Not Available],Negative,,0.0,563.0,0.0,563.0,0.0,563.0,0.0,563.0,
TCGA-2Z-A9JT,4443,TCGA-2Z-A9JT,KIRP,71.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-26128.0,Alive,TUMOR FREE,684.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,684.0,0.0,684.0,0.0,684.0,0.0,684.0,
TCGA-5P-A9KC,4460,TCGA-5P-A9KC,KIRP,51.0,FEMALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-18975.0,Alive,TUMOR FREE,377.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,377.0,0.0,377.0,0.0,377.0,0.0,377.0,
TCGA-V1-A8WL,8243,TCGA-V1-A8WL,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-23725.0,Alive,,1948.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1948.0,0.0,1948.0,0.0,1948.0,0.0,1948.0,
TCGA-BF-A5EP,8811,TCGA-BF-A5EP,SKCM,75.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-27622.0,Alive,TUMOR FREE,335.0,,[Not Available],,,,,[Not Available],,,0.0,335.0,0.0,335.0,,,0.0,335.0,
TCGA-A6-6138,1993,TCGA-A6-6138,COAD,61.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-22523.0,Alive,TUMOR FREE,685.0,,[Not Available],,,,,[Not Available],,,0.0,685.0,0.0,685.0,,,0.0,685.0,
TCGA-62-A46U,6068,TCGA-62-A46U,LUAD,71.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-25998.0,Alive,TUMOR FREE,2067.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2067.0,0.0,2067.0,0.0,2067.0,0.0,2067.0,
TCGA-34-5241,6430,TCGA-34-5241,LUSC,79.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-29098.0,Dead,TUMOR FREE,,515.0,[Not Available],,,,,Stable Disease,,,1.0,515.0,0.0,515.0,,,0.0,515.0,
TCGA-A6-5661,1986,TCGA-A6-5661,COAD,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-29446.0,Alive,TUMOR FREE,1020.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1020.0,0.0,1020.0,0.0,1020.0,0.0,1020.0,
TCGA-CF-A47T,158,TCGA-CF-A47T,BLCA,58.0,FEMALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,[Not Available],-21347.0,Dead,WITH TUMOR,,385.0,[Not Available],Distant Metastasis,Bone,,139.0,Complete Remission/Response,,,1.0,385.0,1.0,385.0,1.0,139.0,1.0,139.0,
TCGA-KK-A8IG,8211,TCGA-KK-A8IG,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-20266.0,Alive,TUMOR FREE,2505.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2505.0,0.0,2505.0,0.0,2505.0,0.0,2505.0,
TCGA-D1-A15Z,10830,TCGA-D1-A15Z,UCEC,72.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26638.0,Dead,TUMOR FREE,,58.0,[Not Available],,,,,Complete Remission/Response,,,1.0,58.0,0.0,58.0,0.0,58.0,0.0,58.0,
TCGA-E9-A1NA,1399,TCGA-E9-A1NA,BRCA,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21397.0,Alive,TUMOR FREE,1112.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0,
TCGA-FD-A5BY,287,TCGA-FD-A5BY,BLCA,63.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-23080.0,Alive,TUMOR FREE,251.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,251.0,0.0,251.0,0.0,251.0,0.0,251.0,
TCGA-86-8674,6206,TCGA-86-8674,LUAD,50.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-18479.0,Alive,TUMOR FREE,806.0,,[Not Available],Locoregional Recurrence,,,334.0,Complete Remission/Response,,,0.0,806.0,0.0,806.0,1.0,334.0,1.0,334.0,
TCGA-2J-AABU,7518,TCGA-2J-AABU,PAAD,56.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,[Not Available],-20641.0,Dead,WITH TUMOR,,277.0,Pancreatic Cancer,Distant Metastasis,Liver,,154.0,Progressive Disease,,,1.0,277.0,1.0,277.0,,,1.0,154.0,
TCGA-CV-A6K2,3604,TCGA-CV-A6K2,HNSC,79.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-29114.0,Dead,WITH TUMOR,,317.0,[Not Available],Locoregional Recurrence,,Infratemporal fossa,134.0,Progressive Disease,,,1.0,317.0,1.0,317.0,,,1.0,134.0,
TCGA-EE-A185,9000,TCGA-EE-A185,SKCM,55.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-20235.0,Dead,WITH TUMOR,,151.0,[Not Available],Regional lymph node,,,85.0,[Not Available],,,1.0,151.0,1.0,151.0,,,1.0,85.0,
TCGA-2G-AAGY,9753,TCGA-2G-AAGY,TGCT,28.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma,[Not Available],2000.0,[Not Available],-10338.0,Alive,TUMOR FREE,5329.0,,[Not Applicable],New Primary Tumor,Testes,,623.0,Complete Remission/Response,,,0.0,5329.0,0.0,5329.0,1.0,623.0,1.0,623.0,
TCGA-FK-A3SH,10277,TCGA-FK-A3SH,THCA,50.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-18609.0,Alive,TUMOR FREE,1463.0,,[Not Available],,,,,[Not Available],,R0,0.0,1463.0,0.0,1463.0,0.0,1463.0,0.0,1463.0,
TCGA-EZ-7264,5095,TCGA-EZ-7264,LGG,47.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-17432.0,Alive,WITH TUMOR,1201.0,,[Not Available],,,,,Stable Disease,,,0.0,1201.0,0.0,1201.0,,,0.0,1201.0,
TCGA-MJ-A850,8731,TCGA-MJ-A850,SARC,28.0,MALE,WHITE,[Not Available],[Not Available],Synovial Sarcoma - Monophasic,[Not Available],2013.0,[Not Available],-10451.0,Alive,TUMOR FREE,681.0,,[Not Available],,,,,[Not Available],[Not Available],RX,0.0,681.0,0.0,681.0,,,0.0,681.0,
TCGA-IK-8125,5260,TCGA-IK-8125,LGG,62.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2009.0,[Not Available],-22745.0,Alive,TUMOR FREE,1301.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0,
TCGA-E2-A1IN,1367,TCGA-E2-A1IN,BRCA,60.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199.0,Alive,TUMOR FREE,675.0,,[Not Available],,,,,[Not Available],Negative,,0.0,675.0,0.0,675.0,0.0,675.0,0.0,675.0,
TCGA-3G-AB0Q,10353,TCGA-3G-AB0Q,THYM,66.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type A,[Not Available],2009.0,[Not Available],-24460.0,Alive,TUMOR FREE,1799.0,,[Not Available],,,,,[Not Available],,,0.0,1799.0,0.0,1799.0,,,0.0,1799.0,
TCGA-D5-6532,2303,TCGA-D5-6532,COAD,61.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-22344.0,Alive,TUMOR FREE,555.0,,[Not Available],,,,,[Not Available],,,0.0,555.0,0.0,555.0,,,0.0,555.0,
TCGA-D8-A4Z1,1299,TCGA-D8-A4Z1,BRCA,68.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25097.0,Alive,TUMOR FREE,659.0,,[Not Available],,,,,[Not Available],Negative,,0.0,659.0,0.0,659.0,0.0,659.0,0.0,659.0,
TCGA-2Y-A9H5,5440,TCGA-2Y-A9H5,LIHC,59.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-21818.0,Dead,WITH TUMOR,,555.0,[Not Available],Locoregional Recurrence,Liver,,258.0,[Not Available],,R0,1.0,555.0,1.0,555.0,1.0,258.0,1.0,258.0,
TCGA-O8-A75V,5758,TCGA-O8-A75V,LIHC,54.0,MALE,[Unknown],Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-19850.0,Alive,TUMOR FREE,538.0,,[Not Available],,,,,[Not Available],,R1,0.0,538.0,0.0,538.0,,,0.0,538.0,
TCGA-CH-5763,7895,TCGA-CH-5763,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-24380.0,Alive,TUMOR FREE,365.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,
TCGA-DU-6399,4997,TCGA-DU-6399,LGG,54.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1998.0,[Not Available],-19906.0,Dead,WITH TUMOR,,2000.0,[Not Available],,,,1629.0,Progressive Disease,,,1.0,2000.0,1.0,2000.0,,,1.0,1629.0,
TCGA-CH-5768,7900,TCGA-CH-5768,PRAD,72.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-26480.0,Alive,TUMOR FREE,731.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,731.0,0.0,731.0,0.0,731.0,0.0,731.0,
TCGA-EK-A2GZ,1718,TCGA-EK-A2GZ,CESC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23599.0,Alive,WITH TUMOR,383.0,,,,,,,[Not Available],,,0.0,383.0,0.0,383.0,,,0.0,383.0,
TCGA-XM-A8RH,10413,TCGA-XM-A8RH,THYM,60.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type B1,[Not Available],2013.0,[Not Available],-21931.0,Alive,TUMOR FREE,363.0,,[Not Available],,,,,[Not Available],,,0.0,363.0,0.0,363.0,,,0.0,363.0,
TCGA-DX-A240,8571,TCGA-DX-A240,SARC,51.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2006.0,[Not Available],-18721.0,Alive,TUMOR FREE,1834.0,,[Not Available],,,,,[Not Available],[Not Available],R0,0.0,1834.0,0.0,1834.0,0.0,1834.0,0.0,1834.0,
TCGA-DU-7007,5010,TCGA-DU-7007,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,1997.0,[Not Available],-12245.0,Dead,,,1915.0,[Not Available],,,,,[Not Available],,,1.0,1915.0,,1915.0,,,0.0,1915.0,
TCGA-E3-A3E2,10018,TCGA-E3-A3E2,THCA,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2007.0,[Not Available],-12714.0,Alive,TUMOR FREE,1922.0,,[Not Available],,,,,[Not Available],,R0,0.0,1922.0,0.0,1922.0,0.0,1922.0,0.0,1922.0,
TCGA-36-2548,7405,TCGA-36-2548,OV,57.0,FEMALE,[Not Available],[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-20897.0,Alive,WITH TUMOR,431.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],395.0,[Not Available],,,0.0,431.0,0.0,431.0,,,1.0,395.0,
TCGA-CN-6994,3352,TCGA-CN-6994,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-24778.0,Alive,TUMOR FREE,1183.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1183.0,0.0,1183.0,,,0.0,1183.0,
TCGA-G4-6625,2390,TCGA-G4-6625,COAD,77.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2004.0,[Not Available],-28163.0,Alive,TUMOR FREE,2792.0,,[Not Available],,,,2564.0,[Not Available],,,0.0,2792.0,0.0,2792.0,,,1.0,2564.0,
TCGA-FB-AAQ1,7566,TCGA-FB-AAQ1,PAAD,49.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-18172.0,Dead,WITH TUMOR,,123.0,,,,,,Stable Disease,,,1.0,123.0,1.0,123.0,,,1.0,123.0,
TCGA-5L-AAT1,511,TCGA-5L-AAT1,BRCA,63.0,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23225.0,Alive,WITH TUMOR,1471.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1471.0,0.0,1471.0,,,0.0,1471.0,
TCGA-ET-A3BO,10231,TCGA-ET-A3BO,THCA,44.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-16110.0,Alive,TUMOR FREE,1533.0,,[Not Available],,,,,[Not Available],,R1,0.0,1533.0,0.0,1533.0,,,0.0,1533.0,
TCGA-QR-A70H,7726,TCGA-QR-A70H,PCPG,36.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2007.0,[Not Available],-13314.0,Alive,TUMOR FREE,816.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,816.0,0.0,816.0,0.0,816.0,0.0,816.0,
TCGA-XU-A92U,10423,TCGA-XU-A92U,THYM,67.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2002.0,[Not Available],-24487.0,Alive,TUMOR FREE,4562.0,,[Not Available],,,,,[Not Available],,,0.0,4562.0,0.0,4562.0,,,0.0,4562.0,
TCGA-EL-A4K7,10114,TCGA-EL-A4K7,THCA,74.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-27306.0,Alive,TUMOR FREE,1251.0,,[Not Available],,,,,[Not Available],,R0,0.0,1251.0,0.0,1251.0,0.0,1251.0,0.0,1251.0,
TCGA-C8-A1HK,1203,TCGA-C8-A1HK,BRCA,53.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Peri (6-12 months since last menstrual period),,Alive,TUMOR FREE,366.0,,[Not Available],,,,,[Not Available],Negative,,0.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,
TCGA-OR-A5LL,75,TCGA-OR-A5LL,ACC,75.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2007.0,[Not Available],-27607.0,Dead,WITH TUMOR,,1613.0,[Not Available],Distant Metastasis,Liver,,213.0,Complete Remission/Response,,,1.0,1613.0,1.0,1613.0,1.0,213.0,1.0,213.0,
TCGA-VQ-A91Q,9678,TCGA-VQ-A91Q,STAD,61.0,MALE,[Unknown],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2009.0,[Not Available],-22303.0,Dead,WITH TUMOR,,633.0,Stomach Cancer,Locoregional Recurrence,,,551.0,Complete Remission/Response,,,1.0,633.0,1.0,633.0,,,1.0,551.0,
TCGA-66-2794,6645,TCGA-66-2794,LUSC,64.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-23710.0,Alive,TUMOR FREE,1645.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1645.0,0.0,1645.0,0.0,1645.0,0.0,1645.0,
TCGA-K7-AAU7,5741,TCGA-K7-AAU7,LIHC,61.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocholangiocarcinoma (Mixed),G2,2013.0,[Not Available],-22476.0,Alive,WITH TUMOR,359.0,,[Not Available],Intrahepatic Recurrence,Liver,,58.0,[Not Available],,RX,0.0,359.0,0.0,359.0,,,1.0,58.0,
TCGA-DB-5277,4936,TCGA-DB-5277,LGG,34.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2007.0,[Not Available],-12725.0,Dead,WITH TUMOR,,1547.0,[Not Available],,,,1156.0,Complete Remission/Response,,,1.0,1547.0,1.0,1547.0,1.0,1156.0,1.0,1156.0,
TCGA-32-1977,3169,TCGA-32-1977,GBM,63.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-23205.0,Alive,WITH TUMOR,3.0,,[Not Available],,,,,[Not Available],,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-ZF-A9R2,475,TCGA-ZF-A9R2,BLCA,75.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-27537.0,Alive,TUMOR FREE,642.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,642.0,0.0,642.0,0.0,642.0,0.0,642.0,
TCGA-ZS-A9CF,5801,TCGA-ZS-A9CF,LIHC,64.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-23510.0,Alive,TUMOR FREE,2412.0,,[Not Available],Intrahepatic Recurrence,Liver,,636.0,[Not Available],,R0,0.0,2412.0,0.0,2412.0,1.0,636.0,1.0,636.0,
TCGA-19-4065,3086,TCGA-19-4065,GBM,36.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-13257.0,Alive,WITH TUMOR,214.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],70.0,[Not Available],,,0.0,214.0,0.0,214.0,,,1.0,70.0,
TCGA-WH-A86K,5418,TCGA-WH-A86K,LGG,65.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-24055.0,Alive,WITH TUMOR,405.0,,[Not Available],,,,,Stable Disease,,,0.0,405.0,0.0,405.0,,,0.0,405.0,
TCGA-55-7911,6009,TCGA-55-7911,LUAD,70.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25746.0,Alive,TUMOR FREE,537.0,,[Not Available],New Primary Tumor,,,515.0,Complete Remission/Response,,,0.0,537.0,0.0,537.0,0.0,537.0,1.0,515.0,
TCGA-DM-A1HA,2337,TCGA-DM-A1HA,COAD,82.0,MALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2000.0,[Not Available],-30272.0,Alive,,4000.0,,[Not Available],,,,,[Not Available],,,0.0,4000.0,0.0,4000.0,,,0.0,4000.0,
TCGA-WB-A81E,7847,TCGA-WB-A81E,PCPG,47.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2011.0,[Not Available],-17407.0,Alive,WITH TUMOR,1476.0,,[Not Available],Locoregional Disease,Lymph Node(s),,887.0,Complete Remission/Response,,,0.0,1476.0,0.0,1476.0,1.0,887.0,1.0,887.0,
TCGA-V5-A7RB,2615,TCGA-V5-A7RB,ESCA,59.0,MALE,[Unknown],[Unknown],Stage IIB,"Esophagus Adenocarcinoma, NOS",GX,,[Not Available],-21654.0,Dead,TUMOR FREE,,161.0,[Not Available],,,,,[Not Available],,,1.0,161.0,0.0,161.0,,,0.0,161.0,
TCGA-BR-8590,9376,TCGA-BR-8590,STAD,62.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-22937.0,Dead,WITH TUMOR,,284.0,[Not Available],Distant Metastasis,Lung,,223.0,Complete Remission/Response,,,1.0,284.0,1.0,284.0,1.0,223.0,1.0,223.0,
TCGA-BA-4078,3247,TCGA-BA-4078,HNSC,83.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2003.0,[Not Available],-30480.0,Dead,WITH TUMOR,,276.0,[Not Available],,,,,[Not Available],,,1.0,276.0,1.0,276.0,,,1.0,276.0,
TCGA-16-1045,3051,TCGA-16-1045,GBM,49.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-18195.0,Dead,WITH TUMOR,883.0,883.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],654.0,[Not Available],,,1.0,883.0,1.0,883.0,,,1.0,654.0,
TCGA-12-3649,2989,TCGA-12-3649,GBM,76.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-27846.0,Dead,WITH TUMOR,351.0,463.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],351.0,[Not Available],,,1.0,463.0,1.0,463.0,,,1.0,351.0,
TCGA-D5-6540,2311,TCGA-D5-6540,COAD,66.0,MALE,WHITE,Stage I,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-24282.0,Alive,TUMOR FREE,491.0,,[Not Available],,,,,[Not Available],,,0.0,491.0,0.0,491.0,,,0.0,491.0,
TCGA-DB-A4XG,4948,TCGA-DB-A4XG,LGG,34.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2006.0,[Not Available],-12550.0,Alive,WITH TUMOR,2219.0,,[Not Available],,,,,Stable Disease,,,0.0,2219.0,0.0,2219.0,,,0.0,2219.0,
TCGA-YL-A8SI,8328,TCGA-YL-A8SI,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-25292.0,Alive,TUMOR FREE,1614.0,,[Not Available],Biochemical evidence of disease,,,1423.0,Complete Remission/Response,,,0.0,1614.0,0.0,1614.0,1.0,1423.0,1.0,1423.0,
TCGA-BR-4279,9287,TCGA-BR-4279,STAD,43.0,MALE,WHITE,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2009.0,[Not Available],-16065.0,Dead,,,291.0,[Not Available],,,,,[Not Available],,,1.0,291.0,,291.0,,,0.0,291.0,
TCGA-2G-AAEX,9712,TCGA-2G-AAEX,TGCT,38.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],2011.0,[Not Available],-13964.0,Alive,TUMOR FREE,1259.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,1259.0,0.0,1259.0,0.0,1259.0,0.0,1259.0,
TCGA-C5-A8XJ,1661,TCGA-C5-A8XJ,CESC,74.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-27087.0,Alive,TUMOR FREE,4467.0,,,,,,,[Not Available],,,0.0,4467.0,0.0,4467.0,,,0.0,4467.0,
TCGA-BT-A20J,124,TCGA-BT-A20J,BLCA,75.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,1999.0,[Not Available],-27646.0,Dead,WITH TUMOR,,579.0,[Not Available],Distant Metastasis,"Other, specify",Adrenal,254.0,Progressive Disease,,,1.0,579.0,1.0,579.0,,,1.0,254.0,
TCGA-FX-A76Y,8681,TCGA-FX-A76Y,SARC,49.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2013.0,[Not Available],-18181.0,Alive,TUMOR FREE,471.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,471.0,0.0,471.0,0.0,471.0,0.0,471.0,
TCGA-IB-7887,7628,TCGA-IB-7887,PAAD,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2009.0,[Not Available],-22990.0,Dead,,,110.0,Pancreatic Cancer,,,,,[Unknown],,,1.0,110.0,1.0,110.0,,,0.0,110.0,
TCGA-AR-A251,949,TCGA-AR-A251,BRCA,51.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18771.0,Alive,TUMOR FREE,3030.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3030.0,0.0,3030.0,0.0,3030.0,0.0,3030.0,
TCGA-G3-A7M6,5720,TCGA-G3-A7M6,LIHC,60.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-22205.0,Alive,WITH TUMOR,632.0,,[Not Available],Locoregional Recurrence,Liver,,293.0,[Not Available],,R0,0.0,632.0,0.0,632.0,1.0,293.0,1.0,293.0,
TCGA-XD-AAUI,7680,TCGA-XD-AAUI,PAAD,50.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-18607.0,Dead,WITH TUMOR,,366.0,Pancreatic Cancer,Distant Metastasis,Liver,,175.0,Progressive Disease,,,1.0,366.0,1.0,366.0,,,1.0,175.0,
TCGA-OE-A75W,7662,TCGA-OE-A75W,PAAD,75.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,[Not Available],-27684.0,Dead,,,267.0,,Distant Metastasis,Liver,,146.0,Progressive Disease,,,1.0,267.0,,267.0,,,1.0,146.0,
TCGA-DX-A6BG,8610,TCGA-DX-A6BG,SARC,51.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2012.0,[Not Available],-18682.0,Alive,WITH TUMOR,1121.0,,[Not Available],Locoregional Recurrence,,,149.0,[Not Available],Negative,R0,0.0,1121.0,0.0,1121.0,1.0,149.0,1.0,149.0,
TCGA-LB-A7SX,7658,TCGA-LB-A7SX,PAAD,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-27295.0,Dead,,,393.0,"Other, non-malignant disease",,,,,Stable Disease,,,1.0,393.0,0.0,393.0,,,0.0,393.0,
TCGA-G4-6298,2371,TCGA-G4-6298,COAD,90.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-32873.0,Dead,WITH TUMOR,,715.0,[Not Available],,,,291.0,[Not Available],,,1.0,715.0,1.0,715.0,,,1.0,291.0,
TCGA-2F-A9KR,96,TCGA-2F-A9KR,BLCA,59.0,FEMALE,[Not Evaluated],Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2000.0,[Not Available],-21848.0,Dead,WITH TUMOR,,3183.0,[Not Available],Distant Metastasis,Lung,,3086.0,Complete Remission/Response,,,1.0,3183.0,1.0,3183.0,1.0,3086.0,1.0,3086.0,
TCGA-QN-A5NN,11080,TCGA-QN-A5NN,UCS,55.0,FEMALE,ASIAN,[Not Applicable],Stage IB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20318.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-DX-A7EU,8633,TCGA-DX-A7EU,SARC,79.0,FEMALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2013.0,[Not Available],-29211.0,Alive,TUMOR FREE,721.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,721.0,0.0,721.0,0.0,721.0,0.0,721.0,
TCGA-DJ-A3UN,9968,TCGA-DJ-A3UN,THCA,51.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18871.0,Alive,TUMOR FREE,986.0,,[Not Available],,,,,[Not Available],,R0,0.0,986.0,0.0,986.0,0.0,986.0,0.0,986.0,
TCGA-EY-A1G7,10941,TCGA-EY-A1G7,UCEC,86.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31603.0,Dead,WITH TUMOR,,189.0,[Not Available],,,,95.0,Complete Remission/Response,,,1.0,189.0,1.0,189.0,1.0,95.0,1.0,95.0,
TCGA-G3-A7M5,5719,TCGA-G3-A7M5,LIHC,76.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-27963.0,Alive,TUMOR FREE,447.0,,[Not Available],,,,,[Not Available],,R0,0.0,447.0,0.0,447.0,0.0,447.0,0.0,447.0,
TCGA-L5-A4OG,2516,TCGA-L5-A4OG,ESCA,79.0,FEMALE,WHITE,Stage I,[Not Available],"Esophagus Adenocarcinoma, NOS",G1,2012.0,[Not Available],-29105.0,Alive,,143.0,,[Not Available],,,,,[Unknown],,,0.0,143.0,0.0,143.0,,,0.0,143.0,
TCGA-V9-A7HT,4699,TCGA-V9-A7HT,KIRP,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-24610.0,Alive,TUMOR FREE,965.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,965.0,0.0,965.0,0.0,965.0,0.0,965.0,
TCGA-E9-A228,1426,TCGA-E9-A228,BRCA,58.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21294.0,Alive,TUMOR FREE,1285.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1285.0,0.0,1285.0,0.0,1285.0,0.0,1285.0,
TCGA-E9-A2JT,1443,TCGA-E9-A2JT,BRCA,63.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23318.0,Alive,TUMOR FREE,288.0,,[Not Available],,,,,[Not Available],Negative,,0.0,288.0,0.0,288.0,0.0,288.0,0.0,288.0,
TCGA-KN-8427,3826,TCGA-KN-8427,KICH,54.0,MALE,WHITE,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-19854.0,Alive,TUMOR FREE,30.0,,[Not Available],,,,,[Not Available],,,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-KB-A6F7,9611,TCGA-KB-A6F7,STAD,54.0,FEMALE,[Unknown],Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2009.0,[Not Available],-19765.0,Alive,TUMOR FREE,1935.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0,
TCGA-RP-A693,9222,TCGA-RP-A693,SKCM,77.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2008.0,[Not Available],-28394.0,Alive,TUMOR FREE,10.0,,[Not Available],,,,,[Not Available],,,0.0,10.0,0.0,10.0,,,0.0,10.0,
TCGA-55-8204,6024,TCGA-55-8204,LUAD,87.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-31818.0,Alive,TUMOR FREE,515.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,515.0,0.0,515.0,0.0,515.0,0.0,515.0,
TCGA-AO-A12H,882,TCGA-AO-A12H,BRCA,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-25515.0,Alive,TUMOR FREE,1234.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1234.0,0.0,1234.0,0.0,1234.0,0.0,1234.0,
TCGA-D8-A73W,1301,TCGA-D8-A73W,BRCA,79.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29125.0,Dead,WITH TUMOR,,385.0,[Not Available],Distant Metastasis,Lung,,21.0,[Not Available],Negative,,1.0,385.0,1.0,385.0,1.0,21.0,1.0,21.0,
TCGA-EE-A181,8996,TCGA-EE-A181,SKCM,82.0,FEMALE,WHITE,Stage II,[Not Applicable],,[Not Available],2005.0,[Not Available],-30003.0,Dead,TUMOR FREE,,1026.0,[Not Available],Locoregional Recurrence,,,788.0,[Not Available],,,1.0,1026.0,0.0,1026.0,,,1.0,788.0,
TCGA-90-A4ED,6758,TCGA-90-A4ED,LUSC,69.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-25453.0,Alive,TUMOR FREE,615.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,615.0,0.0,615.0,0.0,615.0,0.0,615.0,
TCGA-55-8510,6036,TCGA-55-8510,LUAD,55.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-20410.0,Alive,TUMOR FREE,539.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,539.0,0.0,539.0,0.0,539.0,0.0,539.0,
TCGA-2J-AABA,7508,TCGA-2J-AABA,PAAD,55.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-20133.0,Dead,WITH TUMOR,,607.0,Pancreatic Cancer,Distant Metastasis,"Other, specify",subcut nodule,160.0,Progressive Disease,,,1.0,607.0,1.0,607.0,,,1.0,160.0,
TCGA-DX-A3LU,8578,TCGA-DX-A3LU,SARC,60.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2007.0,[Not Available],-21915.0,Alive,TUMOR FREE,2641.0,,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,290.0,[Not Available],Positive,R1,0.0,2641.0,0.0,2641.0,,,1.0,290.0,
TCGA-F1-A448,9535,TCGA-F1-A448,STAD,70.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012.0,[Not Available],-25846.0,Alive,TUMOR FREE,647.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,647.0,0.0,647.0,0.0,647.0,0.0,647.0,
TCGA-EK-A2R9,1730,TCGA-EK-A2R9,CESC,58.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2011.0,[Not Available],-21242.0,Alive,WITH TUMOR,4.0,,,,,,,[Not Available],,,0.0,4.0,0.0,4.0,,,0.0,4.0,
TCGA-MP-A4T7,6301,TCGA-MP-A4T7,LUAD,75.0,FEMALE,[Unknown],Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-27603.0,Dead,,,167.0,[Not Available],,,,,[Unknown],,,1.0,167.0,,167.0,,,0.0,167.0,
TCGA-RZ-AB0B,11081,TCGA-RZ-AB0B,UVM,47.0,FEMALE,WHITE,Stage IV,Stage IV,Epithelioid Cell,[Not Available],2013.0,[Not Available],-17514.0,Dead,TUMOR FREE,,149.0,Metastatic Uveal Melanoma,,,,,[Not Available],,,1.0,149.0,1.0,149.0,,,0.0,149.0,
TCGA-CW-6097,4353,TCGA-CW-6097,KIRC,32.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-11701.0,Dead,WITH TUMOR,,571.0,[Not Available],,,,457.0,[Not Available],,,1.0,571.0,1.0,571.0,,,1.0,457.0,
TCGA-EB-A24D,8940,TCGA-EB-A24D,SKCM,72.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2011.0,[Not Available],-26439.0,Alive,TUMOR FREE,645.0,,[Not Available],Regional lymph node,,,500.0,[Not Available],,,0.0,645.0,0.0,645.0,,,1.0,500.0,
TCGA-CV-A45Y,3585,TCGA-CV-A45Y,HNSC,61.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2000.0,[Not Available],-22442.0,Dead,TUMOR FREE,,2703.0,[Not Available],,,R. Lung,2318.0,Complete Remission/Response,,,1.0,2703.0,0.0,2703.0,,,1.0,2318.0,
TCGA-OR-A5JF,15,TCGA-OR-A5JF,ACC,69.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2007.0,[Not Available],-25502.0,Alive,TUMOR FREE,2015.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2015.0,0.0,2015.0,0.0,2015.0,0.0,2015.0,
TCGA-AD-6889,2189,TCGA-AD-6889,COAD,76.0,MALE,ASIAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],,Dead,TUMOR FREE,,2532.0,[Not Available],,,,1516.0,Complete Remission/Response,,,1.0,2532.0,0.0,2532.0,1.0,1516.0,1.0,1516.0,
TCGA-LN-A9FR,2595,TCGA-LN-A9FR,ESCA,70.0,MALE,ASIAN,Stage IIB,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-25657.0,Alive,TUMOR FREE,373.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,373.0,0.0,373.0,0.0,373.0,0.0,373.0,
TCGA-EW-A1PA,1477,TCGA-EW-A1PA,BRCA,59.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21837.0,Alive,TUMOR FREE,575.0,,[Not Available],,,,,[Not Available],Negative,,0.0,575.0,0.0,575.0,0.0,575.0,0.0,575.0,
TCGA-B2-4098,4073,TCGA-B2-4098,KIRC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-26606.0,Dead,TUMOR FREE,,51.0,[Not Available],,,,,[Not Available],,,1.0,51.0,0.0,51.0,,,0.0,51.0,
TCGA-LN-A7HV,2584,TCGA-LN-A7HV,ESCA,58.0,MALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G1,2012.0,[Not Available],-21462.0,Alive,TUMOR FREE,320.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,320.0,0.0,320.0,0.0,320.0,0.0,320.0,
TCGA-HT-7875,5194,TCGA-HT-7875,LGG,56.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2008.0,[Not Available],-20613.0,Alive,TUMOR FREE,10.0,,[Not Available],,,,,Stable Disease,,,0.0,10.0,0.0,10.0,,,0.0,10.0,
TCGA-GM-A2DD,1504,TCGA-GM-A2DD,BRCA,53.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19415.0,Alive,TUMOR FREE,2282.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2282.0,0.0,2282.0,0.0,2282.0,0.0,2282.0,
TCGA-37-4135,6446,TCGA-37-4135,LUSC,68.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-25041.0,Alive,TUMOR FREE,207.0,,[Not Available],,,,,[Not Available],,,0.0,207.0,0.0,207.0,,,0.0,207.0,
TCGA-IZ-8195,4634,TCGA-IZ-8195,KIRP,82.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-29963.0,Alive,TUMOR FREE,677.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,677.0,0.0,677.0,0.0,677.0,0.0,677.0,
TCGA-96-7545,6776,TCGA-96-7545,LUSC,73.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-26729.0,Dead,,,1736.0,[Not Available],Locoregional Recurrence,,,1693.0,Progressive Disease,,,1.0,1736.0,,1736.0,,,1.0,1693.0,
TCGA-EE-A3JD,9083,TCGA-EE-A3JD,SKCM,70.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2009.0,[Not Available],-25930.0,Dead,WITH TUMOR,,832.0,[Not Available],Distant Metastasis,Lung,,364.0,[Not Available],,,1.0,832.0,1.0,832.0,,,1.0,364.0,
TCGA-39-5029,6460,TCGA-39-5029,LUSC,67.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-24713.0,Dead,WITH TUMOR,,740.0,[Not Available],,,,491.0,Stable Disease,,,1.0,740.0,1.0,740.0,,,1.0,491.0,
TCGA-FD-A5BV,285,TCGA-FD-A5BV,BLCA,47.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-17501.0,Dead,WITH TUMOR,,163.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Peritoneal carcinomatosis,134.0,Progressive Disease,,,1.0,163.0,1.0,163.0,,,1.0,134.0,
TCGA-EE-A184,8999,TCGA-EE-A184,SKCM,72.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2003.0,[Not Available],-26447.0,Dead,,,2073.0,[Not Available],Distant Metastasis,"Other, Specify",Right lower arm,1309.0,[Not Available],,,1.0,2073.0,,2073.0,,,1.0,1309.0,
TCGA-BQ-7055,4563,TCGA-BQ-7055,KIRP,73.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-26749.0,Alive,TUMOR FREE,799.0,,[Not Available],,,,,[Not Available],,,0.0,799.0,0.0,799.0,,,0.0,799.0,
TCGA-ER-A42L,9127,TCGA-ER-A42L,SKCM,49.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],2001.0,[Not Available],-17984.0,Alive,TUMOR FREE,4533.0,,[Not Available],,,,3812.0,[Not Available],,,0.0,4533.0,0.0,4533.0,,,1.0,3812.0,
TCGA-06-0141,2754,TCGA-06-0141,GBM,62.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2000.0,[Not Available],-22926.0,Dead,WITH TUMOR,280.0,313.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],145.0,[Not Available],,,1.0,313.0,1.0,313.0,,,1.0,145.0,
TCGA-2G-AAFG,9718,TCGA-2G-AAFG,TGCT,30.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],1998.0,[Not Available],-11002.0,Alive,TUMOR FREE,6183.0,,[Not Applicable],New Primary Tumor,Testes,,2495.0,Complete Remission/Response,,,0.0,6183.0,0.0,6183.0,1.0,2495.0,1.0,2495.0,
TCGA-D9-A3Z3,8905,TCGA-D9-A3Z3,SKCM,39.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-14489.0,Alive,TUMOR FREE,678.0,,[Not Available],,,,,[Not Available],,,0.0,678.0,0.0,678.0,,,0.0,678.0,
TCGA-DX-A8BJ,8636,TCGA-DX-A8BJ,SARC,76.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2011.0,[Not Available],-28091.0,Dead,TUMOR FREE,,284.0,[Not Available],,,,,[Not Available],Negative,R0,1.0,284.0,0.0,284.0,0.0,284.0,0.0,284.0,
TCGA-BR-8690,9388,TCGA-BR-8690,STAD,54.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-19855.0,Alive,TUMOR FREE,325.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,325.0,0.0,325.0,0.0,325.0,0.0,325.0,
TCGA-AQ-A04H,889,TCGA-AQ-A04H,BRCA,61.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22539.0,Alive,TUMOR FREE,754.0,,[Not Available],,,,,[Not Available],Negative,,0.0,754.0,0.0,754.0,0.0,754.0,0.0,754.0,
TCGA-D9-A1JW,8901,TCGA-D9-A1JW,SKCM,82.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2010.0,[Not Available],-30142.0,Alive,TUMOR FREE,111.0,,[Not Available],Distant Metastasis,"Other, Specify",,10.0,[Not Available],,,0.0,111.0,0.0,111.0,,,1.0,10.0,
TCGA-YU-A90P,9827,TCGA-YU-A90P,TGCT,25.0,MALE,WHITE,Stage IA,Stage IA,Non-Seminoma; Embryonal Carcinoma,[Not Available],2009.0,[Not Available],-9144.0,Alive,TUMOR FREE,2069.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,2069.0,0.0,2069.0,0.0,2069.0,0.0,2069.0,
TCGA-KN-8431,3830,TCGA-KN-8431,KICH,35.0,FEMALE,[Not Evaluated],Stage II,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-13043.0,Alive,TUMOR FREE,588.0,,[Not Available],,,,,[Not Available],,,0.0,588.0,0.0,588.0,,,0.0,588.0,
TCGA-D8-A1JK,1246,TCGA-D8-A1JK,BRCA,90.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Alive,TUMOR FREE,612.0,,[Not Available],,,,,[Not Available],Negative,,0.0,612.0,0.0,612.0,0.0,612.0,0.0,612.0,
TCGA-B6-A0RO,994,TCGA-B6-A0RO,BRCA,71.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1993.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26269.0,Alive,TUMOR FREE,4929.0,,[Not Available],,,,,[Not Available],Negative,,0.0,4929.0,0.0,4929.0,0.0,4929.0,0.0,4929.0,
TCGA-MH-A55W,4644,TCGA-MH-A55W,KIRP,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-18573.0,Alive,TUMOR FREE,1043.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1043.0,0.0,1043.0,0.0,1043.0,0.0,1043.0,
TCGA-DD-AADE,5616,TCGA-DD-AADE,LIHC,50.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2011.0,[Not Available],-18482.0,Alive,WITH TUMOR,1202.0,,[Not Available],Intrahepatic Recurrence,Liver,,168.0,[Not Available],,R0,0.0,1202.0,0.0,1202.0,1.0,168.0,1.0,168.0,
TCGA-BR-6563,9308,TCGA-BR-6563,STAD,60.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-21936.0,Alive,TUMOR FREE,1190.0,,[Not Available],New Primary Tumor,,,148.0,Complete Remission/Response,,,0.0,1190.0,0.0,1190.0,0.0,1190.0,1.0,148.0,
TCGA-HC-7080,8065,TCGA-HC-7080,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-24243.0,Alive,TUMOR FREE,1106.0,,[Not Available],New Primary Tumor,,,894.0,Complete Remission/Response,,,0.0,1106.0,0.0,1106.0,0.0,1106.0,1.0,894.0,
TCGA-5V-A9RR,10383,TCGA-5V-A9RR,THYM,67.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2012.0,[Not Available],-24668.0,Alive,TUMOR FREE,827.0,,[Not Available],,,,,[Not Available],,,0.0,827.0,0.0,827.0,,,0.0,827.0,
TCGA-C5-A7UH,1653,TCGA-C5-A7UH,CESC,55.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2003.0,[Not Available],-20189.0,Alive,TUMOR FREE,3988.0,,,,,,,[Not Available],,,0.0,3988.0,0.0,3988.0,,,0.0,3988.0,
TCGA-RY-A83Y,5315,TCGA-RY-A83Y,LGG,45.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-16470.0,Alive,TUMOR FREE,166.0,,[Not Available],,,,,[Not Available],,,0.0,166.0,0.0,166.0,,,0.0,166.0,
TCGA-IR-A3LL,1783,TCGA-IR-A3LL,CESC,60.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22123.0,Alive,TUMOR FREE,1106.0,,,,,,,Complete Remission/Response,,,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,
TCGA-BJ-A28S,9866,TCGA-BJ-A28S,THCA,79.0,MALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-29143.0,Alive,TUMOR FREE,640.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,640.0,0.0,640.0,,,0.0,640.0,
TCGA-BH-A6R8,1170,TCGA-BH-A6R8,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,[Unknown],-16829.0,Alive,TUMOR FREE,293.0,,[Not Available],,,,,[Not Available],Negative,,0.0,293.0,0.0,293.0,0.0,293.0,0.0,293.0,
TCGA-E1-A7Z4,5093,TCGA-E1-A7Z4,LGG,35.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,1999.0,[Not Available],-12849.0,Dead,WITH TUMOR,,4412.0,[Not Available],,,,846.0,Progressive Disease,,,1.0,4412.0,1.0,4412.0,,,1.0,846.0,
TCGA-22-4605,6378,TCGA-22-4605,LUSC,78.0,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-28623.0,Dead,TUMOR FREE,,974.0,[Not Available],,,,,Complete Remission/Response,,,1.0,974.0,0.0,974.0,0.0,974.0,0.0,974.0,
TCGA-18-5595,6342,TCGA-18-5595,LUSC,50.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-18611.0,Dead,,,827.0,[Not Available],,,,,[Not Available],,,1.0,827.0,,827.0,,,0.0,827.0,
TCGA-GN-A266,9196,TCGA-GN-A266,SKCM,45.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2004.0,[Not Available],-16456.0,Dead,WITH TUMOR,,308.0,[Not Available],Distant Metastasis,Brain,,109.0,[Not Available],,,1.0,308.0,1.0,308.0,,,1.0,109.0,
TCGA-V1-A9Z8,8261,TCGA-V1-A9Z8,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-21900.0,Alive,TUMOR FREE,827.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,827.0,0.0,827.0,0.0,827.0,0.0,827.0,
TCGA-A5-A2K3,10516,TCGA-A5-A2K3,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24907.0,Alive,TUMOR FREE,2012.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2012.0,0.0,2012.0,0.0,2012.0,0.0,2012.0,
TCGA-N5-A4RJ,11028,TCGA-N5-A4RJ,UCS,61.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22341.0,Dead,WITH TUMOR,,550.0,[Not Available],Distant Metastasis,Lymph Node(s),,287.0,Complete Remission/Response,,,1.0,550.0,1.0,550.0,,,1.0,287.0,
TCGA-G4-6294,2368,TCGA-G4-6294,COAD,75.0,MALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2004.0,[Not Available],-27755.0,Dead,WITH TUMOR,,858.0,[Not Available],,,,517.0,[Not Available],,,1.0,858.0,1.0,858.0,,,1.0,517.0,
TCGA-LP-A4AU,1797,TCGA-LP-A4AU,CESC,35.0,FEMALE,ASIAN,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13074.0,Alive,TUMOR FREE,343.0,,,,,,,[Not Available],,,0.0,343.0,0.0,343.0,,,0.0,343.0,
TCGA-DD-A1EC,5527,TCGA-DD-A1EC,LIHC,20.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2004.0,[Not Available],-7363.0,Alive,,602.0,,[Not Available],Extrahepatic Recurrence,"Other, specify",peritoneal,299.0,[Not Available],,R0,0.0,602.0,0.0,602.0,1.0,299.0,1.0,299.0,
TCGA-WB-A81A,7845,TCGA-WB-A81A,PCPG,65.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-23966.0,Alive,TUMOR FREE,735.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,735.0,0.0,735.0,0.0,735.0,0.0,735.0,
TCGA-2G-AAF6,9715,TCGA-2G-AAF6,TGCT,28.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],2005.0,[Not Available],-10281.0,Alive,TUMOR FREE,3491.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,810.0,Complete Remission/Response,,,0.0,3491.0,0.0,3491.0,1.0,810.0,1.0,810.0,
TCGA-EB-A3XC,8944,TCGA-EB-A3XC,SKCM,74.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-27124.0,Alive,TUMOR FREE,650.0,,[Not Available],Distant Metastasis|Regional lymph node,"Other, Specify|[Not Available]",Chest wall|[Not Applicable],74.0,[Not Available],,,0.0,650.0,0.0,650.0,,,1.0,74.0,
TCGA-ZJ-AAXF,1900,TCGA-ZJ-AAXF,CESC,62.0,FEMALE,[Unknown],[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2010.0,[Unknown],-22709.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-BP-4981,4215,TCGA-BP-4981,KIRC,75.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-27676.0,Dead,TUMOR FREE,,1097.0,[Not Available],,,,,[Not Available],,,1.0,1097.0,0.0,1097.0,,,0.0,1097.0,
TCGA-A2-A25F,610,TCGA-A2-A25F,BRCA,66.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24319.0,Alive,TUMOR FREE,322.0,,[Not Available],,,,,[Not Available],Negative,,0.0,322.0,0.0,322.0,0.0,322.0,0.0,322.0,
TCGA-CZ-5470,4386,TCGA-CZ-5470,KIRC,72.0,FEMALE,[Not Available],Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2008.0,[Not Available],-26494.0,Alive,,386.0,,[Not Available],,,,,[Not Available],,,0.0,386.0,0.0,386.0,,,0.0,386.0,
TCGA-DM-A1DA,2335,TCGA-DM-A1DA,COAD,71.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],1999.0,[Not Available],-26169.0,Dead,,228.0,228.0,[Not Available],,,,,[Not Available],,,1.0,228.0,,228.0,,,0.0,228.0,
TCGA-55-A492,6052,TCGA-55-A492,LUAD,70.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-25719.0,Alive,TUMOR FREE,596.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,596.0,0.0,596.0,0.0,596.0,0.0,596.0,
TCGA-58-8387,6549,TCGA-58-8387,LUSC,60.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-21952.0,Dead,TUMOR FREE,,403.0,[Not Available],,,,,Complete Remission/Response,,,1.0,403.0,0.0,403.0,0.0,403.0,0.0,403.0,
TCGA-N8-A4PI,11048,TCGA-N8-A4PI,UCS,71.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26270.0,Dead,WITH TUMOR,,810.0,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,255.0,Partial Remission/Response,,,1.0,810.0,1.0,810.0,,,1.0,255.0,
TCGA-CN-6995,3353,TCGA-CN-6995,HNSC,78.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-28850.0,Dead,TUMOR FREE,,112.0,[Not Available],,,,,Complete Remission/Response,,,1.0,112.0,0.0,112.0,,,0.0,112.0,
TCGA-ZF-A9R7,479,TCGA-ZF-A9R7,BLCA,76.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-28063.0,Alive,TUMOR FREE,665.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,665.0,0.0,665.0,0.0,665.0,0.0,665.0,
TCGA-AR-A1AS,925,TCGA-AR-A1AS,BRCA,54.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20028.0,Alive,TUMOR FREE,1150.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1150.0,0.0,1150.0,0.0,1150.0,0.0,1150.0,
TCGA-OR-A5LE,68,TCGA-OR-A5LE,ACC,14.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],1997.0,[Not Available],-5383.0,Dead,WITH TUMOR,,662.0,[Not Available],Locoregional Recurrence,Peritoneal Surfaces,,265.0,[Unknown],,,1.0,662.0,1.0,662.0,,,1.0,265.0,
TCGA-76-6283,3225,TCGA-76-6283,GBM,71.0,FEMALE,WHITE,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2007.0,[Not Available],-26002.0,Dead,WITH TUMOR,,165.0,[Not Available],,,,,[Not Available],,,1.0,165.0,1.0,165.0,,,1.0,165.0,
TCGA-YL-A8HO,8320,TCGA-YL-A8HO,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-24509.0,Alive,WITH TUMOR,2304.0,,[Not Available],Biochemical evidence of disease,,,1068.0,Stable Disease,,,0.0,2304.0,0.0,2304.0,,,1.0,1068.0,
TCGA-HC-A6AO,8113,TCGA-HC-A6AO,PRAD,52.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-19298.0,Alive,TUMOR FREE,530.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,530.0,0.0,530.0,0.0,530.0,0.0,530.0,
TCGA-BR-8680,9383,TCGA-BR-8680,STAD,45.0,MALE,ASIAN,Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,[Not Available],-16637.0,Alive,TUMOR FREE,972.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,972.0,0.0,972.0,,,0.0,972.0,
TCGA-HT-7467,5140,TCGA-HT-7467,LGG,54.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-19944.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3.0,0.0,3.0,0.0,3.0,0.0,3.0,
TCGA-EM-A2OX,10153,TCGA-EM-A2OX,THCA,46.0,MALE,[Not Available],Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-16911.0,Alive,TUMOR FREE,600.0,,[Not Available],,,,,[Not Available],,R0,0.0,600.0,0.0,600.0,,,0.0,600.0,
TCGA-JX-A3Q8,1795,TCGA-JX-A3Q8,CESC,40.0,FEMALE,ASIAN,[Not Available],Stage IB1,Endocervical Type of Adenocarcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14839.0,Alive,TUMOR FREE,1357.0,,,,,,,Complete Remission/Response,,,0.0,1357.0,0.0,1357.0,0.0,1357.0,0.0,1357.0,
TCGA-3U-A98G,6840,TCGA-3U-A98G,MESO,71.0,MALE,WHITE,Stage IV,[Not Applicable],Biphasic mesothelioma,[Not Available],2012.0,[Not Available],-26185.0,Dead,WITH TUMOR,,630.0,[Not Available],Intrapleural Progression,,,497.0,[Not Available],,R0,1.0,630.0,1.0,630.0,,,1.0,497.0,
TCGA-AZ-4681,2220,TCGA-AZ-4681,COAD,79.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2004.0,[Not Available],-28906.0,Alive,TUMOR FREE,3247.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3247.0,0.0,3247.0,0.0,3247.0,0.0,3247.0,
TCGA-44-5645,5871,TCGA-44-5645,LUAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-22471.0,Alive,TUMOR FREE,852.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,852.0,0.0,852.0,0.0,852.0,0.0,852.0,
TCGA-E7-A541,240,TCGA-E7-A541,BLCA,66.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-24206.0,Dead,TUMOR FREE,,778.0,[Not Available],,,,,Complete Remission/Response,,,1.0,778.0,0.0,778.0,0.0,778.0,0.0,778.0,
TCGA-N9-A4Q4,11059,TCGA-N9-A4Q4,UCS,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22575.0,Alive,,1089.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1089.0,0.0,1089.0,0.0,1089.0,0.0,1089.0,
TCGA-CV-7095,3521,TCGA-CV-7095,HNSC,87.0,FEMALE,[Not Available],Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,[Not Available],-32022.0,Dead,TUMOR FREE,,572.0,[Not Available],,,,,[Not Available],,,1.0,572.0,0.0,572.0,,,0.0,572.0,
TCGA-QR-A6GY,7704,TCGA-QR-A6GY,PCPG,37.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2006.0,[Not Available],-13612.0,Alive,TUMOR FREE,32.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,32.0,0.0,32.0,0.0,32.0,0.0,32.0,
TCGA-IB-AAUO,7648,TCGA-IB-AAUO,PAAD,64.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,[Not Available],-23622.0,Dead,WITH TUMOR,,239.0,,Distant Metastasis,Liver,,74.0,Partial Remission/Response,,,1.0,239.0,1.0,239.0,,,1.0,74.0,
TCGA-J8-A3YH,10327,TCGA-J8-A3YH,THCA,39.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-14470.0,Alive,TUMOR FREE,175.0,,[Not Available],,,,,[Not Available],,R0,0.0,175.0,0.0,175.0,0.0,175.0,0.0,175.0,
TCGA-E9-A1R3,1410,TCGA-E9-A1R3,BRCA,70.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25693.0,Alive,TUMOR FREE,78.0,,[Not Available],,,,,[Not Available],Negative,,0.0,78.0,0.0,78.0,0.0,78.0,0.0,78.0,
TCGA-D7-6528,9498,TCGA-D7-6528,STAD,70.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-25815.0,Alive,TUMOR FREE,463.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,463.0,0.0,463.0,0.0,463.0,0.0,463.0,
TCGA-OL-A5RZ,1561,TCGA-OL-A5RZ,BRCA,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21038.0,Alive,TUMOR FREE,679.0,,[Not Available],,,,,[Not Available],Negative,,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,
TCGA-MP-A4TD,6306,TCGA-MP-A4TD,LUAD,71.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-25983.0,Dead,,,307.0,[Not Available],Locoregional Recurrence,,,226.0,Complete Remission/Response,,,1.0,307.0,,307.0,1.0,226.0,1.0,226.0,
TCGA-CW-5587,4343,TCGA-CW-5587,KIRC,62.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2003.0,[Not Available],-22693.0,Alive,TUMOR FREE,2226.0,,[Not Available],,,,2003.0,[Not Available],,,0.0,2226.0,0.0,2226.0,,,1.0,2003.0,
TCGA-EA-A411,1703,TCGA-EA-A411,CESC,50.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18561.0,Alive,TUMOR FREE,747.0,,,,,,,Complete Remission/Response,,,0.0,747.0,0.0,747.0,0.0,747.0,0.0,747.0,
TCGA-M7-A720,8220,TCGA-M7-A720,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-19642.0,Alive,TUMOR FREE,384.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,384.0,0.0,384.0,0.0,384.0,0.0,384.0,
TCGA-BH-A0AY,1029,TCGA-BH-A0AY,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22703.0,Alive,TUMOR FREE,777.0,,[Not Available],,,,,[Not Available],Negative,,0.0,777.0,0.0,777.0,0.0,777.0,0.0,777.0,
TCGA-LN-A49W,2568,TCGA-LN-A49W,ESCA,73.0,MALE,ASIAN,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,G3,2011.0,[Not Available],-26910.0,Alive,TUMOR FREE,403.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,403.0,0.0,403.0,0.0,403.0,0.0,403.0,
TCGA-FR-A3YO,9131,TCGA-FR-A3YO,SKCM,,FEMALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],2007.0,[Not Available],,Alive,WITH TUMOR,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-43-2578,6470,TCGA-43-2578,LUSC,59.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-21747.0,Dead,TUMOR FREE,,684.0,[Not Available],,,,,Complete Remission/Response,,,1.0,684.0,0.0,684.0,0.0,684.0,0.0,684.0,
TCGA-D3-A5GO,8878,TCGA-D3-A5GO,SKCM,61.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],2001.0,[Not Available],-22287.0,Alive,TUMOR FREE,4195.0,,[Not Available],,,,757.0,[Not Available],,,0.0,4195.0,0.0,4195.0,,,1.0,757.0,
TCGA-FP-A4BF,9547,TCGA-FP-A4BF,STAD,68.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2011.0,[Not Available],-25030.0,Dead,WITH TUMOR,,168.0,[Not Available],Distant Metastasis,Lung,,159.0,Progressive Disease,,,1.0,168.0,1.0,168.0,,,1.0,159.0,
TCGA-WX-AA47,5785,TCGA-WX-AA47,LIHC,33.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-12056.0,Dead,WITH TUMOR,,556.0,[Not Available],Intrahepatic Recurrence,Liver,,103.0,[Not Available],,R0,1.0,556.0,1.0,556.0,1.0,103.0,1.0,103.0,
TCGA-EB-A85J,8990,TCGA-EB-A85J,SKCM,66.0,FEMALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2013.0,[Not Available],-24263.0,Alive,TUMOR FREE,360.0,,[Not Available],Regional lymph node,,,138.0,[Not Available],,,0.0,360.0,0.0,360.0,,,1.0,138.0,
TCGA-19-A6J5,3101,TCGA-19-A6J5,GBM,40.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2012.0,[Not Available],-14970.0,Alive,WITH TUMOR,868.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],784.0,Stable Disease,,,0.0,868.0,0.0,868.0,,,1.0,784.0,
TCGA-CR-7390,3458,TCGA-CR-7390,HNSC,67.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-24575.0,Alive,TUMOR FREE,1508.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1508.0,0.0,1508.0,,,0.0,1508.0,
TCGA-BL-A3JM,120,TCGA-BL-A3JM,BLCA,62.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-23000.0,Dead,WITH TUMOR,,205.0,[Not Available],Metastatic,Bone,,111.0,Progressive Disease,,,1.0,205.0,1.0,205.0,,,1.0,111.0,
TCGA-CJ-4920,4316,TCGA-CJ-4920,KIRC,64.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-23656.0,Dead,TUMOR FREE,,139.0,[Not Available],,,,,[Not Available],,,1.0,139.0,0.0,139.0,,,0.0,139.0,
TCGA-HT-A615,5231,TCGA-HT-A615,LGG,38.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-13892.0,Alive,TUMOR FREE,515.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,515.0,0.0,515.0,0.0,515.0,0.0,515.0,
TCGA-2L-AAQJ,7523,TCGA-2L-AAQJ,PAAD,49.0,FEMALE,WHITE,Stage III,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,[Not Available],-18103.0,Dead,WITH TUMOR,,394.0,Pancreatic Cancer,,,,,Progressive Disease,,,1.0,394.0,1.0,394.0,,,1.0,394.0,
TCGA-2Y-A9GY,5433,TCGA-2Y-A9GY,LIHC,64.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2007.0,[Not Available],-23435.0,Dead,WITH TUMOR,,757.0,[Not Available],Extrahepatic Recurrence,Lung,,637.0,[Not Available],,R0,1.0,757.0,1.0,757.0,1.0,637.0,1.0,637.0,
TCGA-HU-A4GC,9571,TCGA-HU-A4GC,STAD,74.0,MALE,ASIAN,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-27267.0,Alive,TUMOR FREE,99.0,,[Not Available],,,,,Stable Disease,,,0.0,99.0,0.0,99.0,,,0.0,99.0,
TCGA-39-5040,6468,TCGA-39-5040,LUSC,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-21790.0,Dead,WITH TUMOR,,519.0,[Not Available],,,,442.0,Stable Disease,,,1.0,519.0,1.0,519.0,,,1.0,442.0,
TCGA-H5-A2HR,10998,TCGA-H5-A2HR,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25986.0,Alive,TUMOR FREE,53.0,,[Not Available],,,,,[Not Available],,,0.0,53.0,0.0,53.0,,,0.0,53.0,
TCGA-AR-A24M,935,TCGA-AR-A24M,BRCA,38.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14119.0,Alive,TUMOR FREE,3660.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3660.0,0.0,3660.0,0.0,3660.0,0.0,3660.0,
TCGA-EL-A3T8,10089,TCGA-EL-A3T8,THCA,36.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005.0,[Not Available],-13290.0,Alive,TUMOR FREE,3269.0,,[Not Available],,,,,[Not Available],,R0,0.0,3269.0,0.0,3269.0,0.0,3269.0,0.0,3269.0,
TCGA-S7-A7WR,7784,TCGA-S7-A7WR,PCPG,32.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-12011.0,Alive,TUMOR FREE,1238.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1238.0,0.0,1238.0,0.0,1238.0,0.0,1238.0,
TCGA-HC-7078,8063,TCGA-HC-7078,PRAD,69.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-25402.0,Alive,TUMOR FREE,1985.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1985.0,0.0,1985.0,0.0,1985.0,0.0,1985.0,
TCGA-VS-A8QA,1846,TCGA-VS-A8QA,CESC,44.0,FEMALE,[Unknown],[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,GX,2011.0,Peri (6-12 months since last menstrual period),-16072.0,Alive,TUMOR FREE,1099.0,,,,,,,Complete Remission/Response,,,0.0,1099.0,0.0,1099.0,0.0,1099.0,0.0,1099.0,
TCGA-2J-AABO,7514,TCGA-2J-AABO,PAAD,43.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-15869.0,Alive,WITH TUMOR,440.0,,,Distant Metastasis,Liver,,439.0,Progressive Disease,,,0.0,440.0,0.0,440.0,,,1.0,439.0,
TCGA-A3-3365,3915,TCGA-A3-3365,KIRC,46.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-16915.0,Alive,,873.0,,[Not Available],,,,,[Not Available],,,0.0,873.0,0.0,873.0,,,0.0,873.0,
TCGA-G9-6499,8047,TCGA-G9-6499,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-24388.0,Alive,TUMOR FREE,1543.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1543.0,0.0,1543.0,0.0,1543.0,0.0,1543.0,
TCGA-G9-6343,8021,TCGA-G9-6343,PRAD,62.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-22843.0,Alive,TUMOR FREE,2450.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2450.0,0.0,2450.0,0.0,2450.0,0.0,2450.0,
TCGA-60-2711,6571,TCGA-60-2711,LUSC,64.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-23651.0,Alive,TUMOR FREE,1260.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1260.0,0.0,1260.0,0.0,1260.0,0.0,1260.0,
TCGA-DM-A1D7,2332,TCGA-DM-A1D7,COAD,82.0,MALE,WHITE,Stage IIA,[Not Applicable],[Discrepancy],[Not Available],2000.0,[Not Available],-30142.0,Dead,,,405.0,[Not Available],,,,80.0,[Not Available],,,1.0,405.0,,405.0,,,1.0,80.0,
TCGA-HB-A3YV,8685,TCGA-HB-A3YV,SARC,75.0,MALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012.0,[Not Available],-27583.0,Dead,WITH TUMOR,,139.0,[Not Available],,,,,[Not Available],Positive,R1,1.0,139.0,1.0,139.0,,,1.0,139.0,
TCGA-BR-A4J4,9402,TCGA-BR-A4J4,STAD,39.0,MALE,ASIAN,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-14459.0,Alive,TUMOR FREE,16.0,,[Not Available],,,,,[Not Available],,,0.0,16.0,0.0,16.0,,,0.0,16.0,
TCGA-EM-A22I,10130,TCGA-EM-A22I,THCA,52.0,FEMALE,[Not Available],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19003.0,Alive,TUMOR FREE,448.0,,[Not Available],,,,,[Not Available],,R1,0.0,448.0,0.0,448.0,,,0.0,448.0,
TCGA-BR-7901,9332,TCGA-BR-7901,STAD,74.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-27031.0,Dead,TUMOR FREE,,105.0,[Not Available],Locoregional Recurrence,,,91.0,Complete Remission/Response,,,1.0,105.0,0.0,105.0,1.0,91.0,1.0,91.0,
TCGA-2Z-A9J1,4421,TCGA-2Z-A9J1,KIRP,71.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-26244.0,Alive,TUMOR FREE,2298.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2298.0,0.0,2298.0,0.0,2298.0,0.0,2298.0,
TCGA-A7-A4SE,661,TCGA-A7-A4SE,BRCA,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20080.0,Alive,TUMOR FREE,644.0,,[Not Available],,,,,[Not Available],Negative,,0.0,644.0,0.0,644.0,0.0,644.0,0.0,644.0,
TCGA-P6-A5OG,85,TCGA-P6-A5OG,ACC,45.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-16659.0,Dead,WITH TUMOR,,383.0,[Not Available],Distant Metastasis,Lung,,11.0,Complete Remission/Response,,,1.0,383.0,1.0,383.0,,,1.0,11.0,
TCGA-05-5428,5835,TCGA-05-5428,LUAD,57.0,MALE,[Not Available],Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-21061.0,Alive,TUMOR FREE,670.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,670.0,0.0,670.0,0.0,670.0,0.0,670.0,
TCGA-DX-A3UD,8591,TCGA-DX-A3UD,SARC,56.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-20703.0,Alive,WITH TUMOR,1534.0,,[Not Available],Locoregional Recurrence,,,603.0,[Not Available],Negative,R0,0.0,1534.0,0.0,1534.0,1.0,603.0,1.0,603.0,
TCGA-GU-A42R,345,TCGA-GU-A42R,BLCA,68.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-25134.0,Dead,WITH TUMOR,,577.0,[Not Available],Distant Metastasis,Lung,,91.0,Progressive Disease,,,1.0,577.0,1.0,577.0,,,1.0,91.0,
TCGA-VQ-A91U,9680,TCGA-VQ-A91U,STAD,78.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-28791.0,Dead,,,52.0,[Unknown],,,,,[Unknown],,,1.0,52.0,,52.0,,,0.0,52.0,
TCGA-DU-A7TA,5059,TCGA-DU-A7TA,LGG,32.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2007.0,[Not Available],-11764.0,Alive,TUMOR FREE,2565.0,,[Not Available],,,,,Stable Disease,,,0.0,2565.0,0.0,2565.0,,,0.0,2565.0,
TCGA-4X-A9FB,10375,TCGA-4X-A9FB,THYM,44.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2012.0,[Not Available],-16175.0,Alive,TUMOR FREE,717.0,,[Not Available],,,,,[Not Available],,,0.0,717.0,0.0,717.0,,,0.0,717.0,
TCGA-2G-AAF4,9714,TCGA-2G-AAF4,TGCT,30.0,MALE,WHITE,Stage I,Stage IA,Seminoma; NOS,[Not Available],2008.0,[Not Available],-10983.0,Alive,TUMOR FREE,2315.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,2315.0,0.0,2315.0,0.0,2315.0,0.0,2315.0,
TCGA-91-6836,6217,TCGA-91-6836,LUAD,52.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-19216.0,Alive,TUMOR FREE,417.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,417.0,0.0,417.0,0.0,417.0,0.0,417.0,
TCGA-N6-A4VD,11040,TCGA-N6-A4VD,UCS,81.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29658.0,Dead,WITH TUMOR,,112.0,[Not Available],Distant Metastasis,Liver,,49.0,Progressive Disease,,,1.0,112.0,1.0,112.0,,,1.0,49.0,
TCGA-CK-6748,2256,TCGA-CK-6748,COAD,45.0,FEMALE,WHITE,Stage IV,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2008.0,[Not Available],-16529.0,Alive,WITH TUMOR,61.0,,[Not Available],,,,,[Unknown],,,0.0,61.0,0.0,61.0,,,0.0,61.0,
TCGA-DZ-6133,4583,TCGA-DZ-6133,KIRP,66.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2004.0,[Not Available],-24311.0,Dead,TUMOR FREE,,1557.0,[Not Available],,,,,[Not Available],,,1.0,1557.0,0.0,1557.0,,,0.0,1557.0,
TCGA-FF-8047,2426,TCGA-FF-8047,DLBC,38.0,FEMALE,ASIAN,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2011.0,[Not Available],-13996.0,Alive,WITH TUMOR,126.0,,[Not Available],,Leptomeninges,,24.0,Progressive Disease,,,0.0,126.0,0.0,126.0,,,1.0,24.0,
TCGA-GV-A3JW,355,TCGA-GV-A3JW,BLCA,74.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-27091.0,Alive,WITH TUMOR,649.0,,[Not Available],Distant Metastasis,Bone,,271.0,Stable Disease,,,0.0,649.0,0.0,649.0,,,1.0,271.0,
TCGA-HW-A5KJ,5255,TCGA-HW-A5KJ,LGG,68.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-24966.0,Dead,WITH TUMOR,,962.0,[Not Available],,,,615.0,Progressive Disease,,,1.0,962.0,1.0,962.0,,,1.0,615.0,
TCGA-VQ-AA64,9698,TCGA-VQ-AA64,STAD,68.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-25109.0,Dead,WITH TUMOR,,560.0,Stomach Cancer,,,,,[Unknown],,,1.0,560.0,1.0,560.0,,,1.0,560.0,
TCGA-B6-A0RT,998,TCGA-B6-A0RT,BRCA,39.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996.0,Indeterminate (neither Pre or Postmenopausal),-14374.0,Alive,TUMOR FREE,2721.0,,[Not Available],,,,,[Not Available],Close,,0.0,2721.0,0.0,2721.0,,,0.0,2721.0,
TCGA-85-A513,6750,TCGA-85-A513,LUSC,60.0,FEMALE,ASIAN,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-21967.0,Alive,TUMOR FREE,910.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,910.0,0.0,910.0,0.0,910.0,0.0,910.0,
TCGA-DX-A6BE,8608,TCGA-DX-A6BE,SARC,77.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2011.0,[Not Available],-28368.0,Alive,TUMOR FREE,881.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,881.0,0.0,881.0,0.0,881.0,0.0,881.0,
TCGA-E2-A1IH,1362,TCGA-E2-A1IH,BRCA,80.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29444.0,Alive,TUMOR FREE,1026.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1026.0,0.0,1026.0,0.0,1026.0,0.0,1026.0,
TCGA-E7-A4XJ,238,TCGA-E7-A4XJ,BLCA,66.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-24279.0,Dead,TUMOR FREE,,68.0,[Not Available],,,,,Complete Remission/Response,,,1.0,68.0,0.0,68.0,0.0,68.0,0.0,68.0,
TCGA-EJ-5498,7914,TCGA-EJ-5498,PRAD,56.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-20472.0,Alive,TUMOR FREE,1720.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1720.0,0.0,1720.0,0.0,1720.0,0.0,1720.0,
TCGA-18-3407,6326,TCGA-18-3407,LUSC,72.0,MALE,ASIAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-26615.0,Dead,TUMOR FREE,,136.0,[Not Available],,,,,[Not Applicable],,,1.0,136.0,0.0,136.0,,,0.0,136.0,
TCGA-HT-7603,5160,TCGA-HT-7603,LGG,29.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2008.0,[Not Available],-10883.0,Alive,TUMOR FREE,705.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,705.0,0.0,705.0,0.0,705.0,0.0,705.0,
TCGA-VQ-A923,9687,TCGA-VQ-A923,STAD,90.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2008.0,[Not Available],-32873.0,Dead,TUMOR FREE,,61.0,"Other, non-malignant disease",,,,,Complete Remission/Response,,,1.0,61.0,0.0,61.0,0.0,61.0,0.0,61.0,
TCGA-B6-A0RQ,996,TCGA-B6-A0RQ,BRCA,68.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],1994.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25010.0,Dead,TUMOR FREE,,4267.0,[Not Available],,,,,[Not Available],Negative,,1.0,4267.0,0.0,4267.0,0.0,4267.0,0.0,4267.0,
TCGA-DB-A64V,4957,TCGA-DB-A64V,LGG,54.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-19950.0,Alive,TUMOR FREE,889.0,,[Not Available],,,,,Stable Disease,,,0.0,889.0,0.0,889.0,,,0.0,889.0,
TCGA-E9-A1R7,1414,TCGA-E9-A1R7,BRCA,64.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23397.0,Alive,TUMOR FREE,1467.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1467.0,0.0,1467.0,0.0,1467.0,0.0,1467.0,
TCGA-B5-A5OD,10732,TCGA-B5-A5OD,UCEC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2011.0,[Not Available],-24775.0,Alive,TUMOR FREE,1038.0,,[Not Available],,,,,[Not Available],,,0.0,1038.0,0.0,1038.0,,,0.0,1038.0,
TCGA-CV-7178,3530,TCGA-CV-7178,HNSC,64.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2000.0,[Not Available],-23430.0,Dead,WITH TUMOR,,2166.0,[Not Available],,,,,[Not Available],,,1.0,2166.0,1.0,2166.0,,,1.0,2166.0,
TCGA-33-AAS8,6412,TCGA-33-AAS8,LUSC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1998.0,[Not Available],-21675.0,Dead,TUMOR FREE,,1114.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1114.0,0.0,1114.0,0.0,1114.0,0.0,1114.0,
TCGA-77-A5GH,6701,TCGA-77-A5GH,LUSC,81.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-29843.0,Alive,,1182.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1182.0,0.0,1182.0,0.0,1182.0,0.0,1182.0,
TCGA-AR-A1AU,927,TCGA-AR-A1AU,BRCA,39.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14564.0,Alive,TUMOR FREE,2868.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2868.0,0.0,2868.0,0.0,2868.0,0.0,2868.0,
TCGA-63-A5MN,6600,TCGA-63-A5MN,LUSC,78.0,FEMALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-28677.0,Dead,WITH TUMOR,,345.0,[Not Available],,,,320.0,Complete Remission/Response,,,1.0,345.0,1.0,345.0,1.0,320.0,1.0,320.0,
TCGA-E3-A3E0,10016,TCGA-E3-A3E0,THCA,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-12645.0,Alive,TUMOR FREE,2019.0,,[Not Available],,,,,[Not Available],,R0,0.0,2019.0,0.0,2019.0,0.0,2019.0,0.0,2019.0,
TCGA-P5-A77W,5285,TCGA-P5-A77W,LGG,37.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-13545.0,Alive,TUMOR FREE,584.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,584.0,0.0,584.0,0.0,584.0,0.0,584.0,
TCGA-QK-A8ZA,3734,TCGA-QK-A8ZA,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-21979.0,Dead,TUMOR FREE,,371.0,[Not Available],,,,,Complete Remission/Response,,,1.0,371.0,0.0,371.0,,,0.0,371.0,
TCGA-B0-5711,4067,TCGA-B0-5711,KIRC,50.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-18444.0,Alive,WITH TUMOR,3989.0,,[Not Available],,,,3766.0,Complete Remission/Response,,,0.0,3989.0,0.0,3989.0,1.0,3766.0,1.0,3766.0,
TCGA-DM-A0XD,2327,TCGA-DM-A0XD,COAD,65.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2000.0,[Not Available],-23966.0,Dead,,,743.0,[Not Available],,,,484.0,[Not Available],,,1.0,743.0,,743.0,,,1.0,484.0,
TCGA-DE-A0Y3,9906,TCGA-DE-A0Y3,THCA,60.0,FEMALE,ASIAN,Stage IVC,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-22239.0,Alive,TUMOR FREE,1526.0,,[Not Available],Distant Metastasis,Lung,,30.0,[Not Available],,R1,0.0,1526.0,0.0,1526.0,,,1.0,30.0,
TCGA-G3-A3CH,5709,TCGA-G3-A3CH,LIHC,53.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-19473.0,Alive,WITH TUMOR,780.0,,[Not Available],Intrahepatic Recurrence,Liver,,116.0,[Not Available],,R0,0.0,780.0,0.0,780.0,1.0,116.0,1.0,116.0,
TCGA-33-4587,6406,TCGA-33-4587,LUSC,63.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-23062.0,Dead,WITH TUMOR,,1656.0,[Not Available],,,,,Progressive Disease,,,1.0,1656.0,1.0,1656.0,,,1.0,1656.0,
TCGA-GH-A9DA,1768,TCGA-GH-A9DA,CESC,27.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2013.0,[Not Evaluated],-10160.0,Alive,TUMOR FREE,540.0,,,,,,,Complete Remission/Response,,,0.0,540.0,0.0,540.0,0.0,540.0,0.0,540.0,
TCGA-DJ-A3UV,9976,TCGA-DJ-A3UV,THCA,18.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-6850.0,Alive,TUMOR FREE,1466.0,,[Not Available],,,,,[Not Available],,R0,0.0,1466.0,0.0,1466.0,0.0,1466.0,0.0,1466.0,
TCGA-A5-A3LP,10521,TCGA-A5-A3LP,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27131.0,Alive,TUMOR FREE,455.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,
TCGA-43-2581,6471,TCGA-43-2581,LUSC,47.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-17447.0,Alive,TUMOR FREE,1176.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1176.0,0.0,1176.0,0.0,1176.0,0.0,1176.0,
TCGA-44-8117,5892,TCGA-44-8117,LUAD,54.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-19855.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-EJ-8472,7975,TCGA-EJ-8472,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23104.0,Alive,TUMOR FREE,756.0,,[Not Available],Biochemical evidence of disease,,,196.0,Partial Remission/Response,,,0.0,756.0,0.0,756.0,,,1.0,196.0,
TCGA-QT-A5XK,7744,TCGA-QT-A5XK,PCPG,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-20724.0,Alive,TUMOR FREE,211.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,211.0,0.0,211.0,0.0,211.0,0.0,211.0,
TCGA-CV-7415,3555,TCGA-CV-7415,HNSC,60.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1995.0,[Not Available],-22062.0,Dead,WITH TUMOR,,695.0,[Not Available],,,,,[Not Available],,,1.0,695.0,1.0,695.0,,,1.0,695.0,
TCGA-RQ-AAAT,2459,TCGA-RQ-AAAT,DLBC,63.0,FEMALE,WHITE,[Not Applicable],[Not Available],Primary DLBCL of the CNS,[Not Available],2013.0,[Not Available],-23178.0,Alive,TUMOR FREE,17.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,17.0,0.0,17.0,0.0,17.0,0.0,17.0,
TCGA-RD-A8N1,9633,TCGA-RD-A8N1,STAD,70.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2001.0,[Not Available],-25737.0,Alive,TUMOR FREE,3519.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3519.0,0.0,3519.0,0.0,3519.0,0.0,3519.0,
TCGA-95-7947,6240,TCGA-95-7947,LUAD,67.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-24752.0,Alive,TUMOR FREE,477.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,
TCGA-66-2791,6642,TCGA-66-2791,LUSC,66.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-24138.0,Dead,,,153.0,[Not Available],,,,,[Not Available],,,1.0,153.0,,153.0,,,0.0,153.0,
TCGA-E9-A22D,1430,TCGA-E9-A22D,BRCA,38.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14115.0,Alive,TUMOR FREE,1248.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1248.0,0.0,1248.0,0.0,1248.0,0.0,1248.0,
TCGA-FG-A6J3,5131,TCGA-FG-A6J3,LGG,52.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-19138.0,Alive,WITH TUMOR,677.0,,[Not Available],,,,285.0,Progressive Disease,,,0.0,677.0,0.0,677.0,,,1.0,285.0,
TCGA-CV-7252,3542,TCGA-CV-7252,HNSC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1994.0,[Not Available],-22934.0,Dead,WITH TUMOR,,151.0,[Not Available],,,,,Progressive Disease,,,1.0,151.0,1.0,151.0,,,1.0,151.0,
TCGA-ER-A195,9089,TCGA-ER-A195,SKCM,46.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2005.0,[Not Available],-16948.0,Dead,WITH TUMOR,,1078.0,[Not Available],,,,,[Not Available],,,1.0,1078.0,1.0,1078.0,,,1.0,1078.0,
TCGA-FD-A3SL,267,TCGA-FD-A3SL,BLCA,60.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-22020.0,Dead,WITH TUMOR,,712.0,[Not Available],Distant Metastasis,Lung,,260.0,Progressive Disease,,,1.0,712.0,1.0,712.0,,,1.0,260.0,
TCGA-E8-A44K,10038,TCGA-E8-A44K,THCA,50.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-18472.0,Alive,TUMOR FREE,943.0,,[Not Available],,,,,[Not Available],,R0,0.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,
TCGA-YZ-A983,11158,TCGA-YZ-A983,UVM,51.0,FEMALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell,[Not Available],2013.0,[Not Available],-18769.0,Alive,TUMOR FREE,798.0,,[Not Available],,,,,[Not Available],,,0.0,798.0,0.0,798.0,,,0.0,798.0,
TCGA-D1-A17D,10862,TCGA-D1-A17D,UCEC,58.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21441.0,Alive,TUMOR FREE,926.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,926.0,0.0,926.0,0.0,926.0,0.0,926.0,
TCGA-CR-7399,3466,TCGA-CR-7399,HNSC,60.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-22182.0,Alive,TUMOR FREE,181.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,181.0,0.0,181.0,,,0.0,181.0,
TCGA-HF-7131,9550,TCGA-HF-7131,STAD,,FEMALE,[Not Available],Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2007.0,[Not Available],,Alive,TUMOR FREE,,,[Not Available],,,,,Complete Remission/Response,,,0.0,,0.0,,0.0,,0.0,,
TCGA-PQ-A6FI,395,TCGA-PQ-A6FI,BLCA,70.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-25672.0,Alive,TUMOR FREE,372.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,
TCGA-2A-A8VX,7871,TCGA-2A-A8VX,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25904.0,Alive,TUMOR FREE,1378.0,,[Not Available],,,,,[Not Available],,,0.0,1378.0,0.0,1378.0,,,0.0,1378.0,
TCGA-A4-7828,4472,TCGA-A4-7828,KIRP,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-27122.0,Alive,TUMOR FREE,238.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,238.0,0.0,238.0,0.0,238.0,0.0,238.0,
TCGA-CJ-5686,4330,TCGA-CJ-5686,KIRC,59.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-21836.0,Alive,TUMOR FREE,2038.0,,[Not Available],,,,,[Not Available],,,0.0,2038.0,0.0,2038.0,,,0.0,2038.0,
TCGA-WA-A7H4,3769,TCGA-WA-A7H4,HNSC,69.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-25363.0,Alive,TUMOR FREE,443.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,443.0,0.0,443.0,0.0,443.0,0.0,443.0,
TCGA-GR-A4D6,2445,TCGA-GR-A4D6,DLBC,54.0,FEMALE,ASIAN,[Not Applicable],Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010.0,[Not Available],-19838.0,Alive,TUMOR FREE,1334.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1334.0,0.0,1334.0,0.0,1334.0,0.0,1334.0,
TCGA-BR-6564,9309,TCGA-BR-6564,STAD,46.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-17129.0,Dead,TUMOR FREE,,794.0,[Not Available],,,,,Complete Remission/Response,,,1.0,794.0,0.0,794.0,0.0,794.0,0.0,794.0,
TCGA-CR-7365,3439,TCGA-CR-7365,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-22101.0,Alive,TUMOR FREE,1191.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1191.0,0.0,1191.0,,,0.0,1191.0,
TCGA-EB-A3Y6,8948,TCGA-EB-A3Y6,SKCM,56.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-20605.0,Alive,TUMOR FREE,126.0,,[Not Available],,,,,[Not Available],,,0.0,126.0,0.0,126.0,,,0.0,126.0,
TCGA-EM-A2CQ,10146,TCGA-EM-A2CQ,THCA,40.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-14776.0,Alive,TUMOR FREE,374.0,,[Not Available],,,,,[Not Available],,R0,0.0,374.0,0.0,374.0,0.0,374.0,0.0,374.0,
TCGA-GN-A8LK,9209,TCGA-GN-A8LK,SKCM,70.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2009.0,[Not Available],-25725.0,Dead,WITH TUMOR,,1524.0,[Not Available],Locoregional Recurrence,,,436.0,[Not Available],,,1.0,1524.0,1.0,1524.0,,,1.0,436.0,
TCGA-MO-A47P,8732,TCGA-MO-A47P,SARC,37.0,FEMALE,ASIAN,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2012.0,[Not Available],-13765.0,Alive,TUMOR FREE,352.0,,[Not Available],,,,,[Not Available],[Not Available],R0,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,
TCGA-YH-A8SY,7685,TCGA-YH-A8SY,PAAD,73.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],[Discrepancy],G2,2011.0,[Not Available],-26859.0,Alive,,388.0,,,,,,,[Unknown],,,0.0,388.0,0.0,388.0,,,0.0,388.0,
TCGA-DX-A3LW,8579,TCGA-DX-A3LW,SARC,43.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2004.0,[Not Available],-15969.0,Alive,WITH TUMOR,4150.0,,[Not Available],Locoregional Recurrence,,,1125.0,[Not Available],Positive,R1,0.0,4150.0,0.0,4150.0,,,1.0,1125.0,
TCGA-FF-8042,2423,TCGA-FF-8042,DLBC,57.0,FEMALE,ASIAN,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010.0,[Not Available],-21005.0,Alive,TUMOR FREE,946.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,946.0,0.0,946.0,0.0,946.0,0.0,946.0,
TCGA-DX-A1L2,8562,TCGA-DX-A1L2,SARC,78.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2008.0,[Not Available],-28692.0,Alive,WITH TUMOR,2586.0,,[Not Available],Locoregional Recurrence,,,1480.0,[Not Available],[Not Available],R0,0.0,2586.0,0.0,2586.0,1.0,1480.0,1.0,1480.0,
TCGA-DK-A6AV,210,TCGA-DK-A6AV,BLCA,82.0,FEMALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-30089.0,Alive,TUMOR FREE,1952.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1952.0,0.0,1952.0,0.0,1952.0,0.0,1952.0,
TCGA-AR-A24H,932,TCGA-AR-A24H,BRCA,65.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24046.0,Alive,TUMOR FREE,4894.0,,[Not Available],,,,,[Not Available],Negative,,0.0,4894.0,0.0,4894.0,0.0,4894.0,0.0,4894.0,
TCGA-LD-A7W6,1528,TCGA-LD-A7W6,BRCA,54.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20077.0,Alive,TUMOR FREE,404.0,,[Not Available],,,,,[Not Available],Negative,,0.0,404.0,0.0,404.0,0.0,404.0,0.0,404.0,
TCGA-CG-4306,9448,TCGA-CG-4306,STAD,90.0,MALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,[Not Available],-32871.0,Dead,,,31.0,[Not Available],,,,,[Not Available],,,1.0,31.0,,31.0,,,0.0,31.0,
TCGA-WY-A858,5419,TCGA-WY-A858,LGG,32.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-11855.0,Alive,TUMOR FREE,1337.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1337.0,0.0,1337.0,0.0,1337.0,0.0,1337.0,
TCGA-14-0790,3004,TCGA-14-0790,GBM,64.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-23674.0,Dead,WITH TUMOR,419.0,419.0,[Not Available],,,,,[Not Available],,,1.0,419.0,1.0,419.0,,,1.0,419.0,
TCGA-N8-A56S,11055,TCGA-N8-A56S,UCS,75.0,FEMALE,WHITE,[Not Applicable],Stage IB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27519.0,Dead,WITH TUMOR,,371.0,[Not Available],Progression of Disease,Lung,,199.0,Stable Disease,,,1.0,371.0,1.0,371.0,,,1.0,199.0,
TCGA-TQ-A7RR,5399,TCGA-TQ-A7RR,LGG,38.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-14022.0,Alive,TUMOR FREE,787.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,787.0,0.0,787.0,,,0.0,787.0,
TCGA-E2-A574,1390,TCGA-E2-A574,BRCA,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16195.0,Alive,TUMOR FREE,1179.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1179.0,0.0,1179.0,0.0,1179.0,0.0,1179.0,
TCGA-XU-AAY1,10440,TCGA-XU-AAY1,THYM,51.0,FEMALE,ASIAN,[Not Applicable],IIa,Thymoma; Type AB,[Not Available],2005.0,[Not Available],-18777.0,Alive,TUMOR FREE,3268.0,,[Not Available],,,,,[Not Available],,,0.0,3268.0,0.0,3268.0,,,0.0,3268.0,
TCGA-BQ-5881,4541,TCGA-BQ-5881,KIRP,69.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-25481.0,Alive,TUMOR FREE,1454.0,,[Not Available],,,,,[Not Available],,,0.0,1454.0,0.0,1454.0,,,0.0,1454.0,
TCGA-CN-5363,3327,TCGA-CN-5363,HNSC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Stage IVB,Head & Neck Squamous Cell Carcinoma,G3,2007.0,[Not Available],-17635.0,Dead,WITH TUMOR,,253.0,[Not Available],,Distant Metastasis,BONE,53.0,Complete Remission/Response,,,1.0,253.0,1.0,253.0,,,1.0,53.0,
TCGA-IG-A5B8,2486,TCGA-IG-A5B8,ESCA,72.0,MALE,WHITE,Stage IB,[Not Available],Esophagus Squamous Cell Carcinoma,G1,2012.0,[Not Available],-26574.0,Dead,TUMOR FREE,,24.0,[Not Available],,,,,,,,1.0,24.0,0.0,24.0,,,0.0,24.0,
TCGA-SR-A6MS,7807,TCGA-SR-A6MS,PCPG,35.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2007.0,[Not Available],-12979.0,Alive,TUMOR FREE,2492.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2492.0,0.0,2492.0,0.0,2492.0,0.0,2492.0,
TCGA-VS-A9V3,1886,TCGA-VS-A9V3,CESC,62.0,FEMALE,WHITE,[Not Available],Stage IVB,Cervical Squamous Cell Carcinoma,G3,2013.0,[Not Evaluated],-22990.0,Alive,WITH TUMOR,540.0,,,Distant Metastasis,"Other, specify",Mediastinal lymph nodes,456.0,Complete Remission/Response,,,0.0,540.0,0.0,540.0,,,1.0,456.0,
TCGA-E7-A7XN,251,TCGA-E7-A7XN,BLCA,66.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-24466.0,Alive,WITH TUMOR,428.0,,[Not Available],Locoregional (Urothelial tumor event),Bladder,,190.0,Progressive Disease,,,0.0,428.0,0.0,428.0,,,1.0,190.0,
TCGA-D3-A2JC,8841,TCGA-D3-A2JC,SKCM,53.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],2006.0,[Not Available],-19644.0,Alive,TUMOR FREE,2639.0,,[Not Available],,,,,[Not Available],,,0.0,2639.0,0.0,2639.0,,,0.0,2639.0,
TCGA-B5-A3FC,10727,TCGA-B5-A3FC,UCEC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19422.0,Alive,TUMOR FREE,2185.0,,[Not Available],,,,,[Not Available],,,0.0,2185.0,0.0,2185.0,,,0.0,2185.0,
TCGA-46-3765,6491,TCGA-46-3765,LUSC,59.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-21762.0,Alive,TUMOR FREE,405.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,405.0,0.0,405.0,0.0,405.0,0.0,405.0,
TCGA-WN-AB4C,4701,TCGA-WN-AB4C,KIRP,60.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],,Alive,WITH TUMOR,1188.0,,[Not Available],,,,1157.0,Complete Remission/Response,,,0.0,1188.0,0.0,1188.0,1.0,1157.0,1.0,1157.0,
TCGA-B1-A655,4510,TCGA-B1-A655,KIRP,77.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-28433.0,Alive,TUMOR FREE,510.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,510.0,0.0,510.0,0.0,510.0,0.0,510.0,
TCGA-WC-A88A,11153,TCGA-WC-A88A,UVM,75.0,MALE,WHITE,Stage IV,Stage IV,Spindle Cell|Epithelioid Cell,[Not Available],2013.0,[Not Available],-27722.0,Dead,WITH TUMOR,,82.0,Metastatic Uveal Melanoma,,,,,[Not Available],,,1.0,82.0,1.0,82.0,,,1.0,82.0,
TCGA-ET-A3BN,10230,TCGA-ET-A3BN,THCA,33.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-12122.0,Alive,TUMOR FREE,859.0,,[Not Available],,,,,[Not Available],,R0,0.0,859.0,0.0,859.0,0.0,859.0,0.0,859.0,
TCGA-RW-A685,7764,TCGA-RW-A685,PCPG,70.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-25790.0,Alive,TUMOR FREE,26.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,26.0,0.0,26.0,0.0,26.0,0.0,26.0,
TCGA-D7-A6EV,9519,TCGA-D7-A6EV,STAD,71.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,[Not Available],-26226.0,Alive,TUMOR FREE,342.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,342.0,0.0,342.0,0.0,342.0,0.0,342.0,
TCGA-HB-A5W3,8687,TCGA-HB-A5W3,SARC,58.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-21416.0,Dead,WITH TUMOR,,384.0,[Not Available],,,,,[Not Available],Negative,R0,1.0,384.0,1.0,384.0,,,1.0,384.0,
TCGA-DU-A7TJ,5065,TCGA-DU-A7TJ,LGG,55.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-20394.0,Alive,WITH TUMOR,17.0,,[Not Available],,,,,[Unknown],,,0.0,17.0,0.0,17.0,,,0.0,17.0,
TCGA-06-A5U0,2888,TCGA-06-A5U0,GBM,21.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2012.0,[Not Available],-7958.0,Alive,WITH TUMOR,815.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],100.0,Progressive Disease,,,0.0,815.0,0.0,815.0,,,1.0,100.0,
TCGA-08-0386,2918,TCGA-08-0386,GBM,74.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-27053.0,Dead,WITH TUMOR,478.0,548.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],427.0,[Not Available],,,1.0,548.0,1.0,548.0,,,1.0,427.0,
TCGA-VD-A8K8,11118,TCGA-VD-A8K8,UVM,56.0,FEMALE,[Not Evaluated],Stage IIB,Stage IIIA,Epithelioid Cell|Spindle Cell,[Not Available],2011.0,[Not Available],-20454.0,Dead,WITH TUMOR,,1377.0,Metastatic Uveal Melanoma,,,,,[Not Available],,,1.0,1377.0,1.0,1377.0,,,1.0,1377.0,
TCGA-SN-A6IS,9786,TCGA-SN-A6IS,TGCT,26.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS|Non-Seminoma; Teratoma (Mature),[Not Available],2013.0,[Not Available],-9618.0,Alive,TUMOR FREE,496.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,
TCGA-C5-A7CG,1644,TCGA-C5-A7CG,CESC,55.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1997.0,[Not Available],-20242.0,Alive,TUMOR FREE,6408.0,,,,,,,[Not Available],,,0.0,6408.0,0.0,6408.0,,,0.0,6408.0,
TCGA-CR-7374,3447,TCGA-CR-7374,HNSC,67.0,FEMALE,WHITE,[Not Available],Stage II,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-24558.0,Alive,WITH TUMOR,30.0,,[Not Available],,,,,[Not Available],,,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-2J-AABH,7511,TCGA-2J-AABH,PAAD,61.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2011.0,[Not Available],-22425.0,Alive,WITH TUMOR,1287.0,,,Distant Metastasis,"Other, specify",perigastric mass,1287.0,Complete Remission/Response,,,0.0,1287.0,0.0,1287.0,1.0,1287.0,1.0,1287.0,
TCGA-SP-A6QJ,7800,TCGA-SP-A6QJ,PCPG,64.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-23406.0,Alive,TUMOR FREE,472.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,472.0,0.0,472.0,0.0,472.0,0.0,472.0,
TCGA-J4-A83L,8147,TCGA-J4-A83L,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22338.0,Alive,TUMOR FREE,720.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,720.0,0.0,720.0,0.0,720.0,0.0,720.0,
TCGA-D5-6534,2305,TCGA-D5-6534,COAD,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-22778.0,Alive,TUMOR FREE,1316.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1316.0,0.0,1316.0,0.0,1316.0,0.0,1316.0,
TCGA-CV-5434,3473,TCGA-CV-5434,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2000.0,[Not Available],-22182.0,Dead,TUMOR FREE,3295.0,3314.0,[Not Available],,Distant Metastasis,Lung,1859.0,Complete Remission/Response,,,1.0,3314.0,0.0,3314.0,,,1.0,1859.0,
TCGA-VS-A9UI,1870,TCGA-VS-A9UI,CESC,76.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,GX,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27838.0,Dead,TUMOR FREE,,1372.0,,,,,,Complete Remission/Response,,,1.0,1372.0,0.0,1372.0,0.0,1372.0,0.0,1372.0,
TCGA-CV-6441,3493,TCGA-CV-6441,HNSC,60.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-22025.0,Dead,WITH TUMOR,,292.0,[Not Available],Locoregional Recurrence,Oral Cavity,pharyngeal,95.0,Progressive Disease,,,1.0,292.0,1.0,292.0,,,1.0,95.0,
TCGA-77-6844,6660,TCGA-77-6844,LUSC,74.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-27220.0,Dead,,,2284.0,[Not Available],,,,1788.0,Complete Remission/Response,,,1.0,2284.0,,2284.0,1.0,1788.0,1.0,1788.0,
TCGA-76-4932,3217,TCGA-76-4932,GBM,50.0,FEMALE,WHITE,[Not Available],[Not Applicable],Treated primary GBM,[Not Available],2006.0,[Not Available],-18433.0,Dead,WITH TUMOR,1458.0,1458.0,[Not Available],,,,,[Not Available],,,1.0,1458.0,1.0,1458.0,,,1.0,1458.0,
TCGA-70-6722,6656,TCGA-70-6722,LUSC,47.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-17328.0,Alive,WITH TUMOR,367.0,,[Not Available],Locoregional Recurrence,,,293.0,Progressive Disease,,,0.0,367.0,0.0,367.0,,,1.0,293.0,
TCGA-EJ-5512,7927,TCGA-EJ-5512,PRAD,46.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-17127.0,Alive,TUMOR FREE,1733.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1733.0,0.0,1733.0,0.0,1733.0,0.0,1733.0,
TCGA-DB-A75O,4963,TCGA-DB-A75O,LGG,29.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-10812.0,Alive,,935.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,935.0,0.0,935.0,,,0.0,935.0,
TCGA-B5-A11S,10707,TCGA-B5-A11S,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23085.0,Alive,TUMOR FREE,2229.0,,[Not Available],New Primary Tumor,"Other, specify",Breast,41.0,Complete Remission/Response,,,0.0,2229.0,0.0,2229.0,0.0,2229.0,1.0,41.0,
TCGA-J8-A3YG,10326,TCGA-J8-A3YG,THCA,54.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-19785.0,Alive,TUMOR FREE,678.0,,[Not Available],,,,,[Not Available],,R0,0.0,678.0,0.0,678.0,0.0,678.0,0.0,678.0,
TCGA-WZ-A7V5,9803,TCGA-WZ-A7V5,TGCT,27.0,MALE,WHITE,Stage I,[Not Available],Seminoma; NOS,[Not Available],2012.0,[Not Available],-9886.0,Alive,TUMOR FREE,1061.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,1061.0,0.0,1061.0,0.0,1061.0,0.0,1061.0,
TCGA-A7-A26E,643,TCGA-A7-A26E,BRCA,71.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26274.0,Alive,TUMOR FREE,954.0,,[Not Available],,,,,[Not Available],Negative,,0.0,954.0,0.0,954.0,0.0,954.0,0.0,954.0,
TCGA-EM-A2OV,10151,TCGA-EM-A2OV,THCA,64.0,FEMALE,ASIAN,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-23656.0,Alive,TUMOR FREE,674.0,,[Not Available],,,,,[Not Available],,R0,0.0,674.0,0.0,674.0,0.0,674.0,0.0,674.0,
TCGA-BF-AAP2,8820,TCGA-BF-AAP2,SKCM,62.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2013.0,[Not Available],-22734.0,Alive,TUMOR FREE,405.0,,[Not Available],,,,,[Not Available],,,0.0,405.0,0.0,405.0,,,0.0,405.0,
TCGA-EL-A3ZH,10094,TCGA-EL-A3ZH,THCA,42.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-15685.0,Alive,TUMOR FREE,2773.0,,[Not Available],,,,,[Not Available],,R0,0.0,2773.0,0.0,2773.0,0.0,2773.0,0.0,2773.0,
TCGA-FX-A3TO,8679,TCGA-FX-A3TO,SARC,87.0,MALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012.0,[Not Available],-31868.0,Alive,TUMOR FREE,618.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,618.0,0.0,618.0,,,0.0,618.0,
TCGA-GL-6846,4608,TCGA-GL-6846,KIRP,52.0,MALE,WHITE,Stage IV,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],1996.0,[Not Available],-19012.0,Alive,TUMOR FREE,5925.0,,[Not Available],,,,,[Not Available],,,0.0,5925.0,0.0,5925.0,,,0.0,5925.0,
TCGA-EJ-7115,7944,TCGA-EJ-7115,PRAD,65.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-23986.0,Alive,TUMOR FREE,2687.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2687.0,0.0,2687.0,0.0,2687.0,0.0,2687.0,
TCGA-FD-A3SP,271,TCGA-FD-A3SP,BLCA,60.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-22005.0,Alive,TUMOR FREE,783.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,783.0,0.0,783.0,0.0,783.0,0.0,783.0,
TCGA-EC-A1NJ,10916,TCGA-EC-A1NJ,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27002.0,Alive,TUMOR FREE,488.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,488.0,0.0,488.0,0.0,488.0,0.0,488.0,
TCGA-FF-A7CR,2430,TCGA-FF-A7CR,DLBC,61.0,MALE,ASIAN,[Not Applicable],Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2012.0,[Not Available],-22471.0,Dead,WITH TUMOR,,313.0,[Not Available],,"Other, specify",Skin (Calf and Chest wall),290.0,Progressive Disease,,,1.0,313.0,1.0,313.0,,,1.0,290.0,
TCGA-CN-A499,3359,TCGA-CN-A499,HNSC,60.0,FEMALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-21971.0,Alive,TUMOR FREE,717.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,717.0,0.0,717.0,0.0,717.0,0.0,717.0,
TCGA-HC-A4ZV,8108,TCGA-HC-A4ZV,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20634.0,Alive,WITH TUMOR,23.0,,[Not Available],,,,,[Unknown],,,0.0,23.0,0.0,23.0,,,0.0,23.0,
TCGA-IA-A83V,4632,TCGA-IA-A83V,KIRP,63.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2002.0,[Not Available],-23238.0,Dead,,,2941.0,[Not Available],,,,,[Unknown],,,1.0,2941.0,,2941.0,,,0.0,2941.0,
TCGA-A7-A13E,639,TCGA-A7-A13E,BRCA,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22690.0,Dead,WITH TUMOR,,614.0,[Not Available],Distant Metastasis,"Other, specify","Lung, Bone, Liver, Brain and Skin Nodules",556.0,[Not Available],Negative,,1.0,614.0,1.0,614.0,1.0,556.0,1.0,556.0,
TCGA-D5-6928,2320,TCGA-D5-6928,COAD,80.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-29411.0,Alive,TUMOR FREE,354.0,,[Not Available],,,,,[Not Available],,,0.0,354.0,0.0,354.0,,,0.0,354.0,
TCGA-D8-A13Z,1226,TCGA-D8-A13Z,BRCA,51.0,FEMALE,WHITE,[Not Available],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18942.0,Alive,TUMOR FREE,635.0,,[Not Available],,,,,[Not Available],Negative,,0.0,635.0,0.0,635.0,0.0,635.0,0.0,635.0,
TCGA-AX-A2H7,10648,TCGA-AX-A2H7,UCEC,87.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2008.0,[Not Available],-32100.0,Dead,WITH TUMOR,,1241.0,[Not Available],Metastatic,Lung,,684.0,Complete Remission/Response,,,1.0,1241.0,1.0,1241.0,1.0,684.0,1.0,684.0,
TCGA-CE-A484,9902,TCGA-CE-A484,THCA,37.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-13815.0,Alive,TUMOR FREE,378.0,,[Not Available],,,,,[Not Available],,R0,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,
TCGA-F7-A61V,3651,TCGA-F7-A61V,HNSC,54.0,MALE,WHITE,Stage II,[Not Available],Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-19857.0,Alive,TUMOR FREE,759.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,759.0,0.0,759.0,0.0,759.0,0.0,759.0,
TCGA-G4-6320,2384,TCGA-G4-6320,COAD,73.0,MALE,WHITE,Stage III,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-26840.0,Alive,TUMOR FREE,804.0,,[Not Available],,,,,[Not Available],,,0.0,804.0,0.0,804.0,,,0.0,804.0,
TCGA-3H-AB3X,6836,TCGA-3H-AB3X,MESO,62.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2010.0,[Not Available],-22702.0,Alive,TUMOR FREE,1490.0,,[Not Available],,,,,[Not Available],,[Unknown],0.0,1490.0,0.0,1490.0,,,0.0,1490.0,
TCGA-ZF-A9RE,483,TCGA-ZF-A9RE,BLCA,78.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-28622.0,Dead,WITH TUMOR,,106.0,[Not Available],,,,,Progressive Disease,,,1.0,106.0,1.0,106.0,,,1.0,106.0,
TCGA-CV-5970,3483,TCGA-CV-5970,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-21890.0,Dead,WITH TUMOR,406.0,406.0,[Not Available],,,,,[Not Available],,,1.0,406.0,1.0,406.0,,,1.0,406.0,
TCGA-QT-A5XO,7748,TCGA-QT-A5XO,PCPG,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-23154.0,Alive,TUMOR FREE,70.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,70.0,0.0,70.0,0.0,70.0,0.0,70.0,
TCGA-CZ-4866,4366,TCGA-CZ-4866,KIRC,79.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-28878.0,Alive,WITH TUMOR,3267.0,,[Not Available],,,,,[Not Available],,,0.0,3267.0,0.0,3267.0,,,0.0,3267.0,
TCGA-UZ-A9PK,4684,TCGA-UZ-A9PK,KIRP,71.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-25933.0,Alive,TUMOR FREE,3571.0,,[Not Available],,,,3157.0,Complete Remission/Response,,,0.0,3571.0,0.0,3571.0,1.0,3157.0,1.0,3157.0,
TCGA-D8-A1J8,1234,TCGA-D8-A1J8,BRCA,77.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28444.0,Alive,TUMOR FREE,431.0,,[Not Available],,,,,[Not Available],Negative,,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,
TCGA-DD-A3A7,5549,TCGA-DD-A3A7,LIHC,67.0,MALE,[Unknown],Stage IIIB,[Not Applicable],Hepatocellular Carcinoma,G3,1998.0,[Not Available],-24599.0,Dead,WITH TUMOR,,419.0,[Not Available],Intrahepatic Recurrence,Liver,,144.0,[Not Available],,R0,1.0,419.0,1.0,419.0,1.0,144.0,1.0,144.0,
TCGA-DW-7963,4580,TCGA-DW-7963,KIRP,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-15967.0,Alive,TUMOR FREE,1240.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1240.0,0.0,1240.0,0.0,1240.0,0.0,1240.0,
TCGA-XE-AAOF,9820,TCGA-XE-AAOF,TGCT,50.0,MALE,ASIAN,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2009.0,[Not Available],-18490.0,Alive,TUMOR FREE,1268.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,1268.0,0.0,1268.0,0.0,1268.0,0.0,1268.0,
TCGA-VV-A86M,5414,TCGA-VV-A86M,LGG,36.0,FEMALE,[Not Evaluated],[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-13453.0,Alive,TUMOR FREE,487.0,,[Not Available],,,,,[Unknown],,,0.0,487.0,0.0,487.0,,,0.0,487.0,
TCGA-76-6662,3232,TCGA-76-6662,GBM,58.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-21511.0,Dead,WITH TUMOR,,1048.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],205.0,[Not Available],,,1.0,1048.0,1.0,1048.0,,,1.0,205.0,
TCGA-EK-A2PM,1727,TCGA-EK-A2PM,CESC,81.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29747.0,Alive,WITH TUMOR,18.0,,,,,,,[Not Available],,,0.0,18.0,0.0,18.0,,,0.0,18.0,
TCGA-FG-7637,5109,TCGA-FG-7637,LGG,49.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2009.0,[Not Available],-18084.0,Alive,WITH TUMOR,1219.0,,[Not Available],,,,,Stable Disease,,,0.0,1219.0,0.0,1219.0,,,0.0,1219.0,
TCGA-RD-A7C1,9629,TCGA-RD-A7C1,STAD,82.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2005.0,[Not Available],-30171.0,Dead,WITH TUMOR,,507.0,Stomach Cancer,Distant Metastasis,Non-regional / Distant Lymph Nodes,,438.0,Complete Remission/Response,,,1.0,507.0,1.0,507.0,1.0,438.0,1.0,438.0,
TCGA-ED-A7XP,5675,TCGA-ED-A7XP,LIHC,53.0,FEMALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-19504.0,Alive,WITH TUMOR,400.0,,[Not Available],Locoregional Recurrence,Liver,,187.0,[Not Available],,R0,0.0,400.0,0.0,400.0,1.0,187.0,1.0,187.0,
TCGA-RR-A6KA,3239,TCGA-RR-A6KA,GBM,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2012.0,[Not Available],-26582.0,Dead,WITH TUMOR,,191.0,[Not Available],,,,,Partial Remission/Response,,,1.0,191.0,1.0,191.0,,,1.0,191.0,
TCGA-LL-A6FR,1541,TCGA-LL-A6FR,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18520.0,Alive,TUMOR FREE,489.0,,[Not Available],,,,,[Not Available],Negative,,0.0,489.0,0.0,489.0,0.0,489.0,0.0,489.0,
TCGA-VQ-A91E,9675,TCGA-VQ-A91E,STAD,67.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013.0,[Not Available],-24549.0,Alive,TUMOR FREE,664.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,664.0,0.0,664.0,0.0,664.0,0.0,664.0,
TCGA-EE-A2GU,9045,TCGA-EE-A2GU,SKCM,65.0,FEMALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2005.0,[Not Available],-23784.0,Alive,TUMOR FREE,2884.0,,[Not Available],,,,,[Not Available],,,0.0,2884.0,0.0,2884.0,,,0.0,2884.0,
TCGA-XD-AAUL,7681,TCGA-XD-AAUL,PAAD,56.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-20607.0,Alive,TUMOR FREE,498.0,,,,,,,Complete Remission/Response,,,0.0,498.0,0.0,498.0,0.0,498.0,0.0,498.0,
TCGA-J7-A8I2,4640,TCGA-J7-A8I2,KIRP,75.0,MALE,ASIAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-27431.0,Alive,WITH TUMOR,307.0,,[Not Available],,,,268.0,Complete Remission/Response,,,0.0,307.0,0.0,307.0,1.0,268.0,1.0,268.0,
TCGA-AR-A24Q,939,TCGA-AR-A24Q,BRCA,49.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18084.0,Alive,TUMOR FREE,3172.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3172.0,0.0,3172.0,0.0,3172.0,0.0,3172.0,
TCGA-D7-8574,9507,TCGA-D7-8574,STAD,72.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-26586.0,Alive,TUMOR FREE,523.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,523.0,0.0,523.0,0.0,523.0,0.0,523.0,
TCGA-V5-AASV,2618,TCGA-V5-AASV,ESCA,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Available],Esophagus Squamous Cell Carcinoma,G3,,[Not Available],-24559.0,Alive,WITH TUMOR,467.0,,[Not Available],Distant Metastasis,Lung,,322.0,Partial Remission/Response,,,0.0,467.0,0.0,467.0,,,1.0,322.0,
TCGA-05-4420,5822,TCGA-05-4420,LUAD,41.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-15159.0,Alive,TUMOR FREE,912.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,912.0,0.0,912.0,0.0,912.0,0.0,912.0,
TCGA-J8-A42S,10328,TCGA-J8-A42S,THCA,45.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-16609.0,Alive,,75.0,,[Not Available],,,,,[Not Available],,R0,0.0,75.0,0.0,75.0,0.0,75.0,0.0,75.0,
TCGA-QC-A7B5,8743,TCGA-QC-A7B5,SARC,75.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013.0,[Not Available],-27556.0,Alive,TUMOR FREE,398.0,,[Not Available],New Primary Tumor,"Other, specify",skin,259.0,[Not Available],Positive,RX,0.0,398.0,0.0,398.0,,,1.0,259.0,
TCGA-W5-AA2U,1929,TCGA-W5-AA2U,CHOL,78.0,FEMALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2010.0,[Not Available],-28552.0,Dead,WITH TUMOR,,627.0,[Not Available],New Primary Tumor,Lung,,95.0,[Not Available],,R0,1.0,627.0,1.0,627.0,0.0,627.0,1.0,95.0,
TCGA-TM-A84H,5378,TCGA-TM-A84H,LGG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2012.0,[Not Available],-16277.0,Alive,TUMOR FREE,926.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,926.0,0.0,926.0,0.0,926.0,0.0,926.0,
TCGA-AO-A125,871,TCGA-AO-A125,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26466.0,Alive,TUMOR FREE,3456.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3456.0,0.0,3456.0,0.0,3456.0,0.0,3456.0,
TCGA-NC-A5HP,6813,TCGA-NC-A5HP,LUSC,69.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25286.0,Dead,WITH TUMOR,,770.0,[Not Available],Distant Metastasis,,,317.0,Progressive Disease,,,1.0,770.0,1.0,770.0,,,1.0,317.0,
TCGA-BP-4795,4189,TCGA-BP-4795,KIRC,74.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-27162.0,Alive,TUMOR FREE,620.0,,[Not Available],,,,,[Not Available],,,0.0,620.0,0.0,620.0,,,0.0,620.0,
TCGA-DX-AB2T,8662,TCGA-DX-AB2T,SARC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2008.0,[Not Available],-19749.0,Alive,TUMOR FREE,2369.0,,[Not Available],Distant Metastasis,Lung,,784.0,[Not Available],Negative,R0,0.0,2369.0,0.0,2369.0,1.0,784.0,1.0,784.0,
TCGA-2G-AAHN,9764,TCGA-2G-AAHN,TGCT,32.0,MALE,WHITE,Stage I,Stage I,Seminoma; NOS,[Not Available],1996.0,[Not Available],-12028.0,Alive,TUMOR FREE,6445.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,6445.0,0.0,6445.0,0.0,6445.0,0.0,6445.0,
TCGA-DX-A6BA,8606,TCGA-DX-A6BA,SARC,53.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2008.0,[Not Available],-19455.0,Alive,WITH TUMOR,2515.0,,[Not Available],Locoregional Recurrence,,,408.0,[Not Available],Negative,R0,0.0,2515.0,0.0,2515.0,1.0,408.0,1.0,408.0,
TCGA-ZF-A9RL,486,TCGA-ZF-A9RL,BLCA,61.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-22480.0,Alive,TUMOR FREE,2703.0,,[Not Available],Locoregional (Urothelial tumor event),Bladder,,1064.0,Complete Remission/Response,,,0.0,2703.0,0.0,2703.0,1.0,1064.0,1.0,1064.0,
TCGA-W5-AA2I,1921,TCGA-W5-AA2I,CHOL,66.0,MALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2005.0,[Not Available],-24388.0,Dead,WITH TUMOR,,1939.0,[Not Available],New Primary Tumor,"Other, specify",bladder,217.0,[Not Available],,R0,1.0,1939.0,1.0,1939.0,0.0,1939.0,1.0,217.0,
TCGA-DE-A4MD,9914,TCGA-DE-A4MD,THCA,71.0,MALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-26179.0,Alive,TUMOR FREE,764.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,267.0,[Not Available],,R0,0.0,764.0,0.0,764.0,,,1.0,267.0,
TCGA-C5-A7XC,1658,TCGA-C5-A7XC,CESC,26.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2004.0,[Not Available],-9776.0,Alive,TUMOR FREE,1551.0,,,,,,,[Not Available],,,0.0,1551.0,0.0,1551.0,,,0.0,1551.0,
TCGA-CK-5916,2253,TCGA-CK-5916,COAD,71.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2003.0,[Not Available],-26024.0,Dead,WITH TUMOR,,643.0,[Not Available],,,,292.0,Progressive Disease,,,1.0,643.0,1.0,643.0,,,1.0,292.0,
TCGA-EL-A3T0,10083,TCGA-EL-A3T0,THCA,45.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2001.0,[Not Available],-16798.0,Alive,TUMOR FREE,4335.0,,[Not Available],,,,,[Not Available],,R0,0.0,4335.0,0.0,4335.0,0.0,4335.0,0.0,4335.0,
TCGA-CZ-5458,4374,TCGA-CZ-5458,KIRC,43.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-15790.0,Alive,TUMOR FREE,2789.0,,[Not Available],,,,,[Not Available],,,0.0,2789.0,0.0,2789.0,,,0.0,2789.0,
TCGA-CH-5764,7896,TCGA-CH-5764,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-24257.0,Alive,TUMOR FREE,31.0,,[Not Available],,,,,[Not Available],,,0.0,31.0,0.0,31.0,,,0.0,31.0,
TCGA-EE-A17X,8992,TCGA-EE-A17X,SKCM,54.0,MALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2006.0,[Not Available],-20021.0,Dead,WITH TUMOR,,907.0,[Not Available],Locoregional Recurrence,,,531.0,[Not Available],,,1.0,907.0,1.0,907.0,,,1.0,531.0,
TCGA-ZF-AA5P,504,TCGA-ZF-AA5P,BLCA,65.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-23971.0,Alive,TUMOR FREE,372.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,372.0,0.0,372.0,,,0.0,372.0,
TCGA-94-A5I6,6774,TCGA-94-A5I6,LUSC,62.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-22949.0,Alive,WITH TUMOR,538.0,,[Not Available],Distant Metastasis,,,481.0,Progressive Disease,,,0.0,538.0,0.0,538.0,,,1.0,481.0,
TCGA-DU-8162,5034,TCGA-DU-8162,LGG,61.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-22596.0,Dead,WITH TUMOR,,444.0,[Not Available],,,,402.0,Progressive Disease,,,1.0,444.0,1.0,444.0,,,1.0,402.0,
TCGA-PG-A915,11011,TCGA-PG-A915,UCEC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22119.0,Alive,TUMOR FREE,249.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,249.0,0.0,249.0,0.0,249.0,0.0,249.0,
TCGA-EM-A3FM,10172,TCGA-EM-A3FM,THCA,57.0,MALE,[Not Available],Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-20938.0,Alive,WITH TUMOR,639.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,514.0,[Not Available],,R0,0.0,639.0,0.0,639.0,,,1.0,514.0,
TCGA-HT-A74J,5240,TCGA-HT-A74J,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-12393.0,Alive,,320.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,320.0,0.0,320.0,,,0.0,320.0,
TCGA-B7-A5TI,9272,TCGA-B7-A5TI,STAD,52.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-19014.0,Alive,TUMOR FREE,595.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,
TCGA-MI-A75H,5752,TCGA-MI-A75H,LIHC,77.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,[Not Available],2012.0,[Not Available],-28371.0,Alive,WITH TUMOR,747.0,,[Not Available],Locoregional Recurrence,Liver,,301.0,[Not Available],,R0,0.0,747.0,0.0,747.0,1.0,301.0,1.0,301.0,
TCGA-EY-A1H0,10963,TCGA-EY-A1H0,UCEC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20937.0,Alive,WITH TUMOR,588.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,588.0,0.0,588.0,,,0.0,588.0,
TCGA-DU-A76O,5055,TCGA-DU-A76O,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-10960.0,Alive,WITH TUMOR,522.0,,[Not Available],,,,,[Unknown],,,0.0,522.0,0.0,522.0,,,0.0,522.0,
TCGA-OR-A5JQ,25,TCGA-OR-A5JQ,ACC,26.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical Carcinoma- Myxoid Type,[Not Available],2006.0,[Not Available],-9667.0,Alive,TUMOR FREE,1103.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1103.0,0.0,1103.0,0.0,1103.0,0.0,1103.0,
TCGA-86-8054,6187,TCGA-86-8054,LUAD,61.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22584.0,Alive,TUMOR FREE,1148.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1148.0,0.0,1148.0,0.0,1148.0,0.0,1148.0,
TCGA-S9-A6WH,5340,TCGA-S9-A6WH,LGG,73.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-26904.0,Alive,WITH TUMOR,1173.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1173.0,0.0,1173.0,,,0.0,1173.0,
TCGA-06-2559,2853,TCGA-06-2559,GBM,83.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-30580.0,Dead,WITH TUMOR,150.0,150.0,[Not Available],,,,,[Not Available],,,1.0,150.0,1.0,150.0,,,1.0,150.0,
TCGA-MQ-A6BR,6863,TCGA-MQ-A6BR,MESO,55.0,FEMALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2008.0,[Not Available],-20134.0,Alive,WITH TUMOR,2090.0,,[Not Available],Distant Metastasis,"Other, specify",Chest Wall,665.0,[Not Available],,RX,0.0,2090.0,0.0,2090.0,,,1.0,665.0,
TCGA-A2-A0D3,555,TCGA-A2-A0D3,BRCA,42.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15524.0,Alive,TUMOR FREE,1873.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1873.0,0.0,1873.0,0.0,1873.0,0.0,1873.0,
TCGA-HR-A2OH,9214,TCGA-HR-A2OH,SKCM,46.0,FEMALE,[Not Evaluated],Stage IIIB,[Not Applicable],,[Not Available],,[Not Available],-16910.0,Dead,WITH TUMOR,,2004.0,[Not Available],,,,,[Not Available],,,1.0,2004.0,1.0,2004.0,,,1.0,2004.0,
TCGA-85-8287,6723,TCGA-85-8287,LUSC,72.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26401.0,Dead,TUMOR FREE,,23.0,[Not Available],,,,,Complete Remission/Response,,,1.0,23.0,0.0,23.0,0.0,23.0,0.0,23.0,
TCGA-BP-5006,4233,TCGA-BP-5006,KIRC,61.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-22324.0,Alive,TUMOR FREE,840.0,,[Not Available],,,,,[Not Available],,,0.0,840.0,0.0,840.0,,,0.0,840.0,
TCGA-TN-A7HI,3746,TCGA-TN-A7HI,HNSC,56.0,MALE,WHITE,Stage IVA,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-20666.0,Alive,TUMOR FREE,412.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,412.0,0.0,412.0,,,0.0,412.0,
TCGA-AA-3662,2057,TCGA-AA-3662,COAD,80.0,FEMALE,[Not Available],Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-29554.0,Alive,WITH TUMOR,184.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,184.0,0.0,184.0,,,0.0,184.0,
TCGA-IB-7888,7629,TCGA-IB-7888,PAAD,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,[Not Available],-24117.0,Dead,WITH TUMOR,,1332.0,Pancreatic Cancer,Distant Metastasis,"Other, specify",Retroperitoneum,427.0,Stable Disease,,,1.0,1332.0,1.0,1332.0,,,1.0,427.0,
TCGA-AR-A2LM,959,TCGA-AR-A2LM,BRCA,49.0,FEMALE,WHITE,Stage II,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18053.0,Alive,TUMOR FREE,1935.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0,
TCGA-DX-AB2V,8663,TCGA-DX-AB2V,SARC,81.0,MALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2006.0,[Not Available],-29716.0,Alive,TUMOR FREE,3241.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,3241.0,0.0,3241.0,0.0,3241.0,0.0,3241.0,
TCGA-D7-A6F2,9524,TCGA-D7-A6F2,STAD,62.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-22801.0,Alive,TUMOR FREE,476.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,
TCGA-SP-A6QK,7801,TCGA-SP-A6QK,PCPG,46.0,FEMALE,ASIAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2005.0,[Not Available],-16923.0,Alive,TUMOR FREE,3384.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3384.0,0.0,3384.0,0.0,3384.0,0.0,3384.0,
TCGA-BR-4368,9297,TCGA-BR-4368,STAD,78.0,FEMALE,WHITE,Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-28770.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-DD-AACY,5603,TCGA-DD-AACY,LIHC,61.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-22332.0,Alive,WITH TUMOR,1450.0,,[Not Available],Intrahepatic Recurrence,Liver,,776.0,[Not Available],,R0,0.0,1450.0,0.0,1450.0,1.0,776.0,1.0,776.0,
TCGA-TT-A6YP,7819,TCGA-TT-A6YP,PCPG,19.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-7240.0,Alive,TUMOR FREE,1292.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1292.0,0.0,1292.0,0.0,1292.0,0.0,1292.0,
TCGA-HT-7470,5143,TCGA-HT-7470,LGG,37.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-13611.0,Dead,TUMOR FREE,,1220.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1220.0,0.0,1220.0,0.0,1220.0,0.0,1220.0,
TCGA-EJ-5521,7934,TCGA-EJ-5521,PRAD,63.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-23304.0,Alive,TUMOR FREE,2279.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2279.0,0.0,2279.0,0.0,2279.0,0.0,2279.0,
TCGA-85-8350,6725,TCGA-85-8350,LUSC,61.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-22526.0,Alive,TUMOR FREE,683.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,683.0,0.0,683.0,0.0,683.0,0.0,683.0,
TCGA-2J-AABF,7510,TCGA-2J-AABF,PAAD,73.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,[Not Available],-26936.0,Dead,WITH TUMOR,,691.0,Pancreatic Cancer,Distant Metastasis,"Other, specify",Liver/lung,443.0,Progressive Disease,,,1.0,691.0,1.0,691.0,,,1.0,443.0,
TCGA-CN-6988,3349,TCGA-CN-6988,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-17308.0,Alive,TUMOR FREE,318.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,318.0,0.0,318.0,,,0.0,318.0,
TCGA-BQ-7058,4565,TCGA-BQ-7058,KIRP,81.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-29856.0,Dead,WITH TUMOR,,343.0,[Not Available],,,,50.0,[Not Available],,,1.0,343.0,1.0,343.0,,,1.0,50.0,
TCGA-2Z-A9JQ,4440,TCGA-2Z-A9JQ,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-24244.0,Alive,WITH TUMOR,778.0,,[Not Available],,,,600.0,[Unknown],,,0.0,778.0,0.0,778.0,,,1.0,600.0,
TCGA-AL-3473,4500,TCGA-AL-3473,KIRP,55.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-20104.0,Alive,TUMOR FREE,1906.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1906.0,0.0,1906.0,0.0,1906.0,0.0,1906.0,
TCGA-FB-A5VM,7556,TCGA-FB-A5VM,PAAD,74.0,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,[Not Available],-27362.0,Dead,WITH TUMOR,,498.0,Pancreatic Cancer,Distant Metastasis,Liver,,177.0,Progressive Disease,,,1.0,498.0,1.0,498.0,,,1.0,177.0,
TCGA-06-0130,2747,TCGA-06-0130,GBM,54.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-19812.0,Dead,WITH TUMOR,320.0,394.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],244.0,[Not Available],,,1.0,394.0,1.0,394.0,,,1.0,244.0,
TCGA-C5-A1M9,1621,TCGA-C5-A1M9,CESC,46.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Type of Adenocarcinoma,G3,2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17020.0,Dead,WITH TUMOR,,1065.0,Cervical Cancer,Distant Metastasis,Lung,,555.0,Complete Remission/Response,,,1.0,1065.0,1.0,1065.0,1.0,555.0,1.0,555.0,
TCGA-EJ-A6RA,7991,TCGA-EJ-A6RA,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-25679.0,Alive,TUMOR FREE,353.0,,[Not Available],Locoregional Recurrence,,,353.0,Partial Remission/Response,,,0.0,353.0,0.0,353.0,,,1.0,353.0,
TCGA-F7-A622,3654,TCGA-F7-A622,HNSC,75.0,MALE,WHITE,Stage III,[Not Available],Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-27456.0,Dead,WITH TUMOR,,359.0,[Not Available],,,,,Complete Remission/Response,,,1.0,359.0,1.0,359.0,,,1.0,359.0,
TCGA-CJ-5671,4318,TCGA-CJ-5671,KIRC,51.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-18954.0,Alive,TUMOR FREE,3987.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3987.0,0.0,3987.0,0.0,3987.0,0.0,3987.0,
TCGA-DB-5279,4938,TCGA-DB-5279,LGG,59.0,MALE,[Not Available],[Not Available],[Not Available],Oligodendroglioma,G2,2007.0,[Not Available],-21908.0,Alive,TUMOR FREE,1354.0,,[Not Available],,,,695.0,Complete Remission/Response,,,0.0,1354.0,0.0,1354.0,1.0,695.0,1.0,695.0,
TCGA-G3-A25Z,5707,TCGA-G3-A25Z,LIHC,58.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-21509.0,Alive,TUMOR FREE,655.0,,[Not Available],,,,,[Not Available],,R0,0.0,655.0,0.0,655.0,0.0,655.0,0.0,655.0,
TCGA-O2-A52N,6822,TCGA-O2-A52N,LUSC,78.0,MALE,WHITE,Stage I,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-28520.0,Dead,TUMOR FREE,,1006.0,[Not Available],,,,,[Unknown],,,1.0,1006.0,0.0,1006.0,,,0.0,1006.0,
TCGA-38-4630,5847,TCGA-38-4630,LUAD,75.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2000.0,[Not Available],-27667.0,Dead,WITH TUMOR,,1073.0,[Not Available],,,,524.0,Complete Remission/Response,,,1.0,1073.0,1.0,1073.0,1.0,524.0,1.0,524.0,
TCGA-B8-5546,4109,TCGA-B8-5546,KIRC,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-14113.0,Alive,TUMOR FREE,505.0,,[Not Available],,,,,[Not Available],,,0.0,505.0,0.0,505.0,,,0.0,505.0,
TCGA-ZB-A96L,10463,TCGA-ZB-A96L,THYM,70.0,FEMALE,WHITE,[Not Applicable],III,Thymoma; Type B3,[Not Available],2011.0,[Not Available],-25914.0,Alive,TUMOR FREE,1529.0,,[Not Available],,,,,[Not Available],,,0.0,1529.0,0.0,1529.0,,,0.0,1529.0,
TCGA-EE-A3AB,9069,TCGA-EE-A3AB,SKCM,30.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2001.0,[Not Available],-11054.0,Alive,TUMOR FREE,3733.0,,[Not Available],,,,,[Not Available],,,0.0,3733.0,0.0,3733.0,,,0.0,3733.0,
TCGA-OK-A5Q2,1551,TCGA-OK-A5Q2,BRCA,59.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,[Unknown],-21555.0,Alive,,64.0,,[Not Available],,,,,[Not Available],Negative,,0.0,64.0,0.0,64.0,0.0,64.0,0.0,64.0,
TCGA-BR-8285,9344,TCGA-BR-8285,STAD,57.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-20849.0,Dead,TUMOR FREE,,17.0,[Not Available],,,,,Complete Remission/Response,,,1.0,17.0,0.0,17.0,0.0,17.0,0.0,17.0,
TCGA-A3-3357,3910,TCGA-A3-3357,KIRC,62.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-22825.0,Alive,TUMOR FREE,2688.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2688.0,0.0,2688.0,0.0,2688.0,0.0,2688.0,
TCGA-CV-A468,3592,TCGA-CV-A468,HNSC,42.0,MALE,[Not Available],Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2001.0,[Not Available],-15372.0,Dead,TUMOR FREE,,464.0,[Not Available],,,,,Complete Remission/Response,,,1.0,464.0,0.0,464.0,,,0.0,464.0,
TCGA-55-8207,6027,TCGA-55-8207,LUAD,73.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26897.0,Alive,TUMOR FREE,977.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,977.0,0.0,977.0,0.0,977.0,0.0,977.0,
TCGA-EJ-5530,7940,TCGA-EJ-5530,PRAD,61.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-22316.0,Alive,TUMOR FREE,1832.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1832.0,0.0,1832.0,0.0,1832.0,0.0,1832.0,
TCGA-D9-A6EC,8913,TCGA-D9-A6EC,SKCM,56.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2008.0,[Not Available],-20493.0,Alive,TUMOR FREE,2359.0,,[Not Available],,,,,[Not Available],,,0.0,2359.0,0.0,2359.0,,,0.0,2359.0,
TCGA-XF-A9T0,440,TCGA-XF-A9T0,BLCA,68.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-25190.0,Alive,TUMOR FREE,799.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,799.0,0.0,799.0,0.0,799.0,0.0,799.0,
TCGA-D3-A8GL,8890,TCGA-D3-A8GL,SKCM,43.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],1996.0,[Not Available],-15947.0,Dead,WITH TUMOR,,2711.0,[Not Available],Regional lymph node,,,1333.0,[Not Available],,,1.0,2711.0,1.0,2711.0,,,1.0,1333.0,
TCGA-AH-6547,8466,TCGA-AH-6547,READ,79.0,FEMALE,WHITE,[Not Available],[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-29030.0,Dead,TUMOR FREE,,76.0,[Not Available],,,,,Complete Remission/Response,,,1.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,
TCGA-WB-A81K,7853,TCGA-WB-A81K,PCPG,45.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-16483.0,Alive,TUMOR FREE,1218.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1218.0,0.0,1218.0,0.0,1218.0,0.0,1218.0,
TCGA-F4-6806,2360,TCGA-F4-6806,COAD,59.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-21625.0,Alive,WITH TUMOR,1260.0,,[Not Available],Metastatic,,,336.0,Complete Remission/Response,,,0.0,1260.0,0.0,1260.0,1.0,336.0,1.0,336.0,
TCGA-Y8-A897,4705,TCGA-Y8-A897,KIRP,68.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-25047.0,Alive,TUMOR FREE,549.0,,[Not Available],,,,450.0,Complete Remission/Response,,,0.0,549.0,0.0,549.0,1.0,450.0,1.0,450.0,
TCGA-ET-A4KN,10254,TCGA-ET-A4KN,THCA,51.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2012.0,[Not Available],-18889.0,Alive,TUMOR FREE,1009.0,,[Not Available],,,,,[Not Available],,R0,0.0,1009.0,0.0,1009.0,0.0,1009.0,0.0,1009.0,
TCGA-J9-A8CP,8161,TCGA-J9-A8CP,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-24299.0,Alive,TUMOR FREE,386.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,386.0,0.0,386.0,0.0,386.0,0.0,386.0,
TCGA-TN-A7HJ,3747,TCGA-TN-A7HJ,HNSC,51.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-18809.0,Alive,TUMOR FREE,403.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,403.0,0.0,403.0,,,0.0,403.0,
TCGA-2J-AABR,7516,TCGA-2J-AABR,PAAD,60.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,[Not Available],-22131.0,Alive,WITH TUMOR,438.0,,,Distant Metastasis,Liver,,327.0,Progressive Disease,,,0.0,438.0,0.0,438.0,,,1.0,327.0,
TCGA-TQ-A7RU,5401,TCGA-TQ-A7RU,LGG,51.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-18990.0,Alive,WITH TUMOR,1032.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1032.0,0.0,1032.0,,,0.0,1032.0,
TCGA-DD-A3A4,5546,TCGA-DD-A3A4,LIHC,37.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,1998.0,[Not Available],-13739.0,Dead,WITH TUMOR,,612.0,[Not Available],Intrahepatic Recurrence,Liver,,87.0,[Not Available],,R0,1.0,612.0,1.0,612.0,1.0,87.0,1.0,87.0,
TCGA-41-2571,3192,TCGA-41-2571,GBM,89.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-32612.0,Dead,WITH TUMOR,26.0,26.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],26.0,[Not Available],,,1.0,26.0,1.0,26.0,,,1.0,26.0,
TCGA-UY-A9PA,411,TCGA-UY-A9PA,BLCA,48.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-17520.0,Alive,TUMOR FREE,1072.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1072.0,0.0,1072.0,0.0,1072.0,0.0,1072.0,
TCGA-OL-A5D8,1554,TCGA-OL-A5D8,BRCA,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14853.0,Alive,TUMOR FREE,973.0,,[Not Available],,,,,[Not Available],[Unknown],,0.0,973.0,0.0,973.0,,,0.0,973.0,
TCGA-FC-A66V,8011,TCGA-FC-A66V,PRAD,74.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-27282.0,Alive,TUMOR FREE,524.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,
TCGA-DD-A4NR,5567,TCGA-DD-A4NR,LIHC,85.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2005.0,[Not Available],-31386.0,Dead,TUMOR FREE,,9.0,[Not Available],,,,,[Not Available],,R0,1.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,
TCGA-62-8395,6059,TCGA-62-8395,LUAD,80.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-29311.0,Alive,WITH TUMOR,1216.0,,[Not Available],Locoregional Recurrence,,,395.0,Complete Remission/Response,,,0.0,1216.0,0.0,1216.0,1.0,395.0,1.0,395.0,
TCGA-CC-A7IL,5505,TCGA-CC-A7IL,LIHC,61.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-22319.0,Dead,WITH TUMOR,,278.0,[Not Available],Locoregional Recurrence,,,179.0,[Not Available],,R0,1.0,278.0,1.0,278.0,1.0,179.0,1.0,179.0,
TCGA-FG-5962,5098,TCGA-FG-5962,LGG,54.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2009.0,[Not Available],-19818.0,Alive,WITH TUMOR,1453.0,,[Not Available],,,,,Stable Disease,,,0.0,1453.0,0.0,1453.0,,,0.0,1453.0,
TCGA-S9-A6TU,5322,TCGA-S9-A6TU,LGG,38.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2007.0,[Not Available],-14108.0,Alive,WITH TUMOR,2650.0,,[Not Available],,,,1475.0,Partial Remission/Response,,,0.0,2650.0,0.0,2650.0,,,1.0,1475.0,
TCGA-BR-6852,9320,TCGA-BR-6852,STAD,64.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-23469.0,Alive,TUMOR FREE,1367.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1367.0,0.0,1367.0,0.0,1367.0,0.0,1367.0,
TCGA-DU-7010,5013,TCGA-DU-7010,LGG,58.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2001.0,[Not Available],-21199.0,Dead,WITH TUMOR,,456.0,[Not Available],,,,193.0,Progressive Disease,,,1.0,456.0,1.0,456.0,,,1.0,193.0,
TCGA-CR-6482,3431,TCGA-CR-6482,HNSC,62.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-22741.0,Alive,TUMOR FREE,345.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,345.0,0.0,345.0,,,0.0,345.0,
TCGA-06-6693,2880,TCGA-06-6693,GBM,64.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1993.0,[Not Available],-23585.0,Dead,WITH TUMOR,15.0,3667.0,[Not Available],,,,,[Not Available],,,1.0,3667.0,1.0,3667.0,,,1.0,3667.0,
TCGA-HC-8257,8098,TCGA-HC-8257,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25629.0,Alive,TUMOR FREE,726.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,726.0,0.0,726.0,0.0,726.0,0.0,726.0,
TCGA-LN-A49V,2567,TCGA-LN-A49V,ESCA,49.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G3,2011.0,[Not Available],-17922.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-VD-AA8N,11135,TCGA-VD-AA8N,UVM,86.0,MALE,[Not Evaluated],Stage IIB,Stage IIIA,Epithelioid Cell|Spindle Cell,[Not Available],2013.0,[Not Available],-31475.0,Alive,TUMOR FREE,44.0,,[Not Available],,,,,[Not Available],,,0.0,44.0,0.0,44.0,,,0.0,44.0,
TCGA-CN-5369,3332,TCGA-CN-5369,HNSC,90.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2006.0,[Not Available],-32871.0,Dead,TUMOR FREE,,380.0,[Not Available],,,,,Complete Remission/Response,,,1.0,380.0,0.0,380.0,,,0.0,380.0,
TCGA-VR-A8EY,2629,TCGA-VR-A8EY,ESCA,44.0,FEMALE,WHITE,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G1,2012.0,[Not Available],-16255.0,Alive,TUMOR FREE,1025.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1025.0,0.0,1025.0,0.0,1025.0,0.0,1025.0,
TCGA-EK-A2RK,1737,TCGA-EK-A2RK,CESC,67.0,FEMALE,WHITE,[Not Available],Stage IA2,Cervical Squamous Cell Carcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24541.0,Alive,,13.0,,,,,,,[Not Available],,,0.0,13.0,0.0,13.0,,,0.0,13.0,
TCGA-BH-A1ET,1133,TCGA-BH-A1ET,BRCA,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999.0,[Not Available],-20425.0,Dead,TUMOR FREE,,2520.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,2520.0,0.0,2520.0,,,0.0,2520.0,
TCGA-KO-8416,3849,TCGA-KO-8416,KICH,41.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-15261.0,Alive,TUMOR FREE,2752.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2752.0,0.0,2752.0,0.0,2752.0,0.0,2752.0,
TCGA-L5-A4OM,2520,TCGA-L5-A4OM,ESCA,54.0,FEMALE,WHITE,Stage IA,[Not Available],Esophagus Squamous Cell Carcinoma,GX,2010.0,[Not Available],-19845.0,Dead,TUMOR FREE,,1458.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1458.0,0.0,1458.0,0.0,1458.0,0.0,1458.0,
TCGA-13-0757,7013,TCGA-13-0757,OV,71.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,[Not Available],-25999.0,Dead,WITH TUMOR,340.0,340.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],293.0,Complete Remission/Response,,,1.0,340.0,1.0,340.0,1.0,293.0,1.0,293.0,
TCGA-CG-4460,9459,TCGA-CG-4460,STAD,66.0,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],-24229.0,Dead,WITH TUMOR,,669.0,[Not Available],,,,487.0,Partial Remission/Response,,,1.0,669.0,1.0,669.0,,,1.0,487.0,
TCGA-WJ-A86L,5780,TCGA-WJ-A86L,LIHC,68.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-25018.0,Alive,TUMOR FREE,345.0,,[Not Available],,,,,[Not Available],,R0,0.0,345.0,0.0,345.0,0.0,345.0,0.0,345.0,
TCGA-HD-7229,3663,TCGA-HD-7229,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-22076.0,Alive,WITH TUMOR,1027.0,,[Not Available],Locoregional Recurrence,Larynx,,162.0,Progressive Disease,,,0.0,1027.0,0.0,1027.0,,,1.0,162.0,
TCGA-B0-5697,4055,TCGA-B0-5697,KIRC,50.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-18486.0,Alive,TUMOR FREE,2630.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2630.0,0.0,2630.0,0.0,2630.0,0.0,2630.0,
TCGA-05-5423,5833,TCGA-05-5423,LUAD,65.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-23863.0,Alive,TUMOR FREE,151.0,,[Not Available],,,,,[Not Available],,,0.0,151.0,0.0,151.0,,,0.0,151.0,
TCGA-78-7166,6159,TCGA-78-7166,LUAD,84.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-30869.0,Dead,,,258.0,[Not Available],,,,,[Not Available],,,1.0,258.0,,258.0,,,0.0,258.0,
TCGA-CC-5259,5483,TCGA-CC-5259,LIHC,60.0,FEMALE,ASIAN,Stage IIIC,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-21946.0,Alive,WITH TUMOR,250.0,,[Not Available],Locoregional Recurrence,Liver,,180.0,[Not Available],,R0,0.0,250.0,0.0,250.0,1.0,180.0,1.0,180.0,
TCGA-CQ-A4CI,3415,TCGA-CQ-A4CI,HNSC,73.0,MALE,WHITE,Stage III,[Not Available],Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2011.0,[Not Available],-26664.0,Alive,WITH TUMOR,950.0,,[Not Available],,Distant Metastasis,lung,517.0,Complete Remission/Response,,,0.0,950.0,0.0,950.0,1.0,517.0,1.0,517.0,
TCGA-ZM-AA0D,9840,TCGA-ZM-AA0D,TGCT,34.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2012.0,[Not Available],-12738.0,Alive,TUMOR FREE,848.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,848.0,0.0,848.0,0.0,848.0,0.0,848.0,
TCGA-EL-A3MX,10078,TCGA-EL-A3MX,THCA,66.0,FEMALE,WHITE,Stage IVC,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-24178.0,Dead,WITH TUMOR,,1753.0,[Not Available],Distant Metastasis,"Other, specify",Femur,1708.0,[Not Available],,RX,1.0,1753.0,1.0,1753.0,,,1.0,1708.0,
TCGA-BQ-7051,4561,TCGA-BQ-7051,KIRP,74.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-27120.0,Alive,TUMOR FREE,1533.0,,[Not Available],,,,,[Not Available],,,0.0,1533.0,0.0,1533.0,,,0.0,1533.0,
TCGA-77-8133,6678,TCGA-77-8133,LUSC,74.0,MALE,[Not Evaluated],Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-27139.0,Dead,,,1640.0,[Not Available],,,,,[Not Available],,,1.0,1640.0,,1640.0,,,0.0,1640.0,
TCGA-VS-A953,1857,TCGA-VS-A953,CESC,63.0,FEMALE,[Unknown],[Not Available],Stage IVA,Cervical Squamous Cell Carcinoma,GX,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23277.0,Dead,WITH TUMOR,,477.0,Cervical Cancer,,,,,Partial Remission/Response,,,1.0,477.0,1.0,477.0,,,1.0,477.0,
TCGA-BH-A42V,1167,TCGA-BH-A42V,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15158.0,Alive,TUMOR FREE,635.0,,[Not Available],,,,,[Not Available],Negative,,0.0,635.0,0.0,635.0,0.0,635.0,0.0,635.0,
TCGA-MT-A67G,3701,TCGA-MT-A67G,HNSC,53.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-19394.0,Alive,[Discrepancy],190.0,,[Not Available],,,,,[Unknown],,,0.0,190.0,0.0,190.0,,,0.0,190.0,
TCGA-AP-A1E0,10601,TCGA-AP-A1E0,UCEC,40.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G2,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14653.0,Alive,TUMOR FREE,1832.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1832.0,0.0,1832.0,0.0,1832.0,0.0,1832.0,
TCGA-42-2593,7416,TCGA-42-2593,OV,67.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-24823.0,Dead,WITH TUMOR,,45.0,[Not Available],,,,,[Not Applicable],,,1.0,45.0,1.0,45.0,,,1.0,45.0,
TCGA-CG-4304,9446,TCGA-CG-4304,STAD,84.0,MALE,[Not Available],Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],-31017.0,Alive,,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-CR-7395,3463,TCGA-CR-7395,HNSC,80.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-29527.0,Alive,TUMOR FREE,930.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,
TCGA-HZ-8005,7600,TCGA-HZ-8005,PAAD,81.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,[Not Available],-29674.0,Dead,WITH TUMOR,,120.0,Pancreatic Cancer,,,,,Progressive Disease,,,1.0,120.0,1.0,120.0,,,1.0,120.0,
TCGA-AR-A24N,936,TCGA-AR-A24N,BRCA,54.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Peri (6-12 months since last menstrual period),-19989.0,Alive,TUMOR FREE,3035.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3035.0,0.0,3035.0,0.0,3035.0,0.0,3035.0,
TCGA-06-0747,2831,TCGA-06-0747,GBM,53.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-19657.0,Dead,WITH TUMOR,82.0,82.0,[Not Available],,,,,[Not Available],,,1.0,82.0,1.0,82.0,,,1.0,82.0,
TCGA-L5-A8NR,2550,TCGA-L5-A8NR,ESCA,81.0,FEMALE,[Not Evaluated],Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2001.0,[Not Available],-29730.0,Alive,WITH TUMOR,265.0,,[Not Available],Distant Metastasis,Liver,,265.0,[Unknown],,,0.0,265.0,0.0,265.0,,,1.0,265.0,
TCGA-DJ-A2Q5,9958,TCGA-DJ-A2Q5,THCA,51.0,MALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18727.0,Alive,TUMOR FREE,1140.0,,[Not Available],,,,,[Not Available],,R0,0.0,1140.0,0.0,1140.0,,,0.0,1140.0,
TCGA-2G-AAG9,9735,TCGA-2G-AAG9,TGCT,25.0,MALE,WHITE,Stage IIIB,Stage IIIB,Seminoma; NOS,[Not Available],2008.0,[Not Available],-9210.0,Alive,TUMOR FREE,2234.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,2234.0,0.0,2234.0,,,0.0,2234.0,
TCGA-BA-5557,3254,TCGA-BA-5557,HNSC,41.0,FEMALE,[Not Available],Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-15247.0,Alive,TUMOR FREE,623.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,623.0,0.0,623.0,,,0.0,623.0,
TCGA-DC-5869,8485,TCGA-DC-5869,READ,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-22676.0,Alive,TUMOR FREE,943.0,,[Not Available],,,,,[Not Applicable],,,0.0,943.0,0.0,943.0,,,0.0,943.0,
TCGA-BT-A20T,130,TCGA-BT-A20T,BLCA,63.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-23220.0,Dead,WITH TUMOR,,453.0,[Not Available],Distant Metastasis,Liver,,314.0,Progressive Disease,,,1.0,453.0,1.0,453.0,,,1.0,314.0,
TCGA-D9-A3Z1,8904,TCGA-D9-A3Z1,SKCM,66.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-24192.0,Dead,WITH TUMOR,,468.0,[Not Available],Locoregional Recurrence,Lung,,335.0,[Not Available],,,1.0,468.0,1.0,468.0,,,1.0,335.0,
TCGA-E2-A154,1329,TCGA-E2-A154,BRCA,68.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24999.0,Alive,TUMOR FREE,591.0,,[Not Available],,,,,[Not Available],Negative,,0.0,591.0,0.0,591.0,0.0,591.0,0.0,591.0,
TCGA-FI-A3PV,10996,TCGA-FI-A3PV,UCEC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,High Grade,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24898.0,Dead,WITH TUMOR,,1249.0,[Not Available],,,,,[Not Available],,,1.0,1249.0,1.0,1249.0,,,1.0,1249.0,
TCGA-BQ-5878,4538,TCGA-BQ-5878,KIRP,79.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005.0,[Not Available],-29010.0,Alive,WITH TUMOR,1938.0,,[Not Available],,,,1022.0,[Not Available],,,0.0,1938.0,0.0,1938.0,,,1.0,1022.0,
TCGA-CV-6950,3507,TCGA-CV-6950,HNSC,64.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1994.0,[Not Available],-23549.0,Dead,WITH TUMOR,,459.0,[Not Available],Locoregional Recurrence,Oral Cavity,Tonsil,258.0,Complete Remission/Response,,,1.0,459.0,1.0,459.0,,,1.0,258.0,
TCGA-DX-A6YT,8616,TCGA-DX-A6YT,SARC,31.0,FEMALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2008.0,[Not Available],-11633.0,Alive,TUMOR FREE,2044.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,2044.0,0.0,2044.0,0.0,2044.0,0.0,2044.0,
TCGA-OR-A5L4,59,TCGA-OR-A5L4,ACC,48.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-17819.0,Alive,TUMOR FREE,967.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,967.0,0.0,967.0,0.0,967.0,0.0,967.0,
TCGA-EL-A3H3,10072,TCGA-EL-A3H3,THCA,19.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-7000.0,Alive,TUMOR FREE,1319.0,,[Not Available],,,,,[Not Available],,R0,0.0,1319.0,0.0,1319.0,0.0,1319.0,0.0,1319.0,
TCGA-D1-A17C,10861,TCGA-D1-A17C,UCEC,78.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28571.0,Alive,TUMOR FREE,30.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,30.0,0.0,30.0,0.0,30.0,0.0,30.0,
TCGA-DD-A73A,5570,TCGA-DD-A73A,LIHC,71.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-26136.0,Alive,TUMOR FREE,728.0,,[Not Available],,,,,[Not Available],,R0,0.0,728.0,0.0,728.0,0.0,728.0,0.0,728.0,
TCGA-YL-A8SP,8333,TCGA-YL-A8SP,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-21455.0,Alive,WITH TUMOR,2366.0,,[Not Available],Biochemical evidence of disease,,,2036.0,Stable Disease,,,0.0,2366.0,0.0,2366.0,,,1.0,2036.0,
TCGA-X6-A8C5,8789,TCGA-X6-A8C5,SARC,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-23350.0,Alive,TUMOR FREE,1547.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1547.0,0.0,1547.0,0.0,1547.0,0.0,1547.0,
TCGA-C5-A1BJ,1611,TCGA-C5-A1BJ,CESC,34.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,1997.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12611.0,Alive,TUMOR FREE,4385.0,,,,,,,Complete Remission/Response,,,0.0,4385.0,0.0,4385.0,0.0,4385.0,0.0,4385.0,
TCGA-FD-A3B4,258,TCGA-FD-A3B4,BLCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-20379.0,Dead,WITH TUMOR,,510.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Left posterior pelvic wall,359.0,Complete Remission/Response,,,1.0,510.0,1.0,510.0,1.0,359.0,1.0,359.0,
TCGA-4K-AAAL,9780,TCGA-4K-AAAL,TGCT,31.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],2013.0,[Not Available],-11622.0,Alive,TUMOR FREE,483.0,,[Not Applicable],Locoregional Recurrence,Lymph Node(s),,147.0,No Measureable Tumor or Tumor Markers,,,0.0,483.0,0.0,483.0,1.0,147.0,1.0,147.0,
TCGA-CN-6023,3347,TCGA-CN-6023,HNSC,73.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2010.0,[Not Available],-26769.0,Alive,TUMOR FREE,1584.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1584.0,0.0,1584.0,,,0.0,1584.0,
TCGA-D3-A2JN,8849,TCGA-D3-A2JN,SKCM,46.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],2007.0,[Not Available],-17128.0,Dead,TUMOR FREE,,2022.0,[Not Available],,,,,[Not Available],,,1.0,2022.0,0.0,2022.0,,,0.0,2022.0,
TCGA-DM-A1DB,2336,TCGA-DM-A1DB,COAD,68.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2000.0,[Not Available],-24888.0,Dead,,1348.0,1348.0,[Not Available],,,,,[Not Available],,,1.0,1348.0,,1348.0,,,0.0,1348.0,
TCGA-DS-A0VK,1678,TCGA-DS-A0VK,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,1996.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16792.0,Dead,WITH TUMOR,,1118.0,,Distant Metastasis,"Other, specify",Vagina,209.0,Progressive Disease,,,1.0,1118.0,1.0,1118.0,,,1.0,209.0,
TCGA-HD-7754,3665,TCGA-HD-7754,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-25365.0,Alive,TUMOR FREE,783.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,783.0,0.0,783.0,,,0.0,783.0,
TCGA-TQ-A7RW,5403,TCGA-TQ-A7RW,LGG,32.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-11804.0,Dead,WITH TUMOR,,821.0,[Not Available],,,,511.0,Progressive Disease,,,1.0,821.0,1.0,821.0,,,1.0,511.0,
TCGA-32-2634,3183,TCGA-32-2634,GBM,82.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-29964.0,Alive,TUMOR FREE,693.0,,[Not Available],,,,,[Not Available],,,0.0,693.0,0.0,693.0,,,0.0,693.0,
TCGA-B8-4153,4096,TCGA-B8-4153,KIRC,74.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-27031.0,Alive,WITH TUMOR,762.0,,[Not Available],,,,223.0,[Not Available],,,0.0,762.0,0.0,762.0,,,1.0,223.0,
TCGA-UZ-A9PZ,4696,TCGA-UZ-A9PZ,KIRP,65.0,MALE,WHITE,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-23741.0,Alive,TUMOR FREE,657.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,657.0,0.0,657.0,0.0,657.0,0.0,657.0,
TCGA-49-4490,5905,TCGA-49-4490,LUAD,45.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1993.0,[Not Available],-16634.0,Dead,WITH TUMOR,,385.0,[Not Available],,,,,[Not Available],,,1.0,385.0,1.0,385.0,,,1.0,385.0,
TCGA-BW-A5NQ,5481,TCGA-BW-A5NQ,LIHC,63.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-23353.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],,RX,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-EM-A3O3,10178,TCGA-EM-A3O3,THCA,83.0,FEMALE,[Unknown],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-30500.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,[Not Available],,R0,0.0,441.0,0.0,441.0,0.0,441.0,0.0,441.0,
TCGA-CJ-5679,4324,TCGA-CJ-5679,KIRC,73.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2003.0,[Not Available],-26858.0,Dead,WITH TUMOR,,679.0,[Not Available],,,,595.0,[Not Available],,,1.0,679.0,1.0,679.0,,,1.0,595.0,
TCGA-B5-A11V,10709,TCGA-B5-A11V,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23630.0,Alive,TUMOR FREE,595.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,
TCGA-EM-A1CS,10120,TCGA-EM-A1CS,THCA,55.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-20284.0,Alive,TUMOR FREE,817.0,,[Not Available],,,,,[Not Available],,R0,0.0,817.0,0.0,817.0,0.0,817.0,0.0,817.0,
TCGA-FY-A3NM,10283,TCGA-FY-A3NM,THCA,48.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-17734.0,Alive,TUMOR FREE,885.0,,[Not Available],,,,,[Not Available],,R0,0.0,885.0,0.0,885.0,0.0,885.0,0.0,885.0,
TCGA-C5-A7UE,1652,TCGA-C5-A7UE,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2001.0,[Not Available],-16473.0,Alive,TUMOR FREE,4738.0,,,,,,,Complete Remission/Response,,,0.0,4738.0,0.0,4738.0,0.0,4738.0,0.0,4738.0,
TCGA-55-7227,5991,TCGA-55-7227,LUAD,77.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-28458.0,Dead,WITH TUMOR,,952.0,[Not Available],Locoregional Recurrence,,,255.0,Complete Remission/Response,,,1.0,952.0,1.0,952.0,1.0,255.0,1.0,255.0,
TCGA-EE-A3J8,9080,TCGA-EE-A3J8,SKCM,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2006.0,[Not Available],-21688.0,Dead,TUMOR FREE,,1044.0,[Not Available],,,,1035.0,[Not Available],,,1.0,1044.0,0.0,1044.0,,,1.0,1035.0,
TCGA-EM-A3AK,10162,TCGA-EM-A3AK,THCA,62.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-22911.0,Alive,TUMOR FREE,477.0,,[Not Available],,,,,[Not Available],,R0,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,
TCGA-CJ-5675,4320,TCGA-CJ-5675,KIRC,70.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-25617.0,Alive,WITH TUMOR,3936.0,,[Not Available],,,,900.0,Complete Remission/Response,,,0.0,3936.0,0.0,3936.0,1.0,900.0,1.0,900.0,
TCGA-FI-A2EX,10991,TCGA-FI-A2EX,UCEC,58.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21489.0,Alive,WITH TUMOR,284.0,,[Not Available],Metastatic,,,213.0,Complete Remission/Response,,,0.0,284.0,0.0,284.0,1.0,213.0,1.0,213.0,
TCGA-V4-A9EH,11093,TCGA-V4-A9EH,UVM,53.0,MALE,WHITE,Stage IIIB,Stage IIIB,Spindle Cell,[Not Available],2012.0,[Not Available],-19573.0,Alive,TUMOR FREE,670.0,,[Not Available],,,,,[Not Available],,,0.0,670.0,0.0,670.0,,,0.0,670.0,
TCGA-CK-5914,2251,TCGA-CK-5914,COAD,81.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-29586.0,Alive,TUMOR FREE,669.0,,[Not Available],,,,,[Not Available],,,0.0,669.0,0.0,669.0,,,0.0,669.0,
TCGA-HC-8266,8106,TCGA-HC-8266,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20280.0,Alive,WITH TUMOR,473.0,,[Not Available],,,,,[Unknown],,,0.0,473.0,0.0,473.0,,,0.0,473.0,
TCGA-DJ-A1QN,9937,TCGA-DJ-A1QN,THCA,42.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-15343.0,Alive,TUMOR FREE,1295.0,,[Not Available],,,,,[Not Available],,R0,0.0,1295.0,0.0,1295.0,0.0,1295.0,0.0,1295.0,
TCGA-J1-A4AH,6795,TCGA-J1-A4AH,LUSC,70.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-25893.0,Alive,TUMOR FREE,581.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,581.0,0.0,581.0,0.0,581.0,0.0,581.0,
TCGA-BP-4163,4130,TCGA-BP-4163,KIRC,60.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2002.0,[Not Available],-21980.0,Alive,TUMOR FREE,2839.0,,[Not Available],,,,,[Not Available],,,0.0,2839.0,0.0,2839.0,,,0.0,2839.0,
TCGA-CD-8527,9425,TCGA-CD-8527,STAD,72.0,FEMALE,ASIAN,Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,[Not Available],-26503.0,Dead,WITH TUMOR,,218.0,[Not Available],Distant Metastasis,Liver,,159.0,Complete Remission/Response,,,1.0,218.0,1.0,218.0,1.0,159.0,1.0,159.0,
TCGA-D1-A169,10838,TCGA-D1-A169,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IV,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23238.0,Alive,WITH TUMOR,1135.0,,[Not Available],Metastatic,"Other, specify",Bladder nodule,519.0,Complete Remission/Response,,,0.0,1135.0,0.0,1135.0,,,1.0,519.0,
TCGA-CZ-5457,4373,TCGA-CZ-5457,KIRC,62.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-22763.0,Alive,WITH TUMOR,2754.0,,[Not Available],,,,174.0,[Not Available],,,0.0,2754.0,0.0,2754.0,,,1.0,174.0,
TCGA-N7-A59B,11047,TCGA-N7-A59B,UCS,69.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25360.0,Alive,TUMOR FREE,827.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,827.0,0.0,827.0,0.0,827.0,0.0,827.0,
TCGA-Z2-AA3S,9266,TCGA-Z2-AA3S,SKCM,58.0,MALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2006.0,[Not Available],-21318.0,Alive,WITH TUMOR,2950.0,,[Not Available],Distant Metastasis,Lung,,2727.0,[Not Available],,,0.0,2950.0,0.0,2950.0,,,1.0,2727.0,
TCGA-EB-A4OZ,8964,TCGA-EB-A4OZ,SKCM,41.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-15337.0,Alive,TUMOR FREE,620.0,,[Not Available],,,,,[Not Available],,,0.0,620.0,0.0,620.0,,,0.0,620.0,
TCGA-D3-A1Q3,8826,TCGA-D3-A1Q3,SKCM,64.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2001.0,[Not Available],-23604.0,Dead,WITH TUMOR,,507.0,[Not Available],,,,,[Not Available],,,1.0,507.0,1.0,507.0,,,1.0,507.0,
TCGA-HD-7832,3667,TCGA-HD-7832,HNSC,52.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-19192.0,Alive,TUMOR FREE,836.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,836.0,0.0,836.0,,,0.0,836.0,
TCGA-77-7335,6667,TCGA-77-7335,LUSC,62.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1996.0,[Not Available],-22863.0,Dead,,,2133.0,[Not Available],,,,,[Not Available],,,1.0,2133.0,,2133.0,,,0.0,2133.0,
TCGA-D8-A27G,1285,TCGA-D8-A27G,BRCA,75.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27521.0,Alive,TUMOR FREE,409.0,,[Not Available],,,,,[Not Available],Negative,,0.0,409.0,0.0,409.0,0.0,409.0,0.0,409.0,
TCGA-S9-A6U6,5332,TCGA-S9-A6U6,LGG,28.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-10253.0,Alive,TUMOR FREE,1069.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1069.0,0.0,1069.0,0.0,1069.0,0.0,1069.0,
TCGA-CC-A7IG,5500,TCGA-CC-A7IG,LIHC,47.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-17453.0,Dead,WITH TUMOR,,299.0,[Not Available],Locoregional Recurrence,,,195.0,[Not Available],,R0,1.0,299.0,1.0,299.0,1.0,195.0,1.0,195.0,
TCGA-G2-A2EO,317,TCGA-G2-A2EO,BLCA,69.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-25440.0,Dead,TUMOR FREE,,1804.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1804.0,0.0,1804.0,0.0,1804.0,0.0,1804.0,
TCGA-AA-A010,2156,TCGA-AA-A010,COAD,46.0,FEMALE,[Not Available],Stage IIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-16922.0,Alive,TUMOR FREE,1064.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1064.0,0.0,1064.0,0.0,1064.0,0.0,1064.0,
TCGA-AN-A0XT,838,TCGA-AN-A0XT,BRCA,54.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19794.0,Alive,TUMOR FREE,10.0,,[Not Available],,,,,[Not Available],Negative,,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,
TCGA-33-4586,6405,TCGA-33-4586,LUSC,57.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-21148.0,Dead,,,428.0,[Not Available],Locoregional Recurrence,,,169.0,Complete Remission/Response,,,1.0,428.0,,428.0,1.0,169.0,1.0,169.0,
TCGA-73-4659,6114,TCGA-73-4659,LUAD,66.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-24253.0,Dead,WITH TUMOR,711.0,711.0,[Not Available],,,,35.0,Progressive Disease,,,1.0,711.0,1.0,711.0,,,1.0,35.0,
TCGA-FB-AAQ3,7568,TCGA-FB-AAQ3,PAAD,65.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,[Not Available],-23953.0,Dead,TUMOR FREE,,31.0,Surgical Complications,,,,,Complete Remission/Response,,,1.0,31.0,0.0,31.0,0.0,31.0,0.0,31.0,
TCGA-IG-A4QS,2482,TCGA-IG-A4QS,ESCA,71.0,MALE,WHITE,Stage IIIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2012.0,[Not Available],-26273.0,Dead,TUMOR FREE,,118.0,[Not Available],,,,,Complete Remission/Response,,,1.0,118.0,0.0,118.0,0.0,118.0,0.0,118.0,
TCGA-2G-AAGN,9745,TCGA-2G-AAGN,TGCT,41.0,MALE,WHITE,Stage IIIB,Stage IIIB,Non-Seminoma; Embryonal Carcinoma,[Not Available],2004.0,[Not Available],-15145.0,Alive,TUMOR FREE,3656.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,3656.0,0.0,3656.0,,,0.0,3656.0,
TCGA-D1-A2G0,10884,TCGA-D1-A2G0,UCEC,70.0,FEMALE,WHITE,[Not Applicable],Stage IB,Mixed serous and endometrioid,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25573.0,Alive,TUMOR FREE,1484.0,,[Not Available],,,,,[Not Available],,,0.0,1484.0,0.0,1484.0,,,0.0,1484.0,
TCGA-CR-6470,3422,TCGA-CR-6470,HNSC,38.0,MALE,WHITE,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-14133.0,Alive,TUMOR FREE,1521.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1521.0,0.0,1521.0,,,0.0,1521.0,
TCGA-E7-A8O8,254,TCGA-E7-A8O8,BLCA,59.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-21629.0,Alive,TUMOR FREE,13.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,13.0,0.0,13.0,0.0,13.0,0.0,13.0,
TCGA-DB-A64L,4950,TCGA-DB-A64L,LGG,67.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-24690.0,Alive,WITH TUMOR,736.0,,[Not Available],,,,724.0,Complete Remission/Response,,,0.0,736.0,0.0,736.0,1.0,724.0,1.0,724.0,
TCGA-EB-A4OY,8963,TCGA-EB-A4OY,SKCM,65.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-23773.0,Alive,TUMOR FREE,977.0,,[Not Available],,,,,[Not Available],,,0.0,977.0,0.0,977.0,,,0.0,977.0,
TCGA-AU-6004,2202,TCGA-AU-6004,COAD,69.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-25259.0,Alive,TUMOR FREE,824.0,,[Not Available],,,,,[Not Available],,,0.0,824.0,0.0,824.0,,,0.0,824.0,
TCGA-E2-A1IF,1360,TCGA-E2-A1IF,BRCA,74.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27341.0,Alive,TUMOR FREE,1138.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1138.0,0.0,1138.0,0.0,1138.0,0.0,1138.0,
TCGA-B6-A0WT,1002,TCGA-B6-A0WT,BRCA,61.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22362.0,Alive,TUMOR FREE,5739.0,,[Not Available],New Primary Tumor,"Other, specify",right breast cancer contralateral,3862.0,[Not Available],Negative,,0.0,5739.0,0.0,5739.0,1.0,3862.0,1.0,3862.0,
TCGA-NH-A5IV,2397,TCGA-NH-A5IV,COAD,90.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2012.0,[Not Available],-32872.0,Alive,TUMOR FREE,588.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,
TCGA-CM-6677,2291,TCGA-CM-6677,COAD,75.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-27575.0,Alive,TUMOR FREE,337.0,,[Not Available],,,,,[Not Available],,,0.0,337.0,0.0,337.0,,,0.0,337.0,
TCGA-86-7713,6182,TCGA-86-7713,LUAD,70.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25791.0,Alive,TUMOR FREE,1157.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1157.0,0.0,1157.0,0.0,1157.0,0.0,1157.0,
TCGA-49-6743,5915,TCGA-49-6743,LUAD,81.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-29807.0,Alive,TUMOR FREE,1621.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1621.0,0.0,1621.0,0.0,1621.0,0.0,1621.0,
TCGA-D6-A6EO,3625,TCGA-D6-A6EO,HNSC,44.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-16185.0,Alive,TUMOR FREE,759.0,,[Not Available],,,,,Stable Disease,,,0.0,759.0,0.0,759.0,,,0.0,759.0,
TCGA-RC-A7SK,5769,TCGA-RC-A7SK,LIHC,59.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-21814.0,Alive,TUMOR FREE,472.0,,[Not Available],Intrahepatic Recurrence,Liver,,312.0,[Not Available],,R0,0.0,472.0,0.0,472.0,1.0,312.0,1.0,312.0,
TCGA-RM-A68W,7753,TCGA-RM-A68W,PCPG,41.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2010.0,[Not Available],-15273.0,Alive,TUMOR FREE,28.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,28.0,0.0,28.0,0.0,28.0,0.0,28.0,
TCGA-BH-A18S,1126,TCGA-BH-A18S,BRCA,79.0,FEMALE,WHITE,Stage I,[Not Applicable],Mucinous Carcinoma,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28974.0,Dead,TUMOR FREE,,2009.0,[Not Available],,,,,[Not Available],Negative,,1.0,2009.0,0.0,2009.0,0.0,2009.0,0.0,2009.0,
TCGA-AR-A24R,940,TCGA-AR-A24R,BRCA,45.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16642.0,Alive,TUMOR FREE,3430.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3430.0,0.0,3430.0,0.0,3430.0,0.0,3430.0,
TCGA-AR-A1AI,915,TCGA-AR-A1AI,BRCA,47.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Medullary Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17229.0,Alive,TUMOR FREE,3296.0,,[Not Available],New Primary Tumor,"Other, specify",Contralateral Breast,588.0,[Not Available],Negative,,0.0,3296.0,0.0,3296.0,1.0,588.0,1.0,588.0,
TCGA-DJ-A4V5,10010,TCGA-DJ-A4V5,THCA,55.0,MALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-20108.0,Alive,TUMOR FREE,1076.0,,[Not Available],,,,,[Not Available],,R0,0.0,1076.0,0.0,1076.0,,,0.0,1076.0,
TCGA-B5-A0K8,10691,TCGA-B5-A0K8,UCEC,71.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25992.0,Alive,TUMOR FREE,847.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,847.0,0.0,847.0,0.0,847.0,0.0,847.0,
TCGA-EE-A2MS,9065,TCGA-EE-A2MS,SKCM,72.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1999.0,[Not Available],-26466.0,Alive,TUMOR FREE,4942.0,,[Not Available],New primary melanoma,,,1883.0,[Not Available],,,0.0,4942.0,0.0,4942.0,,,1.0,1883.0,
TCGA-RD-A8N2,9634,TCGA-RD-A8N2,STAD,59.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2002.0,[Not Available],-21749.0,Alive,TUMOR FREE,3540.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3540.0,0.0,3540.0,0.0,3540.0,0.0,3540.0,
TCGA-AY-5543,2205,TCGA-AY-5543,COAD,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-23870.0,Alive,TUMOR FREE,1004.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1004.0,0.0,1004.0,,,0.0,1004.0,
TCGA-VM-A8CF,5411,TCGA-VM-A8CF,LGG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-16334.0,Alive,TUMOR FREE,609.0,,[Not Available],,,,,[Unknown],,,0.0,609.0,0.0,609.0,,,0.0,609.0,
TCGA-HT-A61B,5237,TCGA-HT-A61B,LGG,22.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-8335.0,Alive,TUMOR FREE,533.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,533.0,0.0,533.0,0.0,533.0,0.0,533.0,
TCGA-R5-A7ZE,9620,TCGA-R5-A7ZE,STAD,66.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,[Not Available],-24328.0,Dead,WITH TUMOR,,554.0,[Unknown],,,,,Progressive Disease,,,1.0,554.0,1.0,554.0,,,1.0,554.0,
TCGA-ED-A82E,5676,TCGA-ED-A82E,LIHC,60.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-22234.0,Alive,TUMOR FREE,408.0,,[Not Available],,,,,[Not Available],,R0,0.0,408.0,0.0,408.0,0.0,408.0,0.0,408.0,
TCGA-NJ-A55O,6320,TCGA-NJ-A55O,LUAD,56.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-20628.0,Alive,TUMOR FREE,13.0,,[Not Available],,,,,Stable Disease,,,0.0,13.0,0.0,13.0,,,0.0,13.0,
TCGA-VR-AA4G,2633,TCGA-VR-AA4G,ESCA,51.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-18909.0,Alive,TUMOR FREE,549.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,549.0,0.0,549.0,0.0,549.0,0.0,549.0,
TCGA-B5-A1MV,10718,TCGA-B5-A1MV,UCEC,84.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30926.0,Alive,TUMOR FREE,1565.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1565.0,0.0,1565.0,0.0,1565.0,0.0,1565.0,
TCGA-DX-A6B7,8603,TCGA-DX-A6B7,SARC,55.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-20365.0,Alive,TUMOR FREE,1143.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1143.0,0.0,1143.0,0.0,1143.0,0.0,1143.0,
TCGA-P4-AAVM,4662,TCGA-P4-AAVM,KIRP,69.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-25280.0,Alive,TUMOR FREE,1539.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1539.0,0.0,1539.0,0.0,1539.0,0.0,1539.0,
TCGA-73-4666,6116,TCGA-73-4666,LUAD,52.0,FEMALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-19074.0,Alive,TUMOR FREE,800.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,800.0,0.0,800.0,,,0.0,800.0,
TCGA-CH-5753,7891,TCGA-CH-5753,PRAD,70.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-25780.0,Alive,TUMOR FREE,31.0,,[Not Available],,,,,[Not Available],,,0.0,31.0,0.0,31.0,,,0.0,31.0,
TCGA-CN-A49B,3361,TCGA-CN-A49B,HNSC,71.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-26155.0,Alive,TUMOR FREE,904.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,904.0,0.0,904.0,0.0,904.0,0.0,904.0,
TCGA-BB-4225,3282,TCGA-BB-4225,HNSC,73.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,[Not Available],-26687.0,Alive,WITH TUMOR,146.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,146.0,0.0,146.0,,,0.0,146.0,
TCGA-55-A4DG,6056,TCGA-55-A4DG,LUAD,71.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26044.0,Alive,TUMOR FREE,608.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,
TCGA-60-2716,6576,TCGA-60-2716,LUSC,39.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-14345.0,Alive,TUMOR FREE,1475.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1475.0,0.0,1475.0,0.0,1475.0,0.0,1475.0,
TCGA-FD-A43P,276,TCGA-FD-A43P,BLCA,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27201.0,Alive,TUMOR FREE,832.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,832.0,0.0,832.0,0.0,832.0,0.0,832.0,
TCGA-X3-A8G4,9805,TCGA-X3-A8G4,TGCT,33.0,MALE,WHITE,IS,[Not Available],Seminoma; NOS|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Immature),[Not Available],2011.0,[Not Available],-12117.0,Alive,TUMOR FREE,856.0,,[Not Applicable],,,,,,,,0.0,856.0,0.0,856.0,,,0.0,856.0,
TCGA-BQ-5890,4550,TCGA-BQ-5890,KIRP,69.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-25272.0,Alive,TUMOR FREE,233.0,,[Not Available],,,,,[Not Available],,,0.0,233.0,0.0,233.0,,,0.0,233.0,
TCGA-CM-6680,2294,TCGA-CM-6680,COAD,78.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-28701.0,Alive,TUMOR FREE,366.0,,[Not Available],,,,,[Not Available],,,0.0,366.0,0.0,366.0,,,0.0,366.0,
TCGA-LP-A4AX,1800,TCGA-LP-A4AX,CESC,45.0,FEMALE,ASIAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2011.0,Peri (6-12 months since last menstrual period),-16544.0,Alive,TUMOR FREE,380.0,,,,,,,Complete Remission/Response,,,0.0,380.0,0.0,380.0,0.0,380.0,0.0,380.0,
TCGA-2Y-A9H7,5442,TCGA-2Y-A9H7,LIHC,81.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-29752.0,Alive,WITH TUMOR,1168.0,,[Not Available],Locoregional Recurrence,Liver,,1117.0,[Not Available],,R0,0.0,1168.0,0.0,1168.0,1.0,1117.0,1.0,1117.0,
TCGA-77-6845,6661,TCGA-77-6845,LUSC,69.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-25321.0,Dead,,,708.0,[Not Available],,,,,[Not Available],,,1.0,708.0,,708.0,,,0.0,708.0,
TCGA-EE-A2M7,9048,TCGA-EE-A2M7,SKCM,66.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1999.0,[Not Available],-24371.0,Dead,WITH TUMOR,,877.0,[Not Available],Distant Metastasis,"Other, Specify",mediastinal lymph nodes,799.0,[Not Available],,,1.0,877.0,1.0,877.0,,,1.0,799.0,
TCGA-J8-A3O1,10321,TCGA-J8-A3O1,THCA,33.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-12113.0,Alive,TUMOR FREE,827.0,,[Not Available],,,,,[Not Available],,R0,0.0,827.0,0.0,827.0,0.0,827.0,0.0,827.0,
TCGA-HU-8244,9559,TCGA-HU-8244,STAD,77.0,FEMALE,ASIAN,Stage IA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G1,2011.0,[Not Available],-28184.0,Alive,TUMOR FREE,742.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,742.0,0.0,742.0,0.0,742.0,0.0,742.0,
TCGA-78-7147,6144,TCGA-78-7147,LUAD,67.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-24809.0,Dead,WITH TUMOR,,586.0,[Not Available],,,,578.0,[Not Available],,,1.0,586.0,1.0,586.0,,,1.0,578.0,
TCGA-60-2703,6564,TCGA-60-2703,LUSC,73.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-27003.0,Dead,,,2945.0,[Not Available],,,,1757.0,Complete Remission/Response,,,1.0,2945.0,,2945.0,1.0,1757.0,1.0,1757.0,
TCGA-CN-A63W,3366,TCGA-CN-A63W,HNSC,48.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-17693.0,Dead,TUMOR FREE,,377.0,[Not Available],,,,,Complete Remission/Response,,,1.0,377.0,0.0,377.0,,,0.0,377.0,
TCGA-DW-7840,4577,TCGA-DW-7840,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-22141.0,Alive,,114.0,,[Not Available],,,,,[Not Available],,,0.0,114.0,0.0,114.0,,,0.0,114.0,
TCGA-HJ-7597,9556,TCGA-HJ-7597,STAD,71.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2005.0,[Not Available],-26264.0,Dead,WITH TUMOR,,805.0,Stomach Cancer,Locoregional Recurrence,,,231.0,Complete Remission/Response,,,1.0,805.0,1.0,805.0,1.0,231.0,1.0,231.0,
TCGA-L5-A8NL,2546,TCGA-L5-A8NL,ESCA,56.0,MALE,WHITE,Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2004.0,[Not Available],-20542.0,Alive,TUMOR FREE,402.0,,[Not Available],,,,,[Unknown],,,0.0,402.0,0.0,402.0,,,0.0,402.0,
TCGA-S7-A7X2,7792,TCGA-S7-A7X2,PCPG,57.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-21054.0,Alive,TUMOR FREE,736.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,736.0,0.0,736.0,0.0,736.0,0.0,736.0,
TCGA-FP-A4BE,9546,TCGA-FP-A4BE,STAD,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-20148.0,Alive,TUMOR FREE,337.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,337.0,0.0,337.0,0.0,337.0,0.0,337.0,
TCGA-E2-A1IK,1365,TCGA-E2-A1IK,BRCA,71.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26052.0,Alive,TUMOR FREE,1800.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1800.0,0.0,1800.0,0.0,1800.0,0.0,1800.0,
TCGA-CD-5803,9419,TCGA-CD-5803,STAD,78.0,FEMALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,[Not Available],-28608.0,Dead,WITH TUMOR,,341.0,[Not Available],Distant Metastasis,Liver,,300.0,Progressive Disease,,,1.0,341.0,1.0,341.0,,,1.0,300.0,
TCGA-JY-A93D,2504,TCGA-JY-A93D,ESCA,51.0,MALE,WHITE,Stage IIIC,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2012.0,[Not Available],-18813.0,Dead,WITH TUMOR,,960.0,[Not Available],Locoregional Recurrence,"Other, specify",Mediastinal lymph node,732.0,Complete Remission/Response,,,1.0,960.0,1.0,960.0,1.0,732.0,1.0,732.0,
TCGA-FD-A6TH,302,TCGA-FD-A6TH,BLCA,63.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-23236.0,Dead,WITH TUMOR,,131.0,[Not Available],Distant Metastasis,Lung,,126.0,Complete Remission/Response,,,1.0,131.0,1.0,131.0,,,1.0,126.0,
TCGA-IB-A5SO,7637,TCGA-IB-A5SO,PAAD,71.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-26129.0,Dead,WITH TUMOR,,365.0,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,,276.0,Progressive Disease,,,1.0,365.0,1.0,365.0,,,1.0,276.0,
TCGA-06-0124,2741,TCGA-06-0124,GBM,67.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-24591.0,Dead,WITH TUMOR,123.0,620.0,[Not Available],,,,,[Not Available],,,1.0,620.0,1.0,620.0,,,1.0,620.0,
TCGA-UB-A7MF,5777,TCGA-UB-A7MF,LIHC,56.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-20815.0,Dead,WITH TUMOR,,214.0,[Not Available],Intrahepatic Recurrence,Liver,,133.0,[Not Available],,R0,1.0,214.0,1.0,214.0,1.0,133.0,1.0,133.0,
TCGA-D7-6524,9494,TCGA-D7-6524,STAD,53.0,MALE,WHITE,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-19532.0,Alive,WITH TUMOR,543.0,,[Not Available],Locoregional Recurrence,Non-regional / Distant Lymph Nodes,,543.0,Progressive Disease,,,0.0,543.0,0.0,543.0,,,1.0,543.0,
TCGA-DX-AB3C,8674,TCGA-DX-AB3C,SARC,27.0,MALE,WHITE,[Not Available],[Not Available],Synovial Sarcoma - Monophasic,[Not Available],2008.0,[Not Available],-10034.0,Alive,WITH TUMOR,2169.0,,[Not Available],Distant Metastasis,Lung,,567.0,[Not Available],Positive,R0,0.0,2169.0,0.0,2169.0,1.0,567.0,1.0,567.0,
TCGA-DX-A6Z0,8621,TCGA-DX-A6Z0,SARC,78.0,FEMALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2006.0,[Not Available],-28796.0,Dead,TUMOR FREE,,1953.0,[Not Available],,,,,[Not Available],Positive,R1,1.0,1953.0,0.0,1953.0,,,0.0,1953.0,
TCGA-D3-A2JO,8850,TCGA-D3-A2JO,SKCM,50.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-18577.0,Alive,WITH TUMOR,2010.0,,[Not Available],Distant Metastasis,"Other, Specify","Chest wall, soft tissue",50.0,[Not Available],,,0.0,2010.0,0.0,2010.0,,,1.0,50.0,
TCGA-YD-A9TA,9260,TCGA-YD-A9TA,SKCM,75.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2010.0,[Not Available],-27498.0,Alive,TUMOR FREE,1496.0,,[Not Available],,,,,[Not Available],,,0.0,1496.0,0.0,1496.0,,,0.0,1496.0,
TCGA-XF-AAN5,465,TCGA-XF-AAN5,BLCA,61.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-22411.0,Alive,TUMOR FREE,2293.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2293.0,0.0,2293.0,0.0,2293.0,0.0,2293.0,
TCGA-DK-A6B1,213,TCGA-DK-A6B1,BLCA,67.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-24607.0,Alive,TUMOR FREE,2049.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2049.0,0.0,2049.0,0.0,2049.0,0.0,2049.0,
TCGA-DD-AADA,5612,TCGA-DD-AADA,LIHC,66.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-24288.0,Alive,TUMOR FREE,1233.0,,[Not Available],,,,,[Not Available],,R0,0.0,1233.0,0.0,1233.0,0.0,1233.0,0.0,1233.0,
TCGA-GL-A9DD,4616,TCGA-GL-A9DD,KIRP,69.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-25483.0,Alive,TUMOR FREE,341.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,341.0,0.0,341.0,0.0,341.0,0.0,341.0,
TCGA-LL-A9Q3,1548,TCGA-LL-A9Q3,BRCA,69.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25477.0,Alive,TUMOR FREE,532.0,,[Not Available],,,,,[Not Available],Negative,,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,
TCGA-BF-A3DN,8809,TCGA-BF-A3DN,SKCM,81.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-29801.0,Alive,TUMOR FREE,717.0,,[Not Available],,,,,[Not Available],,,0.0,717.0,0.0,717.0,,,0.0,717.0,
TCGA-AY-A71X,2211,TCGA-AY-A71X,COAD,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2013.0,[Not Available],-19904.0,Alive,TUMOR FREE,588.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,
TCGA-44-A47A,5896,TCGA-44-A47A,LUAD,78.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-28782.0,Alive,WITH TUMOR,466.0,,[Not Available],Distant Metastasis,,,397.0,Complete Remission/Response,,,0.0,466.0,0.0,466.0,1.0,397.0,1.0,397.0,
TCGA-75-6206,6132,TCGA-75-6206,LUAD,,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],,[Not Available],,Alive,TUMOR FREE,2590.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2590.0,0.0,2590.0,0.0,2590.0,0.0,2590.0,
TCGA-LH-A9QB,9217,TCGA-LH-A9QB,SKCM,24.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1984.0,[Not Available],-9058.0,Alive,TUMOR FREE,11217.0,,[Not Available],,,,,[Not Available],,,0.0,11217.0,0.0,11217.0,,,0.0,11217.0,
TCGA-CV-5436,3475,TCGA-CV-5436,HNSC,65.0,MALE,[Not Available],Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,[Not Available],-23923.0,Dead,WITH TUMOR,548.0,584.0,[Not Available],,,,,Persistent Disease,,,1.0,584.0,1.0,584.0,,,1.0,584.0,
TCGA-FP-8210,9543,TCGA-FP-8210,STAD,48.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2006.0,[Not Available],-17562.0,Dead,WITH TUMOR,,153.0,Stomach Cancer,,,,,Progressive Disease,,,1.0,153.0,1.0,153.0,,,1.0,153.0,
TCGA-22-4593,6371,TCGA-22-4593,LUSC,77.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-28385.0,Dead,TUMOR FREE,1067.0,1067.0,[Not Available],,,,,[Not Available],,,1.0,1067.0,0.0,1067.0,,,0.0,1067.0,
TCGA-CR-7392,3460,TCGA-CR-7392,HNSC,67.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2009.0,[Not Available],-24650.0,Alive,TUMOR FREE,1425.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1425.0,0.0,1425.0,,,0.0,1425.0,
TCGA-D8-A27M,1290,TCGA-D8-A27M,BRCA,59.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21910.0,Alive,TUMOR FREE,410.0,,[Not Available],,,,,[Not Available],Negative,,0.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,
TCGA-E2-A152,1327,TCGA-E2-A152,BRCA,56.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20705.0,Alive,TUMOR FREE,2128.0,,[Not Available],Distant Metastasis,Liver,,54.0,[Not Available],Negative,,0.0,2128.0,0.0,2128.0,1.0,54.0,1.0,54.0,
TCGA-CM-4750,2263,TCGA-CM-4750,COAD,34.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-12478.0,Alive,TUMOR FREE,244.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,244.0,0.0,244.0,0.0,244.0,0.0,244.0,
TCGA-BH-A0DI,1065,TCGA-BH-A0DI,BRCA,63.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23327.0,Alive,TUMOR FREE,912.0,,[Not Available],,,,,[Not Available],Negative,,0.0,912.0,0.0,912.0,0.0,912.0,0.0,912.0,
TCGA-A2-A04R,530,TCGA-A2-A04R,BRCA,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13483.0,Alive,TUMOR FREE,3709.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3709.0,0.0,3709.0,0.0,3709.0,0.0,3709.0,
TCGA-S9-A6U0,5328,TCGA-S9-A6U0,LGG,46.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-16890.0,Dead,WITH TUMOR,,742.0,[Not Available],,,,692.0,Partial Remission/Response,,,1.0,742.0,1.0,742.0,,,1.0,692.0,
TCGA-DD-AAW1,5662,TCGA-DD-AAW1,LIHC,55.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2009.0,[Not Available],-20288.0,Alive,TUMOR FREE,1989.0,,[Not Available],,,,,[Not Available],,R0,0.0,1989.0,0.0,1989.0,0.0,1989.0,0.0,1989.0,
TCGA-AJ-A3NF,10547,TCGA-AJ-A3NF,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22210.0,Alive,TUMOR FREE,645.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,645.0,0.0,645.0,0.0,645.0,0.0,645.0,
TCGA-AA-3496,2017,TCGA-AA-3496,COAD,83.0,FEMALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2002.0,[Not Available],-30438.0,Alive,WITH TUMOR,31.0,,[Not Available],,,,,[Not Available],,,0.0,31.0,0.0,31.0,,,0.0,31.0,
TCGA-A3-3347,3906,TCGA-A3-3347,KIRC,76.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-27966.0,Dead,WITH TUMOR,,1610.0,[Not Available],,,,610.0,[Not Available],,,1.0,1610.0,1.0,1610.0,,,1.0,610.0,
TCGA-QQ-A8VH,8755,TCGA-QQ-A8VH,SARC,31.0,FEMALE,WHITE,[Not Available],[Not Available],Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2010.0,[Not Available],-11599.0,Dead,WITH TUMOR,,320.0,[Not Available],Locoregional Recurrence,"Other, specify",Spine T6 to apical lung,197.0,[Not Available],Positive,RX,1.0,320.0,1.0,320.0,,,1.0,197.0,
TCGA-VD-A8K7,11117,TCGA-VD-A8K7,UVM,39.0,MALE,[Not Evaluated],Stage IIIA,Stage IIIA,Spindle Cell,[Not Available],2011.0,[Not Available],-14294.0,Alive,TUMOR FREE,1459.0,,[Not Available],,,,,[Not Available],,,0.0,1459.0,0.0,1459.0,,,0.0,1459.0,
TCGA-TM-A7C4,5370,TCGA-TM-A7C4,LGG,39.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-14603.0,Alive,TUMOR FREE,1470.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1470.0,0.0,1470.0,0.0,1470.0,0.0,1470.0,
TCGA-VN-A88M,8270,TCGA-VN-A88M,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-20157.0,Alive,TUMOR FREE,189.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,189.0,0.0,189.0,0.0,189.0,0.0,189.0,
TCGA-KH-A6WC,2507,TCGA-KH-A6WC,ESCA,82.0,MALE,WHITE,Stage IA,Stage IA,Esophagus Squamous Cell Carcinoma,GX,2013.0,[Not Available],-30167.0,Alive,TUMOR FREE,191.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,191.0,0.0,191.0,0.0,191.0,0.0,191.0,
TCGA-HQ-A5NE,371,TCGA-HQ-A5NE,BLCA,57.0,MALE,[Not Evaluated],Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-20647.0,Dead,WITH TUMOR,,370.0,[Not Available],Distant Metastasis,Renal Pelvis,,211.0,Complete Remission/Response,,,1.0,370.0,1.0,370.0,1.0,211.0,1.0,211.0,
TCGA-66-2744,6613,TCGA-66-2744,LUSC,71.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-26084.0,Alive,TUMOR FREE,30.0,,[Not Available],,,,,[Not Available],,,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-95-8494,6243,TCGA-95-8494,LUAD,67.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-24773.0,Alive,,84.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,84.0,0.0,84.0,0.0,84.0,0.0,84.0,
TCGA-E2-A107,1305,TCGA-E2-A107,BRCA,54.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20065.0,Alive,TUMOR FREE,1047.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1047.0,0.0,1047.0,0.0,1047.0,0.0,1047.0,
TCGA-ZF-A9R4,477,TCGA-ZF-A9R4,BLCA,83.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-30398.0,Alive,TUMOR FREE,921.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,921.0,0.0,921.0,0.0,921.0,0.0,921.0,
TCGA-WT-AB44,1597,TCGA-WT-AB44,BRCA,77.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,TUMOR FREE,883.0,,[Not Available],,,,,[Not Available],Negative,,0.0,883.0,0.0,883.0,0.0,883.0,0.0,883.0,
TCGA-VM-A8CE,5410,TCGA-VM-A8CE,LGG,25.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-9363.0,Alive,WITH TUMOR,1191.0,,[Not Available],,,,815.0,[Unknown],,,0.0,1191.0,0.0,1191.0,,,1.0,815.0,
TCGA-CV-6943,3504,TCGA-CV-6943,HNSC,74.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,[Not Available],-27310.0,Dead,WITH TUMOR,,602.0,[Not Available],,,,,[Not Available],,,1.0,602.0,1.0,602.0,,,1.0,602.0,
TCGA-BP-5183,4250,TCGA-BP-5183,KIRC,57.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-20881.0,Alive,TUMOR FREE,1291.0,,[Not Available],,,,485.0,[Not Available],,,0.0,1291.0,0.0,1291.0,,,1.0,485.0,
TCGA-CV-A6JD,3593,TCGA-CV-A6JD,HNSC,82.0,FEMALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,[Not Available],-29988.0,Dead,TUMOR FREE,,182.0,[Not Available],,,,,Complete Remission/Response,,,1.0,182.0,0.0,182.0,,,0.0,182.0,
TCGA-3L-AA1B,1954,TCGA-3L-AA1B,COAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2013.0,[Not Available],-22379.0,Alive,TUMOR FREE,475.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,
TCGA-AF-4110,8377,TCGA-AF-4110,READ,77.0,MALE,WHITE,Stage IVA,[Not Applicable],[Not Available],[Not Available],2010.0,[Not Available],-28289.0,Alive,TUMOR FREE,912.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,912.0,0.0,912.0,,,0.0,912.0,
TCGA-R8-A6MO,5312,TCGA-R8-A6MO,LGG,53.0,FEMALE,ASIAN,[Not Available],[Not Available],Oligodendroglioma,G2,2009.0,[Not Available],-19432.0,Alive,,993.0,,[Not Available],,,,,[Not Available],,,0.0,993.0,0.0,993.0,,,0.0,993.0,
TCGA-DU-A76L,5054,TCGA-DU-A76L,LGG,54.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2000.0,[Not Available],-19823.0,Dead,WITH TUMOR,,814.0,[Not Available],,,,410.0,Progressive Disease,,,1.0,814.0,1.0,814.0,,,1.0,410.0,
TCGA-IB-7644,7618,TCGA-IB-7644,PAAD,65.0,FEMALE,WHITE,Stage IV,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-24043.0,Dead,WITH TUMOR,,394.0,Pancreatic Cancer,Distant Metastasis,"Other, specify","Omentum, Peritoneal surface, Non regional Lymph nodes",306.0,Progressive Disease,,,1.0,394.0,1.0,394.0,,,1.0,306.0,
TCGA-P3-A6SX,3712,TCGA-P3-A6SX,HNSC,67.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2005.0,[Not Available],-24715.0,Dead,TUMOR FREE,,1430.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1430.0,0.0,1430.0,,,0.0,1430.0,
TCGA-HD-A633,3674,TCGA-HD-A633,HNSC,74.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-27057.0,Alive,WITH TUMOR,421.0,,[Not Available],Locoregional Recurrence,Oral Cavity,Buccal Space & Infratemporal Fossa,419.0,Complete Remission/Response,,,0.0,421.0,0.0,421.0,,,1.0,419.0,
TCGA-BR-A4CS,9395,TCGA-BR-A4CS,STAD,77.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-28211.0,Dead,TUMOR FREE,,45.0,[Not Available],,,,,Complete Remission/Response,,,1.0,45.0,0.0,45.0,0.0,45.0,0.0,45.0,
TCGA-G2-A2EK,315,TCGA-G2-A2EK,BLCA,57.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-20995.0,Alive,WITH TUMOR,485.0,,[Not Available],Distant Metastasis,Renal Pelvis,,485.0,Stable Disease,,,0.0,485.0,0.0,485.0,,,1.0,485.0,
TCGA-UF-A7JK,3762,TCGA-UF-A7JK,HNSC,59.0,MALE,[Unknown],Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-21696.0,Dead,WITH TUMOR,,424.0,[Not Available],,Larynx,,341.0,Complete Remission/Response,,,1.0,424.0,1.0,424.0,,,1.0,341.0,
TCGA-QK-A8Z8,3732,TCGA-QK-A8Z8,HNSC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVC,Stage IVC,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-22107.0,Dead,WITH TUMOR,,171.0,[Not Available],,,,,[Unknown],,,1.0,171.0,1.0,171.0,,,1.0,171.0,
TCGA-5P-A9K2,4453,TCGA-5P-A9K2,KIRP,62.0,MALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-22964.0,Alive,TUMOR FREE,2392.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2392.0,0.0,2392.0,0.0,2392.0,0.0,2392.0,
TCGA-37-4133,6445,TCGA-37-4133,LUSC,63.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-23083.0,Alive,TUMOR FREE,238.0,,[Not Available],,,,,[Not Available],,,0.0,238.0,0.0,238.0,,,0.0,238.0,
TCGA-EJ-7314,7949,TCGA-EJ-7314,PRAD,62.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22766.0,Alive,TUMOR FREE,1150.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1150.0,0.0,1150.0,0.0,1150.0,0.0,1150.0,
TCGA-J4-A83K,8146,TCGA-J4-A83K,PRAD,52.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-19299.0,Alive,TUMOR FREE,328.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,328.0,0.0,328.0,0.0,328.0,0.0,328.0,
TCGA-OR-A5LA,64,TCGA-OR-A5LA,ACC,52.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-19242.0,Alive,TUMOR FREE,719.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,719.0,0.0,719.0,0.0,719.0,0.0,719.0,
TCGA-OL-A66J,1565,TCGA-OL-A66J,BRCA,80.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29345.0,Alive,TUMOR FREE,1996.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1996.0,0.0,1996.0,0.0,1996.0,0.0,1996.0,
TCGA-FI-A2D4,10986,TCGA-FI-A2D4,UCEC,44.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16163.0,Dead,WITH TUMOR,,243.0,[Not Available],,,,,Partial Remission/Response,,,1.0,243.0,1.0,243.0,,,1.0,243.0,
TCGA-DD-A11C,5522,TCGA-DD-A11C,LIHC,69.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2006.0,[Not Available],-25403.0,Alive,TUMOR FREE,662.0,,[Not Available],,,,,[Not Available],,RX,0.0,662.0,0.0,662.0,,,0.0,662.0,
TCGA-3A-A9I7,7527,TCGA-3A-A9I7,PAAD,45.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,[Not Available],-16766.0,Alive,WITH TUMOR,1323.0,,,Locoregional Recurrence,Peritoneal Surfaces,,1309.0,[Unknown],,,0.0,1323.0,0.0,1323.0,,,1.0,1309.0,
TCGA-S9-A7J0,5353,TCGA-S9-A7J0,LGG,30.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-10989.0,Alive,WITH TUMOR,609.0,,[Not Available],,,,390.0,Partial Remission/Response,,,0.0,609.0,0.0,609.0,,,1.0,390.0,
TCGA-2G-AAKD,9767,TCGA-2G-AAKD,TGCT,18.0,MALE,WHITE,Stage III,Stage III,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],1997.0,[Not Available],-6814.0,Alive,TUMOR FREE,6340.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,6340.0,0.0,6340.0,,,0.0,6340.0,
TCGA-BG-A0VV,10757,TCGA-BG-A0VV,UCEC,53.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19581.0,Alive,TUMOR FREE,1553.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1553.0,0.0,1553.0,0.0,1553.0,0.0,1553.0,
TCGA-BR-4357,9291,TCGA-BR-4357,STAD,58.0,MALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],-21295.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-HZ-A49H,7608,TCGA-HZ-A49H,PAAD,68.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-24891.0,Alive,TUMOR FREE,491.0,,,,,,,Complete Remission/Response,,,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,
TCGA-QT-A5XN,7747,TCGA-QT-A5XN,PCPG,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-18812.0,Alive,TUMOR FREE,766.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,
TCGA-LL-A7T0,1546,TCGA-LL-A7T0,BRCA,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25867.0,Alive,TUMOR FREE,376.0,,[Not Available],,,,,[Not Available],Negative,,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,
TCGA-KQ-A41P,387,TCGA-KQ-A41P,BLCA,76.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-27816.0,Alive,WITH TUMOR,1094.0,,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,178.0,Stable Disease,,,0.0,1094.0,0.0,1094.0,,,1.0,178.0,
TCGA-34-5928,6432,TCGA-34-5928,LUSC,83.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-30334.0,Alive,TUMOR FREE,1196.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1196.0,0.0,1196.0,0.0,1196.0,0.0,1196.0,
TCGA-05-4410,5818,TCGA-05-4410,LUAD,62.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-22888.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-XF-AAMJ,451,TCGA-XF-AAMJ,BLCA,70.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-25838.0,Dead,TUMOR FREE,,1670.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1670.0,0.0,1670.0,0.0,1670.0,0.0,1670.0,
TCGA-C8-A1HN,1206,TCGA-C8-A1HN,BRCA,56.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20712.0,Alive,TUMOR FREE,394.0,,[Not Available],,,,,[Not Available],Negative,,0.0,394.0,0.0,394.0,0.0,394.0,0.0,394.0,
TCGA-V4-A9EO,11099,TCGA-V4-A9EO,UVM,74.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,[Not Available],2013.0,[Not Available],-27190.0,Alive,TUMOR FREE,773.0,,[Not Available],,,,,[Not Available],,,0.0,773.0,0.0,773.0,,,0.0,773.0,
TCGA-23-2649,7160,TCGA-23-2649,OV,60.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-22210.0,Alive,,116.0,,[Not Available],,,,,[Not Available],,,0.0,116.0,0.0,116.0,,,0.0,116.0,
TCGA-YT-A95G,10444,TCGA-YT-A95G,THYM,61.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type B2,[Not Available],2010.0,[Not Available],-22541.0,Alive,TUMOR FREE,1514.0,,[Not Available],,,,,[Not Available],,,0.0,1514.0,0.0,1514.0,,,0.0,1514.0,
TCGA-DQ-5630,3633,TCGA-DQ-5630,HNSC,73.0,MALE,WHITE,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-26855.0,Alive,TUMOR FREE,1030.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1030.0,0.0,1030.0,0.0,1030.0,0.0,1030.0,
TCGA-DM-A285,2341,TCGA-DM-A285,COAD,71.0,FEMALE,WHITE,Stage IV,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2001.0,[Not Available],-26021.0,Dead,,,179.0,[Not Available],,,,,[Not Available],,,1.0,179.0,,179.0,,,0.0,179.0,
TCGA-BR-4187,9278,TCGA-BR-4187,STAD,56.0,MALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-20635.0,Dead,,,141.0,[Not Available],,,,,[Not Available],,,1.0,141.0,,141.0,,,0.0,141.0,
TCGA-DE-A4MA,9911,TCGA-DE-A4MA,THCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19100.0,Alive,TUMOR FREE,916.0,,[Not Available],,,,,[Not Available],,R0,0.0,916.0,0.0,916.0,0.0,916.0,0.0,916.0,
TCGA-EM-A4FK,10192,TCGA-EM-A4FK,THCA,33.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-12383.0,Alive,TUMOR FREE,649.0,,[Not Available],,,,,[Not Available],,R0,0.0,649.0,0.0,649.0,0.0,649.0,0.0,649.0,
TCGA-BP-4760,4169,TCGA-BP-4760,KIRC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-25268.0,Alive,WITH TUMOR,2361.0,,[Not Available],,,,1457.0,[Not Available],,,0.0,2361.0,0.0,2361.0,,,1.0,1457.0,
TCGA-MQ-A4LM,6857,TCGA-MQ-A4LM,MESO,67.0,MALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2002.0,[Not Available],-24704.0,Dead,,,158.0,[Not Available],Intrapleural Progression,"Other, specify",CONTRALATERAL EFFUSION,113.0,[Not Available],,[Unknown],1.0,158.0,,158.0,,,1.0,113.0,
TCGA-14-0786,3001,TCGA-14-0786,GBM,50.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-18592.0,Dead,WITH TUMOR,701.0,701.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],127.0,[Not Available],,,1.0,701.0,1.0,701.0,,,1.0,127.0,
TCGA-VR-A8Q7,2631,TCGA-VR-A8Q7,ESCA,60.0,MALE,WHITE,Stage IIIA,Stage IIIA,Esophagus Squamous Cell Carcinoma,G3,2010.0,[Not Available],-22149.0,Alive,TUMOR FREE,1590.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1590.0,0.0,1590.0,0.0,1590.0,0.0,1590.0,
TCGA-66-2781,6633,TCGA-66-2781,LUSC,67.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-24471.0,Alive,TUMOR FREE,121.0,,[Not Available],,,,,[Not Available],,,0.0,121.0,0.0,121.0,,,0.0,121.0,
TCGA-BR-7707,9325,TCGA-BR-7707,STAD,69.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-25325.0,Alive,TUMOR FREE,1090.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1090.0,0.0,1090.0,0.0,1090.0,0.0,1090.0,
TCGA-G9-6498,8046,TCGA-G9-6498,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-19568.0,Alive,TUMOR FREE,1952.0,,[Not Available],Biochemical evidence of disease,,,1342.0,Complete Remission/Response,,,0.0,1952.0,0.0,1952.0,1.0,1342.0,1.0,1342.0,
TCGA-KQ-A41Q,388,TCGA-KQ-A41Q,BLCA,89.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-32511.0,Alive,,1429.0,,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,1314.0,[Unknown],,,0.0,1429.0,0.0,1429.0,,,1.0,1314.0,
TCGA-AJ-A3QS,10553,TCGA-AJ-A3QS,UCEC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21162.0,Alive,TUMOR FREE,513.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,513.0,0.0,513.0,0.0,513.0,0.0,513.0,
TCGA-BG-A0MQ,10751,TCGA-BG-A0MQ,UCEC,71.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26284.0,Alive,WITH TUMOR,1817.0,,[Not Available],,,,,Stable Disease,,,0.0,1817.0,0.0,1817.0,,,0.0,1817.0,
TCGA-FG-5965,5101,TCGA-FG-5965,LGG,39.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2008.0,[Not Available],-14249.0,Dead,WITH TUMOR,,1120.0,[Not Available],,,,715.0,Stable Disease,,,1.0,1120.0,1.0,1120.0,,,1.0,715.0,
TCGA-51-4080,6499,TCGA-51-4080,LUSC,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-24054.0,Dead,TUMOR FREE,,12.0,[Not Available],,,,,[Not Available],,,1.0,12.0,0.0,12.0,,,0.0,12.0,
TCGA-2J-AAB6,7505,TCGA-2J-AAB6,PAAD,75.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-27600.0,Dead,WITH TUMOR,,293.0,Pancreatic Cancer,Distant Metastasis,Liver,,169.0,Progressive Disease,,,1.0,293.0,1.0,293.0,,,1.0,169.0,
TCGA-4W-AA9T,3204,TCGA-4W-AA9T,GBM,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2012.0,[Not Available],-19801.0,Alive,TUMOR FREE,778.0,,[Not Available],,[Not Applicable],[Not Applicable],749.0,Progressive Disease,,,0.0,778.0,0.0,778.0,,,1.0,749.0,
TCGA-55-6984,5987,TCGA-55-6984,LUAD,71.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],,Dead,WITH TUMOR,,760.0,[Not Available],,,,724.0,Complete Remission/Response,,,1.0,760.0,1.0,760.0,1.0,724.0,1.0,724.0,
TCGA-99-AA5R,6277,TCGA-99-AA5R,LUAD,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2013.0,[Not Available],-25778.0,Alive,TUMOR FREE,658.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,
TCGA-CN-6020,3344,TCGA-CN-6020,HNSC,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-21232.0,Dead,TUMOR FREE,,205.0,[Not Available],,,,,Complete Remission/Response,,,1.0,205.0,0.0,205.0,,,0.0,205.0,
TCGA-CV-7432,3567,TCGA-CV-7432,HNSC,79.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1998.0,[Not Available],-28875.0,Dead,WITH TUMOR,,2570.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2570.0,1.0,2570.0,,,1.0,2570.0,
TCGA-FD-A5BS,282,TCGA-FD-A5BS,BLCA,68.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-24963.0,Alive,TUMOR FREE,1639.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1639.0,0.0,1639.0,0.0,1639.0,0.0,1639.0,
TCGA-FU-A3YQ,1763,TCGA-FU-A3YQ,CESC,35.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G1,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12816.0,Alive,TUMOR FREE,861.0,,,,,,,Complete Remission/Response,,,0.0,861.0,0.0,861.0,0.0,861.0,0.0,861.0,
TCGA-GC-A3BM,326,TCGA-GC-A3BM,BLCA,70.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-25609.0,Dead,WITH TUMOR,,651.0,[Not Available],,,,,Progressive Disease,,,1.0,651.0,1.0,651.0,,,1.0,651.0,
TCGA-CG-4436,9449,TCGA-CG-4436,STAD,57.0,MALE,[Not Available],Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2005.0,[Not Available],-20941.0,Alive,TUMOR FREE,243.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,243.0,0.0,243.0,0.0,243.0,0.0,243.0,
TCGA-AX-A3GB,10673,TCGA-AX-A3GB,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26724.0,Alive,,440.0,,[Not Available],,,,,[Not Available],,,0.0,440.0,0.0,440.0,,,0.0,440.0,
TCGA-RN-AAAQ,8757,TCGA-RN-AAAQ,SARC,52.0,MALE,WHITE,[Not Available],[Not Available],Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2013.0,[Not Available],-19123.0,Alive,WITH TUMOR,510.0,,[Not Available],Locoregional Recurrence,"Other, specify",Left Shoulder,307.0,[Not Available],[Unknown],[Not Available],0.0,510.0,0.0,510.0,,,1.0,307.0,
TCGA-SR-A6MZ,7813,TCGA-SR-A6MZ,PCPG,46.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-16802.0,Alive,TUMOR FREE,797.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,797.0,0.0,797.0,0.0,797.0,0.0,797.0,
TCGA-OR-A5KB,44,TCGA-OR-A5KB,ACC,61.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-22550.0,Alive,WITH TUMOR,741.0,,[Not Available],Distant Metastasis,Soft Tissue,,214.0,Progressive Disease,,,0.0,741.0,0.0,741.0,,,1.0,214.0,
TCGA-63-A5MJ,6597,TCGA-63-A5MJ,LUSC,54.0,MALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-20018.0,Alive,TUMOR FREE,1824.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1824.0,0.0,1824.0,0.0,1824.0,0.0,1824.0,
TCGA-B5-A0JY,10682,TCGA-B5-A0JY,UCEC,50.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18475.0,Alive,TUMOR FREE,2107.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2107.0,0.0,2107.0,0.0,2107.0,0.0,2107.0,
TCGA-E7-A6MD,245,TCGA-E7-A6MD,BLCA,66.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-24180.0,Alive,,129.0,,[Not Available],,,,,[Unknown],,,0.0,129.0,0.0,129.0,,,0.0,129.0,
TCGA-EJ-A46F,7980,TCGA-EJ-A46F,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21160.0,Alive,TUMOR FREE,783.0,,[Not Available],Biochemical evidence of disease,,,215.0,Partial Remission/Response,,,0.0,783.0,0.0,783.0,,,1.0,215.0,
TCGA-91-6849,6221,TCGA-91-6849,LUAD,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-27676.0,Alive,,35.0,,[Not Available],,,,,[Unknown],,,0.0,35.0,0.0,35.0,,,0.0,35.0,
TCGA-DD-AACN,5593,TCGA-DD-AACN,LIHC,32.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2009.0,[Not Available],-12007.0,Alive,WITH TUMOR,1302.0,,[Not Available],Intrahepatic Recurrence,Liver,,357.0,[Not Available],,R0,0.0,1302.0,0.0,1302.0,1.0,357.0,1.0,357.0,
TCGA-EB-A82C,8988,TCGA-EB-A82C,SKCM,70.0,FEMALE,ASIAN,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-25850.0,Alive,TUMOR FREE,17.0,,[Not Available],,,,,[Not Available],,,0.0,17.0,0.0,17.0,,,0.0,17.0,
TCGA-Y8-A894,4702,TCGA-Y8-A894,KIRP,57.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-20964.0,Alive,TUMOR FREE,567.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,
TCGA-CU-A5W6,178,TCGA-CU-A5W6,BLCA,70.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-25706.0,Dead,TUMOR FREE,,56.0,[Not Available],,,,,Complete Remission/Response,,,1.0,56.0,0.0,56.0,0.0,56.0,0.0,56.0,
TCGA-BH-A1EX,1137,TCGA-BH-A1EX,BRCA,67.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24544.0,Dead,WITH TUMOR,,1508.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1508.0,1.0,1508.0,,,1.0,1508.0,
TCGA-QH-A65R,5289,TCGA-QH-A65R,LGG,38.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-14073.0,Alive,WITH TUMOR,461.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,461.0,0.0,461.0,,,0.0,461.0,
TCGA-CA-5254,2234,TCGA-CA-5254,COAD,42.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-15415.0,Alive,TUMOR FREE,386.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,386.0,0.0,386.0,0.0,386.0,0.0,386.0,
TCGA-EL-A3H1,10070,TCGA-EL-A3H1,THCA,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1993.0,[Not Available],-24328.0,Dead,TUMOR FREE,,1500.0,[Not Available],,,,,[Not Available],,R0,1.0,1500.0,0.0,1500.0,0.0,1500.0,0.0,1500.0,
TCGA-JW-A852,1791,TCGA-JW-A852,CESC,42.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15682.0,Dead,WITH TUMOR,,252.0,Cervical Cancer,New Primary Tumor,,Breast,153.0,Complete Remission/Response,,,1.0,252.0,1.0,252.0,0.0,252.0,1.0,153.0,
TCGA-EL-A3GO,10059,TCGA-EL-A3GO,THCA,31.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-11604.0,Alive,WITH TUMOR,1973.0,,[Not Available],Locoregional Recurrence,,Lt. Thyroid,6.0,[Not Available],,R0,0.0,1973.0,0.0,1973.0,1.0,6.0,1.0,6.0,
TCGA-Q1-A73R,1828,TCGA-Q1-A73R,CESC,45.0,FEMALE,WHITE,[Not Available],Stage I,Endocervical Type of Adenocarcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16701.0,Alive,TUMOR FREE,567.0,,,,,,,Complete Remission/Response,,,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,
TCGA-CD-8532,9430,TCGA-CD-8532,STAD,52.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-19284.0,Dead,WITH TUMOR,,354.0,[Not Available],Locoregional Recurrence,,,282.0,Complete Remission/Response,,,1.0,354.0,1.0,354.0,1.0,282.0,1.0,282.0,
TCGA-AA-3947,2118,TCGA-AA-3947,COAD,60.0,FEMALE,[Not Available],Stage IIB,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2009.0,[Not Available],-22035.0,Alive,TUMOR FREE,1004.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1004.0,0.0,1004.0,0.0,1004.0,0.0,1004.0,
TCGA-BH-A0W3,1109,TCGA-BH-A0W3,BRCA,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Indeterminate (neither Pre or Postmenopausal),-21369.0,Alive,TUMOR FREE,728.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,728.0,0.0,728.0,,,0.0,728.0,
TCGA-FA-A7Q1,2419,TCGA-FA-A7Q1,DLBC,61.0,FEMALE,ASIAN,[Not Applicable],Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013.0,[Not Available],-22454.0,Dead,TUMOR FREE,,248.0,[Not Available],,,,,Complete Remission/Response,,,1.0,248.0,0.0,248.0,0.0,248.0,0.0,248.0,
TCGA-FY-A3W9,10293,TCGA-FY-A3W9,THCA,66.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-24136.0,Alive,TUMOR FREE,658.0,,[Not Available],,,,,[Not Available],,R1,0.0,658.0,0.0,658.0,,,0.0,658.0,
TCGA-S9-A6TZ,5327,TCGA-S9-A6TZ,LGG,39.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-14592.0,Alive,WITH TUMOR,1120.0,,[Not Available],,,,552.0,Partial Remission/Response,,,0.0,1120.0,0.0,1120.0,,,1.0,552.0,
TCGA-BR-8297,9350,TCGA-BR-8297,STAD,58.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",GX,2012.0,[Not Available],-21224.0,Alive,WITH TUMOR,225.0,,[Not Available],,,,,Progressive Disease,,,0.0,225.0,0.0,225.0,,,0.0,225.0,
TCGA-SC-A6LN,6868,TCGA-SC-A6LN,MESO,76.0,MALE,ASIAN,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2012.0,[Not Available],-27917.0,Dead,TUMOR FREE,,414.0,[Not Available],,,,,[Not Available],,R0,1.0,414.0,0.0,414.0,0.0,414.0,0.0,414.0,
TCGA-AA-3506,2019,TCGA-AA-3506,COAD,77.0,MALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2004.0,[Not Available],-28275.0,Alive,WITH TUMOR,1765.0,,[Not Available],,,,,[Unknown],,,0.0,1765.0,0.0,1765.0,,,0.0,1765.0,
TCGA-UY-A78P,407,TCGA-UY-A78P,BLCA,78.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-28719.0,Alive,TUMOR FREE,2380.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2380.0,0.0,2380.0,0.0,2380.0,0.0,2380.0,
TCGA-J8-A3YE,10324,TCGA-J8-A3YE,THCA,31.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-11446.0,Alive,TUMOR FREE,847.0,,[Not Available],,,,,[Not Available],,R0,0.0,847.0,0.0,847.0,0.0,847.0,0.0,847.0,
TCGA-D6-A6EQ,3627,TCGA-D6-A6EQ,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-20876.0,Alive,TUMOR FREE,368.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,368.0,0.0,368.0,,,0.0,368.0,
TCGA-HM-A6W2,1774,TCGA-HM-A6W2,CESC,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IVB,Adenosquamous,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12775.0,Alive,TUMOR FREE,287.0,,,,,,,Complete Remission/Response,,,0.0,287.0,0.0,287.0,,,0.0,287.0,
TCGA-GN-A8LL,9210,TCGA-GN-A8LL,SKCM,68.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-25000.0,Dead,WITH TUMOR,,650.0,[Not Available],,,,,[Not Available],,,1.0,650.0,1.0,650.0,,,1.0,650.0,
TCGA-06-0882,2840,TCGA-06-0882,GBM,30.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-11112.0,Dead,WITH TUMOR,,632.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],213.0,[Not Available],,,1.0,632.0,1.0,632.0,,,1.0,213.0,
TCGA-VM-A8CH,5412,TCGA-VM-A8CH,LGG,24.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-9005.0,Alive,TUMOR FREE,714.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,
TCGA-HT-7874,5193,TCGA-HT-7874,LGG,41.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2008.0,[Not Available],-15045.0,Alive,TUMOR FREE,1130.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1130.0,0.0,1130.0,0.0,1130.0,0.0,1130.0,
TCGA-CV-6942,3503,TCGA-CV-6942,HNSC,73.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,[Not Available],-26941.0,Alive,TUMOR FREE,4282.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4282.0,0.0,4282.0,0.0,4282.0,0.0,4282.0,
TCGA-A2-A0YH,589,TCGA-A2-A0YH,BRCA,53.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19596.0,Alive,TUMOR FREE,659.0,,[Not Available],,,,,[Not Available],Negative,,0.0,659.0,0.0,659.0,0.0,659.0,0.0,659.0,
TCGA-AY-6386,2208,TCGA-AY-6386,COAD,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-24453.0,Alive,TUMOR FREE,542.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,
TCGA-3N-A9WD,8800,TCGA-3N-A9WD,SKCM,82.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2013.0,[Not Available],-30163.0,Dead,WITH TUMOR,,395.0,[Not Available],Distant Metastasis,Brain,,306.0,[Not Available],,,1.0,395.0,1.0,395.0,,,1.0,306.0,
TCGA-A7-A13D,638,TCGA-A7-A13D,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17070.0,Alive,TUMOR FREE,965.0,,[Not Available],,,,,[Not Available],Negative,,0.0,965.0,0.0,965.0,0.0,965.0,0.0,965.0,
TCGA-14-1450,3020,TCGA-14-1450,GBM,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-20960.0,Alive,WITH TUMOR,1788.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],826.0,[Not Available],,,0.0,1788.0,0.0,1788.0,,,1.0,826.0,
TCGA-94-A4VJ,6772,TCGA-94-A4VJ,LUSC,71.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-25991.0,Alive,TUMOR FREE,430.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,430.0,0.0,430.0,0.0,430.0,0.0,430.0,
TCGA-35-4123,5840,TCGA-35-4123,LUAD,38.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-14064.0,Alive,TUMOR FREE,182.0,,[Not Available],,,,,[Not Available],,,0.0,182.0,0.0,182.0,,,0.0,182.0,
TCGA-D5-6538,2309,TCGA-D5-6538,COAD,79.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-29194.0,Alive,TUMOR FREE,521.0,,[Not Available],,,,,[Not Available],,,0.0,521.0,0.0,521.0,,,0.0,521.0,
TCGA-OR-A5J2,2,TCGA-OR-A5J2,ACC,44.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2004.0,[Not Available],-16090.0,Dead,WITH TUMOR,,1677.0,[Not Available],Distant Metastasis,Soft Tissue,,289.0,Progressive Disease,,,1.0,1677.0,1.0,1677.0,,,1.0,289.0,
TCGA-HC-8216,8096,TCGA-HC-8216,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21428.0,Alive,TUMOR FREE,682.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,682.0,0.0,682.0,0.0,682.0,0.0,682.0,
TCGA-CV-7418,3557,TCGA-CV-7418,HNSC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1996.0,[Not Available],-22805.0,Dead,TUMOR FREE,,789.0,[Not Available],Locoregional Recurrence,Hypopharynx,nasopharynx,494.0,Complete Remission/Response,,,1.0,789.0,0.0,789.0,,,1.0,494.0,
TCGA-BH-A0DE,1062,TCGA-BH-A0DE,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22656.0,Alive,TUMOR FREE,2372.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2372.0,0.0,2372.0,0.0,2372.0,0.0,2372.0,
TCGA-A6-5667,1991,TCGA-A6-5667,COAD,40.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-14756.0,Alive,TUMOR FREE,887.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,887.0,0.0,887.0,0.0,887.0,0.0,887.0,
TCGA-ER-A19P,9108,TCGA-ER-A19P,SKCM,47.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1996.0,[Not Available],-17511.0,Dead,WITH TUMOR,,4930.0,[Not Available],Distant Metastasis,Brain,,4352.0,[Not Available],,,1.0,4930.0,1.0,4930.0,,,1.0,4352.0,
TCGA-WB-A81W,7862,TCGA-WB-A81W,PCPG,41.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2007.0,[Not Available],-15001.0,Alive,TUMOR FREE,2379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2379.0,0.0,2379.0,0.0,2379.0,0.0,2379.0,
TCGA-IK-7675,5259,TCGA-IK-7675,LGG,43.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2009.0,[Not Available],-15900.0,Dead,WITH TUMOR,,578.0,[Not Available],,,,123.0,Progressive Disease,,,1.0,578.0,1.0,578.0,,,1.0,123.0,
TCGA-FG-8189,5119,TCGA-FG-8189,LGG,33.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-12384.0,Alive,WITH TUMOR,685.0,,[Not Available],,,,,Stable Disease,,,0.0,685.0,0.0,685.0,,,0.0,685.0,
TCGA-E2-A15D,1336,TCGA-E2-A15D,BRCA,47.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17224.0,Alive,TUMOR FREE,526.0,,[Not Available],,,,,[Not Available],Negative,,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,
TCGA-CV-6959,3514,TCGA-CV-6959,HNSC,48.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,[Not Available],-17679.0,Dead,WITH TUMOR,,256.0,[Not Available],Locoregional Recurrence,,"Rt. Neck mass, skin",103.0,[Not Available],,,1.0,256.0,1.0,256.0,,,1.0,103.0,
TCGA-W9-A837,5417,TCGA-W9-A837,LGG,47.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],,Alive,WITH TUMOR,1553.0,,[Not Available],,,,,Stable Disease,,,0.0,1553.0,0.0,1553.0,,,0.0,1553.0,
TCGA-A1-A0SB,513,TCGA-A1-A0SB,BRCA,70.0,FEMALE,WHITE,Stage I,[Not Applicable],"Other, specify",[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25833.0,Alive,TUMOR FREE,259.0,,[Not Available],,,,,[Not Available],Negative,,0.0,259.0,0.0,259.0,0.0,259.0,0.0,259.0,
TCGA-CR-6491,3435,TCGA-CR-6491,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-22125.0,Alive,WITH TUMOR,693.0,,[Not Available],New Primary Tumor,Distant Metastasis,Lung,499.0,Complete Remission/Response,,,0.0,693.0,0.0,693.0,,,1.0,499.0,
TCGA-KK-A8II,8213,TCGA-KK-A8II,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2004.0,[Not Available],-22460.0,Dead,WITH TUMOR,,3467.0,[Unknown],Biochemical evidence of disease,,,626.0,Progressive Disease,,,1.0,3467.0,1.0,3467.0,,,1.0,626.0,
TCGA-56-7582,6517,TCGA-56-7582,LUSC,83.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-30678.0,Alive,TUMOR FREE,601.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,601.0,0.0,601.0,0.0,601.0,0.0,601.0,
TCGA-A4-7288,4466,TCGA-A4-7288,KIRP,71.0,FEMALE,WHITE,[Not Available],Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-26268.0,Alive,TUMOR FREE,1857.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1857.0,0.0,1857.0,0.0,1857.0,0.0,1857.0,
TCGA-AP-A0LM,10585,TCGA-AP-A0LM,UCEC,33.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12309.0,Alive,TUMOR FREE,825.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,825.0,0.0,825.0,0.0,825.0,0.0,825.0,
TCGA-MA-AA3W,1804,TCGA-MA-AA3W,CESC,54.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20066.0,Alive,TUMOR FREE,685.0,,,,,,,Complete Remission/Response,,,0.0,685.0,0.0,685.0,0.0,685.0,0.0,685.0,
TCGA-FR-A7UA,9139,TCGA-FR-A7UA,SKCM,65.0,FEMALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2011.0,[Not Available],-24032.0,Alive,TUMOR FREE,1164.0,,[Not Available],,,,,[Not Available],,,0.0,1164.0,0.0,1164.0,,,0.0,1164.0,
TCGA-39-5039,6467,TCGA-39-5039,LUSC,76.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-27781.0,Dead,TUMOR FREE,544.0,544.0,[Not Available],,,,,Complete Remission/Response,,,1.0,544.0,0.0,544.0,0.0,544.0,0.0,544.0,
TCGA-S4-A8RM,7669,TCGA-S4-A8RM,PAAD,67.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,[Not Available],-24589.0,Alive,TUMOR FREE,737.0,,,,,,,Complete Remission/Response,,,0.0,737.0,0.0,737.0,0.0,737.0,0.0,737.0,
TCGA-CN-A63Y,3367,TCGA-CN-A63Y,HNSC,46.0,MALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-17125.0,Alive,TUMOR FREE,504.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,504.0,0.0,504.0,0.0,504.0,0.0,504.0,
TCGA-A6-5660,1985,TCGA-A6-5660,COAD,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-26803.0,Alive,TUMOR FREE,888.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,888.0,0.0,888.0,0.0,888.0,0.0,888.0,
TCGA-CK-4952,2248,TCGA-CK-4952,COAD,48.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2007.0,[Not Available],-17826.0,Alive,TUMOR FREE,475.0,,[Not Available],,,,,[Unknown],,,0.0,475.0,0.0,475.0,,,0.0,475.0,
TCGA-YU-A912,9832,TCGA-YU-A912,TGCT,34.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Stage IIIC,Seminoma; NOS,[Not Available],2012.0,[Not Available],-12552.0,Alive,WITH TUMOR,866.0,,[Not Applicable],,,,,"Normalization of Tumor Markers, but Residual Tumor Mass",,,0.0,866.0,0.0,866.0,,,0.0,866.0,
TCGA-18-4721,6340,TCGA-18-4721,LUSC,74.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-27076.0,Alive,TUMOR FREE,4694.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4694.0,0.0,4694.0,0.0,4694.0,0.0,4694.0,
TCGA-A2-A259,604,TCGA-A2-A259,BRCA,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25666.0,Alive,TUMOR FREE,1596.0,,[Not Available],,,,,[Not Available],Close,,0.0,1596.0,0.0,1596.0,,,0.0,1596.0,
TCGA-L5-A8NW,2555,TCGA-L5-A8NW,ESCA,55.0,MALE,WHITE,[Discrepancy],[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2001.0,[Not Available],-20194.0,Dead,WITH TUMOR,,1402.0,[Not Available],Locoregional Recurrence,,,1147.0,,,,1.0,1402.0,1.0,1402.0,,,1.0,1147.0,
TCGA-CQ-6227,3395,TCGA-CQ-6227,HNSC,77.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-28466.0,Dead,WITH TUMOR,,129.0,[Not Available],,,,,Progressive Disease,,,1.0,129.0,1.0,129.0,,,1.0,129.0,
TCGA-IM-A3EB,10311,TCGA-IM-A3EB,THCA,32.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-11822.0,Alive,TUMOR FREE,1488.0,,[Not Available],,,,,[Not Available],,R0,0.0,1488.0,0.0,1488.0,0.0,1488.0,0.0,1488.0,
TCGA-IQ-A61E,3682,TCGA-IQ-A61E,HNSC,55.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-20417.0,Alive,TUMOR FREE,1147.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1147.0,0.0,1147.0,0.0,1147.0,0.0,1147.0,
TCGA-C8-A26Y,1211,TCGA-C8-A26Y,BRCA,90.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Alive,TUMOR FREE,394.0,,[Not Available],,,,,[Not Available],Negative,,0.0,394.0,0.0,394.0,0.0,394.0,0.0,394.0,
TCGA-K4-A5RI,379,TCGA-K4-A5RI,BLCA,67.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-24614.0,Dead,WITH TUMOR,,356.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",ileum,236.0,Progressive Disease,,,1.0,356.0,1.0,356.0,,,1.0,236.0,
TCGA-A7-A4SC,659,TCGA-A7-A4SC,BRCA,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23008.0,Alive,TUMOR FREE,446.0,,[Not Available],,,,,[Not Available],Negative,,0.0,446.0,0.0,446.0,0.0,446.0,0.0,446.0,
TCGA-AC-A3QP,776,TCGA-AC-A3QP,BRCA,79.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29113.0,Alive,TUMOR FREE,675.0,,[Not Available],,,,,[Not Available],Negative,,0.0,675.0,0.0,675.0,0.0,675.0,0.0,675.0,
TCGA-LI-A67I,8722,TCGA-LI-A67I,SARC,75.0,FEMALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2013.0,[Not Available],-27671.0,Alive,TUMOR FREE,922.0,,[Not Available],Distant Metastasis,Lung,,574.0,[Not Available],Positive,RX,0.0,922.0,0.0,922.0,,,1.0,574.0,
TCGA-A7-A56D,663,TCGA-A7-A56D,BRCA,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30783.0,Alive,TUMOR FREE,448.0,,[Not Available],,,,,[Not Available],Negative,,0.0,448.0,0.0,448.0,0.0,448.0,0.0,448.0,
TCGA-44-3398,5864,TCGA-44-3398,LUAD,77.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-28392.0,Alive,TUMOR FREE,1163.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1163.0,0.0,1163.0,0.0,1163.0,0.0,1163.0,
TCGA-06-0876,2835,TCGA-06-0876,GBM,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-26372.0,Alive,WITH TUMOR,1405.0,,[Not Available],,[Not Applicable],[Not Applicable],424.0,[Not Available],,,0.0,1405.0,0.0,1405.0,,,1.0,424.0,
TCGA-EO-A3AY,10933,TCGA-EO-A3AY,UCEC,58.0,FEMALE,[Not Available],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21291.0,Alive,WITH TUMOR,1158.0,,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal Vault,1163.0,Complete Remission/Response,,,0.0,1158.0,0.0,1158.0,1.0,1163.0,1.0,1163.0,
TCGA-OR-A5K2,37,TCGA-OR-A5K2,ACC,32.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-11970.0,Dead,WITH TUMOR,,994.0,[Not Available],Distant Metastasis,Lung,,97.0,Progressive Disease,,,1.0,994.0,1.0,994.0,,,1.0,97.0,
TCGA-AC-A5EH,786,TCGA-AC-A5EH,BRCA,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,[Not Available],-27964.0,Alive,TUMOR FREE,511.0,,[Not Available],,,,,[Not Available],Negative,,0.0,511.0,0.0,511.0,0.0,511.0,0.0,511.0,
TCGA-A8-A075,681,TCGA-A8-A075,BRCA,42.0,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15369.0,Alive,TUMOR FREE,518.0,,[Not Available],,,,,[Not Available],Negative,,0.0,518.0,0.0,518.0,0.0,518.0,0.0,518.0,
TCGA-EW-A423,1491,TCGA-EW-A423,BRCA,75.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27627.0,Alive,TUMOR FREE,533.0,,[Not Available],,,,,[Not Available],Negative,,0.0,533.0,0.0,533.0,0.0,533.0,0.0,533.0,
TCGA-CR-7380,3451,TCGA-CR-7380,HNSC,58.0,MALE,WHITE,Stage IVB,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-21215.0,Dead,WITH TUMOR,,606.0,[Not Available],,Distant Metastasis,Lung,561.0,Complete Remission/Response,,,1.0,606.0,1.0,606.0,,,1.0,561.0,
TCGA-HC-8259,8100,TCGA-HC-8259,PRAD,50.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-18309.0,Alive,TUMOR FREE,924.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,924.0,0.0,924.0,0.0,924.0,0.0,924.0,
TCGA-KK-A8I4,8200,TCGA-KK-A8I4,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-23706.0,Alive,WITH TUMOR,2259.0,,[Not Available],Distant Metastasis,Bone,,1162.0,Progressive Disease,,,0.0,2259.0,0.0,2259.0,,,1.0,1162.0,
TCGA-QR-A6H0,7706,TCGA-QR-A6H0,PCPG,53.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2012.0,[Not Available],-19372.0,Alive,TUMOR FREE,280.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,280.0,0.0,280.0,0.0,280.0,0.0,280.0,
TCGA-XU-A92O,10419,TCGA-XU-A92O,THYM,63.0,MALE,ASIAN,[Not Applicable],I,Thymoma; Type A,[Not Available],2005.0,[Not Available],-23186.0,Alive,TUMOR FREE,3410.0,,[Not Available],,,,,[Not Available],,,0.0,3410.0,0.0,3410.0,,,0.0,3410.0,
TCGA-KK-A8IJ,8214,TCGA-KK-A8IJ,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-21793.0,Alive,,1559.0,,[Not Available],New Primary Tumor,"Other, specify",Melanoma in situ of the right midback,307.0,[Unknown],,,0.0,1559.0,0.0,1559.0,,,1.0,307.0,
TCGA-D3-A5GT,8881,TCGA-D3-A5GT,SKCM,43.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-15935.0,Alive,WITH TUMOR,487.0,,[Not Available],Distant Metastasis|Distant Metastasis|Regional lymph node,Lung|Liver|[Not Available],[Not Applicable]|[Not Applicable]|[Not Applicable],291.0,[Not Available],,,0.0,487.0,0.0,487.0,,,1.0,291.0,
TCGA-CF-A9FH,169,TCGA-CF-A9FH,BLCA,85.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,[Not Available],-31236.0,Alive,TUMOR FREE,-64.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-E8-A418,10030,TCGA-E8-A418,THCA,75.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-27737.0,Alive,TUMOR FREE,92.0,,[Not Available],,,,,[Not Available],,RX,0.0,92.0,0.0,92.0,,,0.0,92.0,
TCGA-NC-A5HM,6810,TCGA-NC-A5HM,LUSC,76.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-27938.0,Alive,TUMOR FREE,1212.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1212.0,0.0,1212.0,0.0,1212.0,0.0,1212.0,
TCGA-36-2551,7407,TCGA-36-2551,OV,57.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-21045.0,Alive,WITH TUMOR,492.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],338.0,Complete Remission/Response,,,0.0,492.0,0.0,492.0,1.0,338.0,1.0,338.0,
TCGA-P3-A6T0,3713,TCGA-P3-A6T0,HNSC,47.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-17259.0,Alive,TUMOR FREE,578.0,,[Not Available],Locoregional Disease,Oral Cavity,,365.0,Complete Remission/Response,,,0.0,578.0,0.0,578.0,,,1.0,365.0,
TCGA-SR-A6MQ,7805,TCGA-SR-A6MQ,PCPG,61.0,FEMALE,ASIAN,[Not Available],[Not Available],Paraganglioma,[Not Available],2008.0,[Not Available],-22621.0,Alive,TUMOR FREE,2087.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2087.0,0.0,2087.0,0.0,2087.0,0.0,2087.0,
TCGA-GR-A4D9,2446,TCGA-GR-A4D9,DLBC,66.0,FEMALE,WHITE,[Not Applicable],Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2009.0,[Not Available],-24405.0,Alive,WITH TUMOR,1739.0,,[Not Available],,Soft Tissue,,1218.0,Complete Remission/Response,,,0.0,1739.0,0.0,1739.0,,,1.0,1218.0,
TCGA-D8-A1JJ,1245,TCGA-D8-A1JJ,BRCA,54.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19966.0,Alive,TUMOR FREE,611.0,,[Not Available],,,,,[Not Available],Negative,,0.0,611.0,0.0,611.0,0.0,611.0,0.0,611.0,
TCGA-AK-3458,3958,TCGA-AK-3458,KIRC,48.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-17557.0,Alive,TUMOR FREE,1168.0,,[Not Available],,,,,[Not Available],,,0.0,1168.0,0.0,1168.0,,,0.0,1168.0,
TCGA-E2-A15O,1346,TCGA-E2-A15O,BRCA,89.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32583.0,Alive,TUMOR FREE,1545.0,,[Not Available],Locoregional Recurrence,,,1210.0,[Not Available],Negative,,0.0,1545.0,0.0,1545.0,1.0,1210.0,1.0,1210.0,
TCGA-R5-A7ZR,9623,TCGA-R5-A7ZR,STAD,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008.0,[Not Available],-25795.0,Dead,WITH TUMOR,,185.0,[Unknown],,,,,Progressive Disease,,,1.0,185.0,1.0,185.0,,,1.0,185.0,
TCGA-44-2665,5860,TCGA-44-2665,LUAD,55.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-20349.0,Alive,TUMOR FREE,1301.0,,[Not Available],,,,,Stable Disease,,,0.0,1301.0,0.0,1301.0,,,0.0,1301.0,
TCGA-KS-A41F,10331,TCGA-KS-A41F,THCA,37.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002.0,[Not Available],-13545.0,Alive,TUMOR FREE,4367.0,,[Not Available],,,,,[Not Available],,R0,0.0,4367.0,0.0,4367.0,0.0,4367.0,0.0,4367.0,
TCGA-SO-A8JP,9790,TCGA-SO-A8JP,TGCT,29.0,MALE,WHITE,Stage I,[Not Available],Seminoma; NOS,[Not Available],2013.0,[Not Available],-10765.0,Alive,TUMOR FREE,540.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,540.0,0.0,540.0,0.0,540.0,0.0,540.0,
TCGA-DK-AA71,227,TCGA-DK-AA71,BLCA,71.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-25950.0,Alive,WITH TUMOR,415.0,,[Not Available],,,,,Stable Disease,,,0.0,415.0,0.0,415.0,,,0.0,415.0,
TCGA-95-A4VP,6246,TCGA-95-A4VP,LUAD,66.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-24130.0,Alive,WITH TUMOR,605.0,,[Not Available],Distant Metastasis,,,216.0,Stable Disease,,,0.0,605.0,0.0,605.0,,,1.0,216.0,
TCGA-O2-A52V,6825,TCGA-O2-A52V,LUSC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-27449.0,Dead,TUMOR FREE,,1335.0,[Not Available],Distant Metastasis,,,690.0,[Unknown],,,1.0,1335.0,0.0,1335.0,,,1.0,690.0,
TCGA-A6-6142,1996,TCGA-A6-6142,COAD,56.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-20485.0,Alive,WITH TUMOR,763.0,,[Not Available],,,,654.0,Complete Remission/Response,,,0.0,763.0,0.0,763.0,,,1.0,654.0,
TCGA-CZ-5987,4391,TCGA-CZ-5987,KIRC,60.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-21928.0,Dead,WITH TUMOR,,445.0,[Not Available],,,,377.0,[Not Available],,,1.0,445.0,1.0,445.0,,,1.0,377.0,
TCGA-L5-A8NU,2553,TCGA-L5-A8NU,ESCA,84.0,MALE,WHITE,Stage IIA,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2001.0,[Not Available],-30738.0,Dead,TUMOR FREE,,2532.0,[Not Available],,,,,,,,1.0,2532.0,0.0,2532.0,,,0.0,2532.0,
TCGA-38-4625,5842,TCGA-38-4625,LUAD,66.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-24241.0,Alive,,2973.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2973.0,0.0,2973.0,0.0,2973.0,0.0,2973.0,
TCGA-4A-A93W,4444,TCGA-4A-A93W,KIRP,66.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-24117.0,Alive,TUMOR FREE,4.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4.0,0.0,4.0,0.0,4.0,0.0,4.0,
TCGA-AJ-A3TW,10554,TCGA-AJ-A3TW,UCEC,78.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28559.0,Alive,TUMOR FREE,513.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,513.0,0.0,513.0,0.0,513.0,0.0,513.0,
TCGA-FY-A2QD,10279,TCGA-FY-A2QD,THCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-22491.0,Alive,TUMOR FREE,38.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,38.0,0.0,38.0,,,0.0,38.0,
TCGA-AP-A0LQ,10589,TCGA-AP-A0LQ,UCEC,59.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21629.0,Alive,TUMOR FREE,2457.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2457.0,0.0,2457.0,0.0,2457.0,0.0,2457.0,
TCGA-AG-4022,8441,TCGA-AG-4022,READ,59.0,FEMALE,[Not Available],Stage II,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2006.0,[Not Available],-21823.0,Alive,TUMOR FREE,1400.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1400.0,0.0,1400.0,0.0,1400.0,0.0,1400.0,
TCGA-A7-A0DB,636,TCGA-A7-A0DB,BRCA,56.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20570.0,Alive,TUMOR FREE,1007.0,,[Not Available],,,,,[Not Available],Close,,0.0,1007.0,0.0,1007.0,,,0.0,1007.0,
TCGA-AK-3455,3956,TCGA-AK-3455,KIRC,71.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-26221.0,Dead,,,683.0,[Not Available],,,,,[Not Available],,,1.0,683.0,,683.0,,,0.0,683.0,
TCGA-ZG-A8QZ,8346,TCGA-ZG-A8QZ,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23980.0,Alive,TUMOR FREE,308.0,,[Not Available],,,,,Stable Disease,,,0.0,308.0,0.0,308.0,,,0.0,308.0,
TCGA-F1-6177,9532,TCGA-F1-6177,STAD,90.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,[Not Available],-32873.0,Alive,TUMOR FREE,200.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,200.0,0.0,200.0,0.0,200.0,0.0,200.0,
TCGA-38-7271,5851,TCGA-38-7271,LUAD,72.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-26440.0,Dead,WITH TUMOR,,800.0,[Not Available],,,,304.0,Complete Remission/Response,,,1.0,800.0,1.0,800.0,1.0,304.0,1.0,304.0,
TCGA-BH-A202,1157,TCGA-BH-A202,BRCA,60.0,FEMALE,WHITE,Stage II,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22052.0,Alive,TUMOR FREE,795.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,795.0,0.0,795.0,,,0.0,795.0,
TCGA-WE-A8K5,9238,TCGA-WE-A8K5,SKCM,65.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2009.0,[Not Available],-23837.0,Dead,WITH TUMOR,,1860.0,[Not Available],Distant Metastasis,Brain,,1498.0,[Not Available],,,1.0,1860.0,1.0,1860.0,,,1.0,1498.0,
TCGA-VM-A8C9,5406,TCGA-VM-A8C9,LGG,37.0,FEMALE,[Not Evaluated],[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-13663.0,Alive,TUMOR FREE,1314.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1314.0,0.0,1314.0,0.0,1314.0,0.0,1314.0,
TCGA-D1-A0ZP,10817,TCGA-D1-A0ZP,UCEC,59.0,FEMALE,WHITE,[Not Applicable],Stage IVA,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21581.0,Alive,TUMOR FREE,911.0,,[Not Available],Locoregional Disease,"Other, specify",Recurrent endometrial carcinoma in retriponeal lymphnodes,629.0,Complete Remission/Response,,,0.0,911.0,0.0,911.0,,,1.0,629.0,
TCGA-21-5782,6355,TCGA-21-5782,LUSC,68.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-24969.0,Dead,,962.0,962.0,[Not Available],,,,,Complete Remission/Response,,,1.0,962.0,,962.0,0.0,962.0,0.0,962.0,
TCGA-PJ-A5Z8,4664,TCGA-PJ-A5Z8,KIRP,60.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-21968.0,Alive,TUMOR FREE,600.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,
TCGA-IM-A41Y,10315,TCGA-IM-A41Y,THCA,42.0,FEMALE,WHITE,Stage I,[Not Applicable],"Other, specify",[Not Available],2012.0,[Not Available],-15694.0,Alive,TUMOR FREE,664.0,,[Not Available],,,,,[Not Available],,R0,0.0,664.0,0.0,664.0,0.0,664.0,0.0,664.0,
TCGA-E2-A1LB,1375,TCGA-E2-A1LB,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15283.0,Alive,TUMOR FREE,2306.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2306.0,0.0,2306.0,0.0,2306.0,0.0,2306.0,
TCGA-DI-A1NN,10905,TCGA-DI-A1NN,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23026.0,Alive,WITH TUMOR,1076.0,,[Not Available],Metastatic,"Other, specify",vagina,1023.0,Complete Remission/Response,,,0.0,1076.0,0.0,1076.0,1.0,1023.0,1.0,1023.0,
TCGA-HT-7483,5156,TCGA-HT-7483,LGG,14.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,1998.0,[Not Available],-5267.0,Alive,TUMOR FREE,5255.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,5255.0,0.0,5255.0,0.0,5255.0,0.0,5255.0,
TCGA-A1-A0SN,523,TCGA-A1-A0SN,BRCA,50.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18401.0,Alive,TUMOR FREE,1196.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1196.0,0.0,1196.0,0.0,1196.0,0.0,1196.0,
TCGA-BH-A1FJ,1150,TCGA-BH-A1FJ,BRCA,66.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998.0,[Not Available],-24262.0,Dead,,,1927.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1927.0,,1927.0,,,0.0,1927.0,
TCGA-BR-8677,9380,TCGA-BR-8677,STAD,74.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-27223.0,Alive,TUMOR FREE,813.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,813.0,0.0,813.0,0.0,813.0,0.0,813.0,
TCGA-DV-A4W0,4405,TCGA-DV-A4W0,KIRC,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2008.0,[Not Available],-20101.0,Alive,WITH TUMOR,2470.0,,[Not Available],,,,2008.0,Stable Disease,,,0.0,2470.0,0.0,2470.0,,,1.0,2008.0,
TCGA-FX-A3NK,8677,TCGA-FX-A3NK,SARC,53.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2011.0,[Not Available],-19533.0,Alive,TUMOR FREE,505.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,505.0,0.0,505.0,0.0,505.0,0.0,505.0,
TCGA-Z5-AAPL,7687,TCGA-Z5-AAPL,PAAD,74.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,[Not Available],-27152.0,Alive,TUMOR FREE,467.0,,,,,,,Complete Remission/Response,,,0.0,467.0,0.0,467.0,0.0,467.0,0.0,467.0,
TCGA-ER-A19A,9094,TCGA-ER-A19A,SKCM,79.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2006.0,[Not Available],-29167.0,Alive,TUMOR FREE,2365.0,,[Not Available],,,,1617.0,[Not Available],,,0.0,2365.0,0.0,2365.0,,,1.0,1617.0,
TCGA-D8-A1Y1,1280,TCGA-D8-A1Y1,BRCA,80.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29474.0,Dead,WITH TUMOR,,302.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,302.0,1.0,302.0,,,1.0,302.0,
TCGA-QU-A6IO,8230,TCGA-QU-A6IO,PRAD,53.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2003.0,[Not Available],-19564.0,Alive,TUMOR FREE,3716.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3716.0,0.0,3716.0,0.0,3716.0,0.0,3716.0,
TCGA-VQ-A8PB,9655,TCGA-VQ-A8PB,STAD,65.0,FEMALE,WHITE,Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2011.0,[Not Available],-23927.0,Dead,TUMOR FREE,,1043.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1043.0,0.0,1043.0,0.0,1043.0,0.0,1043.0,
TCGA-2G-AAGP,9747,TCGA-2G-AAGP,TGCT,33.0,MALE,WHITE,Stage IIA,Stage IIA,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2003.0,[Not Available],-12202.0,Alive,TUMOR FREE,4018.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,4018.0,0.0,4018.0,0.0,4018.0,0.0,4018.0,
TCGA-B8-5159,4103,TCGA-B8-5159,KIRC,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-22462.0,Alive,TUMOR FREE,722.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,722.0,0.0,722.0,0.0,722.0,0.0,722.0,
TCGA-A1-A0SI,519,TCGA-A1-A0SI,BRCA,52.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,[Not Available],-19250.0,Alive,TUMOR FREE,635.0,,[Not Available],,,,,[Not Available],Negative,,0.0,635.0,0.0,635.0,0.0,635.0,0.0,635.0,
TCGA-EK-A2R8,1729,TCGA-EK-A2R8,CESC,48.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17692.0,Alive,WITH TUMOR,44.0,,,,,,,[Not Available],,,0.0,44.0,0.0,44.0,,,0.0,44.0,
TCGA-V4-A9EZ,11108,TCGA-V4-A9EZ,UVM,78.0,FEMALE,WHITE,Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,[Not Available],2012.0,[Not Available],-28619.0,Alive,TUMOR FREE,599.0,,[Not Available],,,,,[Not Available],,,0.0,599.0,0.0,599.0,,,0.0,599.0,
TCGA-G2-AA3D,324,TCGA-G2-AA3D,BLCA,60.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-22205.0,Alive,TUMOR FREE,2139.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2139.0,0.0,2139.0,,,0.0,2139.0,
TCGA-86-8279,6195,TCGA-86-8279,LUAD,46.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-17032.0,Alive,TUMOR FREE,949.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,949.0,0.0,949.0,0.0,949.0,0.0,949.0,
TCGA-ET-A40P,10249,TCGA-ET-A40P,THCA,32.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-11843.0,Alive,TUMOR FREE,1338.0,,[Not Available],,,,,[Not Available],,R0,0.0,1338.0,0.0,1338.0,0.0,1338.0,0.0,1338.0,
TCGA-D3-A3C6,8855,TCGA-D3-A3C6,SKCM,54.0,FEMALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2006.0,[Not Available],-19858.0,Dead,WITH TUMOR,,1766.0,[Not Available],Distant Metastasis,Lung,,1441.0,[Not Available],,,1.0,1766.0,1.0,1766.0,,,1.0,1441.0,
TCGA-HZ-8002,7598,TCGA-HZ-8002,PAAD,61.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-22433.0,Dead,WITH TUMOR,,366.0,,,,,,[Unknown],,,1.0,366.0,1.0,366.0,,,1.0,366.0,
TCGA-35-4122,5839,TCGA-35-4122,LUAD,69.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-25491.0,Alive,TUMOR FREE,225.0,,[Not Available],,,,,[Unknown],,,0.0,225.0,0.0,225.0,,,0.0,225.0,
TCGA-BP-4987,4220,TCGA-BP-4987,KIRC,41.0,FEMALE,ASIAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-15041.0,Alive,TUMOR FREE,1124.0,,[Not Available],,,,,[Not Available],,,0.0,1124.0,0.0,1124.0,,,0.0,1124.0,
TCGA-CG-4438,9451,TCGA-CG-4438,STAD,56.0,MALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,[Not Available],-20574.0,Alive,,1645.0,,[Not Available],,,,,[Not Available],,,0.0,1645.0,0.0,1645.0,,,0.0,1645.0,
TCGA-22-1002,6364,TCGA-22-1002,LUSC,69.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-25359.0,Dead,TUMOR FREE,131.0,131.0,[Not Available],,,,,[Not Available],,,1.0,131.0,0.0,131.0,,,0.0,131.0,
TCGA-CH-5771,7902,TCGA-CH-5771,PRAD,63.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-23101.0,Alive,TUMOR FREE,396.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,
TCGA-56-8625,6535,TCGA-56-8625,LUSC,66.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24188.0,Dead,WITH TUMOR,,315.0,[Not Available],Distant Metastasis,,,272.0,Progressive Disease,,,1.0,315.0,1.0,315.0,,,1.0,272.0,
TCGA-2Z-A9JL,4435,TCGA-2Z-A9JL,KIRP,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-17367.0,Alive,TUMOR FREE,1006.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1006.0,0.0,1006.0,0.0,1006.0,0.0,1006.0,
TCGA-63-A5MB,6593,TCGA-63-A5MB,LUSC,62.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-22930.0,Alive,TUMOR FREE,3123.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3123.0,0.0,3123.0,0.0,3123.0,0.0,3123.0,
TCGA-56-7822,6520,TCGA-56-7822,LUSC,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-27755.0,Dead,WITH TUMOR,,532.0,[Not Available],,,,301.0,[Unknown],,,1.0,532.0,1.0,532.0,,,1.0,301.0,
TCGA-CU-A0YO,173,TCGA-CU-A0YO,BLCA,84.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-30817.0,Dead,WITH TUMOR,,149.0,[Not Available],Metastatic,"Other, specify",peritoneum,118.0,Complete Remission/Response,,,1.0,149.0,1.0,149.0,,,1.0,118.0,
TCGA-BS-A0U9,10801,TCGA-BS-A0U9,UCEC,59.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IIA,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21580.0,Alive,TUMOR FREE,2825.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2825.0,0.0,2825.0,0.0,2825.0,0.0,2825.0,
TCGA-22-4599,6375,TCGA-22-4599,LUSC,73.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-26925.0,Dead,,1161.0,1161.0,[Not Available],,,,,[Not Available],,,1.0,1161.0,,1161.0,,,0.0,1161.0,
TCGA-06-0750,2833,TCGA-06-0750,GBM,43.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-16018.0,Dead,WITH TUMOR,28.0,28.0,[Not Available],,,,,[Not Available],,,1.0,28.0,1.0,28.0,,,1.0,28.0,
TCGA-3A-A9IO,7535,TCGA-3A-A9IO,PAAD,55.0,MALE,WHITE,[Not Available],[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2009.0,[Not Available],-20451.0,Alive,TUMOR FREE,1942.0,,,,,,,[Unknown],,,0.0,1942.0,0.0,1942.0,,,0.0,1942.0,
TCGA-KN-8426,3825,TCGA-KN-8426,KICH,50.0,MALE,WHITE,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-18345.0,Alive,WITH TUMOR,108.0,,[Not Available],,,,,Progressive Disease,,,0.0,108.0,0.0,108.0,,,0.0,108.0,
TCGA-HT-7854,5186,TCGA-HT-7854,LGG,62.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-22738.0,Alive,TUMOR FREE,1201.0,,[Not Available],,,,1147.0,Stable Disease,,,0.0,1201.0,0.0,1201.0,,,1.0,1147.0,
TCGA-L5-A4OH,2517,TCGA-L5-A4OH,ESCA,71.0,MALE,WHITE,Stage I,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2012.0,[Not Available],-26180.0,Alive,TUMOR FREE,992.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,992.0,0.0,992.0,0.0,992.0,0.0,992.0,
TCGA-BF-AAOX,8817,TCGA-BF-AAOX,SKCM,83.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-30318.0,Alive,TUMOR FREE,444.0,,[Not Available],,,,,[Not Available],,,0.0,444.0,0.0,444.0,,,0.0,444.0,
TCGA-AD-A5EK,2198,TCGA-AD-A5EK,COAD,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2012.0,[Not Available],-18731.0,Alive,TUMOR FREE,500.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,500.0,0.0,500.0,0.0,500.0,0.0,500.0,
TCGA-14-2554,3036,TCGA-14-2554,GBM,52.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-19090.0,Dead,WITH TUMOR,532.0,532.0,[Not Available],,,,,[Not Available],,,1.0,532.0,1.0,532.0,,,1.0,532.0,
TCGA-A2-A3XX,618,TCGA-A2-A3XX,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17981.0,Dead,TUMOR FREE,,1439.0,[Not Available],,,,,[Not Available],Negative,,1.0,1439.0,0.0,1439.0,0.0,1439.0,0.0,1439.0,
TCGA-AR-A0TZ,908,TCGA-AR-A0TZ,BRCA,43.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15720.0,Dead,,,3262.0,[Not Available],Distant Metastasis,Bone,,1313.0,[Not Available],Negative,,1.0,3262.0,,3262.0,1.0,1313.0,1.0,1313.0,
TCGA-HU-A4GY,9582,TCGA-HU-A4GY,STAD,76.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-28113.0,Alive,TUMOR FREE,8.0,,[Not Available],,,,,Stable Disease,,,0.0,8.0,0.0,8.0,,,0.0,8.0,
TCGA-D8-A1JM,1248,TCGA-D8-A1JM,BRCA,59.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21602.0,Alive,TUMOR FREE,590.0,,[Not Available],,,,,[Not Available],Negative,,0.0,590.0,0.0,590.0,0.0,590.0,0.0,590.0,
TCGA-77-8139,6681,TCGA-77-8139,LUSC,72.0,MALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-26464.0,Alive,TUMOR FREE,3166.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3166.0,0.0,3166.0,0.0,3166.0,0.0,3166.0,
TCGA-OR-A5KU,50,TCGA-OR-A5KU,ACC,37.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-13559.0,Alive,TUMOR FREE,4673.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4673.0,0.0,4673.0,0.0,4673.0,0.0,4673.0,
TCGA-RQ-A68N,2457,TCGA-RQ-A68N,DLBC,63.0,MALE,WHITE,[Not Applicable],[Not Available],Primary DLBCL of the CNS,[Not Available],2012.0,[Not Available],-23127.0,Alive,TUMOR FREE,788.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,788.0,0.0,788.0,,,0.0,788.0,
TCGA-AL-3466,4495,TCGA-AL-3466,KIRP,41.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004.0,[Not Available],-15181.0,Dead,WITH TUMOR,,293.0,[Not Available],,,,138.0,[Not Available],,,1.0,293.0,1.0,293.0,,,1.0,138.0,
TCGA-M7-A71Y,8218,TCGA-M7-A71Y,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-20357.0,Alive,TUMOR FREE,493.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,493.0,0.0,493.0,0.0,493.0,0.0,493.0,
TCGA-A2-A4S2,627,TCGA-A2-A4S2,BRCA,62.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22936.0,Alive,TUMOR FREE,643.0,,[Not Available],,,,,[Not Available],Negative,,0.0,643.0,0.0,643.0,0.0,643.0,0.0,643.0,
TCGA-C5-A1MQ,1631,TCGA-C5-A1MQ,CESC,35.0,FEMALE,WHITE,[Not Available],Stage IIA,Cervical Squamous Cell Carcinoma,G2,2009.0,[Not Available],-12836.0,Alive,TUMOR FREE,1031.0,,,,,,,Complete Remission/Response,,,0.0,1031.0,0.0,1031.0,0.0,1031.0,0.0,1031.0,
TCGA-D8-A1X6,1255,TCGA-D8-A1X6,BRCA,80.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29256.0,Alive,TUMOR FREE,541.0,,[Not Available],,,,,[Not Available],Negative,,0.0,541.0,0.0,541.0,0.0,541.0,0.0,541.0,
TCGA-DD-AACF,5585,TCGA-DD-AACF,LIHC,68.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2008.0,[Not Available],-25172.0,Dead,WITH TUMOR,,365.0,[Not Available],Locoregional Recurrence,Liver,,119.0,[Not Available],,R0,1.0,365.0,1.0,365.0,1.0,119.0,1.0,119.0,
TCGA-VQ-A91V,9681,TCGA-VQ-A91V,STAD,58.0,MALE,[Unknown],Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-21505.0,Alive,WITH TUMOR,1297.0,,[Not Available],Distant Metastasis,Lung,,504.0,Progressive Disease,,,0.0,1297.0,0.0,1297.0,,,1.0,504.0,
TCGA-BH-A0C1,1058,TCGA-BH-A0C1,BRCA,61.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22377.0,Dead,WITH TUMOR,,1411.0,[Not Available],Distant Metastasis,Bone,,1123.0,[Not Available],Negative,,1.0,1411.0,1.0,1411.0,1.0,1123.0,1.0,1123.0,
TCGA-CZ-5466,4382,TCGA-CZ-5466,KIRC,67.0,MALE,[Not Available],Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-24669.0,Alive,TUMOR FREE,685.0,,[Not Available],,,,,[Not Available],,,0.0,685.0,0.0,685.0,,,0.0,685.0,
TCGA-HQ-A2OE,368,TCGA-HQ-A2OE,BLCA,69.0,MALE,[Not Evaluated],[Not Available],[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),[Unknown],2007.0,[Not Available],,Alive,,1174.0,,[Not Available],,,,,[Unknown],,,0.0,1174.0,0.0,1174.0,,,0.0,1174.0,
TCGA-DX-A7EI,8624,TCGA-DX-A7EI,SARC,78.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2003.0,[Not Available],-28610.0,Dead,WITH TUMOR,,1049.0,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,828.0,[Not Available],Positive,R1,1.0,1049.0,1.0,1049.0,,,1.0,828.0,
TCGA-TQ-A8XE,5404,TCGA-TQ-A8XE,LGG,42.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-15629.0,Dead,WITH TUMOR,,954.0,[Not Available],,,,455.0,Partial Remission/Response,,,1.0,954.0,1.0,954.0,,,1.0,455.0,
TCGA-DB-A64U,4956,TCGA-DB-A64U,LGG,38.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-14019.0,Alive,TUMOR FREE,846.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,846.0,0.0,846.0,0.0,846.0,0.0,846.0,
TCGA-OR-A5LP,79,TCGA-OR-A5LP,ACC,37.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-13574.0,Alive,TUMOR FREE,1857.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1857.0,0.0,1857.0,0.0,1857.0,0.0,1857.0,
TCGA-AX-A3G3,10667,TCGA-AX-A3G3,UCEC,58.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21308.0,Alive,,42.0,,[Not Available],,,,,[Not Available],,,0.0,42.0,0.0,42.0,,,0.0,42.0,
TCGA-AP-A0LF,10579,TCGA-AP-A0LF,UCEC,82.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30027.0,Alive,WITH TUMOR,2859.0,,[Not Available],,,,,[Not Applicable],,,0.0,2859.0,0.0,2859.0,,,0.0,2859.0,
TCGA-B5-A0JT,10678,TCGA-B5-A0JT,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23041.0,Alive,TUMOR FREE,1682.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1682.0,0.0,1682.0,0.0,1682.0,0.0,1682.0,
TCGA-KK-A6E2,8181,TCGA-KK-A6E2,PRAD,54.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2000.0,[Not Available],-19974.0,Alive,TUMOR FREE,5024.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,5024.0,0.0,5024.0,0.0,5024.0,0.0,5024.0,
TCGA-TM-A84O,5383,TCGA-TM-A84O,LGG,61.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-22327.0,Dead,WITH TUMOR,,1011.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1011.0,1.0,1011.0,,,1.0,1011.0,
TCGA-DJ-A2Q0,9953,TCGA-DJ-A2Q0,THCA,57.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-20973.0,Alive,TUMOR FREE,1045.0,,[Not Available],,,,,[Not Available],,R0,0.0,1045.0,0.0,1045.0,0.0,1045.0,0.0,1045.0,
TCGA-D8-A1JP,1250,TCGA-D8-A1JP,BRCA,73.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26862.0,Alive,TUMOR FREE,639.0,,[Not Available],,,,,[Not Available],Negative,,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,
TCGA-ET-A39N,10224,TCGA-ET-A39N,THCA,35.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-12904.0,Alive,TUMOR FREE,3751.0,,[Not Available],,,,,[Not Available],,R0,0.0,3751.0,0.0,3751.0,0.0,3751.0,0.0,3751.0,
TCGA-BP-5192,4258,TCGA-BP-5192,KIRC,59.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-21891.0,Alive,TUMOR FREE,714.0,,[Not Available],,,,,[Not Available],,,0.0,714.0,0.0,714.0,,,0.0,714.0,
TCGA-A4-A5Y1,4491,TCGA-A4-A5Y1,KIRP,75.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-27541.0,Dead,WITH TUMOR,,395.0,[Not Available],,,,296.0,Complete Remission/Response,,,1.0,395.0,1.0,395.0,1.0,296.0,1.0,296.0,
TCGA-KN-8423,3822,TCGA-KN-8423,KICH,44.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-16335.0,Alive,TUMOR FREE,788.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,788.0,0.0,788.0,0.0,788.0,0.0,788.0,
TCGA-AG-3592,8396,TCGA-AG-3592,READ,68.0,MALE,[Not Available],Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2007.0,[Not Available],-25141.0,Alive,TUMOR FREE,1035.0,,[Not Available],,,,,[Not Available],,,0.0,1035.0,0.0,1035.0,,,0.0,1035.0,
TCGA-06-5418,2872,TCGA-06-5418,GBM,75.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-27584.0,Dead,WITH TUMOR,83.0,83.0,[Not Available],,,,,[Not Available],,,1.0,83.0,1.0,83.0,,,1.0,83.0,
TCGA-CU-A0YN,172,TCGA-CU-A0YN,BLCA,60.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,[Not Available],-21927.0,Dead,,,393.0,[Not Available],,,,,[Not Available],,,1.0,393.0,,393.0,,,0.0,393.0,
TCGA-EA-A410,1702,TCGA-EA-A410,CESC,51.0,FEMALE,WHITE,[Not Available],Stage IIA2,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18720.0,Alive,TUMOR FREE,803.0,,,,,,,Complete Remission/Response,,,0.0,803.0,0.0,803.0,0.0,803.0,0.0,803.0,
TCGA-55-7727,6002,TCGA-55-7727,LUAD,70.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25929.0,Alive,TUMOR FREE,119.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,119.0,0.0,119.0,0.0,119.0,0.0,119.0,
TCGA-2Z-A9JG,4431,TCGA-2Z-A9JG,KIRP,64.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-23458.0,Alive,TUMOR FREE,1662.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1662.0,0.0,1662.0,0.0,1662.0,0.0,1662.0,
TCGA-EJ-A7NG,7994,TCGA-EJ-A7NG,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23458.0,Alive,TUMOR FREE,432.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,432.0,0.0,432.0,0.0,432.0,0.0,432.0,
TCGA-CV-7437,3571,TCGA-CV-7437,HNSC,77.0,MALE,[Not Available],Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,GX,1996.0,[Not Available],-28221.0,Dead,WITH TUMOR,,506.0,[Not Available],,,,,[Not Available],,,1.0,506.0,1.0,506.0,,,1.0,506.0,
TCGA-A6-6781,2005,TCGA-A6-6781,COAD,43.0,MALE,WHITE,Stage IIIC,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-15842.0,Alive,TUMOR FREE,598.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,598.0,0.0,598.0,0.0,598.0,0.0,598.0,
TCGA-97-7938,6253,TCGA-97-7938,LUAD,76.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27980.0,Dead,TUMOR FREE,,18.0,[Not Available],,,,,Complete Remission/Response,,,1.0,18.0,0.0,18.0,0.0,18.0,0.0,18.0,
TCGA-IG-A97I,2493,TCGA-IG-A97I,ESCA,58.0,MALE,WHITE,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-21271.0,Alive,TUMOR FREE,370.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,370.0,0.0,370.0,0.0,370.0,0.0,370.0,
TCGA-WE-A8ZX,9246,TCGA-WE-A8ZX,SKCM,45.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-16736.0,Alive,TUMOR FREE,1089.0,,[Not Available],Locoregional Recurrence,,,326.0,[Not Available],,,0.0,1089.0,0.0,1089.0,,,1.0,326.0,
TCGA-BC-A217,5469,TCGA-BC-A217,LIHC,75.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-27411.0,Dead,TUMOR FREE,,1397.0,[Not Available],,,,,[Not Available],,R0,1.0,1397.0,0.0,1397.0,0.0,1397.0,0.0,1397.0,
TCGA-ZB-A965,10450,TCGA-ZB-A965,THYM,75.0,FEMALE,WHITE,[Not Applicable],III,Thymoma; Type A|Thymoma; Type AB,[Not Available],2012.0,[Not Available],-27617.0,Alive,TUMOR FREE,816.0,,[Not Available],,,,,[Not Available],,,0.0,816.0,0.0,816.0,,,0.0,816.0,
TCGA-CJ-4638,4271,TCGA-CJ-4638,KIRC,46.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-17110.0,Dead,WITH TUMOR,,431.0,[Not Available],,,,70.0,[Not Available],,,1.0,431.0,1.0,431.0,,,1.0,70.0,
TCGA-AX-A06L,10623,TCGA-AX-A06L,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23294.0,Alive,TUMOR FREE,1845.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1845.0,0.0,1845.0,0.0,1845.0,0.0,1845.0,
TCGA-HT-7695,5185,TCGA-HT-7695,LGG,29.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2009.0,[Not Available],-10827.0,Alive,TUMOR FREE,442.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,
TCGA-38-A44F,5852,TCGA-38-A44F,LUAD,80.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-29534.0,Alive,TUMOR FREE,133.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,133.0,0.0,133.0,0.0,133.0,0.0,133.0,
TCGA-ZF-AA4W,494,TCGA-ZF-AA4W,BLCA,56.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-20611.0,Alive,,1830.0,,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",penile urethra,1679.0,Complete Remission/Response,,,0.0,1830.0,0.0,1830.0,1.0,1679.0,1.0,1679.0,
TCGA-42-2588,7412,TCGA-42-2588,OV,61.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-22377.0,Dead,WITH TUMOR,,880.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],112.0,Progressive Disease,,,1.0,880.0,1.0,880.0,,,1.0,112.0,
TCGA-BP-5200,4264,TCGA-BP-5200,KIRC,44.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2008.0,[Not Available],-16197.0,Alive,TUMOR FREE,1063.0,,[Not Available],,,,,[Not Available],,,0.0,1063.0,0.0,1063.0,,,0.0,1063.0,
TCGA-98-A53C,6790,TCGA-98-A53C,LUSC,77.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-28146.0,Alive,TUMOR FREE,822.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,
TCGA-AR-A2LN,960,TCGA-AR-A2LN,BRCA,65.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23992.0,Alive,TUMOR FREE,1161.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1161.0,0.0,1161.0,0.0,1161.0,0.0,1161.0,
TCGA-FB-AAQ0,7565,TCGA-FB-AAQ0,PAAD,68.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-24988.0,Dead,TUMOR FREE,,473.0,,,,,,Complete Remission/Response,,,1.0,473.0,0.0,473.0,0.0,473.0,0.0,473.0,
TCGA-06-0154,2765,TCGA-06-0154,GBM,54.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-20018.0,Dead,WITH TUMOR,389.0,424.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],208.0,[Not Available],,,1.0,424.0,1.0,424.0,,,1.0,208.0,
TCGA-3B-A9HT,8545,TCGA-3B-A9HT,SARC,53.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-19637.0,Alive,TUMOR FREE,1665.0,,[Not Available],New Primary Tumor,Liver,,670.0,[Not Available],Negative,R0,0.0,1665.0,0.0,1665.0,0.0,1665.0,1.0,670.0,
TCGA-BS-A0U8,10800,TCGA-BS-A0U8,UCEC,55.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20402.0,Alive,TUMOR FREE,2963.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2963.0,0.0,2963.0,0.0,2963.0,0.0,2963.0,
TCGA-91-6829,6213,TCGA-91-6829,LUAD,78.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-28841.0,Dead,TUMOR FREE,,1258.0,[Not Available],,,,,Progressive Disease,,,1.0,1258.0,0.0,1258.0,,,0.0,1258.0,
TCGA-CV-7425,3562,TCGA-CV-7425,HNSC,77.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2000.0,[Not Available],-28368.0,Dead,WITH TUMOR,,1718.0,[Not Available],,,,,[Not Available],,,1.0,1718.0,1.0,1718.0,,,1.0,1718.0,
TCGA-05-4434,5831,TCGA-05-4434,LUAD,67.0,FEMALE,[Not Available],Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-24472.0,Dead,,,457.0,[Not Available],,,,,[Not Available],,,1.0,457.0,,457.0,,,0.0,457.0,
TCGA-FB-A545,7555,TCGA-FB-A545,PAAD,72.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-26635.0,Dead,TUMOR FREE,,732.0,Pancreatic Cancer,Distant Metastasis,Liver,,378.0,Complete Remission/Response,,,1.0,732.0,1.0,732.0,1.0,378.0,1.0,378.0,
TCGA-85-7710,6711,TCGA-85-7710,LUSC,59.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-21790.0,Alive,TUMOR FREE,42.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,42.0,0.0,42.0,0.0,42.0,0.0,42.0,
TCGA-55-7995,6013,TCGA-55-7995,LUAD,73.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26837.0,Alive,TUMOR FREE,889.0,,[Not Available],Locoregional Recurrence,,,468.0,Complete Remission/Response,,,0.0,889.0,0.0,889.0,1.0,468.0,1.0,468.0,
TCGA-BC-A10R,5458,TCGA-BC-A10R,LIHC,66.0,FEMALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G2,1999.0,[Not Available],-24274.0,Dead,WITH TUMOR,,308.0,[Not Available],Intrahepatic Recurrence,,,199.0,[Not Available],,R0,1.0,308.0,1.0,308.0,1.0,199.0,1.0,199.0,
TCGA-67-6217,6095,TCGA-67-6217,LUAD,73.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-26920.0,Alive,WITH TUMOR,422.0,,[Not Available],,,,296.0,Progressive Disease,,,0.0,422.0,0.0,422.0,,,1.0,296.0,
TCGA-XF-AAN8,467,TCGA-XF-AAN8,BLCA,74.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-27309.0,Dead,,,118.0,[Not Available],,,,,[Unknown],,,1.0,118.0,,118.0,,,0.0,118.0,
TCGA-FJ-A871,309,TCGA-FJ-A871,BLCA,49.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-18051.0,Dead,WITH TUMOR,,272.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Pelvic,106.0,Progressive Disease,,,1.0,272.0,1.0,272.0,,,1.0,106.0,
TCGA-BR-4371,9300,TCGA-BR-4371,STAD,71.0,FEMALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2008.0,[Not Available],-26290.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-E1-5302,5066,TCGA-E1-5302,LGG,41.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,1998.0,[Not Available],-15230.0,Dead,WITH TUMOR,,1525.0,[Not Available],,,,1242.0,Stable Disease,,,1.0,1525.0,1.0,1525.0,,,1.0,1242.0,
TCGA-QH-A65S,5290,TCGA-QH-A65S,LGG,32.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-11861.0,Alive,[Discrepancy],77.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,77.0,0.0,77.0,,,0.0,77.0,
TCGA-63-A5MP,6601,TCGA-63-A5MP,LUSC,56.0,MALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-20818.0,Alive,WITH TUMOR,769.0,,[Not Available],Locoregional Recurrence,,,511.0,Complete Remission/Response,,,0.0,769.0,0.0,769.0,1.0,511.0,1.0,511.0,
TCGA-PE-A5DC,1575,TCGA-PE-A5DC,BRCA,72.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26514.0,Dead,TUMOR FREE,,1430.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1430.0,0.0,1430.0,,,0.0,1430.0,
TCGA-06-5416,2870,TCGA-06-5416,GBM,23.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-8533.0,Alive,WITH TUMOR,204.0,,[Not Available],,,,,[Not Available],,,0.0,204.0,0.0,204.0,,,0.0,204.0,
TCGA-49-6767,5919,TCGA-49-6767,LUAD,46.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-17108.0,Alive,TUMOR FREE,677.0,,[Not Available],,,,,[Unknown],,,0.0,677.0,0.0,677.0,,,0.0,677.0,
TCGA-DJ-A2QC,9965,TCGA-DJ-A2QC,THCA,70.0,FEMALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-25690.0,Alive,TUMOR FREE,1215.0,,[Not Available],,,,,[Not Available],,R0,0.0,1215.0,0.0,1215.0,0.0,1215.0,0.0,1215.0,
TCGA-WB-A822,7865,TCGA-WB-A822,PCPG,23.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2006.0,[Not Available],-8708.0,Alive,WITH TUMOR,3138.0,,[Not Available],Distant Metastasis,Bone,,69.0,Progressive Disease,,,0.0,3138.0,0.0,3138.0,,,1.0,69.0,
TCGA-EK-A3GN,1745,TCGA-EK-A3GN,CESC,47.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2005.0,[Not Available],-17425.0,Alive,WITH TUMOR,27.0,,,,,,,[Not Available],,,0.0,27.0,0.0,27.0,,,0.0,27.0,
TCGA-4T-AA8H,1956,TCGA-4T-AA8H,COAD,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2013.0,[Not Available],-15494.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-TP-A8TV,8235,TCGA-TP-A8TV,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22872.0,Alive,TUMOR FREE,610.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,610.0,0.0,610.0,0.0,610.0,0.0,610.0,
TCGA-EJ-5519,7933,TCGA-EJ-5519,PRAD,64.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-23669.0,Alive,TUMOR FREE,1962.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1962.0,0.0,1962.0,0.0,1962.0,0.0,1962.0,
TCGA-D1-A2G6,10886,TCGA-D1-A2G6,UCEC,53.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19547.0,Dead,WITH TUMOR,,258.0,[Not Available],,,,,[Not Available],,,1.0,258.0,1.0,258.0,,,1.0,258.0,
TCGA-HT-8108,5213,TCGA-HT-8108,LGG,26.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-9539.0,Alive,TUMOR FREE,76.0,,[Not Available],,,,,Stable Disease,,,0.0,76.0,0.0,76.0,,,0.0,76.0,
TCGA-BR-4184,9277,TCGA-BR-4184,STAD,70.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2007.0,[Not Available],-25816.0,Dead,,,212.0,[Not Available],,,,,[Not Available],,,1.0,212.0,,212.0,,,0.0,212.0,
TCGA-CV-A6JU,3599,TCGA-CV-A6JU,HNSC,61.0,FEMALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-22591.0,Alive,TUMOR FREE,110.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,110.0,0.0,110.0,,,0.0,110.0,
TCGA-BR-8676,9379,TCGA-BR-8676,STAD,59.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-21619.0,Alive,TUMOR FREE,229.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,229.0,0.0,229.0,0.0,229.0,0.0,229.0,
TCGA-BH-A0DO,1068,TCGA-BH-A0DO,BRCA,78.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28529.0,Alive,TUMOR FREE,1644.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1644.0,0.0,1644.0,0.0,1644.0,0.0,1644.0,
TCGA-CW-6090,4350,TCGA-CW-6090,KIRC,68.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-24909.0,Alive,TUMOR FREE,2552.0,,[Not Available],,,,2780.0,[Not Available],,,0.0,2552.0,0.0,2552.0,,,1.0,2780.0,
TCGA-CN-4741,3319,TCGA-CN-4741,HNSC,75.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-27506.0,Alive,TUMOR FREE,2239.0,,[Not Available],Locoregional Recurrence,Cervical Lymph Nodes,R NECK,1716.0,Complete Remission/Response,,,0.0,2239.0,0.0,2239.0,,,1.0,1716.0,
TCGA-56-7823,6521,TCGA-56-7823,LUSC,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-21344.0,Alive,TUMOR FREE,1011.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1011.0,0.0,1011.0,0.0,1011.0,0.0,1011.0,
TCGA-4V-A9QX,10372,TCGA-4V-A9QX,THYM,77.0,FEMALE,WHITE,[Not Applicable],III,Thymoma; Type AB,[Not Available],2013.0,[Not Available],-28250.0,Alive,TUMOR FREE,434.0,,[Not Available],,,,,[Not Available],,,0.0,434.0,0.0,434.0,,,0.0,434.0,
TCGA-QG-A5YX,2405,TCGA-QG-A5YX,COAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-22617.0,Alive,TUMOR FREE,1003.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1003.0,0.0,1003.0,0.0,1003.0,0.0,1003.0,
TCGA-LK-A4NW,6844,TCGA-LK-A4NW,MESO,60.0,MALE,WHITE,Stage IV,[Not Applicable],Diffuse malignant mesothelioma - NOS,[Not Available],2007.0,[Not Available],-21922.0,Dead,WITH TUMOR,,546.0,[Not Available],,,,,[Not Available],,RX,1.0,546.0,1.0,546.0,,,1.0,546.0,
TCGA-E7-A8O7,253,TCGA-E7-A8O7,BLCA,52.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,[Not Available],-19063.0,Alive,TUMOR FREE,466.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,466.0,0.0,466.0,0.0,466.0,0.0,466.0,
TCGA-43-A56U,6489,TCGA-43-A56U,LUSC,76.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-27847.0,Alive,TUMOR FREE,432.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,432.0,0.0,432.0,0.0,432.0,0.0,432.0,
TCGA-BQ-5893,4553,TCGA-BQ-5893,KIRP,61.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-22320.0,Dead,WITH TUMOR,,241.0,[Not Available],,,,188.0,[Not Available],,,1.0,241.0,1.0,241.0,,,1.0,188.0,
TCGA-HC-7821,8093,TCGA-HC-7821,PRAD,54.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19894.0,Alive,WITH TUMOR,956.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,956.0,0.0,956.0,0.0,956.0,0.0,956.0,
TCGA-KO-8404,3838,TCGA-KO-8404,KICH,78.0,MALE,WHITE,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-28705.0,Dead,WITH TUMOR,,325.0,[Not Available],,,,148.0,Progressive Disease,,,1.0,325.0,1.0,325.0,,,1.0,148.0,
TCGA-SQ-A6I4,7802,TCGA-SQ-A6I4,PCPG,53.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-19399.0,Alive,TUMOR FREE,43.0,,[Not Available],,,,,[Unknown],,,0.0,43.0,0.0,43.0,,,0.0,43.0,
TCGA-TS-A7P3,6883,TCGA-TS-A7P3,MESO,57.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2011.0,[Not Available],-20964.0,Dead,,,689.0,[Not Available],,,,,[Not Available],,[Unknown],1.0,689.0,,689.0,,,0.0,689.0,
TCGA-FP-8631,9545,TCGA-FP-8631,STAD,68.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-24898.0,Alive,TUMOR FREE,17.0,,[Not Available],,,,,[Not Applicable],,,0.0,17.0,0.0,17.0,,,0.0,17.0,
TCGA-L9-A8F4,6291,TCGA-L9-A8F4,LUAD,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2013.0,[Not Available],-23617.0,Alive,TUMOR FREE,476.0,,[Not Available],,,,,[Not Applicable],,,0.0,476.0,0.0,476.0,,,0.0,476.0,
TCGA-ZD-A8I3,1944,TCGA-ZD-A8I3,CHOL,73.0,FEMALE,ASIAN,Stage II,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2013.0,[Not Available],-26754.0,Dead,WITH TUMOR,,169.0,[Not Available],Locoregional Recurrence,Liver,,59.0,[Not Available],,R0,1.0,169.0,1.0,169.0,1.0,59.0,1.0,59.0,
TCGA-E2-A1LK,1380,TCGA-E2-A1LK,BRCA,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30757.0,Dead,WITH TUMOR,,266.0,[Not Available],Locoregional Disease,"Other, specify",Left axilla,155.0,[Not Available],Negative,,1.0,266.0,1.0,266.0,1.0,155.0,1.0,155.0,
TCGA-CN-5356,3322,TCGA-CN-5356,HNSC,56.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-20540.0,Alive,TUMOR FREE,1409.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1409.0,0.0,1409.0,0.0,1409.0,0.0,1409.0,
TCGA-60-2707,6567,TCGA-60-2707,LUSC,70.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-25758.0,Dead,WITH TUMOR,,667.0,[Not Available],,,,579.0,Complete Remission/Response,,,1.0,667.0,1.0,667.0,1.0,579.0,1.0,579.0,
TCGA-CU-A72E,179,TCGA-CU-A72E,BLCA,76.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-27963.0,Dead,WITH TUMOR,,413.0,[Not Available],New Primary Tumor,Lymph Node Only,,256.0,Partial Remission/Response,,,1.0,413.0,1.0,413.0,,,1.0,256.0,
TCGA-D1-A103,10826,TCGA-D1-A103,UCEC,87.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31841.0,Alive,TUMOR FREE,669.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,669.0,0.0,669.0,0.0,669.0,0.0,669.0,
TCGA-J4-A67M,8134,TCGA-J4-A67M,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-20211.0,Alive,TUMOR FREE,941.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,941.0,0.0,941.0,0.0,941.0,0.0,941.0,
TCGA-BH-A0WA,1113,TCGA-BH-A0WA,BRCA,82.0,FEMALE,WHITE,Stage I,[Not Applicable],[Not Available],[Not Available],2008.0,[Not Available],-30025.0,Alive,TUMOR FREE,701.0,,[Not Available],,,,,[Not Available],Negative,,0.0,701.0,0.0,701.0,0.0,701.0,0.0,701.0,
TCGA-CG-4440,9452,TCGA-CG-4440,STAD,68.0,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,[Not Available],-25171.0,Dead,,,122.0,[Not Available],,,,,[Not Available],,,1.0,122.0,,122.0,,,0.0,122.0,
TCGA-GN-A4U5,9205,TCGA-GN-A4U5,SKCM,61.0,FEMALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2011.0,[Not Available],-22499.0,Alive,TUMOR FREE,1156.0,,[Not Available],,,,,[Not Available],,,0.0,1156.0,0.0,1156.0,,,0.0,1156.0,
TCGA-E7-A3Y1,236,TCGA-E7-A3Y1,BLCA,57.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,[Not Available],-20917.0,Alive,TUMOR FREE,163.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,163.0,0.0,163.0,0.0,163.0,0.0,163.0,
TCGA-4B-A93V,5931,TCGA-4B-A93V,LUAD,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2013.0,[Not Available],-19035.0,Dead,WITH TUMOR,,300.0,[Not Available],Distant Metastasis,,,251.0,Progressive Disease,,,1.0,300.0,1.0,300.0,,,1.0,251.0,
TCGA-KN-8434,3833,TCGA-KN-8434,KICH,65.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2009.0,[Not Available],-23934.0,Alive,TUMOR FREE,1797.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1797.0,0.0,1797.0,0.0,1797.0,0.0,1797.0,
TCGA-DJ-A2PY,9951,TCGA-DJ-A2PY,THCA,46.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-17056.0,Alive,TUMOR FREE,267.0,,[Not Available],,,,,[Not Available],,R0,0.0,267.0,0.0,267.0,0.0,267.0,0.0,267.0,
TCGA-A2-A04U,532,TCGA-A2-A04U,BRCA,47.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Peri (6-12 months since last menstrual period),-17474.0,Alive,TUMOR FREE,2654.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2654.0,0.0,2654.0,0.0,2654.0,0.0,2654.0,
TCGA-FU-A5XV,1766,TCGA-FU-A5XV,CESC,32.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11692.0,Alive,TUMOR FREE,321.0,,,,,,,Complete Remission/Response,,,0.0,321.0,0.0,321.0,0.0,321.0,0.0,321.0,
TCGA-C5-A2LY,1636,TCGA-C5-A2LY,CESC,30.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11018.0,Alive,TUMOR FREE,2383.0,,,,,,,Complete Remission/Response,,,0.0,2383.0,0.0,2383.0,0.0,2383.0,0.0,2383.0,
TCGA-77-7338,6669,TCGA-77-7338,LUSC,64.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1995.0,[Not Available],-23480.0,Dead,,,5.0,[Not Available],,,,,[Not Available],,,1.0,5.0,,5.0,,,0.0,5.0,
TCGA-CV-6933,3494,TCGA-CV-6933,HNSC,53.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1998.0,[Not Available],-19518.0,Dead,TUMOR FREE,,2741.0,[Not Available],,,,,[Not Available],,,1.0,2741.0,0.0,2741.0,,,0.0,2741.0,
TCGA-DJ-A4V2,10008,TCGA-DJ-A4V2,THCA,38.0,FEMALE,[Not Evaluated],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-14126.0,Alive,TUMOR FREE,95.0,,[Not Available],,,,,[Not Available],,R0,0.0,95.0,0.0,95.0,0.0,95.0,0.0,95.0,
TCGA-DF-A2L0,10900,TCGA-DF-A2L0,UCEC,60.0,FEMALE,[Not Evaluated],[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22200.0,Dead,WITH TUMOR,,788.0,[Not Available],Distant Metastasis,"Other, specify",lymph nodes and retroperitoneal tissue,523.0,Complete Remission/Response,,,1.0,788.0,1.0,788.0,1.0,523.0,1.0,523.0,
TCGA-VQ-A8PH,9660,TCGA-VQ-A8PH,STAD,62.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-22940.0,Dead,WITH TUMOR,,389.0,[Not Available],Locoregional Recurrence,,,377.0,Progressive Disease,,,1.0,389.0,1.0,389.0,,,1.0,377.0,
TCGA-AR-A1AT,926,TCGA-AR-A1AT,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22942.0,Dead,,,1272.0,[Not Available],,,,,[Not Available],Negative,,1.0,1272.0,,1272.0,0.0,1272.0,0.0,1272.0,
TCGA-06-0126,2743,TCGA-06-0126,GBM,86.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2001.0,[Not Available],-31627.0,Dead,,3.0,211.0,[Not Available],,,,,[Unknown],,,1.0,211.0,,211.0,,,0.0,211.0,
TCGA-06-6391,2879,TCGA-06-6391,GBM,44.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-16206.0,Dead,WITH TUMOR,,45.0,[Not Available],,,,,[Not Available],,,1.0,45.0,1.0,45.0,,,1.0,45.0,
TCGA-BH-A18L,1120,TCGA-BH-A18L,BRCA,50.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003.0,[Not Available],-18519.0,Dead,,,811.0,[Not Available],,,,,[Not Available],Negative,,1.0,811.0,,811.0,0.0,811.0,0.0,811.0,
TCGA-A3-A6NI,3928,TCGA-A3-A6NI,KIRC,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2011.0,[Not Available],-17190.0,Alive,TUMOR FREE,1018.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1018.0,0.0,1018.0,0.0,1018.0,0.0,1018.0,
TCGA-HC-8264,8104,TCGA-HC-8264,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22177.0,Alive,WITH TUMOR,48.0,,[Not Available],,,,,[Not Applicable],,,0.0,48.0,0.0,48.0,,,0.0,48.0,
TCGA-KP-A3W4,11006,TCGA-KP-A3W4,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23200.0,Dead,WITH TUMOR,,554.0,[Not Available],Distant Metastasis,Liver,,321.0,Partial Remission/Response,,,1.0,554.0,1.0,554.0,,,1.0,321.0,
TCGA-CR-7382,3452,TCGA-CR-7382,HNSC,49.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-18078.0,Alive,TUMOR FREE,796.0,,[Not Available],,Oral Cavity,Tongue,614.0,Complete Remission/Response,,,0.0,796.0,0.0,796.0,,,1.0,614.0,
TCGA-B5-A1MX,10720,TCGA-B5-A1MX,UCEC,47.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17320.0,Alive,TUMOR FREE,1473.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1473.0,0.0,1473.0,0.0,1473.0,0.0,1473.0,
TCGA-BP-5185,4252,TCGA-BP-5185,KIRC,56.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-20470.0,Alive,WITH TUMOR,1132.0,,[Not Available],,,,736.0,[Not Available],,,0.0,1132.0,0.0,1132.0,,,1.0,736.0,
TCGA-AZ-4315,2215,TCGA-AZ-4315,COAD,61.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-22340.0,Alive,TUMOR FREE,1776.0,,[Not Available],,,,,[Not Available],,,0.0,1776.0,0.0,1776.0,,,0.0,1776.0,
TCGA-E9-A5FL,1451,TCGA-E9-A5FL,BRCA,65.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Metaplastic Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24053.0,Alive,TUMOR FREE,24.0,,[Not Available],,,,,[Not Available],Negative,,0.0,24.0,0.0,24.0,0.0,24.0,0.0,24.0,
TCGA-B1-A47N,4507,TCGA-B1-A47N,KIRP,62.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-22800.0,Alive,TUMOR FREE,1110.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1110.0,0.0,1110.0,0.0,1110.0,0.0,1110.0,
TCGA-C8-A12N,1179,TCGA-C8-A12N,BRCA,58.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21428.0,Alive,TUMOR FREE,358.0,,[Not Available],,,,,[Not Available],Negative,,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,
TCGA-CQ-A4C9,3408,TCGA-CQ-A4C9,HNSC,56.0,MALE,[Not Evaluated],Stage III,[Not Available],Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-20732.0,Alive,WITH TUMOR,707.0,,[Not Available],Locoregional Disease,Oral Cavity,,287.0,Complete Remission/Response,,,0.0,707.0,0.0,707.0,1.0,287.0,1.0,287.0,
TCGA-J4-A67Q,8137,TCGA-J4-A67Q,PRAD,77.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-28447.0,Alive,TUMOR FREE,975.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,975.0,0.0,975.0,0.0,975.0,0.0,975.0,
TCGA-B7-A5TK,9274,TCGA-B7-A5TK,STAD,51.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-18750.0,Alive,TUMOR FREE,288.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,288.0,0.0,288.0,0.0,288.0,0.0,288.0,
TCGA-LK-A4O5,6850,TCGA-LK-A4O5,MESO,68.0,FEMALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2011.0,[Not Available],-25000.0,Dead,WITH TUMOR,,387.0,[Not Available],,,,,[Not Available],,R1,1.0,387.0,1.0,387.0,,,1.0,387.0,
TCGA-36-2538,7398,TCGA-36-2538,OV,37.0,FEMALE,[Not Available],[Not Applicable],Stage IIIB,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-13681.0,Alive,WITH TUMOR,763.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],523.0,Complete Remission/Response,,,0.0,763.0,0.0,763.0,1.0,523.0,1.0,523.0,
TCGA-AA-3556,2050,TCGA-AA-3556,COAD,78.0,MALE,[Not Available],Stage I,[Not Applicable],[Not Available],[Not Available],2008.0,[Not Available],-28704.0,Alive,WITH TUMOR,700.0,,[Not Available],,,,,[Unknown],,,0.0,700.0,0.0,700.0,,,0.0,700.0,
TCGA-66-2766,6623,TCGA-66-2766,LUSC,54.0,MALE,[Not Available],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-19814.0,Alive,TUMOR FREE,31.0,,[Not Available],,,,,[Not Available],,,0.0,31.0,0.0,31.0,,,0.0,31.0,
TCGA-DX-AB2J,8656,TCGA-DX-AB2J,SARC,71.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2006.0,[Not Available],-26154.0,Dead,WITH TUMOR,,1235.0,[Not Available],,,,,[Not Available],Positive,R1,1.0,1235.0,1.0,1235.0,,,1.0,1235.0,
TCGA-H8-A6C1,7579,TCGA-H8-A6C1,PAAD,53.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2012.0,[Not Available],-19677.0,Alive,WITH TUMOR,671.0,,,Distant Metastasis,Liver,,455.0,[Discrepancy],,,0.0,671.0,0.0,671.0,,,1.0,455.0,
TCGA-RW-A688,7766,TCGA-RW-A688,PCPG,69.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-25216.0,Alive,TUMOR FREE,37.0,,[Not Available],New Primary Tumor,Lung,,27.0,Complete Remission/Response,,,0.0,37.0,0.0,37.0,0.0,37.0,1.0,27.0,
TCGA-FD-A6TG,301,TCGA-FD-A6TG,BLCA,73.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-26893.0,Dead,TUMOR FREE,,93.0,[Not Available],,,,,[Not Applicable],,,1.0,93.0,0.0,93.0,,,0.0,93.0,
TCGA-HT-7472,5145,TCGA-HT-7472,LGG,38.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-13968.0,Alive,TUMOR FREE,1.0,,[Not Available],,,,,Stable Disease,,,0.0,1.0,0.0,1.0,,,0.0,1.0,
TCGA-A6-A567,2009,TCGA-A6-A567,COAD,56.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-20493.0,Dead,WITH TUMOR,,1881.0,[Not Available],Metastatic,,,612.0,[Unknown],,,1.0,1881.0,1.0,1881.0,,,1.0,612.0,
TCGA-06-0192,2794,TCGA-06-0192,GBM,58.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-21243.0,Dead,WITH TUMOR,,1185.0,[Not Available],Locoregional Disease,[Not Applicable],[Not Applicable],648.0,[Not Available],,,1.0,1185.0,1.0,1185.0,,,1.0,648.0,
TCGA-2Y-A9HA,5445,TCGA-2Y-A9HA,LIHC,70.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-25892.0,Dead,WITH TUMOR,,36.0,[Not Available],,,,,[Not Available],,R0,1.0,36.0,1.0,36.0,,,1.0,36.0,
TCGA-IQ-A61H,3684,TCGA-IQ-A61H,HNSC,76.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-27990.0,Alive,TUMOR FREE,1138.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1138.0,0.0,1138.0,0.0,1138.0,0.0,1138.0,
TCGA-ET-A3BQ,10233,TCGA-ET-A3BQ,THCA,27.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-10034.0,Alive,TUMOR FREE,2331.0,,[Not Available],,,,,[Not Available],,R0,0.0,2331.0,0.0,2331.0,0.0,2331.0,0.0,2331.0,
TCGA-KL-8331,3778,TCGA-KL-8331,KICH,48.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-17710.0,Alive,TUMOR FREE,3010.0,,[Not Available],,,,,[Unknown],,,0.0,3010.0,0.0,3010.0,,,0.0,3010.0,
TCGA-91-A4BC,6226,TCGA-91-A4BC,LUAD,59.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-21565.0,Alive,,44.0,,[Not Available],,,,,[Unknown],,,0.0,44.0,0.0,44.0,,,0.0,44.0,
TCGA-EM-A4FQ,10196,TCGA-EM-A4FQ,THCA,42.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-15534.0,Alive,TUMOR FREE,683.0,,[Not Available],,,,,[Not Available],,R0,0.0,683.0,0.0,683.0,0.0,683.0,0.0,683.0,
TCGA-FD-A6TK,304,TCGA-FD-A6TK,BLCA,60.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-21942.0,Alive,TUMOR FREE,330.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,330.0,0.0,330.0,0.0,330.0,0.0,330.0,
TCGA-D7-6820,9502,TCGA-D7-6820,STAD,64.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-23486.0,Alive,TUMOR FREE,344.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,344.0,0.0,344.0,0.0,344.0,0.0,344.0,
TCGA-EO-A2CH,10929,TCGA-EO-A2CH,UCEC,73.0,FEMALE,[Not Available],[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26966.0,Dead,WITH TUMOR,,590.0,[Not Available],Metastatic,Liver,,304.0,Progressive Disease,,,1.0,590.0,1.0,590.0,,,1.0,304.0,
TCGA-BP-5169,4239,TCGA-BP-5169,KIRC,70.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-25615.0,Alive,TUMOR FREE,193.0,,[Not Available],,,,,[Not Available],,,0.0,193.0,0.0,193.0,,,0.0,193.0,
TCGA-2J-AAB1,7503,TCGA-2J-AAB1,PAAD,65.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2012.0,[Not Available],-23962.0,Dead,TUMOR FREE,,66.0,Pancreatic Cancer,,,,,Complete Remission/Response,,,1.0,66.0,1.0,66.0,0.0,66.0,0.0,66.0,
TCGA-HT-7480,5153,TCGA-HT-7480,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2005.0,[Not Available],-12291.0,Alive,WITH TUMOR,2287.0,,[Not Available],,,,1943.0,Stable Disease,,,0.0,2287.0,0.0,2287.0,,,1.0,1943.0,
TCGA-FX-A3RE,8678,TCGA-FX-A3RE,SARC,65.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-23757.0,Alive,TUMOR FREE,660.0,,[Not Available],,,,,[Not Available],[Unknown],RX,0.0,660.0,0.0,660.0,,,0.0,660.0,
TCGA-CZ-5451,4367,TCGA-CZ-5451,KIRC,74.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-27312.0,Alive,TUMOR FREE,1929.0,,[Not Available],,,,,[Not Available],,,0.0,1929.0,0.0,1929.0,,,0.0,1929.0,
TCGA-78-7149,6146,TCGA-78-7149,LUAD,71.0,MALE,WHITE,Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-26285.0,Alive,,3940.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3940.0,0.0,3940.0,0.0,3940.0,0.0,3940.0,
TCGA-DK-A1A7,183,TCGA-DK-A1A7,BLCA,67.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-24499.0,Alive,WITH TUMOR,560.0,,[Not Available],Metastatic,Lung,,112.0,[Not Available],,,0.0,560.0,0.0,560.0,,,1.0,112.0,
TCGA-AJ-A3BF,10534,TCGA-AJ-A3BF,UCEC,65.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23906.0,Alive,TUMOR FREE,551.0,,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneal LNs,384.0,Complete Remission/Response,,,0.0,551.0,0.0,551.0,1.0,384.0,1.0,384.0,
TCGA-CD-8533,9431,TCGA-CD-8533,STAD,48.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-17821.0,Alive,WITH TUMOR,468.0,,[Not Available],Distant Metastasis,"Other, specify",liver and lung,226.0,Complete Remission/Response,,,0.0,468.0,0.0,468.0,1.0,226.0,1.0,226.0,
TCGA-BT-A20N,125,TCGA-BT-A20N,BLCA,72.0,MALE,[Not Available],Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2003.0,[Not Available],-26456.0,Dead,WITH TUMOR,,795.0,[Not Available],,,,,Progressive Disease,,,1.0,795.0,1.0,795.0,,,1.0,795.0,
TCGA-F5-6812,8527,TCGA-F5-6812,READ,67.0,MALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-24490.0,Alive,TUMOR FREE,1110.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1110.0,0.0,1110.0,0.0,1110.0,0.0,1110.0,
TCGA-HT-7857,5189,TCGA-HT-7857,LGG,24.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2006.0,[Not Available],-8912.0,Alive,TUMOR FREE,7.0,,[Not Available],,,,,[Not Available],,,0.0,7.0,0.0,7.0,,,0.0,7.0,
TCGA-LN-A4MQ,2579,TCGA-LN-A4MQ,ESCA,46.0,MALE,ASIAN,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,G3,2010.0,[Not Available],-16990.0,Alive,TUMOR FREE,375.0,,[Not Available],Locoregional Recurrence,,,25.0,Complete Remission/Response,,,0.0,375.0,0.0,375.0,1.0,25.0,1.0,25.0,
TCGA-AC-A2B8,759,TCGA-AC-A2B8,BRCA,84.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31003.0,Alive,TUMOR FREE,677.0,,[Not Available],New Primary Tumor,"Other, specify",Rectum,654.0,[Not Available],Negative,,0.0,677.0,0.0,677.0,0.0,677.0,1.0,654.0,
TCGA-XR-A8TE,5788,TCGA-XR-A8TE,LIHC,16.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-5862.0,Alive,WITH TUMOR,925.0,,[Not Available],Intrahepatic Recurrence,Liver,,210.0,[Not Available],,R0,0.0,925.0,0.0,925.0,1.0,210.0,1.0,210.0,
TCGA-G5-6641,8536,TCGA-G5-6641,READ,67.0,MALE,WHITE,Stage IIIA,[Not Applicable],Rectal Mucinous Adenocarcinoma,[Not Available],2009.0,[Not Available],-24486.0,Alive,TUMOR FREE,804.0,,[Not Available],,,,,[Not Available],,,0.0,804.0,0.0,804.0,,,0.0,804.0,
TCGA-2Z-A9JE,4430,TCGA-2Z-A9JE,KIRP,59.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-21557.0,Alive,TUMOR FREE,1728.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1728.0,0.0,1728.0,0.0,1728.0,0.0,1728.0,
TCGA-55-A57B,6057,TCGA-55-A57B,LUAD,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-29452.0,Alive,TUMOR FREE,546.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,
TCGA-CN-5374,3335,TCGA-CN-5374,HNSC,56.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2007.0,[Not Available],-20464.0,Dead,TUMOR FREE,,1732.0,[Not Available],,Distant Metastasis,lung,1369.0,Complete Remission/Response,,,1.0,1732.0,0.0,1732.0,,,1.0,1369.0,
TCGA-85-8355,6730,TCGA-85-8355,LUSC,63.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-23227.0,Alive,TUMOR FREE,61.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,61.0,0.0,61.0,0.0,61.0,0.0,61.0,
TCGA-P3-A6T8,3720,TCGA-P3-A6T8,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-19754.0,Alive,TUMOR FREE,400.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,400.0,0.0,400.0,,,0.0,400.0,
TCGA-AZ-6598,2225,TCGA-AZ-6598,COAD,77.0,FEMALE,WHITE,Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2000.0,[Not Available],-28182.0,Dead,TUMOR FREE,,1503.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1503.0,0.0,1503.0,0.0,1503.0,0.0,1503.0,
TCGA-UB-A7MD,5775,TCGA-UB-A7MD,LIHC,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-24717.0,Dead,TUMOR FREE,,52.0,[Not Available],,,,,[Not Available],,R0,1.0,52.0,0.0,52.0,0.0,52.0,0.0,52.0,
TCGA-49-4501,5907,TCGA-49-4501,LUAD,67.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],1996.0,[Not Available],-24817.0,Dead,WITH TUMOR,,1421.0,[Not Available],,,,545.0,Complete Remission/Response,,,1.0,1421.0,1.0,1421.0,1.0,545.0,1.0,545.0,
TCGA-S3-A6ZG,1583,TCGA-S3-A6ZG,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Mixed Histology (please specify),[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26141.0,Alive,TUMOR FREE,562.0,,[Not Available],,,,,[Not Available],Negative,,0.0,562.0,0.0,562.0,0.0,562.0,0.0,562.0,
TCGA-E2-A108,1306,TCGA-E2-A108,BRCA,64.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23530.0,Alive,WITH TUMOR,837.0,,[Not Available],,,,,[Not Available],Negative,,0.0,837.0,0.0,837.0,0.0,837.0,0.0,837.0,
TCGA-CW-5580,4338,TCGA-CW-5580,KIRC,73.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-26696.0,Dead,,,1964.0,[Not Available],,,,,[Not Available],,,1.0,1964.0,,1964.0,,,0.0,1964.0,
TCGA-NC-A5HQ,6814,TCGA-NC-A5HQ,LUSC,70.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25781.0,Dead,,,448.0,[Not Available],,,,,Complete Remission/Response,,,1.0,448.0,,448.0,0.0,448.0,0.0,448.0,
TCGA-06-0238,2810,TCGA-06-0238,GBM,46.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-17037.0,Dead,WITH TUMOR,359.0,405.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],311.0,[Not Available],,,1.0,405.0,1.0,405.0,,,1.0,311.0,
TCGA-OL-A5D6,1552,TCGA-OL-A5D6,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26052.0,Dead,TUMOR FREE,,1104.0,[Not Available],,,,,[Not Available],Negative,,1.0,1104.0,0.0,1104.0,0.0,1104.0,0.0,1104.0,
TCGA-WE-AA9Y,9248,TCGA-WE-AA9Y,SKCM,37.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-13850.0,Alive,TUMOR FREE,370.0,,[Not Available],,,,,[Not Available],,,0.0,370.0,0.0,370.0,,,0.0,370.0,
TCGA-97-A4M6,6270,TCGA-97-A4M6,LUAD,45.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-16764.0,Alive,TUMOR FREE,568.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,568.0,0.0,568.0,0.0,568.0,0.0,568.0,
TCGA-FS-A1ZF,9155,TCGA-FS-A1ZF,SKCM,78.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2007.0,[Not Available],-28491.0,Dead,WITH TUMOR,,470.0,[Not Available],,,,,[Not Available],,,1.0,470.0,1.0,470.0,,,1.0,470.0,
TCGA-FX-A2QS,8675,TCGA-FX-A2QS,SARC,61.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2011.0,[Not Available],-22422.0,Alive,TUMOR FREE,1495.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1495.0,0.0,1495.0,0.0,1495.0,0.0,1495.0,
TCGA-CJ-6033,4337,TCGA-CJ-6033,KIRC,54.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-19919.0,Dead,WITH TUMOR,,224.0,[Not Available],,,,144.0,[Not Available],,,1.0,224.0,1.0,224.0,,,1.0,144.0,
TCGA-DD-AACP,5595,TCGA-DD-AACP,LIHC,64.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2009.0,[Not Available],-23728.0,Alive,,415.0,,[Not Available],,,,,[Not Available],,R0,0.0,415.0,0.0,415.0,0.0,415.0,0.0,415.0,
TCGA-VQ-AA6F,9704,TCGA-VQ-AA6F,STAD,57.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,[Not Available],-21170.0,Alive,TUMOR FREE,1646.0,,[Not Available],Locoregional Recurrence|New Primary Tumor,"Other, specify",,546.0,Progressive Disease,,,0.0,1646.0,0.0,1646.0,,,1.0,546.0,
TCGA-FS-A4F9,9176,TCGA-FS-A4F9,SKCM,80.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-29324.0,Alive,WITH TUMOR,1035.0,,[Not Available],Locoregional Recurrence|Distant Metastasis,[Not Available]|Brain,[Not Applicable]|[Not Applicable],376.0,[Not Available],,,0.0,1035.0,0.0,1035.0,,,1.0,376.0,
TCGA-56-7730,6518,TCGA-56-7730,LUSC,73.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26699.0,Dead,WITH TUMOR,,198.0,[Not Available],,,,,Progressive Disease,,,1.0,198.0,1.0,198.0,,,1.0,198.0,
TCGA-ZJ-AAXN,1903,TCGA-ZJ-AAXN,CESC,34.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,[Not Available],2010.0,[Unknown],-12701.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-A2-A0YG,588,TCGA-A2-A0YG,BRCA,63.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23058.0,Alive,TUMOR FREE,666.0,,[Not Available],,,,,[Not Available],Negative,,0.0,666.0,0.0,666.0,0.0,666.0,0.0,666.0,
TCGA-DJ-A3V6,9986,TCGA-DJ-A3V6,THCA,54.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-19870.0,Alive,TUMOR FREE,818.0,,[Not Available],,,,,[Not Available],,R0,0.0,818.0,0.0,818.0,0.0,818.0,0.0,818.0,
TCGA-V4-A9ED,11090,TCGA-V4-A9ED,UVM,45.0,MALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,[Not Available],2012.0,[Not Available],-16528.0,Alive,TUMOR FREE,1078.0,,[Not Available],,,,,[Not Available],,,0.0,1078.0,0.0,1078.0,,,0.0,1078.0,
TCGA-BA-A6DD,3271,TCGA-BA-A6DD,HNSC,44.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-16401.0,Dead,WITH TUMOR,,173.0,[Not Available],,Cervical Lymph Nodes,,96.0,Progressive Disease,,,1.0,173.0,1.0,173.0,,,1.0,96.0,
TCGA-3A-A9IR,7536,TCGA-3A-A9IR,PAAD,64.0,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2010.0,[Not Available],-23406.0,Alive,TUMOR FREE,1542.0,,,,,,,Complete Remission/Response,,,0.0,1542.0,0.0,1542.0,0.0,1542.0,0.0,1542.0,
TCGA-AR-A1AK,917,TCGA-AR-A1AK,BRCA,70.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25825.0,Alive,TUMOR FREE,3159.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3159.0,0.0,3159.0,0.0,3159.0,0.0,3159.0,
TCGA-FZ-5919,7570,TCGA-FZ-5919,PAAD,59.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2007.0,[Not Available],-21611.0,Dead,WITH TUMOR,,741.0,Pancreatic Cancer,Distant Metastasis,Liver,,55.0,Progressive Disease,,,1.0,741.0,1.0,741.0,,,1.0,55.0,
TCGA-AQ-A54O,896,TCGA-AQ-A54O,BRCA,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,[Not Available],-18694.0,Alive,TUMOR FREE,1001.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,
TCGA-OR-A5JT,28,TCGA-OR-A5JT,ACC,65.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-23794.0,Alive,WITH TUMOR,907.0,,[Not Available],,,,,Stable Disease,,,0.0,907.0,0.0,907.0,,,0.0,907.0,
TCGA-33-4532,6398,TCGA-33-4532,LUSC,68.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-25169.0,Dead,TUMOR FREE,,3924.0,[Not Available],,,,,Complete Remission/Response,,,1.0,3924.0,0.0,3924.0,0.0,3924.0,0.0,3924.0,
TCGA-DX-AB2O,8658,TCGA-DX-AB2O,SARC,78.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2007.0,[Not Available],-28757.0,Alive,TUMOR FREE,2619.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,2619.0,0.0,2619.0,0.0,2619.0,0.0,2619.0,
TCGA-FZ-5924,7575,TCGA-FZ-5924,PAAD,83.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2008.0,[Not Available],-30571.0,Dead,WITH TUMOR,,480.0,,,,,,Progressive Disease,,,1.0,480.0,1.0,480.0,,,1.0,480.0,
TCGA-HC-7748,8085,TCGA-HC-7748,PRAD,60.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22072.0,Alive,TUMOR FREE,792.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,792.0,0.0,792.0,0.0,792.0,0.0,792.0,
TCGA-86-8076,6193,TCGA-86-8076,LUAD,42.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-15605.0,Alive,TUMOR FREE,993.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,993.0,0.0,993.0,0.0,993.0,0.0,993.0,
TCGA-76-6286,3227,TCGA-76-6286,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-22173.0,Dead,WITH TUMOR,638.0,638.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],180.0,[Not Available],,,1.0,638.0,1.0,638.0,,,1.0,180.0,
TCGA-D1-A17T,10872,TCGA-D1-A17T,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24652.0,Alive,TUMOR FREE,71.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,71.0,0.0,71.0,0.0,71.0,0.0,71.0,
TCGA-LN-A4A8,2577,TCGA-LN-A4A8,ESCA,52.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-19046.0,Alive,TUMOR FREE,472.0,,[Not Available],Locoregional Recurrence,,,250.0,Complete Remission/Response,,,0.0,472.0,0.0,472.0,1.0,250.0,1.0,250.0,
TCGA-JY-A938,2501,TCGA-JY-A938,ESCA,75.0,MALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2012.0,[Not Available],-27633.0,Alive,WITH TUMOR,1060.0,,[Not Available],Distant Metastasis,"Other, specify",Adrenal Gland,493.0,Complete Remission/Response,,,0.0,1060.0,0.0,1060.0,1.0,493.0,1.0,493.0,
TCGA-YT-A95F,10443,TCGA-YT-A95F,THYM,55.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2012.0,[Not Available],-20363.0,Alive,TUMOR FREE,775.0,,[Not Available],,,,,[Not Available],,,0.0,775.0,0.0,775.0,,,0.0,775.0,
TCGA-CV-6953,3510,TCGA-CV-6953,HNSC,80.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1997.0,[Not Available],-29465.0,Dead,WITH TUMOR,,1641.0,[Not Available],Locoregional Recurrence,Oral Cavity,oral tongue,1521.0,Complete Remission/Response,,,1.0,1641.0,1.0,1641.0,1.0,1521.0,1.0,1521.0,
TCGA-56-A4BW,6540,TCGA-56-A4BW,LUSC,55.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-20301.0,Alive,TUMOR FREE,585.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,585.0,0.0,585.0,0.0,585.0,0.0,585.0,
TCGA-DD-AAEB,5644,TCGA-DD-AAEB,LIHC,60.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-22121.0,Alive,TUMOR FREE,478.0,,[Not Available],,,,,[Not Available],,R0,0.0,478.0,0.0,478.0,0.0,478.0,0.0,478.0,
TCGA-4Z-AA7S,104,TCGA-4Z-AA7S,BLCA,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-24111.0,Dead,TUMOR FREE,,1064.0,[Not Available],,,,,[Not Applicable],,,1.0,1064.0,0.0,1064.0,,,0.0,1064.0,
TCGA-EA-A439,1704,TCGA-EA-A439,CESC,50.0,FEMALE,ASIAN,[Not Available],Stage IIA1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18529.0,Alive,TUMOR FREE,965.0,,,Locoregional Recurrence,Cervix,,316.0,Complete Remission/Response,,,0.0,965.0,0.0,965.0,1.0,316.0,1.0,316.0,
TCGA-EJ-7318,7952,TCGA-EJ-7318,PRAD,51.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-18686.0,Alive,TUMOR FREE,1029.0,,[Not Available],Locoregional Recurrence,,,380.0,Partial Remission/Response,,,0.0,1029.0,0.0,1029.0,,,1.0,380.0,
TCGA-18-3415,6333,TCGA-18-3415,LUSC,77.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-28430.0,Dead,TUMOR FREE,,2803.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2803.0,0.0,2803.0,0.0,2803.0,0.0,2803.0,
TCGA-92-7341,6762,TCGA-92-7341,LUSC,71.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26134.0,Alive,WITH TUMOR,106.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,106.0,0.0,106.0,,,0.0,106.0,
TCGA-AZ-4615,2218,TCGA-AZ-4615,COAD,84.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-30908.0,Alive,WITH TUMOR,1002.0,,[Not Available],,,,688.0,[Not Available],,,0.0,1002.0,0.0,1002.0,,,1.0,688.0,
TCGA-FD-A3B8,262,TCGA-FD-A3B8,BLCA,56.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-20555.0,Alive,TUMOR FREE,384.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,384.0,0.0,384.0,0.0,384.0,0.0,384.0,
TCGA-44-6774,5877,TCGA-44-6774,LUAD,56.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-20462.0,Alive,TUMOR FREE,658.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,
TCGA-RY-A83X,5314,TCGA-RY-A83X,LGG,46.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-16911.0,Alive,TUMOR FREE,939.0,,[Not Available],,,,,[Not Applicable],,,0.0,939.0,0.0,939.0,,,0.0,939.0,
TCGA-VD-A8KO,11133,TCGA-VD-A8KO,UVM,51.0,MALE,[Not Evaluated],Stage IIA,Stage IIIA,Spindle Cell,[Not Available],2012.0,[Not Available],-18844.0,Alive,TUMOR FREE,795.0,,[Not Available],,,,,[Not Available],,,0.0,795.0,0.0,795.0,,,0.0,795.0,
TCGA-QR-A70G,7725,TCGA-QR-A70G,PCPG,54.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-19914.0,Alive,TUMOR FREE,71.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,71.0,0.0,71.0,0.0,71.0,0.0,71.0,
TCGA-FV-A2QR,5691,TCGA-FV-A2QR,LIHC,75.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2006.0,[Not Available],,Dead,WITH TUMOR,,581.0,[Not Available],Extrahepatic Recurrence,,,561.0,[Not Available],,RX,1.0,581.0,1.0,581.0,,,1.0,561.0,
TCGA-DR-A0ZL,1676,TCGA-DR-A0ZL,CESC,53.0,FEMALE,ASIAN,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19384.0,Alive,TUMOR FREE,2669.0,,,,,,,Complete Remission/Response,,,0.0,2669.0,0.0,2669.0,0.0,2669.0,0.0,2669.0,
TCGA-GC-A3OO,328,TCGA-GC-A3OO,BLCA,79.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-29065.0,Alive,TUMOR FREE,481.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,
TCGA-VD-A8KB,11121,TCGA-VD-A8KB,UVM,66.0,FEMALE,[Not Evaluated],Stage IIB,Stage IIB,Epithelioid Cell|Spindle Cell,[Not Available],2011.0,[Not Available],-24393.0,Alive,TUMOR FREE,1354.0,,[Not Available],Locoregional Recurrence,"Other, specify",Choroid,1032.0,[Not Available],,,0.0,1354.0,0.0,1354.0,,,1.0,1032.0,
TCGA-FV-A4ZQ,5699,TCGA-FV-A4ZQ,LIHC,52.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-19090.0,Alive,TUMOR FREE,12.0,,[Not Available],,,,,[Not Available],,R0,0.0,12.0,0.0,12.0,0.0,12.0,0.0,12.0,
TCGA-EO-A22X,10926,TCGA-EO-A22X,UCEC,36.0,FEMALE,[Not Available],[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13245.0,Alive,TUMOR FREE,1752.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1752.0,0.0,1752.0,0.0,1752.0,0.0,1752.0,
TCGA-SY-A9G0,400,TCGA-SY-A9G0,BLCA,82.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-30205.0,Dead,TUMOR FREE,,1008.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1008.0,0.0,1008.0,,,0.0,1008.0,
TCGA-BJ-A0ZG,9857,TCGA-BJ-A0ZG,THCA,80.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-29375.0,Alive,TUMOR FREE,775.0,,[Not Available],,,,,[Not Available],,RX,0.0,775.0,0.0,775.0,,,0.0,775.0,
TCGA-CQ-7072,3405,TCGA-CQ-7072,HNSC,51.0,MALE,WHITE,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2007.0,[Not Available],-18841.0,Alive,TUMOR FREE,2359.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2359.0,0.0,2359.0,,,0.0,2359.0,
TCGA-XM-A8R8,10405,TCGA-XM-A8R8,THYM,67.0,FEMALE,ASIAN,[Not Applicable],I,Thymoma; Type C,[Not Available],2010.0,[Not Available],-24508.0,Alive,TUMOR FREE,1598.0,,[Not Available],New Primary Tumor,"Other, specify",Breast,244.0,[Not Available],,,0.0,1598.0,0.0,1598.0,,,1.0,244.0,
TCGA-CZ-5988,4392,TCGA-CZ-5988,KIRC,38.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-14131.0,Alive,TUMOR FREE,693.0,,[Not Available],,,,,[Not Available],,,0.0,693.0,0.0,693.0,,,0.0,693.0,
TCGA-N6-A4VG,11043,TCGA-N6-A4VG,UCS,77.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28428.0,Alive,WITH TUMOR,1574.0,,[Not Available],Locoregional Recurrence,Lymph Node(s),,493.0,Partial Remission/Response,,,0.0,1574.0,0.0,1574.0,,,1.0,493.0,
TCGA-HU-A4GD,9572,TCGA-HU-A4GD,STAD,56.0,MALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,[Not Available],-20700.0,Alive,WITH TUMOR,692.0,,[Not Available],Distant Metastasis,Liver,,399.0,Progressive Disease,,,0.0,692.0,0.0,692.0,,,1.0,399.0,
TCGA-MA-AA41,1808,TCGA-MA-AA41,CESC,33.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12398.0,Alive,WITH TUMOR,279.0,,,,,,,Progressive Disease,,,0.0,279.0,0.0,279.0,,,0.0,279.0,
TCGA-XF-A9SV,435,TCGA-XF-A9SV,BLCA,82.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-30265.0,Dead,WITH TUMOR,,388.0,[Not Available],Distant Metastasis,Lung,,237.0,Progressive Disease,,,1.0,388.0,1.0,388.0,,,1.0,237.0,
TCGA-N7-A4Y8,11046,TCGA-N7-A4Y8,UCS,72.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26650.0,Dead,WITH TUMOR,,378.0,[Not Available],Progression of Disease,"Other, specify",Pleural effusion,187.0,Partial Remission/Response,,,1.0,378.0,1.0,378.0,,,1.0,187.0,
TCGA-GK-A6C7,4414,TCGA-GK-A6C7,KIRC,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,[Not Available],2012.0,[Not Available],-28107.0,Alive,TUMOR FREE,61.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,61.0,0.0,61.0,0.0,61.0,0.0,61.0,
TCGA-NC-A5HG,6804,TCGA-NC-A5HG,LUSC,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-21608.0,Alive,TUMOR FREE,1963.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1963.0,0.0,1963.0,0.0,1963.0,0.0,1963.0,
TCGA-56-8304,6525,TCGA-56-8304,LUSC,73.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26803.0,Alive,TUMOR FREE,106.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,106.0,0.0,106.0,0.0,106.0,0.0,106.0,
TCGA-XE-AANJ,9811,TCGA-XE-AANJ,TGCT,39.0,MALE,WHITE,IS,Stage IIIB,Seminoma; NOS,[Not Available],2007.0,[Not Available],-14314.0,Alive,TUMOR FREE,2007.0,,[Not Applicable],Locoregional Recurrence,Lymph Node(s),,328.0,"Normalization of Tumor Markers, but Residual Tumor Mass",,,0.0,2007.0,0.0,2007.0,,,1.0,328.0,
TCGA-KB-A6F5,9610,TCGA-KB-A6F5,STAD,73.0,MALE,[Not Evaluated],Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-26881.0,Alive,TUMOR FREE,169.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,169.0,0.0,169.0,0.0,169.0,0.0,169.0,
TCGA-IB-7651,7623,TCGA-IB-7651,PAAD,64.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2009.0,[Not Available],-23580.0,Dead,WITH TUMOR,,603.0,Pancreatic Cancer,Locoregional Recurrence,,,492.0,Complete Remission/Response,,,1.0,603.0,1.0,603.0,1.0,492.0,1.0,492.0,
TCGA-EB-A3XF,8947,TCGA-EB-A3XF,SKCM,57.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-20910.0,Alive,TUMOR FREE,278.0,,[Not Available],,,,,[Not Available],,,0.0,278.0,0.0,278.0,,,0.0,278.0,
TCGA-E1-5305,5069,TCGA-E1-5305,LGG,34.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2000.0,[Not Available],-12655.0,Dead,WITH TUMOR,,2433.0,[Not Available],,,,1604.0,Stable Disease,,,1.0,2433.0,1.0,2433.0,,,1.0,1604.0,
TCGA-IA-A40Y,4629,TCGA-IA-A40Y,KIRP,60.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-21996.0,Alive,TUMOR FREE,62.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,62.0,0.0,62.0,0.0,62.0,0.0,62.0,
TCGA-RG-A7D4,5770,TCGA-RG-A7D4,LIHC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-25302.0,Alive,TUMOR FREE,1098.0,,[Not Available],,,,,[Not Available],,R0,0.0,1098.0,0.0,1098.0,0.0,1098.0,0.0,1098.0,
TCGA-UZ-A9Q1,4698,TCGA-UZ-A9Q1,KIRP,88.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-32142.0,Alive,TUMOR FREE,1562.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1562.0,0.0,1562.0,0.0,1562.0,0.0,1562.0,
TCGA-DD-AACZ,5604,TCGA-DD-AACZ,LIHC,63.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2010.0,[Not Available],-23230.0,Dead,TUMOR FREE,,171.0,[Not Available],Locoregional Recurrence,Liver,,88.0,[Not Available],,R0,1.0,171.0,0.0,171.0,1.0,88.0,1.0,88.0,
TCGA-HC-A48F,8107,TCGA-HC-A48F,PRAD,47.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-17434.0,Alive,TUMOR FREE,680.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,680.0,0.0,680.0,0.0,680.0,0.0,680.0,
TCGA-IG-A6QS,2489,TCGA-IG-A6QS,ESCA,54.0,MALE,WHITE,Stage IIB,[Not Available],Esophagus Squamous Cell Carcinoma,G1,2013.0,[Not Available],-19900.0,Dead,TUMOR FREE,,303.0,[Not Available],,,,,Complete Remission/Response,,,1.0,303.0,0.0,303.0,0.0,303.0,0.0,303.0,
TCGA-HC-7737,8077,TCGA-HC-7737,PRAD,55.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-20122.0,Alive,TUMOR FREE,1090.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1090.0,0.0,1090.0,0.0,1090.0,0.0,1090.0,
TCGA-DX-A7EF,8623,TCGA-DX-A7EF,SARC,88.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2005.0,[Not Available],-32302.0,Dead,WITH TUMOR,,648.0,[Not Available],Distant Metastasis,Lung,,294.0,[Not Available],Positive,R0,1.0,648.0,1.0,648.0,1.0,294.0,1.0,294.0,
TCGA-DD-A3A6,5548,TCGA-DD-A3A6,LIHC,72.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,1997.0,[Not Available],-26319.0,Dead,TUMOR FREE,,3258.0,[Not Available],,,,,[Not Available],,R0,1.0,3258.0,0.0,3258.0,0.0,3258.0,0.0,3258.0,
TCGA-06-0644,2821,TCGA-06-0644,GBM,71.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-26247.0,Dead,WITH TUMOR,,384.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],85.0,[Not Available],,,1.0,384.0,1.0,384.0,,,1.0,85.0,
TCGA-34-5240,6429,TCGA-34-5240,LUSC,73.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-26735.0,Alive,TUMOR FREE,1541.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1541.0,0.0,1541.0,0.0,1541.0,0.0,1541.0,
TCGA-DU-A5TY,5047,TCGA-DU-A5TY,LGG,46.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-16945.0,Dead,WITH TUMOR,,1033.0,[Not Available],,,,526.0,[Discrepancy],,,1.0,1033.0,1.0,1033.0,,,1.0,526.0,
TCGA-06-A6S0,2890,TCGA-06-A6S0,GBM,79.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2011.0,[Not Available],-29037.0,Dead,WITH TUMOR,,95.0,[Not Available],,,,,Stable Disease,,,1.0,95.0,1.0,95.0,,,1.0,95.0,
TCGA-DJ-A2PS,9945,TCGA-DJ-A2PS,THCA,40.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-14916.0,Alive,TUMOR FREE,797.0,,[Not Available],,,,,[Not Available],,R0,0.0,797.0,0.0,797.0,0.0,797.0,0.0,797.0,
TCGA-2Z-A9JP,4439,TCGA-2Z-A9JP,KIRP,63.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-23207.0,Alive,TUMOR FREE,893.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,893.0,0.0,893.0,0.0,893.0,0.0,893.0,
TCGA-BQ-5891,4551,TCGA-BQ-5891,KIRP,57.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-20945.0,Alive,TUMOR FREE,29.0,,[Not Available],,,,,[Not Available],,,0.0,29.0,0.0,29.0,,,0.0,29.0,
TCGA-EE-A29E,9010,TCGA-EE-A29E,SKCM,54.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2008.0,[Not Available],-19961.0,Alive,TUMOR FREE,1940.0,,[Not Available],,,,,[Not Available],,,0.0,1940.0,0.0,1940.0,,,0.0,1940.0,
TCGA-CZ-5462,4378,TCGA-CZ-5462,KIRC,83.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-30659.0,Dead,WITH TUMOR,,311.0,[Not Available],,,,,[Not Available],,,1.0,311.0,1.0,311.0,,,1.0,311.0,
TCGA-FS-A1ZE,9154,TCGA-FS-A1ZE,SKCM,40.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-14618.0,Dead,WITH TUMOR,,1413.0,[Not Available],,,,761.0,[Not Available],,,1.0,1413.0,1.0,1413.0,,,1.0,761.0,
TCGA-VS-A9V5,1888,TCGA-VS-A9V5,CESC,50.0,FEMALE,WHITE,[Not Available],Stage IIB,Mucinous Adenocarcinoma of Endocervical Type,G2,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18577.0,Dead,WITH TUMOR,,494.0,,,,,,Progressive Disease,,,1.0,494.0,1.0,494.0,,,1.0,494.0,
TCGA-EJ-5507,7922,TCGA-EJ-5507,PRAD,54.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-19759.0,Alive,TUMOR FREE,1457.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1457.0,0.0,1457.0,0.0,1457.0,0.0,1457.0,
TCGA-AJ-A6NU,10558,TCGA-AJ-A6NU,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23498.0,Alive,TUMOR FREE,632.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,632.0,0.0,632.0,0.0,632.0,0.0,632.0,
TCGA-AO-A124,870,TCGA-AO-A124,BRCA,38.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14174.0,Alive,TUMOR FREE,3506.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3506.0,0.0,3506.0,0.0,3506.0,0.0,3506.0,
TCGA-C5-A8XK,1662,TCGA-C5-A8XK,CESC,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Cervical Squamous Cell Carcinoma,G3,2000.0,[Not Available],-11268.0,Alive,TUMOR FREE,3039.0,,,,,,,[Not Available],,,0.0,3039.0,0.0,3039.0,,,0.0,3039.0,
TCGA-VQ-A8E0,9647,TCGA-VQ-A8E0,STAD,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-24848.0,Dead,WITH TUMOR,,562.0,Stomach Cancer,Distant Metastasis,Liver,,531.0,Progressive Disease,,,1.0,562.0,1.0,562.0,,,1.0,531.0,
TCGA-GC-A3I6,327,TCGA-GC-A3I6,BLCA,45.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-16504.0,Dead,WITH TUMOR,,630.0,[Not Available],Locoregional (Urothelial tumor event),Bladder,,546.0,Progressive Disease,,,1.0,630.0,1.0,630.0,,,1.0,546.0,
TCGA-BS-A0TC,10792,TCGA-BS-A0TC,UCEC,69.0,FEMALE,ASIAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25560.0,Alive,TUMOR FREE,2602.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2602.0,0.0,2602.0,0.0,2602.0,0.0,2602.0,
TCGA-BS-A0V8,10812,TCGA-BS-A0V8,UCEC,68.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24981.0,Alive,TUMOR FREE,2544.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2544.0,0.0,2544.0,0.0,2544.0,0.0,2544.0,
TCGA-BB-4223,3280,TCGA-BB-4223,HNSC,48.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,[Not Available],-17608.0,Alive,TUMOR FREE,3221.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3221.0,0.0,3221.0,,,0.0,3221.0,
TCGA-CV-6934,3495,TCGA-CV-6934,HNSC,66.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1998.0,[Not Available],-24180.0,Dead,WITH TUMOR,,65.0,[Not Available],,,,,Complete Remission/Response,,,1.0,65.0,1.0,65.0,,,1.0,65.0,
TCGA-58-A46L,6557,TCGA-58-A46L,LUSC,73.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-26685.0,Alive,TUMOR FREE,1723.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1723.0,0.0,1723.0,0.0,1723.0,0.0,1723.0,
TCGA-CS-4938,4911,TCGA-CS-4938,LGG,31.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2005.0,[Not Available],-11509.0,Alive,WITH TUMOR,3574.0,,[Not Available],,,,,Stable Disease,,,0.0,3574.0,0.0,3574.0,,,0.0,3574.0,
TCGA-CZ-5454,4370,TCGA-CZ-5454,KIRC,63.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-23083.0,Dead,WITH TUMOR,,722.0,[Not Available],,,,423.0,[Not Available],,,1.0,722.0,1.0,722.0,,,1.0,423.0,
TCGA-DG-A2KJ,1672,TCGA-DG-A2KJ,CESC,50.0,FEMALE,[Not Evaluated],[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2006.0,[Unknown],-18453.0,Alive,TUMOR FREE,2893.0,,,,,,,Complete Remission/Response,,,0.0,2893.0,0.0,2893.0,0.0,2893.0,0.0,2893.0,
TCGA-BP-4967,4204,TCGA-BP-4967,KIRC,76.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-27857.0,Alive,TUMOR FREE,205.0,,[Not Available],,,,,[Not Available],,,0.0,205.0,0.0,205.0,,,0.0,205.0,
TCGA-KC-A7FA,8170,TCGA-KC-A7FA,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23208.0,Alive,TUMOR FREE,598.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,598.0,0.0,598.0,0.0,598.0,0.0,598.0,
TCGA-FD-A62S,294,TCGA-FD-A62S,BLCA,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-22000.0,Dead,WITH TUMOR,,406.0,[Not Available],Distant Metastasis,"Other, specify",sigmoid colon,306.0,Progressive Disease,,,1.0,406.0,1.0,406.0,,,1.0,306.0,
TCGA-CC-A7IH,5501,TCGA-CC-A7IH,LIHC,58.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-21381.0,Alive,TUMOR FREE,365.0,,[Not Available],,,,,[Not Available],,R0,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,
TCGA-D8-A145,1231,TCGA-D8-A145,BRCA,80.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29280.0,Alive,TUMOR FREE,410.0,,[Not Available],,,,,[Not Available],Negative,,0.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,
TCGA-05-4390,5810,TCGA-05-4390,LUAD,58.0,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-21430.0,Alive,TUMOR FREE,1126.0,,[Not Available],,,,395.0,Progressive Disease,,,0.0,1126.0,0.0,1126.0,,,1.0,395.0,
TCGA-RC-A7S9,5765,TCGA-RC-A7S9,LIHC,47.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-17403.0,Alive,TUMOR FREE,640.0,,[Not Available],,,,,[Not Available],,R0,0.0,640.0,0.0,640.0,0.0,640.0,0.0,640.0,
TCGA-ZP-A9CZ,5794,TCGA-ZP-A9CZ,LIHC,72.0,MALE,ASIAN,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G1,2011.0,[Not Available],-26403.0,Alive,TUMOR FREE,706.0,,[Not Available],,,,,[Not Available],,R0,0.0,706.0,0.0,706.0,0.0,706.0,0.0,706.0,
TCGA-L5-A88Z,2536,TCGA-L5-A88Z,ESCA,70.0,FEMALE,WHITE,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,GX,2005.0,[Not Available],-25890.0,Alive,TUMOR FREE,225.0,,[Not Available],,,,,[Unknown],,,0.0,225.0,0.0,225.0,,,0.0,225.0,
TCGA-VR-A8EO,2621,TCGA-VR-A8EO,ESCA,49.0,MALE,WHITE,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G3,2013.0,[Not Available],-18123.0,Alive,TUMOR FREE,785.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,785.0,0.0,785.0,0.0,785.0,0.0,785.0,
TCGA-TN-A7HL,3748,TCGA-TN-A7HL,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-21731.0,Alive,TUMOR FREE,619.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,619.0,0.0,619.0,,,0.0,619.0,
TCGA-HC-A632,8110,TCGA-HC-A632,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-24916.0,Alive,TUMOR FREE,61.0,,[Not Available],,,,,[Unknown],,,0.0,61.0,0.0,61.0,,,0.0,61.0,
TCGA-CV-6962,3517,TCGA-CV-6962,HNSC,65.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,[Not Available],-24103.0,Dead,TUMOR FREE,,126.0,[Not Available],,,,,[Not Available],,,1.0,126.0,0.0,126.0,,,0.0,126.0,
TCGA-E7-A6MF,247,TCGA-E7-A6MF,BLCA,37.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,[Not Available],-13867.0,Alive,TUMOR FREE,750.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,750.0,0.0,750.0,0.0,750.0,0.0,750.0,
TCGA-GN-A4U7,9206,TCGA-GN-A4U7,SKCM,56.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-20458.0,Dead,WITH TUMOR,,317.0,[Not Available],Distant Metastasis,Lung,,183.0,[Not Available],,,1.0,317.0,1.0,317.0,,,1.0,183.0,
TCGA-V4-A9EQ,11100,TCGA-V4-A9EQ,UVM,64.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,[Not Available],2010.0,[Not Available],-23408.0,Dead,WITH TUMOR,,455.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,,252.0,[Not Available],,,1.0,455.0,1.0,455.0,,,1.0,252.0,
TCGA-UF-A71B,3752,TCGA-UF-A71B,HNSC,50.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-18404.0,Alive,TUMOR FREE,1506.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1506.0,0.0,1506.0,,,0.0,1506.0,
TCGA-56-5897,6508,TCGA-56-5897,LUSC,74.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-27118.0,Alive,TUMOR FREE,378.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,
TCGA-44-5643,5869,TCGA-44-5643,LUAD,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-19426.0,Alive,TUMOR FREE,1013.0,,[Not Available],,,,,[Not Available],,,0.0,1013.0,0.0,1013.0,,,0.0,1013.0,
TCGA-DH-A7UR,4975,TCGA-DH-A7UR,LGG,59.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2008.0,[Not Available],-21803.0,Alive,TUMOR FREE,1650.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1650.0,0.0,1650.0,0.0,1650.0,0.0,1650.0,
TCGA-BK-A26L,10785,TCGA-BK-A26L,UCEC,71.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26002.0,Alive,TUMOR FREE,734.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,734.0,0.0,734.0,0.0,734.0,0.0,734.0,
TCGA-IM-A3U3,10314,TCGA-IM-A3U3,THCA,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2012.0,[Not Available],-20117.0,Alive,TUMOR FREE,514.0,,[Not Available],,,,,[Not Available],,RX,0.0,514.0,0.0,514.0,,,0.0,514.0,
TCGA-CR-7404,3469,TCGA-CR-7404,HNSC,53.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-19532.0,Alive,WITH TUMOR,1472.0,,[Not Available],,Oropharynx,,234.0,Complete Remission/Response,,,0.0,1472.0,0.0,1472.0,,,1.0,234.0,
TCGA-RS-A6TO,3738,TCGA-RS-A6TO,HNSC,82.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-30104.0,Dead,WITH TUMOR,,387.0,[Not Available],Locoregional Recurrence,Oral Cavity,L floor of mouth,338.0,Complete Remission/Response,,,1.0,387.0,1.0,387.0,,,1.0,338.0,
TCGA-GF-A4EO,9188,TCGA-GF-A4EO,SKCM,74.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-27114.0,Alive,TUMOR FREE,591.0,,[Not Available],,,,,[Not Available],,,0.0,591.0,0.0,591.0,,,0.0,591.0,
TCGA-DU-5854,4985,TCGA-DU-5854,LGG,57.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-21106.0,Alive,WITH TUMOR,257.0,,[Not Available],,,,202.0,Progressive Disease,,,0.0,257.0,0.0,257.0,,,1.0,202.0,
TCGA-DA-A1I5,8922,TCGA-DA-A1I5,SKCM,27.0,FEMALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2003.0,[Not Available],-10017.0,Alive,TUMOR FREE,4107.0,,[Not Available],,,,,[Not Available],,,0.0,4107.0,0.0,4107.0,,,0.0,4107.0,
TCGA-V1-A9OA,8252,TCGA-V1-A9OA,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-22630.0,Alive,,636.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,636.0,0.0,636.0,0.0,636.0,0.0,636.0,
TCGA-21-1082,6353,TCGA-21-1082,LUSC,61.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1997.0,[Not Available],-22492.0,Alive,TUMOR FREE,3644.0,,[Not Available],,,,,[Not Available],,,0.0,3644.0,0.0,3644.0,,,0.0,3644.0,
TCGA-P8-A6RX,7692,TCGA-P8-A6RX,PCPG,65.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2013.0,[Not Available],-23825.0,Alive,TUMOR FREE,540.0,,[Not Available],,,,,[Unknown],,,0.0,540.0,0.0,540.0,,,0.0,540.0,
TCGA-CH-5744,7884,TCGA-CH-5744,PRAD,64.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-23621.0,Alive,TUMOR FREE,60.0,,[Not Available],,,,,[Not Available],,,0.0,60.0,0.0,60.0,,,0.0,60.0,
TCGA-38-4632,5849,TCGA-38-4632,LUAD,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],1998.0,[Not Available],-15418.0,Dead,WITH TUMOR,,1357.0,[Not Available],,,,680.0,Complete Remission/Response,,,1.0,1357.0,1.0,1357.0,,,1.0,680.0,
TCGA-FY-A3R6,10287,TCGA-FY-A3R6,THCA,57.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-21009.0,Alive,TUMOR FREE,423.0,,[Not Available],,,,,[Not Available],,R0,0.0,423.0,0.0,423.0,,,0.0,423.0,
TCGA-OR-A5KS,48,TCGA-OR-A5KS,ACC,72.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2006.0,[Not Available],-26404.0,Alive,TUMOR FREE,2549.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2549.0,0.0,2549.0,0.0,2549.0,0.0,2549.0,
TCGA-BG-A0VX,10759,TCGA-BG-A0VX,UCEC,58.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21425.0,Alive,TUMOR FREE,1043.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1043.0,0.0,1043.0,0.0,1043.0,0.0,1043.0,
TCGA-CJ-4903,4307,TCGA-CJ-4903,KIRC,50.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-18510.0,Alive,TUMOR FREE,1560.0,,[Not Available],,,,,[Not Available],,,0.0,1560.0,0.0,1560.0,,,0.0,1560.0,
TCGA-KL-8344,3791,TCGA-KL-8344,KICH,51.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-18742.0,Alive,TUMOR FREE,876.0,,[Not Available],,,,,[Unknown],,,0.0,876.0,0.0,876.0,,,0.0,876.0,
TCGA-DD-AAEK,5650,TCGA-DD-AAEK,LIHC,51.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-18757.0,Alive,TUMOR FREE,1067.0,,[Not Available],,,,,[Not Available],,R0,0.0,1067.0,0.0,1067.0,0.0,1067.0,0.0,1067.0,
TCGA-FD-A3SS,274,TCGA-FD-A3SS,BLCA,66.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-24408.0,Dead,WITH TUMOR,,391.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",local & retroperitonium,220.0,[Unknown],,,1.0,391.0,1.0,391.0,,,1.0,220.0,
TCGA-AO-A03V,850,TCGA-AO-A03V,BRCA,41.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Peri (6-12 months since last menstrual period),-15284.0,Alive,TUMOR FREE,1351.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1351.0,0.0,1351.0,0.0,1351.0,0.0,1351.0,
TCGA-WD-A7RX,1942,TCGA-WD-A7RX,CHOL,71.0,FEMALE,WHITE,Stage II,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2013.0,[Not Available],-26006.0,Dead,TUMOR FREE,,21.0,[Not Available],,,,,[Not Available],,RX,1.0,21.0,0.0,21.0,,,0.0,21.0,
TCGA-BP-4962,4200,TCGA-BP-4962,KIRC,58.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-21255.0,Alive,TUMOR FREE,1785.0,,[Not Available],,,,,[Not Available],,,0.0,1785.0,0.0,1785.0,,,0.0,1785.0,
TCGA-DD-AAC9,5579,TCGA-DD-AAC9,LIHC,51.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-18911.0,Alive,TUMOR FREE,347.0,,[Not Available],,,,,[Not Available],,R0,0.0,347.0,0.0,347.0,0.0,347.0,0.0,347.0,
TCGA-P3-A6SW,3711,TCGA-P3-A6SW,HNSC,50.0,MALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2005.0,[Not Available],-18536.0,Alive,TUMOR FREE,1120.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1120.0,0.0,1120.0,,,0.0,1120.0,
TCGA-DJ-A4UP,10002,TCGA-DJ-A4UP,THCA,15.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-5655.0,Alive,TUMOR FREE,916.0,,[Not Available],,,,,[Not Available],,R0,0.0,916.0,0.0,916.0,0.0,916.0,0.0,916.0,
TCGA-22-5471,6382,TCGA-22-5471,LUSC,75.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-27749.0,Alive,,1845.0,,[Not Available],,,,229.0,Complete Remission/Response,,,0.0,1845.0,0.0,1845.0,1.0,229.0,1.0,229.0,
TCGA-3B-A9HV,8547,TCGA-3B-A9HV,SARC,48.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-17638.0,Dead,WITH TUMOR,,437.0,[Not Available],Distant Metastasis,Lung,,41.0,[Not Available],Negative,RX,1.0,437.0,1.0,437.0,,,1.0,41.0,
TCGA-A5-A7WK,10523,TCGA-A5-A7WK,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Mixed serous and endometrioid,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26044.0,Alive,WITH TUMOR,560.0,,[Not Available],Locoregional Recurrence,"Other, specify",Paraaortic lymph node,350.0,Complete Remission/Response,,,0.0,560.0,0.0,560.0,1.0,350.0,1.0,350.0,
TCGA-B0-4700,3973,TCGA-B0-4700,KIRC,60.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-22034.0,Dead,WITH TUMOR,,1980.0,[Not Available],,,,,[Not Available],,,1.0,1980.0,1.0,1980.0,,,1.0,1980.0,
TCGA-CG-4301,9445,TCGA-CG-4301,STAD,75.0,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,[Not Available],-27516.0,Alive,WITH TUMOR,92.0,,[Not Available],,,,,[Not Available],,,0.0,92.0,0.0,92.0,,,0.0,92.0,
TCGA-DD-AACV,5600,TCGA-DD-AACV,LIHC,53.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-19660.0,Alive,WITH TUMOR,1531.0,,[Not Available],Intrahepatic Recurrence,Liver,,344.0,[Not Available],,R0,0.0,1531.0,0.0,1531.0,1.0,344.0,1.0,344.0,
TCGA-D3-A8GK,8889,TCGA-D3-A8GK,SKCM,45.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2000.0,[Not Available],-16569.0,Alive,TUMOR FREE,5177.0,,[Not Available],Locoregional Recurrence,,,1555.0,[Not Available],,,0.0,5177.0,0.0,5177.0,,,1.0,1555.0,
TCGA-F9-A4JJ,4589,TCGA-F9-A4JJ,KIRP,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-12893.0,Dead,WITH TUMOR,,325.0,[Not Available],,,,109.0,[Unknown],,,1.0,325.0,1.0,325.0,,,1.0,109.0,
TCGA-HC-7817,8089,TCGA-HC-7817,PRAD,52.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19207.0,Alive,TUMOR FREE,928.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,
TCGA-56-7222,6513,TCGA-56-7222,LUSC,60.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-22097.0,Dead,WITH TUMOR,,562.0,[Not Available],,,,427.0,Complete Remission/Response,,,1.0,562.0,1.0,562.0,1.0,427.0,1.0,427.0,
TCGA-CJ-4637,4270,TCGA-CJ-4637,KIRC,52.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-19101.0,Dead,WITH TUMOR,,2227.0,[Not Available],,,,1821.0,[Not Available],,,1.0,2227.0,1.0,2227.0,,,1.0,1821.0,
TCGA-86-7701,6180,TCGA-86-7701,LUAD,66.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-24209.0,Alive,WITH TUMOR,947.0,,[Not Available],Distant Metastasis,,,424.0,Complete Remission/Response,,,0.0,947.0,0.0,947.0,,,1.0,424.0,
TCGA-S3-AA15,1590,TCGA-S3-AA15,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18659.0,Alive,TUMOR FREE,525.0,,[Not Available],,,,,[Not Available],Negative,,0.0,525.0,0.0,525.0,0.0,525.0,0.0,525.0,
TCGA-ZG-A9N3,8364,TCGA-ZG-A9N3,PRAD,73.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-26902.0,Alive,WITH TUMOR,349.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,349.0,0.0,349.0,,,0.0,349.0,
TCGA-42-2591,7415,TCGA-42-2591,OV,51.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,GX,2009.0,[Not Available],-18654.0,Alive,TUMOR FREE,1240.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1240.0,0.0,1240.0,0.0,1240.0,0.0,1240.0,
TCGA-OR-A5JS,27,TCGA-OR-A5JS,ACC,65.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-24017.0,Alive,WITH TUMOR,383.0,,[Not Available],Distant Metastasis,Lung,,166.0,[Not Available],,,0.0,383.0,0.0,383.0,,,1.0,166.0,
TCGA-DX-A7EN,8627,TCGA-DX-A7EN,SARC,53.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-19588.0,Alive,WITH TUMOR,923.0,,[Not Available],Distant Metastasis,Lung,,352.0,[Not Available],Positive,R0,0.0,923.0,0.0,923.0,1.0,352.0,1.0,352.0,
TCGA-EM-A2OW,10152,TCGA-EM-A2OW,THCA,37.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-13761.0,Alive,TUMOR FREE,1227.0,,[Not Available],,,,,[Not Available],,R0,0.0,1227.0,0.0,1227.0,0.0,1227.0,0.0,1227.0,
TCGA-FY-A40M,10298,TCGA-FY-A40M,THCA,51.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-18722.0,Alive,TUMOR FREE,684.0,,[Not Available],,,,,[Not Available],,R0,0.0,684.0,0.0,684.0,0.0,684.0,0.0,684.0,
TCGA-VQ-A91N,9677,TCGA-VQ-A91N,STAD,59.0,FEMALE,[Unknown],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009.0,[Not Available],-21753.0,Dead,WITH TUMOR,,570.0,Stomach Cancer,Locoregional Recurrence,,,438.0,Progressive Disease,,,1.0,570.0,1.0,570.0,,,1.0,438.0,
TCGA-AM-5820,2199,TCGA-AM-5820,COAD,59.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-21902.0,Alive,TUMOR FREE,14.0,,[Not Available],,,,,[Not Available],,,0.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-HC-7742,8081,TCGA-HC-7742,PRAD,58.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21323.0,Alive,WITH TUMOR,938.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,938.0,0.0,938.0,,,0.0,938.0,
TCGA-NA-A4R0,11066,TCGA-NA-A4R0,UCS,80.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29449.0,Dead,WITH TUMOR,,541.0,[Not Available],,,,,[Not Available],,,1.0,541.0,1.0,541.0,,,1.0,541.0,
TCGA-46-3768,6494,TCGA-46-3768,LUSC,58.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-21307.0,Dead,TUMOR FREE,4.0,299.0,[Not Available],,,,,Complete Remission/Response,,,1.0,299.0,0.0,299.0,0.0,299.0,0.0,299.0,
TCGA-CG-5727,9480,TCGA-CG-5727,STAD,66.0,MALE,[Not Available],Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,[Not Available],-24289.0,Alive,TUMOR FREE,2405.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2405.0,0.0,2405.0,0.0,2405.0,0.0,2405.0,
TCGA-CE-A485,9903,TCGA-CE-A485,THCA,32.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-11997.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],,R0,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-OL-A6VO,1571,TCGA-OL-A6VO,BRCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,[Unknown],-15780.0,Alive,TUMOR FREE,858.0,,[Not Available],,,,,[Not Available],Negative,,0.0,858.0,0.0,858.0,0.0,858.0,0.0,858.0,
TCGA-D8-A143,1230,TCGA-D8-A143,BRCA,51.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18984.0,Alive,TUMOR FREE,431.0,,[Not Available],,,,,[Not Available],Negative,,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,
TCGA-FG-A710,5134,TCGA-FG-A710,LGG,50.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-18415.0,Alive,WITH TUMOR,1115.0,,[Not Available],,,,,Stable Disease,,,0.0,1115.0,0.0,1115.0,,,0.0,1115.0,
TCGA-EK-A2PG,1723,TCGA-EK-A2PG,CESC,88.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Cervical Squamous Cell Carcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32500.0,Alive,,46.0,,,,,,,[Not Available],,,0.0,46.0,0.0,46.0,,,0.0,46.0,
TCGA-BJ-A45E,9886,TCGA-BJ-A45E,THCA,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-17115.0,Alive,TUMOR FREE,639.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,639.0,0.0,639.0,,,0.0,639.0,
TCGA-D1-A3DH,10890,TCGA-D1-A3DH,UCEC,71.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25935.0,Alive,TUMOR FREE,573.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,573.0,0.0,573.0,0.0,573.0,0.0,573.0,
TCGA-D1-A16X,10852,TCGA-D1-A16X,UCEC,54.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19799.0,Alive,TUMOR FREE,111.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,111.0,0.0,111.0,0.0,111.0,0.0,111.0,
TCGA-ER-A2NH,9120,TCGA-ER-A2NH,SKCM,49.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-18220.0,Alive,WITH TUMOR,1264.0,,[Not Available],,,,,[Not Available],,,0.0,1264.0,0.0,1264.0,,,0.0,1264.0,
TCGA-SX-A7SU,4681,TCGA-SX-A7SU,KIRP,47.0,MALE,[Not Evaluated],Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-17349.0,Alive,TUMOR FREE,1331.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1331.0,0.0,1331.0,0.0,1331.0,0.0,1331.0,
TCGA-21-5786,6358,TCGA-21-5786,LUSC,64.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-23649.0,Alive,TUMOR FREE,1032.0,,[Not Available],Locoregional Recurrence,,,817.0,Complete Remission/Response,,,0.0,1032.0,0.0,1032.0,1.0,817.0,1.0,817.0,
TCGA-2G-AAFH,9719,TCGA-2G-AAFH,TGCT,38.0,MALE,WHITE,Stage IIB,Stage IIB,Seminoma; NOS,[Not Available],2011.0,[Not Available],-14120.0,Alive,TUMOR FREE,1375.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,1375.0,0.0,1375.0,0.0,1375.0,0.0,1375.0,
TCGA-DB-A75L,4961,TCGA-DB-A75L,LGG,36.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-13338.0,Alive,TUMOR FREE,342.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,342.0,0.0,342.0,0.0,342.0,0.0,342.0,
TCGA-P3-A6T7,3719,TCGA-P3-A6T7,HNSC,55.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-20301.0,Dead,,,487.0,[Not Available],,,,,Complete Remission/Response,,,1.0,487.0,,487.0,,,0.0,487.0,
TCGA-YU-AA4L,9835,TCGA-YU-AA4L,TGCT,27.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Stage IIIC,Non-Seminoma; Embryonal Carcinoma,[Not Available],2010.0,[Not Available],-9902.0,Alive,TUMOR FREE,1573.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,105.0,[Not Available],,,0.0,1573.0,0.0,1573.0,,,1.0,105.0,
TCGA-XU-AAY0,10439,TCGA-XU-AAY0,THYM,62.0,FEMALE,ASIAN,[Not Applicable],IIa,Thymoma; Type AB,[Not Available],2010.0,[Not Available],-22645.0,Alive,TUMOR FREE,1502.0,,[Not Available],,,,,[Not Available],,,0.0,1502.0,0.0,1502.0,,,0.0,1502.0,
TCGA-DE-A3KN,9908,TCGA-DE-A3KN,THCA,49.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18098.0,Alive,TUMOR FREE,831.0,,[Not Available],,,,,[Not Available],,R0,0.0,831.0,0.0,831.0,,,0.0,831.0,
TCGA-CD-A4MG,9440,TCGA-CD-A4MG,STAD,76.0,MALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-28019.0,Dead,WITH TUMOR,,200.0,[Not Available],Locoregional Recurrence,,,74.0,Complete Remission/Response,,,1.0,200.0,1.0,200.0,1.0,74.0,1.0,74.0,
TCGA-A4-7585,4469,TCGA-A4-7585,KIRP,67.0,MALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-24778.0,Dead,TUMOR FREE,,1070.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1070.0,0.0,1070.0,0.0,1070.0,0.0,1070.0,
TCGA-LN-A49O,2562,TCGA-LN-A49O,ESCA,47.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G3,2011.0,[Not Available],-17237.0,Alive,WITH TUMOR,408.0,,[Not Available],Locoregional Recurrence,,,193.0,Complete Remission/Response,,,0.0,408.0,0.0,408.0,1.0,193.0,1.0,193.0,
TCGA-AC-A2FK,766,TCGA-AC-A2FK,BRCA,45.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006.0,[Not Available],-16627.0,Alive,TUMOR FREE,2650.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2650.0,0.0,2650.0,0.0,2650.0,0.0,2650.0,
TCGA-C5-A1MI,1625,TCGA-C5-A1MI,CESC,50.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2004.0,Peri (6-12 months since last menstrual period),-18336.0,Dead,WITH TUMOR,,1083.0,Cervical Cancer,Distant Metastasis,"Other, specify",distant recurrence multiple sites,805.0,Complete Remission/Response,,,1.0,1083.0,1.0,1083.0,1.0,805.0,1.0,805.0,
TCGA-86-8073,6190,TCGA-86-8073,LUAD,58.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-21214.0,Alive,TUMOR FREE,740.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,740.0,0.0,740.0,0.0,740.0,0.0,740.0,
TCGA-05-4397,5813,TCGA-05-4397,LUAD,65.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-23833.0,Dead,,,731.0,[Not Available],,,,,[Not Available],,,1.0,731.0,,731.0,,,0.0,731.0,
TCGA-BP-5004,4232,TCGA-BP-5004,KIRC,53.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-19383.0,Alive,TUMOR FREE,1126.0,,[Not Available],,,,,[Not Available],,,0.0,1126.0,0.0,1126.0,,,0.0,1126.0,
TCGA-69-A59K,6110,TCGA-69-A59K,LUAD,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22093.0,Alive,TUMOR FREE,591.0,,[Not Available],,,,,Stable Disease,,,0.0,591.0,0.0,591.0,,,0.0,591.0,
TCGA-HC-7211,8069,TCGA-HC-7211,PRAD,62.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-22768.0,Alive,TUMOR FREE,1221.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1221.0,0.0,1221.0,0.0,1221.0,0.0,1221.0,
TCGA-CD-5798,9414,TCGA-CD-5798,STAD,82.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2010.0,[Not Available],-30310.0,Alive,TUMOR FREE,408.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,408.0,0.0,408.0,0.0,408.0,0.0,408.0,
TCGA-DU-7292,5022,TCGA-DU-7292,LGG,69.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,1997.0,[Not Available],-25266.0,Dead,WITH TUMOR,,242.0,[Not Available],,,,91.0,Progressive Disease,,,1.0,242.0,1.0,242.0,,,1.0,91.0,
TCGA-EX-A3L1,1748,TCGA-EX-A3L1,CESC,32.0,FEMALE,WHITE,[Not Available],Stage IIA1,Cervical Squamous Cell Carcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11943.0,Alive,TUMOR FREE,463.0,,,,,,,Complete Remission/Response,,,0.0,463.0,0.0,463.0,0.0,463.0,0.0,463.0,
TCGA-EM-A2OZ,10155,TCGA-EM-A2OZ,THCA,66.0,MALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-24195.0,Alive,TUMOR FREE,1033.0,,[Not Available],,,,,[Not Available],,R0,0.0,1033.0,0.0,1033.0,0.0,1033.0,0.0,1033.0,
TCGA-EM-A3SU,10186,TCGA-EM-A3SU,THCA,43.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-15768.0,Alive,TUMOR FREE,911.0,,[Not Available],,,,,[Not Available],,R0,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,
TCGA-G4-6303,2374,TCGA-G4-6303,COAD,54.0,FEMALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-19800.0,Dead,WITH TUMOR,,2003.0,[Not Available],,,,872.0,[Not Available],,,1.0,2003.0,1.0,2003.0,,,1.0,872.0,
TCGA-G9-6379,8041,TCGA-G9-6379,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-25126.0,Alive,TUMOR FREE,1778.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1778.0,0.0,1778.0,0.0,1778.0,0.0,1778.0,
TCGA-EM-A3SZ,10189,TCGA-EM-A3SZ,THCA,42.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-15659.0,Alive,TUMOR FREE,389.0,,[Not Available],,,,,[Not Available],,R0,0.0,389.0,0.0,389.0,0.0,389.0,0.0,389.0,
TCGA-DK-A3X1,208,TCGA-DK-A3X1,BLCA,78.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-28757.0,Alive,TUMOR FREE,2009.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2009.0,0.0,2009.0,0.0,2009.0,0.0,2009.0,
TCGA-FY-A3I5,10282,TCGA-FY-A3I5,THCA,64.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-23654.0,Alive,TUMOR FREE,238.0,,[Not Available],,,,,[Not Available],,R0,0.0,238.0,0.0,238.0,0.0,238.0,0.0,238.0,
TCGA-G3-A3CG,5708,TCGA-G3-A3CG,LIHC,80.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-29432.0,Alive,WITH TUMOR,673.0,,[Not Available],Intrahepatic Recurrence,Liver,,329.0,[Not Available],,R1,0.0,673.0,0.0,673.0,,,1.0,329.0,
TCGA-C8-A27B,1218,TCGA-C8-A27B,BRCA,48.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Peri (6-12 months since last menstrual period),-17763.0,Alive,TUMOR FREE,439.0,,[Not Available],,,,,[Not Available],Negative,,0.0,439.0,0.0,439.0,0.0,439.0,0.0,439.0,
TCGA-TT-A6YJ,7815,TCGA-TT-A6YJ,PCPG,45.0,FEMALE,[Unknown],[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-16475.0,Alive,TUMOR FREE,132.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,132.0,0.0,132.0,0.0,132.0,0.0,132.0,
TCGA-ZF-AA4R,490,TCGA-ZF-AA4R,BLCA,67.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-24537.0,Dead,WITH TUMOR,,1036.0,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,750.0,[Unknown],,,1.0,1036.0,1.0,1036.0,,,1.0,750.0,
TCGA-E9-A1R0,1408,TCGA-E9-A1R0,BRCA,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21394.0,Alive,TUMOR FREE,860.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,860.0,0.0,860.0,,,0.0,860.0,
TCGA-CR-7376,3448,TCGA-CR-7376,HNSC,83.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-30670.0,Alive,TUMOR FREE,972.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,972.0,0.0,972.0,0.0,972.0,0.0,972.0,
TCGA-EE-A2GE,9032,TCGA-EE-A2GE,SKCM,44.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1999.0,[Not Available],-16353.0,Alive,TUMOR FREE,5286.0,,[Not Available],[Not Available]|[Not Available],[Not Available]|[Not Available],[Not Applicable]|[Not Applicable],5276.0,[Not Available],,,0.0,5286.0,0.0,5286.0,,,1.0,5276.0,
TCGA-HZ-A49G,7607,TCGA-HZ-A49G,PAAD,58.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-21491.0,Alive,WITH TUMOR,660.0,,,,,,,Progressive Disease,,,0.0,660.0,0.0,660.0,,,0.0,660.0,
TCGA-QK-A6II,3726,TCGA-QK-A6II,HNSC,52.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-19113.0,Dead,WITH TUMOR,,284.0,[Not Available],Locoregional Recurrence,Cervical Lymph Nodes,,176.0,Progressive Disease,,,1.0,284.0,1.0,284.0,,,1.0,176.0,
TCGA-EY-A1GM,10952,TCGA-EY-A1GM,UCEC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22010.0,Dead,WITH TUMOR,,995.0,[Not Available],Locoregional Recurrence,,,791.0,Complete Remission/Response,,,1.0,995.0,1.0,995.0,1.0,791.0,1.0,791.0,
TCGA-29-2429,7348,TCGA-29-2429,OV,79.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,[Not Available],-29156.0,Dead,WITH TUMOR,,421.0,[Not Available],,,,,[Unknown],,,1.0,421.0,1.0,421.0,,,1.0,421.0,
TCGA-GM-A2DC,1503,TCGA-GM-A2DC,BRCA,57.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21122.0,Alive,TUMOR FREE,2535.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2535.0,0.0,2535.0,0.0,2535.0,0.0,2535.0,
TCGA-US-A774,7672,TCGA-US-A774,PAAD,76.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-27957.0,Dead,WITH TUMOR,,695.0,Pancreatic Cancer,Distant Metastasis,Liver,,366.0,Progressive Disease,,,1.0,695.0,1.0,695.0,,,1.0,366.0,
TCGA-B8-4146,4093,TCGA-B8-4146,KIRC,41.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2009.0,[Not Available],-15063.0,Alive,TUMOR FREE,511.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,511.0,0.0,511.0,0.0,511.0,0.0,511.0,
TCGA-D7-A4YU,9513,TCGA-D7-A4YU,STAD,73.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-26781.0,Alive,WITH TUMOR,500.0,,[Not Available],,,,,Stable Disease,,,0.0,500.0,0.0,500.0,,,0.0,500.0,
TCGA-S9-A6WP,5346,TCGA-S9-A6WP,LGG,42.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-15658.0,Alive,WITH TUMOR,567.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,567.0,0.0,567.0,,,0.0,567.0,
TCGA-60-2712,6572,TCGA-60-2712,LUSC,79.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-29131.0,Dead,,274.0,274.0,[Not Available],,,,,Complete Remission/Response,,,1.0,274.0,,274.0,0.0,274.0,0.0,274.0,
TCGA-AC-A3W5,780,TCGA-AC-A3W5,BRCA,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,[Not Evaluated],-24029.0,Alive,TUMOR FREE,504.0,,[Not Available],,,,,[Not Available],Close,,0.0,504.0,0.0,504.0,,,0.0,504.0,
TCGA-DA-A95X,8934,TCGA-DA-A95X,SKCM,62.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2009.0,[Not Available],-22718.0,Alive,TUMOR FREE,2249.0,,[Not Available],,,,,[Not Available],,,0.0,2249.0,0.0,2249.0,,,0.0,2249.0,
TCGA-VV-A829,5413,TCGA-VV-A829,LGG,44.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-16163.0,Alive,TUMOR FREE,1127.0,,[Not Available],,,,,Stable Disease,,,0.0,1127.0,0.0,1127.0,,,0.0,1127.0,
TCGA-CI-6619,8473,TCGA-CI-6619,READ,41.0,MALE,WHITE,Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-15322.0,Alive,,184.0,,[Not Available],,,,,[Not Available],,,0.0,184.0,0.0,184.0,,,0.0,184.0,
TCGA-TS-A8AY,6892,TCGA-TS-A8AY,MESO,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2013.0,[Not Available],-17894.0,Dead,,,469.0,[Not Available],,,,,[Not Available],,[Unknown],1.0,469.0,,469.0,,,0.0,469.0,
TCGA-E2-A14P,1315,TCGA-E2-A14P,BRCA,79.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28923.0,Alive,TUMOR FREE,1246.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1246.0,0.0,1246.0,0.0,1246.0,0.0,1246.0,
TCGA-D8-A1X7,1256,TCGA-D8-A1X7,BRCA,40.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14858.0,Alive,TUMOR FREE,509.0,,[Not Available],,,,,[Not Available],Negative,,0.0,509.0,0.0,509.0,0.0,509.0,0.0,509.0,
TCGA-FB-AAQ6,7569,TCGA-FB-AAQ6,PAAD,85.0,MALE,WHITE,Stage IA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-31319.0,Dead,WITH TUMOR,,244.0,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,,213.0,Progressive Disease,,,1.0,244.0,1.0,244.0,,,1.0,213.0,
TCGA-CH-5765,7897,TCGA-CH-5765,PRAD,55.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-20364.0,Alive,TUMOR FREE,700.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,700.0,0.0,700.0,0.0,700.0,0.0,700.0,
TCGA-DD-AAEI,5649,TCGA-DD-AAEI,LIHC,72.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-26465.0,Alive,WITH TUMOR,1531.0,,[Not Available],Extrahepatic Recurrence,Bone,,491.0,[Not Available],,R0,0.0,1531.0,0.0,1531.0,1.0,491.0,1.0,491.0,
TCGA-W5-AA31,1934,TCGA-W5-AA31,CHOL,71.0,MALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2010.0,[Not Available],-26139.0,Alive,TUMOR FREE,10.0,,[Not Available],,,,,[Not Available],,R0,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,
TCGA-B5-A3FA,10725,TCGA-B5-A3FA,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26850.0,Alive,TUMOR FREE,2929.0,,[Not Available],,,,,[Not Available],,,0.0,2929.0,0.0,2929.0,,,0.0,2929.0,
TCGA-A2-A0EW,567,TCGA-A2-A0EW,BRCA,53.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19413.0,Dead,WITH TUMOR,,1884.0,[Not Available],Distant Metastasis,Bone,,1353.0,[Not Available],Positive,,1.0,1884.0,1.0,1884.0,,,1.0,1353.0,
TCGA-GU-AATQ,353,TCGA-GU-AATQ,BLCA,68.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-25185.0,Dead,WITH TUMOR,,213.0,[Not Available],,,,,Stable Disease,,,1.0,213.0,1.0,213.0,,,1.0,213.0,
TCGA-50-5066,5937,TCGA-50-5066,LUAD,72.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-26385.0,Alive,TUMOR FREE,1442.0,,[Not Available],Distant Metastasis,,,477.0,Complete Remission/Response,,,0.0,1442.0,0.0,1442.0,1.0,477.0,1.0,477.0,
TCGA-VR-A8EP,2622,TCGA-VR-A8EP,ESCA,51.0,MALE,WHITE,Stage IIIB,Stage IIB,Esophagus Squamous Cell Carcinoma,G3,2013.0,[Not Available],-18942.0,Alive,TUMOR FREE,824.0,,[Not Available],Locoregional Recurrence,,,242.0,Progressive Disease,,,0.0,824.0,0.0,824.0,,,1.0,242.0,
TCGA-V4-A9EJ,11095,TCGA-V4-A9EJ,UVM,38.0,MALE,WHITE,Stage IIB,Stage IIB,Spindle Cell,[Not Available],2012.0,[Not Available],-13958.0,Alive,TUMOR FREE,746.0,,[Not Available],,,,,[Not Available],,,0.0,746.0,0.0,746.0,,,0.0,746.0,
TCGA-CN-6011,3337,TCGA-CN-6011,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-21016.0,Alive,TUMOR FREE,933.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,933.0,0.0,933.0,,,0.0,933.0,
TCGA-B3-3925,4513,TCGA-B3-3925,KIRP,52.0,MALE,WHITE,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-19224.0,Alive,TUMOR FREE,1029.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1029.0,0.0,1029.0,0.0,1029.0,0.0,1029.0,
TCGA-QR-A70U,7737,TCGA-QR-A70U,PCPG,46.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2009.0,[Not Available],-17062.0,Alive,TUMOR FREE,1473.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1473.0,0.0,1473.0,0.0,1473.0,0.0,1473.0,
TCGA-GF-A6C8,9189,TCGA-GF-A6C8,SKCM,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-22731.0,Alive,,62.0,,[Not Available],,,,,[Not Available],,,0.0,62.0,0.0,62.0,,,0.0,62.0,
TCGA-L4-A4E6,6284,TCGA-L4-A4E6,LUAD,67.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-24631.0,Alive,TUMOR FREE,435.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,435.0,0.0,435.0,0.0,435.0,0.0,435.0,
TCGA-BR-4366,9295,TCGA-BR-4366,STAD,87.0,MALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],-32024.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-ZG-A9LY,8360,TCGA-ZG-A9LY,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-21942.0,Alive,TUMOR FREE,370.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,370.0,0.0,370.0,0.0,370.0,0.0,370.0,
TCGA-BP-4971,4208,TCGA-BP-4971,KIRC,40.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-14675.0,Alive,TUMOR FREE,1487.0,,[Not Available],,,,,[Not Available],,,0.0,1487.0,0.0,1487.0,,,0.0,1487.0,
TCGA-5S-A9Q8,10479,TCGA-5S-A9Q8,UCEC,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2013.0,[Unknown],-18785.0,Alive,,313.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,313.0,0.0,313.0,0.0,313.0,0.0,313.0,
TCGA-2H-A9GQ,2471,TCGA-2H-A9GQ,ESCA,80.0,MALE,[Unknown],Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2001.0,[Not Available],-29497.0,Dead,WITH TUMOR,,128.0,[Not Available],Locoregional Recurrence,,,112.0,,,,1.0,128.0,1.0,128.0,,,1.0,112.0,
TCGA-77-8150,6688,TCGA-77-8150,LUSC,64.0,MALE,[Not Evaluated],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-23474.0,Dead,WITH TUMOR,,1655.0,[Not Available],Locoregional Recurrence,,,1278.0,[Not Applicable],,,1.0,1655.0,1.0,1655.0,,,1.0,1278.0,
TCGA-HW-7486,5244,TCGA-HW-7486,LGG,37.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-13546.0,Alive,TUMOR FREE,1721.0,,[Not Available],,,,,Stable Disease,,,0.0,1721.0,0.0,1721.0,,,0.0,1721.0,
TCGA-D8-A73U,1300,TCGA-D8-A73U,BRCA,88.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32208.0,Alive,WITH TUMOR,492.0,,[Not Available],,,,,[Not Available],Negative,,0.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,
TCGA-ER-A42H,9125,TCGA-ER-A42H,SKCM,76.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2010.0,[Not Available],-28110.0,Dead,WITH TUMOR,,426.0,[Not Available],,,,259.0,[Not Available],,,1.0,426.0,1.0,426.0,,,1.0,259.0,
TCGA-EB-A5VU,8981,TCGA-EB-A5VU,SKCM,56.0,MALE,ASIAN,Stage IIIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-20610.0,Dead,WITH TUMOR,,321.0,[Not Available],Locoregional Recurrence,,,217.0,[Not Available],,,1.0,321.0,1.0,321.0,,,1.0,217.0,
TCGA-77-A5G6,6695,TCGA-77-A5G6,LUSC,66.0,MALE,[Not Evaluated],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-24215.0,Dead,WITH TUMOR,,678.0,[Not Available],Locoregional Recurrence,,,392.0,Complete Remission/Response,,,1.0,678.0,1.0,678.0,1.0,392.0,1.0,392.0,
TCGA-S9-A6U9,5334,TCGA-S9-A6U9,LGG,36.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2006.0,[Not Available],-13460.0,Alive,WITH TUMOR,2918.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,2918.0,0.0,2918.0,,,0.0,2918.0,
TCGA-2Y-A9H8,5443,TCGA-2Y-A9H8,LIHC,85.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-31322.0,Dead,WITH TUMOR,,633.0,[Not Available],Extrahepatic Recurrence,"Other, specify",Kidney,398.0,[Not Available],,R0,1.0,633.0,1.0,633.0,1.0,398.0,1.0,398.0,
TCGA-OL-A66L,1567,TCGA-OL-A66L,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26186.0,Alive,TUMOR FREE,1301.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0,
TCGA-SX-A71S,4669,TCGA-SX-A71S,KIRP,66.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-24211.0,Alive,TUMOR FREE,1504.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1504.0,0.0,1504.0,0.0,1504.0,0.0,1504.0,
TCGA-D8-A1JL,1247,TCGA-D8-A1JL,BRCA,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26484.0,Alive,TUMOR FREE,611.0,,[Not Available],,,,,[Not Available],Negative,,0.0,611.0,0.0,611.0,0.0,611.0,0.0,611.0,
TCGA-AN-A0XO,834,TCGA-AN-A0XO,BRCA,59.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21640.0,Alive,TUMOR FREE,375.0,,[Not Available],,,,,[Not Available],Negative,,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,
TCGA-GF-A3OT,9187,TCGA-GF-A3OT,SKCM,58.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-21359.0,Alive,WITH TUMOR,301.0,,[Not Available],Distant Metastasis,Lung,,248.0,[Not Available],,,0.0,301.0,0.0,301.0,,,1.0,248.0,
TCGA-55-6972,5979,TCGA-55-6972,LUAD,72.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-26625.0,Dead,TUMOR FREE,,1632.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1632.0,0.0,1632.0,0.0,1632.0,0.0,1632.0,
TCGA-WB-A80O,7834,TCGA-WB-A80O,PCPG,83.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-30555.0,Alive,TUMOR FREE,776.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,776.0,0.0,776.0,0.0,776.0,0.0,776.0,
TCGA-66-2786,6637,TCGA-66-2786,LUSC,68.0,FEMALE,[Not Available],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-25051.0,Alive,TUMOR FREE,790.0,,[Not Available],,,,,[Not Applicable],,,0.0,790.0,0.0,790.0,,,0.0,790.0,
TCGA-KC-A7FE,8172,TCGA-KC-A7FE,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22718.0,Alive,TUMOR FREE,352.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,
TCGA-WB-A81J,7852,TCGA-WB-A81J,PCPG,40.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-14665.0,Alive,TUMOR FREE,741.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,741.0,0.0,741.0,0.0,741.0,0.0,741.0,
TCGA-E3-A3E3,10019,TCGA-E3-A3E3,THCA,49.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-18140.0,Alive,TUMOR FREE,1595.0,,[Not Available],Distant Metastasis,Lymph Node Only,,445.0,[Not Available],,R0,0.0,1595.0,0.0,1595.0,1.0,445.0,1.0,445.0,
TCGA-A7-A6VW,668,TCGA-A7-A6VW,BRCA,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17539.0,Alive,TUMOR FREE,285.0,,[Not Available],,,,,[Not Available],Close,,0.0,285.0,0.0,285.0,,,0.0,285.0,
TCGA-ZQ-A9CR,9710,TCGA-ZQ-A9CR,STAD,79.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013.0,[Not Available],-29107.0,Dead,,,24.0,[Unknown],,,,,[Unknown],,,1.0,24.0,,24.0,,,0.0,24.0,
TCGA-G3-A6UC,5718,TCGA-G3-A6UC,LIHC,65.0,MALE,WHITE,Stage IIIB,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-23793.0,Alive,WITH TUMOR,671.0,,[Not Available],Intrahepatic Recurrence,Liver,,639.0,[Not Available],,R0,0.0,671.0,0.0,671.0,1.0,639.0,1.0,639.0,
TCGA-L5-A4ON,2521,TCGA-L5-A4ON,ESCA,65.0,MALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2010.0,[Not Available],-23970.0,Dead,TUMOR FREE,,558.0,[Not Available],,,,,Complete Remission/Response,,,1.0,558.0,0.0,558.0,0.0,558.0,0.0,558.0,
TCGA-A5-A1OK,10514,TCGA-A5-A1OK,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23179.0,Alive,TUMOR FREE,917.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,917.0,0.0,917.0,0.0,917.0,0.0,917.0,
TCGA-GV-A3JV,354,TCGA-GV-A3JV,BLCA,66.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-24243.0,Dead,WITH TUMOR,,434.0,[Not Available],Locoregional (Urothelial tumor event),Bladder,,134.0,Partial Remission/Response,,,1.0,434.0,1.0,434.0,,,1.0,134.0,
TCGA-UZ-A9PV,4694,TCGA-UZ-A9PV,KIRP,65.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-23741.0,Alive,TUMOR FREE,1444.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1444.0,0.0,1444.0,0.0,1444.0,0.0,1444.0,
TCGA-32-2632,3182,TCGA-32-2632,GBM,80.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-29281.0,Dead,WITH TUMOR,,269.0,[Not Available],,,,,Progressive Disease,,,1.0,269.0,1.0,269.0,,,1.0,269.0,
TCGA-DX-AB2W,8664,TCGA-DX-AB2W,SARC,62.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2006.0,[Not Available],-22951.0,Alive,TUMOR FREE,3238.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,3238.0,0.0,3238.0,0.0,3238.0,0.0,3238.0,
TCGA-S9-A7R2,5362,TCGA-S9-A7R2,LGG,69.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-25419.0,Dead,WITH TUMOR,,316.0,[Not Available],,,,,Progressive Disease,,,1.0,316.0,1.0,316.0,,,1.0,316.0,
TCGA-66-2777,6630,TCGA-66-2777,LUSC,71.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-26085.0,Alive,TUMOR FREE,61.0,,[Not Available],,,,,[Not Available],,,0.0,61.0,0.0,61.0,,,0.0,61.0,
TCGA-CA-6717,2241,TCGA-CA-6717,COAD,57.0,MALE,ASIAN,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-20984.0,Alive,TUMOR FREE,388.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,388.0,0.0,388.0,0.0,388.0,0.0,388.0,
TCGA-E2-A570,1387,TCGA-E2-A570,BRCA,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17456.0,Alive,TUMOR FREE,931.0,,[Not Available],,,,,[Not Available],Negative,,0.0,931.0,0.0,931.0,0.0,931.0,0.0,931.0,
TCGA-HT-7605,5162,TCGA-HT-7605,LGG,38.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2008.0,[Not Available],-13892.0,Alive,,139.0,,[Not Available],,,,,[Not Available],,,0.0,139.0,0.0,139.0,,,0.0,139.0,
TCGA-06-0132,2748,TCGA-06-0132,GBM,49.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-18125.0,Dead,WITH TUMOR,570.0,771.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],482.0,[Not Available],,,1.0,771.0,1.0,771.0,,,1.0,482.0,
TCGA-SX-A7SR,4679,TCGA-SX-A7SR,KIRP,66.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-24237.0,Alive,TUMOR FREE,805.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,805.0,0.0,805.0,0.0,805.0,0.0,805.0,
TCGA-MT-A67D,3699,TCGA-MT-A67D,HNSC,55.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-20386.0,Alive,,56.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,56.0,0.0,56.0,0.0,56.0,0.0,56.0,
TCGA-HT-8106,5211,TCGA-HT-8106,LGG,53.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-19555.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,Stable Disease,,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-V3-A9ZY,11083,TCGA-V3-A9ZY,UVM,54.0,MALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell,[Not Available],2013.0,[Not Available],-19894.0,Alive,TUMOR FREE,459.0,,[Not Available],,,,,[Not Available],,,0.0,459.0,0.0,459.0,,,0.0,459.0,
TCGA-VD-AA8Q,11138,TCGA-VD-AA8Q,UVM,71.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell,[Not Available],2013.0,[Not Available],-26285.0,Dead,TUMOR FREE,,636.0,Metastatic Uveal Melanoma,,,,,[Not Available],,,1.0,636.0,1.0,636.0,,,0.0,636.0,
TCGA-34-8454,6435,TCGA-34-8454,LUSC,62.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-22913.0,Alive,TUMOR FREE,1180.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1180.0,0.0,1180.0,0.0,1180.0,0.0,1180.0,
TCGA-L5-A88V,2533,TCGA-L5-A88V,ESCA,60.0,MALE,WHITE,Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2007.0,[Not Available],-22066.0,Alive,TUMOR FREE,79.0,,[Not Available],,,,,[Unknown],,,0.0,79.0,0.0,79.0,,,0.0,79.0,
TCGA-E2-A156,1331,TCGA-E2-A156,BRCA,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22422.0,Alive,TUMOR FREE,726.0,,[Not Available],,,,,[Not Available],Negative,,0.0,726.0,0.0,726.0,0.0,726.0,0.0,726.0,
TCGA-NJ-A4YI,6316,TCGA-NJ-A4YI,LUAD,87.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-31867.0,Dead,,,4.0,[Not Available],,,,,[Unknown],,,1.0,4.0,,4.0,,,0.0,4.0,
TCGA-BH-A0B8,1038,TCGA-BH-A0B8,BRCA,64.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23380.0,Alive,TUMOR FREE,1569.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1569.0,0.0,1569.0,0.0,1569.0,0.0,1569.0,
TCGA-PK-A5H8,88,TCGA-PK-A5H8,ACC,42.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2004.0,[Not Available],-15373.0,Alive,TUMOR FREE,3623.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3623.0,0.0,3623.0,0.0,3623.0,0.0,3623.0,
TCGA-56-A4ZK,6544,TCGA-56-A4ZK,LUSC,76.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-28039.0,Alive,TUMOR FREE,570.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,570.0,0.0,570.0,0.0,570.0,0.0,570.0,
TCGA-B0-5080,4017,TCGA-B0-5080,KIRC,63.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-23052.0,Dead,WITH TUMOR,,342.0,[Not Available],,,,103.0,[Not Available],,,1.0,342.0,1.0,342.0,,,1.0,103.0,
TCGA-HF-7133,9552,TCGA-HF-7133,STAD,,FEMALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2007.0,[Not Available],,Alive,TUMOR FREE,1918.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1918.0,0.0,1918.0,,,0.0,1918.0,
TCGA-YU-A94D,9833,TCGA-YU-A94D,TGCT,28.0,MALE,[Unknown],Stage IIIB,Stage IIIB,Non-Seminoma; Teratoma (Immature),[Not Available],2009.0,[Not Available],-10427.0,Alive,TUMOR FREE,2167.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,2167.0,0.0,2167.0,0.0,2167.0,0.0,2167.0,
TCGA-AC-A7VC,798,TCGA-AC-A7VC,BRCA,56.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Metaplastic Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20479.0,Alive,TUMOR FREE,1.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,
TCGA-EE-A2A6,9028,TCGA-EE-A2A6,SKCM,43.0,MALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2006.0,[Not Available],-15953.0,Alive,TUMOR FREE,2620.0,,[Not Available],New primary melanoma,,,1505.0,[Not Available],,,0.0,2620.0,0.0,2620.0,,,1.0,1505.0,
TCGA-OR-A5LM,76,TCGA-OR-A5LM,ACC,23.0,MALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-8735.0,Alive,TUMOR FREE,1858.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1858.0,0.0,1858.0,0.0,1858.0,0.0,1858.0,
TCGA-D3-A51G,8869,TCGA-D3-A51G,SKCM,,MALE,WHITE,Stage 0,[Not Applicable],,[Not Available],1990.0,[Not Available],,Alive,TUMOR FREE,,,[Not Available],,,,,[Not Available],,,,,,,,,,,
TCGA-3X-AAV9,1909,TCGA-3X-AAV9,CHOL,72.0,MALE,ASIAN,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2010.0,[Not Available],-26349.0,Dead,WITH TUMOR,,339.0,[Not Available],Locoregional Recurrence,Liver,,216.0,[Not Available],,R0,1.0,339.0,1.0,339.0,1.0,216.0,1.0,216.0,
TCGA-13-2061,7107,TCGA-13-2061,OV,58.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-21543.0,Alive,TUMOR FREE,2339.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2339.0,0.0,2339.0,0.0,2339.0,0.0,2339.0,
TCGA-CZ-5463,4379,TCGA-CZ-5463,KIRC,76.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-27911.0,Alive,,662.0,,[Not Available],,,,,[Not Available],,,0.0,662.0,0.0,662.0,,,0.0,662.0,
TCGA-09-2044,6980,TCGA-09-2044,OV,77.0,FEMALE,ASIAN,[Not Applicable],Stage IIB,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-28231.0,Alive,TUMOR FREE,186.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,186.0,0.0,186.0,0.0,186.0,0.0,186.0,
TCGA-BH-A1FN,1153,TCGA-BH-A1FN,BRCA,34.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1997.0,[Not Available],-12525.0,Dead,WITH TUMOR,,2192.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,2192.0,1.0,2192.0,,,1.0,2192.0,
TCGA-D8-A140,1227,TCGA-D8-A140,BRCA,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22900.0,Alive,TUMOR FREE,403.0,,[Not Available],,,,,[Not Available],Negative,,0.0,403.0,0.0,403.0,0.0,403.0,0.0,403.0,
TCGA-CC-A5UD,5496,TCGA-CC-A5UD,LIHC,45.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-16702.0,Dead,WITH TUMOR,,304.0,[Not Available],Locoregional Recurrence,,,182.0,[Not Available],,R0,1.0,304.0,1.0,304.0,1.0,182.0,1.0,182.0,
TCGA-QK-A8Z9,3733,TCGA-QK-A8Z9,HNSC,56.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-20471.0,Dead,WITH TUMOR,,449.0,[Not Available],Distant Metastasis,Distant Metastasis,esophagus,205.0,Complete Remission/Response,,,1.0,449.0,1.0,449.0,,,1.0,205.0,
TCGA-C4-A0F1,147,TCGA-C4-A0F1,BLCA,71.0,MALE,[Not Available],Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-26178.0,Alive,TUMOR FREE,89.0,,[Not Available],,,,,[Not Available],,,0.0,89.0,0.0,89.0,,,0.0,89.0,Redacted
TCGA-G9-6351,8024,TCGA-G9-6351,PRAD,51.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-18723.0,Alive,TUMOR FREE,2048.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2048.0,0.0,2048.0,0.0,2048.0,0.0,2048.0,
TCGA-B0-5100,4030,TCGA-B0-5100,KIRC,72.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,1998.0,[Not Available],-26478.0,Dead,WITH TUMOR,,1913.0,[Not Available],,,,1426.0,[Not Available],,,1.0,1913.0,1.0,1913.0,,,1.0,1426.0,
TCGA-AP-A1E1,10602,TCGA-AP-A1E1,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27072.0,Alive,TUMOR FREE,1395.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1395.0,0.0,1395.0,0.0,1395.0,0.0,1395.0,
TCGA-MU-A5YI,1812,TCGA-MU-A5YI,CESC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IA1,Cervical Squamous Cell Carcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21927.0,Alive,WITH TUMOR,1053.0,,,Distant Metastasis,"Other, specify",Thoracic Spine,630.0,[Not Available],,,0.0,1053.0,0.0,1053.0,,,1.0,630.0,
TCGA-LN-A5U6,2582,TCGA-LN-A5U6,ESCA,54.0,MALE,ASIAN,Stage IIB,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-19840.0,Alive,TUMOR FREE,375.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,
TCGA-CN-5359,3324,TCGA-CN-5359,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-21858.0,Dead,WITH TUMOR,,377.0,[Not Available],,Distant Metastasis,"LUNG, BONES, THUMB",356.0,Complete Remission/Response,,,1.0,377.0,1.0,377.0,,,1.0,356.0,
TCGA-FD-A5BX,286,TCGA-FD-A5BX,BLCA,82.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-30276.0,Dead,WITH TUMOR,,173.0,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,99.0,Progressive Disease,,,1.0,173.0,1.0,173.0,,,1.0,99.0,
TCGA-EE-A2MH,9055,TCGA-EE-A2MH,SKCM,66.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2001.0,[Not Available],-24125.0,Dead,WITH TUMOR,,516.0,[Not Available],Distant Metastasis,Bone,,440.0,[Not Available],,,1.0,516.0,1.0,516.0,,,1.0,440.0,
TCGA-B9-4115,4521,TCGA-B9-4115,KIRP,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-19571.0,Alive,TUMOR FREE,803.0,,[Not Available],,,,,[Not Available],,,0.0,803.0,0.0,803.0,,,0.0,803.0,
TCGA-N5-A4RS,11032,TCGA-N5-A4RS,UCS,65.0,FEMALE,WHITE,[Not Applicable],Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23893.0,Dead,WITH TUMOR,,911.0,[Not Available],Distant Metastasis,Lung,,427.0,Complete Remission/Response,,,1.0,911.0,1.0,911.0,1.0,427.0,1.0,427.0,
TCGA-OR-A5K9,43,TCGA-OR-A5K9,ACC,61.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2002.0,[Not Available],-22596.0,Dead,WITH TUMOR,,344.0,[Not Available],Locoregional Recurrence,Peritoneal Surfaces,,236.0,[Not Available],,,1.0,344.0,1.0,344.0,,,1.0,236.0,
TCGA-BF-A3DJ,8806,TCGA-BF-A3DJ,SKCM,36.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2011.0,[Not Available],-13332.0,Alive,TUMOR FREE,464.0,,[Not Available],Distant Metastasis,Liver,,217.0,[Not Available],,,0.0,464.0,0.0,464.0,,,1.0,217.0,
TCGA-VS-A8EJ,1841,TCGA-VS-A8EJ,CESC,60.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22000.0,Dead,WITH TUMOR,,607.0,Cervical Cancer,,,,,Progressive Disease,,,1.0,607.0,1.0,607.0,,,1.0,607.0,
TCGA-GC-A3RC,330,TCGA-GC-A3RC,BLCA,59.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-21668.0,Alive,TUMOR FREE,484.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,484.0,0.0,484.0,0.0,484.0,0.0,484.0,
TCGA-AJ-A2QM,10530,TCGA-AJ-A2QM,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24776.0,Alive,TUMOR FREE,894.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,894.0,0.0,894.0,0.0,894.0,0.0,894.0,
TCGA-78-7540,6166,TCGA-78-7540,LUAD,66.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],1999.0,[Not Available],-24440.0,Dead,,,1197.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1197.0,,1197.0,0.0,1197.0,0.0,1197.0,
TCGA-FG-8191,5120,TCGA-FG-8191,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-11252.0,Alive,WITH TUMOR,992.0,,[Not Available],,,,,Stable Disease,,,0.0,992.0,0.0,992.0,,,0.0,992.0,
TCGA-G4-6299,2372,TCGA-G4-6299,COAD,69.0,MALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-25318.0,Alive,TUMOR FREE,2268.0,,[Not Available],,,,,[Not Available],,,0.0,2268.0,0.0,2268.0,,,0.0,2268.0,
TCGA-76-4935,3219,TCGA-76-4935,GBM,52.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-19231.0,Dead,TUMOR FREE,,1121.0,[Not Available],,,,,[Unknown],,,1.0,1121.0,0.0,1121.0,,,0.0,1121.0,
TCGA-60-2725,6583,TCGA-60-2725,LUSC,74.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-27073.0,Alive,TUMOR FREE,816.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,816.0,0.0,816.0,0.0,816.0,0.0,816.0,
TCGA-DJ-A13U,9925,TCGA-DJ-A13U,THCA,60.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-22130.0,Alive,TUMOR FREE,1590.0,,[Not Available],,,,,[Not Available],,R0,0.0,1590.0,0.0,1590.0,0.0,1590.0,0.0,1590.0,
TCGA-DJ-A3UT,9974,TCGA-DJ-A3UT,THCA,43.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-15767.0,Alive,TUMOR FREE,1105.0,,[Not Available],,,,,[Not Available],,R0,0.0,1105.0,0.0,1105.0,0.0,1105.0,0.0,1105.0,
TCGA-OL-A97C,1574,TCGA-OL-A97C,BRCA,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24735.0,Alive,TUMOR FREE,271.0,,[Not Available],Distant Metastasis,Lung,,275.0,[Not Available],[Not Available],,0.0,271.0,0.0,271.0,,,1.0,275.0,
TCGA-HT-7693,5183,TCGA-HT-7693,LGG,51.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2008.0,[Not Available],-18956.0,Alive,TUMOR FREE,533.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,533.0,0.0,533.0,,,0.0,533.0,
TCGA-CJ-4918,4315,TCGA-CJ-4918,KIRC,64.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2005.0,[Not Available],-23379.0,Dead,WITH TUMOR,,93.0,[Not Available],,,,33.0,[Not Available],,,1.0,93.0,1.0,93.0,,,1.0,33.0,
TCGA-EO-A22R,10922,TCGA-EO-A22R,UCEC,56.0,FEMALE,[Not Available],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20604.0,Alive,TUMOR FREE,1878.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1878.0,0.0,1878.0,0.0,1878.0,0.0,1878.0,
TCGA-3B-A9HZ,8550,TCGA-3B-A9HZ,SARC,66.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-24433.0,Alive,WITH TUMOR,1170.0,,[Not Available],Distant Metastasis,Lung,,309.0,[Not Available],Positive,R1,0.0,1170.0,0.0,1170.0,,,1.0,309.0,
TCGA-FP-7998,9540,TCGA-FP-7998,STAD,77.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-28302.0,Alive,TUMOR FREE,678.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,678.0,0.0,678.0,0.0,678.0,0.0,678.0,
TCGA-RP-A695,9224,TCGA-RP-A695,SKCM,,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],1999.0,[Not Available],,Alive,TUMOR FREE,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-E2-A15R,1348,TCGA-E2-A15R,BRCA,64.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23570.0,Alive,TUMOR FREE,1732.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1732.0,0.0,1732.0,0.0,1732.0,0.0,1732.0,
TCGA-W5-AA2X,1931,TCGA-W5-AA2X,CHOL,67.0,MALE,WHITE,Stage IVB,[Not Applicable],Cholangiocarcinoma; hilar/perihilar,G4,2010.0,[Not Available],-24797.0,Dead,,,271.0,[Not Available],,,,,[Not Available],,RX,1.0,271.0,,271.0,,,0.0,271.0,
TCGA-FD-A3SJ,266,TCGA-FD-A3SJ,BLCA,59.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-21615.0,Dead,WITH TUMOR,,739.0,[Not Available],Distant Metastasis,Lymph Node Only,,281.0,[Not Applicable],,,1.0,739.0,1.0,739.0,,,1.0,281.0,
TCGA-28-2513,3151,TCGA-28-2513,GBM,69.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-25421.0,Alive,WITH TUMOR,222.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],75.0,[Not Available],,,0.0,222.0,0.0,222.0,,,1.0,75.0,
TCGA-D6-8569,3619,TCGA-D6-8569,HNSC,52.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-19212.0,Alive,TUMOR FREE,770.0,,[Not Available],,,,,Stable Disease,,,0.0,770.0,0.0,770.0,,,0.0,770.0,
TCGA-CG-4477,9468,TCGA-CG-4477,STAD,58.0,FEMALE,[Not Available],Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-21427.0,Alive,WITH TUMOR,942.0,,[Not Available],,,,365.0,Progressive Disease,,,0.0,942.0,0.0,942.0,,,1.0,365.0,
TCGA-2G-AAHA,9760,TCGA-2G-AAHA,TGCT,48.0,MALE,WHITE,Stage IB,Stage IIA,Seminoma; NOS,[Not Available],2005.0,[Not Available],-17658.0,Alive,TUMOR FREE,3349.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,3349.0,0.0,3349.0,,,0.0,3349.0,
TCGA-C8-A12U,1184,TCGA-C8-A12U,BRCA,46.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17045.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],Negative,,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-LN-A49U,2566,TCGA-LN-A49U,ESCA,62.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G1,2011.0,[Not Available],-22969.0,Alive,TUMOR FREE,467.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,467.0,0.0,467.0,0.0,467.0,0.0,467.0,
TCGA-66-2785,6636,TCGA-66-2785,LUSC,65.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-23772.0,Alive,TUMOR FREE,60.0,,[Not Available],,,,,[Not Available],,,0.0,60.0,0.0,60.0,,,0.0,60.0,
TCGA-XU-A92Z,10428,TCGA-XU-A92Z,THYM,76.0,MALE,ASIAN,[Not Applicable],III,Thymoma; Type C,[Not Available],2004.0,[Not Available],-28117.0,Alive,TUMOR FREE,3663.0,,[Not Available],,,,,[Not Available],,,0.0,3663.0,0.0,3663.0,,,0.0,3663.0,
TCGA-D7-8578,9510,TCGA-D7-8578,STAD,72.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-26620.0,Alive,WITH TUMOR,643.0,,[Not Available],Locoregional Recurrence|Distant Metastasis,Lung,,451.0,Complete Remission/Response,,,0.0,643.0,0.0,643.0,1.0,451.0,1.0,451.0,
TCGA-EB-A44P,8958,TCGA-EB-A44P,SKCM,58.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-21519.0,Alive,TUMOR FREE,741.0,,[Not Available],,,,,[Not Available],,,0.0,741.0,0.0,741.0,,,0.0,741.0,
TCGA-23-2643,7157,TCGA-23-2643,OV,74.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-27093.0,Alive,TUMOR FREE,143.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,143.0,0.0,143.0,0.0,143.0,0.0,143.0,
TCGA-49-AAQV,5920,TCGA-49-AAQV,LUAD,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-23370.0,Dead,TUMOR FREE,,677.0,[Not Available],Distant Metastasis,,,509.0,Complete Remission/Response,,,1.0,677.0,0.0,677.0,1.0,509.0,1.0,509.0,
TCGA-DX-A1L0,8560,TCGA-DX-A1L0,SARC,58.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2008.0,[Not Available],-21434.0,Dead,WITH TUMOR,,564.0,[Not Available],Locoregional Recurrence,,,103.0,[Not Available],[Not Available],R1,1.0,564.0,1.0,564.0,,,1.0,103.0,
TCGA-CI-6621,8475,TCGA-CI-6621,READ,63.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-23240.0,Alive,,419.0,,[Not Available],,,,,[Unknown],,,0.0,419.0,0.0,419.0,,,0.0,419.0,
TCGA-Q1-A5R1,1819,TCGA-Q1-A5R1,CESC,32.0,FEMALE,WHITE,[Not Available],Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11705.0,Alive,TUMOR FREE,474.0,,,,,,,Complete Remission/Response,,,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,
TCGA-QR-A7IP,7742,TCGA-QR-A7IP,PCPG,30.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2012.0,[Not Available],-11051.0,Alive,TUMOR FREE,546.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,
TCGA-CV-7103,3527,TCGA-CV-7103,HNSC,49.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2000.0,[Not Available],-18219.0,Dead,WITH TUMOR,,1591.0,[Not Available],,,,,[Not Available],,,1.0,1591.0,1.0,1591.0,,,1.0,1591.0,
TCGA-ZS-A9CD,5799,TCGA-ZS-A9CD,LIHC,73.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-26915.0,Dead,,,1386.0,[Not Available],Intrahepatic Recurrence,Liver,,371.0,[Not Available],,R0,1.0,1386.0,,1386.0,1.0,371.0,1.0,371.0,
TCGA-93-A4JN,6231,TCGA-93-A4JN,LUAD,71.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-26273.0,Alive,WITH TUMOR,718.0,,[Not Available],,,,,Stable Disease,,,0.0,718.0,0.0,718.0,,,0.0,718.0,
TCGA-EW-A1P1,1470,TCGA-EW-A1P1,BRCA,68.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24923.0,Alive,TUMOR FREE,1210.0,,[Not Available],Distant Metastasis,Lung,,1014.0,[Not Available],Negative,,0.0,1210.0,0.0,1210.0,1.0,1014.0,1.0,1014.0,
TCGA-HT-7687,5177,TCGA-HT-7687,LGG,74.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2010.0,[Not Available],-27186.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,Stable Disease,,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-DD-A119,5519,TCGA-DD-A119,LIHC,40.0,MALE,ASIAN,Stage IV,[Not Applicable],Hepatocellular Carcinoma,G3,2003.0,[Not Available],-14613.0,Dead,,,223.0,[Not Available],,,,,[Not Available],,R2,1.0,223.0,,223.0,,,0.0,223.0,
TCGA-EJ-5516,7930,TCGA-EJ-5516,PRAD,49.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-17980.0,Alive,TUMOR FREE,1889.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1889.0,0.0,1889.0,0.0,1889.0,0.0,1889.0,
TCGA-4W-AA9R,3202,TCGA-4W-AA9R,GBM,61.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2012.0,[Not Available],-22317.0,Alive,TUMOR FREE,124.0,,[Not Available],,,,,Progressive Disease,,,0.0,124.0,0.0,124.0,,,0.0,124.0,
TCGA-04-1644,6952,TCGA-04-1644,OV,48.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,[Not Available],-17725.0,Dead,WITH TUMOR,,1487.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],634.0,Partial Remission/Response,,,1.0,1487.0,1.0,1487.0,,,1.0,634.0,
TCGA-BH-A1EV,1135,TCGA-BH-A1EV,BRCA,45.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999.0,[Not Available],-16504.0,Dead,WITH TUMOR,,365.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,365.0,1.0,365.0,,,1.0,365.0,
TCGA-FG-A60L,5128,TCGA-FG-A60L,LGG,34.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-12580.0,Alive,TUMOR FREE,655.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,655.0,0.0,655.0,0.0,655.0,0.0,655.0,
TCGA-L5-A893,2538,TCGA-L5-A893,ESCA,71.0,FEMALE,WHITE,Stage I,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2005.0,[Not Available],-26143.0,Alive,TUMOR FREE,92.0,,[Not Available],,,,,[Unknown],,,0.0,92.0,0.0,92.0,,,0.0,92.0,
TCGA-C8-A132,1192,TCGA-C8-A132,BRCA,56.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20471.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,[Not Available],Negative,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-CV-A6JM,3595,TCGA-CV-A6JM,HNSC,85.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-31147.0,Dead,TUMOR FREE,,194.0,[Not Available],Locoregional Recurrence,Oropharynx,,107.0,Complete Remission/Response,,,1.0,194.0,0.0,194.0,,,1.0,107.0,
TCGA-T2-A6WX,3740,TCGA-T2-A6WX,HNSC,73.0,FEMALE,WHITE,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G1,2010.0,[Not Available],-27005.0,Dead,WITH TUMOR,,209.0,[Not Available],,,,,Progressive Disease,,,1.0,209.0,1.0,209.0,,,1.0,209.0,
TCGA-KM-8439,3795,TCGA-KM-8439,KICH,30.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2011.0,[Not Available],-11266.0,Alive,WITH TUMOR,708.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,708.0,0.0,708.0,,,0.0,708.0,
TCGA-EE-A20B,9001,TCGA-EE-A20B,SKCM,66.0,FEMALE,WHITE,Stage II,[Not Applicable],,[Not Available],2002.0,[Not Available],-24445.0,Alive,TUMOR FREE,4070.0,,[Not Available],,,,,[Not Available],,,0.0,4070.0,0.0,4070.0,,,0.0,4070.0,
TCGA-DU-7015,5018,TCGA-DU-7015,LGG,41.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2004.0,[Not Available],-15041.0,Alive,WITH TUMOR,2761.0,,[Not Available],,,,591.0,Progressive Disease,,,0.0,2761.0,0.0,2761.0,,,1.0,591.0,
TCGA-OL-A5RV,1557,TCGA-OL-A5RV,BRCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15820.0,Alive,TUMOR FREE,1062.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1062.0,0.0,1062.0,0.0,1062.0,0.0,1062.0,
TCGA-CJ-4904,4308,TCGA-CJ-4904,KIRC,60.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-22036.0,Alive,WITH TUMOR,3302.0,,[Not Available],,,,278.0,Stable Disease,,,0.0,3302.0,0.0,3302.0,,,1.0,278.0,
TCGA-53-7626,5964,TCGA-53-7626,LUAD,76.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-28024.0,Dead,WITH TUMOR,,929.0,[Not Available],Locoregional Recurrence,,,865.0,Progressive Disease,,,1.0,929.0,1.0,929.0,,,1.0,865.0,
TCGA-DD-A39Z,5541,TCGA-DD-A39Z,LIHC,43.0,FEMALE,[Not Available],Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,1996.0,[Not Available],-15930.0,Dead,TUMOR FREE,,601.0,[Not Available],,,,,[Not Available],,R0,1.0,601.0,0.0,601.0,0.0,601.0,0.0,601.0,
TCGA-DD-A4NF,5556,TCGA-DD-A4NF,LIHC,72.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-26330.0,Alive,WITH TUMOR,942.0,,[Not Available],Extrahepatic Recurrence,Bone,,656.0,[Not Available],,R0,0.0,942.0,0.0,942.0,1.0,656.0,1.0,656.0,
TCGA-EY-A2OQ,10972,TCGA-EY-A2OQ,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22309.0,Alive,TUMOR FREE,885.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,885.0,0.0,885.0,0.0,885.0,0.0,885.0,
TCGA-JW-A5VI,1786,TCGA-JW-A5VI,CESC,45.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16444.0,Alive,WITH TUMOR,747.0,,,Distant Metastasis,Lung,,558.0,Complete Remission/Response,,,0.0,747.0,0.0,747.0,1.0,558.0,1.0,558.0,
TCGA-98-A53A,6788,TCGA-98-A53A,LUSC,70.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-25662.0,Dead,,,552.0,[Not Available],,,,,Complete Remission/Response,,,1.0,552.0,,552.0,0.0,552.0,0.0,552.0,
TCGA-AJ-A3EL,10541,TCGA-AJ-A3EL,UCEC,47.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17442.0,Alive,TUMOR FREE,684.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,684.0,0.0,684.0,0.0,684.0,0.0,684.0,
TCGA-KN-8435,3834,TCGA-KN-8435,KICH,59.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-21891.0,Alive,TUMOR FREE,3498.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3498.0,0.0,3498.0,0.0,3498.0,0.0,3498.0,
TCGA-CG-4469,9463,TCGA-CG-4469,STAD,70.0,MALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2009.0,[Not Available],-25598.0,Dead,,,215.0,[Not Available],,,,,[Not Available],,,1.0,215.0,,215.0,,,0.0,215.0,
TCGA-85-8276,6721,TCGA-85-8276,LUSC,62.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-22707.0,Alive,WITH TUMOR,1050.0,,[Not Available],Distant Metastasis,,,1048.0,Complete Remission/Response,,,0.0,1050.0,0.0,1050.0,1.0,1048.0,1.0,1048.0,
TCGA-PG-A7D5,11009,TCGA-PG-A7D5,UCEC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23006.0,Alive,TUMOR FREE,1177.0,,[Not Available],,,,,Stable Disease,,,0.0,1177.0,0.0,1177.0,,,0.0,1177.0,
TCGA-A5-A2K4,10517,TCGA-A5-A2K4,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25270.0,Dead,WITH TUMOR,,871.0,[Not Available],Metastatic,"Other, specify",Bowel,528.0,Complete Remission/Response,,,1.0,871.0,1.0,871.0,1.0,528.0,1.0,528.0,
TCGA-JY-A6FG,2499,TCGA-JY-A6FG,ESCA,50.0,MALE,WHITE,Stage III,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2009.0,[Not Available],-18348.0,Dead,TUMOR FREE,,1263.0,[Not Available],,,,,,,,1.0,1263.0,0.0,1263.0,,,0.0,1263.0,
TCGA-JY-A93E,2505,TCGA-JY-A93E,ESCA,61.0,MALE,WHITE,Stage IIIA,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2012.0,[Not Available],-22427.0,Alive,WITH TUMOR,767.0,,[Not Available],,,,,Stable Disease,,,0.0,767.0,0.0,767.0,,,0.0,767.0,
TCGA-44-2662,5858,TCGA-44-2662,LUAD,65.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-24014.0,Alive,TUMOR FREE,1280.0,,[Not Available],,,,245.0,Progressive Disease,,,0.0,1280.0,0.0,1280.0,,,1.0,245.0,
TCGA-EO-A3AV,10932,TCGA-EO-A3AV,UCEC,51.0,FEMALE,[Not Available],[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2010.0,Peri (6-12 months since last menstrual period),-18713.0,Alive,TUMOR FREE,1069.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1069.0,0.0,1069.0,0.0,1069.0,0.0,1069.0,
TCGA-RB-A7B8,7666,TCGA-RB-A7B8,PAAD,81.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2013.0,[Not Available],-29585.0,Dead,TUMOR FREE,,466.0,Pancreatic Cancer,Locoregional Recurrence,,,449.0,Complete Remission/Response,,,1.0,466.0,1.0,466.0,1.0,449.0,1.0,449.0,
TCGA-3X-AAVE,1913,TCGA-3X-AAVE,CHOL,60.0,MALE,ASIAN,Stage II,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2013.0,[Not Available],-21943.0,Alive,TUMOR FREE,650.0,,[Not Available],,,,,[Not Available],,R0,0.0,650.0,0.0,650.0,0.0,650.0,0.0,650.0,
TCGA-F5-6813,8528,TCGA-F5-6813,READ,70.0,MALE,WHITE,Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-25651.0,Dead,WITH TUMOR,,598.0,[Not Available],,,,65.0,[Unknown],,,1.0,598.0,1.0,598.0,,,1.0,65.0,
TCGA-XF-AAMT,455,TCGA-XF-AAMT,BLCA,75.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-27397.0,Dead,WITH TUMOR,,90.0,[Not Available],,,,,Partial Remission/Response,,,1.0,90.0,1.0,90.0,,,1.0,90.0,
TCGA-AJ-A3BK,10538,TCGA-AJ-A3BK,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24943.0,Alive,TUMOR FREE,1031.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1031.0,0.0,1031.0,0.0,1031.0,0.0,1031.0,
TCGA-DU-7294,5023,TCGA-DU-7294,LGG,53.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2003.0,[Not Available],-19616.0,Alive,TUMOR FREE,2869.0,,[Not Available],,,,,Stable Disease,,,0.0,2869.0,0.0,2869.0,,,0.0,2869.0,
TCGA-CG-4475,9466,TCGA-CG-4475,STAD,76.0,MALE,[Not Available],Stage IIB,[Not Applicable],[Not Available],G3,2010.0,[Not Available],-28065.0,Alive,TUMOR FREE,699.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,699.0,0.0,699.0,,,0.0,699.0,
TCGA-W2-A7HH,7828,TCGA-W2-A7HH,PCPG,69.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2012.0,[Not Available],-25291.0,Alive,TUMOR FREE,779.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,779.0,0.0,779.0,0.0,779.0,0.0,779.0,
TCGA-LN-A8I0,2590,TCGA-LN-A8I0,ESCA,52.0,MALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-19328.0,Alive,TUMOR FREE,407.0,,[Not Available],Locoregional Recurrence,,,57.0,Complete Remission/Response,,,0.0,407.0,0.0,407.0,1.0,57.0,1.0,57.0,
TCGA-77-8131,6677,TCGA-77-8131,LUSC,72.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-26611.0,Dead,,,383.0,[Not Available],,,,,[Unknown],,,1.0,383.0,,383.0,,,0.0,383.0,
TCGA-86-7953,6184,TCGA-86-7953,LUAD,69.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25315.0,Alive,TUMOR FREE,997.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,997.0,0.0,997.0,0.0,997.0,0.0,997.0,
TCGA-AC-A5XS,788,TCGA-AC-A5XS,BRCA,74.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,[Not Available],-27160.0,Alive,TUMOR FREE,588.0,,[Not Available],,,,,[Not Available],Negative,,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,
TCGA-2G-AAFJ,9721,TCGA-2G-AAFJ,TGCT,23.0,MALE,ASIAN,[Discrepancy],Stage I,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Yolk Sac Tumor,[Not Available],2013.0,[Not Available],-8415.0,Alive,TUMOR FREE,792.0,,[Not Applicable],,,,313.0,Complete Remission/Response,,,0.0,792.0,0.0,792.0,1.0,313.0,1.0,313.0,
TCGA-UF-A7JJ,3761,TCGA-UF-A7JJ,HNSC,68.0,MALE,[Unknown],Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2013.0,[Not Available],-25201.0,Alive,TUMOR FREE,549.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,549.0,0.0,549.0,,,0.0,549.0,
TCGA-AC-A2BK,760,TCGA-AC-A2BK,BRCA,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28625.0,Alive,TUMOR FREE,2222.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2222.0,0.0,2222.0,0.0,2222.0,0.0,2222.0,
TCGA-CG-5724,9477,TCGA-CG-5724,STAD,59.0,MALE,[Not Available],Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2003.0,[Not Available],-21762.0,Dead,WITH TUMOR,,366.0,[Not Available],,,,122.0,Progressive Disease,,,1.0,366.0,1.0,366.0,,,1.0,122.0,
TCGA-3X-AAVA,1910,TCGA-3X-AAVA,CHOL,50.0,FEMALE,WHITE,Stage II,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2012.0,[Not Available],-18303.0,Dead,WITH TUMOR,,445.0,[Not Available],Extrahepatic Recurrence,Bone,,264.0,[Not Available],,R0,1.0,445.0,1.0,445.0,1.0,264.0,1.0,264.0,
TCGA-A3-3308,3887,TCGA-A3-3308,KIRC,77.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-28287.0,Alive,TUMOR FREE,16.0,,[Not Available],,,,,[Not Available],,,0.0,16.0,0.0,16.0,,,0.0,16.0,
TCGA-CJ-6030,4334,TCGA-CJ-6030,KIRC,65.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-24096.0,Dead,TUMOR FREE,,2299.0,[Not Available],,,,,[Not Available],,,1.0,2299.0,0.0,2299.0,,,0.0,2299.0,
TCGA-A3-3367,3916,TCGA-A3-3367,KIRC,72.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-26489.0,Alive,TUMOR FREE,2270.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2270.0,0.0,2270.0,0.0,2270.0,0.0,2270.0,
TCGA-QF-A5YT,11015,TCGA-QF-A5YT,UCEC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20981.0,Alive,TUMOR FREE,1215.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1215.0,0.0,1215.0,0.0,1215.0,0.0,1215.0,
TCGA-2G-AAGW,9751,TCGA-2G-AAGW,TGCT,38.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor,[Not Available],2001.0,[Not Available],-14197.0,Alive,TUMOR FREE,4899.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,4899.0,0.0,4899.0,0.0,4899.0,0.0,4899.0,
TCGA-W5-AA2O,1925,TCGA-W5-AA2O,CHOL,57.0,MALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2006.0,[Not Available],-21118.0,Dead,WITH TUMOR,,640.0,[Not Available],Intrahepatic Recurrence,Liver,,215.0,[Not Available],,R0,1.0,640.0,1.0,640.0,1.0,215.0,1.0,215.0,
TCGA-VQ-A91K,9676,TCGA-VQ-A91K,STAD,69.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,[Not Available],-25424.0,Alive,TUMOR FREE,1862.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1862.0,0.0,1862.0,0.0,1862.0,0.0,1862.0,
TCGA-DV-A4VX,4403,TCGA-DV-A4VX,KIRC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2008.0,[Not Available],-21670.0,Dead,WITH TUMOR,,1626.0,[Not Available],,,,,Progressive Disease,,,1.0,1626.0,1.0,1626.0,,,1.0,1626.0,
TCGA-RD-A7BW,9628,TCGA-RD-A7BW,STAD,68.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2004.0,[Not Available],-25036.0,Dead,TUMOR FREE,,156.0,"Other, non-malignant disease",,,,,Complete Remission/Response,,,1.0,156.0,0.0,156.0,0.0,156.0,0.0,156.0,
TCGA-FY-A3TY,10292,TCGA-FY-A3TY,THCA,61.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-22556.0,Alive,TUMOR FREE,709.0,,[Not Available],,,,,[Not Available],,R0,0.0,709.0,0.0,709.0,0.0,709.0,0.0,709.0,
TCGA-CR-5243,3416,TCGA-CR-5243,HNSC,51.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,[Not Available],-18812.0,Alive,TUMOR FREE,2562.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2562.0,0.0,2562.0,,,0.0,2562.0,
TCGA-KS-A4I9,10339,TCGA-KS-A4I9,THCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-16961.0,Alive,TUMOR FREE,2658.0,,[Not Available],,,,,[Not Available],,R0,0.0,2658.0,0.0,2658.0,0.0,2658.0,0.0,2658.0,
TCGA-C8-A278,1216,TCGA-C8-A278,BRCA,61.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22598.0,Alive,TUMOR FREE,297.0,,[Not Available],,,,,[Not Available],Negative,,0.0,297.0,0.0,297.0,0.0,297.0,0.0,297.0,
TCGA-WS-AB45,2412,TCGA-WS-AB45,COAD,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2008.0,[Not Available],,Alive,TUMOR FREE,2130.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2130.0,0.0,2130.0,0.0,2130.0,0.0,2130.0,
TCGA-53-7624,5963,TCGA-53-7624,LUAD,40.0,FEMALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-14794.0,Dead,WITH TUMOR,,1043.0,[Not Available],Distant Metastasis,,,400.0,Progressive Disease,,,1.0,1043.0,1.0,1043.0,,,1.0,400.0,
TCGA-AR-A0TS,901,TCGA-AR-A0TS,BRCA,46.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17141.0,Alive,TUMOR FREE,2558.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2558.0,0.0,2558.0,0.0,2558.0,0.0,2558.0,
TCGA-N7-A4Y0,11044,TCGA-N7-A4Y0,UCS,65.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23983.0,Dead,WITH TUMOR,,771.0,[Not Available],Progression of Disease,"Other, specify",retroperitoneum,281.0,[Unknown],,,1.0,771.0,1.0,771.0,,,1.0,281.0,
TCGA-CF-A5U8,163,TCGA-CF-A5U8,BLCA,59.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,[Not Available],-21734.0,Alive,TUMOR FREE,399.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,399.0,0.0,399.0,0.0,399.0,0.0,399.0,
TCGA-D1-A1O0,10880,TCGA-D1-A1O0,UCEC,77.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28162.0,Alive,TUMOR FREE,63.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,63.0,0.0,63.0,0.0,63.0,0.0,63.0,
TCGA-D3-A8GS,8897,TCGA-D3-A8GS,SKCM,52.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1997.0,[Not Available],-19127.0,Dead,WITH TUMOR,,3564.0,[Not Available],Regional lymph node,,,2641.0,[Not Available],,,1.0,3564.0,1.0,3564.0,,,1.0,2641.0,
TCGA-06-0129,2746,TCGA-06-0129,GBM,30.0,MALE,ASIAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-11284.0,Dead,WITH TUMOR,989.0,1024.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],148.0,[Not Available],,,1.0,1024.0,1.0,1024.0,,,1.0,148.0,
TCGA-CN-6012,3338,TCGA-CN-6012,HNSC,66.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-24286.0,Alive,TUMOR FREE,1460.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1460.0,0.0,1460.0,,,0.0,1460.0,
TCGA-HT-7468,5141,TCGA-HT-7468,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-11209.0,Alive,TUMOR FREE,203.0,,[Not Available],,,,,Stable Disease,,,0.0,203.0,0.0,203.0,,,0.0,203.0,
TCGA-DX-A6BF,8609,TCGA-DX-A6BF,SARC,82.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2012.0,[Not Available],-30071.0,Alive,WITH TUMOR,972.0,,[Not Available],Locoregional Recurrence,"Other, specify",,947.0,[Not Available],Positive,R1,0.0,972.0,0.0,972.0,,,1.0,947.0,
TCGA-RW-A68D,7771,TCGA-RW-A68D,PCPG,31.0,FEMALE,ASIAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2006.0,[Not Available],-11438.0,Alive,TUMOR FREE,2214.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2214.0,0.0,2214.0,0.0,2214.0,0.0,2214.0,
TCGA-G6-A8L7,4412,TCGA-G6-A8L7,KIRC,81.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2008.0,[Not Available],-29883.0,Alive,TUMOR FREE,2133.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2133.0,0.0,2133.0,0.0,2133.0,0.0,2133.0,
TCGA-ER-A19K,9103,TCGA-ER-A19K,SKCM,79.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2006.0,[Not Available],-28916.0,Dead,WITH TUMOR,,469.0,[Not Available],Regional lymph node,"Other, Specify",Neck- cervical lymphnode,211.0,[Not Available],,,1.0,469.0,1.0,469.0,,,1.0,211.0,
TCGA-A4-A6HP,4492,TCGA-A4-A6HP,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-24447.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-AY-A8YK,2212,TCGA-AY-A8YK,COAD,44.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2013.0,[Not Available],-16140.0,Alive,TUMOR FREE,573.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,573.0,0.0,573.0,,,0.0,573.0,
TCGA-EE-A2MJ,9057,TCGA-EE-A2MJ,SKCM,60.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],1999.0,[Not Available],-22050.0,Dead,TUMOR FREE,,2927.0,[Not Available],Regional lymph node,,,396.0,[Not Available],,,1.0,2927.0,0.0,2927.0,,,1.0,396.0,
TCGA-BJ-A192,9864,TCGA-BJ-A192,THCA,54.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-19878.0,Alive,TUMOR FREE,1349.0,,[Not Available],,,,,[Not Available],,RX,0.0,1349.0,0.0,1349.0,,,0.0,1349.0,
TCGA-EW-A1OV,1464,TCGA-EW-A1OV,BRCA,56.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20764.0,Alive,TUMOR FREE,789.0,,[Not Available],,,,,[Not Available],Negative,,0.0,789.0,0.0,789.0,0.0,789.0,0.0,789.0,
TCGA-DK-A3IT,202,TCGA-DK-A3IT,BLCA,62.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-22786.0,Alive,TUMOR FREE,648.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,648.0,0.0,648.0,0.0,648.0,0.0,648.0,
TCGA-DF-A2KU,10896,TCGA-DF-A2KU,UCEC,,FEMALE,[Not Evaluated],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,TUMOR FREE,3067.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3067.0,0.0,3067.0,0.0,3067.0,0.0,3067.0,
TCGA-QR-A7IN,7741,TCGA-QR-A7IN,PCPG,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-19237.0,Alive,TUMOR FREE,377.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,377.0,0.0,377.0,0.0,377.0,0.0,377.0,
TCGA-GU-A42P,343,TCGA-GU-A42P,BLCA,72.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-26546.0,Dead,TUMOR FREE,,332.0,[Not Available],,,,,Stable Disease,,,1.0,332.0,0.0,332.0,,,0.0,332.0,
TCGA-MP-A4TE,6307,TCGA-MP-A4TE,LUAD,56.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-20627.0,Dead,WITH TUMOR,,896.0,[Not Available],Locoregional Recurrence,,,226.0,Complete Remission/Response,,,1.0,896.0,1.0,896.0,1.0,226.0,1.0,226.0,
TCGA-BQ-5889,4549,TCGA-BQ-5889,KIRP,63.0,MALE,WHITE,Stage IV,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-23267.0,Dead,WITH TUMOR,,329.0,[Not Available],,,,-35.0,[Not Available],,,1.0,329.0,1.0,329.0,,,1.0,,
TCGA-CV-7097,3522,TCGA-CV-7097,HNSC,53.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2002.0,[Not Available],-19382.0,Dead,WITH TUMOR,,385.0,[Not Available],,,,,[Not Available],,,1.0,385.0,1.0,385.0,,,1.0,385.0,
TCGA-F4-6460,2352,TCGA-F4-6460,COAD,51.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-18637.0,Dead,WITH TUMOR,,972.0,[Not Available],,,,313.0,Complete Remission/Response,,,1.0,972.0,1.0,972.0,1.0,313.0,1.0,313.0,
TCGA-DJ-A3UR,9972,TCGA-DJ-A3UR,THCA,51.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-18808.0,Alive,TUMOR FREE,1105.0,,[Not Available],,,,,[Not Available],,R0,0.0,1105.0,0.0,1105.0,0.0,1105.0,0.0,1105.0,
TCGA-06-0184,2788,TCGA-06-0184,GBM,63.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-23317.0,Dead,WITH TUMOR,,2126.0,[Not Available],,[Not Applicable],[Not Applicable],1276.0,[Not Available],,,1.0,2126.0,1.0,2126.0,,,1.0,1276.0,
TCGA-FJ-A3Z7,305,TCGA-FJ-A3Z7,BLCA,76.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-28052.0,Alive,TUMOR FREE,945.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,945.0,0.0,945.0,,,0.0,945.0,
TCGA-RW-A680,7761,TCGA-RW-A680,PCPG,57.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2011.0,[Not Available],-21010.0,Alive,TUMOR FREE,1449.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0,
TCGA-D6-6515,3610,TCGA-D6-6515,HNSC,82.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-30099.0,Dead,TUMOR FREE,,403.0,[Not Available],,Cervical Lymph Nodes,,195.0,Complete Remission/Response,,,1.0,403.0,0.0,403.0,1.0,195.0,1.0,195.0,
TCGA-VS-A9UT,1878,TCGA-VS-A9UT,CESC,72.0,FEMALE,ASIAN,[Not Available],Stage IB,Mucinous Adenocarcinoma of Endocervical Type,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26603.0,Alive,TUMOR FREE,482.0,,,,,,,Complete Remission/Response,,,0.0,482.0,0.0,482.0,0.0,482.0,0.0,482.0,
TCGA-2H-A9GJ,2465,TCGA-2H-A9GJ,ESCA,57.0,MALE,[Unknown],Stage I,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2000.0,[Not Available],-21180.0,Dead,WITH TUMOR,,1781.0,[Not Available],Locoregional Recurrence,,,1261.0,,,,1.0,1781.0,1.0,1781.0,,,1.0,1261.0,
TCGA-A6-6648,1997,TCGA-A6-6648,COAD,56.0,MALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-20641.0,Alive,WITH TUMOR,766.0,,[Not Available],,,,686.0,[Not Available],,,0.0,766.0,0.0,766.0,,,1.0,686.0,
TCGA-AO-A12A,875,TCGA-AO-A12A,BRCA,47.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17420.0,Alive,TUMOR FREE,3112.0,,[Not Available],,,,,[Not Available],Close,,0.0,3112.0,0.0,3112.0,,,0.0,3112.0,
TCGA-CC-A1HT,5490,TCGA-CC-A1HT,LIHC,50.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-18553.0,Dead,TUMOR FREE,,101.0,[Not Available],,,,,[Not Available],,[Not Available],1.0,101.0,0.0,101.0,,,0.0,101.0,
TCGA-KS-A41I,10332,TCGA-KS-A41I,THCA,47.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2002.0,[Not Available],-17196.0,Alive,TUMOR FREE,486.0,,[Not Available],,,,,[Not Available],,R0,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,
TCGA-OR-A5JD,13,TCGA-OR-A5JD,ACC,57.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical Carcinoma- Oncocytic Type,[Not Available],2005.0,[Not Available],-20989.0,Alive,TUMOR FREE,3038.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3038.0,0.0,3038.0,0.0,3038.0,0.0,3038.0,
TCGA-W3-AA1V,9232,TCGA-W3-AA1V,SKCM,63.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1994.0,[Not Available],-23314.0,Dead,WITH TUMOR,,1280.0,[Not Available],Distant Metastasis,Liver,,1219.0,[Not Available],,,1.0,1280.0,1.0,1280.0,,,1.0,1219.0,
TCGA-OR-A5LT,82,TCGA-OR-A5LT,ACC,57.0,MALE,[Not Evaluated],Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-21032.0,Alive,TUMOR FREE,549.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,549.0,0.0,549.0,0.0,549.0,0.0,549.0,
TCGA-AQ-A7U7,897,TCGA-AQ-A7U7,BRCA,55.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20239.0,Dead,TUMOR FREE,,584.0,[Not Available],,,,,[Not Available],Negative,,1.0,584.0,0.0,584.0,0.0,584.0,0.0,584.0,
TCGA-AX-A1CE,10637,TCGA-AX-A1CE,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21969.0,Alive,TUMOR FREE,1037.0,,[Not Available],,,,,[Not Applicable],,,0.0,1037.0,0.0,1037.0,,,0.0,1037.0,
TCGA-EL-A3GU,10064,TCGA-EL-A3GU,THCA,72.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002.0,[Not Available],-26632.0,Alive,WITH TUMOR,4137.0,,[Not Available],Distant Metastasis,Lung,,544.0,[Not Available],,R0,0.0,4137.0,0.0,4137.0,1.0,544.0,1.0,544.0,
TCGA-B5-A0JU,10679,TCGA-B5-A0JU,UCEC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21159.0,Alive,TUMOR FREE,1802.0,,[Not Available],,,,,[Not Available],,,0.0,1802.0,0.0,1802.0,,,0.0,1802.0,
TCGA-2F-A9KT,97,TCGA-2F-A9KT,BLCA,83.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-30520.0,Alive,TUMOR FREE,3314.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3314.0,0.0,3314.0,0.0,3314.0,0.0,3314.0,
TCGA-C5-A2M2,1639,TCGA-C5-A2M2,CESC,56.0,FEMALE,WHITE,[Not Available],Stage IB2,Endocervical Type of Adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20480.0,Dead,,,1011.0,,,,,,[Not Available],,,1.0,1011.0,,1011.0,,,0.0,1011.0,
TCGA-XF-A9T2,441,TCGA-XF-A9T2,BLCA,54.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-19945.0,Dead,,,575.0,[Not Available],,,,,[Unknown],,,1.0,575.0,,575.0,,,0.0,575.0,
TCGA-XM-A8RB,10407,TCGA-XM-A8RB,THYM,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],I,Thymoma; Type B1,[Not Available],2011.0,[Not Available],-25080.0,Alive,TUMOR FREE,1144.0,,[Not Available],,,,,[Not Available],,,0.0,1144.0,0.0,1144.0,,,0.0,1144.0,
TCGA-C8-A137,1196,TCGA-C8-A137,BRCA,34.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12729.0,Alive,WITH TUMOR,379.0,,[Not Available],Locoregional Recurrence,,,136.0,[Not Available],Negative,,0.0,379.0,0.0,379.0,1.0,136.0,1.0,136.0,
TCGA-ER-A19C,9096,TCGA-ER-A19C,SKCM,77.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1998.0,[Not Available],-28383.0,Dead,WITH TUMOR,,1487.0,[Not Available],,,,,[Not Available],,,1.0,1487.0,1.0,1487.0,,,1.0,1487.0,
TCGA-SR-A6MU,7809,TCGA-SR-A6MU,PCPG,49.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2004.0,[Not Available],-18073.0,Alive,TUMOR FREE,3362.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3362.0,0.0,3362.0,0.0,3362.0,0.0,3362.0,
TCGA-BB-A6UO,3299,TCGA-BB-A6UO,HNSC,61.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-22506.0,Dead,WITH TUMOR,,268.0,[Not Available],,Distant Metastasis,Lung,212.0,Complete Remission/Response,,,1.0,268.0,1.0,268.0,,,1.0,212.0,
TCGA-XF-AAMW,456,TCGA-XF-AAMW,BLCA,79.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-28903.0,Dead,WITH TUMOR,,253.0,[Not Available],,,,,Partial Remission/Response,,,1.0,253.0,1.0,253.0,,,1.0,253.0,
TCGA-EE-A29B,9007,TCGA-EE-A29B,SKCM,67.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2004.0,[Not Available],-24618.0,Dead,WITH TUMOR,,2588.0,[Not Available],New primary melanoma,,,490.0,[Not Available],,,1.0,2588.0,1.0,2588.0,,,1.0,490.0,
TCGA-44-2661,5857,TCGA-44-2661,LUAD,69.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-25313.0,Alive,TUMOR FREE,1159.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1159.0,0.0,1159.0,0.0,1159.0,0.0,1159.0,
TCGA-FF-A7CX,2432,TCGA-FF-A7CX,DLBC,46.0,MALE,ASIAN,[Not Applicable],Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2011.0,[Not Available],-16924.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,385.0,0.0,385.0,,,0.0,385.0,
TCGA-VS-A9UB,1866,TCGA-VS-A9UB,CESC,54.0,FEMALE,[Unknown],[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19737.0,Alive,TUMOR FREE,911.0,,,,,,,Complete Remission/Response,,,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,
TCGA-A1-A0SO,524,TCGA-A1-A0SO,BRCA,67.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24826.0,Alive,TUMOR FREE,852.0,,[Not Available],,,,,[Not Available],Negative,,0.0,852.0,0.0,852.0,0.0,852.0,0.0,852.0,
TCGA-EP-A12J,5680,TCGA-EP-A12J,LIHC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2010.0,[Not Available],-22997.0,Alive,TUMOR FREE,570.0,,[Not Available],,,,,[Not Available],,R0,0.0,570.0,0.0,570.0,0.0,570.0,0.0,570.0,
TCGA-06-0151,2763,TCGA-06-0151,GBM,32.0,FEMALE,WHITE,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],1995.0,[Not Available],-11956.0,Dead,WITH TUMOR,,1417.0,[Not Available],,,,,[Not Available],,,1.0,1417.0,1.0,1417.0,,,1.0,1417.0,
TCGA-06-5411,2865,TCGA-06-5411,GBM,51.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-18832.0,Dead,WITH TUMOR,254.0,254.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],214.0,[Not Available],,,1.0,254.0,1.0,254.0,,,1.0,214.0,
TCGA-D3-A8GO,8893,TCGA-D3-A8GO,SKCM,,FEMALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],1996.0,[Not Available],,Dead,WITH TUMOR,,,[Not Available],,,,,[Not Available],,,1.0,,1.0,,,,1.0,,
TCGA-MP-A4T8,6302,TCGA-MP-A4T8,LUAD,68.0,MALE,[Unknown],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-25069.0,Dead,,,161.0,[Not Available],,,,,[Unknown],,,1.0,161.0,,161.0,,,0.0,161.0,
TCGA-DJ-A2Q7,9960,TCGA-DJ-A2Q7,THCA,52.0,FEMALE,ASIAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19193.0,Alive,TUMOR FREE,1068.0,,[Not Available],,,,,[Not Available],,R0,0.0,1068.0,0.0,1068.0,0.0,1068.0,0.0,1068.0,
TCGA-AR-A2LE,954,TCGA-AR-A2LE,BRCA,69.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25499.0,Alive,TUMOR FREE,5062.0,,[Not Available],New Primary Tumor,"Other, specify",Endometrium,4203.0,[Not Available],Negative,,0.0,5062.0,0.0,5062.0,0.0,5062.0,1.0,4203.0,
TCGA-RC-A7SB,5766,TCGA-RC-A7SB,LIHC,53.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-19698.0,Alive,TUMOR FREE,588.0,,[Not Available],,,,,[Not Available],,R0,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,
TCGA-DU-A6S8,5052,TCGA-DU-A6S8,LGG,74.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-27084.0,Alive,WITH TUMOR,678.0,,[Not Available],,,,641.0,Progressive Disease,,,0.0,678.0,0.0,678.0,,,1.0,641.0,
TCGA-BH-A1FR,1154,TCGA-BH-A1FR,BRCA,73.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Other, specify",[Not Available],1997.0,[Not Available],-26684.0,Dead,WITH TUMOR,,1642.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1642.0,1.0,1642.0,,,1.0,1642.0,
TCGA-39-5024,6457,TCGA-39-5024,LUSC,65.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-23975.0,Alive,TUMOR FREE,2510.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2510.0,0.0,2510.0,0.0,2510.0,0.0,2510.0,
TCGA-CA-6715,2239,TCGA-CA-6715,COAD,63.0,MALE,ASIAN,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-23075.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-A2-A0CS,544,TCGA-A2-A0CS,BRCA,73.0,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26817.0,Dead,TUMOR FREE,,2348.0,[Not Available],,,,,[Not Available],Positive,,1.0,2348.0,0.0,2348.0,,,0.0,2348.0,
TCGA-CV-6945,3505,TCGA-CV-6945,HNSC,41.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1993.0,[Not Available],-15158.0,Dead,WITH TUMOR,,366.0,[Not Available],,,,,[Not Available],,,1.0,366.0,1.0,366.0,,,1.0,366.0,
TCGA-ZF-A9RC,481,TCGA-ZF-A9RC,BLCA,77.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-28275.0,Alive,TUMOR FREE,2868.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2868.0,0.0,2868.0,0.0,2868.0,0.0,2868.0,
TCGA-BA-A6DG,3274,TCGA-BA-A6DG,HNSC,49.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-18052.0,Dead,WITH TUMOR,,69.0,[Not Available],,,,,Progressive Disease,,,1.0,69.0,1.0,69.0,,,1.0,69.0,
TCGA-DD-AAD2,5607,TCGA-DD-AAD2,LIHC,66.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-24221.0,Alive,TUMOR FREE,658.0,,[Not Available],,,,,[Not Available],,R0,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,
TCGA-VS-A9U6,1863,TCGA-VS-A9U6,CESC,52.0,FEMALE,WHITE,[Not Available],Stage IVB,Cervical Squamous Cell Carcinoma,GX,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19109.0,Alive,WITH TUMOR,1320.0,,,Distant Metastasis,,Diaphragm,711.0,Stable Disease,,,0.0,1320.0,0.0,1320.0,,,1.0,711.0,
TCGA-49-AAR9,5925,TCGA-49-AAR9,LUAD,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],1999.0,[Not Available],-22510.0,Dead,WITH TUMOR,,260.0,[Not Available],,,,,Progressive Disease,,,1.0,260.0,1.0,260.0,,,1.0,260.0,
TCGA-E6-A2P9,10914,TCGA-E6-A2P9,UCEC,65.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24088.0,Alive,TUMOR FREE,1386.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1386.0,0.0,1386.0,0.0,1386.0,0.0,1386.0,
TCGA-78-7156,6152,TCGA-78-7156,LUAD,62.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-22720.0,Dead,,,976.0,[Not Available],,,,,[Not Available],,,1.0,976.0,,976.0,,,0.0,976.0,
TCGA-AR-A1AJ,916,TCGA-AR-A1AJ,BRCA,83.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30489.0,Alive,TUMOR FREE,3072.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3072.0,0.0,3072.0,0.0,3072.0,0.0,3072.0,
TCGA-J4-A67L,8133,TCGA-J4-A67L,PRAD,54.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-20034.0,Alive,TUMOR FREE,770.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,770.0,0.0,770.0,0.0,770.0,0.0,770.0,
TCGA-FR-A7U8,9137,TCGA-FR-A7U8,SKCM,50.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-18346.0,Alive,WITH TUMOR,847.0,,[Not Available],Distant Metastasis,Brain,,567.0,[Not Available],,,0.0,847.0,0.0,847.0,,,1.0,567.0,
TCGA-05-4426,5826,TCGA-05-4426,LUAD,71.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-26084.0,Alive,TUMOR FREE,791.0,,[Not Available],,,,457.0,Complete Remission/Response,,,0.0,791.0,0.0,791.0,1.0,457.0,1.0,457.0,
TCGA-55-7283,5993,TCGA-55-7283,LUAD,76.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27946.0,Alive,WITH TUMOR,609.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,609.0,0.0,609.0,,,0.0,609.0,
TCGA-D3-A1Q1,8825,TCGA-D3-A1Q1,SKCM,79.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2004.0,[Not Available],-29212.0,Dead,WITH TUMOR,,504.0,[Not Available],Locoregional Recurrence,,,58.0,[Not Available],,,1.0,504.0,1.0,504.0,,,1.0,58.0,
TCGA-D3-A8GI,8887,TCGA-D3-A8GI,SKCM,68.0,MALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2008.0,[Not Available],-25069.0,Dead,WITH TUMOR,,1780.0,[Not Available],New primary melanoma,,,50.0,[Not Available],,,1.0,1780.0,1.0,1780.0,,,1.0,50.0,
TCGA-P5-A5EY,5268,TCGA-P5-A5EY,LGG,21.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-7716.0,Alive,,72.0,,[Not Available],,,,,[Not Available],,,0.0,72.0,0.0,72.0,,,0.0,72.0,
TCGA-D7-6521,9492,TCGA-D7-6521,STAD,65.0,MALE,WHITE,[Discrepancy],[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-23776.0,Alive,WITH TUMOR,564.0,,[Not Available],Locoregional Recurrence,"Other, specify",,192.0,Progressive Disease,,,0.0,564.0,0.0,564.0,,,1.0,192.0,
TCGA-49-AARN,5927,TCGA-49-AARN,LUAD,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2000.0,[Not Available],-20605.0,Dead,,,1135.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1135.0,,1135.0,0.0,1135.0,0.0,1135.0,
TCGA-05-5420,5832,TCGA-05-5420,LUAD,67.0,MALE,[Not Available],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-24472.0,Alive,WITH TUMOR,457.0,,[Not Available],,,,245.0,Progressive Disease,,,0.0,457.0,0.0,457.0,,,1.0,245.0,
TCGA-38-4629,5846,TCGA-38-4629,LUAD,68.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2003.0,[Not Available],-25104.0,Dead,WITH TUMOR,,864.0,[Not Available],,,,379.0,Complete Remission/Response,,,1.0,864.0,1.0,864.0,1.0,379.0,1.0,379.0,
TCGA-ZM-AA0F,9842,TCGA-ZM-AA0F,TGCT,35.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2013.0,[Not Available],-12973.0,Alive,TUMOR FREE,681.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,681.0,0.0,681.0,0.0,681.0,0.0,681.0,
TCGA-86-8359,6199,TCGA-86-8359,LUAD,52.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-19088.0,Dead,TUMOR FREE,,444.0,[Not Available],,,,,[Unknown],,,1.0,444.0,0.0,444.0,,,0.0,444.0,
TCGA-W5-AA2Z,1932,TCGA-W5-AA2Z,CHOL,29.0,FEMALE,WHITE,Stage II,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2010.0,[Not Available],-10659.0,Alive,WITH TUMOR,1614.0,,[Not Available],,,,,[Not Available],,R1,0.0,1614.0,0.0,1614.0,,,0.0,1614.0,
TCGA-69-8253,6106,TCGA-69-8253,LUAD,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-21771.0,Alive,TUMOR FREE,426.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,
TCGA-EB-A3XB,8943,TCGA-EB-A3XB,SKCM,63.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],2011.0,[Not Available],-23091.0,Alive,TUMOR FREE,796.0,,[Not Available],,,,,[Not Available],,,0.0,796.0,0.0,796.0,,,0.0,796.0,
TCGA-56-A5DS,6546,TCGA-56-A5DS,LUSC,72.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-26355.0,Alive,TUMOR FREE,8.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,8.0,0.0,8.0,0.0,8.0,0.0,8.0,
TCGA-V1-A9ZR,8266,TCGA-V1-A9ZR,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-25185.0,Alive,TUMOR FREE,1361.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1361.0,0.0,1361.0,0.0,1361.0,0.0,1361.0,
TCGA-DU-A6S6,5050,TCGA-DU-A6S6,LGG,35.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2007.0,[Not Available],-12809.0,Alive,TUMOR FREE,2893.0,,[Not Available],,,,2267.0,[Discrepancy],,,0.0,2893.0,0.0,2893.0,,,1.0,2267.0,
TCGA-VM-A8C8,5405,TCGA-VM-A8C8,LGG,50.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-18494.0,Alive,,1397.0,,[Not Available],,,,456.0,[Unknown],,,0.0,1397.0,0.0,1397.0,,,1.0,456.0,
TCGA-CC-A5UE,5497,TCGA-CC-A5UE,LIHC,48.0,MALE,ASIAN,Stage IIIB,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-17805.0,Dead,WITH TUMOR,,272.0,[Not Available],Locoregional Recurrence,,,175.0,[Not Available],,R0,1.0,272.0,1.0,272.0,1.0,175.0,1.0,175.0,
TCGA-R6-A6Y2,2607,TCGA-R6-A6Y2,ESCA,71.0,MALE,WHITE,[Not Available],Stage IIB,"Esophagus Adenocarcinoma, NOS",G3,2005.0,[Not Available],-25940.0,Dead,WITH TUMOR,,283.0,[Not Available],Distant Metastasis,Bone,,102.0,,,,1.0,283.0,1.0,283.0,,,1.0,102.0,
TCGA-OR-A5KT,49,TCGA-OR-A5KT,ACC,44.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2006.0,[Not Available],-16217.0,Alive,TUMOR FREE,2895.0,,[Not Available],Distant Metastasis,"Other, specify",Pancreas,2099.0,Complete Remission/Response,,,0.0,2895.0,0.0,2895.0,1.0,2099.0,1.0,2099.0,
TCGA-XK-AAIW,8303,TCGA-XK-AAIW,PRAD,78.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-28721.0,Alive,TUMOR FREE,1218.0,,[Not Available],New Primary Tumor,,,427.0,Complete Remission/Response,,,0.0,1218.0,0.0,1218.0,0.0,1218.0,1.0,427.0,
TCGA-WC-A87U,11143,TCGA-WC-A87U,UVM,73.0,MALE,WHITE,Stage IIIA,Stage IIB,Spindle Cell,[Not Available],2007.0,[Not Available],-26933.0,Dead,WITH TUMOR,,1581.0,"Other, specify",,,,,[Not Available],,,1.0,1581.0,0.0,1581.0,,,1.0,1581.0,
TCGA-J4-AATZ,8151,TCGA-J4-AATZ,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-24226.0,Alive,WITH TUMOR,412.0,,[Not Available],Biochemical evidence of disease,,,79.0,Complete Remission/Response,,,0.0,412.0,0.0,412.0,1.0,79.0,1.0,79.0,
TCGA-BH-A1FH,1149,TCGA-BH-A1FH,BRCA,47.0,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998.0,[Not Available],-17172.0,Dead,WITH TUMOR,,1034.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1034.0,1.0,1034.0,,,1.0,1034.0,
TCGA-4H-AAAK,509,TCGA-4H-AAAK,BRCA,50.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18371.0,Alive,TUMOR FREE,348.0,,[Not Available],,,,,[Not Available],Negative,,0.0,348.0,0.0,348.0,0.0,348.0,0.0,348.0,
TCGA-VS-A9UL,1872,TCGA-VS-A9UL,CESC,79.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29033.0,Dead,WITH TUMOR,,442.0,Cervical Cancer,Distant Metastasis,,Bone,336.0,Progressive Disease,,,1.0,442.0,1.0,442.0,,,1.0,336.0,
TCGA-DD-A4NK,5561,TCGA-DD-A4NK,LIHC,80.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2004.0,[Not Available],-29244.0,Dead,WITH TUMOR,,1210.0,[Not Available],Intrahepatic Recurrence,Liver,,89.0,[Not Available],,R0,1.0,1210.0,1.0,1210.0,1.0,89.0,1.0,89.0,
TCGA-N9-A4PZ,11056,TCGA-N9-A4PZ,UCS,77.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28211.0,Dead,WITH TUMOR,,667.0,[Not Available],Locoregional Recurrence,Pelvis,,487.0,Complete Remission/Response,,,1.0,667.0,1.0,667.0,1.0,487.0,1.0,487.0,
TCGA-W3-A828,9228,TCGA-W3-A828,SKCM,66.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1997.0,[Not Available],-24258.0,Dead,,,3683.0,[Not Available],,,,,[Not Available],,,1.0,3683.0,,3683.0,,,0.0,3683.0,
TCGA-N1-A6IA,8734,TCGA-N1-A6IA,SARC,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-15112.0,Dead,WITH TUMOR,,224.0,[Not Available],Distant Metastasis,Lung,,116.0,[Not Available],[Unknown],RX,1.0,224.0,1.0,224.0,,,1.0,116.0,
TCGA-DD-A114,5515,TCGA-DD-A114,LIHC,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2005.0,[Not Available],-15410.0,Dead,TUMOR FREE,,1149.0,[Not Available],,,,,[Not Available],,R0,1.0,1149.0,0.0,1149.0,0.0,1149.0,0.0,1149.0,
TCGA-SA-A6C2,7793,TCGA-SA-A6C2,PCPG,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2012.0,[Not Available],-16805.0,Alive,TUMOR FREE,296.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,296.0,0.0,296.0,0.0,296.0,0.0,296.0,
TCGA-EB-A550,8968,TCGA-EB-A550,SKCM,75.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-27556.0,Dead,TUMOR FREE,,264.0,[Not Available],,,,,[Not Available],,,1.0,264.0,0.0,264.0,,,0.0,264.0,
TCGA-LL-A50Y,1533,TCGA-LL-A50Y,BRCA,84.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30934.0,Alive,TUMOR FREE,762.0,,[Not Available],,,,,[Not Available],Negative,,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,
TCGA-IW-A3M6,8707,TCGA-IW-A3M6,SARC,59.0,FEMALE,ASIAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-21674.0,Alive,TUMOR FREE,688.0,,[Not Available],,,,,[Not Available],[Not Available],R0,0.0,688.0,0.0,688.0,0.0,688.0,0.0,688.0,
TCGA-06-0140,2753,TCGA-06-0140,GBM,86.0,MALE,WHITE,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2003.0,[Not Available],-31566.0,Dead,WITH TUMOR,,6.0,[Not Available],,,,,[Not Available],,,1.0,6.0,1.0,6.0,,,1.0,6.0,
TCGA-BF-AAP7,8823,TCGA-BF-AAP7,SKCM,76.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-28073.0,Alive,TUMOR FREE,318.0,,[Not Available],,,,,[Not Available],,,0.0,318.0,0.0,318.0,,,0.0,318.0,
TCGA-46-6026,6497,TCGA-46-6026,LUSC,81.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-29890.0,Alive,TUMOR FREE,423.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,423.0,0.0,423.0,0.0,423.0,0.0,423.0,
TCGA-AC-A8OP,799,TCGA-AC-A8OP,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26550.0,Alive,TUMOR FREE,614.0,,[Not Available],,,,,[Not Available],Negative,,0.0,614.0,0.0,614.0,0.0,614.0,0.0,614.0,
TCGA-AX-A1CF,10638,TCGA-AX-A1CF,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2004.0,[Not Available],-25300.0,Alive,WITH TUMOR,2337.0,,[Not Available],,,,875.0,Progressive Disease,,,0.0,2337.0,0.0,2337.0,,,1.0,875.0,
TCGA-75-6203,6130,TCGA-75-6203,LUAD,,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],,Alive,TUMOR FREE,,,[Not Available],,,,,Complete Remission/Response,,,0.0,,0.0,,0.0,,0.0,,
TCGA-FC-A4JI,8009,TCGA-FC-A4JI,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-25931.0,Alive,TUMOR FREE,877.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,877.0,0.0,877.0,0.0,877.0,0.0,877.0,
TCGA-DU-7306,5030,TCGA-DU-7306,LGG,67.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2008.0,[Not Available],-24800.0,Alive,WITH TUMOR,1277.0,,[Not Available],,,,1250.0,Progressive Disease,,,0.0,1277.0,0.0,1277.0,,,1.0,1250.0,
TCGA-DK-AA6T,223,TCGA-DK-AA6T,BLCA,63.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-23198.0,Alive,TUMOR FREE,572.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,572.0,0.0,572.0,0.0,572.0,0.0,572.0,
TCGA-BP-4989,4222,TCGA-BP-4989,KIRC,58.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-21382.0,Alive,TUMOR FREE,118.0,,[Not Available],,,,,[Not Available],,,0.0,118.0,0.0,118.0,,,0.0,118.0,
TCGA-EW-A2FR,1485,TCGA-EW-A2FR,BRCA,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21628.0,Alive,TUMOR FREE,1673.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1673.0,0.0,1673.0,0.0,1673.0,0.0,1673.0,
TCGA-DK-AA6U,224,TCGA-DK-AA6U,BLCA,64.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),[Unknown],2013.0,[Not Available],-23611.0,Alive,TUMOR FREE,578.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,
TCGA-HT-7884,5200,TCGA-HT-7884,LGG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-16280.0,Alive,[Discrepancy],343.0,,[Not Available],,,,,Stable Disease,,,0.0,343.0,0.0,343.0,,,0.0,343.0,
TCGA-DX-A8BO,8641,TCGA-DX-A8BO,SARC,67.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2011.0,[Not Available],-24513.0,Alive,TUMOR FREE,1240.0,,[Not Available],Locoregional Recurrence,"Other, specify",Calf,333.0,[Not Available],Positive,R1,0.0,1240.0,0.0,1240.0,,,1.0,333.0,
TCGA-DU-8163,5035,TCGA-DU-8163,LGG,29.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-10824.0,Alive,WITH TUMOR,629.0,,[Not Available],,,,509.0,Progressive Disease,,,0.0,629.0,0.0,629.0,,,1.0,509.0,
TCGA-FE-A230,10257,TCGA-FE-A230,THCA,30.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-10999.0,Alive,TUMOR FREE,2173.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,526.0,[Not Available],,R0,0.0,2173.0,0.0,2173.0,1.0,526.0,1.0,526.0,
TCGA-B0-5699,4057,TCGA-B0-5699,KIRC,53.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2003.0,[Not Available],-19647.0,Alive,TUMOR FREE,3841.0,,[Not Available],,,,94.0,Complete Remission/Response,,,0.0,3841.0,0.0,3841.0,1.0,94.0,1.0,94.0,
TCGA-YU-A90W,9830,TCGA-YU-A90W,TGCT,45.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2011.0,[Not Available],-16497.0,Alive,TUMOR FREE,1113.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,1113.0,0.0,1113.0,0.0,1113.0,0.0,1113.0,
TCGA-DJ-A13T,9924,TCGA-DJ-A13T,THCA,37.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-13668.0,Alive,TUMOR FREE,1709.0,,[Not Available],,,,,[Not Available],,R0,0.0,1709.0,0.0,1709.0,0.0,1709.0,0.0,1709.0,
TCGA-14-1823,3032,TCGA-14-1823,GBM,58.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-21384.0,Dead,WITH TUMOR,543.0,543.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],140.0,[Not Available],,,1.0,543.0,1.0,543.0,,,1.0,140.0,
TCGA-XF-AAN0,460,TCGA-XF-AAN0,BLCA,68.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-24877.0,Dead,WITH TUMOR,,1718.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Scrotum and Perineum,603.0,Complete Remission/Response,,,1.0,1718.0,1.0,1718.0,,,1.0,603.0,
TCGA-EL-A3ZG,10093,TCGA-EL-A3ZG,THCA,15.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-5612.0,Alive,TUMOR FREE,2724.0,,[Not Available],,,,,[Not Available],,R0,0.0,2724.0,0.0,2724.0,0.0,2724.0,0.0,2724.0,
TCGA-EJ-5527,7939,TCGA-EJ-5527,PRAD,69.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-25234.0,Alive,TUMOR FREE,1778.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1778.0,0.0,1778.0,0.0,1778.0,0.0,1778.0,
TCGA-77-7141,6665,TCGA-77-7141,LUSC,64.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-23584.0,Alive,,15.0,,[Not Available],,,,,[Not Available],,,0.0,15.0,0.0,15.0,,,0.0,15.0,
TCGA-SL-A6J9,11022,TCGA-SL-A6J9,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26701.0,Alive,,2.0,,[Not Available],,,,,[Unknown],,,0.0,2.0,0.0,2.0,,,0.0,2.0,
TCGA-QU-A6IN,8229,TCGA-QU-A6IN,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2003.0,[Not Available],-22286.0,Alive,TUMOR FREE,4264.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4264.0,0.0,4264.0,0.0,4264.0,0.0,4264.0,
TCGA-DX-A8BP,8642,TCGA-DX-A8BP,SARC,85.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2009.0,[Not Available],-31382.0,Alive,WITH TUMOR,428.0,,[Not Available],Distant Metastasis,Lung,,216.0,[Not Available],Positive,R1,0.0,428.0,0.0,428.0,,,1.0,216.0,
TCGA-AZ-6601,2228,TCGA-AZ-6601,COAD,68.0,MALE,WHITE,Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2001.0,[Not Available],-25082.0,Dead,WITH TUMOR,,3042.0,[Not Available],Locoregional Disease,,,2270.0,Progressive Disease,,,1.0,3042.0,1.0,3042.0,,,1.0,2270.0,
TCGA-02-0003,2647,TCGA-02-0003,GBM,50.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-18341.0,Dead,WITH TUMOR,144.0,144.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],40.0,[Not Available],,,1.0,144.0,1.0,144.0,,,1.0,40.0,
TCGA-VD-A8KL,11130,TCGA-VD-A8KL,UVM,77.0,FEMALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,[Not Available],2013.0,[Not Available],-28450.0,Alive,TUMOR FREE,638.0,,[Not Available],,,,,[Not Available],,,0.0,638.0,0.0,638.0,,,0.0,638.0,
TCGA-BP-4975,4212,TCGA-BP-4975,KIRC,40.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-14710.0,Alive,TUMOR FREE,1433.0,,[Not Available],,,,,[Not Available],,,0.0,1433.0,0.0,1433.0,,,0.0,1433.0,
TCGA-BR-8483,9369,TCGA-BR-8483,STAD,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-21731.0,Alive,TUMOR FREE,164.0,,[Not Available],,,,,[Unknown],,,0.0,164.0,0.0,164.0,,,0.0,164.0,
TCGA-BH-A0BW,1055,TCGA-BH-A0BW,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25974.0,Alive,TUMOR FREE,2371.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2371.0,0.0,2371.0,0.0,2371.0,0.0,2371.0,
TCGA-AR-A0TR,900,TCGA-AR-A0TR,BRCA,68.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25190.0,Dead,,,160.0,[Not Available],,,,,[Not Available],Negative,,1.0,160.0,,160.0,0.0,160.0,0.0,160.0,
TCGA-FU-A2QG,1755,TCGA-FU-A2QG,CESC,29.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2011.0,Peri (6-12 months since last menstrual period),-10865.0,Alive,TUMOR FREE,579.0,,,,,,,Complete Remission/Response,,,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,
TCGA-AH-6903,8471,TCGA-AH-6903,READ,46.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-17030.0,Alive,TUMOR FREE,592.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,592.0,0.0,592.0,0.0,592.0,0.0,592.0,
TCGA-CQ-5326,3379,TCGA-CQ-5326,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2007.0,[Not Available],-24473.0,Dead,WITH TUMOR,,89.0,[Not Available],,,,,Progressive Disease,,,1.0,89.0,1.0,89.0,,,1.0,89.0,
TCGA-56-8201,6524,TCGA-56-8201,LUSC,74.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-27211.0,Dead,WITH TUMOR,,397.0,[Not Available],,,,,[Unknown],,,1.0,397.0,1.0,397.0,,,1.0,397.0,
TCGA-EJ-A7NM,7998,TCGA-EJ-A7NM,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2013.0,[Not Available],-23603.0,Alive,TUMOR FREE,128.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,128.0,0.0,128.0,0.0,128.0,0.0,128.0,
TCGA-EL-A3T1,10084,TCGA-EL-A3T1,THCA,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002.0,[Not Available],-14025.0,Alive,TUMOR FREE,3941.0,,[Not Available],,,,,[Not Available],,R0,0.0,3941.0,0.0,3941.0,0.0,3941.0,0.0,3941.0,
TCGA-22-5481,6390,TCGA-22-5481,LUSC,72.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-26419.0,Dead,,,2409.0,[Not Available],,,,346.0,Complete Remission/Response,,,1.0,2409.0,,2409.0,1.0,346.0,1.0,346.0,
TCGA-97-8172,6256,TCGA-97-8172,LUAD,75.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-27416.0,Alive,TUMOR FREE,545.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,545.0,0.0,545.0,0.0,545.0,0.0,545.0,
TCGA-A2-A25C,607,TCGA-A2-A25C,BRCA,50.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18508.0,Alive,TUMOR FREE,523.0,,[Not Available],,,,,[Not Available],Negative,,0.0,523.0,0.0,523.0,0.0,523.0,0.0,523.0,
TCGA-GV-A6ZA,365,TCGA-GV-A6ZA,BLCA,54.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-19871.0,Alive,TUMOR FREE,691.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,691.0,0.0,691.0,0.0,691.0,0.0,691.0,
TCGA-BJ-A3F0,9880,TCGA-BJ-A3F0,THCA,64.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-23545.0,Alive,TUMOR FREE,424.0,,[Not Available],,,,,[Not Available],,R0,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,
TCGA-05-4382,5807,TCGA-05-4382,LUAD,68.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-24868.0,Alive,TUMOR FREE,607.0,,[Not Available],Distant Metastasis,,,334.0,Complete Remission/Response,,,0.0,607.0,0.0,607.0,1.0,334.0,1.0,334.0,
TCGA-OR-A5JI,18,TCGA-OR-A5JI,ACC,22.0,MALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-8177.0,Alive,TUMOR FREE,2331.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2331.0,0.0,2331.0,0.0,2331.0,0.0,2331.0,
TCGA-CN-4727,3306,TCGA-CN-4727,HNSC,56.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-20748.0,Alive,TUMOR FREE,1560.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1560.0,0.0,1560.0,,,0.0,1560.0,
TCGA-J8-A4HY,10330,TCGA-J8-A4HY,THCA,68.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-25106.0,Alive,TUMOR FREE,6.0,,[Not Available],,,,,[Not Available],,R0,0.0,6.0,0.0,6.0,,,0.0,6.0,
TCGA-D5-6924,2317,TCGA-D5-6924,COAD,68.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-24964.0,Alive,TUMOR FREE,435.0,,[Not Available],,,,,[Not Available],,,0.0,435.0,0.0,435.0,,,0.0,435.0,
TCGA-69-8254,6107,TCGA-69-8254,LUAD,85.0,MALE,WHITE,[Not Available],[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-31134.0,Alive,TUMOR FREE,409.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,409.0,0.0,409.0,0.0,409.0,0.0,409.0,
TCGA-CS-4941,4912,TCGA-CS-4941,LGG,67.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2005.0,[Not Available],-24578.0,Dead,WITH TUMOR,,234.0,[Not Available],,,,9.0,Stable Disease,,,1.0,234.0,1.0,234.0,,,1.0,9.0,
TCGA-BF-A5EQ,8812,TCGA-BF-A5EQ,SKCM,63.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-23353.0,Alive,TUMOR FREE,323.0,,[Not Available],,,,,[Not Available],,,0.0,323.0,0.0,323.0,,,0.0,323.0,
TCGA-MT-A67A,3698,TCGA-MT-A67A,HNSC,85.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-31161.0,Alive,TUMOR FREE,914.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,914.0,0.0,914.0,0.0,914.0,0.0,914.0,
TCGA-CH-5752,7890,TCGA-CH-5752,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-24290.0,Alive,TUMOR FREE,943.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,
TCGA-05-5425,5834,TCGA-05-5425,LUAD,68.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-25020.0,Alive,WITH TUMOR,882.0,,[Not Available],,,,486.0,[Not Applicable],,,0.0,882.0,0.0,882.0,,,1.0,486.0,
TCGA-MX-A5UJ,9616,TCGA-MX-A5UJ,STAD,86.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-31517.0,Alive,TUMOR FREE,600.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,
TCGA-CG-4437,9450,TCGA-CG-4437,STAD,83.0,MALE,[Not Available],Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2006.0,[Not Available],-30467.0,Alive,TUMOR FREE,245.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,245.0,0.0,245.0,0.0,245.0,0.0,245.0,
TCGA-EE-A3JA,9081,TCGA-EE-A3JA,SKCM,44.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2006.0,[Not Available],-16430.0,Dead,WITH TUMOR,,1618.0,[Not Available],Regional lymph node,,,539.0,[Not Available],,,1.0,1618.0,1.0,1618.0,,,1.0,539.0,
TCGA-V4-A9EM,11098,TCGA-V4-A9EM,UVM,53.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell,[Not Available],2012.0,[Not Available],-19413.0,Alive,TUMOR FREE,966.0,,[Not Available],,,,,[Not Available],,,0.0,966.0,0.0,966.0,,,0.0,966.0,
TCGA-IB-7645,7619,TCGA-IB-7645,PAAD,44.0,FEMALE,[Unknown],Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2007.0,[Not Available],-16126.0,Dead,WITH TUMOR,,1502.0,Pancreatic Cancer,Distant Metastasis,Liver,,984.0,Progressive Disease,,,1.0,1502.0,1.0,1502.0,,,1.0,984.0,
TCGA-FS-A1ZW,9168,TCGA-FS-A1ZW,SKCM,65.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2005.0,[Not Available],-24087.0,Alive,TUMOR FREE,1505.0,,[Not Available],,,,,[Not Available],,,0.0,1505.0,0.0,1505.0,,,0.0,1505.0,
TCGA-KQ-A41R,389,TCGA-KQ-A41R,BLCA,80.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-29351.0,Alive,TUMOR FREE,1350.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1350.0,0.0,1350.0,0.0,1350.0,0.0,1350.0,
TCGA-33-6737,6408,TCGA-33-6737,LUSC,71.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-26033.0,Dead,WITH TUMOR,,601.0,[Not Available],,,,,Progressive Disease,,,1.0,601.0,1.0,601.0,,,1.0,601.0,
TCGA-EW-A2FW,1488,TCGA-EW-A2FW,BRCA,52.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19085.0,Alive,TUMOR FREE,672.0,,[Not Available],,,,,[Not Available],Negative,,0.0,672.0,0.0,672.0,0.0,672.0,0.0,672.0,
TCGA-DD-A4NJ,5560,TCGA-DD-A4NJ,LIHC,54.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-19964.0,Alive,WITH TUMOR,928.0,,[Not Available],Intrahepatic Recurrence,Liver,,549.0,[Not Available],,R0,0.0,928.0,0.0,928.0,1.0,549.0,1.0,549.0,
TCGA-EY-A3L3,10973,TCGA-EY-A3L3,UCEC,82.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30138.0,Alive,TUMOR FREE,832.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,832.0,0.0,832.0,0.0,832.0,0.0,832.0,
TCGA-44-6145,5873,TCGA-44-6145,LUAD,62.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22745.0,Alive,TUMOR FREE,595.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,
TCGA-D8-A1JS,1251,TCGA-D8-A1JS,BRCA,77.0,FEMALE,WHITE,Stage IA,[Not Applicable],"Other, specify",[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28178.0,Alive,TUMOR FREE,371.0,,[Not Available],,,,,[Not Available],Negative,,0.0,371.0,0.0,371.0,0.0,371.0,0.0,371.0,
TCGA-49-6744,5916,TCGA-49-6744,LUAD,64.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-23484.0,Alive,TUMOR FREE,1683.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1683.0,0.0,1683.0,0.0,1683.0,0.0,1683.0,
TCGA-VS-A8EG,1838,TCGA-VS-A8EG,CESC,36.0,FEMALE,[Unknown],[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,GX,2011.0,Peri (6-12 months since last menstrual period),-13166.0,Alive,TUMOR FREE,1386.0,,,,,,,Complete Remission/Response,,,0.0,1386.0,0.0,1386.0,0.0,1386.0,0.0,1386.0,
TCGA-85-8666,6737,TCGA-85-8666,LUSC,65.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-23906.0,Dead,TUMOR FREE,,687.0,[Not Available],,,,,Complete Remission/Response,,,1.0,687.0,0.0,687.0,0.0,687.0,0.0,687.0,
TCGA-77-8136,6679,TCGA-77-8136,LUSC,74.0,FEMALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-27193.0,Dead,,,1189.0,[Not Available],Distant Metastasis,,,301.0,[Not Applicable],,,1.0,1189.0,,1189.0,,,1.0,301.0,
TCGA-D5-6535,2306,TCGA-D5-6535,COAD,80.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-29278.0,Alive,TUMOR FREE,460.0,,[Not Available],,,,,[Not Available],,,0.0,460.0,0.0,460.0,,,0.0,460.0,
TCGA-EJ-5532,7942,TCGA-EJ-5532,PRAD,57.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-21110.0,Alive,TUMOR FREE,1828.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1828.0,0.0,1828.0,0.0,1828.0,0.0,1828.0,
TCGA-D8-A1JC,1238,TCGA-D8-A1JC,BRCA,59.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21898.0,Alive,TUMOR FREE,480.0,,[Not Available],,,,,[Not Available],Negative,,0.0,480.0,0.0,480.0,0.0,480.0,0.0,480.0,
TCGA-BR-A44T,9389,TCGA-BR-A44T,STAD,53.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-19407.0,Alive,WITH TUMOR,1038.0,,[Not Available],Locoregional Recurrence,,,682.0,Complete Remission/Response,,,0.0,1038.0,0.0,1038.0,1.0,682.0,1.0,682.0,
TCGA-S9-A6WI,5341,TCGA-S9-A6WI,LGG,56.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2006.0,[Not Available],-20609.0,Alive,WITH TUMOR,2585.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,2585.0,0.0,2585.0,,,0.0,2585.0,
TCGA-Z7-A8R6,1601,TCGA-Z7-A8R6,BRCA,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16955.0,Alive,TUMOR FREE,3256.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3256.0,0.0,3256.0,0.0,3256.0,0.0,3256.0,
TCGA-CF-A9FL,170,TCGA-CF-A9FL,BLCA,85.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-31099.0,Dead,WITH TUMOR,,565.0,[Not Available],Locoregional (Urothelial tumor event),,,322.0,Complete Remission/Response,,,1.0,565.0,1.0,565.0,1.0,322.0,1.0,322.0,
TCGA-A6-2674,1963,TCGA-A6-2674,COAD,71.0,MALE,WHITE,Stage IV,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2009.0,[Not Available],-26292.0,Alive,TUMOR FREE,1331.0,,[Not Available],,,,735.0,Complete Remission/Response,,,0.0,1331.0,0.0,1331.0,,,1.0,735.0,
TCGA-HT-7477,5150,TCGA-HT-7477,LGG,62.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2011.0,[Not Available],-22948.0,Alive,TUMOR FREE,738.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,738.0,0.0,738.0,0.0,738.0,0.0,738.0,
TCGA-V7-A7HQ,1594,TCGA-V7-A7HQ,BRCA,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27684.0,Alive,TUMOR FREE,2033.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2033.0,0.0,2033.0,0.0,2033.0,0.0,2033.0,
TCGA-JW-A5VH,1785,TCGA-JW-A5VH,CESC,53.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IVB,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19423.0,Dead,WITH TUMOR,,100.0,Cervical Cancer,Distant Metastasis,"Other, specify",Brain,94.0,Progressive Disease,,,1.0,100.0,1.0,100.0,,,1.0,94.0,
TCGA-BB-7870,3290,TCGA-BB-7870,HNSC,58.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2009.0,[Not Available],-21443.0,Alive,TUMOR FREE,2016.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2016.0,0.0,2016.0,,,0.0,2016.0,
TCGA-NH-A8F7,2401,TCGA-NH-A8F7,COAD,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2013.0,[Not Available],-19535.0,Alive,WITH TUMOR,543.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,543.0,0.0,543.0,,,0.0,543.0,
TCGA-D8-A141,1228,TCGA-D8-A141,BRCA,40.0,FEMALE,WHITE,[Not Available],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Indeterminate (neither Pre or Postmenopausal),-14626.0,Alive,TUMOR FREE,626.0,,[Not Available],,,,,[Not Available],Negative,,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,
TCGA-EE-A20H,9004,TCGA-EE-A20H,SKCM,56.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1995.0,[Not Available],-20476.0,Dead,WITH TUMOR,,5118.0,[Not Available],Regional lymph node,,,4667.0,[Not Available],,,1.0,5118.0,1.0,5118.0,,,1.0,4667.0,
TCGA-DQ-7588,3635,TCGA-DQ-7588,HNSC,66.0,MALE,WHITE,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-24106.0,Dead,WITH TUMOR,,427.0,[Not Available],,Oral Cavity,,79.0,Persistent Disease,,,1.0,427.0,1.0,427.0,,,1.0,79.0,
TCGA-HC-7213,8071,TCGA-HC-7213,PRAD,53.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-19699.0,Alive,TUMOR FREE,1219.0,,[Not Available],Biochemical evidence of disease,,,170.0,Partial Remission/Response,,,0.0,1219.0,0.0,1219.0,,,1.0,170.0,
TCGA-MP-A4SV,6295,TCGA-MP-A4SV,LUAD,67.0,MALE,[Unknown],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-24516.0,Dead,,,2620.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2620.0,,2620.0,0.0,2620.0,0.0,2620.0,
TCGA-EI-6883,8516,TCGA-EI-6883,READ,63.0,MALE,WHITE,Stage IIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-23268.0,Alive,TUMOR FREE,350.0,,[Not Available],,,,,[Not Available],,,0.0,350.0,0.0,350.0,,,0.0,350.0,
TCGA-Q1-A6DV,1823,TCGA-Q1-A6DV,CESC,36.0,FEMALE,ASIAN,[Not Available],Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13166.0,Alive,TUMOR FREE,491.0,,,,,,,Complete Remission/Response,,,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,
TCGA-N5-A4RU,11034,TCGA-N5-A4RU,UCS,54.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20025.0,Dead,WITH TUMOR,,1526.0,[Not Available],Locoregional Recurrence,Pelvis,,253.0,Complete Remission/Response,,,1.0,1526.0,1.0,1526.0,1.0,253.0,1.0,253.0,
TCGA-2Y-A9H6,5441,TCGA-2Y-A9H6,LIHC,68.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-24982.0,Alive,,357.0,,[Not Available],,,,,[Not Available],,R0,0.0,357.0,0.0,357.0,0.0,357.0,0.0,357.0,
TCGA-CQ-6219,3388,TCGA-CQ-6219,HNSC,50.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-18578.0,Dead,WITH TUMOR,,479.0,[Not Available],,Cervical Lymph Nodes,,195.0,Complete Remission/Response,,,1.0,479.0,1.0,479.0,,,1.0,195.0,
TCGA-3A-A9IB,7529,TCGA-3A-A9IB,PAAD,69.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-25312.0,Dead,,,224.0,,,,,,[Unknown],,,1.0,224.0,,224.0,,,0.0,224.0,
TCGA-AK-3456,3957,TCGA-AK-3456,KIRC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-17821.0,Alive,,1143.0,,[Not Available],,,,,[Not Available],,,0.0,1143.0,0.0,1143.0,,,0.0,1143.0,
TCGA-DU-6392,4991,TCGA-DU-6392,LGG,35.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,1993.0,[Not Available],-12836.0,Alive,TUMOR FREE,6423.0,,[Not Available],,,,950.0,Progressive Disease,,,0.0,6423.0,0.0,6423.0,,,1.0,950.0,
TCGA-TT-A6YK,7816,TCGA-TT-A6YK,PCPG,61.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2011.0,[Not Available],-22500.0,Alive,TUMOR FREE,1136.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1136.0,0.0,1136.0,0.0,1136.0,0.0,1136.0,
TCGA-CF-A8HX,166,TCGA-CF-A8HX,BLCA,55.0,FEMALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-20259.0,Alive,TUMOR FREE,345.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,345.0,0.0,345.0,0.0,345.0,0.0,345.0,
TCGA-HR-A5NC,9215,TCGA-HR-A5NC,SKCM,90.0,FEMALE,[Not Evaluated],[Not Available],[Not Applicable],,[Not Available],,[Not Available],-32871.0,Alive,TUMOR FREE,1000.0,,[Not Available],Locoregional Recurrence,,,154.0,[Not Available],,,0.0,1000.0,0.0,1000.0,,,1.0,154.0,
TCGA-B6-A0RM,992,TCGA-B6-A0RM,BRCA,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1993.0,Indeterminate (neither Pre or Postmenopausal),-21047.0,Dead,TUMOR FREE,,2373.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,2373.0,0.0,2373.0,,,0.0,2373.0,
TCGA-5P-A9K8,4457,TCGA-5P-A9K8,KIRP,51.0,FEMALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-18880.0,Alive,TUMOR FREE,1309.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1309.0,0.0,1309.0,0.0,1309.0,0.0,1309.0,
TCGA-15-0742,3041,TCGA-15-0742,GBM,65.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-24050.0,Dead,,,419.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],232.0,[Not Available],,,1.0,419.0,,419.0,,,1.0,232.0,
TCGA-D3-A5GS,8880,TCGA-D3-A5GS,SKCM,58.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2012.0,[Not Available],-21379.0,Alive,WITH TUMOR,553.0,,[Not Available],Distant Metastasis,Bone,,44.0,[Not Available],,,0.0,553.0,0.0,553.0,,,1.0,44.0,
TCGA-AG-4021,8440,TCGA-AG-4021,READ,84.0,FEMALE,[Not Available],Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2005.0,[Not Available],-31015.0,Dead,WITH TUMOR,,121.0,[Not Available],,,,0.0,[Not Available],,,1.0,121.0,1.0,121.0,,,1.0,0.0,
TCGA-LN-A4A3,2573,TCGA-LN-A4A3,ESCA,61.0,MALE,ASIAN,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,G2,2011.0,[Not Available],-22313.0,Alive,TUMOR FREE,388.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,388.0,0.0,388.0,0.0,388.0,0.0,388.0,
TCGA-B5-A1N2,10723,TCGA-B5-A1N2,UCEC,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25612.0,Dead,WITH TUMOR,,954.0,[Not Available],Distant Metastasis,Brain,,804.0,Complete Remission/Response,,,1.0,954.0,1.0,954.0,1.0,804.0,1.0,804.0,
TCGA-VQ-A91Z,9685,TCGA-VQ-A91Z,STAD,67.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-24652.0,Alive,WITH TUMOR,1690.0,,[Not Available],Locoregional Recurrence,,,1310.0,Complete Remission/Response,,,0.0,1690.0,0.0,1690.0,1.0,1310.0,1.0,1310.0,
TCGA-L9-A444,6286,TCGA-L9-A444,LUAD,60.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22202.0,Alive,TUMOR FREE,307.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,307.0,0.0,307.0,0.0,307.0,0.0,307.0,
TCGA-44-3396,5863,TCGA-44-3396,LUAD,74.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-27073.0,Alive,TUMOR FREE,1130.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1130.0,0.0,1130.0,0.0,1130.0,0.0,1130.0,
TCGA-55-1595,5969,TCGA-55-1595,LUAD,74.0,FEMALE,ASIAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],,Alive,TUMOR FREE,1479.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1479.0,0.0,1479.0,0.0,1479.0,0.0,1479.0,
TCGA-5K-AAAP,10379,TCGA-5K-AAAP,THYM,54.0,MALE,WHITE,[Not Applicable],III,Thymoma; Type A,[Not Available],2010.0,[Not Available],-19939.0,Alive,TUMOR FREE,1054.0,,[Not Available],,,,,[Not Available],,,0.0,1054.0,0.0,1054.0,,,0.0,1054.0,
TCGA-X7-A8D8,10386,TCGA-X7-A8D8,THYM,53.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type AB,[Not Available],2005.0,[Not Available],-19441.0,Alive,TUMOR FREE,58.0,,[Not Available],,,,,[Not Available],,,0.0,58.0,0.0,58.0,,,0.0,58.0,
TCGA-AJ-A3BD,10533,TCGA-AJ-A3BD,UCEC,57.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20998.0,Alive,TUMOR FREE,1039.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1039.0,0.0,1039.0,0.0,1039.0,0.0,1039.0,
TCGA-A2-A0EP,560,TCGA-A2-A0EP,BRCA,56.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20585.0,Alive,TUMOR FREE,3603.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3603.0,0.0,3603.0,0.0,3603.0,0.0,3603.0,
TCGA-X6-A7W8,8781,TCGA-X6-A7W8,SARC,89.0,MALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2011.0,[Not Available],-32848.0,Dead,WITH TUMOR,,804.0,[Not Available],Distant Metastasis,Lung,,146.0,[Not Available],Positive,R1,1.0,804.0,1.0,804.0,,,1.0,146.0,
TCGA-SR-A6MV,7810,TCGA-SR-A6MV,PCPG,35.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2004.0,[Not Available],-13074.0,Alive,WITH TUMOR,3682.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,3682.0,0.0,3682.0,,,0.0,3682.0,
TCGA-VR-AA7I,2636,TCGA-VR-AA7I,ESCA,70.0,MALE,WHITE,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,G1,2010.0,[Not Available],-25855.0,Dead,WITH TUMOR,,484.0,[Not Available],,,,,,,,1.0,484.0,1.0,484.0,,,1.0,484.0,
TCGA-A1-A0SK,521,TCGA-A1-A0SK,BRCA,54.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2007.0,Indeterminate (neither Pre or Postmenopausal),-20048.0,Dead,WITH TUMOR,,967.0,[Not Available],,,,,[Not Available],Negative,,1.0,967.0,1.0,967.0,,,1.0,967.0,
TCGA-HC-7231,8073,TCGA-HC-7231,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24278.0,Alive,TUMOR FREE,939.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,939.0,0.0,939.0,0.0,939.0,0.0,939.0,
TCGA-EJ-7312,7948,TCGA-EJ-7312,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21292.0,Alive,TUMOR FREE,1099.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1099.0,0.0,1099.0,0.0,1099.0,0.0,1099.0,
TCGA-YL-A9WI,8337,TCGA-YL-A9WI,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-23184.0,Alive,TUMOR FREE,1623.0,,[Not Available],,,,,Stable Disease,,,0.0,1623.0,0.0,1623.0,,,0.0,1623.0,
TCGA-HW-7495,5250,TCGA-HW-7495,LGG,45.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-16460.0,Alive,WITH TUMOR,1078.0,,[Not Available],,,,,Progressive Disease,,,0.0,1078.0,0.0,1078.0,,,0.0,1078.0,
TCGA-PN-A8MA,1818,TCGA-PN-A8MA,CESC,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15918.0,Alive,WITH TUMOR,90.0,,,,,,,Stable Disease,,,0.0,90.0,0.0,90.0,,,0.0,90.0,
TCGA-86-8055,6188,TCGA-86-8055,LUAD,79.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-29124.0,Dead,TUMOR FREE,,124.0,[Not Available],,,,,Complete Remission/Response,,,1.0,124.0,0.0,124.0,0.0,124.0,0.0,124.0,
TCGA-DD-AAEG,5647,TCGA-DD-AAEG,LIHC,59.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-21853.0,Alive,TUMOR FREE,719.0,,[Not Available],,,,,[Not Available],,R0,0.0,719.0,0.0,719.0,0.0,719.0,0.0,719.0,
TCGA-G2-A2ES,318,TCGA-G2-A2ES,BLCA,85.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-31293.0,Dead,WITH TUMOR,,1004.0,[Not Available],New Primary Tumor,"Other, specify",,897.0,Progressive Disease,,,1.0,1004.0,1.0,1004.0,,,1.0,897.0,
TCGA-OR-A5LK,74,TCGA-OR-A5LK,ACC,62.0,MALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical Carcinoma- Oncocytic Type,[Not Available],2007.0,[Not Available],-22919.0,Alive,TUMOR FREE,2740.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2740.0,0.0,2740.0,0.0,2740.0,0.0,2740.0,
TCGA-D7-A4YX,9515,TCGA-D7-A4YX,STAD,63.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-23249.0,Alive,TUMOR FREE,1108.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1108.0,0.0,1108.0,0.0,1108.0,0.0,1108.0,
TCGA-GN-A8LN,9211,TCGA-GN-A8LN,SKCM,68.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-24872.0,Alive,WITH TUMOR,772.0,,[Not Available],New primary melanoma,,,186.0,[Not Available],,,0.0,772.0,0.0,772.0,,,1.0,186.0,
TCGA-E3-A3DY,10014,TCGA-E3-A3DY,THCA,37.0,MALE,WHITE,Stage I,[Not Applicable],"Other, specify",[Not Available],2007.0,[Not Available],-13860.0,Alive,TUMOR FREE,2815.0,,[Not Available],,,,,[Not Available],,R0,0.0,2815.0,0.0,2815.0,0.0,2815.0,0.0,2815.0,
TCGA-XF-AAMX,457,TCGA-XF-AAMX,BLCA,87.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-31884.0,Dead,TUMOR FREE,,206.0,[Not Available],,,,,Complete Remission/Response,,,1.0,206.0,0.0,206.0,0.0,206.0,0.0,206.0,
TCGA-L6-A4EP,10343,TCGA-L6-A4EP,THCA,41.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-15292.0,Alive,TUMOR FREE,1016.0,,[Not Available],,,,,[Not Available],,R0,0.0,1016.0,0.0,1016.0,0.0,1016.0,0.0,1016.0,
TCGA-MB-A8JK,8727,TCGA-MB-A8JK,SARC,49.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013.0,[Not Available],-18177.0,Alive,TUMOR FREE,661.0,,[Not Available],,,,,[Not Available],Negative,RX,0.0,661.0,0.0,661.0,,,0.0,661.0,
TCGA-IQ-7630,3679,TCGA-IQ-7630,HNSC,49.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2011.0,[Not Available],-18131.0,Alive,TUMOR FREE,485.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,
TCGA-CV-5973,3485,TCGA-CV-5973,HNSC,62.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2005.0,[Not Available],-22771.0,Alive,TUMOR FREE,2641.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2641.0,0.0,2641.0,0.0,2641.0,0.0,2641.0,
TCGA-GD-A76B,342,TCGA-GD-A76B,BLCA,86.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-31571.0,Alive,TUMOR FREE,224.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,224.0,0.0,224.0,0.0,224.0,0.0,224.0,
TCGA-A2-A0YF,587,TCGA-A2-A0YF,BRCA,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24660.0,Alive,TUMOR FREE,1535.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1535.0,0.0,1535.0,0.0,1535.0,0.0,1535.0,
TCGA-RD-A8N9,9638,TCGA-RD-A8N9,STAD,63.0,FEMALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2009.0,[Not Available],-23059.0,Alive,TUMOR FREE,1083.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1083.0,0.0,1083.0,0.0,1083.0,0.0,1083.0,
TCGA-DJ-A13R,9922,TCGA-DJ-A13R,THCA,50.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-18354.0,Alive,TUMOR FREE,565.0,,[Not Available],,,,,[Not Available],,R0,0.0,565.0,0.0,565.0,0.0,565.0,0.0,565.0,
TCGA-CN-A49C,3362,TCGA-CN-A49C,HNSC,67.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2012.0,[Not Available],-24495.0,Alive,TUMOR FREE,645.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,645.0,0.0,645.0,,,0.0,645.0,
TCGA-DD-A4NA,5552,TCGA-DD-A4NA,LIHC,67.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Hepatocellular Carcinoma,G3,2009.0,[Not Available],-24603.0,Alive,TUMOR FREE,1008.0,,[Not Available],,,,,[Not Available],,R0,0.0,1008.0,0.0,1008.0,0.0,1008.0,0.0,1008.0,
TCGA-VQ-A922,9686,TCGA-VQ-A922,STAD,70.0,MALE,[Unknown],Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-25700.0,Dead,,262.0,275.0,Stomach Cancer,Distant Metastasis,Liver,,252.0,Progressive Disease,,,1.0,275.0,1.0,275.0,,,1.0,252.0,
TCGA-BS-A0TE,10794,TCGA-BS-A0TE,UCEC,35.0,FEMALE,ASIAN,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12983.0,Dead,WITH TUMOR,,146.0,[Not Available],,,,58.0,Progressive Disease,,,1.0,146.0,1.0,146.0,,,1.0,58.0,
TCGA-43-7658,6483,TCGA-43-7658,LUSC,75.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-27734.0,Dead,WITH TUMOR,,2378.0,[Not Available],Distant Metastasis|New Primary Tumor,,,2305.0,Complete Remission/Response,,,1.0,2378.0,1.0,2378.0,1.0,2305.0,1.0,2305.0,
TCGA-EM-A3AJ,10161,TCGA-EM-A3AJ,THCA,39.0,MALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-14399.0,Alive,TUMOR FREE,941.0,,[Not Available],,,,,[Not Available],,R1,0.0,941.0,0.0,941.0,,,0.0,941.0,
TCGA-G4-6311,2380,TCGA-G4-6311,COAD,80.0,MALE,WHITE,Stage III,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-29297.0,Alive,TUMOR FREE,1199.0,,[Not Available],,,,,[Not Available],,,0.0,1199.0,0.0,1199.0,,,0.0,1199.0,
TCGA-A4-A5XZ,4489,TCGA-A4-A5XZ,KIRP,65.0,FEMALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-24006.0,Alive,TUMOR FREE,479.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,479.0,0.0,479.0,0.0,479.0,0.0,479.0,
TCGA-DX-A7ER,8630,TCGA-DX-A7ER,SARC,69.0,MALE,WHITE,[Not Available],[Not Available],Synovial Sarcoma - Monophasic,[Not Available],2008.0,[Not Available],-25363.0,Dead,TUMOR FREE,,1466.0,[Not Available],,,,,[Not Available],Negative,R0,1.0,1466.0,0.0,1466.0,0.0,1466.0,0.0,1466.0,
TCGA-E7-A5KF,242,TCGA-E7-A5KF,BLCA,67.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,[Not Available],-24528.0,Alive,TUMOR FREE,20.0,,[Not Available],,,,,[Not Available],,,0.0,20.0,0.0,20.0,,,0.0,20.0,
TCGA-EE-A20I,9005,TCGA-EE-A20I,SKCM,79.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2008.0,[Not Available],-28883.0,Dead,WITH TUMOR,,412.0,[Not Available],Distant Metastasis,Brain,,53.0,[Not Available],,,1.0,412.0,1.0,412.0,,,1.0,53.0,
TCGA-VQ-A8PT,9668,TCGA-VQ-A8PT,STAD,65.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-23797.0,Alive,TUMOR FREE,900.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,900.0,0.0,900.0,0.0,900.0,0.0,900.0,
TCGA-06-6699,2885,TCGA-06-6699,GBM,58.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-21190.0,Alive,WITH TUMOR,47.0,,[Not Available],,,,,[Not Available],,,0.0,47.0,0.0,47.0,,,0.0,47.0,
TCGA-DX-AB37,8671,TCGA-DX-AB37,SARC,73.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2003.0,[Not Available],-26696.0,Dead,,,2575.0,[Not Available],,,,,[Not Available],Negative,R0,1.0,2575.0,,2575.0,0.0,2575.0,0.0,2575.0,
TCGA-EB-A1NK,8938,TCGA-EB-A1NK,SKCM,48.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2010.0,[Not Available],-17569.0,Alive,TUMOR FREE,1039.0,,[Not Available],,,,,[Not Available],,,0.0,1039.0,0.0,1039.0,,,0.0,1039.0,
TCGA-71-6725,6111,TCGA-71-6725,LUAD,48.0,FEMALE,ASIAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-17793.0,Alive,WITH TUMOR,256.0,,[Not Available],Locoregional Recurrence,,,164.0,Progressive Disease,,,0.0,256.0,0.0,256.0,,,1.0,164.0,
TCGA-60-2698,6563,TCGA-60-2698,LUSC,62.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1993.0,[Not Available],-22800.0,Dead,WITH TUMOR,,311.0,[Not Available],,,,114.0,[Not Available],,,1.0,311.0,1.0,311.0,,,1.0,114.0,
TCGA-S9-A7R7,5365,TCGA-S9-A7R7,LGG,27.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2006.0,[Not Available],-10108.0,Alive,WITH TUMOR,3000.0,,[Not Available],,,,144.0,Progressive Disease,,,0.0,3000.0,0.0,3000.0,,,1.0,144.0,
TCGA-BT-A20P,127,TCGA-BT-A20P,BLCA,81.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,[Not Available],-29634.0,Dead,,,544.0,[Not Available],,,,,[Not Available],,,1.0,544.0,,544.0,,,0.0,544.0,
TCGA-EM-A1CW,10124,TCGA-EM-A1CW,THCA,39.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-14263.0,Alive,TUMOR FREE,549.0,,[Not Available],,,,,[Not Available],,R0,0.0,549.0,0.0,549.0,0.0,549.0,0.0,549.0,
TCGA-GS-A9U3,2455,TCGA-GS-A9U3,DLBC,77.0,FEMALE,WHITE,[Not Applicable],Stage III,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2005.0,[Not Available],-28474.0,Alive,TUMOR FREE,3394.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3394.0,0.0,3394.0,0.0,3394.0,0.0,3394.0,
TCGA-QR-A70D,7723,TCGA-QR-A70D,PCPG,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Paraganglioma,[Not Available],2012.0,[Not Available],-14412.0,Alive,TUMOR FREE,7.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,7.0,0.0,7.0,0.0,7.0,0.0,7.0,
TCGA-OR-A5KO,45,TCGA-OR-A5KO,ACC,39.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-14606.0,Alive,WITH TUMOR,1414.0,,[Not Available],Distant Metastasis,Lung,,541.0,Progressive Disease,,,0.0,1414.0,0.0,1414.0,,,1.0,541.0,
TCGA-EJ-5505,7920,TCGA-EJ-5505,PRAD,57.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-21164.0,Alive,TUMOR FREE,922.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,922.0,0.0,922.0,0.0,922.0,0.0,922.0,
TCGA-EE-A2MU,9067,TCGA-EE-A2MU,SKCM,71.0,MALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2005.0,[Not Available],-26237.0,Alive,TUMOR FREE,1620.0,,[Not Available],,,,,[Not Available],,,0.0,1620.0,0.0,1620.0,,,0.0,1620.0,
TCGA-X7-A8M1,10397,TCGA-X7-A8M1,THYM,51.0,MALE,ASIAN,[Not Applicable],[Not Available],Thymoma; Type AB,[Not Available],2009.0,[Not Available],-18826.0,Alive,TUMOR FREE,1282.0,,[Not Available],,,,,[Not Available],,,0.0,1282.0,0.0,1282.0,,,0.0,1282.0,
TCGA-AZ-6605,2230,TCGA-AZ-6605,COAD,77.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-28485.0,Dead,TUMOR FREE,,159.0,[Not Available],,,,,Stable Disease,,,1.0,159.0,0.0,159.0,,,0.0,159.0,
TCGA-VQ-A91X,9683,TCGA-VQ-A91X,STAD,74.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,[Not Available],-27314.0,Dead,TUMOR FREE,,289.0,"Other, non-malignant disease",,,,,Complete Remission/Response,,,1.0,289.0,0.0,289.0,0.0,289.0,0.0,289.0,
TCGA-KS-A4I5,10337,TCGA-KS-A4I5,THCA,49.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-17963.0,Alive,TUMOR FREE,567.0,,[Not Available],,,,,[Not Available],,R0,0.0,567.0,0.0,567.0,,,0.0,567.0,
TCGA-EL-A3H5,10074,TCGA-EL-A3H5,THCA,57.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-20926.0,Alive,TUMOR FREE,2542.0,,[Not Available],,,,,[Not Available],,R1,0.0,2542.0,0.0,2542.0,,,0.0,2542.0,
TCGA-HE-A5NK,4625,TCGA-HE-A5NK,KIRP,82.0,MALE,[Not Evaluated],[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-30088.0,Alive,TUMOR FREE,2228.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2228.0,0.0,2228.0,0.0,2228.0,0.0,2228.0,
TCGA-HC-7075,8061,TCGA-HC-7075,PRAD,63.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],,Alive,TUMOR FREE,601.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,601.0,0.0,601.0,0.0,601.0,0.0,601.0,
TCGA-OR-A5J7,7,TCGA-OR-A5J7,ACC,30.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-11279.0,Dead,WITH TUMOR,,490.0,[Not Available],Locoregional Recurrence,Retroperitoneal lymph nodes,,162.0,Progressive Disease,,,1.0,490.0,1.0,490.0,,,1.0,162.0,
TCGA-NH-A50V,2396,TCGA-NH-A50V,COAD,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2012.0,[Not Available],-25467.0,Alive,TUMOR FREE,588.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,
TCGA-HB-A3L4,8684,TCGA-HB-A3L4,SARC,46.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2009.0,[Not Available],-17044.0,Dead,WITH TUMOR,,1061.0,[Not Available],Distant Metastasis,Lung,,326.0,[Not Available],Negative,R0,1.0,1061.0,1.0,1061.0,1.0,326.0,1.0,326.0,
TCGA-27-1830,3117,TCGA-27-1830,GBM,57.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-21131.0,Dead,WITH TUMOR,146.0,154.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],124.0,[Not Available],,,1.0,154.0,1.0,154.0,,,1.0,124.0,
TCGA-P5-A736,5283,TCGA-P5-A736,LGG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-16300.0,Alive,TUMOR FREE,230.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,230.0,0.0,230.0,0.0,230.0,0.0,230.0,
TCGA-94-7557,6767,TCGA-94-7557,LUSC,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26802.0,Dead,TUMOR FREE,,5.0,[Not Available],,,,,Complete Remission/Response,,,1.0,5.0,0.0,5.0,0.0,5.0,0.0,5.0,
TCGA-DK-A2I1,192,TCGA-DK-A2I1,BLCA,73.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-26726.0,Alive,TUMOR FREE,546.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,
TCGA-DJ-A3V7,9987,TCGA-DJ-A3V7,THCA,44.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-16257.0,Alive,TUMOR FREE,706.0,,[Not Available],,,,,[Not Available],,R0,0.0,706.0,0.0,706.0,0.0,706.0,0.0,706.0,
TCGA-KL-8339,3786,TCGA-KL-8339,KICH,67.0,MALE,WHITE,Stage IV,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-24545.0,Dead,WITH TUMOR,,855.0,[Not Available],,,,64.0,[Not Evaluated],,,1.0,855.0,1.0,855.0,,,1.0,64.0,
TCGA-3H-AB3O,6832,TCGA-3H-AB3O,MESO,58.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2008.0,[Not Available],-21423.0,Dead,WITH TUMOR,,1302.0,[Not Available],Intrapleural Progression,Ipsilateral Pleura,,627.0,[Not Available],,[Not Available],1.0,1302.0,1.0,1302.0,,,1.0,627.0,
TCGA-58-A46M,6558,TCGA-58-A46M,LUSC,61.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-22592.0,Alive,TUMOR FREE,1072.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1072.0,0.0,1072.0,0.0,1072.0,0.0,1072.0,
TCGA-D5-6932,2324,TCGA-D5-6932,COAD,69.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-25466.0,Alive,TUMOR FREE,346.0,,[Not Available],,,,,[Not Available],,,0.0,346.0,0.0,346.0,,,0.0,346.0,
TCGA-E2-A15T,1350,TCGA-E2-A15T,BRCA,65.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24054.0,Alive,TUMOR FREE,1563.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1563.0,0.0,1563.0,0.0,1563.0,0.0,1563.0,
TCGA-06-5417,2871,TCGA-06-5417,GBM,45.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-16572.0,Alive,WITH TUMOR,155.0,,[Not Available],,,,,[Not Available],,,0.0,155.0,0.0,155.0,,,0.0,155.0,
TCGA-E9-A1RC,1417,TCGA-E9-A1RC,BRCA,56.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Mixed Histology (please specify),[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20795.0,Alive,TUMOR FREE,1224.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1224.0,0.0,1224.0,0.0,1224.0,0.0,1224.0,
TCGA-GM-A2DM,1510,TCGA-GM-A2DM,BRCA,57.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21160.0,Alive,TUMOR FREE,3226.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3226.0,0.0,3226.0,0.0,3226.0,0.0,3226.0,
TCGA-QH-A6CW,5297,TCGA-QH-A6CW,LGG,43.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-15847.0,Alive,TUMOR FREE,414.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,414.0,0.0,414.0,,,0.0,414.0,
TCGA-CJ-5681,4326,TCGA-CJ-5681,KIRC,44.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-16121.0,Dead,WITH TUMOR,,552.0,[Not Available],,,,17.0,[Not Available],,,1.0,552.0,1.0,552.0,,,1.0,17.0,
TCGA-P3-A6T3,3715,TCGA-P3-A6T3,HNSC,49.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-18143.0,Dead,WITH TUMOR,,577.0,[Not Available],Distant Metastasis,Distant Metastasis,Lung,242.0,Complete Remission/Response,,,1.0,577.0,1.0,577.0,,,1.0,242.0,
TCGA-28-5209,3156,TCGA-28-5209,GBM,66.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-24362.0,Alive,,442.0,,[Not Available],,,,,[Not Available],,,0.0,442.0,0.0,442.0,,,0.0,442.0,
TCGA-ET-A25R,10210,TCGA-ET-A25R,THCA,51.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2009.0,[Not Available],-18863.0,Alive,TUMOR FREE,1930.0,,[Not Available],,,,,[Not Available],,R0,0.0,1930.0,0.0,1930.0,0.0,1930.0,0.0,1930.0,
TCGA-EL-A3ZS,10103,TCGA-EL-A3ZS,THCA,22.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-8076.0,Alive,TUMOR FREE,215.0,,[Not Available],,,,,[Not Available],,R0,0.0,215.0,0.0,215.0,0.0,215.0,0.0,215.0,
TCGA-HV-AA8V,7586,TCGA-HV-AA8V,PAAD,50.0,MALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,[Not Available],-18357.0,Alive,,920.0,,,Distant Metastasis,"Other, specify",bone,526.0,[Discrepancy],,,0.0,920.0,0.0,920.0,,,1.0,526.0,
TCGA-KN-8437,3836,TCGA-KN-8437,KICH,42.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-15475.0,Alive,TUMOR FREE,3068.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3068.0,0.0,3068.0,0.0,3068.0,0.0,3068.0,
TCGA-QQ-A8VD,8752,TCGA-QQ-A8VD,SARC,56.0,MALE,WHITE,[Not Available],[Not Available],Desmoid Tumor,[Not Available],2003.0,[Not Available],-20729.0,Alive,WITH TUMOR,3964.0,,[Not Available],Locoregional Recurrence,"Other, specify",left abdominal wall,499.0,[Not Available],Positive,RX,0.0,3964.0,0.0,3964.0,,,1.0,499.0,
TCGA-DR-A0ZM,1677,TCGA-DR-A0ZM,CESC,61.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22464.0,Alive,TUMOR FREE,1791.0,,,,,,,Complete Remission/Response,,,0.0,1791.0,0.0,1791.0,0.0,1791.0,0.0,1791.0,
TCGA-DB-5275,4934,TCGA-DB-5275,LGG,36.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2006.0,[Not Available],-13371.0,Alive,TUMOR FREE,1458.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1458.0,0.0,1458.0,0.0,1458.0,0.0,1458.0,
TCGA-BP-4782,4184,TCGA-BP-4782,KIRC,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-20102.0,Alive,[Discrepancy],354.0,,[Not Available],,,,,[Not Available],,,0.0,354.0,0.0,354.0,,,0.0,354.0,
TCGA-BR-6458,9307,TCGA-BR-6458,STAD,57.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-21069.0,Dead,WITH TUMOR,,588.0,[Not Available],Distant Metastasis,Liver,,574.0,Complete Remission/Response,,,1.0,588.0,1.0,588.0,1.0,574.0,1.0,574.0,
TCGA-13-2057,7104,TCGA-13-2057,OV,59.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-21554.0,Alive,WITH TUMOR,2434.0,,[Not Available],,[Not Applicable],[Not Applicable],897.0,Complete Remission/Response,,,0.0,2434.0,0.0,2434.0,1.0,897.0,1.0,897.0,
TCGA-BH-A1FL,1151,TCGA-BH-A1FL,BRCA,69.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998.0,[Not Available],-25558.0,Dead,WITH TUMOR,,1673.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1673.0,1.0,1673.0,,,1.0,1673.0,
TCGA-GC-A3YS,333,TCGA-GC-A3YS,BLCA,61.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-22515.0,Alive,TUMOR FREE,758.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,758.0,0.0,758.0,,,0.0,758.0,
TCGA-06-6390,2878,TCGA-06-6390,GBM,58.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-21328.0,Dead,WITH TUMOR,164.0,164.0,[Not Available],,,,,[Not Available],,,1.0,164.0,1.0,164.0,,,1.0,164.0,
TCGA-D5-6898,2313,TCGA-D5-6898,COAD,51.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-18874.0,Alive,TUMOR FREE,229.0,,[Not Available],,,,,[Not Available],,,0.0,229.0,0.0,229.0,,,0.0,229.0,
TCGA-PG-A914,11010,TCGA-PG-A914,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26992.0,Alive,TUMOR FREE,687.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,687.0,0.0,687.0,0.0,687.0,0.0,687.0,
TCGA-41-3392,3196,TCGA-41-3392,GBM,88.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-32351.0,Dead,WITH TUMOR,30.0,30.0,[Not Available],,,,,[Not Available],,,1.0,30.0,1.0,30.0,,,1.0,30.0,
TCGA-GN-A265,9195,TCGA-GN-A265,SKCM,53.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2004.0,[Not Available],-19712.0,Alive,TUMOR FREE,2948.0,,[Not Available],Regional lymph node,,,99.0,[Not Available],,,0.0,2948.0,0.0,2948.0,,,1.0,99.0,
TCGA-EW-A1PH,1484,TCGA-EW-A1PH,BRCA,52.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19073.0,Alive,TUMOR FREE,607.0,,[Not Available],,,,,[Not Available],Negative,,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,
TCGA-ES-A2HS,5687,TCGA-ES-A2HS,LIHC,80.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-29268.0,Dead,TUMOR FREE,,688.0,[Not Available],,,,,[Not Available],,R0,1.0,688.0,0.0,688.0,0.0,688.0,0.0,688.0,
TCGA-IW-A3M5,8706,TCGA-IW-A3M5,SARC,76.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-27869.0,Dead,WITH TUMOR,,180.0,[Not Available],Distant Metastasis,Lung,,9.0,[Not Available],Negative,R0,1.0,180.0,1.0,180.0,1.0,9.0,1.0,9.0,
TCGA-KK-A7B0,8195,TCGA-KK-A7B0,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24756.0,Alive,TUMOR FREE,1329.0,,[Not Available],Biochemical evidence of disease,,,606.0,Stable Disease,,,0.0,1329.0,0.0,1329.0,,,1.0,606.0,
TCGA-NH-A6GA,2398,TCGA-NH-A6GA,COAD,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2013.0,[Not Available],-21313.0,Dead,WITH TUMOR,,302.0,[Not Available],,,,6.0,Progressive Disease,,,1.0,302.0,1.0,302.0,,,1.0,6.0,
TCGA-NJ-A4YQ,6318,TCGA-NJ-A4YQ,LUAD,69.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25427.0,Alive,TUMOR FREE,1432.0,,[Not Available],,,,,Stable Disease,,,0.0,1432.0,0.0,1432.0,,,0.0,1432.0,
TCGA-AX-A1CJ,10640,TCGA-AX-A1CJ,UCEC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2006.0,Indeterminate (neither Pre or Postmenopausal),-21655.0,Alive,TUMOR FREE,2233.0,,[Not Available],,,,,[Not Available],,,0.0,2233.0,0.0,2233.0,,,0.0,2233.0,
TCGA-3M-AB46,9268,TCGA-3M-AB46,STAD,70.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,[Not Available],,Alive,TUMOR FREE,1765.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1765.0,0.0,1765.0,0.0,1765.0,0.0,1765.0,
TCGA-EW-A1IW,1455,TCGA-EW-A1IW,BRCA,80.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29529.0,Alive,TUMOR FREE,371.0,,[Not Available],,,,,[Not Available],Negative,,0.0,371.0,0.0,371.0,0.0,371.0,0.0,371.0,
TCGA-XF-A8HI,424,TCGA-XF-A8HI,BLCA,57.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,[Not Available],-21059.0,Dead,WITH TUMOR,,544.0,[Not Available],Distant Metastasis,Lung,,468.0,Progressive Disease,,,1.0,544.0,1.0,544.0,,,1.0,468.0,
TCGA-GM-A5PX,1520,TCGA-GM-A5PX,BRCA,65.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23753.0,Alive,TUMOR FREE,551.0,,[Not Available],,,,,[Not Available],Negative,,0.0,551.0,0.0,551.0,0.0,551.0,0.0,551.0,
TCGA-D1-A102,10825,TCGA-D1-A102,UCEC,49.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Peri (6-12 months since last menstrual period),-17991.0,Alive,TUMOR FREE,135.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,135.0,0.0,135.0,0.0,135.0,0.0,135.0,
TCGA-EE-A2A5,9027,TCGA-EE-A2A5,SKCM,43.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2007.0,[Not Available],-16041.0,Dead,WITH TUMOR,,1195.0,[Not Available],Regional lymph node,,,1028.0,[Not Available],,,1.0,1195.0,1.0,1195.0,,,1.0,1028.0,
TCGA-ED-A97K,5679,TCGA-ED-A97K,LIHC,54.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocholangiocarcinoma (Mixed),G2,2013.0,[Not Available],-20073.0,Alive,TUMOR FREE,6.0,,[Not Available],,,,,[Not Available],,R0,0.0,6.0,0.0,6.0,0.0,6.0,0.0,6.0,
TCGA-67-6216,6094,TCGA-67-6216,LUAD,57.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-20967.0,Alive,TUMOR FREE,141.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,141.0,0.0,141.0,0.0,141.0,0.0,141.0,
TCGA-DD-A116,5517,TCGA-DD-A116,LIHC,68.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2002.0,[Not Available],-24934.0,Dead,TUMOR FREE,,1622.0,[Not Available],Extrahepatic Recurrence,"Other, specify",sternum,828.0,[Not Available],,R0,1.0,1622.0,0.0,1622.0,1.0,828.0,1.0,828.0,Redacted
TCGA-QH-A65Z,5293,TCGA-QH-A65Z,LGG,54.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-19921.0,Alive,TUMOR FREE,427.0,,[Not Available],,,,,Stable Disease,,,0.0,427.0,0.0,427.0,,,0.0,427.0,
TCGA-KU-A66T,3693,TCGA-KU-A66T,HNSC,53.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-19405.0,Alive,TUMOR FREE,552.0,,[Not Available],Locoregional Recurrence,Oral Cavity,Toungue,552.0,Complete Remission/Response,,,0.0,552.0,0.0,552.0,,,1.0,552.0,
TCGA-2H-A9GM,2468,TCGA-2H-A9GM,ESCA,53.0,MALE,[Unknown],Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2000.0,[Not Available],-19484.0,Dead,WITH TUMOR,,424.0,[Not Available],Distant Metastasis,"Other, specify",peritoneum,367.0,,,,1.0,424.0,1.0,424.0,,,1.0,367.0,
TCGA-B0-5696,4054,TCGA-B0-5696,KIRC,69.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2007.0,[Not Available],-25552.0,Alive,WITH TUMOR,2609.0,,[Not Available],,,,1717.0,Complete Remission/Response,,,0.0,2609.0,0.0,2609.0,1.0,1717.0,1.0,1717.0,
TCGA-A7-A4SD,660,TCGA-A7-A4SD,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19131.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,[Not Available],Negative,,0.0,441.0,0.0,441.0,0.0,441.0,0.0,441.0,
TCGA-KK-A6E7,8186,TCGA-KK-A6E7,PRAD,46.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-17074.0,Alive,WITH TUMOR,2760.0,,[Not Available],Biochemical evidence of disease,,,925.0,Partial Remission/Response,,,0.0,2760.0,0.0,2760.0,,,1.0,925.0,
TCGA-G4-6304,2375,TCGA-G4-6304,COAD,66.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-24172.0,Alive,TUMOR FREE,1631.0,,[Not Available],,,,859.0,[Not Available],,,0.0,1631.0,0.0,1631.0,,,1.0,859.0,
TCGA-B0-5690,4048,TCGA-B0-5690,KIRC,53.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2004.0,[Not Available],-19685.0,Alive,WITH TUMOR,3392.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,3392.0,0.0,3392.0,,,0.0,3392.0,
TCGA-UB-A7MB,5773,TCGA-UB-A7MB,LIHC,24.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-8951.0,Alive,WITH TUMOR,601.0,,[Not Available],Intrahepatic Recurrence,Liver,,48.0,[Not Available],,R0,0.0,601.0,0.0,601.0,1.0,48.0,1.0,48.0,
TCGA-DM-A1D4,2330,TCGA-DM-A1D4,COAD,80.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],1999.0,[Not Available],-29403.0,Dead,,2821.0,2821.0,[Not Available],,,,1920.0,[Not Available],,,1.0,2821.0,,2821.0,,,1.0,1920.0,
TCGA-55-7907,6007,TCGA-55-7907,LUAD,77.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-28201.0,Dead,WITH TUMOR,,343.0,[Not Available],Distant Metastasis,,,294.0,Complete Remission/Response,,,1.0,343.0,1.0,343.0,1.0,294.0,1.0,294.0,
TCGA-3A-A9IN,7534,TCGA-3A-A9IN,PAAD,62.0,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2008.0,[Not Available],-22799.0,Alive,TUMOR FREE,2084.0,,,,,,,Complete Remission/Response,,,0.0,2084.0,0.0,2084.0,0.0,2084.0,0.0,2084.0,
TCGA-CX-7219,3608,TCGA-CX-7219,HNSC,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-17222.0,Alive,TUMOR FREE,1045.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1045.0,0.0,1045.0,,,0.0,1045.0,
TCGA-EQ-A4SO,9531,TCGA-EQ-A4SO,STAD,70.0,MALE,WHITE,Stage IIIB,[Not Applicable],[Discrepancy],G2,2012.0,[Not Available],-25897.0,Alive,TUMOR FREE,494.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,494.0,0.0,494.0,0.0,494.0,0.0,494.0,
TCGA-41-2573,3194,TCGA-41-2573,GBM,59.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-21911.0,Alive,WITH TUMOR,272.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],167.0,[Not Available],,,0.0,272.0,0.0,272.0,,,1.0,167.0,
TCGA-WL-A834,1890,TCGA-WL-A834,CESC,57.0,FEMALE,WHITE,[Not Available],[Not Available],Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,Alive,TUMOR FREE,791.0,,,,,,,Partial Remission/Response,,,0.0,791.0,0.0,791.0,,,0.0,791.0,
TCGA-3K-AAZ8,5447,TCGA-3K-AAZ8,LIHC,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-24046.0,Alive,WITH TUMOR,396.0,,[Not Available],Locoregional Recurrence,Liver,,151.0,[Not Available],,RX,0.0,396.0,0.0,396.0,,,1.0,151.0,
TCGA-XK-AAJ3,8304,TCGA-XK-AAJ3,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-20604.0,Alive,TUMOR FREE,1262.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1262.0,0.0,1262.0,0.0,1262.0,0.0,1262.0,
TCGA-NC-A5HJ,6807,TCGA-NC-A5HJ,LUSC,59.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-21730.0,Dead,WITH TUMOR,,418.0,[Not Available],New Primary Tumor,,,328.0,Complete Remission/Response,,,1.0,418.0,1.0,418.0,0.0,418.0,1.0,328.0,
TCGA-L5-A4OF,2515,TCGA-L5-A4OF,ESCA,63.0,MALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2012.0,[Not Available],-23194.0,Dead,,,801.0,[Not Available],,,,,Complete Remission/Response,,,1.0,801.0,,801.0,0.0,801.0,0.0,801.0,
TCGA-IN-A7NT,9605,TCGA-IN-A7NT,STAD,73.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,[Not Available],-26727.0,Alive,TUMOR FREE,323.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,323.0,0.0,323.0,0.0,323.0,0.0,323.0,
TCGA-OR-A5LS,81,TCGA-OR-A5LS,ACC,34.0,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-12663.0,Alive,TUMOR FREE,1096.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,
TCGA-ZH-A8Y1,1945,TCGA-ZH-A8Y1,CHOL,74.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2012.0,[Not Available],-27279.0,Dead,WITH TUMOR,,385.0,[Not Available],Locoregional Recurrence,,,49.0,[Not Available],,R1,1.0,385.0,1.0,385.0,,,1.0,49.0,
TCGA-D8-A1J9,1235,TCGA-D8-A1J9,BRCA,48.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17879.0,Alive,TUMOR FREE,532.0,,[Not Available],,,,,[Not Available],Negative,,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,
TCGA-Z6-A8JD,2641,TCGA-Z6-A8JD,ESCA,53.0,MALE,WHITE,Stage IIB,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-19523.0,Alive,TUMOR FREE,104.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,104.0,0.0,104.0,0.0,104.0,0.0,104.0,
TCGA-O2-A52S,6824,TCGA-O2-A52S,LUSC,57.0,FEMALE,WHITE,Stage III,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-21182.0,Dead,WITH TUMOR,,387.0,[Not Available],Distant Metastasis,,,246.0,[Unknown],,,1.0,387.0,1.0,387.0,,,1.0,246.0,
TCGA-QR-A702,7715,TCGA-QR-A702,PCPG,75.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2010.0,[Not Available],-27395.0,Alive,TUMOR FREE,39.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,39.0,0.0,39.0,0.0,39.0,0.0,39.0,
TCGA-CM-6170,2285,TCGA-CM-6170,COAD,73.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-26663.0,Alive,TUMOR FREE,457.0,,[Not Available],,,,,[Not Available],,,0.0,457.0,0.0,457.0,,,0.0,457.0,
TCGA-WY-A85B,5422,TCGA-WY-A85B,LGG,24.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-8817.0,Alive,TUMOR FREE,1393.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1393.0,0.0,1393.0,0.0,1393.0,0.0,1393.0,
TCGA-D8-A1JH,1243,TCGA-D8-A1JH,BRCA,56.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20497.0,Alive,TUMOR FREE,426.0,,[Not Available],,,,,[Not Available],Negative,,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,
TCGA-A1-A0SM,522,TCGA-A1-A0SM,BRCA,77.0,MALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,[Not Available],-28198.0,Alive,TUMOR FREE,242.0,,[Not Available],,,,,[Not Available],Negative,,0.0,242.0,0.0,242.0,0.0,242.0,0.0,242.0,
TCGA-06-0939,2841,TCGA-06-0939,GBM,79.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-28893.0,Dead,WITH TUMOR,,814.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],329.0,[Not Available],,,1.0,814.0,1.0,814.0,,,1.0,329.0,
TCGA-DS-A1OA,1683,TCGA-DS-A1OA,CESC,77.0,FEMALE,ASIAN,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28160.0,Dead,WITH TUMOR,879.0,879.0,Cervical Cancer,Locoregional Recurrence,,,379.0,[Not Available],,,1.0,879.0,1.0,879.0,,,1.0,379.0,
TCGA-OR-A5JX,32,TCGA-OR-A5JX,ACC,50.0,MALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-18402.0,Alive,TUMOR FREE,950.0,,[Not Available],,,,,[Not Available],,,0.0,950.0,0.0,950.0,,,0.0,950.0,
TCGA-DB-5273,4932,TCGA-DB-5273,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2006.0,[Not Available],-12152.0,Alive,TUMOR FREE,2493.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2493.0,0.0,2493.0,0.0,2493.0,0.0,2493.0,
TCGA-BR-8296,9349,TCGA-BR-8296,STAD,58.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-21527.0,Dead,WITH TUMOR,,474.0,[Not Available],Distant Metastasis,Liver,,390.0,Stable Disease,,,1.0,474.0,1.0,474.0,,,1.0,390.0,
TCGA-AD-A5EJ,2197,TCGA-AD-A5EJ,COAD,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2012.0,[Not Available],-27180.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-CZ-5461,4377,TCGA-CZ-5461,KIRC,52.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-19030.0,Dead,WITH TUMOR,330.0,330.0,[Not Available],,,,48.0,[Not Available],,,1.0,330.0,1.0,330.0,,,1.0,48.0,
TCGA-DW-7838,4575,TCGA-DW-7838,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-24247.0,Alive,WITH TUMOR,744.0,,[Not Available],,,,380.0,[Not Available],,,0.0,744.0,0.0,744.0,,,1.0,380.0,
TCGA-FS-A1YY,9145,TCGA-FS-A1YY,SKCM,55.0,FEMALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],1987.0,[Not Available],-20396.0,Dead,WITH TUMOR,,6953.0,[Not Available],,,,6777.0,[Not Available],,,1.0,6953.0,1.0,6953.0,,,1.0,6777.0,
TCGA-G3-A5SK,5715,TCGA-G3-A5SK,LIHC,58.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-21320.0,Alive,WITH TUMOR,744.0,,[Not Available],Intrahepatic Recurrence,Liver,,483.0,[Not Available],,R0,0.0,744.0,0.0,744.0,1.0,483.0,1.0,483.0,
TCGA-5U-AB0E,10381,TCGA-5U-AB0E,THYM,62.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type B3,[Not Available],2013.0,[Not Available],-22716.0,Alive,TUMOR FREE,687.0,,[Not Available],,,,,[Not Available],,,0.0,687.0,0.0,687.0,,,0.0,687.0,
TCGA-DH-5141,4966,TCGA-DH-5141,LGG,32.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2005.0,[Not Available],-11846.0,Alive,,968.0,,[Not Available],,,,,Stable Disease,,,0.0,968.0,0.0,968.0,,,0.0,968.0,
TCGA-VD-AA8M,11134,TCGA-VD-AA8M,UVM,64.0,MALE,[Not Evaluated],Stage IIA,Stage IIB,Spindle Cell|Epithelioid Cell,[Not Available],2013.0,[Not Available],-23507.0,Alive,TUMOR FREE,6.0,,[Not Available],,,,,[Not Available],,,0.0,6.0,0.0,6.0,,,0.0,6.0,
TCGA-HD-A6HZ,3676,TCGA-HD-A6HZ,HNSC,79.0,FEMALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-29045.0,Alive,TUMOR FREE,111.0,,[Not Available],,,,,[Unknown],,,0.0,111.0,0.0,111.0,,,0.0,111.0,
TCGA-77-8144,6684,TCGA-77-8144,LUSC,70.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-25796.0,Alive,,833.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,833.0,0.0,833.0,0.0,833.0,0.0,833.0,
TCGA-AR-A24P,938,TCGA-AR-A24P,BRCA,47.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17490.0,Alive,,84.0,,[Not Available],,,,,[Not Available],Negative,,0.0,84.0,0.0,84.0,0.0,84.0,0.0,84.0,
TCGA-G7-7501,4601,TCGA-G7-7501,KIRP,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-20165.0,Dead,WITH TUMOR,,624.0,[Not Available],,,,110.0,Progressive Disease,,,1.0,624.0,1.0,624.0,,,1.0,110.0,
TCGA-HT-7607,5164,TCGA-HT-7607,LGG,61.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2008.0,[Not Available],-22585.0,Dead,WITH TUMOR,,96.0,[Not Available],,,,,Progressive Disease,,,1.0,96.0,1.0,96.0,,,1.0,96.0,
TCGA-XM-A8RC,10408,TCGA-XM-A8RC,THYM,67.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2006.0,[Not Available],-24660.0,Alive,TUMOR FREE,2963.0,,[Not Available],,,,,[Not Available],,,0.0,2963.0,0.0,2963.0,,,0.0,2963.0,
TCGA-CN-4735,3313,TCGA-CN-4735,HNSC,52.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-19107.0,Alive,TUMOR FREE,1737.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1737.0,0.0,1737.0,,,0.0,1737.0,
TCGA-B0-5700,4058,TCGA-B0-5700,KIRC,77.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2009.0,[Not Available],-28184.0,Alive,TUMOR FREE,1790.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1790.0,0.0,1790.0,0.0,1790.0,0.0,1790.0,
TCGA-2G-AAGA,9736,TCGA-2G-AAGA,TGCT,38.0,MALE,WHITE,Stage IIA,Stage IIA,Non-Seminoma; Embryonal Carcinoma,[Not Available],2008.0,[Not Available],-14053.0,Alive,TUMOR FREE,2439.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,2439.0,0.0,2439.0,0.0,2439.0,0.0,2439.0,
TCGA-G3-A25U,5702,TCGA-G3-A25U,LIHC,63.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2007.0,[Not Available],-23207.0,Alive,TUMOR FREE,1636.0,,[Not Available],,,,,[Not Available],,R0,0.0,1636.0,0.0,1636.0,0.0,1636.0,0.0,1636.0,
TCGA-XE-A9SE,9809,TCGA-XE-A9SE,TGCT,35.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2008.0,[Not Available],-12850.0,Alive,TUMOR FREE,708.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,708.0,0.0,708.0,0.0,708.0,0.0,708.0,
TCGA-AX-A0J0,10628,TCGA-AX-A0J0,UCEC,47.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17466.0,Alive,TUMOR FREE,1220.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1220.0,0.0,1220.0,0.0,1220.0,0.0,1220.0,
TCGA-C5-A3HF,1642,TCGA-C5-A3HF,CESC,24.0,FEMALE,WHITE,[Not Available],Stage IB2,Mucinous Adenocarcinoma of Endocervical Type,G2,1996.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9115.0,Dead,WITH TUMOR,,543.0,Cervical Cancer,Distant Metastasis,"Other, specify",Pelvis,450.0,[Not Available],,,1.0,543.0,1.0,543.0,,,1.0,450.0,
TCGA-49-4507,5910,TCGA-49-4507,LUAD,73.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1997.0,[Not Available],-26851.0,Dead,WITH TUMOR,,268.0,[Not Available],,,,158.0,Progressive Disease,,,1.0,268.0,1.0,268.0,,,1.0,158.0,
TCGA-DJ-A3V5,9985,TCGA-DJ-A3V5,THCA,76.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-27918.0,Alive,TUMOR FREE,584.0,,[Not Available],,,,,[Not Available],,R1,0.0,584.0,0.0,584.0,,,0.0,584.0,
TCGA-AA-3713,2079,TCGA-AA-3713,COAD,68.0,MALE,[Not Available],Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-24927.0,Alive,TUMOR FREE,579.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,579.0,0.0,579.0,,,0.0,579.0,
TCGA-HT-7478,5151,TCGA-HT-7478,LGG,36.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-13216.0,Alive,TUMOR FREE,194.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,194.0,0.0,194.0,0.0,194.0,0.0,194.0,
TCGA-QT-A7U0,7751,TCGA-QT-A7U0,PCPG,56.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2013.0,[Not Available],-20538.0,Alive,TUMOR FREE,398.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,
TCGA-AJ-A8CW,10561,TCGA-AJ-A8CW,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23554.0,Alive,TUMOR FREE,4.0,,[Not Available],,,,,[Unknown],,,0.0,4.0,0.0,4.0,,,0.0,4.0,
TCGA-BS-A0TJ,10797,TCGA-BS-A0TJ,UCEC,59.0,FEMALE,ASIAN,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21663.0,Alive,TUMOR FREE,2068.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2068.0,0.0,2068.0,0.0,2068.0,0.0,2068.0,
TCGA-NG-A4VW,11078,TCGA-NG-A4VW,UCS,74.0,FEMALE,WHITE,[Not Applicable],Stage IC,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27326.0,Dead,WITH TUMOR,,949.0,[Not Available],Distant Metastasis,Lung,,937.0,Complete Remission/Response,,,1.0,949.0,1.0,949.0,1.0,937.0,1.0,937.0,
TCGA-A4-7287,4465,TCGA-A4-7287,KIRP,75.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-27621.0,Dead,WITH TUMOR,,597.0,[Not Available],,,,234.0,Complete Remission/Response,,,1.0,597.0,1.0,597.0,1.0,234.0,1.0,234.0,
TCGA-CZ-4856,4356,TCGA-CZ-4856,KIRC,62.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-22684.0,Alive,,18.0,,[Not Available],,,,,[Not Available],,,0.0,18.0,0.0,18.0,,,0.0,18.0,
TCGA-44-7660,5884,TCGA-44-7660,LUAD,72.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26594.0,Alive,WITH TUMOR,592.0,,[Not Available],Locoregional Recurrence,,,253.0,Progressive Disease,,,0.0,592.0,0.0,592.0,,,1.0,253.0,
TCGA-5N-A9KI,115,TCGA-5N-A9KI,BLCA,76.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-27777.0,Dead,TUMOR FREE,,76.0,[Not Available],,,,,Complete Remission/Response,,,1.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,
TCGA-KU-A6H7,3694,TCGA-KU-A6H7,HNSC,55.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-20314.0,Alive,TUMOR FREE,586.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,586.0,0.0,586.0,,,0.0,586.0,
TCGA-WB-A81S,7859,TCGA-WB-A81S,PCPG,59.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-21587.0,Alive,TUMOR FREE,723.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,723.0,0.0,723.0,0.0,723.0,0.0,723.0,
TCGA-EL-A3CY,10052,TCGA-EL-A3CY,THCA,28.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2000.0,[Not Available],-10423.0,Alive,TUMOR FREE,127.0,,[Not Available],,,,,[Not Available],,R0,0.0,127.0,0.0,127.0,0.0,127.0,0.0,127.0,
TCGA-06-0128,2745,TCGA-06-0128,GBM,66.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2000.0,[Not Available],-24217.0,Dead,WITH TUMOR,691.0,691.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],190.0,[Not Available],,,1.0,691.0,1.0,691.0,,,1.0,190.0,
TCGA-KL-8335,3782,TCGA-KL-8335,KICH,67.0,MALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-24832.0,Alive,TUMOR FREE,2815.0,,[Not Available],,,,,[Unknown],,,0.0,2815.0,0.0,2815.0,,,0.0,2815.0,
TCGA-TT-A6YN,7817,TCGA-TT-A6YN,PCPG,37.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-13605.0,Alive,TUMOR FREE,606.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,606.0,0.0,606.0,0.0,606.0,0.0,606.0,
TCGA-12-0692,2950,TCGA-12-0692,GBM,75.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2000.0,[Not Available],-27519.0,Dead,WITH TUMOR,80.0,111.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],35.0,[Not Available],,,1.0,111.0,1.0,111.0,,,1.0,35.0,
TCGA-XF-A8HB,417,TCGA-XF-A8HB,BLCA,50.0,FEMALE,[Unknown],Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-18544.0,Alive,TUMOR FREE,1370.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1370.0,0.0,1370.0,0.0,1370.0,0.0,1370.0,
TCGA-V4-A9F5,11114,TCGA-V4-A9F5,UVM,85.0,FEMALE,WHITE,Stage IV,Stage IV,Epithelioid Cell|Spindle Cell,[Not Available],2013.0,[Not Available],-31314.0,Alive,WITH TUMOR,203.0,,[Not Available],Distant Metastasis,Liver,,78.0,[Not Available],,,0.0,203.0,0.0,203.0,,,1.0,78.0,
TCGA-B6-A0X1,1009,TCGA-B6-A0X1,BRCA,48.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1994.0,Indeterminate (neither Pre or Postmenopausal),-17624.0,Dead,TUMOR FREE,,7455.0,[Not Available],Distant Metastasis,Brain,,490.0,[Not Available],Negative,,1.0,7455.0,0.0,7455.0,1.0,490.0,1.0,490.0,
TCGA-BP-5189,4255,TCGA-BP-5189,KIRC,60.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2007.0,[Not Available],-22156.0,Dead,WITH TUMOR,,822.0,[Not Available],,,,634.0,[Not Available],,,1.0,822.0,1.0,822.0,,,1.0,634.0,
TCGA-FY-A4B3,10301,TCGA-FY-A4B3,THCA,51.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-18969.0,Alive,WITH TUMOR,427.0,,[Not Available],,,,,[Not Available],,R1,0.0,427.0,0.0,427.0,,,0.0,427.0,
TCGA-KD-A5QT,8719,TCGA-KD-A5QT,SARC,69.0,FEMALE,[Not Evaluated],[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-25249.0,Alive,TUMOR FREE,499.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,499.0,0.0,499.0,0.0,499.0,0.0,499.0,
TCGA-DJ-A3UM,9967,TCGA-DJ-A3UM,THCA,45.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-16573.0,Alive,TUMOR FREE,944.0,,[Not Available],,,,,[Not Available],,R0,0.0,944.0,0.0,944.0,0.0,944.0,0.0,944.0,
TCGA-J4-A67T,8140,TCGA-J4-A67T,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-23211.0,Alive,TUMOR FREE,183.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,
TCGA-CN-5355,3321,TCGA-CN-5355,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-23670.0,Alive,TUMOR FREE,1278.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1278.0,0.0,1278.0,,,0.0,1278.0,
TCGA-CH-5761,7893,TCGA-CH-5761,PRAD,61.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-22433.0,Alive,TUMOR FREE,28.0,,[Not Available],,,,,[Not Available],,,0.0,28.0,0.0,28.0,,,0.0,28.0,
TCGA-EK-A3GJ,1742,TCGA-EK-A3GJ,CESC,51.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2010.0,[Not Available],-18630.0,Alive,[Discrepancy],3.0,,,,,,,[Not Available],,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-HW-A5KK,5256,TCGA-HW-A5KK,LGG,64.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-23484.0,Dead,WITH TUMOR,,388.0,[Not Available],,,,,Progressive Disease,,,1.0,388.0,1.0,388.0,,,1.0,388.0,
TCGA-50-5941,5947,TCGA-50-5941,LUAD,55.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-20350.0,Alive,TUMOR FREE,1474.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1474.0,0.0,1474.0,0.0,1474.0,0.0,1474.0,
TCGA-MI-A75C,5749,TCGA-MI-A75C,LIHC,64.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-23441.0,Alive,TUMOR FREE,291.0,,[Not Available],,,,,[Not Available],,R0,0.0,291.0,0.0,291.0,0.0,291.0,0.0,291.0,
TCGA-DJ-A1QM,9936,TCGA-DJ-A1QM,THCA,42.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-15418.0,Alive,TUMOR FREE,183.0,,[Not Available],,,,,[Not Available],,R0,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,
TCGA-LP-A7HU,1803,TCGA-LP-A7HU,CESC,53.0,FEMALE,ASIAN,[Not Available],Stage II,Endocervical Type of Adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19595.0,Alive,TUMOR FREE,406.0,,,,,,,Complete Remission/Response,,,0.0,406.0,0.0,406.0,0.0,406.0,0.0,406.0,
TCGA-3Z-A93Z,3883,TCGA-3Z-A93Z,KIRC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2013.0,[Not Available],-25205.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-44-3917,5865,TCGA-44-3917,LUAD,33.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-12179.0,Alive,TUMOR FREE,1183.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1183.0,0.0,1183.0,0.0,1183.0,0.0,1183.0,
TCGA-ZN-A9VW,6915,TCGA-ZN-A9VW,MESO,61.0,MALE,WHITE,Stage IV,[Not Applicable],Biphasic mesothelioma,[Not Available],2010.0,[Not Available],-22588.0,Dead,WITH TUMOR,,84.0,[Not Available],Intrapleural Progression,"Other, specify",right chest wall,-30.0,[Not Available],,[Not Available],1.0,84.0,1.0,84.0,,,1.0,,
TCGA-EL-A3GZ,10069,TCGA-EL-A3GZ,THCA,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2001.0,[Not Available],-12665.0,Alive,TUMOR FREE,4258.0,,[Not Available],,,,,[Not Available],,R0,0.0,4258.0,0.0,4258.0,0.0,4258.0,0.0,4258.0,
TCGA-EW-A1PE,1481,TCGA-EW-A1PE,BRCA,56.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20694.0,Alive,TUMOR FREE,320.0,,[Not Available],,,,,[Not Available],Negative,,0.0,320.0,0.0,320.0,0.0,320.0,0.0,320.0,
TCGA-S9-A6TS,5321,TCGA-S9-A6TS,LGG,48.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2006.0,[Not Available],-17857.0,Dead,WITH TUMOR,,1891.0,[Not Available],,,,1324.0,Progressive Disease,,,1.0,1891.0,1.0,1891.0,,,1.0,1324.0,
TCGA-C8-A275,1215,TCGA-C8-A275,BRCA,56.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20774.0,Alive,TUMOR FREE,1.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,
TCGA-HU-8243,9558,TCGA-HU-8243,STAD,66.0,MALE,ASIAN,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-24187.0,Dead,WITH TUMOR,,180.0,Stomach Cancer,Distant Metastasis,Liver,,132.0,Partial Remission/Response,,,1.0,180.0,1.0,180.0,,,1.0,132.0,
TCGA-14-1395,3016,TCGA-14-1395,GBM,52.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-19237.0,Dead,WITH TUMOR,42.0,42.0,[Not Available],,,,,[Not Available],,,1.0,42.0,1.0,42.0,,,1.0,42.0,
TCGA-43-5670,6475,TCGA-43-5670,LUSC,70.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-25652.0,Alive,TUMOR FREE,849.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,849.0,0.0,849.0,0.0,849.0,0.0,849.0,
TCGA-EI-6511,8510,TCGA-EI-6511,READ,52.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-19237.0,Alive,TUMOR FREE,482.0,,[Not Available],,,,,[Not Available],,,0.0,482.0,0.0,482.0,,,0.0,482.0,
TCGA-DB-A64P,4952,TCGA-DB-A64P,LGG,40.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-14936.0,Alive,TUMOR FREE,916.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,916.0,0.0,916.0,0.0,916.0,0.0,916.0,
TCGA-CV-7101,3525,TCGA-CV-7101,HNSC,80.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1999.0,[Not Available],-29550.0,Dead,TUMOR FREE,,160.0,[Not Available],,,,,[Not Available],,,1.0,160.0,0.0,160.0,,,0.0,160.0,
TCGA-A7-A6VX,669,TCGA-A7-A6VX,BRCA,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25066.0,Alive,TUMOR FREE,317.0,,[Not Available],,,,,[Not Available],Negative,,0.0,317.0,0.0,317.0,0.0,317.0,0.0,317.0,
TCGA-AF-2693,8372,TCGA-AF-2693,READ,75.0,MALE,WHITE,Stage I,[Not Applicable],[Not Available],[Not Available],2009.0,[Not Available],-27443.0,Alive,TUMOR FREE,1155.0,,[Not Available],,,,,[Not Available],,,0.0,1155.0,0.0,1155.0,,,0.0,1155.0,
TCGA-IB-A5SQ,7639,TCGA-IB-A5SQ,PAAD,56.0,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-20760.0,Dead,WITH TUMOR,,219.0,,Distant Metastasis,Lung,,197.0,Complete Remission/Response,,,1.0,219.0,1.0,219.0,1.0,197.0,1.0,197.0,
TCGA-UD-AAC6,6898,TCGA-UD-AAC6,MESO,67.0,MALE,WHITE,Stage II,[Not Applicable],Biphasic mesothelioma,[Not Available],2006.0,[Not Available],-24571.0,Dead,WITH TUMOR,,456.0,[Not Available],Intrapleural Progression,Ipsilateral Pleura,,126.0,[Not Available],,R2,1.0,456.0,1.0,456.0,,,1.0,126.0,
TCGA-DX-A8BX,8649,TCGA-DX-A8BX,SARC,52.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2006.0,[Not Available],-19339.0,Dead,WITH TUMOR,,591.0,[Not Available],,,,,[Not Available],Negative,R0,1.0,591.0,1.0,591.0,,,1.0,591.0,
TCGA-ZB-A96G,10459,TCGA-ZB-A96G,THYM,59.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type AB,[Not Available],2010.0,[Not Available],-21598.0,Alive,TUMOR FREE,1606.0,,[Not Available],,,,,[Not Available],,,0.0,1606.0,0.0,1606.0,,,0.0,1606.0,
TCGA-D6-A6ES,3628,TCGA-D6-A6ES,HNSC,50.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-18408.0,Alive,TUMOR FREE,389.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,389.0,0.0,389.0,,,0.0,389.0,
TCGA-CN-4730,3309,TCGA-CN-4730,HNSC,62.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-22828.0,Alive,TUMOR FREE,817.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,817.0,0.0,817.0,,,0.0,817.0,
TCGA-DK-A3IK,196,TCGA-DK-A3IK,BLCA,87.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-32076.0,Dead,TUMOR FREE,,146.0,[Not Available],,,,,Complete Remission/Response,,,1.0,146.0,0.0,146.0,,,0.0,146.0,
TCGA-BP-4965,4203,TCGA-BP-4965,KIRC,46.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-16992.0,Alive,TUMOR FREE,1871.0,,[Not Available],,,,,[Not Available],,,0.0,1871.0,0.0,1871.0,,,0.0,1871.0,
TCGA-22-1005,6365,TCGA-22-1005,LUSC,63.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-23322.0,Dead,TUMOR FREE,1953.0,1953.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1953.0,0.0,1953.0,0.0,1953.0,0.0,1953.0,
TCGA-E5-A4TZ,233,TCGA-E5-A4TZ,BLCA,64.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-23566.0,Dead,WITH TUMOR,,467.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",soft tissue pelvic mass,435.0,Progressive Disease,,,1.0,467.0,1.0,467.0,,,1.0,435.0,
TCGA-EL-A3GY,10068,TCGA-EL-A3GY,THCA,40.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-14814.0,Alive,WITH TUMOR,3076.0,,[Not Available],,,,,[Not Available],,R0,0.0,3076.0,0.0,3076.0,0.0,3076.0,0.0,3076.0,
TCGA-3U-A98J,6843,TCGA-3U-A98J,MESO,55.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-20338.0,Dead,WITH TUMOR,,741.0,[Not Available],,,,,[Not Available],,[Not Available],1.0,741.0,1.0,741.0,,,1.0,741.0,
TCGA-VQ-AA6G,9705,TCGA-VQ-AA6G,STAD,68.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-25091.0,Dead,WITH TUMOR,,792.0,Stomach Cancer,Distant Metastasis,Lung,,469.0,Progressive Disease,,,1.0,792.0,1.0,792.0,,,1.0,469.0,
TCGA-UC-A7PD,1832,TCGA-UC-A7PD,CESC,21.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1997.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-7855.0,Dead,WITH TUMOR,,355.0,Cervical Cancer,Locoregional Recurrence,,vaginal cuff,202.0,Complete Remission/Response,,,1.0,355.0,1.0,355.0,1.0,202.0,1.0,202.0,
TCGA-B7-A5TN,9275,TCGA-B7-A5TN,STAD,60.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-21962.0,Alive,TUMOR FREE,287.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,287.0,0.0,287.0,0.0,287.0,0.0,287.0,
TCGA-EK-A3GK,1743,TCGA-EK-A3GK,CESC,33.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Type of Adenocarcinoma,G3,2009.0,[Not Available],-12207.0,Alive,TUMOR FREE,15.0,,,,,,,[Not Available],,,0.0,15.0,0.0,15.0,,,0.0,15.0,
TCGA-BH-A18N,1122,TCGA-BH-A18N,BRCA,88.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001.0,[Not Available],-32404.0,Dead,,,1148.0,[Not Available],,,,,[Not Available],Negative,,1.0,1148.0,,1148.0,0.0,1148.0,0.0,1148.0,
TCGA-VQ-A8DZ,9646,TCGA-VQ-A8DZ,STAD,70.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2011.0,[Not Available],-25863.0,Dead,WITH TUMOR,,396.0,Stomach Cancer,,,,,Progressive Disease,,,1.0,396.0,1.0,396.0,,,1.0,396.0,
TCGA-D6-6826,3616,TCGA-D6-6826,HNSC,64.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-23722.0,Dead,TUMOR FREE,,348.0,[Not Available],,,,,Complete Remission/Response,,,1.0,348.0,0.0,348.0,,,0.0,348.0,
TCGA-V1-A8MM,8241,TCGA-V1-A8MM,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-22265.0,Alive,,1195.0,,[Not Available],Biochemical evidence of disease,,,990.0,Complete Remission/Response,,,0.0,1195.0,0.0,1195.0,1.0,990.0,1.0,990.0,
TCGA-5R-AAAM,5454,TCGA-5R-AAAM,LIHC,65.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-24020.0,Dead,TUMOR FREE,,46.0,[Not Available],,,,,[Not Available],,R0,1.0,46.0,0.0,46.0,0.0,46.0,0.0,46.0,
TCGA-E9-A244,1435,TCGA-E9-A244,BRCA,54.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19778.0,Alive,TUMOR FREE,21.0,,[Not Available],,,,,[Not Available],Negative,,0.0,21.0,0.0,21.0,0.0,21.0,0.0,21.0,
TCGA-D3-A51T,8875,TCGA-D3-A51T,SKCM,59.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-21823.0,Alive,TUMOR FREE,818.0,,[Not Available],New primary melanoma,,,210.0,[Not Available],,,0.0,818.0,0.0,818.0,,,1.0,210.0,
TCGA-D5-6541,2312,TCGA-D5-6541,COAD,49.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-18029.0,Alive,TUMOR FREE,474.0,,[Not Available],,,,,[Not Available],,,0.0,474.0,0.0,474.0,,,0.0,474.0,
TCGA-RC-A6M3,5761,TCGA-RC-A6M3,LIHC,24.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2009.0,[Not Available],-8899.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-VP-A87J,8287,TCGA-VP-A87J,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-20792.0,Alive,TUMOR FREE,1774.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1774.0,0.0,1774.0,0.0,1774.0,0.0,1774.0,
TCGA-CZ-5467,4383,TCGA-CZ-5467,KIRC,86.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2007.0,[Not Available],-31473.0,Dead,WITH TUMOR,,73.0,[Not Available],,,,62.0,[Not Available],,,1.0,73.0,1.0,73.0,,,1.0,62.0,
TCGA-KK-A7AP,8188,TCGA-KK-A7AP,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-20403.0,Alive,,196.0,,[Not Available],,,,,[Unknown],,,0.0,196.0,0.0,196.0,,,0.0,196.0,
TCGA-FY-A3BL,10280,TCGA-FY-A3BL,THCA,29.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-10667.0,Alive,TUMOR FREE,621.0,,[Not Available],,,,,[Not Available],,R0,0.0,621.0,0.0,621.0,0.0,621.0,0.0,621.0,
TCGA-B6-A0X4,1010,TCGA-B6-A0X4,BRCA,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22688.0,Dead,WITH TUMOR,,860.0,[Not Available],Distant Metastasis,Bone,,716.0,[Not Available],Negative,,1.0,860.0,1.0,860.0,1.0,716.0,1.0,716.0,
TCGA-KV-A74V,4643,TCGA-KV-A74V,KIRP,40.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-14834.0,Alive,TUMOR FREE,347.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,347.0,0.0,347.0,0.0,347.0,0.0,347.0,
TCGA-KQ-A41O,386,TCGA-KQ-A41O,BLCA,84.0,MALE,[Unknown],Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-30774.0,Alive,TUMOR FREE,1538.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1538.0,0.0,1538.0,,,0.0,1538.0,
TCGA-NK-A7XE,6821,TCGA-NK-A7XE,LUSC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2013.0,[Not Available],-24319.0,Alive,TUMOR FREE,13.0,,[Not Available],,,,,Stable Disease,,,0.0,13.0,0.0,13.0,,,0.0,13.0,
TCGA-DU-A7T8,5058,TCGA-DU-A7T8,LGG,35.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2003.0,[Not Available],-13108.0,Dead,WITH TUMOR,,4229.0,[Not Available],,,,3009.0,Stable Disease,,,1.0,4229.0,1.0,4229.0,,,1.0,3009.0,
TCGA-CV-6961,3516,TCGA-CV-6961,HNSC,61.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,1999.0,[Not Available],-22532.0,Dead,WITH TUMOR,,76.0,[Not Available],,,,,Complete Remission/Response,,,1.0,76.0,1.0,76.0,,,1.0,76.0,
TCGA-CQ-6223,3392,TCGA-CQ-6223,HNSC,69.0,MALE,WHITE,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-25266.0,Alive,TUMOR FREE,1428.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1428.0,0.0,1428.0,,,0.0,1428.0,
TCGA-85-A4QQ,6743,TCGA-85-A4QQ,LUSC,68.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-25065.0,Dead,TUMOR FREE,,927.0,[Not Available],,,,,Complete Remission/Response,,,1.0,927.0,0.0,927.0,0.0,927.0,0.0,927.0,
TCGA-EL-A3TB,10092,TCGA-EL-A3TB,THCA,47.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005.0,[Not Available],-17195.0,Alive,TUMOR FREE,2519.0,,[Not Available],,,,,[Not Available],,R0,0.0,2519.0,0.0,2519.0,0.0,2519.0,0.0,2519.0,
TCGA-VS-A9UJ,1871,TCGA-VS-A9UJ,CESC,55.0,FEMALE,[Unknown],[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,GX,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20264.0,Dead,WITH TUMOR,,52.0,Cervical Cancer,,,,,[Not Available],,,1.0,52.0,1.0,52.0,,,1.0,52.0,
TCGA-G7-6797,4600,TCGA-G7-6797,KIRP,46.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-17004.0,Alive,TUMOR FREE,765.0,,[Not Available],,,,,[Not Available],,,0.0,765.0,0.0,765.0,,,0.0,765.0,
TCGA-DD-AACH,5587,TCGA-DD-AACH,LIHC,69.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2008.0,[Not Available],-25544.0,Dead,TUMOR FREE,,195.0,[Not Available],Intrahepatic Recurrence,Liver,,83.0,[Not Available],,R0,1.0,195.0,0.0,195.0,1.0,83.0,1.0,83.0,
TCGA-C8-A26Z,1212,TCGA-C8-A26Z,BRCA,59.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,TUMOR FREE,470.0,,[Not Available],,,,,[Not Available],Negative,,0.0,470.0,0.0,470.0,0.0,470.0,0.0,470.0,
TCGA-EY-A547,10976,TCGA-EY-A547,UCEC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27686.0,Alive,TUMOR FREE,545.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,545.0,0.0,545.0,0.0,545.0,0.0,545.0,
TCGA-DJ-A1QI,9934,TCGA-DJ-A1QI,THCA,63.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-23072.0,Alive,TUMOR FREE,455.0,,[Not Available],,,,,[Not Available],,R0,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,
TCGA-B1-A656,4511,TCGA-B1-A656,KIRP,64.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-23702.0,Alive,TUMOR FREE,618.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,618.0,0.0,618.0,0.0,618.0,0.0,618.0,
TCGA-LK-A4NZ,6846,TCGA-LK-A4NZ,MESO,75.0,MALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],2009.0,[Not Available],-27720.0,Dead,WITH TUMOR,,244.0,[Not Available],,,,,[Not Available],,R2,1.0,244.0,1.0,244.0,,,1.0,244.0,
TCGA-3A-A9IS,7537,TCGA-3A-A9IS,PAAD,67.0,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2010.0,[Not Available],-24621.0,Alive,TUMOR FREE,998.0,,,,,,,Complete Remission/Response,,,0.0,998.0,0.0,998.0,0.0,998.0,0.0,998.0,
TCGA-TQ-A7RO,5396,TCGA-TQ-A7RO,LGG,29.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-10890.0,Alive,WITH TUMOR,949.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,949.0,0.0,949.0,,,0.0,949.0,
TCGA-25-2398,7300,TCGA-25-2398,OV,71.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,[Not Available],-26267.0,Dead,WITH TUMOR,1369.0,1369.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],577.0,Complete Remission/Response,,,1.0,1369.0,1.0,1369.0,1.0,577.0,1.0,577.0,
TCGA-85-8481,6732,TCGA-85-8481,LUSC,70.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-25782.0,Dead,TUMOR FREE,,236.0,[Not Available],,,,,Partial Remission/Response,,,1.0,236.0,0.0,236.0,,,0.0,236.0,
TCGA-ZB-A96Q,10467,TCGA-ZB-A96Q,THYM,49.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type AB,[Not Available],2013.0,[Not Available],-18249.0,Alive,TUMOR FREE,675.0,,[Not Available],,,,,[Not Available],,,0.0,675.0,0.0,675.0,,,0.0,675.0,
TCGA-EO-A1Y7,10920,TCGA-EO-A1Y7,UCEC,65.0,FEMALE,[Not Available],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24085.0,Alive,WITH TUMOR,1495.0,,[Not Available],Distant Metastasis,Lung,,880.0,Progressive Disease,,,0.0,1495.0,0.0,1495.0,,,1.0,880.0,
TCGA-85-A511,6748,TCGA-85-A511,LUSC,62.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-22759.0,Dead,WITH TUMOR,,455.0,[Not Available],Distant Metastasis,,,390.0,Complete Remission/Response,,,1.0,455.0,1.0,455.0,1.0,390.0,1.0,390.0,
TCGA-CG-5725,9478,TCGA-CG-5725,STAD,72.0,MALE,[Not Available],Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,[Not Available],-26329.0,Dead,WITH TUMOR,,457.0,[Not Available],,,,153.0,Progressive Disease,,,1.0,457.0,1.0,457.0,,,1.0,153.0,
TCGA-BJ-A2P4,9878,TCGA-BJ-A2P4,THCA,29.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-10602.0,Alive,TUMOR FREE,390.0,,[Not Available],,,,,[Not Available],,R0,0.0,390.0,0.0,390.0,0.0,390.0,0.0,390.0,
TCGA-D8-A27N,1291,TCGA-D8-A27N,BRCA,36.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13243.0,Alive,TUMOR FREE,519.0,,[Not Available],,,,,[Not Available],Negative,,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,
TCGA-2Y-A9GU,5429,TCGA-2Y-A9GU,LIHC,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2009.0,[Not Available],-20187.0,Alive,TUMOR FREE,1939.0,,[Not Available],,,,,[Not Available],,R0,0.0,1939.0,0.0,1939.0,0.0,1939.0,0.0,1939.0,
TCGA-FC-7708,8007,TCGA-FC-7708,PRAD,52.0,MALE,ASIAN,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19144.0,Alive,TUMOR FREE,864.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,864.0,0.0,864.0,0.0,864.0,0.0,864.0,
TCGA-OR-A5JE,14,TCGA-OR-A5JE,ACC,17.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2005.0,[Not Available],-6455.0,Dead,WITH TUMOR,,2105.0,[Not Available],Locoregional Recurrence,,,477.0,[Unknown],,,1.0,2105.0,1.0,2105.0,,,1.0,477.0,
TCGA-UT-A88D,6901,TCGA-UT-A88D,MESO,66.0,MALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-24300.0,Dead,TUMOR FREE,,823.0,[Not Available],,,,,[Not Available],,R0,1.0,823.0,0.0,823.0,0.0,823.0,0.0,823.0,
TCGA-HT-A4DS,5222,TCGA-HT-A4DS,LGG,55.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-20296.0,Alive,TUMOR FREE,7.0,,[Not Available],,,,,[Not Available],,,0.0,7.0,0.0,7.0,,,0.0,7.0,
TCGA-85-8351,6726,TCGA-85-8351,LUSC,72.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26437.0,Alive,TUMOR FREE,510.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,510.0,0.0,510.0,0.0,510.0,0.0,510.0,
TCGA-S9-A6WO,5345,TCGA-S9-A6WO,LGG,29.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-10933.0,Alive,WITH TUMOR,566.0,,[Not Available],,,,187.0,Progressive Disease,,,0.0,566.0,0.0,566.0,,,1.0,187.0,
TCGA-C8-A3M8,1220,TCGA-C8-A3M8,BRCA,68.0,FEMALE,ASIAN,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24877.0,Alive,TUMOR FREE,394.0,,[Not Available],,,,,[Not Available],Negative,,0.0,394.0,0.0,394.0,0.0,394.0,0.0,394.0,
TCGA-ZB-A96O,10465,TCGA-ZB-A96O,THYM,54.0,FEMALE,WHITE,[Not Applicable],III,Thymoma; Type B1,[Not Available],2012.0,[Not Available],-19782.0,Alive,TUMOR FREE,1050.0,,[Not Available],,,,,[Not Available],,,0.0,1050.0,0.0,1050.0,,,0.0,1050.0,
TCGA-CV-7235,3533,TCGA-CV-7235,HNSC,67.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2007.0,[Not Available],-24800.0,Alive,TUMOR FREE,2347.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2347.0,0.0,2347.0,0.0,2347.0,0.0,2347.0,
TCGA-02-2485,2737,TCGA-02-2485,GBM,53.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-19494.0,Alive,WITH TUMOR,470.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],186.0,[Not Available],,,0.0,470.0,0.0,470.0,,,1.0,186.0,
TCGA-BT-A0S7,122,TCGA-BT-A0S7,BLCA,75.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-27533.0,Dead,WITH TUMOR,,200.0,[Not Available],,,,,Progressive Disease,,,1.0,200.0,1.0,200.0,,,1.0,200.0,
TCGA-A4-8630,4484,TCGA-A4-8630,KIRP,59.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-21884.0,Alive,TUMOR FREE,436.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,436.0,0.0,436.0,0.0,436.0,0.0,436.0,
TCGA-BG-A0MK,10749,TCGA-BG-A0MK,UCEC,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19034.0,Dead,WITH TUMOR,,1317.0,[Not Available],,,,,Progressive Disease,,,1.0,1317.0,1.0,1317.0,,,1.0,1317.0,
TCGA-39-5031,6462,TCGA-39-5031,LUSC,76.0,FEMALE,[Not Available],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-28106.0,Dead,TUMOR FREE,,1841.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1841.0,0.0,1841.0,0.0,1841.0,0.0,1841.0,
TCGA-J8-A3O0,10320,TCGA-J8-A3O0,THCA,38.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-14214.0,Alive,TUMOR FREE,1313.0,,[Not Available],,,,,[Not Available],,R0,0.0,1313.0,0.0,1313.0,0.0,1313.0,0.0,1313.0,
TCGA-P3-A6T2,3714,TCGA-P3-A6T2,HNSC,45.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-16588.0,Alive,TUMOR FREE,2298.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2298.0,0.0,2298.0,,,0.0,2298.0,
TCGA-OL-A66K,1566,TCGA-OL-A66K,BRCA,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26299.0,Dead,TUMOR FREE,,1275.0,[Not Available],,,,,[Not Available],Negative,,1.0,1275.0,0.0,1275.0,0.0,1275.0,0.0,1275.0,
TCGA-XF-A9SJ,428,TCGA-XF-A9SJ,BLCA,83.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,[Not Available],-30362.0,Dead,WITH TUMOR,,98.0,[Not Available],,,,,Progressive Disease,,,1.0,98.0,1.0,98.0,,,1.0,98.0,
TCGA-IS-A3K6,8701,TCGA-IS-A3K6,SARC,55.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2000.0,[Not Available],-20205.0,Dead,WITH TUMOR,,858.0,[Not Available],,,,,[Not Available],[Not Available],R2,1.0,858.0,1.0,858.0,,,1.0,858.0,
TCGA-ZP-A9D0,5795,TCGA-ZP-A9D0,LIHC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G1,2011.0,[Not Available],-24525.0,Alive,TUMOR FREE,1091.0,,[Not Available],,,,,[Not Available],,R0,0.0,1091.0,0.0,1091.0,0.0,1091.0,0.0,1091.0,
TCGA-ER-A2NF,9118,TCGA-ER-A2NF,SKCM,53.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2010.0,[Not Available],-19499.0,Dead,WITH TUMOR,,877.0,[Not Available],,,,230.0,[Not Available],,,1.0,877.0,1.0,877.0,,,1.0,230.0,
TCGA-BP-4973,4210,TCGA-BP-4973,KIRC,47.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-17461.0,Alive,TUMOR FREE,1384.0,,[Not Available],,,,,[Not Available],,,0.0,1384.0,0.0,1384.0,,,0.0,1384.0,
TCGA-DD-AADW,5632,TCGA-DD-AADW,LIHC,48.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-17781.0,Alive,TUMOR FREE,587.0,,[Not Available],Locoregional Recurrence,Liver,,386.0,[Not Available],,R0,0.0,587.0,0.0,587.0,1.0,386.0,1.0,386.0,
TCGA-S9-A6UA,5335,TCGA-S9-A6UA,LGG,66.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-24242.0,Dead,WITH TUMOR,,178.0,[Not Available],,,,161.0,Progressive Disease,,,1.0,178.0,1.0,178.0,,,1.0,161.0,
TCGA-60-2714,6574,TCGA-60-2714,LUSC,66.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-24169.0,Alive,TUMOR FREE,1531.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1531.0,0.0,1531.0,0.0,1531.0,0.0,1531.0,
TCGA-ET-A3DP,10241,TCGA-ET-A3DP,THCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-15876.0,Alive,TUMOR FREE,2877.0,,[Not Available],,,,,[Not Available],,R0,0.0,2877.0,0.0,2877.0,0.0,2877.0,0.0,2877.0,
TCGA-06-2561,2854,TCGA-06-2561,GBM,53.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-19505.0,Dead,WITH TUMOR,,537.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],78.0,[Not Available],,,1.0,537.0,1.0,537.0,,,1.0,78.0,
TCGA-49-AARE,5926,TCGA-49-AARE,LUAD,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1999.0,[Not Available],-18893.0,Dead,WITH TUMOR,,1229.0,[Not Available],Locoregional Recurrence,,,388.0,Complete Remission/Response,,,1.0,1229.0,1.0,1229.0,1.0,388.0,1.0,388.0,
TCGA-CQ-6228,3396,TCGA-CQ-6228,HNSC,71.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-25942.0,Dead,,,456.0,[Not Available],,Distant Metastasis,left axilla,273.0,Complete Remission/Response,,,1.0,456.0,,456.0,,,1.0,273.0,
TCGA-WE-AAA3,9250,TCGA-WE-AAA3,SKCM,84.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-30843.0,Alive,TUMOR FREE,651.0,,[Not Available],,,,,[Not Available],,,0.0,651.0,0.0,651.0,,,0.0,651.0,
TCGA-5M-AAT4,1957,TCGA-5M-AAT4,COAD,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-27095.0,Dead,WITH TUMOR,,49.0,[Not Available],,,,,Progressive Disease,,,1.0,49.0,1.0,49.0,,,1.0,49.0,
TCGA-MM-A563,4415,TCGA-MM-A563,KIRC,41.0,MALE,BLACK OR AFRICAN AMERICAN,[Discrepancy],[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2012.0,[Not Available],-15037.0,Alive,TUMOR FREE,591.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,591.0,0.0,591.0,0.0,591.0,0.0,591.0,
TCGA-BP-5000,4230,TCGA-BP-5000,KIRC,40.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-14868.0,Alive,TUMOR FREE,563.0,,[Not Available],,,,,[Not Available],,,0.0,563.0,0.0,563.0,,,0.0,563.0,
TCGA-DE-A4MC,9913,TCGA-DE-A4MC,THCA,43.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-15996.0,Alive,TUMOR FREE,913.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,332.0,[Not Available],,R0,0.0,913.0,0.0,913.0,1.0,332.0,1.0,332.0,
TCGA-S9-A7IY,5351,TCGA-S9-A7IY,LGG,39.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2012.0,[Not Available],-14422.0,Alive,WITH TUMOR,715.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,715.0,0.0,715.0,,,0.0,715.0,
TCGA-13-2065,7108,TCGA-13-2065,OV,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-25973.0,Alive,WITH TUMOR,1993.0,,[Not Available],,[Not Applicable],[Not Applicable],946.0,Complete Remission/Response,,,0.0,1993.0,0.0,1993.0,1.0,946.0,1.0,946.0,
TCGA-B2-4101,4075,TCGA-B2-4101,KIRC,52.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-19059.0,Alive,TUMOR FREE,648.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,648.0,0.0,648.0,0.0,648.0,0.0,648.0,
TCGA-AA-3663,2058,TCGA-AA-3663,COAD,42.0,MALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-15675.0,Alive,TUMOR FREE,212.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,212.0,0.0,212.0,0.0,212.0,0.0,212.0,
TCGA-55-7725,6000,TCGA-55-7725,LUAD,68.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-24848.0,Alive,TUMOR FREE,442.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,
TCGA-D3-A51H,8870,TCGA-D3-A51H,SKCM,60.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-22119.0,Alive,TUMOR FREE,1714.0,,[Not Available],Regional lymph node,,,838.0,[Not Available],,,0.0,1714.0,0.0,1714.0,,,1.0,838.0,
TCGA-2G-AAL7,9773,TCGA-2G-AAL7,TGCT,32.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2003.0,[Not Available],-11917.0,Alive,TUMOR FREE,3991.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,2.0,Complete Remission/Response,,,0.0,3991.0,0.0,3991.0,1.0,2.0,1.0,2.0,
TCGA-CC-5258,5482,TCGA-CC-5258,LIHC,48.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-17586.0,Dead,TUMOR FREE,,129.0,[Not Available],,,,,[Not Available],,RX,1.0,129.0,0.0,129.0,,,0.0,129.0,
TCGA-D3-A2J7,8836,TCGA-D3-A2J7,SKCM,67.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2003.0,[Not Available],-24692.0,Dead,WITH TUMOR,,3136.0,[Not Available],Regional lymph node,,,13.0,[Not Available],,,1.0,3136.0,1.0,3136.0,,,1.0,13.0,
TCGA-4N-A93T,1955,TCGA-4N-A93T,COAD,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2013.0,[Not Available],-24523.0,Alive,WITH TUMOR,146.0,,[Not Available],,,,,Stable Disease,,,0.0,146.0,0.0,146.0,,,0.0,146.0,
TCGA-KK-A8IK,8215,TCGA-KK-A8IK,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-20594.0,Alive,TUMOR FREE,2052.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2052.0,0.0,2052.0,0.0,2052.0,0.0,2052.0,
TCGA-WE-A8ZO,9242,TCGA-WE-A8ZO,SKCM,73.0,FEMALE,[Not Evaluated],Stage IIIB,[Not Applicable],,[Not Available],2009.0,[Not Available],-26946.0,Alive,TUMOR FREE,2145.0,,[Not Available],Regional lymph node,,,1371.0,[Not Available],,,0.0,2145.0,0.0,2145.0,,,1.0,1371.0,
TCGA-DX-A3LS,8576,TCGA-DX-A3LS,SARC,78.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2011.0,[Not Available],-28649.0,Dead,WITH TUMOR,,275.0,[Not Available],Distant Metastasis,Lung,,114.0,[Not Available],[Not Available],R1,1.0,275.0,1.0,275.0,,,1.0,114.0,
TCGA-D5-6920,2314,TCGA-D5-6920,COAD,77.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-28124.0,Alive,TUMOR FREE,377.0,,[Not Available],,,,,[Not Available],,,0.0,377.0,0.0,377.0,,,0.0,377.0,
TCGA-XE-AAOB,9817,TCGA-XE-AAOB,TGCT,27.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Choriocarcinoma|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature),[Not Available],2008.0,[Not Available],-9907.0,Dead,WITH TUMOR,,513.0,Testicular Germ Cell Tumor (TGCT),Distant Metastasis,Lymph Node(s),,231.0,,,,1.0,513.0,1.0,513.0,,,1.0,231.0,
TCGA-HC-7212,8070,TCGA-HC-7212,PRAD,56.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-20576.0,Alive,TUMOR FREE,870.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,870.0,0.0,870.0,0.0,870.0,0.0,870.0,
TCGA-EY-A1G8,10942,TCGA-EY-A1G8,UCEC,83.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30517.0,Dead,TUMOR FREE,,456.0,[Not Available],,,,,Complete Remission/Response,,,1.0,456.0,0.0,456.0,0.0,456.0,0.0,456.0,
TCGA-P5-A731,5280,TCGA-P5-A731,LGG,59.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-21715.0,Alive,TUMOR FREE,274.0,,[Not Available],,,,,[Unknown],,,0.0,274.0,0.0,274.0,,,0.0,274.0,
TCGA-WC-A882,11148,TCGA-WC-A882,UVM,50.0,FEMALE,WHITE,Stage IIB,Stage IIB,Spindle Cell,[Not Available],2012.0,[Not Available],-18612.0,Alive,TUMOR FREE,1112.0,,[Not Available],,,,,[Not Available],,,0.0,1112.0,0.0,1112.0,,,0.0,1112.0,
TCGA-BH-A0BV,1054,TCGA-BH-A0BV,BRCA,78.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28699.0,Alive,TUMOR FREE,1519.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1519.0,0.0,1519.0,0.0,1519.0,0.0,1519.0,
TCGA-DM-A1HB,2338,TCGA-DM-A1HB,COAD,75.0,MALE,WHITE,Stage IIIB,[Not Applicable],[Discrepancy],[Not Available],2000.0,[Not Available],-27708.0,Alive,,4126.0,,[Not Available],,,,,[Not Available],,,0.0,4126.0,0.0,4126.0,,,0.0,4126.0,
TCGA-NJ-A4YP,6317,TCGA-NJ-A4YP,LUAD,52.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-19106.0,Alive,TUMOR FREE,50.0,,[Not Available],,,,,Stable Disease,,,0.0,50.0,0.0,50.0,,,0.0,50.0,
TCGA-R6-A8W8,2609,TCGA-R6-A8W8,ESCA,72.0,MALE,WHITE,[Not Available],Stage IIIA,"Esophagus Adenocarcinoma, NOS",G2,2012.0,[Not Available],-26535.0,Dead,WITH TUMOR,,88.0,[Not Available],,,,,,,,1.0,88.0,1.0,88.0,,,1.0,88.0,
TCGA-F4-6856,2366,TCGA-F4-6856,COAD,45.0,MALE,WHITE,Stage I,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-16519.0,Alive,TUMOR FREE,1074.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1074.0,0.0,1074.0,0.0,1074.0,0.0,1074.0,
TCGA-DD-A4NG,5557,TCGA-DD-A4NG,LIHC,77.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-28234.0,Dead,WITH TUMOR,,802.0,[Not Available],Locoregional Recurrence,Liver,,430.0,[Not Available],,R0,1.0,802.0,1.0,802.0,1.0,430.0,1.0,430.0,
TCGA-98-A53H,6792,TCGA-98-A53H,LUSC,76.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-27928.0,Alive,,618.0,,[Not Available],New Primary Tumor,,,427.0,Complete Remission/Response,,,0.0,618.0,0.0,618.0,0.0,618.0,1.0,427.0,
TCGA-44-2655,5853,TCGA-44-2655,LUAD,65.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-23854.0,Alive,TUMOR FREE,1324.0,,[Not Available],New Primary Tumor,,,1009.0,Complete Remission/Response,,,0.0,1324.0,0.0,1324.0,0.0,1324.0,1.0,1009.0,
TCGA-DX-AB2X,8665,TCGA-DX-AB2X,SARC,73.0,FEMALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2010.0,[Not Available],-26736.0,Dead,WITH TUMOR,,404.0,[Not Available],Locoregional Recurrence,,,111.0,[Not Available],Negative,R0,1.0,404.0,1.0,404.0,1.0,111.0,1.0,111.0,
TCGA-G9-6338,8018,TCGA-G9-6338,PRAD,61.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-22360.0,Alive,TUMOR FREE,2028.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2028.0,0.0,2028.0,0.0,2028.0,0.0,2028.0,
TCGA-WE-A8K6,9239,TCGA-WE-A8K6,SKCM,79.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2013.0,[Not Available],-29216.0,Alive,WITH TUMOR,546.0,,[Not Available],Distant Metastasis,Liver,,256.0,[Not Available],,,0.0,546.0,0.0,546.0,,,1.0,256.0,
TCGA-SI-A71P,8762,TCGA-SI-A71P,SARC,50.0,MALE,WHITE,[Not Available],[Not Available],Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2012.0,[Not Available],-18367.0,Alive,TUMOR FREE,771.0,,[Not Available],,,,,[Not Available],[Unknown],RX,0.0,771.0,0.0,771.0,,,0.0,771.0,
TCGA-BA-6872,3261,TCGA-BA-6872,HNSC,47.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2004.0,[Not Available],-17296.0,Dead,WITH TUMOR,,384.0,[Not Available],,,,,[Not Available],,,1.0,384.0,1.0,384.0,,,1.0,384.0,
TCGA-VS-A9V4,1887,TCGA-VS-A9V4,CESC,63.0,FEMALE,WHITE,[Not Available],Stage IVA,Mucinous Adenocarcinoma of Endocervical Type,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23334.0,Dead,WITH TUMOR,,132.0,Cervical Cancer,New Primary Tumor,,Sigmoid colon,100.0,[Unknown],,,1.0,132.0,1.0,132.0,,,1.0,100.0,
TCGA-X7-A8DC,10389,TCGA-X7-A8DC,THYM,68.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2010.0,[Not Available],-25066.0,Alive,TUMOR FREE,1798.0,,[Not Available],,,,,[Not Available],,,0.0,1798.0,0.0,1798.0,,,0.0,1798.0,
TCGA-IG-A3YA,2478,TCGA-IG-A3YA,ESCA,53.0,MALE,WHITE,Stage IIIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-19567.0,Alive,TUMOR FREE,632.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,632.0,0.0,632.0,0.0,632.0,0.0,632.0,
TCGA-19-5947,3088,TCGA-19-5947,GBM,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-17218.0,Dead,WITH TUMOR,202.0,202.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],43.0,[Not Available],,,1.0,202.0,1.0,202.0,,,1.0,43.0,
TCGA-ND-A4WC,11071,TCGA-ND-A4WC,UCS,83.0,FEMALE,ASIAN,[Not Applicable],Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30434.0,Alive,TUMOR FREE,766.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,
TCGA-V1-A8MK,8239,TCGA-V1-A8MK,PRAD,41.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-15330.0,Alive,,508.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,508.0,0.0,508.0,0.0,508.0,0.0,508.0,
TCGA-EE-A2GP,9041,TCGA-EE-A2GP,SKCM,80.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2009.0,[Not Available],-29501.0,Dead,WITH TUMOR,,423.0,[Not Available],Distant Metastasis,Lung,,251.0,[Not Available],,,1.0,423.0,1.0,423.0,,,1.0,251.0,
TCGA-FD-A3B3,257,TCGA-FD-A3B3,BLCA,74.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-27068.0,Dead,TUMOR FREE,,974.0,[Not Available],,,,,Complete Remission/Response,,,1.0,974.0,0.0,974.0,0.0,974.0,0.0,974.0,
TCGA-V4-A9F7,11115,TCGA-V4-A9F7,UVM,78.0,FEMALE,WHITE,Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,[Not Available],2011.0,[Not Available],-28822.0,Alive,TUMOR FREE,1256.0,,[Not Available],,,,,[Not Available],,,0.0,1256.0,0.0,1256.0,,,0.0,1256.0,
TCGA-KM-8443,3799,TCGA-KM-8443,KICH,57.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2009.0,[Not Available],-21183.0,Alive,TUMOR FREE,1520.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1520.0,0.0,1520.0,0.0,1520.0,0.0,1520.0,
TCGA-QH-A6X9,5305,TCGA-QH-A6X9,LGG,73.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-26992.0,Alive,,58.0,,[Not Available],,,,,[Unknown],,,0.0,58.0,0.0,58.0,,,0.0,58.0,
TCGA-HC-A6AS,8116,TCGA-HC-A6AS,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-25661.0,Alive,TUMOR FREE,44.0,,[Not Available],,,,,[Unknown],,,0.0,44.0,0.0,44.0,,,0.0,44.0,
TCGA-BI-A0VR,1604,TCGA-BI-A0VR,CESC,53.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19473.0,Alive,TUMOR FREE,1505.0,,,,,,,[Not Available],,,0.0,1505.0,0.0,1505.0,,,0.0,1505.0,
TCGA-AD-6899,2192,TCGA-AD-6899,COAD,84.0,MALE,WHITE,Stage IIIC,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-30693.0,Dead,TUMOR FREE,,176.0,[Not Available],,,,,Complete Remission/Response,,,1.0,176.0,0.0,176.0,0.0,176.0,0.0,176.0,
TCGA-14-3476,3038,TCGA-14-3476,GBM,74.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-27172.0,Dead,,12.0,12.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],9.0,[Not Available],,,1.0,12.0,,12.0,,,1.0,9.0,
TCGA-B2-4099,4074,TCGA-B2-4099,KIRC,83.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-30355.0,Alive,TUMOR FREE,972.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,972.0,0.0,972.0,0.0,972.0,0.0,972.0,
TCGA-22-4594,6372,TCGA-22-4594,LUSC,60.0,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-22115.0,Dead,,1470.0,1470.0,[Not Available],,,,,[Not Available],,,1.0,1470.0,,1470.0,,,0.0,1470.0,
TCGA-FE-A3PD,10271,TCGA-FE-A3PD,THCA,17.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2006.0,[Not Available],-6386.0,Alive,TUMOR FREE,2396.0,,[Not Available],,,,,[Not Available],,R0,0.0,2396.0,0.0,2396.0,0.0,2396.0,0.0,2396.0,
TCGA-EM-A2CS,10148,TCGA-EM-A2CS,THCA,51.0,FEMALE,[Not Available],Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18990.0,Alive,WITH TUMOR,841.0,,[Not Available],,,,,[Not Available],,R1,0.0,841.0,0.0,841.0,,,0.0,841.0,
TCGA-FU-A23L,1754,TCGA-FU-A23L,CESC,60.0,FEMALE,WHITE,[Not Available],Stage IIA1,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21962.0,Alive,TUMOR FREE,725.0,,,,,,,Complete Remission/Response,,,0.0,725.0,0.0,725.0,0.0,725.0,0.0,725.0,
TCGA-A3-A8CQ,3932,TCGA-A3-A8CQ,KIRC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2011.0,[Not Available],-21572.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,[Unknown],,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-76-6663,3233,TCGA-76-6663,GBM,44.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-16126.0,Dead,WITH TUMOR,,567.0,[Not Available],,,,,[Not Available],,,1.0,567.0,1.0,567.0,,,1.0,567.0,
TCGA-KN-8419,3819,TCGA-KN-8419,KICH,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-15769.0,Alive,TUMOR FREE,714.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,
TCGA-IB-7647,7621,TCGA-IB-7647,PAAD,41.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,[Not Available],-15188.0,Dead,WITH TUMOR,,666.0,Pancreatic Cancer,Distant Metastasis,Liver,,390.0,Progressive Disease,,,1.0,666.0,1.0,666.0,,,1.0,390.0,
TCGA-BR-8360,9351,TCGA-BR-8360,STAD,66.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-24394.0,Alive,TUMOR FREE,188.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,188.0,0.0,188.0,0.0,188.0,0.0,188.0,
TCGA-ZG-A8QY,8345,TCGA-ZG-A8QY,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-24731.0,Alive,WITH TUMOR,404.0,,[Not Available],,,,,Stable Disease,,,0.0,404.0,0.0,404.0,,,0.0,404.0,
TCGA-V4-A9ES,11101,TCGA-V4-A9ES,UVM,54.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,[Not Available],2011.0,[Not Available],-20054.0,Alive,WITH TUMOR,1511.0,,[Not Available],Distant Metastasis,Liver,,1299.0,[Not Available],,,0.0,1511.0,0.0,1511.0,,,1.0,1299.0,
TCGA-78-7162,6157,TCGA-78-7162,LUAD,75.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1991.0,[Not Available],-27593.0,Dead,,,3169.0,[Not Available],,,,2218.0,[Not Available],,,1.0,3169.0,,3169.0,,,1.0,2218.0,
TCGA-C5-A1BK,1612,TCGA-C5-A1BK,CESC,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1994.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13297.0,Alive,TUMOR FREE,5385.0,,,,,,,Complete Remission/Response,,,0.0,5385.0,0.0,5385.0,0.0,5385.0,0.0,5385.0,
TCGA-CL-5917,8480,TCGA-CL-5917,READ,71.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2006.0,[Not Available],-26084.0,Alive,TUMOR FREE,2376.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2376.0,0.0,2376.0,0.0,2376.0,0.0,2376.0,
TCGA-B0-5712,4068,TCGA-B0-5712,KIRC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-24988.0,Alive,WITH TUMOR,2722.0,,[Not Available],,,,725.0,[Not Available],,,0.0,2722.0,0.0,2722.0,,,1.0,725.0,
TCGA-CV-A464,3590,TCGA-CV-A464,HNSC,48.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-17669.0,Alive,TUMOR FREE,1722.0,,[Not Available],Locoregional Disease,,pterygoid,28.0,Complete Remission/Response,,,0.0,1722.0,0.0,1722.0,,,1.0,28.0,
TCGA-DE-A69J,9915,TCGA-DE-A69J,THCA,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-12493.0,Alive,TUMOR FREE,447.0,,[Not Available],,,,,[Not Available],,R0,0.0,447.0,0.0,447.0,0.0,447.0,0.0,447.0,
TCGA-21-1081,6352,TCGA-21-1081,LUSC,69.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1996.0,[Not Available],-25440.0,Dead,WITH TUMOR,284.0,284.0,[Not Available],,,,,[Not Available],,,1.0,284.0,1.0,284.0,,,1.0,284.0,
TCGA-E6-A2P8,10913,TCGA-E6-A2P8,UCEC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IV,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19448.0,Dead,WITH TUMOR,,72.0,[Not Available],Metastatic,Lung,,60.0,Progressive Disease,,,1.0,72.0,1.0,72.0,,,1.0,60.0,
TCGA-FS-A1ZQ,9163,TCGA-FS-A1ZQ,SKCM,31.0,MALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],1997.0,[Not Available],-11599.0,Dead,WITH TUMOR,,4062.0,[Not Available],,,,3940.0,[Not Available],,,1.0,4062.0,1.0,4062.0,,,1.0,3940.0,
TCGA-GL-A59R,4613,TCGA-GL-A59R,KIRP,79.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-29046.0,Alive,TUMOR FREE,378.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,
TCGA-JW-A5VJ,1787,TCGA-JW-A5VJ,CESC,56.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20714.0,Alive,WITH TUMOR,652.0,,,Distant Metastasis,Head & Neck,,267.0,Progressive Disease,,,0.0,652.0,0.0,652.0,,,1.0,267.0,
TCGA-RM-A68T,7752,TCGA-RM-A68T,PCPG,46.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Paraganglioma,[Not Available],2007.0,[Not Available],-17065.0,Alive,TUMOR FREE,2372.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2372.0,0.0,2372.0,0.0,2372.0,0.0,2372.0,
TCGA-EU-5904,4406,TCGA-EU-5904,KIRC,47.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2009.0,[Not Available],-17468.0,Alive,TUMOR FREE,551.0,,[Not Available],,,,,[Not Available],,,0.0,551.0,0.0,551.0,,,0.0,551.0,
TCGA-AX-A1CC,10636,TCGA-AX-A1CC,UCEC,65.0,FEMALE,WHITE,[Not Applicable],Stage IC,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23795.0,Alive,TUMOR FREE,788.0,,[Not Available],,,,,[Not Applicable],,,0.0,788.0,0.0,788.0,,,0.0,788.0,
TCGA-IR-A3LI,1781,TCGA-IR-A3LI,CESC,48.0,FEMALE,WHITE,[Not Available],Stage IVB,Endocervical Type of Adenocarcinoma,G2,2005.0,Peri (6-12 months since last menstrual period),-17741.0,Alive,TUMOR FREE,2493.0,,,,,,,Complete Remission/Response,,,0.0,2493.0,0.0,2493.0,,,0.0,2493.0,
TCGA-D7-6525,9495,TCGA-D7-6525,STAD,58.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-21223.0,Dead,WITH TUMOR,,406.0,[Not Available],Distant Metastasis,,,171.0,Progressive Disease,,,1.0,406.0,1.0,406.0,,,1.0,171.0,
TCGA-74-6573,3205,TCGA-74-6573,GBM,67.0,MALE,[Not Available],[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-24632.0,Dead,WITH TUMOR,,105.0,[Not Available],,,,,[Not Available],,,1.0,105.0,1.0,105.0,,,1.0,105.0,
TCGA-G4-6317,2383,TCGA-G4-6317,COAD,51.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-18822.0,Alive,TUMOR FREE,1095.0,,[Not Available],Metastatic,,,592.0,[Not Available],,,0.0,1095.0,0.0,1095.0,,,1.0,592.0,
TCGA-BR-8679,9382,TCGA-BR-8679,STAD,63.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-23084.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-AR-A1AO,921,TCGA-AR-A1AO,BRCA,47.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17332.0,Alive,TUMOR FREE,2618.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2618.0,0.0,2618.0,0.0,2618.0,0.0,2618.0,
TCGA-S9-A7R3,5363,TCGA-S9-A7R3,LGG,28.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2006.0,[Not Available],-10342.0,Alive,TUMOR FREE,3013.0,,[Not Available],,,,970.0,Partial Remission/Response,,,0.0,3013.0,0.0,3013.0,,,1.0,970.0,
TCGA-QH-A870,5309,TCGA-QH-A870,LGG,38.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-14082.0,Alive,WITH TUMOR,395.0,,[Not Available],,,,335.0,Complete Remission/Response,,,0.0,395.0,0.0,395.0,1.0,335.0,1.0,335.0,
TCGA-KL-8330,3777,TCGA-KL-8330,KICH,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2003.0,[Not Available],-16250.0,Alive,TUMOR FREE,3304.0,,[Not Available],,,,,[Unknown],,,0.0,3304.0,0.0,3304.0,,,0.0,3304.0,
TCGA-V1-A9ZI,8264,TCGA-V1-A9ZI,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-25185.0,Alive,,1640.0,,[Not Available],,,,,Progressive Disease,,,0.0,1640.0,0.0,1640.0,,,0.0,1640.0,
TCGA-DG-A2KH,1671,TCGA-DG-A2KH,CESC,25.0,FEMALE,[Not Evaluated],[Not Available],Stage IB1,Adenosquamous,GX,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9209.0,Alive,,34.0,,,,,,,[Unknown],,,0.0,34.0,0.0,34.0,,,0.0,34.0,
TCGA-XF-A8HC,418,TCGA-XF-A8HC,BLCA,79.0,MALE,ASIAN,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,[Not Available],-28996.0,Dead,,,200.0,[Not Available],,,,,[Unknown],,,1.0,200.0,,200.0,,,0.0,200.0,
TCGA-J4-8198,8130,TCGA-J4-8198,PRAD,49.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-17935.0,Alive,TUMOR FREE,614.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,614.0,0.0,614.0,0.0,614.0,0.0,614.0,
TCGA-MV-A51V,394,TCGA-MV-A51V,BLCA,75.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27430.0,Alive,TUMOR FREE,410.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,
TCGA-YU-A94I,9834,TCGA-YU-A94I,TGCT,66.0,MALE,[Unknown],Stage IA,Stage IA,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2013.0,[Not Available],-24349.0,Alive,TUMOR FREE,536.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,536.0,0.0,536.0,0.0,536.0,0.0,536.0,
TCGA-C8-A1HG,1200,TCGA-C8-A1HG,BRCA,50.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,Alive,TUMOR FREE,345.0,,[Not Available],,,,,[Not Available],Negative,,0.0,345.0,0.0,345.0,0.0,345.0,0.0,345.0,
TCGA-ZX-AA5X,1908,TCGA-ZX-AA5X,CESC,64.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23440.0,Alive,WITH TUMOR,119.0,,,,,,,[Not Applicable],,,0.0,119.0,0.0,119.0,,,0.0,119.0,
TCGA-CF-A47V,159,TCGA-CF-A47V,BLCA,52.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-19265.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,
TCGA-F7-8298,3645,TCGA-F7-8298,HNSC,58.0,MALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-21445.0,Alive,TUMOR FREE,995.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,995.0,0.0,995.0,0.0,995.0,0.0,995.0,
TCGA-PR-A5PG,7695,TCGA-PR-A5PG,PCPG,42.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2007.0,[Not Available],-15577.0,Alive,WITH TUMOR,2485.0,,[Not Available],Distant Metastasis,Bone,,2278.0,Complete Remission/Response,,,0.0,2485.0,0.0,2485.0,1.0,2278.0,1.0,2278.0,
TCGA-06-5856,2873,TCGA-06-5856,GBM,58.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-21232.0,Dead,WITH TUMOR,114.0,114.0,[Not Available],,,,,[Not Available],,,1.0,114.0,1.0,114.0,,,1.0,114.0,
TCGA-38-4626,5843,TCGA-38-4626,LUAD,57.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Lung Adenocarcinoma,[Not Available],2003.0,[Not Available],-20903.0,Alive,TUMOR FREE,3674.0,,[Not Available],New Primary Tumor,,,2518.0,Complete Remission/Response,,,0.0,3674.0,0.0,3674.0,0.0,3674.0,1.0,2518.0,
TCGA-WZ-A8D5,9804,TCGA-WZ-A8D5,TGCT,38.0,MALE,WHITE,[Discrepancy],[Not Available],Seminoma; NOS,[Not Available],2012.0,[Not Available],-13974.0,Alive,TUMOR FREE,774.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,774.0,0.0,774.0,0.0,774.0,0.0,774.0,
TCGA-BC-A10Y,5464,TCGA-BC-A10Y,LIHC,76.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G3,2002.0,[Not Available],-28049.0,Dead,WITH TUMOR,,711.0,[Not Available],Intrahepatic Recurrence,,,400.0,[Not Available],,R0,1.0,711.0,1.0,711.0,1.0,400.0,1.0,400.0,
TCGA-DO-A1JZ,10011,TCGA-DO-A1JZ,THCA,23.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2007.0,[Not Available],-8551.0,Alive,TUMOR FREE,1670.0,,[Not Available],,,,,[Not Available],,R1,0.0,1670.0,0.0,1670.0,,,0.0,1670.0,
TCGA-IQ-A61G,3683,TCGA-IQ-A61G,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21066.0,Alive,WITH TUMOR,360.0,,[Not Available],,Oral Cavity,,249.0,Progressive Disease,,,0.0,360.0,0.0,360.0,,,1.0,249.0,
TCGA-WB-A80M,7832,TCGA-WB-A80M,PCPG,63.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-23163.0,Alive,TUMOR FREE,136.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,136.0,0.0,136.0,0.0,136.0,0.0,136.0,
TCGA-D1-A16D,10840,TCGA-D1-A16D,UCEC,49.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008.0,Peri (6-12 months since last menstrual period),-17933.0,Alive,TUMOR FREE,1141.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1141.0,0.0,1141.0,0.0,1141.0,0.0,1141.0,
TCGA-05-4425,5825,TCGA-05-4425,LUAD,70.0,FEMALE,[Not Available],Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-25902.0,Alive,,669.0,,[Not Available],,,,,[Not Available],,,0.0,669.0,0.0,669.0,,,0.0,669.0,
TCGA-S6-A8JY,9783,TCGA-S6-A8JY,TGCT,27.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],2013.0,[Not Available],-10219.0,Alive,TUMOR FREE,278.0,,[Not Applicable],,,,,[Unknown],,,0.0,278.0,0.0,278.0,,,0.0,278.0,
TCGA-EB-A97M,8991,TCGA-EB-A97M,SKCM,66.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-24228.0,Alive,TUMOR FREE,414.0,,[Not Available],,,,,[Not Available],,,0.0,414.0,0.0,414.0,,,0.0,414.0,
TCGA-CC-A8HV,5509,TCGA-CC-A8HV,LIHC,51.0,FEMALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-18935.0,Dead,WITH TUMOR,,279.0,[Not Available],Locoregional Recurrence,,,149.0,[Not Available],,R0,1.0,279.0,1.0,279.0,1.0,149.0,1.0,149.0,
TCGA-BH-A18F,1114,TCGA-BH-A18F,BRCA,50.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Peri (6-12 months since last menstrual period),-18594.0,Alive,TUMOR FREE,1001.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,
TCGA-E2-A10A,1308,TCGA-E2-A10A,BRCA,41.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15085.0,Alive,WITH TUMOR,1229.0,,[Not Available],Distant Metastasis,Bone,,75.0,[Not Available],Negative,,0.0,1229.0,0.0,1229.0,1.0,75.0,1.0,75.0,
TCGA-C5-A7UI,1654,TCGA-C5-A7UI,CESC,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2004.0,[Not Available],-15349.0,Dead,TUMOR FREE,,2888.0,,,,,,[Not Available],,,1.0,2888.0,0.0,2888.0,,,0.0,2888.0,
TCGA-V4-A9EK,11096,TCGA-V4-A9EK,UVM,37.0,FEMALE,WHITE,Stage IIB,Stage IIB,Spindle Cell,[Not Available],2012.0,[Not Available],-13731.0,Alive,TUMOR FREE,1028.0,,[Not Available],,,,,[Not Available],,,0.0,1028.0,0.0,1028.0,,,0.0,1028.0,
TCGA-32-4208,3185,TCGA-32-4208,GBM,25.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-9213.0,Alive,WITH TUMOR,643.0,,[Not Available],,,,,[Not Available],,,0.0,643.0,0.0,643.0,,,0.0,643.0,
TCGA-OR-A5J6,6,TCGA-OR-A5J6,ACC,29.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2006.0,[Not Available],-10839.0,Alive,TUMOR FREE,2703.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2703.0,0.0,2703.0,0.0,2703.0,0.0,2703.0,
TCGA-D3-A8GD,8885,TCGA-D3-A8GD,SKCM,63.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-23109.0,Alive,TUMOR FREE,718.0,,[Not Available],Distant Metastasis,"Other, Specify",Retroperitoneal lymph nodes,147.0,[Not Available],,,0.0,718.0,0.0,718.0,,,1.0,147.0,
TCGA-66-2763,6621,TCGA-66-2763,LUSC,63.0,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-23315.0,Alive,TUMOR FREE,30.0,,[Not Available],,,,,[Not Available],,,0.0,30.0,0.0,30.0,,,0.0,30.0,
TCGA-CN-5367,3331,TCGA-CN-5367,HNSC,60.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2006.0,[Not Available],-22246.0,Dead,TUMOR FREE,,352.0,[Not Available],,,,,Complete Remission/Response,,,1.0,352.0,0.0,352.0,,,0.0,352.0,
TCGA-DX-A6B9,8605,TCGA-DX-A6B9,SARC,45.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-16561.0,Alive,TUMOR FREE,1138.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1138.0,0.0,1138.0,0.0,1138.0,0.0,1138.0,
TCGA-DU-A7T6,5057,TCGA-DU-A7T6,LGG,73.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2002.0,[Not Available],-26766.0,Dead,WITH TUMOR,,547.0,[Not Available],,,,,[Unknown],,,1.0,547.0,1.0,547.0,,,1.0,547.0,
TCGA-UY-A9PF,415,TCGA-UY-A9PF,BLCA,77.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-28470.0,Alive,TUMOR FREE,117.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,117.0,0.0,117.0,,,0.0,117.0,
TCGA-QS-A5YR,11017,TCGA-QS-A5YR,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22372.0,Alive,WITH TUMOR,719.0,,[Not Available],,,,,Stable Disease,,,0.0,719.0,0.0,719.0,,,0.0,719.0,
TCGA-B0-5702,4060,TCGA-B0-5702,KIRC,71.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-26186.0,Alive,TUMOR FREE,2172.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2172.0,0.0,2172.0,0.0,2172.0,0.0,2172.0,
TCGA-CR-7379,3450,TCGA-CR-7379,HNSC,78.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-28763.0,Alive,TUMOR FREE,1036.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1036.0,0.0,1036.0,,,0.0,1036.0,
TCGA-CQ-5323,3376,TCGA-CQ-5323,HNSC,82.0,MALE,WHITE,Stage I,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,[Not Available],-30173.0,Alive,TUMOR FREE,1466.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1466.0,0.0,1466.0,0.0,1466.0,0.0,1466.0,
TCGA-AJ-A8CT,10559,TCGA-AJ-A8CT,UCEC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21515.0,Alive,TUMOR FREE,82.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,82.0,0.0,82.0,0.0,82.0,0.0,82.0,
TCGA-QR-A70V,7738,TCGA-QR-A70V,PCPG,66.0,FEMALE,[Unknown],[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-24437.0,Alive,TUMOR FREE,2.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2.0,0.0,2.0,0.0,2.0,0.0,2.0,
TCGA-W2-A7UY,7829,TCGA-W2-A7UY,PCPG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-16335.0,Alive,TUMOR FREE,450.0,,[Not Available],,,,,[Unknown],,,0.0,450.0,0.0,450.0,,,0.0,450.0,
TCGA-ET-A39M,10223,TCGA-ET-A39M,THCA,34.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-12441.0,Alive,TUMOR FREE,2582.0,,[Not Available],,,,,[Not Available],,R0,0.0,2582.0,0.0,2582.0,0.0,2582.0,0.0,2582.0,
TCGA-AC-A2FB,762,TCGA-AC-A2FB,BRCA,65.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009.0,[Not Available],-23851.0,Alive,TUMOR FREE,1234.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1234.0,0.0,1234.0,0.0,1234.0,0.0,1234.0,
TCGA-B0-5115,4039,TCGA-B0-5115,KIRC,43.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2009.0,[Not Available],-15935.0,Alive,WITH TUMOR,1604.0,,[Not Available],,,,75.0,Progressive Disease,,,0.0,1604.0,0.0,1604.0,,,1.0,75.0,
TCGA-YF-AA3L,471,TCGA-YF-AA3L,BLCA,47.0,FEMALE,[Unknown],Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-17268.0,Alive,TUMOR FREE,364.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,364.0,0.0,364.0,0.0,364.0,0.0,364.0,
TCGA-VQ-A8PY,9671,TCGA-VQ-A8PY,STAD,47.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009.0,[Not Available],-17230.0,Dead,TUMOR FREE,,436.0,Stomach Cancer,,,,,Complete Remission/Response,,,1.0,436.0,1.0,436.0,0.0,436.0,0.0,436.0,
TCGA-ZF-AA52,497,TCGA-ZF-AA52,BLCA,70.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-25579.0,Dead,,,1077.0,[Not Available],,,,,Partial Remission/Response,,,1.0,1077.0,,1077.0,,,0.0,1077.0,
TCGA-XV-A9W2,9253,TCGA-XV-A9W2,SKCM,81.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],2013.0,[Not Available],-29836.0,Alive,TUMOR FREE,417.0,,[Not Available],,,,,[Not Available],,,0.0,417.0,0.0,417.0,,,0.0,417.0,
TCGA-YL-A9WX,8341,TCGA-YL-A9WX,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-25008.0,Alive,WITH TUMOR,1518.0,,[Not Available],Biochemical evidence of disease,,,1506.0,Stable Disease,,,0.0,1518.0,0.0,1518.0,,,1.0,1506.0,
TCGA-DD-AAW0,5661,TCGA-DD-AAW0,LIHC,54.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2009.0,[Not Available],-19981.0,Alive,TUMOR FREE,2015.0,,[Not Available],,,,,[Not Available],,R0,0.0,2015.0,0.0,2015.0,0.0,2015.0,0.0,2015.0,
TCGA-4Z-AA86,112,TCGA-4Z-AA86,BLCA,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-24465.0,Dead,WITH TUMOR,,311.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Pelvis,136.0,Complete Remission/Response,,,1.0,311.0,1.0,311.0,,,1.0,136.0,
TCGA-XK-AAIV,8302,TCGA-XK-AAIV,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23325.0,Alive,TUMOR FREE,1133.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0,
TCGA-F4-6855,2365,TCGA-F4-6855,COAD,70.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-25890.0,Alive,TUMOR FREE,1442.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1442.0,0.0,1442.0,0.0,1442.0,0.0,1442.0,
TCGA-CM-4748,2262,TCGA-CM-4748,COAD,53.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-19509.0,Alive,TUMOR FREE,792.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,792.0,0.0,792.0,0.0,792.0,0.0,792.0,
TCGA-LB-A9Q5,7660,TCGA-LB-A9Q5,PAAD,63.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,[Not Available],-23218.0,Dead,WITH TUMOR,,313.0,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",omentum,290.0,[Unknown],,,1.0,313.0,1.0,313.0,,,1.0,290.0,
TCGA-AX-A3G9,10672,TCGA-AX-A3G9,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010.0,[Not Available],-23361.0,Alive,,558.0,,[Not Available],,,,,[Not Available],,,0.0,558.0,0.0,558.0,,,0.0,558.0,
TCGA-CC-A8HU,5508,TCGA-CC-A8HU,LIHC,39.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-14367.0,Dead,WITH TUMOR,,344.0,[Not Available],Locoregional Recurrence,,,301.0,[Not Available],,R0,1.0,344.0,1.0,344.0,1.0,301.0,1.0,301.0,
TCGA-14-0781,2999,TCGA-14-0781,GBM,49.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-17903.0,Dead,WITH TUMOR,29.0,29.0,[Not Available],,,,,[Not Available],,,1.0,29.0,1.0,29.0,,,1.0,29.0,
TCGA-ER-A198,9092,TCGA-ER-A198,SKCM,45.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2003.0,[Not Available],-16540.0,Dead,WITH TUMOR,,1544.0,[Not Available],,,,0.0,[Not Available],,,1.0,1544.0,1.0,1544.0,,,1.0,0.0,
TCGA-D3-A2JK,8847,TCGA-D3-A2JK,SKCM,24.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2005.0,[Not Available],-8952.0,Dead,WITH TUMOR,,368.0,[Not Available],Distant Metastasis,Lung,,261.0,[Not Available],,,1.0,368.0,1.0,368.0,,,1.0,261.0,
TCGA-YG-AA3P,9264,TCGA-YG-AA3P,SKCM,63.0,FEMALE,[Unknown],Stage IIB,[Not Applicable],,[Not Available],2013.0,[Not Available],-23219.0,Alive,WITH TUMOR,439.0,,[Not Available],,,,,[Not Available],,,0.0,439.0,0.0,439.0,,,0.0,439.0,
TCGA-FG-A60J,5126,TCGA-FG-A60J,LGG,47.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-17339.0,Alive,TUMOR FREE,449.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,449.0,0.0,449.0,0.0,449.0,0.0,449.0,
TCGA-A5-A0VQ,10509,TCGA-A5-A0VQ,UCEC,62.0,FEMALE,[Not Available],[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22995.0,Alive,TUMOR FREE,485.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,
TCGA-DK-A6B0,212,TCGA-DK-A6B0,BLCA,61.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-22439.0,Alive,TUMOR FREE,2330.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2330.0,0.0,2330.0,0.0,2330.0,0.0,2330.0,
TCGA-K7-A5RG,5739,TCGA-K7-A5RG,LIHC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-24218.0,Alive,TUMOR FREE,519.0,,[Not Available],,,,,[Not Available],,R0,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,
TCGA-2A-AAYO,7875,TCGA-2A-AAYO,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21183.0,Alive,TUMOR FREE,1272.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1272.0,0.0,1272.0,0.0,1272.0,0.0,1272.0,
TCGA-DX-AB2P,8659,TCGA-DX-AB2P,SARC,79.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2005.0,[Not Available],-29136.0,Dead,WITH TUMOR,,367.0,[Not Available],Locoregional Recurrence,,,161.0,[Not Available],Negative,R0,1.0,367.0,1.0,367.0,1.0,161.0,1.0,161.0,
TCGA-BR-8365,9356,TCGA-BR-8365,STAD,70.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-25725.0,Dead,WITH TUMOR,,533.0,[Not Available],,,,,Stable Disease,,,1.0,533.0,1.0,533.0,,,1.0,533.0,
TCGA-IB-A6UF,7642,TCGA-IB-A6UF,PAAD,63.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-23152.0,Alive,WITH TUMOR,666.0,,,Distant Metastasis,Liver,,593.0,Partial Remission/Response,,,0.0,666.0,0.0,666.0,,,1.0,593.0,
TCGA-WQ-AB4B,5782,TCGA-WQ-AB4B,LIHC,62.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-22769.0,Alive,WITH TUMOR,395.0,,[Not Available],Intrahepatic Recurrence,,,273.0,[Not Available],,R0,0.0,395.0,0.0,395.0,1.0,273.0,1.0,273.0,
TCGA-FD-A43Y,280,TCGA-FD-A43Y,BLCA,65.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-23889.0,Dead,TUMOR FREE,,474.0,[Not Available],,,,,Complete Remission/Response,,,1.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,
TCGA-HU-A4HB,9590,TCGA-HU-A4HB,STAD,68.0,MALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-25131.0,Dead,WITH TUMOR,,477.0,[Not Available],Distant Metastasis,,,390.0,Complete Remission/Response,,,1.0,477.0,1.0,477.0,1.0,390.0,1.0,390.0,
TCGA-3H-AB3K,6829,TCGA-3H-AB3K,MESO,64.0,MALE,WHITE,Stage II,[Not Applicable],Diffuse malignant mesothelioma - NOS,[Not Available],2008.0,[Not Available],-23591.0,Dead,WITH TUMOR,,1715.0,[Not Available],Distant Metastasis,Contralateral Pleura,,841.0,[Not Available],,[Not Available],1.0,1715.0,1.0,1715.0,,,1.0,841.0,
TCGA-2G-AALP,9774,TCGA-2G-AALP,TGCT,43.0,MALE,WHITE,Stage IIIB,Stage IIIB,Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature),[Not Available],2007.0,[Not Available],-15977.0,Alive,TUMOR FREE,2645.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,2645.0,0.0,2645.0,,,0.0,2645.0,
TCGA-3A-A9IZ,7541,TCGA-3A-A9IZ,PAAD,47.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-17294.0,Dead,WITH TUMOR,,308.0,Pancreatic Cancer,Locoregional Recurrence,Tumor Bed,,109.0,Progressive Disease,,,1.0,308.0,1.0,308.0,,,1.0,109.0,
TCGA-D7-A74B,9528,TCGA-D7-A74B,STAD,52.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2013.0,[Not Available],-19066.0,Dead,WITH TUMOR,,217.0,Stomach Cancer,Locoregional Recurrence,,,174.0,Progressive Disease,,,1.0,217.0,1.0,217.0,,,1.0,174.0,
TCGA-A2-A1FX,598,TCGA-A2-A1FX,BRCA,61.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22344.0,Alive,TUMOR FREE,1847.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1847.0,0.0,1847.0,0.0,1847.0,0.0,1847.0,
TCGA-CR-5247,3417,TCGA-CR-5247,HNSC,48.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G2,2006.0,[Not Available],-17810.0,Alive,TUMOR FREE,358.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,
TCGA-GR-A4D4,2443,TCGA-GR-A4D4,DLBC,57.0,FEMALE,WHITE,[Not Applicable],Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010.0,[Not Available],-20888.0,Alive,TUMOR FREE,1581.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1581.0,0.0,1581.0,,,0.0,1581.0,
TCGA-V1-A8WS,8245,TCGA-V1-A8WS,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-20805.0,Alive,,474.0,,[Not Available],,,,,Progressive Disease,,,0.0,474.0,0.0,474.0,,,0.0,474.0,
TCGA-FR-A729,9136,TCGA-FR-A729,SKCM,38.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],1996.0,[Not Available],-14043.0,Alive,WITH TUMOR,6716.0,,[Not Available],Distant Metastasis,"Other, Specify",spleen,6299.0,[Not Available],,,0.0,6716.0,0.0,6716.0,,,1.0,6299.0,
TCGA-22-4607,6379,TCGA-22-4607,LUSC,75.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-27601.0,Dead,TUMOR FREE,587.0,587.0,[Not Available],,,,,[Not Available],,,1.0,587.0,0.0,587.0,,,0.0,587.0,
TCGA-M7-A721,8221,TCGA-M7-A721,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-25585.0,Alive,TUMOR FREE,400.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,400.0,0.0,400.0,0.0,400.0,0.0,400.0,
TCGA-NJ-A55R,6321,TCGA-NJ-A55R,LUAD,67.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-24738.0,Alive,TUMOR FREE,603.0,,[Not Available],,,,,Stable Disease,,,0.0,603.0,0.0,603.0,,,0.0,603.0,
TCGA-UE-A6QU,8767,TCGA-UE-A6QU,SARC,90.0,FEMALE,ASIAN,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013.0,[Not Available],-32872.0,Alive,TUMOR FREE,408.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,408.0,0.0,408.0,0.0,408.0,0.0,408.0,
TCGA-G9-7523,8053,TCGA-G9-7523,PRAD,44.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-16269.0,Alive,TUMOR FREE,857.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,857.0,0.0,857.0,0.0,857.0,0.0,857.0,
TCGA-ED-A66Y,5670,TCGA-ED-A66Y,LIHC,51.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-18797.0,Dead,TUMOR FREE,,296.0,[Not Available],,,,,[Not Available],,R0,1.0,296.0,0.0,296.0,0.0,296.0,0.0,296.0,
TCGA-VS-A94Y,1853,TCGA-VS-A94Y,CESC,47.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,GX,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17465.0,Dead,WITH TUMOR,,144.0,Cervical Cancer,,,,,Progressive Disease,,,1.0,144.0,1.0,144.0,,,1.0,144.0,
TCGA-MP-A4T9,6303,TCGA-MP-A4T9,LUAD,54.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-19767.0,Dead,WITH TUMOR,,1265.0,[Not Available],Locoregional Recurrence|Distant Metastasis,,,341.0,Complete Remission/Response,,,1.0,1265.0,1.0,1265.0,1.0,341.0,1.0,341.0,
TCGA-RB-AA9M,7667,TCGA-RB-AA9M,PAAD,43.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,[Not Available],-15807.0,Alive,WITH TUMOR,286.0,,,Distant Metastasis,Liver,,258.0,Progressive Disease,,,0.0,286.0,0.0,286.0,,,1.0,258.0,
TCGA-67-3770,6086,TCGA-67-3770,LUAD,70.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-25658.0,Alive,TUMOR FREE,610.0,,[Not Available],,,,,[Not Available],,,0.0,610.0,0.0,610.0,,,0.0,610.0,
TCGA-UD-AAC7,6899,TCGA-UD-AAC7,MESO,47.0,MALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],2008.0,[Not Available],-17299.0,Dead,WITH TUMOR,,406.0,[Not Available],Intrapleural Progression,Ipsilateral Pleura,,265.0,[Not Available],,R2,1.0,406.0,1.0,406.0,,,1.0,265.0,
TCGA-DD-AACU,5599,TCGA-DD-AACU,LIHC,59.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-21606.0,Alive,TUMOR FREE,1567.0,,[Not Available],,,,,[Not Available],,R0,0.0,1567.0,0.0,1567.0,0.0,1567.0,0.0,1567.0,
TCGA-C8-A3M7,1219,TCGA-C8-A3M7,BRCA,60.0,FEMALE,ASIAN,Stage IIIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22096.0,Dead,WITH TUMOR,,1034.0,[Not Available],Locoregional Recurrence,,,1034.0,[Not Available],Negative,,1.0,1034.0,1.0,1034.0,1.0,1034.0,1.0,1034.0,
TCGA-DX-AB2S,8661,TCGA-DX-AB2S,SARC,53.0,FEMALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2005.0,[Not Available],-19708.0,Alive,TUMOR FREE,280.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,280.0,0.0,280.0,0.0,280.0,0.0,280.0,
TCGA-66-2734,6610,TCGA-66-2734,LUSC,62.0,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-22919.0,Alive,TUMOR FREE,1311.0,,[Not Available],,,,,[Not Applicable],,,0.0,1311.0,0.0,1311.0,,,0.0,1311.0,
TCGA-BR-A4J1,9400,TCGA-BR-A4J1,STAD,63.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-23266.0,Dead,,,22.0,[Unknown],,,,,[Unknown],,,1.0,22.0,,22.0,,,0.0,22.0,
TCGA-85-A5B5,6752,TCGA-85-A5B5,LUSC,58.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-21450.0,Alive,TUMOR FREE,111.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,111.0,0.0,111.0,0.0,111.0,0.0,111.0,
TCGA-AC-A7VB,797,TCGA-AC-A7VB,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,[Unknown],-18806.0,Alive,TUMOR FREE,250.0,,[Not Available],,,,,[Not Available],Negative,,0.0,250.0,0.0,250.0,0.0,250.0,0.0,250.0,
TCGA-HT-7475,5148,TCGA-HT-7475,LGG,67.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2010.0,[Not Available],-24686.0,Alive,TUMOR FREE,530.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,530.0,0.0,530.0,0.0,530.0,0.0,530.0,
TCGA-KL-8337,3784,TCGA-KL-8337,KICH,26.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-9819.0,Alive,TUMOR FREE,1364.0,,[Not Available],,,,,[Unknown],,,0.0,1364.0,0.0,1364.0,,,0.0,1364.0,
TCGA-V4-A9EL,11097,TCGA-V4-A9EL,UVM,60.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell,[Not Available],2012.0,[Not Available],-22150.0,Alive,WITH TUMOR,982.0,,[Not Available],Distant Metastasis,Liver,,413.0,[Not Available],,,0.0,982.0,0.0,982.0,,,1.0,413.0,
TCGA-DU-5855,4986,TCGA-DU-5855,LGG,49.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2010.0,[Not Available],-18234.0,Alive,WITH TUMOR,207.0,,[Not Available],,,,,Stable Disease,,,0.0,207.0,0.0,207.0,,,0.0,207.0,
TCGA-G9-6370,8036,TCGA-G9-6370,PRAD,52.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-19149.0,Alive,TUMOR FREE,1156.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1156.0,0.0,1156.0,0.0,1156.0,0.0,1156.0,
TCGA-XH-A853,10404,TCGA-XH-A853,THYM,67.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],I,Thymoma; Type AB,[Not Available],2011.0,[Not Available],-24556.0,Alive,TUMOR FREE,1220.0,,[Not Available],New Primary Tumor,"Other, specify",right axillary,196.0,[Not Available],,,0.0,1220.0,0.0,1220.0,,,1.0,196.0,
TCGA-EX-A449,1749,TCGA-EX-A449,CESC,42.0,FEMALE,WHITE,[Not Available],Stage IVB,Endocervical Type of Adenocarcinoma,G1,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15559.0,Alive,TUMOR FREE,447.0,,,,,,,Complete Remission/Response,,,0.0,447.0,0.0,447.0,,,0.0,447.0,
TCGA-CD-8536,9434,TCGA-CD-8536,STAD,74.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-27328.0,Alive,TUMOR FREE,378.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,
TCGA-MK-A84Z,10350,TCGA-MK-A84Z,THCA,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2013.0,[Not Available],-27185.0,Alive,TUMOR FREE,728.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,728.0,0.0,728.0,,,0.0,728.0,
TCGA-DU-6402,5000,TCGA-DU-6402,LGG,52.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,1998.0,[Not Available],-19207.0,Dead,WITH TUMOR,,214.0,[Not Available],,,,103.0,Progressive Disease,,,1.0,214.0,1.0,214.0,,,1.0,103.0,
TCGA-VQ-A8PM,9663,TCGA-VQ-A8PM,STAD,56.0,MALE,WHITE,Stage IV,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2009.0,[Not Available],-20665.0,Dead,WITH TUMOR,,57.0,"Other, non-malignant disease",,,,,[Not Applicable],,,1.0,57.0,0.0,57.0,,,1.0,57.0,
TCGA-DK-AA6M,218,TCGA-DK-AA6M,BLCA,64.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-23574.0,Alive,TUMOR FREE,1582.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1582.0,0.0,1582.0,,,0.0,1582.0,
TCGA-VQ-A8P3,9652,TCGA-VQ-A8P3,STAD,72.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-26582.0,Alive,TUMOR FREE,1132.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1132.0,0.0,1132.0,0.0,1132.0,0.0,1132.0,
TCGA-EI-6514,8513,TCGA-EI-6514,READ,59.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-21618.0,Alive,TUMOR FREE,496.0,,[Not Available],,,,,[Not Available],,,0.0,496.0,0.0,496.0,,,0.0,496.0,
TCGA-FG-6691,5105,TCGA-FG-6691,LGG,23.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-8403.0,Alive,WITH TUMOR,1257.0,,[Not Available],,,,913.0,Complete Remission/Response,,,0.0,1257.0,0.0,1257.0,1.0,913.0,1.0,913.0,
TCGA-VN-A88Q,8274,TCGA-VN-A88Q,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2010.0,[Not Available],-22087.0,Alive,TUMOR FREE,1366.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1366.0,0.0,1366.0,0.0,1366.0,0.0,1366.0,
TCGA-EA-A3QE,1700,TCGA-EA-A3QE,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16460.0,Alive,TUMOR FREE,761.0,,,,,,,Complete Remission/Response,,,0.0,761.0,0.0,761.0,0.0,761.0,0.0,761.0,
TCGA-2H-A9GR,2472,TCGA-2H-A9GR,ESCA,80.0,MALE,[Unknown],Stage IIA,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,1999.0,[Not Available],-29451.0,Dead,WITH TUMOR,,987.0,[Not Available],,,,,,,,1.0,987.0,1.0,987.0,,,1.0,987.0,
TCGA-D8-A1Y0,1279,TCGA-D8-A1Y0,BRCA,65.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24083.0,Alive,TUMOR FREE,472.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,472.0,0.0,472.0,,,0.0,472.0,
TCGA-GD-A6C6,341,TCGA-GD-A6C6,BLCA,64.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-23631.0,Alive,TUMOR FREE,67.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,67.0,0.0,67.0,0.0,67.0,0.0,67.0,
TCGA-TS-A7P0,6881,TCGA-TS-A7P0,MESO,42.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2010.0,[Not Available],-15656.0,Dead,,,1261.0,[Not Available],Locoregional Recurrence,Ipsilateral Chest Cavity,,277.0,[Not Available],,[Unknown],1.0,1261.0,,1261.0,,,1.0,277.0,
TCGA-BF-AAP6,8822,TCGA-BF-AAP6,SKCM,55.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2013.0,[Not Available],-20384.0,Alive,TUMOR FREE,325.0,,[Not Available],,,,,[Not Available],,,0.0,325.0,0.0,325.0,,,0.0,325.0,
TCGA-83-5908,6177,TCGA-83-5908,LUAD,59.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-21760.0,Alive,TUMOR FREE,824.0,,[Not Available],,,,,Stable Disease,,,0.0,824.0,0.0,824.0,,,0.0,824.0,
TCGA-BH-A0EI,1085,TCGA-BH-A0EI,BRCA,51.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Peri (6-12 months since last menstrual period),-18741.0,Alive,TUMOR FREE,1926.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1926.0,0.0,1926.0,0.0,1926.0,0.0,1926.0,
TCGA-A1-A0SP,525,TCGA-A1-A0SP,BRCA,40.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,[Not Available],-14954.0,Alive,TUMOR FREE,584.0,,[Not Available],,,,,[Not Available],Negative,,0.0,584.0,0.0,584.0,0.0,584.0,0.0,584.0,
TCGA-DJ-A2PR,9944,TCGA-DJ-A2PR,THCA,27.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-9914.0,Alive,TUMOR FREE,835.0,,[Not Available],,,,,[Not Available],,R0,0.0,835.0,0.0,835.0,0.0,835.0,0.0,835.0,
TCGA-KK-A8IC,8208,TCGA-KK-A8IC,PRAD,54.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-19902.0,Alive,WITH TUMOR,2051.0,,[Not Available],Biochemical evidence of disease,,,1060.0,Progressive Disease,,,0.0,2051.0,0.0,2051.0,,,1.0,1060.0,
TCGA-HU-A4GH,9574,TCGA-HU-A4GH,STAD,75.0,MALE,ASIAN,Stage IA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-27473.0,Alive,TUMOR FREE,358.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,
TCGA-NJ-A55A,6319,TCGA-NJ-A55A,LUAD,76.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-28022.0,Alive,TUMOR FREE,15.0,,[Not Available],,,,,Stable Disease,,,0.0,15.0,0.0,15.0,,,0.0,15.0,
TCGA-38-4631,5848,TCGA-38-4631,LUAD,72.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],1997.0,[Not Available],-26538.0,Dead,WITH TUMOR,,354.0,[Not Available],,,,,Progressive Disease,,,1.0,354.0,1.0,354.0,,,1.0,354.0,
TCGA-EA-A3HS,1696,TCGA-EA-A3HS,CESC,35.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G1,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13117.0,Alive,TUMOR FREE,959.0,,,,,,,Complete Remission/Response,,,0.0,959.0,0.0,959.0,0.0,959.0,0.0,959.0,
TCGA-42-2590,7414,TCGA-42-2590,OV,57.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G2,2009.0,[Not Available],-20965.0,Dead,WITH TUMOR,,317.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],226.0,Progressive Disease,,,1.0,317.0,1.0,317.0,,,1.0,226.0,
TCGA-2G-AAH8,9759,TCGA-2G-AAH8,TGCT,45.0,MALE,WHITE,Stage IIIC,Stage IIIC,Seminoma; NOS,[Not Available],2008.0,[Not Available],-16687.0,Alive,TUMOR FREE,2248.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,2248.0,0.0,2248.0,,,0.0,2248.0,
TCGA-AG-3731,8413,TCGA-AG-3731,READ,65.0,MALE,[Not Available],Stage IV,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2004.0,[Not Available],-23923.0,Alive,TUMOR FREE,1126.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1126.0,0.0,1126.0,,,0.0,1126.0,
TCGA-C5-A1MN,1629,TCGA-C5-A1MN,CESC,42.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15499.0,Dead,TUMOR FREE,,1245.0,,,,,,Complete Remission/Response,,,1.0,1245.0,0.0,1245.0,0.0,1245.0,0.0,1245.0,
TCGA-G4-6297,2370,TCGA-G4-6297,COAD,55.0,FEMALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2005.0,[Not Available],-20103.0,Alive,WITH TUMOR,2506.0,,[Not Available],,,,439.0,[Not Available],,,0.0,2506.0,0.0,2506.0,,,1.0,439.0,
TCGA-ZG-A9L2,8350,TCGA-ZG-A9L2,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25573.0,Alive,WITH TUMOR,1154.0,,[Not Available],Biochemical evidence of disease,,,180.0,Stable Disease,,,0.0,1154.0,0.0,1154.0,,,1.0,180.0,
TCGA-CD-A487,9436,TCGA-CD-A487,STAD,51.0,MALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-18694.0,Alive,TUMOR FREE,374.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,374.0,0.0,374.0,0.0,374.0,0.0,374.0,
TCGA-ZB-A96D,10456,TCGA-ZB-A96D,THYM,52.0,FEMALE,WHITE,[Not Applicable],IIb,Thymoma; Type AB,[Not Available],2009.0,[Not Available],-19274.0,Alive,TUMOR FREE,1960.0,,[Not Available],,,,,[Not Available],,,0.0,1960.0,0.0,1960.0,,,0.0,1960.0,
TCGA-2G-AAG0,9729,TCGA-2G-AAG0,TGCT,23.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature),[Not Available],2010.0,[Not Available],-8687.0,Alive,TUMOR FREE,1529.0,,[Not Applicable],Distant Metastasis,Lung,,90.0,Complete Remission/Response,,,0.0,1529.0,0.0,1529.0,1.0,90.0,1.0,90.0,
TCGA-BR-8487,9373,TCGA-BR-8487,STAD,64.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-23400.0,Alive,TUMOR FREE,34.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,34.0,0.0,34.0,0.0,34.0,0.0,34.0,
TCGA-CJ-4899,4303,TCGA-CJ-4899,KIRC,42.0,MALE,ASIAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-15637.0,Alive,TUMOR FREE,1528.0,,[Not Available],,,,,[Not Available],,,0.0,1528.0,0.0,1528.0,,,0.0,1528.0,
TCGA-HC-7077,8062,TCGA-HC-7077,PRAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-23636.0,Alive,TUMOR FREE,2115.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2115.0,0.0,2115.0,0.0,2115.0,0.0,2115.0,
TCGA-HZ-8638,7606,TCGA-HZ-8638,PAAD,84.0,FEMALE,WHITE,Stage IA,[Not Applicable],Pancreas-Colloid (mucinous non-cystic) Carcinoma,GX,2012.0,[Not Available],-30821.0,Dead,TUMOR FREE,,151.0,Surgical Complications,,,,,Complete Remission/Response,,,1.0,151.0,0.0,151.0,0.0,151.0,0.0,151.0,
TCGA-GR-A4D5,2444,TCGA-GR-A4D5,DLBC,46.0,FEMALE,WHITE,[Not Applicable],Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010.0,[Not Available],-17023.0,Alive,TUMOR FREE,1299.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1299.0,0.0,1299.0,,,0.0,1299.0,
TCGA-85-8352,6727,TCGA-85-8352,LUSC,67.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-24788.0,Dead,WITH TUMOR,,161.0,[Not Available],Distant Metastasis,,,128.0,Complete Remission/Response,,,1.0,161.0,1.0,161.0,1.0,128.0,1.0,128.0,
TCGA-F7-7848,3644,TCGA-F7-7848,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-17251.0,Alive,TUMOR FREE,1131.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1131.0,0.0,1131.0,,,0.0,1131.0,
TCGA-HU-A4GT,9579,TCGA-HU-A4GT,STAD,71.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,[Not Available],-26231.0,Alive,TUMOR FREE,198.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,198.0,0.0,198.0,0.0,198.0,0.0,198.0,
TCGA-VR-A8EX,2628,TCGA-VR-A8EX,ESCA,63.0,MALE,[Unknown],Stage IVA,Stage IVA,Esophagus Squamous Cell Carcinoma,G2,2009.0,[Not Available],-23226.0,Dead,WITH TUMOR,,855.0,[Not Available],,,,,,,,1.0,855.0,1.0,855.0,,,1.0,855.0,
TCGA-05-4422,5823,TCGA-05-4422,LUAD,68.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-24837.0,Alive,,365.0,,[Not Available],,,,,[Not Available],,,0.0,365.0,0.0,365.0,,,0.0,365.0,
TCGA-OR-A5JO,23,TCGA-OR-A5JO,ACC,26.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2005.0,[Not Available],-9547.0,Alive,TUMOR FREE,1194.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1194.0,0.0,1194.0,0.0,1194.0,0.0,1194.0,
TCGA-DU-6406,5004,TCGA-DU-6406,LGG,59.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2001.0,[Not Available],-21634.0,Dead,,,512.0,[Not Available],,,,,[Not Available],,,1.0,512.0,,512.0,,,0.0,512.0,
TCGA-AW-A1PO,10607,TCGA-AW-A1PO,UCEC,66.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24225.0,Alive,TUMOR FREE,17.0,,[Not Available],,,,,[Not Available],,,0.0,17.0,0.0,17.0,,,0.0,17.0,
TCGA-06-0749,2832,TCGA-06-0749,GBM,50.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-18571.0,Dead,WITH TUMOR,66.0,82.0,[Not Available],,,,,[Not Available],,,1.0,82.0,1.0,82.0,,,1.0,82.0,
TCGA-BJ-A28R,9865,TCGA-BJ-A28R,THCA,38.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-14044.0,Alive,TUMOR FREE,1282.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,1282.0,0.0,1282.0,,,0.0,1282.0,
TCGA-FB-A4P5,7553,TCGA-FB-A4P5,PAAD,69.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-25412.0,Dead,WITH TUMOR,,179.0,,,,,,[Unknown],,,1.0,179.0,1.0,179.0,,,1.0,179.0,
TCGA-34-2605,6421,TCGA-34-2605,LUSC,76.0,MALE,WHITE,Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-27833.0,Dead,WITH TUMOR,881.0,881.0,[Not Available],,,,394.0,Complete Remission/Response,,,1.0,881.0,1.0,881.0,1.0,394.0,1.0,394.0,
TCGA-HC-A76W,8119,TCGA-HC-A76W,PRAD,73.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-26755.0,Alive,WITH TUMOR,213.0,,[Not Available],,,,,[Unknown],,,0.0,213.0,0.0,213.0,,,0.0,213.0,
TCGA-56-8083,6523,TCGA-56-8083,LUSC,56.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-20696.0,Alive,TUMOR FREE,150.0,,[Not Available],,,,,[Unknown],,,0.0,150.0,0.0,150.0,,,0.0,150.0,
TCGA-E1-A7YS,5086,TCGA-E1-A7YS,LGG,71.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligodendroglioma,G3,2007.0,[Not Available],-26159.0,Dead,WITH TUMOR,,466.0,[Not Available],,,,,Stable Disease,,,1.0,466.0,1.0,466.0,,,1.0,466.0,
TCGA-VG-A8LO,7501,TCGA-VG-A8LO,OV,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,GB,2013.0,[Not Available],-20274.0,Dead,WITH TUMOR,,24.0,[Not Available],,,,,[Not Applicable],,,1.0,24.0,1.0,24.0,,,1.0,24.0,
TCGA-HE-7130,4620,TCGA-HE-7130,KIRP,,FEMALE,[Not Available],Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],,Alive,TUMOR FREE,1770.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1770.0,0.0,1770.0,0.0,1770.0,0.0,1770.0,
TCGA-CR-5250,3420,TCGA-CR-5250,HNSC,71.0,MALE,WHITE,[Not Available],Stage II,Head & Neck Squamous Cell Carcinoma,G3,2009.0,[Not Available],-26097.0,Alive,TUMOR FREE,799.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,799.0,0.0,799.0,0.0,799.0,0.0,799.0,
TCGA-CZ-5468,4384,TCGA-CZ-5468,KIRC,84.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2007.0,[Not Available],-30729.0,Dead,WITH TUMOR,59.0,59.0,[Not Available],,,,,[Not Available],,,1.0,59.0,1.0,59.0,,,1.0,59.0,
TCGA-KM-8441,3797,TCGA-KM-8441,KICH,61.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2011.0,[Not Available],-22303.0,Alive,WITH TUMOR,876.0,,[Not Available],,,,876.0,Complete Remission/Response,,,0.0,876.0,0.0,876.0,1.0,876.0,1.0,876.0,
TCGA-BH-A0DZ,1075,TCGA-BH-A0DZ,BRCA,43.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15980.0,Alive,TUMOR FREE,495.0,,[Not Available],,,,,[Not Available],Negative,,0.0,495.0,0.0,495.0,0.0,495.0,0.0,495.0,
TCGA-16-0846,3046,TCGA-16-0846,GBM,85.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-31111.0,Dead,WITH TUMOR,119.0,119.0,[Not Available],,,,,[Not Available],,,1.0,119.0,1.0,119.0,,,1.0,119.0,
TCGA-HW-A5KM,5258,TCGA-HW-A5KM,LGG,35.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-12845.0,Alive,WITH TUMOR,630.0,,[Not Available],,,,,Progressive Disease,,,0.0,630.0,0.0,630.0,,,0.0,630.0,
TCGA-DH-A66B,4971,TCGA-DH-A66B,LGG,52.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-19156.0,Alive,WITH TUMOR,1279.0,,[Not Available],,,,,Stable Disease,,,0.0,1279.0,0.0,1279.0,,,0.0,1279.0,
TCGA-HT-A61C,5238,TCGA-HT-A61C,LGG,66.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-24276.0,Dead,WITH TUMOR,,537.0,[Not Available],,,,476.0,Complete Remission/Response,,,1.0,537.0,1.0,537.0,1.0,476.0,1.0,476.0,
TCGA-B5-A11H,10697,TCGA-B5-A11H,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24556.0,Alive,TUMOR FREE,2687.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2687.0,0.0,2687.0,0.0,2687.0,0.0,2687.0,
TCGA-YL-A8SQ,8334,TCGA-YL-A8SQ,PRAD,61.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-22482.0,Alive,WITH TUMOR,2083.0,,[Not Available],Biochemical evidence of disease,,,329.0,Stable Disease,,,0.0,2083.0,0.0,2083.0,,,1.0,329.0,
TCGA-AR-A1AN,920,TCGA-AR-A1AN,BRCA,46.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16974.0,Alive,TUMOR FREE,2920.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2920.0,0.0,2920.0,0.0,2920.0,0.0,2920.0,
TCGA-BP-4164,4131,TCGA-BP-4164,KIRC,51.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2002.0,[Not Available],-18898.0,Dead,TUMOR FREE,,992.0,[Not Available],,,,,[Not Available],,,1.0,992.0,0.0,992.0,,,0.0,992.0,
TCGA-MA-AA3X,1805,TCGA-MA-AA3X,CESC,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18412.0,Alive,TUMOR FREE,617.0,,,,,,,Complete Remission/Response,,,0.0,617.0,0.0,617.0,0.0,617.0,0.0,617.0,
TCGA-FG-A713,5136,TCGA-FG-A713,LGG,74.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-27232.0,Alive,TUMOR FREE,622.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,622.0,0.0,622.0,0.0,622.0,0.0,622.0,
TCGA-G9-6356,8027,TCGA-G9-6356,PRAD,60.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-22010.0,Alive,TUMOR FREE,1434.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1434.0,0.0,1434.0,0.0,1434.0,0.0,1434.0,
TCGA-AZ-6600,2227,TCGA-AZ-6600,COAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2001.0,[Not Available],-23581.0,Dead,WITH TUMOR,,368.0,[Not Available],,,,,Progressive Disease,,,1.0,368.0,1.0,368.0,,,1.0,368.0,
TCGA-BS-A0V7,10811,TCGA-BS-A0V7,UCEC,48.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17810.0,Alive,TUMOR FREE,1934.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1934.0,0.0,1934.0,0.0,1934.0,0.0,1934.0,
TCGA-19-5959,3097,TCGA-19-5959,GBM,77.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-28449.0,Dead,WITH TUMOR,,511.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],119.0,Progressive Disease,,,1.0,511.0,1.0,511.0,,,1.0,119.0,
TCGA-EM-A3FO,10174,TCGA-EM-A3FO,THCA,40.0,MALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-14864.0,Alive,TUMOR FREE,532.0,,[Not Available],,,,,[Not Available],,R0,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,
TCGA-D7-8570,9504,TCGA-D7-8570,STAD,44.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,[Not Available],-16150.0,Alive,WITH TUMOR,752.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,752.0,0.0,752.0,0.0,752.0,0.0,752.0,
TCGA-VQ-A8DL,9642,TCGA-VQ-A8DL,STAD,69.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-25299.0,Dead,TUMOR FREE,,28.0,[Not Available],,,,,Complete Remission/Response,,,1.0,28.0,0.0,28.0,0.0,28.0,0.0,28.0,
TCGA-WP-A9GB,8779,TCGA-WP-A9GB,SARC,59.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],,Dead,WITH TUMOR,,261.0,[Not Available],Distant Metastasis,Lung,,214.0,[Not Available],Negative,RX,1.0,261.0,1.0,261.0,,,1.0,214.0,
TCGA-AR-A1AX,930,TCGA-AR-A1AX,BRCA,64.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23507.0,Alive,TUMOR FREE,2629.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2629.0,0.0,2629.0,0.0,2629.0,0.0,2629.0,
TCGA-B5-A0K9,10692,TCGA-B5-A0K9,UCEC,88.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32289.0,Dead,TUMOR FREE,,409.0,[Not Available],,,,,Complete Remission/Response,,,1.0,409.0,0.0,409.0,0.0,409.0,0.0,409.0,
TCGA-IM-A420,10317,TCGA-IM-A420,THCA,39.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-14332.0,Alive,TUMOR FREE,250.0,,[Not Available],,,,,[Not Available],,R0,0.0,250.0,0.0,250.0,0.0,250.0,0.0,250.0,
TCGA-56-6545,6510,TCGA-56-6545,LUSC,77.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-28400.0,Alive,TUMOR FREE,666.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,666.0,0.0,666.0,0.0,666.0,0.0,666.0,
TCGA-FA-A6HO,2417,TCGA-FA-A6HO,DLBC,58.0,FEMALE,ASIAN,[Not Applicable],[Not Available],Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013.0,[Not Available],-21330.0,Alive,WITH TUMOR,749.0,,[Not Available],,Paraaortic lymph nodes,,739.0,Complete Remission/Response,,,0.0,749.0,0.0,749.0,1.0,739.0,1.0,739.0,
TCGA-GN-A267,9197,TCGA-GN-A267,SKCM,38.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2005.0,[Not Available],-14055.0,Dead,WITH TUMOR,,1960.0,[Not Available],Locoregional Recurrence,,,456.0,[Not Available],,,1.0,1960.0,1.0,1960.0,,,1.0,456.0,
TCGA-VM-A8CD,5409,TCGA-VM-A8CD,LGG,58.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-21200.0,Dead,WITH TUMOR,,240.0,[Not Available],,,,,[Unknown],,,1.0,240.0,1.0,240.0,,,1.0,240.0,
TCGA-ZF-AA4N,489,TCGA-ZF-AA4N,BLCA,74.0,MALE,WHITE,Stage II,[Not Applicable],[Not Available],High Grade,2011.0,[Not Available],-27056.0,Dead,WITH TUMOR,,88.0,[Not Available],,,,,Progressive Disease,,,1.0,88.0,1.0,88.0,,,1.0,88.0,
TCGA-06-5408,2863,TCGA-06-5408,GBM,54.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-20063.0,Dead,WITH TUMOR,342.0,357.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],158.0,[Not Available],,,1.0,357.0,1.0,357.0,,,1.0,158.0,
TCGA-CR-7386,3455,TCGA-CR-7386,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2008.0,[Not Available],-25238.0,Alive,WITH TUMOR,1430.0,,[Not Available],,Distant Metastasis,Lung (distant mets or possible new primary),1028.0,Complete Remission/Response,,,0.0,1430.0,0.0,1430.0,,,1.0,1028.0,
TCGA-D7-6522,9493,TCGA-D7-6522,STAD,58.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-21465.0,Alive,TUMOR FREE,566.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,566.0,0.0,566.0,0.0,566.0,0.0,566.0,
TCGA-32-1970,3166,TCGA-32-1970,GBM,59.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-21613.0,Dead,WITH TUMOR,468.0,468.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],408.0,[Not Available],,,1.0,468.0,1.0,468.0,,,1.0,408.0,
TCGA-OL-A66H,1563,TCGA-OL-A66H,BRCA,,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Mucinous Carcinoma,[Not Available],,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,TUMOR FREE,,,[Not Available],,,,,[Not Available],Negative,,0.0,,0.0,,0.0,,0.0,,
TCGA-WK-A8XS,8773,TCGA-WK-A8XS,SARC,58.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2008.0,[Not Available],-21521.0,Alive,TUMOR FREE,2579.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,2579.0,0.0,2579.0,0.0,2579.0,0.0,2579.0,
TCGA-R8-A73M,5313,TCGA-R8-A73M,LGG,48.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2008.0,[Not Available],-17610.0,Alive,,1806.0,,[Not Available],,,,,[Unknown],,,0.0,1806.0,0.0,1806.0,,,0.0,1806.0,
TCGA-WE-A8ZN,9241,TCGA-WE-A8ZN,SKCM,57.0,MALE,[Not Evaluated],Stage IIB,[Not Applicable],,[Not Available],2009.0,[Not Available],-20942.0,Alive,WITH TUMOR,1794.0,,[Not Available],,,,1449.0,[Not Available],,,0.0,1794.0,0.0,1794.0,,,1.0,1449.0,
TCGA-MB-A8JL,8728,TCGA-MB-A8JL,SARC,53.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2013.0,[Not Available],-19510.0,Alive,TUMOR FREE,600.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,
TCGA-CV-7416,3556,TCGA-CV-7416,HNSC,29.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,1994.0,[Not Available],-10936.0,Dead,,,763.0,[Not Available],,,,,[Not Available],,,1.0,763.0,,763.0,,,0.0,763.0,
TCGA-FD-A3B7,261,TCGA-FD-A3B7,BLCA,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-24245.0,Dead,WITH TUMOR,,122.0,[Not Available],Distant Metastasis,Lymph Node Only,,110.0,Progressive Disease,,,1.0,122.0,1.0,122.0,,,1.0,110.0,
TCGA-L5-A88W,2534,TCGA-L5-A88W,ESCA,67.0,MALE,WHITE,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,GX,2007.0,[Not Available],-24716.0,Dead,WITH TUMOR,,764.0,[Not Available],Distant Metastasis,Liver,,315.0,,,,1.0,764.0,1.0,764.0,,,1.0,315.0,
TCGA-P8-A6RY,7693,TCGA-P8-A6RY,PCPG,55.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-20109.0,Alive,TUMOR FREE,179.0,,[Not Available],,,,,[Not Available],,,0.0,179.0,0.0,179.0,,,0.0,179.0,
TCGA-58-8393,6554,TCGA-58-8393,LUSC,68.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-25132.0,Alive,TUMOR FREE,1058.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1058.0,0.0,1058.0,0.0,1058.0,0.0,1058.0,
TCGA-CS-5393,4917,TCGA-CS-5393,LGG,39.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-14418.0,Alive,TUMOR FREE,1222.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1222.0,0.0,1222.0,0.0,1222.0,0.0,1222.0,
TCGA-55-6971,5978,TCGA-55-6971,LUAD,59.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-21734.0,Alive,TUMOR FREE,1400.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1400.0,0.0,1400.0,0.0,1400.0,0.0,1400.0,
TCGA-D3-A5GU,8882,TCGA-D3-A5GU,SKCM,36.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2002.0,[Not Available],-13296.0,Alive,WITH TUMOR,3808.0,,[Not Available],Distant Metastasis,Bone,,3074.0,[Not Available],,,0.0,3808.0,0.0,3808.0,,,1.0,3074.0,
TCGA-EJ-5542,7943,TCGA-EJ-5542,PRAD,60.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-21942.0,Alive,TUMOR FREE,1513.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1513.0,0.0,1513.0,0.0,1513.0,0.0,1513.0,
TCGA-E2-A1L8,1372,TCGA-E2-A1L8,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19187.0,Alive,TUMOR FREE,2240.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2240.0,0.0,2240.0,0.0,2240.0,0.0,2240.0,
TCGA-P5-A5EW,5266,TCGA-P5-A5EW,LGG,20.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-7612.0,Alive,TUMOR FREE,204.0,,[Not Available],,,,,[Not Available],,,0.0,204.0,0.0,204.0,,,0.0,204.0,
TCGA-EI-6510,8509,TCGA-EI-6510,READ,77.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-28328.0,Alive,TUMOR FREE,556.0,,[Not Available],,,,,[Not Available],,,0.0,556.0,0.0,556.0,,,0.0,556.0,
TCGA-37-A5EL,6449,TCGA-37-A5EL,LUSC,53.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-19371.0,Dead,WITH TUMOR,,1143.0,[Not Available],Distant Metastasis,,,946.0,[Discrepancy],,,1.0,1143.0,1.0,1143.0,,,1.0,946.0,
TCGA-S9-A7J3,5356,TCGA-S9-A7J3,LGG,52.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-19056.0,Alive,WITH TUMOR,629.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,629.0,0.0,629.0,,,0.0,629.0,
TCGA-FG-8187,5117,TCGA-FG-8187,LGG,31.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-11684.0,Alive,TUMOR FREE,611.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,611.0,0.0,611.0,0.0,611.0,0.0,611.0,
TCGA-32-4719,3190,TCGA-32-4719,GBM,73.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-26691.0,Dead,WITH TUMOR,330.0,330.0,[Not Available],,,,,[Not Available],,,1.0,330.0,1.0,330.0,,,1.0,330.0,
TCGA-XM-A8R9,10406,TCGA-XM-A8R9,THYM,71.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type A,[Not Available],2010.0,[Not Available],-26176.0,Alive,TUMOR FREE,1488.0,,[Not Available],,,,,[Not Available],,,0.0,1488.0,0.0,1488.0,,,0.0,1488.0,
TCGA-D7-A6EY,9521,TCGA-D7-A6EY,STAD,72.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013.0,[Not Available],-26526.0,Dead,WITH TUMOR,,348.0,Stomach Cancer,,,,,Progressive Disease,,,1.0,348.0,1.0,348.0,,,1.0,348.0,
TCGA-CJ-4640,4273,TCGA-CJ-4640,KIRC,49.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2004.0,[Not Available],-18178.0,Alive,TUMOR FREE,3480.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3480.0,0.0,3480.0,0.0,3480.0,0.0,3480.0,
TCGA-62-8402,6063,TCGA-62-8402,LUAD,73.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-26934.0,Dead,WITH TUMOR,,1498.0,[Not Available],Distant Metastasis,,,772.0,Complete Remission/Response,,,1.0,1498.0,1.0,1498.0,1.0,772.0,1.0,772.0,
TCGA-BA-A8YP,3278,TCGA-BA-A8YP,HNSC,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Stage IVB,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-18355.0,Alive,TUMOR FREE,499.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,499.0,0.0,499.0,,,0.0,499.0,
TCGA-DD-AAC8,5578,TCGA-DD-AAC8,LIHC,72.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2008.0,[Not Available],-26322.0,Dead,TUMOR FREE,,16.0,[Not Available],,,,,[Not Available],,R0,1.0,16.0,0.0,16.0,0.0,16.0,0.0,16.0,
TCGA-B5-A11F,10695,TCGA-B5-A11F,UCEC,55.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20171.0,Alive,TUMOR FREE,5651.0,,[Not Available],Metastatic,Bone,,1610.0,Complete Remission/Response,,,0.0,5651.0,0.0,5651.0,1.0,1610.0,1.0,1610.0,
TCGA-ET-A39I,10219,TCGA-ET-A39I,THCA,83.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2007.0,[Not Available],-30349.0,Dead,TUMOR FREE,,1011.0,[Not Available],,,,,[Not Available],,R0,1.0,1011.0,0.0,1011.0,0.0,1011.0,0.0,1011.0,
TCGA-63-A5ML,6598,TCGA-63-A5ML,LUSC,68.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-24947.0,Alive,TUMOR FREE,1386.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1386.0,0.0,1386.0,0.0,1386.0,0.0,1386.0,
TCGA-XT-AASU,6905,TCGA-XT-AASU,MESO,60.0,MALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2005.0,[Not Available],-22021.0,Dead,WITH TUMOR,,142.0,[Not Available],Locoregional Recurrence,Ipsilateral Chest Cavity,,133.0,[Not Available],,R0,1.0,142.0,1.0,142.0,1.0,133.0,1.0,133.0,
TCGA-66-2765,6622,TCGA-66-2765,LUSC,64.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-23465.0,Alive,TUMOR FREE,61.0,,[Not Available],,,,,[Not Available],,,0.0,61.0,0.0,61.0,,,0.0,61.0,
TCGA-B0-5083,4019,TCGA-B0-5083,KIRC,63.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-23034.0,Dead,WITH TUMOR,,1045.0,[Not Available],,,,,[Not Available],,,1.0,1045.0,1.0,1045.0,,,1.0,1045.0,
TCGA-DV-5565,4394,TCGA-DV-5565,KIRC,59.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-21642.0,Alive,WITH TUMOR,1329.0,,[Not Available],,,,,[Not Available],,,0.0,1329.0,0.0,1329.0,,,0.0,1329.0,
TCGA-UC-A7PF,1833,TCGA-UC-A7PF,CESC,44.0,FEMALE,[Not Evaluated],[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,1999.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16412.0,Dead,,,2859.0,,,,,,[Not Available],,,1.0,2859.0,,2859.0,,,0.0,2859.0,
TCGA-ZJ-AAXT,1904,TCGA-ZJ-AAXT,CESC,54.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2009.0,[Unknown],-19847.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-BR-4191,9280,TCGA-BR-4191,STAD,72.0,MALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],-26562.0,Dead,,,558.0,[Not Available],,,,,[Not Available],,,1.0,558.0,,558.0,,,0.0,558.0,
TCGA-OL-A5RU,1556,TCGA-OL-A5RU,BRCA,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23108.0,Alive,TUMOR FREE,1219.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1219.0,0.0,1219.0,0.0,1219.0,0.0,1219.0,
TCGA-XM-A8RI,10414,TCGA-XM-A8RI,THYM,77.0,MALE,[Not Evaluated],[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2013.0,[Not Available],-28246.0,Alive,TUMOR FREE,387.0,,[Not Available],,,,,[Not Available],,,0.0,387.0,0.0,387.0,,,0.0,387.0,
TCGA-4V-A9QR,10367,TCGA-4V-A9QR,THYM,51.0,FEMALE,WHITE,[Not Applicable],III,Thymoma; Type B3,[Not Available],2012.0,[Not Available],-18723.0,Alive,TUMOR FREE,780.0,,[Not Available],,,,,[Not Available],,,0.0,780.0,0.0,780.0,,,0.0,780.0,
TCGA-2G-AAKM,9771,TCGA-2G-AAKM,TGCT,14.0,MALE,WHITE,Stage II,Stage IIA,Non-Seminoma; Teratoma (Mature)|[Not Available]|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],1995.0,[Not Available],-5321.0,Dead,TUMOR FREE,,6972.0,[Not Applicable],,,,,Complete Remission/Response,,,1.0,6972.0,0.0,6972.0,0.0,6972.0,0.0,6972.0,
TCGA-WE-AAA4,9251,TCGA-WE-AAA4,SKCM,56.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-20708.0,Alive,WITH TUMOR,760.0,,[Not Available],Distant Metastasis|Locoregional Recurrence,Brain|[Not Available],[Not Applicable]|[Not Applicable],523.0,[Not Available],,,0.0,760.0,0.0,760.0,,,1.0,523.0,
TCGA-55-1596,5970,TCGA-55-1596,LUAD,55.0,MALE,ASIAN,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],-20381.0,Alive,TUMOR FREE,2065.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2065.0,0.0,2065.0,0.0,2065.0,0.0,2065.0,
TCGA-XU-A932,10431,TCGA-XU-A932,THYM,37.0,MALE,ASIAN,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2008.0,[Not Available],-13618.0,Alive,TUMOR FREE,2149.0,,[Not Available],,,,,[Not Available],,,0.0,2149.0,0.0,2149.0,,,0.0,2149.0,
TCGA-CV-A6JZ,3601,TCGA-CV-A6JZ,HNSC,68.0,MALE,WHITE,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-25182.0,Alive,WITH TUMOR,714.0,,[Not Available],Locoregional Recurrence,Oral Cavity,submandibular,393.0,Complete Remission/Response,,,0.0,714.0,0.0,714.0,,,1.0,393.0,
TCGA-HU-A4HD,9591,TCGA-HU-A4HD,STAD,73.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-26699.0,Alive,TUMOR FREE,1016.0,,[Not Available],,,,,Stable Disease,,,0.0,1016.0,0.0,1016.0,,,0.0,1016.0,
TCGA-Z2-AA3V,9267,TCGA-Z2-AA3V,SKCM,57.0,FEMALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2013.0,[Not Available],-20937.0,Alive,TUMOR FREE,486.0,,[Not Available],,,,,[Not Available],,,0.0,486.0,0.0,486.0,,,0.0,486.0,
TCGA-KM-8639,3802,TCGA-KM-8639,KICH,67.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-24640.0,Alive,TUMOR FREE,953.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,953.0,0.0,953.0,0.0,953.0,0.0,953.0,
TCGA-XM-A8RG,10412,TCGA-XM-A8RG,THYM,67.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type A,[Not Available],2013.0,[Not Available],-24802.0,Alive,TUMOR FREE,386.0,,[Not Available],,,,,[Not Available],,,0.0,386.0,0.0,386.0,,,0.0,386.0,
TCGA-F1-6874,9533,TCGA-F1-6874,STAD,79.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-29083.0,Alive,TUMOR FREE,440.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,
TCGA-XU-AAXZ,10438,TCGA-XU-AAXZ,THYM,63.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type B3,[Not Available],2010.0,[Not Available],-23324.0,Alive,TUMOR FREE,1537.0,,[Not Available],,,,,[Not Available],,,0.0,1537.0,0.0,1537.0,,,0.0,1537.0,
TCGA-WE-A8ZT,9245,TCGA-WE-A8ZT,SKCM,25.0,FEMALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2013.0,[Not Available],-9379.0,Alive,TUMOR FREE,359.0,,[Not Available],Locoregional Recurrence,,,69.0,[Not Available],,,0.0,359.0,0.0,359.0,,,1.0,69.0,
TCGA-EE-A2ML,9059,TCGA-EE-A2ML,SKCM,35.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1994.0,[Not Available],-13140.0,Dead,WITH TUMOR,,6590.0,[Not Available],Distant Metastasis,Bone,,4983.0,[Not Available],,,1.0,6590.0,1.0,6590.0,,,1.0,4983.0,
TCGA-L5-A43C,2508,TCGA-L5-A43C,ESCA,81.0,MALE,WHITE,[Not Available],Stage III,"Esophagus Adenocarcinoma, NOS",GX,2009.0,[Not Available],-29753.0,Alive,TUMOR FREE,96.0,,[Not Available],,,,,[Unknown],,,0.0,96.0,0.0,96.0,,,0.0,96.0,
TCGA-OR-A5K5,40,TCGA-OR-A5K5,ACC,59.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2012.0,[Not Available],-21907.0,Dead,WITH TUMOR,,498.0,[Not Available],Distant Metastasis,Lung,,108.0,Progressive Disease,,,1.0,498.0,1.0,498.0,,,1.0,108.0,
TCGA-HW-8321,5253,TCGA-HW-8321,LGG,31.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2011.0,[Not Available],-11474.0,Alive,WITH TUMOR,1294.0,,[Not Available],,,,,Stable Disease,,,0.0,1294.0,0.0,1294.0,,,0.0,1294.0,
TCGA-DK-AA6P,219,TCGA-DK-AA6P,BLCA,72.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-26560.0,Alive,TUMOR FREE,457.0,,[Not Available],Distant Metastasis,Bone,,16.0,Partial Remission/Response,,,0.0,457.0,0.0,457.0,,,1.0,16.0,
TCGA-MN-A4N4,6293,TCGA-MN-A4N4,LUAD,57.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-20888.0,Alive,TUMOR FREE,1175.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1175.0,0.0,1175.0,0.0,1175.0,0.0,1175.0,
TCGA-ER-A19G,9100,TCGA-ER-A19G,SKCM,48.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1987.0,[Not Available],-17820.0,Alive,TUMOR FREE,9188.0,,[Not Available],,,,,[Not Available],,,0.0,9188.0,0.0,9188.0,,,0.0,9188.0,
TCGA-VS-A9UV,1880,TCGA-VS-A9UV,CESC,74.0,FEMALE,[Unknown],[Not Available],Stage IVA,Cervical Squamous Cell Carcinoma,GX,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27348.0,Dead,WITH TUMOR,,104.0,Cervical Cancer,,,,,[Unknown],,,1.0,104.0,1.0,104.0,,,1.0,104.0,
TCGA-WB-A80L,7831,TCGA-WB-A80L,PCPG,30.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-10980.0,Alive,TUMOR FREE,1042.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1042.0,0.0,1042.0,0.0,1042.0,0.0,1042.0,
TCGA-DJ-A13P,9921,TCGA-DJ-A13P,THCA,52.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1999.0,[Not Available],-19297.0,Alive,TUMOR FREE,5150.0,,[Not Available],,,,,[Not Available],,R0,0.0,5150.0,0.0,5150.0,0.0,5150.0,0.0,5150.0,
TCGA-77-7139,6663,TCGA-77-7139,LUSC,56.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-20632.0,Alive,,4261.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4261.0,0.0,4261.0,0.0,4261.0,0.0,4261.0,
TCGA-CD-5799,9415,TCGA-CD-5799,STAD,45.0,MALE,ASIAN,Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,[Not Available],-16533.0,Alive,TUMOR FREE,396.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,
TCGA-DD-A4NQ,5566,TCGA-DD-A4NQ,LIHC,60.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2007.0,[Not Available],-22111.0,Dead,WITH TUMOR,,373.0,[Not Available],Intrahepatic Recurrence,Liver,,126.0,[Not Available],,R0,1.0,373.0,1.0,373.0,1.0,126.0,1.0,126.0,
TCGA-05-4398,5814,TCGA-05-4398,LUAD,47.0,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-17471.0,Alive,TUMOR FREE,1431.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1431.0,0.0,1431.0,0.0,1431.0,0.0,1431.0,
TCGA-BH-A0AU,1026,TCGA-BH-A0AU,BRCA,45.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16688.0,Alive,TUMOR FREE,1914.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1914.0,0.0,1914.0,0.0,1914.0,0.0,1914.0,
TCGA-19-2625,3083,TCGA-19-2625,GBM,76.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-27930.0,Dead,TUMOR FREE,124.0,124.0,[Not Available],,,,,[Not Available],,,1.0,124.0,0.0,124.0,,,0.0,124.0,
TCGA-CS-5396,4920,TCGA-CS-5396,LGG,53.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2010.0,[Not Available],-19399.0,Alive,WITH TUMOR,1631.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1631.0,0.0,1631.0,,,0.0,1631.0,
TCGA-QR-A70R,7735,TCGA-QR-A70R,PCPG,43.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-15917.0,Alive,TUMOR FREE,432.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,432.0,0.0,432.0,0.0,432.0,0.0,432.0,
TCGA-DD-AAE3,5637,TCGA-DD-AAE3,LIHC,50.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-18271.0,Alive,TUMOR FREE,566.0,,[Not Available],,,,,[Not Available],,R0,0.0,566.0,0.0,566.0,0.0,566.0,0.0,566.0,
TCGA-BR-A453,9392,TCGA-BR-A453,STAD,51.0,MALE,ASIAN,Stage IV,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2012.0,[Not Available],-18988.0,Dead,TUMOR FREE,,185.0,[Not Available],,,,,Complete Remission/Response,,,1.0,185.0,0.0,185.0,,,0.0,185.0,
TCGA-33-AASJ,6416,TCGA-33-AASJ,LUSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1999.0,[Not Available],-22179.0,Dead,WITH TUMOR,,3600.0,[Not Available],Locoregional Recurrence,,,1135.0,Complete Remission/Response,,,1.0,3600.0,1.0,3600.0,1.0,1135.0,1.0,1135.0,
TCGA-FZ-5923,7574,TCGA-FZ-5923,PAAD,71.0,MALE,WHITE,Stage IV,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2008.0,[Not Available],-26216.0,Dead,WITH TUMOR,,619.0,,,,,,Progressive Disease,,,1.0,619.0,1.0,619.0,,,1.0,619.0,
TCGA-CM-5341,2266,TCGA-CM-5341,COAD,82.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-30163.0,Alive,TUMOR FREE,884.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,884.0,0.0,884.0,0.0,884.0,0.0,884.0,
TCGA-S9-A6U1,5329,TCGA-S9-A6U1,LGG,22.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-8271.0,Alive,TUMOR FREE,785.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,785.0,0.0,785.0,0.0,785.0,0.0,785.0,
TCGA-AC-A2FF,764,TCGA-AC-A2FF,BRCA,40.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006.0,[Not Available],,Alive,TUMOR FREE,2759.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2759.0,0.0,2759.0,0.0,2759.0,0.0,2759.0,
TCGA-49-4494,5906,TCGA-49-4494,LUAD,77.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1995.0,[Not Available],-28387.0,Dead,WITH TUMOR,,1081.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1081.0,1.0,1081.0,,,1.0,1081.0,
TCGA-E1-5304,5068,TCGA-E1-5304,LGG,42.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,1999.0,[Not Available],-15481.0,Dead,WITH TUMOR,,1251.0,[Not Available],,,,903.0,Stable Disease,,,1.0,1251.0,1.0,1251.0,,,1.0,903.0,
TCGA-AX-A2IO,10659,TCGA-AX-A2IO,UCEC,83.0,FEMALE,WHITE,[Not Applicable],Stage IIA,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30539.0,Alive,TUMOR FREE,1975.0,,[Not Available],,,,,[Not Available],,,0.0,1975.0,0.0,1975.0,,,0.0,1975.0,
TCGA-GN-A9SD,9212,TCGA-GN-A9SD,SKCM,59.0,FEMALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2009.0,[Not Available],-21851.0,Dead,WITH TUMOR,,1807.0,[Not Available],Locoregional Recurrence,,,1137.0,[Not Available],,,1.0,1807.0,1.0,1807.0,,,1.0,1137.0,
TCGA-06-5413,2867,TCGA-06-5413,GBM,67.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-24477.0,Alive,WITH TUMOR,268.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],195.0,[Not Available],,,0.0,268.0,0.0,268.0,,,1.0,195.0,
TCGA-BP-4972,4209,TCGA-BP-4972,KIRC,43.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-16038.0,Alive,TUMOR FREE,1502.0,,[Not Available],,,,,[Not Available],,,0.0,1502.0,0.0,1502.0,,,0.0,1502.0,
TCGA-CN-4734,3312,TCGA-CN-4734,HNSC,70.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-25753.0,Alive,TUMOR FREE,1690.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1690.0,0.0,1690.0,0.0,1690.0,0.0,1690.0,
TCGA-UF-A71A,3751,TCGA-UF-A71A,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2009.0,[Not Available],-24623.0,Dead,WITH TUMOR,,86.0,[Not Available],,,,,Complete Remission/Response,,,1.0,86.0,1.0,86.0,,,1.0,86.0,
TCGA-DX-A48N,8597,TCGA-DX-A48N,SARC,47.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2012.0,[Not Available],-17364.0,Alive,TUMOR FREE,1073.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,1073.0,0.0,1073.0,,,0.0,1073.0,
TCGA-VS-A8EK,1842,TCGA-VS-A8EK,CESC,65.0,FEMALE,WHITE,[Not Available],Stage IVA,Cervical Squamous Cell Carcinoma,G2,2008.0,[Not Evaluated],-23817.0,Dead,WITH TUMOR,,829.0,Cervical Cancer,,,,,Partial Remission/Response,,,1.0,829.0,1.0,829.0,,,1.0,829.0,
TCGA-ER-A19B,9095,TCGA-ER-A19B,SKCM,42.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2000.0,[Not Available],-15437.0,Dead,WITH TUMOR,,2993.0,[Not Available],Regional lymph node,,,829.0,[Not Available],,,1.0,2993.0,1.0,2993.0,,,1.0,829.0,
TCGA-A5-A0GQ,10496,TCGA-A5-A0GQ,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28078.0,Alive,TUMOR FREE,2247.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2247.0,0.0,2247.0,0.0,2247.0,0.0,2247.0,
TCGA-EM-A2P1,10157,TCGA-EM-A2P1,THCA,33.0,MALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-12320.0,Alive,WITH TUMOR,531.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,363.0,[Not Available],,R0,0.0,531.0,0.0,531.0,1.0,363.0,1.0,363.0,
TCGA-77-A5FZ,6692,TCGA-77-A5FZ,LUSC,64.0,MALE,[Not Evaluated],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-23436.0,Dead,,,3838.0,[Not Available],,,,,Complete Remission/Response,,,1.0,3838.0,,3838.0,0.0,3838.0,0.0,3838.0,
TCGA-E2-A105,1303,TCGA-E2-A105,BRCA,79.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28855.0,Alive,TUMOR FREE,1308.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1308.0,0.0,1308.0,0.0,1308.0,0.0,1308.0,
TCGA-18-3412,6331,TCGA-18-3412,LUSC,52.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-19025.0,Dead,WITH TUMOR,,345.0,[Not Available],Distant Metastasis,,,273.0,Progressive Disease,,,1.0,345.0,1.0,345.0,,,1.0,273.0,
TCGA-BR-8384,9368,TCGA-BR-8384,STAD,69.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-25281.0,Alive,TUMOR FREE,113.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,113.0,0.0,113.0,0.0,113.0,0.0,113.0,
TCGA-55-7910,6008,TCGA-55-7910,LUAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-18289.0,Alive,WITH TUMOR,1040.0,,[Not Available],,,,1018.0,Complete Remission/Response,,,0.0,1040.0,0.0,1040.0,1.0,1018.0,1.0,1018.0,
TCGA-AA-3984,2137,TCGA-AA-3984,COAD,61.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-22585.0,Alive,WITH TUMOR,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-77-A5GA,6698,TCGA-77-A5GA,LUSC,76.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-27762.0,Alive,,1280.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1280.0,0.0,1280.0,0.0,1280.0,0.0,1280.0,
TCGA-CN-A63V,3365,TCGA-CN-A63V,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-21734.0,Alive,TUMOR FREE,679.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,679.0,0.0,679.0,,,0.0,679.0,
TCGA-CA-5797,2238,TCGA-CA-5797,COAD,56.0,MALE,ASIAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-20662.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-M9-A5M8,2596,TCGA-M9-A5M8,ESCA,58.0,MALE,[Not Evaluated],Stage IIA,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,,[Not Available],-21433.0,Alive,TUMOR FREE,1007.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1007.0,0.0,1007.0,0.0,1007.0,0.0,1007.0,
TCGA-34-5234,6426,TCGA-34-5234,LUSC,71.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-26072.0,Alive,TUMOR FREE,2271.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2271.0,0.0,2271.0,0.0,2271.0,0.0,2271.0,
TCGA-CR-7391,3459,TCGA-CR-7391,HNSC,36.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G1,2009.0,[Not Available],-13508.0,Alive,TUMOR FREE,913.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,913.0,0.0,913.0,0.0,913.0,0.0,913.0,
TCGA-BP-5008,4235,TCGA-BP-5008,KIRC,46.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-17008.0,Alive,TUMOR FREE,1071.0,,[Not Available],,,,,[Not Available],,,0.0,1071.0,0.0,1071.0,,,0.0,1071.0,
TCGA-DU-5872,4989,TCGA-DU-5872,LGG,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligoastrocytoma,G2,2009.0,[Not Available],-15986.0,Alive,WITH TUMOR,532.0,,[Not Available],,,,265.0,Progressive Disease,,,0.0,532.0,0.0,532.0,,,1.0,265.0,
TCGA-XF-A8HG,422,TCGA-XF-A8HG,BLCA,69.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,[Not Available],-25421.0,Dead,WITH TUMOR,,467.0,[Not Available],Distant Metastasis,Liver,,398.0,Complete Remission/Response,,,1.0,467.0,1.0,467.0,1.0,398.0,1.0,398.0,
TCGA-DX-A3UC,8590,TCGA-DX-A3UC,SARC,37.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2009.0,[Not Available],-13745.0,Alive,WITH TUMOR,2085.0,,[Not Available],Distant Metastasis,Lung,,176.0,[Not Available],Negative,R0,0.0,2085.0,0.0,2085.0,1.0,176.0,1.0,176.0,
TCGA-YL-A9WJ,8338,TCGA-YL-A9WJ,PRAD,47.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-17322.0,Dead,WITH TUMOR,,1855.0,Prostate Cancer,Distant Metastasis,"Other, specify",Neck,1476.0,Progressive Disease,,,1.0,1855.0,1.0,1855.0,,,1.0,1476.0,
TCGA-D7-A4YV,9514,TCGA-D7-A4YV,STAD,69.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-25421.0,Dead,TUMOR FREE,,180.0,[Not Available],,,,,Complete Remission/Response,,,1.0,180.0,0.0,180.0,0.0,180.0,0.0,180.0,
TCGA-CF-A3MG,154,TCGA-CF-A3MG,BLCA,48.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,[Not Available],-17600.0,Alive,TUMOR FREE,369.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,369.0,0.0,369.0,0.0,369.0,0.0,369.0,
TCGA-G6-A8L8,4413,TCGA-G6-A8L8,KIRC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2008.0,[Not Available],-22649.0,Dead,TUMOR FREE,,1091.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1091.0,0.0,1091.0,0.0,1091.0,0.0,1091.0,
TCGA-OR-A5J5,5,TCGA-OR-A5J5,ACC,30.0,MALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-11171.0,Dead,WITH TUMOR,,365.0,[Not Available],Locoregional Recurrence,"Other, specify",vena cava thrombus,50.0,Progressive Disease,,,1.0,365.0,1.0,365.0,,,1.0,50.0,
TCGA-TQ-A7RN,5395,TCGA-TQ-A7RN,LGG,32.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-11823.0,Alive,WITH TUMOR,1026.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1026.0,0.0,1026.0,,,0.0,1026.0,
TCGA-D1-A3JQ,10892,TCGA-D1-A3JQ,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22297.0,Alive,TUMOR FREE,526.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,
TCGA-EL-A3CU,10048,TCGA-EL-A3CU,THCA,70.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2000.0,[Not Available],-25881.0,Alive,TUMOR FREE,4780.0,,[Not Available],,,,,[Not Available],,R0,0.0,4780.0,0.0,4780.0,0.0,4780.0,0.0,4780.0,
TCGA-R5-A7ZI,9622,TCGA-R5-A7ZI,STAD,44.0,FEMALE,WHITE,Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2009.0,[Not Available],-16396.0,Alive,TUMOR FREE,2267.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2267.0,0.0,2267.0,,,0.0,2267.0,
TCGA-XM-AAZ1,10416,TCGA-XM-AAZ1,THYM,42.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type B2|Thymoma; Type B3,[Not Available],2013.0,[Not Available],-15383.0,Alive,TUMOR FREE,397.0,,[Not Available],,,,,[Not Available],,,0.0,397.0,0.0,397.0,,,0.0,397.0,
TCGA-BR-8366,9357,TCGA-BR-8366,STAD,80.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-29394.0,Alive,TUMOR FREE,29.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,29.0,0.0,29.0,0.0,29.0,0.0,29.0,
TCGA-EI-7004,8521,TCGA-EI-7004,READ,37.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Rectal Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-13566.0,Alive,TUMOR FREE,257.0,,[Not Available],,,,,[Not Available],,,0.0,257.0,0.0,257.0,,,0.0,257.0,
TCGA-HU-A4H3,9585,TCGA-HU-A4H3,STAD,56.0,FEMALE,ASIAN,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-20790.0,Alive,WITH TUMOR,882.0,,[Not Available],Distant Metastasis,"Other, specify",,410.0,Progressive Disease,,,0.0,882.0,0.0,882.0,,,1.0,410.0,
TCGA-CJ-5683,4328,TCGA-CJ-5683,KIRC,78.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-28745.0,Alive,TUMOR FREE,1889.0,,[Not Available],,,,,[Not Available],,,0.0,1889.0,0.0,1889.0,,,0.0,1889.0,
TCGA-LA-A7SW,6799,TCGA-LA-A7SW,LUSC,71.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2013.0,[Not Available],-26116.0,Dead,WITH TUMOR,,408.0,[Not Available],Locoregional Recurrence,,,235.0,[Not Available],,,1.0,408.0,1.0,408.0,,,1.0,235.0,
TCGA-3B-A9HO,8540,TCGA-3B-A9HO,SARC,75.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2012.0,[Not Available],-27664.0,Alive,TUMOR FREE,959.0,,[Not Available],New Primary Tumor,"Other, specify",Abdominal Wall,595.0,[Not Available],Positive,R1,0.0,959.0,0.0,959.0,,,1.0,595.0,
TCGA-CX-7086,3607,TCGA-CX-7086,HNSC,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-19434.0,Alive,TUMOR FREE,573.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,573.0,0.0,573.0,,,0.0,573.0,
TCGA-B0-5709,4065,TCGA-B0-5709,KIRC,62.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-22843.0,Alive,TUMOR FREE,3974.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3974.0,0.0,3974.0,0.0,3974.0,0.0,3974.0,
TCGA-CR-6478,3428,TCGA-CR-6478,HNSC,66.0,FEMALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-24244.0,Dead,,,183.0,[Not Available],,,,,Complete Remission/Response,,,1.0,183.0,,183.0,,,0.0,183.0,
TCGA-DU-6401,4999,TCGA-DU-6401,LGG,31.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1998.0,[Not Available],-11595.0,Dead,WITH TUMOR,,2660.0,[Not Available],,,,1886.0,Progressive Disease,,,1.0,2660.0,1.0,2660.0,,,1.0,1886.0,
TCGA-S9-A6UB,5336,TCGA-S9-A6UB,LGG,52.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2005.0,[Not Available],-19223.0,Alive,TUMOR FREE,3761.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3761.0,0.0,3761.0,0.0,3761.0,0.0,3761.0,
TCGA-L7-A56G,2556,TCGA-L7-A56G,ESCA,65.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Esophagus Squamous Cell Carcinoma,G3,2012.0,[Not Available],-24106.0,Dead,WITH TUMOR,,330.0,[Not Available],Distant Metastasis,Lung,,270.0,Stable Disease,,,1.0,330.0,1.0,330.0,,,1.0,270.0,
TCGA-D3-A1Q8,8831,TCGA-D3-A1Q8,SKCM,33.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2004.0,[Not Available],-12330.0,Dead,WITH TUMOR,,854.0,[Not Available],Distant Metastasis,Lung,,147.0,[Not Available],,,1.0,854.0,1.0,854.0,,,1.0,147.0,
TCGA-E9-A22A,1428,TCGA-E9-A22A,BRCA,74.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27288.0,Alive,TUMOR FREE,1189.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0,
TCGA-BJ-A0ZF,9856,TCGA-BJ-A0ZF,THCA,54.0,FEMALE,WHITE,Stage II,[Not Applicable],"Other, specify",[Not Available],2010.0,[Not Available],-19978.0,Alive,WITH TUMOR,1217.0,,[Not Available],Locoregional Recurrence,,,735.0,[Not Available],,R0,0.0,1217.0,0.0,1217.0,1.0,735.0,1.0,735.0,
TCGA-EY-A1GD,10944,TCGA-EY-A1GD,UCEC,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18638.0,Alive,TUMOR FREE,1639.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1639.0,0.0,1639.0,0.0,1639.0,0.0,1639.0,
TCGA-S9-A6TV,5323,TCGA-S9-A6TV,LGG,50.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2010.0,[Not Available],-18321.0,Alive,TUMOR FREE,571.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,571.0,0.0,571.0,0.0,571.0,0.0,571.0,
TCGA-95-7948,6241,TCGA-95-7948,LUAD,42.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-15363.0,Alive,TUMOR FREE,476.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,
TCGA-AP-A1DO,10596,TCGA-AP-A1DO,UCEC,62.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22787.0,Alive,TUMOR FREE,952.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,952.0,0.0,952.0,0.0,952.0,0.0,952.0,
TCGA-DX-A7ET,8632,TCGA-DX-A7ET,SARC,71.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013.0,[Not Available],-26193.0,Alive,TUMOR FREE,463.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,463.0,0.0,463.0,0.0,463.0,0.0,463.0,
TCGA-VD-A8KD,11122,TCGA-VD-A8KD,UVM,72.0,MALE,[Not Evaluated],Stage IV,Stage IV,Epithelioid Cell|Spindle Cell,[Not Available],2012.0,[Not Available],-26457.0,Dead,WITH TUMOR,,114.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,,-4.0,[Not Available],,,1.0,114.0,1.0,114.0,,,1.0,,
TCGA-C5-A7CH,1645,TCGA-C5-A7CH,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2001.0,[Not Available],-15777.0,Alive,TUMOR FREE,4694.0,,,,,,,[Not Available],,,0.0,4694.0,0.0,4694.0,,,0.0,4694.0,
TCGA-CF-A47X,161,TCGA-CF-A47X,BLCA,60.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,[Not Available],-22200.0,Alive,TUMOR FREE,384.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,384.0,0.0,384.0,0.0,384.0,0.0,384.0,
TCGA-EO-A3B0,10935,TCGA-EO-A3B0,UCEC,43.0,FEMALE,ASIAN,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2011.0,Indeterminate (neither Pre or Postmenopausal),-15954.0,Alive,TUMOR FREE,1412.0,,[Not Available],,,,,[Discrepancy],,,0.0,1412.0,0.0,1412.0,,,0.0,1412.0,
TCGA-MP-A4T6,6300,TCGA-MP-A4T6,LUAD,76.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-27993.0,Dead,TUMOR FREE,,1790.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1790.0,0.0,1790.0,0.0,1790.0,0.0,1790.0,
TCGA-AX-A2HC,10651,TCGA-AX-A2HC,UCEC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2006.0,[Not Available],-19485.0,Alive,WITH TUMOR,1044.0,,[Not Available],Metastatic,"Other, specify",Abdomen,756.0,Complete Remission/Response,,,0.0,1044.0,0.0,1044.0,1.0,756.0,1.0,756.0,
TCGA-LK-A4O6,6851,TCGA-LK-A4O6,MESO,66.0,FEMALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2012.0,[Not Available],-24449.0,Dead,WITH TUMOR,,448.0,[Not Available],,,,,[Not Available],,RX,1.0,448.0,1.0,448.0,,,1.0,448.0,
TCGA-X7-A8M3,10398,TCGA-X7-A8M3,THYM,64.0,FEMALE,WHITE,[Not Applicable],III,Thymoma; Type B3,[Not Available],2001.0,[Not Available],-23718.0,Alive,TUMOR FREE,50.0,,[Not Available],,,,,[Not Available],,,0.0,50.0,0.0,50.0,,,0.0,50.0,
TCGA-28-5218,3162,TCGA-28-5218,GBM,63.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-23096.0,Dead,,128.0,157.0,[Not Available],,,,,[Not Available],,,1.0,157.0,,157.0,,,0.0,157.0,
TCGA-AJ-A3OK,10551,TCGA-AJ-A3OK,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26851.0,Alive,TUMOR FREE,485.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,
TCGA-EM-A1YB,10126,TCGA-EM-A1YB,THCA,73.0,FEMALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-26852.0,Alive,TUMOR FREE,592.0,,[Not Available],,,,,[Not Available],,R0,0.0,592.0,0.0,592.0,0.0,592.0,0.0,592.0,
TCGA-D1-A17B,10860,TCGA-D1-A17B,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25504.0,Alive,TUMOR FREE,213.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,213.0,0.0,213.0,0.0,213.0,0.0,213.0,
TCGA-EE-A182,8997,TCGA-EE-A182,SKCM,84.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-30718.0,Dead,WITH TUMOR,,447.0,[Not Available],Locoregional Recurrence,,,270.0,[Not Available],,,1.0,447.0,1.0,447.0,,,1.0,270.0,
TCGA-IZ-A6M9,4637,TCGA-IZ-A6M9,KIRP,63.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-23149.0,Alive,TUMOR FREE,376.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,
TCGA-IB-7890,7631,TCGA-IB-7890,PAAD,73.0,MALE,[Unknown],Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2008.0,[Not Available],-26747.0,Dead,WITH TUMOR,,598.0,Pancreatic Cancer,Distant Metastasis,Liver,,519.0,Progressive Disease,,,1.0,598.0,1.0,598.0,,,1.0,519.0,
TCGA-CQ-5329,3381,TCGA-CQ-5329,HNSC,46.0,FEMALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-17028.0,Alive,TUMOR FREE,2143.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2143.0,0.0,2143.0,0.0,2143.0,0.0,2143.0,
TCGA-DE-A2OL,9907,TCGA-DE-A2OL,THCA,44.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-16253.0,Alive,TUMOR FREE,1145.0,,[Not Available],,,,,[Not Available],,R0,0.0,1145.0,0.0,1145.0,0.0,1145.0,0.0,1145.0,
TCGA-CM-6678,2292,TCGA-CM-6678,COAD,63.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-23070.0,Alive,WITH TUMOR,335.0,,[Not Available],Metastatic,,,0.0,[Not Available],,,0.0,335.0,0.0,335.0,,,1.0,0.0,
TCGA-75-7030,6139,TCGA-75-7030,LUAD,,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],,Alive,TUMOR FREE,,,[Not Available],,,,,Complete Remission/Response,,,0.0,,0.0,,0.0,,0.0,,
TCGA-DU-6407,5005,TCGA-DU-6407,LGG,35.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2001.0,[Not Available],-13021.0,Dead,WITH TUMOR,,2875.0,[Not Available],,,,2397.0,Progressive Disease,,,1.0,2875.0,1.0,2875.0,,,1.0,2397.0,
TCGA-55-7570,5995,TCGA-55-7570,LUAD,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22218.0,Alive,TUMOR FREE,824.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,824.0,0.0,824.0,0.0,824.0,0.0,824.0,
TCGA-Q1-A6DT,1822,TCGA-Q1-A6DT,CESC,55.0,FEMALE,WHITE,[Not Available],Stage I,Cervical Squamous Cell Carcinoma,GX,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20286.0,Dead,WITH TUMOR,,275.0,Cervical Cancer,,,,,[Not Available],,,1.0,275.0,1.0,275.0,,,1.0,275.0,
TCGA-IB-7885,7626,TCGA-IB-7885,PAAD,78.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,[Not Available],-28554.0,Alive,TUMOR FREE,1257.0,,,,,,,Complete Remission/Response,,,0.0,1257.0,0.0,1257.0,0.0,1257.0,0.0,1257.0,
TCGA-EW-A1J6,1463,TCGA-EW-A1J6,BRCA,70.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25830.0,Alive,TUMOR FREE,875.0,,[Not Available],,,,,[Not Available],Negative,,0.0,875.0,0.0,875.0,0.0,875.0,0.0,875.0,
TCGA-L5-A43J,2512,TCGA-L5-A43J,ESCA,90.0,MALE,WHITE,Stage IIB,[Not Available],Esophagus Squamous Cell Carcinoma,G3,2011.0,[Not Available],-32872.0,Dead,WITH TUMOR,,131.0,[Not Available],Distant Metastasis,Liver,,98.0,Progressive Disease,,,1.0,131.0,1.0,131.0,,,1.0,98.0,
TCGA-DX-A48J,8594,TCGA-DX-A48J,SARC,44.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2003.0,[Not Available],-16279.0,Dead,WITH TUMOR,,296.0,[Not Available],Locoregional Recurrence,,,97.0,[Not Available],[Not Available],R0,1.0,296.0,1.0,296.0,1.0,97.0,1.0,97.0,
TCGA-BA-6868,3257,TCGA-BA-6868,HNSC,53.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IVB,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-19608.0,Dead,WITH TUMOR,,472.0,[Not Available],,Distant Metastasis,L neck subdermal mets,344.0,Partial Remission/Response,,,1.0,472.0,1.0,472.0,,,1.0,344.0,
TCGA-06-5415,2869,TCGA-06-5415,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-22213.0,Alive,WITH TUMOR,260.0,,[Not Available],,,,,[Not Available],,,0.0,260.0,0.0,260.0,,,0.0,260.0,
TCGA-QD-A8IV,10351,TCGA-QD-A8IV,THCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2013.0,[Not Available],-18288.0,Alive,TUMOR FREE,392.0,,[Not Available],,,,,[Not Available],,RX,0.0,392.0,0.0,392.0,,,0.0,392.0,
TCGA-BR-A4PE,9409,TCGA-BR-A4PE,STAD,68.0,FEMALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-24986.0,Alive,TUMOR FREE,621.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,621.0,0.0,621.0,0.0,621.0,0.0,621.0,
TCGA-A3-3322,3894,TCGA-A3-3322,KIRC,51.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-18754.0,Alive,TUMOR FREE,1478.0,,[Not Available],,,,,[Not Available],,,0.0,1478.0,0.0,1478.0,,,0.0,1478.0,
TCGA-D5-6530,2301,TCGA-D5-6530,COAD,53.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-19591.0,Alive,TUMOR FREE,621.0,,[Not Available],,,,,[Not Available],,,0.0,621.0,0.0,621.0,,,0.0,621.0,
TCGA-67-6215,6093,TCGA-67-6215,LUAD,52.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-19310.0,Alive,TUMOR FREE,174.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,174.0,0.0,174.0,0.0,174.0,0.0,174.0,
TCGA-DH-A7UT,4977,TCGA-DH-A7UT,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-11014.0,Dead,WITH TUMOR,,531.0,[Not Available],,,,404.0,Stable Disease,,,1.0,531.0,1.0,531.0,,,1.0,404.0,
TCGA-2G-AAFZ,9728,TCGA-2G-AAFZ,TGCT,32.0,MALE,WHITE,Stage III,Stage IIIB,Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature),[Not Available],2011.0,[Not Available],-11761.0,Alive,TUMOR FREE,1353.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,1353.0,0.0,1353.0,,,0.0,1353.0,
TCGA-EB-A42Z,8953,TCGA-EB-A42Z,SKCM,49.0,MALE,ASIAN,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-18157.0,Alive,TUMOR FREE,441.0,,[Not Available],,,,,[Not Available],,,0.0,441.0,0.0,441.0,,,0.0,441.0,
TCGA-D8-A1JF,1241,TCGA-D8-A1JF,BRCA,79.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29199.0,Alive,TUMOR FREE,366.0,,[Not Available],,,,,[Not Available],Negative,,0.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,
TCGA-CV-7427,3563,TCGA-CV-7427,HNSC,73.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1997.0,[Not Available],-26975.0,Dead,TUMOR FREE,,4760.0,[Not Available],Locoregional Recurrence,Oral Cavity,Maxilla,3282.0,Complete Remission/Response,,,1.0,4760.0,0.0,4760.0,1.0,3282.0,1.0,3282.0,
TCGA-33-4533,6399,TCGA-33-4533,LUSC,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-28001.0,Alive,TUMOR FREE,4068.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4068.0,0.0,4068.0,0.0,4068.0,0.0,4068.0,
TCGA-DV-5566,4395,TCGA-DV-5566,KIRC,67.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-24717.0,Alive,WITH TUMOR,1398.0,,[Not Available],,,,,[Not Available],,,0.0,1398.0,0.0,1398.0,,,0.0,1398.0,
TCGA-DX-A3U5,8583,TCGA-DX-A3U5,SARC,52.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2011.0,[Not Available],-19088.0,Alive,TUMOR FREE,969.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,969.0,0.0,969.0,,,0.0,969.0,
TCGA-EB-A3HV,8942,TCGA-EB-A3HV,SKCM,37.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-13712.0,Alive,WITH TUMOR,39.0,,[Not Available],,,,,[Not Available],,,0.0,39.0,0.0,39.0,,,0.0,39.0,
TCGA-E2-A1II,1363,TCGA-E2-A1II,BRCA,51.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18788.0,Alive,TUMOR FREE,1025.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1025.0,0.0,1025.0,0.0,1025.0,0.0,1025.0,
TCGA-74-6578,3208,TCGA-74-6578,GBM,58.0,MALE,[Not Available],[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-21464.0,Alive,WITH TUMOR,436.0,,[Not Available],,[Not Applicable],[Not Applicable],222.0,[Not Available],,,0.0,436.0,0.0,436.0,,,1.0,222.0,
TCGA-28-5213,3158,TCGA-28-5213,GBM,72.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-26491.0,Alive,WITH TUMOR,951.0,,[Not Available],,,,,[Not Applicable],,,0.0,951.0,0.0,951.0,,,0.0,951.0,
TCGA-BR-7704,9324,TCGA-BR-7704,STAD,69.0,FEMALE,WHITE,Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-25300.0,Alive,TUMOR FREE,1072.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1072.0,0.0,1072.0,0.0,1072.0,0.0,1072.0,
TCGA-D7-6519,9490,TCGA-D7-6519,STAD,64.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-23413.0,Alive,WITH TUMOR,625.0,,[Not Available],Distant Metastasis,Liver,cervix,429.0,Progressive Disease,,,0.0,625.0,0.0,625.0,,,1.0,429.0,
TCGA-FI-A2D6,10988,TCGA-FI-A2D6,UCEC,74.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27060.0,Dead,TUMOR FREE,,767.0,[Not Available],,,,,Complete Remission/Response,,,1.0,767.0,0.0,767.0,0.0,767.0,0.0,767.0,
TCGA-F1-A72C,9536,TCGA-F1-A72C,STAD,68.0,MALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,[Not Available],-25104.0,Alive,WITH TUMOR,346.0,,[Not Available],Distant Metastasis,Liver,,343.0,Complete Remission/Response,,,0.0,346.0,0.0,346.0,1.0,343.0,1.0,343.0,
TCGA-K6-A3WQ,11000,TCGA-K6-A3WQ,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22092.0,Dead,WITH TUMOR,,427.0,[Not Available],Locoregional Recurrence,"Other, specify",uterine,351.0,[Not Available],,,1.0,427.0,1.0,427.0,,,1.0,351.0,
TCGA-VD-AA8O,11136,TCGA-VD-AA8O,UVM,77.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Epithelioid Cell|Spindle Cell,[Not Available],2013.0,[Not Available],-28250.0,Dead,WITH TUMOR,,606.0,Metastatic Uveal Melanoma,,,,,[Not Available],,,1.0,606.0,1.0,606.0,,,1.0,606.0,
TCGA-BS-A0UF,10803,TCGA-BS-A0UF,UCEC,65.0,FEMALE,ASIAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23771.0,Alive,TUMOR FREE,2611.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2611.0,0.0,2611.0,0.0,2611.0,0.0,2611.0,
TCGA-E2-A9RU,1392,TCGA-E2-A9RU,BRCA,90.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873.0,Alive,TUMOR FREE,538.0,,[Not Available],,,,,[Not Available],Negative,,0.0,538.0,0.0,538.0,0.0,538.0,0.0,538.0,
TCGA-D1-A3DG,10889,TCGA-D1-A3DG,UCEC,81.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29771.0,Dead,TUMOR FREE,,130.0,[Not Available],,,,,[Not Available],,,1.0,130.0,0.0,130.0,,,0.0,130.0,
TCGA-EJ-5503,7918,TCGA-EJ-5503,PRAD,50.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-18395.0,Alive,TUMOR FREE,1391.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1391.0,0.0,1391.0,0.0,1391.0,0.0,1391.0,
TCGA-50-5933,5943,TCGA-50-5933,LUAD,72.0,MALE,WHITE,Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-26377.0,Dead,TUMOR FREE,2370.0,2393.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2393.0,0.0,2393.0,0.0,2393.0,0.0,2393.0,
TCGA-D8-A1XB,1260,TCGA-D8-A1XB,BRCA,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22976.0,Alive,TUMOR FREE,552.0,,[Not Available],,,,,[Not Available],Negative,,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,
TCGA-DU-A76R,5056,TCGA-DU-A76R,LGG,51.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2006.0,[Not Available],-18939.0,Dead,WITH TUMOR,,648.0,[Not Available],,,,338.0,Progressive Disease,,,1.0,648.0,1.0,648.0,,,1.0,338.0,
TCGA-EB-A44R,8960,TCGA-EB-A44R,SKCM,52.0,MALE,ASIAN,Stage IIIB,[Not Applicable],,[Not Available],2011.0,[Not Available],-19298.0,Dead,TUMOR FREE,,315.0,[Not Available],,,,,[Not Available],,,1.0,315.0,0.0,315.0,,,0.0,315.0,
TCGA-FK-A3SE,10275,TCGA-FK-A3SE,THCA,31.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-11472.0,Alive,TUMOR FREE,670.0,,[Not Available],,,,,[Not Available],,R0,0.0,670.0,0.0,670.0,0.0,670.0,0.0,670.0,
TCGA-C5-A8YR,1664,TCGA-C5-A8YR,CESC,56.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,1994.0,[Not Available],-20672.0,Dead,,,837.0,,Locoregional Recurrence,,regional recurrence NOS,272.0,[Not Available],,,1.0,837.0,,837.0,,,1.0,272.0,
TCGA-B0-4698,3971,TCGA-B0-4698,KIRC,75.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2003.0,[Not Available],-27417.0,Dead,WITH TUMOR,,42.0,[Not Available],,,,,[Not Available],,,1.0,42.0,1.0,42.0,,,1.0,42.0,
TCGA-B2-3923,4071,TCGA-B2-3923,KIRC,59.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-21793.0,Alive,TUMOR FREE,992.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,992.0,0.0,992.0,0.0,992.0,0.0,992.0,
TCGA-CQ-7069,3403,TCGA-CQ-7069,HNSC,77.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-28138.0,Alive,TUMOR FREE,1274.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1274.0,0.0,1274.0,0.0,1274.0,0.0,1274.0,
TCGA-D8-A1JU,1253,TCGA-D8-A1JU,BRCA,51.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18733.0,Alive,TUMOR FREE,447.0,,[Not Available],,,,,[Not Available],Negative,,0.0,447.0,0.0,447.0,0.0,447.0,0.0,447.0,
TCGA-FD-A6TA,295,TCGA-FD-A6TA,BLCA,58.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-21196.0,Alive,TUMOR FREE,1912.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1912.0,0.0,1912.0,,,0.0,1912.0,
TCGA-GD-A3OP,338,TCGA-GD-A3OP,BLCA,84.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-30956.0,Alive,,64.0,,[Not Available],,,,,[Unknown],,,0.0,64.0,0.0,64.0,,,0.0,64.0,
TCGA-L5-A4OT,2527,TCGA-L5-A4OT,ESCA,77.0,MALE,WHITE,Stage IV,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2006.0,[Not Available],-28162.0,Dead,WITH TUMOR,,149.0,[Not Available],,,,,Stable Disease,,,1.0,149.0,1.0,149.0,,,1.0,149.0,
TCGA-GL-A59T,4614,TCGA-GL-A59T,KIRP,46.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-17142.0,Alive,TUMOR FREE,546.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,
TCGA-HT-7608,5165,TCGA-HT-7608,LGG,61.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligoastrocytoma,G2,2007.0,[Not Available],-22302.0,Alive,TUMOR FREE,671.0,,[Not Available],,,,,Stable Disease,,,0.0,671.0,0.0,671.0,,,0.0,671.0,
TCGA-BT-A3PH,138,TCGA-BT-A3PH,BLCA,76.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-28030.0,Dead,WITH TUMOR,,142.0,[Not Available],,,,,Progressive Disease,,,1.0,142.0,1.0,142.0,,,1.0,142.0,
TCGA-IN-A6RP,9601,TCGA-IN-A6RP,STAD,63.0,MALE,WHITE,[Discrepancy],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-23282.0,Alive,WITH TUMOR,196.0,,[Not Available],Distant Metastasis,Liver,,150.0,Progressive Disease,,,0.0,196.0,0.0,196.0,,,1.0,150.0,
TCGA-EJ-7792,7968,TCGA-EJ-7792,PRAD,53.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-19454.0,Alive,TUMOR FREE,1396.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1396.0,0.0,1396.0,0.0,1396.0,0.0,1396.0,
TCGA-95-7562,6237,TCGA-95-7562,LUAD,71.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26000.0,Dead,TUMOR FREE,,87.0,[Not Available],,,,,[Not Evaluated],,,1.0,87.0,0.0,87.0,,,0.0,87.0,
TCGA-GN-A4U9,9208,TCGA-GN-A4U9,SKCM,71.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-26118.0,Dead,WITH TUMOR,,673.0,[Not Available],Locoregional Recurrence,,,151.0,[Not Available],,,1.0,673.0,1.0,673.0,,,1.0,151.0,
TCGA-D5-6529,2300,TCGA-D5-6529,COAD,69.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-25394.0,Alive,WITH TUMOR,614.0,,[Not Available],,,,386.0,[Not Available],,,0.0,614.0,0.0,614.0,,,1.0,386.0,
TCGA-KK-A7B4,8199,TCGA-KK-A7B4,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-23644.0,Alive,WITH TUMOR,987.0,,[Not Available],Biochemical evidence of disease,,,637.0,Stable Disease,,,0.0,987.0,0.0,987.0,,,1.0,637.0,
TCGA-EM-A22N,10135,TCGA-EM-A22N,THCA,68.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-25035.0,Alive,TUMOR FREE,324.0,,[Not Available],,,,,[Not Available],,RX,0.0,324.0,0.0,324.0,,,0.0,324.0,
TCGA-FD-A62O,292,TCGA-FD-A62O,BLCA,74.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27310.0,Dead,TUMOR FREE,,216.0,[Not Available],,,,,[Unknown],,,1.0,216.0,0.0,216.0,,,0.0,216.0,
TCGA-EP-A2KA,5682,TCGA-EP-A2KA,LIHC,52.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-19214.0,Dead,WITH TUMOR,,627.0,[Not Available],Extrahepatic Recurrence,Lung,,293.0,[Not Available],,R0,1.0,627.0,1.0,627.0,1.0,293.0,1.0,293.0,
TCGA-UT-A88G,6903,TCGA-UT-A88G,MESO,73.0,MALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2012.0,[Not Available],-26704.0,Dead,WITH TUMOR,,76.0,[Not Available],Intrapleural Progression,"Other, specify",Right Hemithorax,44.0,[Not Available],,RX,1.0,76.0,1.0,76.0,,,1.0,44.0,
TCGA-D1-A2G7,10887,TCGA-D1-A2G7,UCEC,65.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2007.0,Peri (6-12 months since last menstrual period),-23913.0,Dead,TUMOR FREE,,1793.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1793.0,0.0,1793.0,0.0,1793.0,0.0,1793.0,
TCGA-A6-2681,1970,TCGA-A6-2681,COAD,73.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-26929.0,Alive,TUMOR FREE,1387.0,,[Not Available],,,,1150.0,Complete Remission/Response,,,0.0,1387.0,0.0,1387.0,1.0,1150.0,1.0,1150.0,
TCGA-EJ-7328,7956,TCGA-EJ-7328,PRAD,70.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25756.0,Alive,TUMOR FREE,842.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,
TCGA-C5-A2LT,1633,TCGA-C5-A2LT,CESC,38.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2001.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13966.0,Alive,TUMOR FREE,2226.0,,,,,,,Complete Remission/Response,,,0.0,2226.0,0.0,2226.0,0.0,2226.0,0.0,2226.0,
TCGA-AX-A3FV,10662,TCGA-AX-A3FV,UCEC,62.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,[Not Available],-22752.0,Alive,,-6.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-77-8140,6682,TCGA-77-8140,LUSC,66.0,FEMALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-24415.0,Dead,,,351.0,[Not Available],,,,,[Not Applicable],,,1.0,351.0,,351.0,,,0.0,351.0,
TCGA-WB-A81Q,7857,TCGA-WB-A81Q,PCPG,44.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],1997.0,[Not Available],-16422.0,Dead,WITH TUMOR,,755.0,[Not Available],,,,,Progressive Disease,,,1.0,755.0,1.0,755.0,,,1.0,755.0,
TCGA-BR-6455,9304,TCGA-BR-6455,STAD,59.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-21865.0,Dead,WITH TUMOR,,422.0,[Not Available],Distant Metastasis,Liver,,385.0,Stable Disease,,,1.0,422.0,1.0,422.0,,,1.0,385.0,
TCGA-G9-6494,8044,TCGA-G9-6494,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-24381.0,Alive,WITH TUMOR,1771.0,,[Not Available],,,,,Progressive Disease,,,0.0,1771.0,0.0,1771.0,,,0.0,1771.0,
TCGA-TQ-A7RK,5393,TCGA-TQ-A7RK,LGG,29.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2010.0,[Not Available],-10742.0,Alive,TUMOR FREE,1341.0,,[Not Available],,,,858.0,Complete Remission/Response,,,0.0,1341.0,0.0,1341.0,1.0,858.0,1.0,858.0,
TCGA-W5-AA2H,1920,TCGA-W5-AA2H,CHOL,70.0,FEMALE,WHITE,Stage III,[Not Applicable],Cholangiocarcinoma; distal,G3,2012.0,[Not Available],-25775.0,Alive,TUMOR FREE,1077.0,,[Not Available],,,,,[Not Available],,R0,0.0,1077.0,0.0,1077.0,0.0,1077.0,0.0,1077.0,
TCGA-29-2434,7352,TCGA-29-2434,OV,52.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-18997.0,Alive,TUMOR FREE,349.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,349.0,0.0,349.0,0.0,349.0,0.0,349.0,
TCGA-A6-5656,1982,TCGA-A6-5656,COAD,74.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-27184.0,Alive,TUMOR FREE,1001.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,
TCGA-EJ-7317,7951,TCGA-EJ-7317,PRAD,71.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-26064.0,Alive,TUMOR FREE,771.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,771.0,0.0,771.0,0.0,771.0,0.0,771.0,
TCGA-2Y-A9H9,5444,TCGA-2Y-A9H9,LIHC,70.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-25670.0,Alive,WITH TUMOR,697.0,,[Not Available],Locoregional Recurrence,Liver,,59.0,[Not Available],,R0,0.0,697.0,0.0,697.0,1.0,59.0,1.0,59.0,
TCGA-BH-A0BM,1047,TCGA-BH-A0BM,BRCA,54.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20049.0,Alive,TUMOR FREE,1876.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1876.0,0.0,1876.0,0.0,1876.0,0.0,1876.0,
TCGA-DK-A3IU,203,TCGA-DK-A3IU,BLCA,58.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-21369.0,Dead,WITH TUMOR,,706.0,[Not Available],Distant Metastasis,Lung,,462.0,Complete Remission/Response,,,1.0,706.0,1.0,706.0,1.0,462.0,1.0,462.0,
TCGA-WK-A8Y0,8778,TCGA-WK-A8Y0,SARC,49.0,FEMALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2010.0,[Not Available],-18233.0,Dead,WITH TUMOR,,688.0,[Not Available],Distant Metastasis,Lung,,111.0,[Not Available],Negative,R0,1.0,688.0,1.0,688.0,1.0,111.0,1.0,111.0,
TCGA-J4-8200,8131,TCGA-J4-8200,PRAD,47.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-17167.0,Alive,TUMOR FREE,1218.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1218.0,0.0,1218.0,0.0,1218.0,0.0,1218.0,
TCGA-86-8278,6194,TCGA-86-8278,LUAD,63.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23117.0,Alive,WITH TUMOR,944.0,,[Not Available],,,,29.0,Complete Remission/Response,,,0.0,944.0,0.0,944.0,1.0,29.0,1.0,29.0,
TCGA-06-6697,2883,TCGA-06-6697,GBM,65.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-23763.0,Alive,WITH TUMOR,391.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],306.0,[Not Available],,,0.0,391.0,0.0,391.0,,,1.0,306.0,
TCGA-PQ-A6FN,396,TCGA-PQ-A6FN,BLCA,78.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-28546.0,Alive,,507.0,,[Not Available],,,,,[Unknown],,,0.0,507.0,0.0,507.0,,,0.0,507.0,
TCGA-AZ-4616,2219,TCGA-AZ-4616,COAD,82.0,FEMALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-30043.0,Dead,WITH TUMOR,,156.0,[Not Available],,,,,[Not Available],,,1.0,156.0,1.0,156.0,,,1.0,156.0,
TCGA-B5-A11Z,10713,TCGA-B5-A11Z,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22505.0,Alive,TUMOR FREE,528.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,528.0,0.0,528.0,0.0,528.0,0.0,528.0,
TCGA-DM-A28K,2349,TCGA-DM-A28K,COAD,75.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2003.0,[Not Available],-27428.0,Alive,,2988.0,,[Not Available],,,,,[Not Available],,,0.0,2988.0,0.0,2988.0,,,0.0,2988.0,
TCGA-BL-A5ZZ,121,TCGA-BL-A5ZZ,BLCA,80.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-29247.0,Alive,WITH TUMOR,377.0,,[Not Available],Distant Metastasis,Lung,,242.0,Complete Remission/Response,,,0.0,377.0,0.0,377.0,1.0,242.0,1.0,242.0,
TCGA-AZ-6606,2231,TCGA-AZ-6606,COAD,81.0,MALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-29704.0,Dead,WITH TUMOR,,357.0,[Not Available],,,,,Progressive Disease,,,1.0,357.0,1.0,357.0,,,1.0,357.0,
TCGA-VQ-A91Y,9684,TCGA-VQ-A91Y,STAD,67.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,[Not Available],-24774.0,Dead,WITH TUMOR,,296.0,Stomach Cancer,Distant Metastasis,Lung,,258.0,Progressive Disease,,,1.0,296.0,1.0,296.0,,,1.0,258.0,
TCGA-OR-A5J9,9,TCGA-OR-A5J9,ACC,22.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-8175.0,Alive,WITH TUMOR,1352.0,,[Not Available],Distant Metastasis,Lung,,414.0,Complete Remission/Response,,,0.0,1352.0,0.0,1352.0,1.0,414.0,1.0,414.0,
TCGA-X7-A8M8,10403,TCGA-X7-A8M8,THYM,45.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],I,Thymoma; Type B2,[Not Available],2007.0,[Not Available],-16741.0,Alive,TUMOR FREE,2533.0,,[Not Available],,,,,[Not Available],,,0.0,2533.0,0.0,2533.0,,,0.0,2533.0,
TCGA-22-5485,6393,TCGA-22-5485,LUSC,58.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-21488.0,Dead,WITH TUMOR,916.0,916.0,[Not Available],,,,840.0,Complete Remission/Response,,,1.0,916.0,1.0,916.0,1.0,840.0,1.0,840.0,
TCGA-85-8353,6728,TCGA-85-8353,LUSC,72.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26549.0,Dead,WITH TUMOR,,94.0,[Not Available],,,,,Stable Disease,,,1.0,94.0,1.0,94.0,,,1.0,94.0,
TCGA-D3-A2JD,8842,TCGA-D3-A2JD,SKCM,58.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2007.0,[Not Available],-21440.0,Dead,WITH TUMOR,,361.0,[Not Available],Distant Metastasis,Liver,,85.0,[Not Available],,,1.0,361.0,1.0,361.0,,,1.0,85.0,
TCGA-L6-A4EU,10346,TCGA-L6-A4EU,THCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2012.0,[Not Available],-21192.0,Alive,TUMOR FREE,289.0,,[Not Available],,,,,[Not Available],,R1,0.0,289.0,0.0,289.0,,,0.0,289.0,
TCGA-DJ-A13S,9923,TCGA-DJ-A13S,THCA,19.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-7099.0,Alive,TUMOR FREE,265.0,,[Not Available],,,,,[Not Available],,R0,0.0,265.0,0.0,265.0,0.0,265.0,0.0,265.0,
TCGA-85-8664,6736,TCGA-85-8664,LUSC,73.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26954.0,Dead,WITH TUMOR,,550.0,[Not Available],Distant Metastasis,,,434.0,Complete Remission/Response,,,1.0,550.0,1.0,550.0,1.0,434.0,1.0,434.0,
TCGA-NF-A4X2,11075,TCGA-NF-A4X2,UCS,59.0,FEMALE,WHITE,[Not Applicable],Stage II,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21908.0,Alive,TUMOR FREE,81.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,81.0,0.0,81.0,0.0,81.0,0.0,81.0,
TCGA-DJ-A3UQ,9971,TCGA-DJ-A3UQ,THCA,45.0,FEMALE,ASIAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-16545.0,Alive,TUMOR FREE,595.0,,[Not Available],,,,,[Not Available],,R0,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,
TCGA-AX-A1C7,10632,TCGA-AX-A1C7,UCEC,77.0,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28198.0,Alive,,1054.0,,[Not Available],,,,390.0,[Not Applicable],,,0.0,1054.0,0.0,1054.0,,,1.0,390.0,
TCGA-EM-A3FQ,10176,TCGA-EM-A3FQ,THCA,19.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-7176.0,Alive,WITH TUMOR,492.0,,[Not Available],,,,,[Not Available],,R0,0.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,
TCGA-KK-A59X,8174,TCGA-KK-A59X,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-20416.0,Alive,WITH TUMOR,2535.0,,[Not Available],Locoregional Recurrence,"Other, specify",Bladder,2233.0,[Unknown],,,0.0,2535.0,0.0,2535.0,,,1.0,2233.0,
TCGA-3A-A9IJ,7532,TCGA-3A-A9IJ,PAAD,65.0,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2009.0,[Not Available],-23791.0,Alive,TUMOR FREE,1854.0,,,,,,,Complete Remission/Response,,,0.0,1854.0,0.0,1854.0,0.0,1854.0,0.0,1854.0,
TCGA-J9-A8CK,8157,TCGA-J9-A8CK,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24285.0,Alive,TUMOR FREE,321.0,,[Not Available],,,,,[Not Applicable],,,0.0,321.0,0.0,321.0,,,0.0,321.0,
TCGA-CZ-5465,4381,TCGA-CZ-5465,KIRC,76.0,FEMALE,[Not Available],Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-27838.0,Dead,TUMOR FREE,,2564.0,[Not Available],,,,,[Not Available],,,1.0,2564.0,0.0,2564.0,,,0.0,2564.0,
TCGA-BF-A9VF,8815,TCGA-BF-A9VF,SKCM,77.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-28312.0,Alive,TUMOR FREE,440.0,,[Not Available],,,,,[Not Available],,,0.0,440.0,0.0,440.0,,,0.0,440.0,
TCGA-D1-A0ZR,10819,TCGA-D1-A0ZR,UCEC,57.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Indeterminate (neither Pre or Postmenopausal),-21157.0,Alive,TUMOR FREE,17.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,17.0,0.0,17.0,0.0,17.0,0.0,17.0,
TCGA-55-7914,6011,TCGA-55-7914,LUAD,71.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26105.0,Dead,WITH TUMOR,,187.0,[Not Available],,,,,Progressive Disease,,,1.0,187.0,1.0,187.0,,,1.0,187.0,
TCGA-16-0861,3050,TCGA-16-0861,GBM,65.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-23778.0,,,131.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],94.0,[Not Available],,,0.0,131.0,,131.0,,,1.0,94.0,
TCGA-EW-A1P0,1469,TCGA-EW-A1P0,BRCA,55.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20107.0,Alive,TUMOR FREE,1251.0,,[Not Available],Distant Metastasis,"Other, specify",mediastinal lymph node,1094.0,[Not Available],Negative,,0.0,1251.0,0.0,1251.0,1.0,1094.0,1.0,1094.0,
TCGA-Y8-A8S0,4709,TCGA-Y8-A8S0,KIRP,58.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-21383.0,Alive,TUMOR FREE,183.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,
TCGA-W3-A825,9227,TCGA-W3-A825,SKCM,60.0,FEMALE,WHITE,Stage II,[Not Applicable],,[Not Available],1998.0,[Not Available],-22097.0,Dead,WITH TUMOR,,1917.0,[Not Available],,,,,[Not Available],,,1.0,1917.0,1.0,1917.0,,,1.0,1917.0,
TCGA-EM-A2CJ,10139,TCGA-EM-A2CJ,THCA,49.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-18168.0,Alive,TUMOR FREE,1447.0,,[Not Available],,,,,[Not Available],,R0,0.0,1447.0,0.0,1447.0,0.0,1447.0,0.0,1447.0,
TCGA-HD-7753,3664,TCGA-HD-7753,HNSC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-22774.0,Alive,TUMOR FREE,866.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,866.0,0.0,866.0,0.0,866.0,0.0,866.0,
TCGA-QH-A6CZ,5300,TCGA-QH-A6CZ,LGG,38.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-14007.0,Alive,TUMOR FREE,279.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,279.0,0.0,279.0,,,0.0,279.0,
TCGA-HU-A4G8,9569,TCGA-HU-A4G8,STAD,71.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-26254.0,Alive,TUMOR FREE,690.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,690.0,0.0,690.0,0.0,690.0,0.0,690.0,
TCGA-SC-AA5Z,6872,TCGA-SC-AA5Z,MESO,54.0,MALE,WHITE,Stage IV,[Not Applicable],Epithelioid mesothelioma,[Not Available],2013.0,[Not Available],-19746.0,Alive,WITH TUMOR,664.0,,[Not Available],,,,,[Not Available],,R2,0.0,664.0,0.0,664.0,,,0.0,664.0,
TCGA-A4-7996,4474,TCGA-A4-7996,KIRP,61.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-22559.0,Alive,TUMOR FREE,506.0,,[Not Available],,,,493.0,Complete Remission/Response,,,0.0,506.0,0.0,506.0,1.0,493.0,1.0,493.0,
TCGA-EI-6884,8517,TCGA-EI-6884,READ,71.0,MALE,WHITE,Stage IIIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-25995.0,Alive,TUMOR FREE,328.0,,[Not Available],,,,,[Not Available],,,0.0,328.0,0.0,328.0,,,0.0,328.0,
TCGA-BA-A6DE,3272,TCGA-BA-A6DE,HNSC,70.0,FEMALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-25874.0,Alive,TUMOR FREE,440.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,
TCGA-CJ-4869,4279,TCGA-CJ-4869,KIRC,49.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-17923.0,Alive,WITH TUMOR,2554.0,,[Not Available],,,,1754.0,[Not Available],,,0.0,2554.0,0.0,2554.0,,,1.0,1754.0,
TCGA-EI-6917,8519,TCGA-EI-6917,READ,33.0,MALE,WHITE,Stage IIIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-12113.0,Alive,TUMOR FREE,531.0,,[Not Available],,,,,[Not Available],,,0.0,531.0,0.0,531.0,,,0.0,531.0,
TCGA-OL-A5RW,1558,TCGA-OL-A5RW,BRCA,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14638.0,Alive,TUMOR FREE,1106.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,
TCGA-36-2530,7393,TCGA-36-2530,OV,38.0,FEMALE,ASIAN,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,[Not Available],-13885.0,Alive,WITH TUMOR,1004.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],630.0,Complete Remission/Response,,,0.0,1004.0,0.0,1004.0,1.0,630.0,1.0,630.0,
TCGA-X6-A7WA,8782,TCGA-X6-A7WA,SARC,90.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-32872.0,Alive,TUMOR FREE,1092.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,1092.0,0.0,1092.0,,,0.0,1092.0,
TCGA-ZL-A9V6,10474,TCGA-ZL-A9V6,THYM,61.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type AB,[Not Available],2008.0,[Not Available],-22447.0,Alive,TUMOR FREE,2096.0,,[Not Available],,,,,[Not Available],,,0.0,2096.0,0.0,2096.0,,,0.0,2096.0,
TCGA-AC-A62V,790,TCGA-AC-A62V,BRCA,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,[Not Evaluated],-21389.0,Dead,WITH TUMOR,,348.0,[Not Available],,,,,[Not Available],Negative,,1.0,348.0,1.0,348.0,,,1.0,348.0,
TCGA-GS-A9TZ,2454,TCGA-GS-A9TZ,DLBC,51.0,MALE,WHITE,[Not Applicable],Stage II,Primary mediastinal (thymic) DLBCL,[Not Available],2012.0,[Not Available],-18691.0,Alive,TUMOR FREE,765.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,765.0,0.0,765.0,,,0.0,765.0,
TCGA-BH-A0W7,1112,TCGA-BH-A0W7,BRCA,49.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,[Not Available],-17996.0,Alive,TUMOR FREE,1363.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1363.0,0.0,1363.0,0.0,1363.0,0.0,1363.0,
TCGA-G4-6628,2393,TCGA-G4-6628,COAD,78.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-28772.0,Alive,TUMOR FREE,2424.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2424.0,0.0,2424.0,0.0,2424.0,0.0,2424.0,
TCGA-35-5375,5841,TCGA-35-5375,LUAD,61.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-22628.0,Alive,TUMOR FREE,264.0,,[Not Available],,,,,[Not Available],,,0.0,264.0,0.0,264.0,,,0.0,264.0,
TCGA-HD-A6I0,3677,TCGA-HD-A6I0,HNSC,56.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2013.0,[Not Available],-20491.0,Alive,TUMOR FREE,210.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,210.0,0.0,210.0,,,0.0,210.0,
TCGA-VS-AA62,1889,TCGA-VS-AA62,CESC,51.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2009.0,Peri (6-12 months since last menstrual period),-18792.0,Dead,WITH TUMOR,,469.0,Cervical Cancer,,,,,Progressive Disease,,,1.0,469.0,1.0,469.0,,,1.0,469.0,
TCGA-D8-A1X5,1254,TCGA-D8-A1X5,BRCA,81.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29734.0,Alive,TUMOR FREE,565.0,,[Not Available],,,,,[Not Available],Negative,,0.0,565.0,0.0,565.0,0.0,565.0,0.0,565.0,
TCGA-CV-A45W,3583,TCGA-CV-A45W,HNSC,75.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,[Not Available],-27743.0,Dead,TUMOR FREE,,1398.0,[Not Available],,,,,[Not Available],,,1.0,1398.0,0.0,1398.0,,,0.0,1398.0,
TCGA-AL-3467,4496,TCGA-AL-3467,KIRP,54.0,FEMALE,WHITE,[Not Available],Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005.0,[Not Available],-19783.0,Alive,TUMOR FREE,2135.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2135.0,0.0,2135.0,0.0,2135.0,0.0,2135.0,
TCGA-DD-A3A9,5551,TCGA-DD-A3A9,LIHC,64.0,FEMALE,WHITE,Stage IVB,[Not Applicable],Hepatocellular Carcinoma,G2,2001.0,[Not Available],-23526.0,Dead,WITH TUMOR,,931.0,[Not Available],Extrahepatic Recurrence,Lung,,289.0,[Not Available],,R0,1.0,931.0,1.0,931.0,,,1.0,289.0,
TCGA-85-8584,6735,TCGA-85-8584,LUSC,71.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-26081.0,Dead,TUMOR FREE,,383.0,[Not Available],,,,,Complete Remission/Response,,,1.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-BI-A20A,1606,TCGA-BI-A20A,CESC,49.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2010.0,[Not Available],-18215.0,Alive,TUMOR FREE,720.0,,,,,,,Complete Remission/Response,,,0.0,720.0,0.0,720.0,0.0,720.0,0.0,720.0,
TCGA-55-6979,5982,TCGA-55-6979,LUAD,59.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-21780.0,Dead,WITH TUMOR,,237.0,[Not Available],Distant Metastasis,,,195.0,Progressive Disease,,,1.0,237.0,1.0,237.0,,,1.0,195.0,
TCGA-66-2759,6620,TCGA-66-2759,LUSC,66.0,MALE,[Not Available],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-24287.0,Alive,TUMOR FREE,762.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,
TCGA-AX-A3FZ,10665,TCGA-AX-A3FZ,UCEC,33.0,FEMALE,WHITE,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G3,2010.0,[Not Available],-12331.0,Alive,,6.0,,[Not Available],,,,,[Not Available],,,0.0,6.0,0.0,6.0,,,0.0,6.0,
TCGA-S9-A6WG,5339,TCGA-S9-A6WG,LGG,31.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2007.0,[Not Available],-11509.0,Alive,WITH TUMOR,2602.0,,[Not Available],,,,,Progressive Disease,,,0.0,2602.0,0.0,2602.0,,,0.0,2602.0,
TCGA-R5-A7O7,9619,TCGA-R5-A7O7,STAD,51.0,MALE,WHITE,Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-18984.0,Alive,TUMOR FREE,1389.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1389.0,0.0,1389.0,,,0.0,1389.0,
TCGA-V4-A9F0,11109,TCGA-V4-A9F0,UVM,59.0,MALE,WHITE,Stage IIIB,Stage IIIB,Epithelioid Cell|Spindle Cell,[Not Available],2012.0,[Not Available],-21675.0,Dead,WITH TUMOR,,945.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,,489.0,[Not Available],,,1.0,945.0,1.0,945.0,,,1.0,489.0,
TCGA-WB-A81G,7849,TCGA-WB-A81G,PCPG,25.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-9248.0,Alive,TUMOR FREE,1179.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1179.0,0.0,1179.0,0.0,1179.0,0.0,1179.0,
TCGA-CE-A483,9901,TCGA-CE-A483,THCA,34.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-12768.0,Alive,TUMOR FREE,457.0,,[Not Available],,,,,[Not Available],,R0,0.0,457.0,0.0,457.0,0.0,457.0,0.0,457.0,
TCGA-WB-A80N,7833,TCGA-WB-A80N,PCPG,54.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-19980.0,Alive,TUMOR FREE,144.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,144.0,0.0,144.0,0.0,144.0,0.0,144.0,
TCGA-85-7697,6708,TCGA-85-7697,LUSC,49.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-17921.0,Alive,TUMOR FREE,1063.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1063.0,0.0,1063.0,0.0,1063.0,0.0,1063.0,
TCGA-85-A53L,6751,TCGA-85-A53L,LUSC,63.0,MALE,ASIAN,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-23065.0,Alive,TUMOR FREE,377.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,377.0,0.0,377.0,0.0,377.0,0.0,377.0,
TCGA-R5-A804,9624,TCGA-R5-A804,STAD,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2005.0,[Not Available],-20026.0,Dead,WITH TUMOR,,140.0,[Unknown],,,,,Progressive Disease,,,1.0,140.0,1.0,140.0,,,1.0,140.0,
TCGA-SG-A6Z4,8758,TCGA-SG-A6Z4,SARC,47.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013.0,[Not Available],-17368.0,Alive,WITH TUMOR,576.0,,[Not Available],Distant Metastasis,Lung,,105.0,[Not Available],Negative,R1,0.0,576.0,0.0,576.0,,,1.0,105.0,
TCGA-BP-4977,4214,TCGA-BP-4977,KIRC,57.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-20950.0,Alive,TUMOR FREE,454.0,,[Not Available],,,,,[Not Available],,,0.0,454.0,0.0,454.0,,,0.0,454.0,
TCGA-MP-A4T4,6299,TCGA-MP-A4T4,LUAD,68.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2004.0,[Not Available],-25052.0,Dead,,,2617.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2617.0,,2617.0,0.0,2617.0,0.0,2617.0,
TCGA-BQ-7045,4556,TCGA-BQ-7045,KIRP,78.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2001.0,[Not Available],-28709.0,Dead,TUMOR FREE,,1468.0,[Not Available],,,,,[Not Available],,,1.0,1468.0,0.0,1468.0,,,0.0,1468.0,
TCGA-3U-A98E,6838,TCGA-3U-A98E,MESO,71.0,FEMALE,WHITE,Stage IV,[Not Applicable],Epithelioid mesothelioma,[Not Available],2010.0,[Not Available],-26264.0,Alive,WITH TUMOR,1916.0,,[Not Available],Intrapleural Progression,,,1257.0,[Not Available],,[Not Available],0.0,1916.0,0.0,1916.0,,,1.0,1257.0,
TCGA-2Z-A9JD,4429,TCGA-2Z-A9JD,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-24370.0,Alive,TUMOR FREE,1060.0,,[Not Available],,,,,[Unknown],,,0.0,1060.0,0.0,1060.0,,,0.0,1060.0,
TCGA-D6-6823,3613,TCGA-D6-6823,HNSC,50.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-18611.0,Alive,TUMOR FREE,701.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,701.0,0.0,701.0,0.0,701.0,0.0,701.0,
TCGA-LN-A9FO,2592,TCGA-LN-A9FO,ESCA,42.0,MALE,ASIAN,Stage IIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-15551.0,Alive,TUMOR FREE,4.0,,[Not Available],,,,,,,,0.0,4.0,0.0,4.0,,,0.0,4.0,
TCGA-06-0165,2774,TCGA-06-0165,GBM,52.0,MALE,WHITE,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2001.0,[Not Available],-19198.0,Dead,WITH TUMOR,,324.0,[Not Available],,,,,[Unknown],,,1.0,324.0,1.0,324.0,,,1.0,324.0,
TCGA-68-7756,6649,TCGA-68-7756,LUSC,84.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-30763.0,Alive,,202.0,,[Not Available],,,,,[Not Available],,,0.0,202.0,0.0,202.0,,,0.0,202.0,
TCGA-75-5146,6128,TCGA-75-5146,LUAD,,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],,[Not Available],,Alive,TUMOR FREE,2368.0,,[Not Available],New Primary Tumor,,,1773.0,Complete Remission/Response,,,0.0,2368.0,0.0,2368.0,0.0,2368.0,1.0,1773.0,
TCGA-K7-A5RF,5738,TCGA-K7-A5RF,LIHC,64.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-23557.0,Alive,TUMOR FREE,631.0,,[Not Available],Intrahepatic Recurrence,Liver,,205.0,[Not Available],,R0,0.0,631.0,0.0,631.0,1.0,205.0,1.0,205.0,
TCGA-E2-A15I,1341,TCGA-E2-A15I,BRCA,44.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16163.0,Alive,TUMOR FREE,1692.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1692.0,0.0,1692.0,0.0,1692.0,0.0,1692.0,
TCGA-E9-A1R4,1411,TCGA-E9-A1R4,BRCA,66.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24181.0,Alive,TUMOR FREE,186.0,,[Not Available],,,,,[Not Available],Negative,,0.0,186.0,0.0,186.0,0.0,186.0,0.0,186.0,
TCGA-NJ-A4YG,6315,TCGA-NJ-A4YG,LUAD,65.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-23812.0,Alive,TUMOR FREE,2261.0,,[Not Available],,,,,Stable Disease,,,0.0,2261.0,0.0,2261.0,,,0.0,2261.0,
TCGA-BH-A0H9,1093,TCGA-BH-A0H9,BRCA,69.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25289.0,Alive,TUMOR FREE,1247.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1247.0,0.0,1247.0,0.0,1247.0,0.0,1247.0,
TCGA-EA-A1QT,1693,TCGA-EA-A1QT,CESC,47.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17475.0,Alive,TUMOR FREE,1243.0,,,,,,,Complete Remission/Response,,,0.0,1243.0,0.0,1243.0,0.0,1243.0,0.0,1243.0,
TCGA-DJ-A3V9,9989,TCGA-DJ-A3V9,THCA,50.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-18399.0,Alive,TUMOR FREE,623.0,,[Not Available],,,,,[Not Available],,R0,0.0,623.0,0.0,623.0,,,0.0,623.0,
TCGA-VQ-A928,9691,TCGA-VQ-A928,STAD,49.0,MALE,WHITE,Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2010.0,[Not Available],-18058.0,Dead,WITH TUMOR,,174.0,Stomach Cancer,Distant Metastasis,Liver,,148.0,Progressive Disease,,,1.0,174.0,1.0,174.0,,,1.0,148.0,
TCGA-EL-A3GV,10065,TCGA-EL-A3GV,THCA,65.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-23787.0,Alive,TUMOR FREE,1532.0,,[Not Available],,,,,[Not Available],,R0,0.0,1532.0,0.0,1532.0,0.0,1532.0,0.0,1532.0,
TCGA-HT-8558,5219,TCGA-HT-8558,LGG,29.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-10950.0,Alive,TUMOR FREE,418.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,418.0,0.0,418.0,0.0,418.0,0.0,418.0,
TCGA-C8-A12T,1183,TCGA-C8-A12T,BRCA,43.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],Negative,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-G3-AAV5,5730,TCGA-G3-AAV5,LIHC,67.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-24655.0,Alive,WITH TUMOR,354.0,,[Not Available],Locoregional Recurrence,Liver,,117.0,[Not Available],,R0,0.0,354.0,0.0,354.0,1.0,117.0,1.0,117.0,
TCGA-E2-A14Q,1316,TCGA-E2-A14Q,BRCA,50.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18507.0,Alive,TUMOR FREE,1163.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1163.0,0.0,1163.0,0.0,1163.0,0.0,1163.0,
TCGA-18-4083,6338,TCGA-18-4083,LUSC,63.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-23125.0,Dead,TUMOR FREE,,188.0,[Not Available],,,,,[Unknown],,,1.0,188.0,0.0,188.0,,,0.0,188.0,
TCGA-H2-A3RH,10307,TCGA-H2-A3RH,THCA,41.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-15068.0,Alive,TUMOR FREE,379.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,379.0,0.0,379.0,,,0.0,379.0,
TCGA-AG-3725,8409,TCGA-AG-3725,READ,90.0,FEMALE,[Not Available],Stage III,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2005.0,[Not Available],-32872.0,Alive,TUMOR FREE,638.0,,[Not Available],,,,,[Not Available],,,0.0,638.0,0.0,638.0,,,0.0,638.0,
TCGA-86-7711,6181,TCGA-86-7711,LUAD,70.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25719.0,Dead,WITH TUMOR,,1046.0,[Not Available],,,,,Progressive Disease,,,1.0,1046.0,1.0,1046.0,,,1.0,1046.0,
TCGA-BH-A0B0,1031,TCGA-BH-A0B0,BRCA,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Peri (6-12 months since last menstrual period),-20776.0,Alive,TUMOR FREE,2477.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2477.0,0.0,2477.0,0.0,2477.0,0.0,2477.0,
TCGA-12-5301,2996,TCGA-12-5301,GBM,59.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-21768.0,Dead,WITH TUMOR,62.0,62.0,[Not Available],,,,,[Not Available],,,1.0,62.0,1.0,62.0,,,1.0,62.0,
TCGA-MF-A522,6800,TCGA-MF-A522,LUSC,54.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-20051.0,Dead,WITH TUMOR,,360.0,[Not Available],Distant Metastasis,,,173.0,Partial Remission/Response,,,1.0,360.0,1.0,360.0,,,1.0,173.0,
TCGA-BT-A20U,131,TCGA-BT-A20U,BLCA,70.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-25761.0,Dead,TUMOR FREE,,455.0,[Not Available],,,,,Complete Remission/Response,,,1.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,
TCGA-YU-A90Y,9831,TCGA-YU-A90Y,TGCT,23.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Stage IIIC,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2011.0,[Not Available],-8460.0,Dead,WITH TUMOR,,17.0,Testicular Germ Cell Tumor (TGCT),,,,,,,,1.0,17.0,1.0,17.0,,,1.0,17.0,
TCGA-C8-A12M,1178,TCGA-C8-A12M,BRCA,70.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25811.0,Alive,TUMOR FREE,358.0,,[Not Available],,,,,[Not Available],Negative,,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,
TCGA-75-5122,6125,TCGA-75-5122,LUAD,,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],,Dead,WITH TUMOR,,,[Not Available],,,,,Complete Remission/Response,,,1.0,,1.0,,,,1.0,,
TCGA-FD-A5BR,281,TCGA-FD-A5BR,BLCA,57.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-20964.0,Alive,TUMOR FREE,813.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,813.0,0.0,813.0,0.0,813.0,0.0,813.0,
TCGA-BR-A4J8,9406,TCGA-BR-A4J8,STAD,71.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-26048.0,Alive,TUMOR FREE,411.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,411.0,0.0,411.0,0.0,411.0,0.0,411.0,
TCGA-EO-A1Y8,10921,TCGA-EO-A1Y8,UCEC,87.0,FEMALE,[Not Available],[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31971.0,Alive,TUMOR FREE,1147.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1147.0,0.0,1147.0,0.0,1147.0,0.0,1147.0,
TCGA-VT-A80G,8768,TCGA-VT-A80G,SARC,66.0,MALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013.0,[Not Available],-24128.0,Alive,WITH TUMOR,326.0,,[Not Available],Distant Metastasis,Lung,,26.0,[Not Available],Negative,R0,0.0,326.0,0.0,326.0,1.0,26.0,1.0,26.0,
TCGA-77-8156,6691,TCGA-77-8156,LUSC,60.0,MALE,[Not Evaluated],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-22198.0,Alive,,1106.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,
TCGA-B6-A401,1020,TCGA-B6-A401,BRCA,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,[Unknown],-17438.0,Alive,TUMOR FREE,2596.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2596.0,0.0,2596.0,0.0,2596.0,0.0,2596.0,
TCGA-B6-A0RP,995,TCGA-B6-A0RP,BRCA,73.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Mixed Histology (please specify),[Not Available],1994.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26941.0,Dead,WITH TUMOR,,3126.0,[Not Available],Distant Metastasis,Bone,,2787.0,[Not Available],Negative,,1.0,3126.0,1.0,3126.0,1.0,2787.0,1.0,2787.0,
TCGA-BR-8382,9367,TCGA-BR-8382,STAD,67.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-24737.0,Dead,TUMOR FREE,,762.0,[Not Available],,,,,Complete Remission/Response,,,1.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,
TCGA-85-A4JC,6741,TCGA-85-A4JC,LUSC,84.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-30942.0,Dead,WITH TUMOR,,604.0,[Not Available],Locoregional Recurrence,,,548.0,Complete Remission/Response,,,1.0,604.0,1.0,604.0,1.0,548.0,1.0,548.0,
TCGA-EJ-5517,7931,TCGA-EJ-5517,PRAD,55.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-20422.0,Alive,TUMOR FREE,1889.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1889.0,0.0,1889.0,0.0,1889.0,0.0,1889.0,
TCGA-ET-A3DQ,10242,TCGA-ET-A3DQ,THCA,43.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2008.0,[Not Available],-15871.0,Alive,TUMOR FREE,2581.0,,[Not Available],,,,,[Not Available],,R0,0.0,2581.0,0.0,2581.0,0.0,2581.0,0.0,2581.0,
TCGA-C5-A1M7,1619,TCGA-C5-A1M7,CESC,37.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1999.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13808.0,Alive,TUMOR FREE,1409.0,,,,,,,Complete Remission/Response,,,0.0,1409.0,0.0,1409.0,0.0,1409.0,0.0,1409.0,
TCGA-97-8176,6259,TCGA-97-8176,LUAD,63.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-23170.0,Dead,TUMOR FREE,,468.0,[Not Available],Distant Metastasis,,,39.0,Stable Disease,,,1.0,468.0,0.0,468.0,,,1.0,39.0,
TCGA-CH-5762,7894,TCGA-CH-5762,PRAD,60.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2005.0,[Not Available],-22068.0,Alive,[Discrepancy],1339.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1339.0,0.0,1339.0,0.0,1339.0,0.0,1339.0,
TCGA-76-6661,3231,TCGA-76-6661,GBM,54.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-19965.0,Dead,WITH TUMOR,,727.0,[Not Available],,,,,[Unknown],,,1.0,727.0,1.0,727.0,,,1.0,727.0,
TCGA-QQ-A8VB,8751,TCGA-QQ-A8VB,SARC,68.0,FEMALE,WHITE,[Not Available],[Not Available],Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],1998.0,[Not Available],-24916.0,Alive,TUMOR FREE,5723.0,,[Not Available],New Primary Tumor,"Other, specify",gastrointestinal,2682.0,[Not Available],Negative,RX,0.0,5723.0,0.0,5723.0,,,1.0,2682.0,
TCGA-WC-A87Y,11145,TCGA-WC-A87Y,UVM,59.0,MALE,WHITE,[Not Available],Stage IIIA,Spindle Cell|Epithelioid Cell,[Not Available],2011.0,[Not Available],-21865.0,Dead,TUMOR FREE,,1314.0,Metastatic Uveal Melanoma,,,,,[Not Available],,,1.0,1314.0,1.0,1314.0,,,0.0,1314.0,
TCGA-EL-A4JV,10105,TCGA-EL-A4JV,THCA,41.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-15065.0,Alive,TUMOR FREE,1748.0,,[Not Available],,,,,[Not Available],,R0,0.0,1748.0,0.0,1748.0,0.0,1748.0,0.0,1748.0,
TCGA-WC-AA9A,11154,TCGA-WC-AA9A,UVM,70.0,FEMALE,WHITE,Stage IIA,Stage IIA,Spindle Cell,[Not Available],2011.0,[Not Available],-25641.0,Dead,WITH TUMOR,,453.0,Metastatic Uveal Melanoma,Distant Metastasis,Skin,,371.0,[Not Available],,,1.0,453.0,1.0,453.0,,,1.0,371.0,
TCGA-EL-A3ZR,10102,TCGA-EL-A3ZR,THCA,46.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-16852.0,Alive,TUMOR FREE,1830.0,,[Not Available],,,,,[Not Available],,R0,0.0,1830.0,0.0,1830.0,0.0,1830.0,0.0,1830.0,
TCGA-CV-7411,3552,TCGA-CV-7411,HNSC,64.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,1994.0,[Not Available],-23696.0,Dead,,,2717.0,[Not Available],,,,,[Not Available],,,1.0,2717.0,,2717.0,,,0.0,2717.0,
TCGA-BR-6707,9314,TCGA-BR-6707,STAD,75.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-27529.0,Alive,WITH TUMOR,491.0,,[Not Available],Locoregional Recurrence,,,426.0,Complete Remission/Response,,,0.0,491.0,0.0,491.0,1.0,426.0,1.0,426.0,
TCGA-YL-A8SH,8327,TCGA-YL-A8SH,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-25395.0,Dead,TUMOR FREE,,875.0,"Other, non-malignant disease",,,,,Complete Remission/Response,,,1.0,875.0,0.0,875.0,0.0,875.0,0.0,875.0,
TCGA-B8-A54F,4117,TCGA-B8-A54F,KIRC,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2012.0,[Not Available],-18028.0,Alive,TUMOR FREE,519.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,
TCGA-NC-A5HK,6808,TCGA-NC-A5HK,LUSC,58.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-21531.0,Alive,TUMOR FREE,128.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,128.0,0.0,128.0,0.0,128.0,0.0,128.0,
TCGA-FY-A40N,10299,TCGA-FY-A40N,THCA,55.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-20320.0,Alive,TUMOR FREE,579.0,,[Not Available],,,,,[Not Available],,R0,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,
TCGA-DK-A2I2,193,TCGA-DK-A2I2,BLCA,63.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-23116.0,Dead,WITH TUMOR,,237.0,[Not Available],Distant Metastasis,Liver,,163.0,Complete Remission/Response,,,1.0,237.0,1.0,237.0,,,1.0,163.0,
TCGA-BR-4362,9293,TCGA-BR-4362,STAD,74.0,FEMALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-27179.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-DK-AA74,228,TCGA-DK-AA74,BLCA,75.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-27730.0,Alive,TUMOR FREE,1708.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1708.0,0.0,1708.0,0.0,1708.0,0.0,1708.0,
TCGA-FB-AAPQ,7560,TCGA-FB-AAPQ,PAAD,65.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,[Not Available],-24078.0,Dead,,,1130.0,,,,,,Progressive Disease,,,1.0,1130.0,,1130.0,,,0.0,1130.0,
TCGA-B0-4810,3983,TCGA-B0-4810,KIRC,47.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2001.0,[Not Available],-17402.0,Dead,WITH TUMOR,,478.0,[Not Available],,,,205.0,[Not Available],,,1.0,478.0,1.0,478.0,,,1.0,205.0,
TCGA-34-2596,6418,TCGA-34-2596,LUSC,70.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-25574.0,Dead,TUMOR FREE,80.0,80.0,[Not Available],,,,,Complete Remission/Response,,,1.0,80.0,0.0,80.0,0.0,80.0,0.0,80.0,
TCGA-CJ-4905,4309,TCGA-CJ-4905,KIRC,62.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-22864.0,Alive,TUMOR FREE,1496.0,,[Not Available],,,,,[Not Available],,,0.0,1496.0,0.0,1496.0,,,0.0,1496.0,
TCGA-SX-A7SO,4676,TCGA-SX-A7SO,KIRP,64.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-23534.0,Alive,TUMOR FREE,1257.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1257.0,0.0,1257.0,0.0,1257.0,0.0,1257.0,
TCGA-HD-A634,3675,TCGA-HD-A634,HNSC,56.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-20810.0,Dead,WITH TUMOR,,130.0,[Not Available],,,,,[Unknown],,,1.0,130.0,1.0,130.0,,,1.0,130.0,
TCGA-34-5239,6428,TCGA-34-5239,LUSC,75.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-27528.0,Alive,WITH TUMOR,1834.0,,[Not Available],Distant Metastasis,,,1530.0,Complete Remission/Response,,,0.0,1834.0,0.0,1834.0,1.0,1530.0,1.0,1530.0,
TCGA-E9-A1NE,1402,TCGA-E9-A1NE,BRCA,28.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10564.0,Alive,TUMOR FREE,1088.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1088.0,0.0,1088.0,0.0,1088.0,0.0,1088.0,
TCGA-QM-A5NM,11079,TCGA-QM-A5NM,UCS,67.0,FEMALE,WHITE,[Not Applicable],Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24781.0,Alive,WITH TUMOR,587.0,,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,153.0,[Unknown],,,0.0,587.0,0.0,587.0,,,1.0,153.0,
TCGA-QR-A70C,7722,TCGA-QR-A70C,PCPG,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2004.0,[Not Available],-18628.0,Alive,TUMOR FREE,3534.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3534.0,0.0,3534.0,0.0,3534.0,0.0,3534.0,
TCGA-PG-A916,11012,TCGA-PG-A916,UCEC,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25617.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,522.0,0.0,522.0,0.0,522.0,0.0,522.0,
TCGA-33-AASD,6414,TCGA-33-AASD,LUSC,83.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2001.0,[Not Available],-30623.0,Dead,WITH TUMOR,,3376.0,[Not Available],Locoregional Recurrence,,,1912.0,Progressive Disease,,,1.0,3376.0,1.0,3376.0,,,1.0,1912.0,
TCGA-39-5022,6456,TCGA-39-5022,LUSC,76.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-27856.0,Dead,TUMOR FREE,,1679.0,[Not Available],,,,1448.0,[Not Available],,,1.0,1679.0,0.0,1679.0,,,1.0,1448.0,
TCGA-DS-A5RQ,1688,TCGA-DS-A5RQ,CESC,80.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29526.0,Alive,TUMOR FREE,512.0,,,,,,,Complete Remission/Response,,,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,
TCGA-IN-7808,9593,TCGA-IN-7808,STAD,59.0,MALE,WHITE,[Discrepancy],[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-21569.0,Dead,WITH TUMOR,,105.0,[Not Available],,,,,Progressive Disease,,,1.0,105.0,1.0,105.0,,,1.0,105.0,
TCGA-YZ-A982,11157,TCGA-YZ-A982,UVM,79.0,FEMALE,WHITE,Stage IIIB,Stage IIIB,Spindle Cell,[Not Available],2013.0,[Not Available],-28938.0,Alive,TUMOR FREE,495.0,,[Not Available],,,,,[Not Available],,,0.0,495.0,0.0,495.0,,,0.0,495.0,
TCGA-BR-A4CR,9394,TCGA-BR-A4CR,STAD,70.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-25669.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-AJ-A8CV,10560,TCGA-AJ-A8CV,UCEC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21336.0,Alive,TUMOR FREE,1068.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1068.0,0.0,1068.0,0.0,1068.0,0.0,1068.0,
TCGA-06-0650,2826,TCGA-06-0650,GBM,39.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-14560.0,Dead,WITH TUMOR,717.0,717.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],351.0,[Not Available],,,1.0,717.0,1.0,717.0,,,1.0,351.0,
TCGA-AJ-A5DW,10557,TCGA-AJ-A5DW,UCEC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20711.0,Alive,TUMOR FREE,390.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,390.0,0.0,390.0,0.0,390.0,0.0,390.0,
TCGA-C5-A8XI,1660,TCGA-C5-A8XI,CESC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25220.0,Alive,TUMOR FREE,254.0,,,,,,,[Not Available],,,0.0,254.0,0.0,254.0,,,0.0,254.0,
TCGA-DI-A1NO,10906,TCGA-DI-A1NO,UCEC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24996.0,Dead,WITH TUMOR,,285.0,[Not Available],,,,,Complete Remission/Response,,,1.0,285.0,1.0,285.0,,,1.0,285.0,
TCGA-DJ-A2PO,9941,TCGA-DJ-A2PO,THCA,54.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-20058.0,Alive,TUMOR FREE,243.0,,[Not Available],,,,,[Not Available],,R0,0.0,243.0,0.0,243.0,0.0,243.0,0.0,243.0,
TCGA-NF-A5CP,11076,TCGA-NF-A5CP,UCS,90.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871.0,Dead,WITH TUMOR,,167.0,[Not Available],Progression of Disease,"Other, specify","systemic, lung",106.0,Progressive Disease,,,1.0,167.0,1.0,167.0,,,1.0,106.0,
TCGA-Q9-A6FU,2597,TCGA-Q9-A6FU,ESCA,57.0,FEMALE,WHITE,Stage IIIB,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21108.0,Dead,WITH TUMOR,,157.0,[Not Available],Distant Metastasis,Liver,,99.0,,,,1.0,157.0,1.0,157.0,,,1.0,99.0,
TCGA-55-6642,5973,TCGA-55-6642,LUAD,63.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-23107.0,Alive,TUMOR FREE,2449.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2449.0,0.0,2449.0,0.0,2449.0,0.0,2449.0,
TCGA-IB-AAUN,7647,TCGA-IB-AAUN,PAAD,74.0,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-27128.0,Dead,,,144.0,,Locoregional Recurrence,"Other, specify",,131.0,Complete Remission/Response,,,1.0,144.0,,144.0,1.0,131.0,1.0,131.0,
TCGA-36-2533,7395,TCGA-36-2533,OV,55.0,FEMALE,[Not Available],[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,[Not Available],-20187.0,,,0.0,,[Not Available],,,,,[Not Available],,,,,,,,,0.0,,
TCGA-S9-A6U2,5330,TCGA-S9-A6U2,LGG,48.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-17800.0,Alive,WITH TUMOR,908.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,908.0,0.0,908.0,,,0.0,908.0,
TCGA-CV-A45U,3581,TCGA-CV-A45U,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,1999.0,[Not Available],-21746.0,Dead,WITH TUMOR,,1079.0,[Not Available],,Distant Metastasis,pelvis,1064.0,Complete Remission/Response,,,1.0,1079.0,1.0,1079.0,,,1.0,1064.0,
TCGA-HZ-7925,7595,TCGA-HZ-7925,PAAD,66.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-24150.0,Dead,WITH TUMOR,,614.0,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",Regional LNs,364.0,Complete Remission/Response,,,1.0,614.0,1.0,614.0,1.0,364.0,1.0,364.0,
TCGA-AD-6901,2193,TCGA-AD-6901,COAD,78.0,MALE,WHITE,[Not Available],[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-28579.0,Dead,WITH TUMOR,,682.0,[Not Available],Metastatic,,,468.0,Complete Remission/Response,,,1.0,682.0,1.0,682.0,1.0,468.0,1.0,468.0,
TCGA-BJ-A45G,9888,TCGA-BJ-A45G,THCA,48.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-17831.0,Alive,TUMOR FREE,725.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,725.0,0.0,725.0,,,0.0,725.0,
TCGA-YL-A8SJ,8329,TCGA-YL-A8SJ,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-21916.0,Alive,WITH TUMOR,1395.0,,[Not Available],Biochemical evidence of disease,,,752.0,Complete Remission/Response,,,0.0,1395.0,0.0,1395.0,1.0,752.0,1.0,752.0,
TCGA-DU-7290,5021,TCGA-DU-7290,LGG,45.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,1995.0,[Not Available],-16667.0,Dead,WITH TUMOR,,315.0,[Not Available],,,,,[Not Available],,,1.0,315.0,1.0,315.0,,,1.0,315.0,
TCGA-A4-8098,4476,TCGA-A4-8098,KIRP,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-26685.0,Alive,TUMOR FREE,896.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,896.0,0.0,896.0,0.0,896.0,0.0,896.0,
TCGA-EJ-A46B,7977,TCGA-EJ-A46B,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24305.0,Alive,TUMOR FREE,657.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,657.0,0.0,657.0,0.0,657.0,0.0,657.0,
TCGA-ZC-AAAA,10471,TCGA-ZC-AAAA,THYM,39.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type B2,[Not Available],2012.0,[Not Available],-14429.0,Alive,TUMOR FREE,819.0,,[Not Available],Locoregional Recurrence,"Other, specify",Mediastinum,137.0,[Not Available],,,0.0,819.0,0.0,819.0,,,1.0,137.0,
TCGA-AC-A3OD,775,TCGA-AC-A3OD,BRCA,68.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25186.0,Alive,TUMOR FREE,451.0,,[Not Available],,,,,[Not Available],Negative,,0.0,451.0,0.0,451.0,0.0,451.0,0.0,451.0,
TCGA-QR-A6H4,7710,TCGA-QR-A6H4,PCPG,56.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2007.0,[Not Available],-20492.0,Alive,TUMOR FREE,2661.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2661.0,0.0,2661.0,0.0,2661.0,0.0,2661.0,
TCGA-ZF-AA4U,492,TCGA-ZF-AA4U,BLCA,70.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-25682.0,Dead,WITH TUMOR,,262.0,[Not Available],Distant Metastasis,Bone,,199.0,Progressive Disease,,,1.0,262.0,1.0,262.0,,,1.0,199.0,
TCGA-36-2545,7403,TCGA-36-2545,OV,42.0,FEMALE,[Not Available],[Not Applicable],Stage IIIA,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-15444.0,Alive,TUMOR FREE,557.0,,[Not Available],,,,,[Not Available],,,0.0,557.0,0.0,557.0,,,0.0,557.0,
TCGA-AY-A54L,2209,TCGA-AY-A54L,COAD,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2012.0,[Not Available],-27074.0,Alive,WITH TUMOR,525.0,,[Not Available],,,,396.0,Complete Remission/Response,,,0.0,525.0,0.0,525.0,1.0,396.0,1.0,396.0,
TCGA-D1-A1NZ,10879,TCGA-D1-A1NZ,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22027.0,Alive,TUMOR FREE,548.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,548.0,0.0,548.0,0.0,548.0,0.0,548.0,
TCGA-B6-A0RL,991,TCGA-B6-A0RL,BRCA,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1993.0,[Not Available],-22238.0,Dead,TUMOR FREE,,2469.0,[Not Available],,,,,[Not Available],Negative,,1.0,2469.0,0.0,2469.0,0.0,2469.0,0.0,2469.0,
TCGA-CN-A640,3368,TCGA-CN-A640,HNSC,40.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-14758.0,Dead,TUMOR FREE,,134.0,[Not Available],,,,,Complete Remission/Response,,,1.0,134.0,0.0,134.0,,,0.0,134.0,
TCGA-DX-A7EL,8625,TCGA-DX-A7EL,SARC,56.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2007.0,[Not Available],-20767.0,Alive,TUMOR FREE,2291.0,,[Not Available],Distant Metastasis,Lung,,2249.0,[Not Available],Positive,R0,0.0,2291.0,0.0,2291.0,1.0,2249.0,1.0,2249.0,
TCGA-ZG-A8QX,8344,TCGA-ZG-A8QX,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-20683.0,Alive,TUMOR FREE,442.0,,[Not Available],,,,,Stable Disease,,,0.0,442.0,0.0,442.0,,,0.0,442.0,
TCGA-D8-A1XQ,1270,TCGA-D8-A1XQ,BRCA,69.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25345.0,Alive,TUMOR FREE,499.0,,[Not Available],,,,,[Not Available],Negative,,0.0,499.0,0.0,499.0,0.0,499.0,0.0,499.0,
TCGA-BJ-A28T,9867,TCGA-BJ-A28T,THCA,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-12698.0,Alive,TUMOR FREE,1081.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,1081.0,0.0,1081.0,,,0.0,1081.0,
TCGA-B0-4710,3978,TCGA-B0-4710,KIRC,75.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-27396.0,Alive,TUMOR FREE,1755.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1755.0,0.0,1755.0,0.0,1755.0,0.0,1755.0,
TCGA-XU-AAXW,10435,TCGA-XU-AAXW,THYM,39.0,FEMALE,ASIAN,[Not Applicable],IIa,Thymoma; Type B2,[Not Available],2004.0,[Not Available],-14408.0,Alive,TUMOR FREE,3762.0,,[Not Available],,,,,[Not Available],,,0.0,3762.0,0.0,3762.0,,,0.0,3762.0,
TCGA-96-A4JL,6780,TCGA-96-A4JL,LUSC,78.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-28686.0,Alive,TUMOR FREE,842.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,
TCGA-HC-8262,8103,TCGA-HC-8262,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-20946.0,Alive,TUMOR FREE,679.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,
TCGA-06-0875,2834,TCGA-06-0875,GBM,61.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-22312.0,Alive,TUMOR FREE,1322.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],279.0,[Not Available],,,0.0,1322.0,0.0,1322.0,,,1.0,279.0,
TCGA-63-7021,6589,TCGA-63-7021,LUSC,,MALE,[Not Available],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],,Alive,TUMOR FREE,2142.0,,[Not Available],New Primary Tumor,,,1503.0,Complete Remission/Response,,,0.0,2142.0,0.0,2142.0,0.0,2142.0,1.0,1503.0,
TCGA-44-6777,5880,TCGA-44-6777,LUAD,85.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-31234.0,Dead,TUMOR FREE,,987.0,[Not Available],,,,,Complete Remission/Response,,,1.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,
TCGA-OR-A5L3,58,TCGA-OR-A5L3,ACC,67.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-24763.0,Alive,TUMOR FREE,4628.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4628.0,0.0,4628.0,0.0,4628.0,0.0,4628.0,
TCGA-AR-A5QM,964,TCGA-AR-A5QM,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22780.0,Alive,TUMOR FREE,2231.0,,[Not Available],New Primary Tumor,"Other, specify",Malignant melanoma,968.0,[Not Available],[Not Available],,0.0,2231.0,0.0,2231.0,,,1.0,968.0,
TCGA-92-8064,6764,TCGA-92-8064,LUSC,58.0,MALE,WHITE,[Discrepancy],[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-21417.0,Alive,TUMOR FREE,160.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,160.0,0.0,160.0,0.0,160.0,0.0,160.0,
TCGA-RW-A68A,7768,TCGA-RW-A68A,PCPG,19.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-7248.0,Alive,TUMOR FREE,762.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,
TCGA-OR-A5LJ,73,TCGA-OR-A5LJ,ACC,54.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2005.0,[Not Available],-20069.0,Dead,WITH TUMOR,,1105.0,[Not Available],Distant Metastasis,Lung,,98.0,Progressive Disease,,,1.0,1105.0,1.0,1105.0,,,1.0,98.0,
TCGA-WY-A85A,5421,TCGA-WY-A85A,LGG,20.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2010.0,[Not Available],-7380.0,Alive,TUMOR FREE,1320.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1320.0,0.0,1320.0,,,0.0,1320.0,
TCGA-E2-A576,1391,TCGA-E2-A576,BRCA,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25350.0,Alive,TUMOR FREE,1043.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1043.0,0.0,1043.0,0.0,1043.0,0.0,1043.0,
TCGA-HB-A43Z,8686,TCGA-HB-A43Z,SARC,58.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-21233.0,Alive,WITH TUMOR,1126.0,,[Not Available],Distant Metastasis,Lung,,894.0,[Not Available],Negative,R0,0.0,1126.0,0.0,1126.0,1.0,894.0,1.0,894.0,
TCGA-HT-7473,5146,TCGA-HT-7473,LGG,28.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2010.0,[Not Available],-10306.0,Alive,TUMOR FREE,503.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,503.0,0.0,503.0,0.0,503.0,0.0,503.0,
TCGA-CK-4948,2245,TCGA-CK-4948,COAD,45.0,FEMALE,WHITE,Stage III,[Not Applicable],Colon Adenocarcinoma,[Not Available],2002.0,[Not Available],-16736.0,Alive,TUMOR FREE,4502.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4502.0,0.0,4502.0,0.0,4502.0,0.0,4502.0,
TCGA-EJ-5506,7921,TCGA-EJ-5506,PRAD,67.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-24617.0,Alive,TUMOR FREE,1381.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1381.0,0.0,1381.0,0.0,1381.0,0.0,1381.0,
TCGA-XV-A9VZ,9252,TCGA-XV-A9VZ,SKCM,90.0,FEMALE,WHITE,Stage II,[Not Applicable],,[Not Available],2013.0,[Not Available],-32873.0,Alive,TUMOR FREE,11.0,,[Not Available],,,,,[Not Available],,,0.0,11.0,0.0,11.0,,,0.0,11.0,
TCGA-FY-A3I4,10281,TCGA-FY-A3I4,THCA,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-12677.0,Alive,TUMOR FREE,542.0,,[Not Available],,,,,[Not Available],,R0,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,
TCGA-S6-A8JW,9781,TCGA-S6-A8JW,TGCT,37.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],2013.0,[Not Available],-13861.0,Alive,TUMOR FREE,698.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,698.0,0.0,698.0,0.0,698.0,0.0,698.0,
TCGA-BP-5196,4261,TCGA-BP-5196,KIRC,53.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2008.0,[Not Available],-19719.0,Alive,TUMOR FREE,1018.0,,[Not Available],,,,,[Not Available],,,0.0,1018.0,0.0,1018.0,,,0.0,1018.0,
TCGA-CM-5863,2273,TCGA-CM-5863,COAD,60.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-22127.0,Alive,TUMOR FREE,457.0,,[Not Available],,,,,[Not Available],,,0.0,457.0,0.0,457.0,,,0.0,457.0,
TCGA-FY-A3R7,10288,TCGA-FY-A3R7,THCA,50.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-18403.0,Alive,TUMOR FREE,495.0,,[Not Available],,,,,[Not Available],,[Unknown],0.0,495.0,0.0,495.0,,,0.0,495.0,
TCGA-19-5954,3093,TCGA-19-5954,GBM,72.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-26355.0,Dead,WITH TUMOR,,368.0,[Not Available],,,,,Stable Disease,,,1.0,368.0,1.0,368.0,,,1.0,368.0,
TCGA-CD-8529,9427,TCGA-CD-8529,STAD,65.0,MALE,ASIAN,Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2011.0,[Not Available],-23979.0,Alive,TUMOR FREE,374.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,374.0,0.0,374.0,,,0.0,374.0,
TCGA-FD-A3SQ,272,TCGA-FD-A3SQ,BLCA,62.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-22687.0,Dead,WITH TUMOR,,1423.0,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",sigmoid colon,991.0,Stable Disease,,,1.0,1423.0,1.0,1423.0,,,1.0,991.0,
TCGA-MQ-A6BQ,6862,TCGA-MQ-A6BQ,MESO,58.0,MALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],2009.0,[Not Available],-21236.0,Alive,WITH TUMOR,2359.0,,[Not Available],,,,,[Not Available],,R1,0.0,2359.0,0.0,2359.0,,,0.0,2359.0,
TCGA-SG-A6Z7,8759,TCGA-SG-A6Z7,SARC,44.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2004.0,[Not Available],-16188.0,Dead,TUMOR FREE,,118.0,[Not Available],,,,,[Not Available],[Unknown],RX,1.0,118.0,0.0,118.0,,,0.0,118.0,
TCGA-D1-A1NX,10877,TCGA-D1-A1NX,UCEC,66.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24441.0,Alive,WITH TUMOR,555.0,,[Not Available],Metastatic,"Other, specify",Supraclavicular lymphnodes,476.0,Complete Remission/Response,,,0.0,555.0,0.0,555.0,1.0,476.0,1.0,476.0,
TCGA-D6-A6EN,3624,TCGA-D6-A6EN,HNSC,71.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-26294.0,Alive,TUMOR FREE,687.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,687.0,0.0,687.0,0.0,687.0,0.0,687.0,
TCGA-91-6831,6215,TCGA-91-6831,LUAD,66.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-24436.0,Alive,TUMOR FREE,310.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,310.0,0.0,310.0,0.0,310.0,0.0,310.0,
TCGA-AR-A24Z,947,TCGA-AR-A24Z,BRCA,57.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20900.0,Alive,TUMOR FREE,3001.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3001.0,0.0,3001.0,0.0,3001.0,0.0,3001.0,
TCGA-EM-A4FR,10197,TCGA-EM-A4FR,THCA,28.0,MALE,[Unknown],Stage I,[Not Applicable],"Other, specify",[Not Available],2012.0,[Not Available],-10316.0,Alive,TUMOR FREE,655.0,,[Not Available],,,,,[Not Available],,R0,0.0,655.0,0.0,655.0,0.0,655.0,0.0,655.0,
TCGA-G9-6347,8022,TCGA-G9-6347,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-21721.0,Alive,TUMOR FREE,2089.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2089.0,0.0,2089.0,0.0,2089.0,0.0,2089.0,
TCGA-AY-6196,2206,TCGA-AY-6196,COAD,47.0,MALE,WHITE,Stage IIIC,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-17311.0,Alive,TUMOR FREE,6.0,,[Not Available],,,,,[Not Available],,,0.0,6.0,0.0,6.0,,,0.0,6.0,
TCGA-ER-A19E,9098,TCGA-ER-A19E,SKCM,36.0,FEMALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2008.0,[Not Available],-13297.0,Dead,WITH TUMOR,,396.0,[Not Available],Regional lymph node,"Other, Specify",Cervical lymphnode,64.0,[Not Available],,,1.0,396.0,1.0,396.0,,,1.0,64.0,
TCGA-ZF-A9RG,485,TCGA-ZF-A9RG,BLCA,70.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-25656.0,Alive,WITH TUMOR,1786.0,,[Not Available],Distant Metastasis,"Other, specify",neck lymph node,440.0,Complete Remission/Response,,,0.0,1786.0,0.0,1786.0,1.0,440.0,1.0,440.0,
TCGA-CN-A6V1,3372,TCGA-CN-A6V1,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2013.0,[Not Available],-21730.0,Alive,TUMOR FREE,603.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,603.0,0.0,603.0,,,0.0,603.0,
TCGA-ZG-A9L5,8352,TCGA-ZG-A9L5,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21293.0,Alive,WITH TUMOR,908.0,,[Not Available],,,,,Progressive Disease,,,0.0,908.0,0.0,908.0,,,0.0,908.0,
TCGA-DK-A2I6,195,TCGA-DK-A2I6,BLCA,81.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,[Not Available],-29789.0,Alive,TUMOR FREE,2656.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2656.0,0.0,2656.0,,,0.0,2656.0,
TCGA-G7-6795,4598,TCGA-G7-6795,KIRP,56.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-20478.0,Alive,TUMOR FREE,1194.0,,[Not Available],,,,,[Not Available],,,0.0,1194.0,0.0,1194.0,,,0.0,1194.0,
TCGA-CJ-5672,4319,TCGA-CJ-5672,KIRC,84.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2004.0,[Not Available],-30900.0,Dead,TUMOR FREE,,2190.0,[Not Available],,,,,[Not Available],,,1.0,2190.0,0.0,2190.0,,,0.0,2190.0,
TCGA-22-5473,6384,TCGA-22-5473,LUSC,78.0,MALE,WHITE,[Discrepancy],[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-28826.0,Dead,TUMOR FREE,,1933.0,[Not Available],,,,1655.0,Complete Remission/Response,,,1.0,1933.0,0.0,1933.0,1.0,1655.0,1.0,1655.0,
TCGA-77-A5G3,6694,TCGA-77-A5G3,LUSC,63.0,MALE,[Not Evaluated],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-23171.0,Alive,TUMOR FREE,4570.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4570.0,0.0,4570.0,0.0,4570.0,0.0,4570.0,
TCGA-MK-A4N9,10349,TCGA-MK-A4N9,THCA,41.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-15255.0,Alive,TUMOR FREE,919.0,,[Not Available],,,,,[Not Available],,R0,0.0,919.0,0.0,919.0,0.0,919.0,0.0,919.0,
TCGA-97-7547,6248,TCGA-97-7547,LUAD,67.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-24737.0,Alive,WITH TUMOR,1965.0,,[Not Available],,,,775.0,Progressive Disease,,,0.0,1965.0,0.0,1965.0,,,1.0,775.0,
TCGA-IB-7654,7625,TCGA-IB-7654,PAAD,80.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,[Not Available],-29292.0,Dead,WITH TUMOR,,476.0,Other malignancy,,,,,Progressive Disease,,,1.0,476.0,0.0,476.0,,,1.0,476.0,
TCGA-BH-A0W4,1110,TCGA-BH-A0W4,BRCA,46.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,[Not Available],-16911.0,Alive,TUMOR FREE,759.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,759.0,0.0,759.0,,,0.0,759.0,
TCGA-FE-A22Z,10256,TCGA-FE-A22Z,THCA,61.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2007.0,[Not Available],-22286.0,Alive,WITH TUMOR,2243.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,1215.0,[Not Available],,R0,0.0,2243.0,0.0,2243.0,,,1.0,1215.0,
TCGA-CN-4726,3305,TCGA-CN-4726,HNSC,68.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-25194.0,Dead,WITH TUMOR,,142.0,[Not Available],,Distant Metastasis,SKIN NECK,79.0,Progressive Disease,,,1.0,142.0,1.0,142.0,,,1.0,79.0,
TCGA-06-0185,2789,TCGA-06-0185,GBM,54.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-19923.0,Alive,WITH TUMOR,2246.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],711.0,[Not Available],,,0.0,2246.0,0.0,2246.0,,,1.0,711.0,
TCGA-GN-A263,9193,TCGA-GN-A263,SKCM,24.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2004.0,[Not Available],-8952.0,Dead,WITH TUMOR,,467.0,[Not Available],Distant Metastasis,Liver,,39.0,[Not Available],,,1.0,467.0,1.0,467.0,,,1.0,39.0,
TCGA-UF-A71E,3754,TCGA-UF-A71E,HNSC,63.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2010.0,[Not Available],-23071.0,Dead,TUMOR FREE,,1504.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1504.0,0.0,1504.0,,,0.0,1504.0,
TCGA-D1-A177,10857,TCGA-D1-A177,UCEC,70.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25602.0,Alive,TUMOR FREE,548.0,,[Not Available],Locoregional Disease,"Other, specify",paraaortic lymph nodes,347.0,Complete Remission/Response,,,0.0,548.0,0.0,548.0,1.0,347.0,1.0,347.0,
TCGA-E2-A14V,1321,TCGA-E2-A14V,BRCA,53.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19643.0,Alive,TUMOR FREE,1042.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1042.0,0.0,1042.0,0.0,1042.0,0.0,1042.0,
TCGA-G3-AAV2,5727,TCGA-G3-AAV2,LIHC,50.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-18363.0,Alive,TUMOR FREE,372.0,,[Not Available],,,,,[Not Available],,R0,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,
TCGA-BG-A2AE,10774,TCGA-BG-A2AE,UCEC,57.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Peri (6-12 months since last menstrual period),-21069.0,Alive,TUMOR FREE,721.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,721.0,0.0,721.0,0.0,721.0,0.0,721.0,
TCGA-X7-A8DG,10393,TCGA-X7-A8DG,THYM,47.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type B2,[Not Available],2012.0,[Not Available],-17517.0,Alive,TUMOR FREE,695.0,,[Not Available],,,,,[Not Available],,,0.0,695.0,0.0,695.0,,,0.0,695.0,
TCGA-CL-5918,8481,TCGA-CL-5918,READ,90.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2008.0,[Not Available],-32873.0,Alive,TUMOR FREE,218.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,218.0,0.0,218.0,0.0,218.0,0.0,218.0,
TCGA-S7-A7WW,7788,TCGA-S7-A7WW,PCPG,34.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-12729.0,Alive,TUMOR FREE,706.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,706.0,0.0,706.0,0.0,706.0,0.0,706.0,
TCGA-G2-A3IB,319,TCGA-G2-A3IB,BLCA,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-24149.0,Dead,WITH TUMOR,,220.0,[Not Available],,,,,Progressive Disease,,,1.0,220.0,1.0,220.0,,,1.0,220.0,
TCGA-UY-A9PD,413,TCGA-UY-A9PD,BLCA,80.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-29565.0,Alive,TUMOR FREE,542.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,
TCGA-HU-8249,9561,TCGA-HU-8249,STAD,76.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-28012.0,Alive,TUMOR FREE,881.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,881.0,0.0,881.0,0.0,881.0,0.0,881.0,
TCGA-P4-A5EB,4658,TCGA-P4-A5EB,KIRP,83.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-30395.0,Alive,TUMOR FREE,3015.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3015.0,0.0,3015.0,0.0,3015.0,0.0,3015.0,
TCGA-06-2569,2861,TCGA-06-2569,GBM,24.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-8922.0,Alive,WITH TUMOR,13.0,,[Not Available],,,,,[Not Available],,,0.0,13.0,0.0,13.0,,,0.0,13.0,
TCGA-49-4510,5911,TCGA-49-4510,LUAD,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2001.0,[Not Available],-18762.0,Dead,WITH TUMOR,,896.0,[Not Available],Distant Metastasis,,,502.0,Stable Disease,,,1.0,896.0,1.0,896.0,,,1.0,502.0,
TCGA-EJ-A46I,7983,TCGA-EJ-A46I,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21046.0,Alive,TUMOR FREE,668.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,668.0,0.0,668.0,0.0,668.0,0.0,668.0,
TCGA-DH-A66F,4973,TCGA-DH-A66F,LGG,49.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-18193.0,Alive,TUMOR FREE,523.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,523.0,0.0,523.0,0.0,523.0,0.0,523.0,
TCGA-06-0241,2812,TCGA-06-0241,GBM,65.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-24101.0,Dead,WITH TUMOR,,1481.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],196.0,[Not Available],,,1.0,1481.0,1.0,1481.0,,,1.0,196.0,
TCGA-58-A46K,6556,TCGA-58-A46K,LUSC,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-21867.0,Dead,WITH TUMOR,,1045.0,[Not Available],Locoregional Recurrence|Distant Metastasis,,,735.0,Complete Remission/Response,,,1.0,1045.0,1.0,1045.0,1.0,735.0,1.0,735.0,
TCGA-D1-A17U,10873,TCGA-D1-A17U,UCEC,53.0,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19544.0,Alive,TUMOR FREE,697.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,697.0,0.0,697.0,0.0,697.0,0.0,697.0,
TCGA-55-6712,5974,TCGA-55-6712,LUAD,71.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],,Dead,WITH TUMOR,,171.0,[Not Available],,,,,Progressive Disease,,,1.0,171.0,1.0,171.0,,,1.0,171.0,
TCGA-CS-5390,4916,TCGA-CS-5390,LGG,47.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2005.0,[Not Available],-17460.0,Alive,TUMOR FREE,,,[Not Available],,,,,Complete Remission/Response,,,0.0,,0.0,,0.0,,0.0,,
TCGA-EL-A3GR,10062,TCGA-EL-A3GR,THCA,31.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-11598.0,Alive,TUMOR FREE,3501.0,,[Not Available],,,,,[Not Available],,R0,0.0,3501.0,0.0,3501.0,0.0,3501.0,0.0,3501.0,
TCGA-B5-A11G,10696,TCGA-B5-A11G,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25995.0,Alive,TUMOR FREE,3448.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3448.0,0.0,3448.0,0.0,3448.0,0.0,3448.0,
TCGA-OR-A5LH,71,TCGA-OR-A5LH,ACC,36.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2005.0,[Not Available],-13182.0,Dead,WITH TUMOR,,2385.0,[Not Available],,,,,Progressive Disease,,,1.0,2385.0,1.0,2385.0,,,1.0,2385.0,
TCGA-Q1-A73Q,1827,TCGA-Q1-A73Q,CESC,46.0,FEMALE,WHITE,[Not Available],Stage I,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16851.0,Alive,WITH TUMOR,284.0,,,,,,,[Unknown],,,0.0,284.0,0.0,284.0,,,0.0,284.0,
TCGA-91-6840,6218,TCGA-91-6840,LUAD,59.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-21854.0,Alive,TUMOR FREE,372.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,
TCGA-S7-A7WO,7781,TCGA-S7-A7WO,PCPG,76.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-28114.0,Alive,TUMOR FREE,1080.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1080.0,0.0,1080.0,0.0,1080.0,0.0,1080.0,
TCGA-EA-A3HT,1697,TCGA-EA-A3HT,CESC,68.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G1,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25138.0,Alive,TUMOR FREE,954.0,,,,,,,Complete Remission/Response,,,0.0,954.0,0.0,954.0,0.0,954.0,0.0,954.0,
TCGA-44-6779,5882,TCGA-44-6779,LUAD,50.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-18469.0,Dead,WITH TUMOR,,500.0,[Not Available],,,,232.0,Progressive Disease,,,1.0,500.0,1.0,500.0,,,1.0,232.0,
TCGA-S8-A6BV,2613,TCGA-S8-A6BV,ESCA,76.0,MALE,WHITE,Stage IIIA,Stage IB,"Esophagus Adenocarcinoma, NOS",G2,2012.0,[Not Available],-28111.0,Alive,WITH TUMOR,609.0,,[Not Available],Distant Metastasis,Liver,,267.0,Progressive Disease,,,0.0,609.0,0.0,609.0,,,1.0,267.0,
TCGA-G9-6342,8020,TCGA-G9-6342,PRAD,61.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-22472.0,Alive,TUMOR FREE,1696.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1696.0,0.0,1696.0,0.0,1696.0,0.0,1696.0,
TCGA-BJ-A3PU,9883,TCGA-BJ-A3PU,THCA,52.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19007.0,Alive,TUMOR FREE,567.0,,[Not Available],Distant Metastasis,Lung,,174.0,[Not Available],,R0,0.0,567.0,0.0,567.0,1.0,174.0,1.0,174.0,
TCGA-G9-A9S4,8056,TCGA-G9-A9S4,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-22684.0,Alive,TUMOR FREE,906.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,906.0,0.0,906.0,0.0,906.0,0.0,906.0,
TCGA-R6-A6XQ,2605,TCGA-R6-A6XQ,ESCA,58.0,MALE,WHITE,[Not Available],Stage IVB,"Esophagus Adenocarcinoma, NOS",G3,2008.0,[Not Available],-21410.0,Dead,WITH TUMOR,,193.0,[Not Available],,,,,,,,1.0,193.0,1.0,193.0,,,1.0,193.0,
TCGA-AO-A128,873,TCGA-AO-A128,BRCA,61.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22340.0,Alive,TUMOR FREE,3248.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3248.0,0.0,3248.0,0.0,3248.0,0.0,3248.0,
TCGA-FG-7643,5112,TCGA-FG-7643,LGG,49.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-18206.0,Alive,WITH TUMOR,611.0,,[Not Available],,,,254.0,Stable Disease,,,0.0,611.0,0.0,611.0,,,1.0,254.0,
TCGA-2H-A9GK,2466,TCGA-2H-A9GK,ESCA,43.0,MALE,[Unknown],Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2000.0,[Not Available],-16067.0,Dead,WITH TUMOR,,232.0,[Not Available],Distant Metastasis,"Other, specify",Lymph node,113.0,,,,1.0,232.0,1.0,232.0,,,1.0,113.0,
TCGA-RA-A741,1831,TCGA-RA-A741,CESC,34.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12607.0,Alive,TUMOR FREE,444.0,,,,,,,Complete Remission/Response,,,0.0,444.0,0.0,444.0,0.0,444.0,0.0,444.0,
TCGA-W3-AA1R,9231,TCGA-W3-AA1R,SKCM,71.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1995.0,[Not Available],-26145.0,Dead,WITH TUMOR,,3379.0,[Not Available],Distant Metastasis,Lung,,1037.0,[Not Available],,,1.0,3379.0,1.0,3379.0,,,1.0,1037.0,
TCGA-EY-A1GP,10954,TCGA-EY-A1GP,UCEC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20011.0,Alive,TUMOR FREE,573.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,573.0,0.0,573.0,0.0,573.0,0.0,573.0,
TCGA-EM-A3FL,10171,TCGA-EM-A3FL,THCA,63.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-23183.0,Alive,TUMOR FREE,1441.0,,[Not Available],,,,,[Not Available],,R0,0.0,1441.0,0.0,1441.0,0.0,1441.0,0.0,1441.0,
TCGA-HT-8011,5203,TCGA-HT-8011,LGG,55.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-20175.0,Alive,WITH TUMOR,494.0,,[Not Available],,,,278.0,Stable Disease,,,0.0,494.0,0.0,494.0,,,1.0,278.0,
TCGA-D9-A6EG,8914,TCGA-D9-A6EG,SKCM,56.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2012.0,[Not Available],-20570.0,Dead,,,698.0,[Not Available],Distant Metastasis,Bone,,398.0,[Not Available],,,1.0,698.0,,698.0,,,1.0,398.0,
TCGA-XR-A8TD,5787,TCGA-XR-A8TD,LIHC,49.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-17908.0,Alive,TUMOR FREE,1030.0,,[Not Available],,,,,[Not Available],,R0,0.0,1030.0,0.0,1030.0,0.0,1030.0,0.0,1030.0,
TCGA-D8-A27R,1293,TCGA-D8-A27R,BRCA,41.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15122.0,Alive,TUMOR FREE,307.0,,[Not Available],,,,,[Not Available],Negative,,0.0,307.0,0.0,307.0,0.0,307.0,0.0,307.0,
TCGA-KN-8424,3823,TCGA-KN-8424,KICH,42.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2005.0,[Not Available],-15384.0,Alive,TUMOR FREE,1983.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1983.0,0.0,1983.0,0.0,1983.0,0.0,1983.0,
TCGA-QR-A6GR,7698,TCGA-QR-A6GR,PCPG,30.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2009.0,[Not Available],-11089.0,Alive,TUMOR FREE,703.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,703.0,0.0,703.0,0.0,703.0,0.0,703.0,
TCGA-EM-A3FJ,10169,TCGA-EM-A3FJ,THCA,24.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-9042.0,Alive,TUMOR FREE,850.0,,[Not Available],,,,,[Not Available],,R0,0.0,850.0,0.0,850.0,0.0,850.0,0.0,850.0,
TCGA-DX-A8BL,8638,TCGA-DX-A8BL,SARC,59.0,MALE,WHITE,[Not Available],[Not Available],Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2011.0,[Not Available],-21728.0,Alive,TUMOR FREE,1373.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1373.0,0.0,1373.0,0.0,1373.0,0.0,1373.0,
TCGA-CM-4747,2261,TCGA-CM-4747,COAD,47.0,MALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-17198.0,Alive,[Discrepancy],761.0,,[Not Available],,,,,[Discrepancy],,,0.0,761.0,0.0,761.0,,,0.0,761.0,
TCGA-ET-A2N1,10215,TCGA-ET-A2N1,THCA,47.0,FEMALE,ASIAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-17272.0,Alive,TUMOR FREE,1653.0,,[Not Available],,,,,[Not Available],,R0,0.0,1653.0,0.0,1653.0,0.0,1653.0,0.0,1653.0,
TCGA-MM-A84U,4417,TCGA-MM-A84U,KIRC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2013.0,[Not Available],-21375.0,Alive,TUMOR FREE,700.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,700.0,0.0,700.0,0.0,700.0,0.0,700.0,
TCGA-DB-5276,4935,TCGA-DB-5276,LGG,32.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2007.0,[Not Available],-11738.0,Alive,TUMOR FREE,2218.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2218.0,0.0,2218.0,0.0,2218.0,0.0,2218.0,
TCGA-GL-7773,4609,TCGA-GL-7773,KIRP,63.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-23239.0,Alive,TUMOR FREE,393.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,393.0,0.0,393.0,0.0,393.0,0.0,393.0,
TCGA-L5-A4OQ,2524,TCGA-L5-A4OQ,ESCA,75.0,MALE,WHITE,Stage IIIA,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2010.0,[Not Available],-27565.0,Dead,WITH TUMOR,,42.0,[Not Available],Distant Metastasis,Brain,,29.0,,,,1.0,42.0,1.0,42.0,,,1.0,29.0,
TCGA-FG-A70Y,5132,TCGA-FG-A70Y,LGG,20.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-7421.0,Alive,WITH TUMOR,868.0,,[Not Available],,,,490.0,Complete Remission/Response,,,0.0,868.0,0.0,868.0,1.0,490.0,1.0,490.0,
TCGA-SP-A6QH,7798,TCGA-SP-A6QH,PCPG,35.0,FEMALE,ASIAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2008.0,[Not Available],-12876.0,Alive,TUMOR FREE,2203.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2203.0,0.0,2203.0,0.0,2203.0,0.0,2203.0,
TCGA-A6-4107,1981,TCGA-A6-4107,COAD,57.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-21064.0,Alive,TUMOR FREE,987.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,
TCGA-66-2778,6631,TCGA-66-2778,LUSC,68.0,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-25080.0,Alive,TUMOR FREE,578.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,
TCGA-K4-A6MB,382,TCGA-K4-A6MB,BLCA,64.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-23664.0,Alive,TUMOR FREE,469.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,469.0,0.0,469.0,,,0.0,469.0,
TCGA-2Z-A9J8,4427,TCGA-2Z-A9J8,KIRP,50.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-18498.0,Alive,WITH TUMOR,2790.0,,[Not Available],,,,506.0,Complete Remission/Response,,,0.0,2790.0,0.0,2790.0,1.0,506.0,1.0,506.0,
TCGA-12-0619,2940,TCGA-12-0619,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-21920.0,Dead,WITH TUMOR,316.0,1062.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],203.0,[Not Available],,,1.0,1062.0,1.0,1062.0,,,1.0,203.0,
TCGA-SP-A6QD,7795,TCGA-SP-A6QD,PCPG,26.0,MALE,[Not Evaluated],[Not Available],[Not Available],Pheochromocytoma,[Not Available],2004.0,[Not Available],-9829.0,Alive,TUMOR FREE,3323.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3323.0,0.0,3323.0,0.0,3323.0,0.0,3323.0,
TCGA-KK-A7B2,8197,TCGA-KK-A7B2,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-24845.0,Alive,WITH TUMOR,1099.0,,[Not Available],Biochemical evidence of disease,,,692.0,Stable Disease,,,0.0,1099.0,0.0,1099.0,,,1.0,692.0,
TCGA-B4-5843,4090,TCGA-B4-5843,KIRC,45.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-16779.0,Alive,TUMOR FREE,11.0,,[Not Available],,,,,[Not Applicable],,,0.0,11.0,0.0,11.0,,,0.0,11.0,
TCGA-FS-A1ZH,9157,TCGA-FS-A1ZH,SKCM,71.0,FEMALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2003.0,[Not Available],-26232.0,Dead,WITH TUMOR,,996.0,[Not Available],,,,577.0,[Not Available],,,1.0,996.0,1.0,996.0,,,1.0,577.0,
TCGA-GD-A2C5,337,TCGA-GD-A2C5,BLCA,53.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-19498.0,Alive,WITH TUMOR,812.0,,[Not Available],Metastatic,Lung,,214.0,Progressive Disease,,,0.0,812.0,0.0,812.0,,,1.0,214.0,
TCGA-E9-A5FK,1450,TCGA-E9-A5FK,BRCA,60.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199.0,Alive,TUMOR FREE,812.0,,[Not Available],,,,,[Not Available],Negative,,0.0,812.0,0.0,812.0,0.0,812.0,0.0,812.0,
TCGA-EJ-A8FN,8000,TCGA-EJ-A8FN,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-21506.0,Alive,TUMOR FREE,329.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,329.0,0.0,329.0,0.0,329.0,0.0,329.0,
TCGA-FG-6692,5106,TCGA-FG-6692,LGG,63.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-23374.0,Dead,WITH TUMOR,,561.0,[Not Available],,,,,Stable Disease,,,1.0,561.0,1.0,561.0,,,1.0,561.0,
TCGA-JY-A93F,2506,TCGA-JY-A93F,ESCA,58.0,FEMALE,WHITE,Stage IB,[Not Available],Esophagus Squamous Cell Carcinoma,G1,2012.0,[Not Available],-21257.0,Alive,TUMOR FREE,731.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,731.0,0.0,731.0,0.0,731.0,0.0,731.0,
TCGA-OL-A5RY,1560,TCGA-OL-A5RY,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19216.0,Alive,TUMOR FREE,752.0,,[Not Available],,,,,[Not Available],Negative,,0.0,752.0,0.0,752.0,0.0,752.0,0.0,752.0,
TCGA-50-8459,5961,TCGA-50-8459,LUAD,68.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-24859.0,Alive,WITH TUMOR,1119.0,,[Not Available],Locoregional Recurrence,,,432.0,Progressive Disease,,,0.0,1119.0,0.0,1119.0,,,1.0,432.0,
TCGA-CR-7367,3440,TCGA-CR-7367,HNSC,52.0,MALE,WHITE,Stage IVA,Stage IVB,Head & Neck Squamous Cell Carcinoma,G1,2008.0,[Not Available],-19116.0,Alive,TUMOR FREE,1440.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1440.0,0.0,1440.0,,,0.0,1440.0,
TCGA-46-6025,6496,TCGA-46-6025,LUSC,71.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-26168.0,Alive,TUMOR FREE,324.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,324.0,0.0,324.0,0.0,324.0,0.0,324.0,
TCGA-BJ-A28X,9870,TCGA-BJ-A28X,THCA,32.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-11735.0,Alive,TUMOR FREE,942.0,,[Not Available],,,,494.0,[Not Available],,R0,0.0,942.0,0.0,942.0,1.0,494.0,1.0,494.0,
TCGA-AC-A2BM,761,TCGA-AC-A2BM,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,[Not Available],-15212.0,Alive,TUMOR FREE,3022.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3022.0,0.0,3022.0,0.0,3022.0,0.0,3022.0,
TCGA-AR-A0TQ,899,TCGA-AR-A0TQ,BRCA,27.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9873.0,Alive,TUMOR FREE,2991.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2991.0,0.0,2991.0,0.0,2991.0,0.0,2991.0,
TCGA-EK-A2PK,1725,TCGA-EK-A2PK,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2006.0,Indeterminate (neither Pre or Postmenopausal),-15939.0,Alive,TUMOR FREE,12.0,,,,,,,[Not Available],,,0.0,12.0,0.0,12.0,,,0.0,12.0,
TCGA-C5-A1MF,1623,TCGA-C5-A1MF,CESC,49.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G2,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17911.0,Alive,TUMOR FREE,1617.0,,,,,,,Complete Remission/Response,,,0.0,1617.0,0.0,1617.0,0.0,1617.0,0.0,1617.0,
TCGA-D5-6533,2304,TCGA-D5-6533,COAD,68.0,FEMALE,WHITE,[Discrepancy],[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-24971.0,Alive,TUMOR FREE,775.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,
TCGA-AF-3911,8374,TCGA-AF-3911,READ,48.0,MALE,WHITE,Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2009.0,[Not Available],-17609.0,Alive,WITH TUMOR,1148.0,,[Not Available],,,,695.0,Complete Remission/Response,,,0.0,1148.0,0.0,1148.0,1.0,695.0,1.0,695.0,
TCGA-OR-A5JB,11,TCGA-OR-A5JB,ACC,52.0,MALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-19172.0,Dead,,,551.0,[Not Available],,,,,[Unknown],,,1.0,551.0,,551.0,,,0.0,551.0,
TCGA-OL-A6VQ,1572,TCGA-OL-A6VQ,BRCA,49.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18151.0,Alive,TUMOR FREE,600.0,,[Not Available],,,,,[Not Available],Negative,,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,
TCGA-27-2526,3131,TCGA-27-2526,GBM,79.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-28977.0,Dead,WITH TUMOR,87.0,87.0,[Not Available],,,,,[Not Available],,,1.0,87.0,1.0,87.0,,,1.0,87.0,
TCGA-FV-A3R3,5695,TCGA-FV-A3R3,LIHC,38.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-14231.0,Dead,TUMOR FREE,,366.0,[Not Available],,,,,[Not Available],,R0,1.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,
TCGA-4Z-AA82,109,TCGA-4Z-AA82,BLCA,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-21893.0,Dead,WITH TUMOR,,1556.0,[Not Available],Distant Metastasis,Bone,,1150.0,Complete Remission/Response,,,1.0,1556.0,1.0,1556.0,,,1.0,1150.0,
TCGA-A4-7997,4475,TCGA-A4-7997,KIRP,67.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-24486.0,Alive,TUMOR FREE,927.0,,[Not Available],,,,,[Unknown],,,0.0,927.0,0.0,927.0,,,0.0,927.0,
TCGA-SX-A7SP,4677,TCGA-SX-A7SP,KIRP,66.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-24382.0,Dead,TUMOR FREE,,496.0,[Not Available],,,,,Complete Remission/Response,,,1.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,
TCGA-DD-AAE9,5642,TCGA-DD-AAE9,LIHC,69.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-25451.0,Alive,TUMOR FREE,722.0,,[Not Available],,,,,[Not Available],,R0,0.0,722.0,0.0,722.0,0.0,722.0,0.0,722.0,
TCGA-H4-A2HO,366,TCGA-H4-A2HO,BLCA,53.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-19630.0,Alive,TUMOR FREE,46.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,46.0,0.0,46.0,0.0,46.0,0.0,46.0,
TCGA-EE-A29R,9018,TCGA-EE-A29R,SKCM,48.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2010.0,[Not Available],-17857.0,Alive,WITH TUMOR,440.0,,[Not Available],Distant Metastasis,Lung,,426.0,[Not Available],,,0.0,440.0,0.0,440.0,,,1.0,426.0,
TCGA-C5-A2LX,1635,TCGA-C5-A2LX,CESC,54.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20070.0,Alive,TUMOR FREE,2526.0,,,,,,,Complete Remission/Response,,,0.0,2526.0,0.0,2526.0,0.0,2526.0,0.0,2526.0,
TCGA-66-2800,6647,TCGA-66-2800,LUSC,70.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-25810.0,Alive,TUMOR FREE,1492.0,,[Not Available],,,,,[Not Applicable],,,0.0,1492.0,0.0,1492.0,,,0.0,1492.0,
TCGA-EW-A1P8,1476,TCGA-EW-A1P8,BRCA,58.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21501.0,Dead,WITH TUMOR,,239.0,[Not Available],Distant Metastasis,Lung,,207.0,[Not Available],Negative,,1.0,239.0,1.0,239.0,1.0,207.0,1.0,207.0,
TCGA-DF-A2KV,10897,TCGA-DF-A2KV,UCEC,55.0,FEMALE,[Not Evaluated],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20160.0,Alive,TUMOR FREE,2717.0,,[Not Available],,,,,[Not Available],,,0.0,2717.0,0.0,2717.0,,,0.0,2717.0,
TCGA-22-5482,6391,TCGA-22-5482,LUSC,81.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-29657.0,Dead,TUMOR FREE,357.0,357.0,[Not Available],,,,,Complete Remission/Response,,,1.0,357.0,0.0,357.0,0.0,357.0,0.0,357.0,
TCGA-QR-A6H1,7707,TCGA-QR-A6H1,PCPG,55.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2009.0,[Not Available],-20295.0,Alive,TUMOR FREE,431.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,
TCGA-98-8021,6783,TCGA-98-8021,LUSC,75.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-27738.0,Alive,TUMOR FREE,937.0,,[Not Available],Locoregional Recurrence,,,918.0,Complete Remission/Response,,,0.0,937.0,0.0,937.0,1.0,918.0,1.0,918.0,
TCGA-UY-A78K,402,TCGA-UY-A78K,BLCA,60.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-22020.0,Dead,,,536.0,[Not Available],,,,,Complete Remission/Response,,,1.0,536.0,,536.0,,,0.0,536.0,
TCGA-FU-A3TQ,1760,TCGA-FU-A3TQ,CESC,55.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20302.0,Alive,TUMOR FREE,795.0,,,,,,,Complete Remission/Response,,,0.0,795.0,0.0,795.0,0.0,795.0,0.0,795.0,
TCGA-NQ-A57I,6865,TCGA-NQ-A57I,MESO,71.0,MALE,WHITE,Stage IB,[Not Applicable],Biphasic mesothelioma,[Not Available],2012.0,[Not Available],-26212.0,Dead,WITH TUMOR,,20.0,[Not Available],,,,,[Not Available],,R2,1.0,20.0,1.0,20.0,,,1.0,20.0,
TCGA-18-3406,6325,TCGA-18-3406,LUSC,67.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-24477.0,Dead,WITH TUMOR,,371.0,[Not Available],Locoregional Recurrence,,,357.0,Progressive Disease,,,1.0,371.0,1.0,371.0,,,1.0,357.0,
TCGA-EE-A17Y,8993,TCGA-EE-A17Y,SKCM,69.0,MALE,ASIAN,Stage IIIB,[Not Applicable],,[Not Available],2007.0,[Not Available],-25281.0,Dead,WITH TUMOR,,828.0,[Not Available],Regional lymph node,,,317.0,[Not Available],,,1.0,828.0,1.0,828.0,,,1.0,317.0,
TCGA-QR-A70N,7731,TCGA-QR-A70N,PCPG,32.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2008.0,[Not Available],-11781.0,Alive,TUMOR FREE,43.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,43.0,0.0,43.0,0.0,43.0,0.0,43.0,
TCGA-LL-A73Z,1543,TCGA-LL-A73Z,BRCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20118.0,Dead,WITH TUMOR,,227.0,[Not Available],Distant Metastasis,Brain,,192.0,[Not Available],Positive,,1.0,227.0,1.0,227.0,,,1.0,192.0,
TCGA-X7-A8DE,10391,TCGA-X7-A8DE,THYM,35.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type B2,[Not Available],2011.0,[Not Available],-12957.0,Alive,TUMOR FREE,981.0,,[Not Available],,,,,[Not Available],,,0.0,981.0,0.0,981.0,,,0.0,981.0,
TCGA-BR-8295,9348,TCGA-BR-8295,STAD,60.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-22256.0,Dead,WITH TUMOR,,67.0,[Not Available],,,,,Progressive Disease,,,1.0,67.0,1.0,67.0,,,1.0,67.0,
TCGA-DS-A1OD,1686,TCGA-DS-A1OD,CESC,49.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17954.0,Alive,TUMOR FREE,3874.0,,,,,,,Complete Remission/Response,,,0.0,3874.0,0.0,3874.0,0.0,3874.0,0.0,3874.0,
TCGA-CH-5748,7887,TCGA-CH-5748,PRAD,64.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-23649.0,Alive,WITH TUMOR,31.0,,[Not Available],,,,,[Not Available],,,0.0,31.0,0.0,31.0,,,0.0,31.0,
TCGA-HT-7469,5142,TCGA-HT-7469,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-11097.0,Dead,WITH TUMOR,,351.0,[Not Available],,,,92.0,Progressive Disease,,,1.0,351.0,1.0,351.0,,,1.0,92.0,
TCGA-64-1680,6078,TCGA-64-1680,LUAD,63.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-23267.0,Alive,TUMOR FREE,1126.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1126.0,0.0,1126.0,,,0.0,1126.0,
TCGA-BQ-7061,4568,TCGA-BQ-7061,KIRP,83.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-30662.0,Alive,TUMOR FREE,218.0,,[Not Available],,,,,[Not Available],,,0.0,218.0,0.0,218.0,,,0.0,218.0,
TCGA-EE-A2GJ,9035,TCGA-EE-A2GJ,SKCM,83.0,MALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2004.0,[Not Available],-30602.0,Dead,WITH TUMOR,,3266.0,[Not Available],New primary melanoma,,,733.0,[Not Available],,,1.0,3266.0,1.0,3266.0,,,1.0,733.0,
TCGA-CV-5444,3481,TCGA-CV-5444,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2004.0,[Not Available],-23650.0,Alive,TUMOR FREE,2437.0,,[Not Available],,,,,[Not Available],,,0.0,2437.0,0.0,2437.0,,,0.0,2437.0,
TCGA-S9-A7IQ,5348,TCGA-S9-A7IQ,LGG,45.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-16512.0,Alive,WITH TUMOR,1099.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1099.0,0.0,1099.0,,,0.0,1099.0,
TCGA-28-5214,3159,TCGA-28-5214,GBM,53.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-19520.0,Dead,WITH TUMOR,,713.0,[Not Available],Locoregional Disease,[Not Applicable],[Not Applicable],247.0,[Not Applicable],,,1.0,713.0,1.0,713.0,,,1.0,247.0,
TCGA-FE-A233,10260,TCGA-FE-A233,THCA,18.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-6770.0,Alive,TUMOR FREE,751.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,567.0,[Not Available],,R0,0.0,751.0,0.0,751.0,1.0,567.0,1.0,567.0,
TCGA-G7-A8LC,4605,TCGA-G7-A8LC,KIRP,61.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-22553.0,Alive,TUMOR FREE,702.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,702.0,0.0,702.0,0.0,702.0,0.0,702.0,
TCGA-S9-A6WM,5343,TCGA-S9-A6WM,LGG,59.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-21761.0,Alive,WITH TUMOR,604.0,,[Not Available],,,,505.0,Partial Remission/Response,,,0.0,604.0,0.0,604.0,,,1.0,505.0,
TCGA-Y8-A8RY,4707,TCGA-Y8-A8RY,KIRP,63.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-23192.0,Alive,TUMOR FREE,769.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,769.0,0.0,769.0,0.0,769.0,0.0,769.0,
TCGA-ER-A194,9088,TCGA-ER-A194,SKCM,77.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2005.0,[Not Available],-28175.0,Dead,WITH TUMOR,,1354.0,[Not Available],,,,,[Not Available],,,1.0,1354.0,1.0,1354.0,,,1.0,1354.0,
TCGA-27-2519,3127,TCGA-27-2519,GBM,48.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-17715.0,Dead,WITH TUMOR,,550.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],256.0,[Not Available],,,1.0,550.0,1.0,550.0,,,1.0,256.0,
TCGA-E7-A4IJ,237,TCGA-E7-A4IJ,BLCA,56.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-20723.0,Dead,WITH TUMOR,,674.0,[Not Available],Distant Metastasis,Bone,,620.0,Complete Remission/Response,,,1.0,674.0,1.0,674.0,1.0,620.0,1.0,620.0,
TCGA-VN-A88N,8271,TCGA-VN-A88N,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22695.0,Alive,TUMOR FREE,766.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,
TCGA-A3-3346,3905,TCGA-A3-3346,KIRC,68.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-25118.0,Dead,WITH TUMOR,,137.0,[Not Available],,,,114.0,Progressive Disease,,,1.0,137.0,1.0,137.0,,,1.0,114.0,
TCGA-FD-A43U,278,TCGA-FD-A43U,BLCA,70.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-25841.0,Alive,WITH TUMOR,636.0,,[Not Available],Distant Metastasis,Bone,,497.0,Complete Remission/Response,,,0.0,636.0,0.0,636.0,,,1.0,497.0,
TCGA-BJ-A45J,9891,TCGA-BJ-A45J,THCA,39.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2012.0,[Not Available],-14510.0,Alive,TUMOR FREE,658.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,658.0,0.0,658.0,,,0.0,658.0,
TCGA-MP-A4TA,6304,TCGA-MP-A4TA,LUAD,75.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-27513.0,Dead,WITH TUMOR,,950.0,[Not Available],Distant Metastasis,,,725.0,Complete Remission/Response,,,1.0,950.0,1.0,950.0,1.0,725.0,1.0,725.0,
TCGA-G9-6329,8014,TCGA-G9-6329,PRAD,67.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-24797.0,Alive,TUMOR FREE,1266.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1266.0,0.0,1266.0,0.0,1266.0,0.0,1266.0,
TCGA-MI-A75E,5750,TCGA-MI-A75E,LIHC,61.0,MALE,WHITE,Stage IIIC,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-22457.0,Alive,TUMOR FREE,507.0,,[Not Available],,,,,[Not Available],,R0,0.0,507.0,0.0,507.0,0.0,507.0,0.0,507.0,
TCGA-97-7554,6251,TCGA-97-7554,LUAD,83.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-30327.0,Alive,TUMOR FREE,775.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,
TCGA-D1-A168,10837,TCGA-D1-A168,UCEC,67.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24586.0,Alive,TUMOR FREE,1098.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1098.0,0.0,1098.0,0.0,1098.0,0.0,1098.0,
TCGA-A7-A0DA,635,TCGA-A7-A0DA,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22708.0,Alive,TUMOR FREE,1085.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0,
TCGA-EM-A3O7,10180,TCGA-EM-A3O7,THCA,46.0,FEMALE,[Unknown],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-16842.0,Alive,TUMOR FREE,223.0,,[Not Available],,,,,[Not Available],,R0,0.0,223.0,0.0,223.0,0.0,223.0,0.0,223.0,
TCGA-DK-A3WY,207,TCGA-DK-A3WY,BLCA,67.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2001.0,[Not Available],-24536.0,Alive,TUMOR FREE,4967.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4967.0,0.0,4967.0,0.0,4967.0,0.0,4967.0,
TCGA-XQ-A8TA,8311,TCGA-XQ-A8TA,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-21889.0,Dead,WITH TUMOR,,146.0,Prostate Cancer,,,,,Progressive Disease,,,1.0,146.0,1.0,146.0,,,1.0,146.0,
TCGA-BF-AAP0,8818,TCGA-BF-AAP0,SKCM,40.0,FEMALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2013.0,[Not Available],-14773.0,Alive,TUMOR FREE,454.0,,[Not Available],,,,,[Not Available],,,0.0,454.0,0.0,454.0,,,0.0,454.0,
TCGA-EX-A1H6,1747,TCGA-EX-A1H6,CESC,38.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Type of Adenocarcinoma,G1,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14214.0,Alive,TUMOR FREE,241.0,,,,,,,Complete Remission/Response,,,0.0,241.0,0.0,241.0,0.0,241.0,0.0,241.0,
TCGA-ZF-A9RM,487,TCGA-ZF-A9RM,BLCA,70.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-25642.0,Alive,TUMOR FREE,1455.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1455.0,0.0,1455.0,0.0,1455.0,0.0,1455.0,
TCGA-BP-5201,4265,TCGA-BP-5201,KIRC,63.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2008.0,[Not Available],-23125.0,Alive,WITH TUMOR,951.0,,[Not Available],,,,-19.0,[Not Available],,,0.0,951.0,0.0,951.0,,,1.0,,
TCGA-EK-A2H0,1719,TCGA-EK-A2H0,CESC,24.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-8918.0,Alive,TUMOR FREE,1847.0,,,,,,,Complete Remission/Response,,,0.0,1847.0,0.0,1847.0,0.0,1847.0,0.0,1847.0,
TCGA-E5-A4U1,234,TCGA-E5-A4U1,BLCA,72.0,MALE,[Unknown],Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-26305.0,Alive,WITH TUMOR,1181.0,,[Not Available],Distant Metastasis,Bone,,705.0,Complete Remission/Response,,,0.0,1181.0,0.0,1181.0,1.0,705.0,1.0,705.0,
TCGA-VD-A8KF,11124,TCGA-VD-A8KF,UVM,68.0,MALE,[Not Evaluated],Stage IIIB,Stage IIIB,Epithelioid Cell,[Not Available],2013.0,[Not Available],-25066.0,Dead,WITH TUMOR,,40.0,Metastatic Uveal Melanoma,,,,,[Not Available],,,1.0,40.0,1.0,40.0,,,1.0,40.0,
TCGA-VS-A9V0,1883,TCGA-VS-A9V0,CESC,58.0,FEMALE,[Unknown],[Not Available],Stage IB,Mucinous Adenocarcinoma of Endocervical Type,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-21215.0,Alive,WITH TUMOR,573.0,,,Distant Metastasis,"Other, specify",Retroperitoneal lymph node and pelvic lymph node and lung,475.0,Complete Remission/Response,,,0.0,573.0,0.0,573.0,1.0,475.0,1.0,475.0,
TCGA-EW-A1P5,1473,TCGA-EW-A1P5,BRCA,77.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28177.0,Alive,TUMOR FREE,703.0,,[Not Available],,,,,[Not Available],Negative,,0.0,703.0,0.0,703.0,0.0,703.0,0.0,703.0,
TCGA-FE-A236,10263,TCGA-FE-A236,THCA,33.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-12348.0,Alive,TUMOR FREE,2031.0,,[Not Available],,,,,[Not Available],,R0,0.0,2031.0,0.0,2031.0,0.0,2031.0,0.0,2031.0,
TCGA-VQ-A8PZ,9672,TCGA-VQ-A8PZ,STAD,56.0,FEMALE,WHITE,Stage II,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2008.0,[Not Available],-20735.0,Alive,TUMOR FREE,2233.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2233.0,0.0,2233.0,0.0,2233.0,0.0,2233.0,
TCGA-EY-A4KR,10975,TCGA-EY-A4KR,UCEC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20669.0,Dead,WITH TUMOR,,346.0,[Not Available],,,,,Progressive Disease,,,1.0,346.0,1.0,346.0,,,1.0,346.0,
TCGA-S8-A6BW,2614,TCGA-S8-A6BW,ESCA,51.0,MALE,WHITE,Stage IB,[Not Available],Esophagus Squamous Cell Carcinoma,G1,2012.0,[Not Available],-18944.0,Alive,TUMOR FREE,620.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,620.0,0.0,620.0,0.0,620.0,0.0,620.0,
TCGA-D8-A1XV,1275,TCGA-D8-A1XV,BRCA,84.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30830.0,Alive,TUMOR FREE,461.0,,[Not Available],,,,,[Not Available],Negative,,0.0,461.0,0.0,461.0,0.0,461.0,0.0,461.0,
TCGA-MT-A67F,3700,TCGA-MT-A67F,HNSC,60.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-22057.0,Alive,TUMOR FREE,384.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,384.0,0.0,384.0,,,0.0,384.0,
TCGA-DX-A23Y,8569,TCGA-DX-A23Y,SARC,80.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2006.0,[Not Available],-29272.0,Dead,WITH TUMOR,,191.0,[Not Available],Locoregional Recurrence,,,172.0,[Not Available],[Not Available],R1,1.0,191.0,1.0,191.0,,,1.0,172.0,
TCGA-DB-A64O,4951,TCGA-DB-A64O,LGG,59.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-21811.0,Dead,WITH TUMOR,,775.0,[Not Available],,,,430.0,Stable Disease,,,1.0,775.0,1.0,775.0,,,1.0,430.0,
TCGA-KC-A4BO,8164,TCGA-KC-A4BO,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-20368.0,Alive,TUMOR FREE,607.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,
TCGA-23-2647,7159,TCGA-23-2647,OV,49.0,FEMALE,ASIAN,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-18205.0,Alive,,135.0,,[Not Available],,,,,[Not Available],,,0.0,135.0,0.0,135.0,,,0.0,135.0,
TCGA-FP-A8CX,9548,TCGA-FP-A8CX,STAD,60.0,MALE,WHITE,Stage IIIC,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2013.0,[Not Available],-22000.0,Alive,TUMOR FREE,7.0,,[Not Available],,,,,[Unknown],,,0.0,7.0,0.0,7.0,,,0.0,7.0,
TCGA-E7-A678,244,TCGA-E7-A678,BLCA,55.0,MALE,ASIAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,[Not Available],-20169.0,Alive,TUMOR FREE,798.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,798.0,0.0,798.0,0.0,798.0,0.0,798.0,
TCGA-V1-A8ML,8240,TCGA-V1-A8ML,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-23360.0,Alive,,448.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,448.0,0.0,448.0,0.0,448.0,0.0,448.0,
TCGA-B9-A69E,4532,TCGA-B9-A69E,KIRP,71.0,MALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-26198.0,Alive,TUMOR FREE,452.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,452.0,0.0,452.0,0.0,452.0,0.0,452.0,
TCGA-XF-AAN7,466,TCGA-XF-AAN7,BLCA,60.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-21951.0,Dead,WITH TUMOR,,565.0,[Not Available],Locoregional (Urothelial tumor event),Bladder,,321.0,Complete Remission/Response,,,1.0,565.0,1.0,565.0,,,1.0,321.0,
TCGA-C5-A2M1,1638,TCGA-C5-A2M1,CESC,37.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Type of Adenocarcinoma,G2,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13835.0,Alive,TUMOR FREE,1169.0,,,,,,,Complete Remission/Response,,,0.0,1169.0,0.0,1169.0,0.0,1169.0,0.0,1169.0,
TCGA-HZ-8315,7601,TCGA-HZ-8315,PAAD,54.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-19839.0,Dead,WITH TUMOR,,299.0,Pancreatic Cancer,,,,,[Unknown],,,1.0,299.0,1.0,299.0,,,1.0,299.0,
TCGA-Z4-A9VC,8795,TCGA-Z4-A9VC,SARC,37.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2013.0,[Not Available],-13576.0,Alive,TUMOR FREE,407.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,407.0,0.0,407.0,0.0,407.0,0.0,407.0,
TCGA-MY-A913,1817,TCGA-MY-A913,CESC,28.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IIA,Cervical Squamous Cell Carcinoma,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10379.0,Alive,TUMOR FREE,524.0,,,,,,,Complete Remission/Response,,,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,
TCGA-VQ-A94U,9697,TCGA-VQ-A94U,STAD,70.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G3,2012.0,[Not Available],-25925.0,Alive,TUMOR FREE,819.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,819.0,0.0,819.0,0.0,819.0,0.0,819.0,
TCGA-XE-AANI,9810,TCGA-XE-AANI,TGCT,37.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma,[Not Available],2007.0,[Not Available],-13553.0,Alive,TUMOR FREE,1041.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,1041.0,0.0,1041.0,0.0,1041.0,0.0,1041.0,
TCGA-RD-A8MW,9631,TCGA-RD-A8MW,STAD,72.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2004.0,[Not Available],-26590.0,Dead,WITH TUMOR,1153.0,1153.0,Stomach Cancer,Distant Metastasis,Peritoneal Surfaces,,98.0,Complete Remission/Response,,,1.0,1153.0,1.0,1153.0,1.0,98.0,1.0,98.0,
TCGA-DB-A64R,4954,TCGA-DB-A64R,LGG,24.0,FEMALE,[Not Evaluated],[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-8947.0,Alive,TUMOR FREE,955.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,955.0,0.0,955.0,0.0,955.0,0.0,955.0,
TCGA-LK-A4O2,6848,TCGA-LK-A4O2,MESO,56.0,FEMALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2011.0,[Not Available],-20757.0,Dead,WITH TUMOR,,57.0,[Not Available],,,,,[Not Available],,R2,1.0,57.0,1.0,57.0,,,1.0,57.0,
TCGA-EM-A3FP,10175,TCGA-EM-A3FP,THCA,71.0,FEMALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-26158.0,Alive,TUMOR FREE,529.0,,[Not Available],,,,,[Not Available],,R0,0.0,529.0,0.0,529.0,0.0,529.0,0.0,529.0,
TCGA-HV-AA8X,7587,TCGA-HV-AA8X,PAAD,75.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-27662.0,Dead,WITH TUMOR,,532.0,,Distant Metastasis,"Other, specify",Omentum,375.0,[Discrepancy],,,1.0,532.0,1.0,532.0,,,1.0,375.0,
TCGA-B6-A0RN,993,TCGA-B6-A0RN,BRCA,60.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1993.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22077.0,Alive,TUMOR FREE,8008.0,,[Not Available],,,,,[Not Available],Negative,,0.0,8008.0,0.0,8008.0,0.0,8008.0,0.0,8008.0,
TCGA-19-1790,3076,TCGA-19-1790,GBM,56.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-20626.0,Dead,WITH TUMOR,154.0,154.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],88.0,[Not Available],,,1.0,154.0,1.0,154.0,,,1.0,88.0,
TCGA-V4-A9ET,11102,TCGA-V4-A9ET,UVM,57.0,MALE,WHITE,Stage IIIB,Stage IIIB,Spindle Cell|Epithelioid Cell,[Not Available],2011.0,[Not Available],-21113.0,Alive,TUMOR FREE,1362.0,,[Not Available],,,,,[Not Available],,,0.0,1362.0,0.0,1362.0,,,0.0,1362.0,
TCGA-N5-A4RO,11031,TCGA-N5-A4RO,UCS,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24823.0,Dead,WITH TUMOR,,685.0,[Not Available],Progression of Disease,Lymph Node(s),,407.0,Progressive Disease,,,1.0,685.0,1.0,685.0,,,1.0,407.0,
TCGA-BJ-A28Z,9871,TCGA-BJ-A28Z,THCA,46.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-16912.0,Alive,TUMOR FREE,337.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,337.0,0.0,337.0,,,0.0,337.0,
TCGA-56-8309,6529,TCGA-56-8309,LUSC,66.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-24382.0,Alive,TUMOR FREE,428.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,
TCGA-DC-6158,8490,TCGA-DC-6158,READ,70.0,MALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-25842.0,Dead,TUMOR FREE,,334.0,[Not Available],,,,,[Not Available],,,1.0,334.0,0.0,334.0,,,0.0,334.0,
TCGA-HT-7604,5161,TCGA-HT-7604,LGG,50.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Astrocytoma,G2,2003.0,[Not Available],-18443.0,Alive,TUMOR FREE,3725.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,3725.0,0.0,3725.0,,,0.0,3725.0,
TCGA-LN-A49L,2559,TCGA-LN-A49L,ESCA,44.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2010.0,[Not Available],-16164.0,Dead,TUMOR FREE,,318.0,[Not Available],,,,,Complete Remission/Response,,,1.0,318.0,0.0,318.0,0.0,318.0,0.0,318.0,
TCGA-UB-A7MC,5774,TCGA-UB-A7MC,LIHC,59.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-21733.0,Alive,WITH TUMOR,500.0,,[Not Available],Extrahepatic Recurrence,"Other, specify",Adrenal glands,359.0,[Not Available],,R0,0.0,500.0,0.0,500.0,1.0,359.0,1.0,359.0,
TCGA-4L-AA1F,7877,TCGA-4L-AA1F,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23665.0,Alive,TUMOR FREE,350.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,350.0,0.0,350.0,0.0,350.0,0.0,350.0,
TCGA-B5-A5OE,10733,TCGA-B5-A5OE,UCEC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2011.0,[Not Available],-24905.0,Alive,TUMOR FREE,1063.0,,[Not Available],,,,,[Not Available],,,0.0,1063.0,0.0,1063.0,,,0.0,1063.0,
TCGA-AN-A0XR,836,TCGA-AN-A0XR,BRCA,55.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20381.0,Alive,TUMOR FREE,10.0,,[Not Available],,,,,[Not Available],Negative,,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,
TCGA-GN-A268,9198,TCGA-GN-A268,SKCM,83.0,FEMALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2005.0,[Not Available],-30430.0,Dead,WITH TUMOR,,1910.0,[Not Available],Locoregional Recurrence,,,908.0,[Not Available],,,1.0,1910.0,1.0,1910.0,,,1.0,908.0,
TCGA-AZ-6603,2229,TCGA-AZ-6603,COAD,77.0,FEMALE,WHITE,[Not Available],[Not Applicable],Colon Adenocarcinoma,[Not Available],2002.0,[Not Available],-28424.0,Dead,TUMOR FREE,,899.0,[Not Available],,,,,Complete Remission/Response,,,1.0,899.0,0.0,899.0,0.0,899.0,0.0,899.0,
TCGA-N8-A4PN,11051,TCGA-N8-A4PN,UCS,68.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25064.0,Alive,TUMOR FREE,812.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,812.0,0.0,812.0,0.0,812.0,0.0,812.0,
TCGA-KN-8433,3832,TCGA-KN-8433,KICH,46.0,FEMALE,WHITE,Stage III,[Not Available],Kidney Chromophobe,[Not Available],2008.0,[Not Available],-17108.0,Alive,TUMOR FREE,341.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,341.0,0.0,341.0,0.0,341.0,0.0,341.0,
TCGA-D9-A148,8899,TCGA-D9-A148,SKCM,40.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1999.0,[Not Available],-14805.0,Alive,WITH TUMOR,4609.0,,[Not Available],Distant Metastasis,,,4287.0,[Not Available],,,0.0,4609.0,0.0,4609.0,,,1.0,4287.0,
TCGA-EE-A3JI,9086,TCGA-EE-A3JI,SKCM,48.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1999.0,[Not Available],-17835.0,Dead,WITH TUMOR,,4648.0,[Not Available],New primary melanoma,,,725.0,[Not Available],,,1.0,4648.0,1.0,4648.0,,,1.0,725.0,
TCGA-VS-A9UM,1873,TCGA-VS-A9UM,CESC,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IVB,Cervical Squamous Cell Carcinoma,G2,2011.0,Peri (6-12 months since last menstrual period),-14255.0,Dead,TUMOR FREE,,829.0,,,,,,Complete Remission/Response,,,1.0,829.0,0.0,829.0,,,0.0,829.0,
TCGA-67-4679,6092,TCGA-67-4679,LUAD,69.0,MALE,WHITE,[Discrepancy],[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-25202.0,Alive,TUMOR FREE,448.0,,[Not Available],,,,,[Not Available],,,0.0,448.0,0.0,448.0,,,0.0,448.0,
TCGA-62-8399,6062,TCGA-62-8399,LUAD,62.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-22952.0,Alive,TUMOR FREE,2696.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2696.0,0.0,2696.0,0.0,2696.0,0.0,2696.0,
TCGA-CR-7401,3467,TCGA-CR-7401,HNSC,64.0,MALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-23420.0,Alive,TUMOR FREE,1077.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1077.0,0.0,1077.0,0.0,1077.0,0.0,1077.0,
TCGA-BR-8373,9364,TCGA-BR-8373,STAD,65.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-23744.0,Alive,TUMOR FREE,450.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,450.0,0.0,450.0,0.0,450.0,0.0,450.0,
TCGA-L5-A4OJ,2519,TCGA-L5-A4OJ,ESCA,70.0,FEMALE,WHITE,Stage I,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2012.0,[Not Available],-25657.0,Alive,TUMOR FREE,639.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,
TCGA-FD-A6TF,300,TCGA-FD-A6TF,BLCA,80.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-29317.0,Dead,TUMOR FREE,,69.0,[Not Available],,,,,Progressive Disease,,,1.0,69.0,0.0,69.0,,,0.0,69.0,
TCGA-74-6575,3206,TCGA-74-6575,GBM,73.0,FEMALE,[Not Available],[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-26827.0,Alive,WITH TUMOR,636.0,,[Not Available],,[Not Applicable],[Not Applicable],93.0,[Not Available],,,0.0,636.0,0.0,636.0,,,1.0,93.0,
TCGA-BL-A13I,118,TCGA-BL-A13I,BLCA,57.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-20885.0,Dead,WITH TUMOR,,223.0,[Not Available],Metastatic,,,216.0,Progressive Disease,,,1.0,223.0,1.0,223.0,,,1.0,216.0,
TCGA-XF-A9SZ,439,TCGA-XF-A9SZ,BLCA,79.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-29100.0,Dead,WITH TUMOR,,859.0,[Not Available],Distant Metastasis,Lung,,854.0,Complete Remission/Response,,,1.0,859.0,1.0,859.0,,,1.0,854.0,
TCGA-CQ-A4C7,3407,TCGA-CQ-A4C7,HNSC,88.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-32194.0,Dead,,,353.0,[Not Available],,Oral Cavity,left lateral flap margins overlying reconstructed mandible,207.0,Complete Remission/Response,,,1.0,353.0,,353.0,1.0,207.0,1.0,207.0,
TCGA-CV-7413,3553,TCGA-CV-7413,HNSC,74.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1995.0,[Not Available],-27231.0,Dead,,,294.0,[Not Available],,,,,Complete Remission/Response,,,1.0,294.0,,294.0,0.0,294.0,0.0,294.0,
TCGA-62-8397,6060,TCGA-62-8397,LUAD,70.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-25728.0,Alive,TUMOR FREE,1289.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1289.0,0.0,1289.0,0.0,1289.0,0.0,1289.0,
TCGA-B2-5636,4079,TCGA-B2-5636,KIRC,79.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-28901.0,Alive,TUMOR FREE,919.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,919.0,0.0,919.0,0.0,919.0,0.0,919.0,
TCGA-B0-4823,3994,TCGA-B0-4823,KIRC,88.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2002.0,[Not Available],-32290.0,Dead,TUMOR FREE,,454.0,[Not Available],,,,,[Not Available],,,1.0,454.0,0.0,454.0,,,0.0,454.0,
TCGA-66-2793,6644,TCGA-66-2793,LUSC,68.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-25111.0,Dead,TUMOR FREE,,306.0,[Not Available],,,,,[Not Available],,,1.0,306.0,0.0,306.0,,,0.0,306.0,
TCGA-RW-A68F,7772,TCGA-RW-A68F,PCPG,51.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-18974.0,Alive,TUMOR FREE,1354.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1354.0,0.0,1354.0,0.0,1354.0,0.0,1354.0,
TCGA-CV-7407,3549,TCGA-CV-7407,HNSC,67.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1992.0,[Not Available],-24475.0,Dead,,,1081.0,[Not Available],,,,,[Not Available],,,1.0,1081.0,,1081.0,,,0.0,1081.0,
TCGA-DB-A4XF,4947,TCGA-DB-A4XF,LGG,41.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2011.0,[Not Available],-15066.0,Alive,TUMOR FREE,1021.0,,[Not Available],,,,468.0,Stable Disease,,,0.0,1021.0,0.0,1021.0,,,1.0,468.0,
TCGA-G9-7525,8054,TCGA-G9-7525,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-23481.0,Alive,TUMOR FREE,994.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,994.0,0.0,994.0,0.0,994.0,0.0,994.0,
TCGA-B4-5844,4091,TCGA-B4-5844,KIRC,61.0,FEMALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2010.0,[Not Available],-22409.0,Alive,TUMOR FREE,7.0,,[Not Available],,,,,[Unknown],,,0.0,7.0,0.0,7.0,,,0.0,7.0,
TCGA-73-4670,6118,TCGA-73-4670,LUAD,69.0,FEMALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-25526.0,Alive,WITH TUMOR,131.0,,[Not Available],,,,,Stable Disease,,,0.0,131.0,0.0,131.0,,,0.0,131.0,
TCGA-JV-A5VE,8708,TCGA-JV-A5VE,SARC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-21933.0,Alive,TUMOR FREE,499.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,499.0,0.0,499.0,0.0,499.0,0.0,499.0,
TCGA-EL-A3H7,10075,TCGA-EL-A3H7,THCA,36.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002.0,[Not Available],-13407.0,Alive,TUMOR FREE,4228.0,,[Not Available],,,,,[Not Available],,R0,0.0,4228.0,0.0,4228.0,0.0,4228.0,0.0,4228.0,
TCGA-VQ-A8P5,9653,TCGA-VQ-A8P5,STAD,67.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-24571.0,Dead,,,235.0,[Unknown],,,,,Progressive Disease,,,1.0,235.0,,235.0,,,0.0,235.0,
TCGA-32-2638,3184,TCGA-32-2638,GBM,67.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-24658.0,Dead,WITH TUMOR,,766.0,[Not Available],,,,,[Not Available],,,1.0,766.0,1.0,766.0,,,1.0,766.0,
TCGA-13-1500,7092,TCGA-13-1500,OV,71.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,[Not Available],-26172.0,Dead,WITH TUMOR,425.0,425.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],253.0,Partial Remission/Response,,,1.0,425.0,1.0,425.0,,,1.0,253.0,
TCGA-EJ-7788,7965,TCGA-EJ-7788,PRAD,53.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-19623.0,Alive,TUMOR FREE,859.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,859.0,0.0,859.0,0.0,859.0,0.0,859.0,
TCGA-EL-A3D1,10055,TCGA-EL-A3D1,THCA,39.0,MALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-14245.0,Alive,TUMOR FREE,2997.0,,[Not Available],,,,,[Not Available],,R0,0.0,2997.0,0.0,2997.0,0.0,2997.0,0.0,2997.0,
TCGA-44-8119,5893,TCGA-44-8119,LUAD,73.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27003.0,Alive,TUMOR FREE,285.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,285.0,0.0,285.0,0.0,285.0,0.0,285.0,
TCGA-CF-A47Y,162,TCGA-CF-A47Y,BLCA,55.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,[Not Available],-20432.0,Alive,TUMOR FREE,373.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,373.0,0.0,373.0,0.0,373.0,0.0,373.0,
TCGA-2Z-A9JM,4436,TCGA-2Z-A9JM,KIRP,28.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-10323.0,Alive,TUMOR FREE,934.0,,[Not Available],,,,,[Unknown],,,0.0,934.0,0.0,934.0,,,0.0,934.0,
TCGA-86-8668,6201,TCGA-86-8668,LUAD,61.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22383.0,Alive,TUMOR FREE,423.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,423.0,0.0,423.0,0.0,423.0,0.0,423.0,
TCGA-FU-A3EO,1756,TCGA-FU-A3EO,CESC,55.0,FEMALE,WHITE,[Not Available],Stage IIB,Endocervical Type of Adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20207.0,Alive,TUMOR FREE,490.0,,,,,,,Complete Remission/Response,,,0.0,490.0,0.0,490.0,0.0,490.0,0.0,490.0,
TCGA-UU-A93S,1593,TCGA-UU-A93S,BRCA,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23278.0,Dead,WITH TUMOR,,116.0,[Not Available],,,,,[Not Available],Positive,,1.0,116.0,1.0,116.0,,,1.0,116.0,
TCGA-KD-A5QS,8718,TCGA-KD-A5QS,SARC,55.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2009.0,[Not Available],-20410.0,Dead,WITH TUMOR,,1941.0,[Not Available],Distant Metastasis,Bone,,351.0,[Not Available],[Unknown],RX,1.0,1941.0,1.0,1941.0,,,1.0,351.0,
TCGA-B5-A11W,10710,TCGA-B5-A11W,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22365.0,Alive,TUMOR FREE,593.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,593.0,0.0,593.0,0.0,593.0,0.0,593.0,
TCGA-26-A7UX,3116,TCGA-26-A7UX,GBM,47.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2013.0,[Not Available],-17365.0,Alive,WITH TUMOR,588.0,,[Not Available],Recurrence,[Not Applicable],[Not Applicable],407.0,Stable Disease,,,0.0,588.0,0.0,588.0,,,1.0,407.0,
TCGA-AC-A8OS,802,TCGA-AC-A8OS,BRCA,71.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26248.0,Alive,TUMOR FREE,70.0,,[Not Available],,,,,[Not Available],Negative,,0.0,70.0,0.0,70.0,0.0,70.0,0.0,70.0,
TCGA-DX-A2IZ,8572,TCGA-DX-A2IZ,SARC,60.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2007.0,[Not Available],-22245.0,Alive,TUMOR FREE,261.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,261.0,0.0,261.0,0.0,261.0,0.0,261.0,
TCGA-CH-5754,7892,TCGA-CH-5754,PRAD,65.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-23803.0,Alive,WITH TUMOR,62.0,,[Not Available],,,,,[Not Available],,,0.0,62.0,0.0,62.0,,,0.0,62.0,
TCGA-05-4395,5811,TCGA-05-4395,LUAD,76.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-27971.0,Dead,TUMOR FREE,,0.0,[Not Available],,,,,[Not Available],,,1.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-D8-A27F,1284,TCGA-D8-A27F,BRCA,40.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14731.0,Alive,TUMOR FREE,488.0,,[Not Available],,,,,[Not Available],Negative,,0.0,488.0,0.0,488.0,0.0,488.0,0.0,488.0,
TCGA-DX-AB35,8669,TCGA-DX-AB35,SARC,65.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2012.0,[Not Available],-24026.0,Alive,WITH TUMOR,928.0,,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,284.0,[Not Available],Negative,R0,0.0,928.0,0.0,928.0,1.0,284.0,1.0,284.0,
TCGA-LC-A66R,391,TCGA-LC-A66R,BLCA,78.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-28793.0,Alive,TUMOR FREE,466.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,466.0,0.0,466.0,,,0.0,466.0,
TCGA-NC-A5HN,6811,TCGA-NC-A5HN,LUSC,77.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-28151.0,Alive,TUMOR FREE,1499.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1499.0,0.0,1499.0,0.0,1499.0,0.0,1499.0,
TCGA-CK-4951,2247,TCGA-CK-4951,COAD,79.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2007.0,[Not Available],-28982.0,Dead,TUMOR FREE,,2134.0,[Not Available],Locoregional Disease,,,480.0,[Not Available],,,1.0,2134.0,0.0,2134.0,,,1.0,480.0,
TCGA-DI-A1C3,10904,TCGA-DI-A1C3,UCEC,38.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008.0,[Not Available],-13885.0,Alive,TUMOR FREE,739.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,739.0,0.0,739.0,0.0,739.0,0.0,739.0,
TCGA-G4-6293,2367,TCGA-G4-6293,COAD,49.0,FEMALE,WHITE,Stage III,[Not Applicable],Colon Adenocarcinoma,[Not Available],2002.0,[Not Available],-18076.0,Alive,TUMOR FREE,4051.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4051.0,0.0,4051.0,0.0,4051.0,0.0,4051.0,
TCGA-BR-4369,9298,TCGA-BR-4369,STAD,75.0,MALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,[Not Available],-27509.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-EE-A2ME,9052,TCGA-EE-A2ME,SKCM,51.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1995.0,[Not Available],-18841.0,Dead,WITH TUMOR,,3141.0,[Not Available],Distant Metastasis,"Other, Specify",retroperitoneal nodule,2703.0,[Not Available],,,1.0,3141.0,1.0,3141.0,,,1.0,2703.0,
TCGA-LD-A66U,1525,TCGA-LD-A66U,BRCA,44.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012.0,[Not Evaluated],-16101.0,Alive,TUMOR FREE,646.0,,[Not Available],,,,,[Not Available],Negative,,0.0,646.0,0.0,646.0,0.0,646.0,0.0,646.0,
TCGA-WB-A821,7864,TCGA-WB-A821,PCPG,73.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2006.0,[Not Available],-26805.0,Alive,TUMOR FREE,2832.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2832.0,0.0,2832.0,0.0,2832.0,0.0,2832.0,
TCGA-64-5775,6081,TCGA-64-5775,LUAD,71.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-26058.0,Dead,WITH TUMOR,,62.0,[Not Available],,,,,Progressive Disease,,,1.0,62.0,1.0,62.0,,,1.0,62.0,
TCGA-EO-A3KW,10938,TCGA-EO-A3KW,UCEC,72.0,FEMALE,[Not Available],[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26492.0,Alive,TUMOR FREE,497.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,497.0,0.0,497.0,0.0,497.0,0.0,497.0,
TCGA-BW-A5NO,5479,TCGA-BW-A5NO,LIHC,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-18510.0,Alive,TUMOR FREE,20.0,,[Not Available],,,,,[Not Available],,RX,0.0,20.0,0.0,20.0,,,0.0,20.0,
TCGA-CZ-5460,4376,TCGA-CZ-5460,KIRC,55.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-20392.0,Alive,WITH TUMOR,2873.0,,[Not Available],,,,,[Not Available],,,0.0,2873.0,0.0,2873.0,,,0.0,2873.0,
TCGA-KK-A8IA,8206,TCGA-KK-A8IA,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-25284.0,Alive,,1931.0,,[Not Available],,,,,[Unknown],,,0.0,1931.0,0.0,1931.0,,,0.0,1931.0,
TCGA-IM-A3U2,10313,TCGA-IM-A3U2,THCA,89.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2012.0,[Not Available],-32682.0,Alive,TUMOR FREE,563.0,,[Not Available],,,,,[Not Available],,R0,0.0,563.0,0.0,563.0,,,0.0,563.0,
TCGA-55-8512,6038,TCGA-55-8512,LUAD,41.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-15266.0,Dead,WITH TUMOR,,607.0,[Not Available],,,,,Progressive Disease,,,1.0,607.0,1.0,607.0,,,1.0,607.0,
TCGA-DD-AAED,5645,TCGA-DD-AAED,LIHC,51.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-18722.0,Alive,WITH TUMOR,763.0,,[Not Available],Intrahepatic Recurrence,Liver,,198.0,[Not Available],,R0,0.0,763.0,0.0,763.0,1.0,198.0,1.0,198.0,
TCGA-UD-AAC4,6896,TCGA-UD-AAC4,MESO,65.0,MALE,WHITE,Stage III,[Not Applicable],Diffuse malignant mesothelioma - NOS,[Not Available],2004.0,[Not Available],-23949.0,Dead,WITH TUMOR,,719.0,[Not Available],Intrapleural Progression,Ipsilateral Pleura,,267.0,[Not Available],,R2,1.0,719.0,1.0,719.0,,,1.0,267.0,
TCGA-BJ-A191,9863,TCGA-BJ-A191,THCA,49.0,FEMALE,WHITE,Stage I,[Not Applicable],"Other, specify",[Not Available],2010.0,[Not Available],-18162.0,Alive,TUMOR FREE,147.0,,[Not Available],,,,,[Not Available],,R0,0.0,147.0,0.0,147.0,0.0,147.0,0.0,147.0,
TCGA-VP-A87C,8283,TCGA-VP-A87C,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-24608.0,Alive,TUMOR FREE,1690.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1690.0,0.0,1690.0,0.0,1690.0,0.0,1690.0,
TCGA-BF-AAOU,8816,TCGA-BF-AAOU,SKCM,73.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-26750.0,Alive,TUMOR FREE,476.0,,[Not Available],,,,,[Not Available],,,0.0,476.0,0.0,476.0,,,0.0,476.0,
TCGA-EJ-7783,7961,TCGA-EJ-7783,PRAD,70.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-25600.0,Alive,TUMOR FREE,787.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,787.0,0.0,787.0,0.0,787.0,0.0,787.0,
TCGA-DA-A95Z,8936,TCGA-DA-A95Z,SKCM,87.0,MALE,WHITE,Stage IV,[Not Applicable],,[Not Available],2013.0,[Not Available],-31837.0,Alive,TUMOR FREE,396.0,,[Not Available],,,,,[Not Available],,,0.0,396.0,0.0,396.0,,,0.0,396.0,
TCGA-CN-4733,3311,TCGA-CN-4733,HNSC,61.0,MALE,WHITE,Stage III,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-22561.0,Alive,TUMOR FREE,1586.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1586.0,0.0,1586.0,0.0,1586.0,0.0,1586.0,
TCGA-56-8308,6528,TCGA-56-8308,LUSC,79.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-29139.0,Alive,WITH TUMOR,517.0,,[Not Available],,,,,Stable Disease,,,0.0,517.0,0.0,517.0,,,0.0,517.0,
TCGA-D9-A4Z3,8908,TCGA-D9-A4Z3,SKCM,73.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-26812.0,Alive,TUMOR FREE,505.0,,[Not Available],Locoregional Recurrence,,,100.0,[Not Available],,,0.0,505.0,0.0,505.0,,,1.0,100.0,
TCGA-FJ-A3ZE,307,TCGA-FJ-A3ZE,BLCA,65.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-23866.0,Dead,WITH TUMOR,,324.0,[Not Available],Distant Metastasis,Bone,,152.0,Progressive Disease,,,1.0,324.0,1.0,324.0,,,1.0,152.0,
TCGA-22-5477,6386,TCGA-22-5477,LUSC,65.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-24055.0,Dead,,1346.0,1346.0,[Not Available],,,,511.0,Complete Remission/Response,,,1.0,1346.0,,1346.0,1.0,511.0,1.0,511.0,
TCGA-RD-A7BT,9627,TCGA-RD-A7BT,STAD,66.0,MALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2002.0,[Not Available],-24107.0,Dead,WITH TUMOR,,262.0,Stomach Cancer,Distant Metastasis,"Other, specify",Adrenal gland,123.0,Progressive Disease,,,1.0,262.0,1.0,262.0,,,1.0,123.0,
TCGA-97-A4LX,6264,TCGA-97-A4LX,LUAD,81.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-29915.0,Alive,TUMOR FREE,614.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,614.0,0.0,614.0,0.0,614.0,0.0,614.0,
TCGA-DD-AADF,5617,TCGA-DD-AADF,LIHC,64.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2011.0,[Not Available],-23614.0,Dead,TUMOR FREE,,115.0,[Not Available],,,,,[Not Available],,R0,1.0,115.0,0.0,115.0,0.0,115.0,0.0,115.0,
TCGA-44-6144,5872,TCGA-44-6144,LUAD,58.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-21283.0,Alive,WITH TUMOR,723.0,,[Not Available],,,,399.0,Complete Remission/Response,,,0.0,723.0,0.0,723.0,1.0,399.0,1.0,399.0,
TCGA-05-4424,5824,TCGA-05-4424,LUAD,70.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-25689.0,Alive,WITH TUMOR,913.0,,[Not Available],Distant Metastasis,,,153.0,Progressive Disease,,,0.0,913.0,0.0,913.0,,,1.0,153.0,
TCGA-BH-A0HK,1098,TCGA-BH-A0HK,BRCA,81.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29751.0,Alive,TUMOR FREE,178.0,,[Not Available],,,,,[Not Available],Negative,,0.0,178.0,0.0,178.0,0.0,178.0,0.0,178.0,
TCGA-FD-A5BT,283,TCGA-FD-A5BT,BLCA,84.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-30686.0,Dead,TUMOR FREE,,328.0,[Not Available],,,,,[Not Applicable],,,1.0,328.0,0.0,328.0,,,0.0,328.0,
TCGA-FU-A3TX,1761,TCGA-FU-A3TX,CESC,78.0,FEMALE,[Not Evaluated],[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28825.0,Alive,,45.0,,,,,,,[Unknown],,,0.0,45.0,0.0,45.0,,,0.0,45.0,
TCGA-2E-A9G8,10476,TCGA-2E-A9G8,UCEC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage III,Endometrioid endometrial adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,Alive,TUMOR FREE,1249.0,,[Not Available],Locoregional Recurrence,"Other, specify",abdominal wall,335.0,Progressive Disease,,,0.0,1249.0,0.0,1249.0,,,1.0,335.0,
TCGA-50-5944,5949,TCGA-50-5944,LUAD,69.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-25440.0,Alive,TUMOR FREE,1750.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1750.0,0.0,1750.0,0.0,1750.0,0.0,1750.0,
TCGA-AR-A0U1,910,TCGA-AR-A0U1,BRCA,36.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13467.0,Alive,TUMOR FREE,4052.0,,[Not Available],,,,,[Not Available],Negative,,0.0,4052.0,0.0,4052.0,0.0,4052.0,0.0,4052.0,Redacted
TCGA-A6-6649,1998,TCGA-A6-6649,COAD,66.0,MALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-24237.0,Alive,TUMOR FREE,735.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,735.0,0.0,735.0,0.0,735.0,0.0,735.0,
TCGA-CH-5790,7906,TCGA-CH-5790,PRAD,64.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-23529.0,Alive,TUMOR FREE,974.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,974.0,0.0,974.0,0.0,974.0,0.0,974.0,
TCGA-M7-A725,8225,TCGA-M7-A725,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20474.0,Alive,TUMOR FREE,573.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,573.0,0.0,573.0,0.0,573.0,0.0,573.0,
TCGA-E1-A7YO,5084,TCGA-E1-A7YO,LGG,45.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,1995.0,[Not Available],-16770.0,Dead,WITH TUMOR,,2282.0,[Not Available],,,,1977.0,Stable Disease,,,1.0,2282.0,1.0,2282.0,,,1.0,1977.0,
TCGA-50-5044,5932,TCGA-50-5044,LUAD,72.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2002.0,[Not Available],-26567.0,Dead,WITH TUMOR,,624.0,[Not Available],Distant Metastasis,,,483.0,Progressive Disease,,,1.0,624.0,1.0,624.0,,,1.0,483.0,
TCGA-YU-AA61,9836,TCGA-YU-AA61,TGCT,29.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Immature),[Not Available],2011.0,[Not Available],-10635.0,Alive,TUMOR FREE,864.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,864.0,0.0,864.0,0.0,864.0,0.0,864.0,
TCGA-32-4211,3188,TCGA-32-4211,GBM,56.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-20748.0,Dead,WITH TUMOR,383.0,383.0,[Not Available],,,,,[Not Available],,,1.0,383.0,1.0,383.0,,,1.0,383.0,
TCGA-77-8146,6686,TCGA-77-8146,LUSC,72.0,MALE,[Not Evaluated],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-26533.0,Alive,,3189.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3189.0,0.0,3189.0,0.0,3189.0,0.0,3189.0,
TCGA-VW-A8FI,5416,TCGA-VW-A8FI,LGG,66.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-24411.0,Dead,WITH TUMOR,,245.0,[Not Available],,,,,Stable Disease,,,1.0,245.0,1.0,245.0,,,1.0,245.0,
TCGA-DM-A1D6,2331,TCGA-DM-A1D6,COAD,88.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2000.0,[Not Available],-32302.0,Dead,,1518.0,1518.0,[Not Available],,,,,[Not Available],,,1.0,1518.0,,1518.0,,,0.0,1518.0,
TCGA-L5-A8NG,2541,TCGA-L5-A8NG,ESCA,77.0,MALE,WHITE,Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2001.0,[Not Available],-28219.0,Alive,TUMOR FREE,1094.0,,[Not Available],,,,,[Unknown],,,0.0,1094.0,0.0,1094.0,,,0.0,1094.0,
TCGA-19-5950,3089,TCGA-19-5950,GBM,52.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-19244.0,Dead,WITH TUMOR,,523.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],294.0,Progressive Disease,,,1.0,523.0,1.0,523.0,,,1.0,294.0,
TCGA-C5-A1MP,1630,TCGA-C5-A1MP,CESC,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12692.0,Alive,TUMOR FREE,109.0,,,,,,,Complete Remission/Response,,,0.0,109.0,0.0,109.0,0.0,109.0,0.0,109.0,
TCGA-ZN-A9VU,6913,TCGA-ZN-A9VU,MESO,70.0,MALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-25714.0,Alive,TUMOR FREE,977.0,,[Not Available],Intrapleural Progression,"Other, specify",left chest wall,585.0,[Not Available],,[Not Available],0.0,977.0,0.0,977.0,,,1.0,585.0,
TCGA-A2-A0SX,574,TCGA-A2-A0SX,BRCA,48.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17774.0,Alive,WITH TUMOR,1534.0,,[Not Available],,,,1239.0,[Not Available],Negative,,0.0,1534.0,0.0,1534.0,1.0,1239.0,1.0,1239.0,
TCGA-CM-6172,2287,TCGA-CM-6172,COAD,70.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-25902.0,Alive,TUMOR FREE,335.0,,[Not Available],,,,,[Not Available],,,0.0,335.0,0.0,335.0,,,0.0,335.0,
TCGA-VP-A87H,8286,TCGA-VP-A87H,PRAD,76.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-28060.0,Alive,TUMOR FREE,663.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,663.0,0.0,663.0,0.0,663.0,0.0,663.0,
TCGA-IB-7893,7633,TCGA-IB-7893,PAAD,64.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2009.0,[Not Available],-23703.0,Dead,WITH TUMOR,,117.0,Pancreatic Cancer,Distant Metastasis,Peritoneal Surfaces,,80.0,Progressive Disease,,,1.0,117.0,1.0,117.0,,,1.0,80.0,
TCGA-A3-3385,3926,TCGA-A3-3385,KIRC,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-17114.0,Alive,TUMOR FREE,1993.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1993.0,0.0,1993.0,0.0,1993.0,0.0,1993.0,
TCGA-IE-A4EJ,8695,TCGA-IE-A4EJ,SARC,84.0,FEMALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012.0,[Not Available],-30858.0,Alive,TUMOR FREE,98.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,98.0,0.0,98.0,,,0.0,98.0,
TCGA-DK-A1A6,182,TCGA-DK-A1A6,BLCA,53.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-19554.0,Alive,TUMOR FREE,2020.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2020.0,0.0,2020.0,,,0.0,2020.0,
TCGA-DD-AAVQ,5652,TCGA-DD-AAVQ,LIHC,38.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-13911.0,Alive,TUMOR FREE,2728.0,,[Not Available],Locoregional Recurrence,Liver,,1509.0,[Not Available],,R0,0.0,2728.0,0.0,2728.0,1.0,1509.0,1.0,1509.0,
TCGA-BR-4267,9286,TCGA-BR-4267,STAD,51.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],-18699.0,Dead,,,188.0,[Not Available],,,,,[Not Available],,,1.0,188.0,,188.0,,,0.0,188.0,
TCGA-VQ-A92D,9692,TCGA-VQ-A92D,STAD,67.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009.0,[Not Available],-24595.0,Alive,TUMOR FREE,2032.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2032.0,0.0,2032.0,0.0,2032.0,0.0,2032.0,
TCGA-C8-A1HF,1199,TCGA-C8-A1HF,BRCA,48.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,Alive,TUMOR FREE,332.0,,[Not Available],,,,,[Not Available],Negative,,0.0,332.0,0.0,332.0,0.0,332.0,0.0,332.0,
TCGA-DX-A48O,8598,TCGA-DX-A48O,SARC,63.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-23364.0,Alive,TUMOR FREE,1605.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1605.0,0.0,1605.0,0.0,1605.0,0.0,1605.0,
TCGA-CQ-7071,3404,TCGA-CQ-7071,HNSC,76.0,FEMALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-27928.0,Alive,TUMOR FREE,1311.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1311.0,0.0,1311.0,,,0.0,1311.0,
TCGA-AX-A3G7,10670,TCGA-AX-A3G7,UCEC,71.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2010.0,[Not Available],-26187.0,Alive,,9.0,,[Not Available],,,,,[Not Available],,,0.0,9.0,0.0,9.0,,,0.0,9.0,
TCGA-AJ-A3I9,10543,TCGA-AJ-A3I9,UCEC,52.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19139.0,Dead,WITH TUMOR,,519.0,[Not Available],Distant Metastasis,Bone,,370.0,Complete Remission/Response,,,1.0,519.0,1.0,519.0,1.0,370.0,1.0,370.0,
TCGA-FG-8186,5116,TCGA-FG-8186,LGG,42.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-15431.0,Alive,WITH TUMOR,487.0,,[Not Available],,,,,Stable Disease,,,0.0,487.0,0.0,487.0,,,0.0,487.0,
TCGA-ZN-A9VV,6914,TCGA-ZN-A9VV,MESO,68.0,MALE,WHITE,Stage III,[Not Applicable],Biphasic mesothelioma,[Not Available],2010.0,[Not Available],-25096.0,Alive,WITH TUMOR,1309.0,,[Not Available],Intrapleural Progression,Ipsilateral Pleura,,676.0,[Not Available],,[Not Available],0.0,1309.0,0.0,1309.0,,,1.0,676.0,
TCGA-IW-A3M4,8705,TCGA-IW-A3M4,SARC,48.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2005.0,[Not Available],-17721.0,Alive,TUMOR FREE,2615.0,,[Not Available],Locoregional Disease,,,2207.0,[Not Available],[Not Available],R0,0.0,2615.0,0.0,2615.0,1.0,2207.0,1.0,2207.0,
TCGA-BS-A0T9,10790,TCGA-BS-A0T9,UCEC,39.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14253.0,Dead,WITH TUMOR,,1428.0,[Not Available],,,,634.0,Complete Remission/Response,,,1.0,1428.0,1.0,1428.0,,,1.0,634.0,
TCGA-BP-4994,4226,TCGA-BP-4994,KIRC,54.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-19946.0,Alive,TUMOR FREE,1308.0,,[Not Available],,,,,[Not Available],,,0.0,1308.0,0.0,1308.0,,,0.0,1308.0,
TCGA-22-5478,6387,TCGA-22-5478,LUSC,79.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-28978.0,Dead,TUMOR FREE,24.0,24.0,[Not Available],,,,,Complete Remission/Response,,,1.0,24.0,0.0,24.0,0.0,24.0,0.0,24.0,
TCGA-DI-A1BY,10903,TCGA-DI-A1BY,UCEC,63.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2008.0,[Not Available],-23113.0,Alive,TUMOR FREE,1114.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1114.0,0.0,1114.0,0.0,1114.0,0.0,1114.0,
TCGA-GU-A764,348,TCGA-GU-A764,BLCA,66.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-24343.0,Alive,TUMOR FREE,610.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,610.0,0.0,610.0,0.0,610.0,0.0,610.0,
TCGA-2H-A9GI,2464,TCGA-2H-A9GI,ESCA,68.0,MALE,[Unknown],Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,1999.0,[Not Available],-25097.0,Dead,WITH TUMOR,,435.0,[Not Available],Locoregional Recurrence,,,400.0,,,,1.0,435.0,1.0,435.0,,,1.0,400.0,
TCGA-VS-A9UC,1867,TCGA-VS-A9UC,CESC,32.0,FEMALE,[Unknown],[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2012.0,Peri (6-12 months since last menstrual period),-11790.0,Alive,WITH TUMOR,825.0,,,,,,,Stable Disease,,,0.0,825.0,0.0,825.0,,,0.0,825.0,
TCGA-E2-A14W,1322,TCGA-E2-A14W,BRCA,78.0,MALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,[Not Available],-28664.0,Alive,TUMOR FREE,974.0,,[Not Available],,,,,[Not Available],Negative,,0.0,974.0,0.0,974.0,0.0,974.0,0.0,974.0,
TCGA-BH-A18P,1123,TCGA-BH-A18P,BRCA,60.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003.0,[Not Available],-22222.0,Dead,WITH TUMOR,,921.0,[Not Available],,,,,[Not Available],Negative,,1.0,921.0,1.0,921.0,,,1.0,921.0,
TCGA-22-5479,6388,TCGA-22-5479,LUSC,64.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-23563.0,Dead,,,2625.0,[Not Available],,,,,[Unknown],,,1.0,2625.0,,2625.0,,,0.0,2625.0,
TCGA-J7-8537,4639,TCGA-J7-8537,KIRP,37.0,FEMALE,ASIAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-13628.0,Dead,WITH TUMOR,,321.0,[Not Available],,,,220.0,Complete Remission/Response,,,1.0,321.0,1.0,321.0,1.0,220.0,1.0,220.0,
TCGA-91-A4BD,6227,TCGA-91-A4BD,LUAD,78.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-28544.0,Alive,TUMOR FREE,603.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,603.0,0.0,603.0,0.0,603.0,0.0,603.0,
TCGA-BH-A28Q,1163,TCGA-BH-A28Q,BRCA,46.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16882.0,Alive,TUMOR FREE,1119.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,1119.0,0.0,1119.0,,,0.0,1119.0,
TCGA-GN-A26C,9201,TCGA-GN-A26C,SKCM,77.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2006.0,[Not Available],-28336.0,Dead,WITH TUMOR,,821.0,[Not Available],Distant Metastasis,Lung,,593.0,[Not Available],,,1.0,821.0,1.0,821.0,,,1.0,593.0,
TCGA-CR-7383,3453,TCGA-CR-7383,HNSC,79.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-29122.0,Dead,WITH TUMOR,,521.0,[Not Available],,Oropharynx,,454.0,Complete Remission/Response,,,1.0,521.0,1.0,521.0,1.0,454.0,1.0,454.0,
TCGA-V5-AASW,2619,TCGA-V5-AASW,ESCA,72.0,MALE,WHITE,[Not Available],Stage IIIA,"Esophagus Adenocarcinoma, NOS",G3,,[Not Available],-26571.0,Alive,WITH TUMOR,282.0,,[Not Available],Distant Metastasis,Lung,,282.0,[Unknown],,,0.0,282.0,0.0,282.0,,,1.0,282.0,
TCGA-28-5211,3157,TCGA-28-5211,GBM,42.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-15507.0,Alive,WITH TUMOR,358.0,,[Not Available],,[Not Applicable],[Not Applicable],225.0,[Not Available],,,0.0,358.0,0.0,358.0,,,1.0,225.0,
TCGA-DA-A1I2,8920,TCGA-DA-A1I2,SKCM,45.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],1996.0,[Not Available],-16701.0,Dead,WITH TUMOR,,5370.0,[Not Available],Regional lymph node,,,4679.0,[Not Available],,,1.0,5370.0,1.0,5370.0,,,1.0,4679.0,
TCGA-BK-A0CA,10779,TCGA-BK-A0CA,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22378.0,Alive,TUMOR FREE,1064.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1064.0,0.0,1064.0,0.0,1064.0,0.0,1064.0,
TCGA-73-7499,6123,TCGA-73-7499,LUAD,81.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-29683.0,Dead,TUMOR FREE,,1531.0,[Not Available],Distant Metastasis,,,1447.0,Complete Remission/Response,,,1.0,1531.0,0.0,1531.0,1.0,1447.0,1.0,1447.0,
TCGA-2Y-A9H1,5436,TCGA-2Y-A9H1,LIHC,58.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-21222.0,Dead,WITH TUMOR,,1229.0,[Not Available],Locoregional Recurrence,Liver,,321.0,[Not Available],,R0,1.0,1229.0,1.0,1229.0,1.0,321.0,1.0,321.0,
TCGA-VR-A8ER,2624,TCGA-VR-A8ER,ESCA,54.0,MALE,[Unknown],Stage III,Stage III,Esophagus Squamous Cell Carcinoma,GX,2009.0,[Not Available],-19951.0,Dead,WITH TUMOR,,378.0,[Not Available],,,,,,,,1.0,378.0,1.0,378.0,,,1.0,378.0,
TCGA-97-7553,6250,TCGA-97-7553,LUAD,58.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-21518.0,Alive,TUMOR FREE,1870.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1870.0,0.0,1870.0,0.0,1870.0,0.0,1870.0,
TCGA-BP-5190,4256,TCGA-BP-5190,KIRC,61.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-22285.0,Alive,TUMOR FREE,1011.0,,[Not Available],,,,,[Not Available],,,0.0,1011.0,0.0,1011.0,,,0.0,1011.0,
TCGA-CJ-4641,4274,TCGA-CJ-4641,KIRC,55.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2005.0,[Not Available],-20410.0,Dead,WITH TUMOR,,1661.0,[Not Available],,,,-359.0,[Not Available],,,1.0,1661.0,1.0,1661.0,,,1.0,,
TCGA-06-0145,2757,TCGA-06-0145,GBM,53.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-19661.0,Dead,WITH TUMOR,71.0,71.0,[Not Available],,,,,[Not Available],,,1.0,71.0,1.0,71.0,,,1.0,71.0,
TCGA-CM-6675,2289,TCGA-CM-6675,COAD,35.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-12935.0,Alive,WITH TUMOR,397.0,,[Not Available],,,,337.0,[Not Available],,,0.0,397.0,0.0,397.0,,,1.0,337.0,
TCGA-06-0210,2802,TCGA-06-0210,GBM,72.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1997.0,[Not Available],-26600.0,Dead,WITH TUMOR,151.0,225.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],67.0,[Not Available],,,1.0,225.0,1.0,225.0,,,1.0,67.0,
TCGA-HU-8245,9560,TCGA-HU-8245,STAD,72.0,MALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Papillary Type",G3,2011.0,[Not Available],-26521.0,Alive,TUMOR FREE,552.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,
TCGA-DX-AB2F,8653,TCGA-DX-AB2F,SARC,76.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2013.0,[Not Available],-27840.0,Alive,TUMOR FREE,365.0,,[Not Available],,,,,[Not Available],Positive,R0,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,
TCGA-DJ-A3V8,9988,TCGA-DJ-A3V8,THCA,28.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-10398.0,Alive,TUMOR FREE,647.0,,[Not Available],,,,,[Not Available],,R0,0.0,647.0,0.0,647.0,0.0,647.0,0.0,647.0,
TCGA-OR-A5J3,3,TCGA-OR-A5J3,ACC,23.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-8624.0,Alive,WITH TUMOR,2091.0,,[Not Available],Distant Metastasis,Lung,,53.0,Complete Remission/Response,,,0.0,2091.0,0.0,2091.0,1.0,53.0,1.0,53.0,
TCGA-KN-8430,3829,TCGA-KN-8430,KICH,75.0,MALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2007.0,[Not Available],-27467.0,Dead,WITH TUMOR,,,[Not Available],,,,,[Unknown],,,1.0,,1.0,,,,1.0,,
TCGA-DH-5142,4967,TCGA-DH-5142,LGG,29.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-10678.0,Alive,WITH TUMOR,1943.0,,[Not Available],,,,1627.0,Stable Disease,,,0.0,1943.0,0.0,1943.0,,,1.0,1627.0,
TCGA-B0-5088,4022,TCGA-B0-5088,KIRC,53.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-19677.0,Dead,TUMOR FREE,,563.0,[Not Available],,,,,[Not Available],,,1.0,563.0,0.0,563.0,,,0.0,563.0,
TCGA-73-4676,6120,TCGA-73-4676,LUAD,45.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-16746.0,Dead,WITH TUMOR,,281.0,[Not Available],,,,,[Unknown],,,1.0,281.0,1.0,281.0,,,1.0,281.0,
TCGA-B1-A654,4509,TCGA-B1-A654,KIRP,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-15721.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,
TCGA-ET-A25J,10203,TCGA-ET-A25J,THCA,40.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-14843.0,Alive,TUMOR FREE,2359.0,,[Not Available],,,,,[Not Available],,R0,0.0,2359.0,0.0,2359.0,0.0,2359.0,0.0,2359.0,
TCGA-B8-A54J,4121,TCGA-B8-A54J,KIRC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2012.0,[Not Available],-22071.0,Alive,TUMOR FREE,528.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,528.0,0.0,528.0,0.0,528.0,0.0,528.0,
TCGA-C5-A901,1667,TCGA-C5-A901,CESC,44.0,FEMALE,WHITE,[Not Available],[Not Available],Cervical Squamous Cell Carcinoma,G2,2000.0,[Not Available],-16186.0,Alive,TUMOR FREE,518.0,,,,,,,[Not Available],,,0.0,518.0,0.0,518.0,,,0.0,518.0,
TCGA-FJ-A3Z9,306,TCGA-FJ-A3Z9,BLCA,72.0,MALE,WHITE,[Not Available],[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-26515.0,Dead,TUMOR FREE,,385.0,[Not Available],,,,,Complete Remission/Response,,,1.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-33-AASI,6415,TCGA-33-AASI,LUSC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-23965.0,Dead,WITH TUMOR,,1344.0,[Not Available],,,,,Stable Disease,,,1.0,1344.0,1.0,1344.0,,,1.0,1344.0,
TCGA-FG-7638,5110,TCGA-FG-7638,LGG,31.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-11528.0,Alive,WITH TUMOR,686.0,,[Not Available],,,,407.0,Stable Disease,,,0.0,686.0,0.0,686.0,,,1.0,407.0,
TCGA-FG-A4MX,5124,TCGA-FG-A4MX,LGG,47.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-17381.0,Alive,TUMOR FREE,569.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,569.0,0.0,569.0,0.0,569.0,0.0,569.0,
TCGA-06-A7TK,2892,TCGA-06-A7TK,GBM,64.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2013.0,[Not Available],-23674.0,Dead,WITH TUMOR,,444.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],342.0,Progressive Disease,,,1.0,444.0,1.0,444.0,,,1.0,342.0,
TCGA-26-5135,3111,TCGA-26-5135,GBM,72.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-26490.0,Dead,,,270.0,[Not Available],,,,,[Unknown],,,1.0,270.0,,270.0,,,0.0,270.0,
TCGA-85-A50Z,6746,TCGA-85-A50Z,LUSC,57.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-20941.0,Alive,TUMOR FREE,493.0,,[Not Available],New Primary Tumor,,,462.0,Complete Remission/Response,,,0.0,493.0,0.0,493.0,0.0,493.0,1.0,462.0,
TCGA-L5-A8NM,2547,TCGA-L5-A8NM,ESCA,84.0,FEMALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2004.0,[Not Available],-30936.0,Dead,TUMOR FREE,,236.0,[Not Available],,,,,,,,1.0,236.0,0.0,236.0,,,0.0,236.0,
TCGA-FS-A4F4,9173,TCGA-FS-A4F4,SKCM,64.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],2001.0,[Not Available],-23663.0,Dead,WITH TUMOR,,2028.0,[Not Available],,,,,[Not Available],,,1.0,2028.0,1.0,2028.0,,,1.0,2028.0,
TCGA-VD-AA8R,11139,TCGA-VD-AA8R,UVM,78.0,FEMALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell,[Not Available],2013.0,[Not Available],-28841.0,Alive,TUMOR FREE,6.0,,[Not Available],,,,,[Not Available],,,0.0,6.0,0.0,6.0,,,0.0,6.0,
TCGA-XF-AAMR,454,TCGA-XF-AAMR,BLCA,48.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-17670.0,Alive,TUMOR FREE,2790.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2790.0,0.0,2790.0,0.0,2790.0,0.0,2790.0,
TCGA-BH-A0C0,1057,TCGA-BH-A0C0,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23006.0,Alive,TUMOR FREE,1270.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1270.0,0.0,1270.0,0.0,1270.0,0.0,1270.0,
TCGA-GM-A2DN,1511,TCGA-GM-A2DN,BRCA,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21288.0,Alive,TUMOR FREE,3091.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3091.0,0.0,3091.0,0.0,3091.0,0.0,3091.0,
TCGA-EM-A3O8,10181,TCGA-EM-A3O8,THCA,33.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-12405.0,Alive,TUMOR FREE,381.0,,[Not Available],,,,,[Not Available],,R0,0.0,381.0,0.0,381.0,0.0,381.0,0.0,381.0,
TCGA-85-7843,6712,TCGA-85-7843,LUSC,50.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-18353.0,Alive,,35.0,,[Not Available],,,,,[Not Available],,,0.0,35.0,0.0,35.0,,,0.0,35.0,
TCGA-EX-A69M,1751,TCGA-EX-A69M,CESC,62.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22917.0,Dead,TUMOR FREE,,253.0,,New Primary Tumor,Lung,,77.0,Complete Remission/Response,,,1.0,253.0,0.0,253.0,0.0,253.0,1.0,77.0,
TCGA-B0-4827,3996,TCGA-B0-4827,KIRC,77.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2002.0,[Not Available],-28467.0,Dead,WITH TUMOR,,885.0,[Not Available],,,,668.0,[Not Available],,,1.0,885.0,1.0,885.0,,,1.0,668.0,
TCGA-4K-AA1G,9777,TCGA-4K-AA1G,TGCT,34.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],2013.0,[Not Available],-12696.0,Alive,TUMOR FREE,436.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,436.0,0.0,436.0,0.0,436.0,0.0,436.0,
TCGA-EL-A4KG,10117,TCGA-EL-A4KG,THCA,35.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-12978.0,Alive,TUMOR FREE,739.0,,[Not Available],,,,,[Not Available],,R0,0.0,739.0,0.0,739.0,0.0,739.0,0.0,739.0,
TCGA-JW-A5VG,1784,TCGA-JW-A5VG,CESC,35.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IIA,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13109.0,Alive,TUMOR FREE,834.0,,,,,,,Complete Remission/Response,,,0.0,834.0,0.0,834.0,0.0,834.0,0.0,834.0,
TCGA-DX-A3UB,8589,TCGA-DX-A3UB,SARC,54.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2009.0,[Not Available],-19862.0,Alive,TUMOR FREE,2247.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,2247.0,0.0,2247.0,0.0,2247.0,0.0,2247.0,
TCGA-LL-A7SZ,1545,TCGA-LL-A7SZ,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18161.0,Alive,TUMOR FREE,594.0,,[Not Available],,,,,[Not Available],Negative,,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,
TCGA-D3-A3MR,8864,TCGA-D3-A3MR,SKCM,42.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2004.0,[Not Available],-15695.0,Alive,TUMOR FREE,3151.0,,[Not Available],,,,3108.0,[Not Available],,,0.0,3151.0,0.0,3151.0,,,1.0,3108.0,
TCGA-WB-A817,7842,TCGA-WB-A817,PCPG,27.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-9981.0,Alive,TUMOR FREE,1310.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1310.0,0.0,1310.0,0.0,1310.0,0.0,1310.0,
TCGA-44-A47F,5898,TCGA-44-A47F,LUAD,74.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27122.0,Alive,TUMOR FREE,337.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,337.0,0.0,337.0,0.0,337.0,0.0,337.0,
TCGA-RW-A689,7767,TCGA-RW-A689,PCPG,58.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-21402.0,Alive,TUMOR FREE,828.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,828.0,0.0,828.0,0.0,828.0,0.0,828.0,
TCGA-UB-AA0V,5779,TCGA-UB-AA0V,LIHC,69.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-25340.0,Alive,TUMOR FREE,314.0,,[Not Available],,,,,[Not Available],,R0,0.0,314.0,0.0,314.0,0.0,314.0,0.0,314.0,
TCGA-ET-A25G,10201,TCGA-ET-A25G,THCA,56.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2008.0,[Not Available],-20816.0,Alive,TUMOR FREE,2492.0,,[Not Available],,,,,[Not Available],,R0,0.0,2492.0,0.0,2492.0,0.0,2492.0,0.0,2492.0,
TCGA-HT-7616,5169,TCGA-HT-7616,LGG,75.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2007.0,[Not Available],-27685.0,Dead,WITH TUMOR,,7.0,[Not Available],,,,,Progressive Disease,,,1.0,7.0,1.0,7.0,,,1.0,7.0,
TCGA-75-7027,6138,TCGA-75-7027,LUAD,,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],,[Not Available],,Alive,TUMOR FREE,3059.0,,[Not Available],Locoregional Recurrence,,,2949.0,Complete Remission/Response,,,0.0,3059.0,0.0,3059.0,1.0,2949.0,1.0,2949.0,
TCGA-22-4595,6373,TCGA-22-4595,LUSC,57.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-21146.0,Dead,WITH TUMOR,734.0,734.0,[Not Available],,,,250.0,Complete Remission/Response,,,1.0,734.0,1.0,734.0,1.0,250.0,1.0,250.0,
TCGA-R6-A6DN,2599,TCGA-R6-A6DN,ESCA,58.0,MALE,WHITE,[Not Available],Stage IV,"Esophagus Adenocarcinoma, NOS",G3,2011.0,[Not Available],-21259.0,Dead,WITH TUMOR,,243.0,[Not Available],Distant Metastasis,"Other, specify",Brain,199.0,Partial Remission/Response,,,1.0,243.0,1.0,243.0,,,1.0,199.0,
TCGA-DA-A1HW,8916,TCGA-DA-A1HW,SKCM,37.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2009.0,[Not Available],-13585.0,Alive,TUMOR FREE,820.0,,[Not Available],,,,852.0,[Not Available],,,0.0,820.0,0.0,820.0,,,1.0,852.0,
TCGA-FE-A237,10264,TCGA-FE-A237,THCA,19.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005.0,[Not Available],-7207.0,Alive,TUMOR FREE,3431.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,,492.0,[Not Available],,R0,0.0,3431.0,0.0,3431.0,1.0,492.0,1.0,492.0,
TCGA-ZJ-AAXD,1899,TCGA-ZJ-AAXD,CESC,35.0,FEMALE,[Unknown],[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2010.0,[Unknown],-12968.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-QK-A6IG,3724,TCGA-QK-A6IG,HNSC,69.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-25334.0,Dead,WITH TUMOR,,222.0,[Not Available],Locoregional Disease,Cervical Lymph Nodes,Left level Ib lymph node,142.0,Progressive Disease,,,1.0,222.0,1.0,222.0,,,1.0,142.0,
TCGA-IN-A7NU,9606,TCGA-IN-A7NU,STAD,69.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,[Not Available],-25515.0,Alive,WITH TUMOR,356.0,,[Not Available],Distant Metastasis,,,337.0,Progressive Disease,,,0.0,356.0,0.0,356.0,,,1.0,337.0,
TCGA-85-6560,6704,TCGA-85-6560,LUSC,59.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-21768.0,Alive,TUMOR FREE,1259.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1259.0,0.0,1259.0,0.0,1259.0,0.0,1259.0,
TCGA-HW-7490,5247,TCGA-HW-7490,LGG,41.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-15092.0,Alive,WITH TUMOR,1387.0,,[Not Available],,,,,Progressive Disease,,,0.0,1387.0,0.0,1387.0,,,0.0,1387.0,
TCGA-G9-6364,8031,TCGA-G9-6364,PRAD,72.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-26603.0,Alive,TUMOR FREE,1198.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1198.0,0.0,1198.0,0.0,1198.0,0.0,1198.0,
TCGA-CV-7438,3572,TCGA-CV-7438,HNSC,87.0,FEMALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,[Not Available],-32021.0,Dead,WITH TUMOR,,194.0,[Not Available],,,,,[Not Available],,,1.0,194.0,1.0,194.0,,,1.0,194.0,
TCGA-97-8174,6257,TCGA-97-8174,LUAD,67.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-24725.0,Dead,,,164.0,[Not Available],,,,,[Not Available],,,1.0,164.0,,164.0,,,0.0,164.0,
TCGA-B7-5818,9271,TCGA-B7-5818,STAD,62.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,[Not Available],-22792.0,Alive,TUMOR FREE,356.0,,[Not Available],,,,,[Unknown],,,0.0,356.0,0.0,356.0,,,0.0,356.0,
TCGA-64-5779,6083,TCGA-64-5779,LUAD,61.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-22305.0,Alive,TUMOR FREE,864.0,,[Not Available],Distant Metastasis,,,795.0,Stable Disease,,,0.0,864.0,0.0,864.0,,,1.0,795.0,
TCGA-DD-AAE2,5636,TCGA-DD-AAE2,LIHC,51.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-18695.0,Alive,TUMOR FREE,638.0,,[Not Available],,,,,[Not Available],,R0,0.0,638.0,0.0,638.0,0.0,638.0,0.0,638.0,
TCGA-BH-A5IZ,1168,TCGA-BH-A5IZ,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18927.0,Alive,TUMOR FREE,567.0,,[Not Available],,,,,[Not Available],Negative,,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,
TCGA-EJ-5526,7938,TCGA-EJ-5526,PRAD,56.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-20558.0,Alive,WITH TUMOR,1909.0,,[Not Available],Locoregional Recurrence,,,537.0,Progressive Disease,,,0.0,1909.0,0.0,1909.0,,,1.0,537.0,
TCGA-HM-A3JK,1772,TCGA-HM-A3JK,CESC,64.0,FEMALE,WHITE,[Not Available],Stage IIA2,Cervical Squamous Cell Carcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23618.0,Alive,TUMOR FREE,632.0,,,,,,,Complete Remission/Response,,,0.0,632.0,0.0,632.0,0.0,632.0,0.0,632.0,
TCGA-B8-4620,4099,TCGA-B8-4620,KIRC,70.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-25786.0,Alive,WITH TUMOR,777.0,,[Not Available],,,,604.0,Complete Remission/Response,,,0.0,777.0,0.0,777.0,1.0,604.0,1.0,604.0,
TCGA-FV-A3I0,5692,TCGA-FV-A3I0,LIHC,76.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocholangiocarcinoma (Mixed),G2,2011.0,[Not Available],-28101.0,Alive,WITH TUMOR,848.0,,[Not Available],Intrahepatic Recurrence,Liver,,159.0,[Not Available],,R0,0.0,848.0,0.0,848.0,1.0,159.0,1.0,159.0,
TCGA-DD-AAE4,5638,TCGA-DD-AAE4,LIHC,49.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-18009.0,Alive,WITH TUMOR,608.0,,[Not Available],Locoregional Recurrence,Liver,,111.0,[Not Available],,R0,0.0,608.0,0.0,608.0,1.0,111.0,1.0,111.0,
TCGA-E2-A14N,1313,TCGA-E2-A14N,BRCA,37.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13743.0,Alive,TUMOR FREE,1434.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1434.0,0.0,1434.0,0.0,1434.0,0.0,1434.0,
TCGA-F4-6703,2357,TCGA-F4-6703,COAD,64.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-23644.0,Alive,TUMOR FREE,1456.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1456.0,0.0,1456.0,0.0,1456.0,0.0,1456.0,
TCGA-D3-A3MO,8863,TCGA-D3-A3MO,SKCM,47.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2009.0,[Not Available],-17220.0,Dead,WITH TUMOR,,284.0,[Not Available],Distant Metastasis,Lung,,47.0,[Not Available],,,1.0,284.0,1.0,284.0,,,1.0,47.0,
TCGA-NA-A5I1,11068,TCGA-NA-A5I1,UCS,80.0,FEMALE,WHITE,[Not Applicable],Stage IIIB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2006.0,[Not Available],-29329.0,Dead,WITH TUMOR,,2680.0,[Not Available],Distant Metastasis,Pelvis,,2553.0,Complete Remission/Response,,,1.0,2680.0,1.0,2680.0,1.0,2553.0,1.0,2553.0,
TCGA-5R-AA1D,5453,TCGA-5R-AA1D,LIHC,17.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-6545.0,Alive,TUMOR FREE,449.0,,[Not Available],,,,,[Not Available],,R0,0.0,449.0,0.0,449.0,0.0,449.0,0.0,449.0,
TCGA-BP-4770,4177,TCGA-BP-4770,KIRC,73.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2005.0,[Not Available],-26824.0,Dead,WITH TUMOR,,329.0,[Not Available],,,,169.0,[Not Available],,,1.0,329.0,1.0,329.0,,,1.0,169.0,
TCGA-HZ-8317,7602,TCGA-HZ-8317,PAAD,69.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2012.0,[Not Available],-25214.0,Dead,WITH TUMOR,,378.0,Pancreatic Cancer,,,,,Progressive Disease,,,1.0,378.0,1.0,378.0,,,1.0,378.0,
TCGA-2G-AAG8,9734,TCGA-2G-AAG8,TGCT,21.0,MALE,WHITE,Stage IB,Stage IIA,Non-Seminoma; Embryonal Carcinoma,[Not Available],2008.0,[Not Available],-7688.0,Alive,TUMOR FREE,2289.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,2289.0,0.0,2289.0,0.0,2289.0,0.0,2289.0,
TCGA-FS-A4F8,9175,TCGA-FS-A4F8,SKCM,52.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1997.0,[Not Available],-19137.0,Dead,WITH TUMOR,,5318.0,[Not Available],,,,,[Not Available],,,1.0,5318.0,1.0,5318.0,,,1.0,5318.0,
TCGA-55-7281,5992,TCGA-55-7281,LUAD,70.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25870.0,Alive,WITH TUMOR,872.0,,[Not Available],Distant Metastasis,,,339.0,Complete Remission/Response,,,0.0,872.0,0.0,872.0,1.0,339.0,1.0,339.0,
TCGA-EB-A4IS,8962,TCGA-EB-A4IS,SKCM,77.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-28315.0,Alive,TUMOR FREE,774.0,,[Not Available],,,,,[Not Available],,,0.0,774.0,0.0,774.0,,,0.0,774.0,
TCGA-KK-A8IF,8210,TCGA-KK-A8IF,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-20888.0,Alive,WITH TUMOR,804.0,,[Not Available],Biochemical evidence of disease,,,648.0,[Unknown],,,0.0,804.0,0.0,804.0,,,1.0,648.0,
TCGA-68-7755,6648,TCGA-68-7755,LUSC,60.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-21936.0,Alive,TUMOR FREE,83.0,,[Not Available],,,,,[Not Available],,,0.0,83.0,0.0,83.0,,,0.0,83.0,
TCGA-BR-8369,9360,TCGA-BR-8369,STAD,76.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-28051.0,Alive,WITH TUMOR,427.0,,[Not Available],Distant Metastasis,"Other, specify",Bone,419.0,Complete Remission/Response,,,0.0,427.0,0.0,427.0,1.0,419.0,1.0,419.0,
TCGA-EE-A3J4,9077,TCGA-EE-A3J4,SKCM,72.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1991.0,[Not Available],-26540.0,Dead,WITH TUMOR,,3869.0,[Not Available],Locoregional Recurrence,,,1429.0,[Not Available],,,1.0,3869.0,1.0,3869.0,,,1.0,1429.0,
TCGA-DQ-5631,3634,TCGA-DQ-5631,HNSC,52.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2009.0,[Not Available],-19172.0,Dead,WITH TUMOR,548.0,548.0,[Not Available],,Distant Metastasis,Lung,447.0,Complete Remission/Response,,,1.0,548.0,1.0,548.0,,,1.0,447.0,
TCGA-76-4926,3212,TCGA-76-4926,GBM,68.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-25085.0,Dead,WITH TUMOR,138.0,138.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],34.0,[Not Available],,,1.0,138.0,1.0,138.0,,,1.0,34.0,
TCGA-90-7964,6757,TCGA-90-7964,LUSC,70.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25646.0,Alive,TUMOR FREE,428.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,
TCGA-A7-A0CE,630,TCGA-A7-A0CE,BRCA,57.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Indeterminate (neither Pre or Postmenopausal),-20863.0,Alive,TUMOR FREE,1074.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1074.0,0.0,1074.0,0.0,1074.0,0.0,1074.0,
TCGA-2G-AAHG,9762,TCGA-2G-AAHG,TGCT,25.0,MALE,WHITE,Stage I,Stage I,Seminoma; NOS,[Not Available],1992.0,[Not Available],-9476.0,Alive,TUMOR FREE,1819.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,1819.0,0.0,1819.0,0.0,1819.0,0.0,1819.0,
TCGA-AD-6964,2195,TCGA-AD-6964,COAD,58.0,MALE,WHITE,[Not Available],[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-21457.0,Dead,WITH TUMOR,,331.0,[Not Available],Metastatic,,,325.0,Progressive Disease,,,1.0,331.0,1.0,331.0,,,1.0,325.0,
TCGA-P4-A5ED,4659,TCGA-P4-A5ED,KIRP,51.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005.0,[Not Available],-18698.0,Alive,TUMOR FREE,2816.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2816.0,0.0,2816.0,0.0,2816.0,0.0,2816.0,
TCGA-YS-AA4M,6908,TCGA-YS-AA4M,MESO,66.0,MALE,WHITE,Stage IV,[Not Applicable],Diffuse malignant mesothelioma - NOS,[Not Available],2013.0,[Not Available],-24176.0,Dead,WITH TUMOR,,84.0,[Not Available],Distant Metastasis,Bone,,-131.0,[Not Available],,R2,1.0,84.0,1.0,84.0,,,1.0,,
TCGA-DK-AA6W,225,TCGA-DK-AA6W,BLCA,78.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-28853.0,Dead,WITH TUMOR,,415.0,[Not Available],Distant Metastasis,Lung,,379.0,Stable Disease,,,1.0,415.0,1.0,415.0,,,1.0,379.0,
TCGA-EV-5901,4586,TCGA-EV-5901,KIRP,47.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-17275.0,Alive,TUMOR FREE,1040.0,,[Not Available],,,,,[Not Available],,,0.0,1040.0,0.0,1040.0,,,0.0,1040.0,
TCGA-D1-A1O8,10883,TCGA-D1-A1O8,UCEC,70.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25789.0,Dead,TUMOR FREE,,120.0,[Not Available],,,,,Complete Remission/Response,,,1.0,120.0,0.0,120.0,0.0,120.0,0.0,120.0,
TCGA-DE-A0XZ,9904,TCGA-DE-A0XZ,THCA,65.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-24020.0,Alive,TUMOR FREE,1090.0,,[Not Available],,,,204.0,[Not Available],,R0,0.0,1090.0,0.0,1090.0,1.0,204.0,1.0,204.0,
TCGA-E2-A15E,1337,TCGA-E2-A15E,BRCA,40.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14894.0,Alive,TUMOR FREE,630.0,,[Not Available],,,,,[Not Available],Negative,,0.0,630.0,0.0,630.0,0.0,630.0,0.0,630.0,
TCGA-WA-A7GZ,3768,TCGA-WA-A7GZ,HNSC,58.0,MALE,WHITE,[Not Available],Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21207.0,Dead,TUMOR FREE,,625.0,[Not Available],,,,,Complete Remission/Response,,,1.0,625.0,0.0,625.0,0.0,625.0,0.0,625.0,
TCGA-BR-8588,9374,TCGA-BR-8588,STAD,55.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-20177.0,Alive,TUMOR FREE,389.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,389.0,0.0,389.0,0.0,389.0,0.0,389.0,
TCGA-GM-A2DO,1512,TCGA-GM-A2DO,BRCA,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19842.0,Alive,TUMOR FREE,2596.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2596.0,0.0,2596.0,0.0,2596.0,0.0,2596.0,
TCGA-BS-A0V4,10809,TCGA-BS-A0V4,UCEC,56.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20777.0,Alive,TUMOR FREE,1810.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1810.0,0.0,1810.0,0.0,1810.0,0.0,1810.0,
TCGA-EL-A3D4,10056,TCGA-EL-A3D4,THCA,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-22923.0,Alive,TUMOR FREE,2116.0,,[Not Available],,,,,[Not Available],,R0,0.0,2116.0,0.0,2116.0,,,0.0,2116.0,
TCGA-EM-A1CT,10121,TCGA-EM-A1CT,THCA,76.0,MALE,[Not Available],Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-27944.0,Alive,TUMOR FREE,553.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,553.0,0.0,553.0,,,0.0,553.0,
TCGA-02-0055,2676,TCGA-02-0055,GBM,62.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-22798.0,Dead,WITH TUMOR,76.0,76.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],6.0,[Not Available],,,1.0,76.0,1.0,76.0,,,1.0,6.0,
TCGA-FB-AAPS,7561,TCGA-FB-AAPS,PAAD,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,[Not Available],-22981.0,Alive,,228.0,,,,,,,[Unknown],,,0.0,228.0,0.0,228.0,,,0.0,228.0,
TCGA-DC-6683,8494,TCGA-DC-6683,READ,43.0,MALE,WHITE,Stage IIIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-15918.0,Alive,TUMOR FREE,762.0,,[Not Available],,,,,[Not Applicable],,,0.0,762.0,0.0,762.0,,,0.0,762.0,
TCGA-13-2059,7105,TCGA-13-2059,OV,50.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-18449.0,Alive,WITH TUMOR,2387.0,,[Not Available],,[Not Applicable],[Not Applicable],1005.0,Complete Remission/Response,,,0.0,2387.0,0.0,2387.0,1.0,1005.0,1.0,1005.0,
TCGA-B6-A0WW,1004,TCGA-B6-A0WW,BRCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1997.0,Indeterminate (neither Pre or Postmenopausal),-21479.0,Dead,WITH TUMOR,,558.0,[Not Available],Distant Metastasis,Liver,,447.0,[Not Available],Negative,,1.0,558.0,1.0,558.0,1.0,447.0,1.0,447.0,
TCGA-A4-8312,4479,TCGA-A4-8312,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-22231.0,Alive,TUMOR FREE,708.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,708.0,0.0,708.0,0.0,708.0,0.0,708.0,
TCGA-B8-5163,4105,TCGA-B8-5163,KIRC,63.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-23293.0,Alive,TUMOR FREE,822.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,
TCGA-KL-8329,3776,TCGA-KL-8329,KICH,57.0,FEMALE,ASIAN,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2003.0,[Not Available],-20972.0,Alive,TUMOR FREE,2752.0,,[Not Available],,,,,[Unknown],,,0.0,2752.0,0.0,2752.0,,,0.0,2752.0,
TCGA-YL-A8SB,8324,TCGA-YL-A8SB,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-22991.0,Alive,WITH TUMOR,1719.0,,[Not Available],Biochemical evidence of disease,,,1384.0,Stable Disease,,,0.0,1719.0,0.0,1719.0,,,1.0,1384.0,
TCGA-F9-A97G,4593,TCGA-F9-A97G,KIRP,79.0,MALE,ASIAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-29156.0,Alive,TUMOR FREE,13.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,13.0,0.0,13.0,0.0,13.0,0.0,13.0,
TCGA-AA-3502,2018,TCGA-AA-3502,COAD,73.0,MALE,[Not Available],Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2003.0,[Not Available],-26724.0,Alive,WITH TUMOR,1065.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1065.0,0.0,1065.0,0.0,1065.0,0.0,1065.0,
TCGA-BR-8060,9338,TCGA-BR-8060,STAD,75.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-27561.0,Dead,TUMOR FREE,,348.0,[Not Available],,,,,Complete Remission/Response,,,1.0,348.0,0.0,348.0,0.0,348.0,0.0,348.0,
TCGA-G7-6793,4597,TCGA-G7-6793,KIRP,60.0,FEMALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007.0,[Not Available],-22215.0,Dead,WITH TUMOR,,336.0,[Not Available],,,,,[Not Available],,,1.0,336.0,1.0,336.0,,,1.0,336.0,
TCGA-KL-8346,3793,TCGA-KL-8346,KICH,62.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2008.0,[Not Available],-22651.0,Alive,TUMOR FREE,1897.0,,[Not Available],,,,,[Unknown],,,0.0,1897.0,0.0,1897.0,,,0.0,1897.0,
TCGA-HZ-A77P,7613,TCGA-HZ-A77P,PAAD,77.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2013.0,[Not Available],-28403.0,Alive,TUMOR FREE,330.0,,,,,,,Complete Remission/Response,,,0.0,330.0,0.0,330.0,0.0,330.0,0.0,330.0,
TCGA-A3-3317,3891,TCGA-A3-3317,KIRC,67.0,MALE,[Not Available],Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-24803.0,Alive,TUMOR FREE,1491.0,,[Not Available],,,,560.0,[Not Available],,,0.0,1491.0,0.0,1491.0,,,1.0,560.0,
TCGA-BF-A1PU,8801,TCGA-BF-A1PU,SKCM,46.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2010.0,[Not Available],-17025.0,Alive,TUMOR FREE,387.0,,[Not Available],Distant Metastasis,Lung,,484.0,[Not Available],,,0.0,387.0,0.0,387.0,,,1.0,484.0,
TCGA-CJ-4916,4314,TCGA-CJ-4916,KIRC,69.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-25470.0,Alive,TUMOR FREE,1373.0,,[Not Available],,,,,[Not Available],,,0.0,1373.0,0.0,1373.0,,,0.0,1373.0,
TCGA-DW-7842,4579,TCGA-DW-7842,KIRP,52.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-19166.0,Alive,WITH TUMOR,92.0,,[Not Available],,,,,[Not Available],,,0.0,92.0,0.0,92.0,,,0.0,92.0,
TCGA-A7-A26H,646,TCGA-A7-A26H,BRCA,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26423.0,Alive,WITH TUMOR,724.0,,[Not Available],Distant Metastasis,Liver,,291.0,[Not Available],Negative,,0.0,724.0,0.0,724.0,1.0,291.0,1.0,291.0,
TCGA-E9-A1N9,1398,TCGA-E9-A1N9,BRCA,58.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21228.0,Alive,TUMOR FREE,1101.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1101.0,0.0,1101.0,0.0,1101.0,0.0,1101.0,
TCGA-NK-A5CX,6819,TCGA-NK-A5CX,LUSC,73.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26879.0,Alive,TUMOR FREE,111.0,,[Not Available],,,,,Stable Disease,,,0.0,111.0,0.0,111.0,,,0.0,111.0,
TCGA-B8-5545,4108,TCGA-B8-5545,KIRC,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-15376.0,Alive,TUMOR FREE,1525.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1525.0,0.0,1525.0,0.0,1525.0,0.0,1525.0,
TCGA-KO-8409,3843,TCGA-KO-8409,KICH,69.0,MALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-25419.0,Alive,TUMOR FREE,3180.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3180.0,0.0,3180.0,0.0,3180.0,0.0,3180.0,
TCGA-XU-A92W,10425,TCGA-XU-A92W,THYM,61.0,MALE,WHITE,[Not Applicable],IIa,Thymoma; Type AB,[Not Available],2005.0,[Not Available],-22554.0,Alive,TUMOR FREE,3279.0,,[Not Available],,,,,[Not Available],,,0.0,3279.0,0.0,3279.0,,,0.0,3279.0,
TCGA-AO-A03U,849,TCGA-AO-A03U,BRCA,31.0,FEMALE,WHITE,Stage I,[Not Applicable],"Other, specify",[Not Available],2001.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11354.0,Dead,TUMOR FREE,,1793.0,[Not Available],New Primary Tumor,Lung,,1614.0,[Not Available],Negative,,1.0,1793.0,0.0,1793.0,0.0,1793.0,1.0,1614.0,
TCGA-E2-A10C,1310,TCGA-E2-A10C,BRCA,54.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19849.0,Alive,TUMOR FREE,1220.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1220.0,0.0,1220.0,0.0,1220.0,0.0,1220.0,
TCGA-JY-A939,2502,TCGA-JY-A939,ESCA,77.0,MALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2012.0,[Not Available],-28181.0,Alive,WITH TUMOR,660.0,,[Not Available],,,,,Stable Disease,,,0.0,660.0,0.0,660.0,,,0.0,660.0,
TCGA-DD-A1EB,5526,TCGA-DD-A1EB,LIHC,72.0,FEMALE,[Not Available],Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2001.0,[Not Available],-26471.0,Alive,[Discrepancy],2017.0,,[Not Available],Intrahepatic Recurrence,Liver,,505.0,[Not Available],,R0,0.0,2017.0,0.0,2017.0,1.0,505.0,1.0,505.0,
TCGA-LN-A4A6,2576,TCGA-LN-A4A6,ESCA,65.0,MALE,ASIAN,Stage II,Stage II,Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-24011.0,Alive,TUMOR FREE,391.0,,[Not Available],Locoregional Recurrence,,,158.0,Complete Remission/Response,,,0.0,391.0,0.0,391.0,1.0,158.0,1.0,158.0,
TCGA-IN-A6RI,9596,TCGA-IN-A6RI,STAD,45.0,MALE,WHITE,Stage I,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-16788.0,Alive,TUMOR FREE,559.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,559.0,0.0,559.0,0.0,559.0,0.0,559.0,
TCGA-2J-AAB9,7507,TCGA-2J-AAB9,PAAD,70.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2012.0,[Not Available],-25920.0,Dead,WITH TUMOR,,627.0,Pancreatic Cancer,Distant Metastasis,Liver,,521.0,Complete Remission/Response,,,1.0,627.0,1.0,627.0,1.0,521.0,1.0,521.0,
TCGA-RW-A67X,7759,TCGA-RW-A67X,PCPG,47.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2003.0,[Not Available],-17307.0,Alive,TUMOR FREE,89.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,89.0,0.0,89.0,0.0,89.0,0.0,89.0,
TCGA-A2-A1G0,600,TCGA-A2-A1G0,BRCA,49.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18002.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,[Not Available],Negative,,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,
TCGA-IZ-A6M8,4636,TCGA-IZ-A6M8,KIRP,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-25545.0,Alive,TUMOR FREE,497.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,497.0,0.0,497.0,0.0,497.0,0.0,497.0,
TCGA-AO-A12D,878,TCGA-AO-A12D,BRCA,43.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15774.0,Alive,TUMOR FREE,2515.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2515.0,0.0,2515.0,0.0,2515.0,0.0,2515.0,
TCGA-LN-A7HY,2587,TCGA-LN-A7HY,ESCA,50.0,MALE,ASIAN,Stage III,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-18296.0,Alive,TUMOR FREE,366.0,,[Not Available],Locoregional Recurrence,,,88.0,Complete Remission/Response,,,0.0,366.0,0.0,366.0,1.0,88.0,1.0,88.0,
TCGA-S3-AA14,1589,TCGA-S3-AA14,BRCA,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17352.0,Alive,TUMOR FREE,529.0,,[Not Available],,,,,[Not Available],Negative,,0.0,529.0,0.0,529.0,0.0,529.0,0.0,529.0,
TCGA-H2-A421,10309,TCGA-H2-A421,THCA,34.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-12657.0,Alive,TUMOR FREE,610.0,,[Not Available],,,,,[Not Available],,[Unknown],0.0,610.0,0.0,610.0,,,0.0,610.0,
TCGA-55-7728,6003,TCGA-55-7728,LUAD,64.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23505.0,Alive,TUMOR FREE,704.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,704.0,0.0,704.0,0.0,704.0,0.0,704.0,
TCGA-MO-A47R,8733,TCGA-MO-A47R,SARC,75.0,FEMALE,ASIAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2010.0,[Not Available],-27731.0,Dead,WITH TUMOR,,318.0,[Not Available],Distant Metastasis,Brain,,259.0,[Not Available],[Not Available],R0,1.0,318.0,1.0,318.0,1.0,259.0,1.0,259.0,
TCGA-DB-5281,4940,TCGA-DB-5281,LGG,61.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2006.0,[Not Available],-22342.0,Alive,WITH TUMOR,2381.0,,[Not Available],,,,,Stable Disease,,,0.0,2381.0,0.0,2381.0,,,0.0,2381.0,
TCGA-D8-A1Y2,1281,TCGA-D8-A1Y2,BRCA,71.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26021.0,Alive,TUMOR FREE,433.0,,[Not Available],,,,,[Not Available],Negative,,0.0,433.0,0.0,433.0,0.0,433.0,0.0,433.0,
TCGA-76-6282,3224,TCGA-76-6282,GBM,63.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-23323.0,Dead,WITH TUMOR,519.0,519.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],458.0,[Not Available],,,1.0,519.0,1.0,519.0,,,1.0,458.0,
TCGA-ES-A2HT,5688,TCGA-ES-A2HT,LIHC,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-20023.0,Dead,TUMOR FREE,,438.0,[Not Available],,,,,[Not Available],,R0,1.0,438.0,0.0,438.0,0.0,438.0,0.0,438.0,
TCGA-C5-A1MH,1624,TCGA-C5-A1MH,CESC,71.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26234.0,Dead,WITH TUMOR,,1186.0,Cervical Cancer,Distant Metastasis,Lung,,178.0,Complete Remission/Response,,,1.0,1186.0,1.0,1186.0,1.0,178.0,1.0,178.0,
TCGA-36-2543,7401,TCGA-36-2543,OV,85.0,FEMALE,[Not Available],[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,[Not Available],-31211.0,Dead,WITH TUMOR,68.0,68.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],27.0,Progressive Disease,,,1.0,68.0,1.0,68.0,,,1.0,27.0,
TCGA-HT-A614,5230,TCGA-HT-A614,LGG,47.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-17392.0,Alive,WITH TUMOR,82.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,82.0,0.0,82.0,,,0.0,82.0,
TCGA-S3-AA12,1588,TCGA-S3-AA12,BRCA,82.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30101.0,Alive,TUMOR FREE,574.0,,[Not Available],,,,,[Not Available],Negative,,0.0,574.0,0.0,574.0,0.0,574.0,0.0,574.0,
TCGA-D7-5577,9486,TCGA-D7-5577,STAD,53.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-19668.0,Dead,WITH TUMOR,,782.0,[Not Available],Distant Metastasis,"Other, specify","liver,  peritoneal surfaces, non-regional/distant lymph nodes",376.0,Progressive Disease,,,1.0,782.0,1.0,782.0,,,1.0,376.0,
TCGA-55-5899,5971,TCGA-55-5899,LUAD,58.0,MALE,WHITE,[Discrepancy],[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],,Alive,TUMOR FREE,930.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,
TCGA-KL-8327,3774,TCGA-KL-8327,KICH,46.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2001.0,[Not Available],-17121.0,Alive,TUMOR FREE,4169.0,,[Not Available],,,,,[Unknown],,,0.0,4169.0,0.0,4169.0,,,0.0,4169.0,
TCGA-DD-AAD0,5605,TCGA-DD-AAD0,LIHC,73.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2010.0,[Not Available],-26781.0,Alive,WITH TUMOR,137.0,,[Not Available],Intrahepatic Recurrence,Liver,,47.0,[Not Available],,R0,0.0,137.0,0.0,137.0,1.0,47.0,1.0,47.0,
TCGA-ER-A19H,9101,TCGA-ER-A19H,SKCM,40.0,MALE,WHITE,[Not Available],[Not Applicable],,[Not Available],1995.0,[Not Available],-14935.0,Dead,TUMOR FREE,,4634.0,[Not Available],,,,,[Not Available],,,1.0,4634.0,0.0,4634.0,,,0.0,4634.0,
TCGA-27-1835,3122,TCGA-27-1835,GBM,53.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-19444.0,Dead,WITH TUMOR,648.0,648.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],157.0,[Not Available],,,1.0,648.0,1.0,648.0,,,1.0,157.0,
TCGA-EL-A3N2,10081,TCGA-EL-A3N2,THCA,24.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-8989.0,Alive,TUMOR FREE,902.0,,[Not Available],,,,,[Not Available],,R0,0.0,902.0,0.0,902.0,0.0,902.0,0.0,902.0,
TCGA-YZ-A980,11156,TCGA-YZ-A980,UVM,75.0,MALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell|Epithelioid Cell,[Not Available],2010.0,[Not Available],-27716.0,Alive,TUMOR FREE,1862.0,,[Not Available],New Primary Tumor,"Other, specify",Scalp,1556.0,[Not Available],,,0.0,1862.0,0.0,1862.0,,,1.0,1556.0,
TCGA-85-8048,6715,TCGA-85-8048,LUSC,62.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-22907.0,Alive,TUMOR FREE,765.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,765.0,0.0,765.0,0.0,765.0,0.0,765.0,
TCGA-AC-A23C,755,TCGA-AC-A23C,BRCA,62.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22751.0,Alive,TUMOR FREE,585.0,,[Not Available],,,,,[Not Available],Negative,,0.0,585.0,0.0,585.0,0.0,585.0,0.0,585.0,
TCGA-L5-A8NV,2554,TCGA-L5-A8NV,ESCA,75.0,MALE,WHITE,Stage IIA,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2001.0,[Not Available],-27546.0,Dead,WITH TUMOR,,1599.0,[Not Available],Locoregional Recurrence,,,1252.0,,,,1.0,1599.0,1.0,1599.0,,,1.0,1252.0,
TCGA-NC-A5HD,6801,TCGA-NC-A5HD,LUSC,79.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-28916.0,Dead,TUMOR FREE,,2.0,[Not Available],,,,,[Not Applicable],,,1.0,2.0,0.0,2.0,,,0.0,2.0,
TCGA-GS-A9TV,2450,TCGA-GS-A9TV,DLBC,40.0,FEMALE,WHITE,[Not Applicable],Stage II,Primary mediastinal (thymic) DLBCL,[Not Available],2013.0,[Not Available],-14838.0,Alive,TUMOR FREE,730.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,730.0,0.0,730.0,0.0,730.0,0.0,730.0,
TCGA-D1-A15X,10829,TCGA-D1-A15X,UCEC,45.0,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,High Grade,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16532.0,Alive,TUMOR FREE,909.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,909.0,0.0,909.0,0.0,909.0,0.0,909.0,
TCGA-CV-6956,3513,TCGA-CV-6956,HNSC,67.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1993.0,[Not Available],-24720.0,Dead,WITH TUMOR,,217.0,[Not Available],,,,,Complete Remission/Response,,,1.0,217.0,1.0,217.0,,,1.0,217.0,
TCGA-HZ-7922,7592,TCGA-HZ-7922,PAAD,61.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,[Not Available],-22413.0,Alive,,4.0,,,,,,,[Not Applicable],,,0.0,4.0,0.0,4.0,,,0.0,4.0,
TCGA-OR-A5LC,66,TCGA-OR-A5LC,ACC,71.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-26084.0,Dead,WITH TUMOR,,159.0,[Not Available],Distant Metastasis,Lung,,50.0,Progressive Disease,,,1.0,159.0,1.0,159.0,,,1.0,50.0,
TCGA-FU-A3NI,1759,TCGA-FU-A3NI,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16533.0,Dead,TUMOR FREE,,638.0,,,,,,[Not Available],,,1.0,638.0,0.0,638.0,,,0.0,638.0,
TCGA-JW-A5VL,1789,TCGA-JW-A5VL,CESC,37.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G1,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13604.0,Alive,TUMOR FREE,474.0,,,,,,,Complete Remission/Response,,,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,
TCGA-CC-A9FS,5510,TCGA-CC-A9FS,LIHC,55.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-20157.0,Alive,WITH TUMOR,211.0,,[Not Available],New Primary Tumor,Lung,,109.0,[Not Available],,R0,0.0,211.0,0.0,211.0,0.0,211.0,1.0,109.0,
TCGA-CH-5791,7907,TCGA-CH-5791,PRAD,72.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-26390.0,Alive,,1004.0,,[Not Available],New Primary Tumor,,,396.0,Complete Remission/Response,,,0.0,1004.0,0.0,1004.0,0.0,1004.0,1.0,396.0,
TCGA-ZM-AA0B,9839,TCGA-ZM-AA0B,TGCT,32.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2012.0,[Not Available],-11820.0,Alive,TUMOR FREE,838.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,838.0,0.0,838.0,0.0,838.0,0.0,838.0,
TCGA-44-6146,5874,TCGA-44-6146,LUAD,64.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-23378.0,Alive,TUMOR FREE,728.0,,[Not Available],Locoregional Recurrence,,,631.0,Complete Remission/Response,,,0.0,728.0,0.0,728.0,1.0,631.0,1.0,631.0,
TCGA-EJ-A8FO,8001,TCGA-EJ-A8FO,PRAD,51.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2013.0,[Not Available],-18875.0,Alive,TUMOR FREE,282.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,282.0,0.0,282.0,0.0,282.0,0.0,282.0,
TCGA-PK-A5HC,92,TCGA-PK-A5HC,ACC,44.0,FEMALE,ASIAN,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-16182.0,Alive,WITH TUMOR,679.0,,[Not Available],Distant Metastasis,Lung,,131.0,Complete Remission/Response,,,0.0,679.0,0.0,679.0,1.0,131.0,1.0,131.0,
TCGA-ZN-A9VS,6912,TCGA-ZN-A9VS,MESO,67.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2011.0,[Not Available],-24490.0,Alive,WITH TUMOR,1228.0,,[Not Available],Intrapleural Progression,Ipsilateral Pleura,,1025.0,[Not Available],,[Not Available],0.0,1228.0,0.0,1228.0,,,1.0,1025.0,
TCGA-ZG-A9LZ,8361,TCGA-ZG-A9LZ,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24132.0,Alive,WITH TUMOR,692.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,692.0,0.0,692.0,,,0.0,692.0,
TCGA-CM-4746,2260,TCGA-CM-4746,COAD,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-22403.0,Alive,TUMOR FREE,1126.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1126.0,0.0,1126.0,0.0,1126.0,0.0,1126.0,
TCGA-E2-A14O,1314,TCGA-E2-A14O,BRCA,76.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27837.0,Alive,TUMOR FREE,1359.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1359.0,0.0,1359.0,0.0,1359.0,0.0,1359.0,
TCGA-EW-A1IZ,1458,TCGA-EW-A1IZ,BRCA,53.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19706.0,Alive,TUMOR FREE,554.0,,[Not Available],,,,,[Not Available],Negative,,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,
TCGA-S7-A7WX,7789,TCGA-S7-A7WX,PCPG,52.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-19190.0,Alive,TUMOR FREE,770.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,770.0,0.0,770.0,0.0,770.0,0.0,770.0,
TCGA-2Z-A9JS,4442,TCGA-2Z-A9JS,KIRP,74.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-27053.0,Dead,TUMOR FREE,,492.0,[Not Available],,,,,Complete Remission/Response,,,1.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,
TCGA-D8-A27I,1287,TCGA-D8-A27I,BRCA,58.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21327.0,Alive,TUMOR FREE,439.0,,[Not Available],,,,,[Not Available],Negative,,0.0,439.0,0.0,439.0,0.0,439.0,0.0,439.0,
TCGA-3B-A9HP,8541,TCGA-3B-A9HP,SARC,57.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2007.0,[Not Available],-21094.0,Dead,WITH TUMOR,,1627.0,[Not Available],Distant Metastasis,Lung,,517.0,[Not Available],Positive,R1,1.0,1627.0,1.0,1627.0,,,1.0,517.0,
TCGA-EE-A2MM,9060,TCGA-EE-A2MM,SKCM,63.0,FEMALE,WHITE,Stage I,[Not Applicable],,[Not Available],1993.0,[Not Available],-23132.0,Dead,WITH TUMOR,,5107.0,[Not Available],New primary melanoma,,,1357.0,[Not Available],,,1.0,5107.0,1.0,5107.0,,,1.0,1357.0,
TCGA-ZB-A96V,10469,TCGA-ZB-A96V,THYM,44.0,MALE,WHITE,[Not Applicable],IVb,Thymoma; Type C,[Not Available],2012.0,[Not Available],-16245.0,Alive,TUMOR FREE,932.0,,[Not Available],,,,,[Not Available],,,0.0,932.0,0.0,932.0,,,0.0,932.0,
TCGA-JU-AAVI,10999,TCGA-JU-AAVI,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22289.0,Dead,WITH TUMOR,,540.0,[Not Available],Distant Metastasis,"Other, specify",Porta Hepatis,505.0,Complete Remission/Response,,,1.0,540.0,1.0,540.0,1.0,505.0,1.0,505.0,
TCGA-FS-A1ZR,9164,TCGA-FS-A1ZR,SKCM,36.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1995.0,[Not Available],-13325.0,Dead,WITH TUMOR,,347.0,[Not Available],,,,152.0,[Not Available],,,1.0,347.0,1.0,347.0,,,1.0,152.0,
TCGA-KL-8342,3789,TCGA-KL-8342,KICH,45.0,FEMALE,WHITE,Stage II,[Not Available],Kidney Chromophobe,[Not Available],2006.0,[Not Available],-16550.0,Alive,TUMOR FREE,2248.0,,[Not Available],,,,,[Unknown],,,0.0,2248.0,0.0,2248.0,,,0.0,2248.0,
TCGA-37-5819,6448,TCGA-37-5819,LUSC,64.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-23726.0,Alive,TUMOR FREE,103.0,,[Not Available],,,,,[Not Available],,,0.0,103.0,0.0,103.0,,,0.0,103.0,
TCGA-BR-6565,9310,TCGA-BR-6565,STAD,67.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-24495.0,Dead,WITH TUMOR,,279.0,[Not Available],,,,,Stable Disease,,,1.0,279.0,1.0,279.0,,,1.0,279.0,
TCGA-64-1676,6074,TCGA-64-1676,LUAD,58.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],-21428.0,Alive,TUMOR FREE,1728.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1728.0,0.0,1728.0,0.0,1728.0,0.0,1728.0,
TCGA-A2-A0YL,593,TCGA-A2-A0YL,BRCA,48.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17702.0,Alive,TUMOR FREE,1474.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1474.0,0.0,1474.0,0.0,1474.0,0.0,1474.0,
TCGA-B0-4818,3990,TCGA-B0-4818,KIRC,68.0,FEMALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2002.0,[Not Available],-24853.0,Dead,WITH TUMOR,,510.0,[Not Available],,,,127.0,[Not Available],,,1.0,510.0,1.0,510.0,,,1.0,127.0,
TCGA-S9-A6TX,5325,TCGA-S9-A6TX,LGG,46.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2011.0,[Not Available],-17025.0,Alive,WITH TUMOR,1245.0,,[Not Available],,,,856.0,Complete Remission/Response,,,0.0,1245.0,0.0,1245.0,1.0,856.0,1.0,856.0,
TCGA-ND-A4WA,11070,TCGA-ND-A4WA,UCS,90.0,FEMALE,ASIAN,[Not Applicable],Stage IC,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Dead,TUMOR FREE,,714.0,[Not Available],,,,,Complete Remission/Response,,,1.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,
TCGA-90-A4EE,6759,TCGA-90-A4EE,LUSC,53.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-19676.0,Alive,TUMOR FREE,688.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,688.0,0.0,688.0,0.0,688.0,0.0,688.0,
TCGA-HE-7129,4619,TCGA-HE-7129,KIRP,,MALE,[Not Available],Stage II,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],,Alive,TUMOR FREE,2492.0,,[Not Available],,,,2399.0,Complete Remission/Response,,,0.0,2492.0,0.0,2492.0,1.0,2399.0,1.0,2399.0,
TCGA-93-8067,6230,TCGA-93-8067,LUAD,77.0,MALE,ASIAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-28453.0,Alive,TUMOR FREE,186.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,186.0,0.0,186.0,0.0,186.0,0.0,186.0,
TCGA-FD-A43X,279,TCGA-FD-A43X,BLCA,84.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-30764.0,Alive,TUMOR FREE,110.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,110.0,0.0,110.0,0.0,110.0,0.0,110.0,
TCGA-2G-AAHL,9763,TCGA-2G-AAHL,TGCT,26.0,MALE,WHITE,Stage I,Stage I,Seminoma; NOS,[Not Available],1994.0,[Not Available],-9749.0,Alive,TUMOR FREE,7081.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,7081.0,0.0,7081.0,0.0,7081.0,0.0,7081.0,
TCGA-P5-A730,5279,TCGA-P5-A730,LGG,22.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-8043.0,Alive,TUMOR FREE,333.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,333.0,0.0,333.0,0.0,333.0,0.0,333.0,
TCGA-FD-A3B6,260,TCGA-FD-A3B6,BLCA,75.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-27541.0,Dead,TUMOR FREE,,1005.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1005.0,0.0,1005.0,0.0,1005.0,0.0,1005.0,
TCGA-DE-A4M8,9909,TCGA-DE-A4M8,THCA,61.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-22357.0,Alive,TUMOR FREE,564.0,,[Not Available],,,,,[Not Available],,R0,0.0,564.0,0.0,564.0,0.0,564.0,0.0,564.0,
TCGA-S9-A6U8,5333,TCGA-S9-A6U8,LGG,24.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2005.0,[Not Available],-9044.0,Dead,WITH TUMOR,,2988.0,[Not Available],,,,367.0,Partial Remission/Response,,,1.0,2988.0,1.0,2988.0,,,1.0,367.0,
TCGA-BR-8058,9336,TCGA-BR-8058,STAD,53.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-19658.0,Alive,TUMOR FREE,1133.0,,[Not Available],New Primary Tumor,"Other, specify",Rectum,89.0,Complete Remission/Response,,,0.0,1133.0,0.0,1133.0,0.0,1133.0,1.0,89.0,
TCGA-EE-A2GD,9031,TCGA-EE-A2GD,SKCM,58.0,FEMALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],1984.0,[Not Available],-21526.0,Dead,WITH TUMOR,,10346.0,[Not Available],Locoregional Recurrence,,,3689.0,[Not Available],,,1.0,10346.0,1.0,10346.0,,,1.0,3689.0,
TCGA-EW-A1OX,1466,TCGA-EW-A1OX,BRCA,43.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15837.0,Alive,TUMOR FREE,911.0,,[Not Available],,,,,[Not Available],Negative,,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,
TCGA-QR-A6H3,7709,TCGA-QR-A6H3,PCPG,41.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2013.0,[Not Available],-15106.0,Alive,TUMOR FREE,434.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,434.0,0.0,434.0,0.0,434.0,0.0,434.0,
TCGA-ER-A2NG,9119,TCGA-ER-A2NG,SKCM,43.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-15903.0,Dead,WITH TUMOR,,1490.0,[Not Available],Distant Metastasis,"Other, Specify",Right Deltoid,766.0,[Not Available],,,1.0,1490.0,1.0,1490.0,,,1.0,766.0,
TCGA-G3-AAV7,5732,TCGA-G3-AAV7,LIHC,38.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-14229.0,Alive,TUMOR FREE,361.0,,[Not Available],,,,,[Not Available],,R0,0.0,361.0,0.0,361.0,0.0,361.0,0.0,361.0,
TCGA-A7-A13F,640,TCGA-A7-A13F,BRCA,44.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16363.0,Alive,TUMOR FREE,765.0,,[Not Available],,,,,[Not Available],Negative,,0.0,765.0,0.0,765.0,0.0,765.0,0.0,765.0,
TCGA-IB-7889,7630,TCGA-IB-7889,PAAD,85.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,[Not Available],-31393.0,Dead,WITH TUMOR,,481.0,Pancreatic Cancer,Locoregional Recurrence,,,352.0,Progressive Disease,,,1.0,481.0,1.0,481.0,,,1.0,352.0,
TCGA-CJ-6031,4335,TCGA-CJ-6031,KIRC,54.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2003.0,[Not Available],-19905.0,Alive,TUMOR FREE,1906.0,,[Not Available],,,,,[Not Available],,,0.0,1906.0,0.0,1906.0,,,0.0,1906.0,
TCGA-ET-A3BX,10239,TCGA-ET-A3BX,THCA,24.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-8791.0,Alive,TUMOR FREE,1596.0,,[Not Available],,,,,[Not Available],,R0,0.0,1596.0,0.0,1596.0,0.0,1596.0,0.0,1596.0,
TCGA-DY-A1DF,8500,TCGA-DY-A1DF,READ,73.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2001.0,[Not Available],-26763.0,Dead,,734.0,734.0,[Not Available],,,,,[Not Available],,,1.0,734.0,,734.0,,,0.0,734.0,
TCGA-69-7973,6101,TCGA-69-7973,LUAD,42.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-15355.0,Alive,TUMOR FREE,230.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,230.0,0.0,230.0,0.0,230.0,0.0,230.0,
TCGA-CV-5976,3486,TCGA-CV-5976,HNSC,50.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2006.0,[Not Available],-18267.0,Alive,TUMOR FREE,1478.0,,[Not Available],,,,,[Not Available],,,0.0,1478.0,0.0,1478.0,,,0.0,1478.0,
TCGA-CV-6939,3500,TCGA-CV-6939,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,1994.0,[Not Available],-21947.0,Dead,WITH TUMOR,,666.0,[Not Available],,,,,[Not Available],,,1.0,666.0,1.0,666.0,,,1.0,666.0,
TCGA-49-AARQ,5929,TCGA-49-AARQ,LUAD,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Lung Adenocarcinoma,[Not Available],1996.0,[Not Available],-15065.0,Alive,TUMOR FREE,6732.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,6732.0,0.0,6732.0,0.0,6732.0,0.0,6732.0,
TCGA-A7-A5ZW,665,TCGA-A7-A5ZW,BRCA,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Peri (6-12 months since last menstrual period),-17529.0,Alive,TUMOR FREE,326.0,,[Not Available],,,,,[Not Available],Negative,,0.0,326.0,0.0,326.0,0.0,326.0,0.0,326.0,
TCGA-ET-A3DW,10248,TCGA-ET-A3DW,THCA,64.0,MALE,ASIAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2003.0,[Not Available],-23603.0,Alive,TUMOR FREE,752.0,,[Not Available],,,,,[Not Available],,R0,0.0,752.0,0.0,752.0,0.0,752.0,0.0,752.0,
TCGA-BP-5199,4263,TCGA-BP-5199,KIRC,58.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-21256.0,Alive,TUMOR FREE,1355.0,,[Not Available],,,,,[Not Available],,,0.0,1355.0,0.0,1355.0,,,0.0,1355.0,
TCGA-BH-A0H5,1090,TCGA-BH-A0H5,BRCA,45.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16719.0,Alive,TUMOR FREE,1620.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1620.0,0.0,1620.0,0.0,1620.0,0.0,1620.0,
TCGA-LT-A8JT,393,TCGA-LT-A8JT,BLCA,69.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-25498.0,Alive,TUMOR FREE,641.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,641.0,0.0,641.0,0.0,641.0,0.0,641.0,
TCGA-YL-A9WY,8342,TCGA-YL-A9WY,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21164.0,Alive,WITH TUMOR,1098.0,,[Not Available],Biochemical evidence of disease,,,765.0,Stable Disease,,,0.0,1098.0,0.0,1098.0,,,1.0,765.0,
TCGA-A7-A26J,648,TCGA-A7-A26J,BRCA,49.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17930.0,Alive,TUMOR FREE,627.0,,[Not Available],,,,,[Not Available],Negative,,0.0,627.0,0.0,627.0,0.0,627.0,0.0,627.0,
TCGA-EE-A29X,9023,TCGA-EE-A29X,SKCM,58.0,FEMALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2009.0,[Not Available],-21363.0,Dead,WITH TUMOR,,545.0,[Not Available],Regional lymph node,,,391.0,[Not Available],,,1.0,545.0,1.0,545.0,,,1.0,391.0,
TCGA-FK-A3SD,10274,TCGA-FK-A3SD,THCA,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-22560.0,Alive,TUMOR FREE,32.0,,[Not Available],,,,,[Not Available],,R0,0.0,32.0,0.0,32.0,0.0,32.0,0.0,32.0,
TCGA-AR-A0TP,898,TCGA-AR-A0TP,BRCA,43.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15812.0,Alive,TUMOR FREE,4275.0,,[Not Available],,,,,[Not Available],Negative,,0.0,4275.0,0.0,4275.0,0.0,4275.0,0.0,4275.0,
TCGA-76-6664,3234,TCGA-76-6664,GBM,49.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-18054.0,Alive,WITH TUMOR,1101.0,,[Not Available],,,,,[Unknown],,,0.0,1101.0,0.0,1101.0,,,0.0,1101.0,
TCGA-96-8170,6778,TCGA-96-8170,LUSC,75.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-27558.0,Alive,TUMOR FREE,531.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,531.0,0.0,531.0,0.0,531.0,0.0,531.0,
TCGA-56-7223,6514,TCGA-56-7223,LUSC,66.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-24288.0,Dead,WITH TUMOR,,442.0,[Not Available],Locoregional Recurrence,,,132.0,Progressive Disease,,,1.0,442.0,1.0,442.0,,,1.0,132.0,
TCGA-GV-A3JZ,357,TCGA-GV-A3JZ,BLCA,55.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-20420.0,Alive,WITH TUMOR,603.0,,[Not Available],,,,,Stable Disease,,,0.0,603.0,0.0,603.0,,,0.0,603.0,
TCGA-06-0125,2742,TCGA-06-0125,GBM,63.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2001.0,[Not Available],-23343.0,Dead,WITH TUMOR,1439.0,1448.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],797.0,[Not Available],,,1.0,1448.0,1.0,1448.0,,,1.0,797.0,
TCGA-80-5611,6176,TCGA-80-5611,LUAD,,MALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],,[Not Available],,Alive,TUMOR FREE,2595.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2595.0,0.0,2595.0,0.0,2595.0,0.0,2595.0,
TCGA-2Y-A9GX,5432,TCGA-2Y-A9GX,LIHC,68.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2007.0,[Not Available],-24963.0,Alive,WITH TUMOR,2442.0,,[Not Available],Locoregional Recurrence,Liver,,2133.0,[Not Available],,R1,0.0,2442.0,0.0,2442.0,,,1.0,2133.0,
TCGA-CV-7250,3541,TCGA-CV-7250,HNSC,64.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2000.0,[Not Available],-23489.0,Dead,TUMOR FREE,,2900.0,[Not Available],Distant Metastasis,Distant Metastasis,suprasternal,111.0,Complete Remission/Response,,,1.0,2900.0,0.0,2900.0,,,1.0,111.0,
TCGA-KO-8410,3844,TCGA-KO-8410,KICH,74.0,FEMALE,WHITE,Stage I,[Not Available],Kidney Chromophobe,[Not Available],2004.0,[Not Available],-27084.0,Alive,TUMOR FREE,3136.0,,[Not Available],,,,,[Not Available],,,0.0,3136.0,0.0,3136.0,,,0.0,3136.0,
TCGA-CV-6952,3509,TCGA-CV-6952,HNSC,65.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1996.0,[Not Available],-23892.0,Dead,TUMOR FREE,,185.0,[Not Available],,,,,[Not Available],,,1.0,185.0,0.0,185.0,,,0.0,185.0,
TCGA-4Z-AA7R,103,TCGA-4Z-AA7R,BLCA,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-26781.0,Dead,WITH TUMOR,,522.0,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,,353.0,Partial Remission/Response,,,1.0,522.0,1.0,522.0,,,1.0,353.0,
TCGA-T3-A92N,3745,TCGA-T3-A92N,HNSC,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVC,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-28879.0,Dead,WITH TUMOR,,95.0,[Not Available],Distant Metastasis,Distant Metastasis,Lung,46.0,Progressive Disease,,,1.0,95.0,1.0,95.0,,,1.0,46.0,
TCGA-A3-3380,3923,TCGA-A3-3380,KIRC,54.0,MALE,[Not Available],Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-19828.0,Alive,TUMOR FREE,567.0,,[Not Available],,,,,[Not Available],,,0.0,567.0,0.0,567.0,,,0.0,567.0,
TCGA-TM-A84G,5377,TCGA-TM-A84G,LGG,54.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2010.0,[Not Available],-20014.0,Alive,TUMOR FREE,1236.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1236.0,0.0,1236.0,0.0,1236.0,0.0,1236.0,
TCGA-BP-5174,4242,TCGA-BP-5174,KIRC,45.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-16693.0,Alive,TUMOR FREE,2257.0,,[Not Available],,,,,[Not Available],,,0.0,2257.0,0.0,2257.0,,,0.0,2257.0,
TCGA-C8-A8HQ,1222,TCGA-C8-A8HQ,BRCA,53.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Mucinous Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19432.0,Alive,TUMOR FREE,380.0,,[Not Available],,,,,[Not Available],Negative,,0.0,380.0,0.0,380.0,0.0,380.0,0.0,380.0,
TCGA-EK-A3GM,1744,TCGA-EK-A3GM,CESC,65.0,FEMALE,WHITE,[Not Available],Stage IIA,Endocervical Type of Adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23879.0,Alive,,0.0,,,,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-FA-8693,2413,TCGA-FA-8693,DLBC,75.0,MALE,WHITE,[Not Applicable],Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2012.0,[Not Available],-27468.0,Alive,TUMOR FREE,132.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,132.0,0.0,132.0,0.0,132.0,0.0,132.0,
TCGA-P4-A5E8,4656,TCGA-P4-A5E8,KIRP,57.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004.0,[Not Available],-21132.0,Dead,WITH TUMOR,,1306.0,[Not Available],,,,42.0,[Not Available],,,1.0,1306.0,1.0,1306.0,,,1.0,42.0,
TCGA-E2-A10B,1309,TCGA-E2-A10B,BRCA,67.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24577.0,Alive,TUMOR FREE,1141.0,,[Not Available],New Primary Tumor,Lung,,195.0,[Not Available],Close,,0.0,1141.0,0.0,1141.0,,,1.0,195.0,
TCGA-BJ-A290,9872,TCGA-BJ-A290,THCA,70.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-25803.0,Alive,WITH TUMOR,919.0,,[Not Available],Distant Metastasis,Lung,,329.0,[Not Available],,[Not Available],0.0,919.0,0.0,919.0,,,1.0,329.0,
TCGA-DU-7008,5011,TCGA-DU-7008,LGG,41.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1998.0,[Not Available],-15289.0,Alive,TUMOR FREE,4752.0,,[Not Available],,,,330.0,Progressive Disease,,,0.0,4752.0,0.0,4752.0,,,1.0,330.0,
TCGA-EL-A3D6,10058,TCGA-EL-A3D6,THCA,51.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1999.0,[Not Available],-18640.0,Alive,,3296.0,,[Not Available],,,,,[Not Available],,R1,0.0,3296.0,0.0,3296.0,,,0.0,3296.0,
TCGA-22-0940,6361,TCGA-22-0940,LUSC,71.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-26272.0,Dead,WITH TUMOR,608.0,669.0,[Not Available],,,,,[Not Available],,,1.0,669.0,1.0,669.0,,,1.0,669.0,
TCGA-55-6978,5981,TCGA-55-6978,LUAD,81.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],,Dead,WITH TUMOR,,176.0,[Not Available],,,,42.0,Progressive Disease,,,1.0,176.0,1.0,176.0,,,1.0,42.0,
TCGA-VP-A876,8279,TCGA-VP-A876,PRAD,46.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2005.0,[Not Available],-16934.0,Alive,TUMOR FREE,3333.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3333.0,0.0,3333.0,0.0,3333.0,0.0,3333.0,
TCGA-43-8118,6486,TCGA-43-8118,LUSC,55.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-20224.0,Dead,,,89.0,[Not Available],,,,,[Unknown],,,1.0,89.0,,89.0,,,0.0,89.0,
TCGA-D8-A1JB,1237,TCGA-D8-A1JB,BRCA,54.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19822.0,Alive,TUMOR FREE,1688.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1688.0,0.0,1688.0,0.0,1688.0,0.0,1688.0,
TCGA-55-A493,6053,TCGA-55-A493,LUAD,54.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-20027.0,Alive,TUMOR FREE,28.0,,[Not Available],,,,,[Unknown],,,0.0,28.0,0.0,28.0,,,0.0,28.0,
TCGA-CV-7446,3574,TCGA-CV-7446,HNSC,66.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1998.0,[Not Available],-24170.0,Dead,WITH TUMOR,,1093.0,[Not Available],,,,,[Not Available],,,1.0,1093.0,1.0,1093.0,,,1.0,1093.0,
TCGA-D9-A4Z6,8910,TCGA-D9-A4Z6,SKCM,54.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-20072.0,Dead,WITH TUMOR,,561.0,[Not Available],Distant Metastasis,Brain,,213.0,[Not Available],,,1.0,561.0,1.0,561.0,,,1.0,213.0,
TCGA-B0-4852,4013,TCGA-B0-4852,KIRC,78.0,FEMALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-28552.0,Dead,WITH TUMOR,,1121.0,[Not Available],,,,860.0,[Not Available],,,1.0,1121.0,1.0,1121.0,,,1.0,860.0,
TCGA-A3-3311,3888,TCGA-A3-3311,KIRC,57.0,MALE,[Not Available],Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-21183.0,Dead,TUMOR FREE,,1191.0,[Not Available],,,,,[Not Available],,,1.0,1191.0,0.0,1191.0,,,0.0,1191.0,
TCGA-SY-A9G5,401,TCGA-SY-A9G5,BLCA,66.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-24260.0,Alive,TUMOR FREE,1186.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1186.0,0.0,1186.0,0.0,1186.0,0.0,1186.0,
TCGA-95-A4VK,6244,TCGA-95-A4VK,LUAD,74.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27040.0,Alive,WITH TUMOR,651.0,,[Not Available],Distant Metastasis,,,496.0,Stable Disease,,,0.0,651.0,0.0,651.0,,,1.0,496.0,
TCGA-A6-A56B,2010,TCGA-A6-A56B,COAD,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-20903.0,Dead,TUMOR FREE,,1711.0,[Not Available],,,,1678.0,Complete Remission/Response,,,1.0,1711.0,0.0,1711.0,1.0,1678.0,1.0,1678.0,
TCGA-LN-A49N,2561,TCGA-LN-A49N,ESCA,50.0,MALE,ASIAN,Stage IIB,Stage IIB,Esophagus Squamous Cell Carcinoma,G2,2010.0,[Not Available],-18503.0,Alive,TUMOR FREE,378.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,
TCGA-34-5231,6424,TCGA-34-5231,LUSC,72.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-26525.0,Dead,TUMOR FREE,,1984.0,[Not Available],,,,,Stable Disease,,,1.0,1984.0,0.0,1984.0,,,0.0,1984.0,
TCGA-HU-A4GU,9580,TCGA-HU-A4GU,STAD,73.0,MALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-27024.0,Alive,TUMOR FREE,200.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,200.0,0.0,200.0,0.0,200.0,0.0,200.0,
TCGA-39-5035,6464,TCGA-39-5035,LUSC,72.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-26383.0,Alive,TUMOR FREE,2080.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2080.0,0.0,2080.0,0.0,2080.0,0.0,2080.0,
TCGA-EM-A22O,10136,TCGA-EM-A22O,THCA,75.0,MALE,ASIAN,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-27758.0,Alive,TUMOR FREE,1344.0,,[Not Available],,,,,[Not Available],,R1,0.0,1344.0,0.0,1344.0,,,0.0,1344.0,
TCGA-EJ-7218,7947,TCGA-EJ-7218,PRAD,71.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2006.0,[Not Available],-26181.0,Alive,TUMOR FREE,2542.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2542.0,0.0,2542.0,0.0,2542.0,0.0,2542.0,
TCGA-44-2668,5862,TCGA-44-2668,LUAD,51.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-18856.0,Dead,WITH TUMOR,,761.0,[Not Available],,,,433.0,Complete Remission/Response,,,1.0,761.0,1.0,761.0,1.0,433.0,1.0,433.0,
TCGA-BH-A0HI,1097,TCGA-BH-A0HI,BRCA,78.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28644.0,Alive,TUMOR FREE,620.0,,[Not Available],,,,,[Not Available],Negative,,0.0,620.0,0.0,620.0,0.0,620.0,0.0,620.0,
TCGA-DU-8168,5040,TCGA-DU-8168,LGG,55.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-20136.0,Alive,TUMOR FREE,431.0,,[Not Available],,,,,Stable Disease,,,0.0,431.0,0.0,431.0,,,0.0,431.0,
TCGA-HT-7688,5178,TCGA-HT-7688,LGG,59.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2009.0,[Not Available],-21844.0,Alive,TUMOR FREE,964.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,964.0,0.0,964.0,0.0,964.0,0.0,964.0,
TCGA-A6-2671,1961,TCGA-A6-2671,COAD,85.0,MALE,WHITE,Stage IV,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-31329.0,Dead,WITH TUMOR,,1331.0,[Not Available],,,,535.0,[Not Available],,,1.0,1331.0,1.0,1331.0,,,1.0,535.0,
TCGA-E8-A2EA,10022,TCGA-E8-A2EA,THCA,52.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19159.0,Alive,TUMOR FREE,1085.0,,[Not Available],,,,,[Not Available],,R0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0,
TCGA-DE-A0Y2,9905,TCGA-DE-A0Y2,THCA,30.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-11227.0,Alive,TUMOR FREE,658.0,,[Not Available],,,,,[Not Available],,R0,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,
TCGA-A2-A0CR,543,TCGA-A2-A0CR,BRCA,54.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20075.0,Alive,TUMOR FREE,3283.0,,[Not Available],,,,,[Not Available],Close,,0.0,3283.0,0.0,3283.0,,,0.0,3283.0,
TCGA-N5-A4RD,11026,TCGA-N5-A4RD,UCS,69.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25413.0,Dead,WITH TUMOR,,142.0,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,75.0,Progressive Disease,,,1.0,142.0,1.0,142.0,,,1.0,75.0,
TCGA-25-2397,7299,TCGA-25-2397,OV,59.0,FEMALE,WHITE,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G3,2004.0,[Not Available],-21581.0,Dead,,365.0,365.0,[Not Available],,,,,[Not Available],,,1.0,365.0,,365.0,,,0.0,365.0,
TCGA-C5-A1ML,1628,TCGA-C5-A1ML,CESC,49.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18067.0,Dead,WITH TUMOR,,636.0,Cervical Cancer,,,,,Progressive Disease,,,1.0,636.0,1.0,636.0,,,1.0,636.0,
TCGA-RD-A8N6,9637,TCGA-RD-A8N6,STAD,78.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,[Not Available],-28834.0,Dead,WITH TUMOR,,272.0,Stomach Cancer,Distant Metastasis,Liver,,163.0,Complete Remission/Response,,,1.0,272.0,1.0,272.0,1.0,163.0,1.0,163.0,
TCGA-BL-A13J,119,TCGA-BL-A13J,BLCA,65.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-23927.0,Dead,WITH TUMOR,,81.0,[Not Available],,,,,Stable Disease,,,1.0,81.0,1.0,81.0,,,1.0,81.0,
TCGA-S9-A7R4,5364,TCGA-S9-A7R4,LGG,46.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-17134.0,Alive,WITH TUMOR,914.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,914.0,0.0,914.0,,,0.0,914.0,
TCGA-NC-A5HL,6809,TCGA-NC-A5HL,LUSC,73.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-26977.0,Dead,TUMOR FREE,,88.0,[Not Available],,,,,[Not Applicable],,,1.0,88.0,0.0,88.0,,,0.0,88.0,
TCGA-GV-A40E,363,TCGA-GV-A40E,BLCA,75.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27569.0,Dead,WITH TUMOR,,261.0,[Not Available],Distant Metastasis,Lung,,219.0,Stable Disease,,,1.0,261.0,1.0,261.0,,,1.0,219.0,
TCGA-EU-5907,4409,TCGA-EU-5907,KIRC,81.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-29863.0,Alive,TUMOR FREE,127.0,,[Not Available],,,,,[Not Available],,,0.0,127.0,0.0,127.0,,,0.0,127.0,
TCGA-A1-A0SG,517,TCGA-A1-A0SG,BRCA,61.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22380.0,Alive,,434.0,,[Not Available],,,,,[Not Available],Negative,,0.0,434.0,0.0,434.0,0.0,434.0,0.0,434.0,
TCGA-BP-5168,4238,TCGA-BP-5168,KIRC,75.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2002.0,[Not Available],-27692.0,Dead,TUMOR FREE,,1463.0,[Not Available],,,,,[Not Available],,,1.0,1463.0,0.0,1463.0,,,0.0,1463.0,
TCGA-XP-A8T6,2638,TCGA-XP-A8T6,ESCA,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2009.0,[Not Available],-19886.0,Dead,TUMOR FREE,,763.0,[Not Available],,,,,Complete Remission/Response,,,1.0,763.0,0.0,763.0,0.0,763.0,0.0,763.0,
TCGA-BR-7197,9322,TCGA-BR-7197,STAD,69.0,MALE,WHITE,Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",GX,2011.0,[Not Available],-25445.0,Alive,TUMOR FREE,280.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,280.0,0.0,280.0,0.0,280.0,0.0,280.0,
TCGA-G2-A2EL,316,TCGA-G2-A2EL,BLCA,77.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-28370.0,Dead,WITH TUMOR,,819.0,[Not Available],Distant Metastasis,Bone,,105.0,Stable Disease,,,1.0,819.0,1.0,819.0,,,1.0,105.0,
TCGA-DD-A11B,5521,TCGA-DD-A11B,LIHC,73.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2005.0,[Not Available],-26857.0,Dead,TUMOR FREE,,14.0,[Not Available],,,,,[Not Available],,RX,1.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-VQ-AA69,9700,TCGA-VQ-AA69,STAD,35.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-13087.0,Alive,TUMOR FREE,864.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,864.0,0.0,864.0,0.0,864.0,0.0,864.0,
TCGA-VS-A8EL,1843,TCGA-VS-A8EL,CESC,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G3,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14162.0,Alive,TUMOR FREE,1992.0,,,,,,,Complete Remission/Response,,,0.0,1992.0,0.0,1992.0,0.0,1992.0,0.0,1992.0,
TCGA-DX-A1KX,8557,TCGA-DX-A1KX,SARC,67.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2009.0,[Not Available],-24784.0,Alive,TUMOR FREE,2087.0,,[Not Available],,,,,[Not Available],[Not Available],R0,0.0,2087.0,0.0,2087.0,0.0,2087.0,0.0,2087.0,
TCGA-E2-A56Z,1386,TCGA-E2-A56Z,BRCA,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25282.0,Alive,TUMOR FREE,252.0,,[Not Available],,,,,[Not Available],Negative,,0.0,252.0,0.0,252.0,0.0,252.0,0.0,252.0,
TCGA-IM-A3ED,10312,TCGA-IM-A3ED,THCA,58.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-21278.0,Alive,TUMOR FREE,1442.0,,[Not Available],,,,,[Not Available],,R0,0.0,1442.0,0.0,1442.0,0.0,1442.0,0.0,1442.0,
TCGA-81-5911,3236,TCGA-81-5911,GBM,33.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-12292.0,Alive,WITH TUMOR,539.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],277.0,[Not Available],,,0.0,539.0,0.0,539.0,,,1.0,277.0,
TCGA-HW-8322,5254,TCGA-HW-8322,LGG,39.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2012.0,[Not Available],-14548.0,Alive,WITH TUMOR,758.0,,[Not Available],,,,,Stable Disease,,,0.0,758.0,0.0,758.0,,,0.0,758.0,
TCGA-US-A776,7673,TCGA-US-A776,PAAD,61.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Colloid (mucinous non-cystic) Carcinoma,G2,2011.0,[Not Available],-22283.0,Alive,TUMOR FREE,1216.0,,,,,,,Complete Remission/Response,,,0.0,1216.0,0.0,1216.0,0.0,1216.0,0.0,1216.0,
TCGA-FI-A2F8,10994,TCGA-FI-A2F8,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23649.0,Alive,WITH TUMOR,933.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,933.0,0.0,933.0,0.0,933.0,0.0,933.0,
TCGA-DY-A1H8,8502,TCGA-DY-A1H8,READ,77.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2000.0,[Not Available],-28459.0,Dead,,992.0,992.0,[Not Available],,,,,[Not Available],,,1.0,992.0,,992.0,,,0.0,992.0,
TCGA-WB-A815,7840,TCGA-WB-A815,PCPG,68.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-24859.0,Alive,TUMOR FREE,1630.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1630.0,0.0,1630.0,0.0,1630.0,0.0,1630.0,
TCGA-NA-A4QW,11063,TCGA-NA-A4QW,UCS,61.0,FEMALE,WHITE,[Not Applicable],Stage IIA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22588.0,Alive,TUMOR FREE,2457.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2457.0,0.0,2457.0,0.0,2457.0,0.0,2457.0,
TCGA-FG-A711,5135,TCGA-FG-A711,LGG,33.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-12248.0,Dead,WITH TUMOR,,1481.0,[Not Available],,,,347.0,Progressive Disease,,,1.0,1481.0,1.0,1481.0,,,1.0,347.0,
TCGA-GJ-A9DB,5735,TCGA-GJ-A9DB,LIHC,68.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-25020.0,Dead,,,67.0,[Not Available],,,,,[Not Available],,R0,1.0,67.0,,67.0,0.0,67.0,0.0,67.0,
TCGA-OX-A56R,3238,TCGA-OX-A56R,GBM,68.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2012.0,[Not Available],-25178.0,Dead,WITH TUMOR,,180.0,[Not Available],,,,,Partial Remission/Response,,,1.0,180.0,1.0,180.0,,,1.0,180.0,
TCGA-ET-A3DR,10243,TCGA-ET-A3DR,THCA,42.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-15404.0,Alive,TUMOR FREE,2451.0,,[Not Available],,,,,[Not Available],,R0,0.0,2451.0,0.0,2451.0,0.0,2451.0,0.0,2451.0,
TCGA-43-6647,6477,TCGA-43-6647,LUSC,69.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-25378.0,Alive,TUMOR FREE,757.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,757.0,0.0,757.0,0.0,757.0,0.0,757.0,
TCGA-A2-A0T7,583,TCGA-A2-A0T7,BRCA,51.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18756.0,Alive,TUMOR FREE,631.0,,[Not Available],,,,,[Not Available],Negative,,0.0,631.0,0.0,631.0,0.0,631.0,0.0,631.0,
TCGA-G4-6295,2369,TCGA-G4-6295,COAD,70.0,FEMALE,WHITE,Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2004.0,[Not Available],-25758.0,Alive,TUMOR FREE,254.0,,[Not Available],,,,,[Not Available],,,0.0,254.0,0.0,254.0,,,0.0,254.0,
TCGA-FD-A43N,275,TCGA-FD-A43N,BLCA,76.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-27833.0,Alive,TUMOR FREE,699.0,,[Not Available],,,,,[Not Applicable],,,0.0,699.0,0.0,699.0,,,0.0,699.0,
TCGA-B8-5553,4114,TCGA-B8-5553,KIRC,67.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-24729.0,Alive,TUMOR FREE,435.0,,[Not Available],,,,,[Not Available],,,0.0,435.0,0.0,435.0,,,0.0,435.0,
TCGA-EL-A4K4,10112,TCGA-EL-A4K4,THCA,33.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-12368.0,Alive,WITH TUMOR,1623.0,,[Not Available],,,,,[Not Available],,R0,0.0,1623.0,0.0,1623.0,0.0,1623.0,0.0,1623.0,
TCGA-DM-A282,2340,TCGA-DM-A282,COAD,60.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2000.0,[Not Available],-22265.0,Alive,,4233.0,,[Not Available],,,,,[Not Available],,,0.0,4233.0,0.0,4233.0,,,0.0,4233.0,
TCGA-CE-A13K,9895,TCGA-CE-A13K,THCA,30.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-11122.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],,R0,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-YZ-A985,11160,TCGA-YZ-A985,UVM,41.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,[Not Available],2012.0,[Not Available],-15164.0,Alive,TUMOR FREE,1184.0,,[Not Available],,,,,[Not Available],,,0.0,1184.0,0.0,1184.0,,,0.0,1184.0,
TCGA-TS-A7P8,6886,TCGA-TS-A7P8,MESO,80.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2012.0,[Not Available],-29464.0,Dead,,,457.0,[Not Available],,"Other, specify",Ipsilateral Chest Cavity,301.0,[Not Available],,[Unknown],1.0,457.0,,457.0,,,1.0,301.0,
TCGA-06-2564,2857,TCGA-06-2564,GBM,50.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-18435.0,Alive,WITH TUMOR,181.0,,[Not Available],,,,,[Not Available],,,0.0,181.0,0.0,181.0,,,0.0,181.0,
TCGA-QR-A70Q,7734,TCGA-QR-A70Q,PCPG,33.0,MALE,WHITE,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2012.0,[Not Available],-12394.0,Alive,TUMOR FREE,140.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,140.0,0.0,140.0,0.0,140.0,0.0,140.0,
TCGA-22-5489,6394,TCGA-22-5489,LUSC,64.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-23618.0,Dead,WITH TUMOR,1912.0,1912.0,[Not Available],,,,428.0,Complete Remission/Response,,,1.0,1912.0,1.0,1912.0,1.0,428.0,1.0,428.0,
TCGA-EW-A6SB,1495,TCGA-EW-A6SB,BRCA,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,[Not Available],-22844.0,Alive,TUMOR FREE,760.0,,[Not Available],,,,,[Not Available],Negative,,0.0,760.0,0.0,760.0,0.0,760.0,0.0,760.0,
TCGA-FP-8099,9541,TCGA-FP-8099,STAD,79.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-29129.0,Alive,TUMOR FREE,519.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,
TCGA-28-5219,3163,TCGA-28-5219,GBM,47.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-17254.0,Alive,TUMOR FREE,690.0,,[Not Available],,[Not Applicable],[Not Applicable],258.0,[Not Applicable],,,0.0,690.0,0.0,690.0,,,1.0,258.0,
TCGA-E9-A1R5,1412,TCGA-E9-A1R5,BRCA,63.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23116.0,Alive,TUMOR FREE,92.0,,[Not Available],,,,,[Not Available],Negative,,0.0,92.0,0.0,92.0,0.0,92.0,0.0,92.0,
TCGA-N7-A4Y5,11045,TCGA-N7-A4Y5,UCS,87.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32058.0,Dead,WITH TUMOR,,8.0,[Not Available],,,,,Progressive Disease,,,1.0,8.0,1.0,8.0,,,1.0,8.0,
TCGA-22-0944,6362,TCGA-22-0944,LUSC,61.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-22329.0,Dead,TUMOR FREE,223.0,223.0,[Not Available],,,,,[Not Available],,,1.0,223.0,0.0,223.0,,,0.0,223.0,
TCGA-QR-A6H2,7708,TCGA-QR-A6H2,PCPG,33.0,MALE,ASIAN,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2003.0,[Not Available],-12281.0,Alive,TUMOR FREE,302.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,302.0,0.0,302.0,0.0,302.0,0.0,302.0,
TCGA-66-2782,6634,TCGA-66-2782,LUSC,71.0,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-26237.0,Dead,WITH TUMOR,,365.0,[Not Available],,,,304.0,Progressive Disease,,,1.0,365.0,1.0,365.0,,,1.0,304.0,
TCGA-BH-A0H3,1089,TCGA-BH-A0H3,BRCA,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17152.0,Alive,TUMOR FREE,1928.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1928.0,0.0,1928.0,0.0,1928.0,0.0,1928.0,
TCGA-CM-5860,2270,TCGA-CM-5860,COAD,44.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-16344.0,Alive,TUMOR FREE,974.0,,[Not Available],,,,,[Not Applicable],,,0.0,974.0,0.0,974.0,,,0.0,974.0,
TCGA-DD-A4NS,5568,TCGA-DD-A4NS,LIHC,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2005.0,[Not Available],-22638.0,Dead,WITH TUMOR,,2456.0,[Not Available],Extrahepatic Recurrence,Bone,,893.0,[Not Available],,R0,1.0,2456.0,1.0,2456.0,1.0,893.0,1.0,893.0,
TCGA-BH-A18G,1115,TCGA-BH-A18G,BRCA,81.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29820.0,Alive,TUMOR FREE,149.0,,[Not Available],,,,,[Not Available],Negative,,0.0,149.0,0.0,149.0,0.0,149.0,0.0,149.0,
TCGA-CV-A45T,3580,TCGA-CV-A45T,HNSC,64.0,FEMALE,WHITE,[Discrepancy],Stage II,Head & Neck Squamous Cell Carcinoma,G3,1998.0,[Not Available],-23452.0,Dead,TUMOR FREE,,4856.0,[Not Available],,,,,[Not Available],,,1.0,4856.0,0.0,4856.0,,,0.0,4856.0,
TCGA-EL-A3H4,10073,TCGA-EL-A3H4,THCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-16944.0,Alive,TUMOR FREE,1512.0,,[Not Available],,,,,[Not Available],,R0,0.0,1512.0,0.0,1512.0,,,0.0,1512.0,
TCGA-YA-A8S7,5791,TCGA-YA-A8S7,LIHC,68.0,MALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-25188.0,Dead,WITH TUMOR,,412.0,[Not Available],Extrahepatic Recurrence,Brain,,398.0,[Not Available],,R0,1.0,412.0,1.0,412.0,1.0,398.0,1.0,398.0,
TCGA-IG-A4P3,2481,TCGA-IG-A4P3,ESCA,48.0,MALE,WHITE,Stage IIB,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2012.0,[Not Available],-17860.0,Dead,WITH TUMOR,,567.0,[Not Available],,,,,Progressive Disease,,,1.0,567.0,1.0,567.0,,,1.0,567.0,
TCGA-V4-A9EA,11088,TCGA-V4-A9EA,UVM,66.0,MALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,[Not Available],2012.0,[Not Available],-24234.0,Alive,TUMOR FREE,1348.0,,[Not Available],,,,,[Not Available],,,0.0,1348.0,0.0,1348.0,,,0.0,1348.0,
TCGA-Q1-A5R2,1820,TCGA-Q1-A5R2,CESC,64.0,FEMALE,WHITE,[Not Available],[Not Available],Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23523.0,Alive,TUMOR FREE,499.0,,,,,,,[Not Applicable],,,0.0,499.0,0.0,499.0,,,0.0,499.0,
TCGA-BB-A6UM,3298,TCGA-BB-A6UM,HNSC,52.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,GX,2010.0,[Not Available],-19194.0,Alive,TUMOR FREE,393.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,393.0,0.0,393.0,0.0,393.0,0.0,393.0,
TCGA-CM-6679,2293,TCGA-CM-6679,COAD,58.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-21519.0,Alive,TUMOR FREE,306.0,,[Not Available],,,,,[Not Available],,,0.0,306.0,0.0,306.0,,,0.0,306.0,
TCGA-L5-A8NF,2540,TCGA-L5-A8NF,ESCA,57.0,MALE,WHITE,Stage IVA,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2001.0,[Not Available],-21134.0,Dead,TUMOR FREE,,81.0,[Not Available],,,,,,,,1.0,81.0,0.0,81.0,,,0.0,81.0,
TCGA-NC-A5HO,6812,TCGA-NC-A5HO,LUSC,70.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-25694.0,Alive,TUMOR FREE,1336.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1336.0,0.0,1336.0,0.0,1336.0,0.0,1336.0,
TCGA-KK-A8ID,8209,TCGA-KK-A8ID,PRAD,70.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-25851.0,Alive,TUMOR FREE,2107.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2107.0,0.0,2107.0,0.0,2107.0,0.0,2107.0,
TCGA-GU-A767,350,TCGA-GU-A767,BLCA,81.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-29739.0,Dead,WITH TUMOR,,144.0,[Not Available],,,,,Progressive Disease,,,1.0,144.0,1.0,144.0,,,1.0,144.0,
TCGA-4J-AA1J,1603,TCGA-4J-AA1J,CESC,31.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11611.0,Alive,TUMOR FREE,542.0,,,,,,,Complete Remission/Response,,,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,
TCGA-EJ-5501,7916,TCGA-EJ-5501,PRAD,55.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-20409.0,Alive,TUMOR FREE,1365.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1365.0,0.0,1365.0,0.0,1365.0,0.0,1365.0,
TCGA-QR-A70M,7730,TCGA-QR-A70M,PCPG,38.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-14091.0,Alive,TUMOR FREE,1034.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1034.0,0.0,1034.0,0.0,1034.0,0.0,1034.0,
TCGA-32-2491,3177,TCGA-32-2491,GBM,63.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-23131.0,Dead,WITH TUMOR,372.0,372.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],70.0,[Not Available],,,1.0,372.0,1.0,372.0,,,1.0,70.0,
TCGA-AX-A1CI,10639,TCGA-AX-A1CI,UCEC,61.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22582.0,Alive,TUMOR FREE,2600.0,,[Not Available],,,,,[Not Available],,,0.0,2600.0,0.0,2600.0,,,0.0,2600.0,
TCGA-CG-4441,9453,TCGA-CG-4441,STAD,83.0,MALE,[Not Available],Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2006.0,[Not Available],-30528.0,Dead,,,426.0,[Not Available],,,,,[Not Available],,,1.0,426.0,,426.0,,,0.0,426.0,
TCGA-IQ-A61O,3689,TCGA-IQ-A61O,HNSC,43.0,MALE,WHITE,Stage IVA,Stage IVA,"Head & Neck Squamous Cell Carcinoma, Spindle Cell Variant",GX,2012.0,[Not Available],-15920.0,Dead,TUMOR FREE,,421.0,[Not Available],,,,,Complete Remission/Response,,,1.0,421.0,0.0,421.0,,,0.0,421.0,
TCGA-3P-A9WA,7409,TCGA-3P-A9WA,OV,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIB,Serous Cystadenocarcinoma,G3,2013.0,[Not Available],-20211.0,Alive,TUMOR FREE,420.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,420.0,0.0,420.0,0.0,420.0,0.0,420.0,
TCGA-A2-A0CW,548,TCGA-A2-A0CW,BRCA,67.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24541.0,Alive,TUMOR FREE,3283.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3283.0,0.0,3283.0,0.0,3283.0,0.0,3283.0,
TCGA-UF-A7JV,3766,TCGA-UF-A7JV,HNSC,62.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-22985.0,Dead,WITH TUMOR,,90.0,[Not Available],,Oropharynx,Oropharynx and cervical lymph node,55.0,Complete Remission/Response,,,1.0,90.0,1.0,90.0,,,1.0,55.0,
TCGA-RR-A6KC,3241,TCGA-RR-A6KC,GBM,55.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2010.0,[Not Available],-20302.0,Dead,,,625.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],369.0,Complete Remission/Response,,,1.0,625.0,,625.0,1.0,369.0,1.0,369.0,
TCGA-D8-A27W,1296,TCGA-D8-A27W,BRCA,55.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Mucinous Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20173.0,Alive,TUMOR FREE,373.0,,[Not Available],,,,,[Not Available],Negative,,0.0,373.0,0.0,373.0,0.0,373.0,0.0,373.0,
TCGA-E9-A243,1434,TCGA-E9-A243,BRCA,52.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Peri (6-12 months since last menstrual period),-19035.0,Alive,WITH TUMOR,612.0,,[Not Available],Distant Metastasis,Bone,,305.0,[Not Available],Negative,,0.0,612.0,0.0,612.0,1.0,305.0,1.0,305.0,
TCGA-FT-A61P,311,TCGA-FT-A61P,BLCA,76.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-28082.0,Alive,TUMOR FREE,337.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,337.0,0.0,337.0,,,0.0,337.0,
TCGA-DM-A288,2342,TCGA-DM-A288,COAD,68.0,MALE,WHITE,Stage IIIC,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2001.0,[Not Available],-25084.0,Dead,,427.0,427.0,[Not Available],,,,320.0,[Not Available],,,1.0,427.0,,427.0,,,1.0,320.0,
TCGA-WC-A883,11149,TCGA-WC-A883,UVM,76.0,FEMALE,WHITE,Stage IIIA,Stage IIIC,Spindle Cell|Epithelioid Cell,[Not Available],2012.0,[Not Available],-27953.0,Dead,WITH TUMOR,,241.0,[Unknown],,,,,[Not Available],,,1.0,241.0,1.0,241.0,,,1.0,241.0,
TCGA-ER-A193,9087,TCGA-ER-A193,SKCM,62.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2006.0,[Not Available],-22702.0,Dead,WITH TUMOR,,955.0,[Not Available],Distant Metastasis,Brain,,806.0,[Not Available],,,1.0,955.0,1.0,955.0,,,1.0,806.0,
TCGA-EJ-7793,7969,TCGA-EJ-7793,PRAD,49.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-17982.0,Alive,TUMOR FREE,114.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,114.0,0.0,114.0,0.0,114.0,0.0,114.0,
TCGA-2G-AAH3,9757,TCGA-2G-AAH3,TGCT,20.0,MALE,WHITE,Stage I,Stage I,Seminoma; NOS|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor,[Not Available],1997.0,[Not Available],-7474.0,Alive,TUMOR FREE,1822.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,1822.0,0.0,1822.0,0.0,1822.0,0.0,1822.0,
TCGA-EE-A2GO,9040,TCGA-EE-A2GO,SKCM,66.0,FEMALE,WHITE,Stage II,[Not Applicable],,[Not Available],2002.0,[Not Available],-24159.0,Alive,TUMOR FREE,3857.0,,[Not Available],Regional lymph node,,,2216.0,[Not Available],,,0.0,3857.0,0.0,3857.0,,,1.0,2216.0,
TCGA-S3-A6ZF,1582,TCGA-S3-A6ZF,BRCA,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23650.0,Alive,TUMOR FREE,572.0,,[Not Available],,,,,[Not Available],Negative,,0.0,572.0,0.0,572.0,0.0,572.0,0.0,572.0,
TCGA-XE-AAOC,9818,TCGA-XE-AAOC,TGCT,31.0,MALE,WHITE,Stage IA,Stage IA,Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Yolk Sac Tumor,[Not Available],2008.0,[Not Available],-11566.0,Alive,TUMOR FREE,270.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,270.0,0.0,270.0,0.0,270.0,0.0,270.0,
TCGA-EY-A1GW,10961,TCGA-EY-A1GW,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26979.0,Dead,WITH TUMOR,,337.0,[Not Available],Metastatic,Liver,,190.0,Progressive Disease,,,1.0,337.0,1.0,337.0,,,1.0,190.0,
TCGA-G7-A4TM,4603,TCGA-G7-A4TM,KIRP,40.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-14966.0,Alive,TUMOR FREE,768.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,768.0,0.0,768.0,0.0,768.0,0.0,768.0,
TCGA-DU-7013,5016,TCGA-DU-7013,LGG,59.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2001.0,[Not Available],-21824.0,Dead,WITH TUMOR,,269.0,[Not Available],,,,187.0,Progressive Disease,,,1.0,269.0,1.0,269.0,,,1.0,187.0,
TCGA-50-5068,5938,TCGA-50-5068,LUAD,59.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2003.0,[Not Available],-21728.0,Dead,WITH TUMOR,1499.0,1499.0,[Not Available],Distant Metastasis,,,686.0,Progressive Disease,,,1.0,1499.0,1.0,1499.0,,,1.0,686.0,
TCGA-D5-5538,2296,TCGA-D5-5538,COAD,60.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-21974.0,Dead,WITH TUMOR,,1661.0,[Not Available],,,,1007.0,Progressive Disease,,,1.0,1661.0,1.0,1661.0,,,1.0,1007.0,
TCGA-55-6983,5986,TCGA-55-6983,LUAD,81.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2005.0,[Not Available],,Alive,TUMOR FREE,2823.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2823.0,0.0,2823.0,0.0,2823.0,0.0,2823.0,
TCGA-VP-A872,8277,TCGA-VP-A872,PRAD,60.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2005.0,[Not Available],-22098.0,Alive,TUMOR FREE,3631.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3631.0,0.0,3631.0,0.0,3631.0,0.0,3631.0,
TCGA-DK-A2I4,194,TCGA-DK-A2I4,BLCA,79.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2001.0,[Not Available],-29037.0,Alive,TUMOR FREE,4343.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4343.0,0.0,4343.0,0.0,4343.0,0.0,4343.0,
TCGA-3H-AB3T,6834,TCGA-3H-AB3T,MESO,79.0,MALE,WHITE,Stage I,[Not Applicable],Biphasic mesothelioma,[Not Available],2009.0,[Not Available],-28925.0,Dead,WITH TUMOR,,414.0,[Not Available],Intrapleural Progression,"Other, specify",Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes AND Ipsilateral Chest Wall,312.0,[Not Available],,[Not Available],1.0,414.0,1.0,414.0,,,1.0,312.0,
TCGA-DE-A7U5,9917,TCGA-DE-A7U5,THCA,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2013.0,[Not Available],-13411.0,Alive,,84.0,,[Not Available],,,,,[Not Available],,R1,0.0,84.0,0.0,84.0,,,0.0,84.0,
TCGA-4X-A9F9,10373,TCGA-4X-A9F9,THYM,57.0,FEMALE,WHITE,[Not Applicable],III,Thymoma; Type B1,[Not Available],2013.0,[Not Available],-21168.0,Alive,TUMOR FREE,669.0,,[Not Available],,,,,[Not Available],,,0.0,669.0,0.0,669.0,,,0.0,669.0,
TCGA-D1-A17S,10871,TCGA-D1-A17S,UCEC,59.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21794.0,Alive,TUMOR FREE,739.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,739.0,0.0,739.0,0.0,739.0,0.0,739.0,
TCGA-ET-A3BW,10238,TCGA-ET-A3BW,THCA,30.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-11032.0,Alive,TUMOR FREE,1419.0,,[Not Available],,,,,[Not Available],,R0,0.0,1419.0,0.0,1419.0,0.0,1419.0,0.0,1419.0,
TCGA-GM-A2DA,1501,TCGA-GM-A2DA,BRCA,46.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1993.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16854.0,Dead,WITH TUMOR,,6593.0,[Not Available],Distant Metastasis,Bone,,3014.0,[Not Available],Negative,,1.0,6593.0,1.0,6593.0,1.0,3014.0,1.0,3014.0,
TCGA-YC-A9TC,470,TCGA-YC-A9TC,BLCA,71.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-26283.0,Dead,WITH TUMOR,,20.0,[Not Available],,,,,Progressive Disease,,,1.0,20.0,1.0,20.0,,,1.0,20.0,
TCGA-W5-AA2R,1927,TCGA-W5-AA2R,CHOL,77.0,FEMALE,WHITE,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G3,2006.0,[Not Available],-28367.0,Alive,TUMOR FREE,1542.0,,[Not Available],,,,,[Not Available],,R0,0.0,1542.0,0.0,1542.0,0.0,1542.0,0.0,1542.0,
TCGA-GC-A3RB,329,TCGA-GC-A3RB,BLCA,54.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-20021.0,Alive,TUMOR FREE,582.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,582.0,0.0,582.0,0.0,582.0,0.0,582.0,
TCGA-EB-A6QZ,8985,TCGA-EB-A6QZ,SKCM,76.0,FEMALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2013.0,[Not Available],-28078.0,Dead,WITH TUMOR,,352.0,[Not Available],Regional lymph node|Distant Metastasis,[Not Available]|Brain,[Not Applicable]|[Not Applicable],129.0,[Not Available],,,1.0,352.0,1.0,352.0,,,1.0,129.0,
TCGA-46-3767,6493,TCGA-46-3767,LUSC,76.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-27912.0,Alive,TUMOR FREE,396.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,
TCGA-4V-A9QN,10365,TCGA-4V-A9QN,THYM,40.0,FEMALE,WHITE,[Not Applicable],III,Thymoma; Type B3,[Not Available],2012.0,[Not Available],-14825.0,Alive,WITH TUMOR,970.0,,[Not Available],Distant Metastasis,"Other, specify",PLEURA,937.0,[Not Available],,,0.0,970.0,0.0,970.0,,,1.0,937.0,
TCGA-37-4132,6444,TCGA-37-4132,LUSC,61.0,FEMALE,WHITE,Stage IV,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-22520.0,Alive,TUMOR FREE,227.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,227.0,0.0,227.0,,,0.0,227.0,
TCGA-CQ-5330,3382,TCGA-CQ-5330,HNSC,69.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-25255.0,Alive,TUMOR FREE,1897.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1897.0,0.0,1897.0,,,0.0,1897.0,
TCGA-CR-7368,3441,TCGA-CR-7368,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-19876.0,Alive,TUMOR FREE,1245.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1245.0,0.0,1245.0,,,0.0,1245.0,
TCGA-FN-7833,5139,TCGA-FN-7833,LGG,25.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2011.0,[Not Available],-9228.0,Alive,TUMOR FREE,837.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,837.0,0.0,837.0,0.0,837.0,0.0,837.0,
TCGA-HZ-7924,7594,TCGA-HZ-7924,PAAD,60.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-22090.0,Alive,WITH TUMOR,840.0,,,Distant Metastasis,,Liver,831.0,Complete Remission/Response,,,0.0,840.0,0.0,840.0,1.0,831.0,1.0,831.0,
TCGA-HC-7818,8090,TCGA-HC-7818,PRAD,66.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24391.0,Alive,TUMOR FREE,938.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,938.0,0.0,938.0,0.0,938.0,0.0,938.0,
TCGA-E1-5322,5074,TCGA-E1-5322,LGG,38.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,1999.0,[Not Available],-13903.0,Dead,,,3978.0,[Not Available],,,,1085.0,Stable Disease,,,1.0,3978.0,,3978.0,,,1.0,1085.0,
TCGA-YL-A9WH,8336,TCGA-YL-A9WH,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-24755.0,Alive,,427.0,,[Not Available],,,,,Stable Disease,,,0.0,427.0,0.0,427.0,,,0.0,427.0,
TCGA-D1-A161,10832,TCGA-D1-A161,UCEC,78.0,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28695.0,Alive,TUMOR FREE,892.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,892.0,0.0,892.0,0.0,892.0,0.0,892.0,
TCGA-86-A456,6207,TCGA-86-A456,LUAD,78.0,FEMALE,ASIAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-28533.0,Alive,TUMOR FREE,896.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,896.0,0.0,896.0,0.0,896.0,0.0,896.0,
TCGA-QH-A6XA,5306,TCGA-QH-A6XA,LGG,23.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-8508.0,Alive,TUMOR FREE,502.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,502.0,0.0,502.0,0.0,502.0,0.0,502.0,
TCGA-77-8143,6683,TCGA-77-8143,LUSC,76.0,MALE,[Not Evaluated],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-27772.0,Dead,WITH TUMOR,,803.0,[Not Available],,,,,[Unknown],,,1.0,803.0,1.0,803.0,,,1.0,803.0,
TCGA-KK-A6E6,8185,TCGA-KK-A6E6,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2002.0,[Not Available],-25320.0,Alive,TUMOR FREE,3447.0,,[Not Available],,,,,[Not Available],,,0.0,3447.0,0.0,3447.0,,,0.0,3447.0,
TCGA-F7-A620,3653,TCGA-F7-A620,HNSC,47.0,MALE,WHITE,Stage III,[Not Available],Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-17475.0,Alive,TUMOR FREE,543.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,543.0,0.0,543.0,0.0,543.0,0.0,543.0,
TCGA-QR-A6GW,7702,TCGA-QR-A6GW,PCPG,53.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2009.0,[Not Available],-19639.0,Alive,TUMOR FREE,491.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,
TCGA-QR-A706,7718,TCGA-QR-A706,PCPG,50.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma,[Not Available],2012.0,[Not Available],-18585.0,Alive,TUMOR FREE,125.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,125.0,0.0,125.0,0.0,125.0,0.0,125.0,
TCGA-GV-A40G,364,TCGA-GV-A40G,BLCA,77.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-28204.0,Alive,TUMOR FREE,580.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,580.0,0.0,580.0,0.0,580.0,0.0,580.0,
TCGA-2G-AAGV,9750,TCGA-2G-AAGV,TGCT,23.0,MALE,WHITE,[Discrepancy],Stage IIA,Non-Seminoma; Teratoma (Mature),[Not Available],2002.0,[Not Available],-8612.0,Alive,TUMOR FREE,4527.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,4527.0,0.0,4527.0,0.0,4527.0,0.0,4527.0,
TCGA-BA-4075,3244,TCGA-BA-4075,HNSC,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2004.0,[Not Available],-17951.0,Dead,WITH TUMOR,,283.0,[Not Available],,Oral Cavity,,236.0,Progressive Disease,,,1.0,283.0,1.0,283.0,,,1.0,236.0,
TCGA-ZJ-AB0H,1906,TCGA-ZJ-AB0H,CESC,48.0,FEMALE,[Unknown],[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,[Not Available],2006.0,[Unknown],-17869.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-DX-AB3A,8672,TCGA-DX-AB3A,SARC,80.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2009.0,[Not Available],-29230.0,Dead,WITH TUMOR,,978.0,[Not Available],Locoregional Recurrence,,,533.0,[Not Available],Negative,R0,1.0,978.0,1.0,978.0,1.0,533.0,1.0,533.0,
TCGA-VQ-A8E2,9648,TCGA-VQ-A8E2,STAD,57.0,MALE,ASIAN,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-21112.0,Alive,TUMOR FREE,1319.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1319.0,0.0,1319.0,0.0,1319.0,0.0,1319.0,
TCGA-78-7160,6155,TCGA-78-7160,LUAD,61.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-22385.0,Dead,,,697.0,[Not Available],,,,,Complete Remission/Response,,,1.0,697.0,,697.0,,,0.0,697.0,
TCGA-VD-AA8P,11137,TCGA-VD-AA8P,UVM,64.0,FEMALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell,[Not Available],2013.0,[Not Available],-23555.0,Alive,TUMOR FREE,86.0,,[Not Available],,,,,[Not Available],,,0.0,86.0,0.0,86.0,,,0.0,86.0,
TCGA-TQ-A7RF,5388,TCGA-TQ-A7RF,LGG,27.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2012.0,[Not Available],-9919.0,Alive,WITH TUMOR,650.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,650.0,0.0,650.0,,,0.0,650.0,
TCGA-WQ-A9G7,5781,TCGA-WQ-A9G7,LIHC,71.0,FEMALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],,Alive,TUMOR FREE,30.0,,[Not Available],,,,,[Not Available],,R0,0.0,30.0,0.0,30.0,0.0,30.0,0.0,30.0,
TCGA-OR-A5KP,46,TCGA-OR-A5KP,ACC,45.0,FEMALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2006.0,[Not Available],-16702.0,Alive,TUMOR FREE,2777.0,,[Not Available],Distant Metastasis,Liver,,1250.0,Complete Remission/Response,,,0.0,2777.0,0.0,2777.0,1.0,1250.0,1.0,1250.0,
TCGA-78-7146,6143,TCGA-78-7146,LUAD,71.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1999.0,[Not Available],-26272.0,Dead,,,173.0,[Not Available],,,,,[Not Available],,,1.0,173.0,,173.0,,,0.0,173.0,
TCGA-BR-A4J2,9401,TCGA-BR-A4J2,STAD,70.0,MALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-25891.0,Alive,TUMOR FREE,431.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,
TCGA-DU-8164,5036,TCGA-DU-8164,LGG,51.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-18735.0,Alive,TUMOR FREE,651.0,,[Not Available],,,,,Stable Disease,,,0.0,651.0,0.0,651.0,,,0.0,651.0,
TCGA-FK-A3SG,10276,TCGA-FK-A3SG,THCA,21.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-7710.0,Alive,TUMOR FREE,28.0,,[Not Available],,,,,[Not Available],,R0,0.0,28.0,0.0,28.0,0.0,28.0,0.0,28.0,
TCGA-CQ-A4CH,3414,TCGA-CQ-A4CH,HNSC,58.0,MALE,ASIAN,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-21455.0,Dead,WITH TUMOR,,379.0,[Not Available],,,trachea,210.0,Complete Remission/Response,,,1.0,379.0,1.0,379.0,,,1.0,210.0,
TCGA-HZ-A77O,7612,TCGA-HZ-A77O,PAAD,77.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-28434.0,Dead,WITH TUMOR,,160.0,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,,98.0,Complete Remission/Response,,,1.0,160.0,1.0,160.0,1.0,98.0,1.0,98.0,
TCGA-CZ-4853,4354,TCGA-CZ-4853,KIRC,82.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-30191.0,Alive,TUMOR FREE,774.0,,[Not Available],,,,,[Not Available],,,0.0,774.0,0.0,774.0,,,0.0,774.0,
TCGA-55-A490,6050,TCGA-55-A490,LUAD,78.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-28728.0,Dead,TUMOR FREE,,99.0,[Not Available],,,,,[Not Applicable],,,1.0,99.0,0.0,99.0,,,0.0,99.0,
TCGA-L5-A4OS,2526,TCGA-L5-A4OS,ESCA,86.0,FEMALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2010.0,[Not Available],-31601.0,Alive,TUMOR FREE,1782.0,,[Not Available],,,,,[Unknown],,,0.0,1782.0,0.0,1782.0,,,0.0,1782.0,
TCGA-QK-A64Z,3721,TCGA-QK-A64Z,HNSC,79.0,FEMALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-29037.0,Dead,WITH TUMOR,,641.0,[Not Available],Locoregional Recurrence,Cervical Lymph Nodes,bilateral,553.0,Progressive Disease,,,1.0,641.0,1.0,641.0,,,1.0,553.0,
TCGA-YL-A8SO,8332,TCGA-YL-A8SO,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2004.0,[Not Available],-23584.0,Alive,,3479.0,,[Not Available],,,,,Stable Disease,,,0.0,3479.0,0.0,3479.0,,,0.0,3479.0,
TCGA-CK-5912,2249,TCGA-CK-5912,COAD,81.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2006.0,[Not Available],-29938.0,Dead,TUMOR FREE,,1493.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1493.0,0.0,1493.0,0.0,1493.0,0.0,1493.0,
TCGA-DU-6393,4992,TCGA-DU-6393,LGG,66.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,1993.0,[Not Available],-24282.0,Dead,,,1585.0,[Not Available],,,,,[Not Available],,,1.0,1585.0,,1585.0,,,0.0,1585.0,
TCGA-W5-AA2Q,1926,TCGA-W5-AA2Q,CHOL,68.0,MALE,WHITE,Stage II,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2006.0,[Not Available],-25069.0,Alive,TUMOR FREE,50.0,,[Not Available],,,,,[Not Available],,R0,0.0,50.0,0.0,50.0,0.0,50.0,0.0,50.0,
TCGA-R6-A8W5,2608,TCGA-R6-A8W5,ESCA,60.0,MALE,WHITE,Stage IVA,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2004.0,[Not Available],-21917.0,Dead,WITH TUMOR,,480.0,[Not Available],Distant Metastasis,Liver,,336.0,,,,1.0,480.0,1.0,480.0,,,1.0,336.0,
TCGA-ET-A40T,10253,TCGA-ET-A40T,THCA,26.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-9531.0,Alive,TUMOR FREE,1140.0,,[Not Available],,,,,[Not Available],,RX,0.0,1140.0,0.0,1140.0,,,0.0,1140.0,
TCGA-FS-A4F0,9171,TCGA-FS-A4F0,SKCM,67.0,FEMALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2003.0,[Not Available],-24717.0,Alive,TUMOR FREE,2367.0,,[Not Available],Locoregional Recurrence|Locoregional Recurrence|Locoregional Recurrence|Distant Metastasis|Distant Metastasis,"[Not Available]|[Not Available]|[Not Available]|Lung|Other, Specify",[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable]|lymphnode,872.0,[Not Available],,,0.0,2367.0,0.0,2367.0,,,1.0,872.0,
TCGA-DX-A6YX,8619,TCGA-DX-A6YX,SARC,68.0,FEMALE,[Unknown],[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2005.0,[Not Available],-24871.0,Dead,WITH TUMOR,,513.0,[Not Available],Distant Metastasis,Lung,,200.0,[Not Available],Negative,R0,1.0,513.0,1.0,513.0,1.0,200.0,1.0,200.0,
TCGA-BG-A0YU,10763,TCGA-BG-A0YU,UCEC,37.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13644.0,Alive,TUMOR FREE,451.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,451.0,0.0,451.0,0.0,451.0,0.0,451.0,
TCGA-BR-8370,9361,TCGA-BR-8370,STAD,64.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-23636.0,Alive,TUMOR FREE,101.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,101.0,0.0,101.0,0.0,101.0,0.0,101.0,
TCGA-GM-A2DI,1507,TCGA-GM-A2DI,BRCA,52.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19030.0,Alive,TUMOR FREE,2590.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2590.0,0.0,2590.0,0.0,2590.0,0.0,2590.0,
TCGA-VQ-A8PQ,9666,TCGA-VQ-A8PQ,STAD,50.0,FEMALE,WHITE,Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008.0,[Not Available],-18318.0,Dead,WITH TUMOR,,476.0,Stomach Cancer,Locoregional Recurrence,,,91.0,Progressive Disease,,,1.0,476.0,1.0,476.0,,,1.0,91.0,
TCGA-EX-A69L,1750,TCGA-EX-A69L,CESC,41.0,FEMALE,ASIAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15121.0,Alive,TUMOR FREE,602.0,,,,,,,Complete Remission/Response,,,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,
TCGA-66-2789,6640,TCGA-66-2789,LUSC,73.0,MALE,[Not Available],Stage IIIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-26753.0,Dead,TUMOR FREE,,123.0,[Not Available],,,,,[Not Available],,,1.0,123.0,0.0,123.0,,,0.0,123.0,
TCGA-D3-A8GR,8896,TCGA-D3-A8GR,SKCM,54.0,FEMALE,WHITE,Stage 0,[Not Applicable],,[Not Available],1999.0,[Not Available],-19973.0,Dead,WITH TUMOR,,3943.0,[Not Available],Locoregional Recurrence,,,1720.0,[Not Available],,,,,,,,,,,
TCGA-BR-6709,9315,TCGA-BR-6709,STAD,57.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-20935.0,Dead,WITH TUMOR,,370.0,[Not Available],,,,,Partial Remission/Response,,,1.0,370.0,1.0,370.0,,,1.0,370.0,
TCGA-WB-A81F,7848,TCGA-WB-A81F,PCPG,40.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2009.0,[Not Available],-14933.0,Alive,TUMOR FREE,1737.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1737.0,0.0,1737.0,0.0,1737.0,0.0,1737.0,
TCGA-DD-A39V,5537,TCGA-DD-A39V,LIHC,77.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2000.0,[Not Available],-28254.0,Dead,WITH TUMOR,,643.0,[Not Available],Extrahepatic Recurrence,"Other, specify",second or third rib posteriorly,455.0,[Not Available],,R0,1.0,643.0,1.0,643.0,1.0,455.0,1.0,455.0,
TCGA-S4-A8RO,7670,TCGA-S4-A8RO,PAAD,75.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-27645.0,Alive,WITH TUMOR,525.0,,,Distant Metastasis,Lung,,291.0,Complete Remission/Response,,,0.0,525.0,0.0,525.0,1.0,291.0,1.0,291.0,
TCGA-06-0187,2790,TCGA-06-0187,GBM,69.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-25318.0,Dead,WITH TUMOR,801.0,828.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],531.0,[Not Available],,,1.0,828.0,1.0,828.0,,,1.0,531.0,
TCGA-55-8507,6034,TCGA-55-8507,LUAD,53.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-19390.0,Alive,TUMOR FREE,418.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,418.0,0.0,418.0,0.0,418.0,0.0,418.0,
TCGA-D8-A1XO,1269,TCGA-D8-A1XO,BRCA,56.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20606.0,Alive,TUMOR FREE,1682.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1682.0,0.0,1682.0,0.0,1682.0,0.0,1682.0,
TCGA-DX-A6B8,8604,TCGA-DX-A6B8,SARC,80.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2002.0,[Not Available],-29513.0,Dead,WITH TUMOR,,485.0,[Not Available],Distant Metastasis,Lung,,42.0,[Not Available],Positive,R0,1.0,485.0,1.0,485.0,1.0,42.0,1.0,42.0,
TCGA-HC-8258,8099,TCGA-HC-8258,PRAD,56.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-20703.0,Alive,TUMOR FREE,847.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,847.0,0.0,847.0,0.0,847.0,0.0,847.0,
TCGA-XE-A8H5,9808,TCGA-XE-A8H5,TGCT,29.0,MALE,[Unknown],IS,Stage IS,Seminoma; NOS,[Not Available],2008.0,[Not Available],-10942.0,Alive,TUMOR FREE,1217.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,1217.0,0.0,1217.0,0.0,1217.0,0.0,1217.0,
TCGA-FK-A3S3,10272,TCGA-FK-A3S3,THCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2008.0,[Not Available],-15853.0,Alive,TUMOR FREE,2162.0,,[Not Available],,,,,[Not Available],,R0,0.0,2162.0,0.0,2162.0,0.0,2162.0,0.0,2162.0,
TCGA-DE-A4M9,9910,TCGA-DE-A4M9,THCA,28.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-10384.0,Alive,TUMOR FREE,573.0,,[Not Available],,,,,[Not Available],,R1,0.0,573.0,0.0,573.0,,,0.0,573.0,
TCGA-VQ-A8E3,9649,TCGA-VQ-A8E3,STAD,79.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-28919.0,Dead,,,661.0,[Unknown],Locoregional Recurrence,,,538.0,[Unknown],,,1.0,661.0,,661.0,,,1.0,538.0,
TCGA-05-4430,5828,TCGA-05-4430,LUAD,59.0,FEMALE,[Not Available],Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-21884.0,Alive,TUMOR FREE,761.0,,[Not Available],,,,,[Not Applicable],,,0.0,761.0,0.0,761.0,,,0.0,761.0,
TCGA-CJ-4639,4272,TCGA-CJ-4639,KIRC,49.0,FEMALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-18066.0,Alive,TUMOR FREE,3229.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3229.0,0.0,3229.0,0.0,3229.0,0.0,3229.0,
TCGA-50-6594,5955,TCGA-50-6594,LUAD,79.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-28924.0,Dead,WITH TUMOR,,370.0,[Not Available],Distant Metastasis,,,285.0,Progressive Disease,,,1.0,370.0,1.0,370.0,,,1.0,285.0,
TCGA-KC-A4BN,8163,TCGA-KC-A4BN,PRAD,55.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-20392.0,Alive,TUMOR FREE,1815.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1815.0,0.0,1815.0,0.0,1815.0,0.0,1815.0,
TCGA-B0-5116,4040,TCGA-B0-5116,KIRC,52.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-19352.0,Alive,WITH TUMOR,1274.0,,[Not Available],,,,1129.0,Complete Remission/Response,,,0.0,1274.0,0.0,1274.0,1.0,1129.0,1.0,1129.0,
TCGA-28-6450,3165,TCGA-28-6450,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-22177.0,Dead,WITH TUMOR,165.0,165.0,[Not Available],,,,,[Not Available],,,1.0,165.0,1.0,165.0,,,1.0,165.0,
TCGA-D8-A1X9,1258,TCGA-D8-A1X9,BRCA,66.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24417.0,Alive,TUMOR FREE,727.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,727.0,0.0,727.0,,,0.0,727.0,
TCGA-BH-A0C3,1059,TCGA-BH-A0C3,BRCA,47.0,FEMALE,WHITE,Stage I,[Not Applicable],Mixed Histology (please specify),[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17221.0,Alive,WITH TUMOR,2709.0,,[Not Available],Distant Metastasis,Bone,,2674.0,[Not Available],Negative,,0.0,2709.0,0.0,2709.0,1.0,2674.0,1.0,2674.0,
TCGA-WK-A8XT,8774,TCGA-WK-A8XT,SARC,40.0,FEMALE,WHITE,[Not Available],[Not Available],Synovial Sarcoma - Monophasic,[Not Available],2008.0,[Not Available],-14958.0,Dead,WITH TUMOR,,1262.0,[Not Available],Locoregional Recurrence,"Other, specify",Flank,599.0,[Not Available],Negative,R0,1.0,1262.0,1.0,1262.0,1.0,599.0,1.0,599.0,
TCGA-B7-A5TJ,9273,TCGA-B7-A5TJ,STAD,74.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2012.0,[Not Available],-27057.0,Alive,TUMOR FREE,335.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,335.0,0.0,335.0,0.0,335.0,0.0,335.0,
TCGA-CV-A45V,3582,TCGA-CV-A45V,HNSC,87.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,1999.0,[Not Available],-31936.0,Dead,,,32.0,[Not Available],,,,,[Not Available],,,1.0,32.0,,32.0,,,0.0,32.0,
TCGA-DD-AADC,5614,TCGA-DD-AADC,LIHC,53.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-19527.0,Dead,WITH TUMOR,,425.0,[Not Available],Intrahepatic Recurrence,Liver,,101.0,[Not Available],,R0,1.0,425.0,1.0,425.0,1.0,101.0,1.0,101.0,
TCGA-44-6147,5875,TCGA-44-6147,LUAD,67.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-24631.0,Alive,TUMOR FREE,845.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,845.0,0.0,845.0,0.0,845.0,0.0,845.0,
TCGA-Z6-A9VB,2643,TCGA-Z6-A9VB,ESCA,53.0,MALE,WHITE,Stage IIIA,[Not Available],Esophagus Squamous Cell Carcinoma,G2,2013.0,[Not Available],-19470.0,Alive,TUMOR FREE,40.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,40.0,0.0,40.0,0.0,40.0,0.0,40.0,
TCGA-A4-7915,4473,TCGA-A4-7915,KIRP,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-12832.0,Alive,TUMOR FREE,7.0,,[Not Available],,,,,[Not Available],,,0.0,7.0,0.0,7.0,,,0.0,7.0,
TCGA-BR-8059,9337,TCGA-BR-8059,STAD,72.0,MALE,WHITE,Stage III,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-26474.0,Dead,TUMOR FREE,,439.0,[Not Available],,,,,Complete Remission/Response,,,1.0,439.0,0.0,439.0,0.0,439.0,0.0,439.0,
TCGA-28-2509,3149,TCGA-28-2509,GBM,77.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-28240.0,Alive,,145.0,,[Not Available],,,,,[Not Available],,,0.0,145.0,0.0,145.0,,,0.0,145.0,
TCGA-CQ-5332,3384,TCGA-CQ-5332,HNSC,87.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-32032.0,Dead,,317.0,317.0,[Not Available],,,,,[Not Available],,,1.0,317.0,,317.0,,,0.0,317.0,
TCGA-44-A4SU,5901,TCGA-44-A4SU,LUAD,67.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-24820.0,Dead,WITH TUMOR,,409.0,[Not Available],Locoregional Recurrence,,,260.0,Complete Remission/Response,,,1.0,409.0,1.0,409.0,1.0,260.0,1.0,260.0,
TCGA-77-6843,6659,TCGA-77-6843,LUSC,74.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2002.0,[Not Available],-27291.0,Dead,,,2224.0,[Not Available],,,,,[Not Available],,,1.0,2224.0,,2224.0,,,0.0,2224.0,
TCGA-DA-A1IB,8926,TCGA-DA-A1IB,SKCM,69.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2010.0,[Not Available],-25219.0,Alive,WITH TUMOR,825.0,,[Not Available],Distant Metastasis,Brain,,243.0,[Not Available],,,0.0,825.0,0.0,825.0,,,1.0,243.0,
TCGA-HT-8012,5204,TCGA-HT-8012,LGG,30.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-11295.0,Alive,WITH TUMOR,286.0,,[Not Available],,,,133.0,Stable Disease,,,0.0,286.0,0.0,286.0,,,1.0,133.0,
TCGA-74-6577,3207,TCGA-74-6577,GBM,51.0,MALE,[Not Available],[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-18740.0,Alive,WITH TUMOR,132.0,,[Not Available],,[Not Applicable],[Not Applicable],132.0,[Not Available],,,0.0,132.0,0.0,132.0,,,1.0,132.0,
TCGA-C5-A1ME,1622,TCGA-C5-A1ME,CESC,40.0,FEMALE,WHITE,[Not Available],Stage IB1,Endocervical Type of Adenocarcinoma,G1,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14970.0,Alive,TUMOR FREE,1756.0,,,,,,,Complete Remission/Response,,,0.0,1756.0,0.0,1756.0,0.0,1756.0,0.0,1756.0,
TCGA-DX-A1KW,8556,TCGA-DX-A1KW,SARC,67.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2009.0,[Not Available],-24647.0,Dead,,,995.0,[Not Available],,,,,[Not Available],[Not Available],R1,1.0,995.0,,995.0,,,0.0,995.0,
TCGA-HC-A9TH,8125,TCGA-HC-A9TH,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-21460.0,Alive,WITH TUMOR,844.0,,[Not Available],Biochemical evidence of disease,"Other, specify",Biochemical,351.0,Partial Remission/Response,,,0.0,844.0,0.0,844.0,,,1.0,351.0,
TCGA-BR-8361,9352,TCGA-BR-8361,STAD,71.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-25999.0,Alive,TUMOR FREE,946.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,946.0,0.0,946.0,0.0,946.0,0.0,946.0,
TCGA-CC-A7II,5502,TCGA-CC-A7II,LIHC,54.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-20079.0,Alive,WITH TUMOR,399.0,,[Not Available],Locoregional Recurrence,,,278.0,[Not Available],,R0,0.0,399.0,0.0,399.0,1.0,278.0,1.0,278.0,
TCGA-91-6828,6212,TCGA-91-6828,LUAD,70.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-25870.0,Alive,TUMOR FREE,323.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,323.0,0.0,323.0,0.0,323.0,0.0,323.0,
TCGA-EJ-5504,7919,TCGA-EJ-5504,PRAD,65.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-24072.0,Alive,WITH TUMOR,1427.0,,[Not Available],,,,,Progressive Disease,,,0.0,1427.0,0.0,1427.0,,,0.0,1427.0,
TCGA-IS-A3K7,8702,TCGA-IS-A3K7,SARC,63.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2000.0,[Not Available],-23022.0,Alive,TUMOR FREE,5204.0,,[Not Available],Distant Metastasis,Lung,,119.0,[Not Available],[Not Available],R0,0.0,5204.0,0.0,5204.0,1.0,119.0,1.0,119.0,
TCGA-06-0646,2823,TCGA-06-0646,GBM,60.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-22273.0,Dead,WITH TUMOR,136.0,175.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],90.0,[Not Available],,,1.0,175.0,1.0,175.0,,,1.0,90.0,
TCGA-D8-A1XM,1268,TCGA-D8-A1XM,BRCA,57.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21056.0,Alive,TUMOR FREE,538.0,,[Not Available],,,,,[Not Available],Negative,,0.0,538.0,0.0,538.0,0.0,538.0,0.0,538.0,
TCGA-OR-A5L6,61,TCGA-OR-A5L6,ACC,60.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-22057.0,Alive,TUMOR FREE,861.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,861.0,0.0,861.0,0.0,861.0,0.0,861.0,
TCGA-28-1753,3141,TCGA-28-1753,GBM,53.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-19366.0,Alive,WITH TUMOR,37.0,,[Not Available],,,,,[Not Available],,,0.0,37.0,0.0,37.0,,,0.0,37.0,
TCGA-4Z-AA83,110,TCGA-4Z-AA83,BLCA,52.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-19280.0,Alive,TUMOR FREE,2024.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2024.0,0.0,2024.0,0.0,2024.0,0.0,2024.0,
TCGA-AO-A12G,881,TCGA-AO-A12G,BRCA,75.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27705.0,Alive,TUMOR FREE,1639.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1639.0,0.0,1639.0,0.0,1639.0,0.0,1639.0,
TCGA-HN-A2NL,1521,TCGA-HN-A2NL,BRCA,56.0,FEMALE,[Not Evaluated],Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20483.0,Alive,TUMOR FREE,79.0,,[Not Available],,,,,[Not Available],Negative,,0.0,79.0,0.0,79.0,0.0,79.0,0.0,79.0,
TCGA-CN-4725,3304,TCGA-CN-4725,HNSC,60.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-22171.0,Alive,TUMOR FREE,1157.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1157.0,0.0,1157.0,0.0,1157.0,0.0,1157.0,
TCGA-ZJ-AB0I,1907,TCGA-ZJ-AB0I,CESC,25.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,[Not Available],2006.0,[Unknown],-9486.0,Alive,,0.0,,,,,,,[Unknown],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-CG-5717,9470,TCGA-CG-5717,STAD,58.0,MALE,[Not Available],Stage II,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,[Not Available],-21458.0,Dead,WITH TUMOR,,212.0,[Not Available],,,,120.0,Progressive Disease,,,1.0,212.0,1.0,212.0,,,1.0,120.0,
TCGA-IC-A6RF,2474,TCGA-IC-A6RF,ESCA,69.0,FEMALE,WHITE,Stage IA,Stage IIB,Esophagus Squamous Cell Carcinoma,GX,2013.0,[Not Available],-25417.0,Alive,TUMOR FREE,477.0,,[Not Available],Locoregional Recurrence,"Other, specify",regional lymph nodes,293.0,Complete Remission/Response,,,0.0,477.0,0.0,477.0,1.0,293.0,1.0,293.0,
TCGA-BH-A208,1160,TCGA-BH-A208,BRCA,48.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1995.0,[Not Available],-17715.0,Dead,TUMOR FREE,,1759.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,1759.0,0.0,1759.0,,,0.0,1759.0,
TCGA-60-2704,6565,TCGA-60-2704,LUSC,73.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-26927.0,Dead,WITH TUMOR,,1154.0,[Not Available],,,,532.0,[Not Available],,,1.0,1154.0,1.0,1154.0,,,1.0,532.0,
TCGA-EW-A1P4,1472,TCGA-EW-A1P4,BRCA,43.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Medullary Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15989.0,Alive,TUMOR FREE,907.0,,[Not Available],,,,,[Not Available],Negative,,0.0,907.0,0.0,907.0,0.0,907.0,0.0,907.0,
TCGA-E8-A432,10032,TCGA-E8-A432,THCA,57.0,FEMALE,ASIAN,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-20874.0,Alive,TUMOR FREE,931.0,,[Not Available],Locoregional Recurrence,,,720.0,[Not Available],,R0,0.0,931.0,0.0,931.0,1.0,720.0,1.0,720.0,
TCGA-LN-A49S,2565,TCGA-LN-A49S,ESCA,59.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2011.0,[Not Available],-21865.0,Alive,WITH TUMOR,400.0,,[Not Available],Locoregional Recurrence,,,49.0,Complete Remission/Response,,,0.0,400.0,0.0,400.0,1.0,49.0,1.0,49.0,
TCGA-KK-A59Z,8176,TCGA-KK-A59Z,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-24306.0,Alive,TUMOR FREE,2628.0,,[Not Available],,,,,[Not Applicable],,,0.0,2628.0,0.0,2628.0,,,0.0,2628.0,
TCGA-KB-A93G,9612,TCGA-KB-A93G,STAD,68.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach Adenocarcinoma, Signet Ring Type",G1,2013.0,[Not Available],-24924.0,Alive,TUMOR FREE,613.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,613.0,0.0,613.0,0.0,613.0,0.0,613.0,
TCGA-Z4-A8JB,8794,TCGA-Z4-A8JB,SARC,24.0,FEMALE,WHITE,[Not Available],[Not Available],Desmoid Tumor,[Not Available],2013.0,[Not Available],-9123.0,Alive,TUMOR FREE,133.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,133.0,0.0,133.0,0.0,133.0,0.0,133.0,
TCGA-SX-A7SL,4673,TCGA-SX-A7SL,KIRP,74.0,MALE,[Not Evaluated],Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-27063.0,Alive,TUMOR FREE,823.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,823.0,0.0,823.0,0.0,823.0,0.0,823.0,
TCGA-NA-A4QX,11064,TCGA-NA-A4QX,UCS,60.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22264.0,Dead,WITH TUMOR,833.0,838.0,[Not Available],Distant Metastasis,Pelvis,,566.0,[Not Available],,,1.0,838.0,1.0,838.0,,,1.0,566.0,
TCGA-SX-A71W,4672,TCGA-SX-A71W,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-24110.0,Alive,TUMOR FREE,1076.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1076.0,0.0,1076.0,0.0,1076.0,0.0,1076.0,
TCGA-ZF-AA53,498,TCGA-ZF-AA53,BLCA,60.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-22035.0,Alive,TUMOR FREE,1761.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1761.0,0.0,1761.0,0.0,1761.0,0.0,1761.0,
TCGA-G7-A8LD,4606,TCGA-G7-A8LD,KIRP,71.0,MALE,WHITE,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-25977.0,Dead,WITH TUMOR,,514.0,[Not Available],,,,209.0,Complete Remission/Response,,,1.0,514.0,1.0,514.0,1.0,209.0,1.0,209.0,
TCGA-44-7662,5886,TCGA-44-7662,LUAD,61.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22543.0,Alive,TUMOR FREE,218.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,218.0,0.0,218.0,0.0,218.0,0.0,218.0,
TCGA-BH-A0BG,1044,TCGA-BH-A0BG,BRCA,73.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26988.0,Alive,TUMOR FREE,1871.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1871.0,0.0,1871.0,0.0,1871.0,0.0,1871.0,
TCGA-VQ-A8DV,9645,TCGA-VQ-A8DV,STAD,48.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,[Not Available],-17630.0,Dead,WITH TUMOR,,403.0,Stomach Cancer,Distant Metastasis,Liver,,288.0,Progressive Disease,,,1.0,403.0,1.0,403.0,,,1.0,288.0,
TCGA-YT-A95E,10442,TCGA-YT-A95E,THYM,52.0,MALE,WHITE,[Not Applicable],I,Thymoma; Type B2,[Not Available],2011.0,[Not Available],-19172.0,Alive,TUMOR FREE,1070.0,,[Not Available],,,,,[Not Available],,,0.0,1070.0,0.0,1070.0,,,0.0,1070.0,
TCGA-RW-A8AZ,7776,TCGA-RW-A8AZ,PCPG,66.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-24268.0,Dead,TUMOR FREE,,88.0,[Not Available],,,,,[Unknown],,,1.0,88.0,0.0,88.0,,,0.0,88.0,
TCGA-06-2567,2860,TCGA-06-2567,GBM,65.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-23759.0,Dead,WITH TUMOR,133.0,133.0,[Not Available],,,,,[Not Available],,,1.0,133.0,1.0,133.0,,,1.0,133.0,
TCGA-50-8460,5962,TCGA-50-8460,LUAD,74.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-27270.0,Alive,TUMOR FREE,829.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,829.0,0.0,829.0,0.0,829.0,0.0,829.0,
TCGA-BH-A1EY,1138,TCGA-BH-A1EY,BRCA,79.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28940.0,Dead,WITH TUMOR,,538.0,[Not Available],Distant Metastasis,Lung,Liver,396.0,[Not Available],[Not Available],,1.0,538.0,1.0,538.0,,,1.0,396.0,
TCGA-DX-A8BV,8648,TCGA-DX-A8BV,SARC,57.0,MALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2004.0,[Not Available],-21005.0,Dead,WITH TUMOR,,1845.0,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,357.0,[Not Available],Negative,R0,1.0,1845.0,1.0,1845.0,1.0,357.0,1.0,357.0,
TCGA-BP-4161,4128,TCGA-BP-4161,KIRC,74.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2002.0,[Not Available],-27119.0,Alive,WITH TUMOR,2746.0,,[Not Available],,,,2685.0,[Not Available],,,0.0,2746.0,0.0,2746.0,,,1.0,2685.0,
TCGA-BH-A1FE,1147,TCGA-BH-A1FE,BRCA,31.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998.0,[Not Available],-11650.0,Dead,WITH TUMOR,,2273.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,2273.0,1.0,2273.0,,,1.0,2273.0,
TCGA-CV-7183,3532,TCGA-CV-7183,HNSC,53.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2002.0,[Not Available],-19358.0,Alive,TUMOR FREE,3981.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3981.0,0.0,3981.0,0.0,3981.0,0.0,3981.0,
TCGA-BT-A0YX,123,TCGA-BT-A0YX,BLCA,70.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-25570.0,Dead,WITH TUMOR,,400.0,[Not Available],Metastatic,"Other, specify",lower abdominal wall and right pelvis,326.0,Progressive Disease,,,1.0,400.0,1.0,400.0,,,1.0,326.0,
TCGA-XG-A823,7866,TCGA-XG-A823,PCPG,25.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-9149.0,Alive,TUMOR FREE,614.0,,[Not Available],New Primary Tumor,"Other, specify",Carotid Body,190.0,Complete Remission/Response,,,0.0,614.0,0.0,614.0,0.0,614.0,1.0,190.0,
TCGA-UZ-A9Q0,4697,TCGA-UZ-A9Q0,KIRP,60.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-21915.0,Alive,TUMOR FREE,3368.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3368.0,0.0,3368.0,0.0,3368.0,0.0,3368.0,
TCGA-CR-7398,3465,TCGA-CR-7398,HNSC,53.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-19468.0,Alive,TUMOR FREE,156.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,156.0,0.0,156.0,0.0,156.0,0.0,156.0,
TCGA-CZ-5982,4387,TCGA-CZ-5982,KIRC,59.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2005.0,[Not Available],-21592.0,Alive,TUMOR FREE,2439.0,,[Not Available],,,,,[Not Available],,,0.0,2439.0,0.0,2439.0,,,0.0,2439.0,
TCGA-3B-A9HI,8537,TCGA-3B-A9HI,SARC,68.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2009.0,[Not Available],-24984.0,Alive,WITH TUMOR,1521.0,,[Not Available],Locoregional Recurrence,,,606.0,[Not Available],Positive,R1,0.0,1521.0,0.0,1521.0,,,1.0,606.0,
TCGA-XF-AAMH,450,TCGA-XF-AAMH,BLCA,80.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,[Not Available],-29547.0,Dead,WITH TUMOR,,344.0,[Not Available],Distant Metastasis,"Other, specify",lumbar spine and right hemipelvis,313.0,Progressive Disease,,,1.0,344.0,1.0,344.0,,,1.0,313.0,
TCGA-DU-A76K,5053,TCGA-DU-A76K,LGG,87.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1999.0,[Not Available],-31776.0,Dead,WITH TUMOR,,347.0,[Not Available],,,,203.0,Progressive Disease,,,1.0,347.0,1.0,347.0,,,1.0,203.0,
TCGA-2G-AAHP,9765,TCGA-2G-AAHP,TGCT,31.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,[Not Available],1999.0,[Not Available],-11649.0,Alive,TUMOR FREE,5667.0,,[Not Applicable],New Primary Tumor,Testes,,816.0,Complete Remission/Response,,,0.0,5667.0,0.0,5667.0,1.0,816.0,1.0,816.0,
TCGA-ED-A4XI,5666,TCGA-ED-A4XI,LIHC,58.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2012.0,[Not Available],-21497.0,Alive,TUMOR FREE,819.0,,[Not Available],,,,,[Not Available],,R0,0.0,819.0,0.0,819.0,0.0,819.0,0.0,819.0,
TCGA-EM-A1YE,10129,TCGA-EM-A1YE,THCA,47.0,FEMALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2007.0,[Not Available],-17297.0,Alive,TUMOR FREE,1645.0,,[Not Available],,,,,[Not Available],,R0,0.0,1645.0,0.0,1645.0,0.0,1645.0,0.0,1645.0,
TCGA-E8-A419,10031,TCGA-E8-A419,THCA,30.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-11306.0,Alive,TUMOR FREE,774.0,,[Not Available],,,,,[Not Available],,R0,0.0,774.0,0.0,774.0,0.0,774.0,0.0,774.0,
TCGA-86-8669,6202,TCGA-86-8669,LUAD,64.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-23443.0,Alive,TUMOR FREE,938.0,,[Not Available],Distant Metastasis,,,849.0,Complete Remission/Response,,,0.0,938.0,0.0,938.0,1.0,849.0,1.0,849.0,
TCGA-CM-6167,2282,TCGA-CM-6167,COAD,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-21031.0,Alive,TUMOR FREE,456.0,,[Not Available],,,,,[Not Available],,,0.0,456.0,0.0,456.0,,,0.0,456.0,
TCGA-F4-6808,2362,TCGA-F4-6808,COAD,54.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-19803.0,Alive,TUMOR FREE,1024.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1024.0,0.0,1024.0,0.0,1024.0,0.0,1024.0,
TCGA-AR-A256,953,TCGA-AR-A256,BRCA,45.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16642.0,Dead,,,2854.0,[Not Available],Locoregional Disease,,,1640.0,[Not Available],Negative,,1.0,2854.0,,2854.0,1.0,1640.0,1.0,1640.0,
TCGA-BF-A5EO,8810,TCGA-BF-A5EO,SKCM,65.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-23940.0,Alive,TUMOR FREE,703.0,,[Not Available],,,,,[Not Available],,,0.0,703.0,0.0,703.0,,,0.0,703.0,
TCGA-CR-6474,3426,TCGA-CR-6474,HNSC,51.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,[Not Available],-18840.0,Dead,WITH TUMOR,,564.0,[Not Available],,Cervical Lymph Nodes,Right neck,220.0,Complete Remission/Response,,,1.0,564.0,1.0,564.0,,,1.0,220.0,
TCGA-22-4601,6376,TCGA-22-4601,LUSC,73.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-26937.0,Dead,WITH TUMOR,1057.0,1057.0,[Not Available],,,,525.0,[Not Available],,,1.0,1057.0,1.0,1057.0,,,1.0,525.0,
TCGA-BG-A0VW,10758,TCGA-BG-A0VW,UCEC,77.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28383.0,Alive,TUMOR FREE,1582.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1582.0,0.0,1582.0,0.0,1582.0,0.0,1582.0,
TCGA-AX-A3G8,10671,TCGA-AX-A3G8,UCEC,76.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27899.0,Alive,,36.0,,[Not Available],,,,,[Not Available],,,0.0,36.0,0.0,36.0,,,0.0,36.0,
TCGA-DJ-A3VD,9992,TCGA-DJ-A3VD,THCA,32.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-12019.0,Alive,TUMOR FREE,1238.0,,[Not Available],,,,,[Not Available],,R0,0.0,1238.0,0.0,1238.0,0.0,1238.0,0.0,1238.0,
TCGA-E8-A414,10026,TCGA-E8-A414,THCA,45.0,FEMALE,ASIAN,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-16754.0,Alive,TUMOR FREE,958.0,,[Not Available],,,,,[Not Available],,R0,0.0,958.0,0.0,958.0,0.0,958.0,0.0,958.0,
TCGA-G2-AA3C,323,TCGA-G2-AA3C,BLCA,66.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-24267.0,Dead,WITH TUMOR,,211.0,[Not Available],,,,,[Unknown],,,1.0,211.0,1.0,211.0,,,1.0,211.0,
TCGA-EM-A3AN,10164,TCGA-EM-A3AN,THCA,36.0,FEMALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-13188.0,Alive,TUMOR FREE,1006.0,,[Not Available],,,,,[Not Available],,R1,0.0,1006.0,0.0,1006.0,,,0.0,1006.0,
TCGA-TM-A7C3,5369,TCGA-TM-A7C3,LGG,43.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-16021.0,Dead,WITH TUMOR,,1666.0,[Not Available],,,,713.0,Complete Remission/Response,,,1.0,1666.0,1.0,1666.0,1.0,713.0,1.0,713.0,
TCGA-D8-A1XL,1267,TCGA-D8-A1XL,BRCA,34.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12668.0,Alive,TUMOR FREE,606.0,,[Not Available],,,,,[Not Available],Negative,,0.0,606.0,0.0,606.0,0.0,606.0,0.0,606.0,
TCGA-CC-5262,5486,TCGA-CC-5262,LIHC,67.0,MALE,ASIAN,Stage IIIC,[Not Applicable],Hepatocellular Carcinoma,G1,2010.0,[Not Available],-24787.0,Dead,TUMOR FREE,,103.0,[Not Available],,,,,[Not Available],,[Not Available],1.0,103.0,0.0,103.0,,,0.0,103.0,
TCGA-B9-5156,4526,TCGA-B9-5156,KIRP,51.0,MALE,WHITE,[Not Available],Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-18841.0,Alive,TUMOR FREE,1338.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1338.0,0.0,1338.0,0.0,1338.0,0.0,1338.0,
TCGA-BC-A10T,5460,TCGA-BC-A10T,LIHC,76.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G1,2000.0,[Not Available],-27944.0,Dead,WITH TUMOR,,837.0,[Not Available],Extrahepatic Recurrence,Pulmonary,,598.0,[Not Available],,R1,1.0,837.0,1.0,837.0,,,1.0,598.0,
TCGA-CJ-6028,4333,TCGA-CJ-6028,KIRC,58.0,MALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2003.0,[Not Available],-21380.0,Dead,WITH TUMOR,,1625.0,[Not Available],,,,137.0,[Not Available],,,1.0,1625.0,1.0,1625.0,,,1.0,137.0,
TCGA-KC-A7F5,8168,TCGA-KC-A7F5,PRAD,54.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-20015.0,Alive,TUMOR FREE,91.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,91.0,0.0,91.0,0.0,91.0,0.0,91.0,
TCGA-B5-A3F9,10724,TCGA-B5-A3F9,UCEC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20523.0,Alive,TUMOR FREE,4155.0,,[Not Available],,,,,[Not Available],,,0.0,4155.0,0.0,4155.0,,,0.0,4155.0,
TCGA-CN-6019,3343,TCGA-CN-6019,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-22485.0,Alive,TUMOR FREE,1038.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1038.0,0.0,1038.0,,,0.0,1038.0,
TCGA-60-2724,6582,TCGA-60-2724,LUSC,47.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2008.0,[Not Available],-17462.0,Alive,TUMOR FREE,717.0,,[Not Available],,,,,[Not Available],,,0.0,717.0,0.0,717.0,,,0.0,717.0,
TCGA-BJ-A45K,9892,TCGA-BJ-A45K,THCA,33.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-12138.0,Alive,TUMOR FREE,705.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,705.0,0.0,705.0,,,0.0,705.0,
TCGA-HZ-8003,7599,TCGA-HZ-8003,PAAD,65.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-23868.0,Dead,WITH TUMOR,,596.0,Pancreatic Cancer,,,,,Complete Remission/Response,,,1.0,596.0,1.0,596.0,,,1.0,596.0,
TCGA-T9-A92H,2411,TCGA-T9-A92H,COAD,82.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2013.0,[Not Available],-30058.0,Alive,WITH TUMOR,362.0,,[Not Available],,,,81.0,Complete Remission/Response,,,0.0,362.0,0.0,362.0,1.0,81.0,1.0,81.0,
TCGA-ZJ-AAX4,1895,TCGA-ZJ-AAX4,CESC,85.0,FEMALE,WHITE,[Not Available],Stage II,Cervical Squamous Cell Carcinoma,G3,2008.0,[Unknown],-31258.0,Alive,,21.0,,,,,,,[Unknown],,,0.0,21.0,0.0,21.0,,,0.0,21.0,
TCGA-A2-A0ES,563,TCGA-A2-A0ES,BRCA,52.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19160.0,Alive,TUMOR FREE,2190.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2190.0,0.0,2190.0,0.0,2190.0,0.0,2190.0,
TCGA-KK-A8I8,8204,TCGA-KK-A8I8,PRAD,69.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-25546.0,Alive,TUMOR FREE,967.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,967.0,0.0,967.0,0.0,967.0,0.0,967.0,
TCGA-HT-7681,5174,TCGA-HT-7681,LGG,29.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2009.0,[Not Available],-10790.0,Alive,TUMOR FREE,1359.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1359.0,0.0,1359.0,0.0,1359.0,0.0,1359.0,
TCGA-G9-7519,8050,TCGA-G9-7519,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-21276.0,Alive,TUMOR FREE,849.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,849.0,0.0,849.0,0.0,849.0,0.0,849.0,
TCGA-QQ-A5VD,8750,TCGA-QQ-A5VD,SARC,52.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2011.0,[Not Available],-19004.0,Alive,TUMOR FREE,1129.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1129.0,0.0,1129.0,0.0,1129.0,0.0,1129.0,
TCGA-DX-AB3B,8673,TCGA-DX-AB3B,SARC,28.0,FEMALE,WHITE,[Not Available],[Not Available],Synovial Sarcoma - Monophasic,[Not Available],2009.0,[Not Available],-10337.0,Alive,TUMOR FREE,1548.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,1548.0,0.0,1548.0,0.0,1548.0,0.0,1548.0,
TCGA-CR-6473,3425,TCGA-CR-6473,HNSC,68.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-24857.0,Alive,TUMOR FREE,1125.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1125.0,0.0,1125.0,,,0.0,1125.0,
TCGA-S9-A6WQ,5347,TCGA-S9-A6WQ,LGG,57.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2013.0,[Not Available],-21133.0,Alive,WITH TUMOR,428.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,428.0,0.0,428.0,,,0.0,428.0,
TCGA-FC-7961,8008,TCGA-FC-7961,PRAD,62.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-22888.0,Alive,TUMOR FREE,469.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,469.0,0.0,469.0,0.0,469.0,0.0,469.0,
TCGA-DX-AB2E,8652,TCGA-DX-AB2E,SARC,60.0,MALE,WHITE,[Not Available],[Not Available],Myxofibrosarcoma,[Not Available],2013.0,[Not Available],-22117.0,Alive,WITH TUMOR,541.0,,[Not Available],Distant Metastasis,Lung,,132.0,[Not Available],Positive,R0,0.0,541.0,0.0,541.0,1.0,132.0,1.0,132.0,
TCGA-E6-A1M0,10912,TCGA-E6-A1M0,UCEC,56.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20629.0,Alive,TUMOR FREE,1793.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1793.0,0.0,1793.0,0.0,1793.0,0.0,1793.0,
TCGA-DJ-A3UX,9978,TCGA-DJ-A3UX,THCA,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-17124.0,Alive,WITH TUMOR,345.0,,[Not Available],,,,,[Not Available],,R0,0.0,345.0,0.0,345.0,0.0,345.0,0.0,345.0,
TCGA-F5-6465,8523,TCGA-F5-6465,READ,64.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-23432.0,Alive,TUMOR FREE,1506.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1506.0,0.0,1506.0,0.0,1506.0,0.0,1506.0,
TCGA-EE-A2M6,9047,TCGA-EE-A2M6,SKCM,61.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1997.0,[Not Available],-22564.0,Alive,TUMOR FREE,3932.0,,[Not Available],,,,,[Not Available],,,0.0,3932.0,0.0,3932.0,,,0.0,3932.0,
TCGA-DJ-A2PN,9940,TCGA-DJ-A2PN,THCA,70.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-25690.0,Alive,TUMOR FREE,307.0,,[Not Available],,,,,[Not Available],,R0,0.0,307.0,0.0,307.0,0.0,307.0,0.0,307.0,
TCGA-34-2609,6423,TCGA-34-2609,LUSC,81.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-29871.0,Dead,WITH TUMOR,951.0,951.0,[Not Available],,,,387.0,Complete Remission/Response,,,1.0,951.0,1.0,951.0,1.0,387.0,1.0,387.0,
TCGA-EC-A1QX,10917,TCGA-EC-A1QX,UCEC,71.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26259.0,Alive,TUMOR FREE,224.0,,[Not Available],,,,219.0,Progressive Disease,,,0.0,224.0,0.0,224.0,,,1.0,219.0,
TCGA-NH-A50U,2395,TCGA-NH-A50U,COAD,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2012.0,[Not Available],-15450.0,Dead,WITH TUMOR,,334.0,[Not Available],,,,276.0,Partial Remission/Response,,,1.0,334.0,1.0,334.0,,,1.0,276.0,
TCGA-34-8455,6436,TCGA-34-8455,LUSC,67.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-24624.0,Dead,WITH TUMOR,,123.0,[Not Available],,,,,Progressive Disease,,,1.0,123.0,1.0,123.0,,,1.0,123.0,
TCGA-AX-A1CN,10642,TCGA-AX-A1CN,UCEC,54.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19860.0,Alive,WITH TUMOR,1143.0,,[Not Available],New Primary Tumor,Lung,,1105.0,[Not Available],,,0.0,1143.0,0.0,1143.0,,,1.0,1105.0,
TCGA-D1-A15W,10828,TCGA-D1-A15W,UCEC,58.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21545.0,Alive,TUMOR FREE,915.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,915.0,0.0,915.0,0.0,915.0,0.0,915.0,
TCGA-HT-7611,5168,TCGA-HT-7611,LGG,36.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2007.0,[Not Available],-13314.0,Alive,TUMOR FREE,1752.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1752.0,0.0,1752.0,0.0,1752.0,0.0,1752.0,
TCGA-62-A46Y,6070,TCGA-62-A46Y,LUAD,70.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-25905.0,Dead,WITH TUMOR,,414.0,[Not Available],Distant Metastasis,,,314.0,Complete Remission/Response,,,1.0,414.0,1.0,414.0,1.0,314.0,1.0,314.0,
TCGA-DF-A2KZ,10899,TCGA-DF-A2KZ,UCEC,87.0,FEMALE,[Not Evaluated],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31973.0,Alive,TUMOR FREE,826.0,,[Not Available],,,,,[Not Available],,,0.0,826.0,0.0,826.0,,,0.0,826.0,
TCGA-J9-A8CM,8159,TCGA-J9-A8CM,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-24118.0,Alive,WITH TUMOR,463.0,,[Not Available],Biochemical evidence of disease,,,344.0,Partial Remission/Response,,,0.0,463.0,0.0,463.0,,,1.0,344.0,
TCGA-BJ-A0ZE,9855,TCGA-BJ-A0ZE,THCA,63.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-23250.0,Alive,TUMOR FREE,509.0,,[Not Available],,,,,[Not Available],,R1,0.0,509.0,0.0,509.0,,,0.0,509.0,
TCGA-C5-A902,1668,TCGA-C5-A902,CESC,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2008.0,[Not Available],-12959.0,Alive,TUMOR FREE,149.0,,,,,,,[Not Available],,,0.0,149.0,0.0,149.0,,,0.0,149.0,
TCGA-WB-A81T,7860,TCGA-WB-A81T,PCPG,45.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2013.0,[Not Available],-16506.0,Alive,TUMOR FREE,776.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,776.0,0.0,776.0,0.0,776.0,0.0,776.0,
TCGA-EL-A4K2,10111,TCGA-EL-A4K2,THCA,43.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-15962.0,Alive,TUMOR FREE,928.0,,[Not Available],,,,,[Not Available],,R0,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,
TCGA-ZN-A9VO,6909,TCGA-ZN-A9VO,MESO,36.0,MALE,WHITE,Stage IV,[Not Applicable],Epithelioid mesothelioma,[Not Available],2011.0,[Not Available],-13243.0,Alive,TUMOR FREE,261.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,261.0,0.0,261.0,,,0.0,261.0,
TCGA-J4-A6G3,8142,TCGA-J4-A6G3,PRAD,57.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-20836.0,Alive,WITH TUMOR,849.0,,[Not Available],Biochemical evidence of disease,,,618.0,Partial Remission/Response,,,0.0,849.0,0.0,849.0,,,1.0,618.0,
TCGA-EM-A1CU,10122,TCGA-EM-A1CU,THCA,31.0,MALE,[Not Available],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-11470.0,Alive,TUMOR FREE,636.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,636.0,0.0,636.0,,,0.0,636.0,
TCGA-DD-AADN,5624,TCGA-DD-AADN,LIHC,59.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G4,2012.0,[Not Available],-21632.0,Alive,TUMOR FREE,898.0,,[Not Available],,,,,[Not Available],,R0,0.0,898.0,0.0,898.0,0.0,898.0,0.0,898.0,
TCGA-DU-A6S2,5048,TCGA-DU-A6S2,LGG,37.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Oligodendroglioma,G2,2013.0,[Not Available],-13597.0,Alive,TUMOR FREE,777.0,,[Not Available],,,,,Stable Disease,,,0.0,777.0,0.0,777.0,,,0.0,777.0,
TCGA-2G-AAH0,9755,TCGA-2G-AAH0,TGCT,30.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS|Non-Seminoma; Embryonal Carcinoma,[Not Available],1999.0,[Not Available],-11123.0,Alive,TUMOR FREE,5477.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,107.0,Complete Remission/Response,,,0.0,5477.0,0.0,5477.0,1.0,107.0,1.0,107.0,
TCGA-X7-A8DF,10392,TCGA-X7-A8DF,THYM,40.0,MALE,WHITE,[Not Applicable],[Not Available],Thymoma; Type AB,[Not Available],2012.0,[Not Available],-14804.0,Alive,TUMOR FREE,901.0,,[Not Available],,,,,[Not Available],,,0.0,901.0,0.0,901.0,,,0.0,901.0,
TCGA-63-A5MY,6608,TCGA-63-A5MY,LUSC,63.0,MALE,[Not Evaluated],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-23276.0,Alive,TUMOR FREE,1052.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1052.0,0.0,1052.0,0.0,1052.0,0.0,1052.0,
TCGA-CV-A45Q,3578,TCGA-CV-A45Q,HNSC,69.0,FEMALE,WHITE,[Not Available],Stage IVC,Head & Neck Squamous Cell Carcinoma,G1,1995.0,[Not Available],-25379.0,Dead,TUMOR FREE,,5152.0,[Not Available],,,,,Complete Remission/Response,,,1.0,5152.0,0.0,5152.0,,,0.0,5152.0,
TCGA-ET-A39J,10220,TCGA-ET-A39J,THCA,23.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006.0,[Not Available],-8491.0,Alive,TUMOR FREE,3227.0,,[Not Available],,,,,[Not Available],,R0,0.0,3227.0,0.0,3227.0,0.0,3227.0,0.0,3227.0,
TCGA-ER-A19Q,9109,TCGA-ER-A19Q,SKCM,37.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2001.0,[Not Available],-13648.0,Dead,WITH TUMOR,,1548.0,[Not Available],Distant Metastasis,Bone,,1259.0,[Not Available],,,1.0,1548.0,1.0,1548.0,,,1.0,1259.0,
TCGA-HD-8634,3671,TCGA-HD-8634,HNSC,51.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-18718.0,Dead,TUMOR FREE,,385.0,[Not Available],,,,,Complete Remission/Response,,,1.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-AM-5821,2200,TCGA-AM-5821,COAD,68.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-24903.0,Alive,TUMOR FREE,28.0,,[Not Available],,,,,[Not Available],,,0.0,28.0,0.0,28.0,,,0.0,28.0,
TCGA-EE-A3AE,9072,TCGA-EE-A3AE,SKCM,52.0,FEMALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2009.0,[Not Available],-19216.0,Alive,TUMOR FREE,1658.0,,[Not Available],,,,,[Not Available],,,0.0,1658.0,0.0,1658.0,,,0.0,1658.0,
TCGA-BR-A4IV,9397,TCGA-BR-A4IV,STAD,47.0,MALE,ASIAN,Stage IIIB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-17515.0,Dead,WITH TUMOR,,869.0,[Not Available],Locoregional Recurrence,,,737.0,Complete Remission/Response,,,1.0,869.0,1.0,869.0,1.0,737.0,1.0,737.0,
TCGA-XE-AANR,9812,TCGA-XE-AANR,TGCT,23.0,MALE,WHITE,Stage I,Stage I,Seminoma; NOS,[Not Available],2008.0,[Not Available],-8761.0,Alive,TUMOR FREE,14.0,,[Not Applicable],,,,,[Unknown],,,0.0,14.0,0.0,14.0,,,0.0,14.0,
TCGA-BA-A4IH,3266,TCGA-BA-A4IH,HNSC,57.0,MALE,WHITE,[Discrepancy],Stage IVA,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2012.0,[Not Available],-21094.0,Alive,TUMOR FREE,622.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,622.0,0.0,622.0,,,0.0,622.0,
TCGA-RD-A7BS,9626,TCGA-RD-A7BS,STAD,46.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2001.0,[Not Available],-16847.0,Dead,WITH TUMOR,,336.0,Stomach Cancer,Distant Metastasis,Liver,,244.0,Complete Remission/Response,,,1.0,336.0,1.0,336.0,1.0,244.0,1.0,244.0,
TCGA-FD-A6TD,298,TCGA-FD-A6TD,BLCA,77.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-28328.0,Dead,TUMOR FREE,,386.0,[Not Available],,,,,Complete Remission/Response,,,1.0,386.0,0.0,386.0,0.0,386.0,0.0,386.0,
TCGA-CH-5769,7901,TCGA-CH-5769,PRAD,48.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2007.0,[Not Available],-17807.0,Alive,WITH TUMOR,62.0,,[Not Available],,,,,[Not Available],,,0.0,62.0,0.0,62.0,,,0.0,62.0,
TCGA-S9-A7IS,5349,TCGA-S9-A7IS,LGG,33.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2004.0,[Not Available],-12402.0,Dead,WITH TUMOR,,241.0,[Not Available],,,,,Progressive Disease,,,1.0,241.0,1.0,241.0,,,1.0,241.0,
TCGA-CR-7377,3449,TCGA-CR-7377,HNSC,58.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-21371.0,Dead,,,279.0,[Not Available],,,,,Complete Remission/Response,,,1.0,279.0,,279.0,,,0.0,279.0,
TCGA-JY-A6FB,2496,TCGA-JY-A6FB,ESCA,77.0,MALE,WHITE,Stage I,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2007.0,[Not Available],-28269.0,Alive,TUMOR FREE,1837.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1837.0,0.0,1837.0,0.0,1837.0,0.0,1837.0,
TCGA-50-6591,5952,TCGA-50-6591,LUAD,63.0,FEMALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-23067.0,Dead,WITH TUMOR,,119.0,[Not Available],,,,,Progressive Disease,,,1.0,119.0,1.0,119.0,,,1.0,119.0,
TCGA-55-8620,6045,TCGA-55-8620,LUAD,60.0,MALE,WHITE,Stage IV,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22091.0,Dead,WITH TUMOR,,375.0,[Not Available],,,,,Progressive Disease,,,1.0,375.0,1.0,375.0,,,1.0,375.0,
TCGA-DD-AADJ,5620,TCGA-DD-AADJ,LIHC,70.0,FEMALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-25863.0,Alive,TUMOR FREE,1066.0,,[Not Available],,,,,[Not Available],,R0,0.0,1066.0,0.0,1066.0,0.0,1066.0,0.0,1066.0,
TCGA-C5-A8ZZ,1666,TCGA-C5-A8ZZ,CESC,41.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15262.0,Alive,TUMOR FREE,636.0,,,,,,,[Not Available],,,0.0,636.0,0.0,636.0,,,0.0,636.0,
TCGA-E2-A14X,1323,TCGA-E2-A14X,BRCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20105.0,Alive,TUMOR FREE,972.0,,[Not Available],,,,,[Not Available],Negative,,0.0,972.0,0.0,972.0,0.0,972.0,0.0,972.0,
TCGA-06-0648,2824,TCGA-06-0648,GBM,77.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2007.0,[Not Available],-28477.0,Dead,WITH TUMOR,294.0,298.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],202.0,[Not Available],,,1.0,298.0,1.0,298.0,,,1.0,202.0,
TCGA-86-A4P8,6211,TCGA-86-A4P8,LUAD,59.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-21738.0,Alive,TUMOR FREE,805.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,805.0,0.0,805.0,0.0,805.0,0.0,805.0,
TCGA-55-A491,6051,TCGA-55-A491,LUAD,81.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-29593.0,Alive,TUMOR FREE,626.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,
TCGA-DK-A1AA,184,TCGA-DK-A1AA,BLCA,57.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-21093.0,Alive,TUMOR FREE,578.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,
TCGA-78-8640,6169,TCGA-78-8640,LUAD,59.0,MALE,[Not Evaluated],Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],1994.0,[Not Available],-21832.0,Alive,TUMOR FREE,7062.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,7062.0,0.0,7062.0,0.0,7062.0,0.0,7062.0,
TCGA-BR-6801,9317,TCGA-BR-6801,STAD,70.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-25637.0,Alive,TUMOR FREE,1223.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1223.0,0.0,1223.0,0.0,1223.0,0.0,1223.0,
TCGA-DJ-A3US,9973,TCGA-DJ-A3US,THCA,37.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-13634.0,Alive,TUMOR FREE,998.0,,[Not Available],,,,,[Not Available],,R0,0.0,998.0,0.0,998.0,0.0,998.0,0.0,998.0,
TCGA-86-8673,6205,TCGA-86-8673,LUAD,61.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22571.0,Alive,TUMOR FREE,862.0,,[Not Available],Locoregional Recurrence,,,636.0,Complete Remission/Response,,,0.0,862.0,0.0,862.0,1.0,636.0,1.0,636.0,
TCGA-UF-A7JA,3756,TCGA-UF-A7JA,HNSC,66.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-24121.0,Alive,TUMOR FREE,2265.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2265.0,0.0,2265.0,,,0.0,2265.0,
TCGA-44-2666,5861,TCGA-44-2666,LUAD,43.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-15970.0,Dead,WITH TUMOR,97.0,97.0,[Not Available],,,,,[Not Available],,,1.0,97.0,1.0,97.0,,,1.0,97.0,
TCGA-EP-A3JL,5685,TCGA-EP-A3JL,LIHC,76.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-27886.0,Alive,TUMOR FREE,303.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,303.0,0.0,303.0,,,0.0,303.0,
TCGA-F7-A50I,3648,TCGA-F7-A50I,HNSC,72.0,MALE,WHITE,Stage IVA,[Not Available],Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-26373.0,Alive,TUMOR FREE,92.0,,[Not Available],,,,,[Not Available],,,0.0,92.0,0.0,92.0,,,0.0,92.0,
TCGA-AC-A23H,758,TCGA-AC-A23H,BRCA,90.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873.0,Dead,WITH TUMOR,,174.0,[Not Available],,,,,[Not Available],Negative,,1.0,174.0,1.0,174.0,,,1.0,174.0,
TCGA-CZ-5985,4389,TCGA-CZ-5985,KIRC,58.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-21242.0,Alive,TUMOR FREE,1997.0,,[Not Available],,,,,[Not Available],,,0.0,1997.0,0.0,1997.0,,,0.0,1997.0,
TCGA-BH-AB28,1175,TCGA-BH-AB28,BRCA,53.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013.0,[Unknown],-19570.0,Alive,TUMOR FREE,287.0,,[Not Available],,,,,[Not Available],Negative,,0.0,287.0,0.0,287.0,0.0,287.0,0.0,287.0,
TCGA-TM-A84Q,5384,TCGA-TM-A84Q,LGG,31.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-11668.0,Alive,TUMOR FREE,772.0,,[Not Available],,,,455.0,Complete Remission/Response,,,0.0,772.0,0.0,772.0,1.0,455.0,1.0,455.0,
TCGA-G4-6309,2378,TCGA-G4-6309,COAD,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-14729.0,Alive,TUMOR FREE,2600.0,,[Not Available],,,,2176.0,Complete Remission/Response,,,0.0,2600.0,0.0,2600.0,1.0,2176.0,1.0,2176.0,
TCGA-13-0751,7011,TCGA-13-0751,OV,44.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,GX,1999.0,[Not Available],-16304.0,Dead,WITH TUMOR,1678.0,1678.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],653.0,Complete Remission/Response,,,1.0,1678.0,1.0,1678.0,1.0,653.0,1.0,653.0,
TCGA-QH-A6CV,5296,TCGA-QH-A6CV,LGG,51.0,MALE,ASIAN,[Not Available],[Not Available],Oligoastrocytoma,G3,2013.0,[Not Available],-18955.0,Alive,WITH TUMOR,442.0,,[Not Available],,,,,Stable Disease,,,0.0,442.0,0.0,442.0,,,0.0,442.0,
TCGA-BA-5153,3251,TCGA-BA-5153,HNSC,51.0,MALE,WHITE,[Not Available],Stage III,Head & Neck Squamous Cell Carcinoma,G2,2005.0,[Not Available],-18743.0,Dead,WITH TUMOR,,1762.0,[Not Available],,Distant Metastasis,bone (hip),1522.0,Complete Remission/Response,,,1.0,1762.0,1.0,1762.0,1.0,1522.0,1.0,1522.0,
TCGA-26-5132,3108,TCGA-26-5132,GBM,74.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-27196.0,Alive,TUMOR FREE,286.0,,[Not Available],,,,,[Not Available],,,0.0,286.0,0.0,286.0,,,0.0,286.0,
TCGA-C5-A1BE,1608,TCGA-C5-A1BE,CESC,64.0,FEMALE,WHITE,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G2,2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23727.0,Dead,WITH TUMOR,,2094.0,Cervical Cancer,,,,1674.0,Complete Remission/Response,,,1.0,2094.0,1.0,2094.0,1.0,1674.0,1.0,1674.0,
TCGA-AX-A2HH,10655,TCGA-AX-A2HH,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,[Not Available],-21924.0,Alive,WITH TUMOR,540.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,540.0,0.0,540.0,,,0.0,540.0,
TCGA-4Z-AA87,113,TCGA-4Z-AA87,BLCA,72.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-26430.0,Alive,WITH TUMOR,1454.0,,[Not Available],Distant Metastasis,Bone,,221.0,[Unknown],,,0.0,1454.0,0.0,1454.0,,,1.0,221.0,
TCGA-DB-5270,4931,TCGA-DB-5270,LGG,38.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2002.0,[Not Available],-13904.0,Alive,TUMOR FREE,3733.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3733.0,0.0,3733.0,0.0,3733.0,0.0,3733.0,
TCGA-F1-6875,9534,TCGA-F1-6875,STAD,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,1996.0,[Not Available],-29209.0,Dead,TUMOR FREE,,2197.0,[Not Available],,,,,Complete Remission/Response,,,1.0,2197.0,0.0,2197.0,0.0,2197.0,0.0,2197.0,
TCGA-2F-A9KQ,95,TCGA-2F-A9KQ,BLCA,69.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-25259.0,Alive,TUMOR FREE,2886.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2886.0,0.0,2886.0,0.0,2886.0,0.0,2886.0,
TCGA-AR-A255,952,TCGA-AR-A255,BRCA,62.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22809.0,Alive,TUMOR FREE,2161.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2161.0,0.0,2161.0,0.0,2161.0,0.0,2161.0,
TCGA-EJ-A7NK,7997,TCGA-EJ-A7NK,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-21530.0,Alive,TUMOR FREE,476.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,
TCGA-AX-A1C9,10634,TCGA-AX-A1C9,UCEC,73.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26903.0,Alive,TUMOR FREE,802.0,,[Not Available],,,,,[Not Applicable],,,0.0,802.0,0.0,802.0,,,0.0,802.0,
TCGA-BH-A0BT,1053,TCGA-BH-A0BT,BRCA,56.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,[Not Available],-20625.0,Alive,TUMOR FREE,2365.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2365.0,0.0,2365.0,0.0,2365.0,0.0,2365.0,
TCGA-OR-A5JM,22,TCGA-OR-A5JM,ACC,25.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-9359.0,Dead,WITH TUMOR,,562.0,[Not Available],Distant Metastasis,Liver,,72.0,Progressive Disease,,,1.0,562.0,1.0,562.0,,,1.0,72.0,
TCGA-VS-A8QC,1847,TCGA-VS-A8QC,CESC,51.0,FEMALE,WHITE,[Not Available],Stage IVA,Cervical Squamous Cell Carcinoma,G2,2009.0,Peri (6-12 months since last menstrual period),-18743.0,Dead,WITH TUMOR,,350.0,Cervical Cancer,Distant Metastasis,,Liver,263.0,Progressive Disease,,,1.0,350.0,1.0,350.0,,,1.0,263.0,
TCGA-TS-A7OU,6878,TCGA-TS-A7OU,MESO,56.0,MALE,WHITE,Stage IV,[Not Applicable],Epithelioid mesothelioma,[Not Available],2007.0,[Not Available],-20747.0,Dead,,,1675.0,[Not Available],,,,,[Not Available],,[Not Available],1.0,1675.0,,1675.0,,,0.0,1675.0,
TCGA-37-4130,6443,TCGA-37-4130,LUSC,56.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2010.0,[Not Available],-20652.0,Alive,TUMOR FREE,247.0,,[Not Available],,,,,[Not Available],,,0.0,247.0,0.0,247.0,,,0.0,247.0,
TCGA-FS-A1ZS,9165,TCGA-FS-A1ZS,SKCM,54.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1998.0,[Not Available],-19813.0,Alive,WITH TUMOR,4526.0,,[Not Available],Regional lymph node|Regional lymph node|Distant Metastasis|Regional lymph node|Distant Metastasis|Distant Metastasis,[Not Available]|[Not Available]|Lung|[Not Available]|Lung|Liver,[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable],2861.0,[Not Available],,,0.0,4526.0,0.0,4526.0,,,1.0,2861.0,
TCGA-P5-A72U,5275,TCGA-P5-A72U,LGG,71.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-26002.0,Alive,TUMOR FREE,7.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,7.0,0.0,7.0,0.0,7.0,0.0,7.0,
TCGA-XF-A9SU,434,TCGA-XF-A9SU,BLCA,74.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,[Not Available],-27068.0,Dead,WITH TUMOR,,182.0,[Not Available],Distant Metastasis,Liver,,103.0,Progressive Disease,,,1.0,182.0,1.0,182.0,,,1.0,103.0,
TCGA-BI-A0VS,1605,TCGA-BI-A0VS,CESC,48.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17839.0,Alive,TUMOR FREE,1735.0,,,,,,,Complete Remission/Response,,,0.0,1735.0,0.0,1735.0,0.0,1735.0,0.0,1735.0,
TCGA-V1-A9OQ,8256,TCGA-V1-A9OQ,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-24820.0,Alive,,371.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,371.0,0.0,371.0,0.0,371.0,0.0,371.0,
TCGA-VQ-A8PE,9658,TCGA-VQ-A8PE,STAD,78.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-28755.0,Dead,WITH TUMOR,,675.0,[Not Available],Locoregional Recurrence,,,265.0,Progressive Disease,,,1.0,675.0,1.0,675.0,,,1.0,265.0,
TCGA-2L-AAQA,7520,TCGA-2L-AAQA,PAAD,76.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,[Not Available],-28074.0,Dead,WITH TUMOR,,143.0,Pancreatic Cancer,,,,,Progressive Disease,,,1.0,143.0,1.0,143.0,,,1.0,143.0,
TCGA-CA-5255,2235,TCGA-CA-5255,COAD,45.0,MALE,ASIAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-16743.0,Alive,TUMOR FREE,376.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,
TCGA-VQ-A8P2,9651,TCGA-VQ-A8P2,STAD,68.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2011.0,[Not Available],-25129.0,Alive,TUMOR FREE,1160.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1160.0,0.0,1160.0,0.0,1160.0,0.0,1160.0,
TCGA-BB-4217,3279,TCGA-BB-4217,HNSC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,[Not Available],-25020.0,Alive,WITH TUMOR,187.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,187.0,0.0,187.0,,,0.0,187.0,
TCGA-QQ-A5VA,8747,TCGA-QQ-A5VA,SARC,60.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],1996.0,[Not Available],-22231.0,Dead,WITH TUMOR,,550.0,[Not Available],,,,,[Not Available],Negative,RX,1.0,550.0,1.0,550.0,,,1.0,550.0,
TCGA-B0-5693,4051,TCGA-B0-5693,KIRC,47.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2003.0,[Not Available],-17177.0,Alive,TUMOR FREE,4074.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,4074.0,0.0,4074.0,0.0,4074.0,0.0,4074.0,
TCGA-EF-5830,8503,TCGA-EF-5830,READ,54.0,MALE,WHITE,Stage IIB,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-19802.0,Alive,TUMOR FREE,106.0,,[Not Available],,,,,[Not Applicable],,,0.0,106.0,0.0,106.0,,,0.0,106.0,
TCGA-WB-A81N,7855,TCGA-WB-A81N,PCPG,28.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2010.0,[Not Available],-10283.0,Alive,TUMOR FREE,1887.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1887.0,0.0,1887.0,0.0,1887.0,0.0,1887.0,
TCGA-BH-A0BZ,1056,TCGA-BH-A0BZ,BRCA,59.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21856.0,Alive,TUMOR FREE,2255.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2255.0,0.0,2255.0,0.0,2255.0,0.0,2255.0,
TCGA-21-1077,6348,TCGA-21-1077,LUSC,64.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-23523.0,Dead,WITH TUMOR,1058.0,1058.0,[Not Available],,,,644.0,[Not Available],,,1.0,1058.0,1.0,1058.0,,,1.0,644.0,
TCGA-GN-A4U3,9203,TCGA-GN-A4U3,SKCM,30.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2004.0,[Not Available],-11294.0,Alive,TUMOR FREE,3708.0,,[Not Available],Distant Metastasis|Distant Metastasis,Lung|Brain,[Not Applicable]|[Not Applicable],2274.0,[Not Available],,,0.0,3708.0,0.0,3708.0,,,1.0,2274.0,
TCGA-GM-A2DL,1509,TCGA-GM-A2DL,BRCA,50.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003.0,Peri (6-12 months since last menstrual period),-18475.0,Alive,TUMOR FREE,3519.0,,[Not Available],,,,,[Not Available],Negative,,0.0,3519.0,0.0,3519.0,0.0,3519.0,0.0,3519.0,
TCGA-E2-A1IL,1366,TCGA-E2-A1IL,BRCA,78.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28495.0,Alive,TUMOR FREE,118.0,,[Not Available],,,,,[Not Available],Negative,,0.0,118.0,0.0,118.0,0.0,118.0,0.0,118.0,
TCGA-QH-A6XC,5307,TCGA-QH-A6XC,LGG,48.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-17692.0,Alive,WITH TUMOR,508.0,,[Not Available],,,,438.0,Complete Remission/Response,,,0.0,508.0,0.0,508.0,1.0,438.0,1.0,438.0,
TCGA-DD-A1EK,5535,TCGA-DD-A1EK,LIHC,64.0,FEMALE,WHITE,Stage IVB,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-23437.0,Dead,WITH TUMOR,,558.0,[Not Available],Locoregional Recurrence,Liver,,167.0,[Not Available],,R0,1.0,558.0,1.0,558.0,,,1.0,167.0,
TCGA-85-8582,6734,TCGA-85-8582,LUSC,49.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-18168.0,Alive,TUMOR FREE,1160.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1160.0,0.0,1160.0,0.0,1160.0,0.0,1160.0,
TCGA-CV-6937,3498,TCGA-CV-6937,HNSC,71.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2003.0,[Not Available],-26156.0,Dead,TUMOR FREE,,624.0,[Not Available],,,,,[Not Available],,,1.0,624.0,0.0,624.0,,,0.0,624.0,
TCGA-D3-A1QB,8834,TCGA-D3-A1QB,SKCM,75.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],2005.0,[Not Available],-27566.0,Alive,TUMOR FREE,2912.0,,[Not Available],Locoregional Recurrence,,,0.0,[Not Available],,,0.0,2912.0,0.0,2912.0,,,1.0,0.0,
TCGA-CN-6018,3342,TCGA-CN-6018,HNSC,85.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,[Not Available],-31242.0,Dead,TUMOR FREE,,580.0,[Not Available],,,,,Complete Remission/Response,,,1.0,580.0,0.0,580.0,,,0.0,580.0,
TCGA-A3-3382,3924,TCGA-A3-3382,KIRC,69.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-25207.0,Alive,WITH TUMOR,574.0,,[Not Available],,,,514.0,[Not Available],,,0.0,574.0,0.0,574.0,,,1.0,514.0,
TCGA-BP-5191,4257,TCGA-BP-5191,KIRC,79.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-29207.0,Alive,TUMOR FREE,967.0,,[Not Available],,,,,[Not Available],,,0.0,967.0,0.0,967.0,,,0.0,967.0,
TCGA-G3-A5SJ,5714,TCGA-G3-A5SJ,LIHC,59.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2012.0,[Not Available],-21848.0,Alive,TUMOR FREE,698.0,,[Not Available],Intrahepatic Recurrence,Liver,,308.0,[Not Available],,R0,0.0,698.0,0.0,698.0,1.0,308.0,1.0,308.0,
TCGA-AX-A3FT,10661,TCGA-AX-A3FT,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23543.0,Alive,,6.0,,[Not Available],,,,,[Not Available],,,0.0,6.0,0.0,6.0,,,0.0,6.0,
TCGA-BP-4167,4134,TCGA-BP-4167,KIRC,59.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2003.0,[Not Available],-21901.0,Alive,TUMOR FREE,2718.0,,[Not Available],,,,,[Not Available],,,0.0,2718.0,0.0,2718.0,,,0.0,2718.0,
TCGA-HT-7602,5159,TCGA-HT-7602,LGG,21.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2008.0,[Not Available],-7946.0,Alive,TUMOR FREE,908.0,,[Not Available],,,,,[Not Available],,,0.0,908.0,0.0,908.0,,,0.0,908.0,
TCGA-4K-AA1H,9778,TCGA-4K-AA1H,TGCT,26.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,[Not Available],2013.0,[Not Available],-9658.0,Alive,TUMOR FREE,518.0,,[Not Applicable],,,,,No Measureable Tumor or Tumor Markers,,,0.0,518.0,0.0,518.0,0.0,518.0,0.0,518.0,
TCGA-F9-A7VF,4591,TCGA-F9-A7VF,KIRP,75.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-27446.0,Alive,TUMOR FREE,73.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,73.0,0.0,73.0,0.0,73.0,0.0,73.0,
TCGA-FP-8209,9542,TCGA-FP-8209,STAD,49.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2005.0,[Not Available],-18171.0,Dead,WITH TUMOR,,1811.0,Stomach Cancer,Distant Metastasis,"Other, specify",pancreas,1676.0,Complete Remission/Response,,,1.0,1811.0,1.0,1811.0,1.0,1676.0,1.0,1676.0,
TCGA-G6-A5PC,4410,TCGA-G6-A5PC,KIRC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2012.0,[Not Available],-20029.0,Dead,WITH TUMOR,,242.0,[Not Available],,,,,Progressive Disease,,,1.0,242.0,1.0,242.0,,,1.0,242.0,
TCGA-WB-A814,7839,TCGA-WB-A814,PCPG,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2008.0,[Not Available],-12936.0,Alive,TUMOR FREE,2252.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2252.0,0.0,2252.0,0.0,2252.0,0.0,2252.0,
TCGA-BB-A5HY,3296,TCGA-BB-A5HY,HNSC,64.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,[Not Available],-23640.0,Dead,WITH TUMOR,,321.0,[Not Available],Distant Metastasis,Distant Metastasis,Cerebellum,230.0,Complete Remission/Response,,,1.0,321.0,1.0,321.0,,,1.0,230.0,
TCGA-A3-A6NJ,3929,TCGA-A3-A6NJ,KIRC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G1,2012.0,[Not Available],-20918.0,Alive,TUMOR FREE,468.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,468.0,0.0,468.0,0.0,468.0,0.0,468.0,
TCGA-VM-A8CA,5407,TCGA-VM-A8CA,LGG,54.0,MALE,[Unknown],[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-19991.0,Alive,WITH TUMOR,411.0,,[Not Available],,,,,[Unknown],,,0.0,411.0,0.0,411.0,,,0.0,411.0,
TCGA-J4-A83I,8144,TCGA-J4-A83I,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-23240.0,Alive,TUMOR FREE,685.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,685.0,0.0,685.0,0.0,685.0,0.0,685.0,
TCGA-IR-A3LH,1780,TCGA-IR-A3LH,CESC,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IIA1,Cervical Squamous Cell Carcinoma,G4,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18118.0,Alive,TUMOR FREE,2394.0,,,,,,,Complete Remission/Response,,,0.0,2394.0,0.0,2394.0,0.0,2394.0,0.0,2394.0,
TCGA-BR-A4J6,9404,TCGA-BR-A4J6,STAD,69.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-25279.0,Alive,TUMOR FREE,20.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,20.0,0.0,20.0,0.0,20.0,0.0,20.0,
TCGA-CC-A9FW,5513,TCGA-CC-A9FW,LIHC,68.0,MALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-24891.0,Alive,WITH TUMOR,248.0,,[Not Available],Locoregional Recurrence,,,153.0,[Not Available],,R0,0.0,248.0,0.0,248.0,1.0,153.0,1.0,153.0,
TCGA-WE-A8ZM,9240,TCGA-WE-A8ZM,SKCM,70.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2006.0,[Not Available],-25869.0,Alive,WITH TUMOR,3082.0,,[Not Available],Locoregional Recurrence,,,646.0,[Not Available],,,0.0,3082.0,0.0,3082.0,,,1.0,646.0,
TCGA-G9-6496,8045,TCGA-G9-6496,PRAD,61.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-22602.0,Alive,TUMOR FREE,1726.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1726.0,0.0,1726.0,0.0,1726.0,0.0,1726.0,
TCGA-BH-A0BO,1048,TCGA-BH-A0BO,BRCA,54.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19767.0,Alive,TUMOR FREE,2197.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2197.0,0.0,2197.0,0.0,2197.0,0.0,2197.0,
TCGA-39-5036,6465,TCGA-39-5036,LUSC,73.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-26963.0,Alive,TUMOR FREE,2165.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2165.0,0.0,2165.0,0.0,2165.0,0.0,2165.0,
TCGA-AC-A6IX,795,TCGA-AC-A6IX,BRCA,49.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013.0,Peri (6-12 months since last menstrual period),-17969.0,Alive,TUMOR FREE,373.0,,[Not Available],,,,,[Not Available],Negative,,0.0,373.0,0.0,373.0,0.0,373.0,0.0,373.0,
TCGA-J4-AATV,8150,TCGA-J4-AATV,PRAD,71.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-25943.0,Alive,WITH TUMOR,553.0,,[Not Available],,,,,[Discrepancy],,,0.0,553.0,0.0,553.0,,,0.0,553.0,
TCGA-A7-A13G,641,TCGA-A7-A13G,BRCA,79.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28969.0,Alive,TUMOR FREE,718.0,,[Not Available],New Primary Tumor,"Other, specify","Skin, right leg",586.0,[Not Available],Negative,,0.0,718.0,0.0,718.0,0.0,718.0,1.0,586.0,
TCGA-85-A50M,6745,TCGA-85-A50M,LUSC,47.0,MALE,ASIAN,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-17429.0,Dead,TUMOR FREE,,826.0,[Not Available],,,,,Complete Remission/Response,,,1.0,826.0,0.0,826.0,0.0,826.0,0.0,826.0,
TCGA-EK-A2R7,1728,TCGA-EK-A2R7,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16487.0,Alive,TUMOR FREE,27.0,,,,,,,[Not Available],,,0.0,27.0,0.0,27.0,,,0.0,27.0,
TCGA-F7-A50G,3647,TCGA-F7-A50G,HNSC,66.0,MALE,WHITE,Stage III,[Not Available],Head & Neck Squamous Cell Carcinoma,G1,2012.0,[Not Available],-24285.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,
TCGA-HT-7686,5176,TCGA-HT-7686,LGG,29.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2008.0,[Not Available],-10724.0,Alive,TUMOR FREE,1300.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1300.0,0.0,1300.0,0.0,1300.0,0.0,1300.0,
TCGA-CV-7261,3546,TCGA-CV-7261,HNSC,57.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-20992.0,Alive,TUMOR FREE,1512.0,,[Not Available],,,,,[Not Available],,,0.0,1512.0,0.0,1512.0,,,0.0,1512.0,
TCGA-55-6987,5990,TCGA-55-6987,LUAD,77.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-28382.0,Alive,TUMOR FREE,2137.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2137.0,0.0,2137.0,0.0,2137.0,0.0,2137.0,
TCGA-AY-A69D,2210,TCGA-AY-A69D,COAD,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2012.0,[Not Available],-20299.0,Alive,TUMOR FREE,543.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,543.0,0.0,543.0,0.0,543.0,0.0,543.0,
TCGA-WC-A885,11151,TCGA-WC-A885,UVM,60.0,MALE,WHITE,Stage IIA,Stage IIB,Spindle Cell,[Not Available],2013.0,[Not Available],-21978.0,Alive,TUMOR FREE,686.0,,[Not Available],,,,,[Not Available],,,0.0,686.0,0.0,686.0,,,0.0,686.0,
TCGA-VS-A9UD,1868,TCGA-VS-A9UD,CESC,73.0,FEMALE,WHITE,[Not Available],Stage IIIA,Cervical Squamous Cell Carcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26815.0,Alive,TUMOR FREE,739.0,,,,,,,Complete Remission/Response,,,0.0,739.0,0.0,739.0,0.0,739.0,0.0,739.0,
TCGA-97-A4M2,6267,TCGA-97-A4M2,LUAD,66.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-24313.0,Alive,TUMOR FREE,624.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,624.0,0.0,624.0,0.0,624.0,0.0,624.0,
TCGA-26-1442,3105,TCGA-26-1442,GBM,43.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-15950.0,Alive,WITH TUMOR,953.0,,[Not Available],,,,,[Not Available],,,0.0,953.0,0.0,953.0,,,0.0,953.0,
TCGA-AR-A2LO,961,TCGA-AR-A2LO,BRCA,46.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17080.0,Alive,TUMOR FREE,1198.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1198.0,0.0,1198.0,0.0,1198.0,0.0,1198.0,
TCGA-E7-A97Q,256,TCGA-E7-A97Q,BLCA,60.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-22249.0,Dead,WITH TUMOR,,246.0,[Not Available],,,,,Stable Disease,,,1.0,246.0,1.0,246.0,,,1.0,246.0,
TCGA-T1-A6J8,5771,TCGA-T1-A6J8,LIHC,68.0,MALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-24853.0,Alive,TUMOR FREE,23.0,,[Not Available],,,,,[Not Available],,RX,0.0,23.0,0.0,23.0,,,0.0,23.0,
TCGA-55-8302,6031,TCGA-55-8302,LUAD,54.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-20011.0,Alive,TUMOR FREE,478.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,478.0,0.0,478.0,0.0,478.0,0.0,478.0,
TCGA-DM-A28E,2345,TCGA-DM-A28E,COAD,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2001.0,[Not Available],-26602.0,Alive,,3648.0,,[Not Available],,,,,[Not Available],,,0.0,3648.0,0.0,3648.0,,,0.0,3648.0,
TCGA-2Z-A9JJ,4433,TCGA-2Z-A9JJ,KIRP,69.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-25240.0,Alive,TUMOR FREE,1213.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1213.0,0.0,1213.0,0.0,1213.0,0.0,1213.0,
TCGA-74-6581,3209,TCGA-74-6581,GBM,77.0,MALE,[Not Available],[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-28263.0,Alive,WITH TUMOR,250.0,,[Not Available],,,,,[Not Available],,,0.0,250.0,0.0,250.0,,,0.0,250.0,
TCGA-56-7221,6512,TCGA-56-7221,LUSC,79.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-28873.0,Alive,TUMOR FREE,608.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,
TCGA-2G-AAFM,9723,TCGA-2G-AAFM,TGCT,31.0,MALE,WHITE,Stage IIA,Stage IIA,Non-Seminoma; Embryonal Carcinoma,[Not Available],2013.0,[Not Available],-11607.0,Alive,TUMOR FREE,503.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,503.0,0.0,503.0,0.0,503.0,0.0,503.0,
TCGA-18-3408,6327,TCGA-18-3408,LUSC,77.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-28171.0,Dead,WITH TUMOR,,2304.0,[Not Available],Locoregional Recurrence,,,1793.0,[Unknown],,,1.0,2304.0,1.0,2304.0,,,1.0,1793.0,
TCGA-D9-A6E9,8911,TCGA-D9-A6E9,SKCM,75.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2013.0,[Not Available],-27537.0,Alive,TUMOR FREE,301.0,,[Not Available],,,,,[Not Available],,,0.0,301.0,0.0,301.0,,,0.0,301.0,
TCGA-AX-A2H4,10646,TCGA-AX-A2H4,UCEC,66.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24234.0,Dead,WITH TUMOR,,916.0,[Not Available],Locoregional Disease,"Other, specify","Vaginal cuff, iliac",520.0,Complete Remission/Response,,,1.0,916.0,1.0,916.0,1.0,520.0,1.0,520.0,
TCGA-BT-A2LD,137,TCGA-BT-A2LD,BLCA,78.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-28673.0,Dead,WITH TUMOR,,623.0,[Not Available],Distant Metastasis,"Other, specify",brain and spinal cord,555.0,Progressive Disease,,,1.0,623.0,1.0,623.0,,,1.0,555.0,
TCGA-HU-A4GX,9581,TCGA-HU-A4GX,STAD,70.0,FEMALE,ASIAN,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,[Not Available],-25913.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,
TCGA-D3-A2J6,8835,TCGA-D3-A2J6,SKCM,65.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2002.0,[Not Available],-24066.0,Dead,WITH TUMOR,,1321.0,[Not Available],New primary melanoma,,,448.0,[Not Available],,,1.0,1321.0,1.0,1321.0,,,1.0,448.0,
TCGA-NC-A5HH,6805,TCGA-NC-A5HH,LUSC,53.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-19485.0,Alive,TUMOR FREE,37.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,37.0,0.0,37.0,0.0,37.0,0.0,37.0,
TCGA-VR-AA4D,2632,TCGA-VR-AA4D,ESCA,53.0,MALE,WHITE,Stage IIB,Stage IA,"Esophagus Adenocarcinoma, NOS",G2,2010.0,[Not Available],-19714.0,Dead,WITH TUMOR,,1405.0,[Not Available],Distant Metastasis,Lung,,832.0,Progressive Disease,,,1.0,1405.0,1.0,1405.0,,,1.0,832.0,
TCGA-DU-A7TB,5060,TCGA-DU-A7TB,LGG,56.0,MALE,ASIAN,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-20704.0,Alive,TUMOR FREE,1567.0,,[Not Available],,,,74.0,Progressive Disease,,,0.0,1567.0,0.0,1567.0,,,1.0,74.0,
TCGA-CM-5344,2267,TCGA-CM-5344,COAD,39.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-14426.0,Alive,TUMOR FREE,670.0,,[Not Available],,,,,[Unknown],,,0.0,670.0,0.0,670.0,,,0.0,670.0,
TCGA-XX-A89A,1599,TCGA-XX-A89A,BRCA,68.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25000.0,Alive,TUMOR FREE,488.0,,[Not Available],,,,,[Not Available],Negative,,0.0,488.0,0.0,488.0,0.0,488.0,0.0,488.0,
TCGA-06-0167,2776,TCGA-06-0167,GBM,44.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2001.0,[Not Available],-16170.0,Dead,WITH TUMOR,,347.0,[Not Available],,,,,[Unknown],,,1.0,347.0,1.0,347.0,,,1.0,347.0,
TCGA-98-A539,6787,TCGA-98-A539,LUSC,63.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-23098.0,Alive,WITH TUMOR,173.0,,[Not Available],Locoregional Recurrence,,,173.0,[Not Available],,,0.0,173.0,0.0,173.0,,,1.0,173.0,
TCGA-C8-A138,1197,TCGA-C8-A138,BRCA,54.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20053.0,Alive,TUMOR FREE,380.0,,[Not Available],,,,,[Not Available],Negative,,0.0,380.0,0.0,380.0,0.0,380.0,0.0,380.0,
TCGA-63-A5MH,6595,TCGA-63-A5MH,LUSC,68.0,MALE,[Not Evaluated],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],,[Not Available],-25159.0,Alive,TUMOR FREE,2026.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2026.0,0.0,2026.0,0.0,2026.0,0.0,2026.0,
TCGA-A2-A3XW,617,TCGA-A2-A3XW,BRCA,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15670.0,Alive,TUMOR FREE,1712.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1712.0,0.0,1712.0,0.0,1712.0,0.0,1712.0,
TCGA-CI-6623,8477,TCGA-CI-6623,READ,44.0,MALE,WHITE,Stage I,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2011.0,[Not Available],-16177.0,Alive,TUMOR FREE,1443.0,,[Not Available],,,,,[Unknown],,,0.0,1443.0,0.0,1443.0,,,0.0,1443.0,
TCGA-E9-A245,1436,TCGA-E9-A245,BRCA,47.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17363.0,Alive,TUMOR FREE,26.0,,[Not Available],,,,,[Not Available],Negative,,0.0,26.0,0.0,26.0,0.0,26.0,0.0,26.0,
TCGA-D3-A1Q9,8832,TCGA-D3-A1Q9,SKCM,72.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2005.0,[Not Available],-26471.0,Dead,WITH TUMOR,,961.0,[Not Available],Regional lymph node,,,44.0,[Not Available],,,1.0,961.0,1.0,961.0,,,1.0,44.0,
TCGA-DK-AA77,231,TCGA-DK-AA77,BLCA,61.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-22365.0,Alive,TUMOR FREE,618.0,,[Not Available],Distant Metastasis,"Other, specify",Pelvis,467.0,Stable Disease,,,0.0,618.0,0.0,618.0,,,1.0,467.0,
TCGA-28-5215,3160,TCGA-28-5215,GBM,62.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-22686.0,Dead,WITH TUMOR,237.0,335.0,[Not Available],,[Not Applicable],[Not Applicable],164.0,[Not Available],,,1.0,335.0,1.0,335.0,,,1.0,164.0,
TCGA-TM-A84F,5376,TCGA-TM-A84F,LGG,48.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-17744.0,Alive,TUMOR FREE,1796.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1796.0,0.0,1796.0,0.0,1796.0,0.0,1796.0,
TCGA-JX-A5QV,1796,TCGA-JX-A5QV,CESC,37.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13667.0,Alive,TUMOR FREE,636.0,,,,,,,Complete Remission/Response,,,0.0,636.0,0.0,636.0,0.0,636.0,0.0,636.0,
TCGA-D1-A17L,10866,TCGA-D1-A17L,UCEC,81.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29899.0,Alive,TUMOR FREE,802.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,802.0,0.0,802.0,0.0,802.0,0.0,802.0,
TCGA-76-4934,3218,TCGA-76-4934,GBM,66.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-24319.0,Dead,TUMOR FREE,77.0,77.0,[Not Available],,,,,[Not Available],,,1.0,77.0,0.0,77.0,,,0.0,77.0,
TCGA-K1-A3PN,8711,TCGA-K1-A3PN,SARC,64.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2006.0,[Not Available],-23631.0,Alive,TUMOR FREE,3080.0,,[Not Available],,,,1033.0,[Not Available],Negative,R0,0.0,3080.0,0.0,3080.0,1.0,1033.0,1.0,1033.0,
TCGA-EL-A4K9,10115,TCGA-EL-A4K9,THCA,68.0,MALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-24980.0,Alive,TUMOR FREE,1455.0,,[Not Available],,,,,[Not Available],,R0,0.0,1455.0,0.0,1455.0,0.0,1455.0,0.0,1455.0,
TCGA-B5-A5OC,10731,TCGA-B5-A5OC,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G3,2011.0,[Not Available],-26109.0,Alive,TUMOR FREE,1249.0,,[Not Available],,,,,[Not Available],,,0.0,1249.0,0.0,1249.0,,,0.0,1249.0,
TCGA-BJ-A0YZ,9846,TCGA-BJ-A0YZ,THCA,65.0,MALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-24102.0,Alive,TUMOR FREE,754.0,,[Not Available],,,,,[Not Available],,R0,0.0,754.0,0.0,754.0,0.0,754.0,0.0,754.0,
TCGA-B0-4821,3992,TCGA-B0-4821,KIRC,68.0,FEMALE,ASIAN,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2002.0,[Not Available],-25013.0,Dead,WITH TUMOR,,1230.0,[Not Available],,,,,[Not Available],,,1.0,1230.0,1.0,1230.0,,,1.0,1230.0,
TCGA-DA-A960,8937,TCGA-DA-A960,SKCM,73.0,MALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2012.0,[Not Available],-26708.0,Alive,TUMOR FREE,804.0,,[Not Available],,,,,[Not Available],,,0.0,804.0,0.0,804.0,,,0.0,804.0,
TCGA-IB-A5SP,7638,TCGA-IB-A5SP,PAAD,77.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-28317.0,Alive,WITH TUMOR,482.0,,,Locoregional Recurrence,"Other, specify",Superior Mesenteric Artery,300.0,[Unknown],,,0.0,482.0,0.0,482.0,,,1.0,300.0,
TCGA-CM-6171,2286,TCGA-CM-6171,COAD,77.0,FEMALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-28307.0,Alive,TUMOR FREE,427.0,,[Not Available],,,,,[Not Available],,,0.0,427.0,0.0,427.0,,,0.0,427.0,
TCGA-27-1833,3120,TCGA-27-1833,GBM,67.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2006.0,[Not Available],-24592.0,Dead,WITH TUMOR,555.0,737.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],469.0,[Not Available],,,1.0,737.0,1.0,737.0,,,1.0,469.0,
TCGA-G9-6369,8035,TCGA-G9-6369,PRAD,55.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-20238.0,Alive,TUMOR FREE,1215.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1215.0,0.0,1215.0,0.0,1215.0,0.0,1215.0,
TCGA-ET-A4KQ,10255,TCGA-ET-A4KQ,THCA,45.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-16685.0,Alive,TUMOR FREE,955.0,,[Not Available],,,,,[Not Available],,R0,0.0,955.0,0.0,955.0,0.0,955.0,0.0,955.0,
TCGA-2G-AAGZ,9754,TCGA-2G-AAGZ,TGCT,27.0,MALE,WHITE,Stage IIIA,Stage IIIA,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Choriocarcinoma|Non-Seminoma; Yolk Sac Tumor|Seminoma; NOS,[Not Available],2000.0,[Not Available],-10157.0,Alive,TUMOR FREE,5233.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,5233.0,0.0,5233.0,,,0.0,5233.0,
TCGA-R5-A7ZF,9621,TCGA-R5-A7ZF,STAD,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,[Not Available],-23908.0,Dead,WITH TUMOR,,259.0,Stomach Cancer,,,,,Progressive Disease,,,1.0,259.0,1.0,259.0,,,1.0,259.0,
TCGA-P5-A72X,5277,TCGA-P5-A72X,LGG,21.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2013.0,[Not Available],-7913.0,Alive,TUMOR FREE,403.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,403.0,0.0,403.0,0.0,403.0,0.0,403.0,
TCGA-TS-A7OZ,6880,TCGA-TS-A7OZ,MESO,67.0,MALE,WHITE,Stage III,[Not Applicable],Epithelioid mesothelioma,[Not Available],2010.0,[Not Available],-24745.0,Dead,,,844.0,[Not Available],,,,,[Not Available],,[Not Available],1.0,844.0,,844.0,,,0.0,844.0,
TCGA-55-7726,6001,TCGA-55-7726,LUAD,72.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-26451.0,Alive,TUMOR FREE,652.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,652.0,0.0,652.0,0.0,652.0,0.0,652.0,
TCGA-A2-A0YT,595,TCGA-A2-A0YT,BRCA,56.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20482.0,Dead,TUMOR FREE,,723.0,[Not Available],,,,,[Not Available],Negative,,1.0,723.0,0.0,723.0,0.0,723.0,0.0,723.0,
TCGA-37-3792,6441,TCGA-37-3792,LUSC,69.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-25502.0,Alive,TUMOR FREE,12.0,,[Not Available],,,,,[Not Available],,,0.0,12.0,0.0,12.0,,,0.0,12.0,
TCGA-YR-A95A,1943,TCGA-YR-A95A,CHOL,52.0,MALE,WHITE,Stage IV,[Not Applicable],Cholangiocarcinoma; hilar/perihilar,G2,2009.0,[Not Available],-19292.0,Dead,WITH TUMOR,,26.0,[Not Available],New Primary Tumor,"Other, specify",Adrenal gland,17.0,[Not Available],,R1,1.0,26.0,1.0,26.0,,,1.0,17.0,
TCGA-DJ-A3V4,9984,TCGA-DJ-A3V4,THCA,60.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-22218.0,Alive,TUMOR FREE,1294.0,,[Not Available],,,,,[Not Available],,R0,0.0,1294.0,0.0,1294.0,0.0,1294.0,0.0,1294.0,
TCGA-V1-A8WW,8247,TCGA-V1-A8WW,PRAD,59.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],,[Not Available],-21900.0,Alive,,1078.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1078.0,0.0,1078.0,0.0,1078.0,0.0,1078.0,
TCGA-VS-A8EC,1837,TCGA-VS-A8EC,CESC,55.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2011.0,Peri (6-12 months since last menstrual period),-20286.0,Alive,TUMOR FREE,1415.0,,,,,,,Complete Remission/Response,,,0.0,1415.0,0.0,1415.0,0.0,1415.0,0.0,1415.0,
TCGA-IS-A3KA,8704,TCGA-IS-A3KA,SARC,73.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2004.0,[Not Available],-26775.0,Dead,WITH TUMOR,,413.0,[Not Available],Distant Metastasis,Lung,,76.0,[Not Available],[Not Available],R0,1.0,413.0,1.0,413.0,1.0,76.0,1.0,76.0,
TCGA-M7-A71Z,8219,TCGA-M7-A71Z,PRAD,62.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2013.0,[Not Available],-22785.0,Alive,TUMOR FREE,643.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,643.0,0.0,643.0,0.0,643.0,0.0,643.0,
TCGA-BR-4370,9299,TCGA-BR-4370,STAD,74.0,FEMALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],-27344.0,Alive,,0.0,,[Not Available],,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-3Q-A9WF,10357,TCGA-3Q-A9WF,THYM,71.0,MALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],I,Thymoma; Type B2,[Not Available],2013.0,[Not Available],-26117.0,Alive,,467.0,,[Not Available],,,,,[Not Available],,,0.0,467.0,0.0,467.0,,,0.0,467.0,
TCGA-D8-A1XZ,1278,TCGA-D8-A1XZ,BRCA,81.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29916.0,Alive,TUMOR FREE,466.0,,[Not Available],,,,,[Not Available],Negative,,0.0,466.0,0.0,466.0,0.0,466.0,0.0,466.0,
TCGA-HV-A7OL,7584,TCGA-HV-A7OL,PAAD,70.0,MALE,ASIAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-25768.0,Alive,,252.0,,,Distant Metastasis,Non-regional / Distant Lymph Nodes,,123.0,Stable Disease,,,0.0,252.0,0.0,252.0,,,1.0,123.0,
TCGA-VQ-AA6B,9702,TCGA-VQ-AA6B,STAD,48.0,MALE,WHITE,Stage IIIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,[Not Available],-17852.0,Alive,TUMOR FREE,1002.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1002.0,0.0,1002.0,0.0,1002.0,0.0,1002.0,
TCGA-S7-A7X0,7790,TCGA-S7-A7X0,PCPG,75.0,FEMALE,WHITE,[Not Available],[Not Available],Paraganglioma; Extra-adrenal Pheochromocytoma,[Not Available],2013.0,[Not Available],-27729.0,Alive,TUMOR FREE,546.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,
TCGA-DA-A1I8,8924,TCGA-DA-A1I8,SKCM,63.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2005.0,[Not Available],-23286.0,Dead,WITH TUMOR,,1640.0,[Not Available],Regional lymph node,,,961.0,[Not Available],,,1.0,1640.0,1.0,1640.0,,,1.0,961.0,
TCGA-LP-A4AV,1798,TCGA-LP-A4AV,CESC,63.0,FEMALE,ASIAN,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,2011.0,[Not Evaluated],,Alive,TUMOR FREE,0.0,,,,,,,[Not Available],,,0.0,0.0,0.0,0.0,,,0.0,0.0,
TCGA-B4-5836,4088,TCGA-B4-5836,KIRC,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-22341.0,Alive,TUMOR FREE,141.0,,[Not Available],,,,,[Not Applicable],,,0.0,141.0,0.0,141.0,,,0.0,141.0,
TCGA-2J-AABT,7517,TCGA-2J-AABT,PAAD,72.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-26379.0,Alive,,319.0,,,,,,,[Unknown],,,0.0,319.0,0.0,319.0,,,0.0,319.0,
TCGA-E9-A1NF,1403,TCGA-E9-A1NF,BRCA,60.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21981.0,Dead,WITH TUMOR,,1072.0,[Not Available],Distant Metastasis,Lung,,90.0,[Not Available],Negative,,1.0,1072.0,1.0,1072.0,1.0,90.0,1.0,90.0,
TCGA-S9-A6U5,5331,TCGA-S9-A6U5,LGG,33.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-12417.0,Alive,TUMOR FREE,992.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,992.0,0.0,992.0,0.0,992.0,0.0,992.0,
TCGA-CI-6620,8474,TCGA-CI-6620,READ,41.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-15322.0,Alive,WITH TUMOR,1009.0,,[Not Available],,,,90.0,Progressive Disease,,,0.0,1009.0,0.0,1009.0,,,1.0,90.0,
TCGA-63-5128,6585,TCGA-63-5128,LUSC,,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],,Dead,WITH TUMOR,,,[Not Available],,,,,Complete Remission/Response,,,1.0,,1.0,,,,1.0,,
TCGA-EM-A3OA,10183,TCGA-EM-A3OA,THCA,55.0,FEMALE,[Unknown],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-20284.0,Alive,TUMOR FREE,822.0,,[Not Available],,,,,[Not Available],,R0,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,
TCGA-G4-6321,2385,TCGA-G4-6321,COAD,60.0,FEMALE,WHITE,Stage III,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-21921.0,Alive,TUMOR FREE,672.0,,[Not Available],,,,,[Not Available],,,0.0,672.0,0.0,672.0,,,0.0,672.0,
TCGA-3T-AA9L,10360,TCGA-3T-AA9L,THYM,31.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type B1,[Not Available],2011.0,[Not Available],-11610.0,Alive,WITH TUMOR,1050.0,,[Not Available],Distant Metastasis,"Other, specify",Lung Pleura,702.0,[Not Available],,,0.0,1050.0,0.0,1050.0,,,1.0,702.0,
TCGA-02-0033,2664,TCGA-02-0033,GBM,54.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2003.0,[Not Available],-20070.0,Dead,WITH TUMOR,86.0,86.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],32.0,[Not Available],,,1.0,86.0,1.0,86.0,,,1.0,32.0,
TCGA-E7-A677,243,TCGA-E7-A677,BLCA,81.0,MALE,ASIAN,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,[Not Available],-29613.0,Alive,TUMOR FREE,820.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,820.0,0.0,820.0,0.0,820.0,0.0,820.0,
TCGA-06-0155,2766,TCGA-06-0155,GBM,61.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-22498.0,Dead,WITH TUMOR,263.0,318.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],256.0,[Not Available],,,1.0,318.0,1.0,318.0,,,1.0,256.0,
TCGA-06-2558,2852,TCGA-06-2558,GBM,75.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2008.0,[Not Available],-27511.0,Dead,,23.0,380.0,[Not Available],,,,,[Not Available],,,1.0,380.0,,380.0,,,0.0,380.0,
TCGA-BH-A18K,1119,TCGA-BH-A18K,BRCA,46.0,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999.0,[Not Available],-16824.0,Dead,WITH TUMOR,,2763.0,[Not Available],,,,,[Not Available],Negative,,1.0,2763.0,1.0,2763.0,,,1.0,2763.0,
TCGA-76-4929,3215,TCGA-76-4929,GBM,76.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-27831.0,Dead,WITH TUMOR,111.0,111.0,[Not Available],,,,,[Not Available],,,1.0,111.0,1.0,111.0,,,1.0,111.0,
TCGA-60-2719,6577,TCGA-60-2719,LUSC,83.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-30379.0,Alive,TUMOR FREE,1297.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1297.0,0.0,1297.0,0.0,1297.0,0.0,1297.0,
TCGA-85-A4JB,6740,TCGA-85-A4JB,LUSC,74.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2012.0,[Not Available],-27315.0,Alive,TUMOR FREE,942.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,942.0,0.0,942.0,0.0,942.0,0.0,942.0,
TCGA-BP-4999,4229,TCGA-BP-4999,KIRC,56.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-20518.0,Alive,TUMOR FREE,1266.0,,[Not Available],,,,,[Not Available],,,0.0,1266.0,0.0,1266.0,,,0.0,1266.0,
TCGA-EJ-5496,7912,TCGA-EJ-5496,PRAD,59.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-21897.0,Alive,TUMOR FREE,595.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,
TCGA-DU-A5TW,5046,TCGA-DU-A5TW,LGG,33.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-12107.0,Alive,WITH TUMOR,760.0,,[Not Available],,,,,Progressive Disease,,,0.0,760.0,0.0,760.0,,,0.0,760.0,
TCGA-KP-A3W1,11004,TCGA-KP-A3W1,UCEC,76.0,FEMALE,[Not Evaluated],[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27902.0,Alive,TUMOR FREE,288.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,288.0,0.0,288.0,0.0,288.0,0.0,288.0,
TCGA-95-A4VN,6245,TCGA-95-A4VN,LUAD,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22927.0,Alive,TUMOR FREE,553.0,,[Not Available],,,,,Stable Disease,,,0.0,553.0,0.0,553.0,,,0.0,553.0,
TCGA-DD-AADQ,5627,TCGA-DD-AADQ,LIHC,59.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,2013.0,[Not Available],-21756.0,Alive,TUMOR FREE,436.0,,[Not Available],,,,,[Not Available],,R0,0.0,436.0,0.0,436.0,0.0,436.0,0.0,436.0,
TCGA-ET-A2N4,10217,TCGA-ET-A2N4,THCA,53.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2008.0,[Not Available],-19671.0,Alive,TUMOR FREE,81.0,,[Not Available],,,,,[Not Available],,RX,0.0,81.0,0.0,81.0,,,0.0,81.0,
TCGA-49-6745,5917,TCGA-49-6745,LUAD,82.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-30133.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,[Not Available],,,0.0,522.0,0.0,522.0,,,0.0,522.0,
TCGA-B8-4621,4100,TCGA-B8-4621,KIRC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2010.0,[Not Available],-23176.0,Alive,TUMOR FREE,788.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,788.0,0.0,788.0,0.0,788.0,0.0,788.0,
TCGA-HE-A5NI,4623,TCGA-HE-A5NI,KIRP,73.0,MALE,[Not Evaluated],Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-26985.0,Alive,TUMOR FREE,360.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,360.0,0.0,360.0,0.0,360.0,0.0,360.0,
TCGA-A2-A3XT,614,TCGA-A2-A3XT,BRCA,45.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16649.0,Alive,TUMOR FREE,2770.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2770.0,0.0,2770.0,0.0,2770.0,0.0,2770.0,
TCGA-OR-A5J4,4,TCGA-OR-A5J4,ACC,23.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2000.0,[Not Available],-8451.0,Dead,WITH TUMOR,,423.0,[Not Available],Locoregional Recurrence,Peritoneal Surfaces,,126.0,Progressive Disease,,,1.0,423.0,1.0,423.0,,,1.0,126.0,
TCGA-FW-A3TU,9182,TCGA-FW-A3TU,SKCM,72.0,FEMALE,WHITE,[Not Available],[Not Applicable],,[Not Available],2007.0,[Not Available],-26589.0,Dead,WITH TUMOR,,1691.0,[Not Available],,,,,[Not Available],,,1.0,1691.0,1.0,1691.0,,,1.0,1691.0,
TCGA-EL-A3CM,10041,TCGA-EL-A3CM,THCA,64.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1996.0,[Not Available],-23406.0,Dead,,,813.0,[Not Available],,,,,[Not Available],,R1,1.0,813.0,,813.0,,,0.0,813.0,
TCGA-EY-A1GS,10957,TCGA-EY-A1GS,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26012.0,Dead,WITH TUMOR,,670.0,[Not Available],,,,,Stable Disease,,,1.0,670.0,1.0,670.0,,,1.0,670.0,
TCGA-VR-A8EQ,2623,TCGA-VR-A8EQ,ESCA,73.0,MALE,WHITE,Stage III,Stage III,"Esophagus Adenocarcinoma, NOS",G2,2009.0,[Not Available],-26912.0,Dead,WITH TUMOR,,694.0,[Not Available],,,,,,,,1.0,694.0,1.0,694.0,,,1.0,694.0,
TCGA-DK-A6B5,215,TCGA-DK-A6B5,BLCA,45.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-16453.0,Alive,TUMOR FREE,1542.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1542.0,0.0,1542.0,,,0.0,1542.0,
TCGA-AR-A0U3,912,TCGA-AR-A0U3,BRCA,59.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21755.0,Alive,TUMOR FREE,4080.0,,[Not Available],,,,,[Not Available],Negative,,0.0,4080.0,0.0,4080.0,0.0,4080.0,0.0,4080.0,
TCGA-EM-A3SY,10188,TCGA-EM-A3SY,THCA,36.0,MALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-13461.0,Alive,TUMOR FREE,411.0,,[Not Available],,,,,[Not Available],,R0,0.0,411.0,0.0,411.0,0.0,411.0,0.0,411.0,
TCGA-DD-A1EH,5532,TCGA-DD-A1EH,LIHC,23.0,MALE,WHITE,Stage III,[Not Applicable],Hepatocellular Carcinoma,G3,2008.0,[Not Available],-8499.0,Alive,WITH TUMOR,1495.0,,[Not Available],Intrahepatic Recurrence,Liver,,120.0,[Not Available],,R0,0.0,1495.0,0.0,1495.0,1.0,120.0,1.0,120.0,
TCGA-E2-A15G,1339,TCGA-E2-A15G,BRCA,76.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28013.0,Alive,TUMOR FREE,554.0,,[Not Available],,,,,[Not Available],Negative,,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,
TCGA-GF-A2C7,9186,TCGA-GF-A2C7,SKCM,48.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2011.0,[Not Available],-17545.0,Alive,TUMOR FREE,21.0,,[Not Available],,,,,[Not Available],,,0.0,21.0,0.0,21.0,,,0.0,21.0,
TCGA-D3-A1Q4,8827,TCGA-D3-A1Q4,SKCM,53.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2003.0,[Not Available],-19687.0,Alive,TUMOR FREE,3408.0,,[Not Available],,,,,[Not Available],,,0.0,3408.0,0.0,3408.0,,,0.0,3408.0,
TCGA-KQ-A41N,385,TCGA-KQ-A41N,BLCA,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-26837.0,Alive,TUMOR FREE,1604.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1604.0,0.0,1604.0,0.0,1604.0,0.0,1604.0,
TCGA-77-6842,6658,TCGA-77-6842,LUSC,79.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-28861.0,Dead,,,899.0,[Not Available],,,,201.0,[Not Available],,,1.0,899.0,,899.0,,,1.0,201.0,
TCGA-G2-A2EJ,314,TCGA-G2-A2EJ,BLCA,56.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-20649.0,Alive,TUMOR FREE,1460.0,,[Not Available],Distant Metastasis,Lung,,910.0,Complete Remission/Response,,,0.0,1460.0,0.0,1460.0,1.0,910.0,1.0,910.0,
TCGA-GM-A3XL,1516,TCGA-GM-A3XL,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18171.0,Alive,TUMOR FREE,2108.0,,[Not Available],,,,,[Not Available],Negative,,0.0,2108.0,0.0,2108.0,0.0,2108.0,0.0,2108.0,
TCGA-SJ-A6ZJ,11021,TCGA-SJ-A6ZJ,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22597.0,Alive,TUMOR FREE,556.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,556.0,0.0,556.0,0.0,556.0,0.0,556.0,
TCGA-HM-A3JJ,1771,TCGA-HM-A3JJ,CESC,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14736.0,Dead,WITH TUMOR,,659.0,Cervical Cancer,Distant Metastasis,,,385.0,Complete Remission/Response,,,1.0,659.0,1.0,659.0,1.0,385.0,1.0,385.0,
TCGA-G4-6627,2392,TCGA-G4-6627,COAD,84.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2007.0,[Not Available],-30697.0,Alive,TUMOR FREE,2275.0,,[Not Available],,,,1003.0,Complete Remission/Response,,,0.0,2275.0,0.0,2275.0,1.0,1003.0,1.0,1003.0,
TCGA-EY-A548,10977,TCGA-EY-A548,UCEC,83.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30544.0,Alive,TUMOR FREE,430.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,430.0,0.0,430.0,0.0,430.0,0.0,430.0,
TCGA-G2-A3IE,320,TCGA-G2-A3IE,BLCA,51.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,[Not Available],-18983.0,Dead,WITH TUMOR,,612.0,[Not Available],,,,,Progressive Disease,,,1.0,612.0,1.0,612.0,,,1.0,612.0,
TCGA-K4-AAQO,384,TCGA-K4-AAQO,BLCA,56.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-20683.0,Alive,,359.0,,[Not Available],,,,,[Unknown],,,0.0,359.0,0.0,359.0,,,0.0,359.0,
TCGA-BR-7851,9331,TCGA-BR-7851,STAD,74.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-27091.0,Dead,TUMOR FREE,574.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,,0.0,,0.0,,0.0,,
TCGA-3B-A9I1,8552,TCGA-3B-A9I1,SARC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-20629.0,Dead,WITH TUMOR,,567.0,[Not Available],Distant Metastasis,"Other, specify",Pelvis,192.0,[Not Available],Negative,RX,1.0,567.0,1.0,567.0,,,1.0,192.0,
TCGA-VS-A8Q8,1844,TCGA-VS-A8Q8,CESC,26.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9571.0,Dead,WITH TUMOR,,978.0,Cervical Cancer,Locoregional Recurrence,,Pelvis,488.0,Progressive Disease,,,1.0,978.0,1.0,978.0,,,1.0,488.0,
TCGA-GV-A3QG,359,TCGA-GV-A3QG,BLCA,65.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-23847.0,Dead,WITH TUMOR,,,[Not Available],Distant Metastasis,"Other, specify",Brain,84.0,[Not Applicable],,,1.0,,1.0,,,,1.0,84.0,
TCGA-BP-4983,4217,TCGA-BP-4983,KIRC,67.0,FEMALE,ASIAN,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2006.0,[Not Available],-24558.0,Alive,TUMOR FREE,1413.0,,[Not Available],,,,,[Not Available],,,0.0,1413.0,0.0,1413.0,,,0.0,1413.0,
TCGA-E9-A1RB,1416,TCGA-E9-A1RB,BRCA,40.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14755.0,Dead,TUMOR FREE,,976.0,[Not Available],,,,,[Not Available],Negative,,1.0,976.0,0.0,976.0,0.0,976.0,0.0,976.0,
TCGA-A6-4105,1980,TCGA-A6-4105,COAD,79.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-29097.0,Dead,TUMOR FREE,,442.0,[Not Available],,,,364.0,[Not Available],,,1.0,442.0,0.0,442.0,,,1.0,364.0,
TCGA-EL-A3MZ,10080,TCGA-EL-A3MZ,THCA,66.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1998.0,[Not Available],-24208.0,Dead,TUMOR FREE,,1597.0,[Not Available],,,,,[Not Available],,RX,1.0,1597.0,0.0,1597.0,,,0.0,1597.0,
TCGA-UZ-A9PS,4692,TCGA-UZ-A9PS,KIRP,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-22646.0,Alive,TUMOR FREE,2167.0,,[Not Available],,,,55.0,Complete Remission/Response,,,0.0,2167.0,0.0,2167.0,1.0,55.0,1.0,55.0,
TCGA-3R-A8YX,8554,TCGA-3R-A8YX,SARC,66.0,MALE,[Not Evaluated],[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2013.0,[Not Available],-24412.0,Dead,WITH TUMOR,,17.0,[Not Available],,,,,[Not Available],Positive,R2,1.0,17.0,1.0,17.0,,,1.0,17.0,
TCGA-90-7767,6755,TCGA-90-7767,LUSC,56.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-20534.0,Alive,TUMOR FREE,89.0,,[Not Available],,,,,[Unknown],,,0.0,89.0,0.0,89.0,,,0.0,89.0,
TCGA-OR-A5J8,8,TCGA-OR-A5J8,ACC,66.0,MALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2011.0,[Not Available],-24266.0,Dead,WITH TUMOR,,579.0,[Not Available],Locoregional Recurrence,Peritoneal Surfaces,,530.0,Complete Remission/Response,,,1.0,579.0,1.0,579.0,1.0,530.0,1.0,530.0,
TCGA-CD-8535,9433,TCGA-CD-8535,STAD,59.0,MALE,ASIAN,Stage IIIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-21559.0,Alive,TUMOR FREE,390.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,390.0,0.0,390.0,0.0,390.0,0.0,390.0,
TCGA-CN-A641,3369,TCGA-CN-A641,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-17454.0,Alive,TUMOR FREE,367.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,367.0,0.0,367.0,,,0.0,367.0,
TCGA-A2-A3XZ,620,TCGA-A2-A3XZ,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16978.0,Alive,TUMOR FREE,1532.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1532.0,0.0,1532.0,0.0,1532.0,0.0,1532.0,
TCGA-49-AAR4,5924,TCGA-49-AAR4,LUAD,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-18939.0,Dead,WITH TUMOR,,879.0,[Not Available],,,,,Stable Disease,,,1.0,879.0,1.0,879.0,,,1.0,879.0,
TCGA-DU-5849,4981,TCGA-DU-5849,LGG,48.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2010.0,[Not Available],-17663.0,Alive,TUMOR FREE,443.0,,[Not Available],,,,,Stable Disease,,,0.0,443.0,0.0,443.0,,,0.0,443.0,
TCGA-06-0157,2768,TCGA-06-0157,GBM,63.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-23128.0,Dead,WITH TUMOR,97.0,97.0,[Not Available],,,,,[Not Available],,,1.0,97.0,1.0,97.0,,,1.0,97.0,
TCGA-G3-AAV0,5725,TCGA-G3-AAV0,LIHC,58.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-21249.0,Alive,TUMOR FREE,476.0,,[Not Available],,,,,[Not Available],,R0,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,
TCGA-06-6388,2876,TCGA-06-6388,GBM,64.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-23519.0,Dead,WITH TUMOR,120.0,159.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],85.0,[Not Available],,,1.0,159.0,1.0,159.0,,,1.0,85.0,
TCGA-M7-A724,8224,TCGA-M7-A724,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2012.0,[Not Available],-23595.0,Alive,WITH TUMOR,889.0,,[Not Available],,,,,Progressive Disease,,,0.0,889.0,0.0,889.0,,,0.0,889.0,
TCGA-HT-7873,5192,TCGA-HT-7873,LGG,29.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-10805.0,Alive,WITH TUMOR,718.0,,[Not Available],,,,,Stable Disease,,,0.0,718.0,0.0,718.0,,,0.0,718.0,
TCGA-HT-7479,5152,TCGA-HT-7479,LGG,44.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2011.0,[Not Available],-16137.0,Alive,TUMOR FREE,1227.0,,[Not Available],,,,705.0,Complete Remission/Response,,,0.0,1227.0,0.0,1227.0,1.0,705.0,1.0,705.0,
TCGA-13-A5FU,7112,TCGA-13-A5FU,OV,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IV,Serous Cystadenocarcinoma,G3,2009.0,[Not Available],-22256.0,Dead,WITH TUMOR,,256.0,[Not Available],,,,,Partial Remission/Response,,,1.0,256.0,1.0,256.0,,,1.0,256.0,
TCGA-YY-A8LH,7686,TCGA-YY-A8LH,PAAD,61.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2009.0,[Not Available],-22376.0,Alive,TUMOR FREE,2016.0,,,,,,,Complete Remission/Response,,,0.0,2016.0,0.0,2016.0,0.0,2016.0,0.0,2016.0,
TCGA-N8-A4PP,11053,TCGA-N8-A4PP,UCS,88.0,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Uterine Carcinosarcoma/MMMT: Homologous Type,[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32415.0,Dead,WITH TUMOR,,611.0,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,149.0,Partial Remission/Response,,,1.0,611.0,1.0,611.0,,,1.0,149.0,
TCGA-QA-A7B7,5760,TCGA-QA-A7B7,LIHC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2013.0,[Not Available],-17636.0,Alive,WITH TUMOR,94.0,,[Not Available],Locoregional Recurrence,Liver,,88.0,[Not Available],,RX,0.0,94.0,0.0,94.0,,,1.0,88.0,
TCGA-GL-7966,4610,TCGA-GL-7966,KIRP,28.0,FEMALE,WHITE,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-10428.0,Alive,WITH TUMOR,112.0,,[Not Available],,,,,[Not Available],,,0.0,112.0,0.0,112.0,,,0.0,112.0,
TCGA-FV-A3R2,5694,TCGA-FV-A3R2,LIHC,75.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,[Not Available],2005.0,[Not Available],-27530.0,Dead,TUMOR FREE,,194.0,[Not Available],,,,,[Not Available],,R0,1.0,194.0,0.0,194.0,0.0,194.0,0.0,194.0,
TCGA-56-6546,6511,TCGA-56-6546,LUSC,67.0,MALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-24594.0,Alive,TUMOR FREE,,,[Not Available],,,,,[Not Available],,,0.0,,0.0,,,,0.0,,
TCGA-A4-A5Y0,4490,TCGA-A4-A5Y0,KIRP,61.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-22341.0,Alive,TUMOR FREE,252.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,252.0,0.0,252.0,0.0,252.0,0.0,252.0,
TCGA-FE-A232,10259,TCGA-FE-A232,THCA,44.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007.0,[Not Available],-16280.0,Alive,TUMOR FREE,2424.0,,[Not Available],,,,,[Not Available],,R0,0.0,2424.0,0.0,2424.0,0.0,2424.0,0.0,2424.0,
TCGA-VP-A87K,8288,TCGA-VP-A87K,PRAD,63.0,MALE,[Not Available],[Not Applicable],[Not Applicable],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2010.0,[Not Available],-23030.0,Alive,TUMOR FREE,1306.0,,[Not Available],Biochemical evidence of disease,,,533.0,Complete Remission/Response,,,0.0,1306.0,0.0,1306.0,1.0,533.0,1.0,533.0,
TCGA-D5-5540,2298,TCGA-D5-5540,COAD,73.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-26972.0,Alive,TUMOR FREE,1706.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1706.0,0.0,1706.0,0.0,1706.0,0.0,1706.0,
TCGA-86-8280,6196,TCGA-86-8280,LUAD,54.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-19977.0,Alive,TUMOR FREE,701.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,701.0,0.0,701.0,0.0,701.0,0.0,701.0,
TCGA-DJ-A4V0,10007,TCGA-DJ-A4V0,THCA,36.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-13168.0,Alive,TUMOR FREE,1081.0,,[Not Available],,,,,[Not Available],,R0,0.0,1081.0,0.0,1081.0,0.0,1081.0,0.0,1081.0,
TCGA-DX-A2J4,8575,TCGA-DX-A2J4,SARC,60.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2008.0,[Not Available],-22131.0,Alive,TUMOR FREE,2408.0,,[Not Available],,,,,[Not Available],[Not Available],R0,0.0,2408.0,0.0,2408.0,0.0,2408.0,0.0,2408.0,
TCGA-AN-A0XW,841,TCGA-AN-A0XW,BRCA,36.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13208.0,Alive,TUMOR FREE,170.0,,[Not Available],,,,,[Not Available],Negative,,0.0,170.0,0.0,170.0,0.0,170.0,0.0,170.0,
TCGA-HD-8635,3672,TCGA-HD-8635,HNSC,61.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,[Not Available],-22340.0,Alive,TUMOR FREE,695.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,695.0,0.0,695.0,0.0,695.0,0.0,695.0,
TCGA-DW-7836,4573,TCGA-DW-7836,KIRP,55.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008.0,[Not Available],-20269.0,Alive,TUMOR FREE,1093.0,,[Not Available],,,,,[Not Available],,,0.0,1093.0,0.0,1093.0,,,0.0,1093.0,
TCGA-P6-A5OF,84,TCGA-P6-A5OF,ACC,55.0,FEMALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2010.0,[Not Available],-20106.0,Dead,WITH TUMOR,,207.0,[Not Available],Distant Metastasis,Lung,,143.0,[Unknown],,,1.0,207.0,1.0,207.0,,,1.0,143.0,
TCGA-BK-A56F,10787,TCGA-BK-A56F,UCEC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27523.0,Alive,TUMOR FREE,401.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,401.0,0.0,401.0,0.0,401.0,0.0,401.0,
TCGA-EL-A3CR,10045,TCGA-EL-A3CR,THCA,78.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002.0,[Not Available],-28785.0,Dead,,,233.0,[Not Available],,,,,[Not Available],,R1,1.0,233.0,,233.0,,,0.0,233.0,
TCGA-F2-A44H,7550,TCGA-F2-A44H,PAAD,65.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-24007.0,Alive,TUMOR FREE,586.0,,,,,,,Complete Remission/Response,,,0.0,586.0,0.0,586.0,0.0,586.0,0.0,586.0,
TCGA-BA-5556,3253,TCGA-BA-5556,HNSC,58.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,[Not Available],-21444.0,Alive,TUMOR FREE,725.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,725.0,0.0,725.0,0.0,725.0,0.0,725.0,
TCGA-2G-AAGG,9740,TCGA-2G-AAGG,TGCT,20.0,MALE,WHITE,Stage IIIC,Stage IIIC,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,[Not Available],2007.0,[Not Available],-7330.0,Alive,TUMOR FREE,2611.0,,[Not Applicable],,,,,Partial Remission/Response,,,0.0,2611.0,0.0,2611.0,,,0.0,2611.0,
TCGA-06-6695,2882,TCGA-06-6695,GBM,64.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-23426.0,Alive,WITH TUMOR,253.0,,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],133.0,[Not Available],,,0.0,253.0,0.0,253.0,,,1.0,133.0,
TCGA-DZ-6135,4585,TCGA-DZ-6135,KIRP,45.0,MALE,[Not Available],Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2006.0,[Not Available],-16468.0,Alive,TUMOR FREE,2269.0,,[Not Available],,,,,[Discrepancy],,,0.0,2269.0,0.0,2269.0,,,0.0,2269.0,
TCGA-75-5125,6126,TCGA-75-5125,LUAD,,MALE,[Not Available],Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],,[Not Available],,Dead,WITH TUMOR,,2027.0,[Not Available],,,,1752.0,Complete Remission/Response,,,1.0,2027.0,1.0,2027.0,1.0,1752.0,1.0,1752.0,
TCGA-BS-A0UT,10807,TCGA-BS-A0UT,UCEC,62.0,FEMALE,ASIAN,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22775.0,Alive,TUMOR FREE,2212.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2212.0,0.0,2212.0,0.0,2212.0,0.0,2212.0,
TCGA-BP-5182,4249,TCGA-BP-5182,KIRC,56.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2007.0,[Not Available],-20597.0,Alive,TUMOR FREE,1165.0,,[Not Available],,,,,[Not Available],,,0.0,1165.0,0.0,1165.0,,,0.0,1165.0,
TCGA-EM-A4FV,10199,TCGA-EM-A4FV,THCA,64.0,FEMALE,[Unknown],Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-23627.0,Alive,TUMOR FREE,744.0,,[Not Available],,,,,[Not Available],,R0,0.0,744.0,0.0,744.0,0.0,744.0,0.0,744.0,
TCGA-P5-A5F2,5272,TCGA-P5-A5F2,LGG,36.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2012.0,[Not Available],-13396.0,Alive,WITH TUMOR,242.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,242.0,0.0,242.0,,,0.0,242.0,
TCGA-AJ-A2QK,10528,TCGA-AJ-A2QK,UCEC,65.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23945.0,Alive,WITH TUMOR,643.0,,[Not Available],Distant Metastasis,Liver,,606.0,Complete Remission/Response,,,0.0,643.0,0.0,643.0,1.0,606.0,1.0,606.0,
TCGA-BP-5194,4259,TCGA-BP-5194,KIRC,39.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2008.0,[Not Available],-14551.0,Alive,TUMOR FREE,408.0,,[Not Available],,,,,[Not Available],,,0.0,408.0,0.0,408.0,,,0.0,408.0,
TCGA-DJ-A3VI,9996,TCGA-DJ-A3VI,THCA,52.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-19053.0,Alive,TUMOR FREE,95.0,,[Not Available],,,,,[Not Available],,R0,0.0,95.0,0.0,95.0,0.0,95.0,0.0,95.0,
TCGA-S9-A7QY,5359,TCGA-S9-A7QY,LGG,35.0,FEMALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-12853.0,Alive,WITH TUMOR,863.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,863.0,0.0,863.0,,,0.0,863.0,
TCGA-XU-A930,10429,TCGA-XU-A930,THYM,43.0,MALE,WHITE,[Not Applicable],III,Thymoma; Type B3,[Not Available],2007.0,[Not Available],-15777.0,Alive,TUMOR FREE,2514.0,,[Not Available],,,,,[Not Available],,,0.0,2514.0,0.0,2514.0,,,0.0,2514.0,
TCGA-66-2755,6616,TCGA-66-2755,LUSC,63.0,MALE,[Not Available],Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-23348.0,Alive,TUMOR FREE,28.0,,[Not Available],,,,,[Not Available],,,0.0,28.0,0.0,28.0,,,0.0,28.0,
TCGA-2G-AAHC,9761,TCGA-2G-AAHC,TGCT,33.0,MALE,WHITE,IS,Stage IIA,Seminoma; NOS,[Not Available],1999.0,[Not Available],-12105.0,Alive,TUMOR FREE,5539.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,5539.0,0.0,5539.0,0.0,5539.0,0.0,5539.0,
TCGA-EL-A3T2,10085,TCGA-EL-A3T2,THCA,55.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002.0,[Not Available],-20403.0,Alive,WITH TUMOR,988.0,,[Not Available],Locoregional Recurrence,Lymph Node Only,pretracheal lymph node,903.0,[Not Available],,R0,0.0,988.0,0.0,988.0,1.0,903.0,1.0,903.0,
TCGA-F4-6463,2354,TCGA-F4-6463,COAD,51.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2011.0,[Not Available],-18804.0,Alive,TUMOR FREE,1087.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1087.0,0.0,1087.0,0.0,1087.0,0.0,1087.0,
TCGA-BH-A1F8,1143,TCGA-BH-A1F8,BRCA,90.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871.0,Dead,WITH TUMOR,,763.0,[Not Available],,,,,[Not Available],[Not Available],,1.0,763.0,1.0,763.0,,,1.0,763.0,
TCGA-IA-A83T,4631,TCGA-IA-A83T,KIRP,80.0,MALE,WHITE,[Discrepancy],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2005.0,[Not Available],-29430.0,Dead,,,2684.0,[Not Available],,,,,Stable Disease,,,1.0,2684.0,,2684.0,,,0.0,2684.0,
TCGA-3A-A9I9,7528,TCGA-3A-A9I9,PAAD,67.0,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,[Not Available],-24731.0,Dead,WITH TUMOR,,634.0,Pancreatic Cancer,Locoregional Recurrence,Liver,,513.0,Stable Disease,,,1.0,634.0,1.0,634.0,,,1.0,513.0,
TCGA-76-4931,3216,TCGA-76-4931,GBM,70.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-25812.0,Dead,WITH TUMOR,279.0,279.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],112.0,[Not Available],,,1.0,279.0,1.0,279.0,,,1.0,112.0,
TCGA-OR-A5JL,21,TCGA-OR-A5JL,ACC,36.0,FEMALE,WHITE,Stage I,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2009.0,[Not Available],-13155.0,Alive,TUMOR FREE,2056.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2056.0,0.0,2056.0,0.0,2056.0,0.0,2056.0,
TCGA-CZ-5453,4369,TCGA-CZ-5453,KIRC,67.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-24640.0,Dead,,,2419.0,[Not Available],,,,,[Not Available],,,1.0,2419.0,,2419.0,,,0.0,2419.0,
TCGA-DM-A28M,2350,TCGA-DM-A28M,COAD,63.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2003.0,[Not Available],-23043.0,Alive,,2895.0,,[Not Available],,,,,[Not Available],,,0.0,2895.0,0.0,2895.0,,,0.0,2895.0,
TCGA-DD-AAD5,5609,TCGA-DD-AAD5,LIHC,54.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2011.0,[Not Available],-19748.0,Alive,WITH TUMOR,1345.0,,[Not Available],Intrahepatic Recurrence,Liver,,130.0,[Not Available],,R0,0.0,1345.0,0.0,1345.0,1.0,130.0,1.0,130.0,
TCGA-EE-A29N,9015,TCGA-EE-A29N,SKCM,78.0,MALE,WHITE,I/II NOS,[Not Applicable],,[Not Available],2009.0,[Not Available],-28805.0,Dead,WITH TUMOR,,566.0,[Not Available],New primary melanoma,,,478.0,[Not Available],,,1.0,566.0,1.0,566.0,,,1.0,478.0,
TCGA-41-3393,3197,TCGA-41-3393,GBM,81.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-29904.0,Dead,WITH TUMOR,135.0,135.0,[Not Available],,,,,[Not Available],,,1.0,135.0,1.0,135.0,,,1.0,135.0,
TCGA-CM-4743,2258,TCGA-CM-4743,COAD,69.0,MALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-25291.0,Alive,TUMOR FREE,701.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,701.0,0.0,701.0,0.0,701.0,0.0,701.0,
TCGA-BR-4201,9281,TCGA-BR-4201,STAD,66.0,FEMALE,WHITE,[Not Available],[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2008.0,[Not Available],-24354.0,Dead,,,940.0,[Not Available],,,,,Stable Disease,,,1.0,940.0,,940.0,,,0.0,940.0,
TCGA-CC-A123,5489,TCGA-CC-A123,LIHC,24.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2010.0,[Not Available],-9107.0,Alive,WITH TUMOR,219.0,,[Not Available],New Primary Tumor,Lung,,145.0,[Not Available],,RX,0.0,219.0,0.0,219.0,,,1.0,145.0,
TCGA-L5-A8NT,2552,TCGA-L5-A8NT,ESCA,69.0,MALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2001.0,[Not Available],-25259.0,Alive,WITH TUMOR,825.0,,[Not Available],Distant Metastasis,Liver,,825.0,[Unknown],,,0.0,825.0,0.0,825.0,,,1.0,825.0,
TCGA-EI-6881,8514,TCGA-EI-6881,READ,60.0,MALE,WHITE,Stage IIIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-22057.0,Alive,TUMOR FREE,499.0,,[Not Available],,,,,[Not Available],,,0.0,499.0,0.0,499.0,,,0.0,499.0,
TCGA-C5-A1M8,1620,TCGA-C5-A1M8,CESC,43.0,FEMALE,WHITE,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2001.0,Indeterminate (neither Pre or Postmenopausal),-15848.0,Alive,TUMOR FREE,919.0,,,,,,,Complete Remission/Response,,,0.0,919.0,0.0,919.0,0.0,919.0,0.0,919.0,
TCGA-FY-A3R8,10289,TCGA-FY-A3R8,THCA,62.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-22824.0,Alive,TUMOR FREE,477.0,,[Not Available],,,,,[Not Available],,R0,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,
TCGA-W3-A824,9226,TCGA-W3-A824,SKCM,63.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1995.0,[Not Available],-23131.0,Alive,WITH TUMOR,6940.0,,[Not Available],Distant Metastasis,"Other, Specify",Spleen,2406.0,[Not Available],,,0.0,6940.0,0.0,6940.0,,,1.0,2406.0,
TCGA-BC-A10Z,5465,TCGA-BC-A10Z,LIHC,62.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2003.0,[Not Available],-22913.0,Dead,TUMOR FREE,,34.0,[Not Available],,,,,[Not Available],,R0,1.0,34.0,0.0,34.0,0.0,34.0,0.0,34.0,
TCGA-BQ-5892,4552,TCGA-BQ-5892,KIRP,51.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-18785.0,Alive,TUMOR FREE,364.0,,[Not Available],,,,,[Not Available],,,0.0,364.0,0.0,364.0,,,0.0,364.0,
TCGA-67-3773,6089,TCGA-67-3773,LUAD,84.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-30706.0,Alive,TUMOR FREE,427.0,,[Not Available],,,,,[Not Available],,,0.0,427.0,0.0,427.0,,,0.0,427.0,
TCGA-G7-6789,4594,TCGA-G7-6789,KIRP,53.0,FEMALE,WHITE,Stage IV,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2004.0,[Not Available],-19593.0,Dead,WITH TUMOR,,122.0,[Not Available],,,,,[Not Available],,,1.0,122.0,1.0,122.0,,,1.0,122.0,
TCGA-E9-A1RA,1415,TCGA-E9-A1RA,BRCA,48.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17699.0,Alive,TUMOR FREE,1369.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1369.0,0.0,1369.0,0.0,1369.0,0.0,1369.0,
TCGA-ZB-A961,10446,TCGA-ZB-A961,THYM,69.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type A,[Not Available],2010.0,[Not Available],-25419.0,Dead,TUMOR FREE,,180.0,[Not Available],,,,,[Not Available],,,1.0,180.0,0.0,180.0,,,0.0,180.0,
TCGA-FS-A1ZN,9161,TCGA-FS-A1ZN,SKCM,43.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2002.0,[Not Available],-15890.0,Dead,WITH TUMOR,,730.0,[Not Available],,,,361.0,[Not Available],,,1.0,730.0,1.0,730.0,,,1.0,361.0,
TCGA-6A-AB49,6655,TCGA-6A-AB49,LUSC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],,Dead,TUMOR FREE,,,[Not Available],,,,,Progressive Disease,,,1.0,,0.0,,,,0.0,,
TCGA-2G-AAKH,9769,TCGA-2G-AAKH,TGCT,19.0,MALE,WHITE,Stage II,Stage II,Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS,[Not Available],1996.0,[Not Available],-6954.0,Alive,TUMOR FREE,6862.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,6862.0,0.0,6862.0,0.0,6862.0,0.0,6862.0,
TCGA-05-4250,5806,TCGA-05-4250,LUAD,79.0,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-29068.0,Dead,,,121.0,[Not Available],,,,,[Not Available],,,1.0,121.0,,121.0,,,0.0,121.0,
TCGA-BC-A3KF,5470,TCGA-BC-A3KF,LIHC,66.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-24328.0,Alive,TUMOR FREE,8.0,,[Not Available],,,,,[Not Available],,R0,0.0,8.0,0.0,8.0,0.0,8.0,0.0,8.0,
TCGA-C5-A1MK,1627,TCGA-C5-A1MK,CESC,79.0,FEMALE,WHITE,[Not Available],Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28939.0,Dead,WITH TUMOR,,74.0,Cervical Cancer,,,,,Progressive Disease,,,1.0,74.0,1.0,74.0,,,1.0,74.0,
TCGA-AP-A1DR,10599,TCGA-AP-A1DR,UCEC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21904.0,Alive,TUMOR FREE,1495.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1495.0,0.0,1495.0,0.0,1495.0,0.0,1495.0,
TCGA-KF-A41W,8721,TCGA-KF-A41W,SARC,71.0,FEMALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2012.0,[Not Available],-25969.0,Alive,TUMOR FREE,356.0,,[Not Available],,,,,[Not Available],Negative,RX,0.0,356.0,0.0,356.0,,,0.0,356.0,
TCGA-D5-6931,2323,TCGA-D5-6931,COAD,77.0,MALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-28292.0,Alive,TUMOR FREE,365.0,,[Not Available],,,,,[Not Available],,,0.0,365.0,0.0,365.0,,,0.0,365.0,
TCGA-HQ-A5ND,370,TCGA-HQ-A5ND,BLCA,78.0,MALE,[Not Evaluated],Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,,[Not Available],-28555.0,Dead,WITH TUMOR,,274.0,[Not Available],Distant Metastasis,Lymph Node Only,,84.0,Progressive Disease,,,1.0,274.0,1.0,274.0,,,1.0,84.0,
TCGA-SI-A71Q,8763,TCGA-SI-A71Q,SARC,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2012.0,[Not Available],-12559.0,Alive,TUMOR FREE,996.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,996.0,0.0,996.0,0.0,996.0,0.0,996.0,
TCGA-CZ-5452,4368,TCGA-CZ-5452,KIRC,69.0,MALE,WHITE,Stage II,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2006.0,[Not Available],-25486.0,Alive,TUMOR FREE,1789.0,,[Not Available],,,,,[Not Available],,,0.0,1789.0,0.0,1789.0,,,0.0,1789.0,
TCGA-69-7763,6098,TCGA-69-7763,LUAD,69.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-25316.0,Alive,,690.0,,[Not Available],,,,,[Not Available],,,0.0,690.0,0.0,690.0,,,0.0,690.0,
TCGA-ZP-A9CY,5793,TCGA-ZP-A9CY,LIHC,66.0,FEMALE,WHITE,[Not Available],[Not Applicable],Hepatocellular Carcinoma,G1,2011.0,[Not Available],-24223.0,Alive,TUMOR FREE,782.0,,[Not Available],,,,,[Not Available],,R0,0.0,782.0,0.0,782.0,0.0,782.0,0.0,782.0,
TCGA-B6-A0X0,1008,TCGA-B6-A0X0,BRCA,54.0,FEMALE,WHITE,Stage I,[Not Applicable],"Other, specify",[Not Available],1996.0,Indeterminate (neither Pre or Postmenopausal),-19802.0,Dead,,,3945.0,[Not Available],,,,,[Not Available],Negative,,1.0,3945.0,,3945.0,0.0,3945.0,0.0,3945.0,
TCGA-EL-A4JZ,10108,TCGA-EL-A4JZ,THCA,55.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-20290.0,Alive,TUMOR FREE,1856.0,,[Not Available],,,,,[Not Available],,R0,0.0,1856.0,0.0,1856.0,0.0,1856.0,0.0,1856.0,
TCGA-E2-A15P,1347,TCGA-E2-A15P,BRCA,61.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22524.0,Alive,TUMOR FREE,595.0,,[Not Available],,,,,[Not Available],Negative,,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,
TCGA-VQ-A91W,9682,TCGA-VQ-A91W,STAD,30.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,[Not Available],-10963.0,Alive,,1851.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1851.0,0.0,1851.0,0.0,1851.0,0.0,1851.0,
TCGA-D8-A1XF,1263,TCGA-D8-A1XF,BRCA,45.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16787.0,Alive,TUMOR FREE,463.0,,[Not Available],,,,,[Not Available],[Not Available],,0.0,463.0,0.0,463.0,,,0.0,463.0,
TCGA-FK-A3SB,10273,TCGA-FK-A3SB,THCA,28.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008.0,[Not Available],-10293.0,Alive,TUMOR FREE,125.0,,[Not Available],,,,,[Not Available],,R0,0.0,125.0,0.0,125.0,0.0,125.0,0.0,125.0,
TCGA-BR-6453,9302,TCGA-BR-6453,STAD,54.0,MALE,WHITE,Stage IIA,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,[Not Available],-20061.0,Alive,TUMOR FREE,485.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,
TCGA-HT-7880,5197,TCGA-HT-7880,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2011.0,[Not Available],-11043.0,Alive,TUMOR FREE,162.0,,[Not Available],,,,,[Not Available],,,0.0,162.0,0.0,162.0,,,0.0,162.0,
TCGA-YL-A8S8,8321,TCGA-YL-A8S8,PRAD,68.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2008.0,[Not Available],-25119.0,Alive,WITH TUMOR,1890.0,,[Not Available],Biochemical evidence of disease,,,679.0,Stable Disease,,,0.0,1890.0,0.0,1890.0,,,1.0,679.0,
TCGA-CG-5733,9484,TCGA-CG-5733,STAD,83.0,FEMALE,[Not Available],Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003.0,[Not Available],-30650.0,Dead,WITH TUMOR,,641.0,[Not Available],,,,427.0,Progressive Disease,,,1.0,641.0,1.0,641.0,,,1.0,427.0,
TCGA-DH-5143,4968,TCGA-DH-5143,LGG,30.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2009.0,[Not Available],-11291.0,Alive,WITH TUMOR,1401.0,,[Not Available],,,,,Stable Disease,,,0.0,1401.0,0.0,1401.0,,,0.0,1401.0,
TCGA-41-6646,3201,TCGA-41-6646,GBM,73.0,FEMALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2011.0,[Not Available],-26667.0,Dead,WITH TUMOR,,379.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],200.0,[Not Available],,,1.0,379.0,1.0,379.0,,,1.0,200.0,
TCGA-85-8052,6717,TCGA-85-8052,LUSC,53.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-19671.0,Alive,TUMOR FREE,734.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,734.0,0.0,734.0,0.0,734.0,0.0,734.0,
TCGA-EC-A24G,10918,TCGA-EC-A24G,UCEC,57.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20857.0,Alive,TUMOR FREE,511.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,511.0,0.0,511.0,0.0,511.0,0.0,511.0,
TCGA-EL-A3T3,10086,TCGA-EL-A3T3,THCA,63.0,MALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002.0,[Not Available],-23043.0,Alive,TUMOR FREE,4017.0,,[Not Available],,,,,[Not Available],,R0,0.0,4017.0,0.0,4017.0,0.0,4017.0,0.0,4017.0,
TCGA-2V-A95S,5426,TCGA-2V-A95S,LIHC,,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G3,,[Not Available],,Alive,WITH TUMOR,,,[Not Available],,,,,[Not Available],,R0,0.0,,0.0,,0.0,,0.0,,
TCGA-EB-A5UM,8979,TCGA-EB-A5UM,SKCM,48.0,FEMALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-17867.0,Alive,TUMOR FREE,779.0,,[Not Available],,,,,[Not Available],,,0.0,779.0,0.0,779.0,,,0.0,779.0,
TCGA-21-1083,6354,TCGA-21-1083,LUSC,75.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],1997.0,[Not Available],-27708.0,Dead,TUMOR FREE,267.0,1315.0,[Not Available],,,,,[Not Available],,,1.0,1315.0,0.0,1315.0,,,0.0,1315.0,
TCGA-YC-A8S6,469,TCGA-YC-A8S6,BLCA,71.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-26130.0,Alive,TUMOR FREE,293.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,293.0,0.0,293.0,0.0,293.0,0.0,293.0,
TCGA-E9-A1N5,1395,TCGA-E9-A1N5,BRCA,45.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Mixed Histology (please specify),[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16736.0,Alive,TUMOR FREE,1120.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1120.0,0.0,1120.0,0.0,1120.0,0.0,1120.0,
TCGA-34-2600,6419,TCGA-34-2600,LUSC,76.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2000.0,[Not Available],-28072.0,Dead,TUMOR FREE,1874.0,1874.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1874.0,0.0,1874.0,0.0,1874.0,0.0,1874.0,
TCGA-SP-A6QC,7794,TCGA-SP-A6QC,PCPG,46.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2004.0,[Not Available],-16891.0,Alive,TUMOR FREE,3491.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3491.0,0.0,3491.0,0.0,3491.0,0.0,3491.0,
TCGA-DS-A7WH,1690,TCGA-DS-A7WH,CESC,34.0,FEMALE,WHITE,[Not Available],Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12644.0,Alive,TUMOR FREE,533.0,,,,,,,Complete Remission/Response,,,0.0,533.0,0.0,533.0,0.0,533.0,0.0,533.0,
TCGA-CV-7410,3551,TCGA-CV-7410,HNSC,61.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,GX,1993.0,[Not Available],-22302.0,Dead,WITH TUMOR,,6417.0,[Not Available],,,,,[Not Available],,,1.0,6417.0,1.0,6417.0,,,1.0,6417.0,
TCGA-A7-A26G,645,TCGA-A7-A26G,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18362.0,Alive,TUMOR FREE,722.0,,[Not Available],,,,,[Not Available],Negative,,0.0,722.0,0.0,722.0,0.0,722.0,0.0,722.0,
TCGA-M8-A5N4,7661,TCGA-M8-A5N4,PAAD,48.0,FEMALE,[Not Evaluated],Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,,[Not Available],-17628.0,Alive,WITH TUMOR,584.0,,,Locoregional Recurrence,"Other, specify",retroperitoneal recurrence around the supramesenteric artery and vein and some para aortic nodes,416.0,Partial Remission/Response,,,0.0,584.0,0.0,584.0,,,1.0,416.0,
TCGA-55-8513,6039,TCGA-55-8513,LUAD,77.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-28284.0,Alive,WITH TUMOR,791.0,,[Not Available],Distant Metastasis,,,317.0,Complete Remission/Response,,,0.0,791.0,0.0,791.0,1.0,317.0,1.0,317.0,
TCGA-A6-5662,1987,TCGA-A6-5662,COAD,46.0,MALE,WHITE,Stage IVA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-16873.0,Alive,WITH TUMOR,718.0,,[Not Available],,,,495.0,[Not Available],,,0.0,718.0,0.0,718.0,,,1.0,495.0,
TCGA-L5-A8NN,2548,TCGA-L5-A8NN,ESCA,81.0,MALE,WHITE,Stage III,[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2004.0,[Not Available],-29891.0,Alive,,167.0,,[Not Available],,,,,[Unknown],,,0.0,167.0,0.0,167.0,,,0.0,167.0,
TCGA-S9-A6TY,5326,TCGA-S9-A6TY,LGG,50.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-18564.0,Alive,WITH TUMOR,1076.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1076.0,0.0,1076.0,,,0.0,1076.0,
TCGA-B9-A5W8,4530,TCGA-B9-A5W8,KIRP,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-18440.0,Alive,TUMOR FREE,524.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,
TCGA-73-4662,6115,TCGA-73-4662,LUAD,65.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-23762.0,Alive,TUMOR FREE,2515.0,,[Not Available],,,,21.0,Complete Remission/Response,,,0.0,2515.0,0.0,2515.0,1.0,21.0,1.0,21.0,
TCGA-44-2656,5854,TCGA-44-2656,LUAD,59.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-21766.0,Alive,TUMOR FREE,1429.0,,[Not Available],New Primary Tumor,,,568.0,Complete Remission/Response,,,0.0,1429.0,0.0,1429.0,0.0,1429.0,1.0,568.0,
TCGA-63-7022,6590,TCGA-63-7022,LUSC,,FEMALE,[Not Available],Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],,Alive,TUMOR FREE,2073.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2073.0,0.0,2073.0,0.0,2073.0,0.0,2073.0,
TCGA-F4-6461,2353,TCGA-F4-6461,COAD,41.0,FEMALE,WHITE,Stage IIIC,[Not Applicable],Colon Adenocarcinoma,[Not Available],2011.0,[Not Available],-15151.0,Dead,WITH TUMOR,,338.0,[Not Available],,,,288.0,[Not Available],,,1.0,338.0,1.0,338.0,,,1.0,288.0,
TCGA-B0-5110,4037,TCGA-B0-5110,KIRC,71.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2009.0,[Not Available],-25976.0,Alive,TUMOR FREE,2009.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2009.0,0.0,2009.0,0.0,2009.0,0.0,2009.0,
TCGA-52-7811,6505,TCGA-52-7811,LUSC,67.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2009.0,[Not Available],-24782.0,Dead,WITH TUMOR,,266.0,[Not Available],Distant Metastasis,,,153.0,Progressive Disease,,,1.0,266.0,1.0,266.0,,,1.0,153.0,
TCGA-C8-A12Z,1189,TCGA-C8-A12Z,BRCA,45.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Peri (6-12 months since last menstrual period),-16508.0,Alive,TUMOR FREE,382.0,,[Not Available],,,,,[Not Available],Negative,,0.0,382.0,0.0,382.0,0.0,382.0,0.0,382.0,
TCGA-DD-AACJ,5589,TCGA-DD-AACJ,LIHC,75.0,MALE,ASIAN,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-27528.0,Alive,WITH TUMOR,2102.0,,[Not Available],Locoregional Recurrence,Liver,,100.0,[Not Available],,R0,0.0,2102.0,0.0,2102.0,1.0,100.0,1.0,100.0,
TCGA-EO-A1Y5,10919,TCGA-EO-A1Y5,UCEC,63.0,FEMALE,[Not Available],[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23251.0,Alive,TUMOR FREE,332.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,332.0,0.0,332.0,0.0,332.0,0.0,332.0,
TCGA-DK-A6AW,211,TCGA-DK-A6AW,BLCA,70.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-25644.0,Alive,TUMOR FREE,1621.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1621.0,0.0,1621.0,0.0,1621.0,0.0,1621.0,
TCGA-DK-A1AD,187,TCGA-DK-A1AD,BLCA,69.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2002.0,[Not Available],-25317.0,Alive,TUMOR FREE,3420.0,,[Not Available],,,,,[Not Available],,,0.0,3420.0,0.0,3420.0,,,0.0,3420.0,
TCGA-FG-8181,5113,TCGA-FG-8181,LGG,23.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2012.0,[Not Available],-8642.0,Alive,WITH TUMOR,862.0,,[Not Available],,,,,Stable Disease,,,0.0,862.0,0.0,862.0,,,0.0,862.0,
TCGA-EE-A2M5,9046,TCGA-EE-A2M5,SKCM,49.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1999.0,[Not Available],-17950.0,Dead,WITH TUMOR,,659.0,[Not Available],Locoregional Recurrence,,,537.0,[Not Available],,,1.0,659.0,1.0,659.0,,,1.0,537.0,
TCGA-HU-8238,9557,TCGA-HU-8238,STAD,56.0,MALE,ASIAN,[Discrepancy],[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-20708.0,Alive,TUMOR FREE,46.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,46.0,0.0,46.0,0.0,46.0,0.0,46.0,
TCGA-DB-A64S,4955,TCGA-DB-A64S,LGG,20.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,2012.0,[Not Available],-7389.0,Alive,TUMOR FREE,835.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,835.0,0.0,835.0,0.0,835.0,0.0,835.0,
TCGA-E8-A434,10034,TCGA-E8-A434,THCA,56.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-20492.0,Alive,TUMOR FREE,953.0,,[Not Available],,,,,[Not Available],,R0,0.0,953.0,0.0,953.0,0.0,953.0,0.0,953.0,
TCGA-BJ-A0Z0,9847,TCGA-BJ-A0Z0,THCA,55.0,MALE,[Not Available],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-20361.0,Alive,TUMOR FREE,419.0,,[Not Available],,,,,[Not Available],,R0,0.0,419.0,0.0,419.0,0.0,419.0,0.0,419.0,
TCGA-DH-A66D,4972,TCGA-DH-A66D,LGG,43.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2012.0,[Not Available],-15866.0,Alive,WITH TUMOR,846.0,,[Not Available],,,,,Stable Disease,,,0.0,846.0,0.0,846.0,,,0.0,846.0,
TCGA-A6-2686,1975,TCGA-A6-2686,COAD,81.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2009.0,[Not Available],-29623.0,Dead,TUMOR FREE,,1126.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1126.0,0.0,1126.0,0.0,1126.0,0.0,1126.0,
TCGA-R8-A6MK,5310,TCGA-R8-A6MK,LGG,40.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2005.0,[Not Available],-14716.0,Alive,,2702.0,,[Not Available],,,,,[Unknown],,,0.0,2702.0,0.0,2702.0,,,0.0,2702.0,
TCGA-CQ-7064,3399,TCGA-CQ-7064,HNSC,83.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,[Not Available],-30640.0,Alive,TUMOR FREE,1973.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1973.0,0.0,1973.0,0.0,1973.0,0.0,1973.0,
TCGA-4E-A92E,10477,TCGA-4E-A92E,UCEC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G1,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19818.0,Alive,TUMOR FREE,13.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,13.0,0.0,13.0,0.0,13.0,0.0,13.0,
TCGA-04-1369,6940,TCGA-04-1369,OV,53.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous Cystadenocarcinoma,G2,2004.0,[Not Available],-19571.0,Dead,WITH TUMOR,,642.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],315.0,[Not Available],,,1.0,642.0,1.0,642.0,,,1.0,315.0,
TCGA-AP-A1DM,10595,TCGA-AP-A1DM,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22239.0,Alive,TUMOR FREE,1700.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1700.0,0.0,1700.0,0.0,1700.0,0.0,1700.0,
TCGA-C8-A12O,1180,TCGA-C8-A12O,BRCA,50.0,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18506.0,Alive,TUMOR FREE,385.0,,[Not Available],,,,,[Not Available],Negative,,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,
TCGA-44-7671,5890,TCGA-44-7671,LUAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-23538.0,Alive,WITH TUMOR,889.0,,[Not Available],Locoregional Recurrence,,,883.0,Complete Remission/Response,,,0.0,889.0,0.0,889.0,1.0,883.0,1.0,883.0,
TCGA-A2-A0T0,576,TCGA-A2-A0T0,BRCA,59.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21575.0,Alive,TUMOR FREE,533.0,,[Not Available],,,,,[Not Available],Negative,,0.0,533.0,0.0,533.0,0.0,533.0,0.0,533.0,
TCGA-N5-A4RM,11029,TCGA-N5-A4RM,UCS,62.0,FEMALE,WHITE,[Not Applicable],Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22886.0,Dead,WITH TUMOR,,148.0,[Not Available],Locoregional Recurrence,Pelvis,,144.0,Progressive Disease,,,1.0,148.0,1.0,148.0,,,1.0,144.0,
TCGA-DJ-A3VK,9998,TCGA-DJ-A3VK,THCA,63.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-23255.0,Alive,TUMOR FREE,753.0,,[Not Available],,,,,[Not Available],,R0,0.0,753.0,0.0,753.0,0.0,753.0,0.0,753.0,
TCGA-C8-A26V,1208,TCGA-C8-A26V,BRCA,47.0,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Peri (6-12 months since last menstrual period),-17468.0,Alive,TUMOR FREE,616.0,,[Not Available],,,,,[Not Available],Negative,,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,
TCGA-76-6657,3229,TCGA-76-6657,GBM,74.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-27341.0,Dead,WITH TUMOR,153.0,153.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],135.0,[Not Available],,,1.0,153.0,1.0,153.0,,,1.0,135.0,
TCGA-A3-3313,3889,TCGA-A3-3313,KIRC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2005.0,[Not Available],-21556.0,Dead,TUMOR FREE,735.0,735.0,[Not Available],,,,,[Not Available],,,1.0,735.0,0.0,735.0,,,0.0,735.0,
TCGA-KU-A66S,3692,TCGA-KU-A66S,HNSC,69.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma Basaloid Type,G2,2012.0,[Not Available],-25454.0,Dead,WITH TUMOR,,406.0,[Not Available],Distant Metastasis,Distant Metastasis,Brain Metastasis,389.0,Complete Remission/Response,,,1.0,406.0,1.0,406.0,1.0,389.0,1.0,389.0,
TCGA-D1-A0ZQ,10818,TCGA-D1-A0ZQ,UCEC,90.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873.0,Alive,TUMOR FREE,260.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,260.0,0.0,260.0,0.0,260.0,0.0,260.0,
TCGA-OR-A5LI,72,TCGA-OR-A5LI,ACC,42.0,FEMALE,WHITE,Stage IV,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],1998.0,[Not Available],-15536.0,Dead,WITH TUMOR,,436.0,[Not Available],Distant Metastasis,Bone,,61.0,Progressive Disease,,,1.0,436.0,1.0,436.0,,,1.0,61.0,
TCGA-DY-A1DC,8497,TCGA-DY-A1DC,READ,72.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2000.0,[Not Available],-26436.0,Dead,,,1258.0,[Not Available],Locoregional Disease,,,630.0,[Not Available],,,1.0,1258.0,,1258.0,,,1.0,630.0,
TCGA-E9-A1QZ,1407,TCGA-E9-A1QZ,BRCA,61.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22397.0,Alive,TUMOR FREE,755.0,,[Not Available],,,,,[Not Available],Negative,,0.0,755.0,0.0,755.0,0.0,755.0,0.0,755.0,
TCGA-86-8074,6191,TCGA-86-8074,LUAD,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22862.0,Alive,TUMOR FREE,24.0,,[Not Available],,,,,[Not Available],,,0.0,24.0,0.0,24.0,,,0.0,24.0,
TCGA-AN-A0XS,837,TCGA-AN-A0XS,BRCA,63.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23358.0,Alive,TUMOR FREE,10.0,,[Not Available],,,,,[Not Available],Negative,,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,
TCGA-W3-AA1Q,9230,TCGA-W3-AA1Q,SKCM,57.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],1994.0,[Not Available],-21033.0,Dead,WITH TUMOR,,2101.0,[Not Available],Distant Metastasis,"Other, Specify",Thigh,1066.0,[Not Available],,,1.0,2101.0,1.0,2101.0,,,1.0,1066.0,
TCGA-3C-AALI,506,TCGA-3C-AALI,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18538.0,Alive,TUMOR FREE,4005.0,,[Not Available],,,,,[Not Available],Negative,,0.0,4005.0,0.0,4005.0,0.0,4005.0,0.0,4005.0,
TCGA-FY-A3WA,10294,TCGA-FY-A3WA,THCA,52.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-18993.0,Alive,TUMOR FREE,519.0,,[Not Available],,,,,[Not Available],,R0,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,
TCGA-28-2514,3152,TCGA-28-2514,GBM,45.0,MALE,ASIAN,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2009.0,[Not Available],-16737.0,Alive,,160.0,,[Not Available],,,,,[Not Available],,,0.0,160.0,0.0,160.0,,,0.0,160.0,
TCGA-ER-A3EV,9123,TCGA-ER-A3EV,SKCM,55.0,MALE,WHITE,Stage III,[Not Applicable],,[Not Available],2001.0,[Not Available],-20354.0,Dead,WITH TUMOR,1429.0,1429.0,[Not Available],,,,728.0,[Not Available],,,1.0,1429.0,1.0,1429.0,,,1.0,728.0,
TCGA-99-7458,6272,TCGA-99-7458,LUAD,74.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-27359.0,Alive,WITH TUMOR,747.0,,[Not Available],,,,,Stable Disease,,,0.0,747.0,0.0,747.0,,,0.0,747.0,
TCGA-IB-AAUS,7652,TCGA-IB-AAUS,PAAD,84.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,[Not Available],-30684.0,Alive,WITH TUMOR,225.0,,,,,,,[Not Applicable],,,0.0,225.0,0.0,225.0,,,0.0,225.0,
TCGA-X7-A8D6,10384,TCGA-X7-A8D6,THYM,48.0,FEMALE,WHITE,[Not Applicable],I,Thymoma; Type B2,[Not Available],2002.0,[Not Available],-17771.0,Alive,TUMOR FREE,4225.0,,[Not Available],New Primary Tumor,"Other, specify",breast,2928.0,[Not Available],,,0.0,4225.0,0.0,4225.0,,,1.0,2928.0,
TCGA-D1-A17F,10863,TCGA-D1-A17F,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25116.0,Alive,TUMOR FREE,39.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,39.0,0.0,39.0,0.0,39.0,0.0,39.0,
TCGA-56-8305,6526,TCGA-56-8305,LUSC,72.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-26428.0,Alive,TUMOR FREE,105.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,105.0,0.0,105.0,0.0,105.0,0.0,105.0,
TCGA-06-1806,2850,TCGA-06-1806,GBM,47.0,MALE,WHITE,[Not Available],[Not Applicable],Glioblastoma Multiforme (GBM),[Not Available],2009.0,[Not Available],-17296.0,Dead,WITH TUMOR,,466.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],256.0,Progressive Disease,,,1.0,466.0,1.0,466.0,,,1.0,256.0,
TCGA-G9-7510,8049,TCGA-G9-7510,PRAD,66.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-24187.0,Alive,TUMOR FREE,1185.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1185.0,0.0,1185.0,0.0,1185.0,0.0,1185.0,
TCGA-FD-A6TE,299,TCGA-FD-A6TE,BLCA,54.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-19874.0,Alive,TUMOR FREE,376.0,,[Not Available],Distant Metastasis,"Other, specify",sacrum,321.0,[Unknown],,,0.0,376.0,0.0,376.0,,,1.0,321.0,
TCGA-E2-A15K,1343,TCGA-E2-A15K,BRCA,58.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21514.0,Alive,TUMOR FREE,275.0,,[Not Available],,,,,[Not Available],Negative,,0.0,275.0,0.0,275.0,0.0,275.0,0.0,275.0,
TCGA-BJ-A45D,9885,TCGA-BJ-A45D,THCA,36.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012.0,[Not Available],-13335.0,Alive,TUMOR FREE,331.0,,[Not Available],,,,,[Not Available],,[Not Available],0.0,331.0,0.0,331.0,,,0.0,331.0,
TCGA-J8-A3O2,10322,TCGA-J8-A3O2,THCA,39.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-14339.0,Alive,TUMOR FREE,342.0,,[Not Available],,,,,[Not Available],,R1,0.0,342.0,0.0,342.0,,,0.0,342.0,
TCGA-ZB-A96H,10460,TCGA-ZB-A96H,THYM,73.0,MALE,WHITE,[Not Applicable],IIb,Thymoma; Type A,[Not Available],2010.0,[Not Available],-26683.0,Alive,TUMOR FREE,1504.0,,[Not Available],,,,,[Not Available],,,0.0,1504.0,0.0,1504.0,,,0.0,1504.0,
TCGA-DW-7839,4576,TCGA-DW-7839,KIRP,58.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010.0,[Not Available],-21347.0,Alive,TUMOR FREE,419.0,,[Not Available],,,,,[Not Available],,,0.0,419.0,0.0,419.0,,,0.0,419.0,
TCGA-D1-A0ZZ,10823,TCGA-D1-A0ZZ,UCEC,80.0,FEMALE,WHITE,[Not Applicable],Stage IB,Mixed serous and endometrioid,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29420.0,Alive,TUMOR FREE,686.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,686.0,0.0,686.0,0.0,686.0,0.0,686.0,
TCGA-AJ-A2QO,10532,TCGA-AJ-A2QO,UCEC,85.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31222.0,Dead,TUMOR FREE,,1045.0,[Not Available],,,,,Complete Remission/Response,,,1.0,1045.0,0.0,1045.0,0.0,1045.0,0.0,1045.0,
TCGA-A2-A25B,606,TCGA-A2-A25B,BRCA,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14454.0,Alive,WITH TUMOR,1291.0,,[Not Available],Distant Metastasis,Bone,,1290.0,[Not Available],Close,,0.0,1291.0,0.0,1291.0,,,1.0,1290.0,
TCGA-EL-A3GQ,10061,TCGA-EL-A3GQ,THCA,72.0,FEMALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-26478.0,Alive,TUMOR FREE,1528.0,,[Not Available],,,,,[Not Available],,R0,0.0,1528.0,0.0,1528.0,0.0,1528.0,0.0,1528.0,
TCGA-F6-A8O4,5097,TCGA-F6-A8O4,LGG,44.0,MALE,ASIAN,[Not Available],[Not Available],Astrocytoma,G2,2013.0,[Not Available],-16202.0,Alive,TUMOR FREE,6.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,6.0,0.0,6.0,0.0,6.0,0.0,6.0,
TCGA-FR-A726,9134,TCGA-FR-A726,SKCM,90.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2013.0,[Not Available],-32873.0,Dead,WITH TUMOR,,305.0,[Not Available],Locoregional Recurrence,,,273.0,[Not Available],,,1.0,305.0,1.0,305.0,,,1.0,273.0,
TCGA-HV-A5A5,7582,TCGA-HV-A5A5,PAAD,61.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,[Not Available],-22329.0,Alive,,289.0,,,,,,,Complete Remission/Response,,,0.0,289.0,0.0,289.0,0.0,289.0,0.0,289.0,
TCGA-DU-6395,4994,TCGA-DU-6395,LGG,31.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G2,1994.0,[Not Available],-11584.0,Dead,WITH TUMOR,,1491.0,[Not Available],,,,1197.0,Progressive Disease,,,1.0,1491.0,1.0,1491.0,,,1.0,1197.0,
TCGA-CV-5430,3470,TCGA-CV-5430,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,1999.0,[Not Available],-22577.0,Alive,TUMOR FREE,4241.0,,[Not Available],,Distant Metastasis,Lung,783.0,Complete Remission/Response,,,0.0,4241.0,0.0,4241.0,,,1.0,783.0,
TCGA-E1-A7YD,5075,TCGA-E1-A7YD,LGG,57.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,1998.0,[Not Available],-21020.0,Dead,WITH TUMOR,,435.0,[Not Available],,,,284.0,Stable Disease,,,1.0,435.0,1.0,435.0,,,1.0,284.0,
TCGA-HT-A5RB,5228,TCGA-HT-A5RB,LGG,24.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G2,2011.0,[Not Available],-8820.0,Alive,,3.0,,[Not Available],,,,,[Not Available],,,0.0,3.0,0.0,3.0,,,0.0,3.0,
TCGA-D1-A16V,10851,TCGA-D1-A16V,UCEC,78.0,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28635.0,Dead,TUMOR FREE,,120.0,[Not Available],,,,,Complete Remission/Response,,,1.0,120.0,0.0,120.0,0.0,120.0,0.0,120.0,
TCGA-DK-A1AG,190,TCGA-DK-A1AG,BLCA,65.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,[Not Available],-24095.0,Alive,TUMOR FREE,475.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,
TCGA-E1-5318,5072,TCGA-E1-5318,LGG,42.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1997.0,[Not Available],-15372.0,Dead,WITH TUMOR,2379.0,2379.0,[Not Available],,,,362.0,Progressive Disease,,,1.0,2379.0,1.0,2379.0,,,1.0,362.0,
TCGA-QR-A6GT,7700,TCGA-QR-A6GT,PCPG,63.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2002.0,[Not Available],-23208.0,Alive,WITH TUMOR,4185.0,,[Not Available],Distant Metastasis,Liver,,1476.0,Progressive Disease,,,0.0,4185.0,0.0,4185.0,,,1.0,1476.0,
TCGA-VS-A8QF,1848,TCGA-VS-A8QF,CESC,42.0,FEMALE,WHITE,[Not Available],Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15374.0,Alive,TUMOR FREE,1800.0,,,,,,,Complete Remission/Response,,,0.0,1800.0,0.0,1800.0,0.0,1800.0,0.0,1800.0,
TCGA-A3-A6NN,3931,TCGA-A3-A6NN,KIRC,78.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2012.0,[Not Available],-28689.0,Alive,TUMOR FREE,3.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3.0,0.0,3.0,0.0,3.0,0.0,3.0,
TCGA-BG-A221,10771,TCGA-BG-A221,UCEC,84.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30960.0,Alive,TUMOR FREE,55.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,55.0,0.0,55.0,0.0,55.0,0.0,55.0,
TCGA-EJ-A6RC,7992,TCGA-EJ-A6RC,PRAD,64.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23598.0,Alive,TUMOR FREE,873.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,873.0,0.0,873.0,0.0,873.0,0.0,873.0,
TCGA-50-5049,5934,TCGA-50-5049,LUAD,70.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2006.0,[Not Available],-25577.0,Alive,WITH TUMOR,3094.0,,[Not Available],Locoregional Recurrence,,,1568.0,Progressive Disease,,,0.0,3094.0,0.0,3094.0,,,1.0,1568.0,
TCGA-EL-A3MW,10077,TCGA-EL-A3MW,THCA,55.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2003.0,[Not Available],-20186.0,Alive,TUMOR FREE,3305.0,,[Not Available],,,,,[Not Available],,R0,0.0,3305.0,0.0,3305.0,0.0,3305.0,0.0,3305.0,
TCGA-ET-A2N0,10214,TCGA-ET-A2N0,THCA,51.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-18692.0,Alive,TUMOR FREE,1600.0,,[Not Available],,,,,[Not Available],,R0,0.0,1600.0,0.0,1600.0,0.0,1600.0,0.0,1600.0,
TCGA-2F-A9KW,98,TCGA-2F-A9KW,BLCA,67.0,FEMALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,[Not Available],-24703.0,Dead,WITH TUMOR,,254.0,[Not Available],Distant Metastasis,Bone,,85.0,Stable Disease,,,1.0,254.0,1.0,254.0,,,1.0,85.0,
TCGA-A2-A1FW,597,TCGA-A2-A1FW,BRCA,62.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22779.0,Alive,TUMOR FREE,528.0,,[Not Available],,,,,[Not Available],Negative,,0.0,528.0,0.0,528.0,0.0,528.0,0.0,528.0,
TCGA-KK-A8I6,8202,TCGA-KK-A8I6,PRAD,58.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-21499.0,Alive,TUMOR FREE,668.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,668.0,0.0,668.0,0.0,668.0,0.0,668.0,
TCGA-V4-A9E9,11087,TCGA-V4-A9E9,UVM,50.0,MALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,[Not Available],2012.0,[Not Available],-18387.0,Alive,TUMOR FREE,1246.0,,[Not Available],,,,,[Not Available],,,0.0,1246.0,0.0,1246.0,,,0.0,1246.0,
TCGA-BH-A0H7,1092,TCGA-BH-A0H7,BRCA,65.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23972.0,Alive,TUMOR FREE,702.0,,[Not Available],,,,,[Not Available],Negative,,0.0,702.0,0.0,702.0,0.0,702.0,0.0,702.0,
TCGA-A4-7734,4471,TCGA-A4-7734,KIRP,53.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-19612.0,Alive,TUMOR FREE,27.0,,[Not Available],,,,,[Not Available],,,0.0,27.0,0.0,27.0,,,0.0,27.0,
TCGA-DJ-A3VB,9991,TCGA-DJ-A3VB,THCA,52.0,MALE,[Unknown],Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011.0,[Not Available],-19248.0,Alive,TUMOR FREE,697.0,,[Not Available],,,,,[Not Available],,R0,0.0,697.0,0.0,697.0,0.0,697.0,0.0,697.0,
TCGA-FS-A1ZD,9153,TCGA-FS-A1ZD,SKCM,63.0,MALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2001.0,[Not Available],-23344.0,Dead,WITH TUMOR,,1628.0,[Not Available],,,,1497.0,[Not Available],,,1.0,1628.0,1.0,1628.0,,,1.0,1497.0,
TCGA-2H-A9GO,2470,TCGA-2H-A9GO,ESCA,58.0,MALE,[Unknown],Stage IVA,[Not Available],"Esophagus Adenocarcinoma, NOS",G3,2000.0,[Not Available],-21486.0,Dead,WITH TUMOR,,494.0,[Not Available],Locoregional Recurrence,,,362.0,,,,1.0,494.0,1.0,494.0,,,1.0,362.0,
TCGA-EM-A22P,10137,TCGA-EM-A22P,THCA,64.0,MALE,[Not Available],Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-23723.0,Alive,TUMOR FREE,1256.0,,[Not Available],,,,,[Not Available],,R1,0.0,1256.0,0.0,1256.0,,,0.0,1256.0,
TCGA-FD-A3NA,265,TCGA-FD-A3NA,BLCA,60.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,[Not Available],-21936.0,Alive,TUMOR FREE,1845.0,,[Not Available],New Primary Tumor,Lung,,1338.0,Complete Remission/Response,,,0.0,1845.0,0.0,1845.0,0.0,1845.0,1.0,1338.0,
TCGA-GD-A3OS,340,TCGA-GD-A3OS,BLCA,54.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-19776.0,Alive,WITH TUMOR,638.0,,[Not Available],Locoregional (Urothelial tumor event),Bladder,,223.0,Progressive Disease,,,0.0,638.0,0.0,638.0,,,1.0,223.0,
TCGA-96-8169,6777,TCGA-96-8169,LUSC,67.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-24674.0,Alive,TUMOR FREE,557.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,557.0,0.0,557.0,0.0,557.0,0.0,557.0,
TCGA-05-4384,5808,TCGA-05-4384,LUAD,66.0,MALE,[Not Available],Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-24411.0,Alive,WITH TUMOR,426.0,,[Not Available],Distant Metastasis,,,183.0,Progressive Disease,,,0.0,426.0,0.0,426.0,,,1.0,183.0,
TCGA-5P-A9KE,4461,TCGA-5P-A9KE,KIRP,70.0,MALE,WHITE,[Not Available],Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011.0,[Not Available],-25805.0,Alive,TUMOR FREE,824.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,824.0,0.0,824.0,0.0,824.0,0.0,824.0,
TCGA-AJ-A3EK,10540,TCGA-AJ-A3EK,UCEC,53.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Peri (6-12 months since last menstrual period),-19609.0,Alive,TUMOR FREE,446.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,446.0,0.0,446.0,0.0,446.0,0.0,446.0,
TCGA-FW-A5DY,9185,TCGA-FW-A5DY,SKCM,48.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],2012.0,[Not Available],-17730.0,Alive,TUMOR FREE,587.0,,[Not Available],,,,,[Not Available],,,0.0,587.0,0.0,587.0,,,0.0,587.0,
TCGA-B8-4619,4098,TCGA-B8-4619,KIRC,58.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-21206.0,Alive,TUMOR FREE,523.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,523.0,0.0,523.0,0.0,523.0,0.0,523.0,
TCGA-KR-A7K0,5742,TCGA-KR-A7K0,LIHC,65.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2013.0,[Not Available],-23974.0,Dead,TUMOR FREE,,65.0,[Not Available],,,,,[Not Available],,R0,1.0,65.0,0.0,65.0,0.0,65.0,0.0,65.0,
TCGA-ZH-A8Y6,1950,TCGA-ZH-A8Y6,CHOL,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Cholangiocarcinoma; intrahepatic,G2,2013.0,[Not Available],-14976.0,Alive,TUMOR FREE,519.0,,[Not Available],,,,,[Not Available],,R0,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,
TCGA-BP-4976,4213,TCGA-BP-4976,KIRC,77.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-28380.0,Alive,TUMOR FREE,1632.0,,[Not Available],,,,,[Not Available],,,0.0,1632.0,0.0,1632.0,,,0.0,1632.0,
TCGA-KS-A4I1,10335,TCGA-KS-A4I1,THCA,37.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-13538.0,Alive,TUMOR FREE,812.0,,[Not Available],,,,,[Not Available],,R1,0.0,812.0,0.0,812.0,,,0.0,812.0,
TCGA-50-5072,5939,TCGA-50-5072,LUAD,74.0,MALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-27036.0,Dead,WITH TUMOR,,250.0,[Not Available],Distant Metastasis,,,213.0,Progressive Disease,,,1.0,250.0,1.0,250.0,,,1.0,213.0,
TCGA-AA-3697,2076,TCGA-AA-3697,COAD,77.0,MALE,[Not Available],Stage II,[Not Applicable],Colon Adenocarcinoma,[Not Available],2003.0,[Not Available],-28367.0,Alive,WITH TUMOR,2587.0,,[Not Available],,,,,[Unknown],,,0.0,2587.0,0.0,2587.0,,,0.0,2587.0,
TCGA-3E-AAAY,7543,TCGA-3E-AAAY,PAAD,67.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2008.0,[Not Available],-24760.0,Alive,[Discrepancy],2285.0,,,Distant Metastasis,Lung,,987.0,Complete Remission/Response,,,0.0,2285.0,0.0,2285.0,1.0,987.0,1.0,987.0,
TCGA-Q1-A73O,1825,TCGA-Q1-A73O,CESC,37.0,FEMALE,[Not Evaluated],[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13601.0,Alive,TUMOR FREE,428.0,,,,,,,Complete Remission/Response,,,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,
TCGA-99-8025,6273,TCGA-99-8025,LUAD,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-26634.0,Alive,TUMOR FREE,1060.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1060.0,0.0,1060.0,0.0,1060.0,0.0,1060.0,
TCGA-5B-A90C,10478,TCGA-5B-A90C,UCEC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25518.0,Alive,TUMOR FREE,1202.0,,[Not Available],Locoregional Recurrence,"Other, specify",right pelvic mass,517.0,[Not Available],,,0.0,1202.0,0.0,1202.0,,,1.0,517.0,
TCGA-DJ-A1QG,9932,TCGA-DJ-A1QG,THCA,62.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010.0,[Not Available],-22859.0,Alive,TUMOR FREE,1368.0,,[Not Available],,,,,[Not Available],,R0,0.0,1368.0,0.0,1368.0,0.0,1368.0,0.0,1368.0,
TCGA-B5-A0JS,10677,TCGA-B5-A0JS,UCEC,54.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19995.0,Alive,TUMOR FREE,2627.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2627.0,0.0,2627.0,0.0,2627.0,0.0,2627.0,
TCGA-D9-A6EA,8912,TCGA-D9-A6EA,SKCM,70.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-25582.0,Alive,TUMOR FREE,766.0,,[Not Available],,,,,[Not Available],,,0.0,766.0,0.0,766.0,,,0.0,766.0,
TCGA-DX-AB36,8670,TCGA-DX-AB36,SARC,86.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2008.0,[Not Available],-31704.0,Dead,,,1825.0,[Not Available],,,,,[Not Available],Positive,R1,1.0,1825.0,,1825.0,,,0.0,1825.0,
TCGA-41-3915,3198,TCGA-41-3915,GBM,48.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2010.0,[Not Available],-17880.0,Dead,WITH TUMOR,,360.0,[Not Available],Locoregional Disease,[Not Applicable],[Not Applicable],288.0,[Not Available],,,1.0,360.0,1.0,360.0,,,1.0,288.0,
TCGA-DD-AACC,5582,TCGA-DD-AACC,LIHC,61.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2008.0,[Not Available],-22499.0,Dead,WITH TUMOR,,1685.0,[Not Available],Locoregional Recurrence,Liver,,537.0,[Not Available],,R0,1.0,1685.0,1.0,1685.0,1.0,537.0,1.0,537.0,
TCGA-18-3411,6330,TCGA-18-3411,LUSC,63.0,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2005.0,[Not Available],-23370.0,Alive,TUMOR FREE,3576.0,,[Not Available],,,,,[Unknown],,,0.0,3576.0,0.0,3576.0,,,0.0,3576.0,
TCGA-D8-A1JE,1240,TCGA-D8-A1JE,BRCA,62.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22683.0,Alive,TUMOR FREE,575.0,,[Not Available],,,,,[Not Available],Negative,,0.0,575.0,0.0,575.0,0.0,575.0,0.0,575.0,
TCGA-DG-A2KL,1674,TCGA-DG-A2KL,CESC,53.0,FEMALE,[Not Evaluated],[Not Available],Stage IIA,Cervical Squamous Cell Carcinoma,G1,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19539.0,Alive,TUMOR FREE,1367.0,,,,,,,Complete Remission/Response,,,0.0,1367.0,0.0,1367.0,0.0,1367.0,0.0,1367.0,
TCGA-GC-A6I1,335,TCGA-GC-A6I1,BLCA,90.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-32873.0,Dead,TUMOR FREE,,272.0,[Not Available],,,,,Complete Remission/Response,,,1.0,272.0,0.0,272.0,0.0,272.0,0.0,272.0,
TCGA-QH-A6X8,5304,TCGA-QH-A6X8,LGG,56.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2013.0,[Not Available],-20771.0,Alive,WITH TUMOR,509.0,,[Not Available],,,,,Stable Disease,,,0.0,509.0,0.0,509.0,,,0.0,509.0,
TCGA-DX-A2J0,8573,TCGA-DX-A2J0,SARC,61.0,MALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2005.0,[Not Available],-22369.0,Dead,WITH TUMOR,,295.0,[Not Available],Locoregional Recurrence,,,213.0,[Not Available],[Not Available],R1,1.0,295.0,1.0,295.0,,,1.0,213.0,
TCGA-OL-A66O,1569,TCGA-OL-A66O,BRCA,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14272.0,Alive,TUMOR FREE,528.0,,[Not Available],,,,,[Not Available],Negative,,0.0,528.0,0.0,528.0,0.0,528.0,0.0,528.0,
TCGA-HB-A2OT,8683,TCGA-HB-A2OT,SARC,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2009.0,[Not Available],-28632.0,Alive,TUMOR FREE,2057.0,,[Not Available],,,,,[Not Available],Negative,R0,0.0,2057.0,0.0,2057.0,0.0,2057.0,0.0,2057.0,
TCGA-DA-A1IC,8927,TCGA-DA-A1IC,SKCM,81.0,MALE,WHITE,Stage IIIB,[Not Applicable],,[Not Available],2005.0,[Not Available],-29859.0,Dead,WITH TUMOR,,2071.0,[Not Available],Distant Metastasis,Lung,,1930.0,[Not Available],,,1.0,2071.0,1.0,2071.0,,,1.0,1930.0,
TCGA-AP-A5FX,10606,TCGA-AP-A5FX,UCEC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25063.0,Dead,WITH TUMOR,,1099.0,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneal LN; vulvar mass,407.0,Complete Remission/Response,,,1.0,1099.0,1.0,1099.0,1.0,407.0,1.0,407.0,
TCGA-73-4677,6121,TCGA-73-4677,LUAD,74.0,MALE,WHITE,[Discrepancy],[Not Applicable],Lung Adenocarcinoma,[Not Available],2010.0,[Not Available],-27381.0,Dead,WITH TUMOR,,38.0,[Not Available],,,,,Stable Disease,,,1.0,38.0,1.0,38.0,,,1.0,38.0,
TCGA-DJ-A3VL,9999,TCGA-DJ-A3VL,THCA,38.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-14219.0,Alive,TUMOR FREE,713.0,,[Not Available],New Primary Tumor,"Other, specify",Bowel,411.0,[Not Available],,R0,0.0,713.0,0.0,713.0,0.0,713.0,1.0,411.0,
TCGA-18-3421,6337,TCGA-18-3421,LUSC,65.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2007.0,[Not Available],-23972.0,Alive,TUMOR FREE,2645.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2645.0,0.0,2645.0,0.0,2645.0,0.0,2645.0,
TCGA-FA-A82F,2420,TCGA-FA-A82F,DLBC,48.0,FEMALE,ASIAN,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013.0,[Not Available],-17819.0,Alive,TUMOR FREE,427.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,427.0,0.0,427.0,0.0,427.0,0.0,427.0,
TCGA-KK-A7B1,8196,TCGA-KK-A7B1,PRAD,65.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2011.0,[Not Available],-23803.0,Alive,,1063.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1063.0,0.0,1063.0,0.0,1063.0,0.0,1063.0,
TCGA-ZA-A8F6,9709,TCGA-ZA-A8F6,STAD,71.0,MALE,WHITE,Stage IB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,[Not Available],-26122.0,Alive,TUMOR FREE,525.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,525.0,0.0,525.0,0.0,525.0,0.0,525.0,
TCGA-32-2495,3179,TCGA-32-2495,GBM,59.0,FEMALE,WHITE,[Not Available],[Not Applicable],Treated primary GBM,[Not Available],2008.0,[Not Available],-21860.0,Dead,WITH TUMOR,457.0,457.0,[Not Available],Recurrence,[Not Applicable],[Not Applicable],252.0,[Not Available],,,1.0,457.0,1.0,457.0,,,1.0,252.0,
TCGA-HU-A4GJ,9575,TCGA-HU-A4GJ,STAD,60.0,FEMALE,ASIAN,Stage IIIC,[Not Applicable],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,[Not Available],-22079.0,Alive,WITH TUMOR,650.0,,[Not Available],Distant Metastasis,"Other, specify",ovary,547.0,Progressive Disease,,,0.0,650.0,0.0,650.0,,,1.0,547.0,
TCGA-HU-A4GF,9573,TCGA-HU-A4GF,STAD,69.0,MALE,ASIAN,Stage IIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,[Not Available],-25223.0,Alive,TUMOR FREE,785.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,785.0,0.0,785.0,0.0,785.0,0.0,785.0,
TCGA-06-0158,2769,TCGA-06-0158,GBM,73.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],1998.0,[Not Available],-26856.0,Dead,WITH TUMOR,166.0,329.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],90.0,[Not Available],,,1.0,329.0,1.0,329.0,,,1.0,90.0,
TCGA-B6-A0X7,1012,TCGA-B6-A0X7,BRCA,62.0,FEMALE,WHITE,Stage X,[Not Applicable],Mixed Histology (please specify),[Not Available],1994.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22723.0,Dead,TUMOR FREE,,1781.0,[Not Available],New Primary Tumor,"Other, specify",colon,1104.0,[Not Available],[Not Available],,1.0,1781.0,0.0,1781.0,,,1.0,1104.0,
TCGA-G2-AA3F,325,TCGA-G2-AA3F,BLCA,77.0,MALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-28457.0,Alive,TUMOR FREE,893.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,893.0,0.0,893.0,,,0.0,893.0,
TCGA-J8-A3YF,10325,TCGA-J8-A3YF,THCA,83.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009.0,[Not Available],-30661.0,Alive,TUMOR FREE,751.0,,[Not Available],,,,,[Not Available],,R0,0.0,751.0,0.0,751.0,0.0,751.0,0.0,751.0,
TCGA-HT-8104,5209,TCGA-HT-8104,LGG,51.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-18748.0,Alive,TUMOR FREE,372.0,,[Not Available],,,,,[Not Available],,,0.0,372.0,0.0,372.0,,,0.0,372.0,
TCGA-D9-A4Z2,8907,TCGA-D9-A4Z2,SKCM,50.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-18462.0,Dead,WITH TUMOR,,190.0,[Not Available],Distant Metastasis,Lung,,80.0,[Not Available],,,1.0,190.0,1.0,190.0,,,1.0,80.0,
TCGA-4X-A9FC,10376,TCGA-4X-A9FC,THYM,50.0,FEMALE,WHITE,[Not Applicable],IIa,Thymoma; Type AB,[Not Available],2009.0,[Not Available],-18418.0,Alive,TUMOR FREE,2072.0,,[Not Available],,,,,[Not Available],,,0.0,2072.0,0.0,2072.0,,,0.0,2072.0,
TCGA-CR-7372,3445,TCGA-CR-7372,HNSC,45.0,MALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2009.0,[Not Available],-16610.0,Alive,TUMOR FREE,759.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,759.0,0.0,759.0,0.0,759.0,0.0,759.0,
TCGA-BQ-5887,4547,TCGA-BQ-5887,KIRP,54.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009.0,[Not Available],-19747.0,Alive,TUMOR FREE,771.0,,[Not Available],,,,,[Not Available],,,0.0,771.0,0.0,771.0,,,0.0,771.0,
TCGA-64-1681,6079,TCGA-64-1681,LUAD,61.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2008.0,[Not Available],-22525.0,Dead,,,1167.0,[Not Available],,,,439.0,[Not Available],,,1.0,1167.0,,1167.0,,,1.0,439.0,
TCGA-G4-6586,2388,TCGA-G4-6586,COAD,73.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2008.0,[Not Available],-27020.0,Alive,TUMOR FREE,1089.0,,[Not Available],,,,,[Not Available],,,0.0,1089.0,0.0,1089.0,,,0.0,1089.0,
TCGA-62-A470,6071,TCGA-62-A470,LUAD,84.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-30689.0,Dead,WITH TUMOR,,1194.0,[Not Available],Locoregional Recurrence,,,539.0,Complete Remission/Response,,,1.0,1194.0,1.0,1194.0,1.0,539.0,1.0,539.0,
TCGA-J2-A4AD,6280,TCGA-J2-A4AD,LUAD,61.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-22414.0,Dead,WITH TUMOR,,550.0,[Not Available],Locoregional Recurrence|Distant Metastasis,,,524.0,[Unknown],,,1.0,550.0,1.0,550.0,,,1.0,524.0,
TCGA-60-2713,6573,TCGA-60-2713,LUSC,64.0,MALE,WHITE,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2006.0,[Not Available],-23630.0,Alive,,1731.0,,[Not Available],,,,1356.0,Complete Remission/Response,,,0.0,1731.0,0.0,1731.0,1.0,1356.0,1.0,1356.0,
TCGA-BR-8081,9342,TCGA-BR-8081,STAD,71.0,FEMALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,[Not Available],-26095.0,Alive,TUMOR FREE,981.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,981.0,0.0,981.0,0.0,981.0,0.0,981.0,
TCGA-YL-A8SK,8330,TCGA-YL-A8SK,PRAD,67.0,MALE,[Not Available],[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2010.0,[Not Available],-24759.0,Alive,,1408.0,,[Not Available],,,,,Stable Disease,,,0.0,1408.0,0.0,1408.0,,,0.0,1408.0,
TCGA-Q2-A5QZ,4667,TCGA-Q2-A5QZ,KIRP,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-22531.0,Alive,,428.0,,[Not Available],,,,412.0,Complete Remission/Response,,,0.0,428.0,0.0,428.0,1.0,412.0,1.0,412.0,
TCGA-H7-A76A,3662,TCGA-H7-A76A,HNSC,57.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-20946.0,Alive,TUMOR FREE,637.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,637.0,0.0,637.0,,,0.0,637.0,
TCGA-06-0169,2778,TCGA-06-0169,GBM,68.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2002.0,[Not Available],-25127.0,Dead,WITH TUMOR,95.0,100.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],92.0,[Not Available],,,1.0,100.0,1.0,100.0,,,1.0,92.0,
TCGA-ZF-AA4V,493,TCGA-ZF-AA4V,BLCA,66.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-24448.0,Alive,TUMOR FREE,1806.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1806.0,0.0,1806.0,0.0,1806.0,0.0,1806.0,
TCGA-JW-A5VK,1788,TCGA-JW-A5VK,CESC,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IB2,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15965.0,Alive,TUMOR FREE,623.0,,,,,,,Complete Remission/Response,,,0.0,623.0,0.0,623.0,0.0,623.0,0.0,623.0,
TCGA-EO-A3AU,10931,TCGA-EO-A3AU,UCEC,72.0,FEMALE,[Not Available],[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26406.0,Alive,TUMOR FREE,1543.0,,[Not Available],New Primary Tumor,Lung,,1178.0,Complete Remission/Response,,,0.0,1543.0,0.0,1543.0,0.0,1543.0,1.0,1178.0,
TCGA-CJ-4634,4267,TCGA-CJ-4634,KIRC,60.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2004.0,[Not Available],-22155.0,Alive,TUMOR FREE,3498.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3498.0,0.0,3498.0,0.0,3498.0,0.0,3498.0,
TCGA-EL-A3CS,10046,TCGA-EL-A3CS,THCA,62.0,FEMALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004.0,[Not Available],-22993.0,Dead,WITH TUMOR,,1385.0,[Not Available],,,,,[Not Available],,R0,1.0,1385.0,1.0,1385.0,,,1.0,1385.0,
TCGA-HP-A5N0,5737,TCGA-HP-A5N0,LIHC,90.0,FEMALE,[Not Evaluated],[Not Available],[Not Applicable],Hepatocellular Carcinoma,[Not Available],,[Not Available],-32120.0,Dead,WITH TUMOR,,1147.0,[Not Available],Locoregional Recurrence,Liver,,179.0,[Not Available],,R0,1.0,1147.0,1.0,1147.0,1.0,179.0,1.0,179.0,
TCGA-BR-8381,9366,TCGA-BR-8381,STAD,51.0,MALE,WHITE,Stage IIB,[Not Applicable],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,[Not Available],-18843.0,Alive,TUMOR FREE,224.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,224.0,0.0,224.0,0.0,224.0,0.0,224.0,
TCGA-CS-6290,4924,TCGA-CS-6290,LGG,31.0,MALE,[Not Available],[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-11666.0,Dead,,,1137.0,[Not Available],,,,,Stable Disease,,,1.0,1137.0,,1137.0,,,0.0,1137.0,
TCGA-D3-A3MU,8865,TCGA-D3-A3MU,SKCM,53.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2010.0,[Not Available],-19423.0,Alive,WITH TUMOR,1209.0,,[Not Available],Distant Metastasis,Brain,,750.0,[Not Available],,,0.0,1209.0,0.0,1209.0,,,1.0,750.0,
TCGA-D7-6526,9496,TCGA-D7-6526,STAD,67.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,[Not Available],-24477.0,Alive,TUMOR FREE,523.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,523.0,0.0,523.0,0.0,523.0,0.0,523.0,
TCGA-BJ-A18Y,9860,TCGA-BJ-A18Y,THCA,29.0,MALE,WHITE,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-10832.0,Alive,TUMOR FREE,1563.0,,[Not Available],,,,,[Not Available],,R0,0.0,1563.0,0.0,1563.0,0.0,1563.0,0.0,1563.0,
TCGA-MN-A4N1,6292,TCGA-MN-A4N1,LUAD,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-21939.0,Alive,TUMOR FREE,827.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,827.0,0.0,827.0,0.0,827.0,0.0,827.0,
TCGA-EE-A2MG,9054,TCGA-EE-A2MG,SKCM,23.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],1997.0,[Not Available],-8405.0,Dead,WITH TUMOR,,3139.0,[Not Available],Distant Metastasis,Lung,,2585.0,[Not Available],,,1.0,3139.0,1.0,3139.0,,,1.0,2585.0,
TCGA-QS-A5YQ,11016,TCGA-QS-A5YQ,UCEC,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20425.0,Alive,TUMOR FREE,759.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,759.0,0.0,759.0,0.0,759.0,0.0,759.0,
TCGA-EM-A3O6,10179,TCGA-EM-A3O6,THCA,54.0,FEMALE,[Unknown],Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011.0,[Not Available],-19856.0,Alive,TUMOR FREE,458.0,,[Not Available],,,,,[Not Available],,R0,0.0,458.0,0.0,458.0,0.0,458.0,0.0,458.0,
TCGA-EE-A2GI,9034,TCGA-EE-A2GI,SKCM,39.0,MALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2008.0,[Not Available],-14498.0,Alive,TUMOR FREE,1482.0,,[Not Available],,,,,[Not Available],,,0.0,1482.0,0.0,1482.0,,,0.0,1482.0,
TCGA-VQ-A8PU,9669,TCGA-VQ-A8PU,STAD,72.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,[Not Available],-26625.0,Dead,TUMOR FREE,,832.0,[Not Available],,,,,Complete Remission/Response,,,1.0,832.0,0.0,832.0,0.0,832.0,0.0,832.0,
TCGA-D1-A165,10835,TCGA-D1-A165,UCEC,64.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23526.0,Alive,TUMOR FREE,20.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,20.0,0.0,20.0,0.0,20.0,0.0,20.0,
TCGA-MB-A5Y9,8725,TCGA-MB-A5Y9,SARC,90.0,MALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012.0,[Not Available],-32873.0,Alive,WITH TUMOR,252.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,252.0,0.0,252.0,,,0.0,252.0,
TCGA-D5-5537,2295,TCGA-D5-5537,COAD,83.0,MALE,WHITE,[Discrepancy],[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-30505.0,Dead,WITH TUMOR,,1381.0,[Not Available],,,,722.0,Complete Remission/Response,,,1.0,1381.0,1.0,1381.0,1.0,722.0,1.0,722.0,
TCGA-IC-A6RE,2473,TCGA-IC-A6RE,ESCA,59.0,MALE,WHITE,Stage IIB,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2013.0,[Not Available],-21640.0,Alive,WITH TUMOR,234.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,234.0,0.0,234.0,0.0,234.0,0.0,234.0,
TCGA-R6-A6KZ,2601,TCGA-R6-A6KZ,ESCA,42.0,MALE,WHITE,[Not Available],Stage IV,"Esophagus Adenocarcinoma, NOS",G3,2010.0,[Not Available],-15512.0,Dead,WITH TUMOR,,154.0,[Not Available],,,,,,,,1.0,154.0,1.0,154.0,,,1.0,154.0,
TCGA-CV-7406,3548,TCGA-CV-7406,HNSC,49.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,GX,1999.0,[Not Available],-18250.0,Dead,,,1748.0,[Not Available],,,,,[Not Available],,,1.0,1748.0,,1748.0,,,0.0,1748.0,
TCGA-MQ-A4LC,6854,TCGA-MQ-A4LC,MESO,54.0,MALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],2001.0,[Not Available],-19866.0,Dead,TUMOR FREE,,2790.0,[Not Available],Locoregional Recurrence,Ipsilateral Chest Cavity,,1908.0,[Not Available],,R0,1.0,2790.0,0.0,2790.0,1.0,1908.0,1.0,1908.0,
TCGA-DD-A73C,5572,TCGA-DD-A73C,LIHC,65.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-23782.0,Alive,WITH TUMOR,701.0,,[Not Available],Locoregional Recurrence,Liver,,566.0,[Not Available],,R0,0.0,701.0,0.0,701.0,1.0,566.0,1.0,566.0,
TCGA-PJ-A5Z9,4665,TCGA-PJ-A5Z9,KIRP,80.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012.0,[Not Available],-29365.0,Alive,TUMOR FREE,540.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,540.0,0.0,540.0,0.0,540.0,0.0,540.0,
TCGA-DD-A73E,5574,TCGA-DD-A73E,LIHC,66.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-24377.0,Alive,TUMOR FREE,44.0,,[Not Available],,,,,[Not Available],,R0,0.0,44.0,0.0,44.0,0.0,44.0,0.0,44.0,
TCGA-C8-A12K,1176,TCGA-C8-A12K,BRCA,80.0,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29463.0,Alive,TUMOR FREE,0.0,,[Not Available],,,,,[Not Available],Negative,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,
TCGA-MQ-A4LI,6855,TCGA-MQ-A4LI,MESO,60.0,FEMALE,WHITE,Stage II,[Not Applicable],Epithelioid mesothelioma,[Not Available],1999.0,[Not Available],-21951.0,Dead,WITH TUMOR,,572.0,[Not Available],Distant Metastasis,"Other, specify",Chest,416.0,[Not Available],,R1,1.0,572.0,1.0,572.0,,,1.0,416.0,
TCGA-ET-A3DV,10247,TCGA-ET-A3DV,THCA,68.0,FEMALE,WHITE,Stage II,[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2001.0,[Not Available],-24905.0,Alive,TUMOR FREE,5068.0,,[Not Available],,,,,[Not Available],,R0,0.0,5068.0,0.0,5068.0,0.0,5068.0,0.0,5068.0,
TCGA-DX-A6BK,8612,TCGA-DX-A6BK,SARC,85.0,FEMALE,WHITE,[Not Available],[Not Available],Dedifferentiated liposarcoma,[Not Available],2009.0,[Not Available],-31159.0,Dead,TUMOR FREE,,492.0,[Not Available],,,,,[Not Available],Positive,R1,1.0,492.0,0.0,492.0,,,0.0,492.0,
TCGA-E3-A3E5,10020,TCGA-E3-A3E5,THCA,57.0,MALE,WHITE,Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010.0,[Not Available],-20993.0,Alive,TUMOR FREE,1215.0,,[Not Available],,,,,[Not Available],,RX,0.0,1215.0,0.0,1215.0,,,0.0,1215.0,
TCGA-A5-A1OG,10511,TCGA-A5-A1OG,UCEC,65.0,FEMALE,ASIAN,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23956.0,Dead,WITH TUMOR,,973.0,[Not Available],Metastatic,Lung,,337.0,Complete Remission/Response,,,1.0,973.0,1.0,973.0,1.0,337.0,1.0,337.0,
TCGA-22-5491,6395,TCGA-22-5491,LUSC,74.0,MALE,WHITE,Stage IA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2003.0,[Not Available],-27145.0,Dead,,1713.0,1713.0,[Not Available],,,,,[Not Available],,,1.0,1713.0,,1713.0,,,0.0,1713.0,
TCGA-DW-7834,4572,TCGA-DW-7834,KIRP,53.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,[Not Available],2001.0,[Not Available],-19660.0,Alive,TUMOR FREE,3950.0,,[Not Available],,,,,[Not Available],,,0.0,3950.0,0.0,3950.0,,,0.0,3950.0,
TCGA-DJ-A3V0,9981,TCGA-DJ-A3V0,THCA,56.0,MALE,[Unknown],Stage IVA,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-20496.0,Alive,TUMOR FREE,1125.0,,[Not Available],,,,,[Not Available],,R0,0.0,1125.0,0.0,1125.0,,,0.0,1125.0,
TCGA-CH-5792,7908,TCGA-CH-5792,PRAD,57.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-21002.0,Alive,WITH TUMOR,91.0,,[Not Available],,,,,[Not Available],,,0.0,91.0,0.0,91.0,,,0.0,91.0,
TCGA-AR-A0TX,906,TCGA-AR-A0TX,BRCA,64.0,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23653.0,Alive,TUMOR FREE,1972.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1972.0,0.0,1972.0,0.0,1972.0,0.0,1972.0,
TCGA-JY-A6F8,2494,TCGA-JY-A6F8,ESCA,56.0,MALE,WHITE,Stage I,[Not Available],"Esophagus Adenocarcinoma, NOS",G1,2003.0,[Not Available],-20550.0,Alive,TUMOR FREE,3714.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3714.0,0.0,3714.0,0.0,3714.0,0.0,3714.0,
TCGA-SB-A76C,9785,TCGA-SB-A76C,TGCT,38.0,MALE,WHITE,[Not Available],Stage I,Seminoma; NOS,[Not Available],2013.0,[Not Available],-14023.0,Alive,TUMOR FREE,42.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,42.0,0.0,42.0,0.0,42.0,0.0,42.0,
TCGA-HZ-A4BH,7610,TCGA-HZ-A4BH,PAAD,75.0,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,[Not Available],-27637.0,Alive,WITH TUMOR,194.0,,,,,,,[Unknown],,,0.0,194.0,0.0,194.0,,,0.0,194.0,
TCGA-OY-A56Q,7500,TCGA-OY-A56Q,OV,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIA,Serous Cystadenocarcinoma,G3,2012.0,[Not Available],-28623.0,Alive,TUMOR FREE,576.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,576.0,0.0,576.0,0.0,576.0,0.0,576.0,
TCGA-S6-A8JX,9782,TCGA-S6-A8JX,TGCT,27.0,MALE,WHITE,Stage IB,Stage IB,Seminoma; NOS,[Not Available],2013.0,[Not Available],-9963.0,Alive,TUMOR FREE,552.0,,[Not Applicable],,,,,Complete Remission/Response,,,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,
TCGA-CG-5718,9471,TCGA-CG-5718,STAD,78.0,FEMALE,[Not Available],Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,[Not Available],-28763.0,Dead,TUMOR FREE,,1095.0,[Not Available],,,,,[Unknown],,,1.0,1095.0,0.0,1095.0,,,0.0,1095.0,
TCGA-VS-A9UH,1869,TCGA-VS-A9UH,CESC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],Stage IVA,Cervical Squamous Cell Carcinoma,GX,2010.0,[Not Available],-19454.0,Alive,TUMOR FREE,1427.0,,,,,,,Complete Remission/Response,,,0.0,1427.0,0.0,1427.0,,,0.0,1427.0,
TCGA-FA-A4XK,2415,TCGA-FA-A4XK,DLBC,40.0,MALE,ASIAN,[Not Applicable],Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2012.0,[Not Available],-14723.0,Dead,TUMOR FREE,,708.0,[Not Available],,,,,Complete Remission/Response,,,1.0,708.0,0.0,708.0,0.0,708.0,0.0,708.0,
TCGA-VQ-A925,9689,TCGA-VQ-A925,STAD,66.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,[Not Available],-24230.0,Dead,WITH TUMOR,,138.0,Stomach Cancer,,,,,Progressive Disease,,,1.0,138.0,1.0,138.0,,,1.0,138.0,
TCGA-50-5051,5935,TCGA-50-5051,LUAD,42.0,FEMALE,WHITE,Stage IIIA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2007.0,[Not Available],-15585.0,Dead,WITH TUMOR,,478.0,[Not Available],Distant Metastasis,,,184.0,Progressive Disease,,,1.0,478.0,1.0,478.0,,,1.0,184.0,
TCGA-AC-A23E,756,TCGA-AC-A23E,BRCA,50.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010.0,[Not Available],-18500.0,Alive,TUMOR FREE,698.0,,[Not Available],,,,,[Not Available],Negative,,0.0,698.0,0.0,698.0,0.0,698.0,0.0,698.0,
TCGA-AA-A00N,2149,TCGA-AA-A00N,COAD,75.0,MALE,[Not Available],Stage IIB,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2008.0,[Not Available],-27667.0,Dead,WITH TUMOR,,122.0,[Not Available],,,,,[Not Available],,,1.0,122.0,1.0,122.0,,,1.0,122.0,
TCGA-EE-A3JH,9085,TCGA-EE-A3JH,SKCM,54.0,MALE,WHITE,Stage IB,[Not Applicable],,[Not Available],2003.0,[Not Available],-19852.0,Alive,TUMOR FREE,4086.0,,[Not Available],Regional lymph node,,,537.0,[Not Available],,,0.0,4086.0,0.0,4086.0,,,1.0,537.0,
TCGA-DT-5265,8495,TCGA-DT-5265,READ,51.0,MALE,ASIAN,Stage II,[Not Applicable],Rectal Mucinous Adenocarcinoma,[Not Available],2010.0,[Not Available],-18669.0,Alive,TUMOR FREE,384.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,384.0,0.0,384.0,0.0,384.0,0.0,384.0,
TCGA-EY-A210,10964,TCGA-EY-A210,UCEC,82.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Mixed serous and endometrioid,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30095.0,Alive,TUMOR FREE,383.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,
TCGA-BJ-A2NA,9877,TCGA-BJ-A2NA,THCA,77.0,MALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011.0,[Not Available],-28147.0,Alive,WITH TUMOR,577.0,,[Not Available],Distant Metastasis,,,127.0,[Not Available],,R1,0.0,577.0,0.0,577.0,,,1.0,127.0,
TCGA-BS-A0VI,10813,TCGA-BS-A0VI,UCEC,58.0,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21198.0,Alive,TUMOR FREE,2646.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2646.0,0.0,2646.0,0.0,2646.0,0.0,2646.0,
TCGA-EE-A29G,9011,TCGA-EE-A29G,SKCM,53.0,MALE,WHITE,Stage IIIA,[Not Applicable],,[Not Available],2003.0,[Not Available],-19664.0,Dead,WITH TUMOR,,2192.0,[Not Available],Locoregional Recurrence,,,726.0,[Not Available],,,1.0,2192.0,1.0,2192.0,,,1.0,726.0,
TCGA-EE-A29H,9012,TCGA-EE-A29H,SKCM,59.0,FEMALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2008.0,[Not Available],-21552.0,Alive,TUMOR FREE,1966.0,,[Not Available],Distant Metastasis|Locoregional Recurrence,"Other, Specify|[Not Available]",Perihilar lymph nodes|[Not Applicable],1231.0,[Not Available],,,0.0,1966.0,0.0,1966.0,,,1.0,1231.0,
TCGA-EA-A5ZE,1713,TCGA-EA-A5ZE,CESC,54.0,FEMALE,ASIAN,[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Peri (6-12 months since last menstrual period),-19868.0,Alive,TUMOR FREE,829.0,,,Distant Metastasis,"Other, specify","Lymph node, inguinal",425.0,Complete Remission/Response,,,0.0,829.0,0.0,829.0,1.0,425.0,1.0,425.0,
TCGA-BP-5186,4253,TCGA-BP-5186,KIRC,50.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-18348.0,Alive,TUMOR FREE,693.0,,[Not Available],,,,,[Not Available],,,0.0,693.0,0.0,693.0,,,0.0,693.0,
TCGA-BG-A2L7,10775,TCGA-BG-A2L7,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,[Not Available],-25091.0,Alive,TUMOR FREE,612.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,612.0,0.0,612.0,0.0,612.0,0.0,612.0,
TCGA-EL-A3CP,10044,TCGA-EL-A3CP,THCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Available],[Not Applicable],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],1999.0,[Not Available],-18298.0,Alive,TUMOR FREE,4831.0,,[Not Available],,,,,[Not Available],,RX,0.0,4831.0,0.0,4831.0,,,0.0,4831.0,
TCGA-OR-A5LG,70,TCGA-OR-A5LG,ACC,46.0,MALE,WHITE,Stage III,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-16875.0,Alive,WITH TUMOR,1589.0,,[Not Available],Distant Metastasis,Lung,,1393.0,Complete Remission/Response,,,0.0,1589.0,0.0,1589.0,1.0,1393.0,1.0,1393.0,
TCGA-A6-5665,1989,TCGA-A6-5665,COAD,84.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-30915.0,Alive,TUMOR FREE,671.0,,[Not Available],,,,529.0,[Not Available],,,0.0,671.0,0.0,671.0,,,1.0,529.0,
TCGA-BR-A4J7,9405,TCGA-BR-A4J7,STAD,49.0,MALE,ASIAN,Stage IIB,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012.0,[Not Available],-17932.0,Alive,TUMOR FREE,989.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,989.0,0.0,989.0,0.0,989.0,0.0,989.0,
TCGA-E9-A3HO,1444,TCGA-E9-A3HO,BRCA,49.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18046.0,Alive,TUMOR FREE,1158.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1158.0,0.0,1158.0,0.0,1158.0,0.0,1158.0,
TCGA-E1-A7YK,5080,TCGA-E1-A7YK,LGG,52.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2009.0,[Not Available],-19236.0,Dead,,,378.0,[Not Available],,,,,Stable Disease,,,1.0,378.0,,378.0,,,0.0,378.0,
TCGA-DD-A73D,5573,TCGA-DD-A73D,LIHC,68.0,FEMALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G1,2012.0,[Not Available],-24941.0,Alive,WITH TUMOR,693.0,,[Not Available],Intrahepatic Recurrence,Liver,,592.0,[Not Available],,R0,0.0,693.0,0.0,693.0,1.0,592.0,1.0,592.0,
TCGA-AX-A2HD,10652,TCGA-AX-A2HD,UCEC,69.0,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2008.0,[Not Available],-25499.0,Alive,WITH TUMOR,1414.0,,[Not Available],,,,,Partial Remission/Response,,,0.0,1414.0,0.0,1414.0,,,0.0,1414.0,
TCGA-CJ-4901,4305,TCGA-CJ-4901,KIRC,47.0,MALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2006.0,[Not Available],-17396.0,Alive,TUMOR FREE,1450.0,,[Not Available],,,,,[Not Available],,,0.0,1450.0,0.0,1450.0,,,0.0,1450.0,
TCGA-EE-A2MK,9058,TCGA-EE-A2MK,SKCM,18.0,FEMALE,WHITE,Stage III,[Not Applicable],,[Not Available],1999.0,[Not Available],-6831.0,Alive,TUMOR FREE,5487.0,,[Not Available],,,,,[Not Available],,,0.0,5487.0,0.0,5487.0,,,0.0,5487.0,
TCGA-L5-A4OP,2523,TCGA-L5-A4OP,ESCA,67.0,FEMALE,WHITE,Stage IA,[Not Available],"Esophagus Adenocarcinoma, NOS",G2,2010.0,[Not Available],-24829.0,Alive,TUMOR FREE,218.0,,[Not Available],,,,,[Unknown],,,0.0,218.0,0.0,218.0,,,0.0,218.0,
TCGA-C5-A1BL,1613,TCGA-C5-A1BL,CESC,32.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1994.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11723.0,Alive,TUMOR FREE,5271.0,,,,,,,Complete Remission/Response,,,0.0,5271.0,0.0,5271.0,0.0,5271.0,0.0,5271.0,
TCGA-CQ-6224,3393,TCGA-CQ-6224,HNSC,52.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2009.0,[Not Available],-19051.0,Alive,TUMOR FREE,1721.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1721.0,0.0,1721.0,,,0.0,1721.0,
TCGA-E1-A7YN,5083,TCGA-E1-A7YN,LGG,63.0,FEMALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-23180.0,Dead,WITH TUMOR,,727.0,[Not Available],,,,420.0,Stable Disease,,,1.0,727.0,1.0,727.0,,,1.0,420.0,
TCGA-RW-A684,7763,TCGA-RW-A684,PCPG,64.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-23440.0,Alive,TUMOR FREE,32.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,32.0,0.0,32.0,0.0,32.0,0.0,32.0,
TCGA-S9-A7R1,5361,TCGA-S9-A7R1,LGG,35.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,1999.0,[Not Available],-12828.0,Dead,WITH TUMOR,,5166.0,[Not Available],,,,3637.0,Stable Disease,,,1.0,5166.0,1.0,5166.0,,,1.0,3637.0,
TCGA-3N-A9WB,8798,TCGA-3N-A9WB,SKCM,71.0,MALE,WHITE,Stage IA,[Not Applicable],,[Not Available],2012.0,[Not Available],-26176.0,Dead,WITH TUMOR,,518.0,[Not Available],Locoregional Recurrence,"Other, Specify",Axillary,426.0,[Not Available],,,1.0,518.0,1.0,518.0,,,1.0,426.0,
TCGA-DD-A3A8,5550,TCGA-DD-A3A8,LIHC,75.0,MALE,WHITE,Stage II,[Not Applicable],Hepatocellular Carcinoma,G2,2001.0,[Not Available],-27524.0,Dead,TUMOR FREE,,11.0,[Not Available],,,,,[Not Available],,R0,1.0,11.0,0.0,11.0,0.0,11.0,0.0,11.0,
TCGA-UZ-A9PP,4689,TCGA-UZ-A9PP,KIRP,60.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],,[Not Available],-21915.0,Alive,TUMOR FREE,3010.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,3010.0,0.0,3010.0,0.0,3010.0,0.0,3010.0,
TCGA-EB-A51B,8967,TCGA-EB-A51B,SKCM,53.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-19645.0,Alive,TUMOR FREE,931.0,,[Not Available],,,,,[Not Available],,,0.0,931.0,0.0,931.0,,,0.0,931.0,
TCGA-DD-AACW,5601,TCGA-DD-AACW,LIHC,43.0,MALE,ASIAN,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2010.0,[Not Available],-15872.0,Alive,TUMOR FREE,1424.0,,[Not Available],,,,,[Not Available],,R0,0.0,1424.0,0.0,1424.0,0.0,1424.0,0.0,1424.0,
TCGA-14-0789,3003,TCGA-14-0789,GBM,54.0,MALE,WHITE,[Not Available],[Not Applicable],Untreated primary (de novo) GBM,[Not Available],2005.0,[Not Available],-20050.0,Dead,,342.0,342.0,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],105.0,[Not Available],,,1.0,342.0,,342.0,,,1.0,105.0,
TCGA-K1-A6RV,8717,TCGA-K1-A6RV,SARC,67.0,MALE,WHITE,[Not Available],[Not Available],Leiomyosarcoma (LMS),[Not Available],2013.0,[Not Available],-24701.0,Alive,WITH TUMOR,158.0,,[Not Available],,,,,[Not Available],Positive,R1,0.0,158.0,0.0,158.0,,,0.0,158.0,
TCGA-EB-A3XE,8946,TCGA-EB-A3XE,SKCM,77.0,FEMALE,WHITE,Stage IIA,[Not Applicable],,[Not Available],2012.0,[Not Available],-28148.0,Alive,TUMOR FREE,180.0,,[Not Available],,,,,[Not Available],,,0.0,180.0,0.0,180.0,,,0.0,180.0,
TCGA-EB-A41A,8950,TCGA-EB-A41A,SKCM,90.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-32872.0,Alive,TUMOR FREE,262.0,,[Not Available],,,,,[Not Available],,,0.0,262.0,0.0,262.0,,,0.0,262.0,
TCGA-B8-4143,4092,TCGA-B8-4143,KIRC,66.0,FEMALE,WHITE,Stage IV,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G3,2002.0,[Not Available],-24132.0,Dead,WITH TUMOR,,709.0,[Not Available],,,,,[Not Available],,,1.0,709.0,1.0,709.0,,,1.0,709.0,
TCGA-CN-5358,3323,TCGA-CN-5358,HNSC,60.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,[Not Available],-22138.0,Dead,TUMOR FREE,,261.0,[Not Available],,Cervical Lymph Nodes,,145.0,Complete Remission/Response,,,1.0,261.0,0.0,261.0,1.0,145.0,1.0,145.0,
TCGA-IH-A3EA,9216,TCGA-IH-A3EA,SKCM,61.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2008.0,[Not Available],-22577.0,Alive,WITH TUMOR,524.0,,[Not Available],Distant Metastasis,Brain,,314.0,[Not Available],,,0.0,524.0,0.0,524.0,,,1.0,314.0,
TCGA-W3-AA1W,9233,TCGA-W3-AA1W,SKCM,64.0,MALE,WHITE,Stage II,[Not Applicable],,[Not Available],1996.0,[Not Available],-23711.0,Alive,TUMOR FREE,6666.0,,[Not Available],Regional lymph node,,,335.0,[Not Available],,,0.0,6666.0,0.0,6666.0,,,1.0,335.0,
TCGA-A6-5659,1984,TCGA-A6-5659,COAD,82.0,MALE,WHITE,Stage I,[Not Applicable],Colon Adenocarcinoma,[Not Available],2010.0,[Not Available],-30028.0,Alive,TUMOR FREE,926.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,926.0,0.0,926.0,0.0,926.0,0.0,926.0,
TCGA-EE-A2MC,9050,TCGA-EE-A2MC,SKCM,73.0,MALE,WHITE,Stage I,[Not Applicable],,[Not Available],2000.0,[Not Available],-26872.0,Dead,TUMOR FREE,,1871.0,[Not Available],Distant Metastasis,"Other, Specify",right neck lymph nodes,896.0,[Not Available],,,1.0,1871.0,0.0,1871.0,,,1.0,896.0,
TCGA-A6-A565,2007,TCGA-A6-A565,COAD,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Colon Mucinous Adenocarcinoma,[Not Available],2008.0,[Not Available],-12526.0,Dead,WITH TUMOR,,494.0,[Not Available],,,,301.0,Progressive Disease,,,1.0,494.0,1.0,494.0,,,1.0,301.0,
TCGA-60-2709,6569,TCGA-60-2709,LUSC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2004.0,[Not Available],-25453.0,Alive,TUMOR FREE,1505.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1505.0,0.0,1505.0,0.0,1505.0,0.0,1505.0,
TCGA-E8-A415,10027,TCGA-E8-A415,THCA,39.0,FEMALE,ASIAN,Stage I,[Not Applicable],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012.0,[Not Available],-14288.0,Alive,TUMOR FREE,944.0,,[Not Available],,,,,[Not Available],,R0,0.0,944.0,0.0,944.0,0.0,944.0,0.0,944.0,
TCGA-XF-A9T8,446,TCGA-XF-A9T8,BLCA,64.0,MALE,WHITE,Stage III,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-23403.0,Dead,,,418.0,[Not Available],,,,,[Unknown],,,1.0,418.0,,418.0,,,0.0,418.0,
TCGA-V4-A9F3,11112,TCGA-V4-A9F3,UVM,49.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell,[Not Available],2012.0,[Not Available],-17997.0,Dead,WITH TUMOR,,873.0,[Not Available],Distant Metastasis,Liver,,329.0,[Not Available],,,1.0,873.0,1.0,873.0,,,1.0,329.0,
TCGA-J2-A4AG,6282,TCGA-J2-A4AG,LUAD,66.0,FEMALE,WHITE,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2012.0,[Not Available],-24224.0,Alive,TUMOR FREE,988.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,988.0,0.0,988.0,0.0,988.0,0.0,988.0,
TCGA-CG-4449,9457,TCGA-CG-4449,STAD,81.0,MALE,[Not Available],Stage II,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2007.0,[Not Available],-29705.0,Alive,WITH TUMOR,580.0,,[Not Available],,,,336.0,Partial Remission/Response,,,0.0,580.0,0.0,580.0,,,1.0,336.0,
TCGA-Y8-A895,4703,TCGA-Y8-A895,KIRP,74.0,MALE,WHITE,Stage I,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2013.0,[Not Available],-27139.0,Alive,TUMOR FREE,484.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,484.0,0.0,484.0,0.0,484.0,0.0,484.0,
TCGA-DD-A4ND,5554,TCGA-DD-A4ND,LIHC,56.0,FEMALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G3,2007.0,[Not Available],-20782.0,Alive,TUMOR FREE,2746.0,,[Not Available],New Primary Tumor,"Other, specify",breast cancer,15.0,[Not Available],,R0,0.0,2746.0,0.0,2746.0,0.0,2746.0,1.0,15.0,
TCGA-ZT-A8OM,10475,TCGA-ZT-A8OM,THYM,73.0,FEMALE,WHITE,[Not Applicable],IIb,Thymoma; Type A,[Not Available],2011.0,[Not Available],-26923.0,Alive,TUMOR FREE,1398.0,,[Not Available],,,,,[Not Available],,,0.0,1398.0,0.0,1398.0,,,0.0,1398.0,
TCGA-EJ-5525,7937,TCGA-EJ-5525,PRAD,67.0,MALE,WHITE,[Not Applicable],[Not Applicable],Prostate Adenocarcinoma Acinar Type,[Not Available],2009.0,[Not Available],-24535.0,Alive,WITH TUMOR,1115.0,,[Not Available],Distant Metastasis,Bone,,546.0,Progressive Disease,,,0.0,1115.0,0.0,1115.0,,,1.0,546.0,
TCGA-DU-7302,5028,TCGA-DU-7302,LGG,48.0,FEMALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G3,2006.0,[Not Available],-17656.0,Alive,WITH TUMOR,1834.0,,[Not Available],,,,1374.0,Progressive Disease,,,0.0,1834.0,0.0,1834.0,,,1.0,1374.0,
TCGA-CV-A6JY,3600,TCGA-CV-A6JY,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2011.0,[Not Available],-25321.0,Alive,TUMOR FREE,646.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,646.0,0.0,646.0,,,0.0,646.0,
TCGA-NC-A5HR,6815,TCGA-NC-A5HR,LUSC,75.0,FEMALE,WHITE,Stage IIA,[Not Applicable],Lung Squamous Cell Carcinoma,[Not Available],2011.0,[Not Available],-27629.0,Alive,TUMOR FREE,1244.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1244.0,0.0,1244.0,0.0,1244.0,0.0,1244.0,
TCGA-B0-5121,4044,TCGA-B0-5121,KIRC,56.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2010.0,[Not Available],-20635.0,Alive,TUMOR FREE,1485.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1485.0,0.0,1485.0,0.0,1485.0,0.0,1485.0,
TCGA-VT-A80J,8769,TCGA-VT-A80J,SARC,49.0,FEMALE,WHITE,[Not Available],[Not Available],Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012.0,[Not Available],-17925.0,Alive,TUMOR FREE,796.0,,[Not Available],Distant Metastasis,"Other, specify",inguinal lymph node,355.0,[Not Available],Negative,R0,0.0,796.0,0.0,796.0,1.0,355.0,1.0,355.0,
TCGA-B6-A1KN,1016,TCGA-B6-A1KN,BRCA,57.0,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21183.0,Alive,TUMOR FREE,4233.0,,[Not Available],,,,,[Not Available],Negative,,0.0,4233.0,0.0,4233.0,0.0,4233.0,0.0,4233.0,
TCGA-JX-A3PZ,1793,TCGA-JX-A3PZ,CESC,25.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,1995.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9303.0,Dead,WITH TUMOR,,642.0,Cervical Cancer,Locoregional Recurrence,"Other, specify",Pelvis,491.0,Complete Remission/Response,,,1.0,642.0,1.0,642.0,1.0,491.0,1.0,491.0,
TCGA-E9-A229,1427,TCGA-E9-A229,BRCA,37.0,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13817.0,Alive,TUMOR FREE,1148.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1148.0,0.0,1148.0,0.0,1148.0,0.0,1148.0,
TCGA-E5-A2PC,232,TCGA-E5-A2PC,BLCA,61.0,FEMALE,WHITE,Stage IV,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,[Not Available],-22308.0,Alive,TUMOR FREE,1326.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1326.0,0.0,1326.0,,,0.0,1326.0,
TCGA-DG-A2KM,1675,TCGA-DG-A2KM,CESC,46.0,FEMALE,[Not Evaluated],[Not Available],Stage IB1,Cervical Squamous Cell Carcinoma,G2,2008.0,[Unknown],-16808.0,Alive,TUMOR FREE,1946.0,,,,,,,Complete Remission/Response,,,0.0,1946.0,0.0,1946.0,0.0,1946.0,0.0,1946.0,
TCGA-BG-A0RY,10755,TCGA-BG-A0RY,UCEC,68.0,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24952.0,Alive,TUMOR FREE,469.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,469.0,0.0,469.0,0.0,469.0,0.0,469.0,
TCGA-FG-7641,5111,TCGA-FG-7641,LGG,31.0,MALE,WHITE,[Not Available],[Not Available],Oligodendroglioma,G2,2011.0,[Not Available],-11357.0,Alive,TUMOR FREE,627.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,627.0,0.0,627.0,0.0,627.0,0.0,627.0,
TCGA-L5-A88Y,2535,TCGA-L5-A88Y,ESCA,76.0,MALE,WHITE,[Unknown],[Not Available],"Esophagus Adenocarcinoma, NOS",GX,2006.0,[Not Available],-28061.0,Alive,,11.0,,[Not Available],,,,,[Unknown],,,0.0,11.0,0.0,11.0,,,0.0,11.0,
TCGA-EY-A1GL,10951,TCGA-EY-A1GL,UCEC,51.0,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18761.0,Alive,TUMOR FREE,1014.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,1014.0,0.0,1014.0,0.0,1014.0,0.0,1014.0,
TCGA-EI-6509,8508,TCGA-EI-6509,READ,53.0,MALE,WHITE,Stage IIIC,[Not Applicable],Rectal Adenocarcinoma,[Not Available],2010.0,[Not Available],-19666.0,Alive,WITH TUMOR,517.0,,[Not Available],Metastatic,,,90.0,[Not Available],,,0.0,517.0,0.0,517.0,,,1.0,90.0,
TCGA-CS-5394,4918,TCGA-CS-5394,LGG,40.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2005.0,[Not Available],-14920.0,Alive,,8.0,,[Not Available],,,,,[Unknown],,,0.0,8.0,0.0,8.0,,,0.0,8.0,
TCGA-FG-A4MW,5123,TCGA-FG-A4MW,LGG,63.0,MALE,WHITE,[Not Available],[Not Available],Oligoastrocytoma,G3,2012.0,[Not Available],-23077.0,Dead,WITH TUMOR,,559.0,[Not Available],,,,226.0,Stable Disease,,,1.0,559.0,1.0,559.0,,,1.0,226.0,
TCGA-B5-A1MS,10716,TCGA-B5-A1MS,UCEC,60.0,FEMALE,WHITE,[Not Applicable],Stage IC,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22068.0,Dead,WITH TUMOR,,3112.0,[Not Available],Locoregional Recurrence,"Other, specify",Supraclavicular Fossa,2706.0,Partial Remission/Response,,,1.0,3112.0,1.0,3112.0,,,1.0,2706.0,
TCGA-DJ-A1QH,9933,TCGA-DJ-A1QH,THCA,58.0,FEMALE,WHITE,Stage III,[Not Applicable],Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010.0,[Not Available],-21184.0,Alive,WITH TUMOR,1293.0,,[Not Available],,,,,[Not Available],,R1,0.0,1293.0,0.0,1293.0,,,0.0,1293.0,
TCGA-5P-A9KH,4463,TCGA-5P-A9KH,KIRP,77.0,MALE,WHITE,[Not Available],[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2005.0,[Not Available],-28193.0,Alive,TUMOR FREE,2051.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2051.0,0.0,2051.0,0.0,2051.0,0.0,2051.0,
TCGA-EB-A431,8955,TCGA-EB-A431,SKCM,34.0,MALE,WHITE,Stage IIC,[Not Applicable],,[Not Available],2012.0,[Not Available],-12484.0,Alive,TUMOR FREE,568.0,,[Not Available],,,,,[Not Available],,,0.0,568.0,0.0,568.0,,,0.0,568.0,
TCGA-CG-5726,9479,TCGA-CG-5726,STAD,73.0,MALE,[Not Available],Stage IA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2004.0,[Not Available],-26998.0,Dead,TUMOR FREE,,881.0,[Not Available],,,,,[Not Available],,,1.0,881.0,0.0,881.0,,,0.0,881.0,
TCGA-2G-AAKG,9768,TCGA-2G-AAKG,TGCT,22.0,MALE,WHITE,Stage I,Stage I,Non-Seminoma; Embryonal Carcinoma,[Not Available],1996.0,[Not Available],-8353.0,Alive,TUMOR FREE,6598.0,,[Not Applicable],Locoregional Recurrence,Retroperitoneal lymph nodes,,122.0,Complete Remission/Response,,,0.0,6598.0,0.0,6598.0,1.0,122.0,1.0,122.0,
TCGA-91-7771,6222,TCGA-91-7771,LUAD,62.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-22926.0,Alive,TUMOR FREE,492.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,
TCGA-64-5815,6085,TCGA-64-5815,LUAD,74.0,MALE,WHITE,Stage IIB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2009.0,[Not Available],-27280.0,Alive,TUMOR FREE,866.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,866.0,0.0,866.0,0.0,866.0,0.0,866.0,
TCGA-RD-A8N5,9636,TCGA-RD-A8N5,STAD,78.0,MALE,WHITE,Stage IIIA,[Not Applicable],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2006.0,[Not Available],-28589.0,Dead,TUMOR FREE,,1747.0,"Other, non-malignant disease",,,,,Complete Remission/Response,,,1.0,1747.0,0.0,1747.0,0.0,1747.0,0.0,1747.0,
TCGA-DS-A1OB,1684,TCGA-DS-A1OB,CESC,45.0,FEMALE,WHITE,[Not Available],Stage IB,Cervical Squamous Cell Carcinoma,G2,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16685.0,Dead,WITH TUMOR,,861.0,Cervical Cancer,Distant Metastasis,Head & Neck,,652.0,Complete Remission/Response,,,1.0,861.0,1.0,861.0,1.0,652.0,1.0,652.0,
TCGA-BG-A3PP,10777,TCGA-BG-A3PP,UCEC,82.0,FEMALE,WHITE,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30227.0,Alive,WITH TUMOR,681.0,,[Not Available],Locoregional Recurrence,"Other, specify",Vagina apex,665.0,Progressive Disease,,,0.0,681.0,0.0,681.0,,,1.0,665.0,
TCGA-MT-A7BN,3702,TCGA-MT-A7BN,HNSC,74.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2013.0,[Not Available],-27162.0,Alive,WITH TUMOR,469.0,,[Not Available],Distant Metastasis,Distant Metastasis,lung,179.0,Progressive Disease,,,0.0,469.0,0.0,469.0,,,1.0,179.0,
TCGA-S2-AA1A,6324,TCGA-S2-AA1A,LUAD,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Lung Adenocarcinoma,[Not Available],2013.0,[Not Available],-24903.0,Alive,TUMOR FREE,513.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,513.0,0.0,513.0,0.0,513.0,0.0,513.0,
TCGA-QR-A708,7720,TCGA-QR-A708,PCPG,44.0,FEMALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2011.0,[Not Available],-16170.0,Alive,TUMOR FREE,35.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,35.0,0.0,35.0,0.0,35.0,0.0,35.0,
TCGA-QT-A5XM,7746,TCGA-QT-A5XM,PCPG,43.0,MALE,WHITE,[Not Available],[Not Available],Pheochromocytoma,[Not Available],2012.0,[Not Available],-15915.0,Alive,TUMOR FREE,22.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,22.0,0.0,22.0,0.0,22.0,0.0,22.0,
TCGA-OR-A5JV,30,TCGA-OR-A5JV,ACC,55.0,MALE,WHITE,Stage II,[Not Applicable],Adrenocortical carcinoma- Usual Type,[Not Available],2008.0,[Not Available],-20319.0,Alive,TUMOR FREE,2023.0,,[Not Available],New Primary Tumor,Lymph Node(s),,953.0,Complete Remission/Response,,,0.0,2023.0,0.0,2023.0,0.0,2023.0,1.0,953.0,
TCGA-QK-AA3K,3737,TCGA-QK-AA3K,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,[Not Available],-22093.0,Alive,,253.0,,[Not Available],,,,,[Unknown],,,0.0,253.0,0.0,253.0,,,0.0,253.0,
TCGA-CS-6666,4926,TCGA-CS-6666,LGG,22.0,MALE,WHITE,[Not Available],[Not Available],Astrocytoma,G3,2010.0,[Not Available],-8340.0,Alive,TUMOR FREE,1428.0,,[Not Available],,,,,Stable Disease,,,0.0,1428.0,0.0,1428.0,,,0.0,1428.0,
TCGA-FV-A2QQ,5690,TCGA-FV-A2QQ,LIHC,80.0,MALE,WHITE,Stage I,[Not Applicable],Hepatocellular Carcinoma,G2,2011.0,[Not Available],-29354.0,Alive,TUMOR FREE,729.0,,[Not Available],,,,,[Not Available],,R0,0.0,729.0,0.0,729.0,0.0,729.0,0.0,729.0,
TCGA-AC-A3YJ,784,TCGA-AC-A3YJ,BRCA,66.0,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24439.0,Alive,TUMOR FREE,754.0,,[Not Available],,,,,[Not Available],Negative,,0.0,754.0,0.0,754.0,0.0,754.0,0.0,754.0,
TCGA-91-8496,6223,TCGA-91-8496,LUAD,63.0,FEMALE,WHITE,Stage IB,[Not Applicable],Lung Adenocarcinoma,[Not Available],2011.0,[Not Available],-23358.0,Alive,TUMOR FREE,505.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,505.0,0.0,505.0,0.0,505.0,0.0,505.0,
TCGA-D3-A51F,8868,TCGA-D3-A51F,SKCM,51.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2009.0,[Not Available],-18776.0,Alive,TUMOR FREE,1695.0,,[Not Available],,,,,[Not Available],,,0.0,1695.0,0.0,1695.0,,,0.0,1695.0,
TCGA-V4-A9E7,11085,TCGA-V4-A9E7,UVM,76.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,[Not Available],2011.0,[Not Available],-28025.0,Dead,WITH TUMOR,,415.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,,35.0,[Not Available],,,1.0,415.0,1.0,415.0,,,1.0,35.0,
TCGA-K4-A3WV,374,TCGA-K4-A3WV,BLCA,77.0,FEMALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,[Not Available],-28444.0,Alive,TUMOR FREE,646.0,,[Not Available],,,,,[Not Applicable],,,0.0,646.0,0.0,646.0,,,0.0,646.0,
TCGA-B0-5096,4026,TCGA-B0-5096,KIRC,72.0,FEMALE,WHITE,Stage III,[Not Applicable],Kidney Clear Cell Renal Carcinoma,GX,1998.0,[Not Available],-26574.0,Dead,TUMOR FREE,,68.0,[Not Available],,,,,[Not Available],,,1.0,68.0,0.0,68.0,,,0.0,68.0,
TCGA-EE-A29Q,9017,TCGA-EE-A29Q,SKCM,70.0,FEMALE,WHITE,Stage IIB,[Not Applicable],,[Not Available],2007.0,[Not Available],-25847.0,Dead,WITH TUMOR,,2030.0,[Not Available],Regional lymph node|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Locoregional Recurrence|Distant Metastasis,"[Not Available]|Other, Specify|Other, Specify|Lung|Bone|[Not Available]|Brain",[Not Applicable]|mediastinal lymph nodes|adrenal|[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable],1256.0,[Not Available],,,1.0,2030.0,1.0,2030.0,,,1.0,1256.0,
TCGA-BH-A0BJ,1045,TCGA-BH-A0BJ,BRCA,41.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15027.0,Alive,TUMOR FREE,660.0,,[Not Available],,,,,[Not Available],Negative,,0.0,660.0,0.0,660.0,0.0,660.0,0.0,660.0,
TCGA-AR-A24W,945,TCGA-AR-A24W,BRCA,55.0,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20123.0,Alive,TUMOR FREE,1550.0,,[Not Available],,,,,[Not Available],Negative,,0.0,1550.0,0.0,1550.0,0.0,1550.0,0.0,1550.0,
TCGA-CR-5248,3418,TCGA-CR-5248,HNSC,53.0,MALE,WHITE,[Not Available],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2006.0,[Not Available],-19441.0,Alive,WITH TUMOR,1663.0,,[Not Available],,Cervical Lymph Nodes,,936.0,Complete Remission/Response,,,0.0,1663.0,0.0,1663.0,,,1.0,936.0,
TCGA-BP-4992,4224,TCGA-BP-4992,KIRC,66.0,MALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G4,2007.0,[Not Available],-24438.0,Alive,TUMOR FREE,501.0,,[Not Available],,,,,[Not Available],,,0.0,501.0,0.0,501.0,,,0.0,501.0,
TCGA-GN-A269,9199,TCGA-GN-A269,SKCM,70.0,MALE,WHITE,Stage IIIC,[Not Applicable],,[Not Available],2006.0,[Not Available],-25583.0,Dead,WITH TUMOR,,170.0,[Not Available],,,,,[Not Available],,,1.0,170.0,1.0,170.0,,,1.0,170.0,
TCGA-B0-5695,4053,TCGA-B0-5695,KIRC,61.0,FEMALE,WHITE,Stage I,[Not Applicable],Kidney Clear Cell Renal Carcinoma,G2,2007.0,[Not Available],-22320.0,Alive,TUMOR FREE,2150.0,,[Not Available],,,,,Complete Remission/Response,,,0.0,2150.0,0.0,2150.0,0.0,2150.0,0.0,2150.0,
TCGA-FD-A62P,293,TCGA-FD-A62P,BLCA,76.0,MALE,WHITE,Stage II,[Not Applicable],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,[Not Available],-27843.0,Dead,WITH TUMOR,,191.0,[Not Available],,,,,[Not Applicable],,,1.0,191.0,1.0,191.0,,,1.0,191.0,
